"reads_downloaded_1_1","mapped_read_count_1_1","auc_1_1","bigwig_file_1_1","gdc_cases.case_id_1_1","gdc_file_id_1_1","gdc_updated_datetime_1_1","gdc_file_name_1_1","gdc_submitter_id_1_1","gdc_file_size_1_1","gdc_platform_1_1","gdc_md5sum_1_1","gdc_data_format_1_1","gdc_center.code_1_1","gdc_center.name_1_1","gdc_center.short_name_1_1","gdc_center.center_id_1_1","gdc_center.namespace_1_1","gdc_metadata_files.updated_datetime.analysis_1_1","gdc_metadata_files.created_datetime.analysis_1_1","gdc_metadata_files.file_name.analysis_1_1","gdc_metadata_files.md5sum.analysis_1_1","gdc_metadata_files.file_id.analysis_1_1","gdc_metadata_files.file_size.analysis_1_1","gdc_metadata_files.updated_datetime.experiment_1_1","gdc_metadata_files.file_name.experiment_1_1","gdc_metadata_files.md5sum.experiment_1_1","gdc_metadata_files.file_id.experiment_1_1","gdc_metadata_files.file_size.experiment_1_1","gdc_metadata_files.updated_datetime.run_1_1","gdc_metadata_files.file_name.run_1_1","gdc_metadata_files.md5sum.run_1_1","gdc_metadata_files.file_id.run_1_1","gdc_metadata_files.file_size.run_1_1","gdc_cases.updated_datetime_1_1","gdc_cases.submitter_id_1_1","gdc_cases.demographic.updated_datetime_1_1","gdc_cases.demographic.gender_1_1","gdc_cases.demographic.submitter_id_1_1","gdc_cases.demographic.year_of_birth_1_1","gdc_cases.demographic.race_1_1","gdc_cases.demographic.demographic_id_1_1","gdc_cases.demographic.ethnicity_1_1","gdc_cases.demographic.year_of_death_1_1","gdc_cases.project.name_1_1","gdc_cases.project.primary_site_1_1","gdc_cases.project.project_id_1_1","gdc_cases.tissue_source_site.project_1_1","gdc_cases.tissue_source_site.bcr_id_1_1","gdc_cases.tissue_source_site.code_1_1","gdc_cases.tissue_source_site.tissue_source_site_id_1_1","gdc_cases.tissue_source_site.name_1_1","gdc_cases.diagnoses.classification_of_tumor_1_1","gdc_cases.diagnoses.primary_diagnosis_1_1","gdc_cases.diagnoses.submitter_id_1_1","gdc_cases.diagnoses.tumor_stage_1_1","gdc_cases.diagnoses.age_at_diagnosis_1_1","gdc_cases.diagnoses.vital_status_1_1","gdc_cases.diagnoses.morphology_1_1","gdc_cases.diagnoses.days_to_death_1_1","gdc_cases.diagnoses.days_to_last_follow_up_1_1","gdc_cases.diagnoses.diagnosis_id_1_1","gdc_cases.diagnoses.tissue_or_organ_of_origin_1_1","gdc_cases.diagnoses.days_to_birth_1_1","gdc_cases.diagnoses.treatments.submitter_id_1_1","gdc_cases.diagnoses.treatments.treatment_id_1_1","gdc_cases.samples.sample_type_id_1_1","gdc_cases.samples.oct_embedded_1_1","gdc_cases.samples.submitter_id_1_1","gdc_cases.samples.intermediate_dimension_1_1","gdc_cases.samples.sample_id_1_1","gdc_cases.samples.is_ffpe_1_1","gdc_cases.samples.pathology_report_uuid_1_1","gdc_cases.samples.sample_type_1_1","gdc_cases.samples.shortest_dimension_1_1","gdc_cases.samples.days_to_collection_1_1","gdc_cases.samples.initial_weight_1_1","gdc_cases.samples.longest_dimension_1_1","gdc_cases.samples.portions.creation_datetime_1_1","gdc_cases.samples.portions.portion_number_1_1","gdc_cases.samples.portions.weight_1_1","gdc_cases.samples.portions.submitter_id_1_1","gdc_cases.samples.portions.slides_percent_tumor_nuclei_1","gdc_cases.samples.portions.slides_percent_tumor_nuclei_2","gdc_cases.samples.portions.slides_percent_monocyte_infiltration_1","gdc_cases.samples.portions.slides_percent_monocyte_infiltration_2","gdc_cases.samples.portions.slides_percent_normal_cells_1","gdc_cases.samples.portions.slides_percent_normal_cells_2","gdc_cases.samples.portions.slides_percent_stromal_cells_1","gdc_cases.samples.portions.slides_percent_stromal_cells_2","gdc_cases.samples.portions.slides_updated_datetime_1","gdc_cases.samples.portions.slides_updated_datetime_2","gdc_cases.samples.portions.slides_percent_lymphocyte_infiltration_1","gdc_cases.samples.portions.slides_percent_lymphocyte_infiltration_2","gdc_cases.samples.portions.slides_percent_neutrophil_infiltration_1","gdc_cases.samples.portions.slides_percent_neutrophil_infiltration_2","gdc_cases.samples.portions.slides_section_location_1","gdc_cases.samples.portions.slides_section_location_2","gdc_cases.samples.portions.slides_percent_necrosis_1","gdc_cases.samples.portions.slides_percent_necrosis_2","gdc_cases.samples.portions.slides_slide_id_1","gdc_cases.samples.portions.slides_slide_id_2","gdc_cases.samples.portions.slides_submitter_id_1","gdc_cases.samples.portions.slides_submitter_id_2","gdc_cases.samples.portions.slides_percent_tumor_cells_1","gdc_cases.samples.portions.slides_percent_tumor_cells_2","gdc_cases.samples.portions.portion_id_1_1","gdc_cases.samples.portions.analytes.analyte_type_1_1","gdc_cases.samples.portions.analytes.submitter_id_1_1","gdc_cases.samples.portions.analytes.analyte_id_1_1","gdc_cases.samples.portions.analytes.a260_a280_ratio_1_1","gdc_cases.samples.portions.analytes.concentration_1_1","gdc_cases.samples.portions.analytes.spectrophotometer_method_1_1","gdc_cases.samples.portions.analytes.analyte_type_id_1_1","gdc_cases.samples.portions.analytes.aliquots.source_center_1_1","gdc_cases.samples.portions.analytes.aliquots.submitter_id_1_1","gdc_cases.samples.portions.analytes.aliquots.aliquot_id_1_1","gdc_cases.samples.portions.analytes.aliquots.concentration_1_1","gdc_cases.exposures.cigarettes_per_day_1_1","gdc_cases.exposures.weight_1_1","gdc_cases.exposures.bmi_1_1","gdc_cases.exposures.height_1_1","gdc_cases.exposures.exposure_id_1_1","gdc_cases.exposures.submitter_id_1_1","cgc_filename_1_1","cgc_file_upload_date_1_1","cgc_file_last_modified_date_1_1","cgc_file_submitter_id_1_1","cgc_file_sample_1_1","cgc_file_data_subtype_1_1","cgc_file_size_1_1","cgc_file_access_level_1_1","cgc_file_platform_1_1","cgc_file_investigation_1_1","cgc_file_experimental_strategy_1_1","cgc_file_data_type_1_1","cgc_file_aliquot_1_1","cgc_file_data_submitting_center_1_1","cgc_file_file_id_1_1","cgc_file_case_1_1","cgc_file_disease_type_1_1","cgc_file_data_format_1_1","cgc_file_portion_1_1","cgc_file_published_date_1_1","cgc_file_analyte_1_1","cgc_sample_country_of_sample_procurement_1_1","cgc_sample_is_ffpe_1_1","cgc_sample_sample_type_code_1_1","cgc_sample_shortest_dimension_1_1","cgc_sample_sample_type_1_1","cgc_sample_tissue_source_site_1_1","cgc_sample_days_to_collection_1_1","cgc_sample_portion_1_1","cgc_sample_intermediate_dimension_1_1","cgc_sample_tissue_source_site_code_1_1","cgc_sample_file_1_1","cgc_sample_initial_weight_1_1","cgc_sample_id_1_1","cgc_sample_longest_dimension_1_1","cgc_case_drug_therapy_1_1","cgc_case_program_1_1","cgc_case_year_of_diagnosis_1_1","cgc_case_new_tumor_event_1_1","cgc_case_primary_therapy_outcome_success_1_1","cgc_case_tumor_status_1_1","cgc_case_sample_1_1","cgc_case_age_at_diagnosis_1_1","cgc_case_file_1_1","cgc_case_vital_status_1_1","cgc_case_days_to_death_1_1","cgc_case_id_1_1","cgc_case_ethnicity_1_1","cgc_case_follow_up_1_1","cgc_case_new_tumor_event_after_initial_treatment_1_1","cgc_case_days_to_last_follow_up_1_1","cgc_case_prior_diagnosis_1_1","cgc_case_primary_site_1_1","cgc_case_icd_o3site_1_1","cgc_case_pathologic_n_1_1","cgc_case_histological_diagnosis_1_1","cgc_case_performance_status_score_ecog_1_1","cgc_case_performance_status_score_timing_1_1","cgc_case_clinical_stage_1_1","cgc_case_pathologic_stage_1_1","cgc_case_performance_status_score_karnofsky_1_1","cgc_case_pathologic_t_1_1","cgc_case_icd_o3histology_1_1","cgc_case_gender_1_1","cgc_case_icd10_1_1","cgc_case_batch_number_1_1","cgc_case_clinical_m_1_1","cgc_case_radiation_therapy_1_1","cgc_case_race_1_1","cgc_case_clinical_t_1_1","cgc_portion_portion_number_1_1","cgc_portion_weight_1_1","cgc_portion_slide_1_1","cgc_portion_analyte_1_1","cgc_portion_file_1_1","cgc_portion_id_1_1","cgc_slide_percent_tumor_nuclei_1_1","cgc_slide_percent_normal_cells_1_1","cgc_slide_percent_monocyte_infiltration_1_1","cgc_slide_percent_lymphocyte_infiltration_1_1","cgc_slide_percent_stromal_cells_1_1","cgc_slide_section_location_1_1","cgc_slide_percent_necrosis_1_1","cgc_slide_percent_neutrophil_infiltration_1_1","cgc_slide_id_1_1","cgc_slide_percent_tumor_cells_1_1","cgc_drug_therapy_drug_name_1_1","cgc_drug_therapy_pharmaceutical_therapy_type_1_1","cgc_drug_therapy_id_1_1","cgc_radiation_therapy_id_1_1","cgc_radiation_therapy_radiation_type_1_1","cgc_radiation_therapy_radiation_therapy_site_1_1","cgc_follow_up_new_tumor_event_1_1","cgc_follow_up_new_tumor_event_after_initial_treatment_1_1","cgc_follow_up_days_to_last_follow_up_1_1","cgc_follow_up_tumor_status_1_1","cgc_follow_up_vital_status_1_1","cgc_follow_up_days_to_death_1_1","cgc_follow_up_id_1_1","xml_bcr_patient_barcode_1_1","xml_additional_studies_1_1","xml_tissue_source_site_1_1","xml_patient_id_1_1","xml_informed_consent_verified_1_1","xml_icd_o_3_site_1_1","xml_icd_o_3_histology_1_1","xml_icd_10_1_1","xml_tissue_prospective_collection_indicator_1_1","xml_tissue_retrospective_collection_indicator_1_1","xml_days_to_birth_1_1","xml_gender_1_1","xml_race_list_1_1","xml_ethnicity_1_1","xml_other_dx_1_1","xml_history_of_neoadjuvant_treatment_1_1","xml_vital_status_1_1","xml_days_to_last_followup_1_1","xml_days_to_death_1_1","xml_radiation_therapy_1_1","xml_postoperative_rx_tx_1_1","xml_person_neoplasm_cancer_status_1_1","xml_has_new_tumor_events_information_1_1","xml_day_of_form_completion_1_1","xml_month_of_form_completion_1_1","xml_year_of_form_completion_1_1","xml_has_follow_ups_information_1_1","xml_has_drugs_information_1_1","xml_has_radiations_information_1_1","xml_primary_pathology_days_to_initial_pathologic_diagnosis_1_1","xml_primary_pathology_age_at_initial_pathologic_diagnosis_1_1","xml_primary_pathology_year_of_initial_pathologic_diagnosis_1_1","xml_tumor_tissue_site_1_1","xml_histological_type_1_1","xml_anatomic_neoplasm_subdivision_1_1","xml_days_to_initial_pathologic_diagnosis_1_1","xml_age_at_initial_pathologic_diagnosis_1_1","xml_year_of_initial_pathologic_diagnosis_1_1","xml_initial_pathologic_diagnosis_method_1_1","xml_primary_lymph_node_presentation_assessment_1_1","xml_lymph_node_examined_count_1_1","xml_number_of_lymphnodes_positive_by_he_1_1","xml_neoplasm_histologic_grade_1_1","xml_residual_tumor_1_1","xml_tobacco_smoking_history_1_1","xml_stopped_smoking_year_1_1","xml_number_pack_years_smoked_1_1","xml_targeted_molecular_therapy_1_1","xml_primary_therapy_outcome_success_1_1","xml_stage_event_system_version_1_1","xml_stage_event_clinical_stage_1_1","xml_stage_event_pathologic_stage_1_1","xml_stage_event_tnm_categories_1_1","xml_kras_gene_analysis_performed_1_1","xml_karnofsky_performance_score_1_1","xml_eastern_cancer_oncology_group_1_1","xml_performance_status_scale_timing_1_1","xml_laterality_1_1","xml_menopause_status_1_1","xml_anatomic_neoplasm_subdivisions_1_1","xml_breast_carcinoma_surgical_procedure_name_1_1","xml_breast_carcinoma_progesterone_receptor_status_1_1","xml_margin_status_1_1","xml_breast_carcinoma_estrogen_receptor_status_1_1","xml_diagnosis_1_1"
267257936,257583701,19026607762,"6374E253-2CE1-4CE1-B6E9-9302A951533D.bw","005a6517-2e5a-4ea3-ab36-531522723607","6374e253-2ce1-4ce1-b6e9-9302a951533d","2016-09-29T20:10:29.960604-05:00","TCGA-61-1740-01A-01R-1567-13_rnaseq_fastq.tar","8f018793-a1ee-42ca-8810-58562b0dff18",17741998080,"Illumina HiSeq","569b7be9846bb613da92342adac871bc","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:09:29.680796-05:00","2016-05-03T11:41:05.748550-05:00","8f018793-a1ee-42ca-8810-58562b0dff18_analysis.xml","887e3efacbbc0665cf2fbd90c7fc58b3","f76296cb-6d6d-4d44-b7b9-aaaa4f43e9e3",2181,"2016-09-29T22:36:53.044080-05:00","8f018793-a1ee-42ca-8810-58562b0dff18_experiment.xml","c7fcc69e3c37ac47ef1229a3ad5427f3","bdfbaf60-97cc-4ff9-b93b-1c719c547303",3916,"2016-09-29T22:26:38.745404-05:00","8f018793-a1ee-42ca-8810-58562b0dff18_run.xml","28d8007ea095d99b7dcd547553599009","b79b0cf0-63dd-4ea3-b4b8-d5dee29f3691",1989,"2016-09-08T11:05:04.372719-05:00","TCGA-61-1740","2016-09-02T18:47:48.405605-05:00","female","TCGA-61-1740_demographic",1934,"white","e5fbcd98-33f9-575e-880d-cb5bb82420cb","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1740_diagnosis","not reported",26169,"dead","8441/3",74,74,"6bce9673-5223-59f5-b869-2366b5e46652","c56.9",-26169,"TCGA-61-1740_treatment","cb2dc0c4-bd49-58f3-aa30-fc5f15c8fd08","01",NA,"TCGA-61-1740-01A","0.4","ac9c5b5e-8e14-4a76-a68d-78a8349c40f7",FALSE,"b87690ba-0cd2-458e-938f-553cd5ab6d84","Primary Tumor","0.3",NA,NA,"0.6",1242518400,"01",112,"TCGA-61-1740-01A-01",85,90,NA,NA,0,0,0,0,"2016-09-08T11:05:04.372719-05:00","2016-09-08T11:05:04.372719-05:00",10,5,NA,NA,"TOP","BOTTOM",2,2,"883377e3-85ad-4319-9b4e-448f3b856bcf","5fb2819b-b403-4623-86da-ae6f66b43aa7","TCGA-61-1740-01A-01-TS1","TCGA-61-1740-01A-01-BS1",98,98,"9c36986a-d488-434b-a9f3-5fb27b02791c","RNA","TCGA-61-1740-01A-01R","6dcf8c4b-2243-46b8-a230-4bb889836203",1.8,0.15,"UV Spec","R","22","TCGA-61-1740-01A-01R-1567-13","e7825482-380d-4323-a4fb-d11b365c7073",0.15,NA,NA,NA,NA,"0609ac08-3b1c-5048-8261-f1b3905705dd","TCGA-61-1740_exposure","TCGA-61-1740-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T01:47:26.000Z","2014-03-29T02:21:01.000Z","8F018793-A1EE-42CA-8810-58562B0DFF18","AC9C5B5E-8E14-4A76-A68D-78A8349C40F7","Unaligned reads",17741998080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E7825482-380D-4323-A4FB-D11B365C7073","Canada's Michael Smith Genome Sciences Centre","564a59c0e4b09c884b2735f4","005A6517-2E5A-4EA3-AB36-531522723607","Ovarian Serous Cystadenocarcinoma","TAR","9C36986A-D488-434B-A9F3-5FB27B02791C","2014-03-29T02:21:01.000Z","6DCF8C4B-2243-46B8-A230-4BB889836203","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"9C36986A-D488-434B-A9F3-5FB27B02791C",0.4,"61","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_B03_495160.hg18.seg.txt",NA,"TCGA-61-1740-01A",0.6,"BC6D55FE-44ED-4FF5-92AE-80281EDFCB66","TCGA",2005,NA,NA,"WITH TUMOR","AD48908E-5088-4386-A9B5-4912DA72F84E",71,"4828606006_F_Red.idat","Dead",74,"TCGA-61-1740","NOT HISPANIC OR LATINO","0E3413D9-8C58-4AC6-A310-028165E36DCD",NA,74,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",3,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,112,"883377E3-85AD-4319-9B4E-448F3B856BCF","B3940F2C-653A-48BA-91FE-AE77705F574A","bcgsc.ca.TCGA-61-1740-01A-01R-1567-13.hg19.bcgsc.ca.1.6.0.indel.vcf","TCGA-61-1740-01A-01",85,0,NA,10,0,"TOP",2,NA,"TCGA-61-1740-01A-01-TS1",98,"Tamoxifen","Hormone Therapy","TCGA-61-1740-D28199",NA,NA,NA,NA,NA,74,"WITH TUMOR","Dead",74,"TCGA-61-1740-F28198","TCGA-61-1740",NA,"61","1740","YES","C56.9","8441/3","C56.9",NA,NA,-26169,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",74,74,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,71,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,3,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
119840236,102050058,7359557548,"8839B692-AC8F-4A1D-B94B-473B1BBF448B.bw","01ea6354-137b-47f3-9021-a01a382b1147","8839b692-ac8f-4a1d-b94b-473b1bbf448b","2016-08-21T10:18:47.735140-05:00","TCGA-29-1766-01A-01R-1567-13_rnaseq_fastq.tar","be30f131-63c9-4a43-b1a1-3016a7ba76e3",7300741120,"Illumina HiSeq","602ad865f83524639a2dbb72bfb28f27","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:18:53.781637-05:00","2016-05-03T11:41:05.755204-05:00","be30f131-63c9-4a43-b1a1-3016a7ba76e3_analysis.xml","19f1c5ce18def9376ac22edc92a279ac","d7ef1940-f18e-43bd-853e-64239de94164",2242,"2016-09-29T22:31:22.063746-05:00","be30f131-63c9-4a43-b1a1-3016a7ba76e3_experiment.xml","e27970f9bbc35fa998c8f4436bf19ee4","ba9724a3-862b-483d-9154-129b23145aaa",3916,"2016-09-29T21:14:40.402986-05:00","be30f131-63c9-4a43-b1a1-3016a7ba76e3_run.xml","c2b03e97ff23c3dc7fd8db64b5ae0bb4","8b404f1d-d621-43a1-b74f-494ccb91b932",1990,"2016-09-08T13:04:23.513536-05:00","TCGA-29-1766","2016-09-02T19:07:42.407914-05:00","female","TCGA-29-1766_demographic",1932,"white","e3cac892-2a78-5c30-b392-1ef7da8a05b6","not reported",2009,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c48.2","TCGA-29-1766_diagnosis","not reported",27359,"dead","8441/3",1199,1190,"c3f472b3-884c-5a6a-b8ef-99c8a29a6b21","c48.2",-27359,"TCGA-29-1766_treatment","cf6cb64c-8c40-5221-a2f2-68d7d527e0e5","01",NA,"TCGA-29-1766-01A","0.5","d3a81bab-cce2-48b3-8eb8-9ef9766af108",FALSE,"fc0a444e-3618-459a-a3ee-58ec9e7e1084","Primary Tumor","0.4",NA,NA,"1.3",1243296000,"01",104,"TCGA-29-1766-01A-01",90,90,NA,NA,0,0,50,40,"2016-09-08T13:04:23.513536-05:00","2016-09-08T13:04:23.513536-05:00",NA,2,NA,NA,"BOTTOM","TOP",10,5,"6edc8a3d-a3a8-44b5-8c3e-ed9021de767b","b06eb26c-0803-4278-b5bb-8a23e94145e0","TCGA-29-1766-01A-01-BS1","TCGA-29-1766-01A-01-TS1",40,55,"6f41211d-0473-42b4-af68-67bae746ec31","RNA","TCGA-29-1766-01A-01R","e2bb7dda-497f-49ce-9b78-6692a004f7db",1.8,0.13,"UV Spec","R","22","TCGA-29-1766-01A-01R-1567-13","fb381f7f-a327-49e1-a13a-bca5a06047d3",0.13,NA,NA,NA,NA,"aeae204c-2a27-5464-92c6-767b7b9d15ac","TCGA-29-1766_exposure","TCGA-29-1766-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T08:04:17.000Z","2014-03-27T08:19:02.000Z","BE30F131-63C9-4A43-B1A1-3016A7BA76E3","D3A81BAB-CCE2-48B3-8EB8-9EF9766AF108","Unaligned reads",7300741120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FB381F7F-A327-49E1-A13A-BCA5A06047D3","Canada's Michael Smith Genome Sciences Centre","564a5bffe4b09c884b27bd9c","01EA6354-137B-47F3-9021-A01A382B1147","Ovarian Serous Cystadenocarcinoma","TAR","6F41211D-0473-42B4-AF68-67BAE746EC31","2014-03-27T08:19:02.000Z","E2BB7DDA-497F-49CE-9B78-6692A004F7DB","None","NO",1,0.4,"Primary Tumor","Duke",NA,"6F41211D-0473-42B4-AF68-67BAE746EC31",0.5,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.dd8951d2-5b83-4b78-9b04-52d474639e2f.txt",NA,"TCGA-29-1766-01A",1.3,"EF80A8AF-4328-4FE3-8E92-D75F92C1B8F2","TCGA",2006,NA,NA,"WITH TUMOR","D3A81BAB-CCE2-48B3-8EB8-9EF9766AF108",74,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.dd8951d2-5b83-4b78-9b04-52d474639e2f.txt","Dead",1199,"TCGA-29-1766",NA,"043A6F1D-D0C2-411A-937D-9E5C790ED4AD",NA,1190,NA,"Ovary","C48.2",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C48.2",18,NA,NA,"WHITE",NA,1,104,"B06EB26C-0803-4278-B5BB-8A23E94145E0","EC029558-D4B4-48B0-9DCE-A41AFED8ED42","TCGA-29-1766-01A-01R-1567-13_mirna.bam.bai","TCGA-29-1766-01A-01",90,0,NA,NA,50,"BOTTOM",10,NA,"TCGA-29-1766-01A-01-BS1",40,"Paclitaxel","Chemotherapy","TCGA-29-1766-D27353",NA,NA,NA,"TCGA-29-1766-F27350_NTE-1",NA,1190,"WITH TUMOR","Dead",1199,"TCGA-29-1766-F27350","TCGA-29-1766",NA,"29","1766","YES","C48.2","8441/3","C48.2",NA,NA,-27359,"FEMALE","WHITE",NA,NA,"No","Dead",1190,1199,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Peritoneum ovary","Serous Cystadenocarcinoma","Right",0,74,2006,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
268488884,261735954,19374581295,"D22B2633-C1CF-4E5E-A3AC-983ABA7776F3.bw","02594e5e-8751-47c1-9245-90c66984b665","d22b2633-c1cf-4e5e-a3ac-983aba7776f3","2016-08-26T14:56:46.521970-05:00","TCGA-09-2051-01A-01R-1568-13_rnaseq_fastq.tar","b1ee72e2-7879-4f61-a453-f26ddfbaa0e1",17278648320,"Illumina HiSeq","be96efe037664a5845839bfc97d91c4d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:38:40.114306-05:00","2016-05-03T11:41:05.748550-05:00","b1ee72e2-7879-4f61-a453-f26ddfbaa0e1_analysis.xml","a5fe2227dafd78d939c83c7570e4209c","4fdee942-7b7f-487c-b9bf-d8b6484ea95e",2181,"2016-09-29T19:16:42.471548-05:00","b1ee72e2-7879-4f61-a453-f26ddfbaa0e1_experiment.xml","c619e5c11aef9a95b8edb3160282816a","423077c8-ddde-4057-b540-feeeee98de4c",3916,"2016-09-29T17:48:44.714630-05:00","b1ee72e2-7879-4f61-a453-f26ddfbaa0e1_run.xml","a37fac0826dd43b1ae638cbdb89e34df","0ae35b36-fd32-418d-9ff2-0258d03498ac",1989,"2016-09-08T13:38:23.048696-05:00","TCGA-09-2051","2016-09-02T19:11:58.538605-05:00","female","TCGA-09-2051_demographic",1962,"white","d24768bc-31cf-5dee-8acb-c094538cc104","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2051_diagnosis","not reported",15650,"alive","8441/3",NA,1919,"1d60ab6b-010d-5421-9e30-11b38b71be6e","c56.9",-15650,"TCGA-09-2051_treatment","016cc344-a106-5152-a0c4-a64a22a43942","01",NA,"TCGA-09-2051-01A","0.7","c46d2ade-620c-44a6-93ba-8edda9909c1b",FALSE,"242a1ff3-05ad-4623-b5aa-9bb556e2cfa9","Primary Tumor","0.3",NA,NA,"0.8",1248134400,"01",100,"TCGA-09-2051-01A-01",99,98,NA,NA,0,0,5,10,"2016-09-08T13:38:23.048696-05:00","2016-09-08T13:38:23.048696-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"15f52287-f11d-4aff-baa0-407a7db6113f","09cb2b86-223c-4012-aea0-0fb939abfd46","TCGA-09-2051-01A-01-BS1","TCGA-09-2051-01A-01-TS1",95,90,"7a705344-8abe-4ae6-ba0c-3a4c8a16c229","RNA","TCGA-09-2051-01A-01R","a8879098-49c1-49f9-a24f-83e936e630be",1.8,0.14,"UV Spec","R","22","TCGA-09-2051-01A-01R-1568-13","6bc296b8-ac74-4ff9-872d-5f7e4a3d011a",0.14,NA,NA,NA,NA,"7fa9ef18-0a93-5ba1-9d50-f4916029c1db","TCGA-09-2051_exposure","TCGA-09-2051-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-29T06:35:20.000Z","2014-03-29T07:02:02.000Z","B1EE72E2-7879-4F61-A453-F26DDFBAA0E1","C46D2ADE-620C-44A6-93BA-8EDDA9909C1B","Unaligned reads",17278648320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6BC296B8-AC74-4FF9-872D-5F7E4A3D011A","Canada's Michael Smith Genome Sciences Centre","564a5933e4b08c5d86947fcd","02594E5E-8751-47C1-9245-90C66984B665","Ovarian Serous Cystadenocarcinoma","TAR","7A705344-8ABE-4AE6-BA0C-3A4C8A16C229","2014-03-29T07:02:02.000Z","A8879098-49C1-49F9-A24F-83E936E630BE","None","NO",1,0.3,"Primary Tumor","UCSF",NA,"7A705344-8ABE-4AE6-BA0C-3A4C8A16C229",0.7,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5bcc9755-b429-47c1-9a00-af84edd803aa.txt",NA,"TCGA-09-2051-01A",0.8,"AED478EC-3AE2-4C26-9734-8D6A57A957F5","TCGA",2004,NA,NA,"TUMOR FREE","C46D2ADE-620C-44A6-93BA-8EDDA9909C1B",42,"TCGA-09-2051-01A-01R-1568-13.mirna.quantification.txt","Alive",NA,"TCGA-09-2051","NOT HISPANIC OR LATINO","94294882-49EF-4A27-9A2A-03646C87209D",NA,1919,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,100,"15F52287-F11D-4AFF-BAA0-407A7DB6113F","C008FC33-B5B9-4EC7-8CAD-E411CCEFB08C","1457.CEL","TCGA-09-2051-01A-01",98,0,NA,NA,10,"TOP",0,NA,"TCGA-09-2051-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-09-2051-D24381",NA,NA,NA,"TCGA-09-2051-F24373_NTE-2",NA,1919,"TUMOR FREE","Alive",NA,"TCGA-09-2051-F24373","TCGA-09-2051",NA,"09","2051","YES","C56.9","8441/3","C56.9",NA,NA,-15650,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1919,NA,NA,NA,"TUMOR FREE","NO",3,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,42,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
206931338,202287705,14987442395,"5AE9ED6D-65A9-4C7F-94D7-4ED96D2AB3E9.bw","02d9aa2e-b16a-48ea-a420-5daed9fd51a6","5ae9ed6d-65a9-4c7f-94d7-4ed96d2ab3e9","2016-09-29T19:56:20.145746-05:00","TCGA-24-1427-01A-01R-1565-13_rnaseq_fastq.tar","c4601520-f5d4-4858-bf25-9e841402b2f9",13016678400,"Illumina HiSeq","c3d67e1f28119b4969b724659ff09f2a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:45:09.529428-05:00","2016-05-03T11:40:21.648680-05:00","c4601520-f5d4-4858-bf25-9e841402b2f9_analysis.xml","4ad174688765ef393b614d99ee4c9c78","e8882480-776f-42b2-8c91-6ffa2e62c53d",2181,"2016-09-29T21:42:01.504060-05:00","c4601520-f5d4-4858-bf25-9e841402b2f9_experiment.xml","262e765ef35316ceb1e48c3384ffc452","9c0e919f-1016-4fd8-90e4-5600f65ff7cd",3916,"2016-09-29T20:27:56.997012-05:00","c4601520-f5d4-4858-bf25-9e841402b2f9_run.xml","0fc68c250d648e9b6b6f61836f6f8415","6e2ccd4a-d4bd-494e-86c0-677febff9670",1988,"2016-09-08T13:28:32.811870-05:00","TCGA-24-1427","2016-09-02T19:13:53.487446-05:00","female","TCGA-24-1427_demographic",1950,"not reported","ec306cf2-62ba-5e6a-b350-fab228fd3b76","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1427_diagnosis","not reported",21423,"alive","8441/3",NA,147,"6adf251d-ef48-5413-8547-40f40921f744","c56.9",-21423,"TCGA-24-1427_treatment","61d7052b-b5bb-5959-991d-9fab45e4ff79","01",NA,"TCGA-24-1427-01A","1","93827307-1efa-43b5-aea5-380c6ce5feed",FALSE,"af63c4e2-2f77-4311-bfe2-ee45cfd200bb","Primary Tumor","0.7",NA,NA,"1.7",1232409600,"01",155,"TCGA-24-1427-01A-01",80,90,NA,NA,0,0,20,10,"2016-09-08T13:28:32.811870-05:00","2016-09-08T13:28:32.811870-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"b23b731e-4150-4c0c-b015-e6bbe8933b0b","03d4bcec-43c8-4b9e-a91f-0aae325fc711","TCGA-24-1427-01A-01-TS1","TCGA-24-1427-01A-01-BS1",79,89,"f0b9796a-f82e-4d83-97c3-22968950d0b5","RNA","TCGA-24-1427-01A-01R","0ba6bb69-9144-46fe-8da3-6a2ba8f00200",1.8,0.16,"UV Spec","R","22","TCGA-24-1427-01A-01R-1565-13","5a505632-422c-4083-b867-82a7a503b314",0.16,NA,NA,NA,NA,"7744d13b-9617-51b7-bb92-23681a7132d4","TCGA-24-1427_exposure","TCGA-24-1427-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:41:15.000Z","2014-03-21T23:05:01.000Z","C4601520-F5D4-4858-BF25-9E841402B2F9","93827307-1EFA-43B5-AEA5-380C6CE5FEED","Unaligned reads",13016678400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5A505632-422C-4083-B867-82A7A503B314","Canada's Michael Smith Genome Sciences Centre","564a5c31e4b093830b6d1ce8","02D9AA2E-B16A-48EA-A420-5DAED9FD51A6","Ovarian Serous Cystadenocarcinoma","TAR","F0B9796A-F82E-4D83-97C3-22968950D0B5","2014-03-21T23:05:01.000Z","0BA6BB69-9144-46FE-8DA3-6A2BA8F00200","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"F0B9796A-F82E-4D83-97C3-22968950D0B5",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.87a8658e-3143-4074-9988-b0fed3d25f8b.txt",NA,"TCGA-24-1427-01A",1.7,"F0961AD4-F0C1-406C-AE2D-9D44D6118237","TCGA",2008,NA,NA,"WITH TUMOR","93827307-1EFA-43B5-AEA5-380C6CE5FEED",58,"nationwidechildrens.org_clinical.TCGA-24-1427.xml","Alive",NA,"TCGA-24-1427",NA,"D5A10323-1F25-4C1F-9F25-44F6A2648A1D",NA,147,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,NA,NA,1,155,"B23B731E-4150-4C0C-B015-E6BBE8933B0B","7D92304B-8159-4CF2-BAB5-6E162D47FF6E","THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_A02_455184.hg18.seg.txt","TCGA-24-1427-01A-01",80,0,NA,NA,20,"TOP",1,NA,"TCGA-24-1427-01A-01-TS1",79,"Paclitaxel","Chemotherapy","TCGA-24-1427-D25957",NA,NA,NA,NA,NA,147,"WITH TUMOR","Alive",NA,"TCGA-24-1427-F25956","TCGA-24-1427",NA,"24","1427","YES","C56.9","8441/3","C56.9",NA,NA,-21423,"FEMALE",NA,NA,NA,"No","Alive",147,NA,NA,NA,"WITH TUMOR","NO",15,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
254423664,243270531,17949852007,"3E02B5C5-1842-4151-8628-ACD2790215E4.bw","0484a929-7a7f-4926-8d25-470ddab082ec","3e02b5c5-1842-4151-8628-acd2790215e4","2016-08-25T19:00:57.808337-05:00","TCGA-04-1365-01A-01R-1565-13_rnaseq_fastq.tar","38ce40ca-88ed-4651-a412-c9db113dbebd",16819036160,"Illumina HiSeq","4460467b54bca7eac3a79b19de474789","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:56:35.904203-05:00","2016-05-03T11:40:21.669427-05:00","38ce40ca-88ed-4651-a412-c9db113dbebd_analysis.xml","b108839b367f28be3a150d0bd4749813","ca3f3caf-1b29-46d7-91a9-b130634d1621",2181,"2016-09-29T21:28:54.459893-05:00","38ce40ca-88ed-4651-a412-c9db113dbebd_experiment.xml","250ecebcd6b08bd5c341398ef667af98","941a8d7b-356d-4ab8-b19c-9f91c79560b7",3916,"2016-09-29T22:59:55.289982-05:00","38ce40ca-88ed-4651-a412-c9db113dbebd_run.xml","2a58eea73dc5c96b4515f35f52fe306b","cc2948ef-45e0-44da-8ae9-a40af0f0785f",1989,"2016-09-08T13:28:00.080696-05:00","TCGA-04-1365","2016-09-02T19:12:11.634960-05:00","female","TCGA-04-1365_demographic",1916,"white","ad52a183-6a6a-50ad-8f74-a12962008af9","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1365_diagnosis","not reported",31925,"alive","8441/3",NA,2329,"2dd073be-5331-55f3-bb9b-aa2a4a04d8b8","c56.9",-31925,"TCGA-04-1365_treatment","5c924e77-3ff0-5b67-9f21-44d930d43e93","01",NA,"TCGA-04-1365-01A","1.2","c91df211-f021-40ea-aa79-9fe01a309ad8",FALSE,"049FC54E-4D17-4B68-9E41-268529C9F18F","Primary Tumor","0.6",NA,NA,"1.2",1229644800,"01",124,"TCGA-04-1365-01A-01",99,95,NA,NA,0,0,5,5,"2016-09-08T13:28:00.080696-05:00","2016-09-08T13:28:00.080696-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"e731bd77-daff-44b7-a5cb-19858abb6293","136edbd4-a232-411e-9795-7ab0bd785b14","TCGA-04-1365-01A-01-BS1","TCGA-04-1365-01A-01-TS1",94,94,"c9961dd3-e2d2-4bc6-b81c-cb5bec5c2c54","RNA","TCGA-04-1365-01A-01R","5355cfa3-3f75-4314-85c5-d48519f7ef4d",1.7,0.15,"UV Spec","R","22","TCGA-04-1365-01A-01R-1565-13","2535da6b-39f0-41de-afd3-82cb37916b95",0.15,NA,NA,NA,NA,"e8cd3e1d-1fff-5f8e-aedb-640ea5aeb8d9","TCGA-04-1365_exposure","TCGA-04-1365-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T04:21:49.000Z","2014-03-22T04:55:02.000Z","38CE40CA-88ED-4651-A412-C9DB113DBEBD","C91DF211-F021-40EA-AA79-9FE01A309AD8","Unaligned reads",16819036160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2535DA6B-39F0-41DE-AFD3-82CB37916B95","Canada's Michael Smith Genome Sciences Centre","564a3dd8e4b0298dd2c93006","0484A929-7A7F-4926-8D25-470DDAB082EC","Ovarian Serous Cystadenocarcinoma","TAR","C9961DD3-E2D2-4BC6-B81C-CB5BEC5C2C54","2014-03-22T04:55:02.000Z","5355CFA3-3F75-4314-85C5-D48519F7EF4D","None","NO",1,0.6,"Primary Tumor","Gynecologic Oncology Group",NA,"C9961DD3-E2D2-4BC6-B81C-CB5BEC5C2C54",1.2,"04","US82800149_251976010515_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt",NA,"TCGA-04-1365-01A",1.2,"E830225C-50D9-49DB-9D48-4186BBC20FD6","TCGA",2003,NA,NA,"WITH TUMOR","C91DF211-F021-40EA-AA79-9FE01A309AD8",87,"nationwidechildrens.org_clinical.TCGA-04-1365.xml","Alive",NA,"TCGA-04-1365","NOT HISPANIC OR LATINO","5342E1BF-6201-45CF-8499-DC41206E4420",NA,2329,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,124,"E731BD77-DAFF-44B7-A5CB-19858ABB6293","ACD7C666-C2AC-4D35-82FF-6D2DA41CE87E","US82800149_251976010515_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","TCGA-04-1365-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-04-1365-01A-01-TS1",94,"Carboplatin","Chemotherapy","TCGA-04-1365-D24050",NA,NA,NA,"TCGA-04-1365-F24044_NTE-1",NA,2329,"WITH TUMOR","Alive",NA,"TCGA-04-1365-F24044","TCGA-04-1365",NA,"04","1365","YES","C56.9","8441/3","C56.9",NA,NA,-31925,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2329,NA,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,87,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
197064604,147889578,10301813944,"94C80946-14E8-4CFB-9A66-CA0BF64D5466.bw","04ecaf38-0232-4dcd-9242-308a22cc1331","94c80946-14e8-4cfb-9a66-ca0bf64d5466","2016-08-25T15:52:07.211383-05:00","TCGA-61-1733-01A-01R-1567-13_rnaseq_fastq.tar","710e992a-a774-4cae-ab05-e03b5aa8cf6b",11694366720,"Illumina HiSeq","788104cf44ec43fbfc5da38f60057536","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:05:25.096756-05:00","2016-05-03T11:41:05.755204-05:00","710e992a-a774-4cae-ab05-e03b5aa8cf6b_analysis.xml","7802ae023f71d92d467a59837b27934c","6065a977-fcb6-43dc-92b2-757304242065",2183,"2016-09-29T22:42:26.615248-05:00","710e992a-a774-4cae-ab05-e03b5aa8cf6b_experiment.xml","124ad2be802ab6e82ed4b18f5142f35b","c17a7fde-3d14-4378-966c-60db0667e9ea",3916,"2016-09-29T19:32:53.839421-05:00","710e992a-a774-4cae-ab05-e03b5aa8cf6b_run.xml","b583d5345d23ce45d830ad6b3213fa99","4c5e12e3-5020-4a17-b8a3-a928b6b035b5",1990,"2016-09-08T11:47:26.097447-05:00","TCGA-61-1733","2016-09-02T18:48:13.431889-05:00","female","TCGA-61-1733_demographic",1935,"white","84a893c5-e066-5859-b953-0c02021e7041","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1733_diagnosis","not reported",26180,"alive","8441/3",NA,967,"a285514c-8992-5900-abf4-fa923c71587d","c56.9",-26180,"TCGA-61-1733_treatment","c1f9e9f5-8b41-509f-ab2c-ef451286bf24","01",NA,"TCGA-61-1733-01A","0.6","a047a512-409f-4293-9585-9933f1503f9d",FALSE,"bc4e6e92-d716-4ab3-8459-4f339caecffd","Primary Tumor","0.2",NA,NA,"1.5",1242518400,"01",98,"TCGA-61-1733-01A-01",85,85,NA,NA,0,0,0,0,"2016-09-08T11:47:26.097447-05:00","2016-09-08T11:47:26.097447-05:00",5,NA,NA,NA,"TOP","BOTTOM",2,5,"feaea5e2-8c15-4890-af4c-c81a7c86bff2","29704093-9666-4b98-a73e-4451db841e32","TCGA-61-1733-01A-01-TS1","TCGA-61-1733-01A-01-BS1",98,95,"17748f90-1f61-4177-b8b6-5803581b7cff","RNA","TCGA-61-1733-01A-01R","ec79f582-79f9-4480-9af5-3d6a787bebb7",1.8,0.15,"UV Spec","R","22","TCGA-61-1733-01A-01R-1567-13","e6f856bf-0694-4c21-aecc-0d8dd54761f1",0.15,NA,NA,NA,NA,"ef0d8db0-3a1f-534a-8f28-76a43c508b83","TCGA-61-1733_exposure","TCGA-61-1733-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T07:40:01.000Z","2014-03-27T08:03:01.000Z","710E992A-A774-4CAE-AB05-E03B5AA8CF6B","A047A512-409F-4293-9585-9933F1503F9D","Unaligned reads",11694366720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E6F856BF-0694-4C21-AECC-0D8DD54761F1","Canada's Michael Smith Genome Sciences Centre","564a5c17e4b0ef12181e4778","04ECAF38-0232-4DCD-9242-308A22CC1331","Ovarian Serous Cystadenocarcinoma","TAR","17748F90-1F61-4177-B8B6-5803581B7CFF","2014-03-27T08:03:01.000Z","EC79F582-79F9-4480-9AF5-3D6A787BEBB7","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"17748F90-1F61-4177-B8B6-5803581B7CFF",0.6,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1b2390f5-f59e-4c94-8586-35b620e0dc4d.txt",NA,"TCGA-61-1733-01A",1.5,"C5F1A4AE-9989-4347-8A0A-D1AFA03088C0","TCGA",2006,NA,NA,"WITH TUMOR","A047A512-409F-4293-9585-9933F1503F9D",71,"MSK_252152916023_S01_CGH-v4_10_27Aug08.txt","Alive",NA,"TCGA-61-1733",NA,"A342A16C-6EBA-4AB9-9688-F1B9F952AC7F",NA,967,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,98,"FEAEA5E2-8C15-4890-AF4C-C81A7C86BFF2","01056871-07A6-4768-AC3C-7F9F46FC0ADC","TCGA-61-1733-01A-01R-1567-13_mirna.bam","TCGA-61-1733-01A-01",85,0,NA,NA,0,"BOTTOM",5,NA,"TCGA-61-1733-01A-01-BS1",95,"Docetaxel","Chemotherapy","TCGA-61-1733-D28165",NA,NA,NA,"TCGA-61-1733-F28163_NTE-2",NA,967,"WITH TUMOR","Alive",NA,"TCGA-61-1733-F28163","TCGA-61-1733",NA,"61","1733","YES","C56.9","8441/3","C56.9",NA,NA,-26180,"FEMALE","WHITE",NA,NA,"No","Alive",967,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
134584830,131670784,9736192856,"EB63A0FE-B591-4A4C-B4BD-8BF3790CC88E.bw","05019013-7ea5-4905-ac79-901146ba2ee2","eb63a0fe-b591-4a4c-b4bd-8bf3790cc88e","2016-09-29T23:49:55.249601-05:00","TCGA-29-1688-01A-01R-1566-13_rnaseq_fastq.tar","0b51ff9b-c369-4959-9379-c42e5b27f6a5",8195768320,"Illumina HiSeq","3817df91391d61020292e0dab42c2de1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:06:42.644113-05:00","2016-05-03T11:39:34.528512-05:00","0b51ff9b-c369-4959-9379-c42e5b27f6a5_analysis.xml","fd8e41fa765f045fcf2991bcd0991d41","ab74bc32-2bd7-4188-90d4-1ee1fa7be71e",2181,"2016-09-29T21:36:09.065068-05:00","0b51ff9b-c369-4959-9379-c42e5b27f6a5_experiment.xml","11f8f7084bee30fe9d3143bc0955f9e2","9875af14-57d1-40be-ae2f-9e34524d9fa5",3916,"2016-09-29T23:17:28.922413-05:00","0b51ff9b-c369-4959-9379-c42e5b27f6a5_run.xml","6325bdfcd0b7bc2399482feb14d722ac","d71e2f6a-220b-4f7e-9c81-1516beb30e16",1988,"2016-09-08T12:19:28.110296-05:00","TCGA-29-1688","2016-09-02T19:07:28.989659-05:00","female","TCGA-29-1688_demographic",1953,"white","99a2d09f-0a52-5f26-8588-75ce3c50c76b","not reported",1998,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1688_diagnosis","not reported",14574,"dead","8441/3",2400,2400,"167fdc87-5221-5292-9ca8-de9c2fc60e5b","c56.9",-14574,"TCGA-29-1688_treatment","041496d3-ca85-527c-8ad9-c68f439ff33e","01",NA,"TCGA-29-1688-01A","1.5","3385e66c-5764-4260-929f-b653a23c7afb",FALSE,"cb2bd608-b9d4-497e-9058-2269dc86b5b3","Primary Tumor","0.5",NA,NA,"2.5",1241654400,"01",121,"TCGA-29-1688-01A-01",80,70,NA,NA,0,0,0,0,"2016-09-08T12:19:28.110296-05:00","2016-09-08T12:19:28.110296-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"4b930846-2a6b-42e3-a986-1c74d92d95ae","0917166e-3623-4f88-bc19-5b3e6fd856f9","TCGA-29-1688-01A-01-BS1","TCGA-29-1688-01A-01-TS1",100,100,"3ae8b914-962f-44c2-b91d-75cd81467f1b","RNA","TCGA-29-1688-01A-01R","03717e91-31fb-4e23-ae05-71d227cd5484",1.8,0.15,"UV Spec","R","22","TCGA-29-1688-01A-01R-1566-13","5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf",0.15,NA,NA,NA,NA,"37bd92de-d1a1-5e55-be66-50b0c2f15352","TCGA-29-1688_exposure","TCGA-29-1688-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T06:43:13.000Z","2014-03-20T06:58:01.000Z","0B51FF9B-C369-4959-9379-C42E5B27F6A5","3385E66C-5764-4260-929F-B653A23C7AFB","Unaligned reads",8195768320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5BE6BDBD-61ED-4CEB-BAD5-9559CBE5BEBF","Canada's Michael Smith Genome Sciences Centre","564a31b6e4b08c5d868e6d78","05019013-7EA5-4905-AC79-901146BA2EE2","Ovarian Serous Cystadenocarcinoma","TAR","3AE8B914-962F-44C2-B91D-75CD81467F1B","2014-03-20T06:58:01.000Z","03717E91-31FB-4E23-AE05-71D227CD5484","None","NO",1,0.5,"Primary Tumor","Duke",NA,"3AE8B914-962F-44C2-B91D-75CD81467F1B",1.5,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.46d8cea8-b5a2-4136-bfeb-4969e3ccbd85.txt",NA,"TCGA-29-1688-01A",2.5,"F7096FD1-A75B-40AD-908C-DCDB17D5CD01","TCGA",1992,NA,NA,"WITH TUMOR","457B8886-F5D6-41A5-B818-AF3315173CB7",39,"nationwidechildrens.org_clinical.TCGA-29-1688.xml","Dead",2400,"TCGA-29-1688",NA,"EB9C7A54-595C-42CE-BF50-83F92050181D",NA,2400,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,"A18091DE-1597-462F-ABBE-05F595F2F50E","WHITE",NA,1,121,"4B930846-2A6B-42E3-A986-1C74D92D95AE","E6BF8BC3-2974-4BFC-8358-9885CB761288","TCGA-29-1688-01A-01R-1566-13_mirna.bam.bai","TCGA-29-1688-01A-01",70,0,NA,NA,0,"TOP",0,NA,"TCGA-29-1688-01A-01-TS1",100,"Hexalen","Chemotherapy","TCGA-29-1688-D27135","TCGA-29-1688-R27140","EXTERNAL BEAM","Distant Recurrence","TCGA-29-1688-F27124_NTE-2",NA,2400,"WITH TUMOR","Dead",2400,"TCGA-29-1688-F27124","TCGA-29-1688",NA,"29","1688","YES","C56.9","8441/3","C56.9",NA,NA,-14574,"FEMALE","WHITE",NA,NA,"No","Dead",2400,2400,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,39,1992,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
194997200,189099729,14001081664,"E00D0266-7FA6-4976-9AB7-2BF8E92D4BE5.bw","05263959-c4f5-4540-b6d2-d8c8a128861f","e00d0266-7fa6-4976-9ab7-2bf8e92d4be5","2016-09-29T23:31:36.614206-05:00","TCGA-61-2104-01A-01R-1568-13_rnaseq_fastq.tar","4a7e6bdd-afe9-4a07-905e-33dc3bb9a999",12933314560,"Illumina HiSeq","755e60b3440048ba89a7947d697d0278","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:02:23.674431-05:00","2016-05-03T11:41:05.755204-05:00","4a7e6bdd-afe9-4a07-905e-33dc3bb9a999_analysis.xml","f43c24ce30d94edaade030f790b04dbc","a8d84861-604b-4ae8-99fa-c415524bee0e",2183,"2016-09-29T18:34:42.960547-05:00","4a7e6bdd-afe9-4a07-905e-33dc3bb9a999_experiment.xml","5964f735c0cd661418f80471e4f55be7","27824824-e3ae-4447-8ee5-d8de0b4e6645",3916,"2016-09-29T18:22:01.300398-05:00","4a7e6bdd-afe9-4a07-905e-33dc3bb9a999_run.xml","da360201249158d33b459d3ff2b5a0d9","1f930c5b-c7f7-4926-bfe6-b51c206fe351",1990,"2016-09-08T12:14:45.935699-05:00","TCGA-61-2104","2016-09-02T18:56:19.218245-05:00","female","TCGA-61-2104_demographic",1950,"white","f30ef53b-8af1-5eac-93f1-59318e77e83b","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2104_diagnosis","not reported",19432,"alive","8441/3",NA,2338,"d4287397-a95b-595b-8b83-3bc606532e4f","c56.9",-19432,"TCGA-61-2104_treatment","dbddac35-5f96-5ee1-80a7-39d98af27eaf","01",NA,"TCGA-61-2104-01A","0.6","87b7ed22-4fe1-4539-8c37-ab085e2cb9c1",FALSE,"38d2e115-ec9a-40e5-bfa0-30fb1db60691","Primary Tumor","0.4",NA,NA,"1.5",1250467200,"01",138,"TCGA-61-2104-01A-01",77,85,NA,NA,15,12,5,10,"2016-09-08T12:14:45.935699-05:00","2016-09-08T12:14:45.935699-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,8,"7b3ca402-80d0-4b8c-9bf0-5350be286ef8","fed6e808-15d3-4922-ab69-e3650d4243d1","TCGA-61-2104-01A-01-BS1","TCGA-61-2104-01A-01-TS1",75,70,"0e329e06-f308-4910-8eb0-544b9049fe85","RNA","TCGA-61-2104-01A-01R","d9f193a6-eeeb-40d5-8c3d-e8bf0e2f5369",1.8,0.16,"UV Spec","R","22","TCGA-61-2104-01A-01R-1568-13","721a8fc8-bb54-4ec3-a19c-340c35f05280",0.16,NA,NA,NA,NA,"b267cdf3-1e41-5d56-b6ba-25e0441b86e9","TCGA-61-2104_exposure","TCGA-61-2104-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T08:51:21.000Z","2014-03-27T09:14:01.000Z","4A7E6BDD-AFE9-4A07-905E-33DC3BB9A999","87B7ED22-4FE1-4539-8C37-AB085E2CB9C1","Unaligned reads",12933314560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","721A8FC8-BB54-4EC3-A19C-340C35F05280","Canada's Michael Smith Genome Sciences Centre","564a3bb4e4b09c884b24729d","05263959-C4F5-4540-B6D2-D8C8A128861F","Ovarian Serous Cystadenocarcinoma","TAR","0E329E06-F308-4910-8EB0-544B9049FE85","2014-03-27T09:14:01.000Z","D9F193A6-EEEB-40D5-8C3D-E8BF0E2F5369","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"0E329E06-F308-4910-8EB0-544B9049FE85",0.6,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.14d97fdf-fcf4-4471-8595-4b6b5401caf6.txt",NA,"TCGA-61-2104-01A",1.5,"BC697473-6EBA-4DFB-8A1C-4A4B60DAA0D1","TCGA",2003,NA,NA,NA,"87B7ED22-4FE1-4539-8C37-AB085E2CB9C1",53,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.14d97fdf-fcf4-4471-8595-4b6b5401caf6.txt","Alive",NA,"TCGA-61-2104",NA,"02AC5E72-78E8-458E-9966-F78A3FB86F69",NA,2338,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,138,"FED6E808-15D3-4922-AB69-E3650D4243D1","2E6FD499-5295-4749-B3A0-0FD92B48B0E4","TCGA-61-2104-01A-01R-1568-13_rnaseq_fastq.tar","TCGA-61-2104-01A-01",77,15,NA,NA,5,"BOTTOM",5,NA,"TCGA-61-2104-01A-01-BS1",75,"Taxol","Chemotherapy","TCGA-61-2104-D28446",NA,NA,NA,"TCGA-61-2104-F28442_NTE-2",NA,2338,NA,"Alive",NA,"TCGA-61-2104-F28442","TCGA-61-2104",NA,"61","2104","YES","C56.9","8441/3","C56.9",NA,NA,-19432,"FEMALE","WHITE",NA,NA,"No","Alive",2338,NA,NA,NA,NA,"NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
282998084,269352082,19886590448,"9FC57F0E-A21A-4D05-85A6-764AFF321301.bw","05ba5839-e00a-4a9e-8ba3-ecb490781e62","9fc57f0e-a21a-4d05-85a6-764aff321301","2016-08-25T21:24:46.476541-05:00","TCGA-24-1422-01A-01R-1565-13_rnaseq_fastq.tar","23904880-39e7-4afb-824e-a36f2f2b2cc2",17752401920,"Illumina HiSeq","ec60dffb3bfed0fc86707f03a129c379","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:22:56.677143-05:00","2016-05-03T11:40:21.669427-05:00","23904880-39e7-4afb-824e-a36f2f2b2cc2_analysis.xml","9ed7c28d046376a036d8c428431cf08f","9061997d-e059-486f-b8ca-d904f45f2b3b",2181,"2016-09-29T22:00:34.816735-05:00","23904880-39e7-4afb-824e-a36f2f2b2cc2_experiment.xml","fce481cf98b51fac677901081eafd8c2","a7b673dd-1374-4bc9-8e5a-f675213cae9d",3916,"2016-09-29T21:38:19.806335-05:00","23904880-39e7-4afb-824e-a36f2f2b2cc2_run.xml","56a82b1e40fc2fb42582e3a1fb4f373f","99ccbde3-de03-4691-b6a8-7a0529ea9293",1989,"2016-09-08T13:44:32.910083-05:00","TCGA-24-1422","2016-09-02T19:13:44.084484-05:00","female","TCGA-24-1422_demographic",1926,"black or african american","838591b6-cdae-547d-adfe-1dfcc60db703","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1422_diagnosis","not reported",30234,"dead","8441/3",23,23,"f2ffb8cb-705b-5752-84dd-53e3f9fab12b","c56.9",-30234,"TCGA-24-1422_treatment","a9ea5705-2622-5dc2-b25c-5610263acf81","01",NA,"TCGA-24-1422-01A","1.2","b6568556-a2fb-4eec-a953-b8b81d2fd6dd",FALSE,"8bcb6cf4-84ea-41a1-9113-061a7523c19f","Primary Tumor","0.5",NA,NA,"1.8",1231977600,"01",106,"TCGA-24-1422-01A-01",75,90,NA,NA,10,40,0,0,"2016-09-08T13:44:32.910083-05:00","2016-09-08T13:44:32.910083-05:00",NA,NA,NA,NA,"BOTTOM","TOP",8,10,"53e4f6dd-f37e-4292-aac7-083bf40da8b5","aafeef2d-1616-480b-a3c6-4b9567c5e2ab","TCGA-24-1422-01A-01-BS1","TCGA-24-1422-01A-01-TS1",82,50,"17e10f56-4afe-407b-8f40-688b03a6a458","RNA","TCGA-24-1422-01A-01R","e3fc854b-65fe-4f54-9c56-f2c15db14d35",1.8,0.16,"UV Spec","R","22","TCGA-24-1422-01A-01R-1565-13","99a9d9af-2e42-4a4f-8ad7-3f8b6e145a55",0.16,NA,NA,NA,NA,"bbcc2b2e-8863-58be-a155-4bcc3a3479bf","TCGA-24-1422_exposure","TCGA-24-1422-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:03:00.000Z","2014-03-22T05:38:02.000Z","23904880-39E7-4AFB-824E-A36F2F2B2CC2","B6568556-A2FB-4EEC-A953-B8B81D2FD6DD","Unaligned reads",17752401920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","99A9D9AF-2E42-4A4F-8AD7-3F8B6E145A55","Canada's Michael Smith Genome Sciences Centre","564a5a8fe4b0298dd2cbe2e4","05BA5839-E00A-4A9E-8BA3-ECB490781E62","Ovarian Serous Cystadenocarcinoma","TAR","17E10F56-4AFE-407B-8F40-688B03A6A458","2014-03-22T05:38:02.000Z","E3FC854B-65FE-4F54-9C56-F2C15DB14D35","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"17E10F56-4AFE-407B-8F40-688B03A6A458",1.2,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.52fbe264-2840-4bae-86a9-17f09ebe5053.txt",NA,"TCGA-24-1422-01A",1.8,NA,"TCGA",2008,NA,NA,NA,"B6568556-A2FB-4EEC-A953-B8B81D2FD6DD",82,"nationwidechildrens.org_clinical.TCGA-24-1422.xml","Dead",23,"TCGA-24-1422",NA,"53EE42C9-00E7-4DF7-9070-362B248E998A",NA,23,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,106,"AAFEEF2D-1616-480B-A3C6-4B9567C5E2AB","0A3A252A-F89A-406C-81B7-43B6AF00C3EF","TCGA-24-1422-01A-01R-1565-13_mirna.bam","TCGA-24-1422-01A-01",75,10,NA,NA,0,"BOTTOM",8,NA,"TCGA-24-1422-01A-01-BS1",82,NA,NA,NA,NA,NA,NA,NA,NA,23,NA,"Dead",23,"TCGA-24-1422-F25934","TCGA-24-1422",NA,"24","1422","YES","C56.9","8441/3","C56.9",NA,NA,-30234,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",23,23,NA,NA,NA,"NO",16,4,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,82,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
147050812,140775711,10414211978,"15037D3D-2D9B-4640-B6C5-E3C2951AC0B8.bw","062982f8-9f49-425a-99e9-008af5ed9040","15037d3d-2d9b-4640-b6c5-e3c2951ac0b8","2016-08-25T02:41:13.818772-05:00","TCGA-24-2035-01A-01R-1568-13_rnaseq_fastq.tar","dcf45057-af86-4a73-9641-023b7c1deb84",9454694400,"Illumina HiSeq","5015ce454a0e2e3da9359678c87b7514","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:13:39.182617-05:00","2016-05-03T11:56:42.631594-05:00","dcf45057-af86-4a73-9641-023b7c1deb84_analysis.xml","c83b784b2e6ff6cc2f8ac4eccc407033","afaa3ccc-eea8-47a8-884b-c19b077215ef",2181,"2016-09-29T19:58:16.615388-05:00","dcf45057-af86-4a73-9641-023b7c1deb84_experiment.xml","eec75dfe1accc05277e838a7c2ad3258","5c13d47b-beda-4474-abfe-f7d284cc0335",3916,"2016-09-29T20:28:13.231235-05:00","dcf45057-af86-4a73-9641-023b7c1deb84_run.xml","55733ad4b69991643e0fd2ff72bb9c96","6e5533c1-93b5-4fff-a372-eac52cbe85e7",1988,"2016-09-08T13:05:42.264042-05:00","TCGA-24-2035","2016-09-02T18:56:10.625025-05:00","female","TCGA-24-2035_demographic",1931,"white","07018a25-f50f-5622-ac08-b364ea38ff12","not reported",1998,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2035_diagnosis","not reported",23855,"dead","8441/3",857,857,"0e6482de-13e4-5907-b7c0-18515ebd9c3d","c56.9",-23855,"TCGA-24-2035_treatment","d183dbca-1016-5ed6-8e50-f554c32c5b76","01",NA,"TCGA-24-2035-01A","0.7","e4ccc95d-79ca-49e3-8cd0-c8452c5f9aa2",FALSE,"025d4b31-5832-451a-9f70-e0281f698aa6","Primary Tumor","0.3",NA,NA,"1",1248134400,"01",127,"TCGA-24-2035-01A-01",90,90,0,0,0,0,90,50,"2016-09-08T13:05:42.264042-05:00","2016-09-08T13:05:42.264042-05:00",5,0,0,0,"BOTTOM","TOP",0,0,"1ea4d2d3-feff-446e-a198-cd91ce4d56b7","219f3d14-d927-4732-acfe-9fb918296c53","TCGA-24-2035-01A-01-BS1","TCGA-24-2035-01A-01-TS1",10,50,"433a4bc6-3f6b-40a5-adb0-5cdae48f8a29","RNA","TCGA-24-2035-01A-01R","bb306488-b47f-401d-96c9-a5afda87a866",1.8,0.14,"UV Spec","R","22","TCGA-24-2035-01A-01R-1568-13","e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0",0.14,NA,NA,NA,NA,"ecdc841a-404a-5c34-af8a-0c8856e767f7","TCGA-24-2035_exposure","TCGA-24-2035-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-29T10:13:34.000Z","2014-08-29T12:41:36.000Z","DCF45057-AF86-4A73-9641-023B7C1DEB84","E4CCC95D-79CA-49E3-8CD0-C8452C5F9AA2","Unaligned reads",9454694400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E78F43FF-0B31-4F9B-A9C1-02155EE3D8B0","Canada's Michael Smith Genome Sciences Centre","564a39a2e4b0298dd2c7d73c","062982F8-9F49-425A-99E9-008AF5ED9040","Ovarian Serous Cystadenocarcinoma","TAR","433A4BC6-3F6B-40A5-ADB0-5CDAE48F8A29","2014-08-29T12:41:36.000Z","BB306488-B47F-401D-96C9-A5AFDA87A866","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"433A4BC6-3F6B-40A5-ADB0-5CDAE48F8A29",0.7,"24","TCGA-24-2035-01A-01W-0722-08_IlluminaGA-DNASeq_capture.bam",NA,"TCGA-24-2035-01A",1,"ED9654DA-C2F1-4280-AC44-E22812DD52EF","TCGA",1996,NA,NA,"WITH TUMOR","E4CCC95D-79CA-49E3-8CD0-C8452C5F9AA2",65,"nationwidechildrens.org_clinical.TCGA-24-2035.xml","Dead",857,"TCGA-24-2035",NA,"629FE779-5B72-4D3E-92FF-C21F8CD387D0",NA,857,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,127,"219F3D14-D927-4732-ACFE-9FB918296C53","BB306488-B47F-401D-96C9-A5AFDA87A866","TCGA-24-2035-01A-01W-0722-08_IlluminaGA-DNASeq_capture.bam","TCGA-24-2035-01A-01",90,0,0,0,50,"TOP",0,0,"TCGA-24-2035-01A-01-TS1",50,"PSC833","Chemotherapy","TCGA-24-2035-D26500",NA,NA,NA,"TCGA-24-2035-F26496_NTE-1",NA,857,"WITH TUMOR","Dead",857,"TCGA-24-2035-F26496","TCGA-24-2035",NA,"24","2035","YES","C56.9","8441/3","C56.9",NA,NA,-23855,"FEMALE","WHITE",NA,NA,"No","Dead",857,857,NA,NA,"WITH TUMOR","NO",29,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,65,1996,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
178254502,172936678,12805434829,"52CC5ABB-E3DD-4CCF-A5C6-3DDCD8D7A9DA.bw","0724f800-e873-45d0-bc56-809d0ec4f6e9","52cc5abb-e3dd-4ccf-a5c6-3ddcd8d7a9da","2016-08-25T03:34:23.671915-05:00","TCGA-30-1861-01A-01R-1568-13_rnaseq_fastq.tar","b22d2354-e600-498b-ba7f-f81921df29f6",11473971200,"Illumina HiSeq","3fd85037a9a574bce75f4394f352b4a8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:08:49.340448-05:00","2016-05-03T11:56:42.628809-05:00","b22d2354-e600-498b-ba7f-f81921df29f6_analysis.xml","4787f091295204253835dd6ed5d520b6","3d37b671-a266-41e3-9c2d-73d72c4c1b02",2181,"2016-09-29T23:41:00.755141-05:00","b22d2354-e600-498b-ba7f-f81921df29f6_experiment.xml","700afa806dcb72d1c3cb82e4938c72fc","e5d8a348-1638-431f-96f7-ae4a4e2489a3",3916,"2016-09-29T17:37:45.124297-05:00","b22d2354-e600-498b-ba7f-f81921df29f6_run.xml","ad4a832235868e3f9ef528a1a4a17015","03be6f5b-3d93-4825-88be-1e733341e145",1988,"2016-09-08T11:12:39.019015-05:00","TCGA-30-1861","2016-09-02T18:53:31.567867-05:00","female","TCGA-30-1861_demographic",1928,"white","306e3132-57a0-51fc-87e4-1d00bf8466d0","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1861_diagnosis","not reported",27103,"dead","8441/3",1058,1058,"4df9c324-0ddb-5e04-beb7-a6c37bf5e8a8","c56.9",-27103,"TCGA-30-1861_treatment","f56963e8-ab67-5731-ba95-895fd7b0bc20","01",NA,"TCGA-30-1861-01A","0.4","2642249c-adc7-48e2-8493-1597e269c2c9",FALSE,"446be880-d1d8-4b63-b4d5-5aa0468ccafe","Primary Tumor","0.4",NA,NA,"0.8",1245369600,"01",119,"TCGA-30-1861-01A-01",80,80,NA,NA,0,0,25,25,"2016-09-08T11:12:39.019015-05:00","2016-09-08T11:12:39.019015-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"30a7078c-aeeb-4c9d-b0d8-8d66163299cd","a7c5de2f-252d-44e2-b5fa-9beef553a8d6","TCGA-30-1861-01A-01-BS1","TCGA-30-1861-01A-01-TS1",75,75,"6ee2c939-e84c-4211-878d-e899a27faf00","RNA","TCGA-30-1861-01A-01R","9078a669-44c3-44fc-94b5-c173d6a42848",1.8,0.15,"UV Spec","R","22","TCGA-30-1861-01A-01R-1568-13","32a58029-c8aa-4647-a932-bbf57e82fc48",0.15,NA,NA,NA,NA,"be5a8387-3137-5b46-90ec-2e8f18511a1d","TCGA-30-1861_exposure","TCGA-30-1861-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T03:11:42.000Z","2014-08-26T05:27:27.000Z","B22D2354-E600-498B-BA7F-F81921DF29F6","2642249C-ADC7-48E2-8493-1597E269C2C9","Unaligned reads",11473971200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","32A58029-C8AA-4647-A932-BBF57E82FC48","Canada's Michael Smith Genome Sciences Centre","564a5999e4b093830b6c6adb","0724F800-E873-45D0-BC56-809D0EC4F6E9","Ovarian Serous Cystadenocarcinoma","TAR","6EE2C939-E84C-4211-878D-E899A27FAF00","2014-08-26T05:27:27.000Z","9078A669-44C3-44FC-94B5-C173D6A42848","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"6EE2C939-E84C-4211-878D-E899A27FAF00",0.4,"30","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7e253248-d889-4b00-a098-55cfcb18758b.txt",NA,"TCGA-30-1861-01A",0.8,NA,"TCGA",2002,NA,NA,NA,"CC2A89F3-C2F1-48DB-A435-88EB45F7A559",74,"MSK_252152917546_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Dead",1058,"TCGA-30-1861","NOT HISPANIC OR LATINO",NA,NA,1058,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,119,"A7C5DE2F-252D-44E2-B5FA-9BEEF553A8D6","F0178D81-2EE4-49EB-BA93-EF07F0FE8A15","TCGA-30-1861-01A-01R-1568-13_mirna.bam","TCGA-30-1861-01A-01",80,0,NA,NA,25,"TOP",0,NA,"TCGA-30-1861-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-30-1861",NA,"30","1861","YES","C56.9","8441/3","C56.9",NA,NA,-27103,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1058,1058,NA,NA,NA,"NO",2,6,2009,"NO","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,74,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
103438044,97067904,7140807255,"CEDFB044-C1DF-4928-AE25-EF2DC81006CD.bw","0740321b-f8a5-4e1d-b390-ca6187598fac","cedfb044-c1df-4928-ae25-ef2dc81006cd","2016-08-22T16:58:09.449281-05:00","TCGA-13-0891-01A-01R-1564-13_rnaseq_fastq.tar","c428b7ac-200f-462e-bbe1-77d5cd376392",6249256960,"Illumina HiSeq","1a381feb263a2b0e7e13acad448a0e02","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:10:11.277315-05:00","2016-05-03T11:27:59.332723-05:00","c428b7ac-200f-462e-bbe1-77d5cd376392_analysis.xml","8abd6c9b07e2ee31fc7f9532fabab586","3e14ea41-1c7d-4ca8-b137-2780f63187cf",2265,"2016-09-29T22:26:30.564746-05:00","c428b7ac-200f-462e-bbe1-77d5cd376392_experiment.xml","28413d7c0f60ba1109628defd08bb56d","b7888d76-5232-4c56-87a1-f68de10fc2e4",3916,"2016-09-29T18:49:50.432375-05:00","c428b7ac-200f-462e-bbe1-77d5cd376392_run.xml","8cdd4da840aec35ef7f295e2973e499c","313aa9e8-fe8a-43f7-83b7-e131eadf9ed6",1988,"2016-09-08T13:10:13.358281-05:00","TCGA-13-0891","2016-09-02T19:05:14.987661-05:00","female","TCGA-13-0891_demographic",1930,"white","2fbefc9e-1e10-5799-9005-b6fe7e10fd13","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0891_diagnosis","not reported",26886,"dead","8441/3",3128,2099,"3d1dbced-2a51-54ba-b21b-6492adf26960","c56.9",-26886,"TCGA-13-0891_treatment","ba25d659-2194-544e-8781-bbbc25a11f2a","01",NA,"TCGA-13-0891-01A","1.2","6ff303cc-7d1d-41e5-a839-9f163ba04989",FALSE,"7DF79B3C-8CD7-446D-A13A-BBB69DFE2394","Primary Tumor","0.4",NA,NA,"1.4",1233705600,"01",86,"TCGA-13-0891-01A-01",95,90,NA,NA,5,10,0,0,"2016-09-08T13:10:13.358281-05:00","2016-09-08T13:10:13.358281-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"8d1ded3e-bb87-402e-8103-f421b6ee27dd","720d6bab-786c-4ec2-a692-c70414ced567","TCGA-13-0891-01A-01-BS1","TCGA-13-0891-01A-01-TS1",94,89,"3219705f-bdc7-4ddb-a83c-21c4411ca20b","RNA","TCGA-13-0891-01A-01R","424dcc28-060f-4188-a8e9-767da176de06",1.8,0.15,"UV Spec","R","22","TCGA-13-0891-01A-01R-1564-13","c6666bbe-77cd-497e-88b4-ff73dcf6f399",0.15,NA,NA,NA,NA,"93ad84a9-4ce2-5924-8a83-920c60d0e83a","TCGA-13-0891_exposure","TCGA-13-0891-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-21T00:50:16.000Z","2013-12-21T01:05:02.000Z","C428B7AC-200F-462E-BBE1-77D5CD376392","6FF303CC-7D1D-41E5-A839-9F163BA04989","Unaligned reads",6249256960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C6666BBE-77CD-497E-88B4-FF73DCF6F399","Canada's Michael Smith Genome Sciences Centre","564a596de4b08c5d86949353","0740321B-F8A5-4E1D-B390-CA6187598FAC","Ovarian Serous Cystadenocarcinoma","TAR","3219705F-BDC7-4DDB-A83C-21C4411CA20B","2013-12-21T01:05:02.000Z","424DCC28-060F-4188-A8E9-767DA176DE06","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"3219705F-BDC7-4DDB-A83C-21C4411CA20B",1.2,"13","TCGA-13-0891-01A-01R-0441-02_tags.txt",NA,"TCGA-13-0891-01A",1.4,"C72E692B-29DD-4292-ADD3-4B3889F27442","TCGA",2003,NA,NA,"WITH TUMOR","D3F047D6-6532-4A3E-A508-DD1F8D1C90E9",73,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f305890a-3b48-4e7b-8f31-f2653a5582b8.txt","Alive",NA,"TCGA-13-0891","NOT HISPANIC OR LATINO","86624F11-E43C-4E2A-8E31-1B53B70C599E",NA,2099,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,86,"720D6BAB-786C-4EC2-A692-C70414CED567","9EB5DDCF-5598-40C9-AF23-FCDD393B30EF","TCGA-13-0891-01A-01R-1564-13_GRCh37-lite_rnaseq.bam.bai","TCGA-13-0891-01A-01",95,5,NA,NA,0,"BOTTOM",1,NA,"TCGA-13-0891-01A-01-BS1",94,"Paclitaxel","Chemotherapy","TCGA-13-0891-D24688",NA,NA,NA,"TCGA-13-0891-F24686_NTE-1",NA,2099,"WITH TUMOR","Alive",NA,"TCGA-13-0891-F24686","TCGA-13-0891",NA,"13","0891","YES","C56.9","8441/3","C56.9",NA,NA,-26886,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2099,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2003,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
189695138,182805069,13494067793,"40A58FA6-9329-4E4A-A4C0-C9EE3FA3427D.bw","077079c3-6877-467b-b9cc-5c650aae4f07","40a58fa6-9329-4e4a-a4c0-c9ee3fa3427d","2016-08-25T20:27:31.655606-05:00","TCGA-25-1877-01A-01R-1567-13_rnaseq_fastq.tar","b2a7d6cb-d72d-49a5-8d28-e3ac2b9bd770",11592222720,"Illumina HiSeq","a1e61ae055a8d46a3ffb6677eb5ec57b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:40:40.603143-05:00","2016-05-03T11:41:05.755204-05:00","b2a7d6cb-d72d-49a5-8d28-e3ac2b9bd770_analysis.xml","afe62d9ac4493b336283965f58e54e9d","05a50761-c597-42fc-9f48-3c2a86e2c08d",2203,"2016-09-29T18:24:31.201530-05:00","b2a7d6cb-d72d-49a5-8d28-e3ac2b9bd770_experiment.xml","64cacc131272f1c2494c3f15ce3489a0","212e84a4-3f9f-4707-89e7-4604043231c6",3916,"2016-09-29T21:19:32.400229-05:00","b2a7d6cb-d72d-49a5-8d28-e3ac2b9bd770_run.xml","0ecc4ce69867d89e26e625bb85c3809c","8e421c3d-c59e-443b-b74f-79dfa2242c26",1990,"2016-09-08T10:37:33.464856-05:00","TCGA-25-1877","2016-09-02T18:49:48.143098-05:00","female","TCGA-25-1877_demographic",1912,"white","b10665a5-1955-5d79-92f4-5917a33bfa22","not hispanic or latino",1995,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1877_diagnosis","not reported",29615,"dead","8441/3",730,549,"96598802-b58e-538b-a149-13802533384c","c56.9",-29615,"TCGA-25-1877_treatment","db1814cc-564c-5d6c-b21d-ce6dc60a5b57","01",NA,"TCGA-25-1877-01A","0.4","95bc63bd-436a-4ee4-91dd-95c5188fe261",FALSE,"D98B5A1F-DF34-43E7-826F-BCB45DEC582D","Primary Tumor","0.4",NA,NA,"0.7",1247616000,"01",175,"TCGA-25-1877-01A-01",90,90,0,0,0,0,10,10,"2016-09-08T10:37:33.464856-05:00","2016-09-08T10:37:33.464856-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"5ee23474-2d31-4fb3-b0cd-5c105aa8e6d9","244e6637-9bcf-4aea-ac10-8564d480884a","TCGA-25-1877-01A-01-TS1","TCGA-25-1877-01A-01-BS1",90,90,"85aed4dc-34aa-4917-945a-6c2e78dbe37e","RNA","TCGA-25-1877-01A-01R","291f0c92-b34d-46af-9e0e-ee2d904c8924",1.8,0.14,"UV Spec","R","22","TCGA-25-1877-01A-01R-1567-13","39639797-675b-4f3c-9959-7e3344bea0d1",0.14,NA,NA,NA,NA,"f0e00b3f-8239-54f9-8ff2-5bb244e86ece","TCGA-25-1877_exposure","TCGA-25-1877-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T06:41:35.000Z","2014-03-27T07:04:02.000Z","B2A7D6CB-D72D-49A5-8D28-E3AC2B9BD770","95BC63BD-436A-4EE4-91DD-95C5188FE261","Unaligned reads",11592222720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","39639797-675B-4F3C-9959-7E3344BEA0D1","Canada's Michael Smith Genome Sciences Centre","564a5826e4b08c5d869427cf","077079C3-6877-467B-B9CC-5C650AAE4F07","Ovarian Serous Cystadenocarcinoma","TAR","85AED4DC-34AA-4917-945A-6C2E78DBE37E","2014-03-27T07:04:02.000Z","291F0C92-B34D-46AF-9E0E-EE2D904C8924","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"85AED4DC-34AA-4917-945A-6C2E78DBE37E",0.4,"25","TCGA-25-1877-01A-01R-1567-13.hg19.mirna.quantification.txt",NA,"TCGA-25-1877-01A",0.7,"CD38B202-C4A0-40BB-87E0-14323D353670","TCGA",1993,NA,NA,"WITH TUMOR","95BC63BD-436A-4EE4-91DD-95C5188FE261",81,"nationwidechildrens.org_clinical.TCGA-25-1877.xml","Dead",730,"TCGA-25-1877","NOT HISPANIC OR LATINO","BE06D351-8800-477E-BA18-249A66A7FA24",NA,549,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,175,"5EE23474-2D31-4FB3-B0CD-5C105AA8E6D9","4DC9E91E-8E00-4A27-9FCA-D622E9C206B9","US82800149_251976010821_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","TCGA-25-1877-01A-01",90,0,0,0,10,"TOP",0,0,"TCGA-25-1877-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-25-1877-D26775",NA,NA,NA,"TCGA-25-1877-F26774_NTE-1",NA,549,"WITH TUMOR","Dead",730,"TCGA-25-1877-F26774","TCGA-25-1877",NA,"25","1877","YES","C56.9","8441/3","C56.9",NA,NA,-29615,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",549,730,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,81,1993,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
177230586,173816752,12886894300,"96955B7B-5AFE-4CEE-B27F-0EEDAA90949D.bw","07a859fc-6f78-4905-9035-90e2403dbe8d","96955b7b-5afe-4cee-b27f-0eedaa90949d","2016-08-25T16:45:36.960283-05:00","TCGA-25-1326-01A-01R-1565-13_rnaseq_fastq.tar","52fb1429-c6fe-4d95-a32f-6a7a3cb16e33",11154483200,"Illumina HiSeq","98fbf982ea1d52459b9772530bd3c2ec","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:58:49.945512-05:00","2016-05-03T11:40:21.648680-05:00","52fb1429-c6fe-4d95-a32f-6a7a3cb16e33_analysis.xml","55a35b36d66fea8794aa4a6089b8e977","81442d73-54da-4556-8b56-60b7c65faeee",2181,"2016-10-07T16:10:59.446238-05:00","52fb1429-c6fe-4d95-a32f-6a7a3cb16e33_experiment.xml","bbe7bd8e413ea2d1aff3dbc1b86fb8f7","b447a948-d332-422c-b827-3ef3e03e69e9",3916,"2016-09-29T18:23:39.033300-05:00","52fb1429-c6fe-4d95-a32f-6a7a3cb16e33_run.xml","342bd5882a64224d36794f213c931084","20ad4c6f-747b-4be6-9940-5e28a604bc21",1988,"2016-09-08T13:28:15.055496-05:00","TCGA-25-1326","2016-09-02T19:12:00.266672-05:00","female","TCGA-25-1326_demographic",1941,"white","64e2c7b4-6061-5765-b200-5ae4c9836b78","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1326_diagnosis","not reported",22339,"dead","8441/3",1249,945,"ea06b490-4522-5521-8124-5f077e608a8a","c56.9",-22339,"TCGA-25-1326_treatment","611953da-651f-5fa7-b92a-89fdd2c73eb3","01",NA,"TCGA-25-1326-01A","2.5","655bee4a-887e-495e-9afe-586b75516e7d",FALSE,"B17E5B27-48DB-4E64-A1C3-CAE4921C14DF","Primary Tumor","1.2",NA,NA,"3",1228435200,"01",175,"TCGA-25-1326-01A-01",85,85,NA,NA,NA,NA,20,20,"2016-09-08T13:28:15.055496-05:00","2016-09-08T13:28:15.055496-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,20,"0fbff408-12f4-429e-9d63-c51e858c6971","04f4d76d-fa58-4f40-97d0-c67616253bfb","TCGA-25-1326-01A-01-TS1","TCGA-25-1326-01A-01-BS1",75,60,"e4b95817-fd4c-4bce-bdaa-6013d6e29fe6","RNA","TCGA-25-1326-01A-01R","1582b110-76e8-43e1-bbca-38a8d720d2ce",1.8,0.16,"UV Spec","R","22","TCGA-25-1326-01A-01R-1565-13","b29bd766-95b1-46fa-a070-d2206cd5722a",0.16,NA,NA,NA,NA,"14234a0a-da47-5d89-a87a-eb875e6200d4","TCGA-25-1326_exposure","TCGA-25-1326-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T23:07:55.000Z","2014-03-21T23:37:01.000Z","52FB1429-C6FE-4D95-A32F-6A7A3CB16E33","655BEE4A-887E-495E-9AFE-586B75516E7D","Unaligned reads",11154483200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B29BD766-95B1-46FA-A070-D2206CD5722A","Canada's Michael Smith Genome Sciences Centre","564a5c83e4b09c884b27cf1c","07A859FC-6F78-4905-9035-90E2403DBE8D","Ovarian Serous Cystadenocarcinoma","TAR","E4B95817-FD4C-4BCE-BDAA-6013D6E29FE6","2014-03-21T23:37:01.000Z","1582B110-76E8-43E1-BBCA-38A8D720D2CE","None","NO",1,1.2,"Primary Tumor","Mayo Clinic - Rochester",NA,"E4B95817-FD4C-4BCE-BDAA-6013D6E29FE6",2.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6e7bb043-ec9a-4648-9acd-14526dca800e.txt",NA,"TCGA-25-1326-01A",3,"E9376983-D8C4-4462-94BD-B2BDFE55AB02","TCGA",2002,NA,NA,"WITH TUMOR","D4939C2C-5C54-4FF1-9E88-4DDA95AA3044",61,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6e7bb043-ec9a-4648-9acd-14526dca800e.txt","Dead",1249,"TCGA-25-1326","NOT HISPANIC OR LATINO","7A9AC328-F776-41A3-9F99-0FA250C41F24",NA,945,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,175,"0FBFF408-12F4-429E-9D63-C51E858C6971","FC798032-52E2-482B-AF11-D35614495757","TCGA-25-1326-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-25-1326-01A-01",85,NA,NA,NA,20,"TOP",5,NA,"TCGA-25-1326-01A-01-TS1",75,"Topetecan","Chemotherapy","TCGA-25-1326-D26692",NA,NA,NA,"TCGA-25-1326-F26691_NTE-1",NA,945,"WITH TUMOR","Dead",1249,"TCGA-25-1326-F26691","TCGA-25-1326",NA,"25","1326","YES","C56.9","8441/3","C56.9",NA,NA,-22339,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",945,1249,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
262674986,256039082,18937660137,"ECB2DF14-CF68-44D4-8719-973AE448B992.bw","07fbdb3c-8337-4319-8255-f2363f8a031e","ecb2df14-cf68-44d4-8719-973ae448b992","2016-08-23T12:29:56.230215-05:00","TCGA-61-1728-01A-01R-1568-13_rnaseq_fastq.tar","5a032f31-04a9-4a61-9a64-5fcca645dee0",16926597120,"Illumina HiSeq","b4c1c0a34a4a8677ce72955dc8719327","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:02:44.442013-05:00","2016-05-03T11:41:05.755204-05:00","5a032f31-04a9-4a61-9a64-5fcca645dee0_analysis.xml","21c257357c6ba8fdeb7cafeb96a7289e","83a647b9-a95a-458e-b99a-5e8403e95eb1",2183,"2016-09-29T20:11:31.787897-05:00","5a032f31-04a9-4a61-9a64-5fcca645dee0_experiment.xml","c4f8af1bbdfeae8fdde59b82b5d5a885","641b9a8b-4754-453a-b8e9-d4a175aea6bb",3916,"2016-09-29T17:41:16.954574-05:00","5a032f31-04a9-4a61-9a64-5fcca645dee0_run.xml","75819f7858b505f18eacfeaa466a6ae5","0606ce85-4d9b-44fa-97b5-25df7f3fc77a",1990,"2016-09-08T11:11:02.726675-05:00","TCGA-61-1728","2016-09-02T18:50:14.289698-05:00","female","TCGA-61-1728_demographic",1948,"white","3a226523-d211-5c33-ab72-74b052e22634","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1728_diagnosis","not reported",21582,"alive","8441/3",NA,848,"947ce4f7-c76d-587a-af7d-533e4eeb9b1f","c56.9",-21582,"TCGA-61-1728_treatment","f656a5c5-3c82-5dc0-b931-b7ca5d849549","01",NA,"TCGA-61-1728-01A","0.6","9c3d5caf-78e2-4a1c-9e08-1ca5aa1c5625",FALSE,"7611c4d4-f58b-404e-93f1-949c865c9e12","Primary Tumor","0.2",NA,NA,"1.1",1242518400,"01",145,"TCGA-61-1728-01A-01",90,90,NA,NA,0,0,0,0,"2016-09-08T11:11:02.726675-05:00","2016-09-08T11:11:02.726675-05:00",NA,NA,NA,NA,"BOTTOM","TOP",15,10,"52c330f2-48ca-4158-a994-07cdbc130f80","7436378c-e436-4aba-a1aa-89314dcdccce","TCGA-61-1728-01A-01-BS1","TCGA-61-1728-01A-01-TS1",85,90,"5834c3f4-b593-4ad1-bd92-c838679e5ef4","RNA","TCGA-61-1728-01A-01R","24e866d8-fe78-4821-89b3-6360af6870f3",1.8,0.15,"UV Spec","R","22","TCGA-61-1728-01A-01R-1568-13","bf909020-d6a1-49f1-8007-4192d39abd04",0.15,NA,NA,NA,NA,"b5de6027-d9f5-5928-bf12-740edd51f6b9","TCGA-61-1728_exposure","TCGA-61-1728-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T06:26:01.000Z","2014-03-27T06:57:02.000Z","5A032F31-04A9-4A61-9A64-5FCCA645DEE0","9C3D5CAF-78E2-4A1C-9E08-1CA5AA1C5625","Unaligned reads",16926597120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BF909020-D6A1-49F1-8007-4192D39ABD04","Canada's Michael Smith Genome Sciences Centre","564a3e02e4b0ef12181b44f5","07FBDB3C-8337-4319-8255-F2363F8A031E","Ovarian Serous Cystadenocarcinoma","TAR","5834C3F4-B593-4AD1-BD92-C838679E5EF4","2014-03-27T06:57:02.000Z","24E866D8-FE78-4821-89B3-6360AF6870F3","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"5834C3F4-B593-4AD1-BD92-C838679E5EF4",0.6,"61","4814950011_R01C01_Grn.idat",NA,"TCGA-61-1728-01A",1.1,"F38CDFC3-7031-4308-AD4E-4DC2EE43C0D7","TCGA",2007,NA,NA,"TUMOR FREE","FAB70820-4122-4AE3-9EE2-6158B28F06A2",59,"LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_B12_518042.tangent.copynumber.data.txt","Alive",NA,"TCGA-61-1728","NOT HISPANIC OR LATINO","16D97D30-B99B-4B12-9913-CF03F002008D",NA,848,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,145,"7436378C-E436-4ABA-A1AA-89314DCDCCCE","F9A04E0B-44CE-4244-B5EE-0531AF528535","4814950011_R01C01_Grn.idat","TCGA-61-1728-01A-01",90,0,NA,NA,0,"BOTTOM",15,NA,"TCGA-61-1728-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-61-1728-D28159",NA,NA,NA,"TCGA-61-1728-F28156_NTE-2",NA,848,"TUMOR FREE","Alive",NA,"TCGA-61-1728-F28156","TCGA-61-1728",NA,"61","1728","YES","C56.9","8441/3","C56.9",NA,NA,-21582,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",848,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
226970586,222377803,16425195253,"6D90549C-3B99-4DFC-996D-86211498A8C5.bw","08c64000-d320-4e4d-974b-da503d48890c","6d90549c-3b99-4dfc-996d-86211498a8c5","2016-08-25T14:47:06.751286-05:00","TCGA-24-1553-01A-01R-1566-13_rnaseq_fastq.tar","61e99db2-8ebc-4bf3-a5ff-3d90cd3495bb",13861826560,"Illumina HiSeq","4335bb19d3c86d4f1333ac34015833bc","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:07:28.907592-05:00","2016-05-03T11:39:34.528512-05:00","61e99db2-8ebc-4bf3-a5ff-3d90cd3495bb_analysis.xml","d3fcbeed9901c6ca162b1707d128e9ef","86bfed00-f195-44a1-a587-b69e9b1290e7",2181,"2016-09-29T22:44:59.017941-05:00","61e99db2-8ebc-4bf3-a5ff-3d90cd3495bb_experiment.xml","fecc87f3ad4e65e8f419580ed07d06c9","c310ab6b-7e5a-4557-afe0-066f3cfaef5c",3916,"2016-09-29T18:39:32.480801-05:00","61e99db2-8ebc-4bf3-a5ff-3d90cd3495bb_run.xml","cf99e8e0f49888206b83a3090d9842ab","2ab0e62e-bc25-4ce8-b9f4-3285297361bf",1988,"2016-09-08T12:33:53.138350-05:00","TCGA-24-1553","2016-09-02T19:07:18.028780-05:00","female","TCGA-24-1553_demographic",1944,"white","f6ba61ac-3f98-557c-ac57-f0a30a3dc22b","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1553_diagnosis","not reported",19393,"dead","8441/3",1767,1767,"0f6394e0-ad6b-55a6-bb34-cb34cbc020ef","c56.9",-19393,"TCGA-24-1553_treatment","2013ed67-c225-52e5-91aa-e926eaa05f58","01",NA,"TCGA-24-1553-01A","0.8","aefe6c18-3891-4c17-99d3-16931151d96e",FALSE,"5abe7782-ca53-4add-9a9a-01955859420b","Primary Tumor","0.4",NA,NA,"1.3",1235260800,"01",146,"TCGA-24-1553-01A-01",95,99,NA,NA,0,0,15,5,"2016-09-08T12:33:53.138350-05:00","2016-09-08T12:33:53.138350-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"ff75b56d-efb0-48ab-9ae2-ea6013bd6b85","335b5d27-d22e-4631-a772-ad33e0e3fc49","TCGA-24-1553-01A-01-BS1","TCGA-24-1553-01A-01-TS1",85,95,"98c06ac4-6186-444a-815a-552a1fbd4d78","RNA","TCGA-24-1553-01A-01R","19eacc97-9db1-45c1-87a7-d6609a843120",1.8,0.13,"UV Spec","R","22","TCGA-24-1553-01A-01R-1566-13","7c607e77-a353-4995-855b-36ccaaf3bde6",0.13,NA,NA,NA,NA,"ce400643-26ff-5ee3-8f94-8b8f4471e13c","TCGA-24-1553_exposure","TCGA-24-1553-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T07:21:35.000Z","2014-03-20T07:47:01.000Z","61E99DB2-8EBC-4BF3-A5FF-3D90CD3495BB","AEFE6C18-3891-4C17-99D3-16931151D96E","Unaligned reads",13861826560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7C607E77-A353-4995-855B-36CCAAF3BDE6","Canada's Michael Smith Genome Sciences Centre","564a3da4e4b093830b69fc28","08C64000-D320-4E4D-974B-DA503D48890C","Ovarian Serous Cystadenocarcinoma","TAR","98C06AC4-6186-444A-815A-552A1FBD4D78","2014-03-20T07:47:01.000Z","19EACC97-9DB1-45C1-87A7-D6609A843120","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"98C06AC4-6186-444A-815A-552A1FBD4D78",0.8,"24","APEEK_p_TCGA_GBM16-Ov15_Expr_HT_HG-U133A_96-HTA_B02_464072.CEL",NA,"TCGA-24-1553-01A",1.3,"F6CF4869-E5F8-4D25-80EA-1D2EDB7BE439","TCGA",1997,NA,NA,"WITH TUMOR","AEFE6C18-3891-4C17-99D3-16931151D96E",53,"TCGA-24-1553-01A-01W-0552-10_SOLiD.bam.bai","Dead",1767,"TCGA-24-1553",NA,"7622D214-FE68-459F-80A3-C4740B69AF22",NA,1767,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,146,"FF75B56D-EFB0-48AB-9AE2-EA6013BD6B85","87A7C96C-6B94-4211-81B4-788EA3E7B829","TCGA-24-1553-01A-01R-1566-13_mirna.bam","TCGA-24-1553-01A-01",99,0,NA,NA,5,"TOP",0,NA,"TCGA-24-1553-01A-01-TS1",95,"Topotecan","Chemotherapy","TCGA-24-1553-D26162",NA,NA,NA,"TCGA-24-1553-F26157_NTE-1",NA,1767,"WITH TUMOR","Dead",1767,"TCGA-24-1553-F26157","TCGA-24-1553",NA,"24","1553","YES","C56.9","8441/3","C56.9",NA,NA,-19393,"FEMALE","WHITE",NA,NA,"No","Dead",1767,1767,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
109545294,91888976,6567445203,"9254818C-EBD1-41E3-9EAB-47A86ECD3913.bw","09820a33-80b1-42d0-8366-a0ddaf94b122","9254818c-ebd1-41e3-9eab-47a86ecd3913","2016-08-25T14:53:35.196128-05:00","TCGA-30-1714-01A-02R-1567-13_rnaseq_fastq.tar","dd5fe41d-2fd5-4b06-aba4-ec9f7281b047",6252226560,"Illumina HiSeq","6f115455bcf73ae1bdaf1cf5133956f9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:11:04.336783-05:00","2016-05-03T11:41:05.740436-05:00","dd5fe41d-2fd5-4b06-aba4-ec9f7281b047_analysis.xml","8395e7f659aa41702e2181f298962f6d","18eadcb7-8692-4715-9b18-54146e3e0fe9",2208,"2016-09-29T20:55:51.699971-05:00","dd5fe41d-2fd5-4b06-aba4-ec9f7281b047_experiment.xml","6e805e11c164c30e13bf90901b69e534","7f69f24c-1b4f-4016-8e1d-ea9a3b35465e",3916,"2016-09-29T19:09:07.405241-05:00","dd5fe41d-2fd5-4b06-aba4-ec9f7281b047_run.xml","5843afc5bed26296b42c9b957db46a91","3d6c6777-684d-4d48-9f3a-97ba4d5a6a8e",1988,"2016-09-08T13:39:35.188940-05:00","TCGA-30-1714","2016-09-02T19:07:36.686996-05:00","female","TCGA-30-1714_demographic",1933,"white","490023f5-f2f1-5600-b594-3718d8334148","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1714_diagnosis","not reported",25032,"dead","8441/3",1158,1158,"8d5d54a4-1e71-57dd-aac3-36c47e241a56","c56.9",-25032,"TCGA-30-1714_treatment","b1df4a94-84bb-5f56-9709-b3580d2dcb0c","01",NA,"TCGA-30-1714-01A","0.4","44b8b591-5dd6-4b93-bd8f-d1c3284af41f",FALSE,"7bec7160-e40c-4b47-b0d6-93652c5e27f2","Primary Tumor","0.3",NA,NA,"0.6",1242345600,"02",140,"TCGA-30-1714-01A-02",85,85,NA,NA,0,0,38,23,"2016-09-08T13:39:35.188940-05:00","2016-09-08T13:39:35.188940-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"d9272491-1098-49d2-9bec-c1dfa452548d","d261005c-31b3-4a48-9530-3e24454a3d98","TCGA-30-1714-01A-01-BS1","TCGA-30-1714-01A-02-BS2",60,75,"bebcb16b-0070-47cc-b184-b6d0bdd05d08","RNA","TCGA-30-1714-01A-02R","4d91c2c6-6d27-461a-9e73-17051a1ede6f",1.8,0.15,"UV Spec","R","22","TCGA-30-1714-01A-02R-1567-13","c990f93e-c4e1-4192-b948-31a5bda0ff72",0.15,NA,NA,NA,NA,"be9daf86-84d7-564c-bff7-01df2898eed6","TCGA-30-1714_exposure","TCGA-30-1714-01A-02R-1567-13_rnaseq_fastq.tar","2014-03-27T01:19:36.000Z","2014-03-27T01:33:01.000Z","DD5FE41D-2FD5-4B06-ABA4-EC9F7281B047","44B8B591-5DD6-4B93-BD8F-D1C3284AF41F","Unaligned reads",6252226560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C990F93E-C4E1-4192-B948-31A5BDA0FF72","Canada's Michael Smith Genome Sciences Centre","564a5c42e4b0298dd2cc468b","09820A33-80B1-42D0-8366-A0DDAF94B122","Ovarian Serous Cystadenocarcinoma","TAR","BEBCB16B-0070-47CC-B184-B6D0BDD05D08","2014-03-27T01:33:01.000Z","4D91C2C6-6D27-461A-9E73-17051A1EDE6F","None","NO",1,0.3,"Primary Tumor","Harvard",NA,"BEBCB16B-0070-47CC-B184-B6D0BDD05D08",0.4,"30","4440716457_R01C02_Grn.idat",NA,"TCGA-30-1714-01A",0.6,"E1B0DBD2-3F76-4035-BD5A-4D21FB2D5EAD","TCGA",2001,NA,NA,"WITH TUMOR","44B8B591-5DD6-4B93-BD8F-D1C3284AF41F",68,"SAROS_p_TCGA_B18_SNP_N_GenomeWideSNP_6_G10_489790.hg18.seg.txt","Dead",1158,"TCGA-30-1714","NOT HISPANIC OR LATINO","32BAF547-650E-4412-8B72-977F2BFC79E6",NA,1158,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,"A8B44EF4-48DF-4042-8F23-7968857E10A0","WHITE",NA,2,140,"D9272491-1098-49D2-9BEC-C1DFA452548D","E432143F-BA68-4E3E-826A-21F3707ADB85","TCGA-30-1714-01A-02W-0633-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-30-1714-01A-02",85,0,NA,NA,38,"TOP",2,NA,"TCGA-30-1714-01A-01-BS1",60,"Armidex","Hormone Therapy","TCGA-30-1714-D27531","TCGA-30-1714-R27532","EXTERNAL BEAM","Distant Recurrence","TCGA-30-1714-F27518_NTE-1",NA,1158,"WITH TUMOR","Dead",1158,"TCGA-30-1714-F27518","TCGA-30-1714",NA,"30","1714","YES","C56.9","8441/3","C56.9",NA,NA,-25032,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1158,1158,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
216568054,208527669,15401036507,"3282F146-2782-4877-9EFE-6020AC277A8C.bw","09c77947-a333-4392-b18d-a6c1f08764a1","3282f146-2782-4877-9efe-6020ac277a8c","2016-08-25T13:50:22.599897-05:00","TCGA-24-1842-01A-01R-1567-13_rnaseq_fastq.tar","d3afda7e-b99a-46f8-8dd1-73a5f610801a",14042050560,"Illumina HiSeq","051bb16efc435aab02488b4b5ff182b9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:53:25.188992-05:00","2016-05-03T11:41:05.740763-05:00","d3afda7e-b99a-46f8-8dd1-73a5f610801a_analysis.xml","3ccc23290fe60a91bc97aa75ab01a2bb","7dded360-597f-480a-902e-31beae107cce",2181,"2016-09-29T19:11:47.704742-05:00","d3afda7e-b99a-46f8-8dd1-73a5f610801a_experiment.xml","f7e92d690a46ed48602fa8c6e62a3f91","3f170f49-65b4-41ee-9fc4-bc85bf41448a",3916,"2016-09-29T23:47:42.953558-05:00","d3afda7e-b99a-46f8-8dd1-73a5f610801a_run.xml","aa0485bde8597625c80e2b6ba20a01b3","ea0cbdf7-df7f-4b27-904b-5b2bd2416f2f",1988,"2016-09-08T11:00:08.452761-05:00","TCGA-24-1842","2016-09-02T18:47:43.030413-05:00","female","TCGA-24-1842_demographic",1960,"white","1002b6b2-c01e-55fc-80a0-ffb1512d7c36","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1842_diagnosis","not reported",18227,"alive","8441/3",NA,253,"53645a91-09b0-52fe-a6c3-029904ef194e","c56.9",-18227,"TCGA-24-1842_treatment","c994f920-7c4b-5e02-8f9e-f14efe9b945e","01",NA,"TCGA-24-1842-01A","0.7","8c53c83d-85c8-49b5-8838-cb0585c894b2",FALSE,"3465aae7-0664-44e5-a27f-c02fd73526a1","Primary Tumor","0.7",NA,NA,"1.5",1245024000,"01",123,"TCGA-24-1842-01A-01",85,85,0,0,0,0,15,15,"2016-09-08T11:00:08.452761-05:00","2016-09-08T11:00:08.452761-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"5d87953b-1468-4ca3-b2ce-035d657d7044","9934e7e4-d1e5-4f32-ae50-d290ef1c52eb","TCGA-24-1842-01A-01-TS1","TCGA-24-1842-01A-01-BS1",85,85,"0d9c9ad7-94e6-4c24-ae56-4e14ecfff704","RNA","TCGA-24-1842-01A-01R","6efc1dd3-9f0f-455f-8168-eaf97d7bdaca",1.8,0.16,"UV Spec","R","22","TCGA-24-1842-01A-01R-1567-13","6cb78602-e09f-4dbc-b3e5-684ebe77bddc",0.16,NA,NA,NA,NA,"55e9064e-5c40-5537-9b79-3e781abc16e6","TCGA-24-1842_exposure","TCGA-24-1842-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T20:44:06.000Z","2014-03-26T21:16:02.000Z","D3AFDA7E-B99A-46F8-8DD1-73A5F610801A","8C53C83D-85C8-49B5-8838-CB0585C894B2","Unaligned reads",14042050560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6CB78602-E09F-4DBC-B3E5-684EBE77BDDC","Canada's Michael Smith Genome Sciences Centre","564a37d2e4b0ef1218194c36","09C77947-A333-4392-B18D-A6C1F08764A1","Ovarian Serous Cystadenocarcinoma","TAR","0D9C9AD7-94E6-4C24-AE56-4E14ECFFF704","2014-03-26T21:16:02.000Z","6EFC1DD3-9F0F-455F-8168-EAF97D7BDACA","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"0D9C9AD7-94E6-4C24-AE56-4E14ECFFF704",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5dcf27b7-8966-4c46-a0f6-5a1450f60d1d.txt",NA,"TCGA-24-1842-01A",1.5,"DF6EA24C-564D-43A8-ADF8-78174C16894C","TCGA",2009,NA,NA,"TUMOR FREE","8C53C83D-85C8-49B5-8838-CB0585C894B2",49,"nationwidechildrens.org_clinical.TCGA-24-1842.xml","Alive",NA,"TCGA-24-1842",NA,"EA813AA8-DF86-407B-AEA1-092FB2C8608E",NA,253,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,123,"9934E7E4-D1E5-4F32-AE50-D290EF1C52EB","BF78BBE4-0866-4102-913C-8693FB7C84A1","da8127f3412615927164ae081168714a.bam.bai","TCGA-24-1842-01A-01",85,0,0,0,15,"TOP",0,0,"TCGA-24-1842-01A-01-TS1",85,"Carboplatin","Chemotherapy","TCGA-24-1842-D26326",NA,NA,NA,NA,NA,253,"TUMOR FREE","Alive",NA,"TCGA-24-1842-F26325","TCGA-24-1842",NA,"24","1842","YES","C56.9","8441/3","C56.9",NA,NA,-18227,"FEMALE","WHITE",NA,NA,"No","Alive",253,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
193292806,188274843,13953365631,"F93E0576-DD34-43BB-925D-56E9A03F14A2.bw","0a2d29de-869a-4dc8-ad11-6ee0d0a3a895","f93e0576-dd34-43bb-925d-56e9a03f14a2","2016-08-27T05:52:34.906541-05:00","TCGA-61-1736-01B-01R-1568-13_rnaseq_fastq.tar","5422975a-635b-4196-9a28-e17eb47910e8",12407490560,"Illumina HiSeq","cc850ac879a632e3b65a02af39ec9c6d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:34:41.136357-05:00","2016-05-03T11:56:42.628809-05:00","5422975a-635b-4196-9a28-e17eb47910e8_analysis.xml","79c62430d9973127edc9ce36f1a59d33","7229b3c9-f975-4401-b7d8-d7023af365d3",2181,"2016-09-29T18:33:53.906619-05:00","5422975a-635b-4196-9a28-e17eb47910e8_experiment.xml","0775de00852131eeab456630c14cbee9","26f8d02d-565b-492d-8b19-49a2a242e777",3916,"2016-09-29T18:32:56.199373-05:00","5422975a-635b-4196-9a28-e17eb47910e8_run.xml","e79fcf2a86db84b8ac4f224e2a7384a0","266167ec-cf30-470c-9475-8deb468792b6",1988,"2016-09-08T11:45:43.145919-05:00","TCGA-61-1736","2016-09-02T18:56:18.710803-05:00","female","TCGA-61-1736_demographic",1960,"white","939d1efe-bdfb-577a-94ee-c8c9e51b5fe6","not hispanic or latino",2009,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1736_diagnosis","not reported",16613,"dead","8441/3",1484,1484,"06cbb2ff-f89f-5c49-a700-1241cb4fa9f8","c56.9",-16613,"TCGA-61-1736_treatment","26cdbde5-ebec-5818-8d7a-29010209e452","01",NA,"TCGA-61-1736-01B","0.8","8a5f3650-3bfa-48f9-80c3-270b05daa00c",FALSE,"c034e484-683b-463c-999d-eb1fd9741292","Primary Tumor","0.4",NA,NA,"1",1250553600,"01",111,"TCGA-61-1736-01B-01",95,95,NA,NA,0,0,39,30,"2016-09-08T11:45:43.145919-05:00","2016-09-08T11:45:43.145919-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,0,"e4d5faf5-250e-4f99-bf5e-72d87d5ee298","c1c6008e-be3b-453c-8182-6392ee9a02a3","TCGA-61-1736-01B-01-BS1","TCGA-61-1736-01B-01-TS1",60,70,"3cd8c690-4247-4186-9dc2-a49b25e1e0a7","RNA","TCGA-61-1736-01B-01R","0756e41a-96ad-4994-b725-e505b0f66b19",1.8,0.14,"UV Spec","R","22","TCGA-61-1736-01B-01R-1568-13","89f1ae39-c387-4dff-be38-e3b7265222bb",0.14,NA,NA,NA,NA,"8a4e9f98-dbcb-5d79-834f-ddc219fa1bdf","TCGA-61-1736_exposure","TCGA-61-1736-01B-01R-1568-13_rnaseq_fastq.tar","2014-08-26T05:13:39.000Z","2014-08-26T07:49:13.000Z","5422975A-635B-4196-9A28-E17EB47910E8","8A5F3650-3BFA-48F9-80C3-270B05DAA00C","Unaligned reads",12407490560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","89F1AE39-C387-4DFF-BE38-E3B7265222BB","Canada's Michael Smith Genome Sciences Centre","564a3cebe4b093830b69c173","0A2D29DE-869A-4DC8-AD11-6EE0D0A3A895","Ovarian Serous Cystadenocarcinoma","TAR","3CD8C690-4247-4186-9DC2-A49B25E1E0A7","2014-08-26T07:49:13.000Z","0756E41A-96AD-4994-B725-E505B0F66B19","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"3CD8C690-4247-4186-9DC2-A49B25E1E0A7",0.8,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.de7da1bd-3d13-495a-a931-5ae952aa5ea3.txt",NA,"TCGA-61-1736-01B",1,"F0714214-07D4-4C41-9E61-B6470308EEA9","TCGA",2005,NA,NA,"WITH TUMOR","A55BF675-C2E5-46AD-BD02-6DC6FFD816AE",45,"nationwidechildrens.org_clinical.TCGA-61-1736.xml","Dead",1484,"TCGA-61-1736","NOT HISPANIC OR LATINO","DBEE91E2-9410-4570-9C69-8E43BEB8887D",NA,1484,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,111,"E4D5FAF5-250E-4F99-BF5E-72D87D5EE298","5379AEF5-98BD-4FBE-9745-B568EB6A5912","4828606024_E_Red.idat","TCGA-61-1736-01B-01",95,0,NA,NA,30,"TOP",0,NA,"TCGA-61-1736-01B-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-61-1736-D28178",NA,NA,NA,"TCGA-61-1736-F28175_NTE-2",NA,1484,"WITH TUMOR","Dead",1484,"TCGA-61-1736-F28175","TCGA-61-1736",NA,"61","1736","YES","C56.9","8441/3","C56.9",NA,NA,-16613,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1484,1484,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2005,"Excisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
255537046,247601989,18313979158,"2AE6AABF-F634-4A46-BC6B-950E7EC8E435.bw","0a48873a-092a-4b25-822b-b0b3c18c08a8","2ae6aabf-f634-4a46-bc6b-950e7ec8e435","2016-09-29T18:39:53.988497-05:00","TCGA-24-2024-01A-02R-1568-13_rnaseq_fastq.tar","7b5bbc92-1a3c-4660-9d24-1d996a7b50d3",16676689920,"Illumina HiSeq","8cebdc617cacdaec3a2278d43d5952b9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:57:52.941103-05:00","2016-05-03T11:41:05.740436-05:00","7b5bbc92-1a3c-4660-9d24-1d996a7b50d3_analysis.xml","b01909bbca5b45ba8ba41b79c8c678c0","109d5774-a229-42a2-98ec-94f768240157",2181,"2016-09-29T18:58:25.633698-05:00","7b5bbc92-1a3c-4660-9d24-1d996a7b50d3_experiment.xml","d3aec9801ecaad44a0037717e84739c9","36ae365a-2d61-4d07-b4cb-4262fdc1fdfa",3916,"2016-09-29T21:25:25.592069-05:00","7b5bbc92-1a3c-4660-9d24-1d996a7b50d3_run.xml","5f4fe9c8506fb8fa468c5dbf309fd791","91df5e2e-8cc7-4af4-94f6-3b75f7728783",1988,"2016-09-08T12:16:10.306076-05:00","TCGA-24-2024","2016-09-02T18:56:22.255729-05:00","female","TCGA-24-2024_demographic",1922,"black or african american","7d734828-adb9-5d7e-966d-8e0043300194","not reported",1998,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2024_diagnosis","not reported",26476,"dead","8441/3",1769,1769,"f6efd774-9d62-56da-95f2-00366dfc8c27","c56.9",-26476,"TCGA-24-2024_treatment","823f6596-b65d-5519-86f6-a5c4e5181b3b","01",NA,"TCGA-24-2024-01A","1","a3f8dcad-c42a-4070-80c4-782627bbaca2",FALSE,"4189cfa0-00c3-42fb-91b9-d2f4b4887061","Primary Tumor","0.5",NA,NA,"1.1",1248134400,"02",150,"TCGA-24-2024-01A-02",80,80,0,0,0,0,5,5,"2016-09-08T12:16:10.306076-05:00","2016-09-08T12:16:10.306076-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"bb2cc430-c917-437d-b85e-f8fb69028121","0467ab38-1f2d-4fbb-a6c4-0e38d2e0de33","TCGA-24-2024-01A-02-BS2","TCGA-24-2024-01A-01-BS1",95,95,"5fef661c-4dc0-4f82-8a73-48ab58399977","RNA","TCGA-24-2024-01A-02R","cd096a1b-cd16-4536-a498-0b946ebc7c5a",1.8,0.16,"UV Spec","R","22","TCGA-24-2024-01A-02R-1568-13","bdd5afb1-a251-4541-bbbe-0fcd1126a3ce",0.16,NA,NA,NA,NA,"0e20bc82-7865-5e12-b4c6-7dd726514a2a","TCGA-24-2024_exposure","TCGA-24-2024-01A-02R-1568-13_rnaseq_fastq.tar","2014-03-26T22:58:09.000Z","2014-03-26T23:51:02.000Z","7B5BBC92-1A3C-4660-9D24-1D996A7B50D3","A3F8DCAD-C42A-4070-80C4-782627BBACA2","Unaligned reads",16676689920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BDD5AFB1-A251-4541-BBBE-0FCD1126A3CE","Canada's Michael Smith Genome Sciences Centre","564a5afae4b09c884b278c88","0A48873A-092A-4B25-822B-B0B3C18C08A8","Ovarian Serous Cystadenocarcinoma","TAR","5FEF661C-4DC0-4F82-8A73-48AB58399977","2014-03-26T23:51:02.000Z","CD096A1B-CD16-4536-A498-0B946EBC7C5A","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"5FEF661C-4DC0-4F82-8A73-48AB58399977",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c3771a58-897b-4427-8dbb-70214f74dc03.txt",NA,"TCGA-24-2024-01A",1.1,"B6880A72-50BD-41C7-B4B8-360E632EB75C","TCGA",1994,NA,NA,"WITH TUMOR","A3F8DCAD-C42A-4070-80C4-782627BBACA2",72,"nationwidechildrens.org_clinical.TCGA-24-2024.xml","Dead",1769,"TCGA-24-2024",NA,"EA9BC46B-5020-4F83-98A5-BB896DF3F040",NA,1769,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,2,150,"BB2CC430-C917-437D-B85E-F8FB69028121","EFB017A7-D5FB-43CE-AA0D-1BEE98B86997","TCGA-24-2024-01A-02R-1568-13_rnaseq.bam.bai","TCGA-24-2024-01A-02",80,0,0,0,5,"BOTTOM",0,0,"TCGA-24-2024-01A-02-BS2",95,"Carboplatin","Chemotherapy","TCGA-24-2024-D26452",NA,NA,NA,"TCGA-24-2024-F26450_NTE-2",NA,1769,"WITH TUMOR","Dead",1769,"TCGA-24-2024-F26450","TCGA-24-2024",NA,"24","2024","YES","C56.9","8441/3","C56.9",NA,NA,-26476,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",1769,1769,NA,NA,"WITH TUMOR","NO",26,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,72,1994,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
221595674,216129473,16016974696,"EADF2ED9-D1DE-4676-9BBA-6DA0B61A8737.bw","0aa020cb-69d2-4235-a609-c279a133d8bb","eadf2ed9-d1de-4676-9bba-6da0b61a8737","2016-09-29T23:49:02.228392-05:00","TCGA-61-1737-01A-01R-1567-13_rnaseq_fastq.tar","8543a33c-c6d8-4c69-8157-84fac766e12f",14456545280,"Illumina HiSeq","cf581b18d1a1e4188a3c1b07c323d816","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:41:08.335950-05:00","2016-05-03T11:41:05.748550-05:00","8543a33c-c6d8-4c69-8157-84fac766e12f_analysis.xml","f9b54493edd980300b221c8b1d5a5246","76359831-e8ad-46c0-aa3b-d3a3ef57c196",2181,"2016-09-29T19:10:03.787365-05:00","8543a33c-c6d8-4c69-8157-84fac766e12f_experiment.xml","1918f7dc1cc5cf417e72def65f1124ec","3e00e0ab-edcf-4fa0-b12f-9118433c3d99",3916,"2016-09-29T20:22:15.567629-05:00","8543a33c-c6d8-4c69-8157-84fac766e12f_run.xml","d1dc6824893be97c489d0a4b280d2279","6aa1a00c-72c4-4f4d-b6a2-8c5b7a2b8423",1989,"2016-09-08T12:13:46.189332-05:00","TCGA-61-1737","2016-09-02T18:47:38.903472-05:00","female","TCGA-61-1737_demographic",1963,"white","7a541ca2-8c30-58c9-ad7e-ff1f0d75aa14","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1737_diagnosis","not reported",15515,"alive","8441/3",NA,1364,"12f72a04-d096-517f-b4d6-c4369f4a1bf6","c56.9",-15515,"TCGA-61-1737_treatment","bf28a79c-0327-5f7a-9371-c7dcce64526c","01",NA,"TCGA-61-1737-01A","0.3","782164d9-0804-48f7-bb97-a35ebfb0c372",FALSE,"2fa09bf8-8be5-411c-a9cf-16c12ed1390f","Primary Tumor","0.2",NA,NA,"0.7",1242518400,"01",84,"TCGA-61-1737-01A-01",85,90,NA,NA,0,0,0,0,"2016-09-08T12:13:46.189332-05:00","2016-09-08T12:13:46.189332-05:00",5,NA,NA,NA,"BOTTOM","TOP",5,10,"495692fd-b4aa-44fd-8373-fd64d0a04e02","bea088b8-a989-4ea3-9f43-3ea4138a8c40","TCGA-61-1737-01A-01-BS1","TCGA-61-1737-01A-01-TS1",95,90,"a3d8d731-8fdb-4967-ae4a-9839e43fb20d","RNA","TCGA-61-1737-01A-01R","1ec149d1-5a04-4501-b4cc-0fbabfe3ef7f",1.8,0.15,"UV Spec","R","22","TCGA-61-1737-01A-01R-1567-13","b442230a-d330-45da-adf7-76873d18645c",0.15,NA,NA,NA,NA,"1c1e55cc-254c-5c83-be98-1e92417e7aac","TCGA-61-1737_exposure","TCGA-61-1737-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T03:11:06.000Z","2014-03-29T03:41:02.000Z","8543A33C-C6D8-4C69-8157-84FAC766E12F","782164D9-0804-48F7-BB97-A35EBFB0C372","Unaligned reads",14456545280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B442230A-D330-45DA-ADF7-76873D18645C","Canada's Michael Smith Genome Sciences Centre","564a58b3e4b09c884b26ee1c","0AA020CB-69D2-4235-A609-C279A133D8BB","Ovarian Serous Cystadenocarcinoma","TAR","A3D8D731-8FDB-4967-AE4A-9839E43FB20D","2014-03-29T03:41:02.000Z","1EC149D1-5A04-4501-B4CC-0FBABFE3EF7F","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"A3D8D731-8FDB-4967-AE4A-9839E43FB20D",0.3,"61","bcgsc.ca.TCGA-61-1737-01A-01R-1567-13.hg19.bcgsc.ca.1.6.0.snv.vcf",NA,"TCGA-61-1737-01A",0.7,"BDE9B500-2BBC-4635-9B62-37438F743031","TCGA",2005,NA,NA,"TUMOR FREE","91BFFF29-5884-4491-8C5F-2A5FF108B38B",42,"nationwidechildrens.org_clinical.TCGA-61-1737.xml","Alive",NA,"TCGA-61-1737","NOT HISPANIC OR LATINO","36C9E79E-9559-4EB1-BC79-7274BE460B42",NA,1364,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,84,"BEA088B8-A989-4EA3-9F43-3EA4138A8C40","6D6043CD-FE8C-45E9-8FB6-6148F425AC5A","US82800149_251976010764_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","TCGA-61-1737-01A-01",85,0,NA,5,0,"BOTTOM",5,NA,"TCGA-61-1737-01A-01-BS1",95,"Carboplatin","Chemotherapy","TCGA-61-1737-D28184",NA,NA,NA,NA,NA,1364,"TUMOR FREE","Alive",NA,"TCGA-61-1737-F28182","TCGA-61-1737",NA,"61","1737","YES","C56.9","8441/3","C56.9",NA,NA,-15515,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1364,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,42,2005,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
294495666,286811334,21232914876,"2C30E6F2-734D-452C-8C31-4707DF7ED837.bw","0b2ea4b7-98bb-4190-b682-2c75b447c90a","2c30e6f2-734d-452c-8c31-4707df7ed837","2016-08-25T10:59:56.305797-05:00","TCGA-25-1314-01A-01R-1565-13_rnaseq_fastq.tar","6a1a6c64-7ffe-4ca5-b3dd-e563cf12a277",18767882240,"Illumina HiSeq","26890ab9f810547e45faca8ecee04fb0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:09:03.624169-05:00","2016-05-03T11:40:21.669427-05:00","6a1a6c64-7ffe-4ca5-b3dd-e563cf12a277_analysis.xml","4b8dc9cdc9298755019e8b3caea8e8e8","acd9c317-d179-4943-bcca-e43cbc24fed7",2181,"2016-09-29T18:06:23.181471-05:00","6a1a6c64-7ffe-4ca5-b3dd-e563cf12a277_experiment.xml","eb102bbff6f4594057fc7efb1890ceec","161152ad-4df8-4888-9aa2-63774635464f",3916,"2016-09-29T23:47:03.436540-05:00","6a1a6c64-7ffe-4ca5-b3dd-e563cf12a277_run.xml","a938053507c0ea72aeac729aeb531887","e9b588ec-d68e-4a0a-b2cd-459e2d75b7e5",1989,"2016-09-08T13:38:13.357934-05:00","TCGA-25-1314","2016-09-02T19:12:15.005214-05:00","female","TCGA-25-1314_demographic",1958,"white","e600b6c2-88c6-5447-835f-a71c482c6c16","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1314_diagnosis","not reported",15462,"dead","8441/3",1004,974,"f7caf6fe-7ab2-57f8-946d-0f328ad4f7c2","c56.9",-15462,"TCGA-25-1314_treatment","28bbfaef-289e-53bc-8bb0-f2e5cb461bf9","01",NA,"TCGA-25-1314-01A","2","a3d8fe02-63fa-40ff-9563-38e8d2bf04bb",FALSE,"B208F8AC-5F06-4DAD-A410-5D65D36674D6","Primary Tumor","0.8",NA,NA,"4.5",1228348800,"01",224,"TCGA-25-1314-01A-01",98,98,NA,NA,0,0,5,2,"2016-09-08T13:38:13.357934-05:00","2016-09-08T13:38:13.357934-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"c973eb70-6985-4890-b86b-1a477823b641","9b4cf016-a495-48c9-b3dc-8ae0663d66e7","TCGA-25-1314-01A-01-BS1","TCGA-25-1314-01A-01-TS1",95,98,"94bf9903-be03-43eb-a2a9-5256db63579b","RNA","TCGA-25-1314-01A-01R","c779b142-8190-40f2-b8e7-3d291daaac08",1.8,0.15,"UV Spec","R","22","TCGA-25-1314-01A-01R-1565-13","b571f7cf-e9b8-493f-822b-a489f114420b",0.15,NA,NA,NA,NA,"f754e85f-87ad-5677-b331-2bb29952f552","TCGA-25-1314_exposure","TCGA-25-1314-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T06:53:09.000Z","2014-03-22T07:27:02.000Z","6A1A6C64-7FFE-4CA5-B3DD-E563CF12A277","A3D8FE02-63FA-40FF-9563-38E8D2BF04BB","Unaligned reads",18767882240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B571F7CF-E9B8-493F-822B-A489F114420B","Canada's Michael Smith Genome Sciences Centre","564a59ace4b0ef12181d9f3d","0B2EA4B7-98BB-4190-B682-2C75B447C90A","Ovarian Serous Cystadenocarcinoma","TAR","94BF9903-BE03-43EB-A2A9-5256DB63579B","2014-03-22T07:27:02.000Z","C779B142-8190-40F2-B8E7-3D291DAAAC08","None","NO",1,0.8,"Primary Tumor","Mayo Clinic - Rochester",NA,"94BF9903-BE03-43EB-A2A9-5256DB63579B",2,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b17945ba-39d6-400d-8e3e-e81123595c51.txt",NA,"TCGA-25-1314-01A",4.5,"579CE73B-269E-4C24-894B-9066EDF721FB","TCGA",2000,NA,NA,"WITH TUMOR","A3D8FE02-63FA-40FF-9563-38E8D2BF04BB",42,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b17945ba-39d6-400d-8e3e-e81123595c51.txt","Dead",1004,"TCGA-25-1314","NOT HISPANIC OR LATINO","FE94FAD3-1F4C-4204-AD9B-D8A1AB9B75CC",NA,974,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,224,"C973EB70-6985-4890-B86B-1A477823B641","D0738A67-3E8D-48B5-8235-8F39BE022707","4635311006_A_Red.idat","TCGA-25-1314-01A-01",98,0,NA,NA,2,"TOP",0,NA,"TCGA-25-1314-01A-01-TS1",98,"Carbo","Chemotherapy","TCGA-25-1314-D26634",NA,NA,NA,"TCGA-25-1314-F26633_NTE-2",NA,974,"WITH TUMOR","Dead",1004,"TCGA-25-1314-F26633","TCGA-25-1314",NA,"25","1314","YES","C56.9","8441/3","C56.9",NA,NA,-15462,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",974,1004,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,42,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
229416988,219861155,16259857817,"9332FEF9-623A-4234-B6A9-D200E32A5A85.bw","0ba7b6cc-e5f5-47d7-859a-24e31aa336ab","9332fef9-623a-4234-b6a9-d200e32a5a85","2016-09-29T21:27:28.124698-05:00","TCGA-13-0908-01B-01R-1565-13_rnaseq_fastq.tar","6c027cbf-48e5-456c-bf2d-c8a1bc67301f",15035555840,"Illumina HiSeq","e7e7869aa200ec2b5fab0285c2fa03bf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:50:57.411059-05:00","2016-05-03T11:40:21.669427-05:00","6c027cbf-48e5-456c-bf2d-c8a1bc67301f_analysis.xml","8403620c0c799b574b8107b7df1f33db","a1abedb6-22e9-4a73-ad6d-4df576abb9ad",2210,"2016-08-26T18:03:04.750301-05:00","6c027cbf-48e5-456c-bf2d-c8a1bc67301f_experiment.xml","6d8e669639d63d3d258351d22558ff08","e3a94549-d74a-4902-8789-cfe1da707426",3916,"2016-09-29T19:12:02.609546-05:00","6c027cbf-48e5-456c-bf2d-c8a1bc67301f_run.xml","092098c487b8eb5d235729068f45ed84","3f4081b9-a531-4655-a324-bb70a9a7d0fc",1989,"2016-09-08T13:35:58.456844-05:00","TCGA-13-0908","2016-09-02T19:12:01.269928-05:00","female","TCGA-13-0908_demographic",1947,"white","0efe3097-e953-59c4-8eb1-a4d8d5c68285","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0908_diagnosis","not reported",21422,"dead","8441/3",1843,1364,"c01d98f7-34f8-57cb-9d1c-53780e4956b8","c56.9",-21422,"TCGA-13-0908_treatment","b1adcf6a-97c0-5251-8054-aa11a5482e16","01",NA,"TCGA-13-0908-01B","1.3","b2f596ea-10ad-4a17-aea3-88756fb0b7f9",FALSE,"AE735D44-31EA-4345-9B3E-E92C7F236569","Primary Tumor","0.3",NA,NA,"1.4",1230508800,"01",101,"TCGA-13-0908-01B-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:35:58.456844-05:00","2016-09-08T13:35:58.456844-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"ee2524ac-c719-4a1f-8e39-a71d08e033dc","c5bc1ddd-1c6c-4ab1-aee0-e0885990e553","TCGA-13-0908-01B-01-TS1","TCGA-13-0908-01B-01-BS1",90,90,"8069502b-1ce4-47d8-b97e-0ae489ba44e4","RNA","TCGA-13-0908-01B-01R","b90ed610-0c26-4ca1-b285-a399551ae178",1.8,0.17,"UV Spec","R","22","TCGA-13-0908-01B-01R-1565-13","5324831d-94be-40c6-bcb1-5b29bbbaab1b",0.17,NA,NA,NA,NA,"d283533a-af74-5484-8c6f-5085f46b68a1","TCGA-13-0908_exposure","TCGA-13-0908-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:06:12.000Z","2014-03-22T07:32:01.000Z","6C027CBF-48E5-456C-BF2D-C8A1BC67301F","B2F596EA-10AD-4A17-AEA3-88756FB0B7F9","Unaligned reads",15035555840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5324831D-94BE-40C6-BCB1-5B29BBBAAB1B","Canada's Michael Smith Genome Sciences Centre","564a4068e4b09c884b25daf9","0BA7B6CC-E5F5-47D7-859A-24E31AA336AB","Ovarian Serous Cystadenocarcinoma","TAR","8069502B-1CE4-47D8-B97E-0AE489BA44E4","2014-03-22T07:32:01.000Z","B90ED610-0C26-4CA1-B285-A399551AE178","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"8069502B-1CE4-47D8-B97E-0AE489BA44E4",1.3,"13","TCGA-13-0908-01B-01R-1565-13_rnaseq_fastq.tar",NA,"TCGA-13-0908-01B",1.4,"E0AE3A10-31DD-43B6-B2F1-BEBF0FC5128B","TCGA",2005,NA,NA,"WITH TUMOR","B2F596EA-10AD-4A17-AEA3-88756FB0B7F9",58,"nationwidechildrens.org_clinical.TCGA-13-0908.xml","Alive",NA,"TCGA-13-0908","NOT HISPANIC OR LATINO","93339BF4-F92D-41ED-BBA7-29236A13CCD3",NA,1364,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,101,"C5BC1DDD-1C6C-4AB1-AEE0-E0885990E553","150C0942-04CC-46A9-819C-5910E9F4BF3F","TCGA-13-0908-01B-01R-1565-13_rnaseq_fastq.tar","TCGA-13-0908-01B-01",90,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-13-0908-01B-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-13-0908-D24740",NA,NA,NA,"TCGA-13-0908-F24739_NTE-1",NA,1364,"WITH TUMOR","Alive",NA,"TCGA-13-0908-F24739","TCGA-13-0908",NA,"13","0908","YES","C56.9","8441/3","C56.9",NA,NA,-21422,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1364,NA,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2005,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
122604644,116188817,8525153087,"DF7F3E76-D200-410B-9A31-DA4EF3D03860.bw","0c1a2e7d-e7e4-481e-a012-ef214c444497","df7f3e76-d200-410b-9a31-da4ef3d03860","2016-09-29T23:30:47.805649-05:00","TCGA-04-1542-01A-01R-1566-13_rnaseq_fastq.tar","b5b538b3-b571-40b6-91d7-7e0b621c6dc4",7580928000,"Illumina HiSeq","6f48bdd48ec905b6da9d778bdcd4e074","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:58:05.175326-05:00","2016-05-03T11:40:21.648199-05:00","b5b538b3-b571-40b6-91d7-7e0b621c6dc4_analysis.xml","cfe0b2a4491c3a9abdf9cbfa9aff5195","cb247e5e-d2ed-465e-bd01-be5a2cf39125",2265,"2016-08-26T00:23:38.622087-05:00","b5b538b3-b571-40b6-91d7-7e0b621c6dc4_experiment.xml","4effad72ecc66a35a96dfca83f7dd470","75143dd4-6ce3-4ab5-b1cc-17f9ba3f413e",3916,"2016-09-29T21:54:58.038944-05:00","b5b538b3-b571-40b6-91d7-7e0b621c6dc4_run.xml","7a72dd463b4d46584bab08ba48e14ea9","a43bc281-1b14-4bd3-83bc-d4ed3775a50d",1988,"2016-09-08T13:05:26.258174-05:00","TCGA-04-1542","2016-09-02T19:07:14.338553-05:00","female","TCGA-04-1542_demographic",1949,"white","fb7f748c-1e48-553a-aa93-63181a69f871","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1542_diagnosis","not reported",19263,"dead","8441/3",2561,NA,"5c54e4c7-4168-5896-9e70-26530bcbb200","c56.9",-19263,"TCGA-04-1542_treatment","38e25d4e-a949-58c6-a84d-461f854c58fc","01",NA,"TCGA-04-1542-01A","0.8","d33fd264-13db-4642-afca-37125751cc28",FALSE,"E3103C8A-50CB-43FE-9670-2BFB5D1DC318","Primary Tumor","0.3",NA,NA,"1",1235001600,"01",115,"TCGA-04-1542-01A-01",80,80,NA,NA,42,0,0,20,"2016-09-08T13:05:26.258174-05:00","2016-09-08T13:05:26.258174-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,1,"ab989ce3-156d-40d7-96ff-88a9f77206d2","962fd94a-59f6-49c3-8354-79631e5e19f8","TCGA-04-1542-01A-01-BS1","TCGA-04-1542-01A-01-TS1",63,79,"d531b928-89db-479f-b0d4-94f1ff35f896","RNA","TCGA-04-1542-01A-01R","514a6c1d-2234-4a52-9a94-b81b17f70bcb",1.8,0.13,"UV Spec","R","22","TCGA-04-1542-01A-01R-1566-13","2988eb13-a2c0-4cd2-a559-76f0cce2689b",0.13,NA,NA,NA,NA,"90727d68-af43-5809-a980-a5c2b8e09875","TCGA-04-1542_exposure","TCGA-04-1542-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T05:48:55.000Z","2014-03-25T06:09:01.000Z","B5B538B3-B571-40B6-91D7-7E0B621C6DC4","D33FD264-13DB-4642-AFCA-37125751CC28","Unaligned reads",7580928000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2988EB13-A2C0-4CD2-A559-76F0CCE2689B","Canada's Michael Smith Genome Sciences Centre","564a5b51e4b09c884b27a1de","0C1A2E7D-E7E4-481E-A012-EF214C444497","Ovarian Serous Cystadenocarcinoma","TAR","D531B928-89DB-479F-B0D4-94F1FF35F896","2014-03-25T06:09:01.000Z","514A6C1D-2234-4A52-9A94-B81B17F70BCB","None","NO",1,0.3,"Primary Tumor","Gynecologic Oncology Group",NA,"D531B928-89DB-479F-B0D4-94F1FF35F896",0.8,"04","TCGA-04-1542-01A-01R-1566-13.hg19.spljxn.quantification.txt",NA,"TCGA-04-1542-01A",1,"F22E4162-0E7A-4685-A9F9-F8C7C4413FB7","TCGA",2001,NA,NA,"WITH TUMOR","E7585F75-4992-4C50-8C61-6508A2BDA898",52,"nationwidechildrens.org_clinical.TCGA-04-1542.xml","Dead",2561,"TCGA-04-1542",NA,"6C66CB68-4C55-4A8A-9241-99A2F36BC6FD",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,115,"AB989CE3-156D-40D7-96FF-88A9F77206D2","F7E3867E-9533-4712-9F18-820A75BCDD56","COOKY_p_TCGAb15_ICPp3_061909_GenomeWideSNP_6_D04_465786.tangent.copynumber.data.txt","TCGA-04-1542-01A-01",80,42,NA,NA,0,"BOTTOM",5,NA,"TCGA-04-1542-01A-01-BS1",63,"Paclitaxel","Chemotherapy","TCGA-04-1542-D24119",NA,NA,NA,"TCGA-04-1542-F24118_NTE-1",NA,NA,"WITH TUMOR","Dead",2561,"TCGA-04-1542-F24118","TCGA-04-1542",NA,"04","1542","YES","C56.9","8441/3","C56.9",NA,NA,-19263,"FEMALE","WHITE",NA,NA,"No","Dead",NA,2561,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2001,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
139670332,134369466,9914947534,"D2A74F41-5391-4D1B-BC43-3FCCBD9F8600.bw","0d23fa5b-95f8-4626-a4d2-c72ad3cc553b","d2a74f41-5391-4d1b-bc43-3fccbd9f8600","2016-08-26T14:32:47.791946-05:00","TCGA-13-0720-01A-01R-1564-13_rnaseq_fastq.tar","f613f5e4-6cc2-46db-992b-c1a146ed8aac",8544409600,"Illumina HiSeq","6c586b03f20174818367a0032db46eb2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:35:03.062464-05:00","2016-05-03T11:41:05.750744-05:00","f613f5e4-6cc2-46db-992b-c1a146ed8aac_analysis.xml","1d8c441a2dea33bd284cd524ea583c2a","bce11a73-e515-4d8e-aaee-2cceb2b190b5",2235,"2016-09-29T21:37:43.991266-05:00","f613f5e4-6cc2-46db-992b-c1a146ed8aac_experiment.xml","28610262d4aa7eb5e2ae27abaebb0c04","9975db20-86a5-49c7-8e44-e1996e21101c",3916,"2016-09-29T19:16:12.656465-05:00","f613f5e4-6cc2-46db-992b-c1a146ed8aac_run.xml","63c22fcea6449dffc80bdaaf97658348","41e3b7b3-a22d-453d-9165-976672d2ba3e",1988,"2016-09-08T13:55:13.721508-05:00","TCGA-13-0720","2016-09-02T19:09:24.688005-05:00","female","TCGA-13-0720_demographic",1953,"white","4361c0b6-dffe-5928-aabe-49e87f1a9447","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0720_diagnosis","not reported",17799,"dead","8441/3",1355,1355,"2946e499-dcfb-57a8-8e37-07c35d2228f7","c56.9",-17799,"TCGA-13-0720_treatment","52c3f16b-43d6-5f3b-b00b-54f81ff2d588","01",NA,"TCGA-13-0720-01A","1.2","5c315f82-d4ac-40fd-9cc2-c4bc61286f8e",FALSE,"0A196866-A083-40AC-90E3-5ECA3B141645","Primary Tumor","0.5",NA,NA,"8",1233705600,"01",112,"TCGA-13-0720-01A-01",88,94,NA,NA,10,5,2,1,"2016-09-08T13:55:13.721508-05:00","2016-09-08T13:55:13.721508-05:00",80,NA,20,NA,"TOP","BOTTOM",3,1,"c541bfd4-c049-4fad-ae6d-efc62810bd60","4e8d3836-a57b-4629-93ae-36e54976447d","TCGA-13-0720-01A-01-TS1","TCGA-13-0720-01A-01-BS1",85,93,"1b5d3a07-44a3-4664-b155-500cf5c950fe","RNA","TCGA-13-0720-01A-01R","3412cfba-f90e-4653-b191-9787b2359a9c",1.8,0.16,"UV Spec","R","22","TCGA-13-0720-01A-01R-1564-13","1fe43034-df2b-4bef-be77-07dbb68083a4",0.16,NA,NA,NA,NA,"005392b9-6e68-5d2c-a54a-6c1c6e06ec05","TCGA-13-0720_exposure","TCGA-13-0720-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T16:00:58.000Z","2014-03-28T16:24:02.000Z","F613F5E4-6CC2-46DB-992B-C1A146ED8AAC","5C315F82-D4AC-40FD-9CC2-C4BC61286F8E","Unaligned reads",8544409600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1FE43034-DF2B-4BEF-BE77-07DBB68083A4","Canada's Michael Smith Genome Sciences Centre","564a3f52e4b0ef12181bb1c2","0D23FA5B-95F8-4626-A4D2-C72AD3CC553B","Ovarian Serous Cystadenocarcinoma","TAR","1B5D3A07-44A3-4664-B155-500CF5C950FE","2014-03-28T16:24:02.000Z","3412CFBA-F90E-4653-B191-9787B2359A9C","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"1B5D3A07-44A3-4664-B155-500CF5C950FE",1.2,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5864cd1e-a0da-4553-b12b-75f8941ecbab.txt",NA,"TCGA-13-0720-01A",8,"AEA4D94C-BF50-4440-A9A6-8E32D97645AF","TCGA",2001,NA,NA,"WITH TUMOR","5C315F82-D4AC-40FD-9CC2-C4BC61286F8E",48,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5864cd1e-a0da-4553-b12b-75f8941ecbab.txt","Dead",1355,"TCGA-13-0720","NOT HISPANIC OR LATINO","7DA47E49-E807-4F7F-834C-1ADE13ACA50C",NA,1355,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,112,"C541BFD4-C049-4FAD-AE6D-EFC62810BD60","F606E904-8826-49D8-99AC-1E8C5F8F5FDF","COTES_p_TCGAaffxB8_9a_S_GenomeWideSNP_6_H08_293078.tangent.copynumber.data.txt","TCGA-13-0720-01A-01",88,10,NA,80,2,"TOP",3,20,"TCGA-13-0720-01A-01-TS1",85,"Paclitaxel","Chemotherapy","TCGA-13-0720-D24500",NA,NA,NA,"TCGA-13-0720-F24498_NTE-1",NA,1355,"WITH TUMOR","Dead",1355,"TCGA-13-0720-F24498","TCGA-13-0720",NA,"13","0720","YES","C56.9","8441/3","C56.9",NA,NA,-17799,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1355,1355,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,48,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
167726546,164620609,12180190042,"804CD40E-0E8B-4AF9-8C07-9CB92B1EF049.bw","0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8","804cd40e-0e8b-4af9-8c07-9cb92b1ef049","2016-08-25T21:47:06.240985-05:00","TCGA-13-1403-01A-01R-1565-13_rnaseq_fastq.tar","6d2a94e2-e81f-4c53-961c-7f83908b4965",10328412160,"Illumina HiSeq","e0615202d4daff074b99e136b1130d85","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:20:59.943513-05:00","2016-05-03T11:40:21.648680-05:00","6d2a94e2-e81f-4c53-961c-7f83908b4965_analysis.xml","4697b8d3ba1dac3ba40476ffdd0cd3cc","b411e0d3-4ec5-43c1-9c29-4f89a46b024e",2181,"2016-09-29T17:39:09.460074-05:00","6d2a94e2-e81f-4c53-961c-7f83908b4965_experiment.xml","61f66d8bba119ee49a574c82c91f5569","04a27201-98cb-4fed-bd1d-1a1a07efed99",3916,"2016-09-29T18:54:17.602285-05:00","6d2a94e2-e81f-4c53-961c-7f83908b4965_run.xml","883694833b3db3d5f5ccde925daf1d6a","3410201b-c705-4214-88d7-c59e103b3d27",1988,"2016-09-08T13:19:11.861043-05:00","TCGA-13-1403","2016-09-02T19:12:17.758253-05:00","female","TCGA-13-1403_demographic",1960,"white","cd835f8d-6b5c-5b52-b9f3-6392a04c6f1e","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1403_diagnosis","not reported",17697,"dead","8441/3",2345,331,"2bb5937a-3659-5c77-a650-35e461810f1f","c56.9",-17697,"TCGA-13-1403_treatment","71a4ee5b-ad87-5777-a700-f569bd948d39","01",NA,"TCGA-13-1403-01A","0.9","62043d1b-2c38-4c45-abd0-97ff2f77176b",FALSE,"435619AB-01F5-4AC3-8D28-A8CC0054699F","Primary Tumor","0.4",NA,NA,"1.2",1230508800,"01",134,"TCGA-13-1403-01A-01",95,90,NA,NA,0,0,5,10,"2016-09-08T13:19:11.861043-05:00","2016-09-08T13:19:11.861043-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,5,"ac764ada-e3f7-4b8e-9ba5-6a15e4d53224","d9d6de3c-5c5c-4966-b028-b914002e89c6","TCGA-13-1403-01A-01-BS1","TCGA-13-1403-01A-01-TS1",94,85,"ba5b371b-b766-4d1e-aedf-cb0d3e28eb55","RNA","TCGA-13-1403-01A-01R","f2e8f2b2-85f8-44da-9d17-db980ca34dbe",1.8,0.17,"UV Spec","R","22","TCGA-13-1403-01A-01R-1565-13","3217dd54-d41c-4c63-8bab-ff2c4baaee10",0.17,NA,NA,NA,NA,"d513531f-1601-5c54-a6c3-fd27dd7ad2ec","TCGA-13-1403_exposure","TCGA-13-1403-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:56:18.000Z","2014-03-21T23:18:01.000Z","6D2A94E2-E81F-4C53-961C-7F83908B4965","62043D1B-2C38-4C45-ABD0-97FF2F77176B","Unaligned reads",10328412160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3217DD54-D41C-4C63-8BAB-FF2C4BAAEE10","Canada's Michael Smith Genome Sciences Centre","564a3dece4b093830b6a124a","0D5E232D-5AA2-4F6F-BE58-FFD5F15EE0B8","Ovarian Serous Cystadenocarcinoma","TAR","BA5B371B-B766-4D1E-AEDF-CB0D3E28EB55","2014-03-21T23:18:01.000Z","F2E8F2B2-85F8-44DA-9D17-DB980CA34DBE","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"BA5B371B-B766-4D1E-AEDF-CB0D3E28EB55",0.9,"13","TCGA-13-1403-01A-01R-1565-13_rnaseq_fastq.tar",NA,"TCGA-13-1403-01A",1.2,"F08D91EB-9A00-43AD-89CE-B0780A1D9BF4","TCGA",2008,NA,NA,"TUMOR FREE","62043D1B-2C38-4C45-ABD0-97FF2F77176B",48,"nationwidechildrens.org_clinical.TCGA-13-1403.xml","Alive",NA,"TCGA-13-1403","NOT HISPANIC OR LATINO","1B8EBF1F-79F6-4198-AD79-00CEC38EF301",NA,331,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,134,"D9D6DE3C-5C5C-4966-B028-B914002E89C6","F2E8F2B2-85F8-44DA-9D17-DB980CA34DBE","4520661046_R01C01_Grn.idat","TCGA-13-1403-01A-01",90,0,NA,NA,10,"TOP",5,NA,"TCGA-13-1403-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-13-1403-D24794",NA,NA,NA,NA,NA,331,"TUMOR FREE","Alive",NA,"TCGA-13-1403-F24793","TCGA-13-1403",NA,"13","1403","YES","C56.9","8441/3","C56.9",NA,NA,-17697,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",331,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,48,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
197120706,183209266,13532678782,"C945DDA9-0194-46F4-89E2-13883284D5A4.bw","0de910b1-edaf-47e4-a265-727ee12ac1c3","c945dda9-0194-46f4-89e2-13883284d5a4","2016-08-26T11:26:53.224819-05:00","TCGA-13-0797-01A-01R-1564-13_rnaseq_fastq.tar","09958d2a-6ce7-41b4-bdec-62892c793ce8",13089832960,"Illumina HiSeq","ade3d714cf636dc2f9ae335accd450d9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:21:49.549922-05:00","2016-05-03T11:39:34.522989-05:00","09958d2a-6ce7-41b4-bdec-62892c793ce8_analysis.xml","945109e8b008850e51939e092d5a8576","1f71595f-93ec-40b8-b8da-3fbec98ecc05",2210,"2016-08-28T07:43:05.993920-05:00","09958d2a-6ce7-41b4-bdec-62892c793ce8_experiment.xml","2e96381a56a1ac80f7ac041ea8320fa8","d8ae6090-b4b5-496f-b991-25ed7b57ee32",3916,"2016-09-29T22:58:05.345628-05:00","09958d2a-6ce7-41b4-bdec-62892c793ce8_run.xml","6f505cbe564d4e31b4e7881778bf96b9","cb24cf24-d44f-4e25-a3b9-b0fd145110cc",1990,"2016-09-08T13:24:06.072543-05:00","TCGA-13-0797","2016-09-02T19:09:33.024199-05:00","female","TCGA-13-0797_demographic",1959,"white","000181a9-73a5-5da4-9bf0-5e025cfce047","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0797_diagnosis","not reported",18051,"alive","8441/3",NA,2121,"1721bac4-b2e8-508d-8b99-aed22fef7600","c56.9",-18051,"TCGA-13-0797_treatment","a8e3feee-1dca-5f8c-845b-80182d750816","01",NA,"TCGA-13-0797-01A","1.2","52f8884e-c99a-44ae-8d74-6b219070902e",FALSE,"84ED21CA-E018-44C5-86E4-57927ABBCC9A","Primary Tumor","0.3",NA,NA,"1.6",1233705600,"01",168,"TCGA-13-0797-01A-01",98,98,NA,NA,0,0,10,5,"2016-09-08T13:24:06.072543-05:00","2016-09-08T13:24:06.072543-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"35def05e-dee8-4875-8efd-c2262c07de5c","f73bb3f4-9dac-462a-bbb7-feec138ebf1d","TCGA-13-0797-01A-01-BS1","TCGA-13-0797-01A-01-TS1",90,95,"75597933-0277-4317-b823-db8e18243b37","RNA","TCGA-13-0797-01A-01R","7b94e812-0557-4637-b045-63ba6fe7e764",1.8,0.15,"UV Spec","R","22","TCGA-13-0797-01A-01R-1564-13","9bd35257-52b8-4277-9cc9-48c5f316932b",0.15,NA,NA,NA,NA,"1a91bf4d-e735-55ca-ab18-5d8eb86750ed","TCGA-13-0797_exposure","TCGA-13-0797-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T02:42:42.000Z","2014-03-20T03:09:02.000Z","09958D2A-6CE7-41B4-BDEC-62892C793CE8","52F8884E-C99A-44AE-8D74-6B219070902E","Unaligned reads",13089832960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9BD35257-52B8-4277-9CC9-48C5F316932B","Canada's Michael Smith Genome Sciences Centre","564a5c5fe4b0ef12181e521b","0DE910B1-EDAF-47E4-A265-727EE12AC1C3","Ovarian Serous Cystadenocarcinoma","TAR","75597933-0277-4317-B823-DB8E18243B37","2014-03-20T03:09:02.000Z","7B94E812-0557-4637-B045-63BA6FE7E764","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"75597933-0277-4317-B823-DB8E18243B37",1.2,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0a64d08c-7d28-4c74-ab75-2ff02f1a4de0.txt",NA,"TCGA-13-0797-01A",1.6,"D8CA87B3-32A4-4FAD-9419-710FF00E2CB0","TCGA",2008,NA,NA,"TUMOR FREE","AF85DF9A-2286-49B4-B795-07D8B6AD2368",49,"TCGA-13-0797-01A-01R-1564-13.exon.quantification.txt","Alive",NA,"TCGA-13-0797","NOT HISPANIC OR LATINO",NA,NA,265,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,168,"F73BB3F4-9DAC-462A-BBB7-FEEC138EBF1D","5C7645F9-44DF-45E1-B270-290D933D3126","TCGA-13-0797-01A-01R-1564-13.isoform.quantification.txt","TCGA-13-0797-01A-01",98,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-13-0797-01A-01-BS1",90,"Paclitaxel","Chemotherapy","TCGA-13-0797-D24608",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0797",NA,"13","0797","YES","C56.9","8441/3","C56.9",NA,NA,-18051,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",265,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
294664242,282219552,20835626042,"79B11925-9772-474F-A729-D00315959710.bw","0e1598d8-cbe5-4113-95f1-4bcda061239b","79b11925-9772-474f-a729-d00315959710","2016-08-25T19:53:34.872709-05:00","TCGA-29-1702-01A-01R-1567-13_rnaseq_fastq.tar","eee56b6f-54d7-4f20-945e-658860e57507",19492536320,"Illumina HiSeq","6114c5253165f577995c3422fccbc388","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:15:12.089115-05:00","2016-05-03T11:41:05.748550-05:00","eee56b6f-54d7-4f20-945e-658860e57507_analysis.xml","2e394b9fc6fd318a8cd254b4f20ee085","fafb3527-89f6-4b28-b934-4b87ce3671b3",2181,"2016-09-29T22:46:29.182757-05:00","eee56b6f-54d7-4f20-945e-658860e57507_experiment.xml","3487129f19594d2fe03de896996ae832","c405afa9-dfad-46b8-b837-d8fd0539d1e6",3916,"2016-09-29T21:54:02.431079-05:00","eee56b6f-54d7-4f20-945e-658860e57507_run.xml","ba7780a93d4ee2bc464b3ac6da1bc18f","a3a04101-5f9a-4805-90ca-1104caf82919",1989,"2016-09-08T12:26:20.811115-05:00","TCGA-29-1702","2016-09-02T19:07:22.732172-05:00","female","TCGA-29-1702_demographic",1921,"white","10173208-9da8-5d9c-abe6-266dc021e80f","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1702_diagnosis","not reported",30910,"dead","8441/3",728,568,"cbd53dd3-17ba-5e10-ab96-f4be6dbbfcd2","c56.9",-30910,"TCGA-29-1702_treatment","2c115c8a-cfca-52d0-8c1b-8cecf9f8a4c8","01",NA,"TCGA-29-1702-01A","0.7","7150c48b-144f-40f0-b4d0-e4b34e35556d",FALSE,"f825bb6c-afc2-48ea-9286-09c09c7e9918","Primary Tumor","0.5",NA,NA,"1.2",1242086400,"01",133,"TCGA-29-1702-01A-01",95,95,NA,NA,0,0,0,0,"2016-09-08T12:26:20.811115-05:00","2016-09-08T12:26:20.811115-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,2,"37bc8232-0f2b-4d01-b6a2-9ce4059d88dc","d7ec5a33-2840-4e3b-a587-272f42e1ffc9","TCGA-29-1702-01A-01-BS1","TCGA-29-1702-01A-01-TS1",98,98,"3b14fd3e-0460-4955-8b4f-64ab3ef5e27e","RNA","TCGA-29-1702-01A-01R","53896bca-46ae-4b02-9c8b-d96cb5991b54",1.8,0.15,"UV Spec","R","22","TCGA-29-1702-01A-01R-1567-13","c317689f-a405-4486-9a22-ff6eadd2d5b8",0.15,NA,NA,NA,NA,"72fb7892-4c20-516a-99e9-0471b0856e92","TCGA-29-1702_exposure","TCGA-29-1702-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T02:22:43.000Z","2014-03-29T02:57:01.000Z","EEE56B6F-54D7-4F20-945E-658860E57507","7150C48B-144F-40F0-B4D0-E4B34E35556D","Unaligned reads",19492536320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C317689F-A405-4486-9A22-FF6EADD2D5B8","Canada's Michael Smith Genome Sciences Centre","564a329be4b0298dd2c597ce","0E1598D8-CBE5-4113-95F1-4BCDA061239B","Ovarian Serous Cystadenocarcinoma","TAR","3B14FD3E-0460-4955-8B4F-64AB3EF5E27E","2014-03-29T02:57:01.000Z","53896BCA-46AE-4B02-9C8B-D96CB5991B54","None","NO",1,0.5,"Primary Tumor","Duke",NA,"3B14FD3E-0460-4955-8B4F-64AB3EF5E27E",0.7,"29","TCGA-29-1702-01A-01D-0562-02_S01_CGH_105_Dec08_1_2.txt",NA,"TCGA-29-1702-01A",1.2,"9CBFFC31-FC40-4166-B1B8-601D6F9FA089","TCGA",2005,NA,NA,"WITH TUMOR","7150C48B-144F-40F0-B4D0-E4B34E35556D",84,"nationwidechildrens.org_clinical.TCGA-29-1702.xml","Dead",728,"TCGA-29-1702",NA,"A69603C0-0756-4367-A239-B419EDFC8130",NA,568,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,133,"D7EC5A33-2840-4E3B-A587-272F42E1FFC9","C4C12FAB-FAC0-4D1B-95F4-C037D8531511","TCGA-29-1702-01A-01R-1567-13_rnaseq.bam","TCGA-29-1702-01A-01",95,0,NA,NA,0,"BOTTOM",2,NA,"TCGA-29-1702-01A-01-BS1",98,"Doxil","Chemotherapy","TCGA-29-1702-D27252",NA,NA,NA,"TCGA-29-1702-F27249_NTE-1",NA,568,"WITH TUMOR","Dead",728,"TCGA-29-1702-F27249","TCGA-29-1702",NA,"29","1702","YES","C56.9","8441/3","C56.9",NA,NA,-30910,"FEMALE","WHITE",NA,NA,"No","Dead",568,728,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,84,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
180251150,176178968,13031439377,"192D2069-D96F-40A5-A77F-E8264BACEDB1.bw","0e475b3d-be3c-431a-ab12-5a867ea8f6cd","192d2069-d96f-40a5-a77f-e8264bacedb1","2016-08-25T03:59:32.745863-05:00","TCGA-09-1668-01B-01R-1566-13_rnaseq_fastq.tar","e79bd4e9-bb8c-480b-a533-17469d0c5d21",11148421120,"Illumina HiSeq","0ed60eeeb207cfd602b8f715215ead5d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:21:14.094984-05:00","2016-05-03T11:40:21.662944-05:00","e79bd4e9-bb8c-480b-a533-17469d0c5d21_analysis.xml","4549b55481c6373c82ab32b5d6e5fa48","fec21840-8198-4d33-ab9b-0c4cb6cabbcc",2181,"2016-09-29T23:54:50.881419-05:00","e79bd4e9-bb8c-480b-a533-17469d0c5d21_experiment.xml","c8698f5712869a11546977aeecbf3aa1","ee8ca235-e7bb-489a-b790-6b04ea1b825d",3916,"2016-09-29T21:10:16.139886-05:00","e79bd4e9-bb8c-480b-a533-17469d0c5d21_run.xml","120c211da0968313f702fd055eca1a1e","887d6185-f259-4910-bfe8-c7ecc60a598e",1988,"2016-09-08T11:15:49.223705-05:00","TCGA-09-1668","2016-09-02T18:47:43.688651-05:00","female","TCGA-09-1668_demographic",1947,"white","750dae51-7957-57e9-9cf2-2054e1f5840a","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1668_diagnosis","not reported",20972,"alive","8441/3",NA,1684,"0fbdc72e-a36b-5c66-9042-67e6732464ab","c56.9",-20972,"TCGA-09-1668_treatment","a2ef7309-4ade-5a6a-949f-d52fe5347193","01",NA,"TCGA-09-1668-01B","0.6","3db1f968-6db6-40c7-aacd-44921f0bf709",FALSE,"7740b3ec-1d81-4408-be9e-45ccd7e91b3a","Primary Tumor","0.3",NA,NA,"0.7",1240185600,"01",68,"TCGA-09-1668-01B-01",95,95,NA,NA,0,0,5,10,"2016-09-08T11:15:49.223705-05:00","2016-09-08T11:15:49.223705-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"299ef5ea-edf2-4a0e-81b2-b8c28d985121","a922c1f1-847e-4396-b785-63799e47fc94","TCGA-09-1668-01B-01-BS1","TCGA-09-1668-01B-01-TS1",90,85,"e72e2726-dac4-4624-ab20-3bf25da55669","RNA","TCGA-09-1668-01B-01R","f358ac3e-5dad-4685-8fb8-98f223800f0b",1.8,0.17,"UV Spec","R","22","TCGA-09-1668-01B-01R-1566-13","66894abe-8af5-4fd9-9a59-cf24e57fc07f",0.17,NA,NA,NA,NA,"50a4389b-e604-5ef9-afcb-cd720f5a1b50","TCGA-09-1668_exposure","TCGA-09-1668-01B-01R-1566-13_rnaseq_fastq.tar","2014-03-25T03:14:26.000Z","2014-03-25T03:37:02.000Z","E79BD4E9-BB8C-480B-A533-17469D0C5D21","3DB1F968-6DB6-40C7-AACD-44921F0BF709","Unaligned reads",11148421120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","66894ABE-8AF5-4FD9-9A59-CF24E57FC07F","Canada's Michael Smith Genome Sciences Centre","564a5b9ee4b0ef12181e357f","0E475B3D-BE3C-431A-AB12-5A867EA8F6CD","Ovarian Serous Cystadenocarcinoma","TAR","E72E2726-DAC4-4624-AB20-3BF25DA55669","2014-03-25T03:37:02.000Z","F358AC3E-5DAD-4685-8FB8-98F223800F0B","None","NO",1,0.3,"Primary Tumor","UCSF",NA,"E72E2726-DAC4-4624-AB20-3BF25DA55669",0.6,"09","TCGA-09-1668-01B-01R-1566-13_rnaseq_fastq.tar",NA,"TCGA-09-1668-01B",0.7,"FB1E1DF5-88FC-4470-8A14-B8E52CB01D91","TCGA",2004,NA,NA,"WITH TUMOR","8E46A6BA-C47C-4780-A67C-B624EC73FF34",57,"ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_E12_465990.raw.copynumber.data.txt","Alive",NA,"TCGA-09-1668","NOT HISPANIC OR LATINO","4C6E3ED8-1D30-4366-96FC-60BFA0104DFD",NA,1684,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,68,"A922C1F1-847E-4396-B785-63799E47FC94","FEA7B84D-F0A8-4E73-8786-01400BCABC24","TCGA-09-1668-01B-01R-1566-13_rnaseq_fastq.tar","TCGA-09-1668-01B-01",95,0,NA,NA,5,"BOTTOM",5,NA,"TCGA-09-1668-01B-01-BS1",90,"Taxotere","Chemotherapy","TCGA-09-1668-D24303",NA,NA,NA,NA,NA,1684,"WITH TUMOR","Alive",NA,"TCGA-09-1668-F24300","TCGA-09-1668",NA,"09","1668","YES","C56.9","8441/3","C56.9",NA,NA,-20972,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1684,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,57,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
187847992,176578971,13036931699,"68900FD6-8014-44DA-B67D-CBA9140A1D3F.bw","0f4a4ad1-e394-45c4-9aa9-aadf2bff0628","68900fd6-8014-44da-b67d-cba9140a1d3f","2016-08-25T12:23:16.709447-05:00","TCGA-04-1350-01A-01R-1565-13_rnaseq_fastq.tar","c29f8a2c-ec0c-4aa1-aa7a-235cb3054f3b",11943188480,"Illumina HiSeq","6502bf0601695133599e38d2d99e4d42","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:38:31.540450-05:00","2016-05-03T11:40:21.669427-05:00","c29f8a2c-ec0c-4aa1-aa7a-235cb3054f3b_analysis.xml","3aba777b7d7c4da7497f0c4b2022a652","bf0d7b90-7b20-44b6-9c17-00ff173c8b88",2208,"2016-09-29T22:05:41.260153-05:00","c29f8a2c-ec0c-4aa1-aa7a-235cb3054f3b_experiment.xml","a4b74894697af7435beee302203c6ef7","aadfcf27-b208-4d93-93d1-ff5d034b2929",3916,"2016-09-29T23:34:44.276027-05:00","c29f8a2c-ec0c-4aa1-aa7a-235cb3054f3b_run.xml","b8f78a0cddf9d324c326743ff393b0f5","e1f52f55-af04-47da-938b-458624ecb97f",1989,"2016-09-08T13:44:02.309703-05:00","TCGA-04-1350","2016-09-02T19:11:57.066062-05:00","female","TCGA-04-1350_demographic",1957,"white","a8d4c73c-f71c-5015-9cfe-d6499ca3919b","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1350_diagnosis","not reported",16942,"dead","8441/3",1946,NA,"2755ddb9-4175-5754-a34d-883256cd0dc5","c56.9",-16942,"TCGA-04-1350_treatment","be3ff3bd-d801-5b71-94ab-a9b321903f23","01",NA,"TCGA-04-1350-01A","1","c8a0c290-56de-4ebe-80d3-ca8fb2f85188",FALSE,"C4BB615C-ABBA-4136-AAB4-52EA1FE88D14","Primary Tumor","0.4",NA,NA,"1.5",1229644800,"01",229,"TCGA-04-1350-01A-01",99,99,NA,NA,0,0,5,5,"2016-09-08T13:44:02.309703-05:00","2016-09-08T13:44:02.309703-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"5c94303e-4b9a-48d9-8e64-2541eade8a6b","0013c195-a6a5-45d3-8d87-1025e5a8f258","TCGA-04-1350-01A-01-BS1","TCGA-04-1350-01A-01-TS1",94,94,"9d532938-6a14-4ff1-b219-36fc3d609049","RNA","TCGA-04-1350-01A-01R","5f529d11-b4aa-4745-a556-863ab80ca542",1.8,0.15,"UV Spec","R","22","TCGA-04-1350-01A-01R-1565-13","56822a73-96f7-40ba-a5c2-6eec113b52d9",0.15,NA,NA,NA,NA,"8fce01d5-69b2-50bc-88e3-b84987e878de","TCGA-04-1350_exposure","TCGA-04-1350-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T06:52:06.000Z","2014-03-22T07:16:02.000Z","C29F8A2C-EC0C-4AA1-AA7A-235CB3054F3B","C8A0C290-56DE-4EBE-80D3-CA8FB2F85188","Unaligned reads",11943188480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","56822A73-96F7-40BA-A5C2-6EEC113B52D9","Canada's Michael Smith Genome Sciences Centre","564a3f1ce4b09c884b257b72","0F4A4AD1-E394-45C4-9AA9-AADF2BFF0628","Ovarian Serous Cystadenocarcinoma","TAR","9D532938-6A14-4FF1-B219-36FC3D609049","2014-03-22T07:16:02.000Z","5F529D11-B4AA-4745-A556-863AB80CA542","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"9D532938-6A14-4FF1-B219-36FC3D609049",1,"04","NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_D02_446176.hg19.seg.txt",NA,"TCGA-04-1350-01A",1.5,"D3BC267A-90D8-490C-AC82-32383C4CA950","TCGA",2003,NA,NA,"WITH TUMOR","C8A0C290-56DE-4EBE-80D3-CA8FB2F85188",46,"jhu-usc.edu_OV.HumanMethylation27.4.lvl-3.TCGA-04-1350-01A-01D-0460-05.txt","Dead",1946,"TCGA-04-1350",NA,"7B044C52-3464-4207-BBEC-D65B1CC081F0",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,229,"5C94303E-4B9A-48D9-8E64-2541EADE8A6B","EC599B29-DAF5-494B-B9D9-819BCA8E3983","NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_D02_446176.nocnv_hg19.seg.txt","TCGA-04-1350-01A-01",99,0,NA,NA,5,"TOP",1,NA,"TCGA-04-1350-01A-01-TS1",94,"Avastin","Immunotherapy","TCGA-04-1350-D23995",NA,NA,NA,"TCGA-04-1350-F23988_NTE-1",NA,NA,"WITH TUMOR","Dead",1946,"TCGA-04-1350-F23988","TCGA-04-1350",NA,"04","1350","YES","C56.9","8441/3","C56.9",NA,NA,-16942,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1946,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,46,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
239513368,230772565,17059610897,"50E5597F-CD6F-4816-9E37-A5A651D65E96.bw","0f530b3e-5b6d-4892-9ebd-9138d76fdca7","50e5597f-cd6f-4816-9e37-a5a651d65e96","2016-08-20T06:21:33.194958-05:00","TCGA-36-1570-01A-01R-1566-13_rnaseq_fastq.tar","94d74357-dbd9-4ec0-90fb-01e398134570",15665233920,"Illumina HiSeq","b99aad9dfecc8baba7b137a2bdd5f536","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:41:58.287413-05:00","2016-05-03T11:40:21.662944-05:00","94d74357-dbd9-4ec0-90fb-01e398134570_analysis.xml","e37745bd8e77c2dcaa0ad11d40067bcd","06797e13-9613-44c8-8fc6-d52e1893eac8",2181,"2016-09-29T20:50:15.872518-05:00","94d74357-dbd9-4ec0-90fb-01e398134570_experiment.xml","584c2afe26b6999e2ad4b9b64fd06209","7be334de-8859-4dad-871e-151cc2cc6f96",3916,"2016-09-29T21:08:22.176471-05:00","94d74357-dbd9-4ec0-90fb-01e398134570_run.xml","15c304d15b5b3f6e2758c61520bd50d3","8745d761-fa65-4124-8699-b95236a7ea16",1988,"2016-09-08T10:40:11.449040-05:00","TCGA-36-1570","2016-09-02T18:53:42.107998-05:00","female","TCGA-36-1570_demographic",1958,"white","8bf011e8-2516-55b4-b40b-332a899f5710","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1570_diagnosis","not reported",17956,"alive","8441/3",NA,655,"2a9bd40c-59be-5757-894c-c0b7f1100b5f","c56.9",-17956,"TCGA-36-1570_treatment","4cdec97d-42bf-5508-a2e3-f9c2755ab3ed","01",NA,"TCGA-36-1570-01A","1","22b7e0e2-334c-419c-a243-358ba22e479a",FALSE,"f83833f4-a820-4fb9-a040-c238084976c3","Primary Tumor","0.7",NA,NA,"1.3",1235779200,"01",104,"TCGA-36-1570-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T10:40:11.449040-05:00","2016-09-08T10:40:11.449040-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"6fa53e8d-c4e9-4a35-8000-7c1706f46eb6","b44d5ee7-7e05-4e8c-b2f3-03761aa43052","TCGA-36-1570-01A-01-TS1","TCGA-36-1570-01A-01-BS1",94,94,"ddb0dcde-e2e5-48bf-8f62-7655376de451","RNA","TCGA-36-1570-01A-01R","daa42c88-29bd-4bc7-834d-816c26578e3d",1.8,0.14,"UV Spec","R","22","TCGA-36-1570-01A-01R-1566-13","cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7",0.14,NA,NA,NA,NA,"ffd31bdc-f119-5b30-a33f-75c193af34c4","TCGA-36-1570_exposure","TCGA-36-1570-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T01:46:35.000Z","2014-03-25T02:13:02.000Z","94D74357-DBD9-4EC0-90FB-01E398134570","22B7E0E2-334C-419C-A243-358BA22E479A","Unaligned reads",15665233920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CD799C12-6A2B-4F7A-AF72-F4BD7F69F6C7","Canada's Michael Smith Genome Sciences Centre","564a380ae4b09c884b235564","0F530B3E-5B6D-4892-9EBD-9138D76FDCA7","Ovarian Serous Cystadenocarcinoma","TAR","DDB0DCDE-E2E5-48BF-8F62-7655376DE451","2014-03-25T02:13:02.000Z","DAA42C88-29BD-4BC7-834D-816C26578E3D","None","NO",1,0.7,"Primary Tumor","BC Cancer Agency",NA,"DDB0DCDE-E2E5-48BF-8F62-7655376DE451",1,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0bd6d1dc-2f53-479b-bbaa-ef70250341a2.txt",NA,"TCGA-36-1570-01A",1.3,"90A5225E-1532-4DB6-AEF6-B5596C72151E","TCGA",2007,NA,NA,"WITH TUMOR","49931772-EA7F-4644-955F-086BD55089D2",49,"nationwidechildrens.org_clinical.TCGA-36-1570.xml","Alive",NA,"TCGA-36-1570",NA,"15FA99C0-2FE6-4A73-9C6B-612CF8D56D53",NA,655,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,104,"B44D5EE7-7E05-4E8C-B2F3-03761AA43052","FDA979F6-97BB-4D08-834B-D9EB4A9C6B85","TCGA-36-1570-01A-01W-0615-10_SOLiD.bam.bai","TCGA-36-1570-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-36-1570-01A-01-BS1",94,"Gemcitabine","Chemotherapy","TCGA-36-1570-D27860",NA,NA,NA,"TCGA-36-1570-F27857_NTE-1",NA,655,"WITH TUMOR","Alive",NA,"TCGA-36-1570-F27857","TCGA-36-1570",NA,"36","1570","YES","C56.9","8441/3","C56.9",NA,NA,-17956,"FEMALE","WHITE",NA,NA,"No","Alive",655,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
232635616,225999479,16730069316,"52EC9A4B-8802-4B9B-8B86-47165C10A389.bw","12581634-eebb-4841-8498-71dc9d78c546","52ec9a4b-8802-4b9b-8b86-47165c10a389","2016-08-20T07:31:34.279528-05:00","TCGA-36-1571-01A-01R-1566-13_rnaseq_fastq.tar","d80af706-7971-472a-85b2-77d481116de9",14737530880,"Illumina HiSeq","70c2fb3cbf82feab0703f2b443ed9bce","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:23:40.726883-05:00","2016-05-03T11:40:21.662944-05:00","d80af706-7971-472a-85b2-77d481116de9_analysis.xml","1d63f2f544d453e646d6647d2c6883a6","20b113c3-70f5-42a2-bef0-4afda0bdb859",2181,"2016-09-29T18:44:21.296506-05:00","d80af706-7971-472a-85b2-77d481116de9_experiment.xml","d6aeb09b4a1021ee4c2cf1df58954084","2dc92909-c707-4220-90e3-175d4fe0d27b",3916,"2016-09-29T22:10:57.422498-05:00","d80af706-7971-472a-85b2-77d481116de9_run.xml","6ef242951557fc5dd19f9b7cf57a9d55","adf750b1-e471-4f45-b4ac-73128a7884ec",1988,"2016-09-08T13:08:03.734790-05:00","TCGA-36-1571","2016-09-02T18:47:40.903289-05:00","female","TCGA-36-1571_demographic",1954,"white","45064610-c261-5514-8632-f45474cd4857","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1571_diagnosis","not reported",19608,"dead","8441/3",695,695,"5cdad4c0-aa9e-59d2-b9d8-59157a7f2f7e","c56.9",-19608,"TCGA-36-1571_treatment","6af5f8d5-278b-5da9-b503-b63a549cf3a8","01",NA,"TCGA-36-1571-01A","0.9","a1d026c2-4d7a-4454-a8e3-30e5c243aba0",FALSE,"cee6fb75-8fcc-4347-824e-b00b96e6e481","Primary Tumor","0.9",NA,NA,"1.3",1235779200,"01",100,"TCGA-36-1571-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:08:03.734790-05:00","2016-09-08T13:08:03.734790-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,1,"456cf689-c3f2-47ad-8b8c-8990e20dc816","481fbd5a-885c-415d-8462-550e3b4d54b6","TCGA-36-1571-01A-01-BS1","TCGA-36-1571-01A-01-TS1",95,94,"dcec160c-2969-4959-a77a-bc73ea787b61","RNA","TCGA-36-1571-01A-01R","b783d8c9-2a75-4a3e-84ef-a56ee35aa0a1",1.8,0.14,"UV Spec","R","22","TCGA-36-1571-01A-01R-1566-13","55c68aef-938c-4f68-a74d-f408673fff9c",0.14,NA,NA,NA,NA,"5a5eab17-b41c-52d6-9274-6fbab24cc7ce","TCGA-36-1571_exposure","TCGA-36-1571-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T03:47:59.000Z","2014-03-25T04:14:01.000Z","D80AF706-7971-472A-85B2-77D481116DE9","A1D026C2-4D7A-4454-A8E3-30E5C243ABA0","Unaligned reads",14737530880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","55C68AEF-938C-4F68-A74D-F408673FFF9C","Canada's Michael Smith Genome Sciences Centre","564a37f3e4b08c5d869069ff","12581634-EEBB-4841-8498-71DC9D78C546","Ovarian Serous Cystadenocarcinoma","TAR","DCEC160C-2969-4959-A77A-BC73EA787B61","2014-03-25T04:14:01.000Z","B783D8C9-2A75-4A3E-84EF-A56EE35AA0A1","None","NO",1,0.9,"Primary Tumor","BC Cancer Agency",NA,"DCEC160C-2969-4959-A77A-BC73EA787B61",0.9,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8add1736-9ac5-4d0e-9969-7ea6ffaf635c.txt",NA,"TCGA-36-1571-01A",1.3,"6C4703E2-A040-46B1-8900-B41AA4C1E515","TCGA",2007,NA,NA,"WITH TUMOR","D9F3D1E4-7FB3-483E-97C9-4D3FC44BC114",53,"nationwidechildrens.org_clinical.TCGA-36-1571.xml","Dead",695,"TCGA-36-1571",NA,"00574D51-B04F-42C8-BA1A-F4D8AF2E4EBD",NA,695,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,100,"456CF689-C3F2-47AD-8B8C-8990E20DC816","C30E991E-EF42-40F9-B347-804FA8FF6C60","TCGA-36-1571-01A-01R-1566-13.hg19.spljxn.quantification.txt","TCGA-36-1571-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-36-1571-01A-01-TS1",94,"Paclitaxel","Chemotherapy","TCGA-36-1571-D27864",NA,NA,NA,"TCGA-36-1571-F27862_NTE-1",NA,695,"WITH TUMOR","Dead",695,"TCGA-36-1571-F27862","TCGA-36-1571",NA,"36","1571","YES","C56.9","8441/3","C56.9",NA,NA,-19608,"FEMALE","WHITE",NA,NA,"No","Dead",695,695,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
160462978,158005982,11728277833,"B04AA6FE-DE3C-4387-8249-BB29B873FF1F.bw","13319c20-02f6-4b5f-b24f-3d8f4084094c","b04aa6fe-de3c-4387-8249-bb29b873ff1f","2016-08-26T04:31:22.546693-05:00","TCGA-25-1318-01A-01R-1565-13_rnaseq_fastq.tar","398da9bf-b016-4164-9e95-44ed80944e46",9688360960,"Illumina HiSeq","b6f896be073a02902df5f3dec4edd758","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:05:06.813720-05:00","2016-05-03T11:40:21.662944-05:00","398da9bf-b016-4164-9e95-44ed80944e46_analysis.xml","543ee2a066e3e6826598673a5bbf55f1","cf7b8a1e-0da7-4c9f-8de8-2ad4f4b6cbc9",2181,"2016-09-29T17:41:11.987724-05:00","398da9bf-b016-4164-9e95-44ed80944e46_experiment.xml","0bb6ff0ce697d27601c6b2f18111c74f","05fb1823-79e0-408c-84d9-4d75515afbe6",3916,"2016-09-29T19:42:27.896317-05:00","398da9bf-b016-4164-9e95-44ed80944e46_run.xml","e8d566581422e349bb11e87d47b8f3ce","524204b9-65b8-449b-9c43-4231cd18380e",1988,"2016-09-08T13:40:19.111237-05:00","TCGA-25-1318","2016-09-02T19:12:03.425584-05:00","female","TCGA-25-1318_demographic",1946,"white","f25e1764-8f69-5eb1-824e-789ac5a8ff24","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1318_diagnosis","not reported",19755,"dead","8441/3",1064,1064,"2e841bcd-46c2-5c16-95cc-6d40414476b3","c56.9",-19755,"TCGA-25-1318_treatment","a8dead29-cdfb-544f-a4fd-7ffb3c12f56b","01",NA,"TCGA-25-1318-01A","2","ced18b90-cbcc-4593-9eaf-2d91daa9d756",FALSE,"D9B9F69A-265C-42F4-BCD2-4B136A7FE935","Primary Tumor","0.8",NA,NA,"4.5",1228694400,"01",177,"TCGA-25-1318-01A-01",98,95,NA,NA,NA,NA,15,10,"2016-09-08T13:40:19.111237-05:00","2016-09-08T13:40:19.111237-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"328597ad-7246-4ca7-a534-1d265e9c9a59","71909c29-59a7-45ec-945b-d7965aeec9a5","TCGA-25-1318-01A-01-TS1","TCGA-25-1318-01A-01-BS1",80,85,"6651de6b-f254-4b61-ac6c-14c1f9f65e4b","RNA","TCGA-25-1318-01A-01R","1a921841-2049-4c49-b094-d67dbd5f683b",1.8,0.15,"UV Spec","R","22","TCGA-25-1318-01A-01R-1565-13","4d3e0164-1346-4e8e-b478-29bd8b1f1ce5",0.15,NA,NA,NA,NA,"9b873d69-d172-5649-9537-ef193ac42329","TCGA-25-1318_exposure","TCGA-25-1318-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-24T21:24:40.000Z","2014-03-24T21:56:01.000Z","398DA9BF-B016-4164-9E95-44ED80944E46","CED18B90-CBCC-4593-9EAF-2D91DAA9D756","Unaligned reads",9688360960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4D3E0164-1346-4E8E-B478-29BD8B1F1CE5","Canada's Michael Smith Genome Sciences Centre","564a57d2e4b0ef12181d0108","13319C20-02F6-4B5F-B24F-3D8F4084094C","Ovarian Serous Cystadenocarcinoma","TAR","6651DE6B-F254-4B61-AC6C-14C1F9F65E4B","2014-03-24T21:56:01.000Z","1A921841-2049-4C49-B094-D67DBD5F683B","None","NO",1,0.8,"Primary Tumor","Mayo Clinic - Rochester",NA,"6651DE6B-F254-4B61-AC6C-14C1F9F65E4B",2,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2f954b2b-ab8d-4f81-8717-e85d500987ee.txt",NA,"TCGA-25-1318-01A",4.5,"E9DBB616-A754-4560-91D3-70C2166BFF27","TCGA",2000,NA,NA,"WITH TUMOR","F070A76E-B781-42BD-BEEC-1A8C2C0D713A",54,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2f954b2b-ab8d-4f81-8717-e85d500987ee.txt","Dead",1064,"TCGA-25-1318","NOT HISPANIC OR LATINO","F632B553-5ECB-48EF-84BC-D5372657F82A",NA,1064,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,177,"71909C29-59A7-45EC-945B-D7965AEEC9A5","7671BE8B-C9AC-4CCE-A2F0-070D9105AF92","NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_F08_446050.ismpolish.data.txt","TCGA-25-1318-01A-01",95,NA,NA,NA,10,"BOTTOM",5,NA,"TCGA-25-1318-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-25-1318-D26656",NA,NA,NA,"TCGA-25-1318-F26655_NTE-2",NA,1064,"WITH TUMOR","Dead",1064,"TCGA-25-1318-F26655","TCGA-25-1318",NA,"25","1318","YES","C56.9","8441/3","C56.9",NA,NA,-19755,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1064,1064,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
242086884,234418616,17300307535,"4B6BBFAD-57D4-4023-BF10-A045308016E2.bw","13f5814c-1f99-4ffa-84a4-3bbd8979faae","4b6bbfad-57d4-4023-bf10-a045308016e2","2016-09-29T19:31:16.809901-05:00","TCGA-13-1477-01A-01R-1565-13_rnaseq_fastq.tar","43bf7074-0d8e-4c22-94b0-afb522d69d9e",14330009600,"Illumina HiSeq","3f67bfc960cfac07f147eb2f6bfdc537","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:34:28.492216-05:00","2016-05-03T11:40:21.669427-05:00","43bf7074-0d8e-4c22-94b0-afb522d69d9e_analysis.xml","bab19cbd888c89248bd4116b2be78758","7204d5fc-8ac7-4c5e-a4c1-46bb223be6a5",2208,"2016-10-07T16:48:34.807747-05:00","43bf7074-0d8e-4c22-94b0-afb522d69d9e_experiment.xml","dad457dca449f1179477993f4eb977ce","cfc7de04-59c9-4c51-bfb3-28be57191da5",3916,"2016-09-29T21:35:18.266058-05:00","43bf7074-0d8e-4c22-94b0-afb522d69d9e_run.xml","9e44346a6559129005cb6c565eaa04fa","97ec63de-b963-41e4-821d-08980347657a",1989,"2016-09-08T13:42:53.611963-05:00","TCGA-13-1477","2016-09-02T19:13:58.570327-05:00","female","TCGA-13-1477_demographic",1951,"white","b24d11cb-3d0e-5e1e-a82e-75025a577914","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1477_diagnosis","not reported",18111,"dead","8441/3",1662,1662,"999ac7a5-2147-5a8f-afac-d62ded2f8f79","c56.9",-18111,"TCGA-13-1477_treatment","bc902138-7d50-5a41-ba40-4935459f3eb9","01",NA,"TCGA-13-1477-01A","1.3","79908395-d442-44a3-8e91-97c3ae97ddd5",FALSE,"2507FA0F-9709-4B5D-9EC1-907637FB373A","Primary Tumor","0.3",NA,NA,"1.3",1234310400,"01",132,"TCGA-13-1477-01A-01",80,70,NA,NA,0,0,15,20,"2016-09-08T13:42:53.611963-05:00","2016-09-08T13:42:53.611963-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,0,"40cfd8ee-5054-4b2f-9a66-0820397a0d75","5e469773-19c9-47e2-a141-a9023f02fb54","TCGA-13-1477-01A-01-TS1","TCGA-13-1477-01A-01-BS1",80,80,"25956b20-bce2-4ef6-931d-2bc6cf856486","RNA","TCGA-13-1477-01A-01R","9980828e-6082-4266-a047-ef920d0b0ccf",1.8,0.15,"UV Spec","R","22","TCGA-13-1477-01A-01R-1565-13","eb7fbe7d-ca45-4f35-b384-0d396349da06",0.15,NA,NA,NA,NA,"b6b7d082-d633-51b7-b0e3-4530afa900a1","TCGA-13-1477_exposure","TCGA-13-1477-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T04:28:09.000Z","2014-03-22T05:01:01.000Z","43BF7074-0D8E-4C22-94B0-AFB522D69D9E","79908395-D442-44A3-8E91-97C3AE97DDD5","Unaligned reads",14330009600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EB7FBE7D-CA45-4F35-B384-0D396349DA06","Canada's Michael Smith Genome Sciences Centre","564a3fd3e4b093830b6aaf0d","13F5814C-1F99-4FFA-84A4-3BBD8979FAAE","Ovarian Serous Cystadenocarcinoma","TAR","25956B20-BCE2-4EF6-931D-2BC6CF856486","2014-03-22T05:01:01.000Z","9980828E-6082-4266-A047-EF920D0B0CCF","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"25956B20-BCE2-4EF6-931D-2BC6CF856486",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.fa473bf9-b927-4d17-ac77-ad0e52f01cac.txt",NA,"TCGA-13-1477-01A",1.3,"C4AE4F9D-4EC7-47D4-92BD-82121C761ED6","TCGA",2000,NA,NA,"WITH TUMOR","D5DF4F4C-43DD-4208-BAD3-05F109FC0346",49,"nationwidechildrens.org_clinical.TCGA-13-1477.xml","Dead",1662,"TCGA-13-1477","NOT HISPANIC OR LATINO","15EE294F-4702-4CA4-A8B5-3926EF50FB20",NA,1662,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,132,"5E469773-19C9-47E2-A141-A9023F02FB54","BCC13ED8-5E04-439E-A859-C350E9CF1807","4513233036_F_Grn.idat","TCGA-13-1477-01A-01",70,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-13-1477-01A-01-BS1",80,"Paciltaxel","Chemotherapy","TCGA-13-1477-D24840",NA,NA,NA,"TCGA-13-1477-F24839_NTE-1",NA,1662,"WITH TUMOR","Dead",1662,"TCGA-13-1477-F24839","TCGA-13-1477",NA,"13","1477","YES","C56.9","8441/3","C56.9",NA,NA,-18111,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1662,1662,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2000,"Incisional Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
195712720,186985867,13791477819,"C322AED8-04FE-4F5A-BB6C-DEC20FDFFEAB.bw","14c58def-60ee-48e0-a74b-da4eb77ef344","c322aed8-04fe-4f5a-bb6c-dec20fdffeab","2016-08-26T11:43:44.960762-05:00","TCGA-13-0887-01A-01R-1564-13_rnaseq_fastq.tar","54310ff4-ff38-4c9a-af9f-0fdf32c63000",11968143360,"Illumina HiSeq","ec51207794a97e87944d2caaa69232f1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:49:39.871963-05:00","2016-05-03T11:39:34.528512-05:00","54310ff4-ff38-4c9a-af9f-0fdf32c63000_analysis.xml","b4459ca220da17f5b05d28872925914a","c5f63ebe-7204-4879-9d99-b7deb0c6499f",2208,"2016-08-27T21:31:41.625261-05:00","54310ff4-ff38-4c9a-af9f-0fdf32c63000_experiment.xml","5adfdad654bd4962182962e53cad6d86","fa49b4ca-8424-4f47-9421-79b1b93c1d50",3916,"2016-09-29T18:05:50.454211-05:00","54310ff4-ff38-4c9a-af9f-0fdf32c63000_run.xml","a4afdfa9bd2b9818f8c3214eff6ebd8c","15b2c06d-cd05-47c1-b247-04be737afe16",1988,"2016-09-08T12:43:53.905498-05:00","TCGA-13-0887","2016-09-02T19:06:13.203006-05:00","female","TCGA-13-0887_demographic",1960,"white","05ddf2a8-4ba3-5158-ad54-369b93b80bf4","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0887_diagnosis","not reported",15669,"dead","8441/3",2028,2028,"5e9e3f81-ce0d-57fd-824c-1c7d28ccdbfe","c56.9",-15669,"TCGA-13-0887_treatment","a96bd863-5a58-5e3b-a71d-a2cf736e0240","01",NA,"TCGA-13-0887-01A","1.2","1713ce6c-f182-41df-a356-b073002ca1f7",FALSE,"AAEBFF3C-EA12-4D58-A424-2463307484A3","Primary Tumor","0.4",NA,NA,"1.3",1233705600,"01",124,"TCGA-13-0887-01A-01",95,90,NA,NA,5,10,0,0,"2016-09-08T12:43:53.905498-05:00","2016-09-08T12:43:53.905498-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,1,"8936aa9f-f77e-419d-ae3f-8b88933225ef","03c9ff20-0795-4bd1-8be1-3d7fcd15b7e9","TCGA-13-0887-01A-01-BS1","TCGA-13-0887-01A-01-TS1",85,89,"420c3ca2-01e9-4513-9648-66df967dc4a3","RNA","TCGA-13-0887-01A-01R","777c75d8-3664-4549-877c-82b96ed112e4",1.8,0.16,"UV Spec","R","22","TCGA-13-0887-01A-01R-1564-13","def55de4-e4eb-4693-aa54-889cd0f88051",0.16,NA,NA,NA,NA,"e05d7633-6f0e-5535-97c6-2da5c2b172b1","TCGA-13-0887_exposure","TCGA-13-0887-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T05:22:43.000Z","2014-03-20T05:47:02.000Z","54310FF4-FF38-4C9A-AF9F-0FDF32C63000","1713CE6C-F182-41DF-A356-B073002CA1F7","Unaligned reads",11968143360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DEF55DE4-E4EB-4693-AA54-889CD0F88051","Canada's Michael Smith Genome Sciences Centre","564a5b1de4b09c884b279554","14C58DEF-60EE-48E0-A74B-DA4EB77EF344","Ovarian Serous Cystadenocarcinoma","TAR","420C3CA2-01E9-4513-9648-66DF967DC4A3","2014-03-20T05:47:02.000Z","777C75D8-3664-4549-877C-82B96ED112E4","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"420C3CA2-01E9-4513-9648-66DF967DC4A3",1.2,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0226becf-0ff4-4457-a446-0ed079324b0d.txt",NA,"TCGA-13-0887-01A",1.3,"F8042E57-3947-4AC3-AC85-7C47074317E3","TCGA",2002,NA,NA,"WITH TUMOR","4FF6A1EF-7E21-4975-B126-3B4AED64A645",42,"nationwidechildrens.org_clinical.TCGA-13-0887.xml","Dead",2028,"TCGA-13-0887","NOT HISPANIC OR LATINO","5DB4B8A6-CAF0-4A60-9EB5-01711D0B7AF9",NA,2028,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,124,"8936AA9F-F77E-419D-AE3F-8B88933225EF","DC81635E-5220-4925-B477-946D5005FD80","TCGA-13-0887-01A-01R-1564-13.hg19.spljxn.quantification.txt","TCGA-13-0887-01A-01",95,5,NA,NA,0,"BOTTOM",10,NA,"TCGA-13-0887-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-13-0887-D24670",NA,NA,NA,"TCGA-13-0887-F24668_NTE-1",NA,2028,"WITH TUMOR","Dead",2028,"TCGA-13-0887-F24668","TCGA-13-0887",NA,"13","0887","YES","C56.9","8441/3","C56.9",NA,NA,-15669,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",2028,2028,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,42,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
183129484,175081163,12873465120,"26796E5F-C0C2-466C-9012-882F6D29C149.bw","15170c7f-5880-4fb6-82ce-68d3df0dfb68","26796e5f-c0c2-466c-9012-882f6d29c149","2016-08-19T12:12:25.056371-05:00","TCGA-13-0893-01B-01R-1565-13_rnaseq_fastq.tar","10fdb4cc-a208-47c5-b3a5-031d4ea02c29",11602769920,"Illumina HiSeq","f52fb6f1e37ccf883f6e8587df76d446","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:38:29.462881-05:00","2016-05-03T11:40:21.648680-05:00","10fdb4cc-a208-47c5-b3a5-031d4ea02c29_analysis.xml","c6f4105672a774f620759d9ba05cb7c6","0439acab-0ab3-4da9-823c-9cd84bc96388",2181,"2016-09-29T20:49:57.953877-05:00","10fdb4cc-a208-47c5-b3a5-031d4ea02c29_experiment.xml","755a56899cc6480a9b2a356f42027111","7bb56f30-471d-4ace-86eb-8fa18fd9512c",3916,"2016-09-29T22:02:14.358723-05:00","10fdb4cc-a208-47c5-b3a5-031d4ea02c29_run.xml","327a0791f779ed8af0c3472b06be3b1f","a8bf0e82-7cb0-4396-82e5-5851e2424de3",1988,"2016-09-08T13:36:56.478733-05:00","TCGA-13-0893","2016-09-02T19:11:55.276555-05:00","female","TCGA-13-0893_demographic",1955,"black or african american","6c86e5a1-4fa3-5421-8580-641c2765baa8","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0893_diagnosis","not reported",17573,"dead","8441/3",1319,1319,"74c32721-9793-5e47-9563-559b08a6f618","c56.9",-17573,"TCGA-13-0893_treatment","186be6ea-fe78-538d-aeb7-be248980c0ae","01",NA,"TCGA-13-0893-01B","1","8f4f9492-0d28-4747-b4bb-25ddc99e4327",FALSE,"0648E74B-766C-4AB7-BEEE-D45895413E5E","Primary Tumor","0.3",NA,NA,"1.2",1230508800,"01",113,"TCGA-13-0893-01B-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:36:56.478733-05:00","2016-09-08T13:36:56.478733-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"c090cde5-476a-4ba5-a3eb-9ed8e0a04085","8fa39d98-59e4-4957-857e-06d9db47e419","TCGA-13-0893-01B-01-TS1","TCGA-13-0893-01B-01-BS1",89,89,"87eaef24-c85f-4a0e-b77b-6f42985d701d","RNA","TCGA-13-0893-01B-01R","3bda2735-b9aa-4ada-b0fa-c1ef9630f71e",1.8,0.14,"UV Spec","R","22","TCGA-13-0893-01B-01R-1565-13","2b2d5fc7-b109-4d11-a632-db8016268840",0.14,NA,NA,NA,NA,"29df26eb-d840-5347-b0ec-95dd8fe19a56","TCGA-13-0893_exposure","TCGA-13-0893-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-21T21:50:53.000Z","2014-03-21T22:15:02.000Z","10FDB4CC-A208-47C5-B3A5-031D4EA02C29","8F4F9492-0D28-4747-B4BB-25DDC99E4327","Unaligned reads",11602769920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2B2D5FC7-B109-4D11-A632-DB8016268840","Canada's Michael Smith Genome Sciences Centre","564a5928e4b0298dd2cb6c6a","15170C7F-5880-4FB6-82CE-68D3DF0DFB68","Ovarian Serous Cystadenocarcinoma","TAR","87EAEF24-C85F-4A0E-B77B-6F42985D701D","2014-03-21T22:15:02.000Z","3BDA2735-B9AA-4ADA-B0FA-C1EF9630F71E","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"87EAEF24-C85F-4A0E-B77B-6F42985D701D",1,"13","bcgsc.ca.TCGA-13-0893-01B-01R-1565-13.bcgsc.ca.1.4.0.indel.vcf",NA,"TCGA-13-0893-01B",1.2,"A48FB2D1-82B6-4F3B-B211-2319A0B329A7","TCGA",2003,NA,NA,"WITH TUMOR","8F4F9492-0D28-4747-B4BB-25DDC99E4327",48,"nationwidechildrens.org_clinical.TCGA-13-0893.xml","Dead",1319,"TCGA-13-0893","NOT HISPANIC OR LATINO","2E198688-0234-4FF0-BAE5-0472CE5AF182",NA,1319,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,113,"C090CDE5-476A-4BA5-A3EB-9ED8E0A04085","968B85A3-E89E-4D4B-A9A9-08900F7A2AA5","TCGA-13-0893-01B-01W-0494-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-13-0893-01B-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-13-0893-01B-01-TS1",89,"Carboplatin","Chemotherapy","TCGA-13-0893-D24691",NA,NA,NA,"TCGA-13-0893-F24690_NTE-1",NA,1319,"WITH TUMOR","Dead",1319,"TCGA-13-0893-F24690","TCGA-13-0893",NA,"13","0893","YES","C56.9","8441/3","C56.9",NA,NA,-17573,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Dead",1319,1319,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,48,2003,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
180004894,171729272,12614269104,"A08507D2-0217-46FC-8DE0-F90007AA9DCB.bw","15556b28-c6bd-455a-87b6-4b7b3e33d0e4","a08507d2-0217-46fc-8de0-f90007aa9dcb","2016-08-25T21:58:29.996514-05:00","TCGA-25-1634-01A-01R-1566-13_rnaseq_fastq.tar","6664e287-c7a6-417d-85d5-4893dcb1ec2b",10490849280,"Illumina HiSeq","6ac3e5cf7d7fdc1f668f924df70d99a5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:07:03.989941-05:00","2016-05-03T11:39:34.528512-05:00","6664e287-c7a6-417d-85d5-4893dcb1ec2b_analysis.xml","4082ee06b0c4fc2d50d31dfeab127068","abad283c-ee86-4986-bec5-6628ca2a24f3",2181,"2016-10-07T16:36:35.947306-05:00","6664e287-c7a6-417d-85d5-4893dcb1ec2b_experiment.xml","58b6310ff109b84f3349ad2295dfc117","2645ba51-5e51-4d3e-9564-aca694599abb",3916,"2016-09-29T19:22:40.161383-05:00","6664e287-c7a6-417d-85d5-4893dcb1ec2b_run.xml","1c5754c00cdd5ce16ee65b1e232a196d","45fa2216-5ddd-42f4-a359-6cf71e38c729",1988,"2016-09-08T12:11:19.052522-05:00","TCGA-25-1634","2016-09-02T18:48:56.713752-05:00","female","TCGA-25-1634_demographic",1927,"white","893d4088-f26b-55ea-aa87-aed8cf080262","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1634_diagnosis","not reported",27749,"dead","8441/3",1091,1081,"ccfe5d13-dadc-5a66-a404-f202b80053e2","c56.9",-27749,"TCGA-25-1634_treatment","3cdf91fd-268f-5fbc-aac9-6f7b6d0c4b1f","01",NA,"TCGA-25-1634-01A","1","c0091bb4-1079-4254-ad42-42ac1ddd7f1e",FALSE,"F000A224-05C3-4915-8ECD-02BAFE059232","Primary Tumor","0.1",NA,NA,"1.4",1237420800,"01",119,"TCGA-25-1634-01A-01",85,85,NA,NA,0,0,15,15,"2016-09-08T12:11:19.052522-05:00","2016-09-08T12:11:19.052522-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"4345be84-2118-4725-8b31-1f16902d64b7","d2bf3a3f-c51b-40a9-956d-2f77195d7a69","TCGA-25-1634-01A-01-TS1","TCGA-25-1634-01A-01-BS1",84,84,"623d62d8-b386-4c48-a3be-fffce7003f22","RNA","TCGA-25-1634-01A-01R","988aa522-ee9f-462e-b80f-08a18bb0f2a2",1.8,0.17,"UV Spec","R","22","TCGA-25-1634-01A-01R-1566-13","d10f0cee-d755-43cc-8d3d-8974cea0defb",0.17,NA,NA,NA,NA,"acff4eb3-b3e7-504b-9389-70208a27c061","TCGA-25-1634_exposure","TCGA-25-1634-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T06:08:05.000Z","2014-03-20T06:30:01.000Z","6664E287-C7A6-417D-85D5-4893DCB1EC2B","C0091BB4-1079-4254-AD42-42AC1DDD7F1E","Unaligned reads",10490849280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D10F0CEE-D755-43CC-8D3D-8974CEA0DEFB","Canada's Michael Smith Genome Sciences Centre","564a32b4e4b08c5d868ebdeb","15556B28-C6BD-455A-87B6-4B7B3E33D0E4","Ovarian Serous Cystadenocarcinoma","TAR","623D62D8-B386-4C48-A3BE-FFFCE7003F22","2014-03-20T06:30:01.000Z","988AA522-EE9F-462E-B80F-08A18BB0F2A2","None","NO",1,0.1,"Primary Tumor","Mayo Clinic - Rochester",NA,"623D62D8-B386-4C48-A3BE-FFFCE7003F22",1,"25","TCGA-25-1634-01A-01R-1566-13_GRCh37-lite_mirna.bam",NA,"TCGA-25-1634-01A",1.4,"9A6CE675-728D-4759-B42A-6C3646DCFF73","TCGA",2002,NA,NA,"WITH TUMOR","C0091BB4-1079-4254-AD42-42AC1DDD7F1E",75,"nationwidechildrens.org_clinical.TCGA-25-1634.xml","Dead",1091,"TCGA-25-1634","NOT HISPANIC OR LATINO","116C7279-C17B-4DBB-8FF7-3939C33D41FB",NA,1081,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,"34C70AAD-F121-4FA2-917E-FC7C099EFF6F","WHITE",NA,1,119,"D2BF3A3F-C51B-40A9-956D-2F77195D7A69","EEA11889-1206-4D6E-8563-B295ABC76977","TCGA-25-1634-01A-01W-0615-10_SOLiD.bam.bai","TCGA-25-1634-01A-01",85,0,NA,NA,15,"TOP",1,NA,"TCGA-25-1634-01A-01-TS1",84,"Tamoxifen","Hormone Therapy","TCGA-25-1634-D26753","TCGA-25-1634-R26754","EXTERNAL BEAM","Primary Tumor Field","TCGA-25-1634-F26749_NTE-1",NA,1081,"WITH TUMOR","Dead",1091,"TCGA-25-1634-F26749","TCGA-25-1634",NA,"25","1634","YES","C56.9","8441/3","C56.9",NA,NA,-27749,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1081,1091,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,75,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
178701518,173555516,12863677201,"1492D21A-6458-4B49-B530-7A327FCDD031.bw","15f1a992-0724-4d76-a71a-702ac7753a41","1492d21a-6458-4b49-b530-7a327fcdd031","2016-08-25T02:20:54.668525-05:00","TCGA-25-1870-01A-01R-1567-13_rnaseq_fastq.tar","e929d676-226b-4047-b883-fd69532be2d8",11703859200,"Illumina HiSeq","7573fc2313ff135337f1cd8c0300351a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:39:02.807594-05:00","2016-05-03T11:41:05.748550-05:00","e929d676-226b-4047-b883-fd69532be2d8_analysis.xml","cf08883fa836b7537c9d99fbefc1bc85","e49fb1e8-0c3a-4ca4-a0e2-510413259da5",2181,"2016-08-13T09:51:59.191978-05:00","e929d676-226b-4047-b883-fd69532be2d8_experiment.xml","427e15af80aad8c3df02d88f8acac888","f8cf9a77-70e9-4710-b701-9e0ea9864b8d",3916,"2016-09-29T23:51:37.221228-05:00","e929d676-226b-4047-b883-fd69532be2d8_run.xml","5d48d5a9c45e030e3d48ca048ca26944","ec773a3e-f07c-49ba-bbb8-79cfe19b551a",1989,"2016-09-08T10:44:22.498730-05:00","TCGA-25-1870","2016-09-02T18:50:20.426720-05:00","female","TCGA-25-1870_demographic",1935,"white","c0bb7234-e6e9-5243-a3ab-3e33ef23ba66","not hispanic or latino",1995,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1870_diagnosis","not reported",21550,"dead","8441/3",455,455,"7a970436-b1ad-5ed4-bc9d-c7e4870207ec","c56.9",-21550,"TCGA-25-1870_treatment","fc63c78d-4a19-561f-83e9-7c619a14021d","01",NA,"TCGA-25-1870-01A","0.4","b6eb7ad6-2676-416e-b165-0cf683116793",FALSE,"5F2EF344-7BE6-4D1A-90F8-8CA796C232B3","Primary Tumor","0.2",NA,NA,"0.8",1247529600,"01",82,"TCGA-25-1870-01A-01",90,90,0,0,0,0,10,10,"2016-09-08T10:44:22.498730-05:00","2016-09-08T10:44:22.498730-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"d4ab8919-bcf7-440f-af7b-f66bc835ccfa","e29642cc-97ec-4d8b-b09d-ba85be57dd44","TCGA-25-1870-01A-01-BS1","TCGA-25-1870-01A-01-TS1",90,90,"f1b0c0d5-5d7c-4ef2-a19a-06b11658862a","RNA","TCGA-25-1870-01A-01R","e63c81ae-bc06-4d84-bc85-a652ccbf29dc",1.8,0.15,"UV Spec","R","22","TCGA-25-1870-01A-01R-1567-13","c446d667-ea88-40fe-ad97-fd3fcceb7dd1",0.15,NA,NA,NA,NA,"2be83342-3483-5a89-9457-be91e405fa42","TCGA-25-1870_exposure","TCGA-25-1870-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T22:00:56.000Z","2014-03-28T22:31:02.000Z","E929D676-226B-4047-B883-FD69532BE2D8","B6EB7AD6-2676-416E-B165-0CF683116793","Unaligned reads",11703859200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C446D667-EA88-40FE-AD97-FD3FCCEB7DD1","Canada's Michael Smith Genome Sciences Centre","564a3418e4b09c884b2220b1","15F1A992-0724-4D76-A71A-702AC7753A41","Ovarian Serous Cystadenocarcinoma","TAR","F1B0C0D5-5D7C-4EF2-A19A-06B11658862A","2014-03-28T22:31:02.000Z","E63C81AE-BC06-4D84-BC85-A652CCBF29DC","None","NO",1,0.2,"Primary Tumor","Mayo Clinic - Rochester",NA,"F1B0C0D5-5D7C-4EF2-A19A-06B11658862A",0.4,"25","TCGA-25-1870-01A-01R-1567-13_rnaseq_fastq.tar",NA,"TCGA-25-1870-01A",0.8,"F889655C-9DAA-433C-A1A9-86D2E757677E","TCGA",1994,NA,NA,"WITH TUMOR","E4A2A641-910E-466A-9DEC-05DB9EEE79BE",59,"1355.CEL","Dead",455,"TCGA-25-1870","NOT HISPANIC OR LATINO","D8DD85E5-4709-40CF-8E60-34F345303195",NA,455,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,82,"E29642CC-97EC-4D8B-B09D-BA85BE57DD44","E63C81AE-BC06-4D84-BC85-A652CCBF29DC","TCGA-25-1870-01A-01R-1567-13_rnaseq_fastq.tar","TCGA-25-1870-01A-01",90,0,0,0,10,"TOP",0,0,"TCGA-25-1870-01A-01-TS1",90,"Cytoxan","Chemotherapy","TCGA-25-1870-D26766",NA,NA,NA,"TCGA-25-1870-F26763_NTE-2",NA,455,"WITH TUMOR","Dead",455,"TCGA-25-1870-F26763","TCGA-25-1870",NA,"25","1870","YES","C56.9","8441/3","C56.9",NA,NA,-21550,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",455,455,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,1994,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
145266144,142717688,10565355742,"70650E0D-3BC0-4359-BB36-D8487EABB6DC.bw","15fc17cd-d073-4f81-a4a2-2db3cb9d7069","70650e0d-3bc0-4359-bb36-d8487eabb6dc","2016-09-29T20:31:41.401544-05:00","TCGA-57-1993-01A-01R-1568-13_rnaseq_fastq.tar","fc192f4e-1213-4ddb-9b8e-7659af84b52c",8890961920,"Illumina HiSeq","fca7fd47836d36cf722793e7f5af0307","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:26:18.280706-05:00","2016-05-03T11:56:42.628342-05:00","fc192f4e-1213-4ddb-9b8e-7659af84b52c_analysis.xml","953f4455bb9fa7ffad889fb0cca77adc","483e5e5a-a9e4-407c-b843-9ed4d3c02ccb",2181,"2016-09-29T21:28:53.422198-05:00","fc192f4e-1213-4ddb-9b8e-7659af84b52c_experiment.xml","f2dd082c85ede707174e28d3e8d7ceb5","9417cfe5-33e8-4a13-aceb-9547b7ca576b",3916,"2016-09-29T19:30:21.289900-05:00","fc192f4e-1213-4ddb-9b8e-7659af84b52c_run.xml","008a7858343181dfa9103681ec2fd656","4ad4f70a-a8fe-48e0-b346-02c036392377",1988,"2016-09-08T11:01:21.580778-05:00","TCGA-57-1993","2016-09-02T18:50:38.670083-05:00","female","TCGA-57-1993_demographic",1951,"white","ca281c52-a2d4-5e1b-8bd2-7d277fd5297b","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1993_diagnosis","not reported",20498,"alive","8441/3",NA,763,"3d3ca882-be6d-531d-8a29-55d8eb0f5f55","c56.9",-20498,"TCGA-57-1993_treatment","86b00aca-8e27-53cc-9482-58183bc3d7cc","01",NA,"TCGA-57-1993-01A","0.5","41dbed72-2bd8-4e94-9e20-ba18211bdcbc",FALSE,"55495e3a-6052-4fb1-b8a9-10b54dcdfbea","Primary Tumor","0.5",NA,NA,"1.5",1246233600,"01",139,"TCGA-57-1993-01A-01",95,95,NA,NA,0,0,10,30,"2016-09-08T11:01:21.580778-05:00","2016-09-08T11:01:21.580778-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"26748d79-df35-48ad-9c58-57203a229d85","4aecaa34-5d56-489d-b5a5-a7646864c1c6","TCGA-57-1993-01A-01-TS1","TCGA-57-1993-01A-01-BS1",90,70,"a5e74a0c-875c-4950-b3c8-4a7c0dbbb6c3","RNA","TCGA-57-1993-01A-01R","384ac8e6-d11c-48c2-8f8e-5dec7e871fc7",1.8,0.15,"UV Spec","R","22","TCGA-57-1993-01A-01R-1568-13","55f9061c-54e7-465c-af61-21d8bc8ecbe0",0.15,NA,NA,NA,NA,"6c732fe6-9b26-576d-9db6-c02c28ee1add","TCGA-57-1993_exposure","TCGA-57-1993-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T14:24:08.000Z","2014-08-28T15:33:19.000Z","FC192F4E-1213-4DDB-9B8E-7659AF84B52C","41DBED72-2BD8-4E94-9E20-BA18211BDCBC","Unaligned reads",8890961920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","55F9061C-54E7-465C-AF61-21D8BC8ECBE0","Canada's Michael Smith Genome Sciences Centre","564a35ede4b09c884b22b142","15FC17CD-D073-4F81-A4A2-2DB3CB9D7069","Ovarian Serous Cystadenocarcinoma","TAR","A5E74A0C-875C-4950-B3C8-4A7C0DBBB6C3","2014-08-28T15:33:19.000Z","384AC8E6-D11C-48C2-8F8E-5DEC7E871FC7","None","NO",1,0.5,"Primary Tumor","International Genomics Consortium",NA,"A5E74A0C-875C-4950-B3C8-4A7C0DBBB6C3",0.5,"57","TCGA-57-1993-01A-01R-1568-13_mirna.bam.bai",NA,"TCGA-57-1993-01A",1.5,"B07A8455-73A1-4571-BD1B-3E468EC2F2F8","TCGA",2007,NA,NA,"TUMOR FREE","D5E4F15E-CEF0-4F4C-8B87-6B79FFB6606A",56,"nationwidechildrens.org_clinical.TCGA-57-1993.xml","Alive",NA,"TCGA-57-1993","NOT HISPANIC OR LATINO","C5C65B87-F672-4576-8CC3-10552AEA8459",NA,763,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,139,"4AECAA34-5D56-489D-B5A5-A7646864C1C6","4E179909-4D02-4FDA-A7A2-2B4534F92635","TCGA-57-1993-01A-01R-1568-13_mirna.bam.bai","TCGA-57-1993-01A-01",95,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-57-1993-01A-01-BS1",70,"Taxol","Chemotherapy","TCGA-57-1993-D28094",NA,NA,NA,NA,NA,763,"TUMOR FREE","Alive",NA,"TCGA-57-1993-F28092","TCGA-57-1993",NA,"57","1993","YES","C56.9","8441/3","C56.9",NA,NA,-20498,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",763,NA,NA,NA,"TUMOR FREE","NO",7,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2007,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168668174,164910121,12178450158,"873FE591-6605-486C-AAAB-B5D6C2BB6FBF.bw","16829472-5666-4fba-9bf9-360ec1689aa0","873fe591-6605-486c-aaab-b5d6c2bb6fbf","2016-08-26T00:22:12.964141-05:00","TCGA-59-2351-01A-01R-1569-13_rnaseq_fastq.tar","5ca73922-48dc-4c66-9355-6d471ca95fc7",10609459200,"Illumina HiSeq","cb03078ce4f7d81196e5131b5b869b89","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:46:53.443970-05:00","2016-05-03T11:56:42.631594-05:00","5ca73922-48dc-4c66-9355-6d471ca95fc7_analysis.xml","c6531d74fe39b90edf90578fa1354599","09b902f4-6d73-4c91-aaf7-ba5561240206",2181,"2016-09-29T18:30:53.043204-05:00","5ca73922-48dc-4c66-9355-6d471ca95fc7_experiment.xml","0445594d1159a44216e6e83ebd4ee77c","2531219e-b325-4382-9d37-67e2d2d94eb8",3916,"2016-09-29T22:28:13.148515-05:00","5ca73922-48dc-4c66-9355-6d471ca95fc7_run.xml","dd7c48db5cd133f8d411931a6519e5eb","b8a2b415-29d0-44ed-a736-fadfdec48b89",1988,"2016-09-09T16:20:48.528021-05:00","TCGA-59-2351","2016-09-02T19:11:51.171816-05:00","female","TCGA-59-2351_demographic",1948,"white","3ba18647-da19-54a4-8a1c-be83eb7827d5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2351_diagnosis","not reported",NA,"alive","8441/3",NA,3532,"9e178568-ef7f-5e7a-b7af-7397c47741bb","c56.9",NA,"TCGA-59-2351_treatment","68edb0f8-6e65-5c15-87d8-7dcaf238f2ee","01",NA,"TCGA-59-2351-01A","0.8","5de10a41-af67-4417-9152-54a184a37f68",FALSE,"6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad","Primary Tumor","0.4",NA,NA,"2",1251763200,"01",151,"TCGA-59-2351-01A-01",80,80,NA,NA,1,1,19,19,"2016-09-09T16:20:48.528021-05:00","2016-09-09T16:20:48.528021-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"2bc77b82-f44c-4879-ae75-4d55872e6a9d","966e6ef8-f18b-48d1-86e8-f9c626a4f7cc","TCGA-59-2351-01A-01-BS1","TCGA-59-2351-01A-01-TS1",79,79,"4691ea59-038f-48b4-8b0c-01793ed5cb78","RNA","TCGA-59-2351-01A-01R","9f360b7c-f8b4-475e-9d86-5239ee9cac23",1.8,0.13,"UV Spec","R","22","TCGA-59-2351-01A-01R-1569-13","7e58cfd1-07eb-44e2-a563-fa7a00b338a3",0.13,NA,NA,NA,NA,"666ab165-033e-585c-b2e6-03dc1633c9fd","TCGA-59-2351_exposure","TCGA-59-2351-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-29T08:00:10.000Z","2014-08-29T10:21:33.000Z","5CA73922-48DC-4C66-9355-6D471CA95FC7","5DE10A41-AF67-4417-9152-54A184A37F68","Unaligned reads",10609459200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7E58CFD1-07EB-44E2-A563-FA7A00B338A3","Canada's Michael Smith Genome Sciences Centre","564a594ae4b09c884b271624","16829472-5666-4FBA-9BF9-360EC1689AA0","Ovarian Serous Cystadenocarcinoma","TAR","4691EA59-038F-48B4-8B0C-01793ED5CB78","2014-08-29T10:21:33.000Z","9F360B7C-F8B4-475E-9D86-5239EE9CAC23","None","NO",1,0.4,"Primary Tumor","Roswell Park",NA,"4691EA59-038F-48B4-8B0C-01793ED5CB78",0.8,"59","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2cdeaf4d-f2c6-44fd-872e-965ef80e505b.txt",NA,"TCGA-59-2351-01A",2,NA,"TCGA",1999,NA,NA,"TUMOR FREE","94A34541-07CD-4332-8FA6-6AFEB9849AD0",51,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2cdeaf4d-f2c6-44fd-872e-965ef80e505b.txt","Alive",NA,"TCGA-59-2351","NOT HISPANIC OR LATINO","714F1BFD-54F3-4A05-BBC7-3BC9BC5ACE8E",NA,3532,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,151,"966E6EF8-F18B-48D1-86E8-F9C626A4F7CC","E1EC45E2-1192-4EAF-A2B9-9C82078C634B","AMISS_p_TCGAb24_SNP_N_GenomeWideSNP_6_C06_542408.tangent.copynumber.data.txt","TCGA-59-2351-01A-01",80,1,NA,NA,19,"TOP",1,NA,"TCGA-59-2351-01A-01-TS1",79,NA,NA,NA,NA,NA,NA,"TCGA-59-2351-F28104_NTE-2",NA,3532,"TUMOR FREE","Alive",NA,"TCGA-59-2351-F28104","TCGA-59-2351",NA,"59","2351","YES","C56.9","8441/3","C56.9","NO","YES",NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",3532,NA,NA,NA,"TUMOR FREE","NO",29,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
162620028,158151266,11700714511,"B823982D-4102-4D21-B9CB-8C42830784F4.bw","16ced1b8-64d5-4498-82df-4d37bfe5b310","b823982d-4102-4d21-b9cb-8c42830784f4","2016-08-26T07:19:52.319737-05:00","TCGA-61-1741-01A-02R-1567-13_rnaseq_fastq.tar","1263a12f-b9f0-44e2-9281-9ff5fdab5249",10377472000,"Illumina HiSeq","3145d6446032b910d4a560f02eb862b7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:35:19.989965-05:00","2016-05-03T11:56:42.628809-05:00","1263a12f-b9f0-44e2-9281-9ff5fdab5249_analysis.xml","1602512cfe6fe3cebe0172c1edf48237","7290ab7b-c32b-4839-be21-0d0e4906f73c",2181,"2016-09-29T23:13:22.510871-05:00","1263a12f-b9f0-44e2-9281-9ff5fdab5249_experiment.xml","4e381b75a010937a9dc9d45828728022","d4c68682-70a4-4546-b887-97b74dfd9f3f",3916,"2016-09-29T18:11:36.649191-05:00","1263a12f-b9f0-44e2-9281-9ff5fdab5249_run.xml","a8a788f209b24e29f295935a1d6122a7","1944c3a9-c379-41ce-9143-8fe100e5e5c1",1988,"2016-09-08T13:28:57.529849-05:00","TCGA-61-1741","2016-09-02T19:06:48.891486-05:00","female","TCGA-61-1741_demographic",1928,"white","058fb30f-2085-5770-b4f2-6a6cf64072f7","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1741_diagnosis","not reported",27762,"dead","8441/3",1024,1024,"4338074a-9988-5342-ae53-3406d24b6758","c56.9",-27762,"TCGA-61-1741_treatment","56160cfd-0619-58a1-bbb8-d6d31502c502","01",NA,"TCGA-61-1741-01A","1","e5e22755-8759-4349-a6ba-87fff441183c",FALSE,"e2d0ec41-559c-48d4-8c4d-59e0f9d48823","Primary Tumor","0.4",NA,NA,"1.2",1242518400,"02",149,"TCGA-61-1741-01A-02",90,90,2,NA,0,0,0,0,"2016-09-08T13:28:57.529849-05:00","2016-09-08T13:28:57.529849-05:00",3,5,NA,NA,"TOP","BOTTOM",15,5,"816f2ee6-2268-4214-8cb3-36bc58a5a060","609dafe9-9590-45dd-b689-f49bee6a58ec","TCGA-61-1741-01A-01-BS1","TCGA-61-1741-01A-02-BS2",85,95,"40b04779-cbdd-40cb-bd5d-1dd102126046","RNA","TCGA-61-1741-01A-02R","ac85afc6-d9bf-4385-b5af-fe05d2478628",1.8,0.14,"UV Spec","R","22","TCGA-61-1741-01A-02R-1567-13","92d5764e-c576-47cd-a6bd-68ed0365c213",0.14,NA,NA,NA,NA,"fd20e5cb-4ad5-5411-9ec2-c210ccd889b8","TCGA-61-1741_exposure","TCGA-61-1741-01A-02R-1567-13_rnaseq_fastq.tar","2014-08-25T20:11:16.000Z","2014-08-25T21:31:44.000Z","1263A12F-B9F0-44E2-9281-9FF5FDAB5249","E5E22755-8759-4349-A6BA-87FFF441183C","Unaligned reads",10377472000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","92D5764E-C576-47CD-A6BD-68ED0365C213","Canada's Michael Smith Genome Sciences Centre","564a5ad9e4b09c884b27835a","16CED1B8-64D5-4498-82DF-4D37BFE5B310","Ovarian Serous Cystadenocarcinoma","TAR","40B04779-CBDD-40CB-BD5D-1DD102126046","2014-08-25T21:31:44.000Z","AC85AFC6-D9BF-4385-B5AF-FE05D2478628","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"40B04779-CBDD-40CB-BD5D-1DD102126046",1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.4da87c92-0d8f-4475-b5c8-332329e3d7b2.txt",NA,"TCGA-61-1741-01A",1.2,"DE49CD91-151A-46E9-A204-106B50968A1F","TCGA",2004,NA,NA,"WITH TUMOR","E5E22755-8759-4349-A6BA-87FFF441183C",76,"TCGA-61-1741-01A-02R-1567-13_mirna.bam.bai","Dead",1024,"TCGA-61-1741","NOT HISPANIC OR LATINO","6C399B77-3D5E-4EB6-AE9A-F4857B8B5DAB",NA,1024,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,"3B9ED17E-E786-430B-B4FB-E07EEAF4BECB","WHITE",NA,2,149,"816F2EE6-2268-4214-8CB3-36BC58A5A060","DBF2F6A4-20FA-48AB-8328-36A2AB9583C8","TCGA-61-1741-01A-02R-1567-13_rnaseq_fastq.tar","TCGA-61-1741-01A-02",90,0,NA,5,0,"BOTTOM",5,NA,"TCGA-61-1741-01A-02-BS2",95,"Carboplatin","Chemotherapy","TCGA-61-1741-D28202","TCGA-61-1741-R28207","EXTERNAL BEAM","Local Recurrence","TCGA-61-1741-F28201_NTE-1",NA,1024,"WITH TUMOR","Dead",1024,"TCGA-61-1741-F28201","TCGA-61-1741",NA,"61","1741","YES","C56.9","8441/3","C56.9",NA,NA,-27762,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1024,1024,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,76,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
206885542,200163783,14817070842,"C64256A0-EB9B-490C-BD41-E29F2FF35D3D.bw","17181157-c9e2-4bd6-8653-f5dce56f9053","c64256a0-eb9b-490c-bd41-e29f2ff35d3d","2016-08-26T10:06:32.193401-05:00","TCGA-24-2038-01A-01R-1568-13_rnaseq_fastq.tar","b745586a-cef2-4f50-83c5-4bd481101f01",13014528000,"Illumina HiSeq","7ae29cf0830f59bc0ccf29f643827f3a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:53:08.190406-05:00","2016-05-03T11:41:05.740436-05:00","b745586a-cef2-4f50-83c5-4bd481101f01_analysis.xml","3fb4a574cd8905c7303c80f5e27ce5d4","ed7064c0-dd82-4372-b628-e68ef64f89a0",2181,"2016-09-29T19:31:37.377424-05:00","b745586a-cef2-4f50-83c5-4bd481101f01_experiment.xml","84ddf242eacb469fd016d80990745fdc","4ba34a15-d859-4e58-8adc-40c1324b5d76",3916,"2016-09-29T22:27:11.299431-05:00","b745586a-cef2-4f50-83c5-4bd481101f01_run.xml","6603f711011308300cb5e2859175434c","b7f5517d-23a4-4db8-a823-630c313815ea",1988,"2016-09-08T12:14:27.946119-05:00","TCGA-24-2038","2016-09-02T18:56:16.706041-05:00","female","TCGA-24-2038_demographic",1932,"white","3ea04b59-4837-5855-9da9-a7e5b46b7e10","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2038_diagnosis","not reported",24957,"dead","8441/3",1354,1354,"82ae2a62-aea4-5d85-9136-e3403b28b06c","c56.9",-24957,"TCGA-24-2038_treatment","69152569-be83-508b-94fb-050e944616a9","01",NA,"TCGA-24-2038-01A","0.6","cb5c8591-15ab-46b3-a819-57cbf71c6bce",FALSE,"82958234-9de0-429f-8e63-3e8891f1df81","Primary Tumor","0.4",NA,NA,"1",1248134400,"01",129,"TCGA-24-2038-01A-01",90,90,0,0,0,0,40,5,"2016-09-08T12:14:27.946119-05:00","2016-09-08T12:14:27.946119-05:00",2,0,0,0,"BOTTOM","TOP",0,0,"bfb2b2d1-9854-418f-b254-834554b1f0aa","a774211b-82e3-4362-a5bd-7a7f8367fc3a","TCGA-24-2038-01A-01-BS1","TCGA-24-2038-01A-01-TS1",60,95,"61dd04b3-7185-43f0-9811-02dcd6d18b0d","RNA","TCGA-24-2038-01A-01R","9d213069-5360-466d-8188-4c916373b9f0",1.8,0.15,"UV Spec","R","22","TCGA-24-2038-01A-01R-1568-13","372a8471-dff3-44c0-9393-94ad511a7374",0.15,NA,NA,NA,NA,"ae71bd83-8d1b-506b-9a9b-2cc13e01a223","TCGA-24-2038_exposure","TCGA-24-2038-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T00:20:03.000Z","2014-03-27T00:46:01.000Z","B745586A-CEF2-4F50-83C5-4BD481101F01","CB5C8591-15AB-46B3-A819-57CBF71C6BCE","Unaligned reads",13014528000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","372A8471-DFF3-44C0-9393-94AD511A7374","Canada's Michael Smith Genome Sciences Centre","564a588fe4b093830b6c0fd8","17181157-C9E2-4BD6-8653-F5DCE56F9053","Ovarian Serous Cystadenocarcinoma","TAR","61DD04B3-7185-43F0-9811-02DCD6D18B0D","2014-03-27T00:46:01.000Z","9D213069-5360-466D-8188-4C916373B9F0","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"61DD04B3-7185-43F0-9811-02DCD6D18B0D",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b9526a72-d01f-46bc-896d-4798319abebf.txt",NA,"TCGA-24-2038-01A",1,"D15BE7F1-44D9-45A2-AEBB-C743EE12A8FE","TCGA",2000,NA,NA,"WITH TUMOR","DCDF14EB-C2E9-42AC-BB96-EABAC0B241F1",68,"MSK_252152918065_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Dead",1354,"TCGA-24-2038",NA,"8FC55409-DFDB-43DE-BD4E-9D1F31594CCC",NA,1354,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,129,"BFB2B2D1-9854-418F-B254-834554B1F0AA","EF714E17-AEBE-4C6B-951E-4F1A37505DC5","TCGA-24-2038-01A-01R-1568-13.hg19.spljxn.quantification.txt","TCGA-24-2038-01A-01",90,0,0,0,5,"TOP",0,0,"TCGA-24-2038-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-24-2038-D26520",NA,NA,NA,"TCGA-24-2038-F26518_NTE-2",NA,1354,"WITH TUMOR","Dead",1354,"TCGA-24-2038-F26518","TCGA-24-2038",NA,"24","2038","YES","C56.9","8441/3","C56.9",NA,NA,-24957,"FEMALE","WHITE",NA,NA,"No","Dead",1354,1354,NA,NA,"WITH TUMOR","NO",19,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,68,2000,"Tumor resection",NA,NA,NA,"GB",NA,NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
301497486,289079992,21438862364,"B820B85D-58C6-4DC3-8675-A840265F1ECF.bw","171f7917-69eb-4a3f-9cc0-0e1dffd412c1","b820b85d-58c6-4dc3-8675-a840265f1ecf","2016-08-26T07:30:21.886985-05:00","TCGA-24-1463-01A-01R-1566-13_rnaseq_fastq.tar","bc879c0e-c79d-4684-868e-0b3cfee398a7",20358860800,"Illumina HiSeq","46cc6837f1607d32d36acd870ccc6d16","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:37:31.212284-05:00","2016-05-03T11:39:34.528512-05:00","bc879c0e-c79d-4684-868e-0b3cfee398a7_analysis.xml","63a548934e517fe790dab0e3acb97069","e3bdf235-4017-4368-9c84-d54c19d62954",2181,"2016-09-29T19:45:21.021353-05:00","bc879c0e-c79d-4684-868e-0b3cfee398a7_experiment.xml","bf13b7f3cbbfd2c66e2f6d363cfe70b2","540b5cb3-df1e-4fe2-8b86-50c9a167574d",3916,"2016-09-29T23:06:46.104851-05:00","bc879c0e-c79d-4684-868e-0b3cfee398a7_run.xml","2a450a8475bb84917d3a0cfbd7ec70ff","d0935a26-b74f-4635-b91a-5ad09c2e2728",1988,"2016-09-08T13:20:21.718646-05:00","TCGA-24-1463","2016-09-02T19:13:52.991803-05:00","female","TCGA-24-1463_demographic",1930,"white","9e8c9476-f74b-57c4-9fd8-5a3786d7c834","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1463_diagnosis","not reported",25734,"dead","8441/3",2218,2218,"6f5d29ee-4ea0-5da7-be01-e7daeef0d99f","c56.9",-25734,"TCGA-24-1463_treatment","40e92b8b-02ae-5176-a68b-3325f97769f1","01",NA,"TCGA-24-1463-01A","1.3","58b3222f-4ac0-4920-babc-e35b64cf90c6",FALSE,"864CB084-569A-47F0-A83D-F3FA649A6B00","Primary Tumor","0.5",NA,NA,"2",1234310400,"01",105,"TCGA-24-1463-01A-01",80,75,NA,NA,0,0,19,24,"2016-09-08T13:20:21.718646-05:00","2016-09-08T13:20:21.718646-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"18fd488c-a7e7-4254-9e9f-2fd4b0cf1496","922365e3-495c-4005-8228-710a60603714","TCGA-24-1463-01A-01-BS1","TCGA-24-1463-01A-01-TS1",80,75,"4cb5bfd4-f65a-4989-a430-ddf10abc353d","RNA","TCGA-24-1463-01A-01R","7edb9fc8-3776-47bf-9e18-467c29f9ad42",1.8,0.16,"UV Spec","R","22","TCGA-24-1463-01A-01R-1566-13","939d41b7-9ccb-4cf6-be16-f2792aece5eb",0.16,NA,NA,NA,NA,"160b38a4-efa8-5111-9ef2-e508c0f0a31e","TCGA-24-1463_exposure","TCGA-24-1463-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T04:59:17.000Z","2014-03-20T05:35:02.000Z","BC879C0E-C79D-4684-868E-0B3CFEE398A7","58B3222F-4AC0-4920-BABC-E35B64CF90C6","Unaligned reads",20358860800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","939D41B7-9CCB-4CF6-BE16-F2792AECE5EB","Canada's Michael Smith Genome Sciences Centre","564a3492e4b08c5d868f5509","171F7917-69EB-4A3F-9CC0-0E1DFFD412C1","Ovarian Serous Cystadenocarcinoma","TAR","4CB5BFD4-F65A-4989-A430-DDF10ABC353D","2014-03-20T05:35:02.000Z","7EDB9FC8-3776-47BF-9E18-467C29F9AD42","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"4CB5BFD4-F65A-4989-A430-DDF10ABC353D",1.3,"24","bcgsc.ca.TCGA-24-1463-01A-01R-1566-13.hg19.bcgsc.ca.1.7.0.sv.vcf",NA,"TCGA-24-1463-01A",2,"F8497CC1-74F7-4707-81D7-CD60360EDB9B","TCGA",2000,NA,NA,"WITH TUMOR","FC7E6264-887C-4CA2-9501-B7F01A49949D",70,"nationwidechildrens.org_clinical.TCGA-24-1463.xml","Dead",2218,"TCGA-24-1463","NOT HISPANIC OR LATINO","9B5F38DD-E6EE-4D19-AF8B-C1A46F8B00C0",NA,2218,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,105,"922365E3-495C-4005-8228-710A60603714","67AFDA99-DCF8-4048-B3E2-FD4E95BECC18","THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_H02_455212.tangent.copynumber.data.txt","TCGA-24-1463-01A-01",80,0,NA,NA,19,"BOTTOM",1,NA,"TCGA-24-1463-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-24-1463-D26012",NA,NA,NA,"TCGA-24-1463-F26009_NTE-1",NA,2218,"WITH TUMOR","Dead",2218,"TCGA-24-1463-F26009","TCGA-24-1463",NA,"24","1463","YES","C56.9","8441/3","C56.9",NA,NA,-25734,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",2218,2218,NA,NA,"WITH TUMOR","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,70,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
241653842,236486370,17524084745,"E846120D-D9E6-46F8-9647-2272AB064072.bw","184aac07-44c1-47f1-8adf-50acbcc1762c","e846120d-d9e6-46f8-9647-2272ab064072","2016-08-26T23:09:23.255774-05:00","TCGA-09-2048-01A-01R-1568-13_rnaseq_fastq.tar","de012eef-c869-488e-9694-4d507f97e703",14774579200,"Illumina HiSeq","58f81721499acf1bc6e68ad6898cc31a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:40:22.446826-05:00","2016-05-03T11:41:05.740436-05:00","de012eef-c869-488e-9694-4d507f97e703_analysis.xml","7f7af4f0826a8ce1fcbb3623559ad137","75ba11a2-bd81-427a-90be-1541c4922dd1",2181,"2016-08-29T16:36:12.195048-05:00","de012eef-c869-488e-9694-4d507f97e703_experiment.xml","3c592fe9825178c3497cb85deab1e725","6455234f-1554-4a2b-ac62-e05b2aab8d13",3916,"2016-09-29T22:07:06.793566-05:00","de012eef-c869-488e-9694-4d507f97e703_run.xml","fc7c5367002ea7ced116b9e187b0da65","abb586c9-3629-4a2a-bc76-e6c4c89e16c5",1989,"2016-09-08T13:48:43.569669-05:00","TCGA-09-2048","2016-09-02T19:12:06.444131-05:00","female","TCGA-09-2048_demographic",1936,"white","43dd4513-5e1d-57ed-8b5a-5bf9175bb209","not hispanic or latino",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2048_diagnosis","not reported",23043,"dead","8441/3",138,NA,"e84e8a2c-231c-56f6-97e2-983b9bb2e049","c56.9",-23043,"TCGA-09-2048_treatment","6742f88d-c93f-565f-8b51-0f565f6845e8","01",NA,"TCGA-09-2048-01A","0.7","fe693f25-efb5-46d5-8bab-de5b87eef1ad",FALSE,"0755D708-ADF5-4219-ABC6-BCD9C2BCA089","Primary Tumor","0.2",NA,NA,"1",1248134400,"01",111,"TCGA-09-2048-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:48:43.569669-05:00","2016-09-08T13:48:43.569669-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,5,"185260f3-68dc-4e18-993c-7ac8bab6fe3c","a6b08202-bed9-476e-8919-8a4300021f11","TCGA-09-2048-01A-01-BS1","TCGA-09-2048-01A-01-TS1",94,90,"b89981ed-9095-42bd-8262-a5f7f9c7871e","RNA","TCGA-09-2048-01A-01R","ca81d5aa-4ae6-4f25-b706-a8661466e6b3",1.8,0.14,"UV Spec","R","22","TCGA-09-2048-01A-01R-1568-13","d3220bce-1bf3-47c4-951f-937dac7581be",0.14,NA,NA,NA,NA,"5f92e6b4-a572-54f0-a1df-bcd3de90ed75","TCGA-09-2048_exposure","TCGA-09-2048-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T02:51:17.000Z","2014-03-27T03:24:01.000Z","DE012EEF-C869-488E-9694-4D507F97E703","FE693F25-EFB5-46D5-8BAB-DE5B87EEF1AD","Unaligned reads",14774579200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D3220BCE-1BF3-47C4-951F-937DAC7581BE","Canada's Michael Smith Genome Sciences Centre","564a408be4b0ef12181c18f1","184AAC07-44C1-47F1-8ADF-50ACBCC1762C","Ovarian Serous Cystadenocarcinoma","TAR","B89981ED-9095-42BD-8262-A5F7F9C7871E","2014-03-27T03:24:01.000Z","CA81D5AA-4AE6-4F25-B706-A8661466E6B3","None","NO",1,0.2,"Primary Tumor","UCSF",NA,"B89981ED-9095-42BD-8262-A5F7F9C7871E",0.7,"09","TCGA-09-2048-01A-01R-1568-13_GRCh37-lite_mirna.bam.bai",NA,"TCGA-09-2048-01A",1,"36759FAD-DF49-4C76-9C80-CCBD66D8D40A","TCGA",1999,NA,NA,"WITH TUMOR","FE693F25-EFB5-46D5-8BAB-DE5B87EEF1AD",63,"nationwidechildrens.org_clinical.TCGA-09-2048.xml","Dead",138,"TCGA-09-2048","NOT HISPANIC OR LATINO","7D525BD5-FC5D-4C60-AFF2-5DBECE847B51",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,111,"A6B08202-BED9-476E-8919-8A4300021F11","CA81D5AA-4AE6-4F25-B706-A8661466E6B3","TCGA-09-2048-01A-01R-1568-13_GRCh37-lite_mirna.bam.bai","TCGA-09-2048-01A-01",95,0,NA,NA,5,"TOP",5,NA,"TCGA-09-2048-01A-01-TS1",90,NA,"Chemotherapy","TCGA-09-2048-D24352",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",138,"TCGA-09-2048-F24351","TCGA-09-2048",NA,"09","2048","YES","C56.9","8441/3","C56.9",NA,NA,-23043,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,138,NA,NA,"WITH TUMOR","NO",3,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
236422018,229370617,16987375164,"36880C8C-91A9-49A9-A2D5-957161737F31.bw","1858b58f-fdf4-413c-9c29-96ae85b88a74","36880c8c-91a9-49a9-a2d5-957161737f31","2016-10-19T10:25:55.361787-05:00","TCGA-24-1550-01A-01R-1566-13_rnaseq_fastq.tar","9e931a5a-d753-4103-af80-c87318fe21c6",15385231360,"Illumina HiSeq","f4add0cd7051b1c158bcd9ef5fc24753","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:59:24.308407-05:00","2016-05-03T11:40:21.662944-05:00","9e931a5a-d753-4103-af80-c87318fe21c6_analysis.xml","845bb3f5f2c22af09d7e4c449761ff1f","5cbe9951-cd85-419e-863d-09d80c0d5404",2181,"2016-09-29T23:32:06.517708-05:00","9e931a5a-d753-4103-af80-c87318fe21c6_experiment.xml","b8cea1ce415ba0cdbd94416f068cdf62","e05b48f6-c045-466f-8009-0b45a2448a7a",3916,"2016-09-29T19:13:45.170970-05:00","9e931a5a-d753-4103-af80-c87318fe21c6_run.xml","53d5c2760e174c5b670e6967000f3e8b","40653380-9e44-47dc-94b1-72fca1af2a7f",1988,"2016-09-08T12:20:43.587296-05:00","TCGA-24-1550","2016-09-02T19:07:14.801780-05:00","female","TCGA-24-1550_demographic",1948,"white","398a8019-dc37-529c-a1ed-c9dd8bc38628","not reported",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1550_diagnosis","not reported",18049,"dead","8441/3",1249,1249,"128ce7b5-2666-568d-8370-bd8ce225cb6a","c56.9",-18049,"TCGA-24-1550_treatment","4a777e8f-38d3-5b9a-9567-7ece5a98878f","01",NA,"TCGA-24-1550-01A","1","2726ed05-ac38-41d6-85f3-35ab0bcbc47a",FALSE,"7ebd8d19-0a81-4623-8127-f225ad650d46","Primary Tumor","0.7",NA,NA,"1.5",1235260800,"01",123,"TCGA-24-1550-01A-01",80,85,NA,NA,0,0,25,10,"2016-09-08T12:20:43.587296-05:00","2016-09-08T12:20:43.587296-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,10,"3c468906-1fe3-4438-af83-46db12f8a8cc","d3dfc107-2dd1-412c-9649-239b2f3d9970","TCGA-24-1550-01A-01-TS1","TCGA-24-1550-01A-01-BS1",70,80,"d557693c-3269-431f-86b1-07922a125630","RNA","TCGA-24-1550-01A-01R","2791c102-57d5-4fd3-b297-04c760c0300f",1.8,0.15,"UV Spec","R","22","TCGA-24-1550-01A-01R-1566-13","648cb96f-df1c-48c1-bb15-c37a2784a9db",0.15,NA,NA,NA,NA,"52aab6ee-cfa2-570d-a46d-6c9c325394bc","TCGA-24-1550_exposure","TCGA-24-1550-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-24T22:52:13.000Z","2014-03-24T23:25:02.000Z","9E931A5A-D753-4103-AF80-C87318FE21C6","2726ED05-AC38-41D6-85F3-35AB0BCBC47A","Unaligned reads",15385231360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","648CB96F-DF1C-48C1-BB15-C37A2784A9DB","Canada's Michael Smith Genome Sciences Centre","564a5c1ee4b0ef12181e4874","1858B58F-FDF4-413C-9C29-96AE85B88A74","Ovarian Serous Cystadenocarcinoma","TAR","D557693C-3269-431F-86B1-07922A125630","2014-03-24T23:25:02.000Z","2791C102-57D5-4FD3-B297-04C760C0300F","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"D557693C-3269-431F-86B1-07922A125630",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.907ac822-b65b-45f3-87ea-fc78f06bab60.txt",NA,"TCGA-24-1550-01A",1.5,"C32B99A6-9F34-4281-9364-DE59A8A6F66C","TCGA",1997,NA,NA,"WITH TUMOR","E469F4D7-FA56-4431-A81A-7BA7FC7C1555",49,"COOKY_p_TCGAb15_ICPp3_061909_GenomeWideSNP_6_D07_465780.hg19.seg.txt","Dead",1249,"TCGA-24-1550",NA,"5BDA2645-5465-4ED5-A000-C378FFE3BA62",NA,1249,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,123,"D3DFC107-2DD1-412C-9649-239B2F3D9970","C06A4B7D-AEE9-4C05-BE66-441E4E9BDBEC","TCGA-24-1550-01A-01R-1566-13_mirna.bam","TCGA-24-1550-01A-01",80,0,NA,NA,25,"TOP",5,NA,"TCGA-24-1550-01A-01-TS1",70,"Doxil","Chemotherapy","TCGA-24-1550-D26137",NA,NA,NA,"TCGA-24-1550-F26130_NTE-2",NA,1249,"WITH TUMOR","Dead",1249,"TCGA-24-1550-F26130","TCGA-24-1550",NA,"24","1550","YES","C56.9","8441/3","C56.9",NA,NA,-18049,"FEMALE","WHITE",NA,NA,"No","Dead",1249,1249,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,49,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
134870744,131154494,9709495550,"D52CD6EF-111C-4B8F-8B57-0B55A4D33A04.bw","186d40cd-624c-4016-a497-b30c892d393c","d52cd6ef-111c-4b8f-8b57-0b55a4d33a04","2016-08-26T15:26:18.303410-05:00","TCGA-31-1959-01A-01R-1568-13_rnaseq_fastq.tar","1ab69f77-0093-4317-930c-129a79bcb4ec",8760586240,"Illumina HiSeq","e9a79502de53989693c9c63204eb2404","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:33:11.605206-05:00","2016-05-03T11:41:05.748550-05:00","1ab69f77-0093-4317-930c-129a79bcb4ec_analysis.xml","2c60a2e0a4467eb7f11b5706e9168a73","268a0d51-ccd4-44c0-8c76-eaab91fd349e",2181,"2016-09-29T18:25:30.512456-05:00","1ab69f77-0093-4317-930c-129a79bcb4ec_experiment.xml","ee734195e32d4d4ceddff5bac4d80354","21cb9a93-7f9a-4f04-a829-367b89960fa8",3916,"2016-09-29T19:18:56.786464-05:00","1ab69f77-0093-4317-930c-129a79bcb4ec_run.xml","db67700a5f5fb72c88bd1a969617bc00","439635f6-8231-4d82-8a9d-053438c13b84",1989,"2016-09-08T11:05:13.530415-05:00","TCGA-31-1959","2016-09-02T18:50:20.946967-05:00","female","TCGA-31-1959_demographic",1960,"white","f9c4143c-c920-522f-9333-0e259cb78801","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1959_diagnosis","not reported",18247,"alive","8441/3",NA,67,"121cc11a-b0d3-537e-ae08-106d193c7667","c56.9",-18247,"TCGA-31-1959_treatment","8aca474d-6dba-5b4e-bd7d-3cbe12ceacf0","01",NA,"TCGA-31-1959-01A","0.7","dd8556f8-461a-468d-8604-c4f2366b1cd7",FALSE,"c78c6998-1f86-4dd2-bf41-78f12d43c33a","Primary Tumor","0.2",NA,NA,"1.1",1246838400,"01",92,"TCGA-31-1959-01A-01",70,75,NA,NA,0,0,40,37,"2016-09-08T11:05:13.530415-05:00","2016-09-08T11:05:13.530415-05:00",2,2,NA,NA,"BOTTOM","TOP",0,3,"13ffdaa0-16e9-4e42-b74a-bd8374cbbf8f","c9408cb9-448f-47f7-bad3-36f89f225596","TCGA-31-1959-01A-01-BS1","TCGA-31-1959-01A-01-TS1",60,60,"751378fb-337e-4946-9ff2-9878998c66ba","RNA","TCGA-31-1959-01A-01R","a6d90e53-86b5-4f73-a4df-d5998ebff2ef",1.8,0.14,"UV Spec","R","22","TCGA-31-1959-01A-01R-1568-13","25b1eb9f-7b97-4da2-96a9-a4a3aaaca192",0.14,NA,NA,NA,NA,"21ed04dc-91b8-5504-8ec4-b64288164e0a","TCGA-31-1959_exposure","TCGA-31-1959-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-29T07:51:05.000Z","2014-03-29T08:07:02.000Z","1AB69F77-0093-4317-930C-129A79BCB4EC","DD8556F8-461A-468D-8604-C4F2366B1CD7","Unaligned reads",8760586240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","25B1EB9F-7B97-4DA2-96A9-A4A3AAACA192","Canada's Michael Smith Genome Sciences Centre","564a3427e4b0ef1218181d68","186D40CD-624C-4016-A497-B30C892D393C","Ovarian Serous Cystadenocarcinoma","TAR","751378FB-337E-4946-9FF2-9878998C66BA","2014-03-29T08:07:02.000Z","A6D90E53-86B5-4F73-A4DF-D5998EBFF2EF","None","NO",1,0.2,"Primary Tumor","Imperial College",NA,"751378FB-337E-4946-9FF2-9878998C66BA",0.7,"31","1352.CEL",NA,"TCGA-31-1959-01A",1.1,"5B3D6D1E-FCAA-435B-B73D-24586385E15C","TCGA",2009,NA,NA,"WITH TUMOR","DD8556F8-461A-468D-8604-C4F2366B1CD7",49,"C239.TCGA-31-1959-01A-01W-0699-08.4.bam","Alive",NA,"TCGA-31-1959","NOT HISPANIC OR LATINO","2550CDB2-11F6-4349-91E8-39780C044DBD",NA,67,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,92,"C9408CB9-448F-47F7-BAD3-36F89F225596","A6D90E53-86B5-4F73-A4DF-D5998EBFF2EF","bcgsc.ca.TCGA-31-1959-01A-01R-1568-13.hg19.bcgsc.ca.1.6.0.snv.vcf","TCGA-31-1959-01A-01",75,0,NA,2,37,"TOP",3,NA,"TCGA-31-1959-01A-01-TS1",60,"Paciltaxel","Chemotherapy","TCGA-31-1959-D27717",NA,NA,NA,NA,NA,67,"WITH TUMOR","Alive",NA,"TCGA-31-1959-F27715","TCGA-31-1959",NA,"31","1959","YES","C56.9","8441/3","C56.9",NA,NA,-18247,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",67,NA,NA,NA,"WITH TUMOR","NO",20,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2009,"Excisional Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
275422562,266900005,19764996036,"B9C02C13-6E71-41F4-8A93-8D8C2926FEC7.bw","18d21132-a795-4551-83ba-66483de423a2","b9c02c13-6e71-41f4-8a93-8d8c2926fec7","2016-08-22T07:55:25.173290-05:00","TCGA-29-1698-01A-01R-1567-13_rnaseq_fastq.tar","e545fd71-7cc5-48cd-9d15-86f632702a6a",17895792640,"Illumina HiSeq","8b9abff274c302ce9f63abb9acb40828","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:14:41.207610-05:00","2016-05-03T11:41:05.748550-05:00","e545fd71-7cc5-48cd-9d15-86f632702a6a_analysis.xml","61dc85f2b8239902d5555cfa39cd2482","40eb509e-b07d-48d6-ac39-b6d6d40c38d8",2181,"2016-09-29T20:53:02.646961-05:00","e545fd71-7cc5-48cd-9d15-86f632702a6a_experiment.xml","0db5e694621021323ee8ef8d15757b16","7da3b414-9fb4-49df-96ea-93f30e53441c",3916,"2016-09-29T19:37:56.814034-05:00","e545fd71-7cc5-48cd-9d15-86f632702a6a_run.xml","07cec13c3bccc7facb07e7e4c00c4e2a","4f733d03-1c33-41af-aef0-491f3c7e18ea",1989,"2016-09-08T13:06:06.195734-05:00","TCGA-29-1698","2016-09-02T19:07:38.444413-05:00","female","TCGA-29-1698_demographic",1951,"black or african american","d905ee3a-476c-595e-9777-0f611cb3caf1","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1698_diagnosis","not reported",19611,"alive","8441/3",NA,2078,"e383018c-dd08-5acf-a9de-02abce0898a7","c56.9",-19611,"TCGA-29-1698_treatment","435a5a1a-20b0-5e6f-824e-9b9d6c590a35","01",NA,"TCGA-29-1698-01A","0.9","f66a6768-2ef9-4318-91fe-8f3498553569",FALSE,"133f2df5-6c22-4653-9d2e-f3d5971502b0","Primary Tumor","0.3",NA,NA,"1.4",1242086400,"01",101,"TCGA-29-1698-01A-01",70,70,NA,NA,0,0,45,45,"2016-09-08T13:06:06.195734-05:00","2016-09-08T13:06:06.195734-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"89d30e7a-5494-4d72-aa3b-36dc6e32301e","e59554f2-0729-4985-ac95-a8d46f3f7fcd","TCGA-29-1698-01A-01-BS1","TCGA-29-1698-01A-01-TS1",50,50,"7aafa1d7-ef3a-4398-9556-8db6375e588f","RNA","TCGA-29-1698-01A-01R","9ab5ffbf-2fb5-4454-914a-be32e4876b9a",1.9,0.14,"UV Spec","R","22","TCGA-29-1698-01A-01R-1567-13","74970c45-4cc5-4952-9846-ce2d959437ea",0.14,NA,NA,NA,NA,"33086c7c-38d6-5675-b9db-e7e971fa29ab","TCGA-29-1698_exposure","TCGA-29-1698-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T23:32:44.000Z","2014-03-29T00:28:02.000Z","E545FD71-7CC5-48CD-9D15-86F632702A6A","F66A6768-2EF9-4318-91FE-8F3498553569","Unaligned reads",17895792640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","74970C45-4CC5-4952-9846-CE2D959437EA","Canada's Michael Smith Genome Sciences Centre","564a38c0e4b093830b686a60","18D21132-A795-4551-83BA-66483DE423A2","Ovarian Serous Cystadenocarcinoma","TAR","7AAFA1D7-EF3A-4398-9556-8DB6375E588F","2014-03-29T00:28:02.000Z","9AB5FFBF-2FB5-4454-914A-BE32E4876B9A","None","NO",1,0.3,"Primary Tumor","Duke",NA,"7AAFA1D7-EF3A-4398-9556-8DB6375E588F",0.9,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a40be7ea-f682-4d3e-a749-74aec6961b88.txt",NA,"TCGA-29-1698-01A",1.4,"F5E6D97B-A6DC-4699-8440-CFE1999A7C59","TCGA",2004,NA,NA,"WITH TUMOR","F66A6768-2EF9-4318-91FE-8F3498553569",53,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a40be7ea-f682-4d3e-a749-74aec6961b88.txt","Alive",NA,"TCGA-29-1698",NA,"3F529423-5E1C-423A-82D2-6B60842E06F5",NA,2078,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,101,"E59554F2-0729-4985-AC95-A8D46F3F7FCD","8E8AF626-54A4-4FF2-9378-EF5E0ED71C3E","TCGA-29-1698-01A-01R-1567-13_GRCh37-lite_mirna.bam","TCGA-29-1698-01A-01",70,0,NA,NA,45,"TOP",5,NA,"TCGA-29-1698-01A-01-TS1",50,"Paclitaxel","Chemotherapy","TCGA-29-1698-D27236",NA,NA,NA,"TCGA-29-1698-F27227_NTE-2",NA,2078,"WITH TUMOR","Alive",NA,"TCGA-29-1698-F27227","TCGA-29-1698",NA,"29","1698","YES","C56.9","8441/3","C56.9",NA,NA,-19611,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Alive",2078,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
189825470,176324709,12967065351,"03B89560-E4DE-4B27-8DF9-D5C86C6E6AB6.bw","18e0e996-8f23-4f53-94a5-dde38b550863","03b89560-e4de-4b27-8df9-d5c86c6e6ab6","2016-08-24T05:41:55.524268-05:00","TCGA-13-1409-01A-01R-1565-13_rnaseq_fastq.tar","65aba23f-f9b8-427e-bc3b-59d5e49368f1",11971788800,"Illumina HiSeq","6224f959a287075301d47588446ec049","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:37:38.434269-05:00","2016-05-03T11:40:21.647690-05:00","65aba23f-f9b8-427e-bc3b-59d5e49368f1_analysis.xml","df7cd8af93183159af54546529846c82","74002901-1d81-4bc7-96b3-a71c3a16e3cf",2208,"2016-09-29T23:17:45.090404-05:00","65aba23f-f9b8-427e-bc3b-59d5e49368f1_experiment.xml","99543856b860c0ff9f497b1f878282d6","d74a22a2-4a15-4eb7-a951-8370d569fbb2",3916,"2016-09-29T19:55:00.938350-05:00","65aba23f-f9b8-427e-bc3b-59d5e49368f1_run.xml","faf400c5f321fabc0c70fcc589113ad4","5a1a178b-7aea-48ef-9f3b-5a42eb3c95c9",1989,"2016-09-08T13:51:06.097607-05:00","TCGA-13-1409","2016-09-02T19:12:01.777012-05:00","female","TCGA-13-1409_demographic",1935,"white","cf0eeee1-5dd7-5bef-ad40-5d881bf9d762","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1409_diagnosis","not reported",26836,"dead","8441/3",1742,208,"6b0f33e6-884d-5a93-8335-9f55569790a7","c56.9",-26836,"TCGA-13-1409_treatment","c9c78335-6d3f-52a5-92a9-c41ccbd8d4d8","01",NA,"TCGA-13-1409-01A","1","930c3552-f960-4a57-aa35-b504807a9676",FALSE,"3F18B612-EE50-4459-8CAF-61A12157DD8A","Primary Tumor","0.6",NA,NA,"1.6",1230508800,"01",123,"TCGA-13-1409-01A-01",80,90,NA,NA,0,0,20,10,"2016-09-08T13:51:06.097607-05:00","2016-09-08T13:51:06.097607-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"4226415a-3f9d-4a34-b017-1af964c8be5a","dc1c8c75-97e7-4a32-9581-9c7bac1a0a87","TCGA-13-1409-01A-01-TS1","TCGA-13-1409-01A-01-BS1",75,85,"a5af5acd-6855-40b1-bf2e-1b4c79a1357d","RNA","TCGA-13-1409-01A-01R","d7030b99-aad1-4cc1-bc11-355d380f2474",1.8,0.15,"UV Spec","R","22","TCGA-13-1409-01A-01R-1565-13","850f50c3-4d01-4838-bd3a-641942bb2855",0.15,NA,NA,NA,NA,"b2abdfc3-622c-5617-a7b0-0330eb0f3cf7","TCGA-13-1409_exposure","TCGA-13-1409-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:05:38.000Z","2014-03-22T02:30:02.000Z","65ABA23F-F9B8-427E-BC3B-59D5E49368F1","930C3552-F960-4A57-AA35-B504807A9676","Unaligned reads",11971788800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","850F50C3-4D01-4838-BD3A-641942BB2855","Canada's Michael Smith Genome Sciences Centre","564a5bc6e4b09c884b27b632","18E0E996-8F23-4F53-94A5-DDE38B550863","Ovarian Serous Cystadenocarcinoma","TAR","A5AF5ACD-6855-40B1-BF2E-1B4C79A1357D","2014-03-22T02:30:02.000Z","D7030B99-AAD1-4CC1-BC11-355D380F2474","None","NO",1,0.6,"Primary Tumor","Memorial Sloan Kettering",NA,"A5AF5ACD-6855-40B1-BF2E-1B4C79A1357D",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8c0c5cc9-dbb0-49ed-96c4-7fde7d37fd25.txt",NA,"TCGA-13-1409-01A",1.6,"FDBBF073-C52A-4972-B714-EC92CF255E88","TCGA",2008,NA,NA,"WITH TUMOR","67CE3995-E6C2-4212-9A3E-14C7E2C7F921",73,"NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_B11_446212.ismpolish.data.txt","Alive",NA,"TCGA-13-1409","NOT HISPANIC OR LATINO","581DA1F9-2A0C-42D4-953B-7A311EEACBB6",NA,208,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,123,"DC1C8C75-97E7-4A32-9581-9C7BAC1A0A87","D7030B99-AAD1-4CC1-BC11-355D380F2474","TCGA-13-1409-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-13-1409-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-13-1409-01A-01-BS1",85,"Carboplatin","Chemotherapy","TCGA-13-1409-D24819",NA,NA,NA,NA,NA,208,"WITH TUMOR","Alive",NA,"TCGA-13-1409-F24818","TCGA-13-1409",NA,"13","1409","YES","C56.9","8441/3","C56.9",NA,NA,-26836,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",208,NA,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,73,2008,"Incisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
236517212,227510424,16792152436,"C98ADEAD-A391-4A73-9FB9-39AEADE60D80.bw","19427350-619b-4b9c-a3ba-37f667bb2843","c98adead-a391-4a73-9fb9-39aeade60d80","2016-08-22T14:57:33.821823-05:00","TCGA-24-1603-01A-01R-1566-13_rnaseq_fastq.tar","9c7957ab-887b-4bc5-831e-c9c3fd3f7311",15075788800,"Illumina HiSeq","6f1edbb91b1ec689ede9daea8672e2ed","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:44:07.002748-05:00","2016-05-03T11:40:21.648199-05:00","9c7957ab-887b-4bc5-831e-c9c3fd3f7311_analysis.xml","e25693154560ce35e3c3cf1fa90006f1","07e5cbad-8251-4aec-bad5-ad542a5a70c4",2181,"2016-08-26T07:24:57.031957-05:00","9c7957ab-887b-4bc5-831e-c9c3fd3f7311_experiment.xml","29629631805328ceb957cb0b11574ebf","06a032f4-218c-402c-b7df-dfc290d5fba2",3916,"2016-09-29T23:14:14.556695-05:00","9c7957ab-887b-4bc5-831e-c9c3fd3f7311_run.xml","41a921de077ab9e903387da3824be873","d5499c3e-a91f-42ef-ba10-5273bd4ce2c2",1988,"2016-09-08T12:47:26.806723-05:00","TCGA-24-1603","2016-09-02T19:07:16.999415-05:00","female","TCGA-24-1603_demographic",1943,"white","d5969403-73a4-5315-a0c2-0c82873ad345","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1603_diagnosis","not reported",19681,"dead","8441/3",2742,2742,"6ebcfddc-d5a4-507d-9a7b-141c1dbe899d","c56.9",-19681,"TCGA-24-1603_treatment","9a3a551e-7fcb-5ce7-9efa-913311ec6bfe","01",NA,"TCGA-24-1603-01A","1","bb14a720-4899-48d9-a57b-e1fd2aa9d8ec",FALSE,"b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9","Primary Tumor","0.7",NA,NA,"1",1237420800,"01",142,"TCGA-24-1603-01A-01",95,95,NA,NA,8,8,0,0,"2016-09-08T12:47:26.806723-05:00","2016-09-08T12:47:26.806723-05:00",NA,NA,NA,NA,"BOTTOM","TOP",12,5,"10b614a2-04d5-437a-896b-34d0ecf2db37","41cdbaf5-d3cc-43d2-91ce-9176ab694e1b","TCGA-24-1603-01A-01-BS1","TCGA-24-1603-01A-01-TS1",80,87,"966ebdc5-662e-450b-9c8c-50853ac5c4d6","RNA","TCGA-24-1603-01A-01R","2555d448-3cac-46ba-8d5e-bca158e48dfc",1.8,0.14,"UV Spec","R","22","TCGA-24-1603-01A-01R-1566-13","f4187f4f-9c52-4065-818b-c884183a5a70",0.14,NA,NA,NA,NA,"ad7291cc-bda8-595f-9548-8e14d1e01010","TCGA-24-1603_exposure","TCGA-24-1603-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T06:08:25.000Z","2014-03-25T06:35:01.000Z","9C7957AB-887B-4BC5-831E-C9C3FD3F7311","BB14A720-4899-48D9-A57B-E1FD2AA9D8EC","Unaligned reads",15075788800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F4187F4F-9C52-4065-818B-C884183A5A70","Canada's Michael Smith Genome Sciences Centre","564a382fe4b093830b683bdb","19427350-619B-4B9C-A3BA-37F667BB2843","Ovarian Serous Cystadenocarcinoma","TAR","966EBDC5-662E-450B-9C8C-50853AC5C4D6","2014-03-25T06:35:01.000Z","2555D448-3CAC-46BA-8D5E-BCA158E48DFC","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"966EBDC5-662E-450B-9C8C-50853AC5C4D6",1,"24","TCGA-24-1603-01A-01W-0551-08_IlluminaGA-DNASeq_capture.bam",NA,"TCGA-24-1603-01A",1,"FAECC8EC-F46C-4EA3-A013-3370D0692293","TCGA",1996,NA,NA,"WITH TUMOR","BB14A720-4899-48D9-A57B-E1FD2AA9D8EC",53,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eecacbb1-98ef-4194-957d-5a49f9548657.txt","Dead",2742,"TCGA-24-1603",NA,"7AA0D9F9-ECBE-4159-89A9-08C599697834",NA,2742,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,142,"41CDBAF5-D3CC-43D2-91CE-9176AB694E1B","C10AFC3B-9CFE-4109-BF05-BB5E2D065979","TCGA-24-1603-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-24-1603-01A-01",95,8,NA,NA,0,"BOTTOM",12,NA,"TCGA-24-1603-01A-01-BS1",80,"Topotecan","Chemotherapy","TCGA-24-1603-D26296",NA,NA,NA,"TCGA-24-1603-F26284_NTE-1",NA,2742,"WITH TUMOR","Dead",2742,"TCGA-24-1603-F26284","TCGA-24-1603",NA,"24","1603","YES","C56.9","8441/3","C56.9",NA,NA,-19681,"FEMALE","WHITE",NA,NA,"No","Dead",2742,2742,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,1996,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
174590112,167820302,12422517819,"99FF6CF6-7BD6-44BB-A6BF-ED8CFB40581C.bw","195ecf43-06bd-4ffe-8d8b-a766f3f7179b","99ff6cf6-7bd6-44bb-a6bf-ed8cfb40581c","2016-08-25T18:07:27.529703-05:00","TCGA-24-1418-01A-01R-1565-13_rnaseq_fastq.tar","537916d7-9e96-4416-a0c2-39af06e55b39",11049922560,"Illumina HiSeq","b8597e1a334fb9d5a7b1654a86cfaf00","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:05:50.542168-05:00","2016-05-03T11:40:21.648680-05:00","537916d7-9e96-4416-a0c2-39af06e55b39_analysis.xml","d4416a54dd9b21c1b1d0a21742e02e0f","60a9bc61-6a86-4d96-854e-a6c3c3400007",2181,"2016-08-13T05:30:14.237001-05:00","537916d7-9e96-4416-a0c2-39af06e55b39_experiment.xml","7e4ff74ddc09ea872effd1ad08705b23","968aad96-8bfc-4323-875f-6109f86cf81b",3916,"2016-09-29T21:38:17.320036-05:00","537916d7-9e96-4416-a0c2-39af06e55b39_run.xml","cba68b68c6761790a724ba4ff3dbe3dc","99c5de22-93ab-4570-9875-466f31bb4df5",1988,"2016-09-08T10:25:12.285475-05:00","TCGA-24-1418","2016-09-02T19:13:44.544525-05:00","female","TCGA-24-1418_demographic",1940,"white","f7482f5e-2a1e-5563-bd07-0041884d5457","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1418_diagnosis","not reported",24842,"alive","8441/3",NA,243,"624e0ef7-bfb4-547e-83f8-3468edfbae97","c56.9",-24842,"TCGA-24-1418_treatment","726efb55-eb75-5dfe-a418-915bce72ca08","01",NA,"TCGA-24-1418-01A","1.2","b40f7345-8f0c-4db7-90ba-424ae5ee22ed",FALSE,"14fdb291-ba79-4852-9242-02dc191ca8c5","Primary Tumor","0.3",NA,NA,"1.2",1231977600,"01",135,"TCGA-24-1418-01A-01",70,70,NA,NA,10,20,0,0,"2016-09-08T10:25:12.285475-05:00","2016-09-08T10:25:12.285475-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"8c2fa6a6-86f7-486b-8dda-3c8c0bab4811","384345b7-9a47-4c10-ab17-31a6f1e9a544","TCGA-24-1418-01A-01-BS1","TCGA-24-1418-01A-01-TS1",85,75,"f685a0da-d011-4e2d-b40b-7aaabf4185fd","RNA","TCGA-24-1418-01A-01R","41bd0036-fc58-433d-b081-90eae4e6f0c3",1.8,0.15,"UV Spec","R","22","TCGA-24-1418-01A-01R-1565-13","4e701e9f-9127-4d61-8a72-7e440b969fbe",0.15,NA,NA,NA,NA,"c32f845a-0d2f-581c-8178-a22c88c384ae","TCGA-24-1418_exposure","TCGA-24-1418-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T21:18:51.000Z","2014-03-21T21:43:01.000Z","537916D7-9E96-4416-A0C2-39AF06E55B39","B40F7345-8F0C-4DB7-90BA-424AE5EE22ED","Unaligned reads",11049922560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4E701E9F-9127-4D61-8A72-7E440B969FBE","Canada's Michael Smith Genome Sciences Centre","564a5b39e4b08c5d86952b29","195ECF43-06BD-4FFE-8D8B-A766F3F7179B","Ovarian Serous Cystadenocarcinoma","TAR","F685A0DA-D011-4E2D-B40B-7AAABF4185FD","2014-03-21T21:43:01.000Z","41BD0036-FC58-433D-B081-90EAE4E6F0C3","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"F685A0DA-D011-4E2D-B40B-7AAABF4185FD",1.2,"24","TCGA-24-1418-01A-01W-0549-09_IlluminaGA-DNASeq_exome.bam.bai",NA,"TCGA-24-1418-01A",1.2,"CBFA21BD-902B-45FF-9D92-67B836FA99B9","TCGA",2008,NA,NA,"TUMOR FREE","B40F7345-8F0C-4DB7-90BA-424AE5EE22ED",68,"nationwidechildrens.org_clinical.TCGA-24-1418.xml","Alive",NA,"TCGA-24-1418",NA,"F9FBCEC6-98E7-4E71-8BBD-99BBEC66CA0F",NA,243,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,135,"8C2FA6A6-86F7-486B-8DDA-3C8C0BAB4811","ABEAE9C0-B473-40E1-8291-A6DC65AFF606","TCGA-24-1418-01A-01W-0549-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-24-1418-01A-01",70,20,NA,NA,0,"TOP",5,NA,"TCGA-24-1418-01A-01-TS1",75,"Taxol","Chemotherapy","TCGA-24-1418-D25925",NA,NA,NA,NA,NA,243,"TUMOR FREE","Alive",NA,"TCGA-24-1418-F25924","TCGA-24-1418",NA,"24","1418","YES","C56.9","8441/3","C56.9",NA,NA,-24842,"FEMALE","WHITE",NA,NA,"No","Alive",243,NA,NA,NA,"TUMOR FREE","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,2008,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
181405796,175482336,13011318817,"36CC954C-F90E-41E8-87D3-1AEB51BAB83B.bw","196f4600-b6c9-4652-9f77-65c92883f8c1","36cc954c-f90e-41e8-87d3-1aeb51bab83b","2016-08-25T15:21:31.469403-05:00","TCGA-13-2060-01A-01R-1568-13_rnaseq_fastq.tar","abaf5057-2461-40e4-8a1f-c03d1b8c941a",11523717120,"Illumina HiSeq","7f56ef747fe3e128517521eb3b29cb85","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:01:55.315066-05:00","2016-05-03T11:41:05.755204-05:00","abaf5057-2461-40e4-8a1f-c03d1b8c941a_analysis.xml","55d097587e3d9b2678cbefb31daee471","a8887f18-1f4f-4d2b-b445-77637c44b439",2183,"2016-09-29T17:41:18.554737-05:00","abaf5057-2461-40e4-8a1f-c03d1b8c941a_experiment.xml","e70029830f8c7f6ba63aa9140e9641cb","060bd84a-b1a4-4de5-94a1-d0734e926d8e",3916,"2016-09-29T23:11:17.128057-05:00","abaf5057-2461-40e4-8a1f-c03d1b8c941a_run.xml","6d0381bf8aa51a0de0932b783ec87f3e","d372315f-c7ae-414d-8952-c82b1e33ffe2",1990,"2016-09-08T13:18:32.912784-05:00","TCGA-13-2060","2016-09-02T19:12:00.381451-05:00","female","TCGA-13-2060_demographic",1958,"white","b78eb8ff-ab78-5321-aa85-a563f3b4d1fb","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-2060_diagnosis","not reported",18635,"alive","8441/3",NA,2369,"31073de8-aadc-57d6-99a1-0a6b4d438bb9","c56.9",-18635,"TCGA-13-2060_treatment","3b289c5a-3774-50a6-8cda-424d24af7b96","01",NA,"TCGA-13-2060-01A","1.5","bffd965b-885f-4914-b25b-a993338acaad",FALSE,"F6986C14-4627-424E-81C5-74E1CE38D52D","Primary Tumor","0.5",NA,NA,"2.5",1248134400,"01",144,"TCGA-13-2060-01A-01",80,70,0,0,0,0,10,10,"2016-09-08T13:18:32.912784-05:00","2016-09-08T13:18:32.912784-05:00",15,20,0,0,"TOP","BOTTOM",5,5,"029d23ee-2d6c-4172-9908-837eeb844719","dfa4bfe4-24cf-4410-b813-45a7ba514053","TCGA-13-2060-01A-01-TS1","TCGA-13-2060-01A-01-BS1",85,85,"66095e77-a7e7-41e0-a61d-8debcedb1105","RNA","TCGA-13-2060-01A-01R","8eb50374-84f0-4d88-8d13-cdbf64e21cfa",1.8,0.14,"UV Spec","R","22","TCGA-13-2060-01A-01R-1568-13","32de1e4d-198a-4616-8227-4d633c80124b",0.14,NA,NA,NA,NA,"8a209447-d77c-52c1-a892-8808caea5394","TCGA-13-2060_exposure","TCGA-13-2060-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T04:29:23.000Z","2014-03-27T04:52:01.000Z","ABAF5057-2461-40E4-8A1F-C03D1B8C941A","BFFD965B-885F-4914-B25B-A993338ACAAD","Unaligned reads",11523717120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","32DE1E4D-198A-4616-8227-4D633C80124B","Canada's Michael Smith Genome Sciences Centre","564a5a3de4b09c884b27587d","196F4600-B6C9-4652-9F77-65C92883F8C1","Ovarian Serous Cystadenocarcinoma","TAR","66095E77-A7E7-41E0-A61D-8DEBCEDB1105","2014-03-27T04:52:01.000Z","8EB50374-84F0-4D88-8D13-CDBF64E21CFA","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"66095E77-A7E7-41E0-A61D-8DEBCEDB1105",1.5,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.19465a94-b5e9-4700-8f19-0724f72dd3a4.txt",NA,"TCGA-13-2060-01A",2.5,"F813388D-644D-46C4-B29C-F935CFAF6BC4","TCGA",2009,NA,NA,"TUMOR FREE","BFFD965B-885F-4914-B25B-A993338ACAAD",51,"nationwidechildrens.org_clinical.TCGA-13-2060.xml","Alive",NA,"TCGA-13-2060",NA,"970FA6E8-453C-4CFF-B1E0-F5CADFC60973",NA,262,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,144,"DFA4BFE4-24CF-4410-B813-45A7BA514053","E956009E-D2E3-49E0-B2BA-6DA514C89152","TCGA-13-2060-01A-01R-1568-13_GRCh37-lite_rnaseq.bam","TCGA-13-2060-01A-01",80,0,0,15,10,"TOP",5,0,"TCGA-13-2060-01A-01-TS1",85,"Paclitaxel","Chemotherapy","TCGA-13-2060-D25000",NA,NA,NA,NA,NA,262,"TUMOR FREE","Alive",NA,"TCGA-13-2060-F24998","TCGA-13-2060",NA,"13","2060","YES","C56.9","8441/3","C56.9",NA,NA,-18635,"FEMALE","WHITE",NA,NA,"No","Alive",262,NA,NA,NA,"TUMOR FREE","NO",16,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2009,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
211369324,165947801,11696812049,"116F3F29-AB89-4F00-9003-559041E285EB.bw","1aea3c25-d2bc-4ff5-bc27-32e939944e9d","116f3f29-ab89-4f00-9003-559041e285eb","2016-08-25T01:10:05.467859-05:00","TCGA-29-1785-01A-01R-1567-13_rnaseq_fastq.tar","a47f732f-97f3-40d4-931b-aac374165ed2",12376596480,"Illumina HiSeq","7a9627a7149980902550786d96288546","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:10:15.100906-05:00","2016-05-03T11:41:05.740436-05:00","a47f732f-97f3-40d4-931b-aac374165ed2_analysis.xml","0d9ef3166cfd2142e245993f2dd09f3e","887961a7-96f7-4561-b4fd-ed93a9102af1",2181,"2016-09-29T21:32:09.170243-05:00","a47f732f-97f3-40d4-931b-aac374165ed2_experiment.xml","f697b4cebd7d03e47950917a63d953e0","960a70c1-d8f5-4f36-b36b-7fa9f39aeb9a",3916,"2016-09-29T18:36:05.552850-05:00","a47f732f-97f3-40d4-931b-aac374165ed2_run.xml","c58720092cf810d3f909324ac93a2117","28724120-56d4-46b1-8a07-37a87204322a",1988,"2016-09-08T12:22:01.737714-05:00","TCGA-29-1785","2016-09-02T19:07:39.490888-05:00","female","TCGA-29-1785_demographic",1951,"white","e84a85c2-be73-5952-b964-921c0feadca1","not reported",2009,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1785_diagnosis","not reported",20417,"dead","8441/3",1104,1053,"3af0fe9d-b0be-520d-93e2-62c3dde90896","c56.9",-20417,"TCGA-29-1785_treatment","ed796433-2627-589a-bd13-572865e856d5","01",NA,"TCGA-29-1785-01A","0.7","051e9ab0-af6a-4bd7-8673-c596dc6e78a0",FALSE,"b520ed75-17dd-420f-b444-4436bb03f40f","Primary Tumor","0.4",NA,NA,"1.2",1243296000,"01",112,"TCGA-29-1785-01A-01",70,80,NA,NA,0,0,10,10,"2016-09-08T12:22:01.737714-05:00","2016-09-08T12:22:01.737714-05:00",15,15,NA,NA,"TOP","BOTTOM",2,0,"92dd91fb-debd-463d-bc19-8e9912f80cfc","addf4816-2135-4b77-bf4f-5567c4843928","TCGA-29-1785-01A-01-TS1","TCGA-29-1785-01A-01-BS1",88,90,"c45eaf04-d2b3-4049-aa8d-6104b91f920f","RNA","TCGA-29-1785-01A-01R","fbd44390-8786-45e6-af20-2013481cd750",1.9,0.16,"UV Spec","R","22","TCGA-29-1785-01A-01R-1567-13","dcff1416-56fd-4d8e-a472-a40a00ef3066",0.16,NA,NA,NA,NA,"ce3abbd0-310a-55c5-9205-cfa29ad09bfc","TCGA-29-1785_exposure","TCGA-29-1785-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T23:50:04.000Z","2014-03-27T00:14:02.000Z","A47F732F-97F3-40D4-931B-AAC374165ED2","051E9AB0-AF6A-4BD7-8673-C596DC6E78A0","Unaligned reads",12376596480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DCFF1416-56FD-4D8E-A472-A40A00EF3066","Canada's Michael Smith Genome Sciences Centre","564a3816e4b093830b68358f","1AEA3C25-D2BC-4FF5-BC27-32E939944E9D","Ovarian Serous Cystadenocarcinoma","TAR","C45EAF04-D2B3-4049-AA8D-6104B91F920F","2014-03-27T00:14:02.000Z","FBD44390-8786-45E6-AF20-2013481CD750","None","NO",1,0.4,"Primary Tumor","Duke",NA,"C45EAF04-D2B3-4049-AA8D-6104B91F920F",0.7,"29","bcgsc.ca.TCGA-29-1785-01A-01R-1567-13.hg19.bcgsc.ca.1.7.0.sv.vcf",NA,"TCGA-29-1785-01A",1.2,"F00119E6-143F-459D-8B3A-D340FD6169A6","TCGA",2006,NA,NA,NA,"83AB1393-305A-4807-9631-77B00BAE288F",55,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c7002a87-0a3e-4ffb-b976-b1d7f768dd30.txt","Dead",1104,"TCGA-29-1785",NA,"17F78A1A-2EA9-4F63-8106-86672D28F6DF",NA,1053,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,112,"ADDF4816-2135-4B77-BF4F-5567C4843928","882FCE00-F94B-4031-B4DE-E80B5F31D41C","TCGA-29-1785-01A-01W-0633-09_IlluminaGA-DNASeq_exome_1.bam","TCGA-29-1785-01A-01",80,0,NA,15,10,"BOTTOM",0,NA,"TCGA-29-1785-01A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-29-1785-D27443",NA,NA,NA,"TCGA-29-1785-F27442_NTE-1",NA,1053,NA,"Dead",1104,"TCGA-29-1785-F27442","TCGA-29-1785",NA,"29","1785","YES","C56.9","8441/3","C56.9",NA,NA,-20417,"FEMALE","WHITE",NA,NA,"No","Dead",1053,1104,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,55,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
129094540,125367492,9291997844,"4ECB7DE9-908B-444F-89BB-8E02FF826908.bw","1c0318d9-0472-4840-add4-46bb9f914a30","4ecb7de9-908b-444f-89bb-8e02ff826908","2016-08-25T01:57:45.468094-05:00","TCGA-61-1721-01A-01R-1569-13_rnaseq_fastq.tar","818ea0a5-747c-4130-873e-2e800fa0218c",8162734080,"Illumina HiSeq","e45bda38421b9de284cb44054d2594a0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:07:55.822875-05:00","2016-05-03T11:41:05.740436-05:00","818ea0a5-747c-4130-873e-2e800fa0218c_analysis.xml","e9ab82eded0956470052a8f7218f7c85","ac320cef-af2b-4cb8-9ad9-458d2183e6aa",2181,"2016-09-29T18:11:42.739188-05:00","818ea0a5-747c-4130-873e-2e800fa0218c_experiment.xml","4231d074a0591f9a2f134b390e69cd8e","1953e9f3-895d-49bc-b683-adb73735f42f",3916,"2016-09-29T20:18:12.102420-05:00","818ea0a5-747c-4130-873e-2e800fa0218c_run.xml","c4c5df2c374d2d984e27c56a27f2afd4","68133f6c-00c4-43e4-bd9e-49e24073b977",1988,"2016-09-08T10:42:35.423109-05:00","TCGA-61-1721","2016-09-02T18:50:39.682251-05:00","female","TCGA-61-1721_demographic",1970,"white","1eb55aba-7ecf-530a-91c4-218735f5c0e5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1721_diagnosis","not reported",13894,"alive","8441/3",NA,338,"dcf90374-280a-5d2e-992f-9c76e9acd8e3","c56.9",-13894,"TCGA-61-1721_treatment","317421ae-09b2-5042-acb5-8e8b08650fd1","01",NA,"TCGA-61-1721-01A","0.9","a65361d0-e9ae-4d90-bbf7-70bc213d263e",FALSE,"f44d906c-f069-45e6-9cc4-49eb0da74226","Primary Tumor","0.3",NA,NA,"1",1242518400,"01",123,"TCGA-61-1721-01A-01",80,80,NA,NA,0,0,0,0,"2016-09-08T10:42:35.423109-05:00","2016-09-08T10:42:35.423109-05:00",NA,NA,NA,NA,"TOP","BOTTOM",15,15,"eacba516-57de-4a57-8c1a-28d301941281","8a0e1590-8e6d-4c65-b44c-90096f254f6a","TCGA-61-1721-01A-01-TS1","TCGA-61-1721-01A-01-BS1",85,85,"7e4b5124-2529-4469-ba3c-472c6c668868","RNA","TCGA-61-1721-01A-01R","6a67c51c-3380-4ace-a2ba-c357d8a0b34c",1.8,0.15,"UV Spec","R","22","TCGA-61-1721-01A-01R-1569-13","226f9774-e22b-4b8b-8259-934edb649fc3",0.15,NA,NA,NA,NA,"06a3effc-b48d-5f99-8c19-305119add62d","TCGA-61-1721_exposure","TCGA-61-1721-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T00:55:55.000Z","2014-03-27T01:16:01.000Z","818EA0A5-747C-4130-873E-2E800FA0218C","A65361D0-E9AE-4D90-BBF7-70BC213D263E","Unaligned reads",8162734080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","226F9774-E22B-4B8B-8259-934EDB649FC3","Canada's Michael Smith Genome Sciences Centre","564a3a54e4b08c5d86912b32","1C0318D9-0472-4840-ADD4-46BB9F914A30","Ovarian Serous Cystadenocarcinoma","TAR","7E4B5124-2529-4469-BA3C-472C6C668868","2014-03-27T01:16:01.000Z","6A67C51C-3380-4ACE-A2BA-C357D8A0B34C","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"7E4B5124-2529-4469-BA3C-472C6C668868",0.9,"61","LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_A06_517954.ismpolish.data.txt",NA,"TCGA-61-1721-01A",1,"D4666102-4B7E-48EE-80AE-E210B59C5590","TCGA",2008,NA,NA,"TUMOR FREE","E43B7AC7-2BB4-4256-9F8B-C7EAEB6C9603",38,"LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_G09_517974.hg19.seg.txt","Alive",NA,"TCGA-61-1721","NOT HISPANIC OR LATINO","902BE45D-0481-4E42-8DC7-10A185CA8ADE",NA,338,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,123,"EACBA516-57DE-4A57-8C1A-28D301941281","9FC6A789-79B9-4B06-B48F-B3AC1A8DE796","US82800149_251976010834_S01_GE2_105_Dec08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","TCGA-61-1721-01A-01",80,0,NA,NA,0,"BOTTOM",15,NA,"TCGA-61-1721-01A-01-BS1",85,"Taxotere","Chemotherapy","TCGA-61-1721-D28127",NA,NA,NA,NA,NA,338,"TUMOR FREE","Alive",NA,"TCGA-61-1721-F28123","TCGA-61-1721",NA,"61","1721","YES","C56.9","8441/3","C56.9",NA,NA,-13894,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"Yes","Alive",338,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,38,2008,"Excisional Biopsy",NA,NA,NA,"G1",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
112007974,109686504,8112564156,"B129684C-BA41-4FD2-B2BE-7AD9F43ED6A2.bw","1cc02c64-a34e-46ae-9bc7-5d50f2fefb31","b129684c-ba41-4fd2-b2be-7ad9f43ed6a2","2016-08-26T04:44:23.243119-05:00","TCGA-13-1506-01A-01R-1565-13_rnaseq_fastq.tar","bf00085e-8b90-4592-91e2-8e24ec9e5b43",6350131200,"Illumina HiSeq","d1c2047cea86a8631903fa98b7724441","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:09:01.624184-05:00","2016-05-03T11:40:21.647690-05:00","bf00085e-8b90-4592-91e2-8e24ec9e5b43_analysis.xml","bf8c8ced5de900c4172db70d3a5abd5f","acd430b3-77a4-407f-91ba-8c8ce3bb1715",2181,"2016-08-28T14:21:41.662749-05:00","bf00085e-8b90-4592-91e2-8e24ec9e5b43_experiment.xml","6f1f4411a295b5e9770df46178ee0f9f","088784d6-6cd2-4511-a393-4d950fee3483",3916,"2016-09-29T22:38:27.574363-05:00","bf00085e-8b90-4592-91e2-8e24ec9e5b43_run.xml","ded589d17f99711eb17d7a13fa993c18","bf02a749-ffba-44d9-b555-6299db847175",1989,"2016-09-08T13:49:14.429499-05:00","TCGA-13-1506","2016-09-02T19:13:50.784658-05:00","female","TCGA-13-1506_demographic",1963,"white","75bc4385-e9df-5793-a283-7c3a014c1c85","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1506_diagnosis","not reported",16734,"dead","8441/3",1039,134,"b7b88b39-5b78-5c15-a1fb-100e200d6917","c56.9",-16734,"TCGA-13-1506_treatment","dccd01fd-9917-5b2c-8e65-030281a82c81","01",NA,"TCGA-13-1506-01A","0.6","4725c6d3-c67d-4ce8-a4c1-68c242183ce3",FALSE,"88E423FF-4070-4F01-A0B0-41B45443E762","Primary Tumor","0.2",NA,NA,"1.1",1235001600,"01",148,"TCGA-13-1506-01A-01",99,99,NA,NA,0,0,1,1,"2016-09-08T13:49:14.429499-05:00","2016-09-08T13:49:14.429499-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"d6daf712-ccb4-4ecd-859f-c24b37baee13","790a38ba-47d7-4ac4-a25e-50a17f9a2a87","TCGA-13-1506-01A-01-TS1","TCGA-13-1506-01A-01-BS1",98,98,"97ee27ec-0863-4a67-b5af-e6cd6a82428d","RNA","TCGA-13-1506-01A-01R","459d797e-5c4b-4192-8e2c-1a9c6346f14a",1.8,0.16,"UV Spec","R","22","TCGA-13-1506-01A-01R-1565-13","927c7b6d-3997-453b-81b1-b947341d5819",0.16,NA,NA,NA,NA,"ec4237fb-49d3-5915-9899-d90b86e7f653","TCGA-13-1506_exposure","TCGA-13-1506-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:51:10.000Z","2014-03-22T02:06:02.000Z","BF00085E-8B90-4592-91E2-8E24EC9E5B43","4725C6D3-C67D-4CE8-A4C1-68C242183CE3","Unaligned reads",6350131200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","927C7B6D-3997-453B-81B1-B947341D5819","Canada's Michael Smith Genome Sciences Centre","564a59d2e4b0ef12181dac7d","1CC02C64-A34E-46AE-9BC7-5D50F2FEFB31","Ovarian Serous Cystadenocarcinoma","TAR","97EE27EC-0863-4A67-B5AF-E6CD6A82428D","2014-03-22T02:06:02.000Z","459D797E-5C4B-4192-8E2C-1A9C6346F14A","None","NO",1,0.2,"Primary Tumor","Memorial Sloan Kettering",NA,"97EE27EC-0863-4A67-B5AF-E6CD6A82428D",0.6,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6bdc5656-6cff-48e4-9625-e953d683aed5.txt",NA,"TCGA-13-1506-01A",1.1,"EED33A2F-1991-431E-AED9-A80E2FFF5F9A","TCGA",2008,NA,NA,"TUMOR FREE","8A6FCF40-67E2-466D-9B91-836694F6F888",45,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6bdc5656-6cff-48e4-9625-e953d683aed5.txt","Alive",NA,"TCGA-13-1506","NOT HISPANIC OR LATINO","C38894F1-B486-48FD-ACC2-F53027CB3FFA",NA,134,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,148,"D6DAF712-CCB4-4ECD-859F-C24B37BAEE13","F26A7C80-A9B9-4F9C-AF6D-E4D2098031A3","TCGA-13-1506-01A-01R-1565-13_GRCh37-lite_rnaseq.bam","TCGA-13-1506-01A-01",99,0,NA,NA,1,"BOTTOM",1,NA,"TCGA-13-1506-01A-01-BS1",98,"Carboplatin","Chemotherapy","TCGA-13-1506-D24949",NA,NA,NA,NA,NA,134,"TUMOR FREE","Alive",NA,"TCGA-13-1506-F24944","TCGA-13-1506",NA,"13","1506","YES","C56.9","8441/3","C56.9",NA,NA,-16734,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",134,NA,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
110412364,107805055,7957556857,"C1EE7F45-C972-4ED8-9173-EAC2D9E2B170.bw","1d0225b5-f515-4197-bba7-3dc17e502b88","c1ee7f45-c972-4ed8-9173-eac2d9e2b170","2016-08-26T11:13:48.224916-05:00","TCGA-24-2262-01A-01R-1568-13_rnaseq_fastq.tar","ad24c089-30e1-4a15-9a6f-3e101f5d3284",6586470400,"Illumina HiSeq","f31f6ae8008e81e6a07bb1c744f39b34","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:28:43.111293-05:00","2016-05-03T11:56:42.628342-05:00","ad24c089-30e1-4a15-9a6f-3e101f5d3284_analysis.xml","1c72b0823ee58bce1a9535cc0e1b15d0","de279aa1-047a-40ae-b657-40c19a9f1d27",2181,"2016-09-30T00:13:59.516151-05:00","ad24c089-30e1-4a15-9a6f-3e101f5d3284_experiment.xml","15a4e138e8e8e14efe35120bd44756a4","fa31ba44-c586-4237-bdc5-54c50d6b5284",3916,"2016-09-29T20:40:33.421696-05:00","ad24c089-30e1-4a15-9a6f-3e101f5d3284_run.xml","f8332d5725f80fa4f4655352e49cd180","75d90cbf-3c1d-4f3d-bfa7-87282550819e",1988,"2016-09-08T13:36:51.677815-05:00","TCGA-24-2262","2016-09-02T19:11:53.771397-05:00","female","TCGA-24-2262_demographic",1935,"white","354360d8-cfa6-5226-8582-8db9bf3e8ee9","not reported",1992,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2262_diagnosis","not reported",20861,"dead","8441/3",11,11,"d5a8ef4a-e9fb-5014-939c-b0fcf9d6a2e5","c56.9",-20861,"TCGA-24-2262_treatment","e6ec155b-d287-5959-b056-11401a70ba01","01",NA,"TCGA-24-2262-01A","0.6","c8767fb2-1e4a-42de-b648-847d4a5df78b",FALSE,"d58b58ac-365c-43d0-a893-0becfb6e9fff","Primary Tumor","0.4",NA,NA,"1.5",1250812800,"01",111,"TCGA-24-2262-01A-01",90,90,NA,NA,1,1,9,9,"2016-09-08T13:36:51.677815-05:00","2016-09-08T13:36:51.677815-05:00",NA,NA,NA,NA,"TOP","BOTTOM",15,10,"2458cc8d-8541-420a-a725-db4e4d1e3e6f","4f040506-3126-4be0-9bd2-91ef4ff0c00f","TCGA-24-2262-01A-01-TS1","TCGA-24-2262-01A-01-BS1",75,80,"f1b99ae7-2de9-4f35-9144-75ba7640b23b","RNA","TCGA-24-2262-01A-01R","b168cbf5-8ee1-44b3-85af-7aebc1753af4",1.8,0.15,"UV Spec","R","22","TCGA-24-2262-01A-01R-1568-13","efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe",0.15,NA,NA,NA,NA,"f275ca4e-1ebf-5e5a-bedb-8b6883f56a72","TCGA-24-2262_exposure","TCGA-24-2262-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T18:08:11.000Z","2014-08-27T07:15:43.000Z","AD24C089-30E1-4A15-9A6F-3E101F5D3284","C8767FB2-1E4A-42DE-B648-847D4A5DF78B","Unaligned reads",6586470400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EFB87F4E-6FC7-4B2C-9D56-62B0F7834FBE","Canada's Michael Smith Genome Sciences Centre","564a39c9e4b0ef121819ec8b","1D0225B5-F515-4197-BBA7-3DC17E502B88","Ovarian Serous Cystadenocarcinoma","TAR","F1B99AE7-2DE9-4F35-9144-75BA7640B23B","2014-08-27T07:15:44.000Z","B168CBF5-8EE1-44B3-85AF-7AEBC1753AF4","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"F1B99AE7-2DE9-4F35-9144-75BA7640B23B",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5d31db74-24ef-4322-9880-5189dee10ccb.txt",NA,"TCGA-24-2262-01A",1.5,NA,"TCGA",1992,NA,NA,"WITH TUMOR","C8767FB2-1E4A-42DE-B648-847D4A5DF78B",57,"bcgsc.ca.TCGA-24-2262-01A-01R-1568-13.bcgsc.ca.1.5.0.snv.vcf","Dead",11,"TCGA-24-2262",NA,"30C94FB2-D573-4B84-A3C1-26710AD63770",NA,11,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,111,"4F040506-3126-4BE0-9BD2-91EF4FF0C00F","B168CBF5-8EE1-44B3-85AF-7AEBC1753AF4","1428.CEL","TCGA-24-2262-01A-01",90,1,NA,NA,9,"BOTTOM",10,NA,"TCGA-24-2262-01A-01-BS1",80,NA,NA,NA,NA,NA,NA,NA,NA,11,"WITH TUMOR","Dead",11,"TCGA-24-2262-F26542","TCGA-24-2262",NA,"24","2262","YES","C56.9","8441/3","C56.9",NA,NA,-20861,"FEMALE","WHITE",NA,NA,"No","Dead",11,11,NA,NA,"WITH TUMOR","NO",15,3,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,57,1992,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
218339236,214708139,15918110004,"7F6679C3-1EFF-4008-8D43-B6E75AE60E74.bw","1d192835-524e-429d-bf74-3c4727acb446","7f6679c3-1eff-4008-8d43-b6e75ae60e74","2016-08-21T06:16:18.076607-05:00","TCGA-04-1362-01A-01R-1565-13_rnaseq_fastq.tar","eb6b64de-b196-4598-896b-1da4670e14d2",13431685120,"Illumina HiSeq","13e2d52b935d257f6a545b2f2fb6b73e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:40:28.712855-05:00","2016-05-03T11:40:21.669427-05:00","eb6b64de-b196-4598-896b-1da4670e14d2_analysis.xml","766c08640aa29f86f4e567330170e895","2b4ac20f-da95-4d46-a085-55ce2d2a2014",2181,"2016-08-13T08:11:33.963068-05:00","eb6b64de-b196-4598-896b-1da4670e14d2_experiment.xml","629d92637d59ba4d0163c9c5ea123511","7bd1d3b8-3702-4f41-833f-5c6e34d809f6",3916,"2016-09-29T20:59:52.583936-05:00","eb6b64de-b196-4598-896b-1da4670e14d2_run.xml","9777dc2cc72876267bdcc121c411aa68","81e70e99-4793-440a-8178-5736a1484302",1989,"2016-09-08T13:56:30.713807-05:00","TCGA-04-1362","2016-09-02T19:12:12.200858-05:00","female","TCGA-04-1362_demographic",1943,"white","508c36c3-7b48-5032-937e-d91e566e31a6","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1362_diagnosis","not reported",21745,"dead","8441/3",1348,NA,"6c650e4b-ae78-596e-8ff7-657d4f6db775","c56.9",-21745,"TCGA-04-1362_treatment","e4570351-8389-5e5a-a13c-13883ddf03a2","01",NA,"TCGA-04-1362-01A","1","2cd492fc-4e79-4483-a8d6-31c0156c50c9",FALSE,"D3757F96-E669-4D0E-BBCB-41696AB72004","Primary Tumor","0.6",NA,NA,"1.2",1229644800,"01",122,"TCGA-04-1362-01A-01",99,99,NA,NA,0,0,15,10,"2016-09-08T13:56:30.713807-05:00","2016-09-08T13:56:30.713807-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"4ebe1dd9-f87e-4fbc-bcba-25cf3d39d737","852e1e87-7168-4688-9188-4de1d318423e","TCGA-04-1362-01A-01-TS1","TCGA-04-1362-01A-01-BS1",84,89,"03a3051e-1b8b-437d-baf0-b18ab8ddd508","RNA","TCGA-04-1362-01A-01R","256eb858-fef5-49fc-a719-a05f0a475407",1.8,0.16,"UV Spec","R","22","TCGA-04-1362-01A-01R-1565-13","802ea3c6-e07f-49a1-a1c2-8f90e3197e62",0.16,NA,NA,NA,NA,"ac873f52-dda4-51cc-be88-ce0490c32222","TCGA-04-1362_exposure","TCGA-04-1362-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T06:00:57.000Z","2014-03-22T06:26:02.000Z","EB6B64DE-B196-4598-896B-1DA4670E14D2","2CD492FC-4E79-4483-A8D6-31C0156C50C9","Unaligned reads",13431685120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","802EA3C6-E07F-49A1-A1C2-8F90E3197E62","Canada's Michael Smith Genome Sciences Centre","564a388ce4b08c5d86909b1a","1D192835-524E-429D-BF74-3C4727ACB446","Ovarian Serous Cystadenocarcinoma","TAR","03A3051E-1B8B-437D-BAF0-B18AB8DDD508","2014-03-22T06:26:02.000Z","256EB858-FEF5-49FC-A719-A05F0A475407","None","NO",1,0.6,"Primary Tumor","Gynecologic Oncology Group",NA,"03A3051E-1B8B-437D-BAF0-B18AB8DDD508",1,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e6a03e2b-8fcf-4ad5-9b40-be38c0b08786.txt",NA,"TCGA-04-1362-01A",1.2,"AF62B4E7-990C-4AAD-A592-6ECE7DA45FD8","TCGA",2002,NA,NA,"WITH TUMOR","7059AC71-A890-4E5F-B301-B15D86D7873F",59,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e6a03e2b-8fcf-4ad5-9b40-be38c0b08786.txt","Dead",1348,"TCGA-04-1362",NA,"F6D3414E-AFC6-44A6-A4E2-0E59C5B2A796",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,122,"852E1E87-7168-4688-9188-4DE1D318423E","5573223D-AACA-41FD-9458-7AD08A0F9AB7","TCGA-04-1362-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-04-1362-01A-01",99,0,NA,NA,10,"BOTTOM",1,NA,"TCGA-04-1362-01A-01-BS1",89,"Carboplatin","Chemotherapy","TCGA-04-1362-D24021",NA,NA,NA,"TCGA-04-1362-F24020_NTE-1",NA,NA,"WITH TUMOR","Dead",1348,"TCGA-04-1362-F24020","TCGA-04-1362",NA,"04","1362","YES","C56.9","8441/3","C56.9",NA,NA,-21745,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1348,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
243893124,227706434,16789592092,"6DB4F472-EBD6-4093-9ED5-6AEFB4E04149.bw","1d9893c8-0de3-4b07-b0ba-a53019b23eb4","6db4f472-ebd6-4093-9ed5-6aefb4e04149","2016-08-20T22:11:41.392402-05:00","TCGA-09-0369-01A-01R-1564-13_rnaseq_fastq.tar","3430afc7-6b2a-49c0-b37a-b1e57a987160",16667852800,"Illumina HiSeq","e2d6dc31fbae9da1910b7609ad1d866b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:02:26.266692-05:00","2016-05-03T11:39:34.522989-05:00","3430afc7-6b2a-49c0-b37a-b1e57a987160_analysis.xml","0259c964ec08cdce4bc9cbf193400c5a","13886a98-d428-4b2b-8548-f379b3156dab",2183,"2016-09-29T18:31:32.179766-05:00","3430afc7-6b2a-49c0-b37a-b1e57a987160_experiment.xml","e475117ae0bced527294a466e79c2e5a","258c3f42-e105-4d07-ad79-1d1c85fd5943",3916,"2016-09-29T19:27:42.042241-05:00","3430afc7-6b2a-49c0-b37a-b1e57a987160_run.xml","cbbe73a9835fedb52781777181d36fe0","4920c360-8cbf-467d-9a08-beb2dad48463",1990,"2016-09-08T14:02:46.787332-05:00","TCGA-09-0369","2016-09-02T19:09:43.482662-05:00","female","TCGA-09-0369_demographic",1947,"white","91435668-d5f8-5c6b-8afd-e3e973f0a0aa","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-0369_diagnosis","not reported",20705,"dead","8441/3",1082,NA,"2ccc9ded-6131-5138-ac74-27f15e75a761","c56.9",-20705,"TCGA-09-0369_treatment","702913e1-f549-5908-ba73-05f3a66fc72e","01",NA,"TCGA-09-0369-01A",NA,"effbbc75-67d0-4d2b-bef5-00ed066b0885",FALSE,"c052e190-b5c2-44bf-b5b0-2b37cde18cee","Primary Tumor",NA,NA,NA,NA,1233705600,"01",NA,"TCGA-09-0369-01A-01",98,98,NA,NA,0,0,5,5,"2016-09-08T14:02:46.787332-05:00","2016-09-08T14:02:46.787332-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"a1c0652a-fca9-4ae7-8df7-a7e37d1c9d7d","98dcd946-275e-4aab-ba34-62443d4dfc1c","TCGA-09-0369-01A-01-TS1","TCGA-09-0369-01A-01-BS1",95,95,"48aab2c5-1ac0-42c5-84c8-97fd245bf6e2","RNA","TCGA-09-0369-01A-01R","41982e47-9e0f-4cda-bc47-01fbe6d07906",1.8,0.19,"UV Spec","R","22","TCGA-09-0369-01A-01R-1564-13","1f972766-2f58-4d41-b84c-3493ef2dd0c4",0.19,NA,NA,NA,NA,"e1c94ae2-ead5-5fe5-a89a-94962f15c34c","TCGA-09-0369_exposure","TCGA-09-0369-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T00:28:43.000Z","2014-03-20T01:02:02.000Z","3430AFC7-6B2A-49C0-B37A-B1E57A987160","EFFBBC75-67D0-4D2B-BEF5-00ED066B0885","Unaligned reads",16667852800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1F972766-2F58-4D41-B84C-3493EF2DD0C4","Canada's Michael Smith Genome Sciences Centre","564a3bf7e4b09c884b248837","1D9893C8-0DE3-4B07-B0BA-A53019B23EB4","Ovarian Serous Cystadenocarcinoma","TAR","48AAB2C5-1AC0-42C5-84C8-97FD245BF6E2","2014-03-20T01:02:02.000Z","41982E47-9E0F-4CDA-BC47-01FBE6D07906","None","NO",1,NA,"Primary Tumor","UCSF",NA,"48AAB2C5-1AC0-42C5-84C8-97FD245BF6E2",NA,"09","TCGA-09-0369-01A-01W-0372-09_capture.bam.bai",NA,"TCGA-09-0369-01A",NA,"BBDD7A4D-FEF2-4C8C-861B-13A0F7078F3B","TCGA",2003,NA,NA,"WITH TUMOR","EFFBBC75-67D0-4D2B-BEF5-00ED066B0885",56,"4447820107_B_Grn.idat","Dead",1082,"TCGA-09-0369","NOT HISPANIC OR LATINO","1DF2523E-6D80-4FBD-B56A-101649DD493A",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,NA,"98DCD946-275E-4AAB-BA34-62443D4DFC1C","35C29A23-8258-42E7-9ABF-AE8A61AD5DC4","TCGA-09-0369-01A-01W-0372-09_capture.bam.bai","TCGA-09-0369-01A-01",98,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-09-0369-01A-01-BS1",95,"topotecan","Chemotherapy","TCGA-09-0369-D24224",NA,NA,NA,"TCGA-09-0369-F24217_NTE-2",NA,NA,"WITH TUMOR","Dead",1082,"TCGA-09-0369-F24217","TCGA-09-0369",NA,"09","0369","YES","C56.9","8441/3","C56.9",NA,NA,-20705,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1082,NA,NA,"WITH TUMOR","NO",4,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,56,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
234851340,226149887,16729160274,"2BE0DF8E-7D02-421A-812F-1EA71BBD70B1.bw","1db60f09-7f5a-4f21-8003-06a6abc781db","2be0df8e-7d02-421a-812f-1ea71bbd70b1","2016-08-19T15:03:46.289749-05:00","TCGA-29-1694-01A-01R-1567-13_rnaseq_fastq.tar","083438a1-458b-41f4-871a-91d11b8c2be1",15218094080,"Illumina HiSeq","7ff06bd122fe4279072dba7e4ebad8bb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:14:53.175579-05:00","2016-05-03T11:41:05.748550-05:00","083438a1-458b-41f4-871a-91d11b8c2be1_analysis.xml","1a163864e3b9e4803a3b1a09f052aa50","8b63fc5c-73f9-4ae0-a42b-ac915ae830f8",2181,"2016-10-07T15:41:45.154531-05:00","083438a1-458b-41f4-871a-91d11b8c2be1_experiment.xml","00ba5b204f749b439a6fc98a0f4b9452","a9396222-f18d-44bc-99c5-45268a4c73e1",3916,"2016-09-29T20:02:02.801899-05:00","083438a1-458b-41f4-871a-91d11b8c2be1_run.xml","602b74f7ac057f9a68ab7c6a8b6cec15","5e5ec563-4643-4e9a-bd0c-fe9d603cb87a",1989,"2016-09-08T13:09:04.945204-05:00","TCGA-29-1694","2016-09-02T19:07:21.498492-05:00","female","TCGA-29-1694_demographic",1957,"white","109ece40-b218-5b70-83d3-e21fe429076f","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1694_diagnosis","not reported",16523,"dead","8441/3",1187,NA,"8c0fa4a4-95b4-5ff6-aa24-077fd12ff564","c56.9",-16523,"TCGA-29-1694_treatment","71f71a25-ef58-5fc9-b2b5-ca5883263da3","01",NA,"TCGA-29-1694-01A","1","4d74ff85-24e2-4e93-aa23-94d58efd22e4",FALSE,"ccfb9f1d-1779-4fae-a34f-c46a19d4b095","Primary Tumor","0.3",NA,NA,"1.2",1241740800,"01",98,"TCGA-29-1694-01A-01",85,80,NA,NA,0,0,15,20,"2016-09-08T13:09:04.945204-05:00","2016-09-08T13:09:04.945204-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"d9e65542-f4c3-4c27-96ae-1d8d3f48862b","68cc12ec-6b18-48d1-bfda-6b45bafac0da","TCGA-29-1694-01A-01-TS1","TCGA-29-1694-01A-01-BS1",85,80,"29229350-5046-4a05-a833-1a7349067415","RNA","TCGA-29-1694-01A-01R","61f3b24d-ceba-469d-982d-a31eb635b02c",1.8,0.15,"UV Spec","R","22","TCGA-29-1694-01A-01R-1567-13","e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6",0.15,NA,NA,NA,NA,"a99d0c62-f885-5077-aba3-3c9e46361661","TCGA-29-1694_exposure","TCGA-29-1694-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T03:49:54.000Z","2014-03-29T04:16:01.000Z","083438A1-458B-41F4-871A-91D11B8C2BE1","4D74FF85-24E2-4E93-AA23-94D58EFD22E4","Unaligned reads",15218094080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E0667B02-B4CF-43E7-8CD7-B9FD11B3CEC6","Canada's Michael Smith Genome Sciences Centre","564a5843e4b0ef12181d265d","1DB60F09-7F5A-4F21-8003-06A6ABC781DB","Ovarian Serous Cystadenocarcinoma","TAR","29229350-5046-4A05-A833-1A7349067415","2014-03-29T04:16:01.000Z","61F3B24D-CEBA-469D-982D-A31EB635B02C","None","NO",1,0.3,"Primary Tumor","Duke",NA,"29229350-5046-4A05-A833-1A7349067415",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.463fec61-5758-4225-b43e-b77f36ece717.txt",NA,"TCGA-29-1694-01A",1.2,"CC3697A1-5E61-408E-BD54-3F001F19F4C8","TCGA",2002,NA,NA,"WITH TUMOR","9656BFE0-CB55-4374-9EE7-02F3489E76FC",45,"nationwidechildrens.org_clinical.TCGA-29-1694.xml","Dead",1187,"TCGA-29-1694",NA,"A17E36F4-A75C-4D56-A8A4-F79D48E9513B",NA,1172,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,"9D0C7D69-92D2-43D4-A009-1E652022BF2F","WHITE",NA,1,98,"D9E65542-F4C3-4C27-96AE-1D8D3F48862B","B691D42F-CA6A-4FF3-BCA7-B587327655D9","jhu-usc.edu_OV.HumanMethylation27.8.lvl-2.TCGA-29-1694-01A-01D-0563-05.txt","TCGA-29-1694-01A-01",80,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-29-1694-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-29-1694-D27193","TCGA-29-1694-R27202","RADIOISOTOPES",NA,"TCGA-29-1694-F27192_NTE-1",NA,1172,"WITH TUMOR","Dead",1187,"TCGA-29-1694-F27192","TCGA-29-1694",NA,"29","1694","YES","C56.9","8441/3","C56.9",NA,NA,-16523,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1187,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2002,"Tumor resection",NA,NA,NA,"GX",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
168651884,160982702,11888266237,"C7B624D3-2C1B-4242-B6B4-BDAEDC4C67B8.bw","1e14f098-17b2-4f54-8e4f-e38088008df7","c7b624d3-2c1b-4242-b6b4-bdaedc4c67b8","2016-08-26T10:44:49.166437-05:00","TCGA-13-0714-01A-01R-1564-13_rnaseq_fastq.tar","575f4256-7db7-49dd-87c1-d3ea5f2f62a5",9735106560,"Illumina HiSeq","d10dfcfec76587a4f1d24316d580b8f9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:20:30.039605-05:00","2016-05-03T11:39:34.528512-05:00","575f4256-7db7-49dd-87c1-d3ea5f2f62a5_analysis.xml","cd678083c4178a9ddf618f8462674865","fe46118f-1dc3-4b94-8ed4-d0190a4cebfc",2203,"2016-09-29T17:50:23.191821-05:00","575f4256-7db7-49dd-87c1-d3ea5f2f62a5_experiment.xml","3adb50afdd607f24a2aec1b19af29cd4","0be9b3a1-0884-4e22-8e8f-079cd96e731d",3916,"2016-09-29T23:11:22.010577-05:00","575f4256-7db7-49dd-87c1-d3ea5f2f62a5_run.xml","7bdb66eff59536fedfde7646f36ad33b","d37d2faa-f388-4957-ad1e-210f2d6840a3",1990,"2016-09-08T13:42:00.950639-05:00","TCGA-13-0714","2016-09-02T19:09:23.161548-05:00","female","TCGA-13-0714_demographic",1945,"white","228a6c55-1ab5-5019-bd8f-387fb592df71","not hispanic or latino",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0714_diagnosis","not reported",20109,"dead","8441/3",189,189,"a2212176-e116-5cb8-adee-defab8d379bf","c56.9",-20109,"TCGA-13-0714_treatment","be736da6-b59e-5da9-b184-ad682b358041","01",NA,"TCGA-13-0714-01A","0.6","7cb799d4-b69f-4cac-b975-1df91396250a",FALSE,"96EB4BD1-CE3B-44D8-8095-076712A3E082","Primary Tumor","0.5",NA,NA,"1.2",1233705600,"01",191,"TCGA-13-0714-01A-01",91,81,NA,NA,9,19,NA,NA,"2016-09-08T13:42:00.950639-05:00","2016-09-08T13:42:00.950639-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"26bf9350-7b7e-441a-ab21-86861194cb19","1e09c7c3-482d-45f6-9330-fc2969faa4f7","TCGA-13-0714-01A-01-BS1","TCGA-13-0714-01A-01-TS1",90,80,"3c98bdfc-8269-4e57-b706-191bf0cf8c92","RNA","TCGA-13-0714-01A-01R","db2de945-ce47-4c35-8795-8af8b099aec5",1.8,0.19,"UV Spec","R","22","TCGA-13-0714-01A-01R-1564-13","da337502-6fef-45b6-8770-b2f0889cd802",0.19,NA,NA,NA,NA,"f2e35561-fb1f-55aa-a6db-574c5229e4b0","TCGA-13-0714_exposure","TCGA-13-0714-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T04:24:20.000Z","2014-03-20T04:48:01.000Z","575F4256-7DB7-49DD-87C1-D3EA5F2F62A5","7CB799D4-B69F-4CAC-B975-1DF91396250A","Unaligned reads",9735106560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DA337502-6FEF-45B6-8770-B2F0889CD802","Canada's Michael Smith Genome Sciences Centre","564a38cbe4b093830b686dad","1E14F098-17B2-4F54-8E4F-E38088008DF7","Ovarian Serous Cystadenocarcinoma","TAR","3C98BDFC-8269-4E57-B706-191BF0CF8C92","2014-03-20T04:48:01.000Z","DB2DE945-CE47-4C35-8795-8AF8B099AEC5","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"3C98BDFC-8269-4E57-B706-191BF0CF8C92",0.6,"13","TCGA-13-0714-01A-01W-0370-10_454.bam",NA,"TCGA-13-0714-01A",1.2,"E54432B5-99DF-4C39-B995-647542102AAF","TCGA",2000,NA,NA,"WITH TUMOR","7CB799D4-B69F-4CAC-B975-1DF91396250A",55,"US45102955_251780410356_S01_GE2-v5_95_Feb07.txt_lmean.out.logratio.gene.tcga_level3.data.txt","Dead",189,"TCGA-13-0714","NOT HISPANIC OR LATINO","7FE913A4-D022-4890-A2A8-82C1B9C72755",NA,189,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,191,"26BF9350-7B7E-441A-AB21-86861194CB19","F7E05BD0-06C9-41DD-A75C-DE77C01D17C5","TCGA-13-0714-01A-01W-0370-10_454.bam","TCGA-13-0714-01A-01",91,9,NA,NA,NA,"BOTTOM",1,NA,"TCGA-13-0714-01A-01-BS1",90,"Gemcitabine","Chemotherapy","TCGA-13-0714-D24492",NA,NA,NA,"TCGA-13-0714-F24489_NTE-1",NA,189,"WITH TUMOR","Dead",189,"TCGA-13-0714-F24489","TCGA-13-0714",NA,"13","0714","YES","C56.9","8441/3","C56.9",NA,NA,-20109,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",189,189,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,2000,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
277444844,267549462,19831234907,"299CB633-58A3-4275-BC08-E6F3669C365A.bw","1ede8063-e0e9-466d-891c-ac8916f1b5fa","299cb633-58a3-4275-bc08-e6f3669c365a","2016-08-25T10:07:47.003230-05:00","TCGA-09-1674-01A-01R-1566-13_rnaseq_fastq.tar","f4b7d289-7b02-4a33-8d8c-98de0ceb48ea",18468352000,"Illumina HiSeq","43320b26a77cdefcb73212d88ed536ee","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:15:36.586119-05:00","2016-05-03T11:40:21.662944-05:00","f4b7d289-7b02-4a33-8d8c-98de0ceb48ea_analysis.xml","908b0b7b508715f9e91b9daa174f8c46","fb3ec0d3-0aa6-44c1-8b0b-e35b98329e0d",2181,"2016-09-29T23:04:31.247937-05:00","f4b7d289-7b02-4a33-8d8c-98de0ceb48ea_experiment.xml","e5d7f7a03f34c98c176d1a7e1b5b0ca4","cf13edfc-b050-4d7e-b976-537cf81c04cb",3916,"2016-09-29T19:43:27.334079-05:00","f4b7d289-7b02-4a33-8d8c-98de0ceb48ea_run.xml","3dbaccaf8072bec030c0d0bbf43e7e6d","52d627f8-d819-4f40-be08-d8bab7df7ca7",1988,"2016-09-08T13:18:26.846536-05:00","TCGA-09-1674","2016-09-02T19:07:29.977118-05:00","female","TCGA-09-1674_demographic",1929,"white","7eefb98f-771a-5ff3-bef3-fe4d7b7f4a10","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1674_diagnosis","not reported",28878,"alive","8441/3",NA,260,"7ff83dd1-9fd9-5e82-a1c8-181953c5f320","c56.9",-28878,"TCGA-09-1674_treatment","b66b0332-bce1-592f-8563-04297bc31934","01",NA,"TCGA-09-1674-01A","1.5","59db495c-1778-47a2-b649-968025f08821",FALSE,"d8e0ddd2-304d-4f5e-9225-2cd88ae9984e","Primary Tumor","0.7",NA,NA,"2.1",1240185600,"01",108,"TCGA-09-1674-01A-01",99,99,NA,NA,0,0,5,5,"2016-09-08T13:18:26.846536-05:00","2016-09-08T13:18:26.846536-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"f3f2ff0f-8c71-4d0c-84d2-744f98232846","1548609e-f7e9-40f0-a163-61b669916542","TCGA-09-1674-01A-01-BS1","TCGA-09-1674-01A-01-TS1",90,90,"f438957e-ee30-4510-be3b-4187cd71c6ae","RNA","TCGA-09-1674-01A-01R","6fec3da8-d69a-48f1-886b-017839c85953",1.8,0.17,"UV Spec","R","22","TCGA-09-1674-01A-01R-1566-13","3a81f083-56dc-48a5-be8d-b69a146db93b",0.17,NA,NA,NA,NA,"3cf43dc5-2de2-5f98-8cd9-28ffcf95a856","TCGA-09-1674_exposure","TCGA-09-1674-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-24T21:42:32.000Z","2014-03-24T22:47:02.000Z","F4B7D289-7B02-4A33-8D8C-98DE0CEB48EA","59DB495C-1778-47A2-B649-968025F08821","Unaligned reads",18468352000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3A81F083-56DC-48A5-BE8D-B69A146DB93B","Canada's Michael Smith Genome Sciences Centre","564a5bd4e4b08c5d86954a21","1EDE8063-E0E9-466D-891C-AC8916F1B5FA","Ovarian Serous Cystadenocarcinoma","TAR","F438957E-EE30-4510-BE3B-4187CD71C6AE","2014-03-24T22:47:02.000Z","6FEC3DA8-D69A-48F1-886B-017839C85953","None","NO",1,0.7,"Primary Tumor","UCSF",NA,"F438957E-EE30-4510-BE3B-4187CD71C6AE",1.5,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.872b7aec-febf-4104-8269-bfb0c72fbeec.txt",NA,"TCGA-09-1674-01A",2.1,"C829FCF0-0841-4229-ADF3-10798090ED07","TCGA",2008,NA,NA,"WITH TUMOR","59DB495C-1778-47A2-B649-968025F08821",79,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.872b7aec-febf-4104-8269-bfb0c72fbeec.txt","Alive",NA,"TCGA-09-1674","NOT HISPANIC OR LATINO","AB2E6AE3-6C0C-435D-B0A5-93E3643CD442",NA,260,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,108,"F3F2FF0F-8C71-4D0C-84D2-744F98232846","13C85754-B288-49F5-BE1C-43FF05965D67","TCGA-09-1674-01A-01R-1566-13_GRCh37-lite_rnaseq.bam.bai","TCGA-09-1674-01A-01",99,0,NA,NA,5,"TOP",5,NA,"TCGA-09-1674-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-09-1674-D24324",NA,NA,NA,NA,NA,260,"WITH TUMOR","Alive",NA,"TCGA-09-1674-F24322","TCGA-09-1674",NA,"09","1674","YES","C56.9","8441/3","C56.9",NA,NA,-28878,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",260,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,79,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
159087910,152546502,11237027041,"6818B91B-A181-4345-9938-B75B43BA6C2E.bw","1fe19c6b-71d0-4b07-923b-74ea32210db0","6818b91b-a181-4345-9938-b75b43ba6c2e","2016-08-25T12:13:07.784313-05:00","TCGA-04-1536-01A-01R-1566-13_rnaseq_fastq.tar","e2320fd0-514a-4328-a507-bb52c75e56cd",9933291520,"Illumina HiSeq","5739b54374576b90ba225edb78bcaef2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:05:27.537480-05:00","2016-05-03T11:40:21.648199-05:00","e2320fd0-514a-4328-a507-bb52c75e56cd_analysis.xml","666c737800a19c8263d23979dca1f56c","606d8225-574d-4915-aee1-23268f215191",2235,"2016-10-07T16:25:09.304335-05:00","e2320fd0-514a-4328-a507-bb52c75e56cd_experiment.xml","af9fa892a027d4e141d9c13972b0f3e0","2d76a829-79f3-4342-920b-50f0048ccaeb",3916,"2016-09-29T18:14:16.489186-05:00","e2320fd0-514a-4328-a507-bb52c75e56cd_run.xml","5137f51c41d00d87f9ff25f656b912a2","1add392a-d0a1-4b3a-a2bd-36b7c330bd55",1988,"2016-09-08T10:44:17.906354-05:00","TCGA-04-1536","2016-09-02T18:48:52.008743-05:00","female","TCGA-04-1536_demographic",1941,"black or african american","4075c35e-4315-55c2-8f7e-f4fccace1701","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1536_diagnosis","not reported",21939,"dead","8441/3",885,NA,"f17fde83-65f4-517c-a222-7ce85742a76a","c56.9",-21939,"TCGA-04-1536_treatment","9ce48eab-0d8c-5500-afb6-f15cba3c0ba6","01",NA,"TCGA-04-1536-01A","1.5","841bdebe-253d-4183-a3a1-e2780c859187",FALSE,"167826A1-0854-442E-8AF5-85294D1CB0B9","Primary Tumor","0.2",NA,NA,"1.8",1235001600,"01",116,"TCGA-04-1536-01A-01",95,70,NA,NA,0,10,5,0,"2016-09-08T10:44:17.906354-05:00","2016-09-08T10:44:17.906354-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"08041de2-b6e7-434e-af1a-d616e2e6bf36","269c835e-ebb2-4a0b-a428-8eacb2774937","TCGA-04-1536-01A-01-TS1","TCGA-04-1536-01A-01-BS1",95,85,"7c9b873a-8d33-4cac-a143-2479c57e1b30","RNA","TCGA-04-1536-01A-01R","3a2798dc-0aa3-469c-b4ba-683d12320f07",1.8,0.15,"UV Spec","R","22","TCGA-04-1536-01A-01R-1566-13","6d6a042c-5d29-410a-bbe0-d03d78f9cee9",0.15,NA,NA,NA,NA,"5555db3e-ab6b-51cd-bdbe-3223283273e4","TCGA-04-1536_exposure","TCGA-04-1536-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T04:35:58.000Z","2014-03-25T04:56:01.000Z","E2320FD0-514A-4328-A507-BB52C75E56CD","841BDEBE-253D-4183-A3A1-E2780C859187","Unaligned reads",9933291520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6D6A042C-5D29-410A-BBE0-D03D78F9CEE9","Canada's Michael Smith Genome Sciences Centre","564a5c07e4b09c884b27beb6","1FE19C6B-71D0-4B07-923B-74EA32210DB0","Ovarian Serous Cystadenocarcinoma","TAR","7C9B873A-8D33-4CAC-A143-2479C57E1B30","2014-03-25T04:56:01.000Z","3A2798DC-0AA3-469C-B4BA-683D12320F07","None","NO",1,0.2,"Primary Tumor","Gynecologic Oncology Group",NA,"7C9B873A-8D33-4CAC-A143-2479C57E1B30",1.5,"04","TCGA-04-1536-01A-01R-1566-13.gene.quantification.txt",NA,"TCGA-04-1536-01A",1.8,"FEED8215-093E-4FB3-A54C-38013EB6625F","TCGA",2001,NA,NA,"WITH TUMOR","E7CB6912-1F04-4181-883E-1B975BCA7987",60,"nationwidechildrens.org_clinical.TCGA-04-1536.xml","Dead",885,"TCGA-04-1536",NA,"D2BB276E-782A-46A9-BBEF-889F1B28B446",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,116,"269C835E-EBB2-4A0B-A428-8EACB2774937","A6F33578-8D8E-49E4-BCBE-EBC9F898B78C","US82800149_251976010728_S01_GE2-v5_10_Apr08.txt","TCGA-04-1536-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-04-1536-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-04-1536-D24112",NA,NA,NA,"TCGA-04-1536-F24110_NTE-1",NA,NA,"WITH TUMOR","Dead",885,"TCGA-04-1536-F24110","TCGA-04-1536",NA,"04","1536","YES","C56.9","8441/3","C56.9",NA,NA,-21939,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",NA,885,NA,NA,"WITH TUMOR","NO",3,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,60,2001,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA
165802678,160592663,11840225760,"F39FDB8C-1683-4A4F-83FD-A1521C972501.bw","20336269-5a5b-4ba7-8fe8-665a1f9af738","f39fdb8c-1683-4a4f-83fd-a1521c972501","2016-08-27T03:29:52.235304-05:00","TCGA-25-1633-01A-01R-1566-13_rnaseq_fastq.tar","57127643-c71d-46d4-bce7-e9462f98cb07",10662481920,"Illumina HiSeq","40fdeda4d45273a5340c022aa5b73cb9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:23:39.400180-05:00","2016-05-03T11:40:21.648199-05:00","57127643-c71d-46d4-bce7-e9462f98cb07_analysis.xml","32756177f8e4c70833512b40bb7fe376","46965e91-0953-40d7-a7f7-780625c0458c",2181,"2016-09-29T23:21:34.758318-05:00","57127643-c71d-46d4-bce7-e9462f98cb07_experiment.xml","6e6ce274e31512d3905477e41473a701","d9a3170a-a8f7-4ed8-b77c-2bf02114e4e2",3916,"2016-09-29T23:08:54.486539-05:00","57127643-c71d-46d4-bce7-e9462f98cb07_run.xml","f3e22cd9db546a3bb829a9a64fb19089","d1e99783-96d5-4fa1-8c94-ad31d31c6d25",1988,"2016-09-08T11:04:43.582462-05:00","TCGA-25-1633","2016-09-02T18:47:36.785242-05:00","female","TCGA-25-1633_demographic",1938,"white","e394758b-5b02-5855-a821-a660650ab989","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1633_diagnosis","not reported",23407,"dead","8441/3",1891,1843,"a2f9c05f-49fc-5fcf-8f44-9a62df7e890e","c56.9",-23407,"TCGA-25-1633_treatment","2253f219-7f50-5701-aef6-ab41b0a2129b","01",NA,"TCGA-25-1633-01A","1","170514dc-2d77-48f3-b9d0-42c216211e5b",FALSE,"B3B45EA2-B154-45DC-B49D-422500EA1D9C","Primary Tumor","0.2",NA,NA,"1.3",1237420800,"01",141,"TCGA-25-1633-01A-01",95,80,NA,NA,0,0,5,20,"2016-09-08T11:04:43.582462-05:00","2016-09-08T11:04:43.582462-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"f39839fc-b550-43e5-9f57-937cfdf32219","8a63b727-ea03-48ea-9f9f-7cc786eea30b","TCGA-25-1633-01A-01-TS1","TCGA-25-1633-01A-01-BS1",94,79,"41f2b317-9baf-41c4-8bd0-c555f4ef34bd","RNA","TCGA-25-1633-01A-01R","83146764-198a-4f5c-aa23-05421cbe1bb5",1.8,0.16,"UV Spec","R","22","TCGA-25-1633-01A-01R-1566-13","7517c446-401d-4501-bf27-916e0835deac",0.16,NA,NA,NA,NA,"811bea29-7cd2-522b-b60c-789cc7f37293","TCGA-25-1633_exposure","TCGA-25-1633-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T06:45:54.000Z","2014-03-25T07:09:02.000Z","57127643-C71D-46D4-BCE7-E9462F98CB07","170514DC-2D77-48F3-B9D0-42C216211E5B","Unaligned reads",10662481920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7517C446-401D-4501-BF27-916E0835DEAC","Canada's Michael Smith Genome Sciences Centre","564a3acde4b0298dd2c836a2","20336269-5A5B-4BA7-8FE8-665A1F9AF738","Ovarian Serous Cystadenocarcinoma","TAR","41F2B317-9BAF-41C4-8BD0-C555F4EF34BD","2014-03-25T07:09:02.000Z","83146764-198A-4F5C-AA23-05421CBE1BB5","None","NO",1,0.2,"Primary Tumor","Mayo Clinic - Rochester",NA,"41F2B317-9BAF-41C4-8BD0-C555F4EF34BD",1,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a9062738-4ec8-464c-b5c9-abd82bf322bc.txt",NA,"TCGA-25-1633-01A",1.3,"926932A0-85D9-4736-B465-0F4C56B8A5AF","TCGA",2002,NA,NA,"WITH TUMOR","84A9DAE9-F09D-4EA5-9195-1981C9258D70",64,"nationwidechildrens.org_clinical.TCGA-25-1633.xml","Dead",1891,"TCGA-25-1633","NOT HISPANIC OR LATINO","BDB1AF60-D13A-43C7-A60D-2E6E2406BEBA",NA,1843,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,141,"F39839FC-B550-43E5-9F57-937CFDF32219","83146764-198A-4F5C-AA23-05421CBE1BB5","ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_E05_465996.nocnv_hg19.seg.txt","TCGA-25-1633-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-25-1633-01A-01-TS1",94,"Taxol","Chemotherapy","TCGA-25-1633-D26746",NA,NA,NA,"TCGA-25-1633-F26742_NTE-1",NA,1843,"WITH TUMOR","Dead",1891,"TCGA-25-1633-F26742","TCGA-25-1633",NA,"25","1633","YES","C56.9","8441/3","C56.9",NA,NA,-23407,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1843,1891,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,64,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
266315662,251056191,18545197706,"5779D52D-4380-42D3-8E9F-169AB9DFCD3A.bw","2038fd65-d8f1-4b16-af90-b1c8f9a379a7","5779d52d-4380-42d3-8e9f-169ab9dfcd3a","2016-08-25T05:51:58.694144-05:00","TCGA-13-0905-01B-01R-1565-13_rnaseq_fastq.tar","1f6098b7-5ada-45c5-ad72-b09a120b968c",17666375680,"Illumina HiSeq","fcff4bebda2d2cd4bb09629771364729","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:22:01.320555-05:00","2016-05-03T11:40:21.669427-05:00","1f6098b7-5ada-45c5-ad72-b09a120b968c_analysis.xml","317267a675645ddafdbf1137ca7f7ae4","8fca42f8-9170-4c56-b8f8-00f2c9d09f63",2208,"2016-09-29T20:09:57.685284-05:00","1f6098b7-5ada-45c5-ad72-b09a120b968c_experiment.xml","93428671b040cc866dd66bbd5e47b205","6325b1e7-452f-45fd-b7cb-655da71273b5",3916,"2016-09-29T22:05:35.807821-05:00","1f6098b7-5ada-45c5-ad72-b09a120b968c_run.xml","f7d44730b93df5d96c7085ea34635405","aad27201-afc8-44e9-ac88-9e8ca2ae5ce1",1989,"2016-09-08T10:33:51.798069-05:00","TCGA-13-0905","2016-09-02T19:11:59.136063-05:00","female","TCGA-13-0905_demographic",1954,"white","48698460-7bda-5e2d-bc8b-c4314044aaca","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0905_diagnosis","not reported",18757,"alive","8441/3",NA,3746,"f00a9a54-c99b-5b21-acd3-6fae35b74a82","c56.9",-18757,"TCGA-13-0905_treatment","bd53d914-bb52-5fcd-aa09-68d4e03edab9","01",NA,"TCGA-13-0905-01B","1","3590ce4c-2c63-42f8-ac73-8d813301ef2d",FALSE,"4EC6E47F-60BD-413E-9371-D70E1E89D0CA","Primary Tumor","0.3",NA,NA,"1.2",1230508800,"01",141,"TCGA-13-0905-01B-01",95,95,NA,NA,0,0,5,5,"2016-09-08T10:33:51.798069-05:00","2016-09-08T10:33:51.798069-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"375bb21d-bdbb-43d2-81f7-2c63c90229fd","bff74514-98ec-4d1e-88af-a00aeabd9686","TCGA-13-0905-01B-01-TS1","TCGA-13-0905-01B-01-BS1",94,94,"9698c708-d181-4426-b424-fb8d6067454e","RNA","TCGA-13-0905-01B-01R","edddf635-c923-46e8-914d-d42d860679ad",1.8,0.14,"UV Spec","R","22","TCGA-13-0905-01B-01R-1565-13","6deb1bf0-273a-47ba-9698-3d38ab05f02c",0.14,NA,NA,NA,NA,"d6368bb1-317f-59b9-be18-4a0dfe71f5a7","TCGA-13-0905_exposure","TCGA-13-0905-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-22T04:41:09.000Z","2014-03-22T05:17:01.000Z","1F6098B7-5ADA-45C5-AD72-B09A120B968C","3590CE4C-2C63-42F8-AC73-8D813301EF2D","Unaligned reads",17666375680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6DEB1BF0-273A-47BA-9698-3D38AB05F02C","Canada's Michael Smith Genome Sciences Centre","564a3387e4b093830b66c07a","2038FD65-D8F1-4B16-AF90-B1C8F9A379A7","Ovarian Serous Cystadenocarcinoma","TAR","9698C708-D181-4426-B424-FB8D6067454E","2014-03-22T05:17:01.000Z","EDDDF635-C923-46E8-914D-D42D860679AD","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"9698C708-D181-4426-B424-FB8D6067454E",1,"13","TCGA-13-0905-01B-01R-1565-13_GRCh37-lite_mirna.bam",NA,"TCGA-13-0905-01B",1.2,"FEEDB04F-785C-4C0C-A091-D00618DEA595","TCGA",2005,NA,NA,"TUMOR FREE","3590CE4C-2C63-42F8-AC73-8D813301EF2D",51,"nationwidechildrens.org_clinical.TCGA-13-0905.xml","Alive",NA,"TCGA-13-0905","NOT HISPANIC OR LATINO",NA,NA,1455,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,141,"BFF74514-98EC-4D1E-88AF-A00AEABD9686","F987A602-ADB2-4317-997F-6FECA2431F43","TCGA-13-0905-01B-01R-1565-13_GRCh37-lite_mirna.bam","TCGA-13-0905-01B-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-13-0905-01B-01-BS1",94,"Paciltaxel","Chemotherapy","TCGA-13-0905-D24731",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0905",NA,"13","0905","YES","C56.9","8441/3","C56.9",NA,NA,-18757,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1455,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,51,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
167546482,161610435,11898170720,"22C7B2BE-F14E-48C8-8EBE-12B4DBC9DE3E.bw","206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18","22c7b2be-f14e-48c8-8ebe-12b4dbc9de3e","2016-08-25T07:28:25.623891-05:00","TCGA-24-0982-01A-01R-1565-13_rnaseq_fastq.tar","d9fd94c8-d4d1-4a58-9a36-57e790c14fa4",9795461120,"Illumina HiSeq","ba8fb0477a54fd04d53d93831743de69","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:12:30.631377-05:00","2016-05-03T11:41:05.750744-05:00","d9fd94c8-d4d1-4a58-9a36-57e790c14fa4_analysis.xml","0cfff7d231f67fc57ab8a71256472a2c","d433c9c5-7888-413e-88d2-974ef759f537",2208,"2016-09-29T18:59:41.269703-05:00","d9fd94c8-d4d1-4a58-9a36-57e790c14fa4_experiment.xml","e4524afde44dc43a50960c0152ea0243","377877d9-1361-4889-9a8a-02f09474a32c",3916,"2016-09-29T18:39:41.946835-05:00","d9fd94c8-d4d1-4a58-9a36-57e790c14fa4_run.xml","c0b41420edabf300c4da5c2ae14e021e","2ac89d58-911a-409e-92f8-8cad3fc86ae0",1988,"2016-09-08T12:32:22.292403-05:00","TCGA-24-0982","2016-09-02T19:05:45.383901-05:00","female","TCGA-24-0982_demographic",1926,"white","849e1718-c71c-5361-b7d6-b8cc306d138e","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-0982_diagnosis","not reported",28201,"dead","8441/3",679,679,"39a59ccd-64aa-5441-84ae-81793fbe9199","c56.9",-28201,"TCGA-24-0982_treatment","d81ea43b-389a-5133-a0dd-61f3ff1b9e3b","01",NA,"TCGA-24-0982-01A","0.8","7fec33cd-6f46-44c7-8204-e0f42b543abe",FALSE,"75BE9FE6-5606-4F29-A08F-69E3F50912D0","Primary Tumor","0.8",NA,NA,"1",1233705600,"01",127,"TCGA-24-0982-01A-01",85,75,NA,NA,0,0,25,35,"2016-09-08T12:32:22.292403-05:00","2016-09-08T12:32:22.292403-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"7a24140e-0062-41a3-bf71-a70ce3f4124c","86d455fe-9855-4106-b487-ef4cde3c86de","TCGA-24-0982-01A-01-TS1","TCGA-24-0982-01A-01-BS1",75,65,"14ff92dd-94fa-475a-9b66-6a66e6ba316c","RNA","TCGA-24-0982-01A-01R","482b4082-67ce-4e07-9a22-77d3e6e29efe",1.8,0.16,"UV Spec","R","22","TCGA-24-0982-01A-01R-1565-13","ae158b16-5d93-42d5-a793-3294629af24d",0.16,NA,NA,NA,NA,"1e039aaa-a4ff-5aff-a922-288b7c44e009","TCGA-24-0982_exposure","TCGA-24-0982-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-28T16:12:48.000Z","2014-03-28T16:36:02.000Z","D9FD94C8-D4D1-4A58-9A36-57E790C14FA4","7FEC33CD-6F46-44C7-8204-E0F42B543ABE","Unaligned reads",9795461120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AE158B16-5D93-42D5-A793-3294629AF24D","Canada's Michael Smith Genome Sciences Centre","564a5b0ce4b08c5d86951e41","206CE0ED-36A4-47AB-AC8E-F6FCA6AC5C18","Ovarian Serous Cystadenocarcinoma","TAR","14FF92DD-94FA-475A-9B66-6A66E6BA316C","2014-03-28T16:36:02.000Z","482B4082-67CE-4E07-9A22-77D3E6E29EFE","None","NO",1,0.8,"Primary Tumor","Washington University",NA,"14FF92DD-94FA-475A-9B66-6A66E6BA316C",0.8,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d712585f-3d02-4e1a-a11a-4ffac7295711.txt",NA,"TCGA-24-0982-01A",1,"EF503CEC-E161-41BD-85A3-8BB01F6B1328","TCGA",2003,NA,NA,"WITH TUMOR","7FEC33CD-6F46-44C7-8204-E0F42B543ABE",77,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d712585f-3d02-4e1a-a11a-4ffac7295711.txt","Dead",679,"TCGA-24-0982",NA,"AC8E6667-9F37-442B-9A6E-6497824D60A9",NA,679,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,127,"86D455FE-9855-4106-B487-EF4CDE3C86DE","482B4082-67CE-4E07-9A22-77D3E6E29EFE","AGARS_p_TCGA_B12_RNA_ReDo_HT_HG-U133A_96-HTA_B03_443096.level2.data.txt","TCGA-24-0982-01A-01",85,0,NA,NA,25,"TOP",0,NA,"TCGA-24-0982-01A-01-TS1",75,"Paclitaxel","Chemotherapy","TCGA-24-0982-D25902",NA,NA,NA,"TCGA-24-0982-F25900_NTE-1",NA,679,"WITH TUMOR","Dead",679,"TCGA-24-0982-F25900","TCGA-24-0982",NA,"24","0982","YES","C56.9","8441/3","C56.9",NA,NA,-28201,"FEMALE","WHITE",NA,NA,"No","Dead",679,679,NA,NA,"WITH TUMOR","NO",10,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,77,2003,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
154141214,148838867,10992566748,"BAB6B076-4F0D-4081-977D-7F7C8182882E.bw","20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c","bab6b076-4f0d-4081-977d-7f7c8182882e","2016-09-29T22:31:33.736068-05:00","TCGA-61-2012-01A-01R-1568-13_rnaseq_fastq.tar","f30f88b7-4c35-445a-89ad-ec79c69b6dc7",9765181440,"Illumina HiSeq","8c27ad466c22a731807f27218d79ab6e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:51:16.472452-05:00","2016-05-03T11:56:42.628342-05:00","f30f88b7-4c35-445a-89ad-ec79c69b6dc7_analysis.xml","ef4812bb130a06066e3ff8064f6969f2","0c77246e-dd6e-40a1-bf0f-bb536bf6d5f3",2181,"2016-09-29T21:58:40.011022-05:00","f30f88b7-4c35-445a-89ad-ec79c69b6dc7_experiment.xml","f8f6d1acbea3c865ec65f8e52ca9d9dc","a686d122-deda-4b82-80d9-3370334e4306",3916,"2016-09-29T22:47:21.602474-05:00","f30f88b7-4c35-445a-89ad-ec79c69b6dc7_run.xml","79ced4eac0a2141f2cb8d0355dc32dc3","c49275b9-7984-4872-9cc5-30c1390063d4",1988,"2016-09-08T12:22:06.001198-05:00","TCGA-61-2012","2016-09-02T18:56:23.411538-05:00","female","TCGA-61-2012_demographic",1925,"white","8498c00e-74f7-5fcf-b735-19fa805babfc","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2012_diagnosis","not reported",29830,"alive","8441/3",NA,932,"c2f4be9a-f3ef-5c78-b92f-88a7763041f2","c56.9",-29830,"TCGA-61-2012_treatment","da579c57-8052-52c0-90de-1bb0c90d7898","01",NA,"TCGA-61-2012-01A","0.6","0befd656-457c-4fa2-81c0-6c5a56f70196",FALSE,"534e3236-b9e7-4b0b-a2a3-2fc3a96fac81","Primary Tumor","0.4",NA,NA,"1.6",1247443200,"01",135,"TCGA-61-2012-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:22:06.001198-05:00","2016-09-08T12:22:06.001198-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,10,"d68a617d-bd93-4048-895f-46279334d114","0360d47c-f42a-4f5f-b317-ff0f55799425","TCGA-61-2012-01A-01-TS1","TCGA-61-2012-01A-01-BS1",80,80,"f6ad2d94-29f1-44ab-8602-e4bb9b07f4c1","RNA","TCGA-61-2012-01A-01R","9ee4786e-b524-4c48-8d8e-a39ca3651337",1.8,0.13,"UV Spec","R","22","TCGA-61-2012-01A-01R-1568-13","929c2bc4-4cee-4f82-b336-918fe041a588",0.13,NA,NA,NA,NA,"c12297fa-146b-579e-b1c6-6b6a1a248e3c","TCGA-61-2012_exposure","TCGA-61-2012-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T05:46:23.000Z","2014-08-27T07:09:18.000Z","F30F88B7-4C35-445A-89AD-EC79C69B6DC7","0BEFD656-457C-4FA2-81C0-6C5A56F70196","Unaligned reads",9765181440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","929C2BC4-4CEE-4F82-B336-918FE041A588","Canada's Michael Smith Genome Sciences Centre","564a5b7ee4b0ef12181e30a7","20C6BE4D-7BAF-4EA0-93E2-A5212F2E9B9C","Ovarian Serous Cystadenocarcinoma","TAR","F6AD2D94-29F1-44AB-8602-E4BB9B07F4C1","2014-08-27T07:09:18.000Z","9EE4786E-B524-4C48-8D8E-A39CA3651337","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"F6AD2D94-29F1-44AB-8602-E4BB9B07F4C1",0.6,"61","SOURS_p_TCGAb22_SNP_N_GenomeWideSNP_6_E04_529832.hg19.seg.txt",NA,"TCGA-61-2012-01A",1.6,"D10ED0E0-E577-49C9-8ED4-AD2FB0A269BD","TCGA",2006,NA,NA,NA,"F0756C55-B43C-4D71-AC63-A1434190738F",81,"SOURS_p_TCGAb22_SNP_N_GenomeWideSNP_6_E04_529832.tangent.copynumber.data.txt","Alive",NA,"TCGA-61-2012","NOT HISPANIC OR LATINO","C66877B2-6DE0-46A6-8A98-F8808FC13AF9",NA,932,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,"8FF12E8C-3408-423B-ABB2-27198CD04420","WHITE",NA,1,135,"D68A617D-BD93-4048-895F-46279334D114","E4EA9EDD-2869-4F42-A8B9-544033E44253","jhu-usc.edu_OV.HumanMethylation27.11.lvl-3.TCGA-61-2012-01A-01D-0667-05.txt","TCGA-61-2012-01A-01",90,0,NA,NA,10,"BOTTOM",10,NA,"TCGA-61-2012-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-61-2012-D28353","TCGA-61-2012-R28355",NA,NA,NA,NA,932,NA,"Alive",NA,"TCGA-61-2012-F28352","TCGA-61-2012",NA,"61","2012","YES","C56.9","8441/3","C56.9",NA,NA,-29830,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",932,NA,NA,NA,NA,"NO",8,12,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,81,2006,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
216634912,209941433,15547820534,"CD576099-5450-4232-9B59-08341BED8FFA.bw","20cf00ea-d7da-42bb-bce7-f005f0b952eb","cd576099-5450-4232-9b59-08341bed8ffa","2016-08-22T16:28:05.454745-05:00","TCGA-59-2348-01A-01R-1569-13_rnaseq_fastq.tar","5a6197f9-9b73-419e-9bd2-83e5bdd2c3bc",14224302080,"Illumina HiSeq","aa795d3f28c55de054cf87334e52cccd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:43:17.362657-05:00","2016-05-03T11:56:42.631594-05:00","5a6197f9-9b73-419e-9bd2-83e5bdd2c3bc_analysis.xml","f26dec1681637334c0df5543f489188b","52bda078-8463-4b21-9227-1a4ca87fcc68",2181,"2016-09-29T23:52:26.579831-05:00","5a6197f9-9b73-419e-9bd2-83e5bdd2c3bc_experiment.xml","3dda72821df93eaddf78ee5fe3fce1f0","ecfad601-49b0-4820-bcf5-afcb6340fc70",3916,"2016-09-29T20:22:55.269246-05:00","5a6197f9-9b73-419e-9bd2-83e5bdd2c3bc_run.xml","ba53bb2168b7b58a0063a969cbed0089","6b0f0a12-12de-4def-a01b-433fd451bda1",1988,"2016-09-08T13:47:22.439878-05:00","TCGA-59-2348","2016-09-02T19:11:44.075478-05:00","female","TCGA-59-2348_demographic",1935,"white","6a7ef2cd-8b8c-57fc-af3d-74c34a357885","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2348_diagnosis","not reported",NA,"alive","8441/3",NA,5481,"7fbc9ad4-d3ae-5f9c-bb13-bdfa201dec51","c56.9",NA,"TCGA-59-2348_treatment","87a7a46d-b73f-5b7b-a184-4bac979edb5f","01",NA,"TCGA-59-2348-01A","1","cbdafa49-7dd7-4a42-b0a5-891aad11a802",FALSE,"ffb300e9-cb06-4162-a751-f079fec57153","Primary Tumor","0.4",NA,NA,"2",1251763200,"01",143,"TCGA-59-2348-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:47:22.439878-05:00","2016-09-08T13:47:22.439878-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"2dd39e8f-db2f-4d2c-9799-c289a6d6d505","3d166d77-0129-481e-b769-22faa586c38e","TCGA-59-2348-01A-01-BS1","TCGA-59-2348-01A-01-TS1",85,85,"9da4bbad-1b7e-4a86-9ba8-f7e9599f1d59","RNA","TCGA-59-2348-01A-01R","796fbc4f-6c96-499b-a55c-879fc1be514a",1.8,0.14,"UV Spec","R","22","TCGA-59-2348-01A-01R-1569-13","7162d809-ff1a-4346-bb00-c8086386ec46",0.14,NA,NA,NA,NA,"98e021f3-1c89-5a14-bbb9-e9df13c305fd","TCGA-59-2348_exposure","TCGA-59-2348-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-29T03:15:24.000Z","2014-08-29T06:31:40.000Z","5A6197F9-9B73-419E-9BD2-83E5BDD2C3BC","CBDAFA49-7DD7-4A42-B0A5-891AAD11A802","Unaligned reads",14224302080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7162D809-FF1A-4346-BB00-C8086386EC46","Canada's Michael Smith Genome Sciences Centre","564a37e7e4b09c884b234a37","20CF00EA-D7DA-42BB-BCE7-F005F0B952EB","Ovarian Serous Cystadenocarcinoma","TAR","9DA4BBAD-1B7E-4A86-9BA8-F7E9599F1D59","2014-08-29T06:31:40.000Z","796FBC4F-6C96-499B-A55C-879FC1BE514A","None","NO",1,0.4,"Primary Tumor","Roswell Park",NA,"9DA4BBAD-1B7E-4A86-9BA8-F7E9599F1D59",1,"59","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c37d3098-f79e-4ce7-9ed5-884d82725dff.txt",NA,"TCGA-59-2348-01A",2,NA,"TCGA",1994,NA,NA,"TUMOR FREE","CBDAFA49-7DD7-4A42-B0A5-891AAD11A802",59,"TCGA-59-2348-01A-01R-1569-13_GRCh37-lite_mirna.bam.bai","Alive",NA,"TCGA-59-2348","NOT HISPANIC OR LATINO","46960C42-55EF-44C0-8839-18409AAC5337",NA,5481,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,143,"3D166D77-0129-481E-B769-22FAA586C38E","E51AF10C-F37D-4789-B914-EF172B90D301","TCGA-59-2348-01A-01R-1569-13_rnaseq_fastq.tar","TCGA-59-2348-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-59-2348-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,NA,NA,5481,"TUMOR FREE","Alive",NA,"TCGA-59-2348-F28098","TCGA-59-2348",NA,"59","2348","YES","C56.9","8441/3","C56.9",NA,NA,NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",5481,NA,NA,NA,"TUMOR FREE","NO",29,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,1994,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
188579266,181240166,13379438557,"55DE66CF-EFC1-4513-87CF-6DE234A25A4D.bw","21966708-4e66-4211-add0-f1515b09e362","55de66cf-efc1-4513-87cf-6de234a25a4d","2016-09-29T19:48:19.785797-05:00","TCGA-24-1847-01A-01R-1566-13_rnaseq_fastq.tar","40377b60-fb4e-438a-afcf-9c9ad8630807",12119623680,"Illumina HiSeq","0734ea8162dadf9e7d68be7c74827edf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:57:35.996953-05:00","2016-05-03T11:40:21.648199-05:00","40377b60-fb4e-438a-afcf-9c9ad8630807_analysis.xml","96c6a57f4c377ed261587f1c2cd9f32d","cad46511-0d6d-4ba2-8b45-aede6993002d",2181,"2016-09-29T23:25:51.076556-05:00","40377b60-fb4e-438a-afcf-9c9ad8630807_experiment.xml","ef371835a8201108ac0b27672dd2347b","dc5f9b42-1c5a-4d93-b70d-7aff5260d948",3916,"2016-09-29T19:54:55.012211-05:00","40377b60-fb4e-438a-afcf-9c9ad8630807_run.xml","9255ac43af6dbf5b41731de26f29912c","5a09991c-3bfa-476c-ae57-bbf7a4b11be8",1988,"2016-09-08T12:22:16.148199-05:00","TCGA-24-1847","2016-09-02T19:07:24.755447-05:00","female","TCGA-24-1847_demographic",1964,"white","7dff2c76-7f44-5910-806b-2355bc702bbf","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1847_diagnosis","not reported",16529,"alive","8441/3",NA,343,"3384bda3-487e-5148-92d7-620f7ed61f10","c56.9",-16529,"TCGA-24-1847_treatment","bdef78fe-9ed5-575c-9c8f-1337cd8ecdd5","01",NA,"TCGA-24-1847-01A","0.9","f1989bf4-c884-430d-a075-679f7b4a4b07",FALSE,"20d96d45-40d3-44ad-a9e8-fdc7e545ed5d","Primary Tumor","0.3",NA,NA,"1",1245628800,"01",108,"TCGA-24-1847-01A-01",90,90,0,0,0,0,10,10,"2016-09-08T12:22:16.148199-05:00","2016-09-08T12:22:16.148199-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"801bcc7d-3382-42fa-aff1-076ebcc5bdf4","feb1ba92-5e6b-473e-a1e3-b8660512a989","TCGA-24-1847-01A-01-BS1","TCGA-24-1847-01A-01-TS1",90,90,"85a36ad5-734f-43c6-9e55-9e34b851593b","RNA","TCGA-24-1847-01A-01R","66749a52-3b1a-43bb-98b2-ab99e76789d0",1.8,0.15,"UV Spec","R","22","TCGA-24-1847-01A-01R-1566-13","83354694-078e-411e-89d2-029649708528",0.15,NA,NA,NA,NA,"4fe078cd-5e95-5084-b35a-8e56efe30c7c","TCGA-24-1847_exposure","TCGA-24-1847-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T06:57:43.000Z","2014-03-25T07:21:01.000Z","40377B60-FB4E-438A-AFCF-9C9AD8630807","F1989BF4-C884-430D-A075-679F7B4A4B07","Unaligned reads",12119623680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","83354694-078E-411E-89D2-029649708528","Canada's Michael Smith Genome Sciences Centre","564a595ae4b09c884b271aee","21966708-4E66-4211-ADD0-F1515B09E362","Ovarian Serous Cystadenocarcinoma","TAR","85A36AD5-734F-43C6-9E55-9E34B851593B","2014-03-25T07:21:01.000Z","66749A52-3B1A-43BB-98B2-AB99E76789D0","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"85A36AD5-734F-43C6-9E55-9E34B851593B",0.9,"24","TCGA-24-1847-01A-01W-0633-09_IlluminaGA-DNASeq_exome_1.bam.bai",NA,"TCGA-24-1847-01A",1,"D01C128C-796E-4AA3-9939-631FC9179BBC","TCGA",2009,NA,NA,"TUMOR FREE","F1989BF4-C884-430D-A075-679F7B4A4B07",45,"nationwidechildrens.org_clinical.TCGA-24-1847.xml","Alive",NA,"TCGA-24-1847",NA,"A302CCB0-5B86-4A6A-8121-FDF54689C24C",NA,343,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,108,"FEB1BA92-5E6B-473E-A1E3-B8660512A989","9BE2FABD-9489-4AEA-B640-A41CFC64C47D","TCGA-24-1847-01A-01W-0633-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-24-1847-01A-01",90,0,0,0,10,"TOP",0,0,"TCGA-24-1847-01A-01-TS1",90,"Ciplastin","Chemotherapy","TCGA-24-1847-D26352",NA,NA,NA,NA,NA,343,"TUMOR FREE","Alive",NA,"TCGA-24-1847-F26350","TCGA-24-1847",NA,"24","1847","YES","C56.9","8441/3","C56.9",NA,NA,-16529,"FEMALE","WHITE",NA,NA,"No","Alive",343,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2009,"Excisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
194077366,189578136,14060040418,"FB16D2B3-47E5-4D14-801D-97BFD0B85A37.bw","219f54ef-4235-482d-b799-f2fa9930105c","fb16d2b3-47e5-4d14-801d-97bfd0b85a37","2016-08-23T20:31:28.273397-05:00","TCGA-24-2027-01A-01R-1567-13_rnaseq_fastq.tar","4c0af330-2f58-4eb8-ace0-3bb0c2acfeb0",12784865280,"Illumina HiSeq","dd8f0f61f797ac5d627e52da55f78252","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:49:02.189633-05:00","2016-05-03T11:41:05.748550-05:00","4c0af330-2f58-4eb8-ace0-3bb0c2acfeb0_analysis.xml","097f7aa92f24fc9502a5619414715f68","eadefa51-ef1c-4b90-b320-38c5c8f72be4",2181,"2016-10-07T16:41:58.039215-05:00","4c0af330-2f58-4eb8-ace0-3bb0c2acfeb0_experiment.xml","7138d6452498dc09a6c16600c6877e0e","1f1032e9-0ed1-4f03-95d9-a15cac6c8c9d",3916,"2016-09-29T20:26:40.562311-05:00","4c0af330-2f58-4eb8-ace0-3bb0c2acfeb0_run.xml","1851ae7e00381b170fae820f38dce631","6d67f9af-7141-46a4-aa05-bda307e4246c",1989,"2016-09-08T10:40:16.818618-05:00","TCGA-24-2027","2016-09-02T18:50:40.735745-05:00","female","TCGA-24-2027_demographic",1944,"white","5baa23ff-1696-5388-a54c-c4fbd711013e","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2027_diagnosis","not reported",18835,"dead","8441/3",3337,3337,"7e4bfb50-f7b9-5a44-a69e-28e275a0517e","c56.9",-18835,"TCGA-24-2027_treatment","3f913450-7829-55de-a999-e5e30b983e2e","01",NA,"TCGA-24-2027-01A","0.8","d458ab44-bd23-410d-9ffa-4d469d16c62b",FALSE,"8a4d0373-9d57-4cf7-ac78-d8b558d43df6","Primary Tumor","0.6",NA,NA,"1.6",1248134400,"01",157,"TCGA-24-2027-01A-01",85,85,0,0,0,0,7,5,"2016-09-08T10:40:16.818618-05:00","2016-09-08T10:40:16.818618-05:00",0,0,0,0,"BOTTOM","TOP",3,0,"84920977-5b25-4424-a913-41bc08ac0250","d6d55952-e8db-460f-aaff-9cc1b9044610","TCGA-24-2027-01A-01-BS1","TCGA-24-2027-01A-01-TS1",90,95,"378430bb-b6ce-469c-9c6a-66a6843b382e","RNA","TCGA-24-2027-01A-01R","7c51887a-114f-4223-8bd3-4fbbaa73cacd",1.8,0.15,"UV Spec","R","22","TCGA-24-2027-01A-01R-1567-13","fc1f34ba-12e1-46d8-85ef-15b9486b37c2",0.15,NA,NA,NA,NA,"990b979c-f8e0-5820-abf1-0df4a7a925e9","TCGA-24-2027_exposure","TCGA-24-2027-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T07:20:30.000Z","2014-03-29T07:44:02.000Z","4C0AF330-2F58-4EB8-ACE0-3BB0C2ACFEB0","D458AB44-BD23-410D-9FFA-4D469D16C62B","Unaligned reads",12784865280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FC1F34BA-12E1-46D8-85EF-15B9486B37C2","Canada's Michael Smith Genome Sciences Centre","564a5af2e4b0298dd2cc027c","219F54EF-4235-482D-B799-F2FA9930105C","Ovarian Serous Cystadenocarcinoma","TAR","378430BB-B6CE-469C-9C6A-66A6843B382E","2014-03-29T07:44:02.000Z","7C51887A-114F-4223-8BD3-4FBBAA73CACD","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"378430BB-B6CE-469C-9C6A-66A6843B382E",0.8,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.55afc19d-b001-47f3-9d3d-9bc9a8681031.txt",NA,"TCGA-24-2027-01A",1.6,"F2BD2C6E-2DCD-4F31-A184-CA1B3B57F630","TCGA",1995,NA,NA,"WITH TUMOR","D458AB44-BD23-410D-9FFA-4D469D16C62B",51,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.55afc19d-b001-47f3-9d3d-9bc9a8681031.txt","Dead",3337,"TCGA-24-2027",NA,"734E79C4-B7B3-4238-AA0B-D3F1FE501A3B",NA,3337,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,157,"D6D55952-E8DB-460F-AAFF-9CC1B9044610","BF309B21-252D-4BE8-8C2E-D9CEB5AF35D4","TCGA-24-2027-01A-01R-1567-13_mirna.bam","TCGA-24-2027-01A-01",85,0,0,0,7,"BOTTOM",3,0,"TCGA-24-2027-01A-01-BS1",90,"Taxol","Chemotherapy","TCGA-24-2027-D26472",NA,NA,NA,"TCGA-24-2027-F26460_NTE-1",NA,3337,"WITH TUMOR","Dead",3337,"TCGA-24-2027-F26460","TCGA-24-2027",NA,"24","2027","YES","C56.9","8441/3","C56.9",NA,NA,-18835,"FEMALE","WHITE",NA,NA,"No","Dead",3337,3337,NA,NA,"WITH TUMOR","NO",15,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,1995,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
103722052,96970562,7104201477,"51931C0C-F10D-404F-BC9C-E9F1B755AC99.bw","21f6bf91-dfc6-4a59-8b76-88a0f95c7b47","51931c0c-f10d-404f-bc9c-e9f1b755ac99","2016-08-25T02:48:33.897352-05:00","TCGA-24-1544-01A-01R-1566-13_rnaseq_fastq.tar","809b40d0-7933-4313-8b07-c3fafefe0213",6538455040,"Illumina HiSeq","8417a6b1fb83a735774cc62e8936014e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:36:43.611821-05:00","2016-05-03T11:40:21.648199-05:00","809b40d0-7933-4313-8b07-c3fafefe0213_analysis.xml","3c0bc105f4763e2a6ca4db9636bd5497","0319dd56-0412-455b-ab71-d911b7a97f13",2181,"2016-09-29T21:06:13.794442-05:00","809b40d0-7933-4313-8b07-c3fafefe0213_experiment.xml","5899d186ed438525940efcf9ec0272d2","85f71f1f-c334-42a6-8dd7-2686227f1cdf",3916,"2016-09-29T23:50:24.984225-05:00","809b40d0-7933-4313-8b07-c3fafefe0213_run.xml","07b08ab0db3aa6e0690a59017b79b480","ebb115eb-a9fc-4d29-bb49-a63ccce6bda8",1988,"2016-09-08T10:45:46.775987-05:00","TCGA-24-1544","2016-09-02T18:53:43.894184-05:00","female","TCGA-24-1544_demographic",1929,"black or african american","d6576dc5-1505-5552-85bd-65620144f49e","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1544_diagnosis","not reported",26141,"dead","8441/3",820,820,"b05e9689-4d0c-5974-965f-d8c1411d17ef","c56.9",-26141,"TCGA-24-1544_treatment","7e5eea55-c677-5c45-8463-f4efa49ca963","01",NA,"TCGA-24-1544-01A","0.8","cf7b9151-6479-41af-986c-d9db10e33ca6",FALSE,"2fd78a14-cc3f-4920-9c50-6051579b6ad4","Primary Tumor","0.5",NA,NA,"1.4",1235088000,"01",149,"TCGA-24-1544-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T10:45:46.775987-05:00","2016-09-08T10:45:46.775987-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,5,"8b67402c-67b0-4909-b96c-f8a7f9e85ced","5c0e797d-fd2e-4368-8b27-b77ad0cd4601","TCGA-24-1544-01A-01-BS1","TCGA-24-1544-01A-01-TS1",70,75,"a87fc66d-5ec9-438b-99d1-b4943e512461","RNA","TCGA-24-1544-01A-01R","7d1f8818-cfc3-4716-8cac-d0b2fb48f865",1.8,0.16,"UV Spec","R","22","TCGA-24-1544-01A-01R-1566-13","83333a5a-de0b-4d72-b886-e5488c619827",0.16,NA,NA,NA,NA,"9b6b99bf-0c84-53fb-973c-f344c0718729","TCGA-24-1544_exposure","TCGA-24-1544-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T06:24:38.000Z","2014-03-25T06:39:02.000Z","809B40D0-7933-4313-8B07-C3FAFEFE0213","CF7B9151-6479-41AF-986C-D9DB10E33CA6","Unaligned reads",6538455040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","83333A5A-DE0B-4D72-B886-E5488C619827","Canada's Michael Smith Genome Sciences Centre","564a3ecfe4b08c5d869297d8","21F6BF91-DFC6-4A59-8B76-88A0F95C7B47","Ovarian Serous Cystadenocarcinoma","TAR","A87FC66D-5EC9-438B-99D1-B4943E512461","2014-03-25T06:39:02.000Z","7D1F8818-CFC3-4716-8CAC-D0B2FB48F865","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"A87FC66D-5EC9-438B-99D1-B4943E512461",0.8,"24","bcgsc.ca.TCGA-24-1544-01A-01R-1566-13.hg19.bcgsc.ca.1.6.0.snv.vcf",NA,"TCGA-24-1544-01A",1.4,"B0F731BC-150C-4AA5-A5E0-66F092FB26CD","TCGA",2000,NA,NA,"WITH TUMOR","E2BE3D89-B678-42E8-ACBC-E97E44CAE565",71,"bcgsc.ca.TCGA-24-1544-01A-01R-1566-13.bcgsc.ca.1.5.0.snv.vcf","Dead",820,"TCGA-24-1544",NA,"56EC21C8-C3B5-41B3-ABDC-964351237F88",NA,820,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,149,"8B67402C-67B0-4909-B96C-F8A7F9E85CED","9E0BBF53-7EE6-4147-BB1E-50BA2C87B882","US82800149_251976010734_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","TCGA-24-1544-01A-01",80,0,NA,NA,20,"BOTTOM",10,NA,"TCGA-24-1544-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-24-1544-D26086",NA,NA,NA,"TCGA-24-1544-F26080_NTE-1",NA,820,"WITH TUMOR","Dead",820,"TCGA-24-1544-F26080","TCGA-24-1544",NA,"24","1544","YES","C56.9","8441/3","C56.9",NA,NA,-26141,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",820,820,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
207015776,201993049,14958868256,"C1AEFA60-4226-4929-A709-A0F67DCD7838.bw","22178c3c-6b04-46d8-8041-dc83fa195029","c1aefa60-4226-4929-a709-a0f67dcd7838","2016-08-26T11:13:02.330690-05:00","TCGA-25-2404-01A-01R-1569-13_rnaseq_fastq.tar","2a005a38-304d-482c-b7f1-a52c0b64741d",13084405760,"Illumina HiSeq","24779705ffef95d8bf46a446f3a09127","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:18:16.928108-05:00","2016-05-03T11:55:09.260045-05:00","2a005a38-304d-482c-b7f1-a52c0b64741d_analysis.xml","914b011cc345014cf8d79631ba02de14","b28478e0-393e-4ed3-90fa-74c352c848d3",2181,"2016-09-29T22:21:56.884936-05:00","2a005a38-304d-482c-b7f1-a52c0b64741d_experiment.xml","dd6064e2b501a981a7f915660ce3d820","b4b15f28-3978-4d77-bfa7-6fc3a89eb611",3916,"2016-09-30T00:00:04.038738-05:00","2a005a38-304d-482c-b7f1-a52c0b64741d_run.xml","9a1356153ad4eb62fa2cf34082409c86","f1aea1ce-a563-44e6-a5aa-54ca8e642eb0",1988,"2016-09-08T13:45:02.816291-05:00","TCGA-25-2404","2016-09-02T19:11:56.647573-05:00","female","TCGA-25-2404_demographic",1967,"american indian or alaska native","2491559b-7a65-500d-b886-d23b26c6aadd","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2404_diagnosis","not reported",14184,"dead","8441/3",883,883,"8a61260e-5e20-5dc5-94bf-549afb0dbbd8","c56.9",-14184,"TCGA-25-2404_treatment","87318159-dd0c-52a3-be85-bf3c51c29f67","01",NA,"TCGA-25-2404-01A","1","7c1f016a-1728-4496-acbc-97aa89c5ee58",FALSE,"7B13E549-204D-47F8-93EB-D8C5C8D259FA","Primary Tumor","0.6",NA,NA,"2",1252368000,"01",114,"TCGA-25-2404-01A-01",85,70,NA,NA,1,1,14,28,"2016-09-08T13:45:02.816291-05:00","2016-09-08T13:45:02.816291-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,1,"08aa7e79-0ec6-475e-90bd-4ee3feaf12d1","cc560f7f-9491-4242-80ac-74f2ff537b1b","TCGA-25-2404-01A-01-BS1","TCGA-25-2404-01A-01-TS1",85,70,"3c1cbd1d-e75f-4894-bed9-420f65a14ea1","RNA","TCGA-25-2404-01A-01R","f2afdc8e-06b6-42fb-8884-675558bff89f",1.8,0.14,"UV Spec","R","22","TCGA-25-2404-01A-01R-1569-13","05ab6bb9-0cb1-47f1-8dd2-92a48239e82e",0.14,NA,NA,NA,NA,"5fa758f6-4532-50fb-9c8a-af89ec8f1c93","TCGA-25-2404_exposure","TCGA-25-2404-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T11:21:37.000Z","2014-08-08T12:28:20.000Z","2A005A38-304D-482C-B7F1-A52C0B64741D","7C1F016A-1728-4496-ACBC-97AA89C5EE58","Unaligned reads",13084405760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","05AB6BB9-0CB1-47F1-8DD2-92A48239E82E","Canada's Michael Smith Genome Sciences Centre","564a5c0be4b08c5d86955264","22178C3C-6B04-46D8-8041-DC83FA195029","Ovarian Serous Cystadenocarcinoma","TAR","3C1CBD1D-E75F-4894-BED9-420F65A14EA1","2014-08-08T12:28:20.000Z","F2AFDC8E-06B6-42FB-8884-675558BFF89F","None","NO",1,0.6,"Primary Tumor","Mayo Clinic - Rochester",NA,"3C1CBD1D-E75F-4894-BED9-420F65A14EA1",1,"25","TCGA-25-2404-01A-01R-1569-13_mirna.bam.bai",NA,"TCGA-25-2404-01A",2,"EE45824F-B834-4398-9099-E4D8084DDA45","TCGA",2005,NA,NA,"WITH TUMOR","7F743AD5-A545-43D3-A4F8-65BF8A013FA7",38,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2300785c-d77b-4d40-94e5-7947b18f9c24.txt","Dead",883,"TCGA-25-2404","NOT HISPANIC OR LATINO","8B0B1002-3ED9-4317-BA15-982DC5522748",NA,883,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,1,114,"CC560F7F-9491-4242-80AC-74F2FF537B1B","A414A799-A754-4518-A122-32828D57854C","TCGA-25-2404-01A-01R-1569-13_mirna.bam.bai","TCGA-25-2404-01A-01",70,1,NA,NA,28,"TOP",1,NA,"TCGA-25-2404-01A-01-TS1",70,"Taxol","Chemotherapy","TCGA-25-2404-D26834",NA,NA,NA,"TCGA-25-2404-F26831_NTE-1",NA,883,"WITH TUMOR","Dead",883,"TCGA-25-2404-F26831","TCGA-25-2404",NA,"25","2404","YES","C56.9","8441/3","C56.9",NA,NA,-14184,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","NOT HISPANIC OR LATINO",NA,"No","Dead",883,883,NA,NA,"WITH TUMOR","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,38,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
333519698,312627555,23142561163,"08191513-AD7F-4EED-8517-5AA2254F9D64.bw","23771dab-2aab-4d2b-95e2-9af7092cee6b","08191513-ad7f-4eed-8517-5aa2254f9d64","2016-08-24T11:25:42.504116-05:00","TCGA-09-0366-01A-01R-1564-13_rnaseq_fastq.tar","8e635117-1266-44ec-93e1-e61d52de581d",22428897280,"Illumina HiSeq","78c211ca20e5c141f97f04064f6f7dd8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:22:47.487806-05:00","2016-05-03T11:27:59.332723-05:00","8e635117-1266-44ec-93e1-e61d52de581d_analysis.xml","83dd6a62a0ccc7377cdad405ddaf9346","6af93350-00da-4ce4-9048-c0fa21d442ba",2183,"2016-09-29T20:24:45.912612-05:00","8e635117-1266-44ec-93e1-e61d52de581d_experiment.xml","33a1524e862e2d65ffcba483eefa367f","6c3a25aa-0f41-4b9e-b563-455287c5ee18",3916,"2016-09-29T22:44:44.166442-05:00","8e635117-1266-44ec-93e1-e61d52de581d_run.xml","2197ca05e80e0e96b44917579b037443","c2e7aaf4-09d5-4e67-bd1c-c82c55f96224",1990,"2016-09-08T13:31:04.803309-05:00","TCGA-09-0366","2016-09-02T19:09:36.837800-05:00","female","TCGA-09-0366_demographic",1944,"white","4168d972-f335-5e36-8145-ad9b8ef7441c","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c48.1","TCGA-09-0366_diagnosis","not reported",20440,"dead","8441/3",1757,NA,"8e24dabb-8325-5099-846c-4f4bf21d7515","c48.1",-20440,"TCGA-09-0366_treatment","5ada961d-9f41-50bd-a6c4-ec939f27eb85","01",NA,"TCGA-09-0366-01A",NA,"f2e6f90f-6117-406d-8106-2ef4b37e19d2",FALSE,"6C254448-2CF7-4283-9026-988273C712A1","Primary Tumor",NA,NA,NA,NA,1233705600,"01",NA,"TCGA-09-0366-01A-01",98,98,NA,NA,0,0,5,0,"2016-09-08T13:31:04.803309-05:00","2016-09-08T13:31:04.803309-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"1a24dcff-2bd0-430f-9b17-d2487425878d","8221da81-0e4d-48fd-a814-123e49fdb0b5","TCGA-09-0366-01A-01-BS1","TCGA-09-0366-01A-01-TS1",95,100,"8e2d86fd-25b6-475d-abd3-6a93b204c351","RNA","TCGA-09-0366-01A-01R","1cb92112-2d5a-4fac-9ea3-f5bd0a53ee4c",1.8,0.19,"UV Spec","R","22","TCGA-09-0366-01A-01R-1564-13","cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7",0.19,NA,NA,NA,NA,"3056ef37-85ad-5291-837f-d7355de65319","TCGA-09-0366_exposure","TCGA-09-0366-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-21T00:23:12.000Z","2013-12-21T01:01:02.000Z","8E635117-1266-44EC-93E1-E61D52DE581D","F2E6F90F-6117-406D-8106-2EF4B37E19D2","Unaligned reads",22428897280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CFB1A6E0-F2D8-48BD-9303-FE7BE5276AB7","Canada's Michael Smith Genome Sciences Centre","564a3892e4b093830b685b51","23771DAB-2AAB-4D2B-95E2-9AF7092CEE6B","Ovarian Serous Cystadenocarcinoma","TAR","8E2D86FD-25B6-475D-ABD3-6A93B204C351","2013-12-21T01:01:02.000Z","1CB92112-2D5A-4FAC-9EA3-F5BD0A53EE4C","None","NO",1,NA,"Primary Tumor","UCSF",NA,"8E2D86FD-25B6-475D-ABD3-6A93B204C351",NA,"09","TCGA-09-0366-01A-01R-1986-13_GRCh37-lite_mirna.bam",NA,"TCGA-09-0366-01A",NA,"B0230F3D-A6F8-4E55-A04E-D6D0D37C99E4","TCGA",1999,NA,NA,"WITH TUMOR","F2E6F90F-6117-406D-8106-2EF4B37E19D2",55,"TCGA-09-0366-01A-01W-0371-08_IlluminaGA-DNASeq_capture.bam.bai","Dead",1757,"TCGA-09-0366",NA,"06BA5B59-0675-4FDE-A4AA-237171DE4442",NA,NA,NA,"Ovary","C48.1",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C48.1",9,NA,NA,"WHITE",NA,1,NA,"8221DA81-0E4D-48FD-A814-123E49FDB0B5","CBD0B8D8-2961-4A69-A5CA-EF7E0118C0E9","TCGA-09-0366-01A-01R-1986-13_GRCh37-lite_mirna.bam","TCGA-09-0366-01A-01",98,0,NA,NA,0,"TOP",0,NA,"TCGA-09-0366-01A-01-TS1",100,"topotecan","Chemotherapy","TCGA-09-0366-D24210",NA,NA,NA,"TCGA-09-0366-F24207_NTE-2",NA,NA,"WITH TUMOR","Dead",1757,"TCGA-09-0366-F24207","TCGA-09-0366",NA,"09","0366","YES","C48.1","8441/3","C48.1",NA,NA,-20440,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1757,NA,NA,"WITH TUMOR","NO",4,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
240990284,208109192,15082764603,"E59FE80A-6DAA-4E44-BD9D-4C31A0A827AD.bw","23d32627-9fd2-4312-bcda-ee7409e3983f","e59fe80a-6daa-4e44-bd9d-4c31a0a827ad","2016-09-29T23:40:39.182702-05:00","TCGA-29-1784-01A-02R-1567-13_rnaseq_fastq.tar","e433c1b4-b609-4ec2-88f7-ceb5d6bdbe18",14551900160,"Illumina HiSeq","4aea89a0672ab4a8470b401817125de2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:55:45.849725-05:00","2016-05-03T11:41:05.740436-05:00","e433c1b4-b609-4ec2-88f7-ceb5d6bdbe18_analysis.xml","20f1cf1ce09c0b0f07074ab093d76eb5","0f477545-d6e9-460f-a854-7b1f42dbe616",2181,"2016-09-29T18:27:39.364762-05:00","e433c1b4-b609-4ec2-88f7-ceb5d6bdbe18_experiment.xml","6c372abf70d5b7a9ab03dfabf5a7212e","2332eedc-8285-4f96-a1c1-7e2c3534837b",3916,"2016-09-29T21:25:52.211499-05:00","e433c1b4-b609-4ec2-88f7-ceb5d6bdbe18_run.xml","e4e8072cb9d60e982132ddb241ca2351","9223c1ee-3568-4c70-8015-93662f122e23",1988,"2016-09-08T12:52:02.690933-05:00","TCGA-29-1784","2016-09-02T19:07:45.004439-05:00","female","TCGA-29-1784_demographic",1954,"white","331533e8-2b22-538a-bb92-3ba7f81c58a2","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1784_diagnosis","not reported",20210,"alive","8441/3",NA,163,"3e3aadeb-f781-5f50-86b3-d49f1aa93c4f","c56.9",-20210,"TCGA-29-1784_treatment","23d48b9a-e5f7-5aee-bb22-0a3c67d096a5","01",NA,"TCGA-29-1784-01A","1","90c52b7a-a0fb-4e5f-9c80-ee94516ab8d9",FALSE,"e4614e5d-eb1f-4ac7-a17f-105936745e80","Primary Tumor","0.4",NA,NA,"1.5",1243296000,"02",116,"TCGA-29-1784-01A-02",75,80,NA,NA,0,0,10,5,"2016-09-08T12:52:02.690933-05:00","2016-09-08T12:52:02.690933-05:00",20,15,NA,NA,"TOP","BOTTOM",0,0,"5eb21daa-2637-47ca-ada9-b987cd1621ee","b8defa82-cc0f-44ec-9032-9cd4030304a7","TCGA-29-1784-01A-01-BS1","TCGA-29-1784-01A-02-BS2",90,95,"5424263c-4ee7-4e09-b079-e5d5de5f427e","RNA","TCGA-29-1784-01A-02R","6553e196-3e0e-4ac1-962a-57a03238f376",1.9,0.17,"UV Spec","R","22","TCGA-29-1784-01A-02R-1567-13","c72e442b-36f5-4ea6-a893-505b5ccd8c4f",0.17,NA,NA,NA,NA,"24233ecc-1634-54fa-8dfe-128ea3baaf64","TCGA-29-1784_exposure","TCGA-29-1784-01A-02R-1567-13_rnaseq_fastq.tar","2014-03-27T02:49:52.000Z","2014-03-27T03:15:02.000Z","E433C1B4-B609-4EC2-88F7-CEB5D6BDBE18","90C52B7A-A0FB-4E5F-9C80-EE94516AB8D9","Unaligned reads",14551900160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C72E442B-36F5-4EA6-A893-505B5CCD8C4F","Canada's Michael Smith Genome Sciences Centre","564a5bbee4b093830b6d0c1e","23D32627-9FD2-4312-BCDA-EE7409E3983F","Ovarian Serous Cystadenocarcinoma","TAR","5424263C-4EE7-4E09-B079-E5D5DE5F427E","2014-03-27T03:15:02.000Z","6553E196-3E0E-4AC1-962A-57A03238F376","None","NO",1,0.4,"Primary Tumor","Duke",NA,"5424263C-4EE7-4E09-B079-E5D5DE5F427E",1,"29","TCGA-29-1784-01A-02R-1567-13_GRCh37-lite_mirna.bam.bai",NA,"TCGA-29-1784-01A",1.5,"F607CD30-CC09-4356-B447-BF0F45CBB16C","TCGA",2009,NA,NA,"TUMOR FREE","90C52B7A-A0FB-4E5F-9C80-EE94516AB8D9",55,"nationwidechildrens.org_clinical.TCGA-29-1784.xml","Alive",NA,"TCGA-29-1784",NA,"28926CC4-CEB1-40D1-B84D-C2E9BCB874E6",NA,163,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,2,116,"B8DEFA82-CC0F-44EC-9032-9CD4030304A7","6CDE243F-3625-4CFF-B89A-4793F89E4D98","TCGA-29-1784-01A-02R-1567-13_GRCh37-lite_mirna.bam.bai","TCGA-29-1784-01A-02",80,0,NA,15,5,"BOTTOM",0,NA,"TCGA-29-1784-01A-02-BS2",95,"Paclitaxel; Albumin-Bount","Chemotherapy","TCGA-29-1784-D27439",NA,NA,NA,NA,NA,163,"TUMOR FREE","Alive",NA,"TCGA-29-1784-F27436","TCGA-29-1784",NA,"29","1784","YES","C56.9","8441/3","C56.9",NA,NA,-20210,"FEMALE","WHITE",NA,NA,"No","Alive",163,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,55,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
183243642,178594304,13217820369,"B465060B-E6BE-452F-BC07-13EFE6C98ECA.bw","242943fe-1fa0-4a12-8f7e-9c6c4af1194d","b465060b-e6be-452f-bc07-13efe6c98eca","2016-08-22T04:44:32.407568-05:00","TCGA-61-2088-01A-01R-1568-13_rnaseq_fastq.tar","57567bc2-49cc-4879-9d7e-8ddef866bcea",11834101760,"Illumina HiSeq","0ff6a2c79f6ba90a09be8eeb0551c91e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:34:07.033310-05:00","2016-05-03T11:56:42.628809-05:00","57567bc2-49cc-4879-9d7e-8ddef866bcea_analysis.xml","d66da12eaf5ddccbc2e9b924864fb532","271e87a1-558d-4c0b-88cc-b4b3d4ebae9f",2181,"2016-08-25T22:39:59.909015-05:00","57567bc2-49cc-4879-9d7e-8ddef866bcea_experiment.xml","641ad72296cbd61cd68140eed67a51b6","477a6890-2817-4a0a-93c8-7ffa5e80e0af",3916,"2016-09-29T18:09:29.211598-05:00","57567bc2-49cc-4879-9d7e-8ddef866bcea_run.xml","8a50d5493357414e2d2ab8e62f0d7bbf","17f9d535-269e-49c8-860f-f21f2db6c6b3",1988,"2016-09-08T11:52:00.995028-05:00","TCGA-61-2088","2016-09-02T18:56:17.251442-05:00","female","TCGA-61-2088_demographic",1958,"white","f10f87ea-db88-50ac-8b62-e269aa16ba67","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2088_diagnosis","not reported",18770,"alive","8441/3",NA,145,"6e4a13d0-dffc-5780-9f24-ee952362f22d","c56.9",-18770,"TCGA-61-2088_treatment","ef2a5e93-9f0f-53c1-96d5-da124011ce36","01",NA,"TCGA-61-2088-01A","1","29d36fc7-e849-42aa-bcc8-2fd9f7c9e24e",FALSE,"62624308-45b6-46f3-85a0-5a4639b44bf3","Primary Tumor","0.4",NA,NA,"1.4",1249603200,"01",111,"TCGA-61-2088-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T11:52:00.995028-05:00","2016-09-08T11:52:00.995028-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"3e099147-d41d-42a2-b979-5847180209b4","aed842d4-ca7b-483e-85f5-2843f4dc7005","TCGA-61-2088-01A-01-BS1","TCGA-61-2088-01A-01-TS1",94,94,"0bf84d3a-befa-4285-a973-900c2a27befa","RNA","TCGA-61-2088-01A-01R","97ce9df4-911e-427d-a187-f7d5f5bd3cea",1.8,0.14,"UV Spec","R","22","TCGA-61-2088-01A-01R-1568-13","62fdea50-f152-4f43-9130-a93079b5e61f",0.14,NA,NA,NA,NA,"bf654f43-19d0-5282-b9e7-0ddad2b335fb","TCGA-61-2088_exposure","TCGA-61-2088-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T13:02:00.000Z","2014-08-26T14:33:08.000Z","57567BC2-49CC-4879-9D7E-8DDEF866BCEA","29D36FC7-E849-42AA-BCC8-2FD9F7C9E24E","Unaligned reads",11834101760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","62FDEA50-F152-4F43-9130-A93079B5E61F","Canada's Michael Smith Genome Sciences Centre","564a5a51e4b093830b6ca6b8","242943FE-1FA0-4A12-8F7E-9C6C4AF1194D","Ovarian Serous Cystadenocarcinoma","TAR","0BF84D3A-BEFA-4285-A973-900C2A27BEFA","2014-08-26T14:33:08.000Z","97CE9DF4-911E-427D-A187-F7D5F5BD3CEA","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"0BF84D3A-BEFA-4285-A973-900C2A27BEFA",1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2b716c21-1692-4b95-9363-0c6a23de28d6.txt",NA,"TCGA-61-2088-01A",1.4,"F85675B8-465D-493F-B708-2E8F9CA175A4","TCGA",2009,NA,NA,"TUMOR FREE","375A1BE8-2B04-424D-AEC1-64430283642A",51,"SOURS_p_TCGAb22_SNP_N_GenomeWideSNP_6_B05_529860.nocnv_hg19.seg.txt","Alive",NA,"TCGA-61-2088","NOT HISPANIC OR LATINO",NA,NA,145,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,111,"AED842D4-CA7B-483E-85F5-2843F4DC7005","D1F446BD-7492-423E-8B4D-28A7667390F8","TCGA-61-2088-01A-01R-1568-13_GRCh37-lite_rnaseq.bam.bai","TCGA-61-2088-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-61-2088-01A-01-TS1",94,"Taxotere","Chemotherapy","TCGA-61-2088-D28379",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2088",NA,"61","2088","YES","C56.9","8441/3","C56.9",NA,NA,-18770,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",145,NA,NA,NA,"TUMOR FREE","NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
256326312,248644221,18395189824,"57E380FC-B6AB-466F-9936-D52192888008.bw","242da7d0-8c6a-4395-9a0d-aa36e7c25ce6","57e380fc-b6ab-466f-9936-d52192888008","2016-08-25T05:58:51.999775-05:00","TCGA-29-1763-01A-02R-1567-13_rnaseq_fastq.tar","d6fee9cb-b873-46a5-ba91-8205038f9c71",16664760320,"Illumina HiSeq","7df6a9770a1844599eb32301fcf1bc13","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:18:08.426495-05:00","2016-05-03T11:41:05.748550-05:00","d6fee9cb-b873-46a5-ba91-8205038f9c71_analysis.xml","f769a6bbd31ce515df6a3f5bd45f9788","8d5c99ce-298e-464a-808a-258da7a3ab7d",2181,"2016-09-29T19:45:29.152125-05:00","d6fee9cb-b873-46a5-ba91-8205038f9c71_experiment.xml","02531d2f21a43f111a24472c27e87aba","541da6bb-9c37-4ad1-9582-e88e1e439214",3916,"2016-09-29T18:28:06.033634-05:00","d6fee9cb-b873-46a5-ba91-8205038f9c71_run.xml","db01198a9892b327d5232dbcb8c3cc1c","237962ae-3d42-4fcb-af17-d5f7d9422d9e",1989,"2016-09-08T12:42:24.983103-05:00","TCGA-29-1763","2016-09-02T19:07:41.339758-05:00","female","TCGA-29-1763_demographic",1961,"black or african american","8ae2cac3-bc30-5b1f-969f-cad425be9356","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1763_diagnosis","not reported",16021,"alive","8441/3",NA,2032,"d1f6b014-7b53-518b-a401-c80c673bf79b","c56.9",-16021,"TCGA-29-1763_treatment","b9499b9f-eef9-51af-92a5-55e855112876","01",NA,"TCGA-29-1763-01A","0.7","3231d01a-e80c-46a1-8c9c-3492dca9f250",FALSE,"f90e0db8-f656-411c-be72-8e0774d2336b","Primary Tumor","0.5",NA,NA,"1.3",1243296000,"02",113,"TCGA-29-1763-01A-02",70,75,NA,NA,0,0,0,0,"2016-09-08T12:42:24.983103-05:00","2016-09-08T12:42:24.983103-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"0e52583c-5792-4c59-ac2f-8eb42cc26eba","13339452-2898-48c6-ba63-b39f8fd87e0c","TCGA-29-1763-01A-01-BS1","TCGA-29-1763-01A-02-BS2",95,95,"3b0666f8-b8f9-4289-807d-3baf21029f5f","RNA","TCGA-29-1763-01A-02R","9c396963-dd07-46b4-989d-d42229078351",1.8,0.16,"UV Spec","R","22","TCGA-29-1763-01A-02R-1567-13","af63aa43-ab5f-44c5-85cf-01d84be261a3",0.16,NA,NA,NA,NA,"733e4828-47ed-56c0-bdbd-02eec56e056d","TCGA-29-1763_exposure","TCGA-29-1763-01A-02R-1567-13_rnaseq_fastq.tar","2014-03-29T03:26:17.000Z","2014-03-29T04:06:01.000Z","D6FEE9CB-B873-46A5-BA91-8205038F9C71","3231D01A-E80C-46A1-8C9C-3492DCA9F250","Unaligned reads",16664760320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AF63AA43-AB5F-44C5-85CF-01D84BE261A3","Canada's Michael Smith Genome Sciences Centre","564a56ace4b08c5d8693ac8f","242DA7D0-8C6A-4395-9A0D-AA36E7C25CE6","Ovarian Serous Cystadenocarcinoma","TAR","3B0666F8-B8F9-4289-807D-3BAF21029F5F","2014-03-29T04:06:01.000Z","9C396963-DD07-46B4-989D-D42229078351","None","NO",1,0.5,"Primary Tumor","Duke",NA,"3B0666F8-B8F9-4289-807D-3BAF21029F5F",0.7,"29","TCGA-29-1763-01A-02T-0567-07.probe.tcga_level2.data.txt",NA,"TCGA-29-1763-01A",1.3,"413C6676-1D15-45D6-9312-3EF011666F04","TCGA",2004,NA,NA,"WITH TUMOR","C6FD0A2F-C0D8-4C2F-8A34-EF6384BFBC28",43,"nationwidechildrens.org_clinical.TCGA-29-1763.xml","Alive",NA,"TCGA-29-1763",NA,"5AB2D1A0-ED91-44B1-97EC-51A9F633CBEA",NA,2032,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,"4299F8FB-8407-4EC5-8AAE-7A93350B199D","BLACK OR AFRICAN AMERICAN",NA,2,113,"13339452-2898-48C6-BA63-B39F8FD87E0C","F8FCBBEE-7AB8-4F5F-A2AA-4939BCB62919","TCGA-29-1763-01A-02T-0567-07.probe.tcga_level2.data.txt","TCGA-29-1763-01A-02",75,0,NA,NA,0,"BOTTOM",5,NA,"TCGA-29-1763-01A-02-BS2",95,"Carboplatin","Chemotherapy","TCGA-29-1763-D27328","TCGA-29-1763-R27336","EXTERNAL BEAM","Local Recurrence","TCGA-29-1763-F27325_NTE-2",NA,2032,"WITH TUMOR","Alive",NA,"TCGA-29-1763-F27325","TCGA-29-1763",NA,"29","1763","YES","C56.9","8441/3","C56.9",NA,NA,-16021,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Alive",2032,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,43,2004,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
198812178,194248381,14393408258,"1C59764F-80C5-4BAB-A02F-F5D8A6491551.bw","2517ca7a-6057-4c19-b7e1-f6d078e9881a","1c59764f-80c5-4bab-a02f-f5d8a6491551","2016-08-25T05:15:18.260646-05:00","TCGA-24-2026-01A-01R-1567-13_rnaseq_fastq.tar","6c989c69-a3b7-44af-8fa4-74da9338ad13",12621670400,"Illumina HiSeq","1086e2ee6bf124156111d78b99d02871","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:18:01.069372-05:00","2016-05-03T11:41:05.755204-05:00","6c989c69-a3b7-44af-8fa4-74da9338ad13_analysis.xml","c1bc0082762778968f8b51be4d3f42d5","d771a53d-e36d-404b-952e-cd590db33d4c",2183,"2016-09-29T17:44:40.275858-05:00","6c989c69-a3b7-44af-8fa4-74da9338ad13_experiment.xml","48db3240578bf616debd44870c2859f3","084b25c9-abce-469a-ab98-5fa06340df1c",3916,"2016-09-29T22:36:04.644647-05:00","6c989c69-a3b7-44af-8fa4-74da9338ad13_run.xml","78be5af9af509868d072f44c1f7fb3b6","bd7e556a-38ca-4c92-8a3c-4c45fb62ec2d",1990,"2016-09-09T16:35:06.295674-05:00","TCGA-24-2026","2016-09-02T18:50:14.754643-05:00","female","TCGA-24-2026_demographic",1916,"white","108043f3-cc98-5a3e-9410-f2aea4bf95ec","not reported",1997,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2026_diagnosis","not reported",29050,"dead","8441/3",1059,1059,"d2d82e4b-87db-5610-a968-930933e83fb7","c56.9",-29050,"TCGA-24-2026_treatment","68f6ac27-3f36-54a2-b22a-4c15522f35dc","01",NA,"TCGA-24-2026-01A","1","fe8b3cb8-15ce-4d0c-b168-d8d3db4be176",FALSE,"7fc3cf2f-b132-4dce-b16a-2b4a1162da14","Primary Tumor","1",NA,NA,"1",1248134400,"01",122,"TCGA-24-2026-01A-01",80,90,0,2,0,0,15,10,"2016-09-09T16:35:06.295674-05:00","2016-09-09T16:35:06.295674-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"9da284eb-d410-4006-9a8a-503b1e731363","b2af0e7d-797b-40c0-bd33-71426c55f66f","TCGA-24-2026-01A-01-TS1","TCGA-24-2026-01A-01-BS1",85,90,"d7187c85-3cc8-4859-a53a-e17e46a0e377","RNA","TCGA-24-2026-01A-01R","fae45d31-ca46-4b87-85b3-48e2e1f56fc5",1.8,0.15,"UV Spec","R","22","TCGA-24-2026-01A-01R-1567-13","ce0fd762-e18f-4cca-a4c4-c064dca62e60",0.15,NA,NA,NA,NA,"0257df96-5378-534c-9e7a-71d345cbdba4","TCGA-24-2026_exposure","TCGA-24-2026-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T06:52:31.000Z","2014-03-27T07:15:02.000Z","6C989C69-A3B7-44AF-8FA4-74DA9338AD13","FE8B3CB8-15CE-4D0C-B168-D8D3DB4BE176","Unaligned reads",12621670400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CE0FD762-E18F-4CCA-A4C4-C064DCA62E60","Canada's Michael Smith Genome Sciences Centre","564a3491e4b08c5d868f53e7","2517CA7A-6057-4C19-B7E1-F6D078E9881A","Ovarian Serous Cystadenocarcinoma","TAR","D7187C85-3CC8-4859-A53A-E17E46A0E377","2014-03-27T07:15:02.000Z","FAE45D31-CA46-4B87-85B3-48E2E1F56FC5","None","NO",1,1,"Primary Tumor","Washington University",NA,"D7187C85-3CC8-4859-A53A-E17E46A0E377",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f68086f7-8d41-4631-9346-849088f1f577.txt",NA,"TCGA-24-2026-01A",1,"F88EE7B6-F4E7-481C-9EF4-5FD54DF656E6","TCGA",1995,NA,NA,NA,"FE8B3CB8-15CE-4D0C-B168-D8D3DB4BE176",79,"TCGA-24-2026-01A-01R-1567-13_mirna.bam.bai","Dead",1059,"TCGA-24-2026",NA,"69CED7F3-1E11-4515-89E8-2E5E148F5271",NA,1059,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,122,"B2AF0E7D-797B-40C0-BD33-71426C55F66F","FAE45D31-CA46-4B87-85B3-48E2E1F56FC5","TCGA-24-2026-01A-01R-1567-13_rnaseq.bam","TCGA-24-2026-01A-01",80,0,0,0,15,"TOP",0,0,"TCGA-24-2026-01A-01-TS1",85,"Taxol","Chemotherapy","TCGA-24-2026-D26457",NA,NA,NA,NA,NA,1059,NA,"Dead",1059,"TCGA-24-2026-F26456","TCGA-24-2026",NA,"24","2026","YES","C56.9","8441/3","C56.9",NA,NA,-29050,"FEMALE","WHITE",NA,NA,"No","Dead",1059,1059,NA,NA,NA,"NO",15,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,79,1995,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
286834602,258241742,18903798129,"8556501D-640A-4681-B5FB-716DEC14F7BE.bw","260723bf-9620-450d-bf31-f3a45543f9db","8556501d-640a-4681-b5fb-716dec14f7be","2016-08-04T19:52:37.728486-05:00","TCGA-OY-A56P-01A-12R-A406-31_rnaseq_fastq.tar","0d13688b-c61d-43d9-94ef-12b82dd7ef24",17459865600,"Illumina HiSeq","25ee9c5b9174324b17d0409d3bce1d1f","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T19:48:47.691799-05:00","2016-06-22T11:19:32.361656-05:00","0d13688b-c61d-43d9-94ef-12b82dd7ef24_analysis.xml","9a4a80d0b6b04f586593d0536cdb16fe","56317ba5-1d43-4471-b455-473bdd8db862",2183,"2016-09-30T00:15:51.637240-05:00","0d13688b-c61d-43d9-94ef-12b82dd7ef24_experiment.xml","c4ba23027b58991c6d314bb5a99f1e34","fb656c53-b655-4748-989f-1522ebc6519a",3753,"2016-09-29T20:03:13.035157-05:00","0d13688b-c61d-43d9-94ef-12b82dd7ef24_run.xml","91b9d3e10d0a854f439b1ed2bb932c89","5f106090-703a-40ac-9edf-d2333734ce32",1808,"2016-09-08T11:23:55.145896-05:00","TCGA-OY-A56P","2016-09-02T19:00:51.286617-05:00","female","TCGA-OY-A56P_demographic",1962,"black or african american","24bd713d-fde2-55f4-b722-af81e504bde1","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","NCH","OY","722c892a-5131-509d-bfd1-17a1660e9054","University of North Carolina","not reported","c56.9","TCGA-OY-A56P_diagnosis","not reported",17580,"alive","8460/3",NA,1207,"82ad7dba-92ee-55f3-ba07-577d050bf995","c56.9",-17580,"TCGA-OY-A56P_treatment","d0deb2cc-8645-514b-87f1-025000fd7526","01","false","TCGA-OY-A56P-01A",NA,"38875e85-5516-4775-a4b1-9b2b7ef4d732",FALSE,"D916ED58-54D5-43FC-A5B0-6E4844A7F677","Primary Tumor",NA,796,390,NA,1355184000,"12",30,"TCGA-OY-A56P-01A-12",80,NA,1,NA,0,NA,0,NA,"2016-09-08T11:23:55.145896-05:00",NA,2,NA,0,NA,"TOP",NA,5,NA,"8a88da85-d084-483a-9552-ceba164f1783",NA,"TCGA-OY-A56P-01A-01-TS1",NA,95,NA,"44a2a871-be15-4575-9a81-fa522b53381d","RNA","TCGA-OY-A56P-01A-12R","8320c15c-29ce-418b-87c2-406b6031e081",1.8,0.16,"UV Spec","R","23","TCGA-OY-A56P-01A-12R-A406-31","05689fed-96dd-4c52-b51d-5dc799422b9a",0.16,NA,NA,NA,NA,"acf74214-8fd9-5d96-8f8d-50cc247b3223","TCGA-OY-A56P_exposure","TCGA-OY-A56P-01A-12R-A406-31_rnaseq_fastq.tar","2015-02-06T23:22:29.000Z","2015-02-07T01:27:02.000Z","0D13688B-C61D-43D9-94EF-12B82DD7EF24","38875E85-5516-4775-A4B1-9B2B7EF4D732","Unaligned reads",17459865600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","05689FED-96DD-4C52-B51D-5DC799422B9A","Canada's Michael Smith Genome Sciences Centre","564a3579e4b0298dd2c68023","260723BF-9620-450D-BF31-F3A45543F9DB","Ovarian Serous Cystadenocarcinoma","TAR","44A2A871-BE15-4575-9A81-FA522B53381D","2015-02-07T01:27:02.000Z","8320C15C-29CE-418B-87C2-406B6031E081","United States","NO",1,NA,"Primary Tumor","University of North Carolina",796,"44A2A871-BE15-4575-9A81-FA522B53381D",NA,"OY","dd99c3d5b92204f1e79d62849b42fc14.bam",390,"TCGA-OY-A56P-01A",NA,"4C69AC4B-5520-421E-ADEF-0F12EB0C0911","TCGA",2010,"TCGA-OY-A56P_NTE-2","Complete Remission/Response","WITH TUMOR","69D42FAF-A8F7-4A46-A9A1-5488028454F1",48,"nationwidechildrens.org_clinical.TCGA-OY-A56P.xml","Alive",NA,"TCGA-OY-A56P","NOT HISPANIC OR LATINO","81CEF205-14CE-42CB-8DF5-E36D77C2B390","YES",802,"No","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8460/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,30,"8A88DA85-D084-483A-9552-CEBA164F1783","EB90867A-C85D-4F16-BDA1-ACFEC8A8F949","dd99c3d5b92204f1e79d62849b42fc14.bam","TCGA-OY-A56P-01A-12",80,0,1,2,0,"TOP",5,0,"TCGA-OY-A56P-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-OY-A56P-D40752",NA,NA,NA,NA,NA,1207,"WITH TUMOR","Alive",NA,"TCGA-OY-A56P-F56664","TCGA-OY-A56P",NA,"OY","A56P","YES","C56.9","8460/3","C56.9","YES","NO",-17580,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",802,NA,"NO","YES","WITH TUMOR","YES",4,3,2013,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,48,2010,"Tumor resection",NA,NA,NA,"G3","R2",NA,NA,NA,NA,"Complete Remission/Response",NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
135983964,122252928,9017075663,"EF4AAB43-77FB-4BDB-8A55-6F86E3907043.bw","263e85e2-7b6f-453f-8fd0-e5ea1409fece","ef4aab43-77fb-4bdb-8a55-6f86e3907043","2016-09-29T23:56:08.022744-05:00","TCGA-25-1630-01A-01R-1566-13_rnaseq_fastq.tar","a4c0e6ba-dbb8-4f8c-8faf-f5e0a945f803",8537497600,"Illumina HiSeq","6409984a84fbd7f9bd5cec038366794a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:43:11.129298-05:00","2016-05-03T11:40:21.662944-05:00","a4c0e6ba-dbb8-4f8c-8faf-f5e0a945f803_analysis.xml","df361fca8c11fc1bc0b047dfc5457f72","52ade1bf-cd8f-4d83-bfe1-6d426f4c5764",2181,"2016-09-29T18:22:40.309548-05:00","a4c0e6ba-dbb8-4f8c-8faf-f5e0a945f803_experiment.xml","9e2f6dd4daa133e41adf64627e268ec4","2002cb2c-16ff-49af-a433-b9e882eaf349",3916,"2016-09-30T00:04:42.050985-05:00","a4c0e6ba-dbb8-4f8c-8faf-f5e0a945f803_run.xml","e7650aba9d4e0ec37ecdaf352085fd6d","f4741c31-ce9f-4235-a18e-e1965d6f5aa6",1988,"2016-09-08T11:16:33.988280-05:00","TCGA-25-1630","2016-09-02T18:47:34.244626-05:00","female","TCGA-25-1630_demographic",1929,"white","8731f7e7-074d-5810-ae94-e09b25cf790d","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1630_diagnosis","not reported",27006,"dead","8441/3",1162,239,"3c66f500-b2a5-5482-af5d-a85b32db3b8f","c56.9",-27006,"TCGA-25-1630_treatment","79b18290-a7b8-5b0c-9922-a85b4d5adcc6","01",NA,"TCGA-25-1630-01A","1","899b4fa3-95cb-4f8e-930c-bc29e20b5144",FALSE,"0BF406EC-B97B-4A05-9EBB-F40CF96233E9","Primary Tumor","0.4",NA,NA,"1.4",1237420800,"01",100,"TCGA-25-1630-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T11:16:33.988280-05:00","2016-09-08T11:16:33.988280-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,1,"72d16d97-78e9-46a9-bdfd-db8d5b99041a","cd9becbf-211f-473b-9a38-ff0fecc7ea57","TCGA-25-1630-01A-01-BS1","TCGA-25-1630-01A-01-TS1",85,89,"f980ca5c-af74-44e3-830f-d9dfb88833ed","RNA","TCGA-25-1630-01A-01R","e4e26fa1-321d-40e0-b48c-5f69c7f72adb",1.8,0.16,"UV Spec","R","22","TCGA-25-1630-01A-01R-1566-13","c5a82b6e-048d-4377-9b6c-4417ba1876fe",0.16,NA,NA,NA,NA,"224ce489-f5a5-520c-a738-cfc0ec7d640e","TCGA-25-1630_exposure","TCGA-25-1630-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T03:40:00.000Z","2014-03-25T03:55:02.000Z","A4C0E6BA-DBB8-4F8C-8FAF-F5E0A945F803","899B4FA3-95CB-4F8E-930C-BC29E20B5144","Unaligned reads",8537497600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C5A82B6E-048D-4377-9B6C-4417BA1876FE","Canada's Michael Smith Genome Sciences Centre","564a3721e4b0298dd2c70849","263E85E2-7B6F-453F-8FD0-E5EA1409FECE","Ovarian Serous Cystadenocarcinoma","TAR","F980CA5C-AF74-44E3-830F-D9DFB88833ED","2014-03-25T03:55:02.000Z","E4E26FA1-321D-40E0-B48C-5F69C7F72ADB","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"F980CA5C-AF74-44E3-830F-D9DFB88833ED",1,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c0b3ff41-c34a-4f86-b029-5a761ff85b2e.txt",NA,"TCGA-25-1630-01A",1.4,"9C32D4F7-8CC1-4B59-B283-5DDC42545296","TCGA",2002,NA,NA,NA,"899B4FA3-95CB-4F8E-930C-BC29E20B5144",73,"nationwidechildrens.org_clinical.TCGA-25-1630.xml","Dead",1162,"TCGA-25-1630","NOT HISPANIC OR LATINO","BE6E817C-E570-43DA-88B6-2A0D1B07D6B6",NA,239,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,100,"CD9BECBF-211F-473B-9A38-FF0FECC7EA57","E4E26FA1-321D-40E0-B48C-5F69C7F72ADB","TCGA-25-1630-01A-01R-1566-13_mirna.bam.bai","TCGA-25-1630-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-25-1630-01A-01-TS1",89,"Taxol","Chemotherapy","TCGA-25-1630-D26731",NA,NA,NA,NA,NA,239,NA,"Dead",1162,"TCGA-25-1630-F26729","TCGA-25-1630",NA,"25","1630","YES","C56.9","8441/3","C56.9",NA,NA,-27006,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",239,1162,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
219815414,209517990,15481246344,"1D4F0B66-720D-484D-B8D5-2B290ED208A8.bw","26558703-a659-43f2-86cb-0695989bc14e","1d4f0b66-720d-484d-b8d5-2b290ed208a8","2016-08-25T05:38:48.764831-05:00","TCGA-24-1924-01A-01R-1567-13_rnaseq_fastq.tar","349b33f9-c894-4f9b-9e45-b5f44823b74b",14215168000,"Illumina HiSeq","0d1d8cf2ecf57892164febae4f2d7ce9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:48:52.409927-05:00","2016-05-03T11:41:05.740763-05:00","349b33f9-c894-4f9b-9e45-b5f44823b74b_analysis.xml","ff4d257346703666de3bb362c8f99be8","30a6a0ee-8b76-47c6-b068-623897b10e97",2181,"2016-08-28T10:57:32.519901-05:00","349b33f9-c894-4f9b-9e45-b5f44823b74b_experiment.xml","a9923cdc3b3e104a9f2f03b729d2f56c","dba64c07-0862-4318-88cd-54893eccf88b",3916,"2016-09-29T19:53:53.930373-05:00","349b33f9-c894-4f9b-9e45-b5f44823b74b_run.xml","06cd58c55af027e355c9dbc9209c8db0","5966f96c-9984-43c2-a441-dffdd2d1000a",1988,"2016-09-08T10:43:18.604571-05:00","TCGA-24-1924","2016-09-02T18:50:17.598726-05:00","female","TCGA-24-1924_demographic",1936,"white","ebc2ba2c-fc56-5869-b71c-e4f8b4479474","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1924_diagnosis","not reported",23801,"dead","8441/3",919,919,"2d0eccd4-29ce-5014-9267-b0c39ebbf933","c56.9",-23801,"TCGA-24-1924_treatment","ba91a268-44c4-5348-b906-56556ec299ff","01",NA,"TCGA-24-1924-01A","0.5","525471c8-0249-45ed-a443-db52ca6c04d9",FALSE,"4199b57a-81f5-4d5f-9f4c-1e514dcd26dc","Primary Tumor","0.5",NA,NA,"1",1246147200,"01",148,"TCGA-24-1924-01A-01",70,70,0,0,0,0,20,10,"2016-09-08T10:43:18.604571-05:00","2016-09-08T10:43:18.604571-05:00",0,0,5,10,"BOTTOM","TOP",10,20,"624ef7e2-100f-40c8-b153-82b50e3f35ba","fba40711-32d3-4959-96d3-fcbe4bf6021f","TCGA-24-1924-01A-01-BS1","TCGA-24-1924-01A-01-TS1",70,70,"97a146da-4cce-4d06-9fb0-637c29d7c8f3","RNA","TCGA-24-1924-01A-01R","01fc7dde-58e3-466e-bd10-cdd6e4c4f862",1.8,0.13,"UV Spec","R","22","TCGA-24-1924-01A-01R-1567-13","2592f314-cc0a-4d00-bdcf-6376afd32bb7",0.13,NA,NA,NA,NA,"70d7cd5a-be5f-54b3-a03b-de2573647eee","TCGA-24-1924_exposure","TCGA-24-1924-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T21:01:38.000Z","2014-03-26T21:27:01.000Z","349B33F9-C894-4F9B-9E45-B5F44823B74B","525471C8-0249-45ED-A443-DB52CA6C04D9","Unaligned reads",14215168000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2592F314-CC0A-4D00-BDCF-6376AFD32BB7","Canada's Michael Smith Genome Sciences Centre","564a40c4e4b093830b6aff0d","26558703-A659-43F2-86CB-0695989BC14E","Ovarian Serous Cystadenocarcinoma","TAR","97A146DA-4CCE-4D06-9FB0-637C29D7C8F3","2014-03-26T21:27:01.000Z","01FC7DDE-58E3-466E-BD10-CDD6E4C4F862","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"97A146DA-4CCE-4D06-9FB0-637C29D7C8F3",0.5,"24","TCGA-24-1924-01A-01R-1567-13.hg19.spljxn.quantification.txt",NA,"TCGA-24-1924-01A",1,"E36C9E00-FC2F-4C5E-B431-98EBA3C2118A","TCGA",2001,NA,NA,"WITH TUMOR","72AB9374-8581-403E-8AA2-2E623C99F1AB",65,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d4067ae4-665b-4539-938c-e86a08523d3f.txt","Dead",919,"TCGA-24-1924",NA,"21CCCC06-A7A4-4BDC-A840-CD5F49CE523A",NA,919,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,148,"FBA40711-32D3-4959-96D3-FCBE4BF6021F","36DCD672-44EC-4E0F-9D74-C6655054B074","LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_E01_518064.CEL","TCGA-24-1924-01A-01",70,0,0,0,20,"BOTTOM",10,5,"TCGA-24-1924-01A-01-BS1",70,"Taxol","Chemotherapy","TCGA-24-1924-D26388",NA,NA,NA,"TCGA-24-1924-F26386_NTE-1",NA,919,"WITH TUMOR","Dead",919,"TCGA-24-1924-F26386","TCGA-24-1924",NA,"24","1924","YES","C56.9","8441/3","C56.9",NA,NA,-23801,"FEMALE","WHITE",NA,NA,"No","Dead",919,919,NA,NA,"WITH TUMOR","NO",26,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
187627120,160200525,11548890104,"C886CA33-5080-4E3E-88A2-F9A3CF03A857.bw","27920e1e-b9ab-4587-970a-0cba7025becb","c886ca33-5080-4e3e-88a2-f9a3cf03a857","2016-08-22T14:05:08.309806-05:00","TCGA-13-0901-01B-01R-1565-13_rnaseq_fastq.tar","5db7bca7-dda0-42a2-a1b4-2821496f9c74",11198945280,"Illumina HiSeq","caf78bea61639b50b49b7b0ebb5a0559","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:53:24.910460-05:00","2016-05-03T11:40:21.647690-05:00","5db7bca7-dda0-42a2-a1b4-2821496f9c74_analysis.xml","d33ac1f9fee6f2e0d808f028eff5c8be","7dddcdc8-5383-401b-b3d5-a1bf48065f91",2208,"2016-09-29T23:25:04.533484-05:00","5db7bca7-dda0-42a2-a1b4-2821496f9c74_experiment.xml","2d44d280aa7b5a5d7f60c2e2a2921b83","dbdc7bd2-ea58-4778-8bda-356767b36feb",3916,"2016-09-30T00:07:22.796027-05:00","5db7bca7-dda0-42a2-a1b4-2821496f9c74_run.xml","f640b548f71804f199eec54766e490ae","f610fba5-21fb-4495-9758-1a831f9d393b",1989,"2016-09-08T13:44:49.555683-05:00","TCGA-13-0901","2016-09-02T19:12:04.912694-05:00","female","TCGA-13-0901_demographic",1963,"asian","039bb7cc-4731-57bd-bbe7-dfce13b11b2e","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0901_diagnosis","not reported",15333,"alive","8441/3",NA,589,"8285c0fe-f59c-574b-87d7-0bb866d8ac59","c56.9",-15333,"TCGA-13-0901_treatment","469999a3-4b66-5c0e-a9df-78a39a510a99","01",NA,"TCGA-13-0901-01B","1.3","04cc5fca-1b0e-408b-bc12-b0987c561d53",FALSE,"5613318C-D3D4-436D-B22F-BE8FC36D9686","Primary Tumor","0.4",NA,NA,"1.3",1230508800,"01",123,"TCGA-13-0901-01B-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:44:49.555683-05:00","2016-09-08T13:44:49.555683-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"68cbcd84-0e37-48aa-8e6f-c48b43b93e7b","a01b26f4-7a4c-4529-a400-e6ad62f1a956","TCGA-13-0901-01B-01-TS1","TCGA-13-0901-01B-01-BS1",89,89,"337b223d-c8a9-4c4c-88d7-100483cfad24","RNA","TCGA-13-0901-01B-01R","796c50fd-c41c-478f-8916-140b5a45867e",1.8,0.16,"UV Spec","R","22","TCGA-13-0901-01B-01R-1565-13","4320fb38-5508-4ba7-87f1-43c4dc70854c",0.16,NA,NA,NA,NA,"305002b0-0755-5587-a2f4-61fe18ddc86d","TCGA-13-0901_exposure","TCGA-13-0901-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:51:49.000Z","2014-03-22T02:16:02.000Z","5DB7BCA7-DDA0-42A2-A1B4-2821496F9C74","04CC5FCA-1B0E-408B-BC12-B0987C561D53","Unaligned reads",11198945280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4320FB38-5508-4BA7-87F1-43C4DC70854C","Canada's Michael Smith Genome Sciences Centre","564a3bc4e4b0ef12181a8e1d","27920E1E-B9AB-4587-970A-0CBA7025BECB","Ovarian Serous Cystadenocarcinoma","TAR","337B223D-C8A9-4C4C-88D7-100483CFAD24","2014-03-22T02:16:02.000Z","796C50FD-C41C-478F-8916-140B5A45867E","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"337B223D-C8A9-4C4C-88D7-100483CFAD24",1.3,"13","TCGA-13-0901-01B-01R-1565-13_mirna.bam.bai",NA,"TCGA-13-0901-01B",1.3,"EFB4D63B-68D6-452F-9457-FB4FE0C251DF","TCGA",2004,NA,NA,"WITH TUMOR","9AAC8B4A-6807-4FBC-8698-FAA4CE02CBAA",41,"TCGA-13-0901-10A-01W-0490-10_SOLiD.bam","Alive",NA,"TCGA-13-0901","NOT HISPANIC OR LATINO","98EC4905-62A5-4FB5-9DA0-A73E7E2B4368",NA,589,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"ASIAN",NA,1,123,"A01B26F4-7A4C-4529-A400-E6AD62F1A956","C8551797-C16F-490C-8379-60DFF43DAE41","TCGA-13-0901-01B-01R-1565-13_mirna.bam.bai","TCGA-13-0901-01B-01",90,0,NA,NA,10,"BOTTOM",1,NA,"TCGA-13-0901-01B-01-BS1",89,"Cisplatin","Chemotherapy","TCGA-13-0901-D24713",NA,NA,NA,"TCGA-13-0901-F24712_NTE-1",NA,589,"WITH TUMOR","Alive",NA,"TCGA-13-0901-F24712","TCGA-13-0901",NA,"13","0901","YES","C56.9","8441/3","C56.9",NA,NA,-15333,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",589,NA,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,41,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
137023166,134102880,9902853406,"9AC963E4-F82D-460E-9CAD-C651B879780A.bw","28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf","9ac963e4-f82d-460e-9cad-c651b879780a","2016-08-25T18:24:24.887551-05:00","TCGA-24-2288-01A-01R-1568-13_rnaseq_fastq.tar","c980eb32-a948-4490-a23b-72eb5f5f19e9",8065433600,"Illumina HiSeq","0a13f5438d5172bc1b52402cac07be0b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:06:50.634921-05:00","2016-05-03T11:56:42.628342-05:00","c980eb32-a948-4490-a23b-72eb5f5f19e9_analysis.xml","1da9d57226cfaf2a4df7596b07ebafbd","ab8813c3-13aa-4d22-b2fa-b3827ef85cbf",2181,"2016-09-29T23:58:38.640079-05:00","c980eb32-a948-4490-a23b-72eb5f5f19e9_experiment.xml","97203e0ed0243dab836b3aa378eabbf1","f0d5846e-ed0c-4f82-aa2c-56dbf4a0c4c0",3916,"2016-09-29T17:37:44.421408-05:00","c980eb32-a948-4490-a23b-72eb5f5f19e9_run.xml","a66251acbf33803e64d6fdc396732925","03bbf854-f326-419a-89b9-716336afacd5",1988,"2016-09-08T13:39:36.301221-05:00","TCGA-24-2288","2016-09-02T19:11:48.591603-05:00","female","TCGA-24-2288_demographic",1929,"white","04990ab9-c2a6-52e5-be59-8e9024d7e18c","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2288_diagnosis","not reported",25831,"dead","8441/3",25,25,"54c4860f-11d8-5cff-be3e-d4405cc30f73","c56.9",-25831,"TCGA-24-2288_treatment","a514274f-a2ac-5f8f-9a8b-c8b32dec1aee","01",NA,"TCGA-24-2288-01A","0.6","8f515078-38de-44c1-81ce-e40d8a942fc7",FALSE,"a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45","Primary Tumor","0.5",NA,NA,"1.2",1251676800,"01",148,"TCGA-24-2288-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:39:36.301221-05:00","2016-09-08T13:39:36.301221-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"a45d4cd8-d5c7-4d1c-9911-335e306097da","553695fa-d194-441a-a0b8-05528b9ccb12","TCGA-24-2288-01A-01-BS1","TCGA-24-2288-01A-01-TS1",85,85,"bc83e978-7b52-4c8a-be6f-b231eac6fce3","RNA","TCGA-24-2288-01A-01R","32d0d144-c528-484f-9e3c-9a800f943238",1.8,0.16,"UV Spec","R","22","TCGA-24-2288-01A-01R-1568-13","dbc2cfac-df65-4750-af39-37760bad1057",0.16,NA,NA,NA,NA,"4e89d0a6-a4eb-5dab-aa61-76e633d86256","TCGA-24-2288_exposure","TCGA-24-2288-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T23:07:00.000Z","2014-08-28T00:15:10.000Z","C980EB32-A948-4490-A23B-72EB5F5F19E9","8F515078-38DE-44C1-81CE-E40D8A942FC7","Unaligned reads",8065433600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DBC2CFAC-DF65-4750-AF39-37760BAD1057","Canada's Michael Smith Genome Sciences Centre","564a346de4b0ef12181834ce","28ED2D42-5B4C-4BCA-B2B2-6B2A6D3C42CF","Ovarian Serous Cystadenocarcinoma","TAR","BC83E978-7B52-4C8A-BE6F-B231EAC6FCE3","2014-08-28T00:15:10.000Z","32D0D144-C528-484F-9E3C-9A800F943238","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"BC83E978-7B52-4C8A-BE6F-B231EAC6FCE3",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7c143023-df5b-42cb-958b-962d6f607e92.txt",NA,"TCGA-24-2288-01A",1.2,"F9E65BB5-D987-4920-BA32-65526FA41A72","TCGA",1999,NA,NA,"WITH TUMOR","8F515078-38DE-44C1-81CE-E40D8A942FC7",70,"nationwidechildrens.org_clinical.TCGA-24-2288.xml","Dead",25,"TCGA-24-2288",NA,"B0B53CFC-C2F6-45CC-BD58-F3412C058EA3",NA,25,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,148,"A45D4CD8-D5C7-4D1C-9911-335E306097DA","5D326DE6-FC9D-4AC5-88B6-EBD43424B915","TCGA-24-2288-01A-01T-0712-07.gene.tcga_level3.data.txt","TCGA-24-2288-01A-01",90,0,NA,NA,10,"TOP",5,NA,"TCGA-24-2288-01A-01-TS1",85,"Taxol","Chemotherapy","TCGA-24-2288-D26575",NA,NA,NA,NA,NA,25,"WITH TUMOR","Dead",25,"TCGA-24-2288-F26574","TCGA-24-2288",NA,"24","2288","YES","C56.9","8441/3","C56.9",NA,NA,-25831,"FEMALE","WHITE",NA,NA,"No","Dead",25,25,NA,NA,"WITH TUMOR","NO",19,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,70,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
170864562,165434621,12242089021,"1B6CF403-D0AE-4FFE-A884-660A58F32660.bw","29949b65-2913-4c86-bbd7-b85c5df6f15e","1b6cf403-d0ae-4ffe-a884-660a58f32660","2016-08-25T04:59:34.600513-05:00","TCGA-61-2000-01A-01R-1568-13_rnaseq_fastq.tar","3a0d4edb-5812-42bf-8f3d-cd03c62edf32",10764400640,"Illumina HiSeq","e505ff787e601e27ad3dd93a53984ded","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:51:38.434313-05:00","2016-05-03T11:56:42.628342-05:00","3a0d4edb-5812-42bf-8f3d-cd03c62edf32_analysis.xml","77d2aa64fa4a3f8442377abc16f99726","0cb7f698-8786-444f-9e65-6ca780f3ce65",2181,"2016-08-25T22:40:04.119344-05:00","3a0d4edb-5812-42bf-8f3d-cd03c62edf32_experiment.xml","0a6b48bc7fde83070f0271492a335d4b","9fb0492f-b2be-458d-b94b-838468f1a3ec",3916,"2016-09-29T18:02:46.599614-05:00","3a0d4edb-5812-42bf-8f3d-cd03c62edf32_run.xml","a8e273ec1f7a21e5a8925fcba4dc0bbc","13bb888e-740a-4e32-ba3b-031f9f53bbae",1988,"2016-09-08T12:13:14.172077-05:00","TCGA-61-2000","2016-09-02T18:56:11.607296-05:00","female","TCGA-61-2000_demographic",1941,"white","2281e96f-9ac0-5e8c-9510-0876507277a1","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2000_diagnosis","not reported",24723,"alive","8441/3",NA,441,"9b576de5-79c4-5514-93fa-4d5497230584","c56.9",-24723,"TCGA-61-2000_treatment","1a0f7fd1-d868-5029-81a1-473594177e34","01",NA,"TCGA-61-2000-01A","1","fdb8966d-55c9-49be-80dd-369246604aad",FALSE,"4e13b897-c34a-4422-9c66-7ca8b2734ef2","Primary Tumor","0.4",NA,NA,"1",1247443200,"01",102,"TCGA-61-2000-01A-01",90,90,NA,NA,10,8,10,5,"2016-09-08T12:13:14.172077-05:00","2016-09-08T12:13:14.172077-05:00",NA,NA,NA,NA,"TOP","BOTTOM",15,8,"1ae6e2bd-7e0d-42e1-a0f3-c13499f536a6","9bfc0d2d-aa54-4bb7-9f81-d47995a829da","TCGA-61-2000-01A-01-TS1","TCGA-61-2000-01A-01-BS1",65,79,"54ac58f6-e4d2-48ad-8e2a-ad9371a315e1","RNA","TCGA-61-2000-01A-01R","d8cf1f87-b108-486d-875c-6278b115acac",1.8,0.14,"UV Spec","R","22","TCGA-61-2000-01A-01R-1568-13","f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109",0.14,NA,NA,NA,NA,"3a92791e-5363-54be-b9f0-6ec01a6d3c5b","TCGA-61-2000_exposure","TCGA-61-2000-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T07:05:07.000Z","2014-08-27T20:59:33.000Z","3A0D4EDB-5812-42BF-8F3D-CD03C62EDF32","FDB8966D-55C9-49BE-80DD-369246604AAD","Unaligned reads",10764400640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F4FCCAA6-CD8C-4E5A-A7A8-BEB63CF7B109","Canada's Michael Smith Genome Sciences Centre","564a3641e4b09c884b22cb4d","29949B65-2913-4C86-BBD7-B85C5DF6F15E","Ovarian Serous Cystadenocarcinoma","TAR","54AC58F6-E4D2-48AD-8E2A-AD9371A315E1","2014-08-27T20:59:33.000Z","D8CF1F87-B108-486D-875C-6278B115ACAC","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"54AC58F6-E4D2-48AD-8E2A-AD9371A315E1",1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c7083eed-998f-456d-b294-5fbcf50eff88.txt",NA,"TCGA-61-2000-01A",1,"F43225B8-2247-4397-90FB-8AC91E6A7806","TCGA",2008,NA,NA,"WITH TUMOR","FDB8966D-55C9-49BE-80DD-369246604AAD",67,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c7083eed-998f-456d-b294-5fbcf50eff88.txt","Alive",NA,"TCGA-61-2000","NOT HISPANIC OR LATINO","E1EC40CF-3F01-42E9-859F-D16E3AAFF23E",NA,441,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,102,"9BFC0D2D-AA54-4BB7-9F81-D47995A829DA","7EE83161-844F-4F63-B2F3-D96D48123235","4814968137_R01C01_Red.idat","TCGA-61-2000-01A-01",90,8,NA,NA,5,"BOTTOM",8,NA,"TCGA-61-2000-01A-01-BS1",79,"CCDP","Chemotherapy","TCGA-61-2000-D28314",NA,NA,NA,"TCGA-61-2000-F28311_NTE-2",NA,441,"WITH TUMOR","Alive",NA,"TCGA-61-2000-F28311","TCGA-61-2000",NA,"61","2000","YES","C56.9","8441/3","C56.9",NA,NA,-24723,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",441,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
130455802,123222852,9047778171,"B33316E1-11FD-4C10-956A-C9C6F78508C5.bw","29d26e7e-f4ae-4476-9a3f-27d5ec2ccb8a","b33316e1-11fd-4c10-956a-c9c6f78508c5","2016-08-22T03:54:28.578241-05:00","TCGA-10-0928-01A-02R-1564-13_rnaseq_fastq.tar","01049295-73ed-4dcf-90c0-acc0f6df97a2",7762800640,"Illumina HiSeq","3705ab89dd7215a90027f93af56c2b51","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:49:45.702567-05:00","2016-05-03T11:41:05.750744-05:00","01049295-73ed-4dcf-90c0-acc0f6df97a2_analysis.xml","c2ca3c42a869a7b7bca1521d9e6e78d6","a0dff469-c86c-47f0-98f8-12e24e8c126e",2181,"2016-09-29T19:24:11.442631-05:00","01049295-73ed-4dcf-90c0-acc0f6df97a2_experiment.xml","29ea125eb3454f8448161a68bd39b574","46e8896a-1157-4e6c-871d-93836cd08ea6",3916,"2016-09-29T18:10:02.409199-05:00","01049295-73ed-4dcf-90c0-acc0f6df97a2_run.xml","e793e885bda8c1a923e963f211e28021","1849a8f3-38e1-41b2-adbb-8a86a091ecce",1988,"2016-09-08T12:17:05.736169-05:00","TCGA-10-0928","2016-09-02T19:05:29.407906-05:00","female","TCGA-10-0928_demographic",1929,"white","86af060d-7656-5dea-bef2-06252f78bea5","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0928_diagnosis","not reported",26066,"dead","8441/3",563,563,"b513bda1-4ea9-5a15-be5c-afdf0225f33f","c56.9",-26066,"TCGA-10-0928_treatment","8e5cb970-4c0d-59ae-bbb8-b542474096f1","01",NA,"TCGA-10-0928-01A","0.8","4416312b-c64f-4fb2-9819-6ccf9b8ab219",FALSE,"859b2662-493a-4ead-9ac7-0aa8d0a7a3d8","Primary Tumor","0.4",NA,NA,"1",1233705600,"02",88,"TCGA-10-0928-01A-02",95,95,NA,NA,5,5,5,5,"2016-09-08T12:17:05.736169-05:00","2016-09-08T12:17:05.736169-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"7e1a20f2-31da-4b50-8d26-005e67baa47c","facd92de-6893-4650-a327-1f15554a01fc","TCGA-10-0928-01A-01-BS1","TCGA-10-0928-01A-02-BS2",90,90,"b544b8b2-a5f1-428d-8203-d27ce6b67a17","RNA","TCGA-10-0928-01A-02R","42019bf7-9187-4493-be2d-0d8733365c60",1.8,0.15,"UV Spec","R","22","TCGA-10-0928-01A-02R-1564-13","9aa3ae15-1033-46f1-a304-993f5d41cd50",0.15,NA,NA,NA,NA,"9796105d-6559-52b9-9879-d247d5fe43af","TCGA-10-0928_exposure","TCGA-10-0928-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-28T17:00:05.000Z","2014-03-28T17:21:02.000Z","01049295-73ED-4DCF-90C0-ACC0F6DF97A2","4416312B-C64F-4FB2-9819-6CCF9B8AB219","Unaligned reads",7762800640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9AA3AE15-1033-46F1-A304-993F5D41CD50","Canada's Michael Smith Genome Sciences Centre","564a3c81e4b0ef12181acaf3","29D26E7E-F4AE-4476-9A3F-27D5EC2CCB8A","Ovarian Serous Cystadenocarcinoma","TAR","B544B8B2-A5F1-428D-8203-D27CE6B67A17","2014-03-28T17:21:02.000Z","42019BF7-9187-4493-BE2D-0D8733365C60","None","NO",1,0.4,"Primary Tumor","MD Anderson Cancer Center",NA,"B544B8B2-A5F1-428D-8203-D27CE6B67A17",0.8,"10","TCGA-10-0928-01A-02R-1564-13_rnaseq.bam.bai",NA,"TCGA-10-0928-01A",1,NA,"TCGA",2000,NA,NA,"WITH TUMOR","4416312B-C64F-4FB2-9819-6CCF9B8AB219",71,"nationwidechildrens.org_clinical.TCGA-10-0928.xml","Dead",563,"TCGA-10-0928",NA,"C87807DF-3345-4970-807A-A338040B2C38",NA,563,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,2,88,"FACD92DE-6893-4650-A327-1F15554A01FC","42019BF7-9187-4493-BE2D-0D8733365C60","US82800149_251976010392_S01_GE2-v5_10_Apr08.txt","TCGA-10-0928-01A-02",95,5,NA,NA,5,"BOTTOM",0,NA,"TCGA-10-0928-01A-02-BS2",90,NA,NA,NA,NA,NA,NA,NA,NA,563,"WITH TUMOR","Dead",563,"TCGA-10-0928-F24430","TCGA-10-0928",NA,"10","0928","YES","C56.9","8441/3","C56.9",NA,NA,-26066,"FEMALE","WHITE",NA,NA,"No","Dead",563,563,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA
232401644,222955563,16460342398,"BB02EF6A-C57D-4A79-99C1-ED43A72FFAF7.bw","29dccd25-4c4a-463b-a353-38a193337f38","bb02ef6a-c57d-4a79-99c1-ed43a72ffaf7","2016-08-22T08:34:45.170318-05:00","TCGA-13-1405-01A-01R-1565-13_rnaseq_fastq.tar","52c478c5-991e-4c91-8e85-79552a614150",14774333440,"Illumina HiSeq","aafb111b3d0f8e3c24a8b1327c187c84","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:46:34.698114-05:00","2016-05-03T11:40:21.648680-05:00","52c478c5-991e-4c91-8e85-79552a614150_analysis.xml","206f6ed314c34d46a73a5fef0c3bfe75","7999f4ff-547d-47f3-b43d-723f13fc2fb5",2181,"2016-08-13T02:52:21.310749-05:00","52c478c5-991e-4c91-8e85-79552a614150_experiment.xml","082e4b5440058c8a74f25f7890eece22","396df39c-040a-4517-aca9-1e0ae57fd2db",3916,"2016-09-29T21:08:39.950025-05:00","52c478c5-991e-4c91-8e85-79552a614150_run.xml","9c3fb4e9137a2c8dc39b0a4753c7bd1d","87798438-7760-4af8-bf9b-4c965ebfa60c",1988,"2016-09-08T13:55:29.943963-05:00","TCGA-13-1405","2016-09-02T19:12:08.209331-05:00","female","TCGA-13-1405_demographic",1959,"white","baec593a-b625-575d-9c78-53c435b457e4","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1405_diagnosis","not reported",18218,"dead","8441/3",868,224,"84bc8778-a967-5764-8dc6-e7fb3efed07f","c56.9",-18218,"TCGA-13-1405_treatment","c7850771-7a41-51a9-bb1d-2c5902c69931","01",NA,"TCGA-13-1405-01A","1.3","d900cebf-8795-4385-8f57-77209178ff43",FALSE,"DFB9F8B2-986C-4963-B2D2-837E54174CF0","Primary Tumor","0.5",NA,NA,"1.3",1230508800,"01",133,"TCGA-13-1405-01A-01",85,85,NA,NA,0,0,15,15,"2016-09-08T13:55:29.943963-05:00","2016-09-08T13:55:29.943963-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"75a754e9-5c31-4b53-b8a9-fe6deec738ab","97fd5c92-85f1-4cb2-9ed6-289072e137bb","TCGA-13-1405-01A-01-BS1","TCGA-13-1405-01A-01-TS1",84,84,"659f0e5a-1d50-4e3b-a588-cbf534841e31","RNA","TCGA-13-1405-01A-01R","515f0052-170d-431a-a7d0-715a3bfc0d40",1.8,0.17,"UV Spec","R","22","TCGA-13-1405-01A-01R-1565-13","044d949f-0eb4-44c9-8327-90226936fc7c",0.17,NA,NA,NA,NA,"b2a583cf-c40d-593e-b479-65f986bc2205","TCGA-13-1405_exposure","TCGA-13-1405-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:03:26.000Z","2014-03-21T22:33:01.000Z","52C478C5-991E-4C91-8E85-79552A614150","D900CEBF-8795-4385-8F57-77209178FF43","Unaligned reads",14774333440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","044D949F-0EB4-44C9-8327-90226936FC7C","Canada's Michael Smith Genome Sciences Centre","564a34fde4b09c884b2266dd","29DCCD25-4C4A-463B-A353-38A193337F38","Ovarian Serous Cystadenocarcinoma","TAR","659F0E5A-1D50-4E3B-A588-CBF534841E31","2014-03-21T22:33:01.000Z","515F0052-170D-431A-A7D0-715A3BFC0D40","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"659F0E5A-1D50-4E3B-A588-CBF534841E31",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.79cd114a-31d2-468d-92e6-5ea925e61918.txt",NA,"TCGA-13-1405-01A",1.3,"E2A55A7F-4BFD-43DB-BD46-3D41AD1008E8","TCGA",2008,NA,NA,"TUMOR FREE","D900CEBF-8795-4385-8F57-77209178FF43",49,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.79cd114a-31d2-468d-92e6-5ea925e61918.txt","Alive",NA,"TCGA-13-1405","NOT HISPANIC OR LATINO","94FEAF68-9597-4648-BC84-FE7E67AFC7C7",NA,224,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,133,"75A754E9-5C31-4B53-B8A9-FE6DEEC738AB","FF7BDA2F-5375-45D3-82D8-14C5C86AC254","0950.CEL","TCGA-13-1405-01A-01",85,0,NA,NA,15,"BOTTOM",1,NA,"TCGA-13-1405-01A-01-BS1",84,"Paciltaxel","Chemotherapy","TCGA-13-1405-D24805",NA,NA,NA,NA,NA,224,"TUMOR FREE","Alive",NA,"TCGA-13-1405-F24803","TCGA-13-1405",NA,"13","1405","YES","C56.9","8441/3","C56.9",NA,NA,-18218,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",224,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
240154114,234780772,17375366652,"4DBA59AD-9393-4BE6-88CB-852C62C4A334.bw","2a924999-1fbf-470a-97bd-fd2276a9a366","4dba59ad-9393-4be6-88cb-852c62c4a334","2016-08-25T02:05:05.034284-05:00","TCGA-13-0885-01A-02R-1569-13_rnaseq_fastq.tar","df10c751-4229-45b8-950f-62dea64c6b8a",14007797760,"Illumina HiSeq","526a99aefbe59c45983ab61f8c4353cb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:38:01.805835-05:00","2016-05-03T11:56:42.629049-05:00","df10c751-4229-45b8-950f-62dea64c6b8a_analysis.xml","c599f62e80afee3f381123d18ba3950b","29bb24af-b9ef-40eb-9bfc-0e4d5280309f",2226,"2016-09-30T00:19:47.057167-05:00","df10c751-4229-45b8-950f-62dea64c6b8a_experiment.xml","d668622c73dda41c144ef642ff8479a9","fdd6125a-ac59-46aa-ac44-fd8b09944c54",3916,"2016-09-29T22:59:45.684979-05:00","df10c751-4229-45b8-950f-62dea64c6b8a_run.xml","1d24f8d2a9546c1e11b41aef279740c9","cc16accd-448b-4311-8b40-27d084e435ee",1988,"2016-09-08T13:03:42.262722-05:00","TCGA-13-0885","2016-09-02T19:06:17.593317-05:00","female","TCGA-13-0885_demographic",1930,"white","83bbd790-7f3e-5f1e-91be-9aaf019078bd","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0885_diagnosis","not reported",25763,"alive","8441/3",NA,3388,"65552a39-e03f-5986-9476-19628f3e6d7e","c56.9",-25763,"TCGA-13-0885_treatment","3c9fc7f5-2aed-50e8-b25b-9b2f60e6e352","01",NA,"TCGA-13-0885-01A","0.6","8486f0d0-2bb2-41a0-8b21-308407ce4aba",FALSE,"81DFFD49-45F0-4A20-AC27-B8316B2E0289","Primary Tumor","0.4",NA,NA,"1.2",1233705600,"02",120,"TCGA-13-0885-01A-02",80,80,NA,NA,20,19,0,1,"2016-09-08T13:03:42.262722-05:00","2016-09-08T13:03:42.262722-05:00",NA,90,NA,NA,"BOTTOM","TOP",2,2,"f81d65cc-0e63-43c6-b022-17d16fa61f9a","5245b3d4-1105-40ba-aa2a-8f093459f125","TCGA-13-0885-01A-02-BS2","TCGA-13-0885-01A-01-BS1",78,78,"21a663ad-d772-4797-b1ff-ff5128f22354","RNA","TCGA-13-0885-01A-02R","34a40847-50c8-4150-910a-cf62c86c7e09",1.8,0.16,"UV Spec","R","22","TCGA-13-0885-01A-02R-1569-13","e0f48d4d-4c10-4b83-9a13-9427a08371d3",0.16,NA,NA,NA,NA,"01529f38-3462-595f-b80d-4628e930aaed","TCGA-13-0885_exposure","TCGA-13-0885-01A-02R-1569-13_rnaseq_fastq.tar","2014-08-08T05:18:28.000Z","2014-08-20T23:09:42.000Z","DF10C751-4229-45B8-950F-62DEA64C6B8A","8486F0D0-2BB2-41A0-8B21-308407CE4ABA","Unaligned reads",14007797760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E0F48D4D-4C10-4B83-9A13-9427A08371D3","Canada's Michael Smith Genome Sciences Centre","564a576fe4b08c5d8693ed15","2A924999-1FBF-470A-97BD-FD2276A9A366","Ovarian Serous Cystadenocarcinoma","TAR","21A663AD-D772-4797-B1FF-FF5128F22354","2014-08-08T05:58:14.000Z","34A40847-50C8-4150-910A-CF62C86C7E09","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"21A663AD-D772-4797-B1FF-FF5128F22354",0.6,"13","US82800149_251911813052_S01_miRNA-v1_10_Apr08_1_3.txt",NA,"TCGA-13-0885-01A",1.2,"30BFB060-BC43-4205-A472-4139381C0C69","TCGA",2000,NA,NA,NA,"F8AD89EA-E6EB-4270-BDD8-784EEE2EA0B9",70,"jhu-usc.edu_OV.HumanMethylation27.2.lvl-2.TCGA-13-0885-01A-02D-0402-05.txt","Alive",NA,"TCGA-13-0885","NOT HISPANIC OR LATINO",NA,NA,2780,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,2,120,"F81D65CC-0E63-43C6-B022-17D16FA61F9A","F99A9777-19B5-44DB-BBDB-8968142C6680","US82800149_251911813052_S01_miRNA-v1_10_Apr08_1_3.txt","TCGA-13-0885-01A-02",80,19,NA,90,1,"TOP",2,NA,"TCGA-13-0885-01A-01-BS1",78,"Carboplatin","Chemotherapy","TCGA-13-0885-D24659",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0885",NA,"13","0885","YES","C56.9","8441/3","C56.9",NA,NA,-25763,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2780,NA,NA,NA,NA,"NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,70,2000,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
261759352,253367309,18767609828,"7887EDC4-A0D7-4E57-B3A1-330A5683457D.bw","2ab32e11-80d6-4ed0-a42e-da612219bbdd","7887edc4-a0d7-4e57-b3a1-330a5683457d","2016-08-25T19:27:31.764380-05:00","TCGA-24-2297-01A-01R-1568-13_rnaseq_fastq.tar","9e1c8c36-38be-4c4d-ae79-318784df1157",17098045440,"Illumina HiSeq","3a7a7219a0f332b7b2f98901aad535d1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:42:51.734328-05:00","2016-05-03T11:58:49.360058-05:00","9e1c8c36-38be-4c4d-ae79-318784df1157_analysis.xml","bef41c0fcb166feadd840204e22279cd","52795330-3c17-4cd6-957f-d8ac84b3bac1",2181,"2016-08-26T05:40:08.781365-05:00","9e1c8c36-38be-4c4d-ae79-318784df1157_experiment.xml","5b337a444daee6160db1efbfa44ab7e2","a1e11ec2-d5ed-401b-a848-ea07e9f53dc1",3916,"2016-09-29T19:08:00.519003-05:00","9e1c8c36-38be-4c4d-ae79-318784df1157_run.xml","fd20b08976969f785da2f0fdfc31cced","3cb2f0c8-5125-40ea-a57d-3cd7cda5c84b",1988,"2016-09-08T13:35:55.841624-05:00","TCGA-24-2297","2016-09-02T19:12:01.087223-05:00","female","TCGA-24-2297_demographic",1937,"white","5e77a0b3-6cd4-5602-bdb2-874b275291f9","not reported",1997,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2297_diagnosis","not reported",20487,"dead","8441/3",1699,1699,"036f498f-caec-57c3-8ca1-8d83d027149d","c56.9",-20487,"TCGA-24-2297_treatment","dc3124f9-3068-5934-890b-d005d0885181","01",NA,"TCGA-24-2297-01A","0.6","e1855137-b479-4d9c-b729-ff84263abd89",FALSE,"12b02227-4050-4d02-bdb8-939d348a4c19","Primary Tumor","0.3",NA,NA,"1",1251676800,"01",101,"TCGA-24-2297-01A-01",97,81,NA,NA,8,30,0,0,"2016-09-08T13:35:55.841624-05:00","2016-09-08T13:35:55.841624-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,10,"ef97e135-54be-4846-9f87-c9fe3ab2ddf4","7addcb34-e944-4d8d-84e7-03fb2c107745","TCGA-24-2297-01A-01-TS1","TCGA-24-2297-01A-01-BS1",90,60,"f5bd762b-8f57-46a8-81b4-445cc667c6a8","RNA","TCGA-24-2297-01A-01R","b9711060-225c-415f-a377-c8c7addfde3f",1.8,0.14,"UV Spec","R","22","TCGA-24-2297-01A-01R-1568-13","2b0089bc-b493-4179-bf5c-e58550e1ee5b",0.14,NA,NA,NA,NA,"342787b3-9179-5570-95d0-afb338ca2644","TCGA-24-2297_exposure","TCGA-24-2297-01A-01R-1568-13_rnaseq_fastq.tar","2014-09-22T23:34:09.000Z","2014-09-23T02:31:21.000Z","9E1C8C36-38BE-4C4D-AE79-318784DF1157","E1855137-B479-4D9C-B729-FF84263ABD89","Unaligned reads",17098045440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2B0089BC-B493-4179-BF5C-E58550E1EE5B","Canada's Michael Smith Genome Sciences Centre","564a39e9e4b08c5d869108c5","2AB32E11-80D6-4ED0-A42E-DA612219BBDD","Ovarian Serous Cystadenocarcinoma","TAR","F5BD762B-8F57-46A8-81B4-445CC667C6A8","2014-09-23T02:31:21.000Z","B9711060-225C-415F-A377-C8C7ADDFDE3F","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"F5BD762B-8F57-46A8-81B4-445CC667C6A8",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f700e3e2-462f-4889-82fa-ac614983d642.txt",NA,"TCGA-24-2297-01A",1,"E6AC7E27-9CFB-4E5A-9DB9-EEAC915C3E23","TCGA",1993,NA,NA,NA,"E7730231-9E9C-4FCA-B84C-7FC0966D6CD3",56,"nationwidechildrens.org_clinical.TCGA-24-2297.xml","Dead",1699,"TCGA-24-2297",NA,"02C7C92C-2DF2-46D9-A3DB-88F6135C8FD6",NA,1699,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,101,"EF97E135-54BE-4846-9F87-C9FE3AB2DDF4","B0A1FA49-0ACA-42CA-982C-D59242D19F6B","US82800149_251911813151_S01_miRNA_105_Dec08_2_2.txt","TCGA-24-2297-01A-01",81,30,NA,NA,0,"BOTTOM",10,NA,"TCGA-24-2297-01A-01-BS1",60,"Cytoxan","Chemotherapy","TCGA-24-2297-D26614",NA,NA,NA,NA,NA,1699,NA,"Dead",1699,"TCGA-24-2297-F26612","TCGA-24-2297",NA,"24","2297","YES","C56.9","8441/3","C56.9",NA,NA,-20487,"FEMALE","WHITE",NA,NA,"No","Dead",1699,1699,NA,NA,NA,"NO",26,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,1993,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
196902110,191817754,14197724585,"2CD3AC14-46FB-4260-AE5C-4305C68D49BC.bw","2ae65a06-df0f-4de1-a536-537cae0cc260","2cd3ac14-46fb-4260-ae5c-4305c68d49bc","2016-08-25T11:10:00.931617-05:00","TCGA-61-1724-01A-01R-1568-13_rnaseq_fastq.tar","942840ac-644c-4822-9e0b-e16a1933ef6b",12932608000,"Illumina HiSeq","e90b4ecb3da5b2c9f78d2780b53ea66e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:56:22.117825-05:00","2016-05-03T11:41:05.755204-05:00","942840ac-644c-4822-9e0b-e16a1933ef6b_analysis.xml","dfe4b79b3549f4f9cdb211ba1ee96e7d","7fb99338-1165-4d21-9cff-2ef6604634e7",2183,"2016-09-29T19:09:36.107331-05:00","942840ac-644c-4822-9e0b-e16a1933ef6b_experiment.xml","cc856c4d1a6b0bb73b025750990065a9","3dbb7cab-68a8-42e6-8008-c6e98c776108",3916,"2016-09-29T21:50:42.610792-05:00","942840ac-644c-4822-9e0b-e16a1933ef6b_run.xml","c2a913385f7fc07a9cfe9d5f2ef3fc24","a181166a-fe10-437e-b93a-bd33d0431865",1990,"2016-09-08T10:25:13.505946-05:00","TCGA-61-1724","2016-09-02T18:50:18.173069-05:00","female","TCGA-61-1724_demographic",1960,"white","ea68bd4e-83c7-5ede-a7d8-58a344ab1732","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1724_diagnosis","not reported",17168,"dead","8441/3",637,637,"6395ea1f-b5c3-5f02-a6fb-9d10768d3764","c56.9",-17168,"TCGA-61-1724_treatment","34fef059-2a04-52f6-b86d-44c336665b9f","01",NA,"TCGA-61-1724-01A","1.2","3545a19f-40bc-4414-8895-2a176f2989fa",FALSE,"ec0d70e7-672b-425b-a558-d233e0ef1779","Primary Tumor","0.3",NA,NA,"1.2",1242518400,"01",150,"TCGA-61-1724-01A-01",90,90,NA,NA,0,0,0,5,"2016-09-08T10:25:13.505946-05:00","2016-09-08T10:25:13.505946-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,10,"dc9700ec-ce3c-4286-80bd-a353c376977b","842b750e-e4ef-493a-aa87-8b270df9a629","TCGA-61-1724-01A-01-BS1","TCGA-61-1724-01A-01-TS1",95,85,"b6a8732f-03cc-4550-b249-61d93830c5b5","RNA","TCGA-61-1724-01A-01R","534673b9-2fb1-49c9-964e-a8d546ab9a97",1.8,0.15,"UV Spec","R","22","TCGA-61-1724-01A-01R-1568-13","faab5b85-3c69-4c64-bba0-a8d5404939a2",0.15,NA,NA,NA,NA,"f45474d2-c149-59ee-80ac-9e4b104d8df9","TCGA-61-1724_exposure","TCGA-61-1724-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T03:22:11.000Z","2014-03-27T03:52:01.000Z","942840AC-644C-4822-9E0B-E16A1933EF6B","3545A19F-40BC-4414-8895-2A176F2989FA","Unaligned reads",12932608000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FAAB5B85-3C69-4C64-BBA0-A8D5404939A2","Canada's Michael Smith Genome Sciences Centre","564a3e95e4b09c884b2553ed","2AE65A06-DF0F-4DE1-A536-537CAE0CC260","Ovarian Serous Cystadenocarcinoma","TAR","B6A8732F-03CC-4550-B249-61D93830C5B5","2014-03-27T03:52:01.000Z","534673B9-2FB1-49C9-964E-A8D546AB9A97","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"B6A8732F-03CC-4550-B249-61D93830C5B5",1.2,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eb6edbbc-bc05-4627-b5af-6f91d7b6c5dd.txt",NA,"TCGA-61-1724-01A",1.2,"CD8E9C06-C812-47CD-BE39-6F65386C41EF","TCGA",2007,NA,NA,"WITH TUMOR","3545A19F-40BC-4414-8895-2A176F2989FA",47,"nationwidechildrens.org_clinical.TCGA-61-1724.xml","Dead",637,"TCGA-61-1724","NOT HISPANIC OR LATINO","81734CE6-1983-4B83-A2AC-394D263FEFB0",NA,637,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,150,"DC9700EC-CE3C-4286-80BD-A353C376977B","6E8099D8-A0BC-450B-8673-56AD5F709C39","TCGA-61-1724-01A-01R-1568-13_rnaseq.bam.bai","TCGA-61-1724-01A-01",90,0,NA,NA,0,"BOTTOM",5,NA,"TCGA-61-1724-01A-01-BS1",95,"Taxotere","Chemotherapy","TCGA-61-1724-D28140",NA,NA,NA,"TCGA-61-1724-F28135_NTE-1",NA,637,"WITH TUMOR","Dead",637,"TCGA-61-1724-F28135","TCGA-61-1724",NA,"61","1724","YES","C56.9","8441/3","C56.9",NA,NA,-17168,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",637,637,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,47,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158926502,154799025,11467857733,"BAB8FA79-208A-488D-B955-806263E5D6BB.bw","2b14123b-8fcd-402c-9399-4e7c47f20252","bab8fa79-208a-488d-b955-806263e5d6bb","2016-08-26T08:33:31.903540-05:00","TCGA-24-2290-01A-01R-1568-13_rnaseq_fastq.tar","83344129-5606-43bc-b2af-a879d7a2024c",9988945920,"Illumina HiSeq","3265fc4e8368664aa516f3a94cb65347","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:27:11.922311-05:00","2016-05-03T11:56:42.628342-05:00","83344129-5606-43bc-b2af-a879d7a2024c_analysis.xml","ca6bd2bc8d17e7ed06bd9d1bd128bb9f","22e98f2f-7f6f-49fb-89d9-e971b31dfa0e",2181,"2016-08-13T04:20:58.400106-05:00","83344129-5606-43bc-b2af-a879d7a2024c_experiment.xml","fd18258826f3e51edc5250865e8c6784","a41fe198-24ac-4e28-95af-0ac5fa55cef8",3916,"2016-09-30T00:02:48.351036-05:00","83344129-5606-43bc-b2af-a879d7a2024c_run.xml","1e496763bb812fd2585c1c7812700281","f353e88e-a11a-472b-b33c-cf2b15b2917e",1988,"2016-09-08T14:00:43.962891-05:00","TCGA-24-2290","2016-09-02T19:11:54.428130-05:00","female","TCGA-24-2290_demographic",1941,"white","c59bc65d-24b8-5f31-a7bf-24ec7a57a5c3","not reported",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c48.1","TCGA-24-2290_diagnosis","not reported",20530,"dead","8441/3",1102,1102,"608d39b1-f3d7-5c83-a83a-61248eacbd74","c48.1",-20530,"TCGA-24-2290_treatment","85bbe000-218f-5fdd-a9e9-3873e195ba2f","01",NA,"TCGA-24-2290-01A","1","bbfed693-79e1-4dc7-896e-15b98fc7dbac",FALSE,"71036f77-0d99-427a-883c-75624453890d","Primary Tumor","0.3",NA,NA,"1.5",1251676800,"01",144,"TCGA-24-2290-01A-01",95,85,NA,NA,0,0,5,15,"2016-09-08T14:00:43.962891-05:00","2016-09-08T14:00:43.962891-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,15,"f5d185e3-f27f-4ad4-9f81-8721b109da1d","298bd41d-f2e2-4db3-9582-62d0be13aa8c","TCGA-24-2290-01A-01-BS1","TCGA-24-2290-01A-01-TS1",90,70,"4fefd336-d14e-4e1e-8bf1-16e3c64b6495","RNA","TCGA-24-2290-01A-01R","a653c306-05aa-4064-a547-3b753ff555b3",1.8,0.15,"UV Spec","R","22","TCGA-24-2290-01A-01R-1568-13","a3173b33-aa16-48a2-b733-0345aad49755",0.15,NA,NA,NA,NA,"707b1326-faa7-5565-9aa5-ec5f9f8d0801","TCGA-24-2290_exposure","TCGA-24-2290-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T13:07:28.000Z","2014-08-27T15:07:17.000Z","83344129-5606-43BC-B2AF-A879D7A2024C","BBFED693-79E1-4DC7-896E-15B98FC7DBAC","Unaligned reads",9988945920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A3173B33-AA16-48A2-B733-0345AAD49755","Canada's Michael Smith Genome Sciences Centre","564a35e4e4b09c884b22ae2e","2B14123B-8FCD-402C-9399-4E7C47F20252","Ovarian Serous Cystadenocarcinoma","TAR","4FEFD336-D14E-4E1E-8BF1-16E3C64B6495","2014-08-27T15:07:17.000Z","A653C306-05AA-4064-A547-3B753FF555B3","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"4FEFD336-D14E-4E1E-8BF1-16E3C64B6495",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7ede9f43-4fe6-4cd4-a1fe-b6a0677b40d9.txt",NA,"TCGA-24-2290-01A",1.5,"7019634D-A409-44DF-8BAD-84A1ACA17AE3","TCGA",1997,NA,NA,"WITH TUMOR","D876903D-84EB-456A-B5C1-22207F0A7811",56,"nationwidechildrens.org_clinical.TCGA-24-2290.xml","Dead",1102,"TCGA-24-2290",NA,"F90E554E-790A-4892-875C-01886DD88B5F",NA,1102,NA,"Ovary","C48.1",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C48.1",24,NA,NA,"WHITE",NA,1,144,"F5D185E3-F27F-4AD4-9F81-8721B109DA1D","FEBE8B84-F599-4600-83C0-A0DEED851941","TCGA-24-2290-01A-01R-1568-13_rnaseq.bam","TCGA-24-2290-01A-01",85,0,NA,NA,15,"TOP",15,NA,"TCGA-24-2290-01A-01-TS1",70,"Topotecan","Chemotherapy","TCGA-24-2290-D26588",NA,NA,NA,"TCGA-24-2290-F26583_NTE-1",NA,1102,"WITH TUMOR","Dead",1102,"TCGA-24-2290-F26583","TCGA-24-2290",NA,"24","2290","YES","C48.1","8441/3","C48.1",NA,NA,-20530,"FEMALE","WHITE",NA,NA,"No","Dead",1102,1102,NA,NA,"WITH TUMOR","NO",19,2,2010,"YES","YES","NO",NA,NA,NA,"Omentum","Serous Cystadenocarcinoma",NA,0,56,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
190849590,185131428,13699385680,"98C990E7-7E3B-4200-A88D-E641931302EA.bw","2cb50c2d-e749-4172-b101-d975507435c5","98c990e7-7e3b-4200-a88d-e641931302ea","2016-09-29T21:36:39.486687-05:00","TCGA-24-1567-01A-01R-1566-13_rnaseq_fastq.tar","b0a1b594-3c12-46a4-a723-f8f69e7eaa47",12263249920,"Illumina HiSeq","54bff0fc1fbfb77693e94ee9bebfe3d9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:54:01.423990-05:00","2016-05-03T11:40:21.648199-05:00","b0a1b594-3c12-46a4-a723-f8f69e7eaa47_analysis.xml","f8c5d3149f74fca92931a3d1c2a3c427","33e46306-a88d-40e7-823b-c10ddc97b071",2181,"2016-09-29T18:41:35.006512-05:00","b0a1b594-3c12-46a4-a723-f8f69e7eaa47_experiment.xml","d9d582e99d89d5601013d88c9a8f6e99","2c041125-b603-4741-ad36-a360e555fafe",3916,"2016-09-29T17:53:18.002825-05:00","b0a1b594-3c12-46a4-a723-f8f69e7eaa47_run.xml","e137a39fe87b60867fdb55fe52132266","0dc3688f-b140-4fe1-b483-74d0720b6b93",1988,"2016-09-08T10:46:24.416186-05:00","TCGA-24-1567","2016-09-02T18:47:43.023126-05:00","female","TCGA-24-1567_demographic",1945,"white","ace5236c-02a5-559b-a2d3-bea9b6fc13a9","not reported",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1567_diagnosis","not reported",19843,"dead","8441/3",524,524,"dbe92bcb-69f3-5886-b674-14650afaf711","c56.9",-19843,"TCGA-24-1567_treatment","a278fc4d-ed97-5d6b-8d66-58f0cd87ba68","01",NA,"TCGA-24-1567-01A","0.3","8a3e4430-40be-46e0-bb38-946435911371",FALSE,"90910bbc-49e1-495b-9b06-11056ff401df","Primary Tumor","0.3",NA,NA,"1.1",1235433600,"01",130,"TCGA-24-1567-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T10:46:24.416186-05:00","2016-09-08T10:46:24.416186-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"09e67e5f-318c-42e7-a0bf-b00fc7f85356","1ef24432-6351-443b-9a7d-acbd6a4ab819","TCGA-24-1567-01A-01-TS1","TCGA-24-1567-01A-01-BS1",95,94,"8e7252ae-f413-4af1-b067-3749e1e2321d","RNA","TCGA-24-1567-01A-01R","54c4de33-3dbd-4d5b-b64a-1d0e9ab7978b",1.8,0.14,"UV Spec","R","22","TCGA-24-1567-01A-01R-1566-13","97c0b20f-ee65-42b2-af2d-92dcf48b2cd5",0.14,NA,NA,NA,NA,"043a4847-0135-589a-8f93-cc7c54f92d5a","TCGA-24-1567_exposure","TCGA-24-1567-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T06:32:11.000Z","2014-03-25T06:56:01.000Z","B0A1B594-3C12-46A4-A723-F8F69E7EAA47","8A3E4430-40BE-46E0-BB38-946435911371","Unaligned reads",12263249920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","97C0B20F-EE65-42B2-AF2D-92DCF48B2CD5","Canada's Michael Smith Genome Sciences Centre","564a333ce4b0298dd2c5c9ae","2CB50C2D-E749-4172-B101-D975507435C5","Ovarian Serous Cystadenocarcinoma","TAR","8E7252AE-F413-4AF1-B067-3749E1E2321D","2014-03-25T06:56:01.000Z","54C4DE33-3DBD-4D5B-B64A-1D0E9AB7978B","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"8E7252AE-F413-4AF1-B067-3749E1E2321D",0.3,"24","TCGA-24-1567-01A-01R-1566-13_mirna.bam",NA,"TCGA-24-1567-01A",1.1,"F43D1FFA-D988-4CC3-ACFD-7E4947D8CED1","TCGA",1999,NA,NA,"WITH TUMOR","8A3E4430-40BE-46E0-BB38-946435911371",54,"ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_E02_465970.nocnv_hg19.seg.txt","Dead",524,"TCGA-24-1567",NA,"282F1E10-3ACF-4ADE-BF0F-83CF6B487059",NA,524,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,130,"09E67E5F-318C-42E7-A0BF-B00FC7F85356","54C4DE33-3DBD-4D5B-B64A-1D0E9AB7978B","TCGA-24-1567-01A-01W-0615-10_SOLiD.bam.bai","TCGA-24-1567-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-24-1567-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-24-1567-D26280",NA,NA,NA,"TCGA-24-1567-F26279_NTE-1",NA,524,"WITH TUMOR","Dead",524,"TCGA-24-1567-F26279","TCGA-24-1567",NA,"24","1567","YES","C56.9","8441/3","C56.9",NA,NA,-19843,"FEMALE","WHITE",NA,NA,"No","Dead",524,524,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
260503204,250983541,18599737498,"894EE382-5ACA-4DEB-9267-99ADBEF6DA19.bw","2cb82948-7cbe-4b6c-8414-c02f662de2d0","894ee382-5aca-4deb-9267-99adbef6da19","2016-08-25T12:09:17.465067-05:00","TCGA-23-2084-01A-02R-1568-13_rnaseq_fastq.tar","affc5de3-8a2f-4b03-b20a-bbc155986783",16797614080,"Illumina HiSeq","f6e2bcde76b9cee78784de784b1c67b6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:43:58.387537-05:00","2016-05-03T11:56:42.631594-05:00","affc5de3-8a2f-4b03-b20a-bbc155986783_analysis.xml","e58661eaa88b813cc722fee461b7b2fb","53300e73-469c-42a3-8673-8070001c4be0",2181,"2016-09-29T19:03:01.342256-05:00","affc5de3-8a2f-4b03-b20a-bbc155986783_experiment.xml","2631897bcc6ed224146fe062eb57ef90","399309a4-ed7c-4e7d-96de-4a2745be52ce",3916,"2016-09-29T23:14:54.798543-05:00","affc5de3-8a2f-4b03-b20a-bbc155986783_run.xml","fc971e1c29e6c69d350b52184384867a","d5b09d35-6bc0-4795-b63c-8b8c612568e9",1988,"2016-09-08T11:33:12.307198-05:00","TCGA-23-2084","2016-09-02T18:56:27.073445-05:00","female","TCGA-23-2084_demographic",1955,"white","0344269b-0441-5bd3-9846-3c0415320ab6","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-2084_diagnosis","not reported",16493,"dead","8441/3",1516,NA,"2aaa9e6d-1157-5f86-b34f-9c9abf6e82f8","c56.9",-16493,"TCGA-23-2084_treatment","7a3b9a37-c86c-5a54-a1c3-5bc54d09979c","01",NA,"TCGA-23-2084-01A","1.1","6ea4f0e4-f241-4d14-af35-a9bbcb8f4a9d",FALSE,"00fd3d04-b48e-434e-8d25-0f0949e796cc","Primary Tumor","0.5",NA,NA,"1.4",1248825600,"02",105,"TCGA-23-2084-01A-02",85,90,NA,NA,1,1,14,9,"2016-09-08T11:33:12.307198-05:00","2016-09-08T11:33:12.307198-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"8ea25871-38c9-45a4-b7ac-ec3095f2b9ae","55a32aa7-50fb-4a0a-ac8a-6c62173174ab","TCGA-23-2084-01A-02-BS2","TCGA-23-2084-01A-01-BS1",85,90,"978b1d8a-5a2b-4142-ae22-d55ea0c7632e","RNA","TCGA-23-2084-01A-02R","fc1cc22f-8d1b-4b22-bdf3-3dcd839f7c3d",1.8,0.16,"UV Spec","R","22","TCGA-23-2084-01A-02R-1568-13","858a382c-49dc-4990-8c0f-017fedd9a6db",0.16,NA,NA,NA,NA,"955470fb-ff5f-5156-b8c2-e421835132f1","TCGA-23-2084_exposure","TCGA-23-2084-01A-02R-1568-13_rnaseq_fastq.tar","2014-08-29T12:27:42.000Z","2014-08-29T14:27:14.000Z","AFFC5DE3-8A2F-4B03-B20A-BBC155986783","6EA4F0E4-F241-4D14-AF35-A9BBCB8F4A9D","Unaligned reads",16797614080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","858A382C-49DC-4990-8C0F-017FEDD9A6DB","Canada's Michael Smith Genome Sciences Centre","564a3cd3e4b08c5d8691f69f","2CB82948-7CBE-4B6C-8414-C02F662DE2D0","Ovarian Serous Cystadenocarcinoma","TAR","978B1D8A-5A2B-4142-AE22-D55EA0C7632E","2014-08-29T14:27:14.000Z","FC1CC22F-8D1B-4B22-BDF3-3DCD839F7C3D","None","NO",1,0.5,"Primary Tumor","Cedars Sinai",NA,"978B1D8A-5A2B-4142-AE22-D55EA0C7632E",1.1,"23","TCGA-23-2084-01A-02R-1568-13_mirna.bam",NA,"TCGA-23-2084-01A",1.4,"EB6393B4-8B07-467D-9140-7EDEC56177F7","TCGA",2000,NA,NA,"WITH TUMOR","A3A20185-E22F-43CC-BF31-3DE76D41EFED",45,"nationwidechildrens.org_clinical.TCGA-23-2084.xml","Dead",1516,"TCGA-23-2084","NOT HISPANIC OR LATINO","64E0A5F8-5338-401D-9C5B-85D0B1C484D4",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,2,105,"8EA25871-38C9-45A4-B7AC-EC3095F2B9AE","6AA522AC-577F-4B17-BCF3-CAE79A4C82BC","TCGA-23-2084-01A-02R-1568-13.spljxn.quantification.txt","TCGA-23-2084-01A-02",85,1,NA,NA,14,"BOTTOM",0,NA,"TCGA-23-2084-01A-02-BS2",85,"Ifosfamide","Chemotherapy","TCGA-23-2084-D25806",NA,NA,NA,"TCGA-23-2084-F25795_NTE-2",NA,NA,"WITH TUMOR","Dead",1516,"TCGA-23-2084-F25795","TCGA-23-2084",NA,"23","2084","YES","C56.9","8441/3","C56.9",NA,NA,-16493,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1516,NA,NA,"WITH TUMOR","NO",18,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,45,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
106631546,99896898,7320702480,"98795F95-D26D-438A-AF46-B3BC3553F020.bw","2dfd8a0e-e642-49b3-abd7-f0334927eebb","98795f95-d26d-438a-af46-b3bc3553f020","2016-08-25T17:35:48.283896-05:00","TCGA-23-1119-01A-02R-1565-13_rnaseq_fastq.tar","81817638-4fa1-4e36-b96e-fd7456bcbdfb",6334474240,"Illumina HiSeq","4bf4d49ab00d76d9d3890d97f13efc03","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:15:55.460919-05:00","2016-05-03T11:41:05.750744-05:00","81817638-4fa1-4e36-b96e-fd7456bcbdfb_analysis.xml","bebb56aea5972749e023e632184450bb","8bffd2b3-f104-4832-a5f7-0f2a9ad1e7b3",2208,"2016-09-29T21:31:17.275761-05:00","81817638-4fa1-4e36-b96e-fd7456bcbdfb_experiment.xml","65cb87b3143150c9e407643126718529","9587e131-958f-41ae-adcd-236cfe2a94fc",3916,"2016-09-29T18:13:06.256849-05:00","81817638-4fa1-4e36-b96e-fd7456bcbdfb_run.xml","b05ddff712af3a4f5111b0a1f2c2e03b","1a3006a2-d4d5-4104-8717-391ff773d350",1988,"2016-09-08T12:19:19.305787-05:00","TCGA-23-1119","2016-09-02T19:05:59.476821-05:00","female","TCGA-23-1119_demographic",1933,"white","f3da4ea8-cbc9-5519-9037-d701e149a8f6","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1119_diagnosis","not reported",23686,"alive","8441/3",NA,3953,"cfa1e23f-420a-51df-9119-d916745ddbb1","c56.9",-23686,"TCGA-23-1119_treatment","f6fee3e9-e14b-5301-96fe-88ab01895f94","01",NA,"TCGA-23-1119-01A","0.8","072ba366-b5ad-46bd-ad87-e85057ca6bf7",FALSE,"86389912-6945-49e6-9255-e7a41fde197a","Primary Tumor","0.6",NA,NA,"0.8",1227657600,"02",161,"TCGA-23-1119-01A-02",95,90,NA,NA,0,0,0,0,"2016-09-08T12:19:19.305787-05:00","2016-09-08T12:19:19.305787-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"22ec8a4f-c913-4531-a71a-c6daaa6ad4f2","69056588-dd6a-4365-9780-e3344697ae99","TCGA-23-1119-01A-02-BS2","TCGA-23-1119-01A-01-BS1",0,0,"028b5d24-f4fe-4674-9d70-b97f2b01c9b7","RNA","TCGA-23-1119-01A-02R","6b1add57-a096-4048-bc25-b052a67b992d",1.8,0.16,"UV Spec","R","22","TCGA-23-1119-01A-02R-1565-13","a0e6000c-2e04-4e12-bce6-ef9c29f04252",0.16,NA,NA,NA,NA,"27739612-c539-5c16-af98-30d9a0a1cd32","TCGA-23-1119_exposure","TCGA-23-1119-01A-02R-1565-13_rnaseq_fastq.tar","2014-03-28T18:20:27.000Z","2014-03-28T18:40:01.000Z","81817638-4FA1-4E36-B96E-FD7456BCBDFB","072BA366-B5AD-46BD-AD87-E85057CA6BF7","Unaligned reads",6334474240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A0E6000C-2E04-4E12-BCE6-EF9C29F04252","Canada's Michael Smith Genome Sciences Centre","564a3a0ce4b09c884b23f223","2DFD8A0E-E642-49B3-ABD7-F0334927EEBB","Ovarian Serous Cystadenocarcinoma","TAR","028B5D24-F4FE-4674-9D70-B97F2B01C9B7","2014-03-28T18:40:01.000Z","6B1ADD57-A096-4048-BC25-B052A67B992D","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"028B5D24-F4FE-4674-9D70-B97F2B01C9B7",0.8,"23","TCGA-23-1119-01A-02T-0438-07.probe.tcga_level2.data.txt",NA,"TCGA-23-1119-01A",0.8,"F137B469-6105-4631-9476-7318DFA0DF61","TCGA",1997,NA,NA,"TUMOR FREE","B71F6803-79F6-457D-8792-9E4032B41AFF",64,"nationwidechildrens.org_clinical.TCGA-23-1119.xml","Alive",NA,"TCGA-23-1119","NOT HISPANIC OR LATINO","AD69CAA2-16B6-43A8-AA18-1569F9BD7522",NA,3953,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,161,"69056588-DD6A-4365-9780-E3344697AE99","F83BA0E7-1794-41F0-8BCD-5E7F3705067F","TCGA-23-1119-01A-02W-0484-10_SOLiD_whole_exome_extensions.bam","TCGA-23-1119-01A-02",90,0,NA,NA,0,"TOP",1,NA,"TCGA-23-1119-01A-01-BS1",0,"Carboplatin","Chemotherapy","TCGA-23-1119-D25713",NA,NA,NA,"TCGA-23-1119-F25711_NTE-2",NA,3953,"TUMOR FREE","Alive",NA,"TCGA-23-1119-F25711","TCGA-23-1119",NA,"23","1119","YES","C56.9","8441/3","C56.9",NA,NA,-23686,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",3953,NA,NA,NA,"TUMOR FREE","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,64,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
157106494,150967821,11133629635,"9AD4C328-1554-4C92-931C-30CE8F305FDE.bw","2ebb738c-4829-4720-931a-96c0fd117e2a","9ad4c328-1554-4c92-931c-30ce8f305fde","2016-08-25T18:28:54.757722-05:00","TCGA-13-0730-01A-01R-1564-13_rnaseq_fastq.tar","98965b76-4239-4777-93b2-3ce531b22de9",9472819200,"Illumina HiSeq","440156cdca1bbf4ed4de928173de1034","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:31:13.371914-05:00","2016-05-03T11:39:34.528512-05:00","98965b76-4239-4777-93b2-3ce531b22de9_analysis.xml","73f8641ab5b2905493a04cebe7f40bbf","2563425b-4b16-4604-a79e-a445e450cbba",2183,"2016-09-29T18:01:48.697399-05:00","98965b76-4239-4777-93b2-3ce531b22de9_experiment.xml","41059e8547a5f450760c9f87daf755f7","1322bc85-65c9-4cf4-8527-1909ac241db0",3916,"2016-09-29T22:06:41.636933-05:00","98965b76-4239-4777-93b2-3ce531b22de9_run.xml","f41bfcfb6b6c35f95113f7b18cd12f83","ab712498-a45c-41e6-be0a-5a48fce891dd",1990,"2016-09-08T13:52:07.838006-05:00","TCGA-13-0730","2016-09-02T19:09:37.327564-05:00","female","TCGA-13-0730_demographic",1932,"white","1049f24d-d521-549d-bda2-361501386994","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0730_diagnosis","not reported",26086,"dead","8441/3",542,NA,"fc0019a4-0e6b-5e7d-b8f7-e7a1d85c90e6","c56.9",-26086,"TCGA-13-0730_treatment","e37bbf48-7ace-5775-9bee-668d8cd94a3a","01",NA,"TCGA-13-0730-01A","0.6","bbe4ea81-6f31-4589-8797-b140bcb35d2b",FALSE,"2AF2844E-F1DC-4938-85D3-08B07BB9DCFF","Primary Tumor","0.4",NA,NA,"1.1",1233705600,"01",101,"TCGA-13-0730-01A-01",95,95,NA,NA,0,0,5,15,"2016-09-08T13:52:07.838006-05:00","2016-09-08T13:52:07.838006-05:00",50,50,50,50,"BOTTOM","TOP",5,5,"0d18e57d-ba4f-4185-84a0-dc9b489ed29f","fde90bcb-ed7b-45b6-954f-fbf94f6aa317","TCGA-13-0730-01A-01-BS1","TCGA-13-0730-01A-01-TS1",90,80,"043bee4f-3d2f-41dc-9dcd-bce9eac3bd48","RNA","TCGA-13-0730-01A-01R","c10d066e-3ea1-48f5-926b-e75052441108",1.8,0.17,"UV Spec","R","22","TCGA-13-0730-01A-01R-1564-13","754dfe07-22f4-4070-bbcb-10bfbb649def",0.17,NA,NA,NA,NA,"96d095c2-7a39-5f4d-9372-7f01af4742c7","TCGA-13-0730_exposure","TCGA-13-0730-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T04:35:54.000Z","2014-03-20T04:57:03.000Z","98965B76-4239-4777-93B2-3CE531B22DE9","BBE4EA81-6F31-4589-8797-B140BCB35D2B","Unaligned reads",9472819200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","754DFE07-22F4-4070-BBCB-10BFBB649DEF","Canada's Michael Smith Genome Sciences Centre","564a3709e4b09c884b230695","2EBB738C-4829-4720-931A-96C0FD117E2A","Ovarian Serous Cystadenocarcinoma","TAR","043BEE4F-3D2F-41DC-9DCD-BCE9EAC3BD48","2014-03-20T04:57:03.000Z","C10D066E-3EA1-48F5-926B-E75052441108","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"043BEE4F-3D2F-41DC-9DCD-BCE9EAC3BD48",0.6,"13","COTES_p_TCGAaffxB8_9a_S_GenomeWideSNP_6_H02_293066.ismpolish.data.txt",NA,"TCGA-13-0730-01A",1.1,NA,"TCGA",2003,NA,NA,NA,"BBE4EA81-6F31-4589-8797-B140BCB35D2B",71,"nationwidechildrens.org_clinical.TCGA-13-0730.xml","Dead",542,"TCGA-13-0730","NOT HISPANIC OR LATINO","CD6AEFB1-0800-4A90-9E3B-4248FD561A3B",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,101,"FDE90BCB-ED7B-45B6-954F-FBF94F6AA317","CFBC3445-181A-4FDD-8146-303AAE0431EC","TCGA-13-0730-01A-01R-1564-13.hg19.spljxn.quantification.txt","TCGA-13-0730-01A-01",95,0,NA,50,15,"TOP",5,50,"TCGA-13-0730-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Dead",542,"TCGA-13-0730-F60695","TCGA-13-0730",NA,"13","0730","YES","C56.9","8441/3","C56.9",NA,NA,-26086,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,542,NA,NA,NA,"NO",24,2,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2003,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
178403208,171601633,12659571757,"4D1518D9-D968-4E7F-A702-5157A1A2E83E.bw","2ee36d9d-128b-4761-aa1a-a637da106f3d","4d1518d9-d968-4e7f-a702-5157a1a2e83e","2016-08-25T01:39:12.523446-05:00","TCGA-25-1323-01A-01R-1565-13_rnaseq_fastq.tar","a28c5ef5-0458-4fe3-8fe5-1dbed31f30bd",11388825600,"Illumina HiSeq","b09197d94fc45120af4504c70236dbbf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:13:03.946565-05:00","2016-05-03T11:40:21.647690-05:00","a28c5ef5-0458-4fe3-8fe5-1dbed31f30bd_analysis.xml","93e83c5575cee3be066be538a6b3481c","af4ec286-e0c4-454a-acf6-43d4c90e65a6",2181,"2016-08-26T19:45:49.457848-05:00","a28c5ef5-0458-4fe3-8fe5-1dbed31f30bd_experiment.xml","3badcf610f39da1eab924a74d812e626","e36738d5-7e1d-4595-98fb-ed5e9c5043a6",3916,"2016-09-29T20:59:47.528369-05:00","a28c5ef5-0458-4fe3-8fe5-1dbed31f30bd_run.xml","138f4efb9c39794ddfef499611129dab","81d952b1-e65b-45d6-bcb1-11927f790928",1989,"2016-09-08T13:41:09.482909-05:00","TCGA-25-1323","2016-09-02T19:12:13.467669-05:00","female","TCGA-25-1323_demographic",1929,"white","b7f1ad25-47b4-5bb3-8f7d-332afedb0764","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1323_diagnosis","not reported",26602,"dead","8441/3",395,365,"b3861530-7540-5dbb-af8a-d27f40d5b8d0","c56.9",-26602,"TCGA-25-1323_treatment","74ed6bfb-fdc9-586d-aa2b-cfb506e7dcff","01",NA,"TCGA-25-1323-01A","2","b1d85c32-1698-44ed-a4e2-707611a3889c",FALSE,"AFE55BB2-F0FC-4B39-A61A-2287B62354AD","Primary Tumor","0.6",NA,NA,"2.5",1228435200,"01",153,"TCGA-25-1323-01A-01",80,75,NA,NA,20,0,0,25,"2016-09-08T13:41:09.482909-05:00","2016-09-08T13:41:09.482909-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,10,"a8ee5dae-63b9-4972-be8b-e1ad21e2d3c4","a400c51c-77e2-41e2-be66-b1c4cd67cf7a","TCGA-25-1323-01A-01-TS1","TCGA-25-1323-01A-01-BS1",70,65,"5d5e4f4d-42bb-4e25-b49f-f8ec56373dde","RNA","TCGA-25-1323-01A-01R","b34cf67c-f650-448b-885c-63fcb2fdc8b1",1.8,0.15,"UV Spec","R","22","TCGA-25-1323-01A-01R-1565-13","cd401b89-ae05-4775-94b0-6800f88652b0",0.15,NA,NA,NA,NA,"c8fdb513-7409-5227-81ed-665c0f824b66","TCGA-25-1323_exposure","TCGA-25-1323-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:41:03.000Z","2014-03-22T03:06:01.000Z","A28C5EF5-0458-4FE3-8FE5-1DBED31F30BD","B1D85C32-1698-44ED-A4E2-707611A3889C","Unaligned reads",11388825600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CD401B89-AE05-4775-94B0-6800F88652B0","Canada's Michael Smith Genome Sciences Centre","564a5beee4b09c884b27bb80","2EE36D9D-128B-4761-AA1A-A637DA106F3D","Ovarian Serous Cystadenocarcinoma","TAR","5D5E4F4D-42BB-4E25-B49F-F8EC56373DDE","2014-03-22T03:06:01.000Z","B34CF67C-F650-448B-885C-63FCB2FDC8B1","None","NO",1,0.6,"Primary Tumor","Mayo Clinic - Rochester",NA,"5D5E4F4D-42BB-4E25-B49F-F8EC56373DDE",2,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e89ce7f4-4c3f-4c48-a222-506d3806ad33.txt",NA,"TCGA-25-1323-01A",2.5,"BFD7343E-9A15-493C-9B9D-0895F18FDE09","TCGA",2001,NA,NA,"WITH TUMOR","B1D85C32-1698-44ED-A4E2-707611A3889C",72,"nationwidechildrens.org_clinical.TCGA-25-1323.xml","Dead",395,"TCGA-25-1323","NOT HISPANIC OR LATINO","7DCA5A46-41D3-4C92-BFBC-FF6A771731A1",NA,365,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,153,"A400C51C-77E2-41E2-BE66-B1C4CD67CF7A","B34CF67C-F650-448B-885C-63FCB2FDC8B1","TCGA-25-1323-01A-01R-1565-13_GRCh37-lite_rnaseq.bam","TCGA-25-1323-01A-01",80,20,NA,NA,0,"TOP",10,NA,"TCGA-25-1323-01A-01-TS1",70,"Taxol","Chemotherapy","TCGA-25-1323-D26682",NA,NA,NA,"TCGA-25-1323-F26680_NTE-1",NA,365,"WITH TUMOR","Dead",395,"TCGA-25-1323-F26680","TCGA-25-1323",NA,"25","1323","YES","C56.9","8441/3","C56.9",NA,NA,-26602,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",365,395,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,72,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
184283706,179145098,13207807107,"A6E8AF8C-5D7B-4197-990B-786A869ACB96.bw","3018efe7-13a1-47ae-a726-8fc967c73841","a6e8af8c-5d7b-4197-990b-786a869acb96","2016-08-26T01:00:00.468627-05:00","TCGA-24-1430-01A-01R-1566-13_rnaseq_fastq.tar","d815601a-7db6-4241-84dd-01b9e3a590af",11192207360,"Illumina HiSeq","8f73a5ed22dfb81693cecc07809d5dbe","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:12:01.022051-05:00","2016-05-03T11:40:21.662944-05:00","d815601a-7db6-4241-84dd-01b9e3a590af_analysis.xml","74e3eb1448db9e339dbf0cf23dc6c340","d3e943bf-2174-498b-9bf2-53f9ad92b873",2181,"2016-09-29T20:08:05.696185-05:00","d815601a-7db6-4241-84dd-01b9e3a590af_experiment.xml","e77f2c6d7a7ebb5abf048bc97daa8ea9","62029919-0c4b-4e71-855b-9116ba4c1feb",3916,"2016-09-30T00:13:44.004194-05:00","d815601a-7db6-4241-84dd-01b9e3a590af_run.xml","e84786bf78063b5ed2eb53cb1507b9ef","fa0bb00e-a558-4596-9580-67094bccaac5",1988,"2016-09-08T10:35:24.756938-05:00","TCGA-24-1430","2016-09-02T19:13:36.533260-05:00","female","TCGA-24-1430_demographic",1932,"white","a7a4f433-78e4-5763-b441-d0eb0f1eb85f","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1430_diagnosis","not reported",24939,"dead","8441/3",863,863,"2a0f08c5-3c4b-577d-927e-0626042b4204","c56.9",-24939,"TCGA-24-1430_treatment","5b1f79c6-9afc-5ccc-b844-1230f88cf803","01",NA,"TCGA-24-1430-01A","1.7","eb401991-7a9a-494a-8f7c-072f39e40ec2",FALSE,"d0f95ced-e33f-4796-a6a4-3030f8e21761","Primary Tumor","0.8",NA,NA,"2",1232409600,"01",153,"TCGA-24-1430-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T10:35:24.756938-05:00","2016-09-08T10:35:24.756938-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"da84d3c2-9588-4907-9a03-4ea2847621aa","206fc526-1f7c-49f7-84b3-26ed0be0b14e","TCGA-24-1430-01A-01-BS1","TCGA-24-1430-01A-01-TS1",95,95,"511a763d-60f4-413f-a80e-510336b83668","RNA","TCGA-24-1430-01A-01R","777f285b-2ead-49df-88bc-ed992027d40a",1.8,0.15,"UV Spec","R","22","TCGA-24-1430-01A-01R-1566-13","4c19d12e-0160-4d01-b621-65335156488b",0.15,NA,NA,NA,NA,"c0fbca74-5e83-5463-a75e-109ecf40b36e","TCGA-24-1430_exposure","TCGA-24-1430-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T02:32:48.000Z","2014-03-25T02:54:02.000Z","D815601A-7DB6-4241-84DD-01B9E3A590AF","EB401991-7A9A-494A-8F7C-072F39E40EC2","Unaligned reads",11192207360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4C19D12E-0160-4D01-B621-65335156488B","Canada's Michael Smith Genome Sciences Centre","564a5c78e4b08c5d86956379","3018EFE7-13A1-47AE-A726-8FC967C73841","Ovarian Serous Cystadenocarcinoma","TAR","511A763D-60F4-413F-A80E-510336B83668","2014-03-25T02:54:02.000Z","777F285B-2EAD-49DF-88BC-ED992027D40A","None","NO",1,0.8,"Primary Tumor","Washington University",NA,"511A763D-60F4-413F-A80E-510336B83668",1.7,"24","bcgsc.ca.TCGA-24-1430-01A-01R-1566-13.hg19.bcgsc.ca.1.7.0.sv.vcf",NA,"TCGA-24-1430-01A",2,"CBAF76A6-AE77-42D5-8FF7-FDC31B7A31BB","TCGA",2000,NA,NA,"WITH TUMOR","EB401991-7A9A-494A-8F7C-072F39E40EC2",68,"nationwidechildrens.org_clinical.TCGA-24-1430.xml","Dead",863,"TCGA-24-1430",NA,"A1FBFC62-641E-41CD-BEBB-0044B8433A52",NA,863,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,153,"DA84D3C2-9588-4907-9A03-4EA2847621AA","E814A287-D662-4EC5-A77D-2035B9A7CBA3","TCGA-24-1430-01A-01R-1566-13_GRCh37-lite_mirna.bam","TCGA-24-1430-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-24-1430-01A-01-TS1",95,"Doxil","Chemotherapy","TCGA-24-1430-D25974",NA,NA,NA,"TCGA-24-1430-F25966_NTE-1",NA,863,"WITH TUMOR","Dead",863,"TCGA-24-1430-F25966","TCGA-24-1430",NA,"24","1430","YES","C56.9","8441/3","C56.9",NA,NA,-24939,"FEMALE","WHITE",NA,NA,"No","Dead",863,863,NA,NA,"WITH TUMOR","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
105669418,98447750,7200362552,"DF8B4E19-8C78-4A68-8FAE-DFF01076BC97.bw","31872f6a-d225-4f91-b38d-4505d19e406c","df8b4e19-8c78-4a68-8fae-dff01076bc97","2016-09-29T23:30:51.334991-05:00","TCGA-04-1338-01A-01R-1564-13_rnaseq_fastq.tar","0a8e9c11-c96c-408d-8c14-3717481d83f5",6350776320,"Illumina HiSeq","ae738e2d482deb963ea97b9632b39187","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:23:35.977380-05:00","2016-05-03T11:41:05.750744-05:00","0a8e9c11-c96c-408d-8c14-3717481d83f5_analysis.xml","f07cba7e2b445414e928b4285cae5468","468d68a0-ee2f-4fb3-9de1-49a21bf2976e",2235,"2016-10-07T16:14:35.624741-05:00","0a8e9c11-c96c-408d-8c14-3717481d83f5_experiment.xml","a321215424df5213c923c360634a1f52","957b42f1-a0bf-47e7-86fd-ecd7ea1397a2",3916,"2016-09-29T21:55:04.901310-05:00","0a8e9c11-c96c-408d-8c14-3717481d83f5_run.xml","e3750c6a543c8eea5f7e141ca466c8c1","a44f3c52-71a2-4578-8263-1cb853d46f37",1988,"2016-09-08T12:54:50.043074-05:00","TCGA-04-1338","2016-09-02T19:05:44.841979-05:00","female","TCGA-04-1338_demographic",1927,"white","e8692f76-bc92-57a4-9d02-6ea94d74b7b9","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1338_diagnosis","not reported",28789,"alive","8441/3",NA,1418,"5a6c0be4-e300-56d1-85c2-bb11bf6409b8","c56.9",-28789,"TCGA-04-1338_treatment","281b59c3-bf65-5194-ae83-64187eba70fc","01",NA,"TCGA-04-1338-01A","1","7b90d4ab-6c0a-4428-9ef1-20c7c09ff9e7",FALSE,"889AF2DB-7FF9-45B1-8FD4-28D57CF870A7","Primary Tumor","0.4",NA,NA,"1.5",1229644800,"01",114,"TCGA-04-1338-01A-01",85,85,NA,NA,NA,NA,40,30,"2016-09-08T12:54:50.043074-05:00","2016-09-08T12:54:50.043074-05:00",NA,NA,NA,NA,"BOTTOM","TOP",15,15,"7f2ab5c1-f165-468c-a413-b45b4059bb6f","33f6254c-7df6-4570-b2df-1dde268a9d64","TCGA-04-1338-01A-01-BS1","TCGA-04-1338-01A-01-TS1",45,55,"5c45b224-f1b7-4423-aac9-cc8dbfc84e55","RNA","TCGA-04-1338-01A-01R","53c75a9b-d341-43d1-9425-566d93e2cd98",1.7,0.16,"UV Spec","R","22","TCGA-04-1338-01A-01R-1564-13","ad64ff86-b39c-4704-823d-98fcefd88db6",0.16,NA,NA,NA,NA,"bf7ec4bf-3ce0-5d43-9f58-0df88ae78155","TCGA-04-1338_exposure","TCGA-04-1338-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T17:43:58.000Z","2014-03-28T17:59:02.000Z","0A8E9C11-C96C-408D-8C14-3717481D83F5","7B90D4AB-6C0A-4428-9EF1-20C7C09FF9E7","Unaligned reads",6350776320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AD64FF86-B39C-4704-823D-98FCEFD88DB6","Canada's Michael Smith Genome Sciences Centre","564a5c74e4b0ef12181e559f","31872F6A-D225-4F91-B38D-4505D19E406C","Ovarian Serous Cystadenocarcinoma","TAR","5C45B224-F1B7-4423-AAC9-CC8DBFC84E55","2014-03-28T17:59:02.000Z","53C75A9B-D341-43D1-9425-566D93E2CD98","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"5C45B224-F1B7-4423-AAC9-CC8DBFC84E55",1,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ee14145d-2ec8-4323-804e-c0a15371559b.txt",NA,"TCGA-04-1338-01A",1.5,"C40BA7F9-061D-493A-B88E-70B482FDB3BE","TCGA",2005,NA,NA,"WITH TUMOR","7B90D4AB-6C0A-4428-9EF1-20C7C09FF9E7",78,"nationwidechildrens.org_clinical.TCGA-04-1338.xml","Alive",NA,"TCGA-04-1338","NOT HISPANIC OR LATINO","A1D5C870-53E2-4DCF-91B7-2EDAF75E8168",NA,1418,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,114,"7F2AB5C1-F165-468C-A413-B45B4059BB6F","FBC3D2CE-F158-4946-A5D2-58D48C8FAB23","TCGA-04-1338-01A-01R-1564-13_rnaseq_fastq.tar","TCGA-04-1338-01A-01",85,NA,NA,NA,40,"BOTTOM",15,NA,"TCGA-04-1338-01A-01-BS1",45,"Taxol","Chemotherapy","TCGA-04-1338-D23935",NA,NA,NA,"TCGA-04-1338-F23933_NTE-1",NA,1418,"WITH TUMOR","Alive",NA,"TCGA-04-1338-F23933","TCGA-04-1338",NA,"04","1338","YES","C56.9","8441/3","C56.9",NA,NA,-28789,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1418,NA,NA,NA,"WITH TUMOR","NO",14,7,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,78,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
237610618,221452130,16258988454,"8D2C608F-3280-4CA2-B996-9AE3DBDBBD28.bw","32960bc7-839a-42c5-9460-3917fa578ffc","8d2c608f-3280-4ca2-b996-9ae3dbdbbd28","2016-09-29T21:17:49.047142-05:00","TCGA-13-0726-01A-01R-1564-13_rnaseq_fastq.tar","6df36198-dec6-4b86-aa92-7d8530287bb5",15471247360,"Illumina HiSeq","8c8acfe602d5acd80af6e82e60645cf9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:09:57.217882-05:00","2016-05-03T11:27:59.332723-05:00","6df36198-dec6-4b86-aa92-7d8530287bb5_analysis.xml","0f6938c17cab8f18a1e1d45cffb21795","884b64c6-2801-4ccc-8852-364d599cfe12",2210,"2016-08-26T02:14:37.170950-05:00","6df36198-dec6-4b86-aa92-7d8530287bb5_experiment.xml","89dfc714a9368fecdbd782eb7d650898","216538a7-2729-443b-837f-a9e03900eb20",3916,"2016-09-29T20:27:29.912346-05:00","6df36198-dec6-4b86-aa92-7d8530287bb5_run.xml","7c8f9c5331c9c448be18b7b0cd813834","6de15fc9-05f9-4ab5-9b50-349bb1f158a0",1990,"2016-09-08T13:18:55.034421-05:00","TCGA-13-0726","2016-09-02T19:09:37.881217-05:00","female","TCGA-13-0726_demographic",1947,"white","056db782-ad0b-5cfe-9fe5-55f48edf37d0","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0726_diagnosis","not reported",20134,"dead","8441/3",949,946,"ed0b214c-e415-5615-bfad-27541c16d7bd","c56.9",-20134,"TCGA-13-0726_treatment","a659d0d0-4cd3-5dfa-82bf-b1f1d7eae1bb","01",NA,"TCGA-13-0726-01A","1","391c5d58-68fd-4e17-a095-ebb94d32bf58",FALSE,"7165A995-69AE-4D74-9437-02C4730701C1","Primary Tumor","0.4",NA,NA,"1.5",1233705600,"01",131,"TCGA-13-0726-01A-01",80,90,NA,NA,0,0,40,30,"2016-09-08T13:18:55.034421-05:00","2016-09-08T13:18:55.034421-05:00",NA,50,NA,50,"BOTTOM","TOP",0,0,"a58bbed2-b315-4182-8965-023c55e37725","2a8707fc-2d7b-459a-9707-96c5b4e11f43","TCGA-13-0726-01A-01-BS1","TCGA-13-0726-01A-01-TS1",60,70,"4983a34b-1877-47b1-95ef-59d896a54e74","RNA","TCGA-13-0726-01A-01R","97116276-2869-4411-8c04-15f3723c9f10",1.8,0.17,"UV Spec","R","22","TCGA-13-0726-01A-01R-1564-13","3dd100f9-9261-4e1c-9bbb-95a2c56abfb6",0.17,NA,NA,NA,NA,"a2927499-22fb-56fe-9c9e-f8bc995b9b61","TCGA-13-0726_exposure","TCGA-13-0726-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T21:54:59.000Z","2013-12-20T22:22:01.000Z","6DF36198-DEC6-4B86-AA92-7D8530287BB5","391C5D58-68FD-4E17-A095-EBB94D32BF58","Unaligned reads",15471247360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3DD100F9-9261-4E1C-9BBB-95A2C56ABFB6","Canada's Michael Smith Genome Sciences Centre","564a5744e4b0298dd2cacbf9","32960BC7-839A-42C5-9460-3917FA578FFC","Ovarian Serous Cystadenocarcinoma","TAR","4983A34B-1877-47B1-95EF-59D896A54E74","2013-12-20T22:22:01.000Z","97116276-2869-4411-8C04-15F3723C9F10","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"4983A34B-1877-47B1-95EF-59D896A54E74",1,"13","COTES_p_TCGAaffxB8_9a_S_GenomeWideSNP_6_G06_293050.byallele.copynumber.data.txt",NA,"TCGA-13-0726-01A",1.5,"9297737F-6669-4C71-858D-095117428338","TCGA",2002,NA,NA,"WITH TUMOR","6B9E362D-8F7C-4C04-9275-E92500591908",55,"dda74474d98ed32b9eae17afcf9b3d81.bam.bai","Dead",949,"TCGA-13-0726","NOT HISPANIC OR LATINO","B95035B9-C865-4FE8-88C3-F5723EA3AD15",NA,946,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,131,"A58BBED2-B315-4182-8965-023C55E37725","FBDD761C-1017-4C32-B23F-24A61A35D0F2","TCGA-13-0726-01A-01R-1564-13.hg19.exon.quantification.txt","TCGA-13-0726-01A-01",80,0,NA,NA,40,"BOTTOM",0,NA,"TCGA-13-0726-01A-01-BS1",60,"Carboplatin","Chemotherapy","TCGA-13-0726-D24516",NA,NA,NA,"TCGA-13-0726-F24515_NTE-1",NA,946,"WITH TUMOR","Dead",949,"TCGA-13-0726-F24515","TCGA-13-0726",NA,"13","0726","YES","C56.9","8441/3","C56.9",NA,NA,-20134,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",946,949,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,2002,"Tumor resection",NA,NA,NA,"GX",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158341910,155895745,11544698788,"E7BCBD8D-1219-4A99-948A-47A258A5CD8B.bw","32d4d200-1fdf-44ed-b81f-1954a9c93926","e7bcbd8d-1219-4a99-948a-47a258a5cd8b","2016-08-26T22:28:30.072493-05:00","TCGA-09-1667-01C-01R-1566-13_rnaseq_fastq.tar","412ee7ec-eb0e-4e3d-8c2c-bf9a17a113d6",9610168320,"Illumina HiSeq","f4f10775c60b4ce7846a3aa1d8588ae4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:44:58.632632-05:00","2016-05-03T11:40:21.662944-05:00","412ee7ec-eb0e-4e3d-8c2c-bf9a17a113d6_analysis.xml","e5fe04b89f567a532cd621a5362ecca8","789e5f4d-d6c7-43f2-abef-71dd27d25ef6",2181,"2016-10-07T17:21:41.937846-05:00","412ee7ec-eb0e-4e3d-8c2c-bf9a17a113d6_experiment.xml","a47fe5492ff3d936e5182f875dbbcbe9","624f826c-356b-4d64-953b-8dce9f72491c",3916,"2016-09-29T21:29:14.290476-05:00","412ee7ec-eb0e-4e3d-8c2c-bf9a17a113d6_run.xml","91394a43b8be7c853219e2042a68b49d","94532554-6126-4f97-b992-965bed9a3855",1988,"2016-09-08T10:27:14.824617-05:00","TCGA-09-1667","2016-09-02T18:47:35.863877-05:00","female","TCGA-09-1667_demographic",1943,"white","74bea85c-1cac-5272-9bd3-f20fe9ca3b0d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1667_diagnosis","not reported",22306,"alive","8441/3",NA,1882,"a6b591a1-0fe2-54bb-b79b-392e1358cdb7","c56.9",-22306,"TCGA-09-1667_treatment","dd668383-cf24-5d47-9ef7-1cc2f70f508a","01",NA,"TCGA-09-1667-01C","0.7","111f607f-5b87-4595-9aa7-df9381717bee",FALSE,"0f3fbc34-6dce-467f-a837-442815ebc159","Primary Tumor","0.4",NA,NA,"1",1240185600,"01",106,"TCGA-09-1667-01C-01",90,90,NA,NA,0,5,7,7,"2016-09-08T10:27:14.824617-05:00","2016-09-08T10:27:14.824617-05:00",NA,NA,NA,NA,"BOTTOM","TOP",3,5,"162cb788-9ff3-4ebb-a5e3-8e476026a4db","0a437844-e107-4238-9bf7-3200ff7da548","TCGA-09-1667-01C-01-BS1","TCGA-09-1667-01C-01-TS1",90,83,"ad4d286b-f0e0-475d-af62-263c9eefbcd1","RNA","TCGA-09-1667-01C-01R","bbf6b49c-d014-42ab-8bab-b8e8725e7107",1.8,0.16,"UV Spec","R","22","TCGA-09-1667-01C-01R-1566-13","9b7a1eb0-014f-4cd6-bde8-fd96131fac3e",0.16,NA,NA,NA,NA,"921d5cd3-9c33-5b6a-8cde-75bb5d780b39","TCGA-09-1667_exposure","TCGA-09-1667-01C-01R-1566-13_rnaseq_fastq.tar","2014-03-25T01:10:36.000Z","2014-03-25T01:37:02.000Z","412EE7EC-EB0E-4E3D-8C2C-BF9A17A113D6","111F607F-5B87-4595-9AA7-DF9381717BEE","Unaligned reads",9610168320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9B7A1EB0-014F-4CD6-BDE8-FD96131FAC3E","Canada's Michael Smith Genome Sciences Centre","564a378de4b09c884b232f1f","32D4D200-1FDF-44ED-B81F-1954A9C93926","Ovarian Serous Cystadenocarcinoma","TAR","AD4D286B-F0E0-475D-AF62-263C9EEFBCD1","2014-03-25T01:37:02.000Z","BBF6B49C-D014-42AB-8BAB-B8E8725E7107","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"AD4D286B-F0E0-475D-AF62-263C9EEFBCD1",0.7,"09","TCGA-09-1667-01C-01R-1566-13.hg19.spljxn.quantification.txt",NA,"TCGA-09-1667-01C",1,"75FE69A4-BE66-4430-83BB-26C8E6FC4E3A","TCGA",2004,NA,NA,"WITH TUMOR","A92B7CB8-0FEB-4F8B-ABB7-50DB8E0FAFAA",61,"nationwidechildrens.org_clinical.TCGA-09-1667.xml","Alive",NA,"TCGA-09-1667","NOT HISPANIC OR LATINO","8BED668F-C2DE-4768-9BB9-FF8ADF3D84E3",NA,1882,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,"6929C2C5-1340-4667-A59F-BA92F9C89D11","WHITE",NA,1,106,"162CB788-9FF3-4EBB-A5E3-8E476026A4DB","F2E12C6B-2ADC-4AD5-939B-32E245B6284A","US82800149_251976010739_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","TCGA-09-1667-01C-01",90,5,NA,NA,7,"TOP",5,NA,"TCGA-09-1667-01C-01-TS1",83,"Carboplatin","Chemotherapy","TCGA-09-1667-D24293","TCGA-09-1667-R24298","EXTERNAL BEAM","Local Recurrence","TCGA-09-1667-F24292_NTE-2",NA,1882,"WITH TUMOR","Alive",NA,"TCGA-09-1667-F24292","TCGA-09-1667",NA,"09","1667","YES","C56.9","8441/3","C56.9",NA,NA,-22306,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1882,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2004,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
225546478,218038339,16156067356,"2C9633A5-8ACB-4D16-8120-F098BA14BB04.bw","33d36b64-4688-40a7-9a4f-7cd3d4cc683d","2c9633a5-8acb-4d16-8120-f098ba14bb04","2016-08-25T11:06:50.347828-05:00","TCGA-29-1695-01A-01R-1567-13_rnaseq_fastq.tar","75a15e3e-d333-4cf4-8b44-e4a73144fa10",15119482880,"Illumina HiSeq","1934535d9ea77f1788b1408cd039f69e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:46:19.044507-05:00","2016-05-03T11:41:05.750744-05:00","75a15e3e-d333-4cf4-8b44-e4a73144fa10_analysis.xml","8b2339d263ef60707b44a07cc51ab627","c3e9f10b-6228-44f8-aa36-9d617bf4caf4",2181,"2016-08-13T03:00:49.512048-05:00","75a15e3e-d333-4cf4-8b44-e4a73144fa10_experiment.xml","3fce12250f562c0d0fdcc577c9e34be4","c244a5e0-14fe-4ef9-b49d-2f52a032a00f",3916,"2016-09-29T19:42:52.920337-05:00","75a15e3e-d333-4cf4-8b44-e4a73144fa10_run.xml","9ab0ed8690e21574e406a09a8c9c8d39","527d1419-08cf-487e-afdd-3bbedb0b6ecb",1989,"2016-09-08T13:11:53.936323-05:00","TCGA-29-1695","2016-09-02T19:07:37.852968-05:00","female","TCGA-29-1695_demographic",1941,"white","dce94daf-399a-5bdc-9190-563469a5a908","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1695_diagnosis","not reported",22895,"dead","8441/3",1229,24,"545dae36-7e9c-574c-81a8-71ad91172902","c56.9",-22895,"TCGA-29-1695_treatment","5e98915f-9215-5b0f-a8d2-af86dff4b291","01",NA,"TCGA-29-1695-01A","1","7a1db005-662a-4df4-886a-ec3319bde99a",FALSE,"136a4380-2a2a-489f-8675-886e876f17f7","Primary Tumor","0.4",NA,NA,"1.1",1241740800,"01",105,"TCGA-29-1695-01A-01",85,85,NA,NA,0,0,0,0,"2016-09-08T13:11:53.936323-05:00","2016-09-08T13:11:53.936323-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,2,"7fd5b824-6a98-4ed3-b6e9-6564b12229a6","06ff1b46-dadd-4aa2-a606-8ef843d8374e","TCGA-29-1695-01A-01-TS1","TCGA-29-1695-01A-01-BS1",100,98,"8afbcc19-d83a-4a21-b86d-ad40ae810dce","RNA","TCGA-29-1695-01A-01R","dd5d2660-13c3-416f-8a07-fe77accd6b78",1.8,0.15,"UV Spec","R","22","TCGA-29-1695-01A-01R-1567-13","33f1dda6-7601-48c6-b46d-f0ba759e4048",0.15,NA,NA,NA,NA,"d05c7fd0-0c7b-523b-b508-242d1b7072e9","TCGA-29-1695_exposure","TCGA-29-1695-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T18:14:14.000Z","2014-03-28T18:47:02.000Z","75A15E3E-D333-4CF4-8B44-E4A73144FA10","7A1DB005-662A-4DF4-886A-EC3319BDE99A","Unaligned reads",15119482880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","33F1DDA6-7601-48C6-B46D-F0BA759E4048","Canada's Michael Smith Genome Sciences Centre","564a57b6e4b08c5d86940359","33D36B64-4688-40A7-9A4F-7CD3D4CC683D","Ovarian Serous Cystadenocarcinoma","TAR","8AFBCC19-D83A-4A21-B86D-AD40AE810DCE","2014-03-28T18:47:02.000Z","DD5D2660-13C3-416F-8A07-FE77ACCD6B78","None","NO",1,0.4,"Primary Tumor","Duke",NA,"8AFBCC19-D83A-4A21-B86D-AD40AE810DCE",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.997dba94-b0d4-4872-b93b-d561f71f6ba3.txt",NA,"TCGA-29-1695-01A",1.1,NA,"TCGA",2003,NA,NA,NA,"F80016F2-3605-4A04-99B0-0E0D3DCF5BCD",62,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.997dba94-b0d4-4872-b93b-d561f71f6ba3.txt","Dead",1229,"TCGA-29-1695",NA,"1A796FC4-467E-422F-B7BF-D9857180BAFA",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,105,"7FD5B824-6A98-4ED3-B6E9-6564B12229A6","DD5D2660-13C3-416F-8A07-FE77ACCD6B78","TCGA-29-1695-01A-01R-1567-13_mirna.bam.bai","TCGA-29-1695-01A-01",85,0,NA,NA,0,"BOTTOM",2,NA,"TCGA-29-1695-01A-01-BS1",98,NA,NA,NA,NA,NA,NA,NA,NA,24,NA,"Dead",1229,"TCGA-29-1695-F27204","TCGA-29-1695",NA,"29","1695","YES","C56.9","8441/3","C56.9",NA,NA,-22895,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1229,NA,NA,NA,"NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,62,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
199596112,194288034,14384934588,"985D9304-E4DA-4038-B235-067CBFEAC902.bw","33dc48d8-2e01-482b-944c-ac10da727ec9","985d9304-e4da-4038-b235-067cbfeac902","2016-08-25T17:38:46.799143-05:00","TCGA-61-2003-01A-01R-1568-13_rnaseq_fastq.tar","b8c84b67-9438-4b83-b194-371871110654",12428810240,"Illumina HiSeq","27cec8e3b3059f60cce59ad582ac43ba","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:57:11.483114-05:00","2016-05-03T11:56:42.628342-05:00","b8c84b67-9438-4b83-b194-371871110654_analysis.xml","3cb3e35d0cf5660298453387615d53f8","a5a00d34-bda6-4b53-b1bd-2006ee485a93",2181,"2016-09-29T19:40:59.041793-05:00","b8c84b67-9438-4b83-b194-371871110654_experiment.xml","226c471ec900f178b5daf416932d828a","51522482-c9aa-4f57-a087-e57f907359d1",3916,"2016-09-29T23:35:21.365766-05:00","b8c84b67-9438-4b83-b194-371871110654_run.xml","aa40543747d778adf61181846d34ce00","e25789a1-a7fb-44d3-97ae-e3e779838ec6",1988,"2016-09-08T11:48:48.198395-05:00","TCGA-61-2003","2016-09-02T18:56:11.113659-05:00","female","TCGA-61-2003_demographic",1955,"white","08fce3da-3c8e-5e7f-9af4-734444e2919c","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2003_diagnosis","not reported",19605,"alive","8441/3",NA,122,"ad8f87df-db51-56a1-840d-89f7e394ab23","c56.9",-19605,"TCGA-61-2003_treatment","82bf33a9-33b0-5f3c-a260-0f9e0bc340ec","01",NA,"TCGA-61-2003-01A","1.4","74826da0-ddc4-49b0-bcb5-591691f4f8d6",FALSE,"79c66510-6e38-470f-9e91-d774665d39a6","Primary Tumor","0.2",NA,NA,"1.5",1247443200,"01",120,"TCGA-61-2003-01A-01",95,95,NA,NA,7,7,5,5,"2016-09-08T11:48:48.198395-05:00","2016-09-08T11:48:48.198395-05:00",NA,NA,NA,NA,"BOTTOM","TOP",3,3,"a8771b76-02b4-418e-b9a6-2282807606e4","4a075378-e3da-4b3b-abea-c75c6acfd895","TCGA-61-2003-01A-01-BS1","TCGA-61-2003-01A-01-TS1",85,85,"44425f5b-5bc1-49eb-82a9-62d70f2d62cb","RNA","TCGA-61-2003-01A-01R","81528da3-2c99-4867-92a6-1de2bab7d84a",1.8,0.14,"UV Spec","R","22","TCGA-61-2003-01A-01R-1568-13","bc200f3a-6d31-4480-8785-987f14cfa319",0.14,NA,NA,NA,NA,"ece39e17-c89f-5d1e-af91-deed3a6767b7","TCGA-61-2003_exposure","TCGA-61-2003-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T14:57:44.000Z","2014-08-27T16:47:45.000Z","B8C84B67-9438-4B83-B194-371871110654","74826DA0-DDC4-49B0-BCB5-591691F4F8D6","Unaligned reads",12428810240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BC200F3A-6D31-4480-8785-987F14CFA319","Canada's Michael Smith Genome Sciences Centre","564a3f1ae4b0ef12181b9ee2","33DC48D8-2E01-482B-944C-AC10DA727EC9","Ovarian Serous Cystadenocarcinoma","TAR","44425F5B-5BC1-49EB-82A9-62D70F2D62CB","2014-08-27T16:47:45.000Z","81528DA3-2C99-4867-92A6-1DE2BAB7D84A","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"44425F5B-5BC1-49EB-82A9-62D70F2D62CB",1.4,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.379f3f36-fb28-4eb4-8c56-24c0382bf38f.txt",NA,"TCGA-61-2003-01A",1.5,"C055893D-8966-4ACA-8D83-54C687FA097F","TCGA",2008,NA,NA,"WITH TUMOR","9B3C403F-5A13-49B8-B238-9E5244101317",53,"nationwidechildrens.org_clinical.TCGA-61-2003.xml","Alive",NA,"TCGA-61-2003","NOT HISPANIC OR LATINO","B31360A4-1E89-4989-A36B-11F5E8817B5D",NA,122,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,120,"A8771B76-02B4-418E-B9A6-2282807606E4","B0AF0D0E-0EED-4B6A-AC0C-3C96E5DAB523","TCGA-61-2003-01A-01R-1568-13_mirna.bam","TCGA-61-2003-01A-01",95,7,NA,NA,5,"BOTTOM",3,NA,"TCGA-61-2003-01A-01-BS1",85,"Carboplatin","Chemotherapy","TCGA-61-2003-D28332",NA,NA,NA,NA,NA,122,"WITH TUMOR","Alive",NA,"TCGA-61-2003-F28327","TCGA-61-2003",NA,"61","2003","YES","C56.9","8441/3","C56.9",NA,NA,-19605,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",122,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
163216682,159789062,11806326845,"D34CE243-6F4F-4158-9FC4-77E1640E8A91.bw","3445c524-5a37-40b6-8614-956d76eed939","d34ce243-6f4f-4158-9fc4-77e1640e8a91","2016-08-26T14:54:55.685818-05:00","TCGA-36-1576-01A-01R-1566-13_rnaseq_fastq.tar","39039a6c-cbbe-4926-973b-e88c3a4a653c",9706741760,"Illumina HiSeq","d97e10dc06c761181e0067282b74f19e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:04:07.029571-05:00","2016-05-03T11:39:34.528512-05:00","39039a6c-cbbe-4926-973b-e88c3a4a653c_analysis.xml","db99049e1c4e283b89b10cadfa07b457","3a4b4bdb-ece5-4ae1-ab53-f75ac98cacb3",2181,"2016-08-28T22:28:06.462106-05:00","39039a6c-cbbe-4926-973b-e88c3a4a653c_experiment.xml","37897c3cfd03b0538e03a7148dd620dc","74ba3d60-43c2-4991-9249-26ddf2c8f4ec",3916,"2016-09-29T20:37:51.208233-05:00","39039a6c-cbbe-4926-973b-e88c3a4a653c_run.xml","2deab113bd8da48a064292ffeea0627a","7421a85d-37b9-48db-a705-6a6761a07657",1988,"2016-09-08T11:07:37.513630-05:00","TCGA-36-1576","2016-09-02T18:53:42.724998-05:00","female","TCGA-36-1576_demographic",1930,"not reported","c18e2936-9d87-546c-a5a8-35e127f24d64","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1576_diagnosis","not reported",27778,"alive","8441/3",NA,915,"12f10f5c-d361-5f22-9b2e-011d487caa6b","c56.9",-27778,"TCGA-36-1576_treatment","dff8e585-7ede-5263-b007-1a6ec4555f91","01",NA,"TCGA-36-1576-01A","1","24ffa457-5765-43c1-8cdd-b50a31dc5b56",FALSE,"2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f","Primary Tumor","0.4",NA,NA,"2.6",1235952000,"01",118,"TCGA-36-1576-01A-01",95,95,NA,NA,0,0,10,10,"2016-09-08T11:07:37.513630-05:00","2016-09-08T11:07:37.513630-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"683327b5-b127-439f-9a47-6bf7f1d01203","82732edc-569c-4b5c-80d5-31f530cd30aa","TCGA-36-1576-01A-01-TS1","TCGA-36-1576-01A-01-BS1",88,88,"8c6c041e-f58f-4f00-b980-b5eb264aa0ba","RNA","TCGA-36-1576-01A-01R","014b9a61-7164-4446-afce-38c34cbbfc1b",1.8,0.15,"UV Spec","R","22","TCGA-36-1576-01A-01R-1566-13","55b6bd7c-e77d-4019-93e9-b5410e4807b2",0.15,NA,NA,NA,NA,"f3560a75-9c82-5153-aaa0-1da7bd05f57d","TCGA-36-1576_exposure","TCGA-36-1576-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T06:18:05.000Z","2014-03-20T06:39:02.000Z","39039A6C-CBBE-4926-973B-E88C3A4A653C","24FFA457-5765-43C1-8CDD-B50A31DC5B56","Unaligned reads",9706741760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","55B6BD7C-E77D-4019-93E9-B5410E4807B2","Canada's Michael Smith Genome Sciences Centre","564a5756e4b09c884b268cf1","3445C524-5A37-40B6-8614-956D76EED939","Ovarian Serous Cystadenocarcinoma","TAR","8C6C041E-F58F-4F00-B980-B5EB264AA0BA","2014-03-20T06:39:02.000Z","014B9A61-7164-4446-AFCE-38C34CBBFC1B","None","NO",1,0.4,"Primary Tumor","BC Cancer Agency",NA,"8C6C041E-F58F-4F00-B980-B5EB264AA0BA",1,"36","ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_D03_466146.byallele.copynumber.data.txt",NA,"TCGA-36-1576-01A",2.6,"80BA7CC4-FCBF-4B2D-9604-42E785B2D9EC","TCGA",2006,NA,NA,"WITH TUMOR","D2598E34-DC21-4E6F-980E-B596677CC36B",76,"nationwidechildrens.org_clinical.TCGA-36-1576.xml","Alive",NA,"TCGA-36-1576",NA,"606C8EE1-145A-4A52-85AF-906E692FAABA",NA,915,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",2,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,NA,NA,1,118,"82732EDC-569C-4B5C-80D5-31F530CD30AA","32EFDC45-3FC2-494D-904A-3482EB4BF2C6","TCGA-36-1576-01A-01W-0615-10_SOLiD.bam.bai","TCGA-36-1576-01A-01",95,0,NA,NA,10,"TOP",2,NA,"TCGA-36-1576-01A-01-TS1",88,"Carboplatin","Chemotherapy","TCGA-36-1576-D27875",NA,NA,NA,"TCGA-36-1576-F27874_NTE-1",NA,915,"WITH TUMOR","Alive",NA,"TCGA-36-1576-F27874","TCGA-36-1576",NA,"36","1576","YES","C56.9","8441/3","C56.9",NA,NA,-27778,"FEMALE",NA,NA,NA,"No","Alive",915,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,76,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,2,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
142447638,140119598,10372705591,"65131575-48D3-42C2-B411-3DB871EF5EE1.bw","3491d67a-4f83-4f67-8085-bbb9fe942be5","65131575-48d3-42c2-b411-3db871ef5ee1","2016-08-31T10:51:47.783943-05:00","TCGA-61-1918-01A-01R-1568-13_rnaseq_fastq.tar","556c5491-8f99-418d-a1b9-8c359631a8ea",8169226240,"Illumina HiSeq","607d8f02568a8d73e3b31b7069855ed3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:12:54.682113-05:00","2016-05-03T11:56:42.628342-05:00","556c5491-8f99-418d-a1b9-8c359631a8ea_analysis.xml","da5111987b1dbb204846e731c0325a3a","64f330e4-d2e6-43b3-8082-a1b078c5c784",2181,"2016-09-29T22:37:07.674310-05:00","556c5491-8f99-418d-a1b9-8c359631a8ea_experiment.xml","793ca400c0e0b635e30545dac2e33f40","be28a59a-950c-4df8-8abd-788e8913bde1",3916,"2016-09-29T21:05:01.678809-05:00","556c5491-8f99-418d-a1b9-8c359631a8ea_run.xml","f88a434ce7864527a59836c5f504703f","85240b0a-153f-4016-b7ce-79ca2e9e28b8",1988,"2016-09-08T10:50:14.929628-05:00","TCGA-61-1918","2016-09-02T18:49:01.697279-05:00","female","TCGA-61-1918_demographic",1957,"white","3e70c222-a83b-5da9-9917-afab5c944561","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1918_diagnosis","not reported",16689,"dead","8441/3",479,479,"333c3c88-a293-5542-b167-ffd3a6a82a8d","c56.9",-16689,"TCGA-61-1918_treatment","92769dda-b04b-5014-a5a0-0fb807673dfe","01",NA,"TCGA-61-1918-01A","0.4","f17ca1b8-f58c-4b17-bc4d-3bd33d9aec5f",FALSE,"6c95bd12-e871-4e4e-961f-09a64c1fe2de","Primary Tumor","0.4",NA,NA,"1",1246233600,"01",135,"TCGA-61-1918-01A-01",90,85,NA,NA,0,0,10,15,"2016-09-08T10:50:14.929628-05:00","2016-09-08T10:50:14.929628-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,15,"1f691318-7bee-4a1f-a5ef-09a24185d119","2839dfd5-d116-494f-b31e-512aad6fc514","TCGA-61-1918-01A-01-TS1","TCGA-61-1918-01A-01-BS1",80,70,"ffcc32bc-d62f-465f-b479-b609dc7b4589","RNA","TCGA-61-1918-01A-01R","0515430a-06ed-49ea-9e7c-6aa62f5016c2",1.8,0.14,"UV Spec","R","22","TCGA-61-1918-01A-01R-1568-13","62f75d97-ea9e-4694-8c83-1a0e6d137a02",0.14,NA,NA,NA,NA,"5f347db9-226a-5220-a4a8-19a998b53226","TCGA-61-1918_exposure","TCGA-61-1918-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T20:22:17.000Z","2014-08-28T21:25:23.000Z","556C5491-8F99-418D-A1B9-8C359631A8EA","F17CA1B8-F58C-4B17-BC4D-3BD33D9AEC5F","Unaligned reads",8169226240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","62F75D97-EA9E-4694-8C83-1A0E6D137A02","Canada's Michael Smith Genome Sciences Centre","564a5a9de4b093830b6cbf92","3491D67A-4F83-4F67-8085-BBB9FE942BE5","Ovarian Serous Cystadenocarcinoma","TAR","FFCC32BC-D62F-465F-B479-B609DC7B4589","2014-08-28T21:25:23.000Z","0515430A-06ED-49EA-9E7C-6AA62F5016C2","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"FFCC32BC-D62F-465F-B479-B609DC7B4589",0.4,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8c7cf533-1039-4e1a-9a0a-83c8d8c2e597.txt",NA,"TCGA-61-1918-01A",1,"C63C99B6-FA3C-4A93-9FD6-6E95EF6AAD5C","TCGA",2002,NA,NA,"WITH TUMOR","F17CA1B8-F58C-4B17-BC4D-3BD33D9AEC5F",45,"nationwidechildrens.org_clinical.TCGA-61-1918.xml","Dead",479,"TCGA-61-1918","NOT HISPANIC OR LATINO","F5F189D5-CEDA-430F-996D-DBD6CDBB24A2",NA,479,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,135,"2839DFD5-D116-494F-B31E-512AAD6FC514","E2659FFE-76A2-4DDA-8845-4A4202C77EB7","TCGA-61-1918-01A-01R-1568-13_GRCh37-lite_mirna.bam.bai","TCGA-61-1918-01A-01",90,0,NA,NA,10,"TOP",10,NA,"TCGA-61-1918-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-61-1918-D28296",NA,NA,NA,"TCGA-61-1918-F28295_NTE-1",NA,479,"WITH TUMOR","Dead",479,"TCGA-61-1918-F28295","TCGA-61-1918",NA,"61","1918","YES","C56.9","8441/3","C56.9",NA,NA,-16689,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",479,479,NA,NA,"WITH TUMOR","NO",30,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78827854,76495473,5630445893,"1AE13DFA-670C-43EE-9898-8FA831AEDDB3.bw","34f285ab-6c31-4865-a0a7-a57af3567df0","1ae13dfa-670c-43ee-9898-8fa831aeddb3","2016-08-19T05:36:28.063167-05:00","TCGA-20-0987-01A-02R-1564-13_rnaseq_fastq.tar","d6ea9069-011f-452a-a0df-0eb605f168e2",4957409280,"Illumina HiSeq","8507f74650c68a03a81d2fd240ce91ac","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:22:12.677382-05:00","2016-05-03T11:39:34.528512-05:00","d6ea9069-011f-452a-a0df-0eb605f168e2_analysis.xml","c5489a7e32baa7616e99b9152fe72239","b4d6d9d2-357c-419c-8dc8-769835189009",2267,"2016-09-16T17:19:05.777693-05:00","d6ea9069-011f-452a-a0df-0eb605f168e2_experiment.xml","d1597f841c8b88d373f42a1af4823b6a","2b867781-c6a4-4bd9-bc5e-551d3b1bfed5",3916,"2016-09-29T17:51:35.550652-05:00","d6ea9069-011f-452a-a0df-0eb605f168e2_run.xml","20f0a5ee9dc76201578979dfc06ebf07","0cafb8de-30c2-42ea-8807-3d4e2ea93420",1990,"2016-09-08T12:18:09.141089-05:00","TCGA-20-0987","2016-09-02T19:05:48.959924-05:00","female","TCGA-20-0987_demographic",1943,"white","320febbb-04db-59be-aced-d111a47c27ba","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-0987_diagnosis","not reported",22287,"dead","8441/3",701,NA,"d704293e-b3ad-5c64-946f-4bacf3517263","c56.9",-22287,"TCGA-20-0987_treatment","2bfaa920-0463-5a3d-aab2-bb32658cfbd7","01",NA,"TCGA-20-0987-01A","0.6","27a6b2d1-ad0f-4193-b54c-646560930289",FALSE,"EB7C0C99-8A43-4023-B165-4EFFC1FC5800","Primary Tumor","0.3",NA,NA,"1.5",1233705600,"02",113,"TCGA-20-0987-01A-02",90,80,NA,NA,15,18,0,2,"2016-09-08T12:18:09.141089-05:00","2016-09-08T12:18:09.141089-05:00",NA,NA,NA,NA,"BOTTOM","TOP",20,2,"580a22f9-d1d6-4638-bde8-e2ca93062bf1","5bd6ee19-dc60-48ab-bdb1-b28ed0c70f4c","TCGA-20-0987-01A-02-BS2","TCGA-20-0987-01A-01-BS1",65,78,"3782947c-38f2-4aa5-ab58-35ef29d7dedf","RNA","TCGA-20-0987-01A-02R","5735d18e-a5c0-472a-95e2-f17564dd7b1d",1.8,0.15,"UV Spec","R","22","TCGA-20-0987-01A-02R-1564-13","40dafb8b-7311-4ee3-b5bc-9c9c7ffb8cce",0.15,NA,NA,NA,NA,"61b5ac7c-4d36-5484-b9c9-e5278f67b706","TCGA-20-0987_exposure","TCGA-20-0987-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-20T03:52:09.000Z","2014-03-20T04:06:01.000Z","D6EA9069-011F-452A-A0DF-0EB605F168E2","27A6B2D1-AD0F-4193-B54C-646560930289","Unaligned reads",4957409280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","40DAFB8B-7311-4EE3-B5BC-9C9C7FFB8CCE","Canada's Michael Smith Genome Sciences Centre","564a3ba5e4b09c884b246df5","34F285AB-6C31-4865-A0A7-A57AF3567DF0","Ovarian Serous Cystadenocarcinoma","TAR","3782947C-38F2-4AA5-AB58-35EF29D7DEDF","2014-03-20T04:06:01.000Z","5735D18E-A5C0-472A-95E2-F17564DD7B1D","None","NO",1,0.3,"Primary Tumor","Fox Chase Cancer Center",NA,"3782947C-38F2-4AA5-AB58-35EF29D7DEDF",0.6,"20","QUANT_p_TCGA_Batch12_AFFX_GenomeWideSNP_6_A01_437640.ismpolish.data.txt",NA,"TCGA-20-0987-01A",1.5,"FFF65B98-A78B-436B-BEF7-4A4AD0448BCD","TCGA",2004,NA,NA,"WITH TUMOR","9C06DA40-C6DB-49F4-BA8D-D3BE838BF9F7",61,"TCGA-20-0987-01A-02T-0438-07.probe.tcga_level2.data.txt","Dead",701,"TCGA-20-0987","NOT HISPANIC OR LATINO","2C19C195-D623-46E6-9244-DBD3D124989D",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,113,"580A22F9-D1D6-4638-BDE8-E2CA93062BF1","AED2DDC0-1461-4754-8C8A-B2723749388E","TCGA-20-0987-01A-02R-1564-13_mirna.bam","TCGA-20-0987-01A-02",90,15,NA,NA,0,"BOTTOM",20,NA,"TCGA-20-0987-01A-02-BS2",65,"Taxol","Chemotherapy","TCGA-20-0987-D25519",NA,NA,NA,"TCGA-20-0987-F25518_NTE-1",NA,NA,"WITH TUMOR","Dead",701,"TCGA-20-0987-F25518","TCGA-20-0987",NA,"20","0987","YES","C56.9","8441/3","C56.9",NA,NA,-22287,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,701,NA,NA,"WITH TUMOR","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2004,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
125593838,122849457,9086758962,"3ACDCD29-1B8D-455D-9EE9-D6C903B16D09.bw","34f545ab-d420-4dd2-8db4-3159896efd23","3acdcd29-1b8d-455d-9ee9-d6c903b16d09","2016-08-25T17:15:37.255593-05:00","TCGA-24-1467-01A-01R-1566-13_rnaseq_fastq.tar","4c0846c9-da58-4251-ae0f-847c1dc27e4c",7640299520,"Illumina HiSeq","bebb279c22f6945effe2f32b782a7921","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:47:27.661834-05:00","2016-05-03T11:40:21.662944-05:00","4c0846c9-da58-4251-ae0f-847c1dc27e4c_analysis.xml","24244e1cfdb624e5e667127558f35124","2fc7b79c-6946-45f0-9eb7-bdc6cf213e3c",2181,"2016-09-29T21:15:33.768937-05:00","4c0846c9-da58-4251-ae0f-847c1dc27e4c_experiment.xml","a404221e20e8b0f173c3856c18273961","8bc5da87-b972-47f5-80c4-45675ec9cfd4",3916,"2016-09-29T18:00:52.120444-05:00","4c0846c9-da58-4251-ae0f-847c1dc27e4c_run.xml","dfd324e4e9c2cc5a9f56705995118418","12837c97-8388-436b-b53c-88575409cde0",1988,"2016-09-08T13:21:16.215442-05:00","TCGA-24-1467","2016-09-02T19:13:48.600606-05:00","female","TCGA-24-1467_demographic",1947,"white","6a7e579e-29e7-5428-ae75-1909d32d4438","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1467_diagnosis","not reported",18652,"dead","8441/3",3224,3224,"e3e76f36-15de-5e61-98f3-e52149f98d4a","c56.9",-18652,"TCGA-24-1467_treatment","aca9b339-bbca-5160-a750-2a740c69e77d","01",NA,"TCGA-24-1467-01A","1.2","b0b13b63-cf9d-4cb9-a3fa-217d499763f8",FALSE,"6949EFBE-C2EA-4767-B194-2343254F2752","Primary Tumor","0.7",NA,NA,"1.3",1234310400,"01",106,"TCGA-24-1467-01A-01",80,95,NA,NA,0,0,19,4,"2016-09-08T13:21:16.215442-05:00","2016-09-08T13:21:16.215442-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"2a7d2b3c-a015-48eb-9ca7-da9e52c29a19","8d52fd5c-4233-4756-9250-e1e9da4cd119","TCGA-24-1467-01A-01-BS1","TCGA-24-1467-01A-01-TS1",80,95,"ae599a24-fb3d-4e78-9123-e93435c3fd7e","RNA","TCGA-24-1467-01A-01R","9e3575f4-6cc6-409d-a9f1-10210699b4d7",1.8,0.13,"UV Spec","R","22","TCGA-24-1467-01A-01R-1566-13","22902cdb-69f7-4bfc-a5c3-a56229ee501d",0.13,NA,NA,NA,NA,"d575ea43-29eb-5509-ad8e-c3b089f014c7","TCGA-24-1467_exposure","TCGA-24-1467-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T02:43:06.000Z","2014-03-25T02:58:01.000Z","4C0846C9-DA58-4251-AE0F-847C1DC27E4C","B0B13B63-CF9D-4CB9-A3FA-217D499763F8","Unaligned reads",7640299520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","22902CDB-69F7-4BFC-A5C3-A56229EE501D","Canada's Michael Smith Genome Sciences Centre","564a33b2e4b0298dd2c5efb6","34F545AB-D420-4DD2-8DB4-3159896EFD23","Ovarian Serous Cystadenocarcinoma","TAR","AE599A24-FB3D-4E78-9123-E93435C3FD7E","2014-03-25T02:58:01.000Z","9E3575F4-6CC6-409D-A9F1-10210699B4D7","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"AE599A24-FB3D-4E78-9123-E93435C3FD7E",1.2,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.efc7b16f-9e40-480e-b0ba-0a92cc54c0b9.txt",NA,"TCGA-24-1467-01A",1.3,"FB26DBAA-2CE9-4A77-94DD-C1E3A03FD281","TCGA",1998,NA,NA,"WITH TUMOR","D19E170A-D8E4-4C49-AAF5-1BE1331CC975",51,"TCGA-24-1467-01A-01R-1566-13_GRCh37-lite_mirna.bam.bai","Dead",3224,"TCGA-24-1467",NA,"0B7DB63C-A9E8-47C4-8459-B34E4260D092",NA,3224,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,106,"8D52FD5C-4233-4756-9250-E1E9DA4CD119","D17B9F58-68F6-455C-8077-C4A290599809","0998.CEL","TCGA-24-1467-01A-01",80,0,NA,NA,19,"BOTTOM",1,NA,"TCGA-24-1467-01A-01-BS1",80,"Doxil","Chemotherapy","TCGA-24-1467-D26049",NA,NA,NA,"TCGA-24-1467-F26039_NTE-2",NA,3224,"WITH TUMOR","Dead",3224,"TCGA-24-1467-F26039","TCGA-24-1467",NA,"24","1467","YES","C56.9","8441/3","C56.9",NA,NA,-18652,"FEMALE","WHITE",NA,NA,"No","Dead",3224,3224,NA,NA,"WITH TUMOR","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,51,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
275956960,263543606,19478224815,"C6FBC35B-0113-4F00-BE1A-831D2C551055.bw","35916942-e7aa-45db-ad27-03cba67d4d5b","c6fbc35b-0113-4f00-be1a-831d2c551055","2016-08-26T10:58:16.648671-05:00","TCGA-04-1517-01A-01R-1565-13_rnaseq_fastq.tar","12522acc-e92e-4711-b5cd-e25acad468fd",18707537920,"Illumina HiSeq","8fcd34c63e48f2b39ae4af86b6fdd2c9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:29:09.135935-05:00","2016-05-03T11:40:21.648680-05:00","12522acc-e92e-4711-b5cd-e25acad468fd_analysis.xml","0a92cfaa9e3540424e714161e5cc8f0e","9444eddc-84df-45c6-b9fb-000722a8ffa4",2208,"2016-09-29T18:51:28.781411-05:00","12522acc-e92e-4711-b5cd-e25acad468fd_experiment.xml","58268949a02d684f063bc0ae7933907c","324dcb6f-79b1-40ea-9ec4-edea5deb60f0",3916,"2016-09-29T20:54:51.232981-05:00","12522acc-e92e-4711-b5cd-e25acad468fd_run.xml","247c237c16966f006b90565fc97599cf","7ec5f7e9-f19e-4bc7-89d9-0ade6cbd59c5",1988,"2016-09-08T11:26:08.948275-05:00","TCGA-04-1517","2016-09-02T18:48:52.661128-05:00","female","TCGA-04-1517_demographic",1927,"white","475ebd3e-0dfc-5d80-aa9a-145aa1385328","not reported",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1517_diagnosis","not reported",29045,"dead","8441/3",608,NA,"a533a03b-cac4-5cc9-89ef-905ef85da2e4","c56.9",-29045,"TCGA-04-1517_treatment","0927662c-275a-5ab1-a874-90c4ce75b258","01",NA,"TCGA-04-1517-01A","0.9","bb9d5cff-b801-49c7-b319-86c8d1e78b32",FALSE,"ED992763-74E1-466F-A71A-AC0455AD40F6","Primary Tumor","0.4",NA,NA,"1.5",1235260800,"01",102,"TCGA-04-1517-01A-01",99,95,NA,NA,0,0,5,5,"2016-09-08T11:26:08.948275-05:00","2016-09-08T11:26:08.948275-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,10,"78f024b3-f014-4dee-b615-2714790ac290","44419f12-78c0-405f-af43-289460beb5f8","TCGA-04-1517-01A-01-BS1","TCGA-04-1517-01A-01-TS1",95,85,"d053c615-3976-4321-a4a5-d415e7aacbcd","RNA","TCGA-04-1517-01A-01R","c6a65c34-09c2-47f2-9279-743224ccaa6d",1.8,0.17,"UV Spec","R","22","TCGA-04-1517-01A-01R-1565-13","4ef91e20-24f8-4a34-ac26-b316b37be1cf",0.17,NA,NA,NA,NA,"741a6442-da88-5d5f-8204-f5359de0df78","TCGA-04-1517_exposure","TCGA-04-1517-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T21:46:46.000Z","2014-03-21T22:20:01.000Z","12522ACC-E92E-4711-B5CD-E25ACAD468FD","BB9D5CFF-B801-49C7-B319-86C8D1E78B32","Unaligned reads",18707537920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4EF91E20-24F8-4A34-AC26-B316B37BE1CF","Canada's Michael Smith Genome Sciences Centre","564a5aeee4b093830b6cda22","35916942-E7AA-45DB-AD27-03CBA67D4D5B","Ovarian Serous Cystadenocarcinoma","TAR","D053C615-3976-4321-A4A5-D415E7AACBCD","2014-03-21T22:20:01.000Z","C6A65C34-09C2-47F2-9279-743224CCAA6D","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"D053C615-3976-4321-A4A5-D415E7AACBCD",0.9,"04","TCGA-04-1517-01A-01R-1565-13_GRCh37-lite_rnaseq.bam.bai",NA,"TCGA-04-1517-01A",1.5,"C7C8F6DF-41A9-4999-8081-49601B1917E2","TCGA",2006,NA,NA,"WITH TUMOR","F8EF0AAC-D5A1-4816-A52F-2F136E34B856",79,"nationwidechildrens.org_clinical.TCGA-04-1517.xml","Dead",608,"TCGA-04-1517",NA,"B75FD0B7-9F36-44B6-81E4-69D7CDDD5EC3",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,102,"78F024B3-F014-4DEE-B615-2714790AC290","E4FA3E76-1CF1-4291-B855-42824FA8EDD9","TCGA-04-1517-01A-01R-1565-13_mirna.bam","TCGA-04-1517-01A-01",99,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-04-1517-01A-01-BS1",95,"Gemzar","Chemotherapy","TCGA-04-1517-D24095",NA,NA,NA,"TCGA-04-1517-F24092_NTE-1",NA,NA,"WITH TUMOR","Dead",608,"TCGA-04-1517-F24092","TCGA-04-1517",NA,"04","1517","YES","C56.9","8441/3","C56.9",NA,NA,-29045,"FEMALE","WHITE",NA,NA,"No","Dead",NA,608,NA,NA,"WITH TUMOR","NO",3,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,79,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
170135214,162234778,11982191668,"A8F3285D-A85E-4E73-9D20-9D14AA51916B.bw","36595b52-2b5f-4e87-80eb-37c29109e92a","a8f3285d-a85e-4e73-9d20-9d14aa51916b","2016-08-26T01:43:14.591130-05:00","TCGA-20-0991-01A-01R-1564-13_rnaseq_fastq.tar","3c341fa7-c564-4df3-9735-968b11d45a4b",10854492160,"Illumina HiSeq","6c5ac7c87cae91307f7040e15af6d33b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:41:40.457650-05:00","2016-05-03T11:39:34.522989-05:00","3c341fa7-c564-4df3-9735-968b11d45a4b_analysis.xml","96a1436265bb3b918c9b2cb5d9c1051a","c1050dbd-6593-4708-ace5-6ac177cee66a",2208,"2016-09-29T21:23:41.963021-05:00","3c341fa7-c564-4df3-9735-968b11d45a4b_experiment.xml","5571bf3295d55fe38655f6a96d98062c","90d74c48-0391-497e-a494-bac30eb38185",3916,"2016-09-29T23:27:22.395630-05:00","3c341fa7-c564-4df3-9735-968b11d45a4b_run.xml","3c6c68a005849cd8b395c8a7d2d984b8","dd54a974-cbb2-46c2-b66b-35b8dad162bf",1988,"2016-09-08T12:18:57.591580-05:00","TCGA-20-0991","2016-09-02T19:06:04.299224-05:00","female","TCGA-20-0991_demographic",1928,"white","36753d6c-f821-5dbf-a8b3-662cb2430bed","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-0991_diagnosis","not reported",28694,"alive","8441/3",NA,797,"b12547de-b3e3-59fe-a426-d67e9bb05533","c56.9",-28694,"TCGA-20-0991_treatment","0bac6761-7a5f-5ace-8dca-80cefb181dc5","01",NA,"TCGA-20-0991-01A","0.6","62af5b99-db7f-4c92-97f1-92e825c15729",FALSE,"8FB04F5F-B278-4E3C-A88B-9597F7B93F6E","Primary Tumor","0.4",NA,NA,"0.8",1233705600,"01",85,"TCGA-20-0991-01A-01",98,98,NA,NA,2,2,0,0,"2016-09-08T12:18:57.591580-05:00","2016-09-08T12:18:57.591580-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,2,"667c1bb6-434d-47b1-ac92-8a2996613ffe","0b680a7c-3b52-40f3-88e7-39ff4fb22cc9","TCGA-20-0991-01A-01-BS1","TCGA-20-0991-01A-01-TS1",93,96,"1648463b-ef78-416d-95ca-20d380e74539","RNA","TCGA-20-0991-01A-01R","e0cba84f-cb18-445c-b2d7-7c6d85adf773",1.8,0.15,"UV Spec","R","22","TCGA-20-0991-01A-01R-1564-13","70004d87-7c1b-40e6-b246-04bb349dca6c",0.15,NA,NA,NA,NA,"c487b169-4620-581f-832a-823f24dcf001","TCGA-20-0991_exposure","TCGA-20-0991-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T00:15:21.000Z","2014-03-20T00:37:01.000Z","3C341FA7-C564-4DF3-9735-968B11D45A4B","62AF5B99-DB7F-4C92-97F1-92E825C15729","Unaligned reads",10854492160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","70004D87-7C1B-40E6-B246-04BB349DCA6C","Canada's Michael Smith Genome Sciences Centre","564a3dfae4b093830b6a18a0","36595B52-2B5F-4E87-80EB-37C29109E92A","Ovarian Serous Cystadenocarcinoma","TAR","1648463B-EF78-416D-95CA-20D380E74539","2014-03-20T00:37:01.000Z","E0CBA84F-CB18-445C-B2D7-7C6D85ADF773","None","NO",1,0.4,"Primary Tumor","Fox Chase Cancer Center",NA,"EF26B077-8702-4033-A427-2F845027E1F2",0.6,"20","TCGA-20-0991-01A-01R-1564-13_GRCh37-lite_rnaseq.bam.bai",NA,"TCGA-20-0991-01A",0.8,"8A48BCF0-7943-48DA-89C6-1831CBE9DA03","TCGA",2006,NA,NA,"TUMOR FREE","C6EE7BF1-363D-450A-976E-4AC533F4CFEA",78,"nationwidechildrens.org_clinical.TCGA-20-0991.xml","Alive",NA,"TCGA-20-0991","NOT HISPANIC OR LATINO","974F709B-2B9A-4A59-86A5-15974CDD107B",NA,797,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIB",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,85,"667C1BB6-434D-47B1-AC92-8A2996613FFE","14D1A1BA-3130-4DBA-9BCE-B3216437BD4D","TCGA-20-0991-01A-01R-1564-13_GRCh37-lite_rnaseq.bam.bai","TCGA-20-0991-01A-01",98,2,NA,NA,0,"TOP",2,NA,"TCGA-20-0991-01A-01-TS1",96,"Carboplatin","Chemotherapy","TCGA-20-0991-D25531",NA,NA,NA,NA,NA,797,"TUMOR FREE","Alive",NA,"TCGA-20-0991-F25530","TCGA-20-0991",NA,"20","0991","YES","C56.9","8441/3","C56.9",NA,NA,-28694,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",797,NA,NA,NA,"TUMOR FREE","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,78,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
213351308,206681921,15292249063,"51601A73-2D75-4056-AEBB-8FF8DB813450.bw","374ea8df-ecc4-44b0-b519-33efa5078018","51601a73-2d75-4056-aebb-8ff8db813450","2016-08-25T03:06:06.581023-05:00","TCGA-29-1761-01A-01R-1567-13_rnaseq_fastq.tar","e5a32c49-de4f-4cc9-ac9c-96ea8f2071f0",13908305920,"Illumina HiSeq","e536aeacb16ccf50d0cb29e83d231b35","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:01:54.280060-05:00","2016-05-03T11:41:05.755204-05:00","e5a32c49-de4f-4cc9-ac9c-96ea8f2071f0_analysis.xml","ff7515baa58204d8b402ace77cb14f3c","a88525d7-ee2e-465c-a975-ee7390a060fe",2183,"2016-08-27T18:08:13.143943-05:00","e5a32c49-de4f-4cc9-ac9c-96ea8f2071f0_experiment.xml","fe1737fe2986233a93b6551a47934b1b","ca685b4c-9725-410f-a1b6-83ad6dda0dc5",3916,"2016-09-29T22:34:48.878499-05:00","e5a32c49-de4f-4cc9-ac9c-96ea8f2071f0_run.xml","79372e7e8f807ae025b76cf30eb6589a","bcbafbc7-1ddd-4d79-9e6b-d3e4f0cf7f86",1990,"2016-09-08T12:36:02.807120-05:00","TCGA-29-1761","2016-09-02T19:07:20.192507-05:00","female","TCGA-29-1761_demographic",1918,"asian","5707415c-114a-55b6-9c7a-ffe492bcd227","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1761_diagnosis","not reported",29337,"dead","8441/3",528,517,"d4e1d5f5-41cc-55eb-b085-39c793219da6","c56.9",-29337,"TCGA-29-1761_treatment","8228dadd-a42b-5674-90c3-3f343a60fdae","01",NA,"TCGA-29-1761-01A","0.5","d9939f44-f5d7-469f-b256-4af851190454",FALSE,"63defa27-e729-4514-bdd2-d887c4100854","Primary Tumor","0.4",NA,NA,"0.9",1243123200,"01",127,"TCGA-29-1761-01A-01",75,80,NA,NA,0,0,5,10,"2016-09-08T12:36:02.807120-05:00","2016-09-08T12:36:02.807120-05:00",15,10,NA,NA,"BOTTOM","TOP",5,5,"4a648bd9-d950-4516-baa1-0ee2937785ef","26b76609-e133-4641-93f1-5497015975a4","TCGA-29-1761-01A-01-BS1","TCGA-29-1761-01A-01-TS1",90,85,"355336f6-9d16-4d8d-86b9-6912c5f996ef","RNA","TCGA-29-1761-01A-01R","8b2dc648-c2a0-47bf-9944-2867e802b8e4",1.8,0.15,"UV Spec","R","22","TCGA-29-1761-01A-01R-1567-13","c4446f6f-fae9-414c-8bae-7c78bb894982",0.15,NA,NA,NA,NA,"f62ba290-9835-599e-8b42-225af2890583","TCGA-29-1761_exposure","TCGA-29-1761-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T07:51:16.000Z","2014-03-27T08:15:02.000Z","E5A32C49-DE4F-4CC9-AC9C-96EA8F2071F0","D9939F44-F5D7-469F-B256-4AF851190454","Unaligned reads",13908305920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C4446F6F-FAE9-414C-8BAE-7C78BB894982","Canada's Michael Smith Genome Sciences Centre","564a33bfe4b0298dd2c5f46e","374EA8DF-ECC4-44B0-B519-33EFA5078018","Ovarian Serous Cystadenocarcinoma","TAR","355336F6-9D16-4D8D-86B9-6912C5F996EF","2014-03-27T08:15:02.000Z","8B2DC648-C2A0-47BF-9944-2867E802B8E4","None","NO",1,0.4,"Primary Tumor","Duke",NA,"355336F6-9D16-4D8D-86B9-6912C5F996EF",0.5,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8.txt",NA,"TCGA-29-1761-01A",0.9,"FE321EAC-53EE-44E1-A7B6-8047473FCBF2","TCGA",1998,NA,NA,"WITH TUMOR","EC1F193E-CF44-4536-87C0-F58C9E8E9907",80,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8.txt","Dead",528,"TCGA-29-1761",NA,"D8897DF7-FD26-4FD4-B696-00EFD70CB5FC",NA,517,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"ASIAN",NA,1,127,"4A648BD9-D950-4516-BAA1-0EE2937785EF","D391BAA4-F180-4E0B-9FB7-66DD66ADC1E7","TCGA-29-1761-01A-01W-0633-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-29-1761-01A-01",80,0,NA,10,10,"TOP",5,NA,"TCGA-29-1761-01A-01-TS1",85,"Paclitaxel","Chemotherapy","TCGA-29-1761-D27314",NA,NA,NA,NA,NA,517,"WITH TUMOR","Dead",528,"TCGA-29-1761-F27312","TCGA-29-1761",NA,"29","1761","YES","C56.9","8441/3","C56.9",NA,NA,-29337,"FEMALE","ASIAN",NA,NA,"No","Dead",517,528,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,80,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
90205876,88758012,6575986074,"75021778-A96B-4F57-8C26-68E8F33D7EB7.bw","3768d34f-1527-40db-b116-cd80cee5ec3a","75021778-a96b-4f57-8c26-68e8f33d7eb7","2016-08-25T17:07:29.139034-05:00","TCGA-09-2045-01A-01R-1568-13_rnaseq_fastq.tar","b4b337ae-4156-4638-bffc-2864cecf0e15",5296486400,"Illumina HiSeq","8708c8f7372c0e68d6cc4d075d956b63","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:25:35.035394-05:00","2016-05-03T11:56:42.628342-05:00","b4b337ae-4156-4638-bffc-2864cecf0e15_analysis.xml","3c2cf71ede0e232168bc7f1c45488470","dc317e8f-190a-4fb9-b649-14ab66854a35",2181,"2016-09-29T19:20:20.250534-05:00","b4b337ae-4156-4638-bffc-2864cecf0e15_experiment.xml","4447bfc90cabdf39c4683757c750b499","44835773-b4f1-4734-ae85-18a8bf9e00ca",3916,"2016-09-29T18:36:42.717920-05:00","b4b337ae-4156-4638-bffc-2864cecf0e15_run.xml","216d218726bc0f783ce76338b75b6b0e","28db8610-8bef-4dd5-a54d-53778f3821ff",1988,"2016-09-08T13:38:40.187234-05:00","TCGA-09-2045","2016-09-02T19:11:52.632340-05:00","female","TCGA-09-2045_demographic",1946,"asian","6ca6b1db-10fc-590d-a441-127763862ffa","not hispanic or latino",1998,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2045_diagnosis","not reported",18285,"dead","8441/3",1069,NA,"0ffcd742-a709-52d5-b7ac-ea8a72376fdf","c56.9",-18285,"TCGA-09-2045_treatment","fbf4c9d9-7fcc-5779-8624-88535dfac6a3","01",NA,"TCGA-09-2045-01A","0.7","4d5aaf12-a500-4709-9c99-5b9fef2c79b1",FALSE,"6c826e9d-b1aa-4c84-b294-c8fb41818da1","Primary Tumor","0.4",NA,NA,"1.5",1248134400,"01",161,"TCGA-09-2045-01A-01",90,95,NA,NA,0,0,10,5,"2016-09-08T13:38:40.187234-05:00","2016-09-08T13:38:40.187234-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"0abe6ecb-c4ba-492f-939f-9dfa84b0af35","0f965c79-cfe6-499e-98a9-a696bfe83f6f","TCGA-09-2045-01A-01-TS1","TCGA-09-2045-01A-01-BS1",90,94,"06664e36-b611-4112-8889-63bce9fcce32","RNA","TCGA-09-2045-01A-01R","053e6bec-8aab-429a-b8a3-ec7a3267fa01",1.8,0.14,"UV Spec","R","22","TCGA-09-2045-01A-01R-1568-13","7b412fd9-4414-440f-b768-70666037c768",0.14,NA,NA,NA,NA,"fc7cc3c8-4dc3-5cd9-be5f-0f93e313f6b6","TCGA-09-2045_exposure","TCGA-09-2045-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T00:03:56.000Z","2014-08-28T00:49:16.000Z","B4B337AE-4156-4638-BFFC-2864CECF0E15","4D5AAF12-A500-4709-9C99-5B9FEF2C79B1","Unaligned reads",5296486400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7B412FD9-4414-440F-B768-70666037C768","Canada's Michael Smith Genome Sciences Centre","564a33a6e4b0298dd2c5eb46","3768D34F-1527-40DB-B116-CD80CEE5EC3A","Ovarian Serous Cystadenocarcinoma","TAR","06664E36-B611-4112-8889-63BCE9FCCE32","2014-08-28T00:49:16.000Z","053E6BEC-8AAB-429A-B8A3-EC7A3267FA01","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"06664E36-B611-4112-8889-63BCE9FCCE32",0.7,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.51c5bf06-26be-471c-927c-1cb07bf10a2b.txt",NA,"TCGA-09-2045-01A",1.5,"FC471499-6C71-4641-A6A2-46D6521A837D","TCGA",1996,NA,NA,"WITH TUMOR","705CECF8-E3FA-4025-8AAF-21C6F91D91C0",50,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.51c5bf06-26be-471c-927c-1cb07bf10a2b.txt","Dead",1069,"TCGA-09-2045","NOT HISPANIC OR LATINO","0174CDFC-8808-4567-97BC-03C86CE40B50",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"ASIAN",NA,1,161,"0F965C79-CFE6-499E-98A9-A696BFE83F6F","639F5104-C9AB-4CD6-B6D3-1B4C85CF8BA4","TCGA-09-2045-01A-01W-0799-08_IlluminaGA-DNASeq_capture.bam.bai","TCGA-09-2045-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-09-2045-01A-01-BS1",94,"Toptecan","Chemotherapy","TCGA-09-2045-D24347",NA,NA,NA,"TCGA-09-2045-F24338_NTE-1",NA,NA,"WITH TUMOR","Dead",1069,"TCGA-09-2045-F24338","TCGA-09-2045",NA,"09","2045","YES","C56.9","8441/3","C56.9",NA,NA,-18285,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1069,NA,NA,"WITH TUMOR","NO",3,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,1996,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132780810,125212394,9192523390,"71FFB439-22A1-4EBB-AEA6-A6BCA8CA6648.bw","378f7ea2-86b4-4072-80b8-e12d67193106","71ffb439-22a1-4ebb-aea6-a6bca8ca6648","2016-08-20T22:58:26.187511-05:00","TCGA-13-0923-01A-01R-1564-13_rnaseq_fastq.tar","1338f5b3-a219-4303-880d-c52c57a2f25a",8472227840,"Illumina HiSeq","1cea74c5a339c3a36cb7bc254ca39d2c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:42:27.135992-05:00","2016-05-03T11:27:59.332723-05:00","1338f5b3-a219-4303-880d-c52c57a2f25a_analysis.xml","d60860419ccbe8d52d3c3fe469371172","c17ba414-0858-4135-bc46-43235356bef0",2210,"2016-09-29T23:53:39.472818-05:00","1338f5b3-a219-4303-880d-c52c57a2f25a_experiment.xml","1824e1765b4aa3365d9a845c91360459","edc48ff8-6b26-4f68-b9c4-63232b756c32",3916,"2016-09-29T18:22:21.423074-05:00","1338f5b3-a219-4303-880d-c52c57a2f25a_run.xml","971d88afc18fddd7ae069099daa9ab68","1fcc8e43-11f8-47c5-8bbb-80d019a306e1",1990,"2016-09-08T12:20:07.531731-05:00","TCGA-13-0923","2016-09-02T19:06:12.226313-05:00","female","TCGA-13-0923_demographic",1934,"white","b8d6ce63-c7cb-5f82-a118-f49f9fc7cb75","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0923_diagnosis","not reported",27081,"alive","8441/3",NA,2547,"47744210-bad0-50d1-a104-be4181e7ed85","c56.9",-27081,"TCGA-13-0923_treatment","4c9c8bc1-8450-5812-85a2-9263e7d23512","01",NA,"TCGA-13-0923-01A",NA,"38e5fc32-615e-435d-ae6e-b79701aba593",FALSE,"06AB5B8C-7B57-43B0-8376-7A05C58AFC1A","Primary Tumor",NA,NA,NA,NA,1233705600,"01",NA,"TCGA-13-0923-01A-01",90,85,NA,NA,0,0,10,25,"2016-09-08T12:20:07.531731-05:00","2016-09-08T12:20:07.531731-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"d9d2ce88-c392-4e1a-abfc-ac656d4d2ed1","13b1073e-fdb1-4c7c-9899-5251d0b8d32c","TCGA-13-0923-01A-01-TS1","TCGA-13-0923-01A-01-BS1",85,70,"e47ce510-8c83-4559-8021-df5a77afcec5","RNA","TCGA-13-0923-01A-01R","2c82e0c0-ade1-4b50-a0ec-f3c2bee284ce",1.7,0.15,"UV Spec","R","22","TCGA-13-0923-01A-01R-1564-13","b75de387-11ae-4d46-81a1-54d15ecae42a",0.15,NA,NA,NA,NA,"7c3e5423-ca3d-5408-927a-8967bbe0384c","TCGA-13-0923_exposure","TCGA-13-0923-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-21T00:12:55.000Z","2013-12-21T00:34:02.000Z","1338F5B3-A219-4303-880D-C52C57A2F25A","38E5FC32-615E-435D-AE6E-B79701ABA593","Unaligned reads",8472227840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B75DE387-11AE-4D46-81A1-54D15ECAE42A","Canada's Michael Smith Genome Sciences Centre","564a3767e4b093830b67fd74","378F7EA2-86B4-4072-80B8-E12D67193106","Ovarian Serous Cystadenocarcinoma","TAR","E47CE510-8C83-4559-8021-DF5A77AFCEC5","2013-12-21T00:34:02.000Z","2C82E0C0-ADE1-4B50-A0EC-F3C2BEE284CE","None","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",NA,"E47CE510-8C83-4559-8021-DF5A77AFCEC5",NA,"13","TCGA-13-0923-01A-01R-1564-13_GRCh37-lite_mirna.bam",NA,"TCGA-13-0923-01A",NA,"B303F13F-01DE-4E5A-8FE1-C7EF1B52FE06","TCGA",2008,NA,NA,"TUMOR FREE","C6EE124B-21F1-4A6E-8D86-E248E772A750",74,"nationwidechildrens.org_clinical.TCGA-13-0923.xml","Alive",NA,"TCGA-13-0923","NOT HISPANIC OR LATINO","490BE56A-1798-44B3-9506-10B9657852FA",NA,195,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,NA,"D9D2CE88-C392-4E1A-ABFC-AC656D4D2ED1","EB437B23-1598-4C0B-B20F-73B32A7FCFFA","TCGA-13-0923-01A-01R-1564-13_GRCh37-lite_mirna.bam","TCGA-13-0923-01A-01",90,0,NA,NA,10,"TOP",5,NA,"TCGA-13-0923-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-13-0923-D24783",NA,NA,NA,NA,NA,195,"TUMOR FREE","Alive",NA,"TCGA-13-0923-F24782","TCGA-13-0923",NA,"13","0923","YES","C56.9","8441/3","C56.9",NA,NA,-27081,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",195,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,74,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
165135326,161133463,11942923485,"BEDB0135-0A26-44EF-9028-C4907403B110.bw","384170fc-e8be-426a-a54e-bf1ca61f2986","bedb0135-0a26-44ef-9028-c4907403b110","2016-08-22T09:26:13.339121-05:00","TCGA-24-1431-01A-01R-1566-13_rnaseq_fastq.tar","4609857e-e5ad-43b6-993c-28aec33313e8",10356039680,"Illumina HiSeq","f39dba276fd6f8bf57adc728a7316ab9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:50:55.441493-05:00","2016-05-03T11:40:21.662944-05:00","4609857e-e5ad-43b6-993c-28aec33313e8_analysis.xml","527d81176ec3a891adcb6159f70a1a30","5794c4d7-99a8-4f35-81a8-0105ac129772",2208,"2016-09-29T20:22:24.149653-05:00","4609857e-e5ad-43b6-993c-28aec33313e8_experiment.xml","4a9d5b52911691faf0f0df2ee9a80353","6aba64ce-85b3-4d62-9359-69aaecb676c2",3916,"2016-09-29T17:44:12.467281-05:00","4609857e-e5ad-43b6-993c-28aec33313e8_run.xml","55c8e06c841b125eeb258ed0dc6bf67f","07f86164-b97a-4d0a-b2d7-5638355641a1",1988,"2016-09-08T13:59:25.200070-05:00","TCGA-24-1431","2016-09-02T19:13:38.607629-05:00","female","TCGA-24-1431_demographic",1932,"white","60cbb98e-688e-507e-8f47-5429ab9d40b4","not reported",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1431_diagnosis","not reported",24758,"dead","8441/3",567,583,"4ea91113-9bc3-52d6-92be-98286edfdb2e","c56.9",-24758,"TCGA-24-1431_treatment","59c0259d-6e2a-5736-ace6-f9f0cb199276","01",NA,"TCGA-24-1431-01A","1","44f5f2b7-94ac-4bbd-8ca8-bb5be4b0fbdb",FALSE,"862aa4a2-d399-4aa0-998e-40b331c198ca","Primary Tumor","0.6",NA,NA,"1.5",1232409600,"01",176,"TCGA-24-1431-01A-01",90,95,NA,NA,0,0,10,5,"2016-09-08T13:59:25.200070-05:00","2016-09-08T13:59:25.200070-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"56af0d60-12ff-42cd-bf25-1a6e1282bf6e","cd2b0ba2-18ee-45d6-9b65-28574f20525c","TCGA-24-1431-01A-01-TS1","TCGA-24-1431-01A-01-BS1",90,94,"6a0d445e-4d50-47ee-9c4c-7db2b231527a","RNA","TCGA-24-1431-01A-01R","5e9e8e86-1fc9-4ba8-be18-ffad22931040",1.8,0.16,"UV Spec","R","22","TCGA-24-1431-01A-01R-1566-13","0e968ed4-9fbd-482b-b91d-ce7190dc91ed",0.16,NA,NA,NA,NA,"e8b4dd9a-e328-50dc-b7eb-5d1414db10bc","TCGA-24-1431_exposure","TCGA-24-1431-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T04:12:29.000Z","2014-03-25T04:34:02.000Z","4609857E-E5AD-43B6-993C-28AEC33313E8","44F5F2B7-94AC-4BBD-8CA8-BB5BE4B0FBDB","Unaligned reads",10356039680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0E968ED4-9FBD-482B-B91D-CE7190DC91ED","Canada's Michael Smith Genome Sciences Centre","564a5c78e4b0ef12181e5645","384170FC-E8BE-426A-A54E-BF1CA61F2986","Ovarian Serous Cystadenocarcinoma","TAR","6A0D445E-4D50-47EE-9C4C-7DB2B231527A","2014-03-25T04:34:02.000Z","5E9E8E86-1FC9-4BA8-BE18-FFAD22931040","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"6A0D445E-4D50-47EE-9C4C-7DB2B231527A",1,"24","TCGA-24-1431-01A-01R-1566-13.hg19.mirna.quantification.txt",NA,"TCGA-24-1431-01A",1.5,"F75D63B3-E5E9-4E08-A119-43AA095DEC60","TCGA",1999,NA,NA,"WITH TUMOR","4A78AA71-6F25-4394-AD9E-1DA9D4732768",67,"nationwidechildrens.org_clinical.TCGA-24-1431.xml","Dead",567,"TCGA-24-1431",NA,"D6B3E869-46DD-40C8-AD63-998478C5B806",NA,583,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,176,"CD2B0BA2-18EE-45D6-9B65-28574F20525C","14CE517D-EF77-4F66-B4B9-EEFFEE53034E","SEDUM_p_TCGA_Batch14_Expr_HT_HG-U133A_96-HTA_B08_458670.level3.data.txt","TCGA-24-1431-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-24-1431-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-24-1431-D25978",NA,NA,NA,"TCGA-24-1431-F25977_NTE-1",NA,583,"WITH TUMOR","Dead",567,"TCGA-24-1431-F25977","TCGA-24-1431",NA,"24","1431","YES","C56.9","8441/3","C56.9",NA,NA,-24758,"FEMALE","WHITE",NA,NA,"No","Dead",583,567,NA,NA,"WITH TUMOR","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
152226432,147278433,10879151976,"3B8BA56B-0E7B-4754-8729-8D613D0484E1.bw","390eed6b-50af-48a9-9fd6-3a68a2bbb7f9","3b8ba56b-0e7b-4754-8729-8d613d0484e1","2016-08-25T17:43:26.662370-05:00","TCGA-13-0800-01A-01R-1564-13_rnaseq_fastq.tar","fdf0aca6-f9ee-4682-8f11-386b3722b37c",9116241920,"Illumina HiSeq","75330a84c08ae13f04804f84b6cf1878","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:05:25.914296-05:00","2016-05-03T11:41:05.750744-05:00","fdf0aca6-f9ee-4682-8f11-386b3722b37c_analysis.xml","5ec9d376cbcef790f267df05d5f0eee1","f4dffed7-5478-4e24-9936-08ae49007145",2181,"2016-08-13T03:45:48.798630-05:00","fdf0aca6-f9ee-4682-8f11-386b3722b37c_experiment.xml","232a12c732f151550b9d6e64b2711900","31e71b44-6344-4fef-a779-3b043df80d8c",3916,"2016-09-29T22:29:49.926374-05:00","fdf0aca6-f9ee-4682-8f11-386b3722b37c_run.xml","051c9dd8668092b21b4627ca5c5ff66c","b99aed08-eda3-4e78-acb1-bee27bee071d",1988,"2016-09-08T13:59:23.927822-05:00","TCGA-13-0800","2016-09-02T19:09:35.321381-05:00","female","TCGA-13-0800_demographic",1956,"white","5f1fb8da-be94-5c96-95df-d92366f4f2cd","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0800_diagnosis","not reported",19087,"alive","8441/3",NA,2661,"876d6193-704f-5a99-a4cc-eff9b4e4f2d5","c56.9",-19087,"TCGA-13-0800_treatment","97066293-e221-5df0-9097-d6eb462e5791","01",NA,"TCGA-13-0800-01A","0.9","a99995e3-8d0b-453a-b604-206218279b71",FALSE,"E3206F00-3BC6-44B4-848E-F2ED70E094BD","Primary Tumor","0.3",NA,NA,"1.5",1233705600,"01",141,"TCGA-13-0800-01A-01",95,80,NA,NA,0,0,15,35,"2016-09-08T13:59:23.927822-05:00","2016-09-08T13:59:23.927822-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"b12d32bb-aeed-4d6d-8ee6-f76bc9fb8d76","9a6d87aa-4ea6-4ae9-a1e4-c64f5e9713bf","TCGA-13-0800-01A-01-TS1","TCGA-13-0800-01A-01-BS1",85,60,"63bc8343-32b3-40bb-ab70-bf15f41b8a7d","RNA","TCGA-13-0800-01A-01R","9d48368c-951d-4d00-a3f8-21c19caf4029",1.8,0.16,"UV Spec","R","22","TCGA-13-0800-01A-01R-1564-13","cd93531b-4d92-4be3-95e5-032636dd1ad8",0.16,NA,NA,NA,NA,"1fb1d957-e131-5f48-a3a6-a8f76a64f951","TCGA-13-0800_exposure","TCGA-13-0800-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T16:47:22.000Z","2014-03-28T17:09:02.000Z","FDF0ACA6-F9EE-4682-8F11-386B3722B37C","A99995E3-8D0B-453A-B604-206218279B71","Unaligned reads",9116241920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CD93531B-4D92-4BE3-95E5-032636DD1AD8","Canada's Michael Smith Genome Sciences Centre","564a56f3e4b0298dd2cab098","390EED6B-50AF-48A9-9FD6-3A68A2BBB7F9","Ovarian Serous Cystadenocarcinoma","TAR","63BC8343-32B3-40BB-AB70-BF15F41B8A7D","2014-03-28T17:09:02.000Z","9D48368C-951D-4D00-A3F8-21C19CAF4029","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"63BC8343-32B3-40BB-AB70-BF15F41B8A7D",0.9,"13","TCGA-13-0800-01A-01W-0372-09_capture.bam.bai",NA,"TCGA-13-0800-01A",1.5,"FF5F69D5-3DE1-4738-9A02-DBE76765B393","TCGA",2008,NA,NA,"TUMOR FREE","CD5A08E6-343A-494E-B73A-2B060C33451D",52,"BONES_p_TCGA_Batch8_9_RNA_HT_HG-U133A_96-HTA_D08_297972.level3.data.txt","Alive",NA,"TCGA-13-0800","NOT HISPANIC OR LATINO",NA,NA,247,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,141,"9A6D87AA-4EA6-4AE9-A1E4-C64F5E9713BF","555DF787-AB7B-4E32-B50F-7027066BBBC2","C239.TCGA-13-0800-01A-01W.4.bam","TCGA-13-0800-01A-01",80,0,NA,NA,35,"BOTTOM",5,NA,"TCGA-13-0800-01A-01-BS1",60,"Paclitaxel","Chemotherapy","TCGA-13-0800-D24617",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0800",NA,"13","0800","YES","C56.9","8441/3","C56.9",NA,NA,-19087,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",247,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
117356394,116133179,8610073096,"100BF963-6103-45E6-A760-E44649580CF5.bw","3ac45a71-c463-4f0f-b030-58c475a34418","100bf963-6103-45e6-a760-e44649580cf5","2016-08-18T22:53:30.267242-05:00","TCGA-61-2008-02A-01R-1568-13_rnaseq_fastq.tar","a422b31f-9b43-47d8-8cda-a1a1f4942750",6585487360,"Illumina HiSeq","d7dd664391839bf3aab4022e2ebc9185","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:13:25.256812-05:00","2016-05-03T11:56:42.628342-05:00","a422b31f-9b43-47d8-8cda-a1a1f4942750_analysis.xml","fd9c846525302c9f9dab939c76f78151","af893ce9-63c1-462a-ac7c-6ef6b6ebd6fe",2181,"2016-09-29T17:44:46.001594-05:00","a422b31f-9b43-47d8-8cda-a1a1f4942750_experiment.xml","be4f568a5f852f385198f323a5889c7c","085b5bd6-9d81-4959-9aa9-f2ab9cdcdecc",3916,"2016-09-29T17:52:23.392078-05:00","a422b31f-9b43-47d8-8cda-a1a1f4942750_run.xml","60c34fde5f45eac814fa92b7575680eb","0d2e98d2-3cc1-4b68-8d76-1c7fb69f5ca2",1988,"2016-09-08T11:40:10.255538-05:00","TCGA-61-2008","2016-09-02T18:56:34.042552-05:00","female","TCGA-61-2008_demographic",1967,"asian","32601890-a62f-5eac-821d-10d86af7637f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2008_diagnosis","not reported",14791,"alive","8441/3",NA,932,"4233e6db-8d18-5461-b504-3aa62d11e73f","c56.9",-14791,"TCGA-61-2008_treatment","8e378e12-53e5-58b2-b236-5632aa905b06","02",NA,"TCGA-61-2008-02A","1.5","9983a90e-9f72-4fe0-9d3b-62d25d3356ee",FALSE,"614D7B6A-B3B4-4F1B-9762-0749D559247F","Recurrent Tumor","0.3",NA,NA,"2",1258329600,"01",106,"TCGA-61-2008-02A-01",85,85,NA,NA,0,0,5,5,"2016-09-08T11:40:10.255538-05:00","2016-09-08T11:40:10.255538-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,10,"f04bb94a-6caf-4ba5-a918-08db1b26b964","80e74f58-026f-4665-bbe4-95b89bc2f6c7","TCGA-61-2008-02A-01-TS1","TCGA-61-2008-02A-01-BS1",80,75,"0b8474a8-cd56-48ab-b369-cc576237de66","RNA","TCGA-61-2008-02A-01R","1f57d960-8019-4aa5-a498-11c034287817",1.8,0.15,"UV Spec","R","22","TCGA-61-2008-02A-01R-1568-13","b90a4b33-cb6f-4c75-bc26-ff316ea81cce",0.15,NA,NA,NA,NA,"18c2dbfc-00ed-54a7-8607-a39c4b69bc3e","TCGA-61-2008_exposure","TCGA-61-2008-02A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T01:18:30.000Z","2014-08-28T02:13:13.000Z","A422B31F-9B43-47D8-8CDA-A1A1F4942750","9983A90E-9F72-4FE0-9D3B-62D25D3356EE","Unaligned reads",6585487360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B90A4B33-CB6F-4C75-BC26-FF316EA81CCE","Canada's Michael Smith Genome Sciences Centre","564a3af3e4b093830b691f18","3AC45A71-C463-4F0F-B030-58C475A34418","Ovarian Serous Cystadenocarcinoma","TAR","0B8474A8-CD56-48AB-B369-CC576237DE66","2014-08-28T02:13:13.000Z","1F57D960-8019-4AA5-A498-11C034287817","None","NO",2,0.3,"Recurrent Tumor","University of Pittsburgh",NA,"0B8474A8-CD56-48AB-B369-CC576237DE66",1.5,"61","TCGA-61-2008-02A-01R-1568-13_mirna.bam.bai",NA,"TCGA-61-2008-02A",2,"F5583F7B-A50C-4BF5-A9C9-11A8333D4781","TCGA",2007,NA,NA,"WITH TUMOR","ACCAC5F3-A3A5-4462-835D-1F00ED6CC0AB",40,"US82800149_251976010874_S01_GE2_105_Dec08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","Alive",NA,"TCGA-61-2008","NOT HISPANIC OR LATINO","F45F3FE2-1F97-4E6F-AFC7-D3ABF0F3311A",NA,932,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"ASIAN",NA,1,106,"F04BB94A-6CAF-4BA5-A918-08DB1B26B964","F247B565-11A8-499C-A644-CAEF051AC8A8","TCGA-61-2008-02A-01R-1568-13_mirna.bam.bai","TCGA-61-2008-02A-01",85,0,NA,NA,5,"BOTTOM",10,NA,"TCGA-61-2008-02A-01-BS1",75,"Cisplatin","Chemotherapy","TCGA-61-2008-D28338",NA,NA,NA,"TCGA-61-2008-F28334_NTE-2",NA,932,"WITH TUMOR","Alive",NA,"TCGA-61-2008-F28334","TCGA-61-2008",NA,"61","2008","YES","C56.9","8441/3","C56.9",NA,NA,-14791,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",932,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,40,2007,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
181519002,178309882,13188173055,"C26F21EA-5911-483F-BF64-03904BF93A20.bw","3ac45a71-c463-4f0f-b030-58c475a34418","c26f21ea-5911-483f-bf64-03904bf93a20","2016-08-22T10:49:47.958957-05:00","TCGA-61-2008-01A-02R-1568-13_rnaseq_fastq.tar","7d7a76a3-ea96-40da-9d98-1f1564bcfda6",11097016320,"Illumina HiSeq","4f916a55b11764ac1e94cc4f32585719","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:30:05.212246-05:00","2016-05-03T11:56:42.628342-05:00","7d7a76a3-ea96-40da-9d98-1f1564bcfda6_analysis.xml","3bdc5890cd4817c04518686b8d533e55","6f725c7d-2f7e-4320-a432-cd8bd2ba1964",2181,"2016-10-07T16:56:48.367526-05:00","7d7a76a3-ea96-40da-9d98-1f1564bcfda6_experiment.xml","8bf17b4b7e7b98151e4c3905e39930ff","0810a704-c184-4bc0-8dd9-b10a9077f9da",3916,"2016-09-29T19:24:04.746301-05:00","7d7a76a3-ea96-40da-9d98-1f1564bcfda6_run.xml","2dc3735d7d9ad81cf4fbffdcaca6ae0a","46da35b4-c048-4a74-add0-32ca61d00cf0",1988,"2016-09-08T11:40:10.255538-05:00","TCGA-61-2008","2016-09-02T18:56:34.042552-05:00","female","TCGA-61-2008_demographic",1967,"asian","32601890-a62f-5eac-821d-10d86af7637f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2008_diagnosis","not reported",14791,"alive","8441/3",NA,932,"4233e6db-8d18-5461-b504-3aa62d11e73f","c56.9",-14791,"TCGA-61-2008_treatment","8e378e12-53e5-58b2-b236-5632aa905b06","01",NA,"TCGA-61-2008-01A","0.7","69d76e7a-e0cb-4a8d-b6cd-67d8702d2af9",FALSE,"25448427-9a2c-4c36-bc9d-40a82d6e3710","Primary Tumor","0.4",NA,NA,"1.2",1247443200,"02",146,"TCGA-61-2008-01A-02",70,70,NA,NA,0,1,30,29,"2016-09-08T11:40:10.255538-05:00","2016-09-08T11:40:10.255538-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"3e834d4a-0868-4f2e-bf72-03aa2c766449","ebbf8459-bf7b-4836-a990-3b6d50fae361","TCGA-61-2008-01A-02-BS2","TCGA-61-2008-01A-01-BS1",69,69,"0cdd3869-bac6-4abf-9c15-81569b985211","RNA","TCGA-61-2008-01A-02R","3fe43ef1-3e89-4df8-a7fa-7ad5a2904d7c",1.8,0.14,"UV Spec","R","22","TCGA-61-2008-01A-02R-1568-13","10271f7f-cce6-44fd-8754-7a4beabfb394",0.14,NA,NA,NA,NA,"18c2dbfc-00ed-54a7-8607-a39c4b69bc3e","TCGA-61-2008_exposure","TCGA-61-2008-01A-02R-1568-13_rnaseq_fastq.tar","2014-08-28T12:25:25.000Z","2014-08-28T14:35:27.000Z","7D7A76A3-EA96-40DA-9D98-1F1564BCFDA6","69D76E7A-E0CB-4A8D-B6CD-67D8702D2AF9","Unaligned reads",11097016320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","10271F7F-CCE6-44FD-8754-7A4BEABFB394","Canada's Michael Smith Genome Sciences Centre","564a3af3e4b093830b691ecc","3AC45A71-C463-4F0F-B030-58C475A34418","Ovarian Serous Cystadenocarcinoma","TAR","0CDD3869-BAC6-4ABF-9C15-81569B985211","2014-08-28T14:35:27.000Z","3FE43EF1-3E89-4DF8-A7FA-7AD5A2904D7C","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"0CDD3869-BAC6-4ABF-9C15-81569B985211",0.7,"61","TCGA-61-2008-01A-02W-0927-10_SOLiD.bam",NA,"TCGA-61-2008-01A",1.2,"F5583F7B-A50C-4BF5-A9C9-11A8333D4781","TCGA",2007,NA,NA,"WITH TUMOR","ACCAC5F3-A3A5-4462-835D-1F00ED6CC0AB",40,"US82800149_251976010874_S01_GE2_105_Dec08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","Alive",NA,"TCGA-61-2008","NOT HISPANIC OR LATINO","F45F3FE2-1F97-4E6F-AFC7-D3ABF0F3311A",NA,932,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"ASIAN",NA,2,146,"EBBF8459-BF7B-4836-A990-3B6D50FAE361","B4D72F41-05E5-4DF5-8009-5CA348D8CDDA","TCGA-61-2008-01A-02W-0927-10_SOLiD.bam","TCGA-61-2008-01A-02",70,1,NA,NA,29,"TOP",1,NA,"TCGA-61-2008-01A-01-BS1",69,"Cisplatin","Chemotherapy","TCGA-61-2008-D28338",NA,NA,NA,"TCGA-61-2008-F28334_NTE-2",NA,932,"WITH TUMOR","Alive",NA,"TCGA-61-2008-F28334","TCGA-61-2008",NA,"61","2008","YES","C56.9","8441/3","C56.9",NA,NA,-14791,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",932,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,40,2007,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
197942782,193890240,14349137883,"9E50162D-8149-41D2-86C1-1C892EB98DFA.bw","3b81ec7c-0934-4649-9231-9919dd26dd15","9e50162d-8149-41d2-86c1-1c892eb98dfa","2016-08-25T20:21:00.698223-05:00","TCGA-24-1549-01A-01R-1566-13_rnaseq_fastq.tar","3a474de5-a52c-4939-ad40-0af0c52a3588",12048721920,"Illumina HiSeq","d5be816bea5da20093eea6b51232df8c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:03:13.791011-05:00","2016-05-03T11:40:21.662944-05:00","3a474de5-a52c-4939-ad40-0af0c52a3588_analysis.xml","53e286a55d294fc92049c3de964629eb","a958988a-7c4b-426a-99c2-1f9dddff9080",2181,"2016-08-13T03:25:58.150137-05:00","3a474de5-a52c-4939-ad40-0af0c52a3588_experiment.xml","0f51f9b0311b0103b5d3f74135b41fc2","cb546215-cffc-4114-b952-3527a4835080",3916,"2016-09-29T22:21:39.412320-05:00","3a474de5-a52c-4939-ad40-0af0c52a3588_run.xml","dd1d38a9171bd6289354b5171be95318","b4812d44-e048-4b85-9899-2e14bd611a9d",1988,"2016-09-08T12:46:02.886520-05:00","TCGA-24-1549","2016-09-02T19:07:11.909156-05:00","female","TCGA-24-1549_demographic",1939,"white","c55541b5-4687-5f7e-ad06-df8ce619bf84","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1549_diagnosis","not reported",21432,"dead","8441/3",1721,1721,"f36f2c46-02cd-5d38-a399-09fd46cbb94d","c56.9",-21432,"TCGA-24-1549_treatment","ad5ea13e-3382-5f99-a511-54945c4d6605","01",NA,"TCGA-24-1549-01A","0.6","cd81e8c8-2526-4427-a1db-6ce6bff105e6",FALSE,"6431416b-d089-442d-9db8-32118eed41de","Primary Tumor","0.4",NA,NA,"0.6",1235088000,"01",112,"TCGA-24-1549-01A-01",95,95,NA,NA,0,0,10,15,"2016-09-08T12:46:02.886520-05:00","2016-09-08T12:46:02.886520-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"e8282ab7-a954-4aaf-80fb-ca80fc8891c8","9d2f28ad-f2d5-491d-8df7-54afaf3133cc","TCGA-24-1549-01A-01-TS1","TCGA-24-1549-01A-01-BS1",85,80,"d330ec1f-4010-4899-be2d-e33487e82044","RNA","TCGA-24-1549-01A-01R","f105c9a1-d162-4643-af16-32b90b4b2ab6",1.8,0.15,"UV Spec","R","22","TCGA-24-1549-01A-01R-1566-13","f8ead0c8-9072-4a1d-9e07-f724a0d74a0f",0.15,NA,NA,NA,NA,"aec82ef8-de34-5016-8057-5f4f19d1df9a","TCGA-24-1549_exposure","TCGA-24-1549-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T02:50:05.000Z","2014-03-25T03:14:02.000Z","3A474DE5-A52C-4939-AD40-0AF0C52A3588","CD81E8C8-2526-4427-A1DB-6CE6BFF105E6","Unaligned reads",12048721920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F8EAD0C8-9072-4A1D-9E07-F724A0D74A0F","Canada's Michael Smith Genome Sciences Centre","564a59bae4b08c5d8694adc3","3B81EC7C-0934-4649-9231-9919DD26DD15","Ovarian Serous Cystadenocarcinoma","TAR","D330EC1F-4010-4899-BE2D-E33487E82044","2014-03-25T03:14:02.000Z","F105C9A1-D162-4643-AF16-32B90B4B2AB6","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"D330EC1F-4010-4899-BE2D-E33487E82044",0.6,"24","jhu-usc.edu_OV.HumanMethylation27.6.lvl-2.TCGA-24-1549-01A-01D-0501-05.txt",NA,"TCGA-24-1549-01A",0.6,"F0686F43-A6AF-4C6C-8A21-BA3F086FF822","TCGA",1997,NA,NA,"WITH TUMOR","CD81E8C8-2526-4427-A1DB-6CE6BFF105E6",58,"US82800149_251976010626_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","Dead",1721,"TCGA-24-1549",NA,"1C5BDF4E-CB21-4FD2-8079-C0390BE43A7E",NA,1721,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,112,"E8282AB7-A954-4AAF-80FB-CA80FC8891C8","F44C2655-FE58-4CC1-ABA0-55C865BF3909","bcgsc.ca.TCGA-24-1549-01A-01R-1566-13.hg19.bcgsc.ca.1.7.0.sv.fa","TCGA-24-1549-01A-01",95,0,NA,NA,15,"BOTTOM",5,NA,"TCGA-24-1549-01A-01-BS1",80,"Gemzan","Chemotherapy","TCGA-24-1549-D26120",NA,NA,NA,"TCGA-24-1549-F26113_NTE-2",NA,1721,"WITH TUMOR","Dead",1721,"TCGA-24-1549-F26113","TCGA-24-1549",NA,"24","1549","YES","C56.9","8441/3","C56.9",NA,NA,-21432,"FEMALE","WHITE",NA,NA,"No","Dead",1721,1721,NA,NA,"WITH TUMOR","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
130851076,128156703,9479037869,"09521B29-B002-4AAD-93F1-6E600DD31515.bw","3bc8a74f-49bd-46b6-a3a4-68ca838e83c6","09521b29-b002-4aad-93f1-6e600dd31515","2016-08-24T12:23:29.181638-05:00","TCGA-25-2401-01A-01R-1569-13_rnaseq_fastq.tar","1a909828-f0e7-43d8-b688-0b5e0408ca6b",8063027200,"Illumina HiSeq","a3b51084c1b3781d854b2baba5d5a986","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:44:02.497370-05:00","2016-05-03T11:55:09.260045-05:00","1a909828-f0e7-43d8-b688-0b5e0408ca6b_analysis.xml","9cc643b67c5ee7fafee4afe52b5d4a22","07d84b22-643f-42ff-a5f1-48c7f8514237",2181,"2016-08-27T23:12:37.221400-05:00","1a909828-f0e7-43d8-b688-0b5e0408ca6b_experiment.xml","9c29c83889fb4906fd247eb0a9f25622","7c4fd2e9-52e8-4c20-a77c-8c96d76c33e2",3916,"2016-09-29T22:19:28.650474-05:00","1a909828-f0e7-43d8-b688-0b5e0408ca6b_run.xml","51e6feb486ff6590040dfcd0a35303a6","b334af14-2cbb-4178-a003-e8fbfe757da5",1988,"2016-09-08T13:54:38.932394-05:00","TCGA-25-2401","2016-09-02T19:12:07.086770-05:00","female","TCGA-25-2401_demographic",1940,"white","61b69ecd-1137-5c6b-8e08-e9acae100eb2","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2401_diagnosis","not reported",23711,"dead","8441/3",90,90,"012f225f-1cb8-5962-a806-b05cca31ffd9","c56.9",-23711,"TCGA-25-2401_treatment","d51b968c-33f8-5c0c-a1e2-7f32f53f231f","01",NA,"TCGA-25-2401-01A","1","efc25de9-e672-4b44-9003-5b277a47a625",FALSE,"5B192072-1F11-4316-AC39-81085F7E425D","Primary Tumor","0.3",NA,NA,"1.8",1252022400,"01",162,"TCGA-25-2401-01A-01",90,80,NA,NA,0,1,10,19,"2016-09-08T13:54:38.932394-05:00","2016-09-08T13:54:38.932394-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,5,"998ebf95-b49a-46c5-b501-b877912cbd44","8c7e8e52-32b5-4abc-831a-1e32c7780162","TCGA-25-2401-01A-01-TS1","TCGA-25-2401-01A-01-BS1",89,75,"76282c36-33b4-4f54-a5bb-0a7ea903ab39","RNA","TCGA-25-2401-01A-01R","97e3dec3-1bca-4be2-9b4a-f0656a478fe9",1.8,0.14,"UV Spec","R","22","TCGA-25-2401-01A-01R-1569-13","c3a1cbaf-28cd-451c-ad93-5a03a61a8a2c",0.14,NA,NA,NA,NA,"d89c3107-6446-5500-9455-7eb9d9a3e0d2","TCGA-25-2401_exposure","TCGA-25-2401-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T05:44:40.000Z","2014-08-08T06:08:32.000Z","1A909828-F0E7-43D8-B688-0B5E0408CA6B","EFC25DE9-E672-4B44-9003-5B277A47A625","Unaligned reads",8063027200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C3A1CBAF-28CD-451C-AD93-5A03A61A8A2C","Canada's Michael Smith Genome Sciences Centre","564a39a6e4b0298dd2c7d874","3BC8A74F-49BD-46B6-A3A4-68CA838E83C6","Ovarian Serous Cystadenocarcinoma","TAR","76282C36-33B4-4F54-A5BB-0A7EA903AB39","2014-08-08T06:08:32.000Z","97E3DEC3-1BCA-4BE2-9B4A-F0656A478FE9","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"76282C36-33B4-4F54-A5BB-0A7EA903AB39",1,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8b55fa70-3074-4209-ab77-4634075aa0d1.txt",NA,"TCGA-25-2401-01A",1.8,NA,"TCGA",2004,NA,NA,NA,"EFC25DE9-E672-4B44-9003-5B277A47A625",64,"nationwidechildrens.org_clinical.TCGA-25-2401.xml","Dead",90,"TCGA-25-2401","NOT HISPANIC OR LATINO","94FF5853-4598-4507-831F-006D4AEF14E2",NA,90,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,162,"998EBF95-B49A-46C5-B501-B877912CBD44","DE44C604-5142-4906-8FAB-E57D9DF91C66","DITTY_p_TCGA_B_24_AMplate1_2_HT_HG-U133A_96-HTA_D10_547292.CEL","TCGA-25-2401-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-25-2401-01A-01-TS1",89,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,"Dead",90,"TCGA-25-2401-F26829","TCGA-25-2401",NA,"25","2401","YES","C56.9","8441/3","C56.9",NA,NA,-23711,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",90,90,NA,NA,NA,"NO",5,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,64,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
337514502,314787097,23234764879,"45FD44A6-7976-4453-BD3F-99D21DA3ECC2.bw","3e8a51bf-7e1f-4eab-af83-3c60d04db1bf","45fd44a6-7976-4453-bd3f-99d21da3ecc2","2016-08-20T02:31:10.601007-05:00","TCGA-13-0913-01A-01R-1564-13_rnaseq_fastq.tar","bd41de75-cd48-4cbd-ace0-ebe960601fea",22542673920,"Illumina HiSeq","28545b28228641b0cb1ba30dbe0c4795","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:43:06.383812-05:00","2016-05-03T11:27:59.322672-05:00","bd41de75-cd48-4cbd-ace0-ebe960601fea_analysis.xml","da61fdb01d0c1eafedb6d1ce7af3741d","52a13ee8-73f3-4717-a882-d67bd2a128d5",2183,"2016-09-29T17:57:50.105627-05:00","bd41de75-cd48-4cbd-ace0-ebe960601fea_experiment.xml","dfb0384dc9cabd28878bd0270ca9ff40","1092612c-efa8-4104-9dae-6c8217c13f56",3916,"2016-09-30T00:23:08.293435-05:00","bd41de75-cd48-4cbd-ace0-ebe960601fea_run.xml","2808bf91e7e7befd1a1d77de328bb4c2","fff75bf5-d609-46e4-bc3e-a5e11514ec38",1990,"2016-09-08T12:46:57.169057-05:00","TCGA-13-0913","2016-09-02T19:05:18.771845-05:00","female","TCGA-13-0913_demographic",1953,"white","7566af4a-1027-5501-b6dd-0c2b437a7790","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0913_diagnosis","not reported",19573,"alive","8441/3",NA,3325,"2be71456-45a9-5969-9734-1a2d672374ed","c56.9",-19573,"TCGA-13-0913_treatment","1e298880-0a07-516f-990d-749cd230ff0d","01",NA,"TCGA-13-0913-01A","0.6","c505b908-c303-4e98-b0c3-d4252afd01c2",FALSE,"E8FB6EA9-586A-452F-B6A6-0746F16B51DB","Primary Tumor","0.4",NA,NA,"1.3",1233705600,"01",101,"TCGA-13-0913-01A-01",99,85,NA,NA,0,0,4,25,"2016-09-08T12:46:57.169057-05:00","2016-09-08T12:46:57.169057-05:00",100,100,NA,NA,"TOP","BOTTOM",1,0,"4ad93ffb-b838-4555-a664-fb3e41923260","bcf99833-7903-4104-8814-7b6e5426954f","TCGA-13-0913-01A-01-TS1","TCGA-13-0913-01A-01-BS1",95,75,"4a770b27-e9f9-4fff-8fa0-fc70eab69877","RNA","TCGA-13-0913-01A-01R","4935c698-ba75-4280-8531-31f611a52551",1.8,0.14,"UV Spec","R","22","TCGA-13-0913-01A-01R-1564-13","cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9",0.14,NA,NA,NA,NA,"40f8ef17-df09-5278-97c7-a2231834ed7a","TCGA-13-0913_exposure","TCGA-13-0913-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T08:19:27.000Z","2013-12-20T08:56:02.000Z","BD41DE75-CD48-4CBD-ACE0-EBE960601FEA","C505B908-C303-4E98-B0C3-D4252AFD01C2","Unaligned reads",22542673920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CDAF98B1-FDB5-4575-AA17-E2D2CCBA31F9","Canada's Michael Smith Genome Sciences Centre","564a39fce4b0ef121819fe6f","3E8A51BF-7E1F-4EAB-AF83-3C60D04DB1BF","Ovarian Serous Cystadenocarcinoma","TAR","4A770B27-E9F9-4FFF-8FA0-FC70EAB69877","2013-12-20T08:56:02.000Z","4935C698-BA75-4280-8531-31F611A52551","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"4A770B27-E9F9-4FFF-8FA0-FC70EAB69877",0.6,"13","TCGA-13-0913-01A-01R-1564-13_GRCh37-lite_mirna.bam.bai",NA,"TCGA-13-0913-01A",1.3,"FD329F71-CBC1-4149-9E26-3483110F7C08","TCGA",2006,NA,NA,"WITH TUMOR","C505B908-C303-4E98-B0C3-D4252AFD01C2",53,"nationwidechildrens.org_clinical.TCGA-13-0913.xml","Alive",NA,"TCGA-13-0913","NOT HISPANIC OR LATINO","2196FA5E-C624-4376-A480-5AACC1C81F86",NA,912,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,101,"BCF99833-7903-4104-8814-7B6E5426954F","7BE627C9-6860-415C-9321-8AEA759BD43F","TCGA-13-0913-01A-01R-1564-13_rnaseq_fastq.tar","TCGA-13-0913-01A-01",99,0,NA,100,4,"TOP",1,NA,"TCGA-13-0913-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-13-0913-D24762",NA,NA,NA,"TCGA-13-0913-F24758_NTE-2",NA,912,"WITH TUMOR","Alive",NA,"TCGA-13-0913-F24758","TCGA-13-0913",NA,"13","0913","YES","C56.9","8441/3","C56.9",NA,NA,-19573,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",912,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
74002602,68312721,5020983315,"9EE0976F-1422-4F65-8837-93A192984CDF.bw","3e8a51bf-7e1f-4eab-af83-3c60d04db1bf","9ee0976f-1422-4f65-8837-93a192984cdf","2016-08-25T20:35:08.063972-05:00","TCGA-13-0913-02A-01R-1564-13_rnaseq_fastq.tar","e7b7f3c2-86fc-4e33-b828-7480c998ba91",4888320000,"Illumina HiSeq","2c896e0211b428fb9c6bce2d3caea3bd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:09:00.569622-05:00","2016-05-03T11:39:34.522989-05:00","e7b7f3c2-86fc-4e33-b828-7480c998ba91_analysis.xml","8291ada7c6495963b9ae9fe3a1e13c2b","3d579590-f536-4654-a9d4-bc44c9fd10d4",2267,"2016-09-29T17:45:04.995968-05:00","e7b7f3c2-86fc-4e33-b828-7480c998ba91_experiment.xml","68d30e5d159fb32060b2a3ef2c8421b0","0893ddde-54b9-4c99-a117-9f2fc4140563",3916,"2016-09-29T18:03:50.970826-05:00","e7b7f3c2-86fc-4e33-b828-7480c998ba91_run.xml","c566009d7b66c11436fad01fd03bca67","146e52e5-1f8f-4bdd-a46c-04f2fcce4702",1990,"2016-09-08T12:46:57.169057-05:00","TCGA-13-0913","2016-09-02T19:05:18.771845-05:00","female","TCGA-13-0913_demographic",1953,"white","7566af4a-1027-5501-b6dd-0c2b437a7790","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0913_diagnosis","not reported",19573,"alive","8441/3",NA,3325,"2be71456-45a9-5969-9734-1a2d672374ed","c56.9",-19573,"TCGA-13-0913_treatment","1e298880-0a07-516f-990d-749cd230ff0d","02",NA,"TCGA-13-0913-02A","1","bbe91b44-cb43-4763-8783-169c458c5c3c",FALSE,"61FBF10C-A508-4D83-971D-5A48BA81F08A","Recurrent Tumor","0.3",NA,NA,"1.4",1244160000,"01",171,"TCGA-13-0913-02A-01",70,90,NA,NA,0,0,20,20,"2016-09-08T12:46:57.169057-05:00","2016-09-08T12:46:57.169057-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,10,"1ac7ab05-f6af-42db-acd0-0d303a1dd585","6b3e1267-f670-4836-9e04-012d1b63f14a","TCGA-13-0913-02A-01-BS1","TCGA-13-0913-02A-01-TS1",70,70,"6b986153-ffca-4d53-888b-8adf80cccb5f","RNA","TCGA-13-0913-02A-01R","194a6538-dd75-4ba9-8682-0fb6c5cc552e",1.8,0.14,"UV Spec","R","22","TCGA-13-0913-02A-01R-1564-13","733f0607-6c6b-4385-9868-fa6f155a9a2e",0.14,NA,NA,NA,NA,"40f8ef17-df09-5278-97c7-a2231834ed7a","TCGA-13-0913_exposure","TCGA-13-0913-02A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T02:13:09.000Z","2014-03-20T02:27:02.000Z","E7B7F3C2-86FC-4E33-B828-7480C998BA91","BBE91B44-CB43-4763-8783-169C458C5C3C","Unaligned reads",4888320000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","733F0607-6C6B-4385-9868-FA6F155A9A2E","Canada's Michael Smith Genome Sciences Centre","564a39f7e4b093830b68ce07","3E8A51BF-7E1F-4EAB-AF83-3C60D04DB1BF","Ovarian Serous Cystadenocarcinoma","TAR","6B986153-FFCA-4D53-888B-8ADF80CCCB5F","2014-03-20T02:27:02.000Z","194A6538-DD75-4BA9-8682-0FB6C5CC552E","None","NO",2,0.3,"Recurrent Tumor","Memorial Sloan Kettering",NA,"6B986153-FFCA-4D53-888B-8ADF80CCCB5F",1,"13","TCGA-13-0913-02A-01R-1564-13_GRCh37-lite_mirna.bam",NA,"TCGA-13-0913-02A",1.4,"FD329F71-CBC1-4149-9E26-3483110F7C08","TCGA",2006,NA,NA,"WITH TUMOR","C505B908-C303-4E98-B0C3-D4252AFD01C2",53,"nationwidechildrens.org_clinical.TCGA-13-0913.xml","Alive",NA,"TCGA-13-0913","NOT HISPANIC OR LATINO","2196FA5E-C624-4376-A480-5AACC1C81F86",NA,912,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,171,"6B3E1267-F670-4836-9E04-012D1B63F14A","EEE57520-AB19-4C63-AB5A-619940227D09","TCGA-13-0913-02A-01R-1564-13_GRCh37-lite_mirna.bam","TCGA-13-0913-02A-01",70,0,NA,NA,20,"BOTTOM",10,NA,"TCGA-13-0913-02A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-13-0913-D24762",NA,NA,NA,"TCGA-13-0913-F24758_NTE-2",NA,912,"WITH TUMOR","Alive",NA,"TCGA-13-0913-F24758","TCGA-13-0913",NA,"13","0913","YES","C56.9","8441/3","C56.9",NA,NA,-19573,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",912,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
223788638,215358919,15948874077,"2FBAA1AA-39F7-4C58-A7DA-76B1F4B26B2E.bw","3f917550-89a6-404b-94df-938c99121411","2fbaa1aa-39f7-4c58-a7da-76b1f4b26b2e","2016-08-25T12:43:05.366581-05:00","TCGA-25-1628-01A-01R-1566-13_rnaseq_fastq.tar","06b5be31-e1eb-4ec4-b852-422d62bdae3c",14636482560,"Illumina HiSeq","1b5c47e841f4b6c4b556e6af2e0692cf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:45:16.755392-05:00","2016-05-03T11:40:21.662944-05:00","06b5be31-e1eb-4ec4-b852-422d62bdae3c_analysis.xml","cd17991ada7d1309265fb3bb8c0aaebb","e89af35f-4262-42a0-b483-067a645211e5",2181,"2016-09-29T18:09:30.312164-05:00","06b5be31-e1eb-4ec4-b852-422d62bdae3c_experiment.xml","c19e863a5133e0d06c34696fb8eb0f03","17fdb7fe-0f7f-413c-90a6-4140d47524b9",3916,"2016-09-29T22:57:42.770133-05:00","06b5be31-e1eb-4ec4-b852-422d62bdae3c_run.xml","477df42070ee3374e85bd5f400a6fded","cae637f9-00a0-4a48-b2e3-f24337d89cda",1988,"2016-09-08T10:36:10.752158-05:00","TCGA-25-1628","2016-09-02T18:48:50.381742-05:00","female","TCGA-25-1628_demographic",1935,"white","6e2d232b-ab2e-50d6-bfae-ee839c5600ad","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1628_diagnosis","not reported",24488,"dead","8441/3",627,627,"8a7f1425-a395-5f52-8f54-d892a3e2f7e7","c56.9",-24488,"TCGA-25-1628_treatment","23777ecf-03ee-5cd8-a454-ff354ab7ddc9","01",NA,"TCGA-25-1628-01A","0.5","efe5ae48-c145-4b24-a1df-ba485d355dfa",FALSE,"790D6E48-15D0-45F9-B6DD-182787298EBA","Primary Tumor","0.4",NA,NA,"2",1237420800,"01",105,"TCGA-25-1628-01A-01",95,95,NA,NA,0,0,10,10,"2016-09-08T10:36:10.752158-05:00","2016-09-08T10:36:10.752158-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"b18022f1-2c8f-4a48-b8e9-df04efe7b09c","35d35463-e15c-4be7-b62e-9a8e169c005a","TCGA-25-1628-01A-01-BS1","TCGA-25-1628-01A-01-TS1",85,85,"bf96086a-9aaf-45f3-a95f-e48d8b890e22","RNA","TCGA-25-1628-01A-01R","61f6b4fc-7b00-4d36-a2cc-78d26b620e38",1.8,0.15,"UV Spec","R","22","TCGA-25-1628-01A-01R-1566-13","a3083fd8-f5d0-486b-bf3d-31ae094b1cbf",0.15,NA,NA,NA,NA,"b3623f4d-786d-5919-8fce-97f9f7bf0dff","TCGA-25-1628_exposure","TCGA-25-1628-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T01:33:27.000Z","2014-03-25T01:58:02.000Z","06B5BE31-E1EB-4EC4-B852-422D62BDAE3C","EFE5AE48-C145-4B24-A1DF-BA485D355DFA","Unaligned reads",14636482560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A3083FD8-F5D0-486B-BF3D-31AE094B1CBF","Canada's Michael Smith Genome Sciences Centre","564a3be6e4b09c884b248285","3F917550-89A6-404B-94DF-938C99121411","Ovarian Serous Cystadenocarcinoma","TAR","BF96086A-9AAF-45F3-A95F-E48D8B890E22","2014-03-25T01:58:02.000Z","61F6B4FC-7B00-4D36-A2CC-78D26B620E38","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"BF96086A-9AAF-45F3-A95F-E48D8B890E22",0.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f7ac6f1b-7ee1-4536-84ae-48d20a61df99.txt",NA,"TCGA-25-1628-01A",2,"6B515F85-0F51-40E8-A3C8-80CE274D199E","TCGA",2002,NA,NA,"WITH TUMOR","EFE5AE48-C145-4B24-A1DF-BA485D355DFA",67,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f7ac6f1b-7ee1-4536-84ae-48d20a61df99.txt","Dead",627,"TCGA-25-1628","NOT HISPANIC OR LATINO","50828490-96EB-46A5-9103-3B979676FEA8",NA,627,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,105,"B18022F1-2C8F-4A48-B8E9-DF04EFE7B09C","61F6B4FC-7B00-4D36-A2CC-78D26B620E38","MSK_252152915185_S01_CGH-v4_10_27Aug08.txt","TCGA-25-1628-01A-01",95,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-25-1628-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-25-1628-D26725",NA,NA,NA,"TCGA-25-1628-F26724_NTE-2",NA,627,"WITH TUMOR","Dead",627,"TCGA-25-1628-F26724","TCGA-25-1628",NA,"25","1628","YES","C56.9","8441/3","C56.9",NA,NA,-24488,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",627,627,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,67,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
140217262,133341616,9826398928,"B7A695A4-0B74-41E9-8662-4010C8CA38F0.bw","3fc8f799-5bd3-4f48-baf0-c458ce86ab7e","b7a695a4-0b74-41e9-8662-4010c8ca38f0","2016-08-26T07:06:05.096827-05:00","TCGA-24-1413-01A-01R-1565-13_rnaseq_fastq.tar","f99c51a3-be98-40e5-a1ad-e283bd896bee",8595589120,"Illumina HiSeq","1817a4b750d1509e991adf1cadf49f81","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:40:11.385798-05:00","2016-05-03T11:40:21.647690-05:00","f99c51a3-be98-40e5-a1ad-e283bd896bee_analysis.xml","b5338b854949d367e1a6922fd8cc16e2","759dacb2-8a5a-4679-8cd2-cda73ea7c6fe",2181,"2016-09-29T19:40:20.242400-05:00","f99c51a3-be98-40e5-a1ad-e283bd896bee_experiment.xml","2b2f2e3364a782dc3faf8cab238dc236","50e85fde-789d-4c65-9ab9-bfc112fe0b76",3916,"2016-09-29T18:35:45.612279-05:00","f99c51a3-be98-40e5-a1ad-e283bd896bee_run.xml","264f571b00b60fd71e6b94255d2c5e9d","283d17ff-e996-4194-9ca0-2f055589f0f6",1988,"2016-09-08T13:53:42.224913-05:00","TCGA-24-1413","2016-09-02T19:11:57.581644-05:00","female","TCGA-24-1413_demographic",1957,"white","74a17d97-ff76-50a8-858a-cc082f7219c2","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1413_diagnosis","not reported",18846,"alive","8441/3",NA,192,"7ad436d5-5f18-51e6-a99d-d533a2c7e2cc","c56.9",-18846,"TCGA-24-1413_treatment","d3c5b21a-960c-5ddb-a798-7eb73176d614","01",NA,"TCGA-24-1413-01A","0.6","c20183e0-600b-4d1d-975f-2b6e43c35d0d",FALSE,"2ca18d08-e930-4244-a0d5-316dfbca0fb4","Primary Tumor","0.4",NA,NA,"1.1",1231804800,"01",128,"TCGA-24-1413-01A-01",85,85,NA,NA,40,20,0,0,"2016-09-08T13:53:42.224913-05:00","2016-09-08T13:53:42.224913-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,20,"8e76a2e6-ab2f-4d66-8017-c128c68763d8","963bdc29-e21a-4b5f-9ff7-9bb4d4b6abea","TCGA-24-1413-01A-01-TS1","TCGA-24-1413-01A-01-BS1",50,60,"b6ba711b-f2ae-44ca-b36f-92d77302d57d","RNA","TCGA-24-1413-01A-01R","b61a50f9-93ed-4290-a1e9-68c4278cdca0",1.8,0.15,"UV Spec","R","22","TCGA-24-1413-01A-01R-1565-13","545867ef-1299-410d-bbbf-d6c189344b0f",0.15,NA,NA,NA,NA,"ce2ab9fa-9ea5-5d6a-b2c3-9ddc194812ab","TCGA-24-1413_exposure","TCGA-24-1413-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T00:58:27.000Z","2014-03-22T01:20:03.000Z","F99C51A3-BE98-40E5-A1AD-E283BD896BEE","C20183E0-600B-4D1D-975F-2B6E43C35D0D","Unaligned reads",8595589120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","545867EF-1299-410D-BBBF-D6C189344B0F","Canada's Michael Smith Genome Sciences Centre","564a3740e4b0ef1218191d91","3FC8F799-5BD3-4F48-BAF0-C458CE86AB7E","Ovarian Serous Cystadenocarcinoma","TAR","B6BA711B-F2AE-44CA-B36F-92D77302D57D","2014-03-22T01:20:03.000Z","B61A50F9-93ED-4290-A1E9-68C4278CDCA0","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"B6BA711B-F2AE-44CA-B36F-92D77302D57D",0.6,"24","CELLS_p_TCGA_B13__RNA_HT_HG-U133A_96-HTA_C06_452022.level3.data.txt",NA,"TCGA-24-1413-01A",1.1,"86D3680C-7AF1-4BCF-9466-AC5D0D032144","TCGA",2008,NA,NA,"TUMOR FREE","C20183E0-600B-4D1D-975F-2B6E43C35D0D",51,"nationwidechildrens.org_clinical.TCGA-24-1413.xml","Alive",NA,"TCGA-24-1413",NA,"00E61BDC-FCCD-47A7-BD23-8CE0506D6B7B",NA,192,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,128,"8E76A2E6-AB2F-4D66-8017-C128C68763D8","B61A50F9-93ED-4290-A1E9-68C4278CDCA0","TCGA-24-1413-01A-01R-1565-13_rnaseq.bam","TCGA-24-1413-01A-01",85,40,NA,NA,0,"TOP",10,NA,"TCGA-24-1413-01A-01-TS1",50,"Paclitaxel","Chemotherapy","TCGA-24-1413-D25911",NA,NA,NA,NA,NA,192,"TUMOR FREE","Alive",NA,"TCGA-24-1413-F25910","TCGA-24-1413",NA,"24","1413","YES","C56.9","8441/3","C56.9",NA,NA,-18846,"FEMALE","WHITE",NA,NA,"No","Alive",192,NA,NA,NA,"TUMOR FREE","NO",9,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
163783400,161545673,11960634487,"E9013476-D037-41EA-921E-E9E62E93B75C.bw","40635bf3-d8ba-4833-b623-547e55e5d07e","e9013476-d037-41ea-921e-e9e62e93b75c","2016-08-26T23:06:25.733637-05:00","TCGA-29-2425-01A-01R-1569-13_rnaseq_fastq.tar","f524f673-e657-4c56-9855-83a4f8f036d9",9377013760,"Illumina HiSeq","7599b0c4ae6033bddc2f3b9785433a86","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:07:00.324167-05:00","2016-05-03T11:55:09.260045-05:00","f524f673-e657-4c56-9855-83a4f8f036d9_analysis.xml","c4a19662c7eb84bf0abbc8e87fd64b8b","167885b4-3a2d-47ed-84c4-77507c635792",2181,"2016-10-07T17:34:41.799206-05:00","f524f673-e657-4c56-9855-83a4f8f036d9_experiment.xml","934cfc5fe72b645388cdf02d125a7108","4ccf1faa-b763-49f0-be22-bbc2c2f40ff9",3916,"2016-09-29T18:44:59.805494-05:00","f524f673-e657-4c56-9855-83a4f8f036d9_run.xml","ddc03e3a4f67f1cad07ec5758341e950","2e308fde-b1a4-4bea-8f85-b817852d26e9",1989,"2016-09-08T13:54:24.629445-05:00","TCGA-29-2425","2016-09-02T19:11:53.228261-05:00","female","TCGA-29-2425_demographic",1944,"white","90915e14-fbfa-56e5-8fcd-04df28f44be4","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-2425_diagnosis","not reported",22089,"alive","8441/3",NA,1977,"0d0523a7-c86c-5ce8-a0ab-2cc6094af039","c56.9",-22089,"TCGA-29-2425_treatment","afe76cb3-785a-5ba4-b647-a3aa0f8b49fb","01",NA,"TCGA-29-2425-01A","0.8","0a6d3bb3-512a-47bc-9b84-b6fa017da9c3",FALSE,"ec04e6ae-ae66-4fc2-b77b-485f77ce39bc","Primary Tumor","0.5",NA,NA,"1",1252972800,"01",129,"TCGA-29-2425-01A-01",97,97,NA,NA,0,0,15,10,"2016-09-08T13:54:24.629445-05:00","2016-09-08T13:54:24.629445-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,10,"b02b7e9c-7826-4dda-9fc2-70867e37e9c7","219c877f-a1fc-4322-bc83-e1ab4e10f906","TCGA-29-2425-01A-01-TS1","TCGA-29-2425-01A-01-BS1",80,80,"fcd6a1d7-eec8-4f30-a15b-71c80601f1fd","RNA","TCGA-29-2425-01A-01R","c11674a4-550b-4a24-9972-7412e0dac3fa",1.8,0.15,"UV Spec","R","22","TCGA-29-2425-01A-01R-1569-13","3ce6b8c4-7020-447a-8eb8-5370eef05344",0.15,NA,NA,NA,NA,"0365b72c-fdcf-5eab-b4cf-8f73f7fae320","TCGA-29-2425_exposure","TCGA-29-2425-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T06:51:30.000Z","2014-08-08T07:22:21.000Z","F524F673-E657-4C56-9855-83A4F8F036D9","0A6D3BB3-512A-47BC-9B84-B6FA017DA9C3","Unaligned reads",9377013760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3CE6B8C4-7020-447A-8EB8-5370EEF05344","Canada's Michael Smith Genome Sciences Centre","564a31c2e4b0ef12181759cd","40635BF3-D8BA-4833-B623-547E55E5D07E","Ovarian Serous Cystadenocarcinoma","TAR","FCD6A1D7-EEC8-4F30-A15B-71C80601F1FD","2014-08-08T07:22:21.000Z","C11674A4-550B-4A24-9972-7412E0DAC3FA","None","NO",1,0.5,"Primary Tumor","Duke",NA,"FCD6A1D7-EEC8-4F30-A15B-71C80601F1FD",0.8,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8d87815d-6b5a-4713-9f0b-0ca8609996f2.txt",NA,"TCGA-29-2425-01A",1,"BB6485F6-0925-462B-B098-086512A78E90","TCGA",2004,NA,NA,"TUMOR FREE","37BB404A-9E60-4800-AB73-90BB62628F35",60,"nationwidechildrens.org_clinical.TCGA-29-2425.xml","Alive",NA,"TCGA-29-2425",NA,"DBE47BCC-3E28-4FEC-95CF-F4363C17E184",NA,1977,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,129,"B02B7E9C-7826-4DDA-9FC2-70867E37E9C7","C11674A4-550B-4A24-9972-7412E0DAC3FA","bcgsc.ca.TCGA-29-2425-01A-01R-1569-13.bcgsc.ca.1.4.0.indel.vcf","TCGA-29-2425-01A-01",97,0,NA,NA,15,"TOP",5,NA,"TCGA-29-2425-01A-01-TS1",80,"Paclitaxel","Chemotherapy","TCGA-29-2425-D27463",NA,NA,NA,"TCGA-29-2425-F27462_NTE-2",NA,1977,"TUMOR FREE","Alive",NA,"TCGA-29-2425-F27462","TCGA-29-2425",NA,"29","2425","YES","C56.9","8441/3","C56.9",NA,NA,-22089,"FEMALE","WHITE",NA,NA,"No","Alive",1977,NA,NA,NA,"TUMOR FREE","NO",9,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,60,2004,"Tumor resection",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
330638650,321860528,23824598921,"13FD88E9-3B06-4CB6-949F-395DDDE4B75B.bw","41178cbc-db73-4007-b5d8-febebf7f578d","13fd88e9-3b06-4cb6-949f-395ddde4b75b","2016-09-29T18:03:10.344135-05:00","TCGA-23-2081-01A-01R-1568-13_rnaseq_fastq.tar","3a66e166-8f9f-484f-a9ee-34c09d86f7e8",21352867840,"Illumina HiSeq","7381061fda1040183aa9c7ff822683f3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:25:38.793435-05:00","2016-05-03T11:41:05.748550-05:00","3a66e166-8f9f-484f-a9ee-34c09d86f7e8_analysis.xml","efb7e15ae9c7acd4c98779f9b462e32f","92026595-7f9c-450b-8887-11e7f5656992",2181,"2016-10-07T15:55:37.111194-05:00","3a66e166-8f9f-484f-a9ee-34c09d86f7e8_experiment.xml","c2770afe65f60308ccb3ce2b0a5e30f3","32c18cf4-d3d2-43c4-bea6-7c2668110955",3916,"2016-09-29T20:15:50.998149-05:00","3a66e166-8f9f-484f-a9ee-34c09d86f7e8_run.xml","64dd652373aecac4cc58b91fbdaeeee8","66b69707-44a8-4a25-ba81-fc6a041fc1cf",1989,"2016-09-08T12:39:08.902134-05:00","TCGA-23-2081","2016-09-02T18:56:22.927058-05:00","female","TCGA-23-2081_demographic",1951,"white","dff24d73-a1fd-59fb-a913-7e99897a2a11","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-2081_diagnosis","not reported",18162,"dead","8441/3",2342,NA,"efeb03d8-43a5-5452-bb12-ad1e0ff9a541","c56.9",-18162,"TCGA-23-2081_treatment","cc127931-50ad-5ffb-bf29-fee0891a156f","01",NA,"TCGA-23-2081-01A","0.7","48b84b42-0a80-4429-9d6f-1a51b8aaae2e",FALSE,"05dc597f-052a-461e-a67c-27dac0d10972","Primary Tumor","0.5",NA,NA,"0.8",1248739200,"01",124,"TCGA-23-2081-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:39:08.902134-05:00","2016-09-08T12:39:08.902134-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"19730edb-2ced-493d-95d0-86ec753a6521","a28a9267-eff3-4e25-aa28-3397f0b0773c","TCGA-23-2081-01A-01-TS1","TCGA-23-2081-01A-01-BS1",90,90,"23440342-4277-4ca2-add0-f222ff0e8e2f","RNA","TCGA-23-2081-01A-01R","18530469-346f-41e5-b6cc-3dd9c2abc453",1.8,0.17,"UV Spec","R","22","TCGA-23-2081-01A-01R-1568-13","4c8dd391-5a1c-490e-a7d7-fde372c3ec47",0.17,NA,NA,NA,NA,"56a4b7e6-c7f3-54c6-a8d5-9e1d6c75eba2","TCGA-23-2081_exposure","TCGA-23-2081-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-29T07:32:03.000Z","2014-03-29T08:06:02.000Z","3A66E166-8F9F-484F-A9EE-34C09D86F7E8","48B84B42-0A80-4429-9D6F-1A51B8AAAE2E","Unaligned reads",21352867840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4C8DD391-5A1C-490E-A7D7-FDE372C3EC47","Canada's Michael Smith Genome Sciences Centre","564a38dae4b0ef121819a090","41178CBC-DB73-4007-B5D8-FEBEBF7F578D","Ovarian Serous Cystadenocarcinoma","TAR","23440342-4277-4CA2-ADD0-F222FF0E8E2F","2014-03-29T08:06:02.000Z","18530469-346F-41E5-B6CC-3DD9C2ABC453","None","NO",1,0.5,"Primary Tumor","Cedars Sinai",NA,"23440342-4277-4CA2-ADD0-F222FF0E8E2F",0.7,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.330a8af7-1a12-46a0-8ede-ca4e244de117.txt",NA,"TCGA-23-2081-01A",0.8,"FE9683D7-E2D6-4136-92EA-1D6D51FD5023","TCGA",2000,NA,NA,"WITH TUMOR","9C1230C8-F2E9-411E-8008-00C6E0EDE260",49,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.330a8af7-1a12-46a0-8ede-ca4e244de117.txt","Dead",2342,"TCGA-23-2081","NOT HISPANIC OR LATINO","3BED5A01-64CB-41CF-9ED8-4D91EECC4ADF",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,124,"A28A9267-EFF3-4E25-AA28-3397F0B0773C","6A16A4F7-36E6-48AD-B61A-A026D5890B63","TCGA-23-2081-01A-01R-1568-13_GRCh37-lite_rnaseq.bam.bai","TCGA-23-2081-01A-01",90,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-23-2081-01A-01-BS1",90,"Avastin","Chemotherapy","TCGA-23-2081-D25782",NA,NA,NA,"TCGA-23-2081-F25781_NTE-1",NA,NA,"WITH TUMOR","Dead",2342,"TCGA-23-2081-F25781","TCGA-23-2081",NA,"23","2081","YES","C56.9","8441/3","C56.9",NA,NA,-18162,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,2342,NA,NA,"WITH TUMOR","NO",20,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
185080628,181285306,13356910056,"9103E60E-D1FC-4F0F-B2CD-751921E14EBA.bw","4160e048-f0b0-40f5-805b-e277a5893a3b","9103e60e-d1fc-4f0f-b2cd-751921e14eba","2016-08-21T14:08:52.838184-05:00","TCGA-24-1464-01A-01R-1566-13_rnaseq_fastq.tar","247feb7d-4e8e-4d50-a33b-950735993008",11309424640,"Illumina HiSeq","71f0c9e5c9eb09238f64dde786021fbd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:26:59.820268-05:00","2016-05-03T11:41:05.755204-05:00","247feb7d-4e8e-4d50-a33b-950735993008_analysis.xml","37c9154a809b728b711b246857bfa6cc","b7d7c46a-c77c-4cc1-bc52-fd23b9859fcb",2210,"2016-09-29T21:38:33.917729-05:00","247feb7d-4e8e-4d50-a33b-950735993008_experiment.xml","535d67d30ef3a3103b107b881ea5963e","99ebf596-1744-44ca-b31c-498c2b1ea79b",3916,"2016-09-29T18:25:04.245417-05:00","247feb7d-4e8e-4d50-a33b-950735993008_run.xml","9f47eeaca57fea0240523effa60077e7","21841697-3dcd-44b7-ae76-c29a58218454",1990,"2016-09-08T13:45:12.040537-05:00","TCGA-24-1464","2016-09-02T19:13:49.593751-05:00","female","TCGA-24-1464_demographic",1928,"white","12069954-6818-59be-9f0a-bea245e7b149","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1464_diagnosis","not reported",25874,"dead","8441/3",379,379,"3092467a-bee4-5eb1-bd74-5efa87d5836e","c56.9",-25874,"TCGA-24-1464_treatment","ab42f598-17c8-5847-ae16-a068190bd6f0","01",NA,"TCGA-24-1464-01A","1.2","cd43784d-8829-4cac-819f-d2960c5409cb",FALSE,"242047B0-E0E3-4BA3-A0DF-95887392602E","Primary Tumor","0.7",NA,NA,"1.5",1234310400,"01",130,"TCGA-24-1464-01A-01",90,80,NA,NA,0,0,9,19,"2016-09-08T13:45:12.040537-05:00","2016-09-08T13:45:12.040537-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"33baf922-5467-4b79-8191-fbba9f70c972","4629f765-e185-4cee-b30e-2024f6fad17d","TCGA-24-1464-01A-01-TS1","TCGA-24-1464-01A-01-BS1",90,80,"40cd8a8c-85c6-48f1-9916-e8a7459f0ea0","RNA","TCGA-24-1464-01A-01R","c864f99c-3a2d-43d4-95c5-be700101c6eb",1.8,0.15,"UV Spec","R","22","TCGA-24-1464-01A-01R-1566-13","6eb0fbff-f1b8-4544-91e2-cd593b631ead",0.15,NA,NA,NA,NA,"fb35ab81-ee9e-59be-ae26-85cebc3e5658","TCGA-24-1464_exposure","TCGA-24-1464-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-27T07:21:30.000Z","2014-03-27T07:43:02.000Z","247FEB7D-4E8E-4D50-A33B-950735993008","CD43784D-8829-4CAC-819F-D2960C5409CB","Unaligned reads",11309424640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6EB0FBFF-F1B8-4544-91E2-CD593B631EAD","Canada's Michael Smith Genome Sciences Centre","564a3658e4b09c884b22d234","4160E048-F0B0-40F5-805B-E277A5893A3B","Ovarian Serous Cystadenocarcinoma","TAR","40CD8A8C-85C6-48F1-9916-E8A7459F0EA0","2014-03-27T07:43:02.000Z","C864F99C-3A2D-43D4-95C5-BE700101C6EB","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"40CD8A8C-85C6-48F1-9916-E8A7459F0EA0",1.2,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eef306a8-dd2b-4d8e-90c2-cb05094fd5f2.txt",NA,"TCGA-24-1464-01A",1.5,"B1703138-84C6-4BAE-8A50-718CA2EBDE6F","TCGA",1998,NA,NA,"WITH TUMOR","E0B08AF5-A981-4356-A10E-0487B577E6CC",70,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eef306a8-dd2b-4d8e-90c2-cb05094fd5f2.txt","Dead",379,"TCGA-24-1464",NA,"77EA97CA-736C-4AB4-9670-0941B73C1BB3",NA,379,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,"98F6F36F-33C4-45C5-9AE5-6A9CFF35285A","WHITE",NA,1,130,"4629F765-E185-4CEE-B30E-2024F6FAD17D","ECEE0677-83D5-48D5-B74E-844B87EC6113","TCGA-24-1464-01A-01R-1566-13_mirna.bam","TCGA-24-1464-01A-01",80,0,NA,NA,19,"BOTTOM",1,NA,"TCGA-24-1464-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-24-1464-D26023","TCGA-24-1464-R26026","EXTERNAL BEAM","Primary Tumor Field","TCGA-24-1464-F26022_NTE-1",NA,379,"WITH TUMOR","Dead",379,"TCGA-24-1464-F26022","TCGA-24-1464",NA,"24","1464","YES","C56.9","8441/3","C56.9",NA,NA,-25874,"FEMALE","WHITE",NA,NA,"No","Dead",379,379,NA,NA,"WITH TUMOR","NO",23,3,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,70,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
216075262,210852163,15596074119,"4AEFB9F1-A55D-472E-A963-5BB3364D9D8C.bw","4261267c-7042-4c6e-83ed-12fb401003fc","4aefb9f1-a55d-472e-a963-5bb3364d9d8c","2016-08-26T02:06:50.005642-05:00","TCGA-29-1710-01A-02R-1567-13_rnaseq_fastq.tar","5090f0af-d59b-4fd7-9024-7d3a29469b50",13625077760,"Illumina HiSeq","3f3ec7ae995dd91feca90a7de5a10b6d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:11:19.048201-05:00","2016-05-03T11:41:05.748550-05:00","5090f0af-d59b-4fd7-9024-7d3a29469b50_analysis.xml","37e44c8882fec48c82de766259841d6b","3ec6d9c9-772e-42c1-b631-8208b858b8bc",2181,"2016-09-29T20:55:57.631082-05:00","5090f0af-d59b-4fd7-9024-7d3a29469b50_experiment.xml","1ebbaae90b4e91a0cff87b4968aa4969","7f78ed3c-02e6-4100-9f1b-b4198a92aa51",3916,"2016-09-29T21:30:29.562369-05:00","5090f0af-d59b-4fd7-9024-7d3a29469b50_run.xml","c7cefc17955d10926820d10a24081567","950ddd1a-74ac-4ed4-a63a-45c511fee697",1989,"2016-09-08T13:11:32.859021-05:00","TCGA-29-1710","2016-09-02T19:07:36.025379-05:00","female","TCGA-29-1710_demographic",1952,"white","9a82b4e9-f427-5855-bbf0-dc8473c619e0","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1710_diagnosis","not reported",19969,"dead","8441/3",951,889,"fcbce65c-5e58-502e-bbc5-5dce69cd809f","c56.9",-19969,"TCGA-29-1710_treatment","29cda261-919a-51bc-a091-536c588f2ac4","01",NA,"TCGA-29-1710-01A","1.1","61513da0-4eb3-4cae-bfff-7b05f3362488",FALSE,"52a0d2ae-7467-40f0-b8f3-59812cfac52a","Primary Tumor","0.4",NA,NA,"1.8",1242345600,"02",133,"TCGA-29-1710-01A-02",80,75,NA,NA,0,0,0,0,"2016-09-08T13:11:32.859021-05:00","2016-09-08T13:11:32.859021-05:00",10,15,NA,NA,"TOP","BOTTOM",10,15,"3c2c042d-eb31-43f1-96e2-206e9ddd3a64","8ed645cf-dd4b-4bff-b4c3-db614586760f","TCGA-29-1710-01A-01-BS1","TCGA-29-1710-01A-02-BS2",90,85,"7349f9ec-43fe-460d-adc1-9a76e38c2e49","RNA","TCGA-29-1710-01A-02R","26734927-d929-4a61-a124-9fd5fd63d2c5",1.8,0.15,"UV Spec","R","22","TCGA-29-1710-01A-02R-1567-13","3bf24456-4b70-4313-a04d-19aba239108d",0.15,NA,NA,NA,NA,"12101d8f-0865-5a68-a52b-8789ae4cff64","TCGA-29-1710_exposure","TCGA-29-1710-01A-02R-1567-13_rnaseq_fastq.tar","2014-03-29T04:52:46.000Z","2014-03-29T05:23:01.000Z","5090F0AF-D59B-4FD7-9024-7D3A29469B50","61513DA0-4EB3-4CAE-BFFF-7B05F3362488","Unaligned reads",13625077760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3BF24456-4B70-4313-A04D-19ABA239108D","Canada's Michael Smith Genome Sciences Centre","564a578ee4b0298dd2cae550","4261267C-7042-4C6E-83ED-12FB401003FC","Ovarian Serous Cystadenocarcinoma","TAR","7349F9EC-43FE-460D-ADC1-9A76E38C2E49","2014-03-29T05:23:02.000Z","26734927-D929-4A61-A124-9FD5FD63D2C5","None","NO",1,0.4,"Primary Tumor","Duke",NA,"7349F9EC-43FE-460D-ADC1-9A76E38C2E49",1.1,"29","TCGA-29-1710-01A-02W-0927-10_SOLiD.bam.bai",NA,"TCGA-29-1710-01A",1.8,"E024DBEC-28AE-40C1-9E8F-79C02F82FF18","TCGA",2006,NA,NA,"WITH TUMOR","B0A1C168-A2D6-4E77-BF60-4DEA2A0A368F",54,"nationwidechildrens.org_clinical.TCGA-29-1710.xml","Dead",951,"TCGA-29-1710",NA,"6A1D6BDF-CECF-4C60-A745-F3CF0EBCB1BB",NA,889,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,2,133,"8ED645CF-DD4B-4BFF-B4C3-DB614586760F","6E9769F7-BE4B-4AFA-AAEC-091CD4C8A6C6","TCGA-29-1710-01A-02W-0927-10_SOLiD.bam.bai","TCGA-29-1710-01A-02",80,0,NA,10,0,"TOP",10,NA,"TCGA-29-1710-01A-01-BS1",90,"CEP 11981","Targeted Molecular therapy","TCGA-29-1710-D27305",NA,NA,NA,"TCGA-29-1710-F27294_NTE-2",NA,889,"WITH TUMOR","Dead",951,"TCGA-29-1710-F27294","TCGA-29-1710",NA,"29","1710","YES","C56.9","8441/3","C56.9",NA,NA,-19969,"FEMALE","WHITE",NA,NA,"No","Dead",889,951,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,2006,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
195111822,187969801,13902239564,"05B80211-2230-436E-BA34-FD48337A5DE0.bw","42b3dfa3-152f-4ab7-ac9f-988c7f473bea","05b80211-2230-436e-ba34-fd48337a5de0","2016-08-24T07:08:33.226344-05:00","TCGA-04-1530-01A-02R-1569-13_rnaseq_fastq.tar","6a9508ab-24fc-4f9b-b321-d71c813a9d8d",12265492480,"Illumina HiSeq","43c26c4dbdf690e4d3120dd4c5edbe15","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:33:50.368784-05:00","2016-05-03T11:56:42.628342-05:00","6a9508ab-24fc-4f9b-b321-d71c813a9d8d_analysis.xml","64ddd37eceb773007c29969f59232527","01539865-6990-499d-a81d-8ae6dc1dcd9e",2226,"2016-10-07T16:06:51.783575-05:00","6a9508ab-24fc-4f9b-b321-d71c813a9d8d_experiment.xml","6f3cf9c731d783e3f1d09fbff03fb904","0b8d2119-b24d-4382-9410-94d214c6e1d8",3916,"2016-09-29T23:42:39.507638-05:00","6a9508ab-24fc-4f9b-b321-d71c813a9d8d_run.xml","de6bab0edd715d3385550f3e64199cdc","e6eee2c7-02ab-42ac-bbbd-622fa6608756",1988,"2016-09-08T12:20:52.720436-05:00","TCGA-04-1530","2016-09-02T19:07:07.460781-05:00","female","TCGA-04-1530_demographic",1927,"white","1403a8ca-ec97-5425-bb3c-49e4dc50322c","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1530_diagnosis","not reported",25013,"dead","8441/3",3622,NA,"3f5e6198-cbee-5262-a733-ce32d75b7057","c56.9",-25013,"TCGA-04-1530_treatment","153f2aef-ee14-5507-8a67-d42e561f5ace","01",NA,"TCGA-04-1530-01A","1","2b89e52a-a064-4151-87e1-20fec4eed015",FALSE,"6CB3AECE-ADBB-4AED-A036-2E2D28D68369","Primary Tumor","0.4",NA,NA,"1.4",1235001600,"02",64,"TCGA-04-1530-01A-02",70,70,NA,NA,15,45,0,0,"2016-09-08T12:20:52.720436-05:00","2016-09-08T12:20:52.720436-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,15,"8cb941db-9ee8-49cc-b0c2-211af61b347e","c78fa438-630d-4e54-bd7e-e914836f66bb","TCGA-04-1530-01A-01-BS1","TCGA-04-1530-01A-02-BS2",75,40,"3ad65323-8c46-4a65-8ada-683ffd6c2de9","RNA","TCGA-04-1530-01A-02R","c87da3bf-d82e-4b99-a8e1-85b6e2ee08aa",1.8,0.14,"UV Spec","R","22","TCGA-04-1530-01A-02R-1569-13","b3ad87d3-1240-4fc9-8e29-14a9a5186319",0.14,NA,NA,NA,NA,"0943a6ae-e76e-5927-a4ed-1f8ce920593a","TCGA-04-1530_exposure","TCGA-04-1530-01A-02R-1569-13_rnaseq_fastq.tar","2014-08-28T22:55:21.000Z","2014-08-29T01:05:23.000Z","6A9508AB-24FC-4F9B-B321-D71C813A9D8D","2B89E52A-A064-4151-87E1-20FEC4EED015","Unaligned reads",12265492480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B3AD87D3-1240-4FC9-8E29-14A9A5186319","Canada's Michael Smith Genome Sciences Centre","564a3c16e4b09c884b2490f6","42B3DFA3-152F-4AB7-AC9F-988C7F473BEA","Ovarian Serous Cystadenocarcinoma","TAR","3AD65323-8C46-4A65-8ADA-683FFD6C2DE9","2014-08-29T01:05:23.000Z","C87DA3BF-D82E-4B99-A8E1-85B6E2EE08AA","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"3AD65323-8C46-4A65-8ADA-683FFD6C2DE9",1,"04","TCGA-04-1530-01A-02R-1569-13_rnaseq.bam.bai",NA,"TCGA-04-1530-01A",1.4,"E9327DC6-1775-4AFF-BCE4-B32EA0F465BD","TCGA",1995,NA,NA,"WITH TUMOR","4ABFCD80-4A71-4D92-8801-A24318D51C26",68,"nationwidechildrens.org_clinical.TCGA-04-1530.xml","Dead",3622,"TCGA-04-1530","NOT HISPANIC OR LATINO","AD540BC7-095F-4F96-AD41-0981DA3FCB0E",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,2,64,"C78FA438-630D-4E54-BD7E-E914836F66BB","D52F324A-CC08-4DFB-8A39-C9D150AF4A1A","MSK_252152914884_S01_CGH-v4_10_27Aug08.txt","TCGA-04-1530-01A-02",70,45,NA,NA,0,"BOTTOM",15,NA,"TCGA-04-1530-01A-02-BS2",40,"Taxol","Chemotherapy","TCGA-04-1530-D24105",NA,NA,NA,"TCGA-04-1530-F24104_NTE-2",NA,NA,"WITH TUMOR","Dead",3622,"TCGA-04-1530-F24104","TCGA-04-1530",NA,"04","1530","YES","C56.9","8441/3","C56.9",NA,NA,-25013,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,3622,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,1995,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
264566868,256383567,18963428275,"6B206166-85BC-4A1A-BDD2-B249652FC09E.bw","42ebd30b-175e-4ece-a806-e55cb7e40e96","6b206166-85bc-4a1a-bdd2-b249652fc09e","2016-08-25T13:43:47.605876-05:00","TCGA-29-1697-01A-01R-1567-13_rnaseq_fastq.tar","5fda589c-968a-4581-876f-b986c996bf69",17514915840,"Illumina HiSeq","78ad320a73512d93935ce4eacaf2dc4a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:15:23.935549-05:00","2016-05-03T11:41:05.748550-05:00","5fda589c-968a-4581-876f-b986c996bf69_analysis.xml","e72bf44ff26dd13aa0695907eb3e1566","6673678f-1cd1-4444-9c3b-0ebbd711d721",2181,"2016-09-29T19:45:20.707969-05:00","5fda589c-968a-4581-876f-b986c996bf69_experiment.xml","739c8be801e0015e78889e6ce0e7e6b9","54097469-6406-4eba-945f-e76248610fd6",3916,"2016-09-29T17:54:55.243101-05:00","5fda589c-968a-4581-876f-b986c996bf69_run.xml","2828163d8a692dd99e8c0df3a86dfda1","0eb904d7-3e0b-42c1-9313-edaa80be5dc1",1989,"2016-09-08T13:10:30.299891-05:00","TCGA-29-1697","2016-09-02T19:07:22.102794-05:00","female","TCGA-29-1697_demographic",1941,"white","c1569def-c3d1-50c7-89d8-2a3decd38865","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1697_diagnosis","not reported",22933,"dead","8441/3",949,949,"0be1c54a-5169-5542-894c-fa5257137496","c56.9",-22933,"TCGA-29-1697_treatment","f79e3788-db4d-56a4-994a-eb405d6fccc4","01",NA,"TCGA-29-1697-01A","0.8","3669f3bd-dffe-4737-bf81-07f38deceb2e",FALSE,"294ba09f-347a-4129-847d-211cdf73ca99","Primary Tumor","0.4",NA,NA,"1.9",1242086400,"01",140,"TCGA-29-1697-01A-01",95,95,NA,NA,0,0,0,0,"2016-09-08T13:10:30.299891-05:00","2016-09-08T13:10:30.299891-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"e1588d4d-264d-4973-9cf9-5ade9a3ff5ca","a93e70b2-87b6-41db-ba0d-f370e0abc3c9","TCGA-29-1697-01A-01-TS1","TCGA-29-1697-01A-01-BS1",98,98,"eb49f284-4047-4854-9d30-ff97cf8d3bd6","RNA","TCGA-29-1697-01A-01R","abafa246-ba22-4c5c-9d5d-cad685be95fa",1.8,0.15,"UV Spec","R","22","TCGA-29-1697-01A-01R-1567-13","75435634-4311-49d8-8e42-ae1069c1e2ef",0.15,NA,NA,NA,NA,"5afd9e51-4682-539e-9380-fcc2653dab8d","TCGA-29-1697_exposure","TCGA-29-1697-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T05:25:32.000Z","2014-03-29T05:58:02.000Z","5FDA589C-968A-4581-876F-B986C996BF69","3669F3BD-DFFE-4737-BF81-07F38DECEB2E","Unaligned reads",17514915840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","75435634-4311-49D8-8E42-AE1069C1E2EF","Canada's Michael Smith Genome Sciences Centre","564a59ffe4b0ef12181dbaff","42EBD30B-175E-4ECE-A806-E55CB7E40E96","Ovarian Serous Cystadenocarcinoma","TAR","EB49F284-4047-4854-9D30-FF97CF8D3BD6","2014-03-29T05:58:02.000Z","ABAFA246-BA22-4C5C-9D5D-CAD685BE95FA","None","NO",1,0.4,"Primary Tumor","Duke",NA,"EB49F284-4047-4854-9D30-FF97CF8D3BD6",0.8,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9efe9dcc-44d7-47ae-b404-d324e821910e.txt",NA,"TCGA-29-1697-01A",1.9,"D5003891-7FB6-49CF-A9D9-E8C42CE205F6","TCGA",2003,NA,NA,"WITH TUMOR","CD088ABF-BF81-41E1-92BA-5ABFA3A888F8",62,"US82800149_251976010696_S01_GE2-v5_10_Apr08.txt","Dead",949,"TCGA-29-1697",NA,"9C6B4033-DDBA-482D-A15C-EA455D16687E",NA,949,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,140,"E1588D4D-264D-4973-9CF9-5ADE9A3FF5CA","C1081203-6D9D-4C81-A4F7-C010C1199774","bcgsc.ca.TCGA-29-1697-01A-01R-1567-13.hg19.bcgsc.ca.1.6.0.indel.vcf","TCGA-29-1697-01A-01",95,0,NA,NA,0,"BOTTOM",2,NA,"TCGA-29-1697-01A-01-BS1",98,"Paclitaxel","Chemotherapy","TCGA-29-1697-D27219",NA,NA,NA,"TCGA-29-1697-F27216_NTE-1",NA,949,"WITH TUMOR","Dead",949,"TCGA-29-1697-F27216","TCGA-29-1697",NA,"29","1697","YES","C56.9","8441/3","C56.9",NA,NA,-22933,"FEMALE","WHITE",NA,NA,"No","Dead",949,949,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
126768142,118696408,8747261068,"3EA60F08-5232-4A97-A656-2A0A2F5CED07.bw","446ce2a3-d328-443c-a419-3344baad0e16","3ea60f08-5232-4a97-a656-2a0a2f5ced07","2016-08-19T22:24:43.025820-05:00","TCGA-13-0725-01A-01R-1564-13_rnaseq_fastq.tar","28d4d906-cd50-401c-8440-717a0b6672ed",8558571520,"Illumina HiSeq","a13016a8f9f120fe62fcf9ab41c70361","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:55:41.907704-05:00","2016-05-03T11:27:59.332723-05:00","28d4d906-cd50-401c-8440-717a0b6672ed_analysis.xml","b4da799c1005af0af4ad6cda3ba83c53","a4b2bce8-f68f-439f-a2eb-165a92ed32a4",2210,"2016-08-28T14:20:35.539722-05:00","28d4d906-cd50-401c-8440-717a0b6672ed_experiment.xml","5fb0557f942ba626624f6c6f5309680b","a6c72e16-d328-4fd7-a9ff-568ddf9ef294",3916,"2016-09-29T18:04:29.944370-05:00","28d4d906-cd50-401c-8440-717a0b6672ed_run.xml","370f39600f4723926640b2f0bb71c913","14dddc6b-8010-4506-b789-b69d7c6795df",1990,"2016-09-08T13:38:54.557756-05:00","TCGA-13-0725","2016-09-02T19:09:31.928929-05:00","female","TCGA-13-0725_demographic",1958,"white","7e7cc471-edf6-5cd4-aee4-062c81eadd47","hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0725_diagnosis","not reported",16086,"dead","8441/3",377,377,"5f3845f7-ab3b-5c4b-94b1-84a7afef4150","c56.9",-16086,"TCGA-13-0725_treatment","f02227b1-3a4c-5751-86f1-a116d2791b03","01",NA,"TCGA-13-0725-01A","1","4a52777f-e23f-49f8-b853-be84b9a74bda",FALSE,"A6CD74F2-47A0-4790-BB81-6C636DA16ADC","Primary Tumor","0.5",NA,NA,"1.5",1233705600,"01",117,"TCGA-13-0725-01A-01",95,90,NA,NA,0,40,10,NA,"2016-09-08T13:38:54.557756-05:00","2016-09-08T13:38:54.557756-05:00",50,50,NA,50,"TOP","BOTTOM",0,0,"93a2c5e6-57fa-4784-b8cf-29d898406640","6cd2a2f7-689b-4674-a98e-a7ab00beaa84","TCGA-13-0725-01A-01-TS1","TCGA-13-0725-01A-01-BS1",90,60,"ac35ba6b-0012-4b02-b8e2-183e7d23b02c","RNA","TCGA-13-0725-01A-01R","41389261-5ee2-4fe9-b4f6-2f211dcc1e4b",1.8,0.18,"UV Spec","R","22","TCGA-13-0725-01A-01R-1564-13","5551b356-0f0f-4e21-a2f5-cf539b5a490b",0.18,NA,NA,NA,NA,"2c2993c0-fb12-52d0-a6c7-57dcec0b4c81","TCGA-13-0725_exposure","TCGA-13-0725-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-21T00:41:48.000Z","2013-12-21T00:57:02.000Z","28D4D906-CD50-401C-8440-717A0B6672ED","4A52777F-E23F-49F8-B853-BE84B9A74BDA","Unaligned reads",8558571520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5551B356-0F0F-4E21-A2F5-CF539B5A490B","Canada's Michael Smith Genome Sciences Centre","564a58a8e4b08c5d86945292","446CE2A3-D328-443C-A419-3344BAAD0E16","Ovarian Serous Cystadenocarcinoma","TAR","AC35BA6B-0012-4B02-B8E2-183E7D23B02C","2013-12-21T00:57:02.000Z","41389261-5EE2-4FE9-B4F6-2F211DCC1E4B","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"AC35BA6B-0012-4B02-B8E2-183E7D23B02C",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6701705e-cbfb-4af1-b1ab-898298de7c02.txt",NA,"TCGA-13-0725-01A",1.5,"C01C8AA8-2AD3-4ADD-9C4A-56FA32923507","TCGA",2002,NA,NA,"WITH TUMOR","4A52777F-E23F-49F8-B853-BE84B9A74BDA",44,"nationwidechildrens.org_clinical.TCGA-13-0725.xml","Dead",377,"TCGA-13-0725","HISPANIC OR LATINO","24A9120F-4794-4B42-8EDF-6794E062F04D",NA,377,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,117,"93A2C5E6-57FA-4784-B8CF-29D898406640","A43A7F50-4348-48E9-A256-BC58397541AC","TCGA-13-0725-01A-01R-1564-13_GRCh37-lite_rnaseq.bam.bai","TCGA-13-0725-01A-01",95,0,NA,50,10,"TOP",0,NA,"TCGA-13-0725-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-13-0725-D24513",NA,NA,NA,"TCGA-13-0725-F24510_NTE-1",NA,377,"WITH TUMOR","Dead",377,"TCGA-13-0725-F24510","TCGA-13-0725",NA,"13","0725","YES","C56.9","8441/3","C56.9",NA,NA,-16086,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Dead",377,377,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,2002,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
206887090,201530226,14918028767,"9C55C086-682B-4D21-9C77-085CFE45A07E.bw","44e840c9-ea54-4dba-9b2a-264ef1f2c304","9c55c086-682b-4d21-9c77-085cfe45a07e","2016-08-21T19:04:51.818035-05:00","TCGA-29-1778-01A-01R-1567-13_rnaseq_fastq.tar","892b846d-57eb-40a2-b789-a6d0103ec98b",13311303680,"Illumina HiSeq","2133acf5af11ca0c6c8f1f205ebb26bb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:26:58.672249-05:00","2016-05-03T11:41:05.748550-05:00","892b846d-57eb-40a2-b789-a6d0103ec98b_analysis.xml","3d2a52d7829f1e7a4e96e6e61429cf51","22c442e1-412f-4ffa-a7a2-93b203f62e0e",2181,"2016-10-07T17:28:52.311350-05:00","892b846d-57eb-40a2-b789-a6d0103ec98b_experiment.xml","3fe8cf10a6ef49ea55f813ba691fc4ea","535ad3a2-ae11-4e47-b29a-5b74d082fa31",3916,"2016-09-29T19:03:47.473177-05:00","892b846d-57eb-40a2-b789-a6d0103ec98b_run.xml","2fac8c9b7de84d00683ae3a0229642ec","3a15363c-762d-44ae-9b4c-e2a0290a7928",1989,"2016-09-08T12:47:53.494078-05:00","TCGA-29-1778","2016-09-02T18:48:14.425483-05:00","female","TCGA-29-1778_demographic",1931,"white","c85be1b6-1039-536e-988b-2c193dd334e2","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1778_diagnosis","not reported",28147,"alive","8441/3",NA,454,"64f96092-ae3e-556c-9c0c-cbba2bdef290","c56.9",-28147,"TCGA-29-1778_treatment","fb421159-b9d1-5a4c-8cbd-1e1b8de351f6","01",NA,"TCGA-29-1778-01A","1","be6771b3-dc5e-46fb-998a-a66a6fd63c85",FALSE,"439a81dd-dc54-49e5-942c-4aa8d0be8701","Primary Tumor","0.5",NA,NA,"1.1",1243296000,"01",100,"TCGA-29-1778-01A-01",80,85,NA,NA,0,0,20,40,"2016-09-08T12:47:53.494078-05:00","2016-09-08T12:47:53.494078-05:00",15,10,NA,NA,"TOP","BOTTOM",0,0,"03053642-c87d-488d-b2e6-d75900c0cca3","f22cd01a-2d39-464a-9c96-60391fac355e","TCGA-29-1778-01A-01-TS1","TCGA-29-1778-01A-01-BS1",80,60,"2a69f244-7cd9-4f17-916b-a49b9044b15a","RNA","TCGA-29-1778-01A-01R","3945a35f-a5aa-4840-afd8-dfc3f87d9338",1.8,0.15,"UV Spec","R","22","TCGA-29-1778-01A-01R-1567-13","7ecd0f7a-d186-422b-a2e1-833dfc400e39",0.15,NA,NA,NA,NA,"287a81d3-2ecb-5c42-9c7c-cb03be16c920","TCGA-29-1778_exposure","TCGA-29-1778-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T04:38:38.000Z","2014-03-29T05:04:02.000Z","892B846D-57EB-40A2-B789-A6D0103EC98B","BE6771B3-DC5E-46FB-998A-A66A6FD63C85","Unaligned reads",13311303680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7ECD0F7A-D186-422B-A2E1-833DFC400E39","Canada's Michael Smith Genome Sciences Centre","564a3e82e4b0298dd2c9666e","44E840C9-EA54-4DBA-9B2A-264EF1F2C304","Ovarian Serous Cystadenocarcinoma","TAR","2A69F244-7CD9-4F17-916B-A49B9044B15A","2014-03-29T05:04:02.000Z","3945A35F-A5AA-4840-AFD8-DFC3F87D9338","None","NO",1,0.5,"Primary Tumor","Duke",NA,"2A69F244-7CD9-4F17-916B-A49B9044B15A",1,"29","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_A04_495066.hg19.seg.txt",NA,"TCGA-29-1778-01A",1.1,"FEF2287B-ADE4-4F49-808F-23AAC02719C6","TCGA",2008,NA,NA,"TUMOR FREE","E7B3E723-E8C2-4D82-96F5-F2E53E04BE99",77,"nationwidechildrens.org_clinical.TCGA-29-1778.xml","Alive",NA,"TCGA-29-1778",NA,"04E3CE5F-FEFF-436C-82C2-CCF22CDC34FF",NA,454,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,100,"F22CD01A-2D39-464A-9C96-60391FAC355E","81A711A8-89DB-4273-B3C2-7CFDF73B9D8E","TCGA-29-1778-01A-01R-1567-13_GRCh37-lite_rnaseq.bam","TCGA-29-1778-01A-01",80,0,NA,15,20,"TOP",0,NA,"TCGA-29-1778-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-29-1778-D27422",NA,NA,NA,NA,NA,454,"TUMOR FREE","Alive",NA,"TCGA-29-1778-F27420","TCGA-29-1778",NA,"29","1778","YES","C56.9","8441/3","C56.9",NA,NA,-28147,"FEMALE","WHITE",NA,NA,"No","Alive",454,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,77,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
420951962,401436861,29612894996,"B0CE5521-96E9-4087-89EE-309D785C0F96.bw","45957be6-e4df-4245-acf8-39dfc118ee19","b0ce5521-96e9-4087-89ee-309d785c0f96","2016-08-26T05:02:32.019846-05:00","TCGA-13-0919-01A-01R-1564-13_rnaseq_fastq.tar","32838fec-3b3d-4261-9dd6-53db2521a27c",28129587200,"Illumina HiSeq","16b8a4d149bf7d703312a6b11582f490","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:30:15.923169-05:00","2016-05-03T11:39:34.528512-05:00","32838fec-3b3d-4261-9dd6-53db2521a27c_analysis.xml","6c3eb61a3ebb8614bfcc590c60f0d7ad","4ac50928-37d9-45ab-ba39-380cf8bd72e2",2210,"2016-09-29T21:32:26.688892-05:00","32838fec-3b3d-4261-9dd6-53db2521a27c_experiment.xml","d9b79145ab14fe1d39c97e2f7b51cc29","9638028e-2dd4-492f-a45d-a2e79d331a2a",3916,"2016-09-29T22:15:13.797299-05:00","32838fec-3b3d-4261-9dd6-53db2521a27c_run.xml","e3fc9b4f00e1934520996571cdd044d0","b0aedc93-09fd-4abe-abe3-a094a3e67705",1990,"2016-09-08T13:09:36.414221-05:00","TCGA-13-0919","2016-09-02T19:05:15.904756-05:00","female","TCGA-13-0919_demographic",1955,"white","fe9c6beb-795a-5dfc-a75b-f7e489b3a0c7","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0919_diagnosis","not reported",19337,"alive","8441/3",NA,2571,"d224cf7c-e190-56a6-bbe1-38e2134e4739","c56.9",-19337,"TCGA-13-0919_treatment","beddb3a2-4b7f-5012-827a-292cb976b5a8","01",NA,"TCGA-13-0919-01A","0.8","7be971a8-031f-4dc0-a883-e1976f74eb21",FALSE,"CE2BB148-051E-4D43-B645-B7EA2A64A1CE","Primary Tumor","0.4",NA,NA,"1",1233705600,"01",74,"TCGA-13-0919-01A-01",70,80,NA,NA,0,0,40,30,"2016-09-08T13:09:36.414221-05:00","2016-09-08T13:09:36.414221-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"9dba794e-8d22-47f0-b5bf-9e4704b7096e","3e391512-1c28-4566-badd-6fa329771dac","TCGA-13-0919-01A-01-BS1","TCGA-13-0919-01A-01-TS1",60,70,"27fe39e9-b799-44b3-a410-e29f021f1791","RNA","TCGA-13-0919-01A-01R","f99cc56f-2c0b-4ab7-9a80-59fa506ee86d",1.8,0.15,"UV Spec","R","22","TCGA-13-0919-01A-01R-1564-13","36e20dfd-0d88-47bd-bf1f-164e069019d1",0.15,NA,NA,NA,NA,"0cd5ad0c-ea7c-550f-8d7f-df4ca61595a9","TCGA-13-0919_exposure","TCGA-13-0919-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T02:57:58.000Z","2014-03-20T03:51:03.000Z","32838FEC-3B3D-4261-9DD6-53DB2521A27C","7BE971A8-031F-4DC0-A883-E1976F74EB21","Unaligned reads",28129587200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","36E20DFD-0D88-47BD-BF1F-164E069019D1","Canada's Michael Smith Genome Sciences Centre","564a56fae4b09c884b2672f0","45957BE6-E4DF-4245-ACF8-39DFC118EE19","Ovarian Serous Cystadenocarcinoma","TAR","27FE39E9-B799-44B3-A410-E29F021F1791","2014-03-20T03:51:03.000Z","F99CC56F-2C0B-4AB7-9A80-59FA506EE86D","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"27FE39E9-B799-44B3-A410-E29F021F1791",0.8,"13","TCGA-13-0919-01A-01R-1564-13.hg19.isoform.quantification.txt",NA,"TCGA-13-0919-01A",1,"943463ED-59A4-44D1-A1FE-CD706824FE1F","TCGA",2007,NA,NA,"TUMOR FREE","7BE971A8-031F-4DC0-A883-E1976F74EB21",52,"nationwidechildrens.org_clinical.TCGA-13-0919.xml","Alive",NA,"TCGA-13-0919","NOT HISPANIC OR LATINO","F48B87BD-E3FB-4C13-A59D-3ABA2FBF2585",NA,453,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,74,"9DBA794E-8D22-47F0-B5BF-9E4704B7096E","F99CC56F-2C0B-4AB7-9A80-59FA506EE86D","US82800149_251976010391_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","TCGA-13-0919-01A-01",80,0,NA,NA,30,"TOP",0,NA,"TCGA-13-0919-01A-01-TS1",70,"Paclitaxel","Chemotherapy","TCGA-13-0919-D24773",NA,NA,NA,NA,NA,453,"TUMOR FREE","Alive",NA,"TCGA-13-0919-F24771","TCGA-13-0919",NA,"13","0919","YES","C56.9","8441/3","C56.9",NA,NA,-19337,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",453,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
186515734,181413053,13411124736,"6BF76FE6-F1DA-48F2-B55D-CB106905EA8F.bw","45baebac-32ae-4093-9eba-488b95c1a58d","6bf76fe6-f1da-48f2-b55d-cb106905ea8f","2016-08-09T14:44:57.455540-05:00","TCGA-30-1857-01A-02R-1569-13_rnaseq_fastq.tar","014b8bef-fc8f-4b4b-9be1-9745cf7a82ba",11954421760,"Illumina HiSeq","05ced184f34fb8fe6c4534c08ba2b8f2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:49:02.591922-05:00","2016-06-22T11:19:32.361656-05:00","014b8bef-fc8f-4b4b-9be1-9745cf7a82ba_analysis.xml","9ad60eaaaf30cc8d46d32ad659958a78","7b1cf038-d473-4fa8-9163-c76f0cf083a7",2210,"2016-09-29T19:06:33.578261-05:00","014b8bef-fc8f-4b4b-9be1-9745cf7a82ba_experiment.xml","e9a315118d795c3731784bf6a7d06d40","3bd8f32c-3627-485c-8b6b-f9e968f7be98",3753,"2016-09-29T20:42:25.984615-05:00","014b8bef-fc8f-4b4b-9be1-9745cf7a82ba_run.xml","204cbf829ea53431d37145275625305c","7703e3ed-2384-4c8d-af5e-3230fe961615",1807,"2016-09-08T11:09:17.548877-05:00","TCGA-30-1857","2016-09-02T18:47:39.622796-05:00","female","TCGA-30-1857_demographic",1937,"white","053eda72-806d-5ada-932d-fc4e667f34f0","not hispanic or latino",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1857_diagnosis","not reported",23689,"dead","8441/3",8,8,"d43fe037-2d6d-5cea-b640-8656fb0ccd5c","c56.9",-23689,"TCGA-30-1857_treatment","eda9659e-b534-500a-957b-cc01c9763139","01",NA,"TCGA-30-1857-01A","0.7","9aae154c-ffe9-4e86-9111-903b55de9228",FALSE,"e3d84909-0149-4691-a398-1a6b272dde60","Primary Tumor","0.4",NA,NA,"0.8",1245369600,"02",111,"TCGA-30-1857-01A-02",90,90,NA,NA,0,0,15,20,"2016-09-08T11:09:17.548877-05:00","2016-09-08T11:09:17.548877-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"392b4bb4-7991-4797-b75c-ffe3d94a4599","c7ade19c-60eb-4fee-b487-879801460374","TCGA-30-1857-01A-01-BS1","TCGA-30-1857-01A-02-BS2",85,80,"ed7637fe-3bc8-4c1c-83dc-6dbbb89f91a7","RNA","TCGA-30-1857-01A-02R","ba18152f-72f2-4ca2-8536-f68bb6a0e1bc",1.8,0.15,"UV Spec","R","22","TCGA-30-1857-01A-02R-1569-13","7fc46368-c523-4936-84e3-bb3f77db7c48",0.15,NA,NA,NA,NA,"ca2d637c-2147-5e07-a88f-14d3152a629a","TCGA-30-1857_exposure","TCGA-30-1857-01A-02R-1569-13_rnaseq_fastq.tar","2015-02-06T21:53:07.000Z","2015-02-06T23:34:06.000Z","014B8BEF-FC8F-4B4B-9BE1-9745CF7A82BA","9AAE154C-FFE9-4E86-9111-903B55DE9228","Unaligned reads",11954421760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7FC46368-C523-4936-84E3-BB3F77DB7C48","Canada's Michael Smith Genome Sciences Centre","564a3901e4b08c5d8690c080","45BAEBAC-32AE-4093-9EBA-488B95C1A58D","Ovarian Serous Cystadenocarcinoma","TAR","ED7637FE-3BC8-4C1C-83DC-6DBBB89F91A7","2015-02-06T23:34:07.000Z","BA18152F-72F2-4CA2-8536-F68BB6A0E1BC","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"ED7637FE-3BC8-4C1C-83DC-6DBBB89F91A7",0.7,"30","TCGA-30-1857-01A-02W-0639-09_IlluminaGA-DNASeq_exome_1.bam",NA,"TCGA-30-1857-01A",0.8,NA,"TCGA",2001,NA,NA,"WITH TUMOR","9AAE154C-FFE9-4E86-9111-903B55DE9228",64,"1231.CEL","Dead",8,"TCGA-30-1857","NOT HISPANIC OR LATINO","1E076431-07C6-4BFB-A0E1-FBE4498B5035",NA,8,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,2,111,"C7ADE19C-60EB-4FEE-B487-879801460374","9B987F38-1A8A-4BF3-ACAF-84FFF30C70D0","TCGA-30-1857-01A-02W-0639-09_IlluminaGA-DNASeq_exome_1.bam","TCGA-30-1857-01A-02",90,0,NA,NA,15,"TOP",0,NA,"TCGA-30-1857-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,NA,NA,8,"WITH TUMOR","Dead",8,"TCGA-30-1857-F27564","TCGA-30-1857",NA,"30","1857","YES","C56.9","8441/3","C56.9",NA,NA,-23689,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",8,8,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,64,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
242702206,235645497,17453685368,"D2ECDADA-9D0D-4044-8C61-353CCE45C0E6.bw","460616ec-f66f-483b-88c1-757edd86261d","d2ecdada-9d0d-4044-8c61-353cce45c0e6","2016-08-22T20:36:02.761429-05:00","TCGA-29-1783-01A-01R-1567-13_rnaseq_fastq.tar","f9f35e31-f4c4-400e-b298-8b5ecb337bb6",15521075200,"Illumina HiSeq","d36c6f3ebb4c6c0382ebb51865faed0d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:09:00.645094-05:00","2016-05-03T11:41:05.748550-05:00","f9f35e31-f4c4-400e-b298-8b5ecb337bb6_analysis.xml","0f72ee2e0bf059e2d00fd02d98fecaca","17ae524a-fa88-4861-82c1-830f23221b6b",2181,"2016-09-29T17:41:57.581403-05:00","f9f35e31-f4c4-400e-b298-8b5ecb337bb6_experiment.xml","ea3926963c1804494c8653c59c0d0628","06780f3e-389a-4d0f-93dc-9354d6d9c658",3916,"2016-09-29T21:59:52.183271-05:00","f9f35e31-f4c4-400e-b298-8b5ecb337bb6_run.xml","f488c2864f18918f055e1aabe0787b79","a74743a1-f0e5-4883-b8a3-f7acea31f671",1989,"2016-09-08T13:16:15.861994-05:00","TCGA-29-1783","2016-09-02T19:07:32.142853-05:00","female","TCGA-29-1783_demographic",1951,"white","fd7dbd5b-6da2-5b5c-9857-6f220f063c51","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1783_diagnosis","not reported",21284,"alive","8441/3",NA,220,"76e57c55-e185-57fb-8980-6ccd1a2ee446","c56.9",-21284,"TCGA-29-1783_treatment","f66ffc46-9d26-52f7-9fde-2f846ac8beb9","01",NA,"TCGA-29-1783-01A","1","7d811a29-b303-453e-9c0e-91ae12907510",FALSE,"6ebf4763-bb2a-4ef5-ab22-23460980df1c","Primary Tumor","0.4",NA,NA,"1.2",1243296000,"01",156,"TCGA-29-1783-01A-01",90,90,NA,NA,0,0,20,15,"2016-09-08T13:16:15.861994-05:00","2016-09-08T13:16:15.861994-05:00",5,5,NA,NA,"TOP","BOTTOM",2,0,"4cffe5bf-5305-4080-93ef-b9f7765612fd","8c7be673-e292-4596-b2e7-7b0691de0755","TCGA-29-1783-01A-01-TS1","TCGA-29-1783-01A-01-BS1",78,85,"5c390a96-5bd5-4912-a638-d112b11a8433","RNA","TCGA-29-1783-01A-01R","1573b761-5322-41c5-b902-d64f46524660",1.9,0.15,"UV Spec","R","22","TCGA-29-1783-01A-01R-1567-13","dad3688e-fdd7-4c85-a1df-cf0e1cc0a235",0.15,NA,NA,NA,NA,"44b3c2af-ab52-5953-bbc6-2b547391246d","TCGA-29-1783_exposure","TCGA-29-1783-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T04:22:16.000Z","2014-03-29T04:49:02.000Z","F9F35E31-F4C4-400E-B298-8B5ECB337BB6","7D811A29-B303-453E-9C0E-91AE12907510","Unaligned reads",15521075200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DAD3688E-FDD7-4C85-A1DF-CF0E1CC0A235","Canada's Michael Smith Genome Sciences Centre","564a3f9be4b09c884b25a003","460616EC-F66F-483B-88C1-757EDD86261D","Ovarian Serous Cystadenocarcinoma","TAR","5C390A96-5BD5-4912-A638-D112B11A8433","2014-03-29T04:49:02.000Z","1573B761-5322-41C5-B902-D64F46524660","None","NO",1,0.4,"Primary Tumor","Duke",NA,"5C390A96-5BD5-4912-A638-D112B11A8433",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.82dd8748-e0c5-4030-bf40-fe5d229adeae.txt",NA,"TCGA-29-1783-01A",1.2,"C784772B-4EDC-4349-9D95-598EE3DD7271","TCGA",2009,NA,NA,"TUMOR FREE","7D811A29-B303-453E-9C0E-91AE12907510",58,"nationwidechildrens.org_clinical.TCGA-29-1783.xml","Alive",NA,"TCGA-29-1783",NA,"86E62F5A-909D-4D9B-971E-ECCC8073DAD3",NA,220,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,156,"8C7BE673-E292-4596-B2E7-7B0691DE0755","A1BF23B8-704D-43D8-A0DC-746735CE9081","TCGA-29-1783-01A-01R-1567-13.isoform.quantification.txt","TCGA-29-1783-01A-01",90,0,NA,5,15,"BOTTOM",0,NA,"TCGA-29-1783-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-29-1783-D27433",NA,NA,NA,NA,NA,220,"TUMOR FREE","Alive",NA,"TCGA-29-1783-F27431","TCGA-29-1783",NA,"29","1783","YES","C56.9","8441/3","C56.9",NA,NA,-21284,"FEMALE","WHITE",NA,NA,"No","Alive",220,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,58,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
211933746,204862753,15144941091,"9565D04D-EC61-4EF8-8519-0D84CFB0C794.bw","46395c3d-5e51-477f-946e-e58b87cc7baa","9565d04d-ec61-4ef8-8519-0d84cfb0c794","2016-08-25T16:07:22.650509-05:00","TCGA-25-1320-01A-01R-1565-13_rnaseq_fastq.tar","f6da10c3-3a60-404a-852e-d4a9e49ff7f3",12625254400,"Illumina HiSeq","5c7c1b37cff252f8154c244945e92142","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:18:06.606906-05:00","2016-05-03T11:40:21.647690-05:00","f6da10c3-3a60-404a-852e-d4a9e49ff7f3_analysis.xml","a9c58ec5f584960630cecb02e698a6db","1d428c24-fea2-4cf0-a577-923424e091db",2181,"2016-09-29T23:40:32.971705-05:00","f6da10c3-3a60-404a-852e-d4a9e49ff7f3_experiment.xml","8e6e66128e15d81c3fae13003cff483d","e590d400-3c11-466a-826f-e9381ca4f640",3916,"2016-09-30T00:18:52.506127-05:00","f6da10c3-3a60-404a-852e-d4a9e49ff7f3_run.xml","ad174a15f5b4e1982a2d64d923ecae09","fd3a347a-5bf4-416f-b6ce-8e0cb9b2b7b2",1989,"2016-09-08T13:36:35.537900-05:00","TCGA-25-1320","2016-09-02T19:12:08.735328-05:00","female","TCGA-25-1320_demographic",1936,"white","1720ccc7-09c1-5f51-9513-6a8de9c133e6","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1320_diagnosis","not reported",24018,"dead","8441/3",1155,1124,"1786b36d-9344-51a7-bf6a-5abd3ce5549b","c56.9",-24018,"TCGA-25-1320_treatment","5c815fd4-2587-570d-8b77-cdb0cac1612d","01",NA,"TCGA-25-1320-01A","3","97a91868-8a8d-4b2d-bba2-8bd187f572ac",FALSE,"AF68EF8D-A31D-453B-8083-CF6B9EE4E838","Primary Tumor","1",NA,NA,"3.4",1228435200,"01",112,"TCGA-25-1320-01A-01",95,85,NA,NA,0,0,30,25,"2016-09-08T13:36:35.537900-05:00","2016-09-08T13:36:35.537900-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,5,"61670b41-a75a-42e1-a67e-17b3c9e5d31c","7baccc6e-48b9-4f66-b04a-5a550b77dfce","TCGA-25-1320-01A-01-BS1","TCGA-25-1320-01A-01-TS1",70,70,"db678e66-b2d5-42d1-8ba4-4ad77903b90e","RNA","TCGA-25-1320-01A-01R","b1e2e405-3b0f-49e8-b225-cce836277aab",1.8,0.17,"UV Spec","R","22","TCGA-25-1320-01A-01R-1565-13","52697815-ede2-4ce3-a6d0-2680f6b9bb73",0.17,NA,NA,NA,NA,"d25630cb-de47-51dc-be38-ab27f7fff50d","TCGA-25-1320_exposure","TCGA-25-1320-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:39:48.000Z","2014-03-22T03:12:02.000Z","F6DA10C3-3A60-404A-852E-D4A9E49FF7F3","97A91868-8A8D-4B2D-BBA2-8BD187F572AC","Unaligned reads",12625254400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","52697815-EDE2-4CE3-A6D0-2680F6B9BB73","Canada's Michael Smith Genome Sciences Centre","564a35b6e4b08c5d868fb1ff","46395C3D-5E51-477F-946E-E58B87CC7BAA","Ovarian Serous Cystadenocarcinoma","TAR","DB678E66-B2D5-42D1-8BA4-4AD77903B90E","2014-03-22T03:12:02.000Z","B1E2E405-3B0F-49E8-B225-CCE836277AAB","None","NO",1,1,"Primary Tumor","Mayo Clinic - Rochester",NA,"DB678E66-B2D5-42D1-8BA4-4AD77903B90E",3,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d1b3fd86-d1f2-4621-980a-19f3d9ee76f4.txt",NA,"TCGA-25-1320-01A",3.4,"ACE5AD75-8CC5-441F-80FF-875333731B1C","TCGA",2001,NA,NA,"WITH TUMOR","F1DBB195-198E-436E-A1F4-885F27DCC47A",65,"C239.TCGA-25-1320-01A-01W.8.bam.bai","Dead",1155,"TCGA-25-1320","NOT HISPANIC OR LATINO","96391CFA-B15A-41B8-9967-3AF1DB0693FC",NA,1124,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,112,"7BACCC6E-48B9-4F66-B04A-5A550B77DFCE","CA25C224-A4EB-46A5-8200-757723385E99","TCGA-25-1320-01A-01R-1565-13_GRCh37-lite_rnaseq.bam.bai","TCGA-25-1320-01A-01",85,0,NA,NA,25,"TOP",5,NA,"TCGA-25-1320-01A-01-TS1",70,"Taxol","Chemotherapy","TCGA-25-1320-D26665",NA,NA,NA,"TCGA-25-1320-F26664_NTE-1",NA,1124,"WITH TUMOR","Dead",1155,"TCGA-25-1320-F26664","TCGA-25-1320",NA,"25","1320","YES","C56.9","8441/3","C56.9",NA,NA,-24018,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1124,1155,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
92507268,90601465,6709048536,"EBAFE057-B387-4D2B-8D91-25C83221816D.bw","47681e4b-01e8-4779-b966-ce57aff4b712","ebafe057-b387-4d2b-8d91-25c83221816d","2016-08-23T11:10:48.710973-05:00","TCGA-61-2097-01A-02R-1568-13_rnaseq_fastq.tar","6f665893-9ef8-45c3-8298-07c72ed2c7f2",5940480000,"Illumina HiSeq","4279f301049c36b4dbf166899a8df38d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:46:15.411210-05:00","2016-05-03T11:56:42.628342-05:00","6f665893-9ef8-45c3-8298-07c72ed2c7f2_analysis.xml","66031365983a0716bec57145b54f2fe4","549db5e9-4e14-48db-a6ed-c54ea7d1338e",2181,"2016-09-29T20:30:22.237680-05:00","6f665893-9ef8-45c3-8298-07c72ed2c7f2_experiment.xml","84e8f4f6c1f27ebbe65c22ab6264d304","6fa17947-3fb0-41df-a068-735e711eff53",3916,"2016-09-29T23:36:58.847036-05:00","6f665893-9ef8-45c3-8298-07c72ed2c7f2_run.xml","0a292e16d066a37001cf628692a0a134","e35ffad5-9db5-4036-9d24-faba6e70ddf4",1988,"2016-09-08T11:51:08.845048-05:00","TCGA-61-2097","2016-09-02T18:56:28.331209-05:00","female","TCGA-61-2097_demographic",1932,"white","0cec735d-2aa7-5693-9b29-92c27b94bc05","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2097_diagnosis","not reported",25961,"alive","8441/3",NA,1844,"2ebeca9d-6570-5225-9bf4-a8868ccddcef","c56.9",-25961,"TCGA-61-2097_treatment","a077e56e-400d-5b49-bbed-86e4b3016516","01",NA,"TCGA-61-2097-01A","2","dfcd4fbd-4441-40aa-a36a-13383c8d7f1a",FALSE,"6d23149d-a9b0-422f-a560-bc1b4a3b99d6","Primary Tumor","0.5",NA,NA,"2",1250208000,"02",125,"TCGA-61-2097-01A-02",80,80,0,0,0,0,20,20,"2016-09-08T11:51:08.845048-05:00","2016-09-08T11:51:08.845048-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"0715c892-db1c-44ca-a67b-b73cdbf993b8","eb2c3b3f-e0a2-4012-807f-1b49a2493ab8","TCGA-61-2097-01A-01-BS1","TCGA-61-2097-01A-02-BS2",80,80,"89ea3bd2-aab1-4a5f-9d40-f4a2d31543e7","RNA","TCGA-61-2097-01A-02R","52f1124e-7049-43e3-9df3-c6c1095ad382",1.8,0.15,"UV Spec","R","22","TCGA-61-2097-01A-02R-1568-13","d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1",0.15,NA,NA,NA,NA,"bdb737a2-02c7-5652-962b-a65f38a24f47","TCGA-61-2097_exposure","TCGA-61-2097-01A-02R-1568-13_rnaseq_fastq.tar","2014-08-26T07:32:18.000Z","2014-08-26T20:27:17.000Z","6F665893-9EF8-45C3-8298-07C72ED2C7F2","DFCD4FBD-4441-40AA-A36A-13383C8D7F1A","Unaligned reads",5940480000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D76A99A6-18CD-4A50-9945-EBF5C5CCBFD1","Canada's Michael Smith Genome Sciences Centre","564a5adee4b093830b6cd488","47681E4B-01E8-4779-B966-CE57AFF4B712","Ovarian Serous Cystadenocarcinoma","TAR","89EA3BD2-AAB1-4A5F-9D40-F4A2D31543E7","2014-08-26T20:27:17.000Z","52F1124E-7049-43E3-9DF3-C6C1095AD382","None","NO",1,0.5,"Primary Tumor","University of Pittsburgh",NA,"89EA3BD2-AAB1-4A5F-9D40-F4A2D31543E7",2,"61","bcgsc.ca.TCGA-61-2097-01A-02R-1568-13.hg19.bcgsc.ca.1.7.0.sv.fa",NA,"TCGA-61-2097-01A",2,"AE9A2672-4912-4212-8EBA-36C96D2E1D6F","TCGA",2003,NA,NA,"TUMOR FREE","DFCD4FBD-4441-40AA-A36A-13383C8D7F1A",71,"nationwidechildrens.org_clinical.TCGA-61-2097.xml","Alive",NA,"TCGA-61-2097",NA,NA,NA,1844,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,2,125,"EB2C3B3F-E0A2-4012-807F-1B49A2493AB8","DC184713-BEFF-4E05-9DA9-909EE8053A92","bcgsc.ca.TCGA-61-2097-01A-02R-1568-13.hg19.bcgsc.ca.1.7.0.sv.fa","TCGA-61-2097-01A-02",80,0,0,0,20,"BOTTOM",0,0,"TCGA-61-2097-01A-02-BS2",80,"Interferon gamma","Immunotherapy","TCGA-61-2097-D28416",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2097",NA,"61","2097","YES","C56.9","8441/3","C56.9",NA,NA,-25961,"FEMALE","WHITE",NA,NA,"No","Alive",1844,NA,NA,NA,"TUMOR FREE","NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
163038684,160611563,11886831316,"2CDB897D-ABAF-4EBB-837C-05CC7691D20E.bw","48e66676-dbed-48a4-9a7f-a6d247b15c17","2cdb897d-abaf-4ebb-837c-05cc7691d20e","2016-08-19T15:00:58.915349-05:00","TCGA-57-1586-01A-02R-1567-13_rnaseq_fastq.tar","349581d1-ae0f-4000-b291-e379ff78bd3e",9751848960,"Illumina HiSeq","a98801fa998cf173a03ec1a102906ab8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:20:49.513678-05:00","2016-05-03T11:56:42.628342-05:00","349581d1-ae0f-4000-b291-e379ff78bd3e_analysis.xml","1d09d2bad49d176d7294ff63cc7e856d","b3f8af7a-b048-4ff8-b169-d41ee0764887",2210,"2016-09-29T21:41:04.574298-05:00","349581d1-ae0f-4000-b291-e379ff78bd3e_experiment.xml","04a75053567eab2e36053baf472796f3","9b7f211e-e985-4f6d-80ca-1d5ea6d32106",3916,"2016-09-29T19:19:12.156429-05:00","349581d1-ae0f-4000-b291-e379ff78bd3e_run.xml","c32d3b984a4f42e389ed8af7ed16b384","43c117cb-f00b-40ff-a6dc-a126c2b70b60",1988,"2016-09-08T13:09:44.888042-05:00","TCGA-57-1586","2016-09-02T19:07:27.364601-05:00","female","TCGA-57-1586_demographic",1941,"white","d42e36ed-2e6e-5b2f-a8eb-51b647fce8a9","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1586_diagnosis","not reported",24304,"alive","8441/3",NA,679,"09ee5001-6b33-5395-aca0-afdc0186713b","c56.9",-24304,"TCGA-57-1586_treatment","f6788a24-d566-5385-86e1-ee0fcc2fbb64","01",NA,"TCGA-57-1586-01A","0.6","e4d6fa52-fb29-47ac-aade-8f6020a5b55e",FALSE,"1245d63d-8859-496a-828e-4ccad717c114","Primary Tumor","0.2",NA,NA,"1.5",1242604800,"02",129,"TCGA-57-1586-01A-02",95,90,NA,NA,0,0,5,5,"2016-09-08T13:09:44.888042-05:00","2016-09-08T13:09:44.888042-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,0,"fea4c08b-05ba-4dde-943f-c01766ffac06","e764dd3a-c4f4-4243-9ec1-8f62274fb5ab","TCGA-57-1586-01A-01-BS1","TCGA-57-1586-01A-02-BS2",94,95,"3eca914b-5b2a-41d0-b9c6-e7276c611b98","RNA","TCGA-57-1586-01A-02R","094a970c-acd7-4baf-b58e-1046934ce0d8",1.8,0.15,"UV Spec","R","22","TCGA-57-1586-01A-02R-1567-13","2dcac69e-7167-4979-8327-be74d2c1202b",0.15,NA,NA,NA,NA,"85851f44-210d-5799-a5b7-125e7d495d3e","TCGA-57-1586_exposure","TCGA-57-1586-01A-02R-1567-13_rnaseq_fastq.tar","2014-08-28T15:24:22.000Z","2014-08-28T17:25:21.000Z","349581D1-AE0F-4000-B291-E379FF78BD3E","E4D6FA52-FB29-47AC-AADE-8F6020A5B55E","Unaligned reads",9751848960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2DCAC69E-7167-4979-8327-BE74D2C1202B","Canada's Michael Smith Genome Sciences Centre","564a3c9fe4b09c884b24bb40","48E66676-DBED-48A4-9A7F-A6D247B15C17","Ovarian Serous Cystadenocarcinoma","TAR","3ECA914B-5B2A-41D0-B9C6-E7276C611B98","2014-08-28T17:25:21.000Z","094A970C-ACD7-4BAF-B58E-1046934CE0D8","None","NO",1,0.2,"Primary Tumor","International Genomics Consortium",NA,"3ECA914B-5B2A-41D0-B9C6-E7276C611B98",0.6,"57","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a93a15b9-aef1-403b-85c4-1d5203e6d9dc.txt",NA,"TCGA-57-1586-01A",1.5,"F5064788-37A0-4453-8E48-7AFD74568B5A","TCGA",2007,NA,NA,"WITH TUMOR","E4D6FA52-FB29-47AC-AADE-8F6020A5B55E",66,"SAROS_p_TCGA_B18_SNP_N_GenomeWideSNP_6_A07_489628.tangent.copynumber.data.txt","Alive",NA,"TCGA-57-1586","NOT HISPANIC OR LATINO","63A6F203-F1B7-48B2-BB80-5D6FD277E34C",NA,679,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,2,129,"FEA4C08B-05BA-4DDE-943F-C01766FFAC06","915BCB52-C7F1-4CE4-9FEE-36C612196FF6","4760681021_B_Grn.idat","TCGA-57-1586-01A-02",95,0,NA,NA,5,"TOP",1,NA,"TCGA-57-1586-01A-01-BS1",94,"Carboplatin","Chemotherapy","TCGA-57-1586-D28082",NA,NA,NA,"TCGA-57-1586-F28080_NTE-1",NA,679,"WITH TUMOR","Alive",NA,"TCGA-57-1586-F28080","TCGA-57-1586",NA,"57","1586","YES","C56.9","8441/3","C56.9",NA,NA,-24304,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",679,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
179020764,175372047,12994429273,"FD2F4E8A-F89C-4016-B275-13FC6B4121E9.bw","48f831b0-5d91-44ae-bc4e-db57ca84fe46","fd2f4e8a-f89c-4016-b275-13fc6b4121e9","2016-08-23T21:27:51.506637-05:00","TCGA-24-1417-01A-01R-1565-13_rnaseq_fastq.tar","a48333f4-cf1c-4c6c-a394-3abc53092b6d",11270440960,"Illumina HiSeq","931a8c053edfee97f65ea69afe160bb5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:48:20.016536-05:00","2016-05-03T11:40:21.648680-05:00","a48333f4-cf1c-4c6c-a394-3abc53092b6d_analysis.xml","f21b98c468a248d9768e458a5e98f044","c530c7ea-a903-43c2-a0b0-54ff90c9c334",2181,"2016-09-29T17:52:03.112004-05:00","a48333f4-cf1c-4c6c-a394-3abc53092b6d_experiment.xml","9dd23049faece91d1bcdd0ee13548201","0cf7b4a5-940a-4060-8a42-90cd5d1507b7",3916,"2016-09-29T17:52:44.778596-05:00","a48333f4-cf1c-4c6c-a394-3abc53092b6d_run.xml","85d9b7c84b6173be9b7f33f657db7fbd","0d68d42a-62f1-4e93-bb8f-42cd47f966bb",1988,"2016-09-08T13:30:37.008112-05:00","TCGA-24-1417","2016-09-02T19:13:48.013025-05:00","female","TCGA-24-1417_demographic",1954,"white","f9e14320-3849-5728-8080-595d28eab5c8","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1417_diagnosis","not reported",19775,"alive","8441/3",NA,238,"4b027297-035f-56ce-821c-31213eea6b4c","c56.9",-19775,"TCGA-24-1417_treatment","58e34a10-744d-5bc5-9e6f-18ccef94b95d","01",NA,"TCGA-24-1417-01A","1.1","1fce45c1-b4e9-40fb-b914-23ec7472aca2",FALSE,"4058a172-a0f6-4c91-9c79-aab63525340f","Primary Tumor","0.3",NA,NA,"1.3",1231977600,"01",129,"TCGA-24-1417-01A-01",85,85,NA,NA,15,15,0,0,"2016-09-08T13:30:37.008112-05:00","2016-09-08T13:30:37.008112-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,15,"a1bfa913-5f8b-4f4c-8379-0edee9daad87","23ab8e32-3bc0-43ec-8434-3a1fb7f54ffc","TCGA-24-1417-01A-01-TS1","TCGA-24-1417-01A-01-BS1",75,70,"81d7dfe5-2d79-4868-a38a-2bd1b006acba","RNA","TCGA-24-1417-01A-01R","47fbd0ab-35b4-451f-adf0-fd421d00169c",1.8,0.17,"UV Spec","R","22","TCGA-24-1417-01A-01R-1565-13","e76a7745-3193-4650-9a7a-c96329690be3",0.17,NA,NA,NA,NA,"49f4a464-b4d3-5346-8d57-ae178a5f3b25","TCGA-24-1417_exposure","TCGA-24-1417-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T23:41:37.000Z","2014-03-22T00:05:01.000Z","A48333F4-CF1C-4C6C-A394-3ABC53092B6D","1FCE45C1-B4E9-40FB-B914-23EC7472ACA2","Unaligned reads",11270440960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E76A7745-3193-4650-9A7A-C96329690BE3","Canada's Michael Smith Genome Sciences Centre","564a3570e4b093830b675c8a","48F831B0-5D91-44AE-BC4E-DB57CA84FE46","Ovarian Serous Cystadenocarcinoma","TAR","81D7DFE5-2D79-4868-A38A-2BD1B006ACBA","2014-03-22T00:05:01.000Z","47FBD0AB-35B4-451F-ADF0-FD421D00169C","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"81D7DFE5-2D79-4868-A38A-2BD1B006ACBA",1.1,"24","TCGA-24-1417-01A-01D-0476-02_S01_CGH_105_Dec08.txt",NA,"TCGA-24-1417-01A",1.3,"F6DFBC3C-363E-4BC3-8873-82CBCF734BFA","TCGA",2008,NA,NA,"TUMOR FREE","A90EA1FC-46DE-444F-8973-DFC1A89EAD75",54,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.4e9ef1e1-1dd3-4027-8a72-11dcbce7e12a.txt","Alive",NA,"TCGA-24-1417",NA,"6F2F5940-F189-4422-93FC-7571C6F994BA",NA,238,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,129,"A1BFA913-5F8B-4F4C-8379-0EDEE9DAAD87","E15E84BF-9295-4167-9245-DCEF019AAF34","TCGA-24-1417-01A-01W-0549-09_capture.bam","TCGA-24-1417-01A-01",85,15,NA,NA,0,"TOP",10,NA,"TCGA-24-1417-01A-01-TS1",75,"Carboplatin","Chemotherapy","TCGA-24-1417-D25922",NA,NA,NA,NA,NA,238,"TUMOR FREE","Alive",NA,"TCGA-24-1417-F25920","TCGA-24-1417",NA,"24","1417","YES","C56.9","8441/3","C56.9",NA,NA,-19775,"FEMALE","WHITE",NA,NA,"No","Alive",238,NA,NA,NA,"TUMOR FREE","NO",1,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,54,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
157947470,150733927,11042760145,"1E27DDFF-D487-4CBF-80BC-506CC7C7C74D.bw","499a9b57-ee1a-4012-bbab-c6ad955b5e0a","1e27ddff-d487-4cbf-80bc-506cc7c7c74d","2016-08-25T05:54:31.061406-05:00","TCGA-24-1551-01A-01R-1566-13_rnaseq_fastq.tar","7767355e-52d9-4016-b57d-bf571e0f7d7c",9792747520,"Illumina HiSeq","aa19a6811842a8613d48bf4c6cee7ce4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:34:11.085419-05:00","2016-05-03T11:40:21.648199-05:00","7767355e-52d9-4016-b57d-bf571e0f7d7c_analysis.xml","2f1dc2612438889dd6b03368a80f62c3","4d1cd742-fff6-4fc5-8371-11fa400f22f8",2181,"2016-09-29T18:12:42.573112-05:00","7767355e-52d9-4016-b57d-bf571e0f7d7c_experiment.xml","b1dca4390ab1b432ecf81f567bff9aa8","19edf0de-35ce-494b-8acc-7c51dcba263c",3916,"2016-09-29T20:40:05.721144-05:00","7767355e-52d9-4016-b57d-bf571e0f7d7c_run.xml","42028277112511d6e07bbe6add032d7b","758b4c5b-8a70-425a-a7f0-343c5d64eb13",1988,"2016-09-08T12:14:48.141738-05:00","TCGA-24-1551","2016-09-02T19:07:17.530811-05:00","female","TCGA-24-1551_demographic",1944,"white","ca38c8a5-7219-5217-8608-05cd8bd450f7","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1551_diagnosis","not reported",19661,"dead","8441/3",1579,1579,"d6ee4cbf-9c84-5fef-bb8e-d5df71a1e6f7","c56.9",-19661,"TCGA-24-1551_treatment","9951e7f0-c6b1-519b-b0ef-0e857cde665b","01",NA,"TCGA-24-1551-01A","0.7","a081a22a-184f-44af-92cf-674c7d349e03",FALSE,"474ac527-45a2-4258-bec4-0a48a3b80742","Primary Tumor","0.5",NA,NA,"1.2",1235260800,"01",128,"TCGA-24-1551-01A-01",99,90,NA,NA,0,0,5,15,"2016-09-08T12:14:48.141738-05:00","2016-09-08T12:14:48.141738-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"681cb51e-c47d-4877-8041-54e92143e106","41335e52-92cb-47c1-b5d6-cfaf07041b09","TCGA-24-1551-01A-01-TS1","TCGA-24-1551-01A-01-BS1",90,80,"8e0fd573-95bc-479e-b246-ceeecdf6ed47","RNA","TCGA-24-1551-01A-01R","71826565-cfc2-4642-9444-1f6bb6b21b2b",1.8,0.14,"UV Spec","R","22","TCGA-24-1551-01A-01R-1566-13","0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8",0.14,NA,NA,NA,NA,"0844882a-7265-5a0b-b948-bb76da455180","TCGA-24-1551_exposure","TCGA-24-1551-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T05:57:48.000Z","2014-03-25T06:19:02.000Z","7767355E-52D9-4016-B57D-BF571E0F7D7C","A081A22A-184F-44AF-92CF-674C7D349E03","Unaligned reads",9792747520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0F5F479C-C83B-404B-BD17-EBB2AA5B0DC8","Canada's Michael Smith Genome Sciences Centre","564a3a97e4b08c5d86913fe1","499A9B57-EE1A-4012-BBAB-C6AD955B5E0A","Ovarian Serous Cystadenocarcinoma","TAR","8E0FD573-95BC-479E-B246-CEEECDF6ED47","2014-03-25T06:19:02.000Z","71826565-CFC2-4642-9444-1F6BB6B21B2B","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"8E0FD573-95BC-479E-B246-CEEECDF6ED47",0.7,"24","COOKY_p_TCGAb15_ICPp3_061909_GenomeWideSNP_6_B02_465840.CEL",NA,"TCGA-24-1551-01A",1.2,"EC427308-EA67-43E0-9B4E-A4C9E2DB1D3E","TCGA",1997,NA,NA,"WITH TUMOR","A081A22A-184F-44AF-92CF-674C7D349E03",53,"nationwidechildrens.org_clinical.TCGA-24-1551.xml","Dead",1579,"TCGA-24-1551",NA,"BBE90A89-5F83-4B5D-9EF9-9A9E8A5159FD",NA,1579,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,128,"41335E52-92CB-47C1-B5D6-CFAF07041B09","1A229D0A-BACF-4C9F-8A8A-DEF7C983F152","TCGA-24-1551-01A-01R-1566-13_GRCh37-lite_rnaseq.bam","TCGA-24-1551-01A-01",90,0,NA,NA,15,"BOTTOM",5,NA,"TCGA-24-1551-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-24-1551-D26145",NA,NA,NA,"TCGA-24-1551-F26139_NTE-1",NA,1579,"WITH TUMOR","Dead",1579,"TCGA-24-1551-F26139","TCGA-24-1551",NA,"24","1551","YES","C56.9","8441/3","C56.9",NA,NA,-19661,"FEMALE","WHITE",NA,NA,"No","Dead",1579,1579,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
143295992,139407658,10281010790,"1DD990EF-74A8-4503-B801-C01D6C171E2E.bw","49bfd0fe-48ce-49db-9f76-ce2310410950","1dd990ef-74a8-4503-b801-c01d6c171e2e","2016-08-25T05:47:17.857009-05:00","TCGA-13-1485-01A-02R-1565-13_rnaseq_fastq.tar","805c29ff-dd03-4615-891b-3ca266418a73",8988661760,"Illumina HiSeq","c20e2c9976b5fc780d45b59711f96ef2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:23:24.393632-05:00","2016-05-03T11:40:21.648680-05:00","805c29ff-dd03-4615-891b-3ca266418a73_analysis.xml","1fd86b01e582eeb394f5e0f743e51d85","46706b79-c0d1-44a0-b056-63039d46dec3",2208,"2016-10-07T16:24:32.379615-05:00","805c29ff-dd03-4615-891b-3ca266418a73_experiment.xml","588004d97c0340cc331cb0f5acb43c95","9dff3352-998d-4cd5-85d8-ce718d2a5d6d",3916,"2016-09-29T21:29:00.548121-05:00","805c29ff-dd03-4615-891b-3ca266418a73_run.xml","962601143241ad65569f87300663d790","942cf81f-0320-491d-9fca-76857683291d",1988,"2016-09-08T13:35:40.192010-05:00","TCGA-13-1485","2016-09-02T19:14:00.617739-05:00","female","TCGA-13-1485_demographic",1953,"white","4ad24e85-b885-58a1-a2c0-f1278fae3a4a","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1485_diagnosis","not reported",17642,"dead","8441/3",629,629,"ee7f23f5-f972-5fb6-8afe-1a30f1780e54","c56.9",-17642,"TCGA-13-1485_treatment","3671878d-769a-51b6-b78a-2378e342c7b4","01",NA,"TCGA-13-1485-01A","1.1","558827de-87a0-4041-89b2-fe439ac820a2",FALSE,"5ABB28A5-1BF3-4E90-AD3B-3692893C8686","Primary Tumor","0.3",NA,NA,"1.6",1234396800,"02",130,"TCGA-13-1485-01A-02",80,80,NA,NA,0,0,30,30,"2016-09-08T13:35:40.192010-05:00","2016-09-08T13:35:40.192010-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"d33cd2ff-9521-4ae7-a458-6cd672e3048d","2db443ac-fdab-4759-8e64-eb343b89aa91","TCGA-13-1485-01A-02-BS2","TCGA-13-1485-01A-01-BS1",70,70,"30a464e7-6424-44ff-a858-b847678fc9b6","RNA","TCGA-13-1485-01A-02R","d8fdef60-9f24-4e61-add0-c7ea015a9d2e",1.8,0.15,"UV Spec","R","22","TCGA-13-1485-01A-02R-1565-13","50f08f95-3c5a-4d6b-bacc-ccb4a3a720b8",0.15,NA,NA,NA,NA,"db3db10b-fd4a-5708-bf64-3d2762fe4baa","TCGA-13-1485_exposure","TCGA-13-1485-01A-02R-1565-13_rnaseq_fastq.tar","2014-03-21T23:27:49.000Z","2014-03-21T23:51:02.000Z","805C29FF-DD03-4615-891B-3CA266418A73","558827DE-87A0-4041-89B2-FE439AC820A2","Unaligned reads",8988661760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","50F08F95-3C5A-4D6B-BACC-CCB4A3A720B8","Canada's Michael Smith Genome Sciences Centre","564a5bcee4b0ef12181e3c91","49BFD0FE-48CE-49DB-9F76-CE2310410950","Ovarian Serous Cystadenocarcinoma","TAR","30A464E7-6424-44FF-A858-B847678FC9B6","2014-03-21T23:51:02.000Z","D8FDEF60-9F24-4E61-ADD0-C7EA015A9D2E","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"30A464E7-6424-44FF-A858-B847678FC9B6",1.1,"13","TCGA-13-1485-01A-02R-1565-13_rnaseq_fastq.tar",NA,"TCGA-13-1485-01A",1.6,"9CA66B5D-B2D7-4ED3-91D7-E0A0CC34922A","TCGA",2001,NA,NA,"WITH TUMOR","674D644C-E656-4398-9A3A-99B334B5C918",48,"nationwidechildrens.org_clinical.TCGA-13-1485.xml","Dead",629,"TCGA-13-1485","NOT HISPANIC OR LATINO","C541CBCC-09EE-4152-B710-60D9F09F384D",NA,629,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,2,130,"D33CD2FF-9521-4AE7-A458-6CD672E3048D","D8FDEF60-9F24-4E61-ADD0-C7EA015A9D2E","TCGA-13-1485-01A-02R-1565-13_rnaseq_fastq.tar","TCGA-13-1485-01A-02",80,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-13-1485-01A-02-BS2",70,"Paciltaxel","Chemotherapy","TCGA-13-1485-D24863",NA,NA,NA,"TCGA-13-1485-F24861_NTE-1",NA,629,"WITH TUMOR","Dead",629,"TCGA-13-1485-F24861","TCGA-13-1485",NA,"13","1485","YES","C56.9","8441/3","C56.9",NA,NA,-17642,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",629,629,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,48,2001,"Incisional Biopsy",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
185543186,177668028,13088855945,"4D2DF3FF-343A-4D29-9230-015131B45BD2.bw","49d2c0cf-a3f3-4519-a755-0a5f769df2ea","4d2df3ff-343a-4d29-9230-015131b45bd2","2016-08-25T01:51:10.167144-05:00","TCGA-24-1435-01A-01R-1566-13_rnaseq_fastq.tar","d0b4ac62-7608-40b2-b1c2-dd7c247842ea",11912069120,"Illumina HiSeq","a774abd164b3e9aaef4acfbf9ffed2fc","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:58:33.965383-05:00","2016-05-03T11:40:21.648199-05:00","d0b4ac62-7608-40b2-b1c2-dd7c247842ea_analysis.xml","f7c53de5eaacd4a359262ffc40e312de","5c3e02cb-c8d0-46f7-ac22-e512038289e9",2181,"2016-10-07T17:30:21.333775-05:00","d0b4ac62-7608-40b2-b1c2-dd7c247842ea_experiment.xml","26ab6fa006eafdeaee385d4254b555ee","7c5d8bc2-3baf-4636-ac06-84837f68e545",3916,"2016-09-29T18:59:00.756966-05:00","d0b4ac62-7608-40b2-b1c2-dd7c247842ea_run.xml","093e6f8f4f0ef8808c0a2ddf75e89a8f","3708d5c9-ed0e-4c2b-8ba2-702a0b85d7f0",1988,"2016-09-08T13:36:10.877889-05:00","TCGA-24-1435","2016-09-02T19:13:39.741107-05:00","female","TCGA-24-1435_demographic",1942,"white","1a799775-3d93-5950-9ea0-0ac519e37476","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1435_diagnosis","not reported",21107,"dead","8441/3",1324,1324,"020510a4-78b5-5290-a377-54a07c066478","c56.9",-21107,"TCGA-24-1435_treatment","9504fd23-5eba-5a30-b910-8975b0786281","01",NA,"TCGA-24-1435-01A","1.2","a36ab3e1-b5fb-4557-af54-88d4ada2aaaf",FALSE,"d1574b6c-6cc1-45bc-86d0-97585d8a5c93","Primary Tumor","0.5",NA,NA,"1.5",1232409600,"01",179,"TCGA-24-1435-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:36:10.877889-05:00","2016-09-08T13:36:10.877889-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"d678e541-f8bc-4a7e-87ca-e1df06b156ec","3429e07b-d614-4c41-bf6e-9bfb4fc1e325","TCGA-24-1435-01A-01-TS1","TCGA-24-1435-01A-01-BS1",94,94,"05bbb1d0-8116-48a8-9240-dc9b01b2a20a","RNA","TCGA-24-1435-01A-01R","cf334d2a-3614-4876-bf7f-7792888bb4d0",1.8,0.14,"UV Spec","R","22","TCGA-24-1435-01A-01R-1566-13","c20ba763-e310-448a-9c85-0b4f680e6196",0.14,NA,NA,NA,NA,"210f65e9-4dd3-58c2-9023-df79fc175006","TCGA-24-1435_exposure","TCGA-24-1435-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T07:11:39.000Z","2014-03-25T07:35:01.000Z","D0B4AC62-7608-40B2-B1C2-DD7C247842EA","A36AB3E1-B5FB-4557-AF54-88D4ADA2AAAF","Unaligned reads",11912069120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C20BA763-E310-448A-9C85-0B4F680E6196","Canada's Michael Smith Genome Sciences Centre","564a5b3de4b093830b6cf214","49D2C0CF-A3F3-4519-A755-0A5F769DF2EA","Ovarian Serous Cystadenocarcinoma","TAR","05BBB1D0-8116-48A8-9240-DC9B01B2A20A","2014-03-25T07:35:01.000Z","CF334D2A-3614-4876-BF7F-7792888BB4D0","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"05BBB1D0-8116-48A8-9240-DC9B01B2A20A",1.2,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.591cd2fa-3920-42e9-a1ed-d76898930e6f.txt",NA,"TCGA-24-1435-01A",1.5,"CF7B733E-4265-4EAB-9822-3974D73A0A34","TCGA",1999,NA,NA,"WITH TUMOR","A36AB3E1-B5FB-4557-AF54-88D4ADA2AAAF",57,"nationwidechildrens.org_clinical.TCGA-24-1435.xml","Dead",1324,"TCGA-24-1435",NA,"FAB88B94-18A9-48A3-B679-10658361D8D8",NA,1324,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,179,"D678E541-F8BC-4A7E-87CA-E1DF06B156EC","CF334D2A-3614-4876-BF7F-7792888BB4D0","THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_F02_455262.nocnv_hg19.seg.txt","TCGA-24-1435-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-24-1435-01A-01-BS1",94,"Carboplatin","Chemotherapy","TCGA-24-1435-D25994",NA,NA,NA,"TCGA-24-1435-F25993_NTE-1",NA,1324,"WITH TUMOR","Dead",1324,"TCGA-24-1435-F25993","TCGA-24-1435",NA,"24","1435","YES","C56.9","8441/3","C56.9",NA,NA,-21107,"FEMALE","WHITE",NA,NA,"No","Dead",1324,1324,NA,NA,"WITH TUMOR","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
172077810,167370473,12411848674,"B9949248-D762-4591-B8D6-C296C2B28D8C.bw","4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3","b9949248-d762-4591-b8d6-c296c2b28d8c","2016-08-22T07:17:22.519811-05:00","TCGA-30-1891-01A-01R-1568-13_rnaseq_fastq.tar","b8242143-b8fb-4381-9478-3735942114ef",10878504960,"Illumina HiSeq","9378334537c227514a93ce9662314885","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:45:56.855735-05:00","2016-05-03T11:41:05.755204-05:00","b8242143-b8fb-4381-9478-3735942114ef_analysis.xml","60b3eac2a4e9733a9d399a54f74c0b1e","9e81e8cd-b8ed-4672-a978-249a35448877",2183,"2016-10-07T15:47:54.577798-05:00","b8242143-b8fb-4381-9478-3735942114ef_experiment.xml","4adbf937cef13e8c7a80d0b4e8d9d6d4","013f6b05-b293-4d5e-88d7-902d72935fb5",3916,"2016-09-29T20:46:09.372370-05:00","b8242143-b8fb-4381-9478-3735942114ef_run.xml","740ae0d48e2ef399331a5eca44fd1683","79553302-d0dd-49e4-bb41-0f112bee554a",1990,"2016-09-08T10:38:25.461393-05:00","TCGA-30-1891","2016-09-02T18:50:44.292229-05:00","female","TCGA-30-1891_demographic",1943,"white","1270303a-3e2c-5099-b188-7454f3ec9414","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1891_diagnosis","not reported",22344,"dead","8441/3",914,914,"dcbdfdd3-dfe8-51f7-969c-02ea3474bc0a","c56.9",-22344,"TCGA-30-1891_treatment","b51582d6-b9b9-50c0-af2a-db58b79a9638","01",NA,"TCGA-30-1891-01A","0.8","8e66ac32-4df0-45b2-915e-37eacd1040a2",FALSE,"F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B","Primary Tumor","0.4",NA,NA,"1.2",1245628800,"01",122,"TCGA-30-1891-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T10:38:25.461393-05:00","2016-09-08T10:38:25.461393-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,15,"621013a7-cdb9-4be7-aae2-fe8291645d1c","038ab98b-6a36-43b4-b37b-11775670647a","TCGA-30-1891-01A-01-TS1","TCGA-30-1891-01A-01-BS1",70,65,"bc4548ab-c38f-4398-bb8f-958cbfdb0724","RNA","TCGA-30-1891-01A-01R","a085780c-f121-43c3-814e-6a07d178232d",1.8,0.15,"UV Spec","R","22","TCGA-30-1891-01A-01R-1568-13","690d1437-2a05-4263-8fa7-8f4481893b83",0.15,NA,NA,NA,NA,"e088b6b0-8034-560b-a0d6-423c532191dc","TCGA-30-1891_exposure","TCGA-30-1891-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T04:40:33.000Z","2014-03-27T05:03:02.000Z","B8242143-B8FB-4381-9478-3735942114EF","8E66AC32-4DF0-45B2-915E-37EACD1040A2","Unaligned reads",10878504960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","690D1437-2A05-4263-8FA7-8F4481893B83","Canada's Michael Smith Genome Sciences Centre","564a5883e4b0ef12181d3b34","4A2CA7B8-729D-4FAB-A6F3-A5D1E5D1F4F3","Ovarian Serous Cystadenocarcinoma","TAR","BC4548AB-C38F-4398-BB8F-958CBFDB0724","2014-03-27T05:03:02.000Z","A085780C-F121-43C3-814E-6A07D178232D","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"BC4548AB-C38F-4398-BB8F-958CBFDB0724",0.8,"30","bcgsc.ca.TCGA-30-1891-01A-01R-1568-13.hg19.bcgsc.ca.1.7.0.sv.vcf",NA,"TCGA-30-1891-01A",1.2,"FD0A5766-C375-4546-8ACD-AF9B0CB09E93","TCGA",2004,NA,NA,"WITH TUMOR","8E66AC32-4DF0-45B2-915E-37EACD1040A2",61,"LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_C10_517946.ismpolish.data.txt","Dead",914,"TCGA-30-1891","NOT HISPANIC OR LATINO","8FDC5769-4E01-4A6E-B84D-79E1D6447711",NA,914,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,122,"621013A7-CDB9-4BE7-AAE2-FE8291645D1C","D099A5ED-1A67-413F-82B3-2AA4B61C12FF","TCGA-30-1891-01A-01W-0699-08_IlluminaGA-DNASeq_capture.bam.bai","TCGA-30-1891-01A-01",80,0,NA,NA,20,"BOTTOM",15,NA,"TCGA-30-1891-01A-01-BS1",65,"Gemcitabine","Chemotherapy","TCGA-30-1891-D27645",NA,NA,NA,"TCGA-30-1891-F27640_NTE-2",NA,914,"WITH TUMOR","Dead",914,"TCGA-30-1891-F27640","TCGA-30-1891",NA,"30","1891","YES","C56.9","8441/3","C56.9",NA,NA,-22344,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",914,914,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
138333138,134811060,9982729973,"2D839843-4C8D-400D-8EFF-2BF9B94A27AA.bw","4c099644-047c-42a3-8187-bfcbfe6662e4","2d839843-4c8d-400d-8eff-2bf9b94a27aa","2016-08-19T15:05:01.175282-05:00","TCGA-25-2397-01A-01R-1569-13_rnaseq_fastq.tar","7b72f6c4-3d17-475b-be4a-69f59a771275",8897669120,"Illumina HiSeq","2a7ab574a4dbdc6bc457bd1d7916d080","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:18:39.595686-05:00","2016-05-03T11:55:09.260045-05:00","7b72f6c4-3d17-475b-be4a-69f59a771275_analysis.xml","33d031c7b9e7d39a70cf7c16c57e9112","b2bdc89b-fc7c-4ebc-88e4-a428ec87bf05",2181,"2016-10-07T16:24:48.080077-05:00","7b72f6c4-3d17-475b-be4a-69f59a771275_experiment.xml","d772a8ab3460dd5d24e23969e91da5b8","964438eb-9039-41e9-9691-6aebd11e798f",3916,"2016-09-29T20:15:51.627598-05:00","7b72f6c4-3d17-475b-be4a-69f59a771275_run.xml","0b5e9e7ccb306b011171147b57b5e113","66b857e1-1483-4ad7-bc20-ae54726dcf60",1988,"2016-09-08T13:18:36.889641-05:00","TCGA-25-2397","2016-09-02T19:11:45.378572-05:00","female","TCGA-25-2397_demographic",1945,"white","e9fd5616-7956-5538-a35d-f4e76dc57e64","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2397_diagnosis","not reported",21581,"dead","8441/3",365,365,"6ebe67e6-e13c-5b7f-b1b0-a64ed14ec771","c56.9",-21581,"TCGA-25-2397_treatment","127f7a00-acf1-5504-83f2-8ab4651c1be8","01",NA,"TCGA-25-2397-01A","1.3","6ba4eb6f-f6dc-441d-879a-7e27dc903c7f",FALSE,"D67C4E1F-6A68-4EE6-B143-22038C05C926","Primary Tumor","0.7",NA,NA,"2.2",1252022400,"01",149,"TCGA-25-2397-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:18:36.889641-05:00","2016-09-08T13:18:36.889641-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"ebe0e5f3-86fd-4550-9b05-fa5ee9c47fdf","456a71e7-5889-4716-afab-88b5626885df","TCGA-25-2397-01A-01-TS1","TCGA-25-2397-01A-01-BS1",95,94,"c5fd83c1-758a-411d-bfa5-b712bcf9b186","RNA","TCGA-25-2397-01A-01R","24861690-58af-4925-a4c1-3d237855bcb3",1.8,0.15,"UV Spec","R","22","TCGA-25-2397-01A-01R-1569-13","7ad7080c-730b-4a5d-a8c1-f6387fbee72e",0.15,NA,NA,NA,NA,"5df24b3c-ef52-536a-b09d-75ad9c84df6e","TCGA-25-2397_exposure","TCGA-25-2397-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T10:52:22.000Z","2014-08-08T11:16:25.000Z","7B72F6C4-3D17-475B-BE4A-69F59A771275","6BA4EB6F-F6DC-441D-879A-7E27DC903C7F","Unaligned reads",8897669120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7AD7080C-730B-4A5D-A8C1-F6387FBEE72E","Canada's Michael Smith Genome Sciences Centre","564a3a0fe4b09c884b23f357","4C099644-047C-42A3-8187-BFCBFE6662E4","Ovarian Serous Cystadenocarcinoma","TAR","C5FD83C1-758A-411D-BFA5-B712BCF9B186","2014-08-08T11:16:25.000Z","24861690-58AF-4925-A4C1-3D237855BCB3","None","NO",1,0.7,"Primary Tumor","Mayo Clinic - Rochester",NA,"C5FD83C1-758A-411D-BFA5-B712BCF9B186",1.3,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eac7612a-49d6-4b40-84b7-c68db54e56c1.txt",NA,"TCGA-25-2397-01A",2.2,NA,"TCGA",2004,NA,NA,NA,"A688CCF9-1E73-43CB-999C-E91A5688F728",59,"bcgsc.ca.TCGA-25-2397-01A-01R-1569-13.bcgsc.ca.1.5.0.snv.vcf","Dead",365,"TCGA-25-2397","NOT HISPANIC OR LATINO","3EEAB957-B68A-427B-8555-1C33A30D4C18",NA,365,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,149,"EBE0E5F3-86FD-4550-9B05-FA5EE9C47FDF","87C207F1-82D6-42B4-9F1A-5B02790C0B84","TCGA-25-2397-01A-01R-1569-13.mirna.quantification.txt","TCGA-25-2397-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-25-2397-01A-01-BS1",94,NA,NA,NA,NA,NA,NA,NA,NA,365,NA,"Dead",365,"TCGA-25-2397-F26810","TCGA-25-2397",NA,"25","2397","YES","C56.9","8441/3","C56.9",NA,NA,-21581,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",365,365,NA,NA,NA,"NO",5,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
228100082,220981620,16323269310,"78C429CC-D631-43EA-9049-DAC326C98BDD.bw","4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e","78c429cc-d631-43ea-9049-dac326c98bdd","2016-08-25T19:06:49.429054-05:00","TCGA-24-1562-01A-01R-1566-13_rnaseq_fastq.tar","f67c6cc6-fc0f-4e9e-83e1-a299b8381f7f",13663713280,"Illumina HiSeq","ac897ab1d8ecf9d8e1dde1482691f330","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:14:31.098626-05:00","2016-05-03T11:41:05.740436-05:00","f67c6cc6-fc0f-4e9e-83e1-a299b8381f7f_analysis.xml","2bfacde65ced8706e74035ccdb8fbb13","40d4a1f5-2e2f-48f3-b2e0-7cc3e69c8caa",2181,"2016-08-26T14:41:12.606772-05:00","f67c6cc6-fc0f-4e9e-83e1-a299b8381f7f_experiment.xml","294e238090fd257b13bf66ffe8f741a6","213afa69-7733-46c0-8539-3fed128eb7a2",3916,"2016-09-29T18:28:48.257384-05:00","f67c6cc6-fc0f-4e9e-83e1-a299b8381f7f_run.xml","a95823670cca70e76dc8bb8957d749c9","23f371d5-52b4-4a82-9499-49f8aee45e2a",1988,"2016-09-08T12:57:09.493702-05:00","TCGA-24-1562","2016-09-02T19:07:09.257417-05:00","female","TCGA-24-1562_demographic",1932,"white","3740a77e-8604-5e34-a9b5-3f155618c3a1","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1562_diagnosis","not reported",24747,"dead","8441/3",1384,1384,"dc319f5b-52f4-5442-b2fd-18f751b79b72","c56.9",-24747,"TCGA-24-1562_treatment","2a193a3f-26e3-5c56-9e56-681f8a714c4b","01",NA,"TCGA-24-1562-01A","0.9","a323f2f5-b250-40a6-a318-084a3933e829",FALSE,"0ce36daf-9512-4860-a5a3-b2ff7f487c5a","Primary Tumor","0.5",NA,NA,"1",1235347200,"01",108,"TCGA-24-1562-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:57:09.493702-05:00","2016-09-08T12:57:09.493702-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,10,"7a3a55d0-2158-442e-a14c-89627c590101","f4b420b6-a2f3-4d03-96f4-a429c5d64b8d","TCGA-24-1562-01A-01-BS1","TCGA-24-1562-01A-01-TS1",85,80,"56c819a5-e4e7-4b90-971f-8d8dd81aeddb","RNA","TCGA-24-1562-01A-01R","085ad7a3-b541-4d0f-97e0-beb2efca8bd9",1.8,0.15,"UV Spec","R","22","TCGA-24-1562-01A-01R-1566-13","eb8cb3b3-d1b1-4d2d-b048-7394931040bd",0.15,NA,NA,NA,NA,"59f25aa8-9398-5b01-86fc-5d63339aca6f","TCGA-24-1562_exposure","TCGA-24-1562-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-27T01:04:11.000Z","2014-03-27T01:29:01.000Z","F67C6CC6-FC0F-4E9E-83E1-A299B8381F7F","A323F2F5-B250-40A6-A318-084A3933E829","Unaligned reads",13663713280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EB8CB3B3-D1B1-4D2D-B048-7394931040BD","Canada's Michael Smith Genome Sciences Centre","564a35cbe4b08c5d868fb745","4C18D9CF-4AF4-4A86-8B1C-F78795FBBD7E","Ovarian Serous Cystadenocarcinoma","TAR","56C819A5-E4E7-4B90-971F-8D8DD81AEDDB","2014-03-27T01:29:01.000Z","085AD7A3-B541-4D0F-97E0-BEB2EFCA8BD9","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"56C819A5-E4E7-4B90-971F-8D8DD81AEDDB",0.9,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9082bc34-1aa2-4e77-bb64-22778ee28635.txt",NA,"TCGA-24-1562-01A",1,"EE1FA917-D739-42C0-A6A9-ED708DFB432D","TCGA",1999,NA,NA,"WITH TUMOR","A323F2F5-B250-40A6-A318-084A3933E829",67,"nationwidechildrens.org_clinical.TCGA-24-1562.xml","Dead",1384,"TCGA-24-1562",NA,"28786767-C3FA-429E-A296-8677B91C77FE",NA,1384,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,108,"F4B420B6-A2F3-4D03-96F4-A429C5D64B8D","F8CF0488-4562-4028-89B1-AA6D5C79F213","ec47f322db49e85c11b5cbe6ef4dc8b5.bam.bai","TCGA-24-1562-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-24-1562-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-24-1562-D26245",NA,NA,NA,"TCGA-24-1562-F26237_NTE-1",NA,1384,"WITH TUMOR","Dead",1384,"TCGA-24-1562-F26237","TCGA-24-1562",NA,"24","1562","YES","C56.9","8441/3","C56.9",NA,NA,-24747,"FEMALE","WHITE",NA,NA,"No","Dead",1384,1384,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
204585332,200223961,14810327346,"71241674-DF93-4CA0-A81D-AF85B6479F62.bw","4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1","71241674-df93-4ca0-a81d-af85b6479f62","2016-08-25T16:10:47.530512-05:00","TCGA-31-1950-01A-01R-1568-13_rnaseq_fastq.tar","1aad2059-359f-4e1e-ba20-e6c6313d9f7a",13046056960,"Illumina HiSeq","53558b7b6bd10a53c5deaa1f23829d5b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:31:23.216099-05:00","2016-05-03T11:41:05.755204-05:00","1aad2059-359f-4e1e-ba20-e6c6313d9f7a_analysis.xml","df2542da673da073153dc48b4faafb92","ba9ab408-e0b9-40fe-aea0-7f44aee0be9b",2183,"2016-09-29T22:04:03.016391-05:00","1aad2059-359f-4e1e-ba20-e6c6313d9f7a_experiment.xml","98c2b79d1673dc5918098f27765f6e3a","a9d68a66-0c3b-4d20-8f1d-99e8f230945f",3916,"2016-09-29T21:46:29.366309-05:00","1aad2059-359f-4e1e-ba20-e6c6313d9f7a_run.xml","06c2791dbb8028a355335254ba06916b","9eda382c-6a53-4631-b16e-952db772de1b",1990,"2016-09-08T11:01:00.164061-05:00","TCGA-31-1950","2016-09-02T18:50:41.814414-05:00","female","TCGA-31-1950_demographic",1931,"white","2e01658c-ae7d-592e-8f7b-a56b8851c913","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1950_diagnosis","not reported",28100,"alive","8441/3",NA,571,"c87e9e32-50c5-54fd-8808-7ca57c0c7543","c56.9",-28100,"TCGA-31-1950_treatment","0b4b1ab2-75a9-5a17-aa6e-00429fdae651","01",NA,"TCGA-31-1950-01A","0.9","5ce49570-ce22-4370-9d38-6cf43f808e81",FALSE,"4ed80cbd-e56d-4d09-b8ac-2b6535346b73","Primary Tumor","0.2",NA,NA,"1.2",1246838400,"01",106,"TCGA-31-1950-01A-01",85,85,NA,NA,0,0,85,15,"2016-09-08T11:01:00.164061-05:00","2016-09-08T11:01:00.164061-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,5,"d428155b-53a5-486a-b938-824b3a3f438f","42495a8a-15e3-4fc2-aaeb-37f45493e9a5","TCGA-31-1950-01A-01-BS1","TCGA-31-1950-01A-01-TS1",13,80,"7625c2c5-050a-4451-a462-c7c83130133c","RNA","TCGA-31-1950-01A-01R","0039da56-450d-44a5-824e-f1e080e8e60e",1.8,0.16,"UV Spec","R","22","TCGA-31-1950-01A-01R-1568-13","a32eba80-dbe9-464e-8102-5f77a3c7e177",0.16,NA,NA,NA,NA,"8e178f78-d95b-58f1-9adc-60c31647f493","TCGA-31-1950_exposure","TCGA-31-1950-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T04:17:11.000Z","2014-03-27T04:41:01.000Z","1AAD2059-359F-4E1E-BA20-E6C6313D9F7A","5CE49570-CE22-4370-9D38-6CF43F808E81","Unaligned reads",13046056960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A32EBA80-DBE9-464E-8102-5F77A3C7E177","Canada's Michael Smith Genome Sciences Centre","564a5b88e4b0ef12181e321b","4CA9C0E8-75A7-4665-9D88-6DD2BB44B1E1","Ovarian Serous Cystadenocarcinoma","TAR","7625C2C5-050A-4451-A462-C7C83130133C","2014-03-27T04:41:01.000Z","0039DA56-450D-44A5-824E-F1E080E8E60E","None","NO",1,0.2,"Primary Tumor","Imperial College",NA,"7625C2C5-050A-4451-A462-C7C83130133C",0.9,"31","C239.TCGA-31-1950-01A-01W-0699-08.3.bam.bai",NA,"TCGA-31-1950-01A",1.2,"4979D025-1341-4190-B965-C7DC0349B252","TCGA",2007,NA,NA,"WITH TUMOR","6D0F47F7-805E-4F3D-972C-3DC6A9F586CA",76,"nationwidechildrens.org_clinical.TCGA-31-1950.xml","Alive",NA,"TCGA-31-1950","NOT HISPANIC OR LATINO","28F0E73C-C8C7-4BB4-9D20-F86F2D874E27",NA,571,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,106,"D428155B-53A5-486A-B938-824B3A3F438F","A1FAF453-128E-421E-8614-DD701CF474B1","TCGA-31-1950-01A-01R-1568-13_GRCh37-lite_rnaseq.bam","TCGA-31-1950-01A-01",85,0,NA,NA,15,"TOP",5,NA,"TCGA-31-1950-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-31-1950-D27689",NA,NA,NA,"TCGA-31-1950-F27688_NTE-1",NA,571,"WITH TUMOR","Alive",NA,"TCGA-31-1950-F27688","TCGA-31-1950",NA,"31","1950","YES","C56.9","8441/3","C56.9",NA,NA,-28100,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",571,NA,NA,NA,"WITH TUMOR","NO",19,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,76,2007,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
208854798,203444821,15052253283,"76277FC9-E447-49A4-9407-81917C90ECBD.bw","4d71dd15-cd01-4dae-ad70-6dc325140207","76277fc9-e447-49a4-9407-81917c90ecbd","2016-08-25T17:55:26.234896-05:00","TCGA-23-1029-01B-01R-1567-13_rnaseq_fastq.tar","faf3c5bc-b4a3-4007-a054-8e120c2e6220",13250764800,"Illumina HiSeq","9759874efb83ec331ba5cb8930eb7a94","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:45:11.148225-05:00","2016-05-03T11:56:42.628342-05:00","faf3c5bc-b4a3-4007-a054-8e120c2e6220_analysis.xml","6514ffd892bf210fb64f15a94f5cafd7","53eebc82-f9c2-405b-a906-cac2e69e7bfa",2181,"2016-09-29T19:31:56.333627-05:00","faf3c5bc-b4a3-4007-a054-8e120c2e6220_experiment.xml","aa93852d0e004a8120c0d8f0d8ea68c7","4bd41b5a-4535-4ac2-b2f6-a1ea354ca953",3916,"2016-09-29T23:17:18.081508-05:00","faf3c5bc-b4a3-4007-a054-8e120c2e6220_run.xml","b736fde327148a4de3793766256bcef2","d708aa9d-11d1-4e8f-b2cf-d380fad56b92",1988,"2016-09-08T10:38:06.477920-05:00","TCGA-23-1029","2016-09-02T18:47:40.662337-05:00","female","TCGA-23-1029_demographic",1961,"white","47da8915-429e-5f86-a3b6-e4843fb7c2fb","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1029_diagnosis","not reported",16889,"alive","8441/3",NA,268,"d9297888-91e7-5eb6-9a85-03216ab39514","c56.9",-16889,"TCGA-23-1029_treatment","06f0f0d2-b145-53d0-92bf-9bac4e55328c","01",NA,"TCGA-23-1029-01B","0.8","5e13d3ce-ac89-4316-94a1-8395bd56fbfa",FALSE,"89E1F403-12CB-442A-9588-CF5C0AC0E0A6","Primary Tumor","0.3",NA,NA,"0.8",1244678400,"01",115,"TCGA-23-1029-01B-01",80,80,NA,NA,0,0,20,20,"2016-09-08T10:38:06.477920-05:00","2016-09-08T10:38:06.477920-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"cd4d75b5-bc4f-448a-84a3-f34c172f8d61","f0bd82cb-50ca-4cf3-bd28-c28ff2a7cde8","TCGA-23-1029-01B-01-TS1","TCGA-23-1029-01B-01-BS1",80,75,"a5987ed4-7e26-40ee-af60-8fd77fec4c6c","RNA","TCGA-23-1029-01B-01R","1abd427f-c397-4243-9fbb-fe94870d4b56",1.8,0.15,"UV Spec","R","22","TCGA-23-1029-01B-01R-1567-13","9a54d0fe-f998-4866-bb1f-92be472d843a",0.15,NA,NA,NA,NA,"8d9fa592-447b-5441-a202-910327c0d927","TCGA-23-1029_exposure","TCGA-23-1029-01B-01R-1567-13_rnaseq_fastq.tar","2014-08-27T00:37:08.000Z","2014-08-27T05:57:18.000Z","FAF3C5BC-B4A3-4007-A054-8E120C2E6220","5E13D3CE-AC89-4316-94A1-8395BD56FBFA","Unaligned reads",13250764800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9A54D0FE-F998-4866-BB1F-92BE472D843A","Canada's Michael Smith Genome Sciences Centre","564a5a7ee4b093830b6cb4ee","4D71DD15-CD01-4DAE-AD70-6DC325140207","Ovarian Serous Cystadenocarcinoma","TAR","A5987ED4-7E26-40EE-AF60-8FD77FEC4C6C","2014-08-27T05:57:18.000Z","1ABD427F-C397-4243-9FBB-FE94870D4B56","None","NO",1,0.3,"Primary Tumor","Cedars Sinai",NA,"A5987ED4-7E26-40EE-AF60-8FD77FEC4C6C",0.8,"23","TCGA-23-1029-01B-01R-1567-13_mirna.bam.bai",NA,"TCGA-23-1029-01B",0.8,"EB833CE3-8F8B-4694-B538-A8D573F473D0","TCGA",2007,NA,NA,"TUMOR FREE","93D99A23-4A4D-4E8C-9B76-9401B8B0E236",46,"nationwidechildrens.org_clinical.TCGA-23-1029.xml","Alive",NA,"TCGA-23-1029","NOT HISPANIC OR LATINO","B21097D0-D714-4E0C-A8B9-FECAC7CE4111",NA,268,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,115,"F0BD82CB-50CA-4CF3-BD28-C28FF2A7CDE8","1ABD427F-C397-4243-9FBB-FE94870D4B56","TCGA-23-1029-01B-01W-0639-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-23-1029-01B-01",80,0,NA,NA,20,"BOTTOM",5,NA,"TCGA-23-1029-01B-01-BS1",75,"Paciltaxel","Chemotherapy","TCGA-23-1029-D25641",NA,NA,NA,NA,NA,268,"TUMOR FREE","Alive",NA,"TCGA-23-1029-F25639","TCGA-23-1029",NA,"23","1029","YES","C56.9","8441/3","C56.9",NA,NA,-16889,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",268,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,46,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
170275878,165184847,12211178181,"79DE0216-2CBB-4057-AC90-0366A494F106.bw","4e6f88de-7624-4719-8234-4c9e5b2e2988","79de0216-2cbb-4057-ac90-0366a494f106","2016-08-25T19:28:04.177294-05:00","TCGA-09-1673-01A-01R-1566-13_rnaseq_fastq.tar","72e2dec8-8207-4f2e-9653-7ba7474cf284",10835015680,"Illumina HiSeq","1d11066929b251bc13cd572432134070","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:59:48.184429-05:00","2016-05-03T11:40:21.662944-05:00","72e2dec8-8207-4f2e-9653-7ba7474cf284_analysis.xml","44d582b6857b2199b89dd0d547818a04","f189b594-43eb-4002-98b7-f090ab7da6b8",2181,"2016-09-30T00:03:28.379150-05:00","72e2dec8-8207-4f2e-9653-7ba7474cf284_experiment.xml","4ad79bf19573f708ff631cba240f491f","f3c5d1f9-f703-4b90-9eb1-767019e4403d",3916,"2016-09-29T21:54:55.559552-05:00","72e2dec8-8207-4f2e-9653-7ba7474cf284_run.xml","0df472c0942ff5852ceea9ecaed55c10","a434a16e-c693-41cc-9f7e-67d08a205140",1988,"2016-09-08T12:17:58.085429-05:00","TCGA-09-1673","2016-09-02T19:07:31.138825-05:00","female","TCGA-09-1673_demographic",1958,"white","52ee8dcb-6b70-54da-9a9b-846e68a0b566","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1673_diagnosis","not reported",18599,"alive","8441/3",NA,92,"18cf8d27-34a1-592b-b795-f9dd1ad5ee52","c56.9",-18599,"TCGA-09-1673_treatment","8a696dc3-800d-55d6-ad6e-a0a36d15bc7c","01",NA,"TCGA-09-1673-01A","1","95522925-79b0-4ce7-8323-dce56cbf15cd",FALSE,"d4f7aa96-11e8-4d66-a1be-595ec22de450","Primary Tumor","0.6",NA,NA,"3",1240185600,"01",97,"TCGA-09-1673-01A-01",99,99,NA,NA,0,0,5,5,"2016-09-08T12:17:58.085429-05:00","2016-09-08T12:17:58.085429-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,8,"6c3902a7-444c-4d7d-97c2-4d1dd7c9e19c","6984ccd0-0e27-4549-98fe-c8b864b7c087","TCGA-09-1673-01A-01-TS1","TCGA-09-1673-01A-01-BS1",85,87,"eb47601f-b4bb-4712-8c15-d97c55cca2cd","RNA","TCGA-09-1673-01A-01R","f637e3b8-a9f9-4e9a-9acd-5eb71a8b719f",1.8,0.14,"UV Spec","R","22","TCGA-09-1673-01A-01R-1566-13","37037dcf-fa69-4cd3-b83d-e474d69059b4",0.14,NA,NA,NA,NA,"97abcf42-3e7c-5826-abd7-b5c56dd790da","TCGA-09-1673_exposure","TCGA-09-1673-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T02:13:39.000Z","2014-03-25T02:36:01.000Z","72E2DEC8-8207-4F2E-9653-7BA7474CF284","95522925-79B0-4CE7-8323-DCE56CBF15CD","Unaligned reads",10835015680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","37037DCF-FA69-4CD3-B83D-E474D69059B4","Canada's Michael Smith Genome Sciences Centre","564a3c9ce4b093830b69a788","4E6F88DE-7624-4719-8234-4C9E5B2E2988","Ovarian Serous Cystadenocarcinoma","TAR","EB47601F-B4BB-4712-8C15-D97C55CCA2CD","2014-03-25T02:36:01.000Z","F637E3B8-A9F9-4E9A-9ACD-5EB71A8B719F","None","NO",1,0.6,"Primary Tumor","UCSF",NA,"EB47601F-B4BB-4712-8C15-D97C55CCA2CD",1,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ca0ee85f-6e38-447b-b232-49812c6e2a97.txt",NA,"TCGA-09-1673-01A",3,"930899A5-34A2-46C3-9584-8203D90C4173","TCGA",2008,NA,NA,"WITH TUMOR","EA88F4EB-9B59-4F0D-9231-2EED8652CFAE",50,"MSK_252152915348_S01_CGH-v4_10_27Aug08.txt","Alive",NA,"TCGA-09-1673","NOT HISPANIC OR LATINO","7596FAA8-43BE-4930-A899-CEFEE1F4F8C7",NA,92,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,97,"6C3902A7-444C-4D7D-97C2-4D1DD7C9E19C","ABF6145C-BC16-40A5-9E53-2792756E8A72","TCGA-09-1673-01A-01R-1566-13_mirna.bam","TCGA-09-1673-01A-01",99,0,NA,NA,5,"BOTTOM",8,NA,"TCGA-09-1673-01A-01-BS1",87,"Taxol or Taxotere","Chemotherapy","TCGA-09-1673-D24319",NA,NA,NA,NA,NA,92,"WITH TUMOR","Alive",NA,"TCGA-09-1673-F24318","TCGA-09-1673",NA,"09","1673","YES","C56.9","8441/3","C56.9",NA,NA,-18599,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",92,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168591108,163390392,12079084227,"3B842084-AE30-4666-B80A-8FA36EF628F3.bw","4ea50685-3b63-440a-b037-597ef2529e7d","3b842084-ae30-4666-b80a-8fa36ef628f3","2016-08-25T17:47:05.557413-05:00","TCGA-57-1582-01A-01R-1566-13_rnaseq_fastq.tar","497fd7cd-86ec-4f45-a0cf-c7a6e0477492",10754478080,"Illumina HiSeq","229a53a7b887e893f2e20f1413b74f93","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:02:13.578785-05:00","2016-05-03T11:40:21.662944-05:00","497fd7cd-86ec-4f45-a0cf-c7a6e0477492_analysis.xml","e28a9a98e74faf3133f3cfaba4d499b1","1365391e-ddbd-4220-b899-09b70ff47539",2181,"2016-09-29T20:20:03.785896-05:00","497fd7cd-86ec-4f45-a0cf-c7a6e0477492_experiment.xml","0622514fcce3e6819c0b413da73c5541","6940e413-44ce-45d6-913a-ec65542b69a2",3916,"2016-09-29T18:55:50.973869-05:00","497fd7cd-86ec-4f45-a0cf-c7a6e0477492_run.xml","3bbf166d382af43012125883b36ebcb8","3510f455-c564-41ba-ab2e-d38df6e7fb9b",1988,"2016-09-08T10:41:39.811014-05:00","TCGA-57-1582","2016-09-02T18:48:55.728750-05:00","female","TCGA-57-1582_demographic",1956,"white","cabdf363-332d-5055-8622-1a81a9a566fc","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1582_diagnosis","not reported",NA,"dead","8441/3",731,731,"46a3eb27-df60-59e2-9770-f710ce3057a5","c56.9",NA,"TCGA-57-1582_treatment","2012c078-f776-54bd-9420-efc9f564bc6f","01",NA,"TCGA-57-1582-01A","0.6","84ee744e-ee7f-46e4-b1bd-40524ffcc902",FALSE,"0ed35510-c6ad-416b-8b57-e97005471dc1","Primary Tumor","0.6",NA,NA,"2",1236902400,"01",126,"TCGA-57-1582-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T10:41:39.811014-05:00","2016-09-08T10:41:39.811014-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"178eeee4-86e8-41f6-ac53-394a94d64ccf","9e678536-fc06-43d6-8e9b-82f6376eda8e","TCGA-57-1582-01A-01-BS1","TCGA-57-1582-01A-01-TS1",90,90,"b604c246-8b0a-4304-8701-727349963c2a","RNA","TCGA-57-1582-01A-01R","262b33fc-7786-4f90-adfa-a20a7afab974",1.8,0.15,"UV Spec","R","22","TCGA-57-1582-01A-01R-1566-13","cb7a4405-b9a5-4e1a-825f-c3ee205c8a90",0.15,NA,NA,NA,NA,"1e10fc34-df4d-5e70-9409-2cd6f0a2ed7a","TCGA-57-1582_exposure","TCGA-57-1582-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T04:02:39.000Z","2014-03-25T04:25:02.000Z","497FD7CD-86EC-4F45-A0CF-C7A6E0477492","84EE744E-EE7F-46E4-B1BD-40524FFCC902","Unaligned reads",10754478080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CB7A4405-B9A5-4E1A-825F-C3EE205C8A90","Canada's Michael Smith Genome Sciences Centre","564a5c03e4b0ef12181e446a","4EA50685-3B63-440A-B037-597EF2529E7D","Ovarian Serous Cystadenocarcinoma","TAR","B604C246-8B0A-4304-8701-727349963C2A","2014-03-25T04:25:02.000Z","262B33FC-7786-4F90-ADFA-A20A7AFAB974","None","NO",1,0.6,"Primary Tumor","International Genomics Consortium",NA,"B604C246-8B0A-4304-8701-727349963C2A",0.6,"57","TCGA-57-1582-01A-01R-1566-13_rnaseq_fastq.tar",NA,"TCGA-57-1582-01A",2,"CF142304-EE75-49B0-9661-D6A7F35B0E5F","TCGA",2006,NA,NA,"WITH TUMOR","84EE744E-EE7F-46E4-B1BD-40524FFCC902",50,"nationwidechildrens.org_clinical.TCGA-57-1582.xml","Dead",731,"TCGA-57-1582",NA,"D6EBAC21-C97C-456D-B42E-726017A129D6",NA,731,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,126,"9E678536-FC06-43D6-8E9B-82F6376EDA8E","59087743-5764-4808-B4B7-BC1D9F7C3FE1","TCGA-57-1582-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-57-1582-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-57-1582-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-57-1582-D28065",NA,NA,NA,NA,NA,731,"WITH TUMOR","Dead",731,"TCGA-57-1582-F28059","TCGA-57-1582",NA,"57","1582","YES","C56.9","8441/3","C56.9",NA,NA,NA,"FEMALE","WHITE",NA,NA,"No","Dead",731,731,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,50,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
167352822,162477265,12035327499,"57200367-96F1-48B9-AB7F-DC11EFE866C4.bw","4eac2c98-86d2-4ee6-a1d3-157d013c78dc","57200367-96f1-48b9-ab7f-dc11efe866c4","2016-08-25T05:10:19.465239-05:00","TCGA-09-1666-01A-01R-1566-13_rnaseq_fastq.tar","271a2df3-78dc-4877-ad3a-e479965b2e0e",10298859520,"Illumina HiSeq","5148b07a5f9a1a0be3cb0631af78864f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:37:41.950521-05:00","2016-05-03T11:41:05.740436-05:00","271a2df3-78dc-4877-ad3a-e479965b2e0e_analysis.xml","be6d53e5aed837ea9518aa1e1714f240","4f4c53b1-7ba9-497a-a053-e444827a45c2",2181,"2016-09-29T22:32:18.995076-05:00","271a2df3-78dc-4877-ad3a-e479965b2e0e_experiment.xml","4a27ebadb0ff4f2133bc0420be520cc4","bb2cd819-d634-49bb-a286-1053ccbd58d0",3916,"2016-09-29T22:13:47.181619-05:00","271a2df3-78dc-4877-ad3a-e479965b2e0e_run.xml","9b8cf0bb5fadc995facb93474971a57e","afbddf88-86e3-4785-a223-1378c7367636",1988,"2016-09-08T11:28:48.299300-05:00","TCGA-09-1666","2016-09-02T18:53:41.640662-05:00","female","TCGA-09-1666_demographic",1946,"white","365f1918-1b27-5ca8-8eb2-e4ba49ddcfeb","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1666_diagnosis","not reported",21066,"alive","8441/3",NA,1752,"2bb77198-9515-588e-b65c-6ed8cd866bca","c56.9",-21066,"TCGA-09-1666_treatment","e69dea00-1e6c-5edb-a6f4-8b6eac4085fa","01",NA,"TCGA-09-1666-01A","0.6","77ab9685-021c-4d99-8980-79bec534828e",FALSE,"2de50dd9-b607-4a87-baae-468c4bf43205","Primary Tumor","0.6",NA,NA,"1.5",1240185600,"01",111,"TCGA-09-1666-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T11:28:48.299300-05:00","2016-09-08T11:28:48.299300-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"0176ba08-e81b-4392-b6ae-2be1aac6b1f4","da8d3b7c-3945-4281-8907-19a24dd29f68","TCGA-09-1666-01A-01-TS1","TCGA-09-1666-01A-01-BS1",93,93,"482ae695-203e-44d2-a7da-6079fa10e787","RNA","TCGA-09-1666-01A-01R","9151adb7-8a1e-4781-8737-0940f48bac89",1.8,0.16,"UV Spec","R","22","TCGA-09-1666-01A-01R-1566-13","529b7dd2-075c-4e93-b8c8-6990d3297c30",0.16,NA,NA,NA,NA,"df834f9b-66ce-5662-9a42-710c402c55f5","TCGA-09-1666_exposure","TCGA-09-1666-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-27T00:52:18.000Z","2014-03-27T01:14:01.000Z","271A2DF3-78DC-4877-AD3A-E479965B2E0E","77AB9685-021C-4D99-8980-79BEC534828E","Unaligned reads",10298859520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","529B7DD2-075C-4E93-B8C8-6990D3297C30","Canada's Michael Smith Genome Sciences Centre","564a3e72e4b09c884b254927","4EAC2C98-86D2-4EE6-A1D3-157D013C78DC","Ovarian Serous Cystadenocarcinoma","TAR","482AE695-203E-44D2-A7DA-6079FA10E787","2014-03-27T01:14:01.000Z","9151ADB7-8A1E-4781-8737-0940F48BAC89","None","NO",1,0.6,"Primary Tumor","UCSF",NA,"482AE695-203E-44D2-A7DA-6079FA10E787",0.6,"09","4760681008_D_Grn.idat",NA,"TCGA-09-1666-01A",1.5,"B774ABA5-D495-4FCC-A1DD-0F5F06BA1D9E","TCGA",2003,NA,NA,"WITH TUMOR","AD831878-2791-490D-A38B-9BDC000CF40E",57,"MSK_252152914590_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Alive",NA,"TCGA-09-1666","NOT HISPANIC OR LATINO","F21016C7-5541-4378-869B-7DCADAE9392C",NA,1752,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,111,"DA8D3B7C-3945-4281-8907-19A24DD29F68","F86A26EA-610A-4C17-A312-039D8099B211","TCGA-09-1666-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-09-1666-01A-01",95,0,NA,NA,5,"BOTTOM",2,NA,"TCGA-09-1666-01A-01-BS1",93,"Taxotere","Chemotherapy","TCGA-09-1666-D24283",NA,NA,NA,"TCGA-09-1666-F24279_NTE-2",NA,1752,"WITH TUMOR","Alive",NA,"TCGA-09-1666-F24279","TCGA-09-1666",NA,"09","1666","YES","C56.9","8441/3","C56.9",NA,NA,-21066,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1752,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
173008996,167005542,12340014062,"219B7654-6065-41D3-964B-C829364CD87B.bw","502e8d02-2953-4514-a2e1-6179dd94da73","219b7654-6065-41d3-964b-c829364cd87b","2016-09-29T18:25:12.846939-05:00","TCGA-13-1507-01A-01R-1565-13_rnaseq_fastq.tar","028adba5-ecde-478d-91bf-58f73260ffe0",10123223040,"Illumina HiSeq","68794d0b92065e80f6bc0ff43d27483b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:03:09.572749-05:00","2016-05-03T11:40:21.647690-05:00","028adba5-ecde-478d-91bf-58f73260ffe0_analysis.xml","6d7aea3647357af645aef87086ebf82d","39ab0f97-bbf8-4d3a-ac74-555a30520e9f",2181,"2016-09-29T20:48:50.179889-05:00","028adba5-ecde-478d-91bf-58f73260ffe0_experiment.xml","765e3f522ae2e93444c48586516b519d","7afcf3b2-2e60-4365-9fb7-33cec6d91f85",3916,"2016-09-29T22:36:27.899115-05:00","028adba5-ecde-478d-91bf-58f73260ffe0_run.xml","0498495aab249419725ef367a67b91d7","bdbe71aa-87d0-440a-89bf-649ad3591f69",1989,"2016-09-09T16:11:10.716023-05:00","TCGA-13-1507","2016-09-02T19:13:47.549564-05:00","female","TCGA-13-1507_demographic",1931,"white","4b3ee618-9be0-5230-9ca5-33cab6e8a02f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1507_diagnosis","not reported",28445,"dead","8441/3",1993,145,"3b1937d2-acf2-5a70-ac4c-0df7f5e295f7","c56.9",-28445,"TCGA-13-1507_treatment","ba370601-81b6-599a-b4bb-9ae81c595161","01",NA,"TCGA-13-1507-01A","1.1","fce7a055-f6ea-4dc3-a42f-51b8ed236ca7",FALSE,"0B6D1513-8119-459C-8D5A-8942B8C31179","Primary Tumor","0.4",NA,NA,"2",1235001600,"01",160,"TCGA-13-1507-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-09T16:11:10.716023-05:00","2016-09-09T16:11:10.716023-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"d693a034-776b-4726-b248-fa02fce6680e","b4f68dd8-44d6-4b1f-afdc-2655cf3246df","TCGA-13-1507-01A-01-TS1","TCGA-13-1507-01A-01-BS1",90,90,"ecc6bd1f-24f1-4d2d-810d-f65f45160716","RNA","TCGA-13-1507-01A-01R","43e011da-1c4d-4d96-964c-6ab49995c822",1.8,0.15,"UV Spec","R","22","TCGA-13-1507-01A-01R-1565-13","41a5fa6b-4594-4ef8-b841-fe75c17a13c2",0.15,NA,NA,NA,NA,"201b82f0-3fc8-52ef-8bca-34eca6f94893","TCGA-13-1507_exposure","TCGA-13-1507-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T03:43:52.000Z","2014-03-22T04:07:02.000Z","028ADBA5-ECDE-478D-91BF-58F73260FFE0","FCE7A055-F6EA-4DC3-A42F-51B8ED236CA7","Unaligned reads",10123223040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","41A5FA6B-4594-4EF8-B841-FE75C17A13C2","Canada's Michael Smith Genome Sciences Centre","564a5761e4b0298dd2cad59e","502E8D02-2953-4514-A2E1-6179DD94DA73","Ovarian Serous Cystadenocarcinoma","TAR","ECC6BD1F-24F1-4D2D-810D-F65F45160716","2014-03-22T04:07:02.000Z","43E011DA-1C4D-4D96-964C-6AB49995C822","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"ECC6BD1F-24F1-4D2D-810D-F65F45160716",1.1,"13","TCGA-13-1507-01A-01W-0549-09_capture.bam.bai",NA,"TCGA-13-1507-01A",2,"E69FAABB-E060-4871-B192-FF4AF589B249","TCGA",2008,NA,NA,"TUMOR FREE","FCE7A055-F6EA-4DC3-A42F-51B8ED236CA7",77,"THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_C06_455322.byallele.copynumber.data.txt","Alive",NA,"TCGA-13-1507","NOT HISPANIC OR LATINO","211FF326-C0AF-4317-8B10-C19CC527B139",NA,145,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,160,"D693A034-776B-4726-B248-FA02FCE6680E","ED944420-8335-4D4D-897C-7AB1365E0DA6","TCGA-13-1507-01A-01W-0549-09_capture.bam","TCGA-13-1507-01A-01",95,0,NA,NA,5,"TOP",5,NA,"TCGA-13-1507-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-13-1507-D24953",NA,NA,NA,NA,NA,145,"TUMOR FREE","Alive",NA,"TCGA-13-1507-F24952","TCGA-13-1507",NA,"13","1507","YES","C56.9","8441/3","C56.9",NA,NA,-28445,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",145,NA,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,77,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
293290402,283466061,20950169183,"26923D9B-CE8E-400E-93CD-E0EE1401CB9D.bw","512de609-757b-42be-8b30-c414f71af422","26923d9b-ce8e-400e-93cd-e0ee1401cb9d","2016-09-29T18:33:14.620456-05:00","TCGA-61-2016-01A-01R-1568-13_rnaseq_fastq.tar","da2d23dd-5f38-44f0-8cca-16323f11f71f",19028490240,"Illumina HiSeq","b8b398098dbc65a2e345de5b8f14f8fb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:56:41.148388-05:00","2016-05-03T11:56:42.628342-05:00","da2d23dd-5f38-44f0-8cca-16323f11f71f_analysis.xml","f3a9b1c666344118fc9a49dd6d4429aa","efa04a23-e45f-44d4-96ba-fb78735251af",2181,"2016-09-29T18:18:32.294998-05:00","da2d23dd-5f38-44f0-8cca-16323f11f71f_experiment.xml","67bc0d33cb0f5250f9ac43e37471df34","1d7db430-6aba-46ba-8655-40f7defb2175",3916,"2016-09-29T22:13:21.935439-05:00","da2d23dd-5f38-44f0-8cca-16323f11f71f_run.xml","fe4c4066c41d4cf8dd29379ade76a2cf","af7f2eae-5433-4db9-821d-2f82aa1a49bb",1988,"2016-09-08T11:57:17.995327-05:00","TCGA-61-2016","2016-09-02T18:56:17.713112-05:00","female","TCGA-61-2016_demographic",1955,"white","29e38624-fecd-5f04-b88e-09db2f1de386","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2016_diagnosis","not reported",18788,"dead","8441/3",36,NA,"ff9cb7c9-66ac-5907-9329-78183e6e5040","c56.9",-18788,"TCGA-61-2016_treatment","70c37684-9f15-5798-9b71-4dcfe6f95f9c","01",NA,"TCGA-61-2016-01A","0.6","b15d7b36-c394-4ba4-a896-3e8beb2f8db0",FALSE,"1bb87fde-9ff0-4c33-a388-b655f9647407","Primary Tumor","0.1",NA,NA,"1.5",1247443200,"01",100,"TCGA-61-2016-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T11:57:17.995327-05:00","2016-09-08T11:57:17.995327-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"1fb11083-ac0e-479c-b1e6-be6413fd67c8","594dfeaa-7d8f-4611-a598-47bd791e4340","TCGA-61-2016-01A-01-BS1","TCGA-61-2016-01A-01-TS1",90,90,"87e3fcfb-4fb6-46fb-8fe8-af2d0801699f","RNA","TCGA-61-2016-01A-01R","5cf4b9c5-b7a0-48a2-b64e-ccda4369ebea",1.8,0.14,"UV Spec","R","22","TCGA-61-2016-01A-01R-1568-13","a391b870-b6fb-4ca8-b425-2331fceae442",0.14,NA,NA,NA,NA,"c0e4034b-bc9d-5c45-b543-05143c347921","TCGA-61-2016_exposure","TCGA-61-2016-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T20:15:26.000Z","2014-08-26T23:45:19.000Z","DA2D23DD-5F38-44F0-8CCA-16323F11F71F","B15D7B36-C394-4BA4-A896-3E8BEB2F8DB0","Unaligned reads",19028490240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A391B870-B6FB-4CA8-B425-2331FCEAE442","Canada's Michael Smith Genome Sciences Centre","564a3918e4b08c5d8690c70f","512DE609-757B-42BE-8B30-C414F71AF422","Ovarian Serous Cystadenocarcinoma","TAR","87E3FCFB-4FB6-46FB-8FE8-AF2D0801699F","2014-08-26T23:45:19.000Z","5CF4B9C5-B7A0-48A2-B64E-CCDA4369EBEA","None","NO",1,0.1,"Primary Tumor","University of Pittsburgh",NA,"87E3FCFB-4FB6-46FB-8FE8-AF2D0801699F",0.6,"61","TCGA-61-2016-01A-01R-1568-13_GRCh37-lite_rnaseq.bam.bai",NA,"TCGA-61-2016-01A",1.5,NA,"TCGA",2006,NA,NA,"WITH TUMOR","EF2E23B4-3748-494E-966E-6E4179F76FB2",51,"bcgsc.ca.TCGA-61-2016-01A-01R-1568-13.hg19.bcgsc.ca.1.6.0.snv.vcf","Dead",36,"TCGA-61-2016","NOT HISPANIC OR LATINO","991E4692-11E2-4FF7-9CA7-F07AF311826F",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,100,"594DFEAA-7D8F-4611-A598-47BD791E4340","DFDCB386-C850-48B1-9924-5C3D7511C7D1","TCGA-61-2016-01A-01R-1568-13_GRCh37-lite_rnaseq.bam.bai","TCGA-61-2016-01A-01",90,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-61-2016-01A-01-BS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",36,"TCGA-61-2016-F28357","TCGA-61-2016",NA,"61","2016","YES","C56.9","8441/3","C56.9",NA,NA,-18788,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,36,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
233732334,226057530,16706295866,"21B783EB-B0D0-4B28-9468-D0B130D13E26.bw","5201ee13-2aed-4641-9169-4d5ee07a23da","21b783eb-b0d0-4b28-9468-d0b130d13e26","2016-08-25T07:14:09.209062-05:00","TCGA-24-2023-01A-01R-1567-13_rnaseq_fastq.tar","af6994ad-0502-4eee-82b1-4c54ed002829",14564075520,"Illumina HiSeq","beb573849080d4aaa0b70305f867f2d5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:17:00.853367-05:00","2016-05-03T11:41:05.748550-05:00","af6994ad-0502-4eee-82b1-4c54ed002829_analysis.xml","3ca74c3dab37814322aa72ad35ad5174","b1c2bba3-da53-44c1-806a-beaa5fb04ca9",2181,"2016-08-27T23:12:18.029598-05:00","af6994ad-0502-4eee-82b1-4c54ed002829_experiment.xml","43a89b936d5d4948f1dcab7d8c569e12","205089fc-c6ea-4aea-9379-94c783dbff50",3916,"2016-09-29T19:15:00.568458-05:00","af6994ad-0502-4eee-82b1-4c54ed002829_run.xml","d5050d294542854c06cadabf4d0ee9c1","41232154-1619-4b07-a446-91611bef39b5",1989,"2016-09-08T10:37:34.332848-05:00","TCGA-24-2023","2016-09-02T18:50:16.461441-05:00","female","TCGA-24-2023_demographic",1940,"white","324846aa-8368-59b7-8d95-4373adb15ded","not reported",1997,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2023_diagnosis","not reported",19901,"dead","8441/3",1364,1364,"04bf3f6d-f3c0-510b-a8eb-a46860525c7f","c56.9",-19901,"TCGA-24-2023_treatment","13f840e8-656a-5562-86e9-db457e4e02ca","01",NA,"TCGA-24-2023-01A","1","3ab5e7ea-fc93-4a73-b43d-c3c74ad48bdb",FALSE,"2a255fa6-65cd-4fb7-9d08-1b6aadd6682b","Primary Tumor","0.5",NA,NA,"1.2",1247616000,"01",151,"TCGA-24-2023-01A-01",90,85,0,0,0,0,20,20,"2016-09-08T10:37:34.332848-05:00","2016-09-08T10:37:34.332848-05:00",0,5,0,0,"TOP","BOTTOM",0,0,"86bdd454-e8a5-4343-a6b9-85c9f0b4c291","c8d44f47-325c-41b4-99be-a9383fe47b08","TCGA-24-2023-01A-01-TS1","TCGA-24-2023-01A-01-BS1",80,80,"b0409915-e519-4534-b8fd-c16d55007d96","RNA","TCGA-24-2023-01A-01R","5c9eb981-8a09-4fec-af22-fecd769e031f",1.8,0.15,"UV Spec","R","22","TCGA-24-2023-01A-01R-1567-13","11fd4bb1-0f8d-4830-a7f0-83897a5df11d",0.15,NA,NA,NA,NA,"7f93c034-f85d-5aff-9113-a93103553e8f","TCGA-24-2023_exposure","TCGA-24-2023-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T02:43:56.000Z","2014-03-29T03:09:02.000Z","AF6994AD-0502-4EEE-82B1-4C54ED002829","3AB5E7EA-FC93-4A73-B43D-C3C74AD48BDB","Unaligned reads",14564075520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","11FD4BB1-0F8D-4830-A7F0-83897A5DF11D","Canada's Michael Smith Genome Sciences Centre","564a5bdae4b09c884b27b8d0","5201EE13-2AED-4641-9169-4D5EE07A23DA","Ovarian Serous Cystadenocarcinoma","TAR","B0409915-E519-4534-B8FD-C16D55007D96","2014-03-29T03:09:02.000Z","5C9EB981-8A09-4FEC-AF22-FECD769E031F","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"B0409915-E519-4534-B8FD-C16D55007D96",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.53cd60af-85e4-468e-a6f8-f21be9631a23.txt",NA,"TCGA-24-2023-01A",1.2,"E8D6FBD5-5369-4E58-8EFE-8B2F82CE54D6","TCGA",1994,NA,NA,"WITH TUMOR","C1C14DA5-31A4-4F82-8E5A-E1848FE0135E",54,"nationwidechildrens.org_clinical.TCGA-24-2023.xml","Dead",1364,"TCGA-24-2023",NA,"478E3654-2C9E-4EE7-B80D-D63E0A5C5EBE",NA,1364,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,151,"C8D44F47-325C-41B4-99BE-A9383FE47B08","C36369FE-FCF5-47E9-9FA9-853633FDA8BB","4841860026_D_Red.idat","TCGA-24-2023-01A-01",90,0,0,0,20,"TOP",0,0,"TCGA-24-2023-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-24-2023-D26445",NA,NA,NA,"TCGA-24-2023-F26442_NTE-1",NA,1364,"WITH TUMOR","Dead",1364,"TCGA-24-2023-F26442","TCGA-24-2023",NA,"24","2023","YES","C56.9","8441/3","C56.9",NA,NA,-19901,"FEMALE","WHITE",NA,NA,"No","Dead",1364,1364,NA,NA,"WITH TUMOR","NO",16,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,1994,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
151937918,148366171,10978542357,"67D465A4-8068-4325-ABC5-5917B7D726BB.bw","52386f66-2877-4c75-894e-5c1dc03e6ef4","67d465a4-8068-4325-abc5-5917b7d726bb","2016-08-25T11:57:29.001882-05:00","TCGA-24-1563-01A-01R-1566-13_rnaseq_fastq.tar","c0f9e64a-d9ca-4c62-8b52-04b5931e9687",9627607040,"Illumina HiSeq","ee5fdba4d399e0db19f6127b1b2f5027","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:30:52.876919-05:00","2016-05-03T11:40:21.662944-05:00","c0f9e64a-d9ca-4c62-8b52-04b5931e9687_analysis.xml","f9b4ff2f25f35ca5bf8a8e20eddf357e","9548bf1a-f788-4e9f-9da4-6a0c101de6f2",2181,"2016-09-29T20:55:00.032368-05:00","c0f9e64a-d9ca-4c62-8b52-04b5931e9687_experiment.xml","c321c3e573a04c54aef897a1b92386db","7edba1fe-c70a-4f6b-9dd0-4f54a1086aa2",3916,"2016-09-29T17:46:10.858996-05:00","c0f9e64a-d9ca-4c62-8b52-04b5931e9687_run.xml","a3b634f5de27f431cb07d824dd166a97","094873f6-b6e6-418e-a6cb-b6e6d30081b7",1988,"2016-09-08T12:46:55.716595-05:00","TCGA-24-1563","2016-09-02T19:07:15.298826-05:00","female","TCGA-24-1563_demographic",1933,"black or african american","f6f97e46-62a4-5b7b-bd32-9be8b0952a2c","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1563_diagnosis","not reported",24274,"dead","8441/3",1451,1451,"c88a4db0-50d4-5c23-969b-c211f9b47565","c56.9",-24274,"TCGA-24-1563_treatment","27512de5-2152-56f1-9d7a-00e7b5484dbc","01",NA,"TCGA-24-1563-01A","1.1","9347d927-3747-4f06-ab2a-672aefdf48ea",FALSE,"6fdeb714-439d-49d7-aae0-99166a3e8eba","Primary Tumor","0.4",NA,NA,"1.1",1235347200,"01",133,"TCGA-24-1563-01A-01",90,70,NA,NA,0,0,10,30,"2016-09-08T12:46:55.716595-05:00","2016-09-08T12:46:55.716595-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,1,"3f251140-d701-4deb-b82e-4924e4667a14","77a77ca5-d792-4b25-9b37-f9f5ba572e04","TCGA-24-1563-01A-01-TS1","TCGA-24-1563-01A-01-BS1",85,69,"91b36320-3d8e-4081-84db-4e90c7cf112e","RNA","TCGA-24-1563-01A-01R","4ce1bd1f-d4f6-4acc-b956-6ed570fbb92d",1.8,0.15,"UV Spec","R","22","TCGA-24-1563-01A-01R-1566-13","a9c4a08c-1db7-49eb-8685-b5ca442c3e7a",0.15,NA,NA,NA,NA,"a5ba4d34-56c4-5c87-8e28-1902f343dca3","TCGA-24-1563_exposure","TCGA-24-1563-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-24T21:44:59.000Z","2014-03-24T22:18:01.000Z","C0F9E64A-D9CA-4C62-8B52-04B5931E9687","9347D927-3747-4F06-AB2A-672AEFDF48EA","Unaligned reads",9627607040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A9C4A08C-1DB7-49EB-8685-B5CA442C3E7A","Canada's Michael Smith Genome Sciences Centre","564a3bd2e4b08c5d8691a45e","52386F66-2877-4C75-894E-5C1DC03E6EF4","Ovarian Serous Cystadenocarcinoma","TAR","91B36320-3D8E-4081-84DB-4E90C7CF112E","2014-03-24T22:18:01.000Z","4CE1BD1F-D4F6-4ACC-B956-6ED570FBB92D","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"91B36320-3D8E-4081-84DB-4E90C7CF112E",1.1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e52eaae7-ae99-43fe-a752-89045be81447.txt",NA,"TCGA-24-1563-01A",1.1,"F65E8C56-E88C-4759-8CB6-66183229FCD6","TCGA",1999,NA,NA,"WITH TUMOR","9347D927-3747-4F06-AB2A-672AEFDF48EA",66,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e52eaae7-ae99-43fe-a752-89045be81447.txt","Dead",1451,"TCGA-24-1563",NA,"4A3E5D73-58BA-403C-91A7-92653E760093",NA,1451,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,133,"77A77CA5-D792-4B25-9B37-F9F5BA572E04","9684FF9E-0A40-4531-802D-E43B3BF8C536","TCGA-24-1563-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-24-1563-01A-01",70,0,NA,NA,30,"BOTTOM",1,NA,"TCGA-24-1563-01A-01-BS1",69,"Taxol","Chemotherapy","TCGA-24-1563-D26252",NA,NA,NA,"TCGA-24-1563-F26248_NTE-1",NA,1451,"WITH TUMOR","Dead",1451,"TCGA-24-1563-F26248","TCGA-24-1563",NA,"24","1563","YES","C56.9","8441/3","C56.9",NA,NA,-24274,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",1451,1451,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,66,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
222786236,213616236,15816837298,"30A8ABA0-ECB4-4B44-9630-5FFF862A157F.bw","533f5ff9-466c-4cdb-9c46-b841c2626775","30a8aba0-ecb4-4b44-9630-5fff862a157f","2016-08-09T14:26:42.497537-05:00","TCGA-36-1580-01A-01R-1566-13_rnaseq_fastq.tar","72b01914-e66f-4818-991e-52013cba4e10",14878074880,"Illumina HiSeq","115b6d478a261af17914071205dbd771","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:14:32.285916-05:00","2016-05-03T11:41:05.748550-05:00","72b01914-e66f-4818-991e-52013cba4e10_analysis.xml","68d88afb8508039f558a4b1ce21310a4","1b06090e-1169-45b5-bc7c-ebe7f7584ba2",2181,"2016-09-30T00:15:09.849871-05:00","72b01914-e66f-4818-991e-52013cba4e10_experiment.xml","2cdf7132250c0dc1c808e6354ca00ca3","faf63b6b-364a-4da8-b0ca-27e920a837fb",3916,"2016-09-29T23:22:46.580825-05:00","72b01914-e66f-4818-991e-52013cba4e10_run.xml","ed140b165853710d0d295a6b25504824","da6a8a65-3c18-4c53-b85c-e559d7853b32",1989,"2016-09-08T11:10:49.758091-05:00","TCGA-36-1580","2016-09-02T18:49:49.805837-05:00","female","TCGA-36-1580_demographic",1925,"not reported","8a7b50d7-9032-55a0-b9b9-293f589052cc","not reported",2009,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1580_diagnosis","not reported",29992,"dead","8441/3",737,737,"b6c3e3e6-e354-5dd8-a77d-95a47bd63099","c56.9",-29992,"TCGA-36-1580_treatment","66904e0f-853e-5754-88cb-e9402250bd98","01",NA,"TCGA-36-1580-01A","1","e134063e-745d-4c97-8d48-6f3e238daefc",FALSE,"a647e4da-8579-4848-b545-bc857db85d98","Primary Tumor","0.4",NA,NA,"2",1235952000,"01",119,"TCGA-36-1580-01A-01",70,70,NA,NA,0,0,40,45,"2016-09-08T11:10:49.758091-05:00","2016-09-08T11:10:49.758091-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,10,"b317174e-d87f-4853-bb63-edcaa569f579","2d7f0952-5f56-477d-9dde-9526e5a71b6e","TCGA-36-1580-01A-01-TS1","TCGA-36-1580-01A-01-BS1",55,45,"5a23ef3d-566b-4060-b5a1-f6f9cf9a6a8e","RNA","TCGA-36-1580-01A-01R","d8f3a035-0317-45cc-955d-540bf652d06c",1.8,0.14,"UV Spec","R","22","TCGA-36-1580-01A-01R-1566-13","6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3",0.14,NA,NA,NA,NA,"5350fa43-1e64-57a6-8290-0ea093f3ff4d","TCGA-36-1580_exposure","TCGA-36-1580-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-29T00:15:59.000Z","2014-03-29T00:55:02.000Z","72B01914-E66F-4818-991E-52013CBA4E10","E134063E-745D-4C97-8D48-6F3E238DAEFC","Unaligned reads",14878074880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6A101B07-3CC5-4DA3-90AB-0E45FA5B9CD3","Canada's Michael Smith Genome Sciences Centre","564a336ee4b08c5d868ef910","533F5FF9-466C-4CDB-9C46-B841C2626775","Ovarian Serous Cystadenocarcinoma","TAR","5A23EF3D-566B-4060-B5A1-F6F9CF9A6A8E","2014-03-29T00:55:02.000Z","D8F3A035-0317-45CC-955D-540BF652D06C","None","NO",1,0.4,"Primary Tumor","BC Cancer Agency",NA,"5A23EF3D-566B-4060-B5A1-F6F9CF9A6A8E",1,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1d325272-4508-4a42-97ba-9e59edf59993.txt",NA,"TCGA-36-1580-01A",2,"E781CA54-C93A-4270-99D5-4D97F278B1F6","TCGA",2007,NA,NA,"WITH TUMOR","E134063E-745D-4C97-8D48-6F3E238DAEFC",82,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1d325272-4508-4a42-97ba-9e59edf59993.txt","Dead",737,"TCGA-36-1580",NA,"0A7F42D0-C9D3-4D5C-8122-53760A34E6E1",NA,737,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,NA,NA,1,119,"B317174E-D87F-4853-BB63-EDCAA569F579","97E8CDFE-A0B2-45A4-946B-905CFAD8B89A","TCGA-36-1580-01A-01W-0615-10_SOLiD.bam.bai","TCGA-36-1580-01A-01",70,0,NA,NA,45,"BOTTOM",10,NA,"TCGA-36-1580-01A-01-BS1",45,"Carboplatin","Chemotherapy","TCGA-36-1580-D27891",NA,NA,NA,"TCGA-36-1580-F27889_NTE-1",NA,737,"WITH TUMOR","Dead",737,"TCGA-36-1580-F27889","TCGA-36-1580",NA,"36","1580","YES","C56.9","8441/3","C56.9",NA,NA,-29992,"FEMALE",NA,NA,NA,"No","Dead",737,737,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,82,2007,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
266046900,256817252,19002237129,"71040F61-834D-4A75-960D-5DABBCADD3A0.bw","5495b18a-10ec-427b-83b8-03ef4b587b13","71040f61-834d-4a75-960d-5dabbcadd3a0","2016-08-25T16:16:15.658848-05:00","TCGA-29-1762-01A-01R-1567-13_rnaseq_fastq.tar","6d104bcd-c559-4c01-abf8-e56e53bc7ce9",17481543680,"Illumina HiSeq","42206fe43fd7be60ec05c5e65a81245f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:37:42.906498-05:00","2016-05-03T11:41:05.748550-05:00","6d104bcd-c559-4c01-abf8-e56e53bc7ce9_analysis.xml","d2462b1fb175069683588b99897272d7","740ca850-4bc6-41e4-a606-844e29a7e1be",2181,"2016-09-29T21:48:03.866482-05:00","6d104bcd-c559-4c01-abf8-e56e53bc7ce9_experiment.xml","f45e7e4ca99e2541f905325775490fb6","9fd3d660-d27b-4153-a627-83834ca97e51",3916,"2016-09-29T21:00:14.648697-05:00","6d104bcd-c559-4c01-abf8-e56e53bc7ce9_run.xml","441f1c4eff13566649ae8cf306ceeb11","821d7469-89c8-4781-8e84-a829e7ed26ec",1989,"2016-09-08T12:23:28.311045-05:00","TCGA-29-1762","2016-09-02T19:07:25.264088-05:00","female","TCGA-29-1762_demographic",1939,"white","5670d6e7-a5d0-5321-9e29-1b6c44e7d0d4","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1762_diagnosis","not reported",21879,"dead","8441/3",2634,2606,"0516c666-98fd-5556-b9f5-084913c790dc","c56.9",-21879,"TCGA-29-1762_treatment","166b8b13-30ac-58cb-b940-cfae6060fb58","01",NA,"TCGA-29-1762-01A","0.9","5df514e7-6e12-474a-92f2-067898b351ac",FALSE,"f94712a1-78da-4341-9ac9-6ea41c11610e","Primary Tumor","0.4",NA,NA,"0.9",1243296000,"01",120,"TCGA-29-1762-01A-01",90,85,NA,NA,0,0,5,5,"2016-09-08T12:23:28.311045-05:00","2016-09-08T12:23:28.311045-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,20,"16561800-adee-4503-aea0-31320f85cc44","30a33cd4-4485-4a15-9eb6-2d2bb79ab844","TCGA-29-1762-01A-01-BS1","TCGA-29-1762-01A-01-TS1",85,75,"4d548438-8ad9-4c29-bc1c-cd22f16d55df","RNA","TCGA-29-1762-01A-01R","fc76c02e-d9b1-4fde-9275-2336c3e8ce07",1.8,0.14,"UV Spec","R","22","TCGA-29-1762-01A-01R-1567-13","c3559ae3-3355-4f38-9c07-e557e435fcbd",0.14,NA,NA,NA,NA,"a7f8f7a9-f40e-54e5-88f2-4c0acd4ef24e","TCGA-29-1762_exposure","TCGA-29-1762-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T21:09:47.000Z","2014-03-28T21:51:02.000Z","6D104BCD-C559-4C01-ABF8-E56E53BC7CE9","5DF514E7-6E12-474A-92F2-067898B351AC","Unaligned reads",17481543680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C3559AE3-3355-4F38-9C07-E557E435FCBD","Canada's Michael Smith Genome Sciences Centre","564a58fae4b093830b6c348b","5495B18A-10EC-427B-83B8-03EF4B587B13","Ovarian Serous Cystadenocarcinoma","TAR","4D548438-8AD9-4C29-BC1C-CD22F16D55DF","2014-03-28T21:51:02.000Z","FC76C02E-D9B1-4FDE-9275-2336C3E8CE07","None","NO",1,0.4,"Primary Tumor","Duke",NA,"4D548438-8AD9-4C29-BC1C-CD22F16D55DF",0.9,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a8bcbfb3-7a83-4170-8b2c-fa5447b5abce.txt",NA,"TCGA-29-1762-01A",0.9,"FC15C1DD-7E5F-443E-A5A5-E8BD13E582EE","TCGA",1998,NA,NA,"WITH TUMOR","838BA257-29FC-44DC-A6FA-40649D0B84B1",59,"SAROS_p_TCGA_B18_SNP_N_GenomeWideSNP_6_B11_489710.raw.copynumber.data.txt","Dead",2634,"TCGA-29-1762",NA,"9362C381-3391-410C-8898-C0797A7BDAB2",NA,2606,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",2,"Post-Adjuvant Therapy","Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,120,"30A33CD4-4485-4A15-9EB6-2D2BB79AB844","FDDE213B-7988-4267-BA9C-FC2BABBC3603","TCGA-29-1762-01A-01R-1567-13_rnaseq.bam","TCGA-29-1762-01A-01",85,0,NA,NA,5,"TOP",20,NA,"TCGA-29-1762-01A-01-TS1",75,"Carboplatin","Chemotherapy","TCGA-29-1762-D27321",NA,NA,NA,"TCGA-29-1762-F27316_NTE-1",NA,2606,"WITH TUMOR","Dead",2634,"TCGA-29-1762-F27316","TCGA-29-1762",NA,"29","1762","YES","C56.9","8441/3","C56.9",NA,NA,-21879,"FEMALE","WHITE",NA,NA,"No","Dead",2606,2634,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,1998,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,2,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
240936792,229026459,16896628915,"A4EC5E62-AF75-435A-903F-D35B171CEA2C.bw","5503b3a1-7d03-41b2-9ec8-e478c5414d67","a4ec5e62-af75-435a-903f-d35b171cea2c","2016-08-25T23:53:38.033219-05:00","TCGA-24-1434-01A-01R-1566-13_rnaseq_fastq.tar","0eb605ba-036f-48f0-8a4e-1616407c3192",15753728000,"Illumina HiSeq","dfeaf7b504b698ba323f40efcf564f0c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:28:23.579576-05:00","2016-05-03T11:40:21.662944-05:00","0eb605ba-036f-48f0-8a4e-1616407c3192_analysis.xml","b7f90e160ae537117d05670de79b5ba0","93c8e7f2-36ad-42d8-95ba-e9fe02ade628",2181,"2016-09-29T17:58:27.810917-05:00","0eb605ba-036f-48f0-8a4e-1616407c3192_experiment.xml","df1bf56a830c3b24e7526c27a8a364cf","10fb4e95-fcae-4987-aad2-d65f7bde321e",3916,"2016-09-29T19:23:32.628300-05:00","0eb605ba-036f-48f0-8a4e-1616407c3192_run.xml","fa74685d56c889ee7d94cad672fda49d","4687a14b-5237-4847-931c-6dd9638ea94d",1988,"2016-09-08T10:26:28.222712-05:00","TCGA-24-1434","2016-09-02T19:13:59.645558-05:00","female","TCGA-24-1434_demographic",1940,"white","c792a067-b1c0-5367-8655-db6c055fbd87","not reported",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1434_diagnosis","not reported",21810,"dead","8441/3",568,568,"13f08258-6176-5a27-8f77-a01958a576b2","c56.9",-21810,"TCGA-24-1434_treatment","8c1f4723-4bcf-5383-a19d-9c115b44b9cd","01",NA,"TCGA-24-1434-01A","1.5","e6751f11-2f24-426c-a34f-c03cddc999cc",FALSE,"0a5fd2a4-560b-4769-ba4e-868854471961","Primary Tumor","0.6",NA,NA,"1.5",1232409600,"01",177,"TCGA-24-1434-01A-01",80,90,NA,NA,0,0,20,10,"2016-09-08T10:26:28.222712-05:00","2016-09-08T10:26:28.222712-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,1,"db10a516-27ac-4dde-a922-2b4a804ddead","5c90f4ac-d2c5-4ecc-903e-15c0501db247","TCGA-24-1434-01A-01-BS1","TCGA-24-1434-01A-01-TS1",75,89,"a29595aa-44f9-47ef-a52b-fd80ac1c320c","RNA","TCGA-24-1434-01A-01R","32280c88-e2d4-40af-9e23-170502f9ddf4",1.8,0.16,"UV Spec","R","22","TCGA-24-1434-01A-01R-1566-13","368f21cd-dd07-440d-89f5-5874e37fe63b",0.16,NA,NA,NA,NA,"93fcb479-d851-5781-9fbf-1aa7e749675b","TCGA-24-1434_exposure","TCGA-24-1434-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-24T23:48:58.000Z","2014-03-25T00:25:02.000Z","0EB605BA-036F-48F0-8A4E-1616407C3192","E6751F11-2F24-426C-A34F-C03CDDC999CC","Unaligned reads",15753728000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","368F21CD-DD07-440D-89F5-5874E37FE63B","Canada's Michael Smith Genome Sciences Centre","564a363ce4b0298dd2c6bfa7","5503B3A1-7D03-41B2-9EC8-E478C5414D67","Ovarian Serous Cystadenocarcinoma","TAR","A29595AA-44F9-47EF-A52B-FD80AC1C320C","2014-03-25T00:25:02.000Z","32280C88-E2D4-40AF-9E23-170502F9DDF4","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"A29595AA-44F9-47EF-A52B-FD80AC1C320C",1.5,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0106e887-2791-4c17-9260-07bd927e5d9b.txt",NA,"TCGA-24-1434-01A",1.5,"E6CC7A45-81EF-4091-9C90-12614ADD799C","TCGA",1999,NA,NA,"WITH TUMOR","E6751F11-2F24-426C-A34F-C03CDDC999CC",59,"US82800149_251911813082_S01_miRNA_105_Dec08_1_4.txt","Dead",568,"TCGA-24-1434",NA,"0E4F7BF8-AFFB-45C7-8D16-D2EB4A044257",NA,568,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,177,"DB10A516-27AC-4DDE-A922-2B4A804DDEAD","32310BE5-A1D8-4EB6-9A21-B9FB45B20E7C","TCGA-24-1434-01A-01R-1566-13_mirna.bam","TCGA-24-1434-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-24-1434-01A-01-TS1",89,"Topotecan","Chemotherapy","TCGA-24-1434-D25988",NA,NA,NA,"TCGA-24-1434-F25984_NTE-1",NA,568,"WITH TUMOR","Dead",568,"TCGA-24-1434-F25984","TCGA-24-1434",NA,"24","1434","YES","C56.9","8441/3","C56.9",NA,NA,-21810,"FEMALE","WHITE",NA,NA,"No","Dead",568,568,NA,NA,"WITH TUMOR","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
265462104,245727963,18007992902,"2F6A0808-8F01-4721-938D-F1FC7C5D8357.bw","55153632-1673-487a-85c0-f156377db1fc","2f6a0808-8f01-4721-938d-f1fc7c5d8357","2016-08-25T12:30:35.949103-05:00","TCGA-04-1651-01A-01R-1567-13_rnaseq_fastq.tar","b8cac132-07e2-4ad2-a6b5-00926531b979",16553338880,"Illumina HiSeq","14f65e80ae4f66364d640b4e27073da8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:07:29.887024-05:00","2016-05-03T11:41:05.755204-05:00","b8cac132-07e2-4ad2-a6b5-00926531b979_analysis.xml","48fb7c9d972ba159ed0978f4f1a94a31","86c417cd-f567-4479-9a00-ab9ff8ff0c7d",2237,"2016-09-29T21:18:12.429578-05:00","b8cac132-07e2-4ad2-a6b5-00926531b979_experiment.xml","c0d40b3c35de4792ba836c1d5f8f9635","8d67ee2a-3dd9-45ae-8da4-eb05a440efda",3916,"2016-09-29T18:09:31.894494-05:00","b8cac132-07e2-4ad2-a6b5-00926531b979_run.xml","78014ab0ddae38c3ca6b88955edfc7ce","17ffd209-50dc-46e3-ab73-85191ab61b07",1990,"2016-09-08T12:45:45.104206-05:00","TCGA-04-1651","2016-09-02T19:06:50.503411-05:00","female","TCGA-04-1651_demographic",1951,"white","3b99b3f1-6556-5121-8085-9073925eba9d","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1651_diagnosis","not reported",19628,"dead","8441/3",1102,NA,"d97f7ad8-0280-573e-a4e4-226d1a92d8fb","c56.9",-19628,"TCGA-04-1651_treatment","70576f37-118f-5afe-87eb-148820617bac","01",NA,"TCGA-04-1651-01A","0.4","7d9f2d6d-3ec6-4fed-9d3a-52e813bd8be6",FALSE,"703BEFE1-07E0-48AE-826E-133A59F97068","Primary Tumor","0.3",NA,NA,"1.5",1239235200,"01",100,"TCGA-04-1651-01A-01",90,85,NA,NA,0,0,8,10,"2016-09-08T12:45:45.104206-05:00","2016-09-08T12:45:45.104206-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"246daec2-ff44-40f4-a856-89da1f342016","62199560-a607-40f5-b030-80a174c8125e","TCGA-04-1651-01A-01-TS1","TCGA-04-1651-01A-01-BS1",90,88,"98ec9d66-3316-4665-aa16-d2f9feb8013c","RNA","TCGA-04-1651-01A-01R","fe2481fa-ffe2-4419-9900-f0205d94a4fc",1.8,0.14,"UV Spec","R","22","TCGA-04-1651-01A-01R-1567-13","b8426635-7d02-40e4-b9b9-695ae9a9b3fc",0.14,NA,NA,NA,NA,"7fd072b1-678f-5889-a426-a5074598f8c1","TCGA-04-1651_exposure","TCGA-04-1651-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T08:11:16.000Z","2014-03-27T08:38:02.000Z","B8CAC132-07E2-4AD2-A6B5-00926531B979","7D9F2D6D-3EC6-4FED-9D3A-52E813BD8BE6","Unaligned reads",16553338880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B8426635-7D02-40E4-B9B9-695AE9A9B3FC","Canada's Michael Smith Genome Sciences Centre","564a3782e4b0ef121819328f","55153632-1673-487A-85C0-F156377DB1FC","Ovarian Serous Cystadenocarcinoma","TAR","98EC9D66-3316-4665-AA16-D2F9FEB8013C","2014-03-27T08:38:02.000Z","FE2481FA-FFE2-4419-9900-F0205D94A4FC","None","NO",1,0.3,"Primary Tumor","Gynecologic Oncology Group",NA,"98EC9D66-3316-4665-AA16-D2F9FEB8013C",0.4,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5c0f2819-0ecd-43de-aa9b-6073e34779e5.txt",NA,"TCGA-04-1651-01A",1.5,"A960436A-2466-4C72-8EF7-89B73F8A0114","TCGA",2004,NA,NA,NA,"7D9F2D6D-3EC6-4FED-9D3A-52E813BD8BE6",53,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5c0f2819-0ecd-43de-aa9b-6073e34779e5.txt","Dead",1102,"TCGA-04-1651","NOT HISPANIC OR LATINO","F182F145-563E-4E9E-9D35-77B5E6E2DCAE",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,100,"62199560-A607-40F5-B030-80A174C8125E","FE2481FA-FFE2-4419-9900-F0205D94A4FC","TCGA-04-1651-01A-01R-1567-13_rnaseq_fastq.tar","TCGA-04-1651-01A-01",85,0,NA,NA,10,"BOTTOM",2,NA,"TCGA-04-1651-01A-01-BS1",88,"Cisplatin","Chemotherapy","TCGA-04-1651-D24176",NA,NA,NA,"TCGA-04-1651-F24172_NTE-1",NA,NA,NA,"Dead",1102,"TCGA-04-1651-F24172","TCGA-04-1651",NA,"04","1651","YES","C56.9","8441/3","C56.9",NA,NA,-19628,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1102,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
245201262,212186083,15375085302,"F1A142BF-9737-442D-B9A1-AA03958916D8.bw","561968ce-da9a-4d69-8bc2-bc87b9550f93","f1a142bf-9737-442d-b9a1-aa03958916d8","2016-09-29T23:59:58.706742-05:00","TCGA-13-1501-01A-01R-1565-13_rnaseq_fastq.tar","deb96746-c340-4914-ae12-e97bf88afd20",14487674880,"Illumina HiSeq","f469c6a562e2b4e508f83d92c68f2d9b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:00:59.747327-05:00","2016-05-03T11:40:21.662944-05:00","deb96746-c340-4914-ae12-e97bf88afd20_analysis.xml","184708a3f36db7adcc9e5624247ce0d0","ccd0076f-8cd5-437f-a41c-1f9660c1571f",2235,"2016-08-28T22:27:44.185213-05:00","deb96746-c340-4914-ae12-e97bf88afd20_experiment.xml","14b19df6b7af6f64d45b57bfe06f2b2a","f0199c13-592d-42f9-8095-bec1b91f44c4",3916,"2016-09-29T23:28:02.429857-05:00","deb96746-c340-4914-ae12-e97bf88afd20_run.xml","0d35b0c382412c13afdb70a8518a6cf5","ddc0392e-899b-4158-8e8f-ae7467d3e3d9",1989,"2016-09-08T13:58:35.581970-05:00","TCGA-13-1501","2016-09-02T19:13:40.330028-05:00","female","TCGA-13-1501_demographic",1956,"white","e89502e6-68a4-5a1d-a6c1-13aa96457707","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1501_diagnosis","not reported",18393,"dead","8441/3",1314,999,"834e617b-cd0e-5abb-b039-d8e48e862451","c56.9",-18393,"TCGA-13-1501_treatment","fd6af9dd-59a5-5c52-82e8-86bcf871cdde","01",NA,"TCGA-13-1501-01A","1.2","7579e91b-80df-4ab7-a775-e33418d17b1f",FALSE,"7D27D441-D069-4674-A761-299E315D67C1","Primary Tumor","0.4",NA,NA,"1.5",1235001600,"01",134,"TCGA-13-1501-01A-01",70,70,NA,NA,0,0,30,30,"2016-09-08T13:58:35.581970-05:00","2016-09-08T13:58:35.581970-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,0,"8fabb2f9-a340-49c1-ab64-9208a2fe1760","955ec489-489b-4ec1-8410-3f5e0bccc505","TCGA-13-1501-01A-01-BS1","TCGA-13-1501-01A-01-TS1",69,70,"08dc2059-595a-4d80-bba9-1a82141a825a","RNA","TCGA-13-1501-01A-01R","b081907a-6b9c-49d3-a3a3-84e60228bc52",1.8,0.15,"UV Spec","R","22","TCGA-13-1501-01A-01R-1565-13","d6c7ab9b-7928-4b66-9fc7-7d3c8146e92d",0.15,NA,NA,NA,NA,"2132a89b-b63c-5aa5-94ae-bc89e1989ada","TCGA-13-1501_exposure","TCGA-13-1501-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:55:39.000Z","2014-03-22T08:20:01.000Z","DEB96746-C340-4914-AE12-E97BF88AFD20","7579E91B-80DF-4AB7-A775-E33418D17B1F","Unaligned reads",14487674880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D6C7AB9B-7928-4B66-9FC7-7D3C8146E92D","Canada's Michael Smith Genome Sciences Centre","564a3d7be4b08c5d86922c25","561968CE-DA9A-4D69-8BC2-BC87B9550F93","Ovarian Serous Cystadenocarcinoma","TAR","08DC2059-595A-4D80-BBA9-1A82141A825A","2014-03-22T08:20:02.000Z","B081907A-6B9C-49D3-A3A3-84E60228BC52","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"08DC2059-595A-4D80-BBA9-1A82141A825A",1.2,"13","SEDUM_p_TCGA_Batch14_Expr_HT_HG-U133A_96-HTA_D05_458650.level3.data.txt",NA,"TCGA-13-1501-01A",1.5,"DFD6E676-24DC-4684-8F20-AD1B24C3189C","TCGA",2006,NA,NA,"WITH TUMOR","7C7C8ACA-C42C-4436-BEED-224004749E6F",50,"nationwidechildrens.org_clinical.TCGA-13-1501.xml","Alive",NA,"TCGA-13-1501","NOT HISPANIC OR LATINO","567DDCDB-F843-4F51-81BC-9074B6B2C0A8",NA,999,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,134,"955EC489-489B-4EC1-8410-3F5E0BCCC505","B081907A-6B9C-49D3-A3A3-84E60228BC52","TCGA-13-1501-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai","TCGA-13-1501-01A-01",70,0,NA,NA,30,"TOP",0,NA,"TCGA-13-1501-01A-01-TS1",70,"Paclitaxel","Chemotherapy","TCGA-13-1501-D24933",NA,NA,NA,"TCGA-13-1501-F24931_NTE-1",NA,999,"WITH TUMOR","Alive",NA,"TCGA-13-1501-F24931","TCGA-13-1501",NA,"13","1501","YES","C56.9","8441/3","C56.9",NA,NA,-18393,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",999,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2006,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
105280720,103864183,7674141833,"2DC1CF96-6822-412A-B002-3DC1239D17A7.bw","563853a2-9ac2-48be-adf3-1e547ee2b274","2dc1cf96-6822-412a-b002-3dc1239d17a7","2016-08-25T11:35:59.142101-05:00","TCGA-30-1860-01A-01R-1568-13_rnaseq_fastq.tar","35c48048-118f-44f4-a2cc-00a2fc61eb69",5979504640,"Illumina HiSeq","35f331d9ff2c3d6c041083e3407e7a87","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:34:17.309365-05:00","2016-05-03T11:56:42.628342-05:00","35c48048-118f-44f4-a2cc-00a2fc61eb69_analysis.xml","e3ce089d45eb1060a8e7d4eb1af7968d","bc639119-2f39-42cb-91eb-3adcacc3a673",2181,"2016-09-29T23:57:50.307632-05:00","35c48048-118f-44f4-a2cc-00a2fc61eb69_experiment.xml","ff978e797622782d4bb10c01254a1d56","f04b173a-3198-482d-b1a5-df35d8a4d981",3916,"2016-09-29T22:11:42.841952-05:00","35c48048-118f-44f4-a2cc-00a2fc61eb69_run.xml","f07d442aae828027305cfb5a1577eba7","ae6b33cd-3210-4c5e-9369-b039465ba9e5",1988,"2016-09-08T11:29:37.067451-05:00","TCGA-30-1860","2016-09-02T18:50:22.326455-05:00","female","TCGA-30-1860_demographic",1944,"white","e6e91e72-6dca-5afc-a512-914d653d4a4f","hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1860_diagnosis","not reported",21406,"dead","8441/3",1366,1366,"770910a1-1949-574d-a201-4d4ada40e373","c56.9",-21406,"TCGA-30-1860_treatment","0849482a-d6f8-57ba-94b3-5252b4b71bd2","01",NA,"TCGA-30-1860-01A","0.4","5ae1ae22-b891-472a-b737-e48c73b91798",FALSE,"d5b8e59f-1ae5-4e22-b933-48e48a364788","Primary Tumor","0.3",NA,NA,"0.5",1245369600,"01",103,"TCGA-30-1860-01A-01",95,95,NA,NA,0,0,5,10,"2016-09-08T11:29:37.067451-05:00","2016-09-08T11:29:37.067451-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,0,"3f2f52d2-e19d-4b63-9bf7-d02377f667b7","751e5a7f-2a59-40cc-866f-cc3780f7330b","TCGA-30-1860-01A-01-BS1","TCGA-30-1860-01A-01-TS1",85,90,"b25ba42d-dd08-495c-83f6-71ee932db6f2","RNA","TCGA-30-1860-01A-01R","fdbcb9be-686b-4301-a1f7-b1efed35c4ca",1.8,0.15,"UV Spec","R","22","TCGA-30-1860-01A-01R-1568-13","1b8eed7b-173e-4e38-80a4-a3a0aea469a1",0.15,NA,NA,NA,NA,"55774a0d-a4d8-5b58-ae1b-3b84e53723ba","TCGA-30-1860_exposure","TCGA-30-1860-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T02:01:29.000Z","2014-08-28T02:47:35.000Z","35C48048-118F-44F4-A2CC-00A2FC61EB69","5AE1AE22-B891-472A-B737-E48C73B91798","Unaligned reads",5979504640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1B8EED7B-173E-4E38-80A4-A3A0AEA469A1","Canada's Michael Smith Genome Sciences Centre","564a5a12e4b0ef12181dc1cf","563853A2-9AC2-48BE-ADF3-1E547EE2B274","Ovarian Serous Cystadenocarcinoma","TAR","B25BA42D-DD08-495C-83F6-71EE932DB6F2","2014-08-28T02:47:35.000Z","FDBCB9BE-686B-4301-A1F7-B1EFED35C4CA","None","NO",1,0.3,"Primary Tumor","Harvard",NA,"B25BA42D-DD08-495C-83F6-71EE932DB6F2",0.4,"30","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5c4486d9-1d91-4f42-83fd-85526c4f0836.txt",NA,"TCGA-30-1860-01A",0.5,"D3CE4085-CA82-4143-AD0B-EC81FF9F2EA9","TCGA",2002,NA,NA,"WITH TUMOR","5AE1AE22-B891-472A-B737-E48C73B91798",58,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5c4486d9-1d91-4f42-83fd-85526c4f0836.txt","Dead",1366,"TCGA-30-1860","HISPANIC OR LATINO","1893088C-1C0B-4D3C-BF14-C89F641B604E",NA,1366,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,"10498612-21CB-499F-9A2D-701E15D53EAC","WHITE",NA,1,103,"751E5A7F-2A59-40CC-866F-CC3780F7330B","9D9C74D9-D5DA-4901-9539-525CB098DE57","LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_D03_518052.hg19.seg.txt","TCGA-30-1860-01A-01",95,0,NA,NA,10,"TOP",0,NA,"TCGA-30-1860-01A-01-TS1",90,"Avastin","Targeted Molecular therapy","TCGA-30-1860-D27589","TCGA-30-1860-R27590","EXTERNAL BEAM","Primary Tumor Field","TCGA-30-1860-F27580_NTE-1",NA,1366,"WITH TUMOR","Dead",1366,"TCGA-30-1860-F27580","TCGA-30-1860",NA,"30","1860","YES","C56.9","8441/3","C56.9",NA,NA,-21406,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Dead",1366,1366,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
143682570,140742524,10415577343,"9C57AC2A-83C8-41EB-8DC3-9A897D8F8110.bw","565d06a1-3640-4274-8fb3-8cad7e578876","9c57ac2a-83c8-41eb-8dc3-9a897d8f8110","2016-09-29T21:42:28.795228-05:00","TCGA-61-1998-01A-01R-1568-13_rnaseq_fastq.tar","22961b7e-9497-407c-85f9-266e9b3a371e",8277534720,"Illumina HiSeq","2036f27daa145d028fe335ba94a47462","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:07:37.189610-05:00","2016-05-03T11:56:42.628342-05:00","22961b7e-9497-407c-85f9-266e9b3a371e_analysis.xml","83ff601da6deb786c06003a7d7bdfc9e","3c77f2a5-8f9e-437c-b7cb-8a61dde6bedb",2181,"2016-09-29T20:15:50.515344-05:00","22961b7e-9497-407c-85f9-266e9b3a371e_experiment.xml","a03ce8b9d61c82bd6bcf460027da475c","66b57a80-324d-40d9-86c2-2664969f4fa2",3916,"2016-09-29T23:41:31.196922-05:00","22961b7e-9497-407c-85f9-266e9b3a371e_run.xml","477d86088774d99823bbd4be7d3f06fa","e62df20d-8ee3-487c-b2b4-00c34603e0b2",1988,"2016-09-08T11:46:25.738517-05:00","TCGA-61-1998","2016-09-02T18:56:33.396029-05:00","female","TCGA-61-1998_demographic",1961,"white","dcf3372c-5c88-5b4b-96fe-6f38ca251168","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1998_diagnosis","not reported",17855,"alive","8441/3",NA,168,"720e8667-af0a-5909-9705-68bab71ed9f5","c56.9",-17855,"TCGA-61-1998_treatment","e3fafe10-5118-51b1-8db6-d84c45daec73","01",NA,"TCGA-61-1998-01A","0.5","981e7677-6bde-4617-8c24-732d606b81e4",FALSE,"788d25c6-75c4-4c85-be93-98dec021219a","Primary Tumor","0.1",NA,NA,"1",1247443200,"01",119,"TCGA-61-1998-01A-01",90,90,NA,NA,15,15,40,72,"2016-09-08T11:46:25.738517-05:00","2016-09-08T11:46:25.738517-05:00",NA,NA,NA,NA,"TOP","BOTTOM",15,5,"594237ab-2edf-49de-b4ab-b59f95a07052","16a1dc45-c69e-46ef-b90c-e3434676491d","TCGA-61-1998-01A-01-TS1","TCGA-61-1998-01A-01-BS1",30,8,"4c40be97-c972-47f7-bb31-6e331fa52610","RNA","TCGA-61-1998-01A-01R","b78bf7f3-25ae-4e77-8715-f9e719c7baea",1.8,0.13,"UV Spec","R","22","TCGA-61-1998-01A-01R-1568-13","0814c20e-fe77-4ff9-ab5e-a8ae2f74069d",0.13,NA,NA,NA,NA,"8ade61dd-42cb-5e69-99ac-3f1d5e6f3214","TCGA-61-1998_exposure","TCGA-61-1998-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T16:32:52.000Z","2014-08-27T18:21:13.000Z","22961B7E-9497-407C-85F9-266E9B3A371E","981E7677-6BDE-4617-8C24-732D606B81E4","Unaligned reads",8277534720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0814C20E-FE77-4FF9-AB5E-A8AE2F74069D","Canada's Michael Smith Genome Sciences Centre","564a5694e4b0ef12181c9870","565D06A1-3640-4274-8FB3-8CAD7E578876","Ovarian Serous Cystadenocarcinoma","TAR","4C40BE97-C972-47F7-BB31-6E331FA52610","2014-08-27T18:21:13.000Z","B78BF7F3-25AE-4E77-8715-F9E719C7BAEA","None","NO",1,0.1,"Primary Tumor","University of Pittsburgh",NA,"4C40BE97-C972-47F7-BB31-6E331FA52610",0.5,"61","US82800149_251976010906_S01_GE2_105_Dec08.txt",NA,"TCGA-61-1998-01A",1,"D1901164-9C69-4AA7-BFC2-BF9A93581E24","TCGA",2009,NA,NA,"WITH TUMOR","981E7677-6BDE-4617-8C24-732D606B81E4",48,"nationwidechildrens.org_clinical.TCGA-61-1998.xml","Alive",NA,"TCGA-61-1998","NOT HISPANIC OR LATINO","0D0DA8B8-E9F8-4DBB-9A7F-FF76D2DC734F",NA,168,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,119,"594237AB-2EDF-49DE-B4AB-B59F95A07052","E1132A25-041D-4323-A5FB-37401BF947A7","US82800149_251976010906_S01_GE2_105_Dec08.txt","TCGA-61-1998-01A-01",90,15,NA,NA,72,"BOTTOM",5,NA,"TCGA-61-1998-01A-01-BS1",8,"Carboplatin","Chemotherapy","TCGA-61-1998-D28308",NA,NA,NA,NA,NA,168,"WITH TUMOR","Alive",NA,"TCGA-61-1998-F28306","TCGA-61-1998",NA,"61","1998","YES","C56.9","8441/3","C56.9",NA,NA,-17855,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",168,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,48,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
234286716,223070532,16493046912,"D22198BE-2B03-4A06-9EB6-696B67E8CEFB.bw","56a30462-2819-4c18-95be-8e73880a4921","d22198be-2b03-4a06-9eb6-696b67e8cefb","2016-09-29T23:09:14.486118-05:00","TCGA-13-1498-01A-01R-1565-13_rnaseq_fastq.tar","876715f9-7df1-4964-a77b-41c33d1de215",15586048000,"Illumina HiSeq","abf565764c307311feab175b3e58a70f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:46:59.767916-05:00","2016-05-03T11:40:21.647690-05:00","876715f9-7df1-4964-a77b-41c33d1de215_analysis.xml","8623a5a928a7e9a74e0b1c8e237db5b7","9f2dcf41-b5f1-412f-b091-39641b04c87b",2181,"2016-09-29T23:31:07.653620-05:00","876715f9-7df1-4964-a77b-41c33d1de215_experiment.xml","cfb0e875f1d6148fcc247637e2a2ba09","dfbb8b2f-5dee-430b-a53f-83fa5be6d120",3916,"2016-09-29T22:43:49.686684-05:00","876715f9-7df1-4964-a77b-41c33d1de215_run.xml","b659063fca5a4f6b954149156984ab48","c2576234-7847-45f1-8ba6-d5dd1724461f",1988,"2016-09-08T14:04:31.450776-05:00","TCGA-13-1498","2016-09-02T19:13:37.062937-05:00","female","TCGA-13-1498_demographic",1933,"white","28950168-4541-54cc-bdd4-8a03516ad698","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1498_diagnosis","not reported",26820,"dead","8441/3",2012,1144,"7014b3d8-1e77-5bd5-963a-cc54ff5b2d8f","c56.9",-26820,"TCGA-13-1498_treatment","c5f54909-dc1a-531f-bce2-b9e66054c35d","01",NA,"TCGA-13-1498-01A","0.5","b38f209a-000b-4cbf-a4bd-0bc6f027fce3",FALSE,"0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1","Primary Tumor","0.4",NA,NA,"1.1",1234915200,"01",131,"TCGA-13-1498-01A-01",90,95,NA,NA,0,0,10,5,"2016-09-08T14:04:31.450776-05:00","2016-09-08T14:04:31.450776-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,1,"c1a533e4-aaec-4ffe-aa78-2f5d3887d768","860b1710-d464-4027-b6be-02694c7027a3","TCGA-13-1498-01A-01-TS1","TCGA-13-1498-01A-01-BS1",80,94,"3c71ab8d-314b-4e10-aec8-6d4ce4127e4e","RNA","TCGA-13-1498-01A-01R","00a3f8c5-119b-46f7-a6b5-6fe40ccc35ba",1.8,0.16,"UV Spec","R","22","TCGA-13-1498-01A-01R-1565-13","176d1ca2-eb1d-4f49-9b10-c129c822fa5a",0.16,NA,NA,NA,NA,"d0c40a01-dad8-5477-9f5b-962ac1e560d8","TCGA-13-1498_exposure","TCGA-13-1498-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T23:54:30.000Z","2014-03-22T00:28:02.000Z","876715F9-7DF1-4964-A77B-41C33D1DE215","B38F209A-000B-4CBF-A4BD-0BC6F027FCE3","Unaligned reads",15586048000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","176D1CA2-EB1D-4F49-9B10-C129C822FA5A","Canada's Michael Smith Genome Sciences Centre","564a57fee4b0ef12181d105e","56A30462-2819-4C18-95BE-8E73880A4921","Ovarian Serous Cystadenocarcinoma","TAR","3C71AB8D-314B-4E10-AEC8-6D4CE4127E4E","2014-03-22T00:28:02.000Z","00A3F8C5-119B-46F7-A6B5-6FE40CCC35BA","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"3C71AB8D-314B-4E10-AEC8-6D4CE4127E4E",0.5,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.17dca857-f830-4be9-9f2b-5619ae7eb73f.txt",NA,"TCGA-13-1498-01A",1.1,"E3D7554B-1876-4B8C-B4E8-D94F161120B4","TCGA",2006,NA,NA,"WITH TUMOR","B38F209A-000B-4CBF-A4BD-0BC6F027FCE3",73,"THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_C11_455336.CEL","Alive",NA,"TCGA-13-1498","NOT HISPANIC OR LATINO","9BEF7216-B734-4D71-B19D-86C2B34BA46E",NA,1144,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,131,"C1A533E4-AAEC-4FFE-AA78-2F5D3887D768","7B701832-F2E1-4CCF-AC94-16B2D2C0E9F9","TCGA-13-1498-01A-01W-0549-09_capture.bam","TCGA-13-1498-01A-01",90,0,NA,NA,10,"TOP",10,NA,"TCGA-13-1498-01A-01-TS1",80,"Paclitaxel","Chemotherapy","TCGA-13-1498-D24916",NA,NA,NA,"TCGA-13-1498-F24914_NTE-1",NA,1144,"WITH TUMOR","Alive",NA,"TCGA-13-1498-F24914","TCGA-13-1498",NA,"13","1498","YES","C56.9","8441/3","C56.9",NA,NA,-26820,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1144,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,73,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
210394894,199933844,14745102086,"68BACBAD-DC56-4ADF-BB44-86750A866657.bw","58427bce-6b81-4083-aeda-25f59e292bbc","68bacbad-dc56-4adf-bb44-86750a866657","2016-08-25T12:36:37.510008-05:00","TCGA-25-1316-01A-01R-1565-13_rnaseq_fastq.tar","a8078dcf-493d-44f3-b868-8f266996b8fa",14100387840,"Illumina HiSeq","22f0bf890aad374576ccf8ca5b05a6c6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:12:03.733140-05:00","2016-05-03T11:40:21.669427-05:00","a8078dcf-493d-44f3-b868-8f266996b8fa_analysis.xml","f9405c1e0865d17de8295680029a7c5d","d3f1445c-82fb-40ea-8a77-3441f5caa61c",2181,"2016-09-29T22:32:14.075524-05:00","a8078dcf-493d-44f3-b868-8f266996b8fa_experiment.xml","ab9370c14530ef1f91284400e52242fa","bb21e50a-2104-42eb-bb93-f4834e4ed259",3916,"2016-09-29T22:46:36.604120-05:00","a8078dcf-493d-44f3-b868-8f266996b8fa_run.xml","34d23780161fdee7fad06a59526a1ddb","c4186770-52cc-4928-b19d-ecc1a314dfd3",1989,"2016-09-08T13:34:03.190303-05:00","TCGA-25-1316","2016-09-02T19:11:59.792443-05:00","female","TCGA-25-1316_demographic",1945,"white","8f0f2afc-3c1a-5e58-bdac-9601041f917b","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1316_diagnosis","not reported",20331,"dead","8441/3",1279,1126,"01932ba3-2753-5aa5-b4bc-15b1972bc184","c56.9",-20331,"TCGA-25-1316_treatment","9ffd597a-dcc4-59f7-97dc-c7f403419f02","01",NA,"TCGA-25-1316-01A","2.5","fdf5e5b9-8d6c-4581-93d4-bedae0bf371d",FALSE,"B766CB7E-C4EC-489C-AEF0-BE28132D5BA5","Primary Tumor","1.5",NA,NA,"3",1228348800,"01",147,"TCGA-25-1316-01A-01",98,98,NA,NA,0,0,2,5,"2016-09-08T13:34:03.190303-05:00","2016-09-08T13:34:03.190303-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"050f7f9f-a802-4a8e-8467-e40a36e90503","14e296ac-b3bd-43b1-b67d-0f0e6446f94c","TCGA-25-1316-01A-01-TS1","TCGA-25-1316-01A-01-BS1",98,95,"6e1181f2-912e-4c07-a174-a0b125ba484d","RNA","TCGA-25-1316-01A-01R","decde436-3932-4c8a-a8f7-21465e53cbca",1.8,0.16,"UV Spec","R","22","TCGA-25-1316-01A-01R-1565-13","6cb5e275-1284-482b-a4e9-933acf9aad44",0.16,NA,NA,NA,NA,"d53c26d1-cc65-5449-8ea6-3eef9f2b81d9","TCGA-25-1316_exposure","TCGA-25-1316-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:19:10.000Z","2014-03-22T05:45:02.000Z","A8078DCF-493D-44F3-B868-8F266996B8FA","FDF5E5B9-8D6C-4581-93D4-BEDAE0BF371D","Unaligned reads",14100387840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6CB5E275-1284-482B-A4E9-933ACF9AAD44","Canada's Michael Smith Genome Sciences Centre","564a3846e4b0298dd2c76775","58427BCE-6B81-4083-AEDA-25F59E292BBC","Ovarian Serous Cystadenocarcinoma","TAR","6E1181F2-912E-4C07-A174-A0B125BA484D","2014-03-22T05:45:02.000Z","DECDE436-3932-4C8A-A8F7-21465E53CBCA","None","NO",1,1.5,"Primary Tumor","Mayo Clinic - Rochester",NA,"6E1181F2-912E-4C07-A174-A0B125BA484D",2.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.4d3e28c0-7510-4c0e-a4c2-d2af7bcb82b4.txt",NA,"TCGA-25-1316-01A",3,"937633F3-8AC6-4073-B96B-B491F465F7F6","TCGA",2000,NA,NA,"WITH TUMOR","FDF5E5B9-8D6C-4581-93D4-BEDAE0BF371D",55,"NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_D12_446072.tangent.copynumber.data.txt","Dead",1279,"TCGA-25-1316","NOT HISPANIC OR LATINO","66D2E9B2-0219-4B9A-AA62-D52E65461829",NA,1126,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,147,"14E296AC-B3BD-43B1-B67D-0F0E6446F94C","DECDE436-3932-4C8A-A8F7-21465E53CBCA","TCGA-25-1316-01A-01R-1565-13_mirna.bam","TCGA-25-1316-01A-01",98,0,NA,NA,2,"TOP",0,NA,"TCGA-25-1316-01A-01-TS1",98,"Taxol","Chemotherapy","TCGA-25-1316-D26649",NA,NA,NA,"TCGA-25-1316-F26646_NTE-1",NA,1126,"WITH TUMOR","Dead",1279,"TCGA-25-1316-F26646","TCGA-25-1316",NA,"25","1316","YES","C56.9","8441/3","C56.9",NA,NA,-20331,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1126,1279,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,55,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158464598,153332907,11352874703,"7DFBA494-6746-4FF7-9948-FC9BA297F499.bw","58f5a54e-de50-4cca-afa1-cc331d8b3479","7dfba494-6746-4ff7-9948-fc9ba297f499","2016-08-25T20:58:20.014499-05:00","TCGA-30-1862-01A-02R-1568-13_rnaseq_fastq.tar","c06215b2-0ed8-4336-b4ae-75431b8e82f4",10343383040,"Illumina HiSeq","4202cb4b720976ef4be1f6cc16d6d1e9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:28:36.373849-05:00","2016-05-03T11:56:42.628342-05:00","c06215b2-0ed8-4336-b4ae-75431b8e82f4_analysis.xml","bba2ebc73aa0c2f9c2ea5fbe25dfa057","6e8ea2b6-73c0-45f0-b8c7-73abd0b4aff0",2181,"2016-09-29T20:48:18.692533-05:00","c06215b2-0ed8-4336-b4ae-75431b8e82f4_experiment.xml","cd8b0e18d261cd74cbddea614f6a3a4b","7aa9c104-0493-48ba-b584-15aa4a10d20b",3916,"2016-09-29T19:16:28.988164-05:00","c06215b2-0ed8-4336-b4ae-75431b8e82f4_run.xml","c17302ff38f4c50a307b0f2a4c4f3c55","4211a0d6-14f1-4241-97e6-e9153bdce35f",1988,"2016-09-08T10:35:39.143442-05:00","TCGA-30-1862","2016-09-02T18:50:24.777752-05:00","female","TCGA-30-1862_demographic",1938,"white","bf047813-e305-5aa3-a47a-6582e28a88c3","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1862_diagnosis","not reported",23895,"dead","8441/3",186,186,"43530a4f-d2b9-5c4b-b4a5-1450b2fa35a4","c56.9",-23895,"TCGA-30-1862_treatment","e901e62d-705b-53c7-8bfa-c10e4797f089","01",NA,"TCGA-30-1862-01A",NA,"6211110a-552c-492f-b066-c3b41db7fbad",FALSE,"a6b7b0c1-5954-487b-b27d-73850a08a194","Primary Tumor",NA,NA,NA,NA,1245369600,"02",124,"TCGA-30-1862-01A-02",70,80,NA,NA,0,0,40,30,"2016-09-08T10:35:39.143442-05:00","2016-09-08T10:35:39.143442-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"e21a9aeb-597a-4202-9026-5d8505237256","223b3dda-6e14-404e-9301-85e97e8a8e65","TCGA-30-1862-01A-01-BS1","TCGA-30-1862-01A-02-BS2",60,70,"435274be-1d2a-4b64-9d4b-2bceaf700030","RNA","TCGA-30-1862-01A-02R","27716f4a-11a2-4c5f-9387-fc8dc613131d",1.8,0.15,"UV Spec","R","22","TCGA-30-1862-01A-02R-1568-13","ab0701bc-0bc5-4008-a75b-5f665ef9c14a",0.15,NA,NA,NA,NA,"d37c4968-3168-5776-9692-5b5cc8845e9e","TCGA-30-1862_exposure","TCGA-30-1862-01A-02R-1568-13_rnaseq_fastq.tar","2014-08-27T06:56:13.000Z","2014-08-27T11:41:09.000Z","C06215B2-0ED8-4336-B4AE-75431B8E82F4","6211110A-552C-492F-B066-C3B41DB7FBAD","Unaligned reads",10343383040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AB0701BC-0BC5-4008-A75B-5F665EF9C14A","Canada's Michael Smith Genome Sciences Centre","564a36bfe4b093830b67c7b9","58F5A54E-DE50-4CCA-AFA1-CC331D8B3479","Ovarian Serous Cystadenocarcinoma","TAR","435274BE-1D2A-4B64-9D4B-2BCEAF700030","2014-08-27T11:41:09.000Z","27716F4A-11A2-4C5F-9387-FC8DC613131D","None","NO",1,NA,"Primary Tumor","Harvard",NA,"435274BE-1D2A-4B64-9D4B-2BCEAF700030",NA,"30","TCGA-30-1862-01A-02R-1568-13_rnaseq_fastq.tar",NA,"TCGA-30-1862-01A",NA,NA,"TCGA",2003,NA,NA,"WITH TUMOR","D18C6DBF-06AA-4493-84BD-81E8D9FCEF06",65,"TCGA-30-1862-01A-02R-1568-13.hg19.spljxn.quantification.txt","Dead",186,"TCGA-30-1862","NOT HISPANIC OR LATINO","98838264-1D26-43DC-A7F7-7D0B7A0E956B",NA,186,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,2,124,"E21A9AEB-597A-4202-9026-5D8505237256","B18B46E0-49BC-4EA3-A8DC-7AE1578A2837","TCGA-30-1862-01A-02R-1568-13_rnaseq_fastq.tar","TCGA-30-1862-01A-02",70,0,NA,NA,40,"TOP",0,NA,"TCGA-30-1862-01A-01-BS1",60,NA,NA,NA,NA,NA,NA,NA,NA,186,"WITH TUMOR","Dead",186,"TCGA-30-1862-F27593","TCGA-30-1862",NA,"30","1862","YES","C56.9","8441/3","C56.9",NA,NA,-23895,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",186,186,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,65,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
166099048,163306464,12089787365,"00B39945-A227-46EB-B737-27D12370FE6A.bw","59b3fbfe-0b7c-41e5-b756-ee7e23730df5","00b39945-a227-46eb-b737-27d12370fe6a","2016-08-24T12:58:35.433130-05:00","TCGA-24-2281-01A-01R-1568-13_rnaseq_fastq.tar","0bafdfdd-bdb6-43ec-b51a-7e2612455ed8",10194411520,"Illumina HiSeq","fb7aa2298c3781eeaff1679390dd600f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:14:40.664821-05:00","2016-05-03T11:56:42.628342-05:00","0bafdfdd-bdb6-43ec-b51a-7e2612455ed8_analysis.xml","2fafb7a6653602b723cc1b4c2ea94a05","b052f3b7-1057-4f90-8072-261d9e31caec",2181,"2016-08-26T00:26:23.540784-05:00","0bafdfdd-bdb6-43ec-b51a-7e2612455ed8_experiment.xml","7f36bba99173c269e3718201be909fe1","fb89f40c-e2fa-4860-8d26-2d1d1d0a1496",3916,"2016-09-30T00:10:14.462351-05:00","0bafdfdd-bdb6-43ec-b51a-7e2612455ed8_run.xml","de489ff7b90276315ca1a9f5e5ecbdff","f7d632ee-6dff-4305-a54e-7fe62cceb8a4",1988,"2016-09-08T13:21:32.073992-05:00","TCGA-24-2281","2016-09-02T19:11:52.126017-05:00","female","TCGA-24-2281_demographic",1938,"white","31c47fb8-f9c9-5bd3-a2e0-1416b999df2b","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2281_diagnosis","not reported",25019,"alive","8441/3",NA,1357,"c9b6188c-636e-5f19-9261-7b9a70e42044","c56.9",-25019,"TCGA-24-2281_treatment","7f1743f0-eb08-56bc-88cc-14c67bb223f5","01",NA,"TCGA-24-2281-01A","0.9","fcd83e7f-2210-465d-8362-3b5e2c368625",FALSE,"363dc00f-480d-4a3f-8950-80a6bc0b7dd8","Primary Tumor","0.2",NA,NA,"1.5",1251676800,"01",131,"TCGA-24-2281-01A-01",70,70,NA,NA,0,0,25,35,"2016-09-08T13:21:32.073992-05:00","2016-09-08T13:21:32.073992-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"1f2b1446-69d7-4e61-a21b-4ddbd68a092f","0d68fc45-8e3a-4161-b2e8-34dd9094b284","TCGA-24-2281-01A-01-TS1","TCGA-24-2281-01A-01-BS1",70,60,"67c03d2b-64a0-4f5c-ae70-bc9b9703a46c","RNA","TCGA-24-2281-01A-01R","076ae210-4b7f-4137-b888-cc1f6df9f765",1.8,0.14,"UV Spec","R","22","TCGA-24-2281-01A-01R-1568-13","44948279-405d-42f6-ad29-465150ee6d85",0.14,NA,NA,NA,NA,"2376f600-f890-5dfe-8951-c29f22d4bb12","TCGA-24-2281_exposure","TCGA-24-2281-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T04:35:42.000Z","2014-08-28T06:05:33.000Z","0BAFDFDD-BDB6-43EC-B51A-7E2612455ED8","FCD83E7F-2210-465D-8362-3B5E2C368625","Unaligned reads",10194411520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","44948279-405D-42F6-AD29-465150EE6D85","Canada's Michael Smith Genome Sciences Centre","564a4001e4b08c5d8692fadd","59B3FBFE-0B7C-41E5-B756-EE7E23730DF5","Ovarian Serous Cystadenocarcinoma","TAR","67C03D2B-64A0-4F5C-AE70-BC9B9703A46C","2014-08-28T06:05:33.000Z","076AE210-4B7F-4137-B888-CC1F6DF9F765","None","NO",1,0.2,"Primary Tumor","Washington University",NA,"67C03D2B-64A0-4F5C-AE70-BC9B9703A46C",0.9,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e83257be-084b-405a-8098-b10055d1ad85.txt",NA,"TCGA-24-2281-01A",1.5,"C3BC6BFA-AEAF-48C8-9AFB-72F424B38730","TCGA",2006,NA,NA,"TUMOR FREE","FCD83E7F-2210-465D-8362-3B5E2C368625",68,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e83257be-084b-405a-8098-b10055d1ad85.txt","Alive",NA,"TCGA-24-2281",NA,"5AF8F13C-15CE-4BDE-BE6F-7ADC93A93883",NA,1357,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIA",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,131,"0D68FC45-8E3A-4161-B2E8-34DD9094B284","82463BBC-E44F-4771-AAFA-5EFD3643984E","TCGA-24-2281-01A-01R-1568-13_mirna.bam.bai","TCGA-24-2281-01A-01",70,0,NA,NA,25,"TOP",5,NA,"TCGA-24-2281-01A-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-24-2281-D26571",NA,NA,NA,NA,NA,1357,"TUMOR FREE","Alive",NA,"TCGA-24-2281-F26570","TCGA-24-2281",NA,"24","2281","YES","C56.9","8441/3","C56.9",NA,NA,-25019,"FEMALE","WHITE",NA,NA,"No","Alive",1357,NA,NA,NA,"TUMOR FREE","NO",5,4,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
296543568,287436624,21291194345,"6FA15950-94D4-4D46-A0E5-45D899089443.bw","5abb6d80-fc39-49a4-8db5-3db24543feb6","6fa15950-94d4-4d46-a0e5-45d899089443","2016-09-29T20:30:22.138764-05:00","TCGA-29-1770-02A-01R-1567-13_rnaseq_fastq.tar","c8db605e-f7e7-41ff-a564-8857550540bd",19270400000,"Illumina HiSeq","d1e2dd3ba6ca02ca940f1922c727ffd0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:35:54.342853-05:00","2016-05-03T11:56:42.628809-05:00","c8db605e-f7e7-41ff-a564-8857550540bd_analysis.xml","8279e5e202b2f14b4bf0983651a8970d","984d5676-b8cb-4c6b-9f82-66d5d994c1b1",2181,"2016-09-29T18:34:46.419039-05:00","c8db605e-f7e7-41ff-a564-8857550540bd_experiment.xml","53867a1ebf8d8dfbb88b90802ed0da36","278f0f03-b1a2-409e-8707-56cebd447fe2",3916,"2016-09-29T17:38:43.252853-05:00","c8db605e-f7e7-41ff-a564-8857550540bd_run.xml","869350bb16e2c9026b1f9e3d82694fcd","045f7806-052f-4b61-95f1-42340f68d6ad",1988,"2016-09-08T13:05:14.632860-05:00","TCGA-29-1770","2016-09-02T19:07:19.196999-05:00","female","TCGA-29-1770_demographic",1953,"white","08af8cb4-296c-5a4f-b5fc-951011920166","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1770_diagnosis","not reported",20015,"alive","8441/3",NA,741,"05b7bdb6-00fc-573b-88b0-3985a0a97199","c56.9",-20015,"TCGA-29-1770_treatment","bafb4da9-41ca-51be-92f7-f757fdb708d4","02",NA,"TCGA-29-1770-02A","0.4","a22ee89e-b248-496c-bd1c-90d09d4433e1",FALSE,"49220236-FBFE-44AA-89BC-FC4E7CBC94FA","Recurrent Tumor","0.2",NA,NA,"0.4",1259712000,"01",42,"TCGA-29-1770-02A-01",90,95,NA,NA,0,0,20,10,"2016-09-08T13:05:14.632860-05:00","2016-09-08T13:05:14.632860-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"65332f9d-d051-45da-9b53-3e5f6ed625f8","446a3c89-4a95-4aed-b096-cab2ec0147b5","TCGA-29-1770-02A-01-TS1","TCGA-29-1770-02A-01-BS1",80,90,"5b5eaa61-6c00-41ae-bbaa-ae30ee5f13c8","RNA","TCGA-29-1770-02A-01R","f13c7818-cb57-4775-8f05-2defd481f8a2",1.9,0.15,"UV Spec","R","22","TCGA-29-1770-02A-01R-1567-13","ea119111-5217-4b8a-88e0-36dc77782241",0.15,NA,NA,NA,NA,"84d5a4ba-43c1-57a8-9dfd-10ba90d03001","TCGA-29-1770_exposure","TCGA-29-1770-02A-01R-1567-13_rnaseq_fastq.tar","2014-08-26T00:09:15.000Z","2014-08-26T02:41:40.000Z","C8DB605E-F7E7-41FF-A564-8857550540BD","A22EE89E-B248-496C-BD1C-90D09D4433E1","Unaligned reads",19270400000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EA119111-5217-4B8A-88E0-36DC77782241","Canada's Michael Smith Genome Sciences Centre","564a3c45e4b093830b698c17","5ABB6D80-FC39-49A4-8DB5-3DB24543FEB6","Ovarian Serous Cystadenocarcinoma","TAR","5B5EAA61-6C00-41AE-BBAA-AE30EE5F13C8","2014-08-26T02:41:40.000Z","F13C7818-CB57-4775-8F05-2DEFD481F8A2","None","NO",2,0.2,"Recurrent Tumor","Duke",NA,"5B5EAA61-6C00-41AE-BBAA-AE30EE5F13C8",0.4,"29","TCGA-29-1770-02A-01W-0927-10_SOLiD.bam",NA,"TCGA-29-1770-02A",0.4,"CA385D1C-E8CD-4C8D-B8B6-E3F6342B9B43","TCGA",2007,NA,NA,"WITH TUMOR","E14EECDB-9843-4549-917B-EE1E3D77025D",54,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1577dc3d-937d-4fbb-b280-25f969e43f81.txt","Alive",NA,"TCGA-29-1770",NA,"D7A26E91-AB1F-4ADA-B736-84F1DE3922B1",NA,741,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,42,"65332F9D-D051-45DA-9B53-3E5F6ED625F8","45A142EE-DBE6-4D47-AA56-8391E36B1F7B","TCGA-29-1770-02A-01R-1567-13_mirna.bam.bai","TCGA-29-1770-02A-01",95,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-29-1770-02A-01-BS1",90,"Avastin","Targeted Molecular therapy","TCGA-29-1770-D27381",NA,NA,NA,"TCGA-29-1770-F27373_NTE-2",NA,741,"WITH TUMOR","Alive",NA,"TCGA-29-1770-F27373","TCGA-29-1770",NA,"29","1770","YES","C56.9","8441/3","C56.9",NA,NA,-20015,"FEMALE","WHITE",NA,NA,"No","Alive",741,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,2007,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
207345978,201561922,14914354996,"DE451B99-D33B-4A35-BB0E-AAED631B56C3.bw","5abb6d80-fc39-49a4-8db5-3db24543feb6","de451b99-d33b-4a35-bb0e-aaed631b56c3","2016-08-23T04:26:35.728855-05:00","TCGA-29-1770-01A-01R-1567-13_rnaseq_fastq.tar","62b097fd-7c5b-4f65-b7d1-d762ef048bdc",12764887040,"Illumina HiSeq","ce0afc9000f7d68c10563ffd5bec7ad4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:07:37.646074-05:00","2016-05-03T11:41:05.740436-05:00","62b097fd-7c5b-4f65-b7d1-d762ef048bdc_analysis.xml","b55933ab11d30d44110ce7238df68de9","61b3c6cc-c54d-444e-ac1d-b461fda5195f",2181,"2016-09-29T19:16:05.508537-05:00","62b097fd-7c5b-4f65-b7d1-d762ef048bdc_experiment.xml","eb5d82e38b550c03a0e4d458e80c76f3","41cdc44d-b79b-4264-93e9-3332e205f4d6",3916,"2016-09-29T18:18:31.725791-05:00","62b097fd-7c5b-4f65-b7d1-d762ef048bdc_run.xml","1866fb47c986e0abf87e460c2097d178","1d7c3b48-9dca-4173-9b86-68be86605879",1988,"2016-09-08T13:05:14.632860-05:00","TCGA-29-1770","2016-09-02T19:07:19.196999-05:00","female","TCGA-29-1770_demographic",1953,"white","08af8cb4-296c-5a4f-b5fc-951011920166","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1770_diagnosis","not reported",20015,"alive","8441/3",NA,741,"05b7bdb6-00fc-573b-88b0-3985a0a97199","c56.9",-20015,"TCGA-29-1770_treatment","bafb4da9-41ca-51be-92f7-f757fdb708d4","01",NA,"TCGA-29-1770-01A","0.6","e14eecdb-9843-4549-917b-ee1e3d77025d",FALSE,"05816aac-55d2-4604-9300-e268f73338fe","Primary Tumor","0.5",NA,NA,"1.2",1243296000,"01",115,"TCGA-29-1770-01A-01",90,90,NA,NA,0,0,35,20,"2016-09-08T13:05:14.632860-05:00","2016-09-08T13:05:14.632860-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,0,"60fcddf8-3637-40ae-8ab1-135c28d702e2","ee73a932-fda4-4c43-b713-155de66a089c","TCGA-29-1770-01A-01-BS1","TCGA-29-1770-01A-01-TS1",60,80,"fb6159a5-f237-4544-bc25-81867a34c21d","RNA","TCGA-29-1770-01A-01R","ba3844ed-001a-4397-8fd4-82fb24803e75",1.8,0.17,"UV Spec","R","22","TCGA-29-1770-01A-01R-1567-13","5ba75bb8-6229-4d6a-80e5-9a79a548e167",0.17,NA,NA,NA,NA,"84d5a4ba-43c1-57a8-9dfd-10ba90d03001","TCGA-29-1770_exposure","TCGA-29-1770-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T00:36:15.000Z","2014-03-27T01:02:02.000Z","62B097FD-7C5B-4F65-B7D1-D762EF048BDC","E14EECDB-9843-4549-917B-EE1E3D77025D","Unaligned reads",12764887040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5BA75BB8-6229-4D6A-80E5-9A79A548E167","Canada's Michael Smith Genome Sciences Centre","564a3c46e4b0ef12181ab7d0","5ABB6D80-FC39-49A4-8DB5-3DB24543FEB6","Ovarian Serous Cystadenocarcinoma","TAR","FB6159A5-F237-4544-BC25-81867A34C21D","2014-03-27T01:02:02.000Z","BA3844ED-001A-4397-8FD4-82FB24803E75","None","NO",1,0.5,"Primary Tumor","Duke",NA,"FB6159A5-F237-4544-BC25-81867A34C21D",0.6,"29","SAROS_p_TCGA_B18_SNP_N_GenomeWideSNP_6_H05_489612.hg18.seg.txt",NA,"TCGA-29-1770-01A",1.2,"CA385D1C-E8CD-4C8D-B8B6-E3F6342B9B43","TCGA",2007,NA,NA,"WITH TUMOR","E14EECDB-9843-4549-917B-EE1E3D77025D",54,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1577dc3d-937d-4fbb-b280-25f969e43f81.txt","Alive",NA,"TCGA-29-1770",NA,"D7A26E91-AB1F-4ADA-B736-84F1DE3922B1",NA,741,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,115,"EE73A932-FDA4-4C43-B713-155DE66A089C","669BD429-3EF4-4830-ADB3-9028C2C7CA4F","TCGA-29-1770-01A-01R-1567-13_rnaseq_fastq.tar","TCGA-29-1770-01A-01",90,0,NA,NA,35,"BOTTOM",5,NA,"TCGA-29-1770-01A-01-BS1",60,"Avastin","Targeted Molecular therapy","TCGA-29-1770-D27381",NA,NA,NA,"TCGA-29-1770-F27373_NTE-2",NA,741,"WITH TUMOR","Alive",NA,"TCGA-29-1770-F27373","TCGA-29-1770",NA,"29","1770","YES","C56.9","8441/3","C56.9",NA,NA,-20015,"FEMALE","WHITE",NA,NA,"No","Alive",741,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,2007,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
170301130,168194481,12457889213,"1DE68F26-5F22-4B90-A0F4-4775865D5E35.bw","5c127332-5ca0-45f1-a5ac-4876ad94e491","1de68f26-5f22-4b90-a0f4-4775865d5e35","2016-08-25T05:45:46.653320-05:00","TCGA-25-2400-01A-01R-1569-13_rnaseq_fastq.tar","3c1408e2-c7d2-4b81-a410-3f54a0758ab5",9779937280,"Illumina HiSeq","fc5d4c6c880071ad7eced0ede9615049","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:53:22.883690-05:00","2016-05-03T11:55:09.260045-05:00","3c1408e2-c7d2-4b81-a410-3f54a0758ab5_analysis.xml","32cbb2ccacac4320af7e257fdb25811c","c850ede5-6013-436e-9e34-aca6ba01079b",2181,"2016-08-28T20:52:00.330232-05:00","3c1408e2-c7d2-4b81-a410-3f54a0758ab5_experiment.xml","400b840e38c4e92296c6511ccdb11588","08c3566a-3ab5-4886-b717-28762a9d96ad",3916,"2016-09-29T17:39:37.821795-05:00","3c1408e2-c7d2-4b81-a410-3f54a0758ab5_run.xml","13c7217f92e570815e3c03373efee517","04ef95c2-ee75-489e-8d42-039b8473491d",1989,"2016-09-08T13:46:59.238770-05:00","TCGA-25-2400","2016-09-02T19:12:04.614711-05:00","female","TCGA-25-2400_demographic",1928,"white","3c33fcef-becb-52f1-8639-ed1171c7abf6","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2400_diagnosis","not reported",27789,"dead","8441/3",1278,1278,"f39bd60a-a005-5137-a928-fc58efb4c5d7","c56.9",-27789,"TCGA-25-2400_treatment","42214af6-e6c0-52d7-8f63-48cb7d376457","01",NA,"TCGA-25-2400-01A","1.1","b5e8849b-9002-4b65-a2ea-6a46c04aba4a",FALSE,"0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C","Primary Tumor","0.5",NA,NA,"1.1",1252022400,"01",135,"TCGA-25-2400-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:46:59.238770-05:00","2016-09-08T13:46:59.238770-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"bff6af4f-f392-43f9-bb3f-955ee0871789","881b0e48-63ea-433e-86f2-361f288cfd94","TCGA-25-2400-01A-01-BS1","TCGA-25-2400-01A-01-TS1",89,89,"7efea88f-0952-4088-9998-dff35aa7ccf2","RNA","TCGA-25-2400-01A-01R","1a2568ed-a431-4105-afd9-f60d06560476",1.8,0.15,"UV Spec","R","22","TCGA-25-2400-01A-01R-1569-13","5c98c2c5-806f-4562-ad57-e152ea8388ab",0.15,NA,NA,NA,NA,"5629bc6a-8447-5850-9e03-3f7fdc39a215","TCGA-25-2400_exposure","TCGA-25-2400-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T06:18:13.000Z","2014-08-08T06:50:15.000Z","3C1408E2-C7D2-4B81-A410-3F54A0758AB5","B5E8849B-9002-4B65-A2EA-6A46C04ABA4A","Unaligned reads",9779937280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5C98C2C5-806F-4562-AD57-E152EA8388AB","Canada's Michael Smith Genome Sciences Centre","564a5b16e4b0ef12181e14f5","5C127332-5CA0-45F1-A5AC-4876AD94E491","Ovarian Serous Cystadenocarcinoma","TAR","7EFEA88F-0952-4088-9998-DFF35AA7CCF2","2014-08-08T06:50:15.000Z","1A2568ED-A431-4105-AFD9-F60D06560476","None","NO",1,0.5,"Primary Tumor","Mayo Clinic - Rochester",NA,"7EFEA88F-0952-4088-9998-DFF35AA7CCF2",1.1,"25","MSK_252152920200_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt",NA,"TCGA-25-2400-01A",1.1,"CA0C6A83-308F-49C2-8E37-8B1F9A7132EC","TCGA",2004,NA,NA,"WITH TUMOR","B5E8849B-9002-4B65-A2EA-6A46C04ABA4A",76,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ab4e5114-ba2a-4706-8be1-a359c4e5b547.txt","Dead",1278,"TCGA-25-2400","NOT HISPANIC OR LATINO","97A1075F-1009-4E51-AD56-1D86AB3F66FA",NA,1278,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,135,"BFF6AF4F-F392-43F9-BB3F-955EE0871789","CFFCF9BC-EBFE-4132-B44D-04889F3021CF","TCGA-25-2400-01A-01R-1569-13_mirna.bam.bai","TCGA-25-2400-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-25-2400-01A-01-TS1",89,"Carboplatin","Chemotherapy","TCGA-25-2400-D26825",NA,NA,NA,"TCGA-25-2400-F26823_NTE-1",NA,1278,"WITH TUMOR","Dead",1278,"TCGA-25-2400-F26823","TCGA-25-2400",NA,"25","2400","YES","C56.9","8441/3","C56.9",NA,NA,-27789,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1278,1278,NA,NA,"WITH TUMOR","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,76,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
139937776,137824239,10207063679,"7E84698B-0394-4498-A8D4-F3F96F49E669.bw","5c159ab5-8475-4d93-89b8-b6befed4a5b3","7e84698b-0394-4498-a8d4-f3f96f49e669","2016-08-21T05:08:39.224121-05:00","TCGA-13-0883-01A-02R-1569-13_rnaseq_fastq.tar","2229cf9d-4fab-4a28-9846-443e1362b2ef",8373514240,"Illumina HiSeq","cdc29dd13610d7589137ad3d3d6b3965","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:48:14.202727-05:00","2016-05-03T11:55:09.260543-05:00","2229cf9d-4fab-4a28-9846-443e1362b2ef_analysis.xml","fa52ee48943658ee6ded422042a3cb9c","30423f65-4eaa-499c-a3a2-b57874bc31cd",2181,"2016-09-29T19:40:44.109226-05:00","2229cf9d-4fab-4a28-9846-443e1362b2ef_experiment.xml","1a416c85068640beb2532fc80082c518","51257ee0-9fb0-40c2-a356-931a4cc4924a",3916,"2016-09-29T18:27:07.377818-05:00","2229cf9d-4fab-4a28-9846-443e1362b2ef_run.xml","6bceb55db3f1537cd0f811f509f9cb7e","22db42d1-6dc6-4c1d-a97c-07f72775baa1",1988,"2016-09-08T12:34:27.766389-05:00","TCGA-13-0883","2016-09-02T19:06:10.944108-05:00","female","TCGA-13-0883_demographic",1941,"white","580cfffe-92f6-5401-9167-dac54793bc2e","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0883_diagnosis","not reported",22395,"dead","8441/3",2097,2097,"1ca82c95-b632-5780-9c0b-cc470669922c","c56.9",-22395,"TCGA-13-0883_treatment","aa138e2d-759a-59fa-85ed-c7a2a5d7e157","01",NA,"TCGA-13-0883-01A","1.1","c084ec17-62a3-43d7-bc0d-ab806bcd35a3",FALSE,"7AC6471C-1BA0-4AA5-9A2E-70413C9768F8","Primary Tumor","0.4",NA,NA,"1.4",1233705600,"02",173,"TCGA-13-0883-01A-02",80,90,NA,NA,20,10,0,0,"2016-09-08T12:34:27.766389-05:00","2016-09-08T12:34:27.766389-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"a00b3891-5c61-43b1-a0d3-9857ac0d942a","b3603594-ed44-4e5e-861a-52aa4eeb71de","TCGA-13-0883-01A-01-BS1","TCGA-13-0883-01A-02-BS2",78,88,"62d3a2bd-8a72-48ca-bf02-47ecd8535d84","RNA","TCGA-13-0883-01A-02R","c12585e6-4b3f-4917-b379-60ca456070be",1.8,0.16,"UV Spec","R","22","TCGA-13-0883-01A-02R-1569-13","1cc5dd24-87c4-4b49-851f-618d0ca98875",0.16,NA,NA,NA,NA,"63106c97-3353-5b85-9e0e-e093ed3ecc0e","TCGA-13-0883_exposure","TCGA-13-0883-01A-02R-1569-13_rnaseq_fastq.tar","2014-08-07T23:21:58.000Z","2014-08-07T23:44:36.000Z","2229CF9D-4FAB-4A28-9846-443E1362B2EF","C084EC17-62A3-43D7-BC0D-AB806BCD35A3","Unaligned reads",8373514240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1CC5DD24-87C4-4B49-851F-618D0CA98875","Canada's Michael Smith Genome Sciences Centre","564a5c48e4b09c884b27c743","5C159AB5-8475-4D93-89B8-B6BEFED4A5B3","Ovarian Serous Cystadenocarcinoma","TAR","62D3A2BD-8A72-48CA-BF02-47ECD8535D84","2014-08-07T23:44:36.000Z","C12585E6-4B3F-4917-B379-60CA456070BE","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"62D3A2BD-8A72-48CA-BF02-47ECD8535D84",1.1,"13","TCGA-13-0883-01A-02W-0420-08_IlluminaGA-DNASeq_capture.bam",NA,"TCGA-13-0883-01A",1.4,"D214B9D5-80DD-4328-91A0-0C5F62E7C3C2","TCGA",2002,NA,NA,"WITH TUMOR","C084EC17-62A3-43D7-BC0D-AB806BCD35A3",61,"nationwidechildrens.org_clinical.TCGA-13-0883.xml","Dead",2097,"TCGA-13-0883","NOT HISPANIC OR LATINO","0AD0A258-A395-4214-915D-499FB9671A1E",NA,2097,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,2,173,"A00B3891-5C61-43B1-A0D3-9857AC0D942A","ACC3C131-6F61-4EBF-BD28-16EDC4D6E47F","US82800149_251976010379_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","TCGA-13-0883-01A-02",80,20,NA,NA,0,"TOP",2,NA,"TCGA-13-0883-01A-01-BS1",78,"Cisplatin","Chemotherapy","TCGA-13-0883-D24649",NA,NA,NA,"TCGA-13-0883-F24646_NTE-1",NA,2097,"WITH TUMOR","Dead",2097,"TCGA-13-0883-F24646","TCGA-13-0883",NA,"13","0883","YES","C56.9","8441/3","C56.9",NA,NA,-22395,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",2097,2097,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2002,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
407366572,387076722,28453500550,"D29F2335-9151-406E-8C3A-58AA99B7EB69.bw","5c6f3cd4-19c5-418d-b1be-d3fbf63e99db","d29f2335-9151-406e-8c3a-58aa99b7eb69","2016-08-22T21:22:11.975643-05:00","TCGA-13-0899-01A-01R-1564-13_rnaseq_fastq.tar","e93c5562-34b4-461a-ab97-42aae98c4349",27188838400,"Illumina HiSeq","a94271f551db55080964ca1a130c6313","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:39:08.731438-05:00","2016-05-03T11:39:34.522989-05:00","e93c5562-34b4-461a-ab97-42aae98c4349_analysis.xml","0a50176801d2592bb059610000916e64","04a0889a-d75d-45a3-8c4a-d22ef9b8c391",2183,"2016-09-30T00:11:13.964350-05:00","e93c5562-34b4-461a-ab97-42aae98c4349_experiment.xml","ee08d33b9fc46bd823911fe680d7b41e","f8733c45-a13f-4035-9e10-9bfc24239ed2",3916,"2016-09-30T00:15:23.966774-05:00","e93c5562-34b4-461a-ab97-42aae98c4349_run.xml","a3c1fdde7f9010c6d0b636a9813668ca","fb1eb3f6-afbd-4da5-8c5c-749d54eda925",1990,"2016-09-08T12:36:22.476007-05:00","TCGA-13-0899","2016-09-02T19:05:30.959554-05:00","female","TCGA-13-0899_demographic",1944,"white","cb83a315-81d1-5941-9ecb-26ee6ebcbe64","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0899_diagnosis","not reported",22031,"dead","8441/3",2012,1708,"39542801-2152-5d8a-85de-8d641a606424","c56.9",-22031,"TCGA-13-0899_treatment","2e4dc611-2eae-5df7-8df5-1cb73dce374a","01",NA,"TCGA-13-0899-01A","1.3","d14005f6-55df-422b-a152-3c313b8df92f",FALSE,"AB15D325-CCD6-452F-8662-158E3153AFC4","Primary Tumor","0.5",NA,NA,"1.6",1233705600,"01",137,"TCGA-13-0899-01A-01",85,80,NA,NA,20,20,1,0,"2016-09-08T12:36:22.476007-05:00","2016-09-08T12:36:22.476007-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"2685cda5-6261-4f47-b643-cbb7d9a70dd6","038bf72a-ce13-4f12-886b-4add8942d1f6","TCGA-13-0899-01A-01-TS1","TCGA-13-0899-01A-01-BS1",79,79,"99033ee8-a8b7-4107-b815-661c7aaa07f1","RNA","TCGA-13-0899-01A-01R","2fb3f35b-b714-4d38-9857-a7f8061981bc",1.8,0.14,"UV Spec","R","22","TCGA-13-0899-01A-01R-1564-13","605d0aed-4637-4a09-82dd-eedd1aa76ca0",0.14,NA,NA,NA,NA,"f269feec-fc23-59ec-a0f1-fb854c9ddeee","TCGA-13-0899_exposure","TCGA-13-0899-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T01:40:11.000Z","2014-03-20T02:31:02.000Z","E93C5562-34B4-461A-AB97-42AAE98C4349","D14005F6-55DF-422B-A152-3C313B8DF92F","Unaligned reads",27188838400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","605D0AED-4637-4A09-82DD-EEDD1AA76CA0","Canada's Michael Smith Genome Sciences Centre","564a5b42e4b093830b6cf376","5C6F3CD4-19C5-418D-B1BE-D3FBF63E99DB","Ovarian Serous Cystadenocarcinoma","TAR","99033EE8-A8B7-4107-B815-661C7AAA07F1","2014-03-20T02:31:02.000Z","2FB3F35B-B714-4D38-9857-A7F8061981BC","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"99033EE8-A8B7-4107-B815-661C7AAA07F1",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eacc42b9-bd6e-468c-8560-6d699ae97737.txt",NA,"TCGA-13-0899-01A",1.6,"F1500CB6-1ACC-4EBA-A03D-BDF3B9327360","TCGA",2004,NA,NA,"WITH TUMOR","F245D828-5631-47E6-9A0C-114165F800A6",60,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eacc42b9-bd6e-468c-8560-6d699ae97737.txt","Alive",NA,"TCGA-13-0899","NOT HISPANIC OR LATINO","FD6B2332-5712-4DF7-BF7B-366934559985",NA,1708,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,137,"2685CDA5-6261-4F47-B643-CBB7D9A70DD6","F7D4A58D-F957-4303-9F09-B1CA552582D2","jhu-usc.edu_OV.HumanMethylation27.2.lvl-2.TCGA-13-0899-01A-01D-0402-05.txt","TCGA-13-0899-01A-01",85,20,NA,NA,1,"TOP",0,NA,"TCGA-13-0899-01A-01-TS1",79,"Paclitaxel","Chemotherapy","TCGA-13-0899-D24706",NA,NA,NA,"TCGA-13-0899-F24704_NTE-1",NA,1708,"WITH TUMOR","Alive",NA,"TCGA-13-0899-F24704","TCGA-13-0899",NA,"13","0899","YES","C56.9","8441/3","C56.9",NA,NA,-22031,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1708,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,60,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
149571542,140116302,10247347584,"92CEB4B5-0400-45DD-9DEE-E988CB4BB76D.bw","5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5","92ceb4b5-0400-45dd-9dee-e988cb4bb76d","2016-08-25T15:09:11.237867-05:00","TCGA-29-1777-01A-01R-1567-13_rnaseq_fastq.tar","0824efa1-e4c4-4104-83b3-f84fe90b6884",8844728320,"Illumina HiSeq","093493852cdb5612444b69ad5db33c72","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:17:21.885221-05:00","2016-05-03T11:41:05.755204-05:00","0824efa1-e4c4-4104-83b3-f84fe90b6884_analysis.xml","0946251493ea03e6f4fac3940d69a2d6","b20274a3-760b-4480-871c-5a3f8b5682e0",2242,"2016-08-13T05:12:38.404656-05:00","0824efa1-e4c4-4104-83b3-f84fe90b6884_experiment.xml","daabec0c0e4e82ee33daa83cdfd24f24","a7deb1a6-e204-436e-bcc8-1cc1b239868e",3916,"2016-09-29T22:34:59.889026-05:00","0824efa1-e4c4-4104-83b3-f84fe90b6884_run.xml","cc3396bf956634cdccabed1a2e0a714e","bcd82f39-7579-488a-b472-1e33d008990c",1990,"2016-09-08T10:27:31.341853-05:00","TCGA-29-1777","2016-09-02T18:47:42.520680-05:00","female","TCGA-29-1777_demographic",1961,"white","76f43d25-03dd-5e87-a305-baf33d049fbf","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1777_diagnosis","not reported",17356,"alive","8441/3",NA,374,"06faab0f-085d-5399-a16e-833cb5d7e9d7","c56.9",-17356,"TCGA-29-1777_treatment","1926b00e-c834-5070-8fe4-063f9171cb7f","01",NA,"TCGA-29-1777-01A","0.6","afb43292-69c2-4d84-84f5-0bde9a6e9ea5",FALSE,"bfd59906-509b-4ca3-9282-c881f9962e15","Primary Tumor","0.5",NA,NA,"1.3",1243296000,"01",147,"TCGA-29-1777-01A-01",80,85,NA,NA,0,0,25,20,"2016-09-08T10:27:31.341853-05:00","2016-09-08T10:27:31.341853-05:00",5,5,NA,NA,"BOTTOM","TOP",0,0,"e18509e1-c5b0-4c84-b397-22b8d89f8ccb","ebda1d10-aaa2-453b-b650-7d7f128ee0a7","TCGA-29-1777-01A-01-BS1","TCGA-29-1777-01A-01-TS1",75,80,"0ea85734-9934-4283-9de3-bc59e2b0ccfb","RNA","TCGA-29-1777-01A-01R","fb8bef1b-94e4-44a9-b4a7-db2026306032",1.8,0.17,"UV Spec","R","22","TCGA-29-1777-01A-01R-1567-13","cbeba637-1a32-45f1-83f3-614725665436",0.17,NA,NA,NA,NA,"ed38b22e-e67f-5167-89ec-2e3c7eedb3f7","TCGA-29-1777_exposure","TCGA-29-1777-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T07:04:05.000Z","2014-03-27T07:20:01.000Z","0824EFA1-E4C4-4104-83B3-F84FE90B6884","AFB43292-69C2-4D84-84F5-0BDE9A6E9EA5","Unaligned reads",8844728320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CBEBA637-1A32-45F1-83F3-614725665436","Canada's Michael Smith Genome Sciences Centre","564a5b76e4b093830b6d016a","5CED5B58-FAB4-4BCD-B706-D6E49CE0CFC5","Ovarian Serous Cystadenocarcinoma","TAR","0EA85734-9934-4283-9DE3-BC59E2B0CCFB","2014-03-27T07:20:01.000Z","FB8BEF1B-94E4-44A9-B4A7-DB2026306032","None","NO",1,0.5,"Primary Tumor","Duke",NA,"0EA85734-9934-4283-9DE3-BC59E2B0CCFB",0.6,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9b5e802b-56e7-4f93-8869-2db3170006bc.txt",NA,"TCGA-29-1777-01A",1.3,"B75CAA77-A905-4A32-B84B-DA1B1C8917A5","TCGA",2008,NA,NA,"WITH TUMOR","AFB43292-69C2-4D84-84F5-0BDE9A6E9EA5",47,"nationwidechildrens.org_clinical.TCGA-29-1777.xml","Alive",NA,"TCGA-29-1777",NA,"26534F1E-AE94-44AF-8630-10166F59E9A1",NA,374,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,147,"E18509E1-C5B0-4C84-B397-22B8D89F8CCB","FB8BEF1B-94E4-44A9-B4A7-DB2026306032","TCGA-29-1777-01A-01R-1567-13.isoform.quantification.txt","TCGA-29-1777-01A-01",85,0,NA,5,20,"TOP",0,NA,"TCGA-29-1777-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-29-1777-D27416",NA,NA,NA,NA,NA,374,"WITH TUMOR","Alive",NA,"TCGA-29-1777-F27415","TCGA-29-1777",NA,"29","1777","YES","C56.9","8441/3","C56.9",NA,NA,-17356,"FEMALE","WHITE",NA,NA,"No","Alive",374,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,47,2008,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
261893294,254121030,18841969021,"1848D6A6-9725-46BA-A953-CE76F6CC7684.bw","5d1a54fe-e0df-4c17-b623-b649a136dc82","1848d6a6-9725-46ba-a953-ce76f6cc7684","2016-08-25T03:42:31.130373-05:00","TCGA-61-2101-01A-01R-1568-13_rnaseq_fastq.tar","cf9a58d6-8f6e-4613-9618-53ede4040193",17295196160,"Illumina HiSeq","d0cbc5b62703a856bd7f08cb378ce5cd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:26:50.995381-05:00","2016-05-03T11:41:05.755204-05:00","cf9a58d6-8f6e-4613-9618-53ede4040193_analysis.xml","e426b81b9e466246ea7f918c9d8831eb","489aaf06-d96f-483b-8a60-331f95d34573",2183,"2016-09-29T22:59:33.542415-05:00","cf9a58d6-8f6e-4613-9618-53ede4040193_experiment.xml","5c05991b24302a277ebed189b45eae73","cbf8abde-ffb7-41a7-9a99-571fc2b41a8a",3916,"2016-09-29T22:54:45.926075-05:00","cf9a58d6-8f6e-4613-9618-53ede4040193_run.xml","b887b40b8cb3ed0685b685472618c25c","c91ed3cd-e05b-43bc-b9cc-c4d95cf8e5cb",1990,"2016-09-08T12:13:23.606996-05:00","TCGA-61-2101","2016-09-02T18:56:27.854690-05:00","female","TCGA-61-2101_demographic",1944,"white","b7c5d9f0-7661-5b83-b542-63db349c7ce3","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2101_diagnosis","not reported",20287,"dead","8441/3",1688,NA,"bcf6dd1a-9c55-5d62-950c-9c3e804897d1","c56.9",-20287,"TCGA-61-2101_treatment","420624e8-613c-5017-8e58-2363bfb58d49","01",NA,"TCGA-61-2101-01A","0.4","46d32513-dc68-4261-8e1b-26d407b6546a",FALSE,"b9d85995-85dd-4b00-b93f-3387cd018475","Primary Tumor","0.4",NA,NA,"1.5",1250467200,"01",141,"TCGA-61-2101-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:13:23.606996-05:00","2016-09-08T12:13:23.606996-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"d5aab1ba-183b-4f16-8f4c-5902e34d5ea3","ea43cb3b-f8d4-4869-bf64-ce0af7638a57","TCGA-61-2101-01A-01-TS1","TCGA-61-2101-01A-01-BS1",90,90,"3fb8aedd-61a1-4169-b4b1-753f4104c09e","RNA","TCGA-61-2101-01A-01R","7b3b08e4-7b60-4606-b530-85ab3384efa5",1.8,0.15,"UV Spec","R","22","TCGA-61-2101-01A-01R-1568-13","95970bdb-e1f2-49dc-903b-c30088cef71d",0.15,NA,NA,NA,NA,"3db319a4-0177-59e2-905c-936040312204","TCGA-61-2101_exposure","TCGA-61-2101-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T08:35:35.000Z","2014-03-27T09:03:02.000Z","CF9A58D6-8F6E-4613-9618-53EDE4040193","46D32513-DC68-4261-8E1B-26D407B6546A","Unaligned reads",17295196160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","95970BDB-E1F2-49DC-903B-C30088CEF71D","Canada's Michael Smith Genome Sciences Centre","564a584de4b0ef12181d29f6","5D1A54FE-E0DF-4C17-B623-B649A136DC82","Ovarian Serous Cystadenocarcinoma","TAR","3FB8AEDD-61A1-4169-B4B1-753F4104C09E","2014-03-27T09:03:02.000Z","7B3B08E4-7B60-4606-B530-85AB3384EFA5","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"3FB8AEDD-61A1-4169-B4B1-753F4104C09E",0.4,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c33bc4d6-607a-425b-bffd-e818b69949f8.txt",NA,"TCGA-61-2101-01A",1.5,"BB3E3E24-B6DB-4A5C-AE01-B27AB1C1628C","TCGA",1999,NA,NA,"WITH TUMOR","46D32513-DC68-4261-8E1B-26D407B6546A",55,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c33bc4d6-607a-425b-bffd-e818b69949f8.txt","Dead",1688,"TCGA-61-2101","NOT HISPANIC OR LATINO","D25C7CEB-DE04-4A5B-87E1-8C217938DE7D",NA,1688,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,100,NA,"8441/3","FEMALE","C56.9",22,NA,"BCE41480-77EB-4E42-BE71-741A6CE4CAED","WHITE",NA,1,141,"EA43CB3B-F8D4-4869-BF64-CE0AF7638A57","7B3B08E4-7B60-4606-B530-85AB3384EFA5","TCGA-61-2101-01A-01R-1568-13_mirna.bam.bai","TCGA-61-2101-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-61-2101-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-61-2101-D28426","TCGA-61-2101-R28436","EXTERNAL BEAM","Primary Tumor Field",NA,NA,1688,"WITH TUMOR","Dead",1688,"TCGA-61-2101-F28422","TCGA-61-2101",NA,"61","2101","YES","C56.9","8441/3","C56.9",NA,NA,-20287,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1688,NA,NA,"WITH TUMOR","NO",7,12,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,1999,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,100,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
290550788,281904585,20865095710,"F0B60FEF-0246-412D-8E1D-50E4A5F7790A.bw","5d36676e-4140-44b5-aa0e-b2af092b7dc0","f0b60fef-0246-412d-8e1d-50e4a5f7790a","2016-08-27T02:40:24.476689-05:00","TCGA-24-1555-01A-01R-1566-13_rnaseq_fastq.tar","9c647127-e0ba-472e-8949-2367335ee7d3",18852106240,"Illumina HiSeq","e8e6c05c1805601209fa6a54b58895b4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:36:31.300280-05:00","2016-05-03T11:39:34.528512-05:00","9c647127-e0ba-472e-8949-2367335ee7d3_analysis.xml","d6a3a9587e04dc87f73775847bff9705","73478b18-9671-4036-b66c-a93d959ea119",2181,"2016-10-07T15:46:33.109924-05:00","9c647127-e0ba-472e-8949-2367335ee7d3_experiment.xml","9e959a52667f1fd0c4890a1c924f3179","31cd1a61-f334-437d-988e-0deecc7ed49e",3916,"2016-09-29T20:34:58.754517-05:00","9c647127-e0ba-472e-8949-2367335ee7d3_run.xml","17b5d11391fc8c910cd01dd6a6ef11e4","725b0f52-e9fa-41e8-a3f4-990fa0e4ec98",1988,"2016-09-08T13:01:15.515053-05:00","TCGA-24-1555","2016-09-02T19:07:11.390154-05:00","female","TCGA-24-1555_demographic",1947,"white","c78d7d69-2916-5e30-85d8-5d59a1e088d4","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1555_diagnosis","not reported",18404,"dead","8441/3",2692,2692,"b46f42db-5cc4-512f-b5e5-6c173746e090","c56.9",-18404,"TCGA-24-1555_treatment","e0430018-d232-53b2-aa49-4487cde4b9d9","01",NA,"TCGA-24-1555-01A","1","b359856a-959f-4b31-9e92-ef33c591c17a",FALSE,"b7b2f370-207a-4849-b7a0-528789363a02","Primary Tumor","0.4",NA,NA,"1",1235260800,"01",162,"TCGA-24-1555-01A-01",95,90,NA,NA,0,0,20,25,"2016-09-08T13:01:15.515053-05:00","2016-09-08T13:01:15.515053-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"e0c74d87-fa4e-45f2-8ba8-f481917d6022","dc5cdfbc-c7c9-44e2-97f4-176329e01371","TCGA-24-1555-01A-01-TS1","TCGA-24-1555-01A-01-BS1",80,75,"c2376d9c-3142-49a7-bd22-7b6d2d4de2b4","RNA","TCGA-24-1555-01A-01R","eb386307-bd13-4249-8f39-4e3fc4ae1c79",1.8,0.14,"UV Spec","R","22","TCGA-24-1555-01A-01R-1566-13","0ec7ea28-7bd4-45c3-b03c-d855014fa4f4",0.14,NA,NA,NA,NA,"d05aea60-3b76-5290-810e-b0a6fe15859f","TCGA-24-1555_exposure","TCGA-24-1555-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T09:10:27.000Z","2014-03-20T09:43:02.000Z","9C647127-E0BA-472E-8949-2367335EE7D3","B359856A-959F-4B31-9E92-EF33C591C17A","Unaligned reads",18852106240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0EC7EA28-7BD4-45C3-B03C-D855014FA4F4","Canada's Michael Smith Genome Sciences Centre","564a3510e4b0ef12181868b2","5D36676E-4140-44B5-AA0E-B2AF092B7DC0","Ovarian Serous Cystadenocarcinoma","TAR","C2376D9C-3142-49A7-BD22-7B6D2D4DE2B4","2014-03-20T09:43:02.000Z","EB386307-BD13-4249-8F39-4E3FC4AE1C79","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"C2376D9C-3142-49A7-BD22-7B6D2D4DE2B4",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.10cb1259-03bf-4d9e-946e-bea05e4f23bd.txt",NA,"TCGA-24-1555-01A",1,"BC8F5F9C-8A23-44D0-A253-3A6CC0100BE1","TCGA",1997,NA,NA,"WITH TUMOR","DDBAE478-8A2E-42F1-B9B7-767E18802BA4",50,"nationwidechildrens.org_clinical.TCGA-24-1555.xml","Dead",2692,"TCGA-24-1555",NA,"5867B96D-991E-437A-9E0C-B4C7846721AD",NA,2692,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,162,"DC5CDFBC-C7C9-44E2-97F4-176329E01371","EC74FE6C-3740-4F2E-8F0B-5AA9BD6EC41C","TCGA-24-1555-01A-01W-0552-10_SOLiD.bam.bai","TCGA-24-1555-01A-01",90,0,NA,NA,25,"BOTTOM",0,NA,"TCGA-24-1555-01A-01-BS1",75,"Gemzar","Chemotherapy","TCGA-24-1555-D26179",NA,NA,NA,"TCGA-24-1555-F26171_NTE-1",NA,2692,"WITH TUMOR","Dead",2692,"TCGA-24-1555-F26171","TCGA-24-1555",NA,"24","1555","YES","C56.9","8441/3","C56.9",NA,NA,-18404,"FEMALE","WHITE",NA,NA,"No","Dead",2692,2692,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
124839264,118271810,8726725812,"763F284D-B99A-4646-A84C-5EFB15C07376.bw","5d603bba-62e6-48fb-b8fc-401109abcaee","763f284d-b99a-4646-a84c-5efb15c07376","2016-08-21T01:24:10.412886-05:00","TCGA-30-1853-01A-02R-1567-13_rnaseq_fastq.tar","eac6dc32-74f2-42c7-8ee4-6b6a7321ad84",7751874560,"Illumina HiSeq","f572df1684ed2a115dc0233113d03cc1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:38:11.576582-05:00","2016-05-03T11:41:05.740436-05:00","eac6dc32-74f2-42c7-8ee4-6b6a7321ad84_analysis.xml","8d85fd5e827a1627b2d7175e1c01f289","e41a227b-60a0-42e4-8549-806516881a25",2265,"2016-09-29T19:11:46.117051-05:00","eac6dc32-74f2-42c7-8ee4-6b6a7321ad84_experiment.xml","573212285af541bfdd1b4b76660216ff","3f12c505-bebb-431f-9c87-ee067b59a7cf",3916,"2016-09-29T20:19:18.990480-05:00","eac6dc32-74f2-42c7-8ee4-6b6a7321ad84_run.xml","851176afa52d2631f76acc2d46d5fc35","68c97148-8b0c-4273-9bf2-aa9f4d3e1700",1988,"2016-09-08T11:15:51.759262-05:00","TCGA-30-1853","2016-09-02T18:50:42.473098-05:00","female","TCGA-30-1853_demographic",1942,"white","9649f5ae-33a3-5b79-b29f-c90792bbbc57","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1853_diagnosis","not reported",21404,"dead","8441/3",1103,1103,"0de0b75a-d428-5237-ac4d-c3078e11272d","c56.9",-21404,"TCGA-30-1853_treatment","92fcd1cb-811d-50be-9e36-8cfd9f8c6788","01",NA,"TCGA-30-1853-01A","0.6","35817ec6-5c0c-44d7-b5a8-b6de3ab24fdd",FALSE,"ded9ba4c-8d3d-450b-a345-772a3e3ae288","Primary Tumor","0.4",NA,NA,"1",1245369600,"02",131,"TCGA-30-1853-01A-02",99,99,NA,NA,0,0,1,1,"2016-09-08T11:15:51.759262-05:00","2016-09-08T11:15:51.759262-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"97d7d1f1-3b08-47ed-84d2-9c7439d1720c","59402746-32fc-4ce7-ac6f-235da20da619","TCGA-30-1853-01A-01-BS1","TCGA-30-1853-01A-02-BS2",98,98,"a53e6cad-652e-4911-a849-69a0c88f193b","RNA","TCGA-30-1853-01A-02R","71f3c368-3988-480b-9b90-62232d5a49a8",1.8,0.14,"UV Spec","R","22","TCGA-30-1853-01A-02R-1567-13","fc32468d-de77-4e0e-b1a2-203ac119cb02",0.14,NA,NA,NA,NA,"f0fdac4e-a099-546d-8444-e2214869a76c","TCGA-30-1853_exposure","TCGA-30-1853-01A-02R-1567-13_rnaseq_fastq.tar","2014-03-27T02:09:58.000Z","2014-03-27T02:30:01.000Z","EAC6DC32-74F2-42C7-8EE4-6B6A7321AD84","35817EC6-5C0C-44D7-B5A8-B6DE3AB24FDD","Unaligned reads",7751874560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FC32468D-DE77-4E0E-B1A2-203AC119CB02","Canada's Michael Smith Genome Sciences Centre","564a5aa7e4b0ef12181df256","5D603BBA-62E6-48FB-B8FC-401109ABCAEE","Ovarian Serous Cystadenocarcinoma","TAR","A53E6CAD-652E-4911-A849-69A0C88F193B","2014-03-27T02:30:01.000Z","71F3C368-3988-480B-9B90-62232D5A49A8","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"A53E6CAD-652E-4911-A849-69A0C88F193B",0.6,"30","TCGA-30-1853-01A-02R-1567-13_rnaseq_fastq.tar",NA,"TCGA-30-1853-01A",1,"AEE7C046-3C2E-4A58-80B4-4B642C08A7E9","TCGA",2000,NA,NA,"WITH TUMOR","86B04237-3AC4-45A4-B41F-781860999AC7",58,"nationwidechildrens.org_clinical.TCGA-30-1853.xml","Dead",1103,"TCGA-30-1853","NOT HISPANIC OR LATINO","333DFD72-26D5-496A-BCC6-C256A5360B5C",NA,1103,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,2,131,"97D7D1F1-3B08-47ED-84D2-9C7439D1720C","C4474482-978E-4F2B-8096-2B9CD15033C3","TCGA-30-1853-01A-02R-1567-13.hg19.spljxn.quantification.txt","TCGA-30-1853-01A-02",99,0,NA,NA,1,"BOTTOM",1,NA,"TCGA-30-1853-01A-02-BS2",98,"Carboplatin","Chemotherapy","TCGA-30-1853-D27544",NA,NA,NA,"TCGA-30-1853-F27542_NTE-2",NA,1103,"WITH TUMOR","Dead",1103,"TCGA-30-1853-F27542","TCGA-30-1853",NA,"30","1853","YES","C56.9","8441/3","C56.9",NA,NA,-21404,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1103,1103,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
223269632,216565484,16024928419,"994BE7F6-D486-4E45-9C4F-7AA200B04AED.bw","5d7027f5-60a0-47ab-a79d-667c9acc0e54","994be7f6-d486-4e45-9c4f-7aa200b04aed","2016-08-25T17:59:04.504905-05:00","TCGA-24-1616-01A-01R-1566-13_rnaseq_fastq.tar","4fd840de-b2d2-4376-889c-8418d0fd4f70",14524303360,"Illumina HiSeq","d38f3ae9576adcfa71652c0944391a4c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:58:41.863510-05:00","2016-05-03T11:39:34.528512-05:00","4fd840de-b2d2-4376-889c-8418d0fd4f70_analysis.xml","b6679b450256d9545819fd99fe46ff88","5c541e8d-7460-47c8-829a-5bf145be855e",2181,"2016-10-07T15:58:18.327965-05:00","4fd840de-b2d2-4376-889c-8418d0fd4f70_experiment.xml","713bb664dcdb8dbc613541971194d273","0ac7a2da-0219-4d93-9465-eae5ec083ca4",3916,"2016-09-29T22:30:47.726015-05:00","4fd840de-b2d2-4376-889c-8418d0fd4f70_run.xml","978c027d87d16f5ef15bc87580cb9685","ba3fc5c8-c909-435a-b1f4-6597cd3837c3",1988,"2016-09-08T12:59:04.665120-05:00","TCGA-24-1616","2016-09-02T19:07:09.727438-05:00","female","TCGA-24-1616_demographic",1945,"white","b5a2d23a-7e9e-5ce2-bf23-c98e8e04a0a6","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1616_diagnosis","not reported",20785,"dead","8441/3",1163,1163,"661d13d0-4961-5a39-bd67-d1665dda7bc5","c56.9",-20785,"TCGA-24-1616_treatment","e6ea5986-200c-5661-801e-6fd1cda8c46f","01",NA,"TCGA-24-1616-01A","0.7","20d8a43d-e1a7-4e85-8da2-2e9b5f1d3a9a",FALSE,"d8c764d9-0fe8-488e-8aa1-da73a8c10b01","Primary Tumor","0.4",NA,NA,"0.9",1237420800,"01",106,"TCGA-24-1616-01A-01",70,80,NA,NA,0,0,35,30,"2016-09-08T12:59:04.665120-05:00","2016-09-08T12:59:04.665120-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,0,"8b605a9a-3f71-4af6-b7eb-1bb33efa45ed","88f13167-f84b-47af-9e96-c9e2750a70e3","TCGA-24-1616-01A-01-TS1","TCGA-24-1616-01A-01-BS1",60,70,"8506679e-5ddf-4185-a99e-5f2a923ee70f","RNA","TCGA-24-1616-01A-01R","ba4cc7ff-3f7e-414b-90bc-6c35a3f50dc8",1.8,0.17,"UV Spec","R","22","TCGA-24-1616-01A-01R-1566-13","c334b353-0652-49fb-8cd6-5bcf8485e5d0",0.17,NA,NA,NA,NA,"07d64dfb-f638-534f-9c67-4ae276c6bbfc","TCGA-24-1616_exposure","TCGA-24-1616-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T09:30:22.000Z","2014-03-20T09:55:01.000Z","4FD840DE-B2D2-4376-889C-8418D0FD4F70","20D8A43D-E1A7-4E85-8DA2-2E9B5F1D3A9A","Unaligned reads",14524303360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C334B353-0652-49FB-8CD6-5BCF8485E5D0","Canada's Michael Smith Genome Sciences Centre","564a3df6e4b093830b6a1588","5D7027F5-60A0-47AB-A79D-667C9ACC0E54","Ovarian Serous Cystadenocarcinoma","TAR","8506679E-5DDF-4185-A99E-5F2A923EE70F","2014-03-20T09:55:01.000Z","BA4CC7FF-3F7E-414B-90BC-6C35A3F50DC8","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"8506679E-5DDF-4185-A99E-5F2A923EE70F",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3e449bae-1749-47d9-adc1-6e70b0c829dc.txt",NA,"TCGA-24-1616-01A",0.9,"B2D785F8-6F1A-4971-8CE9-822F6D1F7270","TCGA",2001,NA,NA,"WITH TUMOR","736FA8C5-C126-40E0-92BA-72928D36C225",56,"nationwidechildrens.org_clinical.TCGA-24-1616.xml","Dead",1163,"TCGA-24-1616",NA,"127C2B96-0BA3-4DB7-8DE7-AF44DA6AA3DF",NA,1163,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,106,"88F13167-F84B-47AF-9E96-C9E2750A70E3","BA4CC7FF-3F7E-414B-90BC-6C35A3F50DC8","TCGA-24-1616-01A-01R-1566-13_mirna.bam.bai","TCGA-24-1616-01A-01",80,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-24-1616-01A-01-BS1",70,"Taxol","Chemotherapy","TCGA-24-1616-D26321",NA,NA,NA,"TCGA-24-1616-F26315_NTE-1",NA,1163,"WITH TUMOR","Dead",1163,"TCGA-24-1616-F26315","TCGA-24-1616",NA,"24","1616","YES","C56.9","8441/3","C56.9",NA,NA,-20785,"FEMALE","WHITE",NA,NA,"No","Dead",1163,1163,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
243320990,232836158,17212445850,"54C0AB23-0161-4346-AF6D-466B68B5AB79.bw","5e18b17d-4626-4b6d-8ac6-e560cee0376c","54c0ab23-0161-4346-af6d-466b68b5ab79","2016-08-20T08:39:42.312328-05:00","TCGA-24-1419-01A-01R-1565-13_rnaseq_fastq.tar","401697b6-1e3d-44ef-b57c-e0ced8cbbb9c",15898818560,"Illumina HiSeq","e2242337483df5c6df20808aa9ff2021","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:34:00.398938-05:00","2016-05-03T11:40:21.648680-05:00","401697b6-1e3d-44ef-b57c-e0ced8cbbb9c_analysis.xml","735864efd807af382784151bb26514f2","71b9f280-d93a-411b-abab-a5ad76db4a52",2181,"2016-09-29T20:47:20.067282-05:00","401697b6-1e3d-44ef-b57c-e0ced8cbbb9c_experiment.xml","349aa76a45fede88494832598ad95503","7a0a5e16-11c7-460c-a2c7-a44e2368c003",3916,"2016-09-29T20:51:11.288316-05:00","401697b6-1e3d-44ef-b57c-e0ced8cbbb9c_run.xml","d26c3f119c7a21adaeab6cd0233aaeba","7c7aacea-3047-47d3-9578-8df41725eb50",1988,"2016-09-08T13:56:41.401728-05:00","TCGA-24-1419","2016-09-02T19:14:00.113005-05:00","female","TCGA-24-1419_demographic",1946,"white","3f13178e-a4ea-57f8-a075-e6c7d1ca68bd","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1419_diagnosis","not reported",22659,"alive","8441/3",NA,239,"0e5dd5f1-3f97-56e1-a043-2c72b348edc7","c56.9",-22659,"TCGA-24-1419_treatment","9d51deb3-1711-5307-8b2d-811f88bca941","01",NA,"TCGA-24-1419-01A","1.2","92d562df-4a58-43da-8811-843d3d3c9438",FALSE,"0a8c75aa-8031-4f1d-9dba-9029b009d677","Primary Tumor","0.3",NA,NA,"1.8",1231891200,"01",137,"TCGA-24-1419-01A-01",95,90,NA,NA,25,15,0,0,"2016-09-08T13:56:41.401728-05:00","2016-09-08T13:56:41.401728-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,2,"4e3b292c-2e03-4a9a-8d8c-4b1c178e2039","08bb7421-dfee-4e8f-8bdb-74a1626872f1","TCGA-24-1419-01A-01-TS1","TCGA-24-1419-01A-01-BS1",75,83,"0d70b9ce-2ae5-4b7f-b60c-5d3d967628e4","RNA","TCGA-24-1419-01A-01R","94d566ab-09f2-45ca-b039-77d8ac00ae00",1.8,0.15,"UV Spec","R","22","TCGA-24-1419-01A-01R-1565-13","7bf43d51-2714-419e-a52f-863ca54c90e5",0.15,NA,NA,NA,NA,"f841956a-b3e8-5f7f-be89-7e31f86b880e","TCGA-24-1419_exposure","TCGA-24-1419-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:19:28.000Z","2014-03-21T22:52:01.000Z","401697B6-1E3D-44EF-B57C-E0CED8CBBB9C","92D562DF-4A58-43DA-8811-843D3D3C9438","Unaligned reads",15898818560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7BF43D51-2714-419E-A52F-863CA54C90E5","Canada's Michael Smith Genome Sciences Centre","564a3ce8e4b093830b69bfbe","5E18B17D-4626-4B6D-8AC6-E560CEE0376C","Ovarian Serous Cystadenocarcinoma","TAR","0D70B9CE-2AE5-4B7F-B60C-5D3D967628E4","2014-03-21T22:52:02.000Z","94D566AB-09F2-45CA-B039-77D8AC00AE00","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"0D70B9CE-2AE5-4B7F-B60C-5D3D967628E4",1.2,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e55a0b2e-1cba-4732-a04d-2dc2eb49cdcc.txt",NA,"TCGA-24-1419-01A",1.8,"248762EA-E200-4742-B0F3-BCD821F96CF3","TCGA",2008,NA,NA,"TUMOR FREE","CF7561B2-7D31-41FD-A0D1-FB5BAE41F2C7",62,"nationwidechildrens.org_clinical.TCGA-24-1419.xml","Alive",NA,"TCGA-24-1419",NA,"96D20828-BB11-4024-9701-2E35AB3FC712",NA,239,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,137,"4E3B292C-2E03-4A9A-8D8C-4B1C178E2039","D72D8D12-8BC6-4F10-99CB-C0D84AB83214","TCGA-24-1419-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai","TCGA-24-1419-01A-01",95,25,NA,NA,0,"TOP",0,NA,"TCGA-24-1419-01A-01-TS1",75,"Pacitaxel","Chemotherapy","TCGA-24-1419-D25931",NA,NA,NA,NA,NA,239,"TUMOR FREE","Alive",NA,"TCGA-24-1419-F25929","TCGA-24-1419",NA,"24","1419","YES","C56.9","8441/3","C56.9",NA,NA,-22659,"FEMALE","WHITE",NA,NA,"No","Alive",239,NA,NA,NA,"TUMOR FREE","NO",15,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
263203826,256277846,18965252592,"7A48C8F9-C13C-42AA-B7D2-C7618C6F81AA.bw","5ed14506-f69a-4da8-9965-72d3270b9f72","7a48c8f9-c13c-42aa-b7d2-c7618c6f81aa","2016-08-25T19:58:04.682876-05:00","TCGA-57-1585-01A-01R-1566-13_rnaseq_fastq.tar","00afbc45-f831-43db-9874-13a2b9ffd960",16959150080,"Illumina HiSeq","79e49cb935cd8cb9a967c2153bcb592f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:11:04.298029-05:00","2016-05-03T11:55:09.260045-05:00","00afbc45-f831-43db-9874-13a2b9ffd960_analysis.xml","0324a5f6e95f5a034afc3e12d59aaa10","18eaa5b5-b5f9-47a0-97d2-fd51429a5061",2181,"2016-09-29T18:59:43.916552-05:00","00afbc45-f831-43db-9874-13a2b9ffd960_experiment.xml","dccdbb4bd05e67cbf1c89bf3299fdebc","3781312f-3912-4dbc-9a5c-7efef3ae95d5",3916,"2016-09-29T21:15:31.064229-05:00","00afbc45-f831-43db-9874-13a2b9ffd960_run.xml","d047ff4ea40718b4c38eb543a550520a","8bbd2306-26f2-4eca-8dfc-c7526d1a5fb6",1988,"2016-09-08T10:46:19.676042-05:00","TCGA-57-1585","2016-09-02T18:47:38.663731-05:00","female","TCGA-57-1585_demographic",1950,"white","2f038007-2450-5b90-830c-b6054faa83c3","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1585_diagnosis","not reported",20862,"dead","8441/3",53,53,"b2f8b028-ac9c-5bbc-9a49-f4d0e7331f71","c56.9",-20862,"TCGA-57-1585_treatment","f72d699b-9f21-5812-b0e3-9187bf1e3bc9","01",NA,"TCGA-57-1585-01A","0.6","1e9787c4-b4f7-481a-b44d-cf975ec8bfb7",FALSE,"2c748aca-e5b2-4418-9820-1343293d379f","Primary Tumor","0.3",NA,NA,"0.8",1237161600,"01",111,"TCGA-57-1585-01A-01",90,85,NA,NA,0,0,10,15,"2016-09-08T10:46:19.676042-05:00","2016-09-08T10:46:19.676042-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"7964fedc-0a0c-4908-95a8-a5a8be5d8023","dc0fc133-7b19-49c1-a568-3b1372306ae0","TCGA-57-1585-01A-01-TS1","TCGA-57-1585-01A-01-BS1",85,80,"5ad238f3-e3e3-49fd-ad4b-ce27bbbd6519","RNA","TCGA-57-1585-01A-01R","445e429d-82bd-4e01-bde1-0571781f75f9",1.8,0.15,"UV Spec","R","22","TCGA-57-1585-01A-01R-1566-13","06df1324-bc1b-4bc3-bb01-4ef55a5aeef5",0.15,NA,NA,NA,NA,"1e612314-cb4e-52c3-9a42-ae6b3b2b3212","TCGA-57-1585_exposure","TCGA-57-1585-01A-01R-1566-13_rnaseq_fastq.tar","2014-08-08T09:00:38.000Z","2014-08-08T11:04:26.000Z","00AFBC45-F831-43DB-9874-13A2B9FFD960","1E9787C4-B4F7-481A-B44D-CF975EC8BFB7","Unaligned reads",16959150080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","06DF1324-BC1B-4BC3-BB01-4EF55A5AEEF5","Canada's Michael Smith Genome Sciences Centre","564a5610e4b09c884b262ffe","5ED14506-F69A-4DA8-9965-72D3270B9F72","Ovarian Serous Cystadenocarcinoma","TAR","5AD238F3-E3E3-49FD-AD4B-CE27BBBD6519","2014-08-08T11:04:27.000Z","445E429D-82BD-4E01-BDE1-0571781F75F9","None","NO",1,0.3,"Primary Tumor","International Genomics Consortium",NA,"5AD238F3-E3E3-49FD-AD4B-CE27BBBD6519",0.6,"57","4760681041_G_Red.idat",NA,"TCGA-57-1585-01A",0.8,"E291CD52-9AE7-45F5-A0BD-FC522F30F01B","TCGA",2007,NA,NA,"WITH TUMOR","C04CD528-0592-417E-9362-863721865E51",57,"MSK_252152914792_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Dead",53,"TCGA-57-1585","NOT HISPANIC OR LATINO","80632215-5601-43AF-AD21-18FBA962496E",NA,53,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,111,"DC0FC133-7B19-49C1-A568-3B1372306AE0","A0FFB4DB-DC36-4122-ADEA-B3911D908F42","TCGA-57-1585-01A-01W-0615-10_SOLiD.bam.bai","TCGA-57-1585-01A-01",85,0,NA,NA,15,"BOTTOM",5,NA,"TCGA-57-1585-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-57-1585-D28078",NA,NA,NA,NA,NA,53,"WITH TUMOR","Dead",53,"TCGA-57-1585-F28076","TCGA-57-1585",NA,"57","1585","YES","C56.9","8441/3","C56.9",NA,NA,-20862,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",53,53,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
392158228,381461973,28243734330,"54C21CDF-5B83-4F88-8B00-6458A171BCE8.bw","5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4","54c21cdf-5b83-4f88-8b00-6458a171bce8","2016-09-29T19:46:29.527282-05:00","TCGA-13-0916-01A-01R-1564-13_rnaseq_fastq.tar","66364a2d-39ea-4490-a9d0-ab9eaeb353f8",24936867840,"Illumina HiSeq","c2e6976ede110c7e0fedc9ba92f02936","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:11:15.269747-05:00","2016-05-03T11:39:34.522989-05:00","66364a2d-39ea-4490-a9d0-ab9eaeb353f8_analysis.xml","412bea18ca52eff682e6f44483ad5e5a","d36c2f68-68a4-45d6-9624-f6f790f24d2e",2181,"2016-09-29T17:42:58.763027-05:00","66364a2d-39ea-4490-a9d0-ab9eaeb353f8_experiment.xml","b97885e124004c2facd9b19d5cdc9cc1","072219d3-7e2f-4062-9809-f9145a47c1ab",3916,"2016-09-29T21:32:34.125768-05:00","66364a2d-39ea-4490-a9d0-ab9eaeb353f8_run.xml","9e3a6d8670f22e0503be870291184e09","964af63b-4ff0-43ee-9de3-48a0f567cd43",1988,"2016-09-08T13:13:22.346408-05:00","TCGA-13-0916","2016-09-02T19:06:10.471557-05:00","female","TCGA-13-0916_demographic",1957,"white","eb66def4-8b14-5b5c-9c01-bd60707a8e18","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0916_diagnosis","not reported",18189,"alive","8441/3",NA,1785,"013ba4e2-f2d0-5a07-a02e-5293a1da0678","c56.9",-18189,"TCGA-13-0916_treatment","0f6be681-a693-5dbc-88d9-01ab2afb79d0","01",NA,"TCGA-13-0916-01A","1","4a2528c7-eaba-46da-b1e5-431a17bff9c7",FALSE,"28A2A65C-70A2-40D2-A03A-F68884457C14","Primary Tumor","0.6",NA,NA,"1.5",1233705600,"01",99,"TCGA-13-0916-01A-01",98,98,NA,NA,0,0,5,5,"2016-09-08T13:13:22.346408-05:00","2016-09-08T13:13:22.346408-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"1f9f945b-dbd0-4bec-99c7-350d23343b9c","af6a32f4-c8f5-42fb-aaed-6d40c9076a1e","TCGA-13-0916-01A-01-BS1","TCGA-13-0916-01A-01-TS1",95,95,"1f453407-36f2-4871-b353-33d91d5dccf4","RNA","TCGA-13-0916-01A-01R","b2481956-64c2-45d9-a6dc-797138dd40d5",1.8,0.15,"UV Spec","R","22","TCGA-13-0916-01A-01R-1564-13","63c52e46-68cf-4dac-9bd7-37081daa4474",0.15,NA,NA,NA,NA,"56cd5a0d-e1cd-5922-97f2-46b9770797a0","TCGA-13-0916_exposure","TCGA-13-0916-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-19T22:26:07.000Z","2014-03-19T23:18:02.000Z","66364A2D-39EA-4490-A9D0-AB9EAEB353F8","4A2528C7-EABA-46DA-B1E5-431A17BFF9C7","Unaligned reads",24936867840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","63C52E46-68CF-4DAC-9BD7-37081DAA4474","Canada's Michael Smith Genome Sciences Centre","564a5aa3e4b093830b6cc129","5F60BC2D-738F-43FC-A3FB-61EC6E80E3D4","Ovarian Serous Cystadenocarcinoma","TAR","1F453407-36F2-4871-B353-33D91D5DCCF4","2014-03-19T23:18:03.000Z","B2481956-64C2-45D9-A6DC-797138DD40D5","None","NO",1,0.6,"Primary Tumor","Memorial Sloan Kettering",NA,"1F453407-36F2-4871-B353-33D91D5DCCF4",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3a88bad5-3325-409f-8023-5e2df3ba1bf4.txt",NA,"TCGA-13-0916-01A",1.5,"E035FE81-878F-4509-AD6E-98266495E5BD","TCGA",2006,NA,NA,"TUMOR FREE","4A2528C7-EABA-46DA-B1E5-431A17BFF9C7",49,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3a88bad5-3325-409f-8023-5e2df3ba1bf4.txt","Alive",NA,"TCGA-13-0916","NOT HISPANIC OR LATINO","E104764B-EFB0-4872-8F3F-D164A3D89D09",NA,644,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,99,"AF6A32F4-C8F5-42FB-AAED-6D40C9076A1E","F8D5D960-B9EA-4A10-A263-914AFD1EBB47","US82800149_251976010337_S01_GE2-v5_10_Apr08.txt","TCGA-13-0916-01A-01",98,0,NA,NA,5,"TOP",0,NA,"TCGA-13-0916-01A-01-TS1",95,"Paclitaxel","Chemotherapy","TCGA-13-0916-D24768",NA,NA,NA,NA,NA,644,"TUMOR FREE","Alive",NA,"TCGA-13-0916-F24765","TCGA-13-0916",NA,"13","0916","YES","C56.9","8441/3","C56.9",NA,NA,-18189,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",644,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
215307414,208549026,15476246141,"063AEE90-0DBB-4B0F-A7F3-DE0600DEA9AD.bw","60014a6e-6a13-4f92-bbfd-eeeee9632f98","063aee90-0dbb-4b0f-a7f3-de0600dea9ad","2016-08-24T07:57:38.866164-05:00","TCGA-09-1670-01A-01R-1566-13_rnaseq_fastq.tar","6351723f-d369-441c-b645-7e5baef70cbc",14257336320,"Illumina HiSeq","7b39f1ed38b1ab241e31ec680dc8d354","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:11:54.192230-05:00","2016-05-03T11:41:05.748550-05:00","6351723f-d369-441c-b645-7e5baef70cbc_analysis.xml","db61434a605962a10d22532f633dcfa2","d3d76dfa-4b7c-40a5-b628-7d453f642225",2181,"2016-09-29T21:53:35.738813-05:00","6351723f-d369-441c-b645-7e5baef70cbc_experiment.xml","03590fceae748d50b4ecada02f267eca","a35a9267-f116-4b42-bba0-b32c2214d7db",3916,"2016-09-29T22:36:59.677770-05:00","6351723f-d369-441c-b645-7e5baef70cbc_run.xml","c3e5f023e5f7f7c7b757eb48600804e0","be115b3f-4e5d-4c83-916c-dcd4dee8ae5d",1989,"2016-09-08T12:50:39.739642-05:00","TCGA-09-1670","2016-09-02T19:07:28.472369-05:00","female","TCGA-09-1670_demographic",1948,"white","6b43a657-6688-5c19-a029-98a9960eb782","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1670_diagnosis","not reported",21147,"alive","8441/3",NA,547,"35db92e7-eaa8-5d22-ba3a-cde96978732d","c56.9",-21147,"TCGA-09-1670_treatment","ed415d17-e6ec-504f-a7da-248bb4055e92","01",NA,"TCGA-09-1670-01A","0.5","1ad76860-b19e-45ac-b81a-bb0bdac2b5ab",FALSE,"5cc85cd9-99c4-4087-bdc5-8039b0369538","Primary Tumor","0.4",NA,NA,"1.6",1240185600,"01",96,"TCGA-09-1670-01A-01",99,99,NA,NA,0,0,5,5,"2016-09-08T12:50:39.739642-05:00","2016-09-08T12:50:39.739642-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"e32f1bda-c2b1-4475-a544-b4cc03320371","add0cb07-6946-4e37-ac37-5bf786c99bc8","TCGA-09-1670-01A-01-TS1","TCGA-09-1670-01A-01-BS1",95,95,"99db2200-966d-41b4-8268-1da18e4fdfb8","RNA","TCGA-09-1670-01A-01R","89007f69-a97a-4123-9b44-11e38df9d244",1.8,0.16,"UV Spec","R","22","TCGA-09-1670-01A-01R-1566-13","eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4",0.16,NA,NA,NA,NA,"c15fb269-5358-580b-be4e-fd7afa02568b","TCGA-09-1670_exposure","TCGA-09-1670-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-29T06:01:43.000Z","2014-03-29T06:32:01.000Z","6351723F-D369-441C-B645-7E5BAEF70CBC","1AD76860-B19E-45AC-B81A-BB0BDAC2B5AB","Unaligned reads",14257336320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EB2322DD-5A7F-41C0-9BE2-7E1F7DC485B4","Canada's Michael Smith Genome Sciences Centre","564a5babe4b0298dd2cc30f2","60014A6E-6A13-4F92-BBFD-EEEEE9632F98","Ovarian Serous Cystadenocarcinoma","TAR","99DB2200-966D-41B4-8268-1DA18E4FDFB8","2014-03-29T06:32:01.000Z","89007F69-A97A-4123-9B44-11E38DF9D244","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"99DB2200-966D-41B4-8268-1DA18E4FDFB8",0.5,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.950ea36f-87d6-4730-b11d-e8eae3e0fe79.txt",NA,"TCGA-09-1670-01A",1.6,"E72190F5-2626-4416-8A8C-E8435831131C","TCGA",2005,NA,NA,"WITH TUMOR","1AD76860-B19E-45AC-B81A-BB0BDAC2B5AB",57,"nationwidechildrens.org_clinical.TCGA-09-1670.xml","Alive",NA,"TCGA-09-1670",NA,"80B17801-1C09-408A-BB5B-A95402C021C0",NA,547,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,96,"E32F1BDA-C2B1-4475-A544-B4CC03320371","C695A688-0798-47DC-91D3-DE6E2FAAD1C6","TCGA-09-1670-01A-01R-1566-13_mirna.bam.bai","TCGA-09-1670-01A-01",99,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-09-1670-01A-01-BS1",95,"Taxol","Chemotherapy","TCGA-09-1670-D24310",NA,NA,NA,"TCGA-09-1670-F24309_NTE-1",NA,547,"WITH TUMOR","Alive",NA,"TCGA-09-1670-F24309","TCGA-09-1670",NA,"09","1670","YES","C56.9","8441/3","C56.9",NA,NA,-21147,"FEMALE","WHITE",NA,NA,"No","Alive",547,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
183285166,173796127,12865536151,"54B452B4-B06A-433F-A627-B2D2AFE048FE.bw","602e2934-223a-44db-8c33-06eb05d72f94","54b452b4-b06a-433f-a627-b2d2afe048fe","2016-08-25T04:18:19.902098-05:00","TCGA-57-1994-01A-01R-1568-13_rnaseq_fastq.tar","8f39ebab-2402-4a13-b65c-239b85220cdf",12426045440,"Illumina HiSeq","5684dbcacbc7c1b74bd2358b14253107","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:17:37.758140-05:00","2016-05-03T11:56:42.631594-05:00","8f39ebab-2402-4a13-b65c-239b85220cdf_analysis.xml","672e842fdb10131380cbdbefa883a793","8d0b5ec8-941d-48e2-ab0b-49b6c2daf65b",2181,"2016-09-29T20:43:04.709547-05:00","8f39ebab-2402-4a13-b65c-239b85220cdf_experiment.xml","5648d1514944989184641b97cf3fa32b","7768f930-d1da-44e1-a047-4edd79f78934",3916,"2016-09-29T20:51:42.197638-05:00","8f39ebab-2402-4a13-b65c-239b85220cdf_run.xml","2c311751f4490275cbb215b153cc7873","7ccfa9b0-4bc7-4228-bbdb-60283f29d404",1988,"2016-09-08T11:05:52.138694-05:00","TCGA-57-1994","2016-09-02T18:50:18.638735-05:00","female","TCGA-57-1994_demographic",1941,"white","bd5457d3-56e5-5b22-9a6c-7e0490fffb31","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1994_diagnosis","not reported",23062,"alive","8441/3",NA,761,"f930091a-6f43-5cce-960e-931dad13eb66","c56.9",-23062,"TCGA-57-1994_treatment","11b280e8-d263-5ead-afac-b43658b894c3","01",NA,"TCGA-57-1994-01A","0.5","a2667408-6465-4258-9e68-f88ec3cd7b7d",FALSE,"54c3dd01-b473-424f-987a-c5d6e972e9bb","Primary Tumor","0.4",NA,NA,"0.5",1246233600,"01",96,"TCGA-57-1994-01A-01",90,95,NA,NA,0,0,10,5,"2016-09-08T11:05:52.138694-05:00","2016-09-08T11:05:52.138694-05:00",NA,1,NA,NA,"TOP","BOTTOM",10,5,"739ef125-4790-490d-bf6b-7e7fbe966335","1c54ff54-4fce-4f01-b009-5c75dbbf525e","TCGA-57-1994-01A-01-TS1","TCGA-57-1994-01A-01-BS1",80,90,"7838fa3d-cd82-47fd-ba3f-01dc86625e23","RNA","TCGA-57-1994-01A-01R","f7ff5f3c-05f5-447e-aa4c-f493ebf817ac",1.8,0.15,"UV Spec","R","22","TCGA-57-1994-01A-01R-1568-13","2cf309ea-0c2e-4f28-a94b-342dc9a1aae8",0.15,NA,NA,NA,NA,"74feb4b4-35aa-55e5-bbbb-e1c165065bba","TCGA-57-1994_exposure","TCGA-57-1994-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-29T14:15:17.000Z","2014-08-29T16:25:38.000Z","8F39EBAB-2402-4A13-B65C-239B85220CDF","A2667408-6465-4258-9E68-F88EC3CD7B7D","Unaligned reads",12426045440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2CF309EA-0C2E-4F28-A94B-342DC9A1AAE8","Canada's Michael Smith Genome Sciences Centre","564a591fe4b0298dd2cb68c8","602E2934-223A-44DB-8C33-06EB05D72F94","Ovarian Serous Cystadenocarcinoma","TAR","7838FA3D-CD82-47FD-BA3F-01DC86625E23","2014-08-29T16:25:38.000Z","F7FF5F3C-05F5-447E-AA4C-F493EBF817AC","None","NO",1,0.4,"Primary Tumor","International Genomics Consortium",NA,"7838FA3D-CD82-47FD-BA3F-01DC86625E23",0.5,"57","TCGA-57-1994-01A-01R-1568-13_mirna.bam.bai",NA,"TCGA-57-1994-01A",0.5,NA,"TCGA",2004,NA,NA,NA,"A2667408-6465-4258-9E68-F88EC3CD7B7D",63,"nationwidechildrens.org_clinical.TCGA-57-1994.xml","Alive",NA,"TCGA-57-1994",NA,"0C4A4165-8E20-496F-B731-9666C8C63D86",NA,761,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,NA,NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,96,"739EF125-4790-490D-BF6B-7E7FBE966335","38148C64-B975-4B51-917C-856480075AF9","TCGA-57-1994-01A-01R-1568-13_mirna.bam.bai","TCGA-57-1994-01A-01",95,0,NA,1,5,"BOTTOM",5,NA,"TCGA-57-1994-01A-01-BS1",90,NA,NA,NA,NA,NA,NA,NA,NA,761,NA,"Alive",NA,"TCGA-57-1994-F28096","TCGA-57-1994",NA,"57","1994","YES","C56.9","8441/3","C56.9",NA,NA,-23062,"FEMALE","WHITE",NA,NA,"No","Alive",761,NA,NA,NA,NA,"NO",10,6,2011,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,63,2004,"Tumor resection",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
250058568,239971980,17760969628,"876D3927-036E-4BF9-AA43-DC1CAF39F6AA.bw","60cce7ac-d27d-44a6-9873-ecf91da5e906","876d3927-036e-4bf9-aa43-dc1caf39f6aa","2016-08-31T11:37:48.111427-05:00","TCGA-23-1123-01A-01R-1565-13_rnaseq_fastq.tar","33766722-a47f-47a4-b17d-ba3f10c55901",15773716480,"Illumina HiSeq","747d14e8302cbe2aacfee2d9cdbd24cc","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:50:59.773748-05:00","2016-05-03T11:40:21.669427-05:00","33766722-a47f-47a4-b17d-ba3f10c55901_analysis.xml","67107b1dcb24831a7640ffba0a4262b6","31fd00ce-bb78-4c68-80f5-aa215c0f2bf9",2181,"2016-10-07T17:37:54.578689-05:00","33766722-a47f-47a4-b17d-ba3f10c55901_experiment.xml","6250abb30991aadba69043a9ec4e8eac","65585df8-9bfa-47cb-b796-b40dba491377",3916,"2016-09-29T18:13:04.878514-05:00","33766722-a47f-47a4-b17d-ba3f10c55901_run.xml","fe7540accf553cda9b2ecddbdb5e507b","1a2d6e45-b5c6-4f7e-91eb-b7593872d8ae",1989,"2016-09-08T12:55:11.207626-05:00","TCGA-23-1123","2016-09-02T19:05:45.843927-05:00","female","TCGA-23-1123_demographic",1939,"white","ce764708-fee9-5782-b207-acbf274a2c5e","not hispanic or latino",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1123_diagnosis","not reported",21552,"dead","8441/3",1018,NA,"394df501-4b80-527f-91ba-621c945330b6","c56.9",-21552,"TCGA-23-1123_treatment","fdde878a-f1e1-5022-90a0-86319fee955a","01",NA,"TCGA-23-1123-01A","0.8","ed537d83-388b-4125-8c8c-204a0bcbcde8",FALSE,"28f9189b-24eb-4540-8551-4eaacc296c20","Primary Tumor","0.6",NA,NA,"0.8",1227571200,"01",131,"TCGA-23-1123-01A-01",95,95,NA,NA,0,0,0,0,"2016-09-08T12:55:11.207626-05:00","2016-09-08T12:55:11.207626-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"9d6036ea-f3bb-4e32-b1b1-51d0a4363b3a","cd3395cb-5e52-4549-8e3d-731ad55c5534","TCGA-23-1123-01A-01-TS1","TCGA-23-1123-01A-01-BS1",0,0,"ededaff5-f223-4e4d-89c5-b8f3eb6ba74e","RNA","TCGA-23-1123-01A-01R","37806515-25d9-4b0f-b556-fe6239f12cb9",1.8,0.15,"UV Spec","R","22","TCGA-23-1123-01A-01R-1565-13","71543abc-9f15-48d9-994d-e7b963a4d8f3",0.15,NA,NA,NA,NA,"c12c61b4-81df-5b38-87ec-b153a7ee4938","TCGA-23-1123_exposure","TCGA-23-1123-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:24:41.000Z","2014-03-22T05:57:02.000Z","33766722-A47F-47A4-B17D-BA3F10C55901","ED537D83-388B-4125-8C8C-204A0BCBCDE8","Unaligned reads",15773716480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","71543ABC-9F15-48D9-994D-E7B963A4D8F3","Canada's Michael Smith Genome Sciences Centre","564a5c4fe4b09c884b27c837","60CCE7AC-D27D-44A6-9873-ECF91DA5E906","Ovarian Serous Cystadenocarcinoma","TAR","EDEDAFF5-F223-4E4D-89C5-B8F3EB6BA74E","2014-03-22T05:57:02.000Z","37806515-25D9-4B0F-B556-FE6239F12CB9","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"EDEDAFF5-F223-4E4D-89C5-B8F3EB6BA74E",0.8,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.184da43f-2906-495a-a714-031b30a78cdb.txt",NA,"TCGA-23-1123-01A",0.8,"D80CF2A4-4284-404D-A4D6-72FC39B01DFF","TCGA",1998,NA,NA,"WITH TUMOR","ED537D83-388B-4125-8C8C-204A0BCBCDE8",59,"TCGA-23-1123-01A-01R-1565-13.isoform.quantification.txt","Dead",1018,"TCGA-23-1123","NOT HISPANIC OR LATINO","C472DA3F-A91F-41A5-B7E9-345A90ED3ADA",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,131,"CD3395CB-5E52-4549-8E3D-731AD55C5534","C0B5C8B3-3981-4612-9B21-4BC11C913043","TCGA-23-1123-01A-01R-1565-13_mirna.bam","TCGA-23-1123-01A-01",95,0,NA,NA,0,"TOP",0,NA,"TCGA-23-1123-01A-01-TS1",0,"Carboplatin","Chemotherapy","TCGA-23-1123-D25734",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",1018,"TCGA-23-1123-F25733","TCGA-23-1123",NA,"23","1123","YES","C56.9","8441/3","C56.9",NA,NA,-21552,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1018,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,59,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
223847584,214006908,15797735540,"9CBEB375-516F-45EE-9A66-6EAB4E9DBD65.bw","611600a6-43ec-4029-9682-cd6d6a3312ec","9cbeb375-516f-45ee-9a66-6eab4e9dbd65","2016-09-29T21:43:07.392192-05:00","TCGA-13-1483-01A-01R-1565-13_rnaseq_fastq.tar","1496fdd7-65a5-4b56-ae52-e171f305f1d7",14524170240,"Illumina HiSeq","1db472aa9e4dd0e58ff6433b6034e4c5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:52:00.591357-05:00","2016-05-03T11:40:21.669427-05:00","1496fdd7-65a5-4b56-ae52-e171f305f1d7_analysis.xml","ca2bf4768add6e818a7013382f07102e","0cf0e029-d9c9-4f18-ad08-32dcd976184e",2208,"2016-09-29T22:43:11.027249-05:00","1496fdd7-65a5-4b56-ae52-e171f305f1d7_experiment.xml","a4b7ec15f08f7685329725ce47e969a0","c1f14f87-f3f6-4daf-83a1-f46360b6a3e1",3916,"2016-09-29T19:57:34.029871-05:00","1496fdd7-65a5-4b56-ae52-e171f305f1d7_run.xml","5541a661851f9dcf0ebf730e0607adf1","5babd866-46cc-4d24-a94e-e1d831442d1d",1989,"2016-09-08T13:47:13.583106-05:00","TCGA-13-1483","2016-09-02T19:13:46.554024-05:00","female","TCGA-13-1483_demographic",1939,"white","1b6e413d-3075-5578-96e1-c7441bed86cd","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1483_diagnosis","not reported",22342,"dead","8441/3",895,895,"7c0462b7-dd23-5dc0-855f-2377dab52877","c56.9",-22342,"TCGA-13-1483_treatment","d1b07c9f-3521-5664-b0e8-f9a4cb10a15f","01",NA,"TCGA-13-1483-01A","1.4","ee7d5c16-fb34-4500-87f4-c920f797d9f5",FALSE,"c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db","Primary Tumor","0.4",NA,NA,"1.8",1234396800,"01",118,"TCGA-13-1483-01A-01",70,75,10,10,0,0,40,45,"2016-09-08T13:47:13.583106-05:00","2016-09-08T13:47:13.583106-05:00",40,40,50,50,"TOP","BOTTOM",10,5,"da3bd09a-1930-49c2-a2c0-592f45fa3859","ddf45f15-dac1-461f-8937-3ac159a33d50","TCGA-13-1483-01A-01-TS1","TCGA-13-1483-01A-01-BS1",50,50,"e157ea22-ddef-4d00-81f9-9774ea04c2a4","RNA","TCGA-13-1483-01A-01R","02aa300d-75e3-4c82-b780-4c636e177757",1.8,0.15,"UV Spec","R","22","TCGA-13-1483-01A-01R-1565-13","1120f746-aeb6-457a-946e-46ed665a9211",0.15,NA,NA,NA,NA,"82786649-99d9-5b2b-ac2c-f52ef3c2984d","TCGA-13-1483_exposure","TCGA-13-1483-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:58:28.000Z","2014-03-22T06:29:01.000Z","1496FDD7-65A5-4B56-AE52-E171F305F1D7","EE7D5C16-FB34-4500-87F4-C920F797D9F5","Unaligned reads",14524170240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1120F746-AEB6-457A-946E-46ED665A9211","Canada's Michael Smith Genome Sciences Centre","564a5a31e4b0ef12181dcb76","611600A6-43EC-4029-9682-CD6D6A3312EC","Ovarian Serous Cystadenocarcinoma","TAR","E157EA22-DDEF-4D00-81F9-9774EA04C2A4","2014-03-22T06:29:01.000Z","02AA300D-75E3-4C82-B780-4C636E177757","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"E157EA22-DDEF-4D00-81F9-9774EA04C2A4",1.4,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3ab7ed23-61b4-4c74-8668-25b7ee186bf7.txt",NA,"TCGA-13-1483-01A",1.8,"CB6D0C9B-51F7-4BC1-9355-880EC0FA012A","TCGA",2000,NA,NA,"WITH TUMOR","EE7D5C16-FB34-4500-87F4-C920F797D9F5",61,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3ab7ed23-61b4-4c74-8668-25b7ee186bf7.txt","Dead",895,"TCGA-13-1483","NOT HISPANIC OR LATINO","0D764FF1-764E-47B7-9BF2-DFD722372DAA",NA,895,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,118,"DA3BD09A-1930-49C2-A2C0-592F45FA3859","B7B0BAD0-CF5B-4190-B61A-CD14FE8AE3E8","US82800149_251976010639_S01_GE2-v5_10_Apr08.txt","TCGA-13-1483-01A-01",75,0,10,40,45,"BOTTOM",5,50,"TCGA-13-1483-01A-01-BS1",50,"Carboplatin","Chemotherapy","TCGA-13-1483-D24853",NA,NA,NA,"TCGA-13-1483-F24852_NTE-1",NA,895,"WITH TUMOR","Dead",895,"TCGA-13-1483-F24852","TCGA-13-1483",NA,"13","1483","YES","C56.9","8441/3","C56.9",NA,NA,-22342,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",895,895,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,61,2000,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
197489362,192971560,14261868492,"039BECB9-7CEB-4057-9825-B3601C9CFC6B.bw","619b14f3-b8cc-4c0a-8304-6719853d592a","039becb9-7ceb-4057-9825-b3601c9cfc6b","2016-09-29T17:37:32.731136-05:00","TCGA-24-0968-01A-01R-1569-13_rnaseq_fastq.tar","6a1cbc34-6ac6-4c81-a784-833a4860cccc",12068894720,"Illumina HiSeq","1a11fd2bc4d06d94c0cc188d8570e609","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:59:11.551510-05:00","2016-05-03T11:41:05.740436-05:00","6a1cbc34-6ac6-4c81-a784-833a4860cccc_analysis.xml","e7c00055fd2613b96db1a5958c2545f4","a6daba04-6ace-487a-ae73-678fd7850cb7",2235,"2016-09-29T20:46:09.987607-05:00","6a1cbc34-6ac6-4c81-a784-833a4860cccc_experiment.xml","de21c26a252e82af36987943fe98aa53","79578d33-c360-49c1-b248-7ad474c02b97",3916,"2016-09-29T20:33:58.945680-05:00","6a1cbc34-6ac6-4c81-a784-833a4860cccc_run.xml","b8fa62e29ae54510ebe12a75cbc5ec4e","71b5ac69-27cf-468f-b17a-010ef23d3efa",1988,"2016-09-08T12:58:52.110792-05:00","TCGA-24-0968","2016-09-02T19:05:54.557930-05:00","female","TCGA-24-0968_demographic",1946,"white","df7b1d1e-430e-5b44-b7fe-e7cadded22e0","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-0968_diagnosis","not reported",21664,"dead","8441/3",NA,598,"87361581-dac1-527d-bb58-01c4d69a5e91","c56.9",-21664,"TCGA-24-0968_treatment","8d2c6479-f37b-5d93-b863-876e8fa63988","01",NA,"TCGA-24-0968-01A","0.8","bd548e12-22a8-471f-b13f-fd7ea5e4e406",FALSE,"887A21BF-12C4-47C7-A48D-A7FAA05C57B2","Primary Tumor","0.6",NA,NA,"1.2",1233705600,"01",126,"TCGA-24-0968-01A-01",85,92,NA,NA,0,0,20,10,"2016-09-08T12:58:52.110792-05:00","2016-09-08T12:58:52.110792-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"75dde44c-1150-4c27-9b81-42cc7c8be0bf","0ecb0b53-3dd6-46d9-a492-c179639330a6","TCGA-24-0968-01A-01-BS1","TCGA-24-0968-01A-01-TS1",80,90,"f7659147-70c8-4992-821b-62041abdcb73","RNA","TCGA-24-0968-01A-01R","f8421895-6ee9-45ce-b5a7-a5952332ce48",1.8,0.14,"UV Spec","R","22","TCGA-24-0968-01A-01R-1569-13","b2f7c706-ec61-45d4-9394-44921dc99f8c",0.14,NA,NA,NA,NA,"8e2695d2-3312-5696-9808-e7a2be82ad3f","TCGA-24-0968_exposure","TCGA-24-0968-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T01:05:10.000Z","2014-03-27T01:30:02.000Z","6A1CBC34-6AC6-4C81-A784-833A4860CCCC","BD548E12-22A8-471F-B13F-FD7EA5E4E406","Unaligned reads",12068894720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B2F7C706-EC61-45D4-9394-44921DC99F8C","Canada's Michael Smith Genome Sciences Centre","564a3539e4b0ef1218187640","619B14F3-B8CC-4C0A-8304-6719853D592A","Ovarian Serous Cystadenocarcinoma","TAR","F7659147-70C8-4992-821B-62041ABDCB73","2014-03-27T01:30:02.000Z","F8421895-6EE9-45CE-B5A7-A5952332CE48","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"F7659147-70C8-4992-821B-62041ABDCB73",0.8,"24","TCGA-24-0968-01A-01R-1569-13.hg19.gene.quantification.txt",NA,"TCGA-24-0968-01A",1.2,"E3ED5AB9-5714-4914-8344-71CAFCD55745","TCGA",2005,NA,NA,"WITH TUMOR","CEA23E46-CA9B-4A8B-B5ED-F1569422C5CF",59,"bcgsc.ca.TCGA-24-0968-01A-01R-1569-13.hg19.bcgsc.ca.1.6.0.indel.vcf","Dead",NA,"TCGA-24-0968",NA,"F0D9FAE8-B67D-4AFC-B337-8433EF184F86",NA,598,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,126,"75DDE44C-1150-4C27-9B81-42CC7C8BE0BF","B72EAEEB-9120-43D2-B439-BAA57E568058","TCGA-24-0968-01A-01R-1569-13.hg19.mirna.quantification.txt","TCGA-24-0968-01A-01",85,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-24-0968-01A-01-BS1",80,"Gemzar","Chemotherapy","TCGA-24-0968-D25889",NA,NA,NA,NA,NA,598,"WITH TUMOR","Dead",NA,"TCGA-24-0968-F25880","TCGA-24-0968",NA,"24","0968","YES","C56.9","8441/3","C56.9",NA,NA,-21664,"FEMALE","WHITE",NA,NA,"No","Dead",598,NA,NA,NA,"WITH TUMOR","NO",10,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,59,2005,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
204138216,198836228,14742435222,"2CCA6EB5-C215-41A9-BCD6-6A77813D319C.bw","61feee94-3ac9-42fe-aaa3-dc6a3efe563c","2cca6eb5-c215-41a9-bcd6-6a77813d319c","2016-08-25T11:12:03.739972-05:00","TCGA-31-1953-01A-01R-1568-13_rnaseq_fastq.tar","8135420e-1541-42ba-ab59-c40c8e789a12",13232998400,"Illumina HiSeq","9362eb42896143009c49001d4323b558","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:44:38.216328-05:00","2016-05-03T11:56:42.628809-05:00","8135420e-1541-42ba-ab59-c40c8e789a12_analysis.xml","4e088b2e939f2a1419e78dcc9b4053b6","78658a69-6936-4240-8c38-cd9521388b3b",2181,"2016-09-29T21:53:19.674984-05:00","8135420e-1541-42ba-ab59-c40c8e789a12_experiment.xml","655c2af741098e57df7b206d12077dff","a32e9da7-e840-4bde-9819-7bc3c91f1134",3916,"2016-09-29T21:53:13.617047-05:00","8135420e-1541-42ba-ab59-c40c8e789a12_run.xml","47365c6a2cc29999c9b549e31a94fb7b","a31ac018-3073-4cd9-9c3d-cc56d8152894",1988,"2016-09-08T10:34:10.852772-05:00","TCGA-31-1953","2016-09-02T18:50:13.726417-05:00","female","TCGA-31-1953_demographic",1956,"asian","3bd53964-0f52-57a9-8645-6b78d6e3b5ce","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1953_diagnosis","not reported",19064,"alive","8441/3",NA,204,"afe49009-fc98-5b1d-9903-ccc3d9c5d4fb","c56.9",-19064,"TCGA-31-1953_treatment","17c4216b-0dbb-576d-bec5-8806fd89f076","01",NA,"TCGA-31-1953-01A","0.5","0918328b-5726-4429-a7dc-bb4d4869575b",FALSE,"c824400d-b062-4a04-b805-f717426d688e","Primary Tumor","0.1",NA,NA,"1",1246838400,"01",133,"TCGA-31-1953-01A-01",95,95,NA,NA,0,0,8,10,"2016-09-08T10:34:10.852772-05:00","2016-09-08T10:34:10.852772-05:00",1,3,NA,NA,"TOP","BOTTOM",2,0,"d23dcd07-a0b5-4eb2-9773-4ab7ffb396ff","f0a27d64-d7c9-438e-9ef0-636ee0881eb0","TCGA-31-1953-01A-01-TS1","TCGA-31-1953-01A-01-BS1",90,90,"f8b5f9fa-5d33-422b-bd71-75d1cfcbbe32","RNA","TCGA-31-1953-01A-01R","95633b3d-6d4b-4c20-88a0-4d910ed9b751",1.8,0.17,"UV Spec","R","22","TCGA-31-1953-01A-01R-1568-13","7b31fc47-0299-4449-aa5b-622ba549371f",0.17,NA,NA,NA,NA,"d0d19a74-8777-500d-8754-0464b95d299d","TCGA-31-1953_exposure","TCGA-31-1953-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T10:46:24.000Z","2014-08-26T13:15:20.000Z","8135420E-1541-42BA-AB59-C40C8E789A12","0918328B-5726-4429-A7DC-BB4D4869575B","Unaligned reads",13232998400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7B31FC47-0299-4449-AA5B-622BA549371F","Canada's Michael Smith Genome Sciences Centre","564a5b12e4b09c884b2792af","61FEEE94-3AC9-42FE-AAA3-DC6A3EFE563C","Ovarian Serous Cystadenocarcinoma","TAR","F8B5F9FA-5D33-422B-BD71-75D1CFCBBE32","2014-08-26T13:15:20.000Z","95633B3D-6D4B-4C20-88A0-4D910ED9B751","None","NO",1,0.1,"Primary Tumor","Imperial College",NA,"F8B5F9FA-5D33-422B-BD71-75D1CFCBBE32",0.5,"31","4814950168_R01C01_Grn.idat",NA,"TCGA-31-1953-01A",1,"ECE15379-890E-4D24-8C23-A9BD4DCD8E46","TCGA",2008,NA,NA,"WITH TUMOR","7E548279-F39D-4D78-BC5E-9B70E1886368",52,"nationwidechildrens.org_clinical.TCGA-31-1953.xml","Alive",NA,"TCGA-31-1953","NOT HISPANIC OR LATINO","0B48F22B-FC99-4647-BD44-0E2A250C6D91",NA,204,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"ASIAN",NA,1,133,"D23DCD07-A0B5-4EB2-9773-4AB7FFB396FF","95633B3D-6D4B-4C20-88A0-4D910ED9B751","4814950168_R01C01_Grn.idat","TCGA-31-1953-01A-01",95,0,NA,3,10,"BOTTOM",0,NA,"TCGA-31-1953-01A-01-BS1",90,"Paciltaxle","Chemotherapy","TCGA-31-1953-D27702",NA,NA,NA,"TCGA-31-1953-F27698_NTE-1",NA,204,"WITH TUMOR","Alive",NA,"TCGA-31-1953-F27698","TCGA-31-1953",NA,"31","1953","YES","C56.9","8441/3","C56.9",NA,NA,-19064,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",204,NA,NA,NA,"WITH TUMOR","NO",20,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
103630442,97861407,7224787797,"2CCA5192-4A24-4502-99DE-EC03B553A03D.bw","6209e80d-a115-4f8e-bf0d-18461401a1c6","2cca5192-4a24-4502-99de-ec03b553a03d","2016-08-25T11:03:32.303002-05:00","TCGA-23-1113-01A-01R-1564-13_rnaseq_fastq.tar","958620d5-d19f-47e7-b16d-54e3f7a0e025",6851031040,"Illumina HiSeq","54afcc60e2da13d1fdcd20fcac925d5f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:45:02.299495-05:00","2016-05-03T11:39:34.528512-05:00","958620d5-d19f-47e7-b16d-54e3f7a0e025_analysis.xml","b34fe81dc0f2f20327a3fcee07141789","e86fffa3-48d8-464c-bf3b-5ca22ebde27a",2210,"2016-09-29T19:30:55.270099-05:00","958620d5-d19f-47e7-b16d-54e3f7a0e025_experiment.xml","0b4f293269d52fc989a404627f085c41","4b340982-ef29-418e-82f0-4d2429b7d3e9",3916,"2016-09-29T17:47:56.756933-05:00","958620d5-d19f-47e7-b16d-54e3f7a0e025_run.xml","0ddfdbb192eb98db39ff958978409839","0a5b0341-673a-4384-a593-b629138c1cb9",1990,"2016-09-08T12:27:50.669006-05:00","TCGA-23-1113","2016-09-02T19:05:58.366094-05:00","female","TCGA-23-1113_demographic",1954,"white","5a2431ef-c08f-54a7-8154-48b049a5370f","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1113_diagnosis","not reported",17791,"dead","8441/3",949,NA,"b23cc40b-3cda-5ccc-9089-804096c70d8b","c56.9",-17791,"TCGA-23-1113_treatment","f9bad516-36e1-5939-aae3-a947ec9eb0b2","01",NA,"TCGA-23-1113-01A","0.8","9552886e-881b-4bed-842c-596fcc8d87c3",FALSE,"a7fa848e-2492-4802-9cb2-58ec66fc3dd4","Primary Tumor","0.8",NA,NA,"1",1227571200,"01",110,"TCGA-23-1113-01A-01",95,95,NA,NA,0,0,NA,NA,"2016-09-08T12:27:50.669006-05:00","2016-09-08T12:27:50.669006-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,1,"57c411b9-9c95-4c31-a3b5-110683e0e020","2458fccf-526c-4639-84fa-54061bcc3cd5","TCGA-23-1113-01A-01-TS1","TCGA-23-1113-01A-01-BS1",NA,NA,"5576fa57-1c5c-4c56-87e2-a17a30694287","RNA","TCGA-23-1113-01A-01R","3cfb2d0f-678f-4057-949b-29dcccddc28d",1.8,0.15,"UV Spec","R","22","TCGA-23-1113-01A-01R-1564-13","88656b94-cd24-4c4c-b625-635ef692cf13",0.15,NA,NA,NA,NA,"28b53c86-4393-5d93-93df-5a253eb820a0","TCGA-23-1113_exposure","TCGA-23-1113-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T04:17:51.000Z","2014-03-20T04:32:02.000Z","958620D5-D19F-47E7-B16D-54E3F7A0E025","9552886E-881B-4BED-842C-596FCC8D87C3","Unaligned reads",6851031040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","88656B94-CD24-4C4C-B625-635EF692CF13","Canada's Michael Smith Genome Sciences Centre","564a400fe4b0ef12181beff3","6209E80D-A115-4F8E-BF0D-18461401A1C6","Ovarian Serous Cystadenocarcinoma","TAR","5576FA57-1C5C-4C56-87E2-A17A30694287","2014-03-20T04:32:02.000Z","3CFB2D0F-678F-4057-949B-29DCCCDDC28D","None","NO",1,0.8,"Primary Tumor","Cedars Sinai",NA,"5576FA57-1C5C-4C56-87E2-A17A30694287",0.8,"23","TCGA-23-1113-01A-01R-1564-13_GRCh37-lite_mirna.bam",NA,"TCGA-23-1113-01A",1,"D6010400-23C3-4365-A990-0AA37395B0FA","TCGA",2002,NA,NA,"WITH TUMOR","DF2D4E9F-359C-4033-9451-F402198BE3A6",48,"nationwidechildrens.org_clinical.TCGA-23-1113.xml","Dead",949,"TCGA-23-1113","NOT HISPANIC OR LATINO","8F74E7A1-1849-44B8-8387-31BFF5E4BFB7",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,110,"57C411B9-9C95-4C31-A3B5-110683E0E020","F9086F35-563D-4A93-81C3-C99514F3CA62","TCGA-23-1113-01A-01R-1564-13_GRCh37-lite_mirna.bam.bai","TCGA-23-1113-01A-01",95,0,NA,NA,NA,"TOP",5,NA,"TCGA-23-1113-01A-01-TS1",NA,"Carboplatin","Chemotherapy","TCGA-23-1113-D25678",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",949,"TCGA-23-1113-F25677","TCGA-23-1113",NA,"23","1113","YES","C56.9","8441/3","C56.9",NA,NA,-17791,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,949,NA,NA,"WITH TUMOR","NO",19,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,48,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
165829104,160497097,11858678382,"0D24351E-EBD6-4BD1-9A88-24DE07339221.bw","62379be5-13f0-474b-94d3-6f944ec4ee96","0d24351e-ebd6-4bd1-9a88-24de07339221","2016-08-24T19:13:30.136588-05:00","TCGA-24-1552-01A-01R-1566-13_rnaseq_fastq.tar","221fe4a9-a184-4667-a5d5-80d055b25e90",10835189760,"Illumina HiSeq","c001324373087ad407381ec79c3c4133","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:13:56.335404-05:00","2016-05-03T11:40:21.648199-05:00","221fe4a9-a184-4667-a5d5-80d055b25e90_analysis.xml","1568d49f3f8582bd5387b28b7a258b9a","1aa53d63-5578-43b2-8bee-a3507a6bbcd5",2181,"2016-09-29T18:17:39.413174-05:00","221fe4a9-a184-4667-a5d5-80d055b25e90_experiment.xml","114b80798edc14f9e746b85c4c90809c","1cf928b4-05b6-49d7-a67f-cd0d8986e79b",3916,"2016-09-29T18:01:51.366223-05:00","221fe4a9-a184-4667-a5d5-80d055b25e90_run.xml","27219ee997c6aa4dc78fab7a337f1f70","132a8588-69d2-4dc2-ad78-bfe73d9d450b",1988,"2016-09-08T13:01:15.481705-05:00","TCGA-24-1552","2016-09-02T19:07:10.853840-05:00","female","TCGA-24-1552_demographic",1920,"white","74a423cc-a9ec-5dd0-b5aa-5054a39621ef","not reported",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1552_diagnosis","not reported",28129,"dead","8441/3",1259,1259,"88f98d56-7d93-59ed-92e9-0c71546a7a92","c56.9",-28129,"TCGA-24-1552_treatment","b46cd276-b012-5291-9186-339e1ef23cd4","01",NA,"TCGA-24-1552-01A","0.8","411b4c26-fcc4-438a-8731-d0cf5dd6c74f",FALSE,"FF7B6D0B-D13B-473E-A924-C63CB0B46511","Primary Tumor","0.8",NA,NA,"0.9",1235260800,"01",135,"TCGA-24-1552-01A-01",99,99,NA,NA,0,0,3,5,"2016-09-08T13:01:15.481705-05:00","2016-09-08T13:01:15.481705-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,5,"295ebff0-1ee5-4fe1-a6e1-35951c014456","7af35fc5-d9df-4cce-a0c6-30dde43ad0a2","TCGA-24-1552-01A-01-TS1","TCGA-24-1552-01A-01-BS1",95,90,"a58861b9-cde9-48dd-a2de-010a9c047710","RNA","TCGA-24-1552-01A-01R","772f2ed2-7be2-4063-91ea-112bdcd3e927",1.8,0.14,"UV Spec","R","22","TCGA-24-1552-01A-01R-1566-13","990bcb1f-7269-4020-8ea5-8ba338b390b8",0.14,NA,NA,NA,NA,"66de3699-aecc-541d-96c5-f999f181a7c6","TCGA-24-1552_exposure","TCGA-24-1552-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T07:41:59.000Z","2014-03-25T08:04:02.000Z","221FE4A9-A184-4667-A5D5-80D055B25E90","411B4C26-FCC4-438A-8731-D0CF5DD6C74F","Unaligned reads",10835189760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","990BCB1F-7269-4020-8EA5-8BA338B390B8","Canada's Michael Smith Genome Sciences Centre","564a3a87e4b093830b68fc9c","62379BE5-13F0-474B-94D3-6F944EC4EE96","Ovarian Serous Cystadenocarcinoma","TAR","A58861B9-CDE9-48DD-A2DE-010A9C047710","2014-03-25T08:04:02.000Z","772F2ED2-7BE2-4063-91EA-112BDCD3E927","None","NO",1,0.8,"Primary Tumor","Washington University",NA,"A58861B9-CDE9-48DD-A2DE-010A9C047710",0.8,"24","4760681052_J_Grn.idat",NA,"TCGA-24-1552-01A",0.9,"F3E0BFC1-9550-4386-A99E-EA615344961C","TCGA",1997,NA,NA,"WITH TUMOR","56AB98BE-19EB-46B8-9A20-BEA4D694F06C",77,"TCGA-24-1552-10A-01W-0551-08_IlluminaGA-DNASeq_capture.bam.bai","Dead",1259,"TCGA-24-1552",NA,"9EA4DE18-69C5-4737-B8EC-956D3C28D2C2",NA,1259,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,135,"7AF35FC5-D9DF-4CCE-A0C6-30DDE43AD0A2","772F2ED2-7BE2-4063-91EA-112BDCD3E927","TCGA-24-1552-01A-01R-1566-13_GRCh37-lite_rnaseq.bam.bai","TCGA-24-1552-01A-01",99,0,NA,NA,3,"TOP",2,NA,"TCGA-24-1552-01A-01-TS1",95,"Doxil","Chemotherapy","TCGA-24-1552-D26152",NA,NA,NA,"TCGA-24-1552-F26148_NTE-1",NA,1259,"WITH TUMOR","Dead",1259,"TCGA-24-1552-F26148","TCGA-24-1552",NA,"24","1552","YES","C56.9","8441/3","C56.9",NA,NA,-28129,"FEMALE","WHITE",NA,NA,"No","Dead",1259,1259,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,77,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
161260352,158045231,11728365808,"6F1E493F-EB93-4661-BD3D-51C934E8AAD2.bw","6264e699-d40b-4ebc-b443-0a0edcb220dc","6f1e493f-eb93-4661-bd3d-51c934e8aad2","2016-08-25T15:08:31.619709-05:00","TCGA-25-2396-01A-01R-1569-13_rnaseq_fastq.tar","89ffff65-95bf-4665-ab08-f9c9fd5d6c73",10147624960,"Illumina HiSeq","20547b311c1997fe3571dffd3f789a2f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:31:03.850561-05:00","2016-05-03T11:55:09.260045-05:00","89ffff65-95bf-4665-ab08-f9c9fd5d6c73_analysis.xml","613ad587e2a6f0447960fea6712b3e4e","254de597-eaab-4a97-9752-f3221ea1bd58",2181,"2016-09-29T23:46:06.785726-05:00","89ffff65-95bf-4665-ab08-f9c9fd5d6c73_experiment.xml","0fdb06bd6b43ea6b1f14b2ffebcdda77","e917acfb-20f9-4ef8-94e7-a27f161bc095",3916,"2016-09-29T22:42:13.293726-05:00","89ffff65-95bf-4665-ab08-f9c9fd5d6c73_run.xml","b85c57664d1a3bc92321bf7fb8e3dc16","c15cc01a-73be-41af-88a0-c0f39fb63f6f",1988,"2016-09-08T13:27:41.941004-05:00","TCGA-25-2396","2016-09-02T19:11:50.224938-05:00","female","TCGA-25-2396_demographic",1933,"white","abae41c1-1b5e-5262-b644-b8d7fc00fabd","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2396_diagnosis","not reported",26145,"dead","8441/3",92,92,"962f2f69-2e79-50fc-ba72-03bf96cc0d4b","c56.9",-26145,"TCGA-25-2396_treatment","8f8e49d6-d0fd-5c94-8001-0861b70d6517","01",NA,"TCGA-25-2396-01A","1","96d1655d-0a5e-4e2e-b9eb-f422ced79483",FALSE,"5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF","Primary Tumor","1",NA,NA,"1",1252022400,"01",144,"TCGA-25-2396-01A-01",90,90,NA,NA,0,1,10,10,"2016-09-08T13:27:41.941004-05:00","2016-09-08T13:27:41.941004-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"80e91a24-243b-410c-a9dc-790aa3b8f6ca","cfdcc756-47ed-4f58-a6b5-825c9eba0da5","TCGA-25-2396-01A-01-TS1","TCGA-25-2396-01A-01-BS1",90,88,"ff9883df-d839-4b72-8cbc-846238c86523","RNA","TCGA-25-2396-01A-01R","d4e2dc59-69d1-4a1d-8c43-f7d3a077e27d",1.8,0.14,"UV Spec","R","22","TCGA-25-2396-01A-01R-1569-13","43352a4d-f866-4ed7-81f5-5dc478c10992",0.14,NA,NA,NA,NA,"b667f658-306e-5fe3-ae98-507e47096106","TCGA-25-2396_exposure","TCGA-25-2396-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T08:29:42.000Z","2014-08-08T09:10:08.000Z","89FFFF65-95BF-4665-AB08-F9C9FD5D6C73","96D1655D-0A5E-4E2E-B9EB-F422CED79483","Unaligned reads",10147624960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","43352A4D-F866-4ED7-81F5-5DC478C10992","Canada's Michael Smith Genome Sciences Centre","564a5985e4b0298dd2cb8a88","6264E699-D40B-4EBC-B443-0A0EDCB220DC","Ovarian Serous Cystadenocarcinoma","TAR","FF9883DF-D839-4B72-8CBC-846238C86523","2014-08-08T09:10:08.000Z","D4E2DC59-69D1-4A1D-8C43-F7D3A077E27D","None","NO",1,1,"Primary Tumor","Mayo Clinic - Rochester",NA,"FF9883DF-D839-4B72-8CBC-846238C86523",1,"25","TCGA-25-2396-01A-01R-1569-13.hg19.gene.quantification.txt",NA,"TCGA-25-2396-01A",1,NA,"TCGA",2004,NA,NA,NA,"96D1655D-0A5E-4E2E-B9EB-F422CED79483",71,"TCGA-25-2396-01A-01R-1569-13.hg19.exon.quantification.txt","Dead",92,"TCGA-25-2396","NOT HISPANIC OR LATINO","B232044D-3DBA-49C2-93AE-C83E8D7469EF",NA,92,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,144,"CFDCC756-47ED-4F58-A6B5-825C9EBA0DA5","F19D3D15-5F21-450A-88D8-8DE98A66FF19","bcgsc.ca.TCGA-25-2396-01A-01R-1569-13.bcgsc.ca.1.4.0.indel.vcf","TCGA-25-2396-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-25-2396-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,92,NA,"Dead",92,"TCGA-25-2396-F26808","TCGA-25-2396",NA,"25","2396","YES","C56.9","8441/3","C56.9",NA,NA,-26145,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",92,92,NA,NA,NA,"NO",5,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
249083508,208485839,15002090539,"34091E7A-BBEB-4A71-BCEF-9CE85DA47841.bw","62efb5ae-43dc-4a4c-a898-6cd9c6dba027","34091e7a-bbeb-4a71-bcef-9ce85da47841","2016-08-19T18:26:24.221687-05:00","TCGA-24-1930-01A-01R-1567-13_rnaseq_fastq.tar","dfa605a4-47d7-430a-9b43-a6a66acb66bf",15626096640,"Illumina HiSeq","51e12d424e697c857455a5c8caee1cc2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:11:31.396468-05:00","2016-05-03T11:41:05.740763-05:00","dfa605a4-47d7-430a-9b43-a6a66acb66bf_analysis.xml","1eda530cf475ed9ffc998fd86d5b2da8","3ee840a5-3032-4cd5-b3e4-e22ee496e37a",2181,"2016-10-07T17:34:54.905482-05:00","dfa605a4-47d7-430a-9b43-a6a66acb66bf_experiment.xml","f11729ceaed7404a5c34723c0d18926f","4cd4f3c8-ed76-4e93-b3ef-9f05e7be55ce",3916,"2016-09-29T23:36:15.659552-05:00","dfa605a4-47d7-430a-9b43-a6a66acb66bf_run.xml","0bb6afb6a03321e5715c4832a2d4604c","e2eb605c-d080-4205-9b3d-03e6a5437046",1988,"2016-09-08T10:46:27.775010-05:00","TCGA-24-1930","2016-09-02T18:49:49.316795-05:00","female","TCGA-24-1930_demographic",1945,"white","54ce0094-e7b7-5ac4-b909-215939d4d01e","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1930_diagnosis","not reported",19387,"dead","8441/3",2467,2467,"2cd199cc-198a-518f-b3da-a3f3640b2ba7","c56.9",-19387,"TCGA-24-1930_treatment","2262a9a9-e859-55d3-90bd-5074c52ee546","01",NA,"TCGA-24-1930-01A","1","b9e08539-3921-490e-9f35-013f9704d516",FALSE,"746ac85a-ea6d-4d60-859f-69bf580a707c","Primary Tumor","0.6",NA,NA,"1",1246147200,"01",122,"TCGA-24-1930-01A-01",90,90,0,0,0,0,10,10,"2016-09-08T10:46:27.775010-05:00","2016-09-08T10:46:27.775010-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"0e6935ab-52a7-41ec-b55a-af0ffd17022c","bb8a446a-db5c-45a5-b5f3-0e7f84a60370","TCGA-24-1930-01A-01-BS1","TCGA-24-1930-01A-01-TS1",90,90,"3d1e9654-d74d-4397-984e-611a5f3d5738","RNA","TCGA-24-1930-01A-01R","6d31d489-8ab5-4756-928f-621d2f05cfd3",1.8,0.15,"UV Spec","R","22","TCGA-24-1930-01A-01R-1567-13","d85ca8ac-9458-4f3a-b2ef-db4df852f75e",0.15,NA,NA,NA,NA,"19295c42-b1ba-54e1-9079-425927e2234f","TCGA-24-1930_exposure","TCGA-24-1930-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T21:32:49.000Z","2014-03-26T22:05:02.000Z","DFA605A4-47D7-430A-9B43-A6A66ACB66BF","B9E08539-3921-490E-9F35-013F9704D516","Unaligned reads",15626096640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D85CA8AC-9458-4F3A-B2EF-DB4DF852F75E","Canada's Michael Smith Genome Sciences Centre","564a3441e4b08c5d868f3ae2","62EFB5AE-43DC-4A4C-A898-6CD9C6DBA027","Ovarian Serous Cystadenocarcinoma","TAR","3D1E9654-D74D-4397-984E-611A5F3D5738","2014-03-26T22:05:02.000Z","6D31D489-8AB5-4756-928F-621D2F05CFD3","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"3D1E9654-D74D-4397-984E-611A5F3D5738",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.bf3c2d8b-6072-4f59-8f19-128cfff7314e.txt",NA,"TCGA-24-1930-01A",1,"E547BD75-7DC8-4F1B-842E-A0194CE97A1A","TCGA",1998,NA,NA,"WITH TUMOR","DA9EA4B4-6C4B-45E7-972B-1DF61F07F2E3",53,"TCGA-24-1930-01A-01R-1567-13_GRCh37-lite_rnaseq.bam.bai","Dead",2467,"TCGA-24-1930",NA,"4E109663-798B-40DF-A011-0527BB6151FF",NA,2467,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,100,NA,"8441/3","FEMALE","C56.9",21,NA,"109437D5-619C-4FE7-912E-982AF9627594","WHITE",NA,1,122,"BB8A446A-DB5C-45A5-B5F3-0E7F84A60370","DB0EB69B-037B-486B-BC15-1FA73B9192A1","bcgsc.ca.TCGA-24-1930-01A-01R-1567-13.hg19.bcgsc.ca.1.6.0.snv.vcf","TCGA-24-1930-01A-01",90,0,0,0,10,"BOTTOM",0,0,"TCGA-24-1930-01A-01-BS1",90,"Gemzar","Chemotherapy","TCGA-24-1930-D26425","TCGA-24-1930-R26427","EXTERNAL BEAM","Distant Recurrence","TCGA-24-1930-F26410_NTE-3",NA,2467,"WITH TUMOR","Dead",2467,"TCGA-24-1930-F26410","TCGA-24-1930",NA,"24","1930","YES","C56.9","8441/3","C56.9",NA,NA,-19387,"FEMALE","WHITE",NA,NA,"No","Dead",2467,2467,NA,NA,"WITH TUMOR","NO",5,4,2010,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,100,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
228229674,218844810,16164067950,"B8284A02-7485-4A4B-BE86-6125A735E222.bw","635f5335-b008-428e-b005-615776a6643f","b8284a02-7485-4a4b-be86-6125a735e222","2016-08-26T07:24:58.071616-05:00","TCGA-25-1315-01A-01R-1565-13_rnaseq_fastq.tar","36e131ad-d368-4421-bd3a-9769c853679f",14440212480,"Illumina HiSeq","c007e81d331172530c41bf89235ffc6a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:36:58.085460-05:00","2016-05-03T11:40:21.647690-05:00","36e131ad-d368-4421-bd3a-9769c853679f_analysis.xml","f58d62e858b7dd50540dc509b9349496","98fff0dd-590c-465b-ae6e-9fd81ebf93bc",2181,"2016-09-29T21:47:10.095190-05:00","36e131ad-d368-4421-bd3a-9769c853679f_experiment.xml","8d3ce20006cee48d408a5780908054e1","9f45617f-00df-4051-bc27-5eb9eb0d27bb",3916,"2016-09-29T18:03:58.107055-05:00","36e131ad-d368-4421-bd3a-9769c853679f_run.xml","741db8a000749b90a57685877e5843fa","1486cbe8-46be-4fda-8c3a-e76af127861d",1989,"2016-09-08T13:35:37.622993-05:00","TCGA-25-1315","2016-09-02T19:12:15.974400-05:00","female","TCGA-25-1315_demographic",1950,"white","37be6983-075c-55d9-a482-fc41dcc71bb0","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1315_diagnosis","not reported",18263,"dead","8441/3",1583,1553,"b068f29c-7d2b-5d20-8748-67a56d85ac72","c56.9",-18263,"TCGA-25-1315_treatment","faca2e40-1fb3-5d24-81c3-6a26cd0dd2d5","01",NA,"TCGA-25-1315-01A","2","d1a2fb08-a7b9-4920-af5a-33118478a429",FALSE,"486E22A0-A224-4471-BA52-9F52E021B131","Primary Tumor","0.9",NA,NA,"3.5",1228435200,"01",156,"TCGA-25-1315-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:35:37.622993-05:00","2016-09-08T13:35:37.622993-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"2ea40aad-f13d-46af-89a6-0e04116a5d54","617ad1a6-305c-4ca3-b86c-b1de86429a0a","TCGA-25-1315-01A-01-BS1","TCGA-25-1315-01A-01-TS1",95,95,"468d2550-2808-420f-acd4-57e56e5a6d2b","RNA","TCGA-25-1315-01A-01R","48c5b79c-4b1a-4083-898e-4201afe70bd3",1.8,0.16,"UV Spec","R","22","TCGA-25-1315-01A-01R-1565-13","b6908d33-80c8-4fc0-bd1d-829ec3161527",0.16,NA,NA,NA,NA,"523f6260-7445-5207-9cfa-624d18a0f551","TCGA-25-1315_exposure","TCGA-25-1315-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:21:14.000Z","2014-03-22T02:54:02.000Z","36E131AD-D368-4421-BD3A-9769C853679F","D1A2FB08-A7B9-4920-AF5A-33118478A429","Unaligned reads",14440212480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B6908D33-80C8-4FC0-BD1D-829EC3161527","Canada's Michael Smith Genome Sciences Centre","564a379de4b0ef1218193a7d","635F5335-B008-428E-B005-615776A6643F","Ovarian Serous Cystadenocarcinoma","TAR","468D2550-2808-420F-ACD4-57E56E5A6D2B","2014-03-22T02:54:02.000Z","48C5B79C-4B1A-4083-898E-4201AFE70BD3","None","NO",1,0.9,"Primary Tumor","Mayo Clinic - Rochester",NA,"468D2550-2808-420F-ACD4-57E56E5A6D2B",2,"25","TCGA-25-1315-01A-01R-1565-13.mirna.quantification.txt",NA,"TCGA-25-1315-01A",3.5,"D4F35481-A6A4-428F-A818-6234B6CED3C3","TCGA",2000,NA,NA,"WITH TUMOR","D1A2FB08-A7B9-4920-AF5A-33118478A429",50,"nationwidechildrens.org_clinical.TCGA-25-1315.xml","Dead",1583,"TCGA-25-1315","NOT HISPANIC OR LATINO","5F76897A-AFA8-4E00-A593-08AD2E7A93D7",NA,1553,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,156,"617AD1A6-305C-4CA3-B86C-B1DE86429A0A","80F00C2D-DE78-46E4-9E9A-1B49500087AA","TCGA-25-1315-01A-01R-1565-13.hg19.gene.quantification.txt","TCGA-25-1315-01A-01",95,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-25-1315-01A-01-BS1",95,"Taxol","Chemotherapy","TCGA-25-1315-D26643",NA,NA,NA,"TCGA-25-1315-F26639_NTE-2",NA,1553,"WITH TUMOR","Dead",1583,"TCGA-25-1315-F26639","TCGA-25-1315",NA,"25","1315","YES","C56.9","8441/3","C56.9",NA,NA,-18263,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1553,1583,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
145802216,138519965,10198880141,"69E0F82A-A67A-44CA-9B03-24E40F902427.bw","63a75e0b-9241-4f0e-9236-01a2e2c05b7e","69e0f82a-a67a-44ca-9b03-24e40f902427","2016-08-20T19:28:55.303259-05:00","TCGA-13-0884-01B-01R-1565-13_rnaseq_fastq.tar","e610b6ca-e7aa-49cc-85b9-56ee38e48bf6",8785879040,"Illumina HiSeq","74f7b3ab0d3852fdaca1e5f120b4a3d2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:40:13.076429-05:00","2016-05-03T11:40:21.647690-05:00","e610b6ca-e7aa-49cc-85b9-56ee38e48bf6_analysis.xml","41acf2c1822d4a0a9fbe30826fd24227","75a37d56-3da6-4284-8412-ab59645e3b86",2235,"2016-09-29T19:22:31.780447-05:00","e610b6ca-e7aa-49cc-85b9-56ee38e48bf6_experiment.xml","1363e595728a8e75260a7cc342d59284","45e131c5-9f4c-4cf4-b08b-817a233938d9",3916,"2016-09-29T18:48:24.605785-05:00","e610b6ca-e7aa-49cc-85b9-56ee38e48bf6_run.xml","2e8e0d31af0873493b13dbdfb91770f8","305bccba-acf5-4c5a-ba4d-5a8f3c123fcb",1988,"2016-09-08T13:26:05.187827-05:00","TCGA-13-0884","2016-09-02T19:12:18.297319-05:00","female","TCGA-13-0884_demographic",1960,"white","ae611d16-8057-5154-9ece-95a2375c0d0d","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0884_diagnosis","not reported",14538,"dead","8441/3",3260,3260,"e48908e4-4f4e-59d5-a1a0-2344695aed5f","c56.9",-14538,"TCGA-13-0884_treatment","7867df2e-1008-525a-80a2-a852709f7689","01",NA,"TCGA-13-0884-01B","0.7","4aa80346-4292-4863-9891-bb4c218880b3",FALSE,"D15552F3-1407-4C01-9B59-DFAC5D4EF095","Primary Tumor","0.5",NA,NA,"1.3",1230508800,"01",107,"TCGA-13-0884-01B-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:26:05.187827-05:00","2016-09-08T13:26:05.187827-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"4bcf3062-6cc6-4759-9515-4d1674763ca5","48ab706e-f243-4f72-b7c5-8b4a5b5dbcc0","TCGA-13-0884-01B-01-TS1","TCGA-13-0884-01B-01-BS1",89,89,"57704565-219c-480e-8795-2e8838a01204","RNA","TCGA-13-0884-01B-01R","dd2892e3-1bec-4a0d-8881-7c8c72633291",1.8,0.16,"UV Spec","R","22","TCGA-13-0884-01B-01R-1565-13","5339b819-0e19-4b7d-a098-6f58afc07180",0.16,NA,NA,NA,NA,"ae3d590c-11b2-5603-ae72-36477e4c585a","TCGA-13-0884_exposure","TCGA-13-0884-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-22T00:35:52.000Z","2014-03-22T00:57:02.000Z","E610B6CA-E7AA-49CC-85B9-56EE38E48BF6","4AA80346-4292-4863-9891-BB4C218880B3","Unaligned reads",8785879040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5339B819-0E19-4B7D-A098-6F58AFC07180","Canada's Michael Smith Genome Sciences Centre","564a5612e4b0298dd2ca6720","63A75E0B-9241-4F0E-9236-01A2E2C05B7E","Ovarian Serous Cystadenocarcinoma","TAR","57704565-219C-480E-8795-2E8838A01204","2014-03-22T00:57:02.000Z","DD2892E3-1BEC-4A0D-8881-7C8C72633291","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"57704565-219C-480E-8795-2E8838A01204",0.7,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2185ae8b-2257-4cc5-b08d-cf91dffa760d.txt",NA,"TCGA-13-0884-01B",1.3,"FC570206-CA8E-42F3-A1F2-A46AEA37A65E","TCGA",1999,NA,NA,"WITH TUMOR","752480D2-FAA4-4093-B5D0-20D3B4B65122",39,"CELLS_p_TCGA_B13__RNA_HT_HG-U133A_96-HTA_C04_452000.level3.data.txt","Dead",3260,"TCGA-13-0884","NOT HISPANIC OR LATINO","E819D979-7EFE-4737-B8B4-0A64E5588D4B",NA,3260,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,107,"4BCF3062-6CC6-4759-9515-4D1674763CA5","CD413801-F4CB-405F-834F-3887F2FEBC5B","bcgsc.ca.TCGA-13-0884-01B-01R-1565-13.hg19.bcgsc.ca.1.7.0.sv.fa","TCGA-13-0884-01B-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-13-0884-01B-01-TS1",89,"Carboplatin","Chemotherapy","TCGA-13-0884-D24652",NA,NA,NA,"TCGA-13-0884-F24651_NTE-1",NA,3260,"WITH TUMOR","Dead",3260,"TCGA-13-0884-F24651","TCGA-13-0884",NA,"13","0884","YES","C56.9","8441/3","C56.9",NA,NA,-14538,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",3260,3260,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,39,1999,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
222845428,212854338,15718061610,"6BF81116-B1DF-4632-8352-AE89A43BABCD.bw","63c6a89b-b28c-434a-a632-5de6545db731","6bf81116-b1df-4632-8352-ae89a43babcd","2016-08-25T14:01:27.176658-05:00","TCGA-13-1492-01A-01R-1565-13_rnaseq_fastq.tar","cb116253-7320-4e13-a7ff-6649f1a3af86",14491361280,"Illumina HiSeq","4840fade31d89255fc2fee0de03a45f8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:24:31.158833-05:00","2016-05-03T11:40:21.669427-05:00","cb116253-7320-4e13-a7ff-6649f1a3af86_analysis.xml","0213498ad3d87c8f0660880a76d06d08","6c118c1c-6bb1-4fc3-a4cf-b4e9ddbfb566",2208,"2016-09-29T19:59:47.666487-05:00","cb116253-7320-4e13-a7ff-6649f1a3af86_experiment.xml","f68ceaf6d20edad8a9e465490cb248cc","5cfe29a6-8835-4244-a057-11582b535fb4",3916,"2016-09-29T22:18:15.314478-05:00","cb116253-7320-4e13-a7ff-6649f1a3af86_run.xml","5e978ce4d53d304143f4e521459fcf14","b282da45-bb25-41b9-b036-8900c8e9d440",1989,"2016-09-08T13:22:27.284109-05:00","TCGA-13-1492","2016-09-02T19:13:57.531748-05:00","female","TCGA-13-1492_demographic",1936,"white","71d375c1-b32a-5221-950d-48517ae1bf94","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1492_diagnosis","not reported",24332,"dead","8441/3",3819,2237,"a182868e-521c-5039-8b4e-1c047fbbfd11","c56.9",-24332,"TCGA-13-1492_treatment","bc3d82c5-b314-50ed-802b-3b50c6bdf997","01",NA,"TCGA-13-1492-01A","1.2","e66d5c81-a9e3-4642-9bcb-655372f247a5",FALSE,"566BE185-8A2E-43C4-9762-65216AB9AC44","Primary Tumor","0.4",NA,NA,"2.5",1234483200,"01",127,"TCGA-13-1492-01A-01",99,99,NA,NA,0,0,1,1,"2016-09-08T13:22:27.284109-05:00","2016-09-08T13:22:27.284109-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"893fd41e-d481-4430-b8e3-b7952e9a4f6a","8f143732-b6e9-4ce4-bc41-b2aa51955587","TCGA-13-1492-01A-01-TS1","TCGA-13-1492-01A-01-BS1",94,94,"0c5226bd-5c9b-4506-8004-2136ec69767c","RNA","TCGA-13-1492-01A-01R","b676e030-b7e4-4a20-aac9-57b8c7a2028c",1.8,0.16,"UV Spec","R","22","TCGA-13-1492-01A-01R-1565-13","3991212e-874f-4c0c-a822-4a149ecda1b2",0.16,NA,NA,NA,NA,"e66bd566-a80d-5010-9202-e4a1c8cf4232","TCGA-13-1492_exposure","TCGA-13-1492-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T06:14:53.000Z","2014-03-22T06:46:01.000Z","CB116253-7320-4E13-A7FF-6649F1A3AF86","E66D5C81-A9E3-4642-9BCB-655372F247A5","Unaligned reads",14491361280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3991212E-874F-4C0C-A822-4A149ECDA1B2","Canada's Michael Smith Genome Sciences Centre","564a59f6e4b093830b6c88ca","63C6A89B-B28C-434A-A632-5DE6545DB731","Ovarian Serous Cystadenocarcinoma","TAR","0C5226BD-5C9B-4506-8004-2136EC69767C","2014-03-22T06:46:01.000Z","B676E030-B7E4-4A20-AAC9-57B8C7A2028C","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"0C5226BD-5C9B-4506-8004-2136EC69767C",1.2,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.943e741f-3371-4167-99e0-fd795663874c.txt",NA,"TCGA-13-1492-01A",2.5,"C73B40CA-5B10-47A1-AC49-E4DD24DB1E05","TCGA",2002,NA,NA,"TUMOR FREE","E66D5C81-A9E3-4642-9BCB-655372F247A5",66,"TCGA-13-1492-01A-01T-0480-07.gene.tcga_level3.data.txt","Alive",NA,"TCGA-13-1492","NOT HISPANIC OR LATINO","62DE4389-6BB4-42FF-84A9-3AB406E99C05",NA,2237,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,127,"893FD41E-D481-4430-B8E3-B7952E9A4F6A","E6139A80-A46F-48FE-8D5B-28864AF5550C","TCGA-13-1492-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-13-1492-01A-01",99,0,NA,NA,1,"BOTTOM",5,NA,"TCGA-13-1492-01A-01-BS1",94,"Paciltaxel","Chemotherapy","TCGA-13-1492-D24891",NA,NA,NA,NA,NA,2237,"TUMOR FREE","Alive",NA,"TCGA-13-1492-F24889","TCGA-13-1492",NA,"13","1492","YES","C56.9","8441/3","C56.9",NA,NA,-24332,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2237,NA,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,66,2002,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
265208920,244739086,17913535986,"A6158098-8F9B-4110-9226-A00EF48D42E3.bw","644a88a7-dc56-468a-af5c-60278aab7642","a6158098-8f9b-4110-9226-a00ef48d42e3","2016-08-26T00:34:57.953602-05:00","TCGA-09-1659-01B-01R-1564-13_rnaseq_fastq.tar","cceca647-fc31-447f-8a0f-83e793c6d441",17104302080,"Illumina HiSeq","7676919663cc89903bf2b6df88179799","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:08:04.690296-05:00","2016-05-03T11:27:59.332723-05:00","cceca647-fc31-447f-8a0f-83e793c6d441_analysis.xml","cc90fdbae9c37e32f455c35323f540ad","f68200dd-d10a-4f44-8b51-5712e8d4aabe",2183,"2016-09-29T18:04:50.829091-05:00","cceca647-fc31-447f-8a0f-83e793c6d441_experiment.xml","18285ec57ed01fa4e4016be0608a8000","1513d986-bdf8-41cd-bd72-77bd01842165",3916,"2016-09-29T20:33:11.144339-05:00","cceca647-fc31-447f-8a0f-83e793c6d441_run.xml","c80deb088a61cffee5538478f63c44a0","714a9e05-473b-4371-9dc7-49068f940c81",1990,"2016-09-08T10:38:36.521624-05:00","TCGA-09-1659","2016-09-02T18:48:48.747434-05:00","female","TCGA-09-1659_demographic",1946,"white","a5962b77-641c-5dd7-8efa-361ca8a34954","not hispanic or latino",1997,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1659_diagnosis","not reported",18733,"dead","8441/3",304,NA,"0f558703-06e8-564a-b36a-1cec509b1429","c56.9",-18733,"TCGA-09-1659_treatment","41d0d5a4-19a7-54b1-8a5b-6025e3d5dc59","01",NA,"TCGA-09-1659-01B","0.6","01a6f7cd-10cc-4f33-aa75-b29abd6c2edb",FALSE,"f10b2e12-02b2-42e0-a5b2-a02c1daabbdf","Primary Tumor","0.4",NA,NA,"1",1240185600,"01",110,"TCGA-09-1659-01B-01",85,85,NA,NA,5,17,0,0,"2016-09-08T10:38:36.521624-05:00","2016-09-08T10:38:36.521624-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,3,"8a082fbd-7649-4b19-8cb6-24f30dc4b2ba","e8c4fbf1-6540-4e8e-b163-58d009066a2e","TCGA-09-1659-01B-01-TS1","TCGA-09-1659-01B-01-BS1",85,80,"bb0aaf3c-cc37-4d91-9b09-2f5af33cf3e5","RNA","TCGA-09-1659-01B-01R","2c8256d0-fd64-4057-8c95-46c6b368fad1",1.8,0.16,"UV Spec","R","22","TCGA-09-1659-01B-01R-1564-13","32d5209e-2ef2-4ef0-b902-585542d7d16b",0.16,NA,NA,NA,NA,"36e75525-1e23-5bda-9d69-3412294da0ef","TCGA-09-1659_exposure","TCGA-09-1659-01B-01R-1564-13_rnaseq_fastq.tar","2013-12-20T23:29:04.000Z","2013-12-20T23:56:02.000Z","CCECA647-FC31-447F-8A0F-83E793C6D441","01A6F7CD-10CC-4F33-AA75-B29ABD6C2EDB","Unaligned reads",17104302080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","32D5209E-2EF2-4EF0-B902-585542D7D16B","Canada's Michael Smith Genome Sciences Centre","564a3545e4b0ef1218187a0a","644A88A7-DC56-468A-AF5C-60278AAB7642","Ovarian Serous Cystadenocarcinoma","TAR","BB0AAF3C-CC37-4D91-9B09-2F5AF33CF3E5","2013-12-20T23:56:02.000Z","2C8256D0-FD64-4057-8C95-46C6B368FAD1","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"BB0AAF3C-CC37-4D91-9B09-2F5AF33CF3E5",0.6,"09","TCGA-09-1659-01B-01W-0615-10_SOLiD.bam",NA,"TCGA-09-1659-01B",1,"E95461E2-9E4C-4E78-823C-562005B13FD2","TCGA",1997,NA,NA,"WITH TUMOR","0CB6EC4A-E89D-48A9-8001-53DE353DDC50",51,"US82800149_251976010672_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.gene.tcga_level3.data.txt","Dead",304,"TCGA-09-1659","NOT HISPANIC OR LATINO","43FA1BF4-AEBC-4742-975B-F4FAC71B3092",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,110,"E8C4FBF1-6540-4E8E-B163-58D009066A2E","EC5A7E79-C55C-49A6-85DF-8C2C0CF5EB83","TCGA-09-1659-01B-01W-0615-10_SOLiD.bam","TCGA-09-1659-01B-01",85,5,NA,NA,0,"TOP",10,NA,"TCGA-09-1659-01B-01-TS1",85,"Taxol","Chemotherapy","TCGA-09-1659-D24229",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",304,"TCGA-09-1659-F24226","TCGA-09-1659",NA,"09","1659","YES","C56.9","8441/3","C56.9",NA,NA,-18733,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,304,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
278835860,262087342,19339477930,"A83A5CA3-F7EF-4067-98C9-645977A8F885.bw","6485b68f-caa7-45cd-9bc5-78c2add8191d","a83a5ca3-f7ef-4067-98c9-645977a8f885","2016-08-26T01:28:24.797384-05:00","TCGA-13-0762-01A-01R-1564-13_rnaseq_fastq.tar","95b7246b-191e-477d-9b2d-f8810a26df04",18117283840,"Illumina HiSeq","5ee7581cfbece3a08251fbc0d43598e1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:06:45.441101-05:00","2016-05-03T11:39:34.522989-05:00","95b7246b-191e-477d-9b2d-f8810a26df04_analysis.xml","7dd61c2fbf5aafd1595e07732059fc8b","ab7da716-341f-4447-a775-a2749a5d96de",2210,"2016-09-29T20:10:56.900635-05:00","95b7246b-191e-477d-9b2d-f8810a26df04_experiment.xml","c1393bd5b51fa7ca7a18f9962051cee1","63baf25f-1796-4210-a2f9-e7ec101c215a",3916,"2016-09-29T23:33:30.920762-05:00","95b7246b-191e-477d-9b2d-f8810a26df04_run.xml","331fad3a671a95b20e7825681769d254","e13b3e29-f0a3-41fe-a866-898861e108f8",1990,"2016-09-08T13:46:10.356134-05:00","TCGA-13-0762","2016-09-02T19:09:42.476733-05:00","female","TCGA-13-0762_demographic",1941,"white","35416893-69c6-54f9-881e-2201d801d116","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0762_diagnosis","not reported",23960,"alive","8441/3",NA,3400,"814eacd3-27a0-5c0c-b4f7-18f4355ab3c4","c56.9",-23960,"TCGA-13-0762_treatment","bca2d4a7-9197-54e5-977c-c66c5ac81669","01",NA,"TCGA-13-0762-01A","0.8","b76ac1b8-f934-45d1-a7d1-780f99a79584",FALSE,"5FC6D44F-6057-4014-9800-86050279F42E","Primary Tumor","0.2",NA,NA,"1.1",1233705600,"01",150,"TCGA-13-0762-01A-01",95,95,NA,NA,5,0,NA,10,"2016-09-08T13:46:10.356134-05:00","2016-09-08T13:46:10.356134-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,0,"6f3b37f7-9bef-4866-bb07-dbb60257d37c","6e3dc8cb-c3cf-4b6c-a27c-7a692b97ee22","TCGA-13-0762-01A-01-BS1","TCGA-13-0762-01A-01-TS1",94,90,"daf7af4e-f651-4bbe-a68d-ab4a2ca2841d","RNA","TCGA-13-0762-01A-01R","f92d2af0-2617-4380-a3e8-45a1a6a17b8f",1.8,0.18,"UV Spec","R","22","TCGA-13-0762-01A-01R-1564-13","c2f1b1b8-f914-4665-a779-901ebb41965f",0.18,NA,NA,NA,NA,"0d3d4cba-04c6-5d5b-8374-0c3fb8a9e3cb","TCGA-13-0762_exposure","TCGA-13-0762-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T01:06:26.000Z","2014-03-20T01:40:01.000Z","95B7246B-191E-477D-9B2D-F8810A26DF04","B76AC1B8-F934-45D1-A7D1-780F99A79584","Unaligned reads",18117283840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C2F1B1B8-F914-4665-A779-901EBB41965F","Canada's Michael Smith Genome Sciences Centre","564a5b61e4b08c5d8695365f","6485B68F-CAA7-45CD-9BC5-78C2ADD8191D","Ovarian Serous Cystadenocarcinoma","TAR","DAF7AF4E-F651-4BBE-A68D-AB4A2CA2841D","2014-03-20T01:40:01.000Z","F92D2AF0-2617-4380-A3E8-45A1A6A17B8F","None","NO",1,0.2,"Primary Tumor","Memorial Sloan Kettering",NA,"DAF7AF4E-F651-4BBE-A68D-AB4A2CA2841D",0.8,"13","TCGA-13-0762-01A-01R-1564-13_rnaseq_fastq.tar",NA,"TCGA-13-0762-01A",1.1,"93F06508-DCCF-4618-83F4-C16FD7AC7E53","TCGA",2006,NA,NA,"TUMOR FREE","BD8461F0-E2D3-454F-B70D-3355C8539B9D",65,"nationwidechildrens.org_clinical.TCGA-13-0762.xml","Alive",NA,"TCGA-13-0762","NOT HISPANIC OR LATINO",NA,NA,981,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,150,"6E3DC8CB-C3CF-4B6C-A27C-7A692B97EE22","883C1C97-C262-4C73-B155-1A8A636A5CCF","TCGA-13-0762-01A-01R-1564-13_rnaseq.bam","TCGA-13-0762-01A-01",95,0,NA,NA,10,"TOP",0,NA,"TCGA-13-0762-01A-01-TS1",90,"Paclitaxel","Chemotherapy","TCGA-13-0762-D24551",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0762",NA,"13","0762","YES","C56.9","8441/3","C56.9",NA,NA,-23960,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",981,NA,NA,NA,"TUMOR FREE","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
221242170,217257659,16091429565,"0EFE7B9E-3715-4117-8D9B-D764F76C8522.bw","65435f50-a35d-49e3-a36e-b95d9e274ca0","0efe7b9e-3715-4117-8d9b-d764f76c8522","2016-08-24T21:33:26.752166-05:00","TCGA-24-1604-01A-01R-1566-13_rnaseq_fastq.tar","1cbeb3f7-67e2-439a-908f-503875b55383",13239367680,"Illumina HiSeq","1e7dad51318c5b5481c2507b4b49dd32","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:52:12.152275-05:00","2016-05-03T11:40:21.648199-05:00","1cbeb3f7-67e2-439a-908f-503875b55383_analysis.xml","a4302a92c6dd7af1c30d5b92507f4d64","c792d7ab-4f15-4448-92ad-1d0f4849145a",2181,"2016-09-29T23:02:09.075333-05:00","1cbeb3f7-67e2-439a-908f-503875b55383_experiment.xml","4252f3a15cd21658b32cd6809f65dd6e","cd915e76-321b-4376-a64f-836db05cd4db",3916,"2016-09-29T19:16:24.398951-05:00","1cbeb3f7-67e2-439a-908f-503875b55383_run.xml","818149d3b8cf1ee2c2d80fa62abf252b","4203327e-53c3-4d3f-b25a-6d72d3e263ad",1988,"2016-09-08T12:13:48.325894-05:00","TCGA-24-1604","2016-09-02T19:07:12.896266-05:00","female","TCGA-24-1604_demographic",1930,"white","88b4acdd-e3e8-5e2a-9820-0fd2ed174d45","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1604_diagnosis","not reported",24471,"dead","8441/3",2688,2688,"d92abbe4-d3f0-57cb-84bb-a07a6746bd3f","c56.9",-24471,"TCGA-24-1604_treatment","7678f010-6e8d-582c-8bf7-40cdc871a1f8","01",NA,"TCGA-24-1604-01A","1.3","b3909bea-c426-4dad-94a9-15577e9f0c09",FALSE,"de978a3d-92f9-4bd8-98f4-f8a3ec09b362","Primary Tumor","0.6",NA,NA,"1.4",1237420800,"01",129,"TCGA-24-1604-01A-01",90,93,NA,NA,45,25,0,0,"2016-09-08T12:13:48.325894-05:00","2016-09-08T12:13:48.325894-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"6d8ad821-149e-41cc-9926-71b32c12469c","723beda5-e12c-4e4a-8023-fd758839a322","TCGA-24-1604-01A-01-TS1","TCGA-24-1604-01A-01-BS1",50,70,"6abefb40-eb92-4c06-ae5e-2369d915d3aa","RNA","TCGA-24-1604-01A-01R","8983b9c7-d0a3-45c3-98fb-718e85d6e672",1.8,0.15,"UV Spec","R","22","TCGA-24-1604-01A-01R-1566-13","a658045c-93a6-4aac-abbb-1cd6093b7735",0.15,NA,NA,NA,NA,"4bb90ccb-8c8e-5373-87cc-801696c49069","TCGA-24-1604_exposure","TCGA-24-1604-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T07:53:26.000Z","2014-03-25T08:19:02.000Z","1CBEB3F7-67E2-439A-908F-503875B55383","B3909BEA-C426-4DAD-94A9-15577E9F0C09","Unaligned reads",13239367680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A658045C-93A6-4AAC-ABBB-1CD6093B7735","Canada's Michael Smith Genome Sciences Centre","564a3b48e4b093830b693bf8","65435F50-A35D-49E3-A36E-B95D9E274CA0","Ovarian Serous Cystadenocarcinoma","TAR","6ABEFB40-EB92-4C06-AE5E-2369D915D3AA","2014-03-25T08:19:02.000Z","8983B9C7-D0A3-45C3-98FB-718E85D6E672","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"6ABEFB40-EB92-4C06-AE5E-2369D915D3AA",1.3,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2350016d-f638-4c02-a24b-76f1df75cb69.txt",NA,"TCGA-24-1604-01A",1.4,"BED4FFB4-9A55-4D58-B397-DA646F96AA74","TCGA",1996,NA,NA,"WITH TUMOR","B3909BEA-C426-4DAD-94A9-15577E9F0C09",66,"TCGA-24-1604-01A-01R-1566-13_rnaseq_fastq.tar","Dead",2688,"TCGA-24-1604",NA,"36C37A67-9B4F-42CC-93E8-4AEA5CB551A4",NA,2688,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,"F525E3CC-C70A-4E0D-B2EB-CB6999C51466","WHITE",NA,1,129,"723BEDA5-E12C-4E4A-8023-FD758839A322","76C83D57-4790-4C81-9887-2AE1681FCA9C","TCGA-24-1604-01A-01R-1566-13_GRCh37-lite_mirna.bam.bai","TCGA-24-1604-01A-01",90,45,NA,NA,0,"TOP",5,NA,"TCGA-24-1604-01A-01-TS1",50,"Doxil","Chemotherapy","TCGA-24-1604-D26303","TCGA-24-1604-R26304","EXTERNAL BEAM","Distant Recurrence",NA,NA,2688,"WITH TUMOR","Dead",2688,"TCGA-24-1604-F26299","TCGA-24-1604",NA,"24","1604","YES","C56.9","8441/3","C56.9",NA,NA,-24471,"FEMALE","WHITE",NA,NA,"No","Dead",2688,2688,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,1996,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
357492522,341488380,25134594981,"5CB782F0-C835-48AA-965C-54D87AFD0B13.bw","65ddccd2-70a7-48b3-88e1-9d6fd1dcd11b","5cb782f0-c835-48aa-965c-54d87afd0b13","2016-08-25T08:13:44.902038-05:00","TCGA-10-0934-01A-02R-1564-13_rnaseq_fastq.tar","7b5daab2-b26e-4bd9-b635-5b2442e2d5bc",22954147840,"Illumina HiSeq","e38e3bea9e592b9a9407e8f551003f2e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:20:17.082570-05:00","2016-05-03T11:27:59.332723-05:00","7b5daab2-b26e-4bd9-b635-5b2442e2d5bc_analysis.xml","2ba1ece07b708505dc74c02a8f8b563c","8ebc1cdd-607d-4ea0-814a-b75ce9b7911e",2210,"2016-09-29T20:20:21.040451-05:00","7b5daab2-b26e-4bd9-b635-5b2442e2d5bc_experiment.xml","e91235a1dc6166ba7cd890296709e133","6971ca35-9207-4f71-8087-e5799d0657f7",3916,"2016-09-29T23:01:03.813317-05:00","7b5daab2-b26e-4bd9-b635-5b2442e2d5bc_run.xml","6b12dc2c05b1ec5eca44487fa419dada","ccdd13d8-39c5-4011-a799-34aa20d9928f",1990,"2016-09-08T12:45:17.059702-05:00","TCGA-10-0934","2016-09-02T19:06:15.992493-05:00","female","TCGA-10-0934_demographic",1953,"white","bebf0413-27c1-5758-8bfb-0168b5a20b99","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0934_diagnosis","not reported",18602,"dead","8441/3",204,119,"b67a50b0-1627-587d-b7eb-dfc734a74286","c56.9",-18602,"TCGA-10-0934_treatment","12c8e62c-13ae-552e-a731-1f1c36e5c149","01",NA,"TCGA-10-0934-01A","0.6","27a33c2d-6704-4164-aa5b-894665dea55f",FALSE,"a5c94c47-086b-4d69-a03f-74df709fdc56","Primary Tumor","0.4",NA,NA,"0.9",1233705600,"02",88,"TCGA-10-0934-01A-02",90,85,NA,NA,5,5,5,10,"2016-09-08T12:45:17.059702-05:00","2016-09-08T12:45:17.059702-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"9d515b55-0fa2-4ce2-9997-6a906c044489","01aac644-35c3-4a9d-baaa-74f6c5322362","TCGA-10-0934-01A-02-BS2","TCGA-10-0934-01A-01-BS1",90,85,"4733a5b9-bfa7-4137-84e3-46a1c1930767","RNA","TCGA-10-0934-01A-02R","71ed7cd2-fda6-4445-866e-d208e599780e",1.8,0.15,"UV Spec","R","22","TCGA-10-0934-01A-02R-1564-13","5b759ce4-2632-4d85-89fe-30a85069e9a8",0.15,NA,NA,NA,NA,"41d19c27-8380-5ce0-bab6-2fae6a899734","TCGA-10-0934_exposure","TCGA-10-0934-01A-02R-1564-13_rnaseq_fastq.tar","2013-12-20T22:54:06.000Z","2013-12-20T23:32:02.000Z","7B5DAAB2-B26E-4BD9-B635-5B2442E2D5BC","27A33C2D-6704-4164-AA5B-894665DEA55F","Unaligned reads",22954147840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5B759CE4-2632-4D85-89FE-30A85069E9A8","Canada's Michael Smith Genome Sciences Centre","564a5c59e4b093830b6d22d7","65DDCCD2-70A7-48B3-88E1-9D6FD1DCD11B","Ovarian Serous Cystadenocarcinoma","TAR","4733A5B9-BFA7-4137-84E3-46A1C1930767","2013-12-20T23:32:02.000Z","71ED7CD2-FDA6-4445-866E-D208E599780E","None","NO",1,0.4,"Primary Tumor","MD Anderson Cancer Center",NA,"E7B62593-41A6-461C-A57A-889596A753DE",0.6,"10","TCGA-10-0934-01A-02W-0420-08_IlluminaGA-DNASeq_capture.bam.bai",NA,"TCGA-10-0934-01A",0.9,"8905B636-EB21-4DA2-9C21-10097B036851","TCGA",2003,NA,NA,"WITH TUMOR","27A33C2D-6704-4164-AA5B-894665DEA55F",50,"nationwidechildrens.org_clinical.TCGA-10-0934.xml","Dead",204,"TCGA-10-0934","NOT HISPANIC OR LATINO","0D547712-8F13-4099-8C98-DBBD9132ACEE",NA,119,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,2,88,"9D515B55-0FA2-4CE2-9997-6A906C044489","C544515B-7E1C-4965-93AD-CA5DDD5596EC","TCGA-10-0934-01A-02W-0420-08_IlluminaGA-DNASeq_capture.bam.bai","TCGA-10-0934-01A-02",90,5,NA,NA,5,"BOTTOM",0,NA,"TCGA-10-0934-01A-02-BS2",90,"Taxol","Chemotherapy","TCGA-10-0934-D24459",NA,NA,NA,"TCGA-10-0934-F24458_NTE-2",NA,119,"WITH TUMOR","Dead",204,"TCGA-10-0934-F24458","TCGA-10-0934",NA,"10","0934","YES","C56.9","8441/3","C56.9",NA,NA,-18602,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",119,204,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
197267702,191890175,14228446610,"4D2D0B6B-AE4D-415A-BFF9-DBBA752561A0.bw","662d77d1-1a43-427a-813b-e11edd30868e","4d2d0b6b-ae4d-415a-bff9-dbba752561a0","2016-09-29T19:34:16.364405-05:00","TCGA-25-1626-01A-01R-1566-13_rnaseq_fastq.tar","88b89729-563e-4bc8-a97f-82516258cfd6",12481095680,"Illumina HiSeq","028e1a037e96de7d586d6326027b36a0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:34:10.322838-05:00","2016-05-03T11:41:05.750744-05:00","88b89729-563e-4bc8-a97f-82516258cfd6_analysis.xml","756dcc49318fd88ac9408a4be7f59958","71d29655-2538-4b88-b301-227778aad689",2183,"2016-09-29T19:53:50.663470-05:00","88b89729-563e-4bc8-a97f-82516258cfd6_experiment.xml","c6633731dbae08153172c18174db9bd9","595ebe6f-a7eb-46de-9ff4-9f940ae7a991",3916,"2016-09-29T20:21:16.056336-05:00","88b89729-563e-4bc8-a97f-82516258cfd6_run.xml","656f62e21d1d2483e792220ce1bf2549","69fdc788-8d9c-40e6-a9f5-914dd2dc0cce",1990,"2016-09-08T11:00:33.567329-05:00","TCGA-25-1626","2016-09-02T18:48:57.356970-05:00","female","TCGA-25-1626_demographic",1941,"white","7a6939c1-85fa-5b74-b9c5-60e18347c35a","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1626_diagnosis","not reported",23932,"dead","8441/3",518,481,"f5f5f800-6d60-522d-a538-95bf6adaa275","c56.9",-23932,"TCGA-25-1626_treatment","2a73c773-6a90-5db2-b0d0-3a7ef3e20122","01",NA,"TCGA-25-1626-01A","0.5","1b396d98-af47-49c3-bf45-9f26ed32d71c",FALSE,"4B54A1C9-6F08-435B-B85F-736D4278EA82","Primary Tumor","0.4",NA,NA,"1.4",1237420800,"01",117,"TCGA-25-1626-01A-01",75,70,NA,NA,0,0,30,40,"2016-09-08T11:00:33.567329-05:00","2016-09-08T11:00:33.567329-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"a288053e-86fd-4189-8dba-641155072fc7","84f55106-8f41-49e6-b9e5-2c70a99aaeef","TCGA-25-1626-01A-01-BS1","TCGA-25-1626-01A-01-TS1",65,55,"e2b5f773-736b-46d7-b60b-63d98692759b","RNA","TCGA-25-1626-01A-01R","b337168c-f0fc-47a1-bfa5-974be2c59248",1.8,0.15,"UV Spec","R","22","TCGA-25-1626-01A-01R-1566-13","daaba89d-acd3-4670-a618-89e5973b03f4",0.15,NA,NA,NA,NA,"8cc51124-e4e5-54c5-9c33-5902d489749d","TCGA-25-1626_exposure","TCGA-25-1626-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T17:17:51.000Z","2014-03-28T17:42:02.000Z","88B89729-563E-4BC8-A97F-82516258CFD6","1B396D98-AF47-49C3-BF45-9F26ED32D71C","Unaligned reads",12481095680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DAABA89D-ACD3-4670-A618-89E5973B03F4","Canada's Michael Smith Genome Sciences Centre","564a411fe4b093830b6b1c36","662D77D1-1A43-427A-813B-E11EDD30868E","Ovarian Serous Cystadenocarcinoma","TAR","E2B5F773-736B-46D7-B60B-63D98692759B","2014-03-28T17:42:02.000Z","B337168C-F0FC-47A1-BFA5-974BE2C59248","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"E2B5F773-736B-46D7-B60B-63D98692759B",0.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7a9090de-0e14-4fc3-a2d7-c42629b3afd7.txt",NA,"TCGA-25-1626-01A",1.4,"E35EE48A-E2ED-46C0-BC8D-99B1952BA6C4","TCGA",2006,NA,NA,"WITH TUMOR","1B396D98-AF47-49C3-BF45-9F26ED32D71C",65,"nationwidechildrens.org_clinical.TCGA-25-1626.xml","Dead",518,"TCGA-25-1626","NOT HISPANIC OR LATINO","827174FF-D45F-4226-80A0-DF0BCC8D9F66",NA,481,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,117,"A288053E-86FD-4189-8DBA-641155072FC7","D869CD9A-75E8-4651-B8F3-8C82B7861168","TCGA-25-1626-01A-01R-1566-13_mirna.bam.bai","TCGA-25-1626-01A-01",75,0,NA,NA,30,"BOTTOM",5,NA,"TCGA-25-1626-01A-01-BS1",65,"Doxil","Chemotherapy","TCGA-25-1626-D26720",NA,NA,NA,"TCGA-25-1626-F26716_NTE-1",NA,481,"WITH TUMOR","Dead",518,"TCGA-25-1626-F26716","TCGA-25-1626",NA,"25","1626","YES","C56.9","8441/3","C56.9",NA,NA,-23932,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",481,518,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,65,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
288322744,276866753,20482410726,"73986461-AF2C-4656-AFF0-BFD7B4889C6A.bw","66c92b9e-de3c-4d1a-bb69-46ffbc6caf33","73986461-af2c-4656-aff0-bfd7b4889c6a","2016-08-25T17:21:52.002594-05:00","TCGA-24-1548-01A-01R-1566-13_rnaseq_fastq.tar","1f9b7ad8-ce89-4e73-baa1-2289e2d05f1f",19393955840,"Illumina HiSeq","6ab7de2b1b5111323de2f0bf05444494","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:50:57.590141-05:00","2016-05-03T11:41:05.750744-05:00","1f9b7ad8-ce89-4e73-baa1-2289e2d05f1f_analysis.xml","8e1f25c97a11493fab948e343d9aaec6","31f5a02b-c13f-4e13-b458-8e3ef92434d8",2181,"2016-08-27T18:08:29.471138-05:00","1f9b7ad8-ce89-4e73-baa1-2289e2d05f1f_experiment.xml","375e1f8e60d578498fdcbfcac0482aab","1c7e47d8-d293-4433-888b-1ae23cb8dc72",3916,"2016-09-30T00:01:21.123203-05:00","1f9b7ad8-ce89-4e73-baa1-2289e2d05f1f_run.xml","26282c886a8a6bade9ef3c450d4a1893","f272ef4c-a6e5-44f3-8268-44ab3ee52b64",1988,"2016-09-08T11:02:13.468181-05:00","TCGA-24-1548","2016-09-02T18:48:45.624551-05:00","female","TCGA-24-1548_demographic",1940,"white","31a687e4-6949-5697-b241-1ff704021006","not reported",1998,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1548_diagnosis","not reported",20945,"dead","8441/3",493,493,"8eaff24a-deb4-59b6-9bec-4fdf16ac70bf","c56.9",-20945,"TCGA-24-1548_treatment","43227535-0173-536d-954d-34a51afbada3","01",NA,"TCGA-24-1548-01A","0.7","5d4e65aa-d7d0-43ec-b395-df2f01b1a203",FALSE,"d7b9bc71-e243-478f-a116-7e9371b87327","Primary Tumor","0.4",NA,NA,"1.2",1235088000,"01",110,"TCGA-24-1548-01A-01",99,95,NA,NA,0,0,5,20,"2016-09-08T11:02:13.468181-05:00","2016-09-08T11:02:13.468181-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,2,"6114d437-d41e-412e-a3ca-80b15ddf73cd","f934c9c9-8ca7-4dfa-acf9-9776b6604001","TCGA-24-1548-01A-01-TS1","TCGA-24-1548-01A-01-BS1",95,78,"34738b28-78db-47b2-b32b-92e6b789d3e6","RNA","TCGA-24-1548-01A-01R","447d3347-cfbd-4d08-ac11-8c7a2a314e12",1.8,0.16,"UV Spec","R","22","TCGA-24-1548-01A-01R-1566-13","77b1c06b-46ef-4c8c-8a82-37f83e3c48cf",0.16,NA,NA,NA,NA,"4ef87554-0560-5009-bddf-0bae1cad80cf","TCGA-24-1548_exposure","TCGA-24-1548-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T16:17:32.000Z","2014-03-28T17:04:02.000Z","1F9B7AD8-CE89-4E73-BAA1-2289E2D05F1F","5D4E65AA-D7D0-43EC-B395-DF2F01B1A203","Unaligned reads",19393955840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","77B1C06B-46EF-4C8C-8A82-37F83E3C48CF","Canada's Michael Smith Genome Sciences Centre","564a391fe4b09c884b23ab4e","66C92B9E-DE3C-4D1A-BB69-46FFBC6CAF33","Ovarian Serous Cystadenocarcinoma","TAR","34738B28-78DB-47B2-B32B-92E6B789D3E6","2014-03-28T17:04:02.000Z","447D3347-CFBD-4D08-AC11-8C7A2A314E12","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"34738B28-78DB-47B2-B32B-92E6B789D3E6",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.adc1690a-194c-44ea-8344-7bac461ab669.txt",NA,"TCGA-24-1548-01A",1.2,"B8403EA4-D3D0-4AC1-982D-8B6FC8F73F25","TCGA",1997,NA,NA,"WITH TUMOR","96F72B40-4178-4522-B754-A01EB2D7FEBA",57,"TCGA-24-1548-01A-01R-1566-13_GRCh37-lite_mirna.bam.bai","Dead",493,"TCGA-24-1548",NA,"F784A2BC-8872-4F2A-AD6E-6A270A01E198",NA,493,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,110,"F934C9C9-8CA7-4DFA-ACF9-9776B6604001","9FFF887F-5D18-4CB8-B7D3-C9FC3E4ABC18","TCGA-24-1548-01A-01R-1566-13_mirna.bam.bai","TCGA-24-1548-01A-01",95,0,NA,NA,20,"BOTTOM",2,NA,"TCGA-24-1548-01A-01-BS1",78,"Taxol","Chemotherapy","TCGA-24-1548-D26109",NA,NA,NA,"TCGA-24-1548-F26101_NTE-1",NA,493,"WITH TUMOR","Dead",493,"TCGA-24-1548-F26101","TCGA-24-1548",NA,"24","1548","YES","C56.9","8441/3","C56.9",NA,NA,-20945,"FEMALE","WHITE",NA,NA,"No","Dead",493,493,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
163458032,157817252,11662176147,"6F378639-3DE3-42B0-99F4-F7BA46234686.bw","66face4a-f35c-4364-90e5-8f28e6372606","6f378639-3de3-42b0-99f4-f7ba46234686","2016-08-25T15:14:55.810489-05:00","TCGA-25-1312-01A-01R-1565-13_rnaseq_fastq.tar","e731021d-016f-4a3f-b869-0f25130baa6c",9732945920,"Illumina HiSeq","2e5acf08076be2112bb66c3febe8188c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:25:48.316420-05:00","2016-05-03T11:40:21.647690-05:00","e731021d-016f-4a3f-b869-0f25130baa6c_analysis.xml","8949175bf921e8bf1ecdff3ab5903d46","6cddd2db-cb6c-4d8f-a4b0-766dfbfe7284",2181,"2016-09-29T22:42:58.248761-05:00","e731021d-016f-4a3f-b869-0f25130baa6c_experiment.xml","b681431c45ffed47d7251139fa44afb5","c1d08723-cedd-4840-843f-5f1185788065",3916,"2016-09-29T20:02:00.344602-05:00","e731021d-016f-4a3f-b869-0f25130baa6c_run.xml","f1f2193b1493ee607c279e6b936a25a6","5e571b32-c49f-487b-866f-101c69075946",1989,"2016-09-08T13:40:37.592037-05:00","TCGA-25-1312","2016-09-02T19:12:15.455453-05:00","female","TCGA-25-1312_demographic",1932,"white","3eec1dc1-4d6d-5b73-bbde-6688b95c256a","not hispanic or latino",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1312_diagnosis","not reported",25537,"dead","8441/3",31,31,"7c0d838a-d4ca-5f23-85c8-672a6ef301b9","c56.9",-25537,"TCGA-25-1312_treatment","46926ff0-1c00-56ad-a1f3-e60215b191eb","01",NA,"TCGA-25-1312-01A","2.5","ce884866-7563-44b2-a7b0-849512c66abf",FALSE,"9AD5ADDB-713E-4FF7-97F1-123FA771AC5B","Primary Tumor","1",NA,NA,"3",1228435200,"01",132,"TCGA-25-1312-01A-01",95,95,NA,NA,0,0,15,10,"2016-09-08T13:40:37.592037-05:00","2016-09-08T13:40:37.592037-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"01f182af-46ce-4838-9897-7a489c40734e","9d91008f-8c12-4e4e-aefe-ee9daff487f8","TCGA-25-1312-01A-01-BS1","TCGA-25-1312-01A-01-TS1",85,90,"85ac94a4-3c0f-4d84-ae16-d142f4e10a21","RNA","TCGA-25-1312-01A-01R","7521aa42-f196-455c-aa83-4ad15120194f",1.8,0.15,"UV Spec","R","22","TCGA-25-1312-01A-01R-1565-13","0d7561dc-7069-41df-ba49-8fcd4df52efb",0.15,NA,NA,NA,NA,"43418cbe-3707-5295-9368-98505ecded6a","TCGA-25-1312_exposure","TCGA-25-1312-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:26:43.000Z","2014-03-22T02:51:01.000Z","E731021D-016F-4A3F-B869-0F25130BAA6C","CE884866-7563-44B2-A7B0-849512C66ABF","Unaligned reads",9732945920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0D7561DC-7069-41DF-BA49-8FCD4DF52EFB","Canada's Michael Smith Genome Sciences Centre","564a5ac6e4b09c884b277e51","66FACE4A-F35C-4364-90E5-8F28E6372606","Ovarian Serous Cystadenocarcinoma","TAR","85AC94A4-3C0F-4D84-AE16-D142F4E10A21","2014-03-22T02:51:01.000Z","7521AA42-F196-455C-AA83-4AD15120194F","None","NO",1,1,"Primary Tumor","Mayo Clinic - Rochester",NA,"85AC94A4-3C0F-4D84-AE16-D142F4E10A21",2.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b.txt",NA,"TCGA-25-1312-01A",3,NA,"TCGA",2001,NA,NA,NA,"CE884866-7563-44B2-A7B0-849512C66ABF",69,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b.txt","Dead",31,"TCGA-25-1312","NOT HISPANIC OR LATINO","988EBD14-2804-4352-B66E-133006EA6A1E",NA,31,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,132,"9D91008F-8C12-4E4E-AEFE-EE9DAFF487F8","ACF6BE7D-9043-4D1C-BFA4-86938331F6D6","TCGA-25-1312-01A-01R-1565-13_rnaseq.bam","TCGA-25-1312-01A-01",95,0,NA,NA,10,"TOP",0,NA,"TCGA-25-1312-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,31,NA,"Dead",31,"TCGA-25-1312-F26626","TCGA-25-1312",NA,"25","1312","YES","C56.9","8441/3","C56.9",NA,NA,-25537,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",31,31,NA,NA,NA,"NO",27,3,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,69,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
160607104,155598232,11518671141,"6B558D0E-C8E0-42F8-9E9C-6E85481F4A1F.bw","6746533a-8d0b-4ebc-87ec-49c8738121a8","6b558d0e-c8e0-42f8-9e9c-6e85481f4a1f","2016-08-25T13:28:42.517170-05:00","TCGA-09-0364-01A-02R-1564-13_rnaseq_fastq.tar","98e4a2df-3bf6-4c3e-80f9-fbe9e5377a0e",10782074880,"Illumina HiSeq","ff5e5e0d8e620853c5eaf77995c60423","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:07:10.212621-05:00","2016-05-03T11:41:05.776497-05:00","98e4a2df-3bf6-4c3e-80f9-fbe9e5377a0e_analysis.xml","baf642e7d58527f173a96be724ce8120","868d6c78-8c60-4514-8722-0ad8374654b6",2183,"2016-08-13T07:50:53.689677-05:00","98e4a2df-3bf6-4c3e-80f9-fbe9e5377a0e_experiment.xml","c45094da0930839ace93a733cecabb94","543c3177-ca80-495c-972b-1278d3e38355",3916,"2016-09-30T00:19:12.815551-05:00","98e4a2df-3bf6-4c3e-80f9-fbe9e5377a0e_run.xml","ff9df8f4317761f8f4f148fc2e208c33","fd738ad9-e9dc-4f1a-83d1-7ccf7cb67afa",1990,"2016-09-08T13:37:12.165460-05:00","TCGA-09-0364","2016-09-02T19:09:33.502336-05:00","female","TCGA-09-0364_demographic",1918,"white","96fdbdf8-56b5-569a-b4f2-a155e1ed249d","not hispanic or latino",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-0364_diagnosis","not reported",29262,"dead","8441/3",887,NA,"42b4a2fe-7c3d-5839-b189-e22b4b061c28","c56.9",-29262,"TCGA-09-0364_treatment","dabdbfb4-d19e-5d16-b464-b9a38486eafd","01",NA,"TCGA-09-0364-01A",NA,"469795c3-7cfa-4b95-9b0f-3fc7a3336f22",FALSE,"27b9efd3-7748-4deb-96a2-3869a19bfa6f","Primary Tumor",NA,NA,NA,NA,1233705600,"02",NA,"TCGA-09-0364-01A-02",95,95,NA,NA,0,0,10,10,"2016-09-08T13:37:12.165460-05:00","2016-09-08T13:37:12.165460-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"1546ea7d-1678-4910-a51e-2a1a41a96fc7","cc970d57-686a-4e49-b83b-b1b4c6b70410","TCGA-09-0364-01A-01-BS1","TCGA-09-0364-01A-02-BS2",90,90,"1c2624d8-ae43-4772-829a-4cdaa1b7cc4d","RNA","TCGA-09-0364-01A-02R","989c5d99-5f32-4435-8026-069ac89d2d31",1.8,0.16,"UV Spec","R","22","TCGA-09-0364-01A-02R-1564-13","2d0702a8-bf85-458e-879c-ebc03a2aa3d1",0.16,NA,NA,NA,NA,"3b2ea46d-bcd6-5c71-8ee8-3a33ab9879b4","TCGA-09-0364_exposure","TCGA-09-0364-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-28T21:05:29.000Z","2014-04-04T07:07:02.000Z","98E4A2DF-3BF6-4C3E-80F9-FBE9E5377A0E","469795C3-7CFA-4B95-9B0F-3FC7A3336F22","Unaligned reads",10782074880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2D0702A8-BF85-458E-879C-EBC03A2AA3D1","Canada's Michael Smith Genome Sciences Centre","564a3b0ce4b09c884b2440be","6746533A-8D0B-4EBC-87EC-49C8738121A8","Ovarian Serous Cystadenocarcinoma","TAR","1C2624D8-AE43-4772-829A-4CDAA1B7CC4D","2014-04-04T07:07:02.000Z","989C5D99-5F32-4435-8026-069AC89D2D31","None","NO",1,NA,"Primary Tumor","UCSF",NA,"1C2624D8-AE43-4772-829A-4CDAA1B7CC4D",NA,"09","4440716732_R01C01_Grn.idat",NA,"TCGA-09-0364-01A",NA,"780B9212-5BFD-40FF-ACEF-8D60CB64BDB2","TCGA",1998,NA,NA,"WITH TUMOR","469795C3-7CFA-4B95-9B0F-3FC7A3336F22",80,"nationwidechildrens.org_clinical.TCGA-09-0364.xml","Dead",887,"TCGA-09-0364","NOT HISPANIC OR LATINO","C1122B65-E8B1-4C58-99B9-D78C3678332C",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,"5F377A9A-DCDB-4C6C-BA0E-4629D6A0254C","WHITE",NA,2,NA,"CC970D57-686A-4E49-B83B-B1B4C6B70410","BC86C066-0AFF-426E-88C5-3FE2FBEF8E0C","4440716732_R01C01_Grn.idat","TCGA-09-0364-01A-02",95,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-09-0364-01A-02-BS2",90,"Carboplatinum","Chemotherapy","TCGA-09-0364-D24199","TCGA-09-0364-R24201","EXTERNAL BEAM","Local Recurrence","TCGA-09-0364-F24198_NTE-1",NA,NA,"WITH TUMOR","Dead",887,"TCGA-09-0364-F24198","TCGA-09-0364",NA,"09","0364","YES","C56.9","8441/3","C56.9",NA,NA,-29262,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,887,NA,NA,"WITH TUMOR","NO",4,3,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,80,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
229709640,222752751,16494569357,"A4071CDC-9382-4852-AD36-0DDC0D321E21.bw","67f526f1-def5-43b4-bc89-154baae190fc","a4071cdc-9382-4852-ad36-0ddc0d321e21","2016-08-25T23:32:21.557576-05:00","TCGA-24-1846-01A-01R-1567-13_rnaseq_fastq.tar","78195229-848e-4735-ac04-865d18600ad2",14787973120,"Illumina HiSeq","dcc9c5287d47641b7ad5df4f2125aa6d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:11:52.328297-05:00","2016-05-03T11:41:05.748550-05:00","78195229-848e-4735-ac04-865d18600ad2_analysis.xml","9d2dd966cd54ddf6e7604a3958a383e9","3f25c965-93e3-43eb-b386-b299a69da38e",2181,"2016-09-29T23:28:35.470326-05:00","78195229-848e-4735-ac04-865d18600ad2_experiment.xml","3d7937147be95464a0835abfabab158c","de138bf1-7dc4-42a6-a471-c41bc6e81434",3916,"2016-09-29T18:10:45.335943-05:00","78195229-848e-4735-ac04-865d18600ad2_run.xml","66a8a9b47355e5bbc063b6c29867c554","18b554a2-ff5c-4ef9-858e-4da670cabb9b",1989,"2016-09-08T11:04:46.236369-05:00","TCGA-24-1846","2016-09-02T18:47:49.506089-05:00","female","TCGA-24-1846_demographic",1964,"not reported","c265a8c5-231d-5f56-bea9-1444d77aeceb","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1846_diagnosis","not reported",16534,"alive","8441/3",NA,133,"cc622c11-e77b-5fd6-b673-baeb226d3ce6","c56.9",-16534,"TCGA-24-1846_treatment","d13984a8-7135-5021-a2f0-7bc08c643fbe","01",NA,"TCGA-24-1846-01A","0.7","046c032f-69e8-4815-b7ab-28858392d6b0",FALSE,"fb12e5b3-1529-4873-90fd-7ba0a78dd9f4","Primary Tumor","0.6",NA,NA,"1.1",1245628800,"01",134,"TCGA-24-1846-01A-01",70,80,0,0,0,0,10,5,"2016-09-08T11:04:46.236369-05:00","2016-09-08T11:04:46.236369-05:00",0,0,20,15,"TOP","BOTTOM",20,15,"cbd38011-a782-4c70-8498-79c3d143409e","08e47dff-31a5-4515-8b39-58f3e11a4c7a","TCGA-24-1846-01A-01-TS1","TCGA-24-1846-01A-01-BS1",70,80,"2ca00e1f-a87c-4872-ba4e-2a9971dcdbba","RNA","TCGA-24-1846-01A-01R","0fe6a4c1-7f25-4ac3-b848-e60a4f353cfb",1.8,0.15,"UV Spec","R","22","TCGA-24-1846-01A-01R-1567-13","4b073708-9525-4340-90dc-ede08ee24977",0.15,NA,NA,NA,NA,"e9cac973-f068-58be-98fd-fbc7b1f029fd","TCGA-24-1846_exposure","TCGA-24-1846-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T20:46:46.000Z","2014-03-28T21:25:02.000Z","78195229-848E-4735-AC04-865D18600AD2","046C032F-69E8-4815-B7AB-28858392D6B0","Unaligned reads",14787973120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4B073708-9525-4340-90DC-EDE08EE24977","Canada's Michael Smith Genome Sciences Centre","564a5961e4b0ef12181d85f7","67F526F1-DEF5-43B4-BC89-154BAAE190FC","Ovarian Serous Cystadenocarcinoma","TAR","2CA00E1F-A87C-4872-BA4E-2A9971DCDBBA","2014-03-28T21:25:02.000Z","0FE6A4C1-7F25-4AC3-B848-E60A4F353CFB","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"2CA00E1F-A87C-4872-BA4E-2A9971DCDBBA",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.15134c0c-7253-481e-83e3-7d1c57bc521d.txt",NA,"TCGA-24-1846-01A",1.1,"B64016E1-72C8-4A3B-8F11-3DC2A09DD64B","TCGA",2009,NA,NA,NA,"FF34C329-3618-4F55-A692-7FDB63FE0542",45,"4828606041_H_Grn.idat","Alive",NA,"TCGA-24-1846",NA,"E73B1EDE-ABFF-4032-AF69-0C538317414F",NA,133,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,NA,NA,1,134,"CBD38011-A782-4C70-8498-79C3D143409E","710D763B-B662-41A0-9852-1891D697FA85","TCGA-24-1846-01A-01R-1567-13_rnaseq_fastq.tar","TCGA-24-1846-01A-01",80,0,0,0,5,"BOTTOM",15,15,"TCGA-24-1846-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-24-1846-D26347",NA,NA,NA,NA,NA,133,NA,"Alive",NA,"TCGA-24-1846-F26346","TCGA-24-1846",NA,"24","1846","YES","C56.9","8441/3","C56.9",NA,NA,-16534,"FEMALE",NA,NA,NA,"No","Alive",133,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
198594762,193513229,14340230351,"30237648-5C4F-4EBF-9DBF-8D4D5A781741.bw","6a1be87b-c4e0-4fd4-b050-50a245b22038","30237648-5c4f-4ebf-9dbf-8d4d5a781741","2016-08-25T12:47:08.090811-05:00","TCGA-25-1631-01A-01R-1569-13_rnaseq_fastq.tar","72cae22f-5119-4374-b8de-c42d2e11f3e1",12637265920,"Illumina HiSeq","fc3b802dae8a99ceabbfacb552fc1546","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:07:53.179540-05:00","2016-05-03T11:55:09.260045-05:00","72cae22f-5119-4374-b8de-c42d2e11f3e1_analysis.xml","a08b63ce3dc67821595b5f816a48e137","61e06631-8f3c-4d29-b596-7b980d735506",2181,"2016-09-29T21:37:48.672230-05:00","72cae22f-5119-4374-b8de-c42d2e11f3e1_experiment.xml","8e1e38120370e22312677a41786f3692","9980aaa8-cd8d-461f-bc0d-27c7f4583285",3916,"2016-09-29T18:37:32.229302-05:00","72cae22f-5119-4374-b8de-c42d2e11f3e1_run.xml","06625b0a4bb4307284d5eed8a9345096","297078ab-2176-4993-8c63-7e311c303f94",1988,"2016-09-08T10:32:06.088569-05:00","TCGA-25-1631","2016-09-02T18:47:40.387664-05:00","female","TCGA-25-1631_demographic",1929,"white","add82ac4-19b9-5d45-a879-a9ca0d73962b","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1631_diagnosis","not reported",26687,"dead","8441/3",9,9,"407c0da4-f263-5ceb-abd5-c62004aaf0b5","c56.9",-26687,"TCGA-25-1631_treatment","d5a84b53-ef3f-574a-b25e-9ca3b214e0c4","01",NA,"TCGA-25-1631-01A","2","6b4aff1a-568e-453f-9679-55b3442c491d",FALSE,"1C74F61E-1131-4782-8117-20C59B86D845","Primary Tumor","0.4",NA,NA,"2",1237420800,"01",110,"TCGA-25-1631-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T10:32:06.088569-05:00","2016-09-08T10:32:06.088569-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,10,"64da2a3d-515c-4393-9b63-f70b3ddef2b8","0c3e79d3-e8ee-4721-94ee-cf2923f033bc","TCGA-25-1631-01A-01-TS1","TCGA-25-1631-01A-01-BS1",80,80,"82b03dfe-f3ac-40e8-b8d8-7b4f6b9ebbee","RNA","TCGA-25-1631-01A-01R","072b11fc-5a77-4e81-8450-8b19251b54b9",1.8,0.13,"UV Spec","R","22","TCGA-25-1631-01A-01R-1569-13","29c4cab9-c19e-4416-ad88-484cc02a980f",0.13,NA,NA,NA,NA,"fee08a9b-c82e-5df8-b48a-6a4266858d57","TCGA-25-1631_exposure","TCGA-25-1631-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T01:50:00.000Z","2014-08-08T03:50:19.000Z","72CAE22F-5119-4374-B8DE-C42D2E11F3E1","6B4AFF1A-568E-453F-9679-55B3442C491D","Unaligned reads",12637265920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","29C4CAB9-C19E-4416-AD88-484CC02A980F","Canada's Michael Smith Genome Sciences Centre","564a3b90e4b09c884b2467e8","6A1BE87B-C4E0-4FD4-B050-50A245B22038","Ovarian Serous Cystadenocarcinoma","TAR","82B03DFE-F3AC-40E8-B8D8-7B4F6B9EBBEE","2014-08-08T03:50:19.000Z","072B11FC-5A77-4E81-8450-8B19251B54B9","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"82B03DFE-F3AC-40E8-B8D8-7B4F6B9EBBEE",2,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.51225525-5680-46ab-8e00-f35ed4df6470.txt",NA,"TCGA-25-1631-01A",2,NA,"TCGA",2002,NA,NA,"TUMOR FREE","6B4AFF1A-568E-453F-9679-55B3442C491D",73,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.51225525-5680-46ab-8e00-f35ed4df6470.txt","Dead",9,"TCGA-25-1631","NOT HISPANIC OR LATINO","E5C704B8-3C25-452D-9629-1B554AD6DC1E",NA,9,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,110,"64DA2A3D-515C-4393-9B63-F70B3DDEF2B8","CF31FA72-E244-41D3-90C0-49D0591F4BF1","TCGA-25-1631-01A-01W-0615-10_SOLiD.bam.bai","TCGA-25-1631-01A-01",90,0,NA,NA,10,"BOTTOM",10,NA,"TCGA-25-1631-01A-01-BS1",80,NA,NA,NA,NA,NA,NA,NA,NA,9,"TUMOR FREE","Dead",9,"TCGA-25-1631-F26733","TCGA-25-1631",NA,"25","1631","YES","C56.9","8441/3","C56.9",NA,NA,-26687,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",9,9,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
245439548,232965792,17181888945,"37494906-CB8D-4E43-AE25-936E66372A12.bw","6a57948c-0dc5-4ea2-8043-380f26763752","37494906-cb8d-4e43-ae25-936e66372a12","2016-08-25T15:44:59.240131-05:00","TCGA-24-0975-01A-02R-1565-13_rnaseq_fastq.tar","4ed8dbd0-c31d-473c-860b-6fb8b580b7bd",16080609280,"Illumina HiSeq","7e4742588fd8f678318010221f3d71dd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:35:23.704785-05:00","2016-05-03T11:40:21.669427-05:00","4ed8dbd0-c31d-473c-860b-6fb8b580b7bd_analysis.xml","21e354a8c6330da995969697ea1f3979","4ddf11ae-52d7-4dbe-89d0-678ffbade0d6",2181,"2016-10-07T16:00:27.756458-05:00","4ed8dbd0-c31d-473c-860b-6fb8b580b7bd_experiment.xml","00b1273482c10f2619df58137f140b8f","ab03c8e1-8853-409c-9368-93fd64bdd7e0",3916,"2016-09-29T22:40:27.610149-05:00","4ed8dbd0-c31d-473c-860b-6fb8b580b7bd_run.xml","763fabb046e1e6bd0f7d6bc689e1b423","c04549ec-aa21-4e73-ba68-45e9cec6f0a4",1989,"2016-09-08T12:20:01.325472-05:00","TCGA-24-0975","2016-09-02T19:05:48.401222-05:00","female","TCGA-24-0975_demographic",1946,"white","7ce08a4a-f076-5e4d-bbe0-a5ed3392d0a2","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-0975_diagnosis","not reported",21417,"dead","8441/3",663,663,"76d84c00-0eb7-5a28-bb2c-e6fb683fecb8","c56.9",-21417,"TCGA-24-0975_treatment","2c412943-9ae2-58df-8030-170df09b3888","01",NA,"TCGA-24-0975-01A","1","b28f3b6f-8224-41e1-8777-23688e0155d1",FALSE,"8AA65DCA-E057-486F-AEFA-D8A3485416EC","Primary Tumor","0.7",NA,NA,"1.5",1233705600,"02",180,"TCGA-24-0975-01A-02",85,85,NA,NA,0,0,15,20,"2016-09-08T12:20:01.325472-05:00","2016-09-08T12:20:01.325472-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,0,"d32e86c9-9517-4e76-8e5c-d0022828bbdd","3defbb5a-45f4-4e55-8ed1-c968b4ff2ced","TCGA-24-0975-01A-01-BS1","TCGA-24-0975-01A-02-BS2",80,80,"30f49707-7a77-4ec9-be69-86787a3d25de","RNA","TCGA-24-0975-01A-02R","67058d90-2f50-4702-8d50-3967b17dd12c",1.8,0.16,"UV Spec","R","22","TCGA-24-0975-01A-02R-1565-13","a16723c4-d5b1-40a0-9890-570351738879",0.16,NA,NA,NA,NA,"09a4f179-f0d2-5a7f-af65-d970dc799202","TCGA-24-0975_exposure","TCGA-24-0975-01A-02R-1565-13_rnaseq_fastq.tar","2014-03-22T06:32:16.000Z","2014-03-22T07:04:02.000Z","4ED8DBD0-C31D-473C-860B-6FB8B580B7BD","B28F3B6F-8224-41E1-8777-23688E0155D1","Unaligned reads",16080609280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A16723C4-D5B1-40A0-9890-570351738879","Canada's Michael Smith Genome Sciences Centre","564a3edfe4b093830b6a5f8a","6A57948C-0DC5-4EA2-8043-380F26763752","Ovarian Serous Cystadenocarcinoma","TAR","30F49707-7A77-4EC9-BE69-86787A3D25DE","2014-03-22T07:04:02.000Z","67058D90-2F50-4702-8D50-3967B17DD12C","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"30F49707-7A77-4EC9-BE69-86787A3D25DE",1,"24","TCGA-24-0975-01A-02R-1565-13_rnaseq_fastq.tar",NA,"TCGA-24-0975-01A",1.5,"FBDE8509-B99C-4069-86EA-638A3EFF0D8D","TCGA",2004,NA,NA,"WITH TUMOR","D76A4BDA-6153-444B-8AE8-C56458870291",58,"nationwidechildrens.org_clinical.TCGA-24-0975.xml","Dead",663,"TCGA-24-0975",NA,"FC2F81AB-FA8A-47F3-A537-77A64D2C2BFF",NA,663,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,"0FF29145-A460-4150-A863-1B8D8C40D89A","WHITE",NA,2,180,"D32E86C9-9517-4E76-8E5C-D0022828BBDD","67058D90-2F50-4702-8D50-3967B17DD12C","TCGA-24-0975-01A-02R-1565-13_rnaseq_fastq.tar","TCGA-24-0975-01A-02",85,0,NA,NA,15,"TOP",5,NA,"TCGA-24-0975-01A-01-BS1",80,"Navelbine","Chemotherapy","TCGA-24-0975-D25867","TCGA-24-0975-R25868","EXTERNAL BEAM","Distant Recurrence",NA,NA,663,"WITH TUMOR","Dead",663,"TCGA-24-0975-F25861","TCGA-24-0975",NA,"24","0975","YES","C56.9","8441/3","C56.9",NA,NA,-21417,"FEMALE","WHITE",NA,NA,"No","Dead",663,663,NA,NA,"WITH TUMOR","NO",9,3,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
252033918,245486662,18160723964,"E328F881-F87C-4219-946F-5DB4ED3E2043.bw","6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d","e328f881-f87c-4219-946f-5db4ed3e2043","2016-08-26T21:12:16.722097-05:00","TCGA-25-1321-01A-01R-1565-13_rnaseq_fastq.tar","e24c7222-1da5-4c53-8f3f-4bfa790668ab",15373158400,"Illumina HiSeq","be2bbfc0e265717295460e9ebef7b957","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:02:08.174520-05:00","2016-05-03T11:40:21.669427-05:00","e24c7222-1da5-4c53-8f3f-4bfa790668ab_analysis.xml","b8e7516ae8160e8c826be344d361ff0d","f2f01471-2873-40e5-9326-5202c71c87dd",2181,"2016-09-29T18:50:22.289456-05:00","e24c7222-1da5-4c53-8f3f-4bfa790668ab_experiment.xml","758278f21cd4bc8d57c1b185cf0ef9c9","31924f66-4180-4a4b-86f5-19df8778f1e6",3916,"2016-09-29T22:45:50.933904-05:00","e24c7222-1da5-4c53-8f3f-4bfa790668ab_run.xml","960f828219b03284c9a636499e7371cd","c39a24eb-9ce8-40d6-9799-3b59d3ea4a7c",1989,"2016-09-08T13:41:29.682383-05:00","TCGA-25-1321","2016-09-02T19:11:53.465323-05:00","female","TCGA-25-1321_demographic",1936,"white","90f4c061-f159-5a33-9711-19ed94507147","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1321_diagnosis","not reported",23987,"dead","8441/3",1033,1033,"75f56478-bab2-51ee-821d-9db5567f6b98","c56.9",-23987,"TCGA-25-1321_treatment","0210d1cd-b459-5acf-95bd-bd0e38b825be","01",NA,"TCGA-25-1321-01A","1.6","57f7a91d-c569-433f-ae21-8a22e5d187bf",FALSE,"5D309784-AED1-4946-817D-37AC8969315C","Primary Tumor","0.8",NA,NA,"3",1228348800,"01",187,"TCGA-25-1321-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:41:29.682383-05:00","2016-09-08T13:41:29.682383-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"3cdd3537-543e-41b9-b024-f4b843205c0e","83ae5429-f69e-4e70-8f65-f27fa68b5d5b","TCGA-25-1321-01A-01-TS1","TCGA-25-1321-01A-01-BS1",90,85,"58dc0e2f-7972-41a2-95c5-a466ebfe63a1","RNA","TCGA-25-1321-01A-01R","74fbd8cf-b8a3-4ed2-87a7-80e3026aa6a2",1.8,0.16,"UV Spec","R","22","TCGA-25-1321-01A-01R-1565-13","74ad9d3e-97a9-419d-8842-3fb37d3f099a",0.16,NA,NA,NA,NA,"1985a053-495a-5aac-a209-4fe3d2c89950","TCGA-25-1321_exposure","TCGA-25-1321-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T04:10:09.000Z","2014-03-22T04:44:01.000Z","E24C7222-1DA5-4C53-8F3F-4BFA790668AB","57F7A91D-C569-433F-AE21-8A22E5D187BF","Unaligned reads",15373158400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","74AD9D3E-97A9-419D-8842-3FB37D3F099A","Canada's Michael Smith Genome Sciences Centre","564a5a47e4b093830b6ca358","6AD8BC89-D8E9-48C2-BC25-C8E51F972B4D","Ovarian Serous Cystadenocarcinoma","TAR","58DC0E2F-7972-41A2-95C5-A466EBFE63A1","2014-03-22T04:44:01.000Z","74FBD8CF-B8A3-4ED2-87A7-80E3026AA6A2","None","NO",1,0.8,"Primary Tumor","Mayo Clinic - Rochester",NA,"58DC0E2F-7972-41A2-95C5-A466EBFE63A1",1.6,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9790631d-f673-415e-8644-5419b2b956b2.txt",NA,"TCGA-25-1321-01A",3,"FBB96AD3-036D-4338-B798-0B952467B432","TCGA",2001,NA,NA,"WITH TUMOR","75F6893D-B88D-4CA6-B4BD-BDBB78C827CC",65,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9790631d-f673-415e-8644-5419b2b956b2.txt","Dead",1033,"TCGA-25-1321","NOT HISPANIC OR LATINO","06FCA474-4B69-4A35-8807-EE9385CCD71C",NA,1033,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,187,"83AE5429-F69E-4E70-8F65-F27FA68B5D5B","C6288D67-66E6-4175-9F15-88A92AB00B61","TCGA-25-1321-01A-01R-1565-13_rnaseq.bam","TCGA-25-1321-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-25-1321-01A-01-BS1",85,"Carbo","Chemotherapy","TCGA-25-1321-D26671",NA,NA,NA,"TCGA-25-1321-F26670_NTE-2",NA,1033,"WITH TUMOR","Dead",1033,"TCGA-25-1321-F26670","TCGA-25-1321",NA,"25","1321","YES","C56.9","8441/3","C56.9",NA,NA,-23987,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1033,1033,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
215832910,204664757,15118101577,"8E2E8518-857D-4AC2-8D15-7FA0A1DBB412.bw","6b06281b-d3a9-440e-a86c-ee7db003352a","8e2e8518-857d-4ac2-8d15-7fa0a1dbb412","2016-08-25T13:48:57.988953-05:00","TCGA-29-1690-01A-01R-1566-13_rnaseq_fastq.tar","19b6916a-411d-4c46-92ef-a84356340b3e",14390466560,"Illumina HiSeq","4c810023ed10eec2f5117cdc6b6a7bb8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:33:17.448263-05:00","2016-05-03T11:39:34.528512-05:00","19b6916a-411d-4c46-92ef-a84356340b3e_analysis.xml","2a0469ab80dba6667f0d1f9b4fb8410b","bbcceedb-82ba-4820-97ff-3df52617e2f1",2181,"2016-10-07T17:32:22.770842-05:00","19b6916a-411d-4c46-92ef-a84356340b3e_experiment.xml","c38684f819d0e34e0affe45ac1341f0d","7cb3a4a6-f270-4e9f-a77b-5ce586eb77d7",3916,"2016-09-29T17:49:06.260806-05:00","19b6916a-411d-4c46-92ef-a84356340b3e_run.xml","75319dacbcf11cc10ce7bbb382e89e9a","0b1b9beb-ae83-4f03-8de8-11dd0be03272",1988,"2016-09-08T13:31:57.902821-05:00","TCGA-29-1690","2016-09-02T19:07:42.880153-05:00","female","TCGA-29-1690_demographic",1927,"white","bcfa97b6-fdd7-5b5f-8943-3e2bb1b2f8a1","not reported",1996,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1690_diagnosis","not reported",24319,"dead","8441/3",1448,1360,"dd1b849b-25d5-5b61-8c30-9bdbb0ea6514","c56.9",-24319,"TCGA-29-1690_treatment","e83411da-55fb-57c5-b623-4e184c181a72","01",NA,"TCGA-29-1690-01A","1.3","50633d92-0d7d-476e-8d4b-9a8de94771a2",FALSE,"a44f0507-fc95-410a-a6b2-b66caacee30e","Primary Tumor","0.7",NA,NA,"1.4",1241654400,"01",129,"TCGA-29-1690-01A-01",90,95,NA,NA,0,0,0,0,"2016-09-08T13:31:57.902821-05:00","2016-09-08T13:31:57.902821-05:00",NA,NA,NA,1,"BOTTOM","TOP",0,0,"93d3d15e-ec2b-4359-ba33-8bc7e19384eb","760c759f-58f3-452d-a7a3-de166e8b1659","TCGA-29-1690-01A-01-BS1","TCGA-29-1690-01A-01-TS1",100,100,"6d684e18-bf9e-4a96-bdf5-5317f15e2db5","RNA","TCGA-29-1690-01A-01R","72239f7b-29d5-4413-b72a-9e5aaf832e58",1.8,0.15,"UV Spec","R","22","TCGA-29-1690-01A-01R-1566-13","d78906d7-c8f2-4bf0-86cc-2b60b067aaa6",0.15,NA,NA,NA,NA,"148ad2a8-c77d-553d-aeff-cffa564383ff","TCGA-29-1690_exposure","TCGA-29-1690-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T08:55:40.000Z","2014-03-20T09:21:02.000Z","19B6916A-411D-4C46-92EF-A84356340B3E","50633D92-0D7D-476E-8D4B-9A8DE94771A2","Unaligned reads",14390466560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D78906D7-C8F2-4BF0-86CC-2B60B067AAA6","Canada's Michael Smith Genome Sciences Centre","564a5b40e4b0298dd2cc19e6","6B06281B-D3A9-440E-A86C-EE7DB003352A","Ovarian Serous Cystadenocarcinoma","TAR","6D684E18-BF9E-4A96-BDF5-5317F15E2DB5","2014-03-20T09:21:02.000Z","72239F7B-29D5-4413-B72A-9E5AAF832E58","None","NO",1,0.7,"Primary Tumor","Duke",NA,"6D684E18-BF9E-4A96-BDF5-5317F15E2DB5",1.3,"29","US82800149_251976010690_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.gene.tcga_level3.data.txt",NA,"TCGA-29-1690-01A",1.4,"9FFC6761-7C68-4A4C-AC9D-2CD3FE1748E7","TCGA",1993,NA,NA,"WITH TUMOR","50633D92-0D7D-476E-8D4B-9A8DE94771A2",66,"SAROS_p_TCGA_B18_SNP_N_GenomeWideSNP_6_H02_489680.hg19.seg.txt","Dead",1448,"TCGA-29-1690",NA,"6429B19F-5BE1-4EDF-9C06-A0A292DEDE40",NA,1360,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,129,"760C759F-58F3-452D-A7A3-DE166E8B1659","EF4B133F-3C0B-4BDB-9326-07051A5E96CD","TCGA-29-1690-01A-01W-0633-09_IlluminaGA-DNASeq_exome_1.bam.bai","TCGA-29-1690-01A-01",90,0,NA,NA,0,"BOTTOM",0,NA,"TCGA-29-1690-01A-01-BS1",100,"Carboplatin","Chemotherapy","TCGA-29-1690-D27143",NA,NA,NA,NA,NA,1360,"WITH TUMOR","Dead",1448,"TCGA-29-1690-F27142","TCGA-29-1690",NA,"29","1690","YES","C56.9","8441/3","C56.9",NA,NA,-24319,"FEMALE","WHITE",NA,NA,"No","Dead",1360,1448,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,1993,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
216798860,209907209,15530529528,"C03F53F3-BE08-4A4B-B19A-D9A9DCB54ED4.bw","6b2a9f9a-fe96-4311-a330-925c4ad36fe7","c03f53f3-be08-4a4b-b19a-d9a9dcb54ed4","2016-08-26T10:55:54.993618-05:00","TCGA-23-1111-01A-01R-1567-13_rnaseq_fastq.tar","9e9ef3bc-2ca8-45b5-8879-4e47dfd7e7b0",13984542720,"Illumina HiSeq","a93861047684c3eeebb8a488d8f1b4ad","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:42:35.466038-05:00","2016-05-03T11:41:05.750744-05:00","9e9ef3bc-2ca8-45b5-8879-4e47dfd7e7b0_analysis.xml","042903dea988833e03fed0d9a52c6b0b","2caae440-cc65-4ae7-b7d0-3cbe0eee1e6c",2181,"2016-09-29T19:21:10.862368-05:00","9e9ef3bc-2ca8-45b5-8879-4e47dfd7e7b0_experiment.xml","1625e1d2d27a227d620b0e7177fdbeef","450d6ee6-f6f0-405a-a704-06972d14c81e",3916,"2016-09-29T22:16:19.587123-05:00","9e9ef3bc-2ca8-45b5-8879-4e47dfd7e7b0_run.xml","829b1e5ffc48138f6a64214bf9c2b3ac","b1603fe0-457a-4360-9c75-78d15f4e9a7e",1989,"2016-09-09T16:04:28.896405-05:00","TCGA-23-1111","2016-09-02T18:47:34.685245-05:00","female","TCGA-23-1111_demographic",1945,"white","c6a9c1d3-b55e-5ef9-a771-a2a379aa9539","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1111_diagnosis","not reported",23171,"alive","8441/3",NA,98,"b706f41e-b852-562e-b355-bba9f964e38a","c56.9",-23171,"TCGA-23-1111_treatment","a3567e3c-4b84-5146-9bd0-d18a0d6f2496","01",NA,"TCGA-23-1111-01A","0.9","2dc30180-9f69-4dd5-914c-1a27fcf170bd",FALSE,"ba3ae03c-74d4-4b5f-849f-71466bae7c0e","Primary Tumor","0.4",NA,NA,"0.9",1227571200,"01",131,"TCGA-23-1111-01A-01",95,95,NA,NA,NA,NA,NA,NA,"2016-09-09T16:04:28.896405-05:00","2016-09-09T16:04:28.896405-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"2a2f4620-789a-400f-bf1a-10b72d876ef7","9949d5f1-ef9c-493a-b04e-3b617d2b30c6","TCGA-23-1111-01A-01-TS1","TCGA-23-1111-01A-01-BS1",NA,NA,"eba72607-0bcc-48c5-8c9b-68d0ebc00365","RNA","TCGA-23-1111-01A-01R","83ccfe48-f941-4126-89df-199321869406",1.8,0.16,"UV Spec","R","22","TCGA-23-1111-01A-01R-1567-13","f38e46dc-67b9-448a-8d24-507291e55bca",0.16,NA,NA,NA,NA,"fe565ed8-73d8-59a7-a26a-5a07a70eeea9","TCGA-23-1111_exposure","TCGA-23-1111-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T20:31:44.000Z","2014-03-28T20:57:01.000Z","9E9EF3BC-2CA8-45B5-8879-4E47DFD7E7B0","2DC30180-9F69-4DD5-914C-1A27FCF170BD","Unaligned reads",13984542720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F38E46DC-67B9-448A-8D24-507291E55BCA","Canada's Michael Smith Genome Sciences Centre","564a34cfe4b093830b672930","6B2A9F9A-FE96-4311-A330-925C4AD36FE7","Ovarian Serous Cystadenocarcinoma","TAR","EBA72607-0BCC-48C5-8C9B-68D0EBC00365","2014-03-28T20:57:01.000Z","83CCFE48-F941-4126-89DF-199321869406","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"EBA72607-0BCC-48C5-8C9B-68D0EBC00365",0.9,"23","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_C04_495146.byallele.copynumber.data.txt",NA,"TCGA-23-1111-01A",0.9,"5B8A8E00-E4BE-4A14-A676-A1E13668A596","TCGA",2008,NA,NA,NA,"EBEF3F72-3870-4BEE-9BE8-F9C8BAD75902",63,"TCGA-23-1111-01A-01W-0639-09_IlluminaGA-DNASeq_exome_1.bam.bai","Alive",NA,"TCGA-23-1111",NA,"5E8299C1-4DB5-4867-AFC7-DB96E4F3FE68",NA,98,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,131,"9949D5F1-EF9C-493A-B04E-3B617D2B30C6","C0372D1B-61DC-4B05-9F3D-965F2BDB3FD3","622175782193b9545690bdcc05a879b8.bam.bai","TCGA-23-1111-01A-01",95,NA,NA,NA,NA,"TOP",5,NA,"TCGA-23-1111-01A-01-TS1",NA,"Investigal drug Avastin","Chemotherapy","TCGA-23-1111-D25674",NA,NA,NA,NA,NA,98,NA,"Alive",NA,"TCGA-23-1111-F25672","TCGA-23-1111",NA,"23","1111","YES","C56.9","8441/3","C56.9",NA,NA,-23171,"FEMALE","WHITE",NA,NA,"No","Alive",98,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,63,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
135753008,126926200,9305874589,"B1D7C786-47EA-4E0B-8448-0189AA045BF4.bw","6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf","b1d7c786-47ea-4e0b-8448-0189aa045bf4","2016-08-26T04:56:32.118335-05:00","TCGA-13-0888-01A-01R-1564-13_rnaseq_fastq.tar","f03c489b-ae35-441a-92e4-7092fa3818fb",7816591360,"Illumina HiSeq","ff20fbb63140952f8529e0b00b5ee9ce","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:38:47.085022-05:00","2016-05-03T11:41:05.750744-05:00","f03c489b-ae35-441a-92e4-7092fa3818fb_analysis.xml","e2dfd45c8ef53f40a1d5c7ce69774328","74bb0325-3956-4c64-96b3-aa61a30f0307",2208,"2016-10-07T17:28:43.349499-05:00","f03c489b-ae35-441a-92e4-7092fa3818fb_experiment.xml","3e273246a6ab82ef238ea50cbab08fe4","53568a0d-ff37-42ca-b7e5-28951e74061a",3916,"2016-09-29T20:39:19.966360-05:00","f03c489b-ae35-441a-92e4-7092fa3818fb_run.xml","6c4ccf010b624e3539c9a70cd8887cf9","75134160-246c-40af-bc68-e24a28ae6fef",1988,"2016-09-08T12:45:14.695040-05:00","TCGA-13-0888","2016-09-02T19:05:27.548365-05:00","female","TCGA-13-0888_demographic",1925,"white","352a0590-c7a1-5b86-8a71-0f34b1ff6d0d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0888_diagnosis","not reported",28498,"dead","8441/3",2811,2141,"83afec30-398a-5fbb-87e1-c57d34a7da26","c56.9",-28498,"TCGA-13-0888_treatment","2708db92-2815-586a-94ce-9660f24951e3","01",NA,"TCGA-13-0888-01A","0.8","34cd279f-98ef-49de-8b13-16913f972d4e",FALSE,"DFDEBDE5-C16E-4B29-9986-8EB557648AC5","Primary Tumor","0.4",NA,NA,"1.2",1233705600,"01",81,"TCGA-13-0888-01A-01",85,85,NA,NA,15,15,0,0,"2016-09-08T12:45:14.695040-05:00","2016-09-08T12:45:14.695040-05:00",NA,NA,NA,NA,"TOP","BOTTOM",20,15,"ffd7136c-4224-4e96-b6bd-91271f3be8be","958e8b83-20ce-4ec9-9e0f-62be3c6ba1cb","TCGA-13-0888-01A-01-TS1","TCGA-13-0888-01A-01-BS1",65,70,"90fefa8a-33f9-4e74-9e38-3f9718cfad23","RNA","TCGA-13-0888-01A-01R","344f5204-ebba-454b-a47f-facfb6611bda",1.8,0.15,"UV Spec","R","22","TCGA-13-0888-01A-01R-1564-13","b6ee33d9-26fc-491a-90af-25f3da976da0",0.15,NA,NA,NA,NA,"437a542c-6360-5798-97af-e8ae5e8fe13e","TCGA-13-0888_exposure","TCGA-13-0888-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T17:13:50.000Z","2014-03-28T17:34:01.000Z","F03C489B-AE35-441A-92E4-7092FA3818FB","34CD279F-98EF-49DE-8B13-16913F972D4E","Unaligned reads",7816591360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B6EE33D9-26FC-491A-90AF-25F3DA976DA0","Canada's Michael Smith Genome Sciences Centre","564a3a6de4b093830b68f4f6","6CF9F872-2E59-45CF-BB5E-EBD7FA1B3CAF","Ovarian Serous Cystadenocarcinoma","TAR","90FEFA8A-33F9-4E74-9E38-3F9718CFAD23","2014-03-28T17:34:01.000Z","344F5204-EBBA-454B-A47F-FACFB6611BDA","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"90FEFA8A-33F9-4E74-9E38-3F9718CFAD23",0.8,"13","C239.TCGA-13-0888-01A-01W.10.bam",NA,"TCGA-13-0888-01A",1.2,"6FF16BE4-EF53-4E2D-B800-E9FE11910306","TCGA",2003,NA,NA,"TUMOR FREE","3EB7CF7A-0658-4224-AB6F-8997F6952D60",78,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.bb0f85fb-5126-4934-89bc-39e1044dee03.txt","Alive",NA,"TCGA-13-0888","NOT HISPANIC OR LATINO",NA,NA,2141,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,81,"FFD7136C-4224-4E96-B6BD-91271F3BE8BE","A2D2A5AC-B280-4794-AC17-0E22E030C4FE","RACKS_p_TCGAaffxB10b_11_S_GenomeWideSNP_6_F09_429446.hg18.seg.txt","TCGA-13-0888-01A-01",85,15,NA,NA,0,"BOTTOM",15,NA,"TCGA-13-0888-01A-01-BS1",70,"Paclitaxel","Chemotherapy","TCGA-13-0888-D24675",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0888",NA,"13","0888","YES","C56.9","8441/3","C56.9",NA,NA,-28498,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2141,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,78,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
208350570,202730181,14973641916,"FDB9F3D8-93F2-4710-A5FF-D414DB4A2282.bw","6d10d4ee-6331-4bba-93bc-a7b64cc0b22a","fdb9f3d8-93f2-4710-a5ff-d414db4a2282","2016-08-27T07:31:41.833186-05:00","TCGA-04-1331-01A-01R-1569-13_rnaseq_fastq.tar","2e13491b-c707-49e6-852c-ccd1d6252b00",13158103040,"Illumina HiSeq","29a567d65a4f936f623157da85914ffb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:51:43.245423-05:00","2016-05-03T11:56:42.659770-05:00","2e13491b-c707-49e6-852c-ccd1d6252b00_analysis.xml","64a85a448a904a934d1f1051171339c0","0cc2a28c-1891-45f7-9b68-67f568fcf043",2208,"2016-09-29T23:15:51.955951-05:00","2e13491b-c707-49e6-852c-ccd1d6252b00_experiment.xml","f3af12a3c84ae4745446fa58cdbf7724","d6359bf4-1cc0-4c52-95de-5ef67151eb4e",3916,"2016-09-29T21:51:51.300039-05:00","2e13491b-c707-49e6-852c-ccd1d6252b00_run.xml","96c26f205b64051a34bea686f3237a13","a240ea74-c57f-4e1c-951c-25c5a8bea5ec",1988,"2016-09-08T12:20:47.033083-05:00","TCGA-04-1331","2016-09-02T19:05:55.583755-05:00","female","TCGA-04-1331_demographic",1926,"white","484bfbce-553b-5967-b6b1-2db46d395d5d","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1331_diagnosis","not reported",28848,"dead","8441/3",1336,1224,"a5055ee4-957a-58aa-9f8d-4ee8c627de20","c56.9",-28848,"TCGA-04-1331_treatment","ccb64579-fa43-532e-9f4f-97223d2e70ff","01",NA,"TCGA-04-1331-01A","0.4","a1ec9279-c1a6-4e58-97ed-9ec1f36187c5",FALSE,"2CF541C5-B56A-4946-A5C4-DBB4D71D7908","Primary Tumor","0.4",NA,NA,"0.5",1229558400,"01",91,"TCGA-04-1331-01A-01",88,90,NA,NA,0,0,65,20,"2016-09-08T12:20:47.033083-05:00","2016-09-08T12:20:47.033083-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,2,"27aaf831-a80b-4a55-a239-3a24caca9c28","76f57a19-5698-4204-bb11-7b6a106d620a","TCGA-04-1331-01A-01-BS1","TCGA-04-1331-01A-01-TS1",30,78,"63d33d83-7761-4065-8b16-09dd121371fe","RNA","TCGA-04-1331-01A-01R","a8039ce1-b55e-49f4-89bc-43263c0b581e",1.8,0.15,"UV Spec","R","22","TCGA-04-1331-01A-01R-1569-13","7fbfdb3e-1fd2-4206-8d2e-7f68e4a15844",0.15,NA,NA,NA,NA,"122a86dc-7f10-51fb-9b7f-a194a444007d","TCGA-04-1331_exposure","TCGA-04-1331-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T01:27:58.000Z","2014-08-20T23:09:32.000Z","2E13491B-C707-49E6-852C-CCD1D6252B00","A1EC9279-C1A6-4E58-97ED-9EC1F36187C5","Unaligned reads",13158103040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7FBFDB3E-1FD2-4206-8D2E-7F68E4A15844","Canada's Michael Smith Genome Sciences Centre","564a5ae7e4b0ef12181e070b","6D10D4EE-6331-4BBA-93BC-A7B64CC0B22A","Ovarian Serous Cystadenocarcinoma","TAR","63D33D83-7761-4065-8B16-09DD121371FE","2014-08-08T02:02:19.000Z","A8039CE1-B55E-49F4-89BC-43263C0B581E","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"63D33D83-7761-4065-8B16-09DD121371FE",0.4,"04","bcgsc.ca.TCGA-04-1331-01A-01R-1569-13.hg19.bcgsc.ca.1.6.0.indel.vcf",NA,"TCGA-04-1331-01A",0.5,"8248D776-145A-4301-8D69-09567AEDCF3D","TCGA",2004,NA,NA,"WITH TUMOR","D2959EA3-AB1D-4F28-AE54-F6C0232F5E43",78,"nationwidechildrens.org_clinical.TCGA-04-1331.xml","Dead",1336,"TCGA-04-1331","NOT HISPANIC OR LATINO","301B373D-8ABE-471E-8805-51BCF72A4FC2",NA,1224,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,91,"76F57A19-5698-4204-BB11-7B6A106D620A","A8039CE1-B55E-49F4-89BC-43263C0B581E","bcgsc.ca.TCGA-04-1331-01A-01R-1569-13.hg19.bcgsc.ca.1.6.0.indel.vcf","TCGA-04-1331-01A-01",90,0,NA,NA,20,"TOP",2,NA,"TCGA-04-1331-01A-01-TS1",78,"Taxol","Chemotherapy","TCGA-04-1331-D23907",NA,NA,NA,"TCGA-04-1331-F23906_NTE-1",NA,1224,"WITH TUMOR","Dead",1336,"TCGA-04-1331-F23906","TCGA-04-1331",NA,"04","1331","YES","C56.9","8441/3","C56.9",NA,NA,-28848,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1224,1336,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,78,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
286202442,278538904,20613638030,"D106E558-1E06-443A-9A6E-C6AD2284EE56.bw","6e84e89d-4f35-43b8-b47d-b1343b8c1ab9","d106e558-1e06-443a-9a6e-c6ad2284ee56","2016-08-26T14:42:53.073242-05:00","TCGA-24-1436-01A-01R-1566-13_rnaseq_fastq.tar","8ca14cbb-ae52-48bf-adf8-ebc52150692e",18248079360,"Illumina HiSeq","b771157ba6fbf63f9100f0b2053d0744","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:43:13.270488-05:00","2016-05-03T11:39:34.528512-05:00","8ca14cbb-ae52-48bf-adf8-ebc52150692e_analysis.xml","caecba07a6fc3144a6c0f203486b7422","52b31c00-5da0-4099-b183-f81460215924",2181,"2016-09-29T23:37:28.790427-05:00","8ca14cbb-ae52-48bf-adf8-ebc52150692e_experiment.xml","351779d0cedf638edd57013c8ff66a97","e3b67d03-7d34-431c-9c0b-aad9c9488a2b",3916,"2016-09-29T18:16:04.725179-05:00","8ca14cbb-ae52-48bf-adf8-ebc52150692e_run.xml","602ebcf84fb4076269d1f97dc0051d10","1bf5b965-f87f-4e37-b53f-751b2ef00495",1988,"2016-09-08T13:32:23.779966-05:00","TCGA-24-1436","2016-09-02T19:13:56.558640-05:00","female","TCGA-24-1436_demographic",1942,"white","a0107c28-a218-5aa9-a28b-c327f9ff8509","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1436_diagnosis","not reported",20881,"dead","8441/3",260,260,"c1b7821e-d547-564e-bd56-2021a2829cce","c56.9",-20881,"TCGA-24-1436_treatment","4cca1b40-400e-579f-8430-9ad31c25a430","01",NA,"TCGA-24-1436-01A","0.7","e1eda97e-24fe-4dc8-92eb-080399b1d82d",FALSE,"621d3f29-b555-4767-83dd-a6989af0be12","Primary Tumor","0.3",NA,NA,"1.5",1232409600,"01",120,"TCGA-24-1436-01A-01",90,95,NA,NA,0,0,10,5,"2016-09-08T13:32:23.779966-05:00","2016-09-08T13:32:23.779966-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"a8567283-4710-4476-95d5-c3a1ebdfd57b","f7f90832-d8ba-40ae-b5d9-3f9b558d7e65","TCGA-24-1436-01A-01-TS1","TCGA-24-1436-01A-01-BS1",90,89,"c9b2ef02-62ab-4705-9ef7-63a87b3ac163","RNA","TCGA-24-1436-01A-01R","f33af35d-51f3-438c-ae4c-c17eb3bcc8bf",1.8,0.15,"UV Spec","R","22","TCGA-24-1436-01A-01R-1566-13","45ff767a-721a-4d89-b5e9-0c6e7eba476d",0.15,NA,NA,NA,NA,"edb534eb-c7a2-5c85-83e7-ef68d1ad9891","TCGA-24-1436_exposure","TCGA-24-1436-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T06:50:52.000Z","2014-03-20T07:24:02.000Z","8CA14CBB-AE52-48BF-ADF8-EBC52150692E","E1EDA97E-24FE-4DC8-92EB-080399B1D82D","Unaligned reads",18248079360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","45FF767A-721A-4D89-B5E9-0C6E7EBA476D","Canada's Michael Smith Genome Sciences Centre","564a3632e4b09c884b22c64a","6E84E89D-4F35-43B8-B47D-B1343B8C1AB9","Ovarian Serous Cystadenocarcinoma","TAR","C9B2EF02-62AB-4705-9EF7-63A87B3AC163","2014-03-20T07:24:02.000Z","F33AF35D-51F3-438C-AE4C-C17EB3BCC8BF","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"C9B2EF02-62AB-4705-9EF7-63A87B3AC163",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d6aaae43-70fd-461e-b240-8ba220221828.txt",NA,"TCGA-24-1436-01A",1.5,"075DB38D-494A-43D6-87AC-701EEF1C15BB","TCGA",1999,NA,NA,"WITH TUMOR","E1EDA97E-24FE-4DC8-92EB-080399B1D82D",57,"THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_G02_455286.byallele.copynumber.data.txt","Dead",260,"TCGA-24-1436",NA,"CC0A65C7-68C1-48E5-8E0A-7FC5A09D1317",NA,260,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,120,"F7F90832-D8BA-40AE-B5D9-3F9B558D7E65","F81D51A7-9CB0-408D-B596-B1B24E5894FB","TCGA-24-1436-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-24-1436-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-24-1436-01A-01-BS1",89,"Carboplatin","Chemotherapy","TCGA-24-1436-D26005",NA,NA,NA,NA,NA,260,"WITH TUMOR","Dead",260,"TCGA-24-1436-F26004","TCGA-24-1436",NA,"24","1436","YES","C56.9","8441/3","C56.9",NA,NA,-20881,"FEMALE","WHITE",NA,NA,"No","Dead",260,260,NA,NA,"WITH TUMOR","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,57,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
331011340,316605298,23429922932,"533E380E-6EB2-450B-BC02-54A234B3842A.bw","6ea9877f-eb8d-4ee9-af4c-32a78474d9a6","533e380e-6eb2-450b-bc02-54a234b3842a","2016-08-20T08:23:36.487814-05:00","TCGA-36-1575-01A-01R-1566-13_rnaseq_fastq.tar","83ca86d3-6e91-4036-93ae-5c408567a082",22046832640,"Illumina HiSeq","0c41af574f48b72ec443ac87b214ec71","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:33:04.671270-05:00","2016-05-03T11:40:21.662944-05:00","83ca86d3-6e91-4036-93ae-5c408567a082_analysis.xml","cfca1ca626e455f8cf80b8d786083a9c","00dafa85-16b6-4d06-ae9d-13787ed14036",2181,"2016-09-29T21:15:45.778604-05:00","83ca86d3-6e91-4036-93ae-5c408567a082_experiment.xml","ebdbdf98bd28d32dc3c52c5a1970723a","8be8eb7c-a6a9-4143-91ef-304205ae4592",3916,"2016-09-29T17:43:40.189340-05:00","83ca86d3-6e91-4036-93ae-5c408567a082_run.xml","87c66abcdadd1816505072b3a92f2189","0796b812-e48a-42a3-b831-e929fc2e4aa2",1988,"2016-09-08T10:32:16.031717-05:00","TCGA-36-1575","2016-09-02T18:47:34.774228-05:00","female","TCGA-36-1575_demographic",1923,"not reported","dd3e8198-e1e2-5976-a248-79485941dd2d","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1575_diagnosis","not reported",30592,"alive","8441/3",NA,260,"e7428b28-df7a-5573-8867-a864e51c6a92","c56.9",-30592,"TCGA-36-1575_treatment","d67ba0e7-920f-53a6-a76e-c8a76ed42d7e","01",NA,"TCGA-36-1575-01A","0.8","e53c2985-f410-43f1-8fde-7181112b9c14",FALSE,"44cf8eee-71b1-4499-815a-7d1c3092dbe3","Primary Tumor","0.4",NA,NA,"1.6",1235952000,"01",120,"TCGA-36-1575-01A-01",95,95,NA,NA,15,0,5,10,"2016-09-08T10:32:16.031717-05:00","2016-09-08T10:32:16.031717-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"021beb01-2e1f-45dc-b2fd-aa11ae9f2570","3790ada2-ef51-47a2-910c-a95d6c5ceecd","TCGA-36-1575-01A-01-BS1","TCGA-36-1575-01A-01-TS1",80,85,"d5b389c4-908c-40fe-8d65-e28ae9b74efa","RNA","TCGA-36-1575-01A-01R","9aaa127f-7ff4-45c1-983f-3b9c17c6c3f5",1.8,0.14,"UV Spec","R","22","TCGA-36-1575-01A-01R-1566-13","a28ef775-c78b-416f-afeb-89ba265440f0",0.14,NA,NA,NA,NA,"a16cf690-b298-5709-9ef3-01afa026cb9e","TCGA-36-1575_exposure","TCGA-36-1575-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T00:13:03.000Z","2014-03-25T01:07:02.000Z","83CA86D3-6E91-4036-93AE-5C408567A082","E53C2985-F410-43F1-8FDE-7181112B9C14","Unaligned reads",22046832640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A28EF775-C78B-416F-AFEB-89BA265440F0","Canada's Michael Smith Genome Sciences Centre","564a3459e4b09c884b223569","6EA9877F-EB8D-4EE9-AF4C-32A78474D9A6","Ovarian Serous Cystadenocarcinoma","TAR","D5B389C4-908C-40FE-8D65-E28AE9B74EFA","2014-03-25T01:07:02.000Z","9AAA127F-7FF4-45C1-983F-3B9C17C6C3F5","None","NO",1,0.4,"Primary Tumor","BC Cancer Agency",NA,"D5B389C4-908C-40FE-8D65-E28AE9B74EFA",0.8,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ba2a2d99-a0a6-4d8d-a207-d1a82501f18d.txt",NA,"TCGA-36-1575-01A",1.6,NA,"TCGA",2006,NA,NA,"TUMOR FREE","E53C2985-F410-43F1-8FDE-7181112B9C14",83,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ba2a2d99-a0a6-4d8d-a207-d1a82501f18d.txt","Alive",NA,"TCGA-36-1575",NA,"A467ED8B-FFFC-416C-BAEC-1A137A98D03B",NA,260,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,NA,NA,1,120,"3790ADA2-EF51-47A2-910C-A95D6C5CEECD","9AAA127F-7FF4-45C1-983F-3B9C17C6C3F5","TCGA-36-1575-01A-01R-1566-13_GRCh37-lite_rnaseq.bam.bai","TCGA-36-1575-01A-01",95,0,NA,NA,10,"TOP",5,NA,"TCGA-36-1575-01A-01-TS1",85,NA,NA,NA,NA,NA,NA,NA,NA,260,"TUMOR FREE","Alive",NA,"TCGA-36-1575-F27872","TCGA-36-1575",NA,"36","1575","YES","C56.9","8441/3","C56.9",NA,NA,-30592,"FEMALE",NA,NA,NA,"No","Alive",260,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,83,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
135323380,132203331,9782308975,"57B29C2A-2DDC-4F07-A09E-A835C253DB96.bw","6f25001a-f890-4fd0-a994-e62a9ea5c6f3","57b29c2a-2ddc-4f07-a09e-a835c253db96","2016-08-20T09:57:47.558569-05:00","TCGA-29-2427-01A-01R-1569-13_rnaseq_fastq.tar","1c61982a-51be-4bb7-b74c-9c274a8101cc",8132864000,"Illumina HiSeq","fb3f4deeb1734126ca0e9c2a160d28c5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:07:51.740274-05:00","2016-05-03T11:41:05.740763-05:00","1c61982a-51be-4bb7-b74c-9c274a8101cc_analysis.xml","2763c7d78f4cd1d91f9729bfe1081339","f65c79b0-9611-43c7-9cff-095d8fe31a0a",2181,"2016-09-29T17:52:46.230195-05:00","1c61982a-51be-4bb7-b74c-9c274a8101cc_experiment.xml","fc26a35dc472fde72dc4c9d7598a2a20","0d6c7b63-70df-4ea3-ba41-a387575621d6",3916,"2016-09-29T21:56:49.404269-05:00","1c61982a-51be-4bb7-b74c-9c274a8101cc_run.xml","5e40e955ed4538d5e5d77ac10785c001","a561a890-f86e-4af0-8140-4cf1b064b49b",1988,"2016-09-08T13:34:17.125701-05:00","TCGA-29-2427","2016-09-02T19:11:43.569132-05:00","female","TCGA-29-2427_demographic",1944,"white","4444344c-f573-5cad-9e24-348cf054c8ca","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-2427_diagnosis","not reported",21940,"alive","8441/3",NA,1900,"da1f114e-7c5a-51fc-9d84-66d67b4f7676","c56.9",-21940,"TCGA-29-2427_treatment","252184f3-65c1-51c2-bfbf-33ef83c9971a","01",NA,"TCGA-29-2427-01A","1","41b8564a-48df-44ab-9242-8d1d89697658",FALSE,"b53536ca-770c-4482-b2f7-4284d804db2e","Primary Tumor","0.5",NA,NA,"1.5",1252972800,"01",159,"TCGA-29-2427-01A-01",90,90,NA,NA,0,0,15,15,"2016-09-08T13:34:17.125701-05:00","2016-09-08T13:34:17.125701-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"18e2a214-81fd-424b-9df8-79f5cb01a124","9a2ec747-2714-4a3a-84a5-5d6855ee018f","TCGA-29-2427-01A-01-BS1","TCGA-29-2427-01A-01-TS1",80,80,"07a1666c-2b86-4021-a6f9-2ea4b06ebef9","RNA","TCGA-29-2427-01A-01R","64a01f37-4193-47a9-a2e5-bf73320f486c",1.8,0.13,"UV Spec","R","22","TCGA-29-2427-01A-01R-1569-13","f1579d6e-6efd-47b5-b2b4-a97e1480ce0a",0.13,NA,NA,NA,NA,"3d04038a-6194-5c3a-aac4-3dce1f0b418b","TCGA-29-2427_exposure","TCGA-29-2427-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-26T21:33:10.000Z","2014-03-26T21:53:02.000Z","1C61982A-51BE-4BB7-B74C-9C274A8101CC","41B8564A-48DF-44AB-9242-8D1D89697658","Unaligned reads",8132864000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F1579D6E-6EFD-47B5-B2B4-A97E1480CE0A","Canada's Michael Smith Genome Sciences Centre","564a39b4e4b08c5d8690f83b","6F25001A-F890-4FD0-A994-E62A9EA5C6F3","Ovarian Serous Cystadenocarcinoma","TAR","07A1666C-2B86-4021-A6F9-2EA4B06EBEF9","2014-03-26T21:53:02.000Z","64A01F37-4193-47A9-A2E5-BF73320F486C","None","NO",1,0.5,"Primary Tumor","Duke",NA,"07A1666C-2B86-4021-A6F9-2EA4B06EBEF9",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.596d6d8e-d15c-442b-bcd4-ed2dec59aef2.txt",NA,"TCGA-29-2427-01A",1.5,"EE835A1C-74F7-4113-A155-EDB8C347A4B2","TCGA",2004,NA,NA,"WITH TUMOR","7EE7F3C1-2C6F-49C8-8477-4C76E7B4E4DE",60,"nationwidechildrens.org_clinical.TCGA-29-2427.xml","Alive",NA,"TCGA-29-2427",NA,"43E966C8-610E-48A8-9E83-B2635E874AA0",NA,1900,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,159,"9A2EC747-2714-4A3A-84A5-5D6855EE018F","8419B348-0B54-449C-829A-407B63AC5A86","AMISS_p_TCGAb24_SNP_N_GenomeWideSNP_6_F05_542524.hg18.seg.txt","TCGA-29-2427-01A-01",90,0,NA,NA,15,"BOTTOM",5,NA,"TCGA-29-2427-01A-01-BS1",80,"Cisplatin","Chemotherapy","TCGA-29-2427-D27475",NA,NA,NA,"TCGA-29-2427-F27470_NTE-1",NA,1900,"WITH TUMOR","Alive",NA,"TCGA-29-2427-F27470","TCGA-29-2427",NA,"29","2427","YES","C56.9","8441/3","C56.9",NA,NA,-21940,"FEMALE","WHITE",NA,NA,"No","Alive",1900,NA,NA,NA,"WITH TUMOR","NO",8,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,60,2004,"Tumor resection",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
233289856,224973579,16638411146,"0EE4FD08-9E68-41DF-9C72-BCFDB065B714.bw","6fb71a0c-bc50-48c8-acfa-db94be1e151a","0ee4fd08-9e68-41df-9c72-bcfdb065b714","2016-08-24T21:26:14.879400-05:00","TCGA-29-1693-01A-01R-1567-13_rnaseq_fastq.tar","2b66c6fc-2024-4591-ad7f-14604ad6c414",15418736640,"Illumina HiSeq","0eff24f054fe641a3d137991cddb98b4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:19:37.027743-05:00","2016-05-03T11:41:05.748550-05:00","2b66c6fc-2024-4591-ad7f-14604ad6c414_analysis.xml","fc912d209e9b141e8024672735acde06","1e1cf3b3-ab61-444e-96d8-8bc6e2a5f621",2181,"2016-08-26T14:41:25.510861-05:00","2b66c6fc-2024-4591-ad7f-14604ad6c414_experiment.xml","0848c8304fce52e289416e8616ad97a7","5a048aac-f30b-4831-b7db-cc6d0efdf68e",3916,"2016-09-29T18:31:23.667501-05:00","2b66c6fc-2024-4591-ad7f-14604ad6c414_run.xml","36c75b677b4796eeb85cf4a7a44df46c","257b5a21-3f15-4dad-a411-ccc05a5818a7",1989,"2016-09-08T13:16:54.899742-05:00","TCGA-29-1693","2016-09-02T19:07:41.847744-05:00","female","TCGA-29-1693_demographic",1929,"white","0af1dec6-33f4-596f-864c-bc10b4e264f1","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1693_diagnosis","not reported",26300,"alive","8441/3",NA,3096,"ebc68b2a-3891-5bad-92aa-ae5e37033678","c56.9",-26300,"TCGA-29-1693_treatment","07f20521-78b1-5110-a0ef-d60bc53f10a8","01",NA,"TCGA-29-1693-01A","0.7","13caa1a6-03a5-4fcf-9b54-4dfa86fb5c84",FALSE,"90087244-634d-45eb-a877-ff7cc6bd2282","Primary Tumor","0.4",NA,NA,"0.7",1241740800,"01",126,"TCGA-29-1693-01A-01",85,90,NA,NA,0,0,0,0,"2016-09-08T13:16:54.899742-05:00","2016-09-08T13:16:54.899742-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"4e3372ca-7a0e-4716-882e-2513dcdcbf14","df0f1f1b-2da4-4ee3-a5c3-77d2ed3830a6","TCGA-29-1693-01A-01-TS1","TCGA-29-1693-01A-01-BS1",98,98,"e9236c1e-21f6-40e9-8588-f92f07a62745","RNA","TCGA-29-1693-01A-01R","ad590357-2dcc-48ff-ae9f-1a29f68cdc78",1.8,0.15,"UV Spec","R","22","TCGA-29-1693-01A-01R-1567-13","7e5d2390-1e04-4e46-aa48-4b0131076007",0.15,NA,NA,NA,NA,"af301e16-2bb8-51cf-93f5-663ce1cc8971","TCGA-29-1693_exposure","TCGA-29-1693-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T01:31:41.000Z","2014-03-29T01:58:02.000Z","2B66C6FC-2024-4591-AD7F-14604AD6C414","13CAA1A6-03A5-4FCF-9B54-4DFA86FB5C84","Unaligned reads",15418736640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7E5D2390-1E04-4E46-AA48-4B0131076007","Canada's Michael Smith Genome Sciences Centre","564a58c8e4b0ef12181d5264","6FB71A0C-BC50-48C8-ACFA-DB94BE1E151A","Ovarian Serous Cystadenocarcinoma","TAR","E9236C1E-21F6-40E9-8588-F92F07A62745","2014-03-29T01:58:02.000Z","AD590357-2DCC-48FF-AE9F-1A29F68CDC78","None","NO",1,0.4,"Primary Tumor","Duke",NA,"E9236C1E-21F6-40E9-8588-F92F07A62745",0.7,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.75dd78d6-cd26-476f-927f-ddb0d4a9c66f.txt",NA,"TCGA-29-1693-01A",0.7,"0DB74B13-EE6A-4798-8578-305AE89EDED5","TCGA",2001,NA,NA,"WITH TUMOR","1B3A3407-BBC5-4B42-B9CD-9352003EEEC2",72,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.75dd78d6-cd26-476f-927f-ddb0d4a9c66f.txt","Alive",NA,"TCGA-29-1693",NA,"12658BED-F067-4263-B749-1E9839821A25",NA,3096,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,"89BA49FE-0519-4CA3-AE20-23DC5D6A5FF2","WHITE",NA,1,126,"DF0F1F1B-2DA4-4EE3-A5C3-77D2ED3830A6","A4FF8C92-A2C5-499A-A5B2-A3775531DB9E","TCGA-29-1693-01A-01R-1567-13.hg19.exon.quantification.txt","TCGA-29-1693-01A-01",85,0,NA,NA,0,"TOP",2,NA,"TCGA-29-1693-01A-01-TS1",98,"Paclitaxel","Chemotherapy","TCGA-29-1693-D27185","TCGA-29-1693-R27190","EXTERNAL BEAM","Primary Tumor Field","TCGA-29-1693-F27174_NTE-2",NA,3096,"WITH TUMOR","Alive",NA,"TCGA-29-1693-F27174","TCGA-29-1693",NA,"29","1693","YES","C56.9","8441/3","C56.9",NA,NA,-26300,"FEMALE","WHITE",NA,NA,"No","Alive",3096,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,72,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
142143962,139279675,10317921976,"33BF0EC9-3FBE-41D3-BDDA-9A84648542CE.bw","6fee41dc-b8a9-4347-8085-b7e05f813ad0","33bf0ec9-3fbe-41d3-bdda-9a84648542ce","2016-08-25T14:10:30.998658-05:00","TCGA-31-1944-01A-01R-1568-13_rnaseq_fastq.tar","b9851c97-5105-4df2-9a29-60c5cae19fd6",8983173120,"Illumina HiSeq","6311d7c61236c36848c773e5e5fa6214","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:54:10.300837-05:00","2016-05-03T11:56:42.628342-05:00","b9851c97-5105-4df2-9a29-60c5cae19fd6_analysis.xml","544d7c7b219415f15b11ddabd6c2d7ce","c8c86e5f-f6b6-4675-b3e8-c13c9be26ac6",2181,"2016-09-29T20:20:33.196478-05:00","b9851c97-5105-4df2-9a29-60c5cae19fd6_experiment.xml","df1dd6ce9a1c4f2f061fa14f1423c9a1","698dc254-7563-4467-a162-28aab0a11fe2",3916,"2016-09-29T19:55:28.488651-05:00","b9851c97-5105-4df2-9a29-60c5cae19fd6_run.xml","202f537732901b4000751b9a60ac7107","5a62e16f-e5a7-4422-94c9-6c7e498df75d",1988,"2016-09-08T10:36:09.177545-05:00","TCGA-31-1944","2016-09-02T18:50:38.188159-05:00","female","TCGA-31-1944_demographic",1958,"white","1846915b-b3b0-5629-bb73-f78bf2081edf","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1944_diagnosis","not reported",17207,"alive","8441/3",NA,1386,"b0da2290-ee62-5e0f-a177-72bc672062ec","c56.9",-17207,"TCGA-31-1944_treatment","b53485cf-2228-50ab-a344-6deb35087b3f","01",NA,"TCGA-31-1944-01A","0.5","69617aa2-3b7b-47b5-9f34-2051339dfd34",FALSE,"bd7361f7-07c1-4be8-92c6-4f0a3dea99b2","Primary Tumor","0.3",NA,NA,"1",1246838400,"01",124,"TCGA-31-1944-01A-01",90,95,NA,NA,0,0,20,27,"2016-09-08T10:36:09.177545-05:00","2016-09-08T10:36:09.177545-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,3,"b8440d12-6207-4950-9b2f-4b6c007c6220","1a8b04f1-bcc9-49fc-931d-c973e12f26f6","TCGA-31-1944-01A-01-TS1","TCGA-31-1944-01A-01-BS1",70,70,"196b5edd-12b5-404e-9256-1f721a059fe0","RNA","TCGA-31-1944-01A-01R","f48d33b4-83e7-41f2-adb4-44b7427dd2df",1.8,0.16,"UV Spec","R","22","TCGA-31-1944-01A-01R-1568-13","c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2",0.16,NA,NA,NA,NA,"c36c4285-bcd1-5470-a3c1-e7d39443a0f3","TCGA-31-1944_exposure","TCGA-31-1944-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T07:46:21.000Z","2014-08-28T11:11:16.000Z","B9851C97-5105-4DF2-9A29-60C5CAE19FD6","69617AA2-3B7B-47B5-9F34-2051339DFD34","Unaligned reads",8983173120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C8A1EC95-A4B3-4FB2-B135-1C7616DB9AB2","Canada's Michael Smith Genome Sciences Centre","564a3326e4b093830b66a0e8","6FEE41DC-B8A9-4347-8085-B7E05F813AD0","Ovarian Serous Cystadenocarcinoma","TAR","196B5EDD-12B5-404E-9256-1F721A059FE0","2014-08-28T11:11:16.000Z","F48D33B4-83E7-41F2-ADB4-44B7427DD2DF","None","NO",1,0.3,"Primary Tumor","Imperial College",NA,"196B5EDD-12B5-404E-9256-1F721A059FE0",0.5,"31","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.332735d2-c077-400a-b011-1f0984b07339.txt",NA,"TCGA-31-1944-01A",1,"FD7A3513-DDFF-4504-A30A-3788779F9E79","TCGA",2005,NA,NA,"WITH TUMOR","F25A64AE-0003-4B2A-A26C-56FA9ABAB925",47,"nationwidechildrens.org_clinical.TCGA-31-1944.xml","Alive",NA,"TCGA-31-1944","NOT HISPANIC OR LATINO","D1397F20-F35B-48A1-8D55-FDF484D16766",NA,1386,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,124,"B8440D12-6207-4950-9B2F-4B6C007C6220","F48D33B4-83E7-41F2-ADB4-44B7427DD2DF","TCGA-31-1944-01A-01R-1568-13_mirna.bam","TCGA-31-1944-01A-01",95,0,NA,NA,27,"BOTTOM",3,NA,"TCGA-31-1944-01A-01-BS1",70,"Paciltaxel","Chemotherapy","TCGA-31-1944-D27672",NA,NA,NA,"TCGA-31-1944-F27668_NTE-2",NA,1386,"WITH TUMOR","Alive",NA,"TCGA-31-1944-F27668","TCGA-31-1944",NA,"31","1944","YES","C56.9","8441/3","C56.9",NA,NA,-17207,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1386,NA,NA,NA,"WITH TUMOR","NO",19,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,47,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
155333340,149810022,11028484591,"7FB968BC-48C8-401A-A677-A22076FA6A8E.bw","700e91bb-d675-41b2-bbbd-935767c7b447","7fb968bc-48c8-401a-a677-a22076fa6a8e","2016-08-25T21:28:09.218386-05:00","TCGA-23-1118-01A-01R-1564-13_rnaseq_fastq.tar","ecd2e949-d04b-4401-9e0d-08684ad0861d",8932065280,"Illumina HiSeq","f379080dab69fb5a902e4350427fb0e9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:55:15.004301-05:00","2016-05-03T11:41:05.750744-05:00","ecd2e949-d04b-4401-9e0d-08684ad0861d_analysis.xml","36b7f6b937e17a62e737ed097fd1d2fa","7f059c13-e929-45be-b168-aa39ec79409b",2208,"2016-09-29T19:15:25.204025-05:00","ecd2e949-d04b-4401-9e0d-08684ad0861d_experiment.xml","f8ec6adc2199675c13bcfc1869a1fa15","41613a9a-0ed8-45d0-b1b1-384540b13fc7",3916,"2016-09-29T18:30:14.994366-05:00","ecd2e949-d04b-4401-9e0d-08684ad0861d_run.xml","5ff031e8e8034a2235bb94a5149fecbf","24d3f76d-1272-4fc1-ad63-a3e2637802cb",1988,"2016-09-08T13:11:08.449222-05:00","TCGA-23-1118","2016-09-02T19:05:57.860043-05:00","female","TCGA-23-1118_demographic",1956,"white","9365e233-5048-5e21-8118-2106e29f75eb","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1118_diagnosis","not reported",16471,"alive","8441/3",NA,2616,"3e654e05-d3e9-57f4-9bda-b31211ca6a22","c56.9",-16471,"TCGA-23-1118_treatment","85cb3d17-bf01-575b-b9f6-6a789b2f494f","01",NA,"TCGA-23-1118-01A","0.7","e1be8ad9-1a52-4677-8436-3da22ad12e9a",FALSE,"2f53a2c6-b67a-4966-b300-5e00968b15f3","Primary Tumor","0.7",NA,NA,"0.8",1227657600,"01",101,"TCGA-23-1118-01A-01",90,95,NA,NA,NA,NA,NA,NA,"2016-09-08T13:11:08.449222-05:00","2016-09-08T13:11:08.449222-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,0,"8d624207-a194-492d-b84f-da0a617d2fc2","fbcfe18d-548d-4c26-8ed8-c13545b48e49","TCGA-23-1118-01A-01-BS1","TCGA-23-1118-01A-01-TS1",NA,NA,"e5b2d2fd-d455-41cb-bf7c-0a5f77deafc1","RNA","TCGA-23-1118-01A-01R","d902eb23-c35d-400a-81ac-17728b2e2876",1.8,0.15,"UV Spec","R","22","TCGA-23-1118-01A-01R-1564-13","9e73d9f4-dd7c-439f-a8c5-236311e3facf",0.15,NA,NA,NA,NA,"aeb2b56a-2e5d-5a27-841d-227b2f274594","TCGA-23-1118_exposure","TCGA-23-1118-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T18:43:34.000Z","2014-03-28T07:07:02.000Z","ECD2E949-D04B-4401-9E0D-08684AD0861D","E1BE8AD9-1A52-4677-8436-3DA22AD12E9A","Unaligned reads",8932065280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9E73D9F4-DD7C-439F-A8C5-236311E3FACF","Canada's Michael Smith Genome Sciences Centre","564a5684e4b0ef12181c93c5","700E91BB-D675-41B2-BBBD-935767C7B447","Ovarian Serous Cystadenocarcinoma","TAR","E5B2D2FD-D455-41CB-BF7C-0A5F77DEAFC1","2014-03-28T07:07:02.000Z","D902EB23-C35D-400A-81AC-17728B2E2876","None","NO",1,0.7,"Primary Tumor","Cedars Sinai",NA,"E5B2D2FD-D455-41CB-BF7C-0A5F77DEAFC1",0.7,"23","TCGA-23-1118-01A-01R-1564-13_mirna.bam.bai",NA,"TCGA-23-1118-01A",0.8,"553AE8B5-BBA0-4760-BC39-007B45663EBA","TCGA",2001,NA,NA,"TUMOR FREE","E1BE8AD9-1A52-4677-8436-3DA22AD12E9A",45,"QUANT_p_TCGA_Batch12_AFFX_GenomeWideSNP_6_A10_437626.nocnv_hg19.seg.txt","Alive",NA,"TCGA-23-1118","NOT HISPANIC OR LATINO","2C2E8996-31A2-4D40-AE52-A14131EB9684",NA,2616,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,101,"FBCFE18D-548D-4C26-8ED8-C13545B48E49","F5DA1330-DBF1-44FF-9CA6-C6A146806C78","TCGA-23-1118-01A-01R-1564-13_mirna.bam.bai","TCGA-23-1118-01A-01",90,NA,NA,NA,NA,"BOTTOM",10,NA,"TCGA-23-1118-01A-01-BS1",NA,"Carboplatin","Chemotherapy","TCGA-23-1118-D25709",NA,NA,NA,NA,NA,2616,"TUMOR FREE","Alive",NA,"TCGA-23-1118-F25708","TCGA-23-1118",NA,"23","1118","YES","C56.9","8441/3","C56.9",NA,NA,-16471,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2616,NA,NA,NA,"TUMOR FREE","NO",20,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,45,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
288099798,271027887,19967186595,"EA1EF4D1-C86B-4EB3-B73D-41268B0A66A5.bw","7016714b-6af8-45dd-8341-1493927e5515","ea1ef4d1-c86b-4eb3-b73d-41268b0a66a5","2016-09-29T23:47:49.563782-05:00","TCGA-10-0936-01A-01R-1564-13_rnaseq_fastq.tar","5dea6d25-6795-4b3d-a34e-44c8bcfe42eb",18086543360,"Illumina HiSeq","d8fce792e781778adde191ed95167331","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:52:53.635242-05:00","2016-05-03T11:41:05.776497-05:00","5dea6d25-6795-4b3d-a34e-44c8bcfe42eb_analysis.xml","123ed440badf29d32b4ab20584bdf162","0d837d08-3bc2-4ed5-a01d-9fffe2d99d55",2183,"2016-09-29T22:23:08.297581-05:00","5dea6d25-6795-4b3d-a34e-44c8bcfe42eb_experiment.xml","82c7cab25069484ac9d7e326de6dcc14","b568bf74-c9aa-479f-9b80-f8a321c85550",3916,"2016-09-29T18:14:46.675075-05:00","5dea6d25-6795-4b3d-a34e-44c8bcfe42eb_run.xml","2f43c3280c33b69e4db0819feca48b98","1b29f39c-6a6e-48d0-8487-3f569d35008e",1990,"2016-09-08T12:45:13.340714-05:00","TCGA-10-0936","2016-09-02T19:06:18.154489-05:00","female","TCGA-10-0936_demographic",1936,"black or african american","014b5a3f-ce4b-5e1b-bb9f-caa0d307e19f","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0936_diagnosis","not reported",25454,"dead","8441/3",1123,1089,"68108d81-543a-5c73-a998-dd9bd6fdcd9e","c56.9",-25454,"TCGA-10-0936_treatment","7402965a-bc8e-5082-b49c-5c5fa25f5a84","01",NA,"TCGA-10-0936-01A","0.6","88c24748-3aee-4a05-8730-9a802f1876d2",FALSE,"6b9a13e4-760e-476f-a0a7-fb42ab7c63c5","Primary Tumor","0.5",NA,NA,"1",1233705600,"01",159,"TCGA-10-0936-01A-01",90,90,NA,NA,5,5,5,5,"2016-09-08T12:45:13.340714-05:00","2016-09-08T12:45:13.340714-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"3ede0f32-9bf9-46be-aabd-4793365bf020","e5976a6c-f284-43bd-9597-6f9d3b5439dc","TCGA-10-0936-01A-01-BS1","TCGA-10-0936-01A-01-TS1",90,90,"b891699a-f445-4c67-b7c7-f9a5e88285df","RNA","TCGA-10-0936-01A-01R","805911c8-210d-436a-81ed-e8f8ffacc048",1.7,0.14,"UV Spec","R","22","TCGA-10-0936-01A-01R-1564-13","04112b9c-6ef4-49cd-bed8-43151b5bbe1f",0.14,NA,NA,NA,NA,"77fda196-b774-5602-b4f8-648e52d4de46","TCGA-10-0936_exposure","TCGA-10-0936-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T21:05:15.000Z","2014-04-04T07:10:01.000Z","5DEA6D25-6795-4B3D-A34E-44C8BCFE42EB","88C24748-3AEE-4A05-8730-9A802F1876D2","Unaligned reads",18086543360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","04112B9C-6EF4-49CD-BED8-43151B5BBE1F","Canada's Michael Smith Genome Sciences Centre","564a5b94e4b0ef12181e33c1","7016714B-6AF8-45DD-8341-1493927E5515","Ovarian Serous Cystadenocarcinoma","TAR","B891699A-F445-4C67-B7C7-F9A5E88285DF","2014-04-04T07:10:02.000Z","805911C8-210D-436A-81ED-E8F8FFACC048","None","NO",1,0.5,"Primary Tumor","MD Anderson Cancer Center",NA,"B891699A-F445-4C67-B7C7-F9A5E88285DF",0.6,"10","TCGA-10-0936-01A-01R-1564-13_rnaseq_fastq.tar",NA,"TCGA-10-0936-01A",1,"F6BCA061-1141-4801-8241-CD2004E60D5D","TCGA",2005,NA,NA,"WITH TUMOR","88C24748-3AEE-4A05-8730-9A802F1876D2",69,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5e8ac787-50cc-45ea-9fc4-efe67b6d05ff.txt","Dead",1123,"TCGA-10-0936","NOT HISPANIC OR LATINO","8A1857BA-C686-4630-B137-6C45BA21274C",NA,1089,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,159,"E5976A6C-F284-43BD-9597-6F9D3B5439DC","E8A46637-4385-405B-9549-21E5DB52B392","MSK_252152912791_S01_CGH-v4_10_27Aug08.txt","TCGA-10-0936-01A-01",90,5,NA,NA,5,"TOP",0,NA,"TCGA-10-0936-01A-01-TS1",90,"Doxil","Chemotherapy","TCGA-10-0936-D24471",NA,NA,NA,NA,NA,1089,"WITH TUMOR","Dead",1123,"TCGA-10-0936-F24466","TCGA-10-0936",NA,"10","0936","YES","C56.9","8441/3","C56.9",NA,NA,-25454,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Dead",1089,1123,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,69,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
182344982,178213870,13194593349,"644A11B1-B048-4CC2-B9BA-BECE2E25BA7A.bw","708eec28-2348-4e15-b98c-8c6f9d057b1e","644a11b1-b048-4cc2-b9ba-bece2e25ba7a","2016-08-25T10:41:04.346365-05:00","TCGA-59-2355-01A-01R-1569-13_rnaseq_fastq.tar","fed55439-110e-43fe-bc72-d06bb3527596",11504824320,"Illumina HiSeq","5b3aeb9323a8fd5cfd4117a4827608a7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:30:46.346301-05:00","2016-05-03T11:55:09.260045-05:00","fed55439-110e-43fe-bc72-d06bb3527596_analysis.xml","0c7efe5bd502c24b48643051d81e8e16","251de850-f7fa-4b7d-bd3f-862724b6b56b",2181,"2016-09-29T23:25:28.096579-05:00","fed55439-110e-43fe-bc72-d06bb3527596_experiment.xml","38a256b849fa352fca213ae67605f1b9","dc201d89-a83b-4a3b-88a7-1994332ab1cf",3916,"2016-09-29T22:24:57.618301-05:00","fed55439-110e-43fe-bc72-d06bb3527596_run.xml","dabb922ac09eed8299091353196e7b58","b690d313-f838-44be-a63b-303caffacc33",1988,"2016-09-08T13:32:38.474026-05:00","TCGA-59-2355","2016-09-02T19:11:41.168357-05:00","female","TCGA-59-2355_demographic",1948,"white","ea0a2db7-aa6f-51d6-b99f-2e20666781ef","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2355_diagnosis","not reported",NA,"dead","8441/3",65,NA,"399bd74f-6959-50b6-9977-29d7ab3b4588","c56.9",NA,"TCGA-59-2355_treatment","c74b03d1-9ee4-5d0f-a5d0-39b066358ffd","01",NA,"TCGA-59-2355-01A","0.4","fc1a6b07-e91e-47c5-bf00-80be3c167605",FALSE,"322bedf6-e6b5-4275-a186-0075a2ec271e","Primary Tumor","0.2",NA,NA,"0.6",1251763200,"01",125,"TCGA-59-2355-01A-01",85,80,NA,NA,0,0,15,20,"2016-09-08T13:32:38.474026-05:00","2016-09-08T13:32:38.474026-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,20,"07a67953-f1fe-4440-9bc3-a51e2a4a8ab7","d33e6280-0dad-46b2-bb0f-397d05a2f7da","TCGA-59-2355-01A-01-TS1","TCGA-59-2355-01A-01-BS1",85,60,"9b78ac7c-f6ad-4841-acc7-8c03b73e532b","RNA","TCGA-59-2355-01A-01R","03b3f308-19f6-4113-b44b-18c18b63b7d1",1.8,0.14,"UV Spec","R","22","TCGA-59-2355-01A-01R-1569-13","866c7355-e2ec-4816-953f-7bf791033283",0.14,NA,NA,NA,NA,"fe87a81d-611f-5261-974b-4bb9c63b427e","TCGA-59-2355_exposure","TCGA-59-2355-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T04:58:42.000Z","2014-08-08T05:30:29.000Z","FED55439-110E-43FE-BC72-D06BB3527596","FC1A6B07-E91E-47C5-BF00-80BE3C167605","Unaligned reads",11504824320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","866C7355-E2EC-4816-953F-7BF791033283","Canada's Michael Smith Genome Sciences Centre","564a3620e4b08c5d868fd326","708EEC28-2348-4E15-B98C-8C6F9D057B1E","Ovarian Serous Cystadenocarcinoma","TAR","9B78AC7C-F6AD-4841-ACC7-8C03B73E532B","2014-08-08T05:30:29.000Z","03B3F308-19F6-4113-B44B-18C18B63B7D1","None","NO",1,0.2,"Primary Tumor","Roswell Park",NA,"9B78AC7C-F6AD-4841-ACC7-8C03B73E532B",0.4,"59","TCGA-59-2355-01A-01T-0712-07.probe.tcga_level2.data.txt",NA,"TCGA-59-2355-01A",0.6,"A484B2DA-A6D7-403B-B76E-17312504BDBC","TCGA",2006,NA,NA,"WITH TUMOR","FC1A6B07-E91E-47C5-BF00-80BE3C167605",58,"nationwidechildrens.org_clinical.TCGA-59-2355.xml","Dead",65,"TCGA-59-2355","NOT HISPANIC OR LATINO","395E39DD-FE65-4C7C-AE0D-6065C0217D5F",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,125,"D33E6280-0DAD-46B2-BB0F-397D05A2F7DA","B605D093-6851-4BE0-BED9-6198C394FB81","C239.TCGA-59-2355-01A-01W-0799-08.2.bam.bai","TCGA-59-2355-01A-01",85,0,NA,NA,15,"TOP",0,NA,"TCGA-59-2355-01A-01-TS1",85,"Taxol","Chemotherapy","TCGA-59-2355-D28113",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",65,"TCGA-59-2355-F28111","TCGA-59-2355",NA,"59","2355","YES","C56.9","8441/3","C56.9",NA,NA,NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,65,NA,NA,"WITH TUMOR","NO",29,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,58,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110822064,103385982,7655592763,"2B317F61-8B44-4E81-80DB-ABE7F978E4CE.bw","70fe08bd-a0b4-4a88-b82e-813b176f8e40","2b317f61-8b44-4e81-80db-abe7f978e4ce","2016-08-25T10:26:33.559428-05:00","TCGA-23-1116-01A-01R-1564-13_rnaseq_fastq.tar","22398d8c-4b8c-4865-97d8-c2a528fb60ec",7520849920,"Illumina HiSeq","f105ccd03561225a835b8b59945c093d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:13:59.832499-05:00","2016-05-03T11:39:34.522989-05:00","22398d8c-4b8c-4865-97d8-c2a528fb60ec_analysis.xml","d007c7456544e06e313f0ee42d897706","fa3348cf-e990-4f3f-a37c-0bda90cfa8ce",2208,"2016-09-29T20:10:43.247668-05:00","22398d8c-4b8c-4865-97d8-c2a528fb60ec_experiment.xml","3fbed2650c809a0f0cae024f26514b19","6397dde8-242f-4d63-b259-1ec8770ba3ab",3916,"2016-09-29T18:11:24.107438-05:00","22398d8c-4b8c-4865-97d8-c2a528fb60ec_run.xml","c4a85afb882146ac6407aa326163657c","191e808e-593e-4e38-8311-7a940fb0106e",1988,"2016-09-08T13:10:28.213429-05:00","TCGA-23-1116","2016-09-02T19:05:57.371237-05:00","female","TCGA-23-1116_demographic",1925,"white","4b9f2013-cf47-571e-8a15-8f1207cd8a5a","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1116_diagnosis","not reported",30464,"dead","8441/3",592,139,"d0a829b8-ce2d-5f29-8ac9-e83d900af073","c56.9",-30464,"TCGA-23-1116_treatment","2841e495-9897-5d46-ae74-44b8a692f808","01",NA,"TCGA-23-1116-01A","0.8","91fbc26e-c049-49af-8307-22c7980079df",FALSE,"d39c8f94-c4f0-4166-864b-912d7535f2b6","Primary Tumor","0.6",NA,NA,"1",1227571200,"01",106,"TCGA-23-1116-01A-01",80,90,NA,NA,0,0,NA,NA,"2016-09-08T13:10:28.213429-05:00","2016-09-08T13:10:28.213429-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"e0a68198-f101-4469-9dbf-f9b0c9c8ca63","a02dca17-bfe8-419b-b790-944bff16fcf2","TCGA-23-1116-01A-01-TS1","TCGA-23-1116-01A-01-BS1",NA,NA,"ecd1760f-ab95-4a1d-922c-e6801da984db","RNA","TCGA-23-1116-01A-01R","65b49803-c9eb-49f0-a2d4-dd8941f2542e",1.8,0.16,"UV Spec","R","22","TCGA-23-1116-01A-01R-1564-13","ab28a926-0266-4602-8e90-529934cf43ab",0.16,NA,NA,NA,NA,"6969a1ad-9414-5040-9585-d51d51e0fa6b","TCGA-23-1116_exposure","TCGA-23-1116-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-19T23:40:07.000Z","2014-03-19T23:55:01.000Z","22398D8C-4B8C-4865-97D8-C2A528FB60EC","91FBC26E-C049-49AF-8307-22C7980079DF","Unaligned reads",7520849920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AB28A926-0266-4602-8E90-529934CF43AB","Canada's Michael Smith Genome Sciences Centre","564a5baee4b093830b6d09ea","70FE08BD-A0B4-4A88-B82E-813B176F8E40","Ovarian Serous Cystadenocarcinoma","TAR","ECD1760F-AB95-4A1D-922C-E6801DA984DB","2014-03-19T23:55:01.000Z","65B49803-C9EB-49F0-A2D4-DD8941F2542E","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"ECD1760F-AB95-4A1D-922C-E6801DA984DB",0.8,"23","TCGA-23-1116-01A-01R-1564-13_GRCh37-lite_rnaseq.bam",NA,"TCGA-23-1116-01A",1,"FDCBD10E-6A29-44AF-A6D3-0AE779462F28","TCGA",2008,NA,NA,NA,"E8BAEFC6-192A-4C7A-B2E7-9BB422E9FD93",83,"nationwidechildrens.org_clinical.TCGA-23-1116.xml","Alive",NA,"TCGA-23-1116","NOT HISPANIC OR LATINO","E5378114-5A3C-43F3-9DE2-0E3A86B3C462",NA,139,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,106,"A02DCA17-BFE8-419B-B790-944BFF16FCF2","AE2D9B2A-8755-40E6-A543-61E4F69E94A6","TCGA-23-1116-01A-01R-1564-13_GRCh37-lite_rnaseq.bam","TCGA-23-1116-01A-01",90,0,NA,NA,NA,"BOTTOM",5,NA,"TCGA-23-1116-01A-01-BS1",NA,"Carboplatin","Chemotherapy","TCGA-23-1116-D25750",NA,NA,NA,"TCGA-23-1116-F72416_NTE-2","YES",NA,"WITH TUMOR","Dead",592,"TCGA-23-1116-F72416","TCGA-23-1116",NA,"23","1116","YES","C56.9","8441/3","C56.9",NA,NA,-30464,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",139,NA,NA,NA,NA,"NO",20,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,83,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
187217576,182808820,13548902819,"76D67B0F-0273-43CB-A7CD-2A065EBD2EC5.bw","71faa2c1-0d5b-4dcc-bdf9-f2405f29907c","76d67b0f-0273-43cb-a7cd-2a065ebd2ec5","2016-08-25T18:08:33.379919-05:00","TCGA-61-2113-01A-01R-1568-13_rnaseq_fastq.tar","dd3db917-33dd-4775-9fd5-a4ea0abedfa2",12058091520,"Illumina HiSeq","57e81bb30d21df7109bc1c33c9f648cb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:18:48.098783-05:00","2016-05-03T11:41:05.748550-05:00","dd3db917-33dd-4775-9fd5-a4ea0abedfa2_analysis.xml","9984629ea6671539ab12e0d303d9e112","d7e13421-73c5-4c6b-b5b8-61de76c0cf10",2181,"2016-09-29T18:10:34.076819-05:00","dd3db917-33dd-4775-9fd5-a4ea0abedfa2_experiment.xml","0984ca6d06b419171bbd00dc46d2f616","1898686d-af1b-499a-8e77-3d1f56cdc49b",3916,"2016-09-29T20:51:50.502474-05:00","dd3db917-33dd-4775-9fd5-a4ea0abedfa2_run.xml","3fd1567c720407ff3dd9d830c1fe7c66","7ce16389-f050-4f99-ae9b-a1a365518f53",1989,"2016-09-08T11:19:41.968220-05:00","TCGA-61-2113","2016-09-02T18:56:20.799980-05:00","female","TCGA-61-2113_demographic",1946,"white","74216962-1bf9-5e6b-8285-3865c6655eac","not hispanic or latino",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2113_diagnosis","not reported",19722,"dead","8441/3",676,676,"6b483d36-30fc-5513-8cba-f768ad1d62e3","c56.9",-19722,"TCGA-61-2113_treatment","f215980e-01ac-56cb-906b-bf98d6d20a30","01",NA,"TCGA-61-2113-01A","0.8","9ba8451e-7ffc-43f2-b602-8ce8764dfc14",FALSE,"d10e1b61-73c4-4ab7-bc4b-8c7827856602","Primary Tumor","0.4",NA,NA,"1.6",1250467200,"01",127,"TCGA-61-2113-01A-01",70,70,NA,NA,0,0,30,30,"2016-09-08T11:19:41.968220-05:00","2016-09-08T11:19:41.968220-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"25ef0623-cbe2-44b4-a956-5934342adc0d","91aa5d6b-d95f-4465-b1a5-d7697dab7d29","TCGA-61-2113-01A-01-BS1","TCGA-61-2113-01A-01-TS1",70,70,"a4c1bf5e-5fe6-49fb-acf4-f8e0c80ea5c6","RNA","TCGA-61-2113-01A-01R","ac4fd38d-5875-4341-a8e1-ad8ea9148631",1.8,0.14,"UV Spec","R","22","TCGA-61-2113-01A-01R-1568-13","d5752594-1a2c-47c8-a40b-bffd5b6b7e71",0.14,NA,NA,NA,NA,"3b3e3fc4-5510-5e5e-b655-8397e71ae569","TCGA-61-2113_exposure","TCGA-61-2113-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-29T06:51:00.000Z","2014-03-29T07:13:01.000Z","DD3DB917-33DD-4775-9FD5-A4EA0ABEDFA2","9BA8451E-7FFC-43F2-B602-8CE8764DFC14","Unaligned reads",12058091520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D5752594-1A2C-47C8-A40B-BFFD5B6B7E71","Canada's Michael Smith Genome Sciences Centre","564a3824e4b0298dd2c75d31","71FAA2C1-0D5B-4DCC-BDF9-F2405F29907C","Ovarian Serous Cystadenocarcinoma","TAR","A4C1BF5E-5FE6-49FB-ACF4-F8E0C80EA5C6","2014-03-29T07:13:01.000Z","AC4FD38D-5875-4341-A8E1-AD8EA9148631","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"A4C1BF5E-5FE6-49FB-ACF4-F8E0C80EA5C6",0.8,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a8827db2-9eab-4285-bf50-ab2b9e19be57.txt",NA,"TCGA-61-2113-01A",1.6,"D4D534C2-01BE-4EFF-BFB2-369EE917DCF2","TCGA",1999,NA,NA,NA,"9BA8451E-7FFC-43F2-B602-8CE8764DFC14",53,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a8827db2-9eab-4285-bf50-ab2b9e19be57.txt","Dead",676,"TCGA-61-2113","NOT HISPANIC OR LATINO","58E8E9BC-2BF0-47E6-A806-3A51341022FB",NA,676,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,127,"91AA5D6B-D95F-4465-B1A5-D7697DAB7D29","AC4FD38D-5875-4341-A8E1-AD8EA9148631","bcgsc.ca.TCGA-61-2113-01A-01R-1568-13.hg19.bcgsc.ca.1.6.0.snv.vcf","TCGA-61-2113-01A-01",70,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-61-2113-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-61-2113-D28481",NA,NA,NA,"TCGA-61-2113-F28479_NTE-1",NA,676,NA,"Dead",676,"TCGA-61-2113-F28479","TCGA-61-2113",NA,"61","2113","YES","C56.9","8441/3","C56.9",NA,NA,-19722,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",676,676,NA,NA,NA,"NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,53,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
211017684,204056828,15086797191,"82F1D468-086C-4BFD-9801-0EAF489B8617.bw","7248cd60-be22-44bc-bc58-f644db0940a2","82f1d468-086c-4bfd-9801-0eaf489b8617","2016-08-25T22:52:28.774198-05:00","TCGA-13-1489-02A-01R-1565-13_rnaseq_fastq.tar","ab145467-80a2-4b5f-b71d-1cb8b4c3d6f1",12904867840,"Illumina HiSeq","2db06963e96d82b77ce657e63a91cde4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:04:52.266684-05:00","2016-05-03T11:40:21.662944-05:00","ab145467-80a2-4b5f-b71d-1cb8b4c3d6f1_analysis.xml","4c0e1ea4770439800da72ed49b89eadb","cf4f8660-ddc0-4ddb-b048-f944cb0d09d5",2181,"2016-09-29T23:40:15.962888-05:00","ab145467-80a2-4b5f-b71d-1cb8b4c3d6f1_experiment.xml","8b4d44002ba64e6bfdc1d9df98bfb366","e563eb0b-8616-486e-a10f-76340dbe4ad5",3916,"2016-09-29T18:03:30.434327-05:00","ab145467-80a2-4b5f-b71d-1cb8b4c3d6f1_run.xml","11f95d65a57dd5b2c7841e44919f5e6b","1439ec82-5b58-4670-bb9c-b0fa323436cc",1989,"2016-09-08T10:30:05.261666-05:00","TCGA-13-1489","2016-09-02T19:13:37.593924-05:00","female","TCGA-13-1489_demographic",1932,"white","39bca6ab-f7fe-59fd-b376-b16f300c341d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1489_diagnosis","not reported",25768,"dead","8441/3",2553,2521,"f903544f-b690-54a3-b3e5-faa412f474d7","c56.9",-25768,"TCGA-13-1489_treatment","ad9e7582-766f-591a-8ef5-78df3f6d07be","02",NA,"TCGA-13-1489-02A","0.8","cba94907-4590-492b-88db-613d97208ccf",FALSE,"639712E8-5C63-433C-8F23-4C78FF37D8FC","Recurrent Tumor","0.4",NA,NA,"1",1244160000,"01",134,"TCGA-13-1489-02A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T10:30:05.261666-05:00","2016-09-08T10:30:05.261666-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"a3a8a1e6-ffaa-4156-b54f-0fadcd0371aa","acc6b322-9319-4b2b-b0e5-4d54d649a56d","TCGA-13-1489-02A-01-BS1","TCGA-13-1489-02A-01-TS1",90,90,"653bd22c-b4a4-4dcf-92cb-9386592db3b6","RNA","TCGA-13-1489-02A-01R","58ffa935-a8c9-43b2-85bf-5b2227dea9b8",1.8,0.15,"UV Spec","R","22","TCGA-13-1489-02A-01R-1565-13","d8cd1ca1-dc00-4a48-ab81-5d23daed6fce",0.15,NA,NA,NA,NA,"888ccf70-daf2-573f-986b-b9a6a79b4635","TCGA-13-1489_exposure","TCGA-13-1489-02A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:51:13.000Z","2014-03-22T08:15:02.000Z","AB145467-80A2-4B5F-B71D-1CB8B4C3D6F1","CBA94907-4590-492B-88DB-613D97208CCF","Unaligned reads",12904867840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D8CD1CA1-DC00-4A48-AB81-5D23DAED6FCE","Canada's Michael Smith Genome Sciences Centre","564a32e4e4b08c5d868ecdda","7248CD60-BE22-44BC-BC58-F644DB0940A2","Ovarian Serous Cystadenocarcinoma","TAR","653BD22C-B4A4-4DCF-92CB-9386592DB3B6","2014-03-22T08:15:02.000Z","58FFA935-A8C9-43B2-85BF-5B2227DEA9B8","None","NO",2,0.4,"Recurrent Tumor","Memorial Sloan Kettering",NA,"653BD22C-B4A4-4DCF-92CB-9386592DB3B6",0.8,"13","TCGA-13-1489-02A-01W-0927-10_SOLiD.bam.bai",NA,"TCGA-13-1489-02A",1,"FC5425F7-3273-4BB3-838A-03543F181941","TCGA",2002,NA,NA,"WITH TUMOR","CBA94907-4590-492B-88DB-613D97208CCF",70,"PAGED_p_TCGA_182_OvGBM_SNP_N_GenomeWideSNP_6_F02_896190.hg18.seg.txt","Alive",NA,"TCGA-13-1489","NOT HISPANIC OR LATINO","9B9579E6-5CD9-4F4F-B084-67D406CAD426",NA,2521,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,134,"ACC6B322-9319-4B2B-B0E5-4D54D649A56D","EEE7D616-11D6-4FCB-8DC4-BDBD9EAFD1D4","TCGA-13-1489-02A-01W-0927-10_SOLiD.bam.bai","TCGA-13-1489-02A-01",95,0,NA,NA,5,"BOTTOM",5,NA,"TCGA-13-1489-02A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-13-1489-D24879",NA,NA,NA,"TCGA-13-1489-F24875_NTE-2",NA,2521,"WITH TUMOR","Alive",NA,"TCGA-13-1489-F24875","TCGA-13-1489",NA,"13","1489","YES","C56.9","8441/3","C56.9",NA,NA,-25768,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2521,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,70,2002,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
211664304,205499405,15238246749,"BADA8C36-D5D2-48E0-B647-FA429D0F448D.bw","7248cd60-be22-44bc-bc58-f644db0940a2","bada8c36-d5d2-48e0-b647-fa429d0f448d","2016-08-22T08:21:35.392659-05:00","TCGA-13-1489-01A-01R-1565-13_rnaseq_fastq.tar","4272c000-485e-4f16-abff-203c4cf1988e",12825497600,"Illumina HiSeq","4b4a43a8e48f49b316de3e4ae782b1de","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:36:15.949795-05:00","2016-05-03T11:40:21.669427-05:00","4272c000-485e-4f16-abff-203c4cf1988e_analysis.xml","9514ac3690bb127b1f6e08f20161ad00","4e66239c-3c95-4b39-aaf5-cb3df59f759e",2208,"2016-09-29T23:25:10.226386-05:00","4272c000-485e-4f16-abff-203c4cf1988e_experiment.xml","e60a50a73653c2df733390afcd16784e","dbee6740-6c6c-4ba3-a02c-feec68e63567",3916,"2016-09-29T18:45:18.668559-05:00","4272c000-485e-4f16-abff-203c4cf1988e_run.xml","a7cf31ba4ef6549901046a9dca167880","2e6700cc-7aa8-47a6-8863-5fa912da7237",1989,"2016-09-08T10:30:05.261666-05:00","TCGA-13-1489","2016-09-02T19:13:37.593924-05:00","female","TCGA-13-1489_demographic",1932,"white","39bca6ab-f7fe-59fd-b376-b16f300c341d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1489_diagnosis","not reported",25768,"dead","8441/3",2553,2521,"f903544f-b690-54a3-b3e5-faa412f474d7","c56.9",-25768,"TCGA-13-1489_treatment","ad9e7582-766f-591a-8ef5-78df3f6d07be","01",NA,"TCGA-13-1489-01A","1","4b2b6e5e-248c-46f6-938a-95571577e02d",FALSE,"C65BE57D-0015-49BB-A4BE-81D7B302F464","Primary Tumor","0.4",NA,NA,"1.7",1234396800,"01",170,"TCGA-13-1489-01A-01",98,95,NA,NA,5,5,0,0,"2016-09-08T10:30:05.261666-05:00","2016-09-08T10:30:05.261666-05:00",50,NA,50,NA,"TOP","BOTTOM",2,10,"afac158d-0de2-4e56-a1e8-1970763d8563","89a1069f-7323-4169-9dbd-3dd204338851","TCGA-13-1489-01A-01-TS1","TCGA-13-1489-01A-01-BS1",95,85,"a9c02458-5ed0-422e-ad6e-bb875d94c09b","RNA","TCGA-13-1489-01A-01R","e735fa2a-87a9-496e-8292-c62bf0700e66",1.8,0.15,"UV Spec","R","22","TCGA-13-1489-01A-01R-1565-13","dcb03592-9f67-49bf-bc78-d89d69de14a8",0.15,NA,NA,NA,NA,"888ccf70-daf2-573f-986b-b9a6a79b4635","TCGA-13-1489_exposure","TCGA-13-1489-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T04:48:08.000Z","2014-03-22T05:16:02.000Z","4272C000-485E-4F16-ABFF-203C4CF1988E","4B2B6E5E-248C-46F6-938A-95571577E02D","Unaligned reads",12825497600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DCB03592-9F67-49BF-BC78-D89D69DE14A8","Canada's Michael Smith Genome Sciences Centre","564a32eae4b0ef121817b833","7248CD60-BE22-44BC-BC58-F644DB0940A2","Ovarian Serous Cystadenocarcinoma","TAR","A9C02458-5ED0-422E-AD6E-BB875D94C09B","2014-03-22T05:16:02.000Z","E735FA2A-87A9-496E-8292-C62BF0700E66","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"A9C02458-5ED0-422E-AD6E-BB875D94C09B",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f99befac-a46e-43a1-91b7-e4a492dae82f.txt",NA,"TCGA-13-1489-01A",1.7,"FC5425F7-3273-4BB3-838A-03543F181941","TCGA",2002,NA,NA,"WITH TUMOR","CBA94907-4590-492B-88DB-613D97208CCF",70,"PAGED_p_TCGA_182_OvGBM_SNP_N_GenomeWideSNP_6_F02_896190.hg18.seg.txt","Alive",NA,"TCGA-13-1489","NOT HISPANIC OR LATINO","9B9579E6-5CD9-4F4F-B084-67D406CAD426",NA,2521,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,170,"89A1069F-7323-4169-9DBD-3DD204338851","E735FA2A-87A9-496E-8292-C62BF0700E66","TCGA-13-1489-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-13-1489-01A-01",95,5,NA,NA,0,"BOTTOM",10,NA,"TCGA-13-1489-01A-01-BS1",85,"Carboplatin","Chemotherapy","TCGA-13-1489-D24879",NA,NA,NA,"TCGA-13-1489-F24875_NTE-2",NA,2521,"WITH TUMOR","Alive",NA,"TCGA-13-1489-F24875","TCGA-13-1489",NA,"13","1489","YES","C56.9","8441/3","C56.9",NA,NA,-25768,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2521,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,70,2002,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
155494220,144873315,10635678445,"176D6B13-144E-4946-9C8C-8AFD29FD5BE4.bw","72c40fba-f502-489b-ad87-843f52655894","176d6b13-144e-4946-9c8c-8afd29fd5be4","2016-09-29T18:08:34.675734-05:00","TCGA-61-1738-01A-01R-1567-13_rnaseq_fastq.tar","965f4569-6cfa-4772-b826-59f0167cc228",9295656960,"Illumina HiSeq","bcbc3de24151956d1036c63781c58f0c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:09:53.148783-05:00","2016-05-03T11:41:05.755204-05:00","965f4569-6cfa-4772-b826-59f0167cc228_analysis.xml","d08535b01439fbd007038f80c3577f7d","ad600bea-f78f-4006-b5a0-8b2e7d07892b",2183,"2016-08-13T09:34:31.544326-05:00","965f4569-6cfa-4772-b826-59f0167cc228_experiment.xml","3510aaf547ee57d4837fc086bcebacdf","16af351b-085b-49c5-b521-6d5e566a8d03",3916,"2016-09-29T21:33:45.352453-05:00","965f4569-6cfa-4772-b826-59f0167cc228_run.xml","fa91882d51e91c2e9ccc52196a0c14ed","970222f6-c9fb-4ac9-8a28-4364ce2f001c",1990,"2016-09-08T13:25:13.636725-05:00","TCGA-61-1738","2016-09-02T19:06:51.184497-05:00","female","TCGA-61-1738_demographic",1945,"black or african american","b3cb6309-cf5e-5396-ad1d-840561b1e2ed","not reported",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1738_diagnosis","not reported",21965,"dead","8441/3",1089,1089,"5ab9e1b0-8ef3-58e0-9d0d-da2727fd5dc1","c56.9",-21965,"TCGA-61-1738_treatment","1eaf6e5c-6627-55fb-8f09-f6de63ab34d8","01",NA,"TCGA-61-1738-01A","1.2","ce503b11-3be6-4c58-85b6-d987033232e0",FALSE,"05898c76-9832-4724-ada5-ff47eb3838b5","Primary Tumor","0.2",NA,NA,"1.2",1242518400,"01",154,"TCGA-61-1738-01A-01",95,90,NA,2,0,0,0,0,"2016-09-08T13:25:13.636725-05:00","2016-09-08T13:25:13.636725-05:00",NA,3,NA,NA,"TOP","BOTTOM",2,5,"cbef3d98-4444-4703-b76e-0474439cb502","941a44db-9fde-4bcb-9a7e-88c3a8afa74c","TCGA-61-1738-01A-01-TS1","TCGA-61-1738-01A-01-BS1",98,95,"70e2f786-7418-4fb2-9ac4-ff6c310637cc","RNA","TCGA-61-1738-01A-01R","a77abfa5-9177-4ec4-aee1-4e55566ac926",1.8,0.15,"UV Spec","R","22","TCGA-61-1738-01A-01R-1567-13","1ca9af90-a8db-4f7e-b17a-0bf32fed98c7",0.15,NA,NA,NA,NA,"965a1b04-8fe6-50dc-bc27-796406a917f4","TCGA-61-1738_exposure","TCGA-61-1738-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T07:12:42.000Z","2014-03-27T07:34:01.000Z","965F4569-6CFA-4772-B826-59F0167CC228","CE503B11-3BE6-4C58-85B6-D987033232E0","Unaligned reads",9295656960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1CA9AF90-A8DB-4F7E-B17A-0BF32FED98C7","Canada's Michael Smith Genome Sciences Centre","564a59b2e4b0298dd2cb989f","72C40FBA-F502-489B-AD87-843F52655894","Ovarian Serous Cystadenocarcinoma","TAR","70E2F786-7418-4FB2-9AC4-FF6C310637CC","2014-03-27T07:34:02.000Z","A77ABFA5-9177-4EC4-AEE1-4E55566AC926","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"70E2F786-7418-4FB2-9AC4-FF6C310637CC",1.2,"61","TCGA-61-1738-01A-01R-1567-13_GRCh37-lite_rnaseq.bam.bai",NA,"TCGA-61-1738-01A",1.2,"B26E2E7F-9A62-4F34-90D4-D3463BAAAB74","TCGA",2005,NA,NA,"WITH TUMOR","CE503B11-3BE6-4C58-85B6-D987033232E0",60,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3fed489e-8243-43c5-8ca2-37979d540d22.txt","Dead",1089,"TCGA-61-1738",NA,"8A114A36-F83C-41C5-9E9B-3F3E303592CA",NA,1089,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,154,"CBEF3D98-4444-4703-B76E-0474439CB502","C5F259C5-4528-42D0-857C-3FC0DAFC5A93","LENOS_p_TCGA_Batch18and19_HT_HG-U133A_96-HTA_E03_491230.level2.data.txt","TCGA-61-1738-01A-01",90,0,2,3,0,"BOTTOM",5,NA,"TCGA-61-1738-01A-01-BS1",95,"Carboplatin","Chemotherapy","TCGA-61-1738-D28192",NA,NA,NA,"TCGA-61-1738-F28190_NTE-2",NA,1089,"WITH TUMOR","Dead",1089,"TCGA-61-1738-F28190","TCGA-61-1738",NA,"61","1738","YES","C56.9","8441/3","C56.9",NA,NA,-21965,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",1089,1089,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,60,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
214886346,209691542,15515496447,"563EC711-9FD5-46FD-974B-CE078C996A9E.bw","7413c891-f74e-456f-bc70-69c83fb53c70","563ec711-9fd5-46fd-974b-ce078c996a9e","2016-08-25T05:05:13.590863-05:00","TCGA-25-2392-01A-01R-1569-13_rnaseq_fastq.tar","2e63554b-8e72-46e6-b093-7a69164e2b46",13526251520,"Illumina HiSeq","fd56017b58bcec511f72094b0584e540","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:57:00.564583-05:00","2016-05-03T11:55:09.260045-05:00","2e63554b-8e72-46e6-b093-7a69164e2b46_analysis.xml","0dbf03f27211d1d8bb1d37e06506897b","a57d9ef1-e15e-4c01-b721-51f86bec2671",2181,"2016-09-29T20:53:07.323917-05:00","2e63554b-8e72-46e6-b093-7a69164e2b46_experiment.xml","40687b774f146d742a1971fa923c4bb0","7db0af40-d4f8-459b-b1d3-4fab385d9dbc",3916,"2016-09-29T20:23:44.699183-05:00","2e63554b-8e72-46e6-b093-7a69164e2b46_run.xml","c9649055d518828445774756b714b577","6b948203-1ecb-4394-b6f2-8ff8d91ca0c1",1988,"2016-09-08T13:49:30.455740-05:00","TCGA-25-2392","2016-09-02T19:12:03.009692-05:00","female","TCGA-25-2392_demographic",1928,"white","0239e132-69ad-584f-a099-4a1b626fdc4d","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2392_diagnosis","not reported",27667,"dead","8441/3",31,31,"99ca4e5c-3912-5835-8d01-9492e0b5074f","c56.9",-27667,"TCGA-25-2392_treatment","f156e02a-a3e2-5333-8eb7-3ad870a73902","01",NA,"TCGA-25-2392-01A","1","bbfeb712-4736-49c9-9cc6-74a94c6e8195",FALSE,"C520D0D6-F104-492C-A4C2-844390F55570","Primary Tumor","0.3",NA,NA,"1.5",1252022400,"01",175,"TCGA-25-2392-01A-01",95,85,NA,NA,0,0,5,15,"2016-09-08T13:49:30.455740-05:00","2016-09-08T13:49:30.455740-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,0,"e2bc74f8-5f1e-480a-9daa-91508a8c7a80","67d64f48-5192-4066-882d-a373ed1fb8f1","TCGA-25-2392-01A-01-TS1","TCGA-25-2392-01A-01-BS1",94,85,"4edc6e9d-3f94-4326-a5b7-2a041a0a34aa","RNA","TCGA-25-2392-01A-01R","7d97700d-1f24-4f28-adc2-f82361483227",1.8,0.15,"UV Spec","R","22","TCGA-25-2392-01A-01R-1569-13","95b7a71d-8cf5-4660-ac1d-52a888cd2f20",0.15,NA,NA,NA,NA,"7198e7c3-6f5c-577b-ac33-c5d1dbe24418","TCGA-25-2392_exposure","TCGA-25-2392-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T03:37:24.000Z","2014-08-08T05:12:18.000Z","2E63554B-8E72-46E6-B093-7A69164E2B46","BBFEB712-4736-49C9-9CC6-74A94C6E8195","Unaligned reads",13526251520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","95B7A71D-8CF5-4660-AC1D-52A888CD2F20","Canada's Michael Smith Genome Sciences Centre","564a3c54e4b08c5d8691ceb1","7413C891-F74E-456F-BC70-69C83FB53C70","Ovarian Serous Cystadenocarcinoma","TAR","4EDC6E9D-3F94-4326-A5B7-2A041A0A34AA","2014-08-08T05:12:18.000Z","7D97700D-1F24-4F28-ADC2-F82361483227","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"4EDC6E9D-3F94-4326-A5B7-2A041A0A34AA",1,"25","TCGA-25-2392-01A-01R-1569-13_GRCh37-lite_mirna.bam.bai",NA,"TCGA-25-2392-01A",1.5,NA,"TCGA",2003,NA,NA,NA,"BBFEB712-4736-49C9-9CC6-74A94C6E8195",75,"nationwidechildrens.org_clinical.TCGA-25-2392.xml","Dead",31,"TCGA-25-2392","NOT HISPANIC OR LATINO","D9EBEF02-CD9D-4EC0-851A-3192D9744CD5",NA,31,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,175,"E2BC74F8-5F1E-480A-9DAA-91508A8C7A80","ECE7DB7C-E56A-41B0-960F-F5B5A3268BD9","TCGA-25-2392-01A-01R-1569-13_GRCh37-lite_mirna.bam.bai","TCGA-25-2392-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-25-2392-01A-01-TS1",94,NA,NA,NA,NA,NA,NA,NA,NA,31,NA,"Dead",31,"TCGA-25-2392-F26801","TCGA-25-2392",NA,"25","2392","YES","C56.9","8441/3","C56.9",NA,NA,-27667,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",31,31,NA,NA,NA,"NO",5,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,75,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
184020914,175037912,12957846103,"EF64E8CC-3C08-47B5-BB64-F80BE2590266.bw","7472b3ba-9b15-4d97-8708-a2dd82ca0f45","ef64e8cc-3c08-47b5-bb64-f80be2590266","2016-09-29T23:56:16.827260-05:00","TCGA-29-1776-01A-01R-1567-13_rnaseq_fastq.tar","ff44cc1c-9bf6-4731-ac32-6421bbd1148b",11967088640,"Illumina HiSeq","df6bf98f8333933fb6bb3b2dcc1859c4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:22:13.548718-05:00","2016-05-03T11:41:05.740763-05:00","ff44cc1c-9bf6-4731-ac32-6421bbd1148b_analysis.xml","44f5eabf5b75d0619e726317d08037f7","ff619136-3276-4959-bef0-f1392de7321d",2181,"2016-10-07T16:33:58.401685-05:00","ff44cc1c-9bf6-4731-ac32-6421bbd1148b_experiment.xml","3d659d15cbd001a19b15987a0fbc9d78","d6870fad-afda-4987-b6ff-8833d02e7824",3916,"2016-09-29T19:14:45.123065-05:00","ff44cc1c-9bf6-4731-ac32-6421bbd1148b_run.xml","87a14c39163721883f014f6a8bb29330","40f6fe01-bf6e-4380-b2bd-519804849726",1988,"2016-09-08T11:12:23.075442-05:00","TCGA-29-1776","2016-09-02T18:47:46.867297-05:00","female","TCGA-29-1776_demographic",1945,"black or african american","ab7de0f2-baa5-58ec-bd27-60f24523a32a","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1776_diagnosis","not reported",23016,"alive","8441/3",NA,360,"0716ed12-2ffb-546f-a3c1-8a2cefdfaab5","c56.9",-23016,"TCGA-29-1776_treatment","cccdf89e-7a68-5630-b208-ecb71e11900a","01",NA,"TCGA-29-1776-01A","0.7","5b6791a5-2fec-41c8-87fb-9d83a3bed4bc",FALSE,"eb6df66e-c6ee-4c63-889d-9f4b6ca170c7","Primary Tumor","0.4",NA,NA,"0.9",1243296000,"01",134,"TCGA-29-1776-01A-01",90,90,NA,NA,0,0,25,15,"2016-09-08T11:12:23.075442-05:00","2016-09-08T11:12:23.075442-05:00",5,5,NA,NA,"TOP","BOTTOM",0,0,"03055f59-cdd6-4ca9-8418-1736106b21df","0b7528ff-07cf-4940-88be-d12a3191aaef","TCGA-29-1776-01A-01-TS1","TCGA-29-1776-01A-01-BS1",75,85,"147309dc-6b56-46db-afc7-f271de4f8d47","RNA","TCGA-29-1776-01A-01R","3d66b44d-3c68-48c3-88a6-4682f8be095c",1.8,0.15,"UV Spec","R","22","TCGA-29-1776-01A-01R-1567-13","50867fed-2fda-4c45-aa08-042087e7daa9",0.15,NA,NA,NA,NA,"05d982f8-545e-5432-8d63-63aea9c666e8","TCGA-29-1776_exposure","TCGA-29-1776-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T21:17:51.000Z","2014-03-26T21:42:02.000Z","FF44CC1C-9BF6-4731-AC32-6421BBD1148B","5B6791A5-2FEC-41C8-87FB-9D83A3BED4BC","Unaligned reads",11967088640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","50867FED-2FDA-4C45-AA08-042087E7DAA9","Canada's Michael Smith Genome Sciences Centre","564a395ae4b093830b689b76","7472B3BA-9B15-4D97-8708-A2DD82CA0F45","Ovarian Serous Cystadenocarcinoma","TAR","147309DC-6B56-46DB-AFC7-F271DE4F8D47","2014-03-26T21:42:02.000Z","3D66B44D-3C68-48C3-88A6-4682F8BE095C","None","NO",1,0.4,"Primary Tumor","Duke",NA,"147309DC-6B56-46DB-AFC7-F271DE4F8D47",0.7,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3da0c471-ede3-480f-b692-f94939ed8ac3.txt",NA,"TCGA-29-1776-01A",0.9,"DC28ACFE-77B0-4F61-B4D1-2CEFB76D2598","TCGA",2008,NA,NA,"WITH TUMOR","C725AA6B-1B53-4D5A-82B9-13813D6207BD",63,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3da0c471-ede3-480f-b692-f94939ed8ac3.txt","Alive",NA,"TCGA-29-1776",NA,"FD4AB0EB-64C8-4130-B885-6CE0DABFA184",NA,360,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,134,"0B7528FF-07CF-4940-88BE-D12A3191AAEF","90FFF4C8-C6F5-4D06-BE90-69C5E1D2F6DC","TCGA-29-1776-01A-01R-1567-13_mirna.bam","TCGA-29-1776-01A-01",90,0,NA,5,15,"BOTTOM",0,NA,"TCGA-29-1776-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-29-1776-D27411",NA,NA,NA,NA,NA,360,"WITH TUMOR","Alive",NA,"TCGA-29-1776-F27409","TCGA-29-1776",NA,"29","1776","YES","C56.9","8441/3","C56.9",NA,NA,-23016,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Alive",360,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
198996456,194962972,14384781238,"EA1D192D-989F-4E57-96AF-685B5E2273E7.bw","74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7","ea1d192d-989f-4e57-96af-685b5e2273e7","2016-09-29T23:47:48.714092-05:00","TCGA-13-1495-01A-01R-1565-13_rnaseq_fastq.tar","5fd80cae-11ea-475d-b8f4-d7d475abe832",12217671680,"Illumina HiSeq","a5074fb9b92e1af8c0e4d7204b301c0a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:38:51.600653-05:00","2016-05-03T11:40:21.648680-05:00","5fd80cae-11ea-475d-b8f4-d7d475abe832_analysis.xml","1cd4f84fceefdaea5076b0b99361a052","74c924cc-8105-4784-9332-7b7050709cdd",2208,"2016-09-29T21:18:09.728921-05:00","5fd80cae-11ea-475d-b8f4-d7d475abe832_experiment.xml","32ba9fdf6d7d235d74cfbac870b4ae31","8d5fc51a-e32a-4f61-886b-cfa51111bab8",3916,"2016-09-29T19:08:20.909145-05:00","5fd80cae-11ea-475d-b8f4-d7d475abe832_run.xml","17c17c335d7f54f122ffec73913a929a","3ce94fcf-365a-49dc-ae5c-66c1da6e8fc0",1988,"2016-09-08T13:52:49.774795-05:00","TCGA-13-1495","2016-09-02T19:13:57.022942-05:00","female","TCGA-13-1495_demographic",1944,"white","1cb753ba-3ecc-572a-8d29-c4ed3c9a35f4","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1495_diagnosis","not reported",22046,"dead","8441/3",2749,1498,"4f419b0f-ece4-5df0-9ea1-9d12e5078189","c56.9",-22046,"TCGA-13-1495_treatment","cf47d22a-a147-5264-9647-4afc0f4be049","01",NA,"TCGA-13-1495-01A","1.5","98675894-f21c-4dc4-b822-a6e52634d470",FALSE,"51F0A8BF-0E86-402D-BE9F-D41771ED98A3","Primary Tumor","0.4",NA,NA,"2.1",1234483200,"01",128,"TCGA-13-1495-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T13:52:49.774795-05:00","2016-09-08T13:52:49.774795-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"ae354aba-3dfc-4e7c-a02b-bfa4d5562264","beca9d8a-6867-45d1-a81e-03dc4e7989b0","TCGA-13-1495-01A-01-BS1","TCGA-13-1495-01A-01-TS1",79,79,"3a018c7b-3334-4c02-88cc-70e40ec30235","RNA","TCGA-13-1495-01A-01R","ed7bfbb4-4c2f-4c25-b856-63d9fcc60371",1.8,0.16,"UV Spec","R","22","TCGA-13-1495-01A-01R-1565-13","845d11ec-7fc7-4498-a0f4-1187413c5914",0.16,NA,NA,NA,NA,"778322fe-6700-5ffc-a9cc-ed84f0709999","TCGA-13-1495_exposure","TCGA-13-1495-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:08:28.000Z","2014-03-21T22:30:02.000Z","5FD80CAE-11EA-475D-B8F4-D7D475ABE832","98675894-F21C-4DC4-B822-A6E52634D470","Unaligned reads",12217671680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","845D11EC-7FC7-4498-A0F4-1187413C5914","Canada's Michael Smith Genome Sciences Centre","564a59f9e4b0ef12181db914","74DCDFB4-A637-4111-9A22-4B4BC7BBC8F7","Ovarian Serous Cystadenocarcinoma","TAR","3A018C7B-3334-4C02-88CC-70E40EC30235","2014-03-21T22:30:02.000Z","ED7BFBB4-4C2F-4C25-B856-63D9FCC60371","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"3A018C7B-3334-4C02-88CC-70E40EC30235",1.5,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.15443f5b-51c9-496d-bf7a-99693ca3b943.txt",NA,"TCGA-13-1495-01A",2.1,"EF97D8D6-AEA8-42DE-9B62-054E1106D2AE","TCGA",2004,NA,NA,"WITH TUMOR","98675894-F21C-4DC4-B822-A6E52634D470",60,"TCGA-13-1495-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai","Alive",NA,"TCGA-13-1495","NOT HISPANIC OR LATINO","FF28EB04-B270-4A74-9B59-FCDC531EAEAF",NA,1498,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,128,"BECA9D8A-6867-45D1-A81E-03DC4E7989B0","B844278A-B1C0-449B-829A-CD40A117DE85","MSK_252152914182_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","TCGA-13-1495-01A-01",80,0,NA,NA,20,"TOP",1,NA,"TCGA-13-1495-01A-01-TS1",79,"Carboplatin","Chemotherapy","TCGA-13-1495-D24898",NA,NA,NA,"TCGA-13-1495-F24897_NTE-2",NA,1498,"WITH TUMOR","Alive",NA,"TCGA-13-1495-F24897","TCGA-13-1495",NA,"13","1495","YES","C56.9","8441/3","C56.9",NA,NA,-22046,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1498,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,60,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
229098514,219922341,16244911281,"9DC9671C-37FD-40A0-8D6C-6AC830F39C32.bw","756f6768-e69a-4fe9-aa41-7c58aabe4577","9dc9671c-37fd-40a0-8d6c-6ac830f39c32","2016-09-29T21:44:47.991762-05:00","TCGA-13-1511-01A-01R-1565-13_rnaseq_fastq.tar","6fcfb027-9666-4c57-b1bd-a9ca3d3da04b",14437580800,"Illumina HiSeq","172066e0f97794c0a7db09c6063af37c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:14:48.913738-05:00","2016-05-03T11:40:21.647690-05:00","6fcfb027-9666-4c57-b1bd-a9ca3d3da04b_analysis.xml","c9ad93f8541d302e21d395d0f8c28923","8b5779ec-8de2-4720-a779-f1764e6adfc6",2181,"2016-08-26T23:05:22.077264-05:00","6fcfb027-9666-4c57-b1bd-a9ca3d3da04b_experiment.xml","3c604d4ec052baffe42845cb79465dff","9d0a2de5-fd56-4f57-9df2-f7b1b6c7525e",3916,"2016-09-29T23:28:29.324843-05:00","6fcfb027-9666-4c57-b1bd-a9ca3d3da04b_run.xml","92325bbf773e45e7e54e448e8e7cf6ef","de040e83-74e9-41db-b939-4606aaa906ce",1989,"2016-09-08T13:34:09.022702-05:00","TCGA-13-1511","2016-09-02T19:13:51.339492-05:00","female","TCGA-13-1511_demographic",1956,"asian","e28453c8-ec26-52b0-ab4d-a347b02c3a2f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1511_diagnosis","not reported",19258,"dead","8441/3",1650,119,"46631da2-f6dd-5b78-8999-4f18d5131f9c","c56.9",-19258,"TCGA-13-1511_treatment","d7c83c4a-d7b2-5205-8dc3-85c3c56af640","01",NA,"TCGA-13-1511-01A","1.6","c24a2f48-af41-4e1b-9e23-fbac94d02da4",FALSE,"CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0","Primary Tumor","0.4",NA,NA,"2.2",1235001600,"01",165,"TCGA-13-1511-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:34:09.022702-05:00","2016-09-08T13:34:09.022702-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"4fb08454-15fa-40f8-9d21-d7b75fa68fbe","1db24a7e-5116-4fad-a830-8ffa5736985b","TCGA-13-1511-01A-01-TS1","TCGA-13-1511-01A-01-BS1",90,90,"974b608d-c669-47bb-af1f-29980272dbe6","RNA","TCGA-13-1511-01A-01R","4bed8faa-e912-457b-a001-b1f09bfe8660",1.8,0.15,"UV Spec","R","22","TCGA-13-1511-01A-01R-1565-13","ccd83080-7a51-4952-b4af-d13e9c182bc0",0.15,NA,NA,NA,NA,"3d20aecd-ddf6-52f9-8e56-7db9884dde3c","TCGA-13-1511_exposure","TCGA-13-1511-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T03:29:38.000Z","2014-03-22T04:02:02.000Z","6FCFB027-9666-4C57-B1BD-A9CA3D3DA04B","C24A2F48-AF41-4E1B-9E23-FBAC94D02DA4","Unaligned reads",14437580800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CCD83080-7A51-4952-B4AF-D13E9C182BC0","Canada's Michael Smith Genome Sciences Centre","564a36b0e4b09c884b22ed18","756F6768-E69A-4FE9-AA41-7C58AABE4577","Ovarian Serous Cystadenocarcinoma","TAR","974B608D-C669-47BB-AF1F-29980272DBE6","2014-03-22T04:02:02.000Z","4BED8FAA-E912-457B-A001-B1F09BFE8660","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"974B608D-C669-47BB-AF1F-29980272DBE6",1.6,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a5d23561-577b-4b73-979e-8908b15b223e.txt",NA,"TCGA-13-1511-01A",2.2,"8C238471-C7DE-4922-875E-68B8C9EE6F25","TCGA",2008,NA,NA,"WITH TUMOR","0ACEE8B3-7DAD-48F7-A5BE-3C8AB20D2011",52,"SEDUM_p_TCGA_Batch14_Expr_HT_HG-U133A_96-HTA_C12_458640.level2.data.txt","Alive",NA,"TCGA-13-1511","NOT HISPANIC OR LATINO","4B9AB047-2F5E-4454-8F69-F40A45D563CF",NA,119,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,60,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"ASIAN",NA,1,165,"4FB08454-15FA-40F8-9D21-D7B75FA68FBE","D28336A3-A8B8-4469-BBA2-F348798304FC","TCGA-13-1511-01A-01R-1565-13_GRCh37-lite_rnaseq.bam","TCGA-13-1511-01A-01",95,0,NA,NA,5,"BOTTOM",5,NA,"TCGA-13-1511-01A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-13-1511-D24966",NA,NA,NA,NA,NA,119,"WITH TUMOR","Alive",NA,"TCGA-13-1511-F24965","TCGA-13-1511",NA,"13","1511","YES","C56.9","8441/3","C56.9",NA,NA,-19258,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",119,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
138566042,136683610,10100457772,"73C996B8-5E28-46D7-85C8-28BAA4E4B15D.bw","758e6b52-062e-4ca0-84d1-ea38477414ac","73c996b8-5e28-46d7-85c8-28baa4e4b15d","2016-08-21T00:11:47.940175-05:00","TCGA-59-2352-01A-01R-1569-13_rnaseq_fastq.tar","c2391b2f-430f-448a-bcbb-4abac8bee5d3",7999641600,"Illumina HiSeq","1299c3b22d1167c64551ac26377f8def","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:41:59.917167-05:00","2016-05-03T11:55:09.260045-05:00","c2391b2f-430f-448a-bcbb-4abac8bee5d3_analysis.xml","baff7e1024bd7679654a956f6ed94cd5","c13b60eb-0eb1-4ec7-91ac-eb0be6137e49",2181,"2016-08-13T08:17:12.127026-05:00","c2391b2f-430f-448a-bcbb-4abac8bee5d3_experiment.xml","c9a89d1058063033f6b79cb4a88fcf32","d5b566a6-3e04-42f2-8e67-84f0042d7ccc",3916,"2016-09-29T23:24:51.102362-05:00","c2391b2f-430f-448a-bcbb-4abac8bee5d3_run.xml","d03a0642efa55bfb330c01757afbdf41","dbb4f4ce-ad69-463d-bf5f-b5d7ee42c2e5",1989,"2016-09-08T13:56:12.168255-05:00","TCGA-59-2352","2016-09-02T19:11:39.663296-05:00","female","TCGA-59-2352_demographic",1924,"white","ea4eb7f5-e69a-5300-8b57-2b53ea2b245f","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2352_diagnosis","not reported",NA,"dead","8441/3",286,NA,"ea0ad7ed-ad39-564d-80bc-d7365bdeeff0","c56.9",NA,"TCGA-59-2352_treatment","766420b9-7a3c-5667-a5d4-395a3941463e","01",NA,"TCGA-59-2352-01A","1.2","2892b681-6001-4124-ae86-3363be75463b",FALSE,"15f65643-b84c-4239-bc14-0ddacdfe0425","Primary Tumor","0.4",NA,NA,"2",1251763200,"01",127,"TCGA-59-2352-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:56:12.168255-05:00","2016-09-08T13:56:12.168255-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,5,"ef2a283e-ca0f-47fe-aff7-c10c4423c09a","a137850c-18c0-48b5-91aa-dafec1feb1ff","TCGA-59-2352-01A-01-TS1","TCGA-59-2352-01A-01-BS1",89,85,"51c94c62-410c-4e31-8f4f-8c67fae5a203","RNA","TCGA-59-2352-01A-01R","cb39af02-00f4-4431-8f6f-55b2f2744fdd",1.8,0.15,"UV Spec","R","22","TCGA-59-2352-01A-01R-1569-13","a209a8f4-9462-4ade-be57-caaec54999cb",0.15,NA,NA,NA,NA,"15b02919-4e00-5ca0-816a-e8b62388f9d2","TCGA-59-2352_exposure","TCGA-59-2352-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T06:00:23.000Z","2014-08-08T06:32:06.000Z","C2391B2F-430F-448A-BCBB-4ABAC8BEE5D3","2892B681-6001-4124-AE86-3363BE75463B","Unaligned reads",7999641600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A209A8F4-9462-4ADE-BE57-CAAEC54999CB","Canada's Michael Smith Genome Sciences Centre","564a57dde4b0298dd2cafe73","758E6B52-062E-4CA0-84D1-EA38477414AC","Ovarian Serous Cystadenocarcinoma","TAR","51C94C62-410C-4E31-8F4F-8C67FAE5A203","2014-08-08T06:32:06.000Z","CB39AF02-00F4-4431-8F6F-55B2F2744FDD","None","NO",1,0.4,"Primary Tumor","Roswell Park",NA,"51C94C62-410C-4E31-8F4F-8C67FAE5A203",1.2,"59","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d9066d98-0039-4956-9e7e-9931b8c28379.txt",NA,"TCGA-59-2352-01A",2,NA,"TCGA",2002,NA,NA,"WITH TUMOR","2892B681-6001-4124-AE86-3363BE75463B",78,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d9066d98-0039-4956-9e7e-9931b8c28379.txt","Dead",286,"TCGA-59-2352","NOT HISPANIC OR LATINO",NA,NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,127,"EF2A283E-CA0F-47FE-AFF7-C10C4423C09A","CB39AF02-00F4-4431-8F6F-55B2F2744FDD","TCGA-59-2352-01A-01R-1569-13_rnaseq.bam.bai","TCGA-59-2352-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-59-2352-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-2352",NA,"59","2352","YES","C56.9","8441/3","C56.9","NO","YES",NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,286,NA,NA,"WITH TUMOR","NO",29,1,2010,"NO","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,78,2002,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
292651366,284387792,21077168630,"9FC48E2B-5E80-4B40-A964-4C3FC65CE5BF.bw","7592a659-7175-486f-a16e-24a4b4365a36","9fc48e2b-5e80-4b40-a964-4c3fc65ce5bf","2016-08-21T20:22:51.646776-05:00","TCGA-24-1556-01A-01R-1566-13_rnaseq_fastq.tar","4f9db397-033b-4c96-914f-dbe4e6cc1b90",19124776960,"Illumina HiSeq","3e5dc32acf26b4b88892858665ba5239","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:12:50.974154-05:00","2016-05-03T11:41:05.748550-05:00","4f9db397-033b-4c96-914f-dbe4e6cc1b90_analysis.xml","14b59a7bbf1a827d7437d47a0e66a893","1a09d429-4d1f-4b61-af41-59b94a2a68d7",2181,"2016-09-29T22:45:06.585536-05:00","4f9db397-033b-4c96-914f-dbe4e6cc1b90_experiment.xml","7e0935d4c81d2c3e924541fdbdf0e135","c3239b50-6893-4e9b-a812-58462630eb59",3916,"2016-09-29T19:32:30.579664-05:00","4f9db397-033b-4c96-914f-dbe4e6cc1b90_run.xml","965c00493594d301eee465712c2c409f","4c1bc190-7644-4321-a225-98ef0b23c719",1989,"2016-09-08T11:17:20.789382-05:00","TCGA-24-1556","2016-09-02T18:54:37.041191-05:00","female","TCGA-24-1556_demographic",1950,"white","2dcec934-ec62-5a81-9bbc-8582f8129183","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1556_diagnosis","not reported",18517,"dead","8441/3",2148,2148,"21fca019-acce-5868-9629-eaf16a9567a7","c56.9",-18517,"TCGA-24-1556_treatment","fc7d1943-885f-55f8-8dc6-fbc6b5f3f66d","01",NA,"TCGA-24-1556-01A","1","ba4d22b5-f97a-413f-9cc7-30d1e5c91f7e",FALSE,"75c91323-45a7-4629-b014-f7eda2f1075e","Primary Tumor","0.6",NA,NA,"1.9",1235347200,"01",117,"TCGA-24-1556-01A-01",85,85,NA,NA,0,0,5,10,"2016-09-08T11:17:20.789382-05:00","2016-09-08T11:17:20.789382-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"29948e55-dd31-40a5-a86e-90948524ec9f","4581d48a-a056-41e6-baf5-69e5ffaf9bac","TCGA-24-1556-01A-01-BS1","TCGA-24-1556-01A-01-TS1",95,90,"b0d7ae23-448a-41b3-9939-66d4db7aa7ce","RNA","TCGA-24-1556-01A-01R","3ba3817b-9de3-43f2-a5ab-da942542342d",1.8,0.16,"UV Spec","R","22","TCGA-24-1556-01A-01R-1566-13","31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd",0.16,NA,NA,NA,NA,"1da5e803-23db-52d1-93ba-35f39a90bea8","TCGA-24-1556_exposure","TCGA-24-1556-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T22:22:28.000Z","2014-03-28T23:22:01.000Z","4F9DB397-033B-4C96-914F-DBE4E6CC1B90","BA4D22B5-F97A-413F-9CC7-30D1E5C91F7E","Unaligned reads",19124776960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","31E8AE73-7C3F-45EC-B4C9-D3F2EE1CA4FD","Canada's Michael Smith Genome Sciences Centre","564a5c71e4b0ef12181e551f","7592A659-7175-486F-A16E-24A4B4365A36","Ovarian Serous Cystadenocarcinoma","TAR","B0D7AE23-448A-41B3-9939-66D4DB7AA7CE","2014-03-28T23:22:01.000Z","3BA3817B-9DE3-43F2-A5AB-DA942542342D","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"B0D7AE23-448A-41B3-9939-66D4DB7AA7CE",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7c4dcb9c-346b-4b52-9b64-f835ebc85dba.txt",NA,"TCGA-24-1556-01A",1.9,"D5AE144A-C41E-497B-9F77-A10744C020B8","TCGA",2000,NA,NA,"WITH TUMOR","74F5DDB0-FF50-4685-AF45-BB4ED56875FB",50,"ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_H07_466052.hg18.seg.txt","Dead",2148,"TCGA-24-1556",NA,"AE13E174-65C7-41D1-A531-10166F114BFE",NA,2148,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,"2F80B629-8CE2-406F-9495-6BF0D707B63C","WHITE",NA,1,117,"4581D48A-A056-41E6-BAF5-69E5FFAF9BAC","E8C502EC-6775-420B-B87E-F4A607764AA3","TCGA-24-1556-01A-01R-1566-13.exon.quantification.txt","TCGA-24-1556-01A-01",85,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-24-1556-01A-01-BS1",95,"Carboplatin","Chemotherapy","TCGA-24-1556-D26185","TCGA-24-1556-R26192",NA,"Local Recurrence","TCGA-24-1556-F26184_NTE-2",NA,2148,"WITH TUMOR","Dead",2148,"TCGA-24-1556-F26184","TCGA-24-1556",NA,"24","1556","YES","C56.9","8441/3","C56.9",NA,NA,-18517,"FEMALE","WHITE",NA,NA,"No","Dead",2148,2148,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,50,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
80761816,79935415,5912832720,"723C5794-B977-44E8-A15C-396179621EFB.bw","75f2d97a-b96c-403f-8055-5c5c8083e856","723c5794-b977-44e8-a15c-396179621efb","2016-08-20T22:50:07.843314-05:00","TCGA-61-1910-01A-01R-1567-13_rnaseq_fastq.tar","dbdecb86-09ff-4d30-972c-6fc0e4d1496d",4548147200,"Illumina HiSeq","e9d69b4977ff576209acd6e952422543","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:17:10.089204-05:00","2016-05-03T11:56:42.628342-05:00","dbdecb86-09ff-4d30-972c-6fc0e4d1496d_analysis.xml","50b346fd8e99e6317986c1084b851064","8cc4e5cc-27e9-4861-b7d3-609b363c8ce7",2181,"2016-08-13T03:00:52.867444-05:00","dbdecb86-09ff-4d30-972c-6fc0e4d1496d_experiment.xml","b8a3b19ac976f2517ebb80c8a1a147f2","2a4711ab-b338-4606-9458-8ee6e6db62e2",3916,"2016-09-29T22:52:37.501234-05:00","dbdecb86-09ff-4d30-972c-6fc0e4d1496d_run.xml","289fda1411b771dec6a638a6edc807df","c7dd14f0-3be8-4121-bc9c-c259dfdbc4c6",1988,"2016-09-08T12:18:16.419375-05:00","TCGA-61-1910","2016-09-02T19:06:49.986590-05:00","female","TCGA-61-1910_demographic",1950,"white","e31f8f34-ab84-5c8c-b48d-12a9d06a7117","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1910_diagnosis","not reported",20779,"alive","8441/3",NA,1127,"f94bab54-9a7b-555b-899c-90c46cb49a3f","c56.9",-20779,"TCGA-61-1910_treatment","80d6ae6b-b047-592e-9704-2f282ea6c50c","01",NA,"TCGA-61-1910-01A","1","a8786e7f-5004-43c8-a5a8-fc2fb89d2ab0",FALSE,"32905714-6e41-4df8-91dd-6d3068475b40","Primary Tumor","0.4",NA,NA,"1.5",1246233600,"01",132,"TCGA-61-1910-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T12:18:16.419375-05:00","2016-09-08T12:18:16.419375-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"8c1da66c-6d4f-438e-8d73-2f04af158488","e0a84385-0458-4590-9ff6-ebe9c92e2d08","TCGA-61-1910-01A-01-TS1","TCGA-61-1910-01A-01-BS1",94,94,"91876dee-1ef7-41db-a257-4b2d08d9da66","RNA","TCGA-61-1910-01A-01R","0612b7c1-5ba8-46e9-ace1-5ae8aa9366cb",1.8,0.14,"UV Spec","R","22","TCGA-61-1910-01A-01R-1567-13","65e4e40b-f27f-4b84-9979-af659564363d",0.14,NA,NA,NA,NA,"a6c33e70-d70c-546c-94d5-8f8a16f5aa95","TCGA-61-1910_exposure","TCGA-61-1910-01A-01R-1567-13_rnaseq_fastq.tar","2014-08-28T00:42:55.000Z","2014-08-28T01:29:15.000Z","DBDECB86-09FF-4D30-972C-6FC0E4D1496D","A8786E7F-5004-43C8-A5A8-FC2FB89D2AB0","Unaligned reads",4548147200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","65E4E40B-F27F-4B84-9979-AF659564363D","Canada's Michael Smith Genome Sciences Centre","564a58bce4b08c5d869459fa","75F2D97A-B96C-403F-8055-5C5C8083E856","Ovarian Serous Cystadenocarcinoma","TAR","91876DEE-1EF7-41DB-A257-4B2D08D9DA66","2014-08-28T01:29:15.000Z","0612B7C1-5BA8-46E9-ACE1-5AE8AA9366CB","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"91876DEE-1EF7-41DB-A257-4B2D08D9DA66",1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.18b958a6-f51e-4fb3-a240-cfe22c05d967.txt",NA,"TCGA-61-1910-01A",1.5,"4A16E1DC-ABA9-48C9-B387-2F5461CBC49B","TCGA",2006,NA,NA,"TUMOR FREE","F2C7732F-3197-4DAF-82C5-B2F44CE05B7A",56,"nationwidechildrens.org_clinical.TCGA-61-1910.xml","Alive",NA,"TCGA-61-1910","NOT HISPANIC OR LATINO","EF3544B8-339A-4E76-A50B-3D8C27DFB9DE",NA,1127,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,132,"E0A84385-0458-4590-9FF6-EBE9C92E2D08","ED55D852-8934-454B-A7A0-443CB590DDD5","TCGA-61-1910-01A-01R-1567-13_GRCh37-lite_mirna.bam.bai","TCGA-61-1910-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-61-1910-01A-01-BS1",94,"Taxol","Chemotherapy","TCGA-61-1910-D28258",NA,NA,NA,NA,NA,1127,"TUMOR FREE","Alive",NA,"TCGA-61-1910-F28256","TCGA-61-1910",NA,"61","1910","YES","C56.9","8441/3","C56.9",NA,NA,-20779,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1127,NA,NA,NA,"TUMOR FREE","NO",1,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
212714476,203657052,15039316956,"25E9BF78-2B1A-447A-84F1-FFE80B92BA7E.bw","76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8","25e9bf78-2b1a-447a-84f1-ffe80b92ba7e","2016-08-25T08:39:04.482492-05:00","TCGA-57-1583-01A-01R-1566-13_rnaseq_fastq.tar","0c48cf3a-2014-4b88-bd61-e2d3fb07cbf8",13829611520,"Illumina HiSeq","17a7e7ccd1107ac3801b2a6e8a51321c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:24:55.398600-05:00","2016-05-03T11:40:21.648199-05:00","0c48cf3a-2014-4b88-bd61-e2d3fb07cbf8_analysis.xml","e56728a2b2a39c9e733089b154cfbb14","919812fc-8b2a-4fe3-9da0-fd58577236d7",2181,"2016-08-13T02:20:52.193202-05:00","0c48cf3a-2014-4b88-bd61-e2d3fb07cbf8_experiment.xml","295535f5ed11e3c013439a25f4ea14d7","035cf6ec-583a-4c59-a038-f3f441e1f3be",3916,"2016-09-29T19:31:09.463087-05:00","0c48cf3a-2014-4b88-bd61-e2d3fb07cbf8_run.xml","b9047b4037b69f3f0ed49c3a3133bc39","4b583ef3-0eb2-481a-bdf5-56119818b0b8",1988,"2016-09-08T10:40:23.473083-05:00","TCGA-57-1583","2016-09-02T18:48:56.246123-05:00","female","TCGA-57-1583_demographic",1949,"black or african american","65d45d68-52f7-5bf9-83b6-a053ab03eef7","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1583_diagnosis","not reported",21167,"dead","8441/3",346,346,"03a569c0-4d70-554f-9b61-b414ecfffa8e","c56.9",-21167,"TCGA-57-1583_treatment","34e4a5f6-22af-59c9-9dd1-e4c91dff74c6","01",NA,"TCGA-57-1583-01A","1","04b379ac-220b-4582-84c8-be370d5ad619",FALSE,"b899b485-621f-46df-8bda-97b0fbe10b6d","Primary Tumor","0.4",NA,NA,"1.4",1237161600,"01",98,"TCGA-57-1583-01A-01",95,95,NA,NA,0,0,10,10,"2016-09-08T10:40:23.473083-05:00","2016-09-08T10:40:23.473083-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"cef6fee1-8770-4bb4-938d-7f620a481a6a","77fcc4ab-f8e0-4afd-b935-28aafb05feda","TCGA-57-1583-01A-01-TS1","TCGA-57-1583-01A-01-BS1",94,94,"153b158f-4ca0-4607-ba28-74e15ed4be10","RNA","TCGA-57-1583-01A-01R","61f9f252-6319-4970-8720-9fd4bca79e74",1.8,0.15,"UV Spec","R","22","TCGA-57-1583-01A-01R-1566-13","3a37e320-0301-4f2b-bf09-f102c12502b1",0.15,NA,NA,NA,NA,"41253661-d91a-5eca-9047-dd94251c5c8f","TCGA-57-1583_exposure","TCGA-57-1583-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T05:32:57.000Z","2014-03-25T05:58:01.000Z","0C48CF3A-2014-4B88-BD61-E2D3FB07CBF8","04B379AC-220B-4582-84C8-BE370D5AD619","Unaligned reads",13829611520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3A37E320-0301-4F2B-BF09-F102C12502B1","Canada's Michael Smith Genome Sciences Centre","564a3722e4b0ef1218191385","76CC2D21-EEBC-4F09-9BC7-DBF7AF0AAFA8","Ovarian Serous Cystadenocarcinoma","TAR","153B158F-4CA0-4607-BA28-74E15ED4BE10","2014-03-25T05:58:01.000Z","61F9F252-6319-4970-8720-9FD4BCA79E74","None","NO",1,0.4,"Primary Tumor","International Genomics Consortium",NA,"153B158F-4CA0-4607-BA28-74E15ED4BE10",1,"57","ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_B04_466098.nocnv_hg18.seg.txt",NA,"TCGA-57-1583-01A",1.4,"FCAF527F-AC45-49BA-B12E-0898F26AA9FE","TCGA",2006,NA,NA,"WITH TUMOR","7496794A-ADCB-4076-B9DD-1267C48E3138",57,"nationwidechildrens.org_clinical.TCGA-57-1583.xml","Dead",346,"TCGA-57-1583",NA,"226DA9F5-F0BA-4F11-9C5E-1E1C53456CE7",NA,346,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,98,"CEF6FEE1-8770-4BB4-938D-7F620A481A6A","F3603F72-E6F1-4D44-A356-8A4587588079","bcgsc.ca.TCGA-57-1583-01A-01R-1566-13.hg19.bcgsc.ca.1.7.0.sv.fa","TCGA-57-1583-01A-01",95,0,NA,NA,10,"TOP",1,NA,"TCGA-57-1583-01A-01-TS1",94,"Taxol","Chemotherapy","TCGA-57-1583-D28070",NA,NA,NA,NA,NA,346,"WITH TUMOR","Dead",346,"TCGA-57-1583-F28068","TCGA-57-1583",NA,"57","1583","YES","C56.9","8441/3","C56.9",NA,NA,-21167,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",346,346,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,57,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
293373656,276961959,20456039722,"9A25B536-A45F-481F-A982-B42ECA2149B0.bw","774ce281-96b2-467a-9170-079797ee10f7","9a25b536-a45f-481f-a982-b42eca2149b0","2016-08-25T18:18:29.916114-05:00","TCGA-13-0765-01A-01R-1564-13_rnaseq_fastq.tar","b698d880-21ff-4f86-a702-290adba843ce",19642214400,"Illumina HiSeq","411af5e3d008f8890fd41e133b1e6952","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:03:37.958967-05:00","2016-05-03T11:39:34.522989-05:00","b698d880-21ff-4f86-a702-290adba843ce_analysis.xml","78731a8e322251a036080d6f16378fd4","144aeb67-9f5c-4511-bb12-880b3172c39b",2210,"2016-08-30T07:05:42.421771-05:00","b698d880-21ff-4f86-a702-290adba843ce_experiment.xml","bf69db0f4bee11ee6f367596a586854b","9bfcfcc7-5a95-4340-9ecf-2ca67217b7ca",3916,"2016-09-29T18:34:22.706395-05:00","b698d880-21ff-4f86-a702-290adba843ce_run.xml","ff08773f59532eff1d305597f7785449","274ba2b1-28af-447c-afe9-fc00e4c331f4",1990,"2016-09-08T13:39:48.255988-05:00","TCGA-13-0765","2016-09-02T19:09:36.350900-05:00","female","TCGA-13-0765_demographic",1956,"white","7d9699a9-4ea0-5b30-bcda-46dac07eac0a","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0765_diagnosis","not reported",18574,"dead","8441/3",1389,869,"15b1a19f-09af-5637-a630-135ff926fb81","c56.9",-18574,"TCGA-13-0765_treatment","e85c2b74-e4ec-55fd-b9e6-2edf90f5a946","01",NA,"TCGA-13-0765-01A","0.6","1fa2d0a4-26a3-4b7b-818b-e20cc200a0ed",FALSE,"96588189-C273-4095-88C5-9E22368813C0","Primary Tumor","0.3",NA,NA,"1.2",1233705600,"01",83,"TCGA-13-0765-01A-01",90,99,NA,NA,0,1,5,NA,"2016-09-08T13:39:48.255988-05:00","2016-09-08T13:39:48.255988-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"9d588c3d-dc12-4984-a9d6-c5d048ab5f47","8f9bff9c-ecb0-4f82-aef3-6b55da5dc88c","TCGA-13-0765-01A-01-TS1","TCGA-13-0765-01A-01-BS1",95,98,"980df042-9548-4789-abde-4fa640e3e76e","RNA","TCGA-13-0765-01A-01R","777a4691-563e-448e-8204-8ad28b267eca",1.8,0.18,"UV Spec","R","22","TCGA-13-0765-01A-01R-1564-13","d5c33d85-54da-455b-aa65-aaec79af99b0",0.18,NA,NA,NA,NA,"4297e867-0a1b-5f52-975c-941e707f3ca9","TCGA-13-0765_exposure","TCGA-13-0765-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T02:18:05.000Z","2014-03-20T02:55:02.000Z","B698D880-21FF-4F86-A702-290ADBA843CE","1FA2D0A4-26A3-4B7B-818B-E20CC200A0ED","Unaligned reads",19642214400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D5C33D85-54DA-455B-AA65-AAEC79AF99B0","Canada's Michael Smith Genome Sciences Centre","564a3cb3e4b09c884b24c1a4","774CE281-96B2-467A-9170-079797EE10F7","Ovarian Serous Cystadenocarcinoma","TAR","980DF042-9548-4789-ABDE-4FA640E3E76E","2014-03-20T02:55:02.000Z","777A4691-563E-448E-8204-8AD28B267ECA","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"980DF042-9548-4789-ABDE-4FA640E3E76E",0.6,"13","TCGA-13-0765-01A-01W-0372-09_capture.bam",NA,"TCGA-13-0765-01A",1.2,"E10F7682-E704-4461-99A6-BFB0F4230525","TCGA",2006,NA,NA,"WITH TUMOR","D030D7A0-0840-45E4-890E-587F856F82EF",50,"0750.CEL","Alive",NA,"TCGA-13-0765","NOT HISPANIC OR LATINO","2A56CD1F-6CF2-4E9D-842A-B2A72E8DC65F",NA,869,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,83,"9D588C3D-DC12-4984-A9D6-C5D048AB5F47","DC666251-E6B0-49DE-9878-F5920D3267C3","TCGA-13-0765-01A-01R-0441-02_tags.txt","TCGA-13-0765-01A-01",99,1,NA,NA,NA,"BOTTOM",1,NA,"TCGA-13-0765-01A-01-BS1",98,"Paclitaxel","Chemotherapy","TCGA-13-0765-D24561",NA,NA,NA,"TCGA-13-0765-F24559_NTE-1",NA,869,"WITH TUMOR","Alive",NA,"TCGA-13-0765-F24559","TCGA-13-0765",NA,"13","0765","YES","C56.9","8441/3","C56.9",NA,NA,-18574,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",869,NA,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
304146732,295536547,21913871296,"A1C23774-EE19-48AD-A27D-5AAAB158A061.bw","778ce436-a825-4689-81c1-b7c965404163","a1c23774-ee19-48ad-a27d-5aaab158a061","2016-08-25T22:18:42.860793-05:00","TCGA-61-2095-01A-01R-1568-13_rnaseq_fastq.tar","547debdc-48cb-4d89-a928-726a6303fd72",20094986240,"Illumina HiSeq","3ed888872586716a0b5c45f59d5ee2b4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:13:11.728187-05:00","2016-05-03T11:41:05.748550-05:00","547debdc-48cb-4d89-a928-726a6303fd72_analysis.xml","3ec00012e3c5aa69be0e020e5707716e","af6453a1-c2d6-44b4-93e8-d8a1267205e0",2181,"2016-09-29T21:43:32.576352-05:00","547debdc-48cb-4d89-a928-726a6303fd72_experiment.xml","e60dfcfb28c8888d0a1fbc6a517dbf01","9cfe0435-351e-428e-9dfa-95abd6d5ada6",3916,"2016-09-29T19:58:49.327241-05:00","547debdc-48cb-4d89-a928-726a6303fd72_run.xml","b82b9189e07a74f44fb2fae6ad8a6f3a","5c6a8551-ef6b-4210-bb5c-4b19ee5c5e4a",1989,"2016-09-08T12:14:02.701110-05:00","TCGA-61-2095","2016-09-02T18:56:09.774930-05:00","female","TCGA-61-2095_demographic",1949,"white","f4e599b6-8cb0-5ad4-9f8a-a704e2149024","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2095_diagnosis","not reported",19797,"dead","8441/3",1875,NA,"8ce0f291-c03c-56b4-aeba-38388907fd38","c56.9",-19797,"TCGA-61-2095_treatment","8c453945-df19-57fd-94d0-49bd2bf6ade1","01",NA,"TCGA-61-2095-01A","1","b2cde517-9404-45b2-bd39-3dedb4e129fc",FALSE,"3e08408b-b76a-4a32-b3f1-4590459f4af8","Primary Tumor","0.4",NA,NA,"1.2",1250208000,"01",110,"TCGA-61-2095-01A-01",80,80,NA,NA,0,0,39,38,"2016-09-08T12:14:02.701110-05:00","2016-09-08T12:14:02.701110-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,2,"813c48d7-f747-4a93-b238-4fa77a1a54a5","4b9d42fd-49cc-43ef-9ec3-6fc41e6ab132","TCGA-61-2095-01A-01-BS1","TCGA-61-2095-01A-01-TS1",60,60,"45359972-aef3-4eb2-a552-a427e943c775","RNA","TCGA-61-2095-01A-01R","4b0d4ecf-7b56-4851-ba71-0c5243466078",1.8,0.15,"UV Spec","R","22","TCGA-61-2095-01A-01R-1568-13","15a11ef0-5e18-44d0-ba50-73cf356b8408",0.15,NA,NA,NA,NA,"6f4b51e0-d216-54d7-ab32-1abb6df2104c","TCGA-61-2095_exposure","TCGA-61-2095-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-29T07:01:42.000Z","2014-03-29T07:36:02.000Z","547DEBDC-48CB-4D89-A928-726A6303FD72","B2CDE517-9404-45B2-BD39-3DEDB4E129FC","Unaligned reads",20094986240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","15A11EF0-5E18-44D0-BA50-73CF356B8408","Canada's Michael Smith Genome Sciences Centre","564a5992e4b0298dd2cb8e6f","778CE436-A825-4689-81C1-B7C965404163","Ovarian Serous Cystadenocarcinoma","TAR","45359972-AEF3-4EB2-A552-A427E943C775","2014-03-29T07:36:02.000Z","4B0D4ECF-7B56-4851-BA71-0C5243466078","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"45359972-AEF3-4EB2-A552-A427E943C775",1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.74a1f15a-05c4-4d85-a731-9a4e5281f644.txt",NA,"TCGA-61-2095-01A",1.2,"E9C95270-88D0-44F3-972D-75A8BFD8447E","TCGA",2003,NA,NA,"WITH TUMOR","B2CDE517-9404-45B2-BD39-3DEDB4E129FC",54,"nationwidechildrens.org_clinical.TCGA-61-2095.xml","Dead",1875,"TCGA-61-2095","NOT HISPANIC OR LATINO","B64C63F4-4421-42FE-B4F4-FE30BE2673CB",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,110,"813C48D7-F747-4A93-B238-4FA77A1A54A5","93B34CA7-DE2B-48A9-A137-7209C85B38CA","TCGA-61-2095-01A-01R-1568-13.gene.quantification.txt","TCGA-61-2095-01A-01",80,0,NA,NA,38,"TOP",2,NA,"TCGA-61-2095-01A-01-TS1",60,"Doxil","Chemotherapy","TCGA-61-2095-D28392",NA,NA,NA,"TCGA-61-2095-F28389_NTE-2",NA,NA,"WITH TUMOR","Dead",1875,"TCGA-61-2095-F28389","TCGA-61-2095",NA,"61","2095","YES","C56.9","8441/3","C56.9",NA,NA,-19797,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1875,NA,NA,"WITH TUMOR","NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
203920682,193085657,14248101969,"0CA91E9E-116A-4B4F-B601-660CA8D9D0C9.bw","78777a80-cc6c-46c9-a14a-837ac7943719","0ca91e9e-116a-4b4f-b601-660ca8d9d0c9","2016-08-24T18:27:46.280966-05:00","TCGA-25-1317-01A-01R-1565-13_rnaseq_fastq.tar","4cbc1d32-e2d7-407a-ab1e-7bfa4267b861",13531432960,"Illumina HiSeq","54eb7081c22768895c9c4c6bd69e51d7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:12:16.289026-05:00","2016-05-03T11:40:21.662944-05:00","4cbc1d32-e2d7-407a-ab1e-7bfa4267b861_analysis.xml","74c21a293be0efa0efe8d7bef1dc6258","aec4d6a2-5f6b-4139-b9eb-941254f7b1bc",2181,"2016-09-29T23:02:22.059127-05:00","4cbc1d32-e2d7-407a-ab1e-7bfa4267b861_experiment.xml","ca250c3be7f252c5174023c1f61b24c5","cdb3ae3a-3f05-4d04-85ee-5a41ae6b3acd",3916,"2016-09-29T19:23:21.348049-05:00","4cbc1d32-e2d7-407a-ab1e-7bfa4267b861_run.xml","7b6796c7ba62c82bc64cddf3d68526c4","46688886-2c07-47fb-b672-a9b027048745",1989,"2016-09-08T13:26:37.286720-05:00","TCGA-25-1317","2016-09-02T19:12:00.798569-05:00","female","TCGA-25-1317_demographic",1934,"white","f8742fb7-df55-59c6-9428-0487f950eb36","not hispanic or latino",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1317_diagnosis","not reported",24199,"dead","8441/3",61,NA,"34c73698-1092-5f12-b670-e84b1ca08e3a","c56.9",-24199,"TCGA-25-1317_treatment","f4c86966-2794-5f8d-9798-9e283cacfe2c","01",NA,"TCGA-25-1317-01A","1.4","12be4fe0-391e-4bdd-9af9-33fa7a135975",FALSE,"5DC53520-0991-42B6-B10D-0D62C3F92BAD","Primary Tumor","0.5",NA,NA,"1.5",1228348800,"01",108,"TCGA-25-1317-01A-01",90,85,NA,NA,0,0,30,40,"2016-09-08T13:26:37.286720-05:00","2016-09-08T13:26:37.286720-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,10,"7237ad91-a258-4544-a2c4-1fb411af658a","c33273aa-4977-48d6-ac62-00d1f61260c8","TCGA-25-1317-01A-01-BS1","TCGA-25-1317-01A-01-TS1",70,50,"d01f67d9-bbbd-473c-bcd6-63861fa5e36a","RNA","TCGA-25-1317-01A-01R","304d494e-2f41-4a65-aa5a-f7641e3369f6",1.8,0.15,"UV Spec","R","22","TCGA-25-1317-01A-01R-1565-13","423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf",0.15,NA,NA,NA,NA,"4c07a069-461c-516a-b231-36e8ee4b8deb","TCGA-25-1317_exposure","TCGA-25-1317-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:40:15.000Z","2014-03-22T08:06:01.000Z","4CBC1D32-E2D7-407A-AB1E-7BFA4267B861","12BE4FE0-391E-4BDD-9AF9-33FA7A135975","Unaligned reads",13531432960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","423F3C95-8BF5-4C2C-8B7A-343D9AF1D0BF","Canada's Michael Smith Genome Sciences Centre","564a566be4b09c884b264a6a","78777A80-CC6C-46C9-A14A-837AC7943719","Ovarian Serous Cystadenocarcinoma","TAR","D01F67D9-BBBD-473C-BCD6-63861FA5E36A","2014-03-22T08:06:01.000Z","304D494E-2F41-4A65-AA5A-F7641E3369F6","None","NO",1,0.5,"Primary Tumor","Mayo Clinic - Rochester",NA,"D01F67D9-BBBD-473C-BCD6-63861FA5E36A",1.4,"25","TCGA-25-1317-01A-01R-1565-13_mirna.bam",NA,"TCGA-25-1317-01A",1.5,"4415066A-D41D-4847-B874-98A231029CF3","TCGA",2000,NA,NA,NA,"318F0E7A-F20A-45AE-BD1E-62FFCF752E26",66,"NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_E05_446094.hg19.seg.txt","Dead",61,"TCGA-25-1317","NOT HISPANIC OR LATINO","72AE7E80-C25A-4051-86DA-8D77657354E5",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,108,"C33273AA-4977-48D6-AC62-00D1F61260C8","D8C94402-B114-458A-9375-BD7504F8FEA1","TCGA-25-1317-01A-01R-1565-13_mirna.bam","TCGA-25-1317-01A-01",90,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-25-1317-01A-01-BS1",70,"Taxol","Chemotherapy","TCGA-25-1317-D26652",NA,NA,NA,NA,NA,NA,NA,"Dead",61,"TCGA-25-1317-F26651","TCGA-25-1317",NA,"25","1317","YES","C56.9","8441/3","C56.9",NA,NA,-24199,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,61,NA,NA,NA,"NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156635750,145168882,10744771117,"659A5D79-89F4-4506-A361-03B15C72C033.bw","79e6e31c-22a1-481c-903b-ab5499cbd450","659a5d79-89f4-4506-a361-03b15c72c033","2016-08-25T11:08:27.152473-05:00","TCGA-13-0897-01A-01R-1564-13_rnaseq_fastq.tar","8e8b4f26-f090-418d-843c-d498d8bbce7e",10503956480,"Illumina HiSeq","29c399118372282181ec547625185cff","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:53:39.705728-05:00","2016-05-03T11:27:59.322672-05:00","8e8b4f26-f090-418d-843c-d498d8bbce7e_analysis.xml","961ec2138e1195d5536f712c0e694a3b","33ae318f-6c60-4076-9fb5-3c4c88c46b33",2183,"2016-08-13T04:55:11.469808-05:00","8e8b4f26-f090-418d-843c-d498d8bbce7e_experiment.xml","34193324a36c0c7950dd84eb88ddcabe","22ff3f59-26de-44d1-9767-79af5bd19750",3916,"2016-09-29T19:14:58.203092-05:00","8e8b4f26-f090-418d-843c-d498d8bbce7e_run.xml","0a92860c998ca7e9a20da16992c9cf9e","411b1d8e-666d-426a-bf46-df4d5890cab2",1990,"2016-09-08T12:37:28.531056-05:00","TCGA-13-0897","2016-09-02T19:06:17.135441-05:00","female","TCGA-13-0897_demographic",1950,"white","98f76dc4-21fd-5024-915b-f6c36aa533ae","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0897_diagnosis","not reported",19894,"dead","8441/3",2182,1748,"2867623c-36a9-589a-b65a-25518a378ba0","c56.9",-19894,"TCGA-13-0897_treatment","ffb36efb-aef4-5ef0-9837-15590806facc","01",NA,"TCGA-13-0897-01A","0.5","daabfedb-ac0a-4bc9-b145-9bef04bdd66f",FALSE,"058A5354-D36C-4398-AC2C-12447FDB0966","Primary Tumor","0.5",NA,NA,"1.1",1233705600,"01",94,"TCGA-13-0897-01A-01",90,90,NA,NA,10,10,0,0,"2016-09-08T12:37:28.531056-05:00","2016-09-08T12:37:28.531056-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,1,"dcac13fe-5762-4440-8ef6-f20f7add987c","06f71559-c811-4995-9983-f16452175b36","TCGA-13-0897-01A-01-BS1","TCGA-13-0897-01A-01-TS1",88,89,"814120ca-3d11-4fc7-913e-fadf27a37650","RNA","TCGA-13-0897-01A-01R","83eeecce-43b3-4131-8d7c-31f19716d157",1.8,0.16,"UV Spec","R","22","TCGA-13-0897-01A-01R-1564-13","479b74bf-5003-45e1-9505-687146a5fc45",0.16,NA,NA,NA,NA,"a3a3afcc-01f3-59b9-be80-84b073f498a6","TCGA-13-0897_exposure","TCGA-13-0897-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T08:10:41.000Z","2013-12-20T08:33:02.000Z","8E8B4F26-F090-418D-843C-D498D8BBCE7E","DAABFEDB-AC0A-4BC9-B145-9BEF04BDD66F","Unaligned reads",10503956480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","479B74BF-5003-45E1-9505-687146A5FC45","Canada's Michael Smith Genome Sciences Centre","564a5ba7e4b08c5d8695439f","79E6E31C-22A1-481C-903B-AB5499CBD450","Ovarian Serous Cystadenocarcinoma","TAR","814120CA-3D11-4FC7-913E-FADF27A37650","2013-12-20T08:33:02.000Z","83EEECCE-43B3-4131-8D7C-31F19716D157","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"814120CA-3D11-4FC7-913E-FADF27A37650",0.5,"13","TCGA-13-0897-01A-01R-1564-13_mirna.bam.bai",NA,"TCGA-13-0897-01A",1.1,"CC1F5F91-E9E0-43F6-9E1F-688DAA23A656","TCGA",2004,NA,NA,"WITH TUMOR","DAABFEDB-AC0A-4BC9-B145-9BEF04BDD66F",54,"jhu-usc.edu_OV.HumanMethylation27.2.lvl-3.TCGA-13-0897-01A-01D-0402-05.txt","Alive",NA,"TCGA-13-0897","NOT HISPANIC OR LATINO","575C5F5C-BA76-49E9-8A0B-FE1F1223BD4D",NA,1748,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,94,"DCAC13FE-5762-4440-8EF6-F20F7ADD987C","83EEECCE-43B3-4131-8D7C-31F19716D157","RACKS_p_TCGAaffxB10b_11_S_GenomeWideSNP_6_C09_429514.CEL","TCGA-13-0897-01A-01",90,10,NA,NA,0,"TOP",1,NA,"TCGA-13-0897-01A-01-TS1",89,"Paclitaxel","Chemotherapy","TCGA-13-0897-D24702",NA,NA,NA,"TCGA-13-0897-F24700_NTE-2",NA,1748,"WITH TUMOR","Alive",NA,"TCGA-13-0897-F24700","TCGA-13-0897",NA,"13","0897","YES","C56.9","8441/3","C56.9",NA,NA,-19894,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1748,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,54,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
127408574,124971896,9246311335,"D6973BEB-0DCB-4163-B854-13D7BFB055B2.bw","79fd602b-3e8e-4353-aa78-4f5f170b607d","d6973beb-0dcb-4163-b854-13d7bfb055b2","2016-08-26T15:51:17.864841-05:00","TCGA-25-1328-01A-01R-1565-13_rnaseq_fastq.tar","5e8fcb28-ba88-47c4-bb06-03b34c966492",7153049600,"Illumina HiSeq","593a99aa8826ef186c358e4991f0c3f0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:02:47.542340-05:00","2016-05-03T11:40:21.647690-05:00","5e8fcb28-ba88-47c4-bb06-03b34c966492_analysis.xml","b6ef14e05f60f80ae29fba86addf6949","5ed672ec-e7ae-43b3-8ecc-0bc36f2db4ad",2181,"2016-09-29T22:06:28.658366-05:00","5e8fcb28-ba88-47c4-bb06-03b34c966492_experiment.xml","61be5a014fe642cb83018a03b05f3093","ab4f2fd5-3728-4ced-afac-2fcf1b7b676c",3916,"2016-09-29T19:58:54.507106-05:00","5e8fcb28-ba88-47c4-bb06-03b34c966492_run.xml","43f743490e0d920fbb77c4b0ccf55da5","5c76518c-8e47-4bf9-9eb4-cdab34241e7b",1989,"2016-09-09T16:35:12.660972-05:00","TCGA-25-1328","2016-09-02T19:12:16.466089-05:00","female","TCGA-25-1328_demographic",1963,"white","04824ef8-fadb-546a-bfc0-957cf62e574e","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1328_diagnosis","not reported",13911,"dead","8441/3",2009,1979,"b7fddc9e-b9ea-58bc-8db5-3e808b1953a1","c56.9",-13911,"TCGA-25-1328_treatment","53a24073-31e5-5429-81ae-5e46520bfad4","01",NA,"TCGA-25-1328-01A","1.8","1ff50970-b13c-4aef-bfb7-fb1b516ff079",FALSE,"A2DA7EB3-8E42-4E86-9352-99673F51AEFF","Primary Tumor","1",NA,NA,"2.8",1228694400,"01",117,"TCGA-25-1328-01A-01",95,95,NA,NA,NA,NA,10,5,"2016-09-09T16:35:12.660972-05:00","2016-09-09T16:35:12.660972-05:00",NA,NA,NA,NA,"BOTTOM","TOP",20,5,"8d6019d0-3250-41ee-9af3-cb18b44ee0ea","7302303f-6917-4ca2-9547-8a657c7274e5","TCGA-25-1328-01A-01-BS1","TCGA-25-1328-01A-01-TS1",70,90,"ac96ba4f-f4e5-4a96-b39e-9e3ebf913fa3","RNA","TCGA-25-1328-01A-01R","20fb9f66-3332-49fb-85cc-426099998b0a",1.8,0.16,"UV Spec","R","22","TCGA-25-1328-01A-01R-1565-13","9ba8d6bf-1541-4127-bc60-73091d2d81c7",0.16,NA,NA,NA,NA,"4994cee7-bacc-57c1-a7f9-3d26ef92e4be","TCGA-25-1328_exposure","TCGA-25-1328-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:25:23.000Z","2014-03-22T01:46:02.000Z","5E8FCB28-BA88-47C4-BB06-03B34C966492","1FF50970-B13C-4AEF-BFB7-FB1B516FF079","Unaligned reads",7153049600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9BA8D6BF-1541-4127-BC60-73091D2D81C7","Canada's Michael Smith Genome Sciences Centre","564a5afde4b0ef12181e0e11","79FD602B-3E8E-4353-AA78-4F5F170B607D","Ovarian Serous Cystadenocarcinoma","TAR","AC96BA4F-F4E5-4A96-B39E-9E3EBF913FA3","2014-03-22T01:46:02.000Z","20FB9F66-3332-49FB-85CC-426099998B0A","None","NO",1,1,"Primary Tumor","Mayo Clinic - Rochester",NA,"AC96BA4F-F4E5-4A96-B39E-9E3EBF913FA3",1.8,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d064cdc4-ad95-4e85-b9b0-6871d9c2698d.txt",NA,"TCGA-25-1328-01A",2.8,"C713FC4F-E804-4CDE-9A55-E2302007534C","TCGA",2001,NA,NA,"WITH TUMOR","292F07FF-3C30-465F-A323-47A2753AFDB3",38,"nationwidechildrens.org_clinical.TCGA-25-1328.xml","Dead",2009,"TCGA-25-1328","NOT HISPANIC OR LATINO","9B2CF6B3-C423-4721-90B4-AE9C1FB5C92F",NA,1979,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,117,"7302303F-6917-4CA2-9547-8A657C7274E5","B3DDF0BD-F9DB-40EA-9558-A14414F6F425","TCGA-25-1328-01A-01W-0492-08_IlluminaGA-DNASeq_capture.bam.bai","TCGA-25-1328-01A-01",95,NA,NA,NA,5,"TOP",5,NA,"TCGA-25-1328-01A-01-TS1",90,"Carbo","Chemotherapy","TCGA-25-1328-D26703",NA,NA,NA,"TCGA-25-1328-F26698_NTE-2",NA,1979,"WITH TUMOR","Dead",2009,"TCGA-25-1328-F26698","TCGA-25-1328",NA,"25","1328","YES","C56.9","8441/3","C56.9",NA,NA,-13911,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1979,2009,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,38,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102195196,99510576,7373609700,"AB119B64-C950-4736-A5D3-7B930D0B68BD.bw","7a08efd0-f984-430e-a8eb-1881047214b6","ab119b64-c950-4736-a5d3-7b930d0b68bd","2016-08-22T00:11:42.047250-05:00","TCGA-61-2102-01A-01R-1568-13_rnaseq_fastq.tar","8a036fcb-a285-458a-86c0-d8dd09f9f62f",6701342720,"Illumina HiSeq","b57cd703bb7583616930fbf8e58c3f3d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:29:16.936913-05:00","2016-05-03T11:56:42.628809-05:00","8a036fcb-a285-458a-86c0-d8dd09f9f62f_analysis.xml","aec3db867dda0dc10c5aed2046755ea5","de8b419c-36e4-4263-a93f-c067ef0bb2ab",2181,"2016-09-29T19:21:51.381733-05:00","8a036fcb-a285-458a-86c0-d8dd09f9f62f_experiment.xml","ca86c43649597e2ddb965e62ec7dbf86","45777ce0-e0cb-4ba0-85f7-8507a4fd2869",3916,"2016-09-29T22:17:32.080030-05:00","8a036fcb-a285-458a-86c0-d8dd09f9f62f_run.xml","baf788ba7914316f25777e6dad2909da","b21851df-34f0-438e-b477-22067625f24a",1988,"2016-09-08T12:03:26.774360-05:00","TCGA-61-2102","2016-09-02T18:56:13.319858-05:00","female","TCGA-61-2102_demographic",1925,"white","59f2314e-8e36-5351-b82e-da8dc14da71e","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2102_diagnosis","not reported",27256,"dead","8441/3",197,197,"84670ab1-8300-5eb8-b801-8c98bdb6bb25","c56.9",-27256,"TCGA-61-2102_treatment","fb9a5e5e-2e41-553f-884d-4c76f7b94700","01",NA,"TCGA-61-2102-01A","0.5","d800778e-cc83-4447-9cfa-ca29adeacb8f",FALSE,"f0521e47-1cc3-4f72-9efd-3d128f57e614","Primary Tumor","0.3",NA,NA,"1.5",1250467200,"01",162,"TCGA-61-2102-01A-01",85,85,NA,NA,85,25,85,0,"2016-09-08T12:03:26.774360-05:00","2016-09-08T12:03:26.774360-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,15,"560f25cb-a79f-4eee-ad74-a0130d207db1","1597b3f0-3481-4fe3-964c-3d54a2db6283","TCGA-61-2102-01A-01-TS1","TCGA-61-2102-01A-01-BS1",5,60,"91fba3e8-2706-4172-a6e6-50e092077678","RNA","TCGA-61-2102-01A-01R","b1bbb84a-afce-4949-8ce6-bbf3488d7e49",1.8,0.15,"UV Spec","R","22","TCGA-61-2102-01A-01R-1568-13","7ac6af79-c14a-4026-84aa-a288afcb96da",0.15,NA,NA,NA,NA,"20f2c491-f925-52d2-803c-e88009aab836","TCGA-61-2102_exposure","TCGA-61-2102-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T02:24:18.000Z","2014-08-26T03:19:21.000Z","8A036FCB-A285-458A-86C0-D8DD09F9F62F","D800778E-CC83-4447-9CFA-CA29ADEACB8F","Unaligned reads",6701342720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7AC6AF79-C14A-4026-84AA-A288AFCB96DA","Canada's Michael Smith Genome Sciences Centre","564a3ea6e4b093830b6a4d9b","7A08EFD0-F984-430E-A8EB-1881047214B6","Ovarian Serous Cystadenocarcinoma","TAR","91FBA3E8-2706-4172-A6E6-50E092077678","2014-08-26T03:19:21.000Z","B1BBB84A-AFCE-4949-8CE6-BBF3488D7E49","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"91FBA3E8-2706-4172-A6E6-50E092077678",0.5,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0f492d79-0174-4e9f-8693-2827ba83fd7c.txt",NA,"TCGA-61-2102-01A",1.5,"9C357105-FE4D-4EC2-93E3-529F563FD5D8","TCGA",1999,NA,NA,"WITH TUMOR","D800778E-CC83-4447-9CFA-CA29ADEACB8F",74,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0f492d79-0174-4e9f-8693-2827ba83fd7c.txt","Dead",197,"TCGA-61-2102",NA,"0B2AA437-7686-4D29-AC07-BC166237EDBF",NA,197,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,162,"560F25CB-A79F-4EEE-AD74-A0130D207DB1","D9F31D91-CBFE-4AC6-B5CC-EB781C640E1A","C239.TCGA-61-2102-01A-01W-0722-08.4.bam.bai","TCGA-61-2102-01A-01",85,25,NA,NA,0,"BOTTOM",15,NA,"TCGA-61-2102-01A-01-BS1",60,"Carboplatin","Chemotherapy","TCGA-61-2102-D28440",NA,NA,NA,NA,NA,197,"WITH TUMOR","Dead",197,"TCGA-61-2102-F28438","TCGA-61-2102",NA,"61","2102","YES","C56.9","8441/3","C56.9",NA,NA,-27256,"FEMALE","WHITE",NA,NA,"No","Dead",197,197,NA,NA,"WITH TUMOR","NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,74,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
133570930,129885618,9617662196,"42CC2290-AB0C-4423-B367-3C37D9744419.bw","7ab3765f-910a-41c9-86cc-08534d2a4e4b","42cc2290-ab0c-4423-b367-3c37d9744419","2016-09-29T19:17:39.514512-05:00","TCGA-61-1907-01A-01R-1567-13_rnaseq_fastq.tar","f3605166-32a9-4fb3-9dcc-4ddb688f0d7a",8106936320,"Illumina HiSeq","7bc8daafe18f569b8fd283b04b93e124","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:30:20.295368-05:00","2016-05-03T11:41:05.740763-05:00","f3605166-32a9-4fb3-9dcc-4ddb688f0d7a_analysis.xml","40734695ba1a4354c0a987307f871788","df32784d-0d11-48ab-9ecb-99f26b209eb0",2181,"2016-08-29T06:46:07.022891-05:00","f3605166-32a9-4fb3-9dcc-4ddb688f0d7a_experiment.xml","5fa73af9841ca8bb7bb9a1818408a72f","5f8d92a9-2827-430f-a150-aaad1d93ac72",3916,"2016-09-29T23:48:11.009791-05:00","f3605166-32a9-4fb3-9dcc-4ddb688f0d7a_run.xml","226d42ecedb199d188f1736c5dfa54ef","ea5ac2d4-8f8a-4d75-950d-838b5d96b2f6",1988,"2016-09-08T11:04:10.215108-05:00","TCGA-61-1907","2016-09-02T18:47:35.858423-05:00","female","TCGA-61-1907_demographic",1943,"white","6bdcf0d2-e322-541f-990b-836a67d89453","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1907_diagnosis","not reported",23204,"alive","8441/3",NA,952,"f1a0d46b-6431-59c0-a037-7730f9269b42","c56.9",-23204,"TCGA-61-1907_treatment","e2cf157b-2a68-59de-a307-1262ad857b1b","01",NA,"TCGA-61-1907-01A","0.9","0230bc74-adc5-4443-ac9e-342d7f344ce7",FALSE,"ae7e4795-496e-47d0-ad60-cec04e5876b0","Primary Tumor","0.4",NA,NA,"1.6",1246233600,"01",121,"TCGA-61-1907-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T11:04:10.215108-05:00","2016-09-08T11:04:10.215108-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,1,"525f99b8-8596-4e25-b42a-4832e9dcb408","b0464aeb-8877-43cb-82b3-e993183285a6","TCGA-61-1907-01A-01-BS1","TCGA-61-1907-01A-01-TS1",95,94,"32c4eb7d-281f-409c-9115-266eccf8c0c2","RNA","TCGA-61-1907-01A-01R","12df98d3-bfc2-4207-8572-ea9ce1373de3",1.8,0.15,"UV Spec","R","22","TCGA-61-1907-01A-01R-1567-13","6d9a1fe4-7131-487c-a7ff-0cf8a53919ed",0.15,NA,NA,NA,NA,"fade20dd-fa87-5c8b-a1c7-a0dcab04f72a","TCGA-61-1907_exposure","TCGA-61-1907-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T22:31:24.000Z","2014-03-26T22:53:02.000Z","F3605166-32A9-4FB3-9DCC-4DDB688F0D7A","0230BC74-ADC5-4443-AC9E-342D7F344CE7","Unaligned reads",8106936320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6D9A1FE4-7131-487C-A7FF-0CF8A53919ED","Canada's Michael Smith Genome Sciences Centre","564a5b2be4b0298dd2cc1402","7AB3765F-910A-41C9-86CC-08534D2A4E4B","Ovarian Serous Cystadenocarcinoma","TAR","32C4EB7D-281F-409C-9115-266ECCF8C0C2","2014-03-26T22:53:02.000Z","12DF98D3-BFC2-4207-8572-EA9CE1373DE3","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"32C4EB7D-281F-409C-9115-266ECCF8C0C2",0.9,"61","4493922178_R01C01_Grn.idat",NA,"TCGA-61-1907-01A",1.6,"B7771071-32EA-49C0-95CE-797CCCA2D8B5","TCGA",2006,NA,NA,"WITH TUMOR","50C4ACBD-0A7B-4473-B70C-5631566A1851",63,"bcgsc.ca.TCGA-61-1907-01A-01R-1567-13.bcgsc.ca.1.5.0.snv.vcf","Alive",NA,"TCGA-61-1907","NOT HISPANIC OR LATINO","62747011-66CB-4750-A1B1-5614DE54B2E5",NA,952,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,121,"B0464AEB-8877-43CB-82B3-E993183285A6","BD2F433B-6882-465C-9F7C-D096C9B511A5","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_B06_495114.byallele.copynumber.data.txt","TCGA-61-1907-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-61-1907-01A-01-TS1",94,"Oxaliplatin","Chemotherapy","TCGA-61-1907-D28251",NA,NA,NA,"TCGA-61-1907-F28250_NTE-1",NA,952,"WITH TUMOR","Alive",NA,"TCGA-61-1907-F28250","TCGA-61-1907",NA,"61","1907","YES","C56.9","8441/3","C56.9",NA,NA,-23204,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",952,NA,NA,NA,"WITH TUMOR","NO",1,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156202458,148662121,11007453903,"9BC72F77-4106-465C-A9D0-0446E112F218.bw","7c466a5f-a6b4-4d1a-a0f5-ddcd7ef90ff1","9bc72f77-4106-465c-a9d0-0446e112f218","2016-08-25T18:52:50.175806-05:00","TCGA-23-1109-01A-01R-1564-13_rnaseq_fastq.tar","1c065e74-f28d-40ff-86b2-3674dc65d231",10330183680,"Illumina HiSeq","c35f7f45861ee75a7e697a8dccb660fe","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:21:11.153815-05:00","2016-05-03T11:27:59.354684-05:00","1c065e74-f28d-40ff-86b2-3674dc65d231_analysis.xml","25749967984ad02a9bc578cf1562a3db","8f4c39a7-8a02-4c81-82f2-c05804eb04ed",2183,"2016-08-27T23:10:24.700758-05:00","1c065e74-f28d-40ff-86b2-3674dc65d231_experiment.xml","7651ea65a4455fab867b1faf44b419e2","4c47ba1f-72b3-49bf-b532-f7f0d4873786",3916,"2016-09-29T18:48:23.936517-05:00","1c065e74-f28d-40ff-86b2-3674dc65d231_run.xml","c8ced28fafdb585f298a5ded7dcbd149","30595391-8b74-4bbf-b806-198a4ed403ee",1990,"2016-09-08T12:30:12.401590-05:00","TCGA-23-1109","2016-09-02T19:05:59.932194-05:00","female","TCGA-23-1109_demographic",1937,"white","51854744-93b7-5026-a52b-398fdc2b8ec0","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1109_diagnosis","not reported",23002,"dead","8441/3",1562,1562,"412e8ae0-f962-5ef4-8fa1-0cb072d378af","c56.9",-23002,"TCGA-23-1109_treatment","5ad1d6e4-f119-548e-994c-585e7119e113","01",NA,"TCGA-23-1109-01A","0.9","146f9463-de59-4418-9099-2425a6f86a0f",FALSE,"d70d81ca-5eb2-426c-afc7-4d52bc36bfb2","Primary Tumor","0.8",NA,NA,"1",1227657600,"01",105,"TCGA-23-1109-01A-01",90,90,NA,NA,0,0,NA,NA,"2016-09-08T12:30:12.401590-05:00","2016-09-08T12:30:12.401590-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"36198b33-5879-4991-91b7-f5b6621f8f6d","97b03fed-53f2-4f0d-92f8-bd428a8727c9","TCGA-23-1109-01A-01-BS1","TCGA-23-1109-01A-01-TS1",NA,NA,"2cae90e9-d2b6-413c-a453-1c477e8fb206","RNA","TCGA-23-1109-01A-01R","522ecca3-fee2-4364-8b5b-692b49128ed0",1.8,0.15,"UV Spec","R","22","TCGA-23-1109-01A-01R-1564-13","d47e074a-f78e-40c5-8af4-f737ce010041",0.15,NA,NA,NA,NA,"6601a690-32ba-5451-92c3-54bd7e222a45","TCGA-23-1109_exposure","TCGA-23-1109-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-21T01:10:46.000Z","2013-12-21T01:33:01.000Z","1C065E74-F28D-40FF-86B2-3674DC65D231","146F9463-DE59-4418-9099-2425A6F86A0F","Unaligned reads",10330183680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D47E074A-F78E-40C5-8AF4-F737CE010041","Canada's Michael Smith Genome Sciences Centre","564a3453e4b08c5d868f40f4","7C466A5F-A6B4-4D1A-A0F5-DDCD7EF90FF1","Ovarian Serous Cystadenocarcinoma","TAR","2CAE90E9-D2B6-413C-A453-1C477E8FB206","2013-12-21T01:33:01.000Z","522ECCA3-FEE2-4364-8B5B-692B49128ED0","None","NO",1,0.8,"Primary Tumor","Cedars Sinai",NA,"2CAE90E9-D2B6-413C-A453-1C477E8FB206",0.9,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b8d71b4b-6d11-47da-b15d-a3eac835a9a9.txt",NA,"TCGA-23-1109-01A",1,NA,"TCGA",1999,NA,NA,"WITH TUMOR","146F9463-DE59-4418-9099-2425A6F86A0F",62,"QUANT_p_TCGA_Batch12_AFFX_GenomeWideSNP_6_E03_437742.nocnv_hg18.seg.txt","Dead",1562,"TCGA-23-1109","NOT HISPANIC OR LATINO","BF98D383-003D-451A-B7FA-7986DF387D5C",NA,1562,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,"9294A1C2-8B3A-40E0-8112-1DD01671610E","WHITE",NA,1,105,"97B03FED-53F2-4F0D-92F8-BD428A8727C9","FFCA94EB-30E7-4D2A-AE16-7849D047CA19","4493586071_E_Grn.idat","TCGA-23-1109-01A-01",90,0,NA,NA,NA,"TOP",0,NA,"TCGA-23-1109-01A-01-TS1",NA,NA,NA,NA,"TCGA-23-1109-R25664","EXTERNAL BEAM","Local Recurrence","TCGA-23-1109-F25663_NTE-2",NA,1562,"WITH TUMOR","Dead",1562,"TCGA-23-1109-F25663","TCGA-23-1109",NA,"23","1109","YES","C56.9","8441/3","C56.9",NA,NA,-23002,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1562,1562,NA,NA,"WITH TUMOR","NO",19,2,2009,"YES","NO","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,62,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102213026,94825803,6966651660,"D80B6617-0E4C-47C9-A2A5-E4C1CDD11D54.bw","7ca97692-0bf5-4bbd-81ce-10a051d04bd5","d80b6617-0e4c-47c9-a2a5-e4c1cdd11d54","2016-08-26T16:29:46.807616-05:00","TCGA-10-0938-01A-02R-1564-13_rnaseq_fastq.tar","0a6685a0-7df2-480b-bbcb-b4a6c0959ab8",6983628800,"Illumina HiSeq","52bf56d21c9d6fd836259628fb7aa456","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:07:54.393679-05:00","2016-05-03T11:39:34.522989-05:00","0a6685a0-7df2-480b-bbcb-b4a6c0959ab8_analysis.xml","1d9954f8948c1b95877d292af02d1480","ac2dd6ee-ddbc-47b5-a200-d3a510ce18ae",2208,"2016-09-29T18:39:30.580440-05:00","0a6685a0-7df2-480b-bbcb-b4a6c0959ab8_experiment.xml","71258193975934e753e0612682f39177","2aac98f3-55ef-49df-99c5-23f612f06ce6",3916,"2016-09-29T22:02:14.546628-05:00","0a6685a0-7df2-480b-bbcb-b4a6c0959ab8_run.xml","88aefdc9a101ee96ee2ed3729bd91acd","a8c03d2a-553c-46b0-983c-17c168b469ab",1988,"2016-09-08T12:22:04.168006-05:00","TCGA-10-0938","2016-09-02T19:05:28.872338-05:00","female","TCGA-10-0938_demographic",1922,"white","6b9e14b1-a534-5fd8-9147-5a6e1b068be7","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0938_diagnosis","not reported",29558,"dead","8441/3",636,604,"95b0caf3-50a8-5bc7-ac12-e0b9f543e36e","c56.9",-29558,"TCGA-10-0938_treatment","897d1bc2-1b39-5451-96fa-c762361d9bce","01",NA,"TCGA-10-0938-01A","0.6","c11664e8-8883-4a0f-87c3-6fdc903860d5",FALSE,"faa8920a-3b4a-4767-bdb1-5d086e51fe92","Primary Tumor","0.6",NA,NA,"1",1233705600,"02",169,"TCGA-10-0938-01A-02",80,85,NA,NA,5,10,15,20,"2016-09-08T12:22:04.168006-05:00","2016-09-08T12:22:04.168006-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"4143e826-d8fd-41bd-a948-34cbcc3c7518","22a8ea74-7de1-453c-857c-2e7001fa42fe","TCGA-10-0938-01A-02-BS2","TCGA-10-0938-01A-01-BS1",80,70,"e49c6c83-a54e-4c21-bfeb-4921e4499545","RNA","TCGA-10-0938-01A-02R","fa99d9ea-8c28-4870-886c-bc160ae6b166",1.8,0.16,"UV Spec","R","22","TCGA-10-0938-01A-02R-1564-13","f7b5774e-bfb3-4e6d-8a24-009f3c294109",0.16,NA,NA,NA,NA,"a8087d55-acf0-51f4-9b6c-849f7cd48e8f","TCGA-10-0938_exposure","TCGA-10-0938-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-19T22:19:17.000Z","2014-03-19T22:34:02.000Z","0A6685A0-7DF2-480B-BBCB-B4A6C0959AB8","C11664E8-8883-4A0F-87C3-6FDC903860D5","Unaligned reads",6983628800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F7B5774E-BFB3-4E6D-8A24-009F3C294109","Canada's Michael Smith Genome Sciences Centre","564a3d3ae4b093830b69d956","7CA97692-0BF5-4BBD-81CE-10A051D04BD5","Ovarian Serous Cystadenocarcinoma","TAR","E49C6C83-A54E-4C21-BFEB-4921E4499545","2014-03-19T22:34:02.000Z","FA99D9EA-8C28-4870-886C-BC160AE6B166","None","NO",1,0.6,"Primary Tumor","MD Anderson Cancer Center",NA,"E49C6C83-A54E-4C21-BFEB-4921E4499545",0.6,"10","TCGA-10-0938-01A-02R-1564-13_rnaseq_fastq.tar",NA,"TCGA-10-0938-01A",1,"C66F69B0-DCCA-4E31-A97D-F082C418B72E","TCGA",2002,NA,NA,"WITH TUMOR","C11664E8-8883-4A0F-87C3-6FDC903860D5",80,"nationwidechildrens.org_clinical.TCGA-10-0938.xml","Dead",636,"TCGA-10-0938",NA,"18A036E5-6796-4246-8BB6-2F23E0727CA7",NA,604,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",2,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,2,169,"4143E826-D8FD-41BD-A948-34CBCC3C7518","B63603A0-6078-4CD3-9EBE-4264BA190EB6","TCGA-10-0938-01A-02R-1564-13_rnaseq.bam.bai","TCGA-10-0938-01A-02",80,5,NA,NA,15,"BOTTOM",0,NA,"TCGA-10-0938-01A-02-BS2",80,"Carboplatin","Chemotherapy","TCGA-10-0938-D24484",NA,NA,NA,"TCGA-10-0938-F24483_NTE-2",NA,604,"WITH TUMOR","Dead",636,"TCGA-10-0938-F24483","TCGA-10-0938",NA,"10","0938","YES","C56.9","8441/3","C56.9",NA,NA,-29558,"FEMALE","WHITE",NA,NA,"No","Dead",604,636,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,80,2002,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA
229166248,222622654,16409457529,"8547C275-DB56-4B91-8094-6A0C7F39B3CC.bw","7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e","8547c275-db56-4b91-8094-6a0c7f39b3cc","2016-08-26T00:02:38.833491-05:00","TCGA-09-2044-01B-01R-1568-13_rnaseq_fastq.tar","33dbeedd-0d3c-4ecb-aca9-a8624c46746a",14536714240,"Illumina HiSeq","f2184ac1af84b2d93dd5c10acc241ad7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:42:28.829395-05:00","2016-05-03T11:41:05.755204-05:00","33dbeedd-0d3c-4ecb-aca9-a8624c46746a_analysis.xml","7a6f4e7e358a5d0eac4924b5cb745534","9c57ccd6-ee3b-4d71-975b-6e0c26b1a5db",2183,"2016-09-29T18:44:52.686281-05:00","33dbeedd-0d3c-4ecb-aca9-a8624c46746a_experiment.xml","5aa1aa7c05809e68fd74f53e01c31d93","2e1ec292-734d-4a39-8787-02be0f103b1d",3916,"2016-09-29T22:17:05.153512-05:00","33dbeedd-0d3c-4ecb-aca9-a8624c46746a_run.xml","7d32e5965699b9cafa42f44bcfdd1751","b1cfba9e-6b6a-4d82-b526-d044f900b030",1990,"2016-09-08T13:47:51.628412-05:00","TCGA-09-2044","2016-09-02T19:11:44.602863-05:00","female","TCGA-09-2044_demographic",1932,"asian","1d738d5b-91e3-54ea-8834-4818e8cc11ed","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2044_diagnosis","not reported",28231,"alive","8441/3",NA,186,"44bb6d41-522c-5051-b9a5-d0fb8e4f3d93","c56.9",-28231,"TCGA-09-2044_treatment","154fbe2f-d112-5bb8-8427-fb209bdab068","01",NA,"TCGA-09-2044-01B","1.4","1f60c05e-f171-4815-b0da-40aa1b24f300",FALSE,"42d7c4ad-b379-4dc0-ba67-16aa6ead89d9","Primary Tumor","0.4",NA,NA,"1.8",1248134400,"01",159,"TCGA-09-2044-01B-01",90,95,NA,NA,1,0,9,5,"2016-09-08T13:47:51.628412-05:00","2016-09-08T13:47:51.628412-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"e382e900-de5f-4cf6-87b9-afa4aebea4b4","3ee9af83-dbc6-4c81-9732-2c174fb32946","TCGA-09-2044-01B-01-TS1","TCGA-09-2044-01B-01-BS1",90,94,"815854b2-c54d-49b8-b1f4-7773d1dad3d0","RNA","TCGA-09-2044-01B-01R","08693365-98ab-4cc4-8bd7-a2778680f41e",1.8,0.15,"UV Spec","R","22","TCGA-09-2044-01B-01R-1568-13","658b4847-33bc-414c-a2bb-ce9379ef57bd",0.15,NA,NA,NA,NA,"74de3056-5c7a-535c-95a2-77211c636726","TCGA-09-2044_exposure","TCGA-09-2044-01B-01R-1568-13_rnaseq_fastq.tar","2014-03-27T03:53:01.000Z","2014-03-27T04:18:02.000Z","33DBEEDD-0D3C-4ECB-ACA9-A8624C46746A","1F60C05E-F171-4815-B0DA-40AA1B24F300","Unaligned reads",14536714240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","658B4847-33BC-414C-A2BB-CE9379EF57BD","Canada's Michael Smith Genome Sciences Centre","564a3b24e4b08c5d86916d68","7D03DDB6-F3FE-4B50-8BBA-514AA65E7D0E","Ovarian Serous Cystadenocarcinoma","TAR","815854B2-C54D-49B8-B1F4-7773D1DAD3D0","2014-03-27T04:18:02.000Z","08693365-98AB-4CC4-8BD7-A2778680F41E","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"815854B2-C54D-49B8-B1F4-7773D1DAD3D0",1.4,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.32c1a264-b1dd-4307-ab4d-f710ea9692cc.txt",NA,"TCGA-09-2044-01B",1.8,"47992E98-D20A-4EAA-8D9A-E0098CF2E22A","TCGA",2009,NA,NA,"TUMOR FREE","35DE4A50-30D7-4AC6-BF08-BDFD95C8C135",77,"nationwidechildrens.org_clinical.TCGA-09-2044.xml","Alive",NA,"TCGA-09-2044","NOT HISPANIC OR LATINO","EC42F6F2-8D69-40BE-A123-4B0A090AF2D2",NA,186,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"ASIAN",NA,1,159,"E382E900-DE5F-4CF6-87B9-AFA4AEBEA4B4","D491CF80-BFBD-46CB-B1D4-797A214E2BD7","TCGA-09-2044-01B-01R-1568-13_mirna.bam","TCGA-09-2044-01B-01",90,1,NA,NA,9,"TOP",0,NA,"TCGA-09-2044-01B-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-09-2044-D24335",NA,NA,NA,NA,NA,186,"TUMOR FREE","Alive",NA,"TCGA-09-2044-F24334","TCGA-09-2044",NA,"09","2044","YES","C56.9","8441/3","C56.9",NA,NA,-28231,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",186,NA,NA,NA,"TUMOR FREE","NO",2,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,77,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
287185562,273751750,20271197820,"A9A3A33B-82B2-44CF-86A6-664BCA31B01E.bw","7d1e9451-7a6a-4086-af7f-3ed57505daf0","a9a3a33b-82b2-44cf-86a6-664bca31b01e","2016-09-29T22:03:43.410284-05:00","TCGA-30-1855-01A-01R-1567-13_rnaseq_fastq.tar","0d58428a-b523-4aa2-b8bb-bfac271e9731",19109263360,"Illumina HiSeq","69e2370c51c67b1af136b86bc2fdd6bf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:36:02.041678-05:00","2016-05-03T11:41:05.748550-05:00","0d58428a-b523-4aa2-b8bb-bfac271e9731_analysis.xml","8c72605846702fcf24e487af4215d47b","72ff3428-cf12-4fc8-9b2c-6ae95717e3ca",2181,"2016-08-13T02:20:23.390275-05:00","0d58428a-b523-4aa2-b8bb-bfac271e9731_experiment.xml","388655482043c94fc4d4f71f15a1c74b","64a9a3e4-2599-45f5-adb8-5936a82b2db6",3916,"2016-09-29T22:55:14.410352-05:00","0d58428a-b523-4aa2-b8bb-bfac271e9731_run.xml","d7fefea933c0e0b3c48d340242db7f50","c968b20e-a8a1-4965-91be-8c202cac9f2f",1989,"2016-09-08T10:49:26.452776-05:00","TCGA-30-1855","2016-09-02T18:48:12.097833-05:00","female","TCGA-30-1855_demographic",1940,"white","d4ad8143-9fc3-5b79-9367-651779374b19","not hispanic or latino",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1855_diagnosis","not reported",22394,"dead","8441/3",75,75,"2db40c1c-301c-58b3-8fd4-4144f4d41779","c56.9",-22394,"TCGA-30-1855_treatment","fcb0a9f1-f52d-52c1-a814-5d5107a211c2","01",NA,"TCGA-30-1855-01A","0.6","74590212-e087-46be-aaf2-43e259aef8e6",FALSE,"cba111de-b005-4460-b4d1-d8b24126d1d3","Primary Tumor","0.4",NA,NA,"1",1245369600,"01",106,"TCGA-30-1855-01A-01",70,95,NA,NA,0,0,40,10,"2016-09-08T10:49:26.452776-05:00","2016-09-08T10:49:26.452776-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"1829cd37-82d6-4958-b2e3-15aa55f1ee99","aef422e1-e675-4917-a6a3-0a8aeed50cf2","TCGA-30-1855-01A-01-TS1","TCGA-30-1855-01A-01-BS1",60,90,"7342fea7-7250-4f29-955a-56640389f634","RNA","TCGA-30-1855-01A-01R","1f2a2f72-e682-4b0b-af0a-06f6cf4f413d",1.8,0.15,"UV Spec","R","22","TCGA-30-1855-01A-01R-1567-13","732d0664-c343-4a63-9dc3-40985e540a59",0.15,NA,NA,NA,NA,"4e2c94b4-c31e-56a6-8338-017344e4564f","TCGA-30-1855_exposure","TCGA-30-1855-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T00:44:32.000Z","2014-03-29T01:48:02.000Z","0D58428A-B523-4AA2-B8BB-BFAC271E9731","74590212-E087-46BE-AAF2-43E259AEF8E6","Unaligned reads",19109263360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","732D0664-C343-4A63-9DC3-40985E540A59","Canada's Michael Smith Genome Sciences Centre","564a57bfe4b0ef12181cfaed","7D1E9451-7A6A-4086-AF7F-3ED57505DAF0","Ovarian Serous Cystadenocarcinoma","TAR","7342FEA7-7250-4F29-955A-56640389F634","2014-03-29T01:48:02.000Z","1F2A2F72-E682-4B0B-AF0A-06F6CF4F413D","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"7342FEA7-7250-4F29-955A-56640389F634",0.6,"30","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6b1438ab-2904-4d21-865d-f14c76777f62.txt",NA,"TCGA-30-1855-01A",1,NA,"TCGA",2001,NA,NA,"WITH TUMOR","C5652F22-39B2-4F87-AF4B-5F5C66F763FB",61,"4828606041_B_Grn.idat","Dead",75,"TCGA-30-1855","NOT HISPANIC OR LATINO","87943368-20BB-43F9-8D5A-B63C57B9E63D",NA,75,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,106,"AEF422E1-E675-4917-A6A3-0A8AEED50CF2","FD6B4A16-36A4-4658-AA51-622F996E4405","TCGA-30-1855-01A-01R-1567-13_mirna.bam.bai","TCGA-30-1855-01A-01",70,0,NA,NA,40,"TOP",0,NA,"TCGA-30-1855-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,NA,75,"WITH TUMOR","Dead",75,"TCGA-30-1855-F27550","TCGA-30-1855",NA,"30","1855","YES","C56.9","8441/3","C56.9",NA,NA,-22394,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",75,75,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,61,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
258817320,251548673,18648009301,"FF6ED40A-A666-484D-A9E1-B14F226EF7B6.bw","7d82ce56-32eb-4107-aa5c-c568764805c9","ff6ed40a-a666-484d-a9e1-b14f226ef7b6","2016-08-27T08:05:14.722035-05:00","TCGA-36-1569-01A-01R-1566-13_rnaseq_fastq.tar","d595bf3d-5882-4a79-8af6-7367afd25709",17107107840,"Illumina HiSeq","9bd62a1bec708cb391b943e0e256a4c4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:03:04.012264-05:00","2016-05-03T11:41:05.750744-05:00","d595bf3d-5882-4a79-8af6-7367afd25709_analysis.xml","399967206a917f6ce215a56d97951a7c","83da2427-fe48-4d20-9a5a-a4c62a782c89",2181,"2016-09-29T23:14:59.299199-05:00","d595bf3d-5882-4a79-8af6-7367afd25709_experiment.xml","3062a21d4ef2f4d2f860fc48d26eeb39","d5be64b7-ed1e-4f9a-94c4-c8a128cc86b6",3916,"2016-09-29T18:16:12.670887-05:00","d595bf3d-5882-4a79-8af6-7367afd25709_run.xml","6e94926598bf237bc1cdd5cecc7eb81b","1c0c65a5-6b3b-466e-bf36-7b64b7de5aed",1989,"2016-09-08T12:14:41.390328-05:00","TCGA-36-1569","2016-09-02T18:48:45.096570-05:00","female","TCGA-36-1569_demographic",1955,"white","ccfa0a00-6da8-544e-b65d-fcaddc7d839a","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1569_diagnosis","not reported",19151,"alive","8441/3",NA,885,"e53d6502-63a5-5b12-b41d-ff5effc62a8e","c56.9",-19151,"TCGA-36-1569_treatment","499ee2db-64c0-5acc-8b37-9c55a09eea9c","01",NA,"TCGA-36-1569-01A","0.9","eacec9c7-f638-4f61-bd7b-a60995267213",FALSE,"52192360-2ACE-401C-9642-B3D6F677362D","Primary Tumor","0.4",NA,NA,"1.6",1235779200,"01",106,"TCGA-36-1569-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:14:41.390328-05:00","2016-09-08T12:14:41.390328-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"f47a78ac-7858-487d-9012-24c5c39db80d","2db04a2a-1eb8-4a91-8876-32d02009cacb","TCGA-36-1569-01A-01-TS1","TCGA-36-1569-01A-01-BS1",90,90,"88aee093-9b08-418d-a13b-bfeec9fc3925","RNA","TCGA-36-1569-01A-01R","f163f23e-7afd-45d5-aec2-0cfb89cbb5e8",1.8,0.16,"UV Spec","R","22","TCGA-36-1569-01A-01R-1566-13","bb12d2f5-1865-435a-8edf-f9ee7689e0a4",0.16,NA,NA,NA,NA,"76be120f-a72f-5d20-b2c3-cd1fef8d8b1c","TCGA-36-1569_exposure","TCGA-36-1569-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T07:43:47.000Z","2014-03-28T20:27:02.000Z","D595BF3D-5882-4A79-8AF6-7367AFD25709","EACEC9C7-F638-4F61-BD7B-A60995267213","Unaligned reads",17107107840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BB12D2F5-1865-435A-8EDF-F9EE7689E0A4","Canada's Michael Smith Genome Sciences Centre","564a5918e4b0ef12181d6ddb","7D82CE56-32EB-4107-AA5C-C568764805C9","Ovarian Serous Cystadenocarcinoma","TAR","88AEE093-9B08-418D-A13B-BFEEC9FC3925","2014-03-28T20:27:02.000Z","F163F23E-7AFD-45D5-AEC2-0CFB89CBB5E8","None","NO",1,0.4,"Primary Tumor","BC Cancer Agency",NA,"88AEE093-9B08-418D-A13B-BFEEC9FC3925",0.9,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.44783ce8-15cb-45b3-9a4f-e45925356334.txt",NA,"TCGA-36-1569-01A",1.6,NA,"TCGA",2007,NA,NA,NA,"EACEC9C7-F638-4F61-BD7B-A60995267213",52,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.44783ce8-15cb-45b3-9a4f-e45925356334.txt","Alive",NA,"TCGA-36-1569",NA,"770C209C-66CE-470E-A8FC-DABDDCC580D7",NA,885,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,106,"F47A78AC-7858-487D-9012-24C5C39DB80D","F163F23E-7AFD-45D5-AEC2-0CFB89CBB5E8","TCGA-36-1569-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-36-1569-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-36-1569-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,885,NA,"Alive",NA,"TCGA-36-1569-F27855","TCGA-36-1569",NA,"36","1569","YES","C56.9","8441/3","C56.9",NA,NA,-19151,"FEMALE","WHITE",NA,NA,"No","Alive",885,NA,NA,NA,NA,"NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2007,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
110982340,108575302,8037282916,"D6299306-314F-4F29-B777-BBFFBD37B1D6.bw","7dcc809b-e33a-4453-b92a-c00786f48cb0","d6299306-314f-4f29-b777-bbffbd37b1d6","2016-08-26T15:40:54.145025-05:00","TCGA-24-1557-01A-01R-1566-13_rnaseq_fastq.tar","0b4d443d-cfa8-42c0-aaf9-be947584ba59",6753832960,"Illumina HiSeq","766cb7909418656fb46aeefb4b6832fd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:32:13.952005-05:00","2016-05-03T11:40:21.662944-05:00","0b4d443d-cfa8-42c0-aaf9-be947584ba59_analysis.xml","baf61ddba1eae4af09cc79ec45eb7bce","70b690d0-86e9-4d98-b3e8-bee5a43faabf",2181,"2016-09-29T23:59:58.444670-05:00","0b4d443d-cfa8-42c0-aaf9-be947584ba59_experiment.xml","b77f0061bd97b0d70f7681203df9f208","f1a0d152-991b-4bc0-9092-6c8e91bc64f8",3916,"2016-09-29T22:55:55.919759-05:00","0b4d443d-cfa8-42c0-aaf9-be947584ba59_run.xml","f7591b55c4ee0898ca48f704241c8baa","c9d16344-c1ba-4111-a8fa-3cac6df30c10",1988,"2016-09-08T10:39:22.339595-05:00","TCGA-24-1557","2016-09-02T18:48:48.297885-05:00","female","TCGA-24-1557_demographic",1951,"white","c20d3b88-776c-5d07-aa24-9bff0c574c2b","not reported",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1557_diagnosis","not reported",17943,"dead","8441/3",1213,1213,"017a1126-1b80-5060-b971-d27b20147a99","c56.9",-17943,"TCGA-24-1557_treatment","e67a217f-812e-5248-be04-40dd2c35c244","01",NA,"TCGA-24-1557-01A","0.9","fa79b363-380e-48ae-bb82-db395085353c",FALSE,"ec04339c-f1ae-4519-bddf-e60cc1f30d52","Primary Tumor","0.5",NA,NA,"1.5",1235347200,"01",121,"TCGA-24-1557-01A-01",90,85,NA,NA,0,0,8,10,"2016-09-08T10:39:22.339595-05:00","2016-09-08T10:39:22.339595-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,5,"37ecb22e-99d5-46d8-b90f-34c35bb96139","d09c8628-1498-4b56-8be4-82531a96b579","TCGA-24-1557-01A-01-TS1","TCGA-24-1557-01A-01-BS1",90,85,"c3c6697d-2ddc-4a7f-9123-14e430ee2766","RNA","TCGA-24-1557-01A-01R","c3cb4f02-5939-4861-8779-3549c858200f",1.8,0.15,"UV Spec","R","22","TCGA-24-1557-01A-01R-1566-13","bca48aa6-25bc-49e4-8bb5-edf38362b4a8",0.15,NA,NA,NA,NA,"b0dcd669-0f99-571d-88b7-d19045df4b98","TCGA-24-1557_exposure","TCGA-24-1557-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T01:27:03.000Z","2014-03-25T01:42:01.000Z","0B4D443D-CFA8-42C0-AAF9-BE947584BA59","FA79B363-380E-48AE-BB82-DB395085353C","Unaligned reads",6753832960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BCA48AA6-25BC-49E4-8BB5-EDF38362B4A8","Canada's Michael Smith Genome Sciences Centre","564a58c7e4b0ef12181d513d","7DCC809B-E33A-4453-B92A-C00786F48CB0","Ovarian Serous Cystadenocarcinoma","TAR","C3C6697D-2DDC-4A7F-9123-14E430EE2766","2014-03-25T01:42:01.000Z","C3CB4F02-5939-4861-8779-3549C858200F","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"C3C6697D-2DDC-4A7F-9123-14E430EE2766",0.9,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d534bbdd-5827-426e-ad74-9346b06716f5.txt",NA,"TCGA-24-1557-01A",1.5,"E57199E1-666F-4ECF-BB4B-4EA3DDD7B2F1","TCGA",2000,NA,NA,"WITH TUMOR","FA79B363-380E-48AE-BB82-DB395085353C",49,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d534bbdd-5827-426e-ad74-9346b06716f5.txt","Dead",1213,"TCGA-24-1557",NA,"300786CC-F4E9-45C3-8987-C78CB62F21EA",NA,1213,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,121,"D09C8628-1498-4B56-8BE4-82531A96B579","C3CB4F02-5939-4861-8779-3549C858200F","TCGA-24-1557-01A-01R-1566-13_GRCh37-lite_mirna.bam","TCGA-24-1557-01A-01",90,0,NA,NA,8,"TOP",2,NA,"TCGA-24-1557-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-24-1557-D26201",NA,NA,NA,"TCGA-24-1557-F26194_NTE-1",NA,1213,"WITH TUMOR","Dead",1213,"TCGA-24-1557-F26194","TCGA-24-1557",NA,"24","1557","YES","C56.9","8441/3","C56.9",NA,NA,-17943,"FEMALE","WHITE",NA,NA,"No","Dead",1213,1213,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
255372788,249868174,18541043769,"56C97EAA-717E-42CE-916F-69BEFD8CC602.bw","7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2","56c97eaa-717e-42ce-916f-69befd8cc602","2016-08-20T10:09:04.119069-05:00","TCGA-24-1105-01A-01R-1565-13_rnaseq_fastq.tar","c77ed0c8-6f4d-4248-af47-bb8a61f4adc5",15733504000,"Illumina HiSeq","82e2b7e05a7f04aa9830545962fc18bb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:46:33.687350-05:00","2016-05-03T11:40:21.669427-05:00","c77ed0c8-6f4d-4248-af47-bb8a61f4adc5_analysis.xml","06b2329b34f4bad3eaab9b67296594b8","79976e0d-2706-457a-b8c0-df9634e2682a",2210,"2016-08-29T03:33:49.404543-05:00","c77ed0c8-6f4d-4248-af47-bb8a61f4adc5_experiment.xml","90cf44dbc549dbe7408365c5becbf74f","db57290d-4f94-4e6c-a932-477d6ff81a58",3916,"2016-09-29T20:13:49.903897-05:00","c77ed0c8-6f4d-4248-af47-bb8a61f4adc5_run.xml","bed1cf1e61df522e157f0b8d72444359","6579cd73-38ee-4f6d-bb92-bc4bd93588ee",1989,"2016-09-08T12:46:02.180340-05:00","TCGA-24-1105","2016-09-02T19:05:58.941036-05:00","female","TCGA-24-1105_demographic",1965,"white","8580420d-47dd-59ce-8343-b6d4b53415e6","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1105_diagnosis","not reported",13187,"dead","8441/3",1442,1442,"fe611014-c242-5d62-9a13-f3b96ce70bc3","c56.9",-13187,"TCGA-24-1105_treatment","6193e8fc-9c24-5bb3-8826-fda7e5d90222","01",NA,"TCGA-24-1105-01A","1","ae4aa065-8b1d-42a3-98ef-357e19c1f1e1",FALSE,"DE593AFC-BC21-4183-94A6-B8BA9931B70F","Primary Tumor","0.8",NA,NA,"1.4",1227657600,"01",130,"TCGA-24-1105-01A-01",90,90,NA,NA,NA,NA,NA,NA,"2016-09-08T12:46:02.180340-05:00","2016-09-08T12:46:02.180340-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,5,"b1eba572-c739-453d-8612-b5e33a50bbac","6aefaf25-f9ca-4d2e-8fe1-c76af069cfb9","TCGA-24-1105-01A-01-TS1","TCGA-24-1105-01A-01-BS1",NA,NA,"c73cc52e-7d80-4c6c-9687-02d63adf0835","RNA","TCGA-24-1105-01A-01R","c75d7ff8-f0b7-4084-a2fd-bb843cfa7a7a",1.8,0.15,"UV Spec","R","22","TCGA-24-1105-01A-01R-1565-13","fd57adc4-669c-4916-a2f5-e5f92cb0adb6",0.15,NA,NA,NA,NA,"eeb2cd91-bb70-5ff5-819c-f3d2d01c37d7","TCGA-24-1105_exposure","TCGA-24-1105-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:42:39.000Z","2014-03-22T06:15:01.000Z","C77ED0C8-6F4D-4248-AF47-BB8A61F4ADC5","AE4AA065-8B1D-42A3-98EF-357E19C1F1E1","Unaligned reads",15733504000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FD57ADC4-669C-4916-A2F5-E5F92CB0ADB6","Canada's Michael Smith Genome Sciences Centre","564a3d7fe4b0ef12181b1b86","7E01F23A-0B0E-46A2-9F30-C3A9D2C779D2","Ovarian Serous Cystadenocarcinoma","TAR","C73CC52E-7D80-4C6C-9687-02D63ADF0835","2014-03-22T06:15:01.000Z","C75D7FF8-F0B7-4084-A2FD-BB843CFA7A7A","None","NO",1,0.8,"Primary Tumor","Washington University",NA,"C73CC52E-7D80-4C6C-9687-02D63ADF0835",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ea5d304a-364c-4633-860b-f2e7be2ca00e.txt",NA,"TCGA-24-1105-01A",1.4,"F2B55619-C372-4F75-83AC-52DD647BCBF0","TCGA",2001,NA,NA,"WITH TUMOR","D059AA60-E69B-40F6-B301-BC03A86DA5E9",36,"TCGA-24-1105-10A-01W-0484-10_SOLiD.bam","Dead",1442,"TCGA-24-1105",NA,"DA2B0E1E-FF62-4999-AA12-32768135104D",NA,1442,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,"06461927-0E16-4D01-B765-C5F76574560D","WHITE",NA,1,130,"B1EBA572-C739-453D-8612-B5E33A50BBAC","C75D7FF8-F0B7-4084-A2FD-BB843CFA7A7A","AGARS_p_TCGA_B12_RNA_ReDo_HT_HG-U133A_96-HTA_C02_443110.CEL","TCGA-24-1105-01A-01",90,NA,NA,NA,NA,"BOTTOM",5,NA,"TCGA-24-1105-01A-01-BS1",NA,"Carboplatin","Chemotherapy","TCGA-24-1105-D25853","TCGA-24-1105-R25859","EXTERNAL BEAM","Distant Recurrence","TCGA-24-1105-F25844_NTE-1",NA,1442,"WITH TUMOR","Dead",1442,"TCGA-24-1105-F25844","TCGA-24-1105",NA,"24","1105","YES","C56.9","8441/3","C56.9",NA,NA,-13187,"FEMALE","WHITE",NA,NA,"No","Dead",1442,1442,NA,NA,"WITH TUMOR","NO",9,3,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,36,2001,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
99931610,94653961,6978201162,"D10F5F42-D184-425A-B16B-574EBC54D438.bw","7e34d3c1-1fab-4326-9a69-4260d2bac558","d10f5f42-d184-425a-b16b-574ebc54d438","2016-08-26T13:54:19.748828-05:00","TCGA-13-0804-01A-01R-1564-13_rnaseq_fastq.tar","d2af5756-722a-4d97-bd04-530b0f821225",6413977600,"Illumina HiSeq","1c1dc852f2c6ce051e0f64ce78ddaee5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:04:08.954660-05:00","2016-05-03T11:41:05.776497-05:00","d2af5756-722a-4d97-bd04-530b0f821225_analysis.xml","06b23362c1375572c1c0cac803308c2c","5fa0dfb1-a301-44f8-a529-442227b7dc16",2210,"2016-09-29T23:06:04.084834-05:00","d2af5756-722a-4d97-bd04-530b0f821225_experiment.xml","0d502738071c7976012babd1b691d0a3","d01f24a9-dd08-482b-bea1-e5c425157251",3916,"2016-09-29T23:36:58.880339-05:00","d2af5756-722a-4d97-bd04-530b0f821225_run.xml","45ccd813b738e33cf25417d0af9b6b58","e3600456-5e66-4ceb-a4ef-0810345c58a7",1990,"2016-09-08T13:16:19.087013-05:00","TCGA-13-0804","2016-09-02T19:09:29.619678-05:00","female","TCGA-13-0804_demographic",1930,"white","8b22ed63-d399-5745-b49d-e471cc2b44b8","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0804_diagnosis","not reported",27021,"dead","8441/3",1073,1073,"f43741dc-837f-5308-a339-6bfc823b87e7","c56.9",-27021,"TCGA-13-0804_treatment","275af04f-ee9a-5d95-94a0-05805c337d99","01",NA,"TCGA-13-0804-01A","1.3","7432f954-a16f-4053-bedd-aa776f939f71",FALSE,"34870541-DEE9-4B39-A292-117E443B1CBF","Primary Tumor","0.3",NA,NA,"1.5",1233705600,"01",146,"TCGA-13-0804-01A-01",98,98,NA,NA,0,0,5,4,"2016-09-08T13:16:19.087013-05:00","2016-09-08T13:16:19.087013-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"b9fae803-f9dd-47ee-8417-3f7af1bbf123","bc23d958-ae94-4d3f-ad5c-2a42dbc98154","TCGA-13-0804-01A-01-TS1","TCGA-13-0804-01A-01-BS1",95,95,"503d11a0-88cd-4d99-b1f6-23380ea51de9","RNA","TCGA-13-0804-01A-01R","5c6e4cf9-b03b-4ea6-96dc-8101d6de5edb",1.8,0.17,"UV Spec","R","22","TCGA-13-0804-01A-01R-1564-13","220b144c-9f9c-459a-b332-5d6e5dedb686",0.17,NA,NA,NA,NA,"bb6447ea-4585-5551-8f49-941909778071","TCGA-13-0804_exposure","TCGA-13-0804-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T21:05:06.000Z","2014-04-04T07:05:02.000Z","D2AF5756-722A-4D97-BD04-530B0F821225","7432F954-A16F-4053-BEDD-AA776F939F71","Unaligned reads",6413977600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","220B144C-9F9C-459A-B332-5D6E5DEDB686","Canada's Michael Smith Genome Sciences Centre","564a57eae4b09c884b26b725","7E34D3C1-1FAB-4326-9A69-4260D2BAC558","Ovarian Serous Cystadenocarcinoma","TAR","503D11A0-88CD-4D99-B1F6-23380EA51DE9","2014-04-04T07:05:02.000Z","5C6E4CF9-B03B-4EA6-96DC-8101D6DE5EDB","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"503D11A0-88CD-4D99-B1F6-23380EA51DE9",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.50ffbcf0-99c5-4528-bd60-8a054b3566a8.txt",NA,"TCGA-13-0804-01A",1.5,"9BA0BB7A-0471-4D62-A672-769E560548FD","TCGA",2003,NA,NA,"WITH TUMOR","7432F954-A16F-4053-BEDD-AA776F939F71",73,"nationwidechildrens.org_clinical.TCGA-13-0804.xml","Dead",1073,"TCGA-13-0804","NOT HISPANIC OR LATINO","3A4FAD46-797D-4276-B625-8CC78D3545F1",NA,1073,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,146,"BC23D958-AE94-4D3F-AD5C-2A42DBC98154","FAA00431-FC02-423C-B588-6CB60801E311","US45102955_251780410354_S01_GE2-v5_95_Feb07.txt_lmean.out.logratio.probe.tcga_level2.data.txt","TCGA-13-0804-01A-01",98,0,NA,NA,4,"BOTTOM",1,NA,"TCGA-13-0804-01A-01-BS1",95,"Paclitaxel","Chemotherapy","TCGA-13-0804-D24635",NA,NA,NA,"TCGA-13-0804-F24633_NTE-1",NA,1073,"WITH TUMOR","Dead",1073,"TCGA-13-0804-F24633","TCGA-13-0804",NA,"13","0804","YES","C56.9","8441/3","C56.9",NA,NA,-27021,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1073,1073,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2003,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
231909998,226951550,16787066303,"B32C0FA6-1E17-4FEA-B54F-471175985689.bw","7e4e7914-ec23-4c55-98d6-3c5eecffa8e4","b32c0fa6-1e17-4fea-b54f-471175985689","2016-08-26T05:38:38.477452-05:00","TCGA-24-2298-01A-01R-1569-13_rnaseq_fastq.tar","798bae5d-4cad-47ab-b148-4650331ec892",14604390400,"Illumina HiSeq","7e70f35b76184c089a6909f2a0e31ac3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:46:01.269141-05:00","2016-05-03T11:56:42.631594-05:00","798bae5d-4cad-47ab-b148-4650331ec892_analysis.xml","a84a909feac0ea8b082295e1721565ad","5479ae94-5ab5-406c-a601-e8b320edeb54",2181,"2016-09-29T18:51:16.047324-05:00","798bae5d-4cad-47ab-b148-4650331ec892_experiment.xml","f1529d0e9c8da2b0bd62b2f2305a9378","322c4229-4b74-47f6-be66-4d71cf919512",3916,"2016-09-29T19:23:43.605820-05:00","798bae5d-4cad-47ab-b148-4650331ec892_run.xml","e64c093c0fb4b96b73c4f9266dbf2141","46a0fd5d-7db1-42a3-89cc-2ecc47f89d79",1988,"2016-09-08T13:43:22.018496-05:00","TCGA-24-2298","2016-09-02T19:11:55.497903-05:00","female","TCGA-24-2298_demographic",1938,"white","38d463fa-52e1-5bde-ba99-892ae69ef237","not reported",1997,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2298_diagnosis","not reported",20453,"dead","8441/3",1620,1620,"13e8bf35-e57d-57bc-a649-ba968b92dd9d","c56.9",-20453,"TCGA-24-2298_treatment","5d8058bd-49e3-5610-b7f5-2c424cb4966d","01",NA,"TCGA-24-2298-01A","0.4","96e08856-06cc-463d-b2c5-5ed29204f66e",FALSE,"fe9d7bf4-a278-4842-b911-018d0127ef20","Primary Tumor","0.4",NA,NA,"1",1251676800,"01",161,"TCGA-24-2298-01A-01",88,89,NA,NA,27,25,0,0,"2016-09-08T13:43:22.018496-05:00","2016-09-08T13:43:22.018496-05:00",NA,NA,NA,NA,"BOTTOM","TOP",3,1,"3257628a-82df-49ba-ba4c-5ab509434c97","17f016db-5fb5-4bdb-a5b3-5d3ae85e69fb","TCGA-24-2298-01A-01-BS1","TCGA-24-2298-01A-01-TS1",70,74,"09989586-a5ec-4bdd-afa9-e2deebbb8db6","RNA","TCGA-24-2298-01A-01R","2e19fa49-b036-45c0-a9ab-16f2b4fc8042",1.8,0.14,"UV Spec","R","22","TCGA-24-2298-01A-01R-1569-13","7b39cb0a-7152-4037-9989-57545a1df980",0.14,NA,NA,NA,NA,"673853f3-879e-5bf1-9131-c4a93a1cef1e","TCGA-24-2298_exposure","TCGA-24-2298-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-29T06:22:23.000Z","2014-08-29T08:13:24.000Z","798BAE5D-4CAD-47AB-B148-4650331EC892","96E08856-06CC-463D-B2C5-5ED29204F66E","Unaligned reads",14604390400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7B39CB0A-7152-4037-9989-57545A1DF980","Canada's Michael Smith Genome Sciences Centre","564a3cbfe4b093830b69b3e3","7E4E7914-EC23-4C55-98D6-3C5EECFFA8E4","Ovarian Serous Cystadenocarcinoma","TAR","09989586-A5EC-4BDD-AFA9-E2DEEBBB8DB6","2014-08-29T08:13:24.000Z","2E19FA49-B036-45C0-A9AB-16F2B4FC8042","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"09989586-A5EC-4BDD-AFA9-E2DEEBBB8DB6",0.4,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a99356d2-7d94-4274-9720-3defe513159a.txt",NA,"TCGA-24-2298-01A",1,"FE77059F-2F22-47C8-9EAA-BF0724926C0F","TCGA",1993,NA,NA,"WITH TUMOR","96E08856-06CC-463D-B2C5-5ED29204F66E",55,"1447.CEL","Dead",1620,"TCGA-24-2298",NA,"7D8007B6-CE25-4492-AAF7-BEA05F783983",NA,1620,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,161,"17F016DB-5FB5-4BDB-A5B3-5D3AE85E69FB","8170A69D-0B30-425C-B38C-00C4E7E155AE","TCGA-24-2298-01A-01R-1569-13_GRCh37-lite_mirna.bam.bai","TCGA-24-2298-01A-01",89,25,NA,NA,0,"TOP",1,NA,"TCGA-24-2298-01A-01-TS1",74,"Carboplatin","Chemotherapy","TCGA-24-2298-D26622",NA,NA,NA,"TCGA-24-2298-F26616_NTE-1",NA,1620,"WITH TUMOR","Dead",1620,"TCGA-24-2298-F26616","TCGA-24-2298",NA,"24","2298","YES","C56.9","8441/3","C56.9",NA,NA,-20453,"FEMALE","WHITE",NA,NA,"No","Dead",1620,1620,NA,NA,"WITH TUMOR","NO",16,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,1993,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
229485284,206054268,15115770739,"EEC59881-40F8-4070-91F5-7E0737E10966.bw","7ebc776e-bde1-4563-adb1-8bd441872733","eec59881-40f8-4070-91f5-7e0737e10966","2016-08-09T14:43:35.500905-05:00","TCGA-59-A5PD-01A-11R-A406-31_rnaseq_fastq.tar","46338f2f-9d7d-4c0b-8792-b6b8feb19ca7",14686525440,"Illumina HiSeq","be829b3efead16060d479483fdeb3564","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T22:55:22.283714-05:00","2016-06-22T11:19:32.361656-05:00","46338f2f-9d7d-4c0b-8792-b6b8feb19ca7_analysis.xml","2ff299022314d8b5419604145e9df7f4","c98009bc-2274-4245-8897-ef95b3a7b8eb",2183,"2016-09-29T23:00:01.286851-05:00","46338f2f-9d7d-4c0b-8792-b6b8feb19ca7_experiment.xml","5ef376543af2d12e4e6882c696af0ae8","cc3891bb-8c41-4f20-b267-72019f7f6454",3753,"2016-09-29T18:29:06.307275-05:00","46338f2f-9d7d-4c0b-8792-b6b8feb19ca7_run.xml","dda42e23b20c0975dace6f656c144cb9","241f041c-d2b8-4721-9e0a-93024652400e",1807,"2016-09-08T12:16:56.303879-05:00","TCGA-59-A5PD","2016-09-02T19:00:49.464856-05:00","female","TCGA-59-A5PD_demographic",1956,"black or african american","84b549ae-9aa7-5dd3-aaef-b55ad5f6eb0d","not hispanic or latino",2012,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-A5PD_diagnosis","not reported",20263,"dead","8441/3",624,NA,"5ed98837-320c-5c31-8af9-e461980aa32f","c56.9",-20263,"TCGA-59-A5PD_treatment","bc577759-b3e4-5129-808e-a75df0eeb960","01","false","TCGA-59-A5PD-01A",NA,"9609e049-77c8-46ea-884e-32e18d7a9602",FALSE,"9A3CB382-654F-4DFD-BF41-7615710D2825","Primary Tumor",NA,730,130,NA,1360627200,"11",30,"TCGA-59-A5PD-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T12:16:56.303879-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"ab7fbb47-0d01-4fdf-bfcf-42fcb4dacf4c",NA,"TCGA-59-A5PD-01A-01-TSA",NA,60,NA,"edb3dc0c-65d3-4b63-9faf-5ddd9c7e8b46","RNA","TCGA-59-A5PD-01A-11R","be90f089-49c4-4e3d-a213-58642e77ff1e",1.78,0.17,"UV Spec","R","23","TCGA-59-A5PD-01A-11R-A406-31","356a00a0-d19a-498c-8ed7-20ce89cd21eb",0.17,NA,NA,NA,NA,"a8257457-ab0b-59f1-a293-07529ad150fb","TCGA-59-A5PD_exposure","TCGA-59-A5PD-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T06:38:52.000Z","2015-02-07T07:12:23.000Z","46338F2F-9D7D-4C0B-8792-B6B8FEB19CA7","9609E049-77C8-46EA-884E-32E18D7A9602","Unaligned reads",14686525440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","356A00A0-D19A-498C-8ED7-20CE89CD21EB","Canada's Michael Smith Genome Sciences Centre","564a5b07e4b0298dd2cc0956","7EBC776E-BDE1-4563-ADB1-8BD441872733","Ovarian Serous Cystadenocarcinoma","TAR","EDB3DC0C-65D3-4B63-9FAF-5DDD9C7E8B46","2015-02-07T07:12:23.000Z","BE90F089-49C4-4E3D-A213-58642E77FF1E","United States","NO",1,NA,"Primary Tumor","Roswell Park",730,"EDB3DC0C-65D3-4B63-9FAF-5DDD9C7E8B46",NA,"59","TCGA-59-A5PD-01A-11R-A407-13_mirna.bam",130,"TCGA-59-A5PD-01A",NA,NA,"TCGA",2011,"TCGA-59-A5PD_NTE-2","Complete Remission/Response","WITH TUMOR","E90BCD66-6C24-47A1-9AA8-22318BE45486",55,"TCGA-59-A5PD-01A-11R-A407-13_mirna.bam","Dead",624,"TCGA-59-A5PD","NOT HISPANIC OR LATINO",NA,"YES",NA,"Yes, History of Synchronous/Bilateral Malignancy","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IC",NA,100,NA,"8441/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"AB7FBB47-0D01-4FDF-BFCF-42FCB4DACF4C","BE90F089-49C4-4E3D-A213-58642E77FF1E","TCGA-59-A5PD-01A-11R-A407-13_mirna.bam","TCGA-59-A5PD-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-59-A5PD-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-59-A5PD",NA,"59","A5PD","YES","C56.9","8441/3","C56.9","NO","YES",-20263,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes, History of Synchronous/Bilateral Malignancy","No","Dead",NA,624,"NO","NO","WITH TUMOR","YES",25,6,2013,"NO","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,55,2011,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,"Complete Remission/Response",NA,4,NA,NA,NA,100,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
221463174,204448836,14960352922,"E3CE7C32-470E-46FC-840D-C9792E937651.bw","7fd6ab8a-201e-431d-a886-6ab553b6ca36","e3ce7c32-470e-46fc-840d-c9792e937651","2016-09-29T23:37:37.342969-05:00","TCGA-29-1707-02A-01R-1567-13_rnaseq_fastq.tar","90728273-3ced-4d93-bd9e-0d91d30f0928",13441443840,"Illumina HiSeq","2be00ef94f51d52a32f623b189078f42","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:16:02.323656-05:00","2016-05-03T11:41:05.740436-05:00","90728273-3ced-4d93-bd9e-0d91d30f0928_analysis.xml","f870abea80cae062da627b5e6c57f34d","66d4a56a-15fd-4d1e-80fd-ec337e9ff3db",2210,"2016-10-07T17:50:50.224002-05:00","90728273-3ced-4d93-bd9e-0d91d30f0928_experiment.xml","22ece4db88916744193d2b90463be7c5","47ca0ceb-23d4-417a-9b5a-862c8a4ab0a1",3916,"2016-09-29T21:45:40.813945-05:00","90728273-3ced-4d93-bd9e-0d91d30f0928_run.xml","1f9832259b19769ab74f397e8bd2a616","9e573b20-b9c0-4682-b716-a193bc5c76e8",1988,"2016-09-08T13:10:23.039688-05:00","TCGA-29-1707","2016-09-02T19:07:43.962801-05:00","female","TCGA-29-1707_demographic",1965,"white","fe01d20e-05e0-5be5-89e4-ddd1074b6831","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1707_diagnosis","not reported",15017,"alive","8441/3",NA,1277,"4c54de9f-0492-581d-9ba1-398bd16c52c8","c56.9",-15017,"TCGA-29-1707_treatment","49206d4a-5ccc-5b1d-99ac-32b9bfa5c296","02",NA,"TCGA-29-1707-02A","0.6","f2a14f3d-6181-48d6-8f44-48b36ab1f246",FALSE,"264DFD3E-7413-4DEA-A115-14887718139D","Recurrent Tumor","0.5",NA,NA,"1",1259712000,"01",145,"TCGA-29-1707-02A-01",95,95,NA,NA,0,0,10,10,"2016-09-08T13:10:23.039688-05:00","2016-09-08T13:10:23.039688-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"6b3cfbf5-060f-42a5-9887-e6fe885ee8d9","38223c59-9e68-497a-ad88-5cafaaf27191","TCGA-29-1707-02A-01-BS1","TCGA-29-1707-02A-01-TS1",90,90,"1b04fc12-fae5-4495-9ba3-0f6e2c5d5d75","RNA","TCGA-29-1707-02A-01R","65b5f9e2-4887-4358-a9bf-4aa3bcaf363a",1.8,0.15,"UV Spec","R","22","TCGA-29-1707-02A-01R-1567-13","5a1abe99-6d9f-4534-a32c-30672353ee04",0.15,NA,NA,NA,NA,"8c8f3b31-ebdc-5fcb-9955-e6cbbb032f52","TCGA-29-1707_exposure","TCGA-29-1707-02A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T22:59:46.000Z","2014-03-26T23:45:02.000Z","90728273-3CED-4D93-BD9E-0D91D30F0928","F2A14F3D-6181-48D6-8F44-48B36AB1F246","Unaligned reads",13441443840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5A1ABE99-6D9F-4534-A32C-30672353EE04","Canada's Michael Smith Genome Sciences Centre","564a33fee4b08c5d868f272a","7FD6AB8A-201E-431D-A886-6AB553B6CA36","Ovarian Serous Cystadenocarcinoma","TAR","1B04FC12-FAE5-4495-9BA3-0F6E2C5D5D75","2014-03-26T23:45:02.000Z","65B5F9E2-4887-4358-A9BF-4AA3BCAF363A","None","NO",2,0.5,"Recurrent Tumor","Duke",NA,"1B04FC12-FAE5-4495-9BA3-0F6E2C5D5D75",0.6,"29","TCGA-29-1707-02A-01R-1567-13_mirna.bam.bai",NA,"TCGA-29-1707-02A",1,"FC8868BB-2ED5-4725-A212-CD48BBF7C30F","TCGA",2006,NA,NA,NA,"F2A14F3D-6181-48D6-8F44-48B36AB1F246",41,"bcgsc.ca.TCGA-29-1707-02A-01R-1567-13.bcgsc.ca.1.5.0.snv.vcf","Alive",NA,"TCGA-29-1707",NA,"EEFDC8C2-4C4C-4B1D-94B8-2E7210DF54C3",NA,1277,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,145,"6B3CFBF5-060F-42A5-9887-E6FE885EE8D9","E2FDE7BB-4899-4889-B2ED-7ED35E3620B9","TCGA-29-1707-02A-01R-1567-13_mirna.bam.bai","TCGA-29-1707-02A-01",95,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-29-1707-02A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-29-1707-D27292",NA,NA,NA,"TCGA-29-1707-F27288_NTE-2",NA,1277,NA,"Alive",NA,"TCGA-29-1707-F27288","TCGA-29-1707",NA,"29","1707","YES","C56.9","8441/3","C56.9",NA,NA,-15017,"FEMALE","WHITE",NA,NA,"No","Alive",1277,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,41,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
195002726,188602463,13945742616,"A1B4E7EA-9E08-4961-A8C1-5F5366D9BF76.bw","808eb134-9c7d-43bb-b86c-2f3259193954","a1b4e7ea-9e08-4961-a8c1-5f5366d9bf76","2016-08-25T22:08:52.243781-05:00","TCGA-25-1623-01A-01R-1566-13_rnaseq_fastq.tar","031e29a9-ceb4-438e-9b29-b8e8166843ec",12453314560,"Illumina HiSeq","bedd0feccc989d0f771c92b62464288c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:32:51.919877-05:00","2016-05-03T11:39:34.528512-05:00","031e29a9-ceb4-438e-9b29-b8e8166843ec_analysis.xml","a3bb83aaf70a5ac37e22e47cba90b76e","967ed05c-53a1-4b94-8d91-046115e8ff9d",2181,"2016-09-29T18:28:04.259426-05:00","031e29a9-ceb4-438e-9b29-b8e8166843ec_experiment.xml","98536e1a124158ecabb4506f883a1eb4","2373435e-4c0d-4674-bb15-9cca1d311c09",3916,"2016-09-29T21:08:00.102646-05:00","031e29a9-ceb4-438e-9b29-b8e8166843ec_run.xml","b6f030943db0c31db551aea87477e902","87101552-f14b-4178-a661-dba65cb09c97",1988,"2016-09-08T12:09:08.650977-05:00","TCGA-25-1623","2016-09-02T18:48:46.943550-05:00","female","TCGA-25-1623_demographic",1935,"white","23ac0f67-276c-5d57-b52e-1764a643b863","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1623_diagnosis","not reported",26060,"dead","8441/3",565,565,"c76423fa-47c5-5e83-9344-ce0ca6c75063","c56.9",-26060,"TCGA-25-1623_treatment","0e34a67f-e60a-5054-bc19-16e8b492c914","01",NA,"TCGA-25-1623-01A","1","09f0e0d8-1f35-4781-8c71-5b0843483cd7",FALSE,"A57CB221-076A-4EE5-8C77-D1E33070597C","Primary Tumor","0.3",NA,NA,"1.8",1237420800,"01",100,"TCGA-25-1623-01A-01",80,70,NA,NA,0,0,25,40,"2016-09-08T12:09:08.650977-05:00","2016-09-08T12:09:08.650977-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"e305f292-cf49-4cc0-bd23-bc1399e95e4a","0fe7be03-c1ff-4faf-9c06-fc7a7c5060c4","TCGA-25-1623-01A-01-BS1","TCGA-25-1623-01A-01-TS1",70,55,"0454d8f9-b1d6-4726-9e3f-130e5291e72b","RNA","TCGA-25-1623-01A-01R","cdb8fa05-7a39-437b-949f-07887caecd03",1.8,0.15,"UV Spec","R","22","TCGA-25-1623-01A-01R-1566-13","3e4f0ca7-8428-47df-80a3-3bc9153aedfa",0.15,NA,NA,NA,NA,"8cdbd05e-e11a-5374-83b7-726df134ad12","TCGA-25-1623_exposure","TCGA-25-1623-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T05:56:12.000Z","2014-03-20T06:19:03.000Z","031E29A9-CEB4-438E-9B29-B8E8166843EC","09F0E0D8-1F35-4781-8C71-5B0843483CD7","Unaligned reads",12453314560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3E4F0CA7-8428-47DF-80A3-3BC9153AEDFA","Canada's Michael Smith Genome Sciences Centre","564a3682e4b08c5d868ff2ba","808EB134-9C7D-43BB-B86C-2F3259193954","Ovarian Serous Cystadenocarcinoma","TAR","0454D8F9-B1D6-4726-9E3F-130E5291E72B","2014-03-20T06:19:03.000Z","CDB8FA05-7A39-437B-949F-07887CAECD03","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"0454D8F9-B1D6-4726-9E3F-130E5291E72B",1,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ef62a625-cf2c-45d1-aa59-9d44e16a37fa.txt",NA,"TCGA-25-1623-01A",1.8,"F38D9A87-50EC-4E63-9295-238F9C127577","TCGA",2006,NA,NA,"WITH TUMOR","AD6A0223-4526-4D80-9AE1-64B8E8AD576A",71,"ACOLD_p_TCGA_Batch17_SNP_N_GenomeWideSNP_6_E04_465974.ismpolish.data.txt","Dead",565,"TCGA-25-1623","NOT HISPANIC OR LATINO","3089D69D-A5CF-47D4-AE07-46478224B106",NA,565,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,100,"E305F292-CF49-4CC0-BD23-BC1399E95E4A","CDB8FA05-7A39-437B-949F-07887CAECD03","GHYLL_p_TCGABatch17_Mashima45_HT_HG-U133A_96-HTA_C04_472030.level2.data.txt","TCGA-25-1623-01A-01",70,0,NA,NA,40,"TOP",5,NA,"TCGA-25-1623-01A-01-TS1",55,"Taxol","Chemotherapy","TCGA-25-1623-D26709",NA,NA,NA,"TCGA-25-1623-F26707_NTE-1",NA,565,"WITH TUMOR","Dead",565,"TCGA-25-1623-F26707","TCGA-25-1623",NA,"25","1623","YES","C56.9","8441/3","C56.9",NA,NA,-26060,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",565,565,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
168527526,162426335,11996282797,"20B5FCF9-B5EB-4FE8-841F-7C9403B0995A.bw","80f85c54-e12f-4afa-8fa5-5f3e083b6f95","20b5fcf9-b5eb-4fe8-841f-7c9403b0995a","2016-09-29T18:23:42.739813-05:00","TCGA-04-1364-01A-01R-1565-13_rnaseq_fastq.tar","33e1c646-2ee1-44ab-9049-3760c13c42d5",10985000960,"Illumina HiSeq","ee136d170240eddc912676f53b474c09","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:10:48.479520-05:00","2016-05-03T11:40:21.647690-05:00","33e1c646-2ee1-44ab-9049-3760c13c42d5_analysis.xml","36504344c39510e5a0db86749d7a00ae","d3248252-bac5-48f5-9e1d-1e7611cbeb4a",2181,"2016-08-29T08:33:49.802718-05:00","33e1c646-2ee1-44ab-9049-3760c13c42d5_experiment.xml","0cdaf1d42b6907b578f6e1ea218e012f","c447ca88-670d-42ae-867f-51bf4fd2638b",3916,"2016-09-29T19:29:43.326672-05:00","33e1c646-2ee1-44ab-9049-3760c13c42d5_run.xml","fd4fc4a4e920322e7d81904010369b73","4a69d429-ac7a-4201-b1c0-53a50c001fa6",1989,"2016-09-08T13:18:29.117076-05:00","TCGA-04-1364","2016-09-02T19:12:03.904325-05:00","female","TCGA-04-1364_demographic",1942,"white","fca74eca-e5f7-5dfb-8b16-08f9b4d83590","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1364_diagnosis","not reported",22294,"dead","8441/3",1024,NA,"6b68d896-594c-5763-b893-8203984ca9c1","c56.9",-22294,"TCGA-04-1364_treatment","6cec0a76-dfae-5167-8402-ce169f777321","01",NA,"TCGA-04-1364-01A","0.6","c8f56f7e-6b69-4276-ba97-7a70c4fa5071",FALSE,"CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4","Primary Tumor","0.3",NA,NA,"1.2",1229644800,"01",152,"TCGA-04-1364-01A-01",99,99,NA,NA,0,0,5,5,"2016-09-08T13:18:29.117076-05:00","2016-09-08T13:18:29.117076-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"9fef64ee-6549-4b5b-a306-401d62d57d92","d155a2aa-3dd7-4418-9c71-d6529df0f381","TCGA-04-1364-01A-01-TS1","TCGA-04-1364-01A-01-BS1",93,93,"76db9f2d-cbf5-40aa-953f-5a792c277855","RNA","TCGA-04-1364-01A-01R","9b54e08c-da2d-4714-8587-5f7b69ca4a8c",1.8,0.16,"UV Spec","R","22","TCGA-04-1364-01A-01R-1565-13","2fadaf5a-402b-483d-bc26-08feb3dc162d",0.16,NA,NA,NA,NA,"251b044c-36dc-5255-8cf1-59e9575685fd","TCGA-04-1364_exposure","TCGA-04-1364-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:37:37.000Z","2014-03-22T02:05:01.000Z","33E1C646-2EE1-44AB-9049-3760C13C42D5","C8F56F7E-6B69-4276-BA97-7A70C4FA5071","Unaligned reads",10985000960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2FADAF5A-402B-483D-BC26-08FEB3DC162D","Canada's Michael Smith Genome Sciences Centre","564a5a38e4b0ef12181dce41","80F85C54-E12F-4AFA-8FA5-5F3E083B6F95","Ovarian Serous Cystadenocarcinoma","TAR","76DB9F2D-CBF5-40AA-953F-5A792C277855","2014-03-22T02:05:01.000Z","9B54E08C-DA2D-4714-8587-5F7B69CA4A8C","None","NO",1,0.3,"Primary Tumor","Gynecologic Oncology Group",NA,"76DB9F2D-CBF5-40AA-953F-5A792C277855",0.6,"04","TCGA-04-1364-01A-01R-1565-13_rnaseq_fastq.tar",NA,"TCGA-04-1364-01A",1.2,"F0840D96-E4AC-4CB5-BB8C-37F30AE5FBCE","TCGA",2003,NA,NA,"WITH TUMOR","D1AFDD95-8824-4287-B8F9-06C28CC0A766",61,"nationwidechildrens.org_clinical.TCGA-04-1364.xml","Dead",1024,"TCGA-04-1364","NOT HISPANIC OR LATINO","4A04D83D-7AE1-45E0-81A1-55960AFDF90B",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,152,"9FEF64EE-6549-4B5B-A306-401D62D57D92","F380B941-A9B8-4DCC-B0E1-BA555B349507","MSK_252152912421_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","TCGA-04-1364-01A-01",99,0,NA,NA,5,"BOTTOM",2,NA,"TCGA-04-1364-01A-01-BS1",93,"Paclitaxel","Chemotherapy","TCGA-04-1364-D24031",NA,NA,NA,"TCGA-04-1364-F24028_NTE-1",NA,NA,"WITH TUMOR","Dead",1024,"TCGA-04-1364-F24028","TCGA-04-1364",NA,"04","1364","YES","C56.9","8441/3","C56.9",NA,NA,-22294,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1024,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
187574986,182537300,13516840313,"EB187529-4F67-4C45-AB12-7652D31E5C03.bw","818dc159-aba4-46bc-a4ed-68ee0f8c4461","eb187529-4f67-4c45-ab12-7652d31e5c03","2016-09-29T23:49:25.099165-05:00","TCGA-25-2042-01A-01R-1568-13_rnaseq_fastq.tar","23ff75fd-94f5-458b-a737-d9e1fbb7b9c9",12033239040,"Illumina HiSeq","304d15ace04894b39179188b47f20235","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:22:36.959832-05:00","2016-05-03T11:56:42.628809-05:00","23ff75fd-94f5-458b-a737-d9e1fbb7b9c9_analysis.xml","662d49d18326b13ecb261b7bcd5bec36","b518960c-fd72-4b19-9d2f-63f011c2f4e3",2181,"2016-09-29T23:55:11.160085-05:00","23ff75fd-94f5-458b-a737-d9e1fbb7b9c9_experiment.xml","36ec136099ec137b8d0ed6b2a1629680","eec1833b-ee3e-497a-b51a-3fbfa623cf45",3916,"2016-09-29T22:26:46.516421-05:00","23ff75fd-94f5-458b-a737-d9e1fbb7b9c9_run.xml","9871f482ae316b39e3445f4b8ef850de","b7b24b6e-a5f5-49c2-87ca-d15ae09ff078",1988,"2016-09-08T13:53:37.384591-05:00","TCGA-25-2042","2016-09-02T19:11:54.970298-05:00","female","TCGA-25-2042_demographic",1946,"american indian or alaska native","6b47a6c1-f0cd-5fa9-9205-69c8f3ec37e7","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2042_diagnosis","not reported",22127,"dead","8441/3",396,396,"2a402414-8c80-5260-9406-443e0dadda66","c56.9",-22127,"TCGA-25-2042_treatment","cd4c75d9-43a1-5f3a-bf7d-81632cf8e2a7","01",NA,"TCGA-25-2042-01A","0.6","71484ed8-3496-48b2-81b8-888d04f10f0a",FALSE,"4D14A408-E3F6-47EB-A67C-0606450DB0C5","Primary Tumor","0.3",NA,NA,"1.4",1247616000,"01",111,"TCGA-25-2042-01A-01",85,85,NA,NA,0,0,68,68,"2016-09-08T13:53:37.384591-05:00","2016-09-08T13:53:37.384591-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"a7d0928a-7742-4678-8183-b9f192787900","682d08f1-28cd-4f93-a65b-7d735574c7db","TCGA-25-2042-01A-01-TS1","TCGA-25-2042-01A-01-BS1",30,30,"9fb74096-c9db-4415-b630-1a77cdacb130","RNA","TCGA-25-2042-01A-01R","12e5f40d-b2c3-43da-8795-f8dabfd905d1",1.8,0.15,"UV Spec","R","22","TCGA-25-2042-01A-01R-1568-13","ae1e5f8d-cdd9-41f5-b56c-80dfe27e1b6c",0.15,NA,NA,NA,NA,"f89baac8-8e53-5e4d-a982-c84f1e062f66","TCGA-25-2042_exposure","TCGA-25-2042-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-25T21:24:13.000Z","2014-08-26T00:19:22.000Z","23FF75FD-94F5-458B-A737-D9E1FBB7B9C9","71484ED8-3496-48B2-81B8-888D04F10F0A","Unaligned reads",12033239040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AE1E5F8D-CDD9-41F5-B56C-80DFE27E1B6C","Canada's Michael Smith Genome Sciences Centre","564a5b1ce4b09c884b279526","818DC159-ABA4-46BC-A4ED-68EE0F8C4461","Ovarian Serous Cystadenocarcinoma","TAR","9FB74096-C9DB-4415-B630-1A77CDACB130","2014-08-26T00:19:22.000Z","12E5F40D-B2C3-43DA-8795-F8DABFD905D1","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"9FB74096-C9DB-4415-B630-1A77CDACB130",0.6,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.59676524-6b40-4bcc-b488-120781e23d22.txt",NA,"TCGA-25-2042-01A",1.4,"F51EFCD0-D4F8-4952-8DED-9510E58C4648","TCGA",2006,NA,NA,"WITH TUMOR","71484ED8-3496-48B2-81B8-888D04F10F0A",60,"AMISS_p_TCGAb24_SNP_N_GenomeWideSNP_6_E09_542480.raw.copynumber.data.txt","Dead",396,"TCGA-25-2042","NOT HISPANIC OR LATINO","67CBDCBF-2E6A-4DE9-9658-9BBD8AE0F47F",NA,396,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,1,111,"A7D0928A-7742-4678-8183-B9F192787900","DC48631D-4A53-4F32-BBAE-280BF9C4A0E2","AMISS_p_TCGAb24_SNP_N_GenomeWideSNP_6_F03_542472.birdseed.data.txt","TCGA-25-2042-01A-01",85,0,NA,NA,68,"TOP",2,NA,"TCGA-25-2042-01A-01-TS1",30,"Taxol","Chemotherapy","TCGA-25-2042-D26786",NA,NA,NA,"TCGA-25-2042-F26785_NTE-1",NA,396,"WITH TUMOR","Dead",396,"TCGA-25-2042-F26785","TCGA-25-2042",NA,"25","2042","YES","C56.9","8441/3","C56.9",NA,NA,-22127,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","NOT HISPANIC OR LATINO",NA,"No","Dead",396,396,NA,NA,"WITH TUMOR","NO",20,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,60,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
167675892,158170214,11651394134,"20EDAF4F-4935-47B4-8232-5C6ABAD9E270.bw","82093ed9-a3c8-4e34-931f-4ec7ae745711","20edaf4f-4935-47b4-8232-5c6abad9e270","2016-08-25T06:52:45.381466-05:00","TCGA-13-1512-01A-01R-1565-13_rnaseq_fastq.tar","cd60f4fa-494d-4253-baa4-c96f81d35863",10306897920,"Illumina HiSeq","d6ebc9aec1bd6ba506ce67f04dc3a1e4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:05:16.792049-05:00","2016-05-03T11:40:21.662944-05:00","cd60f4fa-494d-4253-baa4-c96f81d35863_analysis.xml","7c6149c95e9c31a49f1924d309e0053c","aa9b575f-e370-4f55-b882-eb9994a795f5",2181,"2016-09-29T23:39:23.683088-05:00","cd60f4fa-494d-4253-baa4-c96f81d35863_experiment.xml","f8b7b7bc847142d63a1c1047aa87cb1a","e4d935d9-2042-4709-8478-87960ecda5b4",3916,"2016-09-29T18:41:11.858307-05:00","cd60f4fa-494d-4253-baa4-c96f81d35863_run.xml","b264becd845fb1de8970f630c55d33c6","2bc1e823-c912-4519-ab55-64a627c6aeb0",1989,"2016-09-08T13:50:24.197387-05:00","TCGA-13-1512","2016-09-02T19:13:45.068904-05:00","female","TCGA-13-1512_demographic",1959,"white","605e97f3-8618-5b7b-8c23-0e82f639a1f0","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1512_diagnosis","not reported",18134,"alive","8441/3",NA,442,"f8565836-3634-5b5c-8823-e193d83d3527","c56.9",-18134,"TCGA-13-1512_treatment","4097ce7e-d213-575d-8b16-c7b485005a51","01",NA,"TCGA-13-1512-01A","1.4","92baeb34-1fa4-4ee5-8c29-5596c4a29a29",FALSE,"66DC098E-9ADD-4446-AB6D-FEA35D5FD33B","Primary Tumor","0.4",NA,NA,"2",1235001600,"01",143,"TCGA-13-1512-01A-01",99,99,NA,NA,0,0,1,1,"2016-09-08T13:50:24.197387-05:00","2016-09-08T13:50:24.197387-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,10,"2fd7c3b6-e8fe-4542-b392-811c192282ae","fbdc48b1-7344-41d9-90a4-f585b9b202b5","TCGA-13-1512-01A-01-TS1","TCGA-13-1512-01A-01-BS1",94,89,"c9887497-c0ab-4707-ba50-4fbfc7849da5","RNA","TCGA-13-1512-01A-01R","40774eef-173a-4056-a434-0a64ef36d2cc",1.8,0.13,"UV Spec","R","22","TCGA-13-1512-01A-01R-1565-13","67e85198-4b8c-45db-b433-683b1899f3ea",0.13,NA,NA,NA,NA,"cf64c369-6ad4-54f6-9803-7da73135acd9","TCGA-13-1512_exposure","TCGA-13-1512-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T08:10:36.000Z","2014-03-22T08:32:01.000Z","CD60F4FA-494D-4253-BAA4-C96F81D35863","92BAEB34-1FA4-4EE5-8C29-5596C4A29A29","Unaligned reads",10306897920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","67E85198-4B8C-45DB-B433-683B1899F3EA","Canada's Michael Smith Genome Sciences Centre","564a3ec4e4b0ef12181b82b3","82093ED9-A3C8-4E34-931F-4EC7AE745711","Ovarian Serous Cystadenocarcinoma","TAR","C9887497-C0AB-4707-BA50-4FBFC7849DA5","2014-03-22T08:32:01.000Z","40774EEF-173A-4056-A434-0A64EF36D2CC","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"C9887497-C0AB-4707-BA50-4FBFC7849DA5",1.4,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.70bd95ea-f6ca-4b5a-b744-e174576d1063.txt",NA,"TCGA-13-1512-01A",2,"FF3734CB-1218-44B6-9238-000101EA4D25","TCGA",2008,NA,NA,NA,"C503ECD7-B764-4B29-9DDE-CF49B707453A",49,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.70bd95ea-f6ca-4b5a-b744-e174576d1063.txt","Alive",NA,"TCGA-13-1512","NOT HISPANIC OR LATINO","440D2B6F-C84D-4658-B921-7D114EA5C138",NA,94,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,143,"FBDC48B1-7344-41D9-90A4-F585B9B202B5","ED8A00C1-64C6-4BB0-84BE-39FD5A4F9106","TCGA-13-1512-01A-01R-1565-13_mirna.bam.bai","TCGA-13-1512-01A-01",99,0,NA,NA,1,"BOTTOM",10,NA,"TCGA-13-1512-01A-01-BS1",89,"Paclitaxel","Chemotherapy","TCGA-13-1512-D24972",NA,NA,NA,NA,NA,94,NA,"Alive",NA,"TCGA-13-1512-F24970","TCGA-13-1512",NA,"13","1512","YES","C56.9","8441/3","C56.9",NA,NA,-18134,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",94,NA,NA,NA,NA,"NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,2008,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
140133080,132972345,9809276519,"EB6F4C11-9485-4214-B0F1-A92115ACE830.bw","838693d5-1ae0-4d75-834b-e1b89b96b0ed","eb6f4c11-9485-4214-b0f1-a92115ace830","2016-09-29T23:49:58.783773-05:00","TCGA-29-1768-01A-01R-1567-13_rnaseq_fastq.tar","c0334b1a-e471-4baf-9d27-15949aa04db1",8462469120,"Illumina HiSeq","ae5d3008c393fdfc11da4d20c4ced3f2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:11:50.732959-05:00","2016-05-03T11:41:05.755204-05:00","c0334b1a-e471-4baf-9d27-15949aa04db1_analysis.xml","b1071bf199b5a73d6cf9310058047dab","ae7fa722-321e-47e5-a115-969a5a0965a9",2242,"2016-08-29T21:33:15.341464-05:00","c0334b1a-e471-4baf-9d27-15949aa04db1_experiment.xml","0092a0872bb98091ff733c20d11c99f6","6f3d41ed-21c9-4280-9a78-ef574ec066d6",3916,"2016-09-29T23:43:14.943548-05:00","c0334b1a-e471-4baf-9d27-15949aa04db1_run.xml","aac2f9c945d535010b749f5f7ccc00cc","e74a7e16-ae71-4a75-a997-7d705faa75f8",1990,"2016-09-08T12:49:21.864400-05:00","TCGA-29-1768","2016-09-02T19:07:31.642295-05:00","female","TCGA-29-1768_demographic",1956,"white","b5de4fa5-1048-53ef-a848-07a9f6060389","not reported",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1768_diagnosis","not reported",18396,"dead","8441/3",952,950,"302790a0-c173-5320-8b25-111b75f0f6eb","c56.9",-18396,"TCGA-29-1768_treatment","4f251ebd-6d1c-552c-b671-fdc13d5ad0b6","01",NA,"TCGA-29-1768-01A","0.5","f21ac7ce-b8b2-4c44-be65-4c4abf8a86c4",FALSE,"12d9b343-a52d-4a36-ba7b-31bfeb66da50","Primary Tumor","0.4",NA,NA,"1",1243296000,"01",116,"TCGA-29-1768-01A-01",80,90,NA,NA,0,0,75,50,"2016-09-08T12:49:21.864400-05:00","2016-09-08T12:49:21.864400-05:00",5,NA,NA,NA,"BOTTOM","TOP",0,0,"0bd351c0-aed9-4bb2-a773-e56918399ad5","62464711-a212-4d0b-8ae8-d4e75c238043","TCGA-29-1768-01A-01-BS1","TCGA-29-1768-01A-01-TS1",25,50,"4a93f819-f50a-429a-bc77-75c1afbe4597","RNA","TCGA-29-1768-01A-01R","86a5e014-0e18-4526-ad42-f686fb274779",1.8,0.17,"UV Spec","R","22","TCGA-29-1768-01A-01R-1567-13","d327786c-eb87-43b2-abd1-7bb9446cf34f",0.17,NA,NA,NA,NA,"e337f9ae-f30d-552e-a71f-902013895052","TCGA-29-1768_exposure","TCGA-29-1768-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T07:32:20.000Z","2014-03-27T07:48:01.000Z","C0334B1A-E471-4BAF-9D27-15949AA04DB1","F21AC7CE-B8B2-4C44-BE65-4C4ABF8A86C4","Unaligned reads",8462469120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D327786C-EB87-43B2-ABD1-7BB9446CF34F","Canada's Michael Smith Genome Sciences Centre","564a5b4ce4b09c884b27a098","838693D5-1AE0-4D75-834B-E1B89B96B0ED","Ovarian Serous Cystadenocarcinoma","TAR","4A93F819-F50A-429A-BC77-75C1AFBE4597","2014-03-27T07:48:01.000Z","86A5E014-0E18-4526-AD42-F686FB274779","None","NO",1,0.4,"Primary Tumor","Duke",NA,"4A93F819-F50A-429A-BC77-75C1AFBE4597",0.5,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f70a1542-3bd5-4ebe-880a-e8f7c75faaba.txt",NA,"TCGA-29-1768-01A",1,"ED65A20A-8958-4FFF-BA00-02ED6343C835","TCGA",2006,NA,NA,"WITH TUMOR","F21AC7CE-B8B2-4C44-BE65-4C4ABF8A86C4",50,"US82800149_251976010749_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","Dead",952,"TCGA-29-1768",NA,"D01CE2B3-4094-4593-84D7-6372BFB8657E",NA,950,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,116,"62464711-A212-4D0B-8AE8-D4E75C238043","EDDDF1C0-F67F-440D-BCDF-CD7C4B90D33A","TCGA-29-1768-01A-01R-1567-13.hg19.mirna.quantification.txt","TCGA-29-1768-01A-01",80,0,NA,5,75,"BOTTOM",0,NA,"TCGA-29-1768-01A-01-BS1",25,"Gemcitabine","Chemotherapy","TCGA-29-1768-D27362",NA,NA,NA,"TCGA-29-1768-F27358_NTE-1",NA,950,"WITH TUMOR","Dead",952,"TCGA-29-1768-F27358","TCGA-29-1768",NA,"29","1768","YES","C56.9","8441/3","C56.9",NA,NA,-18396,"FEMALE","WHITE",NA,NA,"No","Dead",950,952,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
123331790,120377332,8928200883,"2EB207C8-97E1-4F3F-97B7-ABF11D130326.bw","8449955f-42d9-46f6-919a-5cc5d59e6284","2eb207c8-97e1-4f3f-97b7-abf11d130326","2016-08-25T12:07:04.620833-05:00","TCGA-24-1923-01A-01R-1567-13_rnaseq_fastq.tar","3bdbfa0c-04a2-4f46-8360-e0c615ab1f2a",8027043840,"Illumina HiSeq","109efcf7d6c1e2fbf96f7e4d7d47b188","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:17:15.109054-05:00","2016-05-03T11:41:05.755204-05:00","3bdbfa0c-04a2-4f46-8360-e0c615ab1f2a_analysis.xml","1608c08ceafc2aae3c946a122093ae13","d6ffa480-51cc-4784-b8f5-39b0c192ece2",2210,"2016-09-29T17:34:01.641651-05:00","3bdbfa0c-04a2-4f46-8360-e0c615ab1f2a_experiment.xml","92306817f48443052b717460f359f72c","01766e3d-f0e3-46d3-b0dc-13a74e5b0447",3916,"2016-09-29T18:55:41.903184-05:00","3bdbfa0c-04a2-4f46-8360-e0c615ab1f2a_run.xml","5b45885e6242a2ef27d09f7d78232a9b","34f5da87-027c-4ca6-b339-8f9f936f4dfd",1990,"2016-09-08T11:17:47.968748-05:00","TCGA-24-1923","2016-09-02T18:50:24.285125-05:00","female","TCGA-24-1923_demographic",1950,"white","96d5e3f2-4a30-5a3a-ba6f-eecd943d1046","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1923_diagnosis","not reported",18628,"dead","8441/3",690,690,"ee2e4650-934a-5367-946a-baa0ebb000e2","c56.9",-18628,"TCGA-24-1923_treatment","aa018f9d-8c45-57dd-9697-3f2fe2e0e89d","01",NA,"TCGA-24-1923-01A","0.6","84d06f56-6611-4fa1-89fd-df8780f7f446",FALSE,"6ae8158a-e236-4cc0-88d2-50756216f0e7","Primary Tumor","0.6",NA,NA,"1.3",1246147200,"01",100,"TCGA-24-1923-01A-01",70,90,0,0,0,0,15,5,"2016-09-08T11:17:47.968748-05:00","2016-09-08T11:17:47.968748-05:00",0,0,10,5,"TOP","BOTTOM",15,5,"efa7fe61-eeee-4f33-a76e-def9e1e4347b","2f93d2e1-4288-44cf-b6c0-1b8e4d964e75","TCGA-24-1923-01A-01-TS1","TCGA-24-1923-01A-01-BS1",70,90,"2d4a29e0-efc5-4a2e-a7ed-36e08cdac283","RNA","TCGA-24-1923-01A-01R","44d176bd-a939-4839-88a5-f8d18d7a1525",1.8,0.13,"UV Spec","R","22","TCGA-24-1923-01A-01R-1567-13","d34ae25d-8073-4129-a1b8-3f43e19af73b",0.13,NA,NA,NA,NA,"8829ffd1-1226-5fae-9eb0-90c166e2a5e4","TCGA-24-1923_exposure","TCGA-24-1923-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T09:21:31.000Z","2014-03-27T09:36:02.000Z","3BDBFA0C-04A2-4F46-8360-E0C615AB1F2A","84D06F56-6611-4FA1-89FD-DF8780F7F446","Unaligned reads",8027043840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D34AE25D-8073-4129-A1B8-3F43E19AF73B","Canada's Michael Smith Genome Sciences Centre","564a40dae4b0ef12181c32ae","8449955F-42D9-46F6-919A-5CC5D59E6284","Ovarian Serous Cystadenocarcinoma","TAR","2D4A29E0-EFC5-4A2E-A7ED-36E08CDAC283","2014-03-27T09:36:02.000Z","44D176BD-A939-4839-88A5-F8D18D7A1525","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"2D4A29E0-EFC5-4A2E-A7ED-36E08CDAC283",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9c88c21f-4bb9-41cc-b942-9c6e73a46511.txt",NA,"TCGA-24-1923-01A",1.3,"EA59CC77-D039-49F3-9EBC-8A903228C266","TCGA",2001,NA,NA,"WITH TUMOR","84D06F56-6611-4FA1-89FD-DF8780F7F446",51,"LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_D01_518000.ismpolish.data.txt","Dead",690,"TCGA-24-1923",NA,"A490CC6B-D715-4C9E-8039-8508AF334257",NA,690,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,100,"EFA7FE61-EEEE-4F33-A76E-DEF9E1E4347B","CBBF737C-9500-442F-AF13-0AC75B50312A","TCGA-24-1923-01A-01R-1567-13.isoform.quantification.txt","TCGA-24-1923-01A-01",70,0,0,0,15,"TOP",15,10,"TCGA-24-1923-01A-01-TS1",70,"Doxil","Chemotherapy","TCGA-24-1923-D26382",NA,NA,NA,"TCGA-24-1923-F26379_NTE-1",NA,690,"WITH TUMOR","Dead",690,"TCGA-24-1923-F26379","TCGA-24-1923",NA,"24","1923","YES","C56.9","8441/3","C56.9",NA,NA,-18628,"FEMALE","WHITE",NA,NA,"No","Dead",690,690,NA,NA,"WITH TUMOR","NO",19,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2001,"Incisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
107414186,101073941,7405684131,"1588114F-6C7F-4052-9140-52D95CAB0C52.bw","85a85a11-7200-4e96-97af-6ba26d680d59","1588114f-6c7f-4052-9140-52d95cab0c52","2016-08-25T02:37:14.503287-05:00","TCGA-13-0920-01A-01R-1564-13_rnaseq_fastq.tar","4f2b637a-da1f-4a57-a391-88132f55ba27",6393610240,"Illumina HiSeq","40a35cdc56b1e68b1e35b16c58336066","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:57:16.020019-05:00","2016-05-03T11:41:05.750744-05:00","4f2b637a-da1f-4a57-a391-88132f55ba27_analysis.xml","8f84ec26974e3736a8cf3994198daea1","804b0aec-a331-4d73-8f8a-e1540f05c6e6",2181,"2016-08-26T04:02:08.255965-05:00","4f2b637a-da1f-4a57-a391-88132f55ba27_experiment.xml","36fbafd0c0bc4a531bc216d2d7875e3b","46155c45-25b8-4b96-9cb1-3e0d1977fadc",3916,"2016-09-30T00:12:01.126432-05:00","4f2b637a-da1f-4a57-a391-88132f55ba27_run.xml","368af42047414d6239a05503546fc86a","f8f2d10e-2ab1-4d8f-9673-0293849c1935",1988,"2016-09-08T12:48:47.907604-05:00","TCGA-13-0920","2016-09-02T19:05:31.640813-05:00","female","TCGA-13-0920_demographic",1942,"white","4d9e60db-29bf-55a5-b771-45b205a0536b","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0920_diagnosis","not reported",24064,"dead","8441/3",1484,420,"aa92074b-b296-596b-a4d9-ceb3ab1e0160","c56.9",-24064,"TCGA-13-0920_treatment","2ef54a76-92fa-5238-a468-e54efb2cf108","01",NA,"TCGA-13-0920-01A","0.7","a2530fac-9d42-4fbe-881b-e9bad5a2d793",FALSE,"6880B406-08B2-43CE-9274-5826B1BE9114","Primary Tumor","0.4",NA,NA,"1",1233705600,"01",113,"TCGA-13-0920-01A-01",90,90,NA,NA,0,0,20,20,"2016-09-08T12:48:47.907604-05:00","2016-09-08T12:48:47.907604-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"865199e6-7b94-40ef-82e8-e65aa9377818","b7b9daea-d790-433c-93b2-db5e26827f30","TCGA-13-0920-01A-01-TS1","TCGA-13-0920-01A-01-BS1",80,80,"98846f4e-19c8-46fd-97a8-bfa90e1c62c5","RNA","TCGA-13-0920-01A-01R","26a45072-a0b6-4f68-8548-4da1cc6e866a",1.8,0.14,"UV Spec","R","22","TCGA-13-0920-01A-01R-1564-13","2d8e1b4d-85d0-4bfd-99f7-59559dabe978",0.14,NA,NA,NA,NA,"bde5cd78-5a04-548a-b5fa-e39faebbba77","TCGA-13-0920_exposure","TCGA-13-0920-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T17:35:17.000Z","2014-03-28T17:49:01.000Z","4F2B637A-DA1F-4A57-A391-88132F55BA27","A2530FAC-9D42-4FBE-881B-E9BAD5A2D793","Unaligned reads",6393610240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2D8E1B4D-85D0-4BFD-99F7-59559DABE978","Canada's Michael Smith Genome Sciences Centre","564a59dbe4b093830b6c7fe2","85A85A11-7200-4E96-97AF-6BA26D680D59","Ovarian Serous Cystadenocarcinoma","TAR","98846F4E-19C8-46FD-97A8-BFA90E1C62C5","2014-03-28T17:49:01.000Z","26A45072-A0B6-4F68-8548-4DA1CC6E866A","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"98846F4E-19C8-46FD-97A8-BFA90E1C62C5",0.7,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1aaaee17-5206-42cc-b678-f4a4e712ae54.txt",NA,"TCGA-13-0920-01A",1,"7886C638-9120-43DC-A93D-657BAE62D49D","TCGA",2007,NA,NA,"WITH TUMOR","C0A54DE1-ADCD-489B-81F7-13647A56C44A",65,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1aaaee17-5206-42cc-b678-f4a4e712ae54.txt","Alive",NA,"TCGA-13-0920","NOT HISPANIC OR LATINO","7520C61E-B168-410F-9EEB-CDA2DEAED2A7",NA,420,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,113,"865199E6-7B94-40EF-82E8-E65AA9377818","92B6450D-6A38-4F25-B418-540B8F338E7F","TCGA-13-0920-01A-01R-1564-13_rnaseq_fastq.tar","TCGA-13-0920-01A-01",90,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-13-0920-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-13-0920-D24776",NA,NA,NA,"TCGA-13-0920-F24775_NTE-1",NA,420,"WITH TUMOR","Alive",NA,"TCGA-13-0920-F24775","TCGA-13-0920",NA,"13","0920","YES","C56.9","8441/3","C56.9",NA,NA,-24064,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",420,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
251524868,244104980,18077664569,"F960A921-36AD-4D3E-99BE-4FB9A4869B6B.bw","85bb4987-51e7-40fe-ad59-2aa56754eca9","f960a921-36ad-4d3e-99be-4fb9a4869b6b","2016-08-27T06:09:39.946254-05:00","TCGA-61-2002-01A-01R-1568-13_rnaseq_fastq.tar","919933d9-f0c4-4e0c-953f-7691571a1f52",16479662080,"Illumina HiSeq","185d4c258d52465c135d49c9cf35d3a6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:16:47.344600-05:00","2016-05-03T11:41:05.755204-05:00","919933d9-f0c4-4e0c-953f-7691571a1f52_analysis.xml","68720e79f83caea2e3d9dc87897c5555","d6bb1ab3-8e0e-4137-bf8a-456b13eb3152",2183,"2016-09-29T23:17:33.632696-05:00","919933d9-f0c4-4e0c-953f-7691571a1f52_experiment.xml","d7e1e14060f450748efd341edb70e3fc","d72a8708-22f0-4633-a7d9-9e9c5edf622b",3916,"2016-09-29T21:08:00.914583-05:00","919933d9-f0c4-4e0c-953f-7691571a1f52_run.xml","b0a8471688e17e95a316b60e730c8160","871304d3-e5a9-4a54-ab72-c6fee69029d5",1990,"2016-09-08T12:48:02.843270-05:00","TCGA-61-2002","2016-09-02T18:56:30.622908-05:00","female","TCGA-61-2002_demographic",1962,"white","eaf6457d-9150-5a07-a240-9aabc2e07928","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2002_diagnosis","not reported",17115,"alive","8441/3",NA,547,"578ddcf5-2778-5527-9652-d17bc06c620c","c56.9",-17115,"TCGA-61-2002_treatment","77095dda-43e6-5a0a-bcb5-fb3ab57e2fec","01",NA,"TCGA-61-2002-01A","0.4","c9aa3e59-a10a-4e4c-b8cb-40d970f43df7",FALSE,"8030b8aa-9686-45b3-bf39-1889a6b8b36f","Primary Tumor","0.2",NA,NA,"1.2",1247443200,"01",161,"TCGA-61-2002-01A-01",90,95,NA,NA,8,10,8,5,"2016-09-08T12:48:02.843270-05:00","2016-09-08T12:48:02.843270-05:00",NA,NA,NA,NA,"BOTTOM","TOP",8,5,"0ac8e44a-e0cc-44e6-91b7-32686289b3da","7f64b50a-e622-4523-ac97-24023925caf1","TCGA-61-2002-01A-01-BS1","TCGA-61-2002-01A-01-TS1",76,80,"421cc42a-68cd-47bf-bb82-8b55acb883b0","RNA","TCGA-61-2002-01A-01R","0d9bf4ba-57c4-4e16-ad25-954c8495a9ee",1.8,0.14,"UV Spec","R","22","TCGA-61-2002-01A-01R-1568-13","14cd154a-6ea5-4ad9-92e4-72f53ee5d60b",0.14,NA,NA,NA,NA,"daedbb3d-0565-5bef-b85d-29db62b241aa","TCGA-61-2002_exposure","TCGA-61-2002-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T03:37:27.000Z","2014-03-27T04:04:01.000Z","919933D9-F0C4-4E0C-953F-7691571A1F52","C9AA3E59-A10A-4E4C-B8CB-40D970F43DF7","Unaligned reads",16479662080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","14CD154A-6EA5-4AD9-92E4-72F53EE5D60B","Canada's Michael Smith Genome Sciences Centre","564a5b28e4b0298dd2cc12d1","85BB4987-51E7-40FE-AD59-2AA56754ECA9","Ovarian Serous Cystadenocarcinoma","TAR","421CC42A-68CD-47BF-BB82-8B55ACB883B0","2014-03-27T04:04:01.000Z","0D9BF4BA-57C4-4E16-AD25-954C8495A9EE","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"421CC42A-68CD-47BF-BB82-8B55ACB883B0",0.4,"61","C239.TCGA-61-2002-01A-01W-0722-08.2.bam.bai",NA,"TCGA-61-2002-01A",1.2,"EB420498-8627-4216-AB0A-82DE0025A5CA","TCGA",2008,NA,NA,"WITH TUMOR","C9AA3E59-A10A-4E4C-B8CB-40D970F43DF7",46,"nationwidechildrens.org_clinical.TCGA-61-2002.xml","Alive",NA,"TCGA-61-2002","NOT HISPANIC OR LATINO","7707C515-3224-4835-89C6-76F1F0D0E875",NA,547,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,161,"7F64B50A-E622-4523-AC97-24023925CAF1","56F3C32C-8236-478E-8019-0BBF8DD172B9","C239.TCGA-61-2002-01A-01W-0722-08.2.bam.bai","TCGA-61-2002-01A-01",90,8,NA,NA,8,"BOTTOM",8,NA,"TCGA-61-2002-01A-01-BS1",76,"Avastin","Chemotherapy","TCGA-61-2002-D28325",NA,NA,NA,NA,NA,547,"WITH TUMOR","Alive",NA,"TCGA-61-2002-F28321","TCGA-61-2002",NA,"61","2002","YES","C56.9","8441/3","C56.9",NA,NA,-17115,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",547,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,46,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
249195906,219769156,16102827965,"FB656602-744B-45B4-AF07-AD3285BCA0BB.bw","8628f1b2-3763-4ba9-a375-083874bb18f2","fb656602-744b-45b4-af07-ad3285bca0bb","2016-08-05T02:49:41.986257-05:00","TCGA-VG-A8LO-01A-11R-A406-31_rnaseq_fastq.tar","b2904a9d-c557-425d-b29a-73a6ebbcb510",15963197440,"Illumina HiSeq","9b09b7d675e41969ee2252824e6f1df2","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T19:38:13.512017-05:00","2016-06-22T11:19:32.361656-05:00","b2904a9d-c557-425d-b29a-73a6ebbcb510_analysis.xml","eb9212832025cf3478934dab7da67e6a","4f9d66d3-f893-497a-8136-99afe7df3e1e",2183,"2016-09-29T17:52:45.152543-05:00","b2904a9d-c557-425d-b29a-73a6ebbcb510_experiment.xml","4bbd158d20af99d2aa452530cec352c8","0d6a0a18-2b0d-4422-a98c-a54be0008f74",3753,"2016-09-29T21:01:38.868703-05:00","b2904a9d-c557-425d-b29a-73a6ebbcb510_run.xml","186123d9e9d98fab8ae32d11c5620c4f","83047b0f-59ad-49e2-bbd9-f64c51122c61",1807,"2016-09-08T11:41:20.306303-05:00","TCGA-VG-A8LO","2016-09-02T19:00:47.286021-05:00","female","TCGA-VG-A8LO_demographic",1958,"black or african american","bd84ae7e-b25d-59f9-9161-7cc10e02bf9f","not hispanic or latino",2013,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","NCH","VG","1c07df32-5f63-5d9d-8317-643884a64e79","Institute of Human Virology Nigeria","not reported","c56.9","TCGA-VG-A8LO_diagnosis","not reported",20274,"dead","8460/3",24,NA,"aaaed386-e2f5-53c2-bdc4-6508fdec1123","c56.9",-20274,"TCGA-VG-A8LO_treatment","24e3a3e4-fea0-54a7-81de-f636e54333f7","01","false","TCGA-VG-A8LO-01A",NA,"ccd3903e-eee6-41f0-9a07-4351a00a7dc3",FALSE,"6FF4C359-F127-44E6-A1A2-641D60A3665F","Primary Tumor",NA,122,260,NA,1386028800,"11",30,"TCGA-VG-A8LO-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:41:20.306303-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"b39a4d64-82a1-4a04-8ab6-918f3058b83b",NA,"TCGA-VG-A8LO-01A-01-DX1",NA,90,NA,"7baa0d2c-064f-490c-974b-ca6d3f2d2176","RNA","TCGA-VG-A8LO-01A-11R","64ca0f4d-9a26-4376-bd63-5cc1939e527b",1.84,0.18,"UV Spec","R","23","TCGA-VG-A8LO-01A-11R-A406-31","fbad0ba1-131d-48af-9957-e9ca56f54e84",0.18,NA,NA,NA,NA,"18a1e7d0-12f6-52dd-b04c-b461755fcc2c","TCGA-VG-A8LO_exposure","TCGA-VG-A8LO-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T07:01:10.000Z","2015-02-07T08:39:11.000Z","B2904A9D-C557-425D-B29A-73A6EBBCB510","CCD3903E-EEE6-41F0-9A07-4351A00A7DC3","Unaligned reads",15963197440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FBAD0BA1-131D-48AF-9957-E9CA56F54E84","Canada's Michael Smith Genome Sciences Centre","564a33d8e4b08c5d868f1a38","8628F1B2-3763-4BA9-A375-083874BB18F2","Ovarian Serous Cystadenocarcinoma","TAR","7BAA0D2C-064F-490C-974B-CA6D3F2D2176","2015-02-07T08:39:11.000Z","64CA0F4D-9A26-4376-BD63-5CC1939E527B","Nigeria","NO",1,NA,"Primary Tumor","Institute of Human Virology Nigeria",122,"7BAA0D2C-064F-490C-974B-CA6D3F2D2176",NA,"VG","TCGA-VG-A8LO-01A-11R-A406-31_rnaseq.bam.bai",260,"TCGA-VG-A8LO-01A",NA,"FC9C6E78-2625-4BFD-879D-1E1FFFD56E85","TCGA",2013,NA,NA,"WITH TUMOR","CCD3903E-EEE6-41F0-9A07-4351A00A7DC3",55,"nationwidechildrens.org_clinical.TCGA-VG-A8LO.xml","Dead",24,"TCGA-VG-A8LO","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",4,"Other","Stage IV",NA,50,NA,"8460/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"B39A4D64-82A1-4A04-8AB6-918F3058B83B","C9869663-D3D8-477D-882A-618FDC900147","TCGA-VG-A8LO-01A-11R-A406-31_rnaseq.bam.bai","TCGA-VG-A8LO-01A-11",90,0,0,0,10,"TOP",0,0,"TCGA-VG-A8LO-01A-01-DX1",90,"paclitaxel","Chemotherapy","TCGA-VG-A8LO-D60809",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-VG-A8LO",NA,"VG","A8LO","YES","C56.9","8460/3","C56.9","YES","NO",-20274,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,24,"NO","YES","WITH TUMOR","YES",25,3,2014,"NO","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,55,2013,"Excisional Biopsy",NA,NA,NA,"GB","R2",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,50,4,"Other",NA,NA,NA,NA,NA,NA,NA,NA
189941320,185084954,13681163638,"A57B85C7-3FC2-4045-8C37-8F665C1B1459.bw","8652ddee-98f4-4584-b450-e6f2f5c9d7ec","a57b85c7-3fc2-4045-8c37-8f665c1b1459","2016-08-21T22:15:23.238793-05:00","TCGA-04-1356-01A-01R-1569-13_rnaseq_fastq.tar","e5d4f6fb-05d8-4172-aa77-d3e9551991ef",12145981440,"Illumina HiSeq","ba5d86f0df80e3c6aac41cce1c961f7f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:00:46.557939-05:00","2016-05-03T11:41:05.740436-05:00","e5d4f6fb-05d8-4172-aa77-d3e9551991ef_analysis.xml","debdec0d8ad3ea3bace09dec93fea18d","5d965ed5-29f1-4904-a5f3-fab8cf7b80f1",2208,"2016-09-30T00:16:47.955637-05:00","e5d4f6fb-05d8-4172-aa77-d3e9551991ef_experiment.xml","97e7635d95d1b63b584582c51829f5d5","fbeedd60-a95c-4700-8b3b-b9f7564ccaeb",3916,"2016-09-29T21:45:02.297864-05:00","e5d4f6fb-05d8-4172-aa77-d3e9551991ef_run.xml","2a7f521b958eefc0645f811344094ed5","9deeddf1-b3d3-4f96-89d1-48fa97aba39b",1988,"2016-09-08T13:16:12.199347-05:00","TCGA-04-1356","2016-09-02T19:12:06.447023-05:00","female","TCGA-04-1356_demographic",1942,"white","6f4e3146-4cfe-55b8-8427-ff6397b2269e","hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1356_diagnosis","not reported",22855,"dead","8441/3",1499,NA,"9c12fc68-20a6-5db7-aa57-9cc51005f642","c56.9",-22855,"TCGA-04-1356_treatment","dee40d08-8480-526a-a9d8-342a0fd44479","01",NA,"TCGA-04-1356-01A","1","3d1f80f8-1033-48d9-9b97-36f025486b0a",FALSE,"7D26B212-1DE7-43CC-A0DC-A9071C3A534F","Primary Tumor","0.4",NA,NA,"1.2",1229558400,"01",114,"TCGA-04-1356-01A-01",99,95,NA,NA,0,0,5,10,"2016-09-08T13:16:12.199347-05:00","2016-09-08T13:16:12.199347-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,5,"1874f2aa-ad0f-47e3-8e23-367b0d246260","5269e379-7422-4dfd-87fe-65f585209d21","TCGA-04-1356-01A-01-TS1","TCGA-04-1356-01A-01-BS1",85,85,"0584b714-53fa-41ac-a17a-6cefc7443ccc","RNA","TCGA-04-1356-01A-01R","5d507d61-03b8-4c36-9c8e-63cd99b8d77d",1.8,0.16,"UV Spec","R","22","TCGA-04-1356-01A-01R-1569-13","dc4a5c2f-8b96-4d3b-9553-a02510ba445f",0.16,NA,NA,NA,NA,"9834c924-f3c2-59f7-a562-fa189c92125b","TCGA-04-1356_exposure","TCGA-04-1356-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T01:30:29.000Z","2014-03-27T01:55:02.000Z","E5D4F6FB-05D8-4172-AA77-D3E9551991EF","3D1F80F8-1033-48D9-9B97-36F025486B0A","Unaligned reads",12145981440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","DC4A5C2F-8B96-4D3B-9553-A02510BA445F","Canada's Michael Smith Genome Sciences Centre","564a31d1e4b08c5d868e7528","8652DDEE-98F4-4584-B450-E6F2F5C9D7EC","Ovarian Serous Cystadenocarcinoma","TAR","0584B714-53FA-41AC-A17A-6CEFC7443CCC","2014-03-27T01:55:02.000Z","5D507D61-03B8-4C36-9C8E-63CD99B8D77D","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"0584B714-53FA-41AC-A17A-6CEFC7443CCC",1,"04","C239.TCGA-04-1356-01A-01W.8.bam.bai",NA,"TCGA-04-1356-01A",1.2,"DCC12929-7C55-426B-83CD-0F693A953CFB","TCGA",2004,NA,NA,"WITH TUMOR","73512990-DCA7-4681-9029-8BEB1367BE73",62,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6b9482bd-967a-447e-8f6f-324c7ec41b4d.txt","Dead",1499,"TCGA-04-1356","HISPANIC OR LATINO","5860DEBC-E1F5-4CBF-A327-55EAADA5452E",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Operative","Stage IIC",NA,80,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,114,"5269E379-7422-4DFD-87FE-65F585209D21","A8FFD679-0834-4102-A191-A7EE09A34ED9","bcgsc.ca.TCGA-04-1356-01A-01R-1569-13.bcgsc.ca.1.5.0.snv.vcf","TCGA-04-1356-01A-01",99,0,NA,NA,5,"TOP",10,NA,"TCGA-04-1356-01A-01-TS1",85,"Taxol","Chemotherapy","TCGA-04-1356-D24006",NA,NA,NA,"TCGA-04-1356-F24005_NTE-1",NA,NA,"WITH TUMOR","Dead",1499,"TCGA-04-1356-F24005","TCGA-04-1356",NA,"04","1356","YES","C56.9","8441/3","C56.9",NA,NA,-22855,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Dead",NA,1499,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,80,NA,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
263839818,256697551,19010520946,"691E37EE-96BE-4D6C-9797-67491D7575EA.bw","867f9563-16c9-45a8-b519-6df61ba1b6b7","691e37ee-96be-4d6c-9797-67491d7575ea","2016-08-25T12:59:43.298443-05:00","TCGA-09-1662-01A-01R-1566-13_rnaseq_fastq.tar","e1fc2f9b-7066-4863-87fc-1f357d2b5c3d",16891934720,"Illumina HiSeq","47ad1f0943492f69e4a9e6afe5290e2f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:35:37.357164-05:00","2016-05-03T11:39:34.528512-05:00","e1fc2f9b-7066-4863-87fc-1f357d2b5c3d_analysis.xml","294fb2f6826e5bffb4f0ff6ef3babe34","026db19d-e67d-465c-b815-f04cd105ebfe",2181,"2016-08-13T05:59:05.045057-05:00","e1fc2f9b-7066-4863-87fc-1f357d2b5c3d_experiment.xml","91064d7a07cb82828beca1e1e760d372","d179a4d0-74d4-44eb-80fb-3bcaa249d0ad",3916,"2016-09-29T17:50:46.783962-05:00","e1fc2f9b-7066-4863-87fc-1f357d2b5c3d_run.xml","6ddcd9e1b89adb5203964841346e54e2","0c23f784-157c-4a7c-a68c-6cb7cc2615ba",1988,"2016-09-08T10:46:33.355276-05:00","TCGA-09-1662","2016-09-02T18:48:49.260920-05:00","female","TCGA-09-1662_demographic",1943,"white","b1157df0-4b67-57c6-a41d-2425cbc0a707","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1662_diagnosis","not reported",21246,"dead","8441/3",2717,NA,"5b81cf5b-651e-5c5e-a09f-53be4eca5931","c56.9",-21246,"TCGA-09-1662_treatment","081f9cc1-d2cf-528e-8029-566cc8be67e1","01",NA,"TCGA-09-1662-01A","0.7","510f8684-3686-4192-b2a3-dd2499365f78",FALSE,"8e2676a4-2ac3-42af-be7d-cf74b6d82f2f","Primary Tumor","0.5",NA,NA,"1.5",1240185600,"01",127,"TCGA-09-1662-01A-01",85,95,NA,NA,8,10,0,0,"2016-09-08T10:46:33.355276-05:00","2016-09-08T10:46:33.355276-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,3,"991a3778-5f86-4d75-93d3-93b24310153c","47ad6cd0-c2f1-4aae-aa2a-ff9dae3583db","TCGA-09-1662-01A-01-TS1","TCGA-09-1662-01A-01-BS1",87,87,"47364d4b-dbed-4978-a38b-a1b6671d6935","RNA","TCGA-09-1662-01A-01R","8b90471f-de03-46c1-a5e2-09ac18de7193",1.8,0.16,"UV Spec","R","22","TCGA-09-1662-01A-01R-1566-13","759060d9-af2e-4098-b4ee-7aa2214acba8",0.16,NA,NA,NA,NA,"56dbe702-1653-55fc-9bca-2b2ad5d36a61","TCGA-09-1662_exposure","TCGA-09-1662-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T07:35:56.000Z","2014-03-20T08:08:02.000Z","E1FC2F9B-7066-4863-87FC-1F357D2B5C3D","510F8684-3686-4192-B2A3-DD2499365F78","Unaligned reads",16891934720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","759060D9-AF2E-4098-B4EE-7AA2214ACBA8","Canada's Michael Smith Genome Sciences Centre","564a3c0be4b093830b6979c5","867F9563-16C9-45A8-B519-6DF61BA1B6B7","Ovarian Serous Cystadenocarcinoma","TAR","47364D4B-DBED-4978-A38B-A1B6671D6935","2014-03-20T08:08:02.000Z","8B90471F-DE03-46C1-A5E2-09AC18DE7193","None","NO",1,0.5,"Primary Tumor","UCSF",NA,"47364D4B-DBED-4978-A38B-A1B6671D6935",0.7,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.253b785e-f10b-4d0e-88cb-4db4a3610c7c.txt",NA,"TCGA-09-1662-01A",1.5,"FB873564-DF62-4403-9335-80C56C7B00F9","TCGA",2001,NA,NA,"WITH TUMOR","612B8ADF-3DB2-4458-A4B9-09342E2F6F68",58,"nationwidechildrens.org_clinical.TCGA-09-1662.xml","Dead",2717,"TCGA-09-1662","NOT HISPANIC OR LATINO","0B2F4DDB-FA9E-45EC-97AB-A8FC3D0F4BE8",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,127,"991A3778-5F86-4D75-93D3-93B24310153C","D1B80594-DA09-4B0D-BAB3-2D0C79DE59BA","TCGA-09-1662-01A-01R-1566-13_GRCh37-lite_mirna.bam","TCGA-09-1662-01A-01",85,8,NA,NA,0,"TOP",5,NA,"TCGA-09-1662-01A-01-TS1",87,"Carboplatin","Chemotherapy","TCGA-09-1662-D24245",NA,NA,NA,"TCGA-09-1662-F24243_NTE-2",NA,NA,"WITH TUMOR","Dead",2717,"TCGA-09-1662-F24243","TCGA-09-1662",NA,"09","1662","YES","C56.9","8441/3","C56.9",NA,NA,-21246,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,2717,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,58,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
166211532,155475825,11427492366,"38443F8E-9707-4995-BA83-39C8D93A2AF1.bw","86b513ba-df09-485d-92d4-fb9e888f7350","38443f8e-9707-4995-ba83-39c8d93a2af1","2016-08-19T19:39:26.576133-05:00","TCGA-29-1701-01A-01R-1567-13_rnaseq_fastq.tar","c24a9e5e-8bde-4ae8-9093-a6370bd9d9e4",9951979520,"Illumina HiSeq","68d00c800aa790388332f8e753831e23","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:55:00.238666-05:00","2016-05-03T11:41:05.740436-05:00","c24a9e5e-8bde-4ae8-9093-a6370bd9d9e4_analysis.xml","38e034b135bc2814a3a78744b4e88252","3483ae0c-4fdd-4368-9944-a0dd7622fddf",2181,"2016-08-13T02:39:19.727976-05:00","c24a9e5e-8bde-4ae8-9093-a6370bd9d9e4_experiment.xml","96b5c8ffc510e4bc4528e3d21ce3cdfe","1b684161-90d6-4d9a-a2f3-117037543ab1",3916,"2016-09-29T23:46:51.034243-05:00","c24a9e5e-8bde-4ae8-9093-a6370bd9d9e4_run.xml","be05fb10f31aa76e03e806934be5a5b2","e997fa8d-34b9-4d13-b071-2234d0907ce7",1988,"2016-09-08T13:01:33.379739-05:00","TCGA-29-1701","2016-09-02T19:07:23.739374-05:00","female","TCGA-29-1701_demographic",1948,"white","5a7b3dcd-6dc2-5969-88a3-e6623cb00004","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1701_diagnosis","not reported",20737,"dead","8441/3",515,514,"7970b8af-897d-58cd-9c10-f467a239f1d1","c56.9",-20737,"TCGA-29-1701_treatment","2411538c-6d01-5b61-969d-ff4d50ed1969","01",NA,"TCGA-29-1701-01A","1.1","eae870be-bbc8-4ffe-bffc-86d87414ff4b",FALSE,"f7568046-b77a-4654-9f94-8978bd3e22c4","Primary Tumor","0.6",NA,NA,"1.3",1242086400,"01",97,"TCGA-29-1701-01A-01",90,90,NA,NA,0,0,0,0,"2016-09-08T13:01:33.379739-05:00","2016-09-08T13:01:33.379739-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,2,"d847a62d-bdbf-4972-b4f1-4d817ced7de5","1e5a96c0-8c8b-49fe-8083-4e9b2248d324","TCGA-29-1701-01A-01-BS1","TCGA-29-1701-01A-01-TS1",98,98,"3be60d94-02c6-4ebf-967c-e842877627be","RNA","TCGA-29-1701-01A-01R","c9c89c72-dbea-42fa-a0d3-ae48915fdb73",1.8,0.16,"UV Spec","R","22","TCGA-29-1701-01A-01R-1567-13","e5e6f25b-d641-4598-8bb1-0850750ef048",0.16,NA,NA,NA,NA,"51ff74bd-eb63-5ebf-81a2-207d7b074690","TCGA-29-1701_exposure","TCGA-29-1701-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T01:39:01.000Z","2014-03-27T02:02:02.000Z","C24A9E5E-8BDE-4AE8-9093-A6370BD9D9E4","EAE870BE-BBC8-4FFE-BFFC-86D87414FF4B","Unaligned reads",9951979520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E5E6F25B-D641-4598-8BB1-0850750EF048","Canada's Michael Smith Genome Sciences Centre","564a3b62e4b0298dd2c866f5","86B513BA-DF09-485D-92D4-FB9E888F7350","Ovarian Serous Cystadenocarcinoma","TAR","3BE60D94-02C6-4EBF-967C-E842877627BE","2014-03-27T02:02:02.000Z","C9C89C72-DBEA-42FA-A0D3-AE48915FDB73","None","NO",1,0.6,"Primary Tumor","Duke",NA,"3BE60D94-02C6-4EBF-967C-E842877627BE",1.1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d770980a-b6ef-4e85-8ed6-a22702326573.txt",NA,"TCGA-29-1701-01A",1.3,"8A9DBE36-B51F-41EC-A7F0-2CD48435FF0E","TCGA",2004,NA,NA,"WITH TUMOR","EAE870BE-BBC8-4FFE-BFFC-86D87414FF4B",56,"TCGA-29-1701-01A-01R-1567-13_GRCh37-lite_mirna.bam.bai","Dead",515,"TCGA-29-1701",NA,"54915DDA-C60B-4540-8BA8-7325A9FE50C7",NA,514,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,97,"D847A62D-BDBF-4972-B4F1-4D817CED7DE5","D4A5CE04-1DE1-40FA-9360-D4A5DDE28AFB","b79b1f435df5a5365d9523b52a78c058.bam","TCGA-29-1701-01A-01",90,0,NA,NA,0,"BOTTOM",2,NA,"TCGA-29-1701-01A-01-BS1",98,"Paclitaxel","Chemotherapy","TCGA-29-1701-D27244",NA,NA,NA,"TCGA-29-1701-F27243_NTE-1",NA,514,"WITH TUMOR","Dead",515,"TCGA-29-1701-F27243","TCGA-29-1701",NA,"29","1701","YES","C56.9","8441/3","C56.9",NA,NA,-20737,"FEMALE","WHITE",NA,NA,"No","Dead",514,515,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
140288354,137155028,10159608460,"DC56C1DC-3FC8-49CA-BC9E-AFED2BEF11A0.bw","872d2922-7292-4681-adb7-d3b267eccbe7","dc56c1dc-3fc8-49ca-bc9e-afed2bef11a0","2016-08-26T18:15:03.558980-05:00","TCGA-24-2033-01A-01R-1568-13_rnaseq_fastq.tar","c1917f76-96ae-404e-932a-e138237d2d97",8488458240,"Illumina HiSeq","d8fde0df1a491658a8ed8de026c65551","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:19:50.381345-05:00","2016-05-03T11:58:49.360058-05:00","c1917f76-96ae-404e-932a-e138237d2d97_analysis.xml","439ec0289709155a3bcadf0065ee00fb","691c8d8b-a81a-44a1-8c2e-8b9dd998f398",2181,"2016-08-27T00:48:22.189827-05:00","c1917f76-96ae-404e-932a-e138237d2d97_experiment.xml","026a977d4bd9f7654844da8808b98c03","f38381c8-c7b6-40cc-9245-bdd90cf884cb",3916,"2016-09-29T22:41:20.262070-05:00","c1917f76-96ae-404e-932a-e138237d2d97_run.xml","a13adea924e2dd8274de568ab389e975","c0cd8cd5-b52d-47e5-8973-afb42b78b255",1988,"2016-09-08T12:46:58.718365-05:00","TCGA-24-2033","2016-09-02T18:56:18.230233-05:00","female","TCGA-24-2033_demographic",1908,"white","7726c9f9-3852-5bc5-99d6-00a44e1d0173","not reported",1996,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2033_diagnosis","not reported",31977,"dead","8441/3",562,562,"54f526da-dd2d-5ca2-ba04-32fa91ce3f46","c56.9",-31977,"TCGA-24-2033_treatment","2b692939-01eb-5f0f-9fb5-c6bb2f44a78f","01",NA,"TCGA-24-2033-01A","0.7","88152ab3-4bbc-4d80-9e1e-34c96de3d604",FALSE,"c804dedf-5495-4051-b87f-974afe4d5718","Primary Tumor","0.7",NA,NA,"1",1248134400,"01",131,"TCGA-24-2033-01A-01",85,85,0,0,0,0,5,35,"2016-09-08T12:46:58.718365-05:00","2016-09-08T12:46:58.718365-05:00",0,5,0,0,"TOP","BOTTOM",0,0,"88804778-148e-4bc9-9ea2-958f6e212d0c","c452734b-3ab3-4067-b7d3-fce4e584a18e","TCGA-24-2033-01A-01-TS1","TCGA-24-2033-01A-01-BS1",95,65,"4131ce66-68c1-42f3-a80d-0b5291dc2b6b","RNA","TCGA-24-2033-01A-01R","dd71759b-1a5b-4b79-bb6a-63639a015215",1.8,0.16,"UV Spec","R","22","TCGA-24-2033-01A-01R-1568-13","b03b75e2-d1d0-4fd7-b66e-891f7b0acb76",0.16,NA,NA,NA,NA,"1a838110-04e1-50c5-9d1f-625e18682fb0","TCGA-24-2033_exposure","TCGA-24-2033-01A-01R-1568-13_rnaseq_fastq.tar","2014-09-23T03:29:01.000Z","2014-09-23T05:11:20.000Z","C1917F76-96AE-404E-932A-E138237D2D97","88152AB3-4BBC-4D80-9E1E-34C96DE3D604","Unaligned reads",8488458240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B03B75E2-D1D0-4FD7-B66E-891F7B0ACB76","Canada's Michael Smith Genome Sciences Centre","564a35d5e4b0298dd2c69f17","872D2922-7292-4681-ADB7-D3B267ECCBE7","Ovarian Serous Cystadenocarcinoma","TAR","4131CE66-68C1-42F3-A80D-0B5291DC2B6B","2014-09-23T05:11:20.000Z","DD71759B-1A5B-4B79-BB6A-63639A015215","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"4131CE66-68C1-42F3-A80D-0B5291DC2B6B",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d671c1b8-d45e-4d50-bf32-458677874c49.txt",NA,"TCGA-24-2033-01A",1,"EF87003D-E997-422D-84AF-6D400D8D9CC9","TCGA",1995,NA,NA,"WITH TUMOR","88152AB3-4BBC-4D80-9E1E-34C96DE3D604",87,"SOURS_p_TCGAb22_SNP_N_GenomeWideSNP_6_E02_529902.hg18.seg.txt","Dead",562,"TCGA-24-2033",NA,"803D2C06-FA19-4069-8E38-943EB8AFC387",NA,562,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,131,"C452734B-3AB3-4067-B7D3-FCE4E584A18E","EC6D7B21-322D-4DDA-8AC5-99F566C4141C","TCGA-24-2033-01A-01R-1568-13_rnaseq.bam","TCGA-24-2033-01A-01",85,0,0,5,35,"BOTTOM",0,0,"TCGA-24-2033-01A-01-BS1",65,"Topotecan","Chemotherapy","TCGA-24-2033-D26493",NA,NA,NA,"TCGA-24-2033-F26490_NTE-1",NA,562,"WITH TUMOR","Dead",562,"TCGA-24-2033-F26490","TCGA-24-2033",NA,"24","2033","YES","C56.9","8441/3","C56.9",NA,NA,-31977,"FEMALE","WHITE",NA,NA,"No","Dead",562,562,NA,NA,"WITH TUMOR","NO",15,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,87,1995,"Tumor resection",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
174977976,169610572,12567894434,"2EE2F4A6-C908-48B0-8D5D-5B3A4111FB21.bw","87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4","2ee2f4a6-c908-48b0-8d5d-5b3a4111fb21","2016-08-19T15:45:22.096980-05:00","TCGA-61-1917-01A-01R-1568-13_rnaseq_fastq.tar","76de1af4-063b-480d-8ec5-dbb3e22f7f1b",10883194880,"Illumina HiSeq","d27d87b1b9d9fbcbd6c8a5439169db79","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:41:45.908116-05:00","2016-05-03T11:41:05.755204-05:00","76de1af4-063b-480d-8ec5-dbb3e22f7f1b_analysis.xml","97ac5eaad9181d90c12c62930d1a534e","e6569f21-9294-421c-a374-d3b0576598dd",2181,"2016-08-29T00:42:59.108191-05:00","76de1af4-063b-480d-8ec5-dbb3e22f7f1b_experiment.xml","d8d409a1c3be64067efc270cfd311dbd","a2d5f6c9-b955-4876-b6d4-62ced4054a0a",3916,"2016-09-29T23:26:37.434119-05:00","76de1af4-063b-480d-8ec5-dbb3e22f7f1b_run.xml","9b2a22fbaeae64c68edc3e75d0ca9896","dcdbd9e6-5876-4e5e-a97b-c686252daf9b",1989,"2016-09-08T10:46:22.834200-05:00","TCGA-61-1917","2016-09-02T18:49:47.649866-05:00","female","TCGA-61-1917_demographic",1942,"white","74f5f727-b63b-5e72-8e77-a97f9b879973","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1917_diagnosis","not reported",21972,"dead","8441/3",1321,1321,"cb076281-fc07-59e0-98e5-006fcdb7e319","c56.9",-21972,"TCGA-61-1917_treatment","925949a3-cbd9-5646-b879-60045d81afeb","01",NA,"TCGA-61-1917-01A","0.6","ec9f63ce-bf4d-4970-9df3-8bafabc8d9f5",FALSE,"ebb81051-f181-4878-85ac-7e00ad6aca85","Primary Tumor","0.1",NA,NA,"2",1246233600,"01",186,"TCGA-61-1917-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T10:46:22.834200-05:00","2016-09-08T10:46:22.834200-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,5,"2da11de5-e96c-4f15-9429-f35b69a56f25","f2019c54-70c5-4120-8bf5-8ec49d415ab8","TCGA-61-1917-01A-01-TS1","TCGA-61-1917-01A-01-BS1",80,85,"141e3588-f585-428b-aa70-776bf60a1cb4","RNA","TCGA-61-1917-01A-01R","a73ec858-4925-457f-9458-7488ec5f3229",1.8,0.13,"UV Spec","R","22","TCGA-61-1917-01A-01R-1568-13","519aea8b-5e08-47b2-bb98-b311f2dba540",0.13,NA,NA,NA,NA,"52dcda84-2e60-5d26-9480-5b73c63035c7","TCGA-61-1917_exposure","TCGA-61-1917-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T03:09:09.000Z","2014-03-27T03:33:01.000Z","76DE1AF4-063B-480D-8EC5-DBB3E22F7F1B","EC9F63CE-BF4D-4970-9DF3-8BAFABC8D9F5","Unaligned reads",10883194880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","519AEA8B-5E08-47B2-BB98-B311F2DBA540","Canada's Michael Smith Genome Sciences Centre","564a3fe8e4b0298dd2c9da92","87CDF9A8-0579-4D3E-B4DF-0F8EEF63D7F4","Ovarian Serous Cystadenocarcinoma","TAR","141E3588-F585-428B-AA70-776BF60A1CB4","2014-03-27T03:33:01.000Z","A73EC858-4925-457F-9458-7488EC5F3229","None","NO",1,0.1,"Primary Tumor","University of Pittsburgh",NA,"141E3588-F585-428B-AA70-776BF60A1CB4",0.6,"61","TCGA-61-1917-01A-01R-1568-13_mirna.bam",NA,"TCGA-61-1917-01A",2,"E7226494-66F0-4F59-8453-395E4E996045","TCGA",2002,NA,NA,NA,"EC9F63CE-BF4D-4970-9DF3-8BAFABC8D9F5",60,"nationwidechildrens.org_clinical.TCGA-61-1917.xml","Dead",1321,"TCGA-61-1917","NOT HISPANIC OR LATINO","A316538E-69FD-4B85-86E5-E43C4AEAB4E4",NA,1321,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,186,"F2019C54-70C5-4120-8BF5-8EC49D415AB8","39986F27-5D1B-4374-BA59-31DE089A5FED","TCGA-61-1917-01A-01R-1568-13_mirna.bam","TCGA-61-1917-01A-01",90,0,NA,NA,10,"TOP",10,NA,"TCGA-61-1917-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-61-1917-D28292",NA,NA,NA,NA,NA,1321,NA,"Dead",1321,"TCGA-61-1917-F28290","TCGA-61-1917",NA,"61","1917","YES","C56.9","8441/3","C56.9",NA,NA,-21972,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1321,1321,NA,NA,NA,"NO",30,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,60,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
177483700,173047094,12811108809,"D67FDA28-D47C-4672-867E-367DF0202E52.bw","88180134-710f-46ea-9b06-5e5d860d6d9f","d67fda28-d47c-4672-867e-367df0202e52","2016-08-26T16:05:33.258108-05:00","TCGA-61-2110-01A-01R-1568-13_rnaseq_fastq.tar","4edaa981-1b7c-4170-bb48-c2b418828eec",11236669440,"Illumina HiSeq","6cce173932b2f132e657f3bfb9626154","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:33:13.671999-05:00","2016-05-03T11:41:05.740436-05:00","4edaa981-1b7c-4170-bb48-c2b418828eec_analysis.xml","b5ed02a8f654b8920c248c940a3c5f40","4c8ec6cd-9c42-4599-add6-fd9029cfaf62",2181,"2016-09-29T18:28:25.326743-05:00","4edaa981-1b7c-4170-bb48-c2b418828eec_experiment.xml","661a9c53f614e44093fa1ab0abb5e312","23b6bfcf-3d03-4552-843c-400352618274",3916,"2016-09-29T20:48:25.222000-05:00","4edaa981-1b7c-4170-bb48-c2b418828eec_run.xml","694e9549b3d2ff8aa0f447117c2f9411","7abbd371-f629-4824-b21d-23f881a7d675",1988,"2016-09-08T12:49:17.327691-05:00","TCGA-61-2110","2016-09-02T18:56:25.410885-05:00","female","TCGA-61-2110_demographic",1942,"white","f60176dd-6543-512c-8308-244afc979cf1","not hispanic or latino",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2110_diagnosis","not reported",20718,"dead","8441/3",1354,1354,"1e51ebe2-c57d-5a2a-8421-1f6cbdf4003b","c56.9",-20718,"TCGA-61-2110_treatment","40938b97-fc11-528c-8a13-07959e393c9c","01",NA,"TCGA-61-2110-01A","0.4","6ae6b10a-fc2b-4c6e-a30e-0299c22ac042",FALSE,"d7a597dc-d607-4e20-90a9-a181d6c11d17","Primary Tumor","0.1",NA,NA,"0.4",1250467200,"01",94,"TCGA-61-2110-01A-01",70,75,NA,NA,45,25,3,5,"2016-09-08T12:49:17.327691-05:00","2016-09-08T12:49:17.327691-05:00",NA,NA,NA,NA,"BOTTOM","TOP",7,5,"e42d96bc-a002-4f4c-817b-d3a5b1af1172","657eac90-dffd-4a49-815e-751d197a315e","TCGA-61-2110-01A-01-BS1","TCGA-61-2110-01A-01-TS1",45,65,"b3f5ca74-ca20-4a79-9d40-45e1af4f270e","RNA","TCGA-61-2110-01A-01R","54c27ebd-e56a-4929-8ac5-9c3f548ac0e1",1.8,0.13,"UV Spec","R","22","TCGA-61-2110-01A-01R-1568-13","6561cdb8-8499-41a6-8a79-ef0119e34c66",0.13,NA,NA,NA,NA,"19696bca-7ac0-59c1-9468-86fc8b0a04ba","TCGA-61-2110_exposure","TCGA-61-2110-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T00:07:12.000Z","2014-03-27T00:30:02.000Z","4EDAA981-1B7C-4170-BB48-C2B418828EEC","6AE6B10A-FC2B-4C6E-A30E-0299C22AC042","Unaligned reads",11236669440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6561CDB8-8499-41A6-8A79-EF0119E34C66","Canada's Michael Smith Genome Sciences Centre","564a32c1e4b0ef121817ac36","88180134-710F-46EA-9B06-5E5D860D6D9F","Ovarian Serous Cystadenocarcinoma","TAR","B3F5CA74-CA20-4A79-9D40-45E1AF4F270E","2014-03-27T00:30:02.000Z","54C27EBD-E56A-4929-8AC5-9C3F548AC0E1","None","NO",1,0.1,"Primary Tumor","University of Pittsburgh",NA,"B3F5CA74-CA20-4A79-9D40-45E1AF4F270E",0.4,"61","TCGA-61-2110-01A-01W-0722-08_IlluminaGA-DNASeq_capture.bam.bai",NA,"TCGA-61-2110-01A",0.4,"E104ED61-6AC7-4C6C-AD84-389D00289ED8","TCGA",1998,NA,NA,"WITH TUMOR","6AE6B10A-FC2B-4C6E-A30E-0299C22AC042",56,"nationwidechildrens.org_clinical.TCGA-61-2110.xml","Dead",1354,"TCGA-61-2110","NOT HISPANIC OR LATINO","47C8D668-E766-409D-B4BD-EB05A7BEFB17",NA,1354,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,"0A8EE0E7-6928-425C-9669-747C96E6EE7D","WHITE",NA,1,94,"E42D96BC-A002-4F4C-817B-D3A5B1AF1172","93CFAFB2-5809-4294-BBAE-AA321557F7BA","TCGA-61-2110-01A-01R-1568-13_rnaseq_fastq.tar","TCGA-61-2110-01A-01",75,25,NA,NA,5,"TOP",5,NA,"TCGA-61-2110-01A-01-TS1",65,"Tamoxifen","Hormone Therapy","TCGA-61-2110-D28463","TCGA-61-2110-R28465","EXTERNAL BEAM","Local Recurrence","TCGA-61-2110-F28456_NTE-2",NA,1354,"WITH TUMOR","Dead",1354,"TCGA-61-2110-F28456","TCGA-61-2110",NA,"61","2110","YES","C56.9","8441/3","C56.9",NA,NA,-20718,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1354,1354,NA,NA,"WITH TUMOR","NO",4,12,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,1998,"Tumor resection",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
291498620,280979708,20802941742,"FD5382F5-6500-4CD7-85C6-97488B2187B4.bw","88d61634-913c-435a-8d25-e019c8dab7da","fd5382f5-6500-4cd7-85c6-97488b2187b4","2016-08-27T07:50:45.122186-05:00","TCGA-25-1625-01A-01R-1566-13_rnaseq_fastq.tar","f3d8e259-3dfe-4ae4-a0f0-c8b0984bb8f7",19258112000,"Illumina HiSeq","f8b12b9a7d5d9ba463a8b0b17b67d1c6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:10:24.759836-05:00","2016-05-03T11:39:34.528512-05:00","f3d8e259-3dfe-4ae4-a0f0-c8b0984bb8f7_analysis.xml","64146b584ff189bcf5f237a4d0577000","adafa834-a345-4e98-acdc-967f22ea0a58",2181,"2016-09-29T20:32:38.920880-05:00","f3d8e259-3dfe-4ae4-a0f0-c8b0984bb8f7_experiment.xml","ea4d59a6db3e10818b4d1aa5508a0c90","70f75b55-1a50-4e28-913c-a163f4b1b90f",3916,"2016-09-29T22:24:14.218317-05:00","f3d8e259-3dfe-4ae4-a0f0-c8b0984bb8f7_run.xml","d074ac9a39cb6f845886af65d88bf17a","b61e3ec7-f5d6-4ea1-988b-825093c88473",1988,"2016-09-08T11:22:18.946512-05:00","TCGA-25-1625","2016-09-02T18:47:41.416873-05:00","female","TCGA-25-1625_demographic",1940,"white","06877d4c-0fbc-5556-8685-4c48593f955d","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1625_diagnosis","not reported",24298,"dead","8441/3",840,548,"1f62e295-6408-55a9-935c-279bb362319e","c56.9",-24298,"TCGA-25-1625_treatment","9eda4617-0d41-58fa-8c1d-7c3a837481f7","01",NA,"TCGA-25-1625-01A","1.3","4ee39504-ac69-4dd7-b8a4-8d1cc3c20418",FALSE,"BDE314E3-1E2C-440E-8561-A260C1D0933A","Primary Tumor","0.3",NA,NA,"1.5",1237420800,"01",102,"TCGA-25-1625-01A-01",90,80,NA,NA,30,15,5,10,"2016-09-08T11:22:18.946512-05:00","2016-09-08T11:22:18.946512-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"e40d6e75-c7b0-4835-9e09-ff2efc2e1a27","c3f7e429-0929-40fd-9b13-e2e3df734776","TCGA-25-1625-01A-01-TS1","TCGA-25-1625-01A-01-BS1",60,70,"bbcbdfb9-f029-484b-82c0-658d022643a2","RNA","TCGA-25-1625-01A-01R","d459e8a3-f103-4da9-a5e7-68c146e40e80",1.8,0.15,"UV Spec","R","22","TCGA-25-1625-01A-01R-1566-13","921fab94-5522-4c08-8e02-13fb6ea2d388",0.15,NA,NA,NA,NA,"ad91e8ad-2497-5db2-b546-90e7b8edd6a4","TCGA-25-1625_exposure","TCGA-25-1625-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T04:22:33.000Z","2014-03-20T04:56:02.000Z","F3D8E259-3DFE-4AE4-A0F0-C8B0984BB8F7","4EE39504-AC69-4DD7-B8A4-8D1CC3C20418","Unaligned reads",19258112000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","921FAB94-5522-4C08-8E02-13FB6EA2D388","Canada's Michael Smith Genome Sciences Centre","564a3421e4b093830b66f250","88D61634-913C-435A-8D25-E019C8DAB7DA","Ovarian Serous Cystadenocarcinoma","TAR","BBCBDFB9-F029-484B-82C0-658D022643A2","2014-03-20T04:56:02.000Z","D459E8A3-F103-4DA9-A5E7-68C146E40E80","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"BBCBDFB9-F029-484B-82C0-658D022643A2",1.3,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ffb78d5c-46f5-4f3a-8572-55df5db80a1d.txt",NA,"TCGA-25-1625-01A",1.5,"CF67AC82-70F1-4F1E-BFF1-F4E1F59F7BC0","TCGA",2006,NA,NA,"WITH TUMOR","A86635E2-8EE6-4F0A-ADCD-29B19B122E78",66,"nationwidechildrens.org_clinical.TCGA-25-1625.xml","Dead",840,"TCGA-25-1625","NOT HISPANIC OR LATINO","08AF2828-7B39-4FA2-B029-1131F1B50B8D",NA,548,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,102,"E40D6E75-C7B0-4835-9E09-FF2EFC2E1A27","D459E8A3-F103-4DA9-A5E7-68C146E40E80","TCGA-25-1625-01A-01W-0615-10_SOLiD.bam.bai","TCGA-25-1625-01A-01",90,30,NA,NA,5,"TOP",5,NA,"TCGA-25-1625-01A-01-TS1",60,"Taxol","Chemotherapy","TCGA-25-1625-D26713",NA,NA,NA,"TCGA-25-1625-F26712_NTE-2",NA,548,"WITH TUMOR","Dead",840,"TCGA-25-1625-F26712","TCGA-25-1625",NA,"25","1625","YES","C56.9","8441/3","C56.9",NA,NA,-24298,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",548,840,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
257560266,237182495,17439282849,"BC8994E6-FD91-4B7C-950C-C953FD175A03.bw","8a98a6e6-b763-4824-858b-fd2738e6c9a3","bc8994e6-fd91-4b7c-950c-c953fd175a03","2016-08-26T09:18:35.030318-05:00","TCGA-29-1696-01A-01R-1567-13_rnaseq_fastq.tar","29745979-a76b-4351-a8d8-b5f982a20705",15860930560,"Illumina HiSeq","fa7d79366a745563516582f7d7b09893","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:39:18.849110-05:00","2016-05-03T11:41:05.755204-05:00","29745979-a76b-4351-a8d8-b5f982a20705_analysis.xml","cf68bdc821735b23c16351b3af0a536a","e4cec50b-1d35-446b-ada9-a545ec579cf4",2181,"2016-09-29T21:14:46.752826-05:00","29745979-a76b-4351-a8d8-b5f982a20705_experiment.xml","80327ce19417e51feaefc0a377a96a1a","8b520c0e-51ad-45c4-9b30-79e036d73041",3916,"2016-09-29T22:56:38.191209-05:00","29745979-a76b-4351-a8d8-b5f982a20705_run.xml","00a62fc439a8cd608b98fea4523277f4","ca46d5bd-ae39-417a-9800-34c5ef6b6a62",1988,"2016-09-08T13:29:04.660588-05:00","TCGA-29-1696","2016-09-02T19:07:26.310647-05:00","female","TCGA-29-1696_demographic",1960,"white","c51e54e0-2edf-5cdc-8ca8-6d6d57b1a6fc","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1696_diagnosis","not reported",15818,"dead","8441/3",1032,1025,"f5ff0990-b997-5fdd-801b-60df58027c40","c56.9",-15818,"TCGA-29-1696_treatment","69800ea4-51dd-5371-ae98-68bd783855f1","01",NA,"TCGA-29-1696-01A","0.8","75d36397-75e8-4925-bf1e-6f73bd9293ba",FALSE,"5e817943-3108-4838-bf8c-85c4507eb873","Primary Tumor","0.3",NA,NA,"0.8",1242000000,"01",126,"TCGA-29-1696-01A-01",95,70,NA,NA,0,0,0,0,"2016-09-08T13:29:04.660588-05:00","2016-09-08T13:29:04.660588-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"9f136ba5-516c-439d-8e2d-a9061cce1191","5ba62db5-014b-4d13-89d9-10a481d6a10b","TCGA-29-1696-01A-01-TS1","TCGA-29-1696-01A-01-BS1",100,100,"a123453e-4d3f-4c37-b577-73c2ea6174be","RNA","TCGA-29-1696-01A-01R","67da1a33-39e9-4660-bc6d-91e796b8f9bc",1.8,0.14,"UV Spec","R","22","TCGA-29-1696-01A-01R-1567-13","23c4ab1a-f8ce-47be-ab03-abfc66ea70ef",0.14,NA,NA,NA,NA,"afe7e355-e3f0-5bff-ad31-cd161439faeb","TCGA-29-1696_exposure","TCGA-29-1696-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T03:18:54.000Z","2014-03-27T03:51:02.000Z","29745979-A76B-4351-A8D8-B5F982A20705","75D36397-75E8-4925-BF1E-6F73BD9293BA","Unaligned reads",15860930560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","23C4AB1A-F8CE-47BE-AB03-ABFC66EA70EF","Canada's Michael Smith Genome Sciences Centre","564a3667e4b093830b67ab9e","8A98A6E6-B763-4824-858B-FD2738E6C9A3","Ovarian Serous Cystadenocarcinoma","TAR","A123453E-4D3F-4C37-B577-73C2EA6174BE","2014-03-27T03:51:02.000Z","67DA1A33-39E9-4660-BC6D-91E796B8F9BC","None","NO",1,0.3,"Primary Tumor","Duke",NA,"A123453E-4D3F-4C37-B577-73C2EA6174BE",0.8,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.93ea52c3-dc03-4845-9493-f1ecdd9e9124.txt",NA,"TCGA-29-1696-01A",0.8,"A99ED1D2-8B6D-4027-869A-87359A36904F","TCGA",2003,NA,NA,"WITH TUMOR","A43812D7-DE9E-424B-A493-6196518A961E",43,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.93ea52c3-dc03-4845-9493-f1ecdd9e9124.txt","Dead",1032,"TCGA-29-1696",NA,"82BD749E-D9AA-4DA7-BD7D-57255E9C7E2E",NA,1025,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,126,"9F136BA5-516C-439D-8E2D-A9061CCE1191","8E6DB4A0-0B36-4B46-96EA-072720A76104","a6bfbbf5cb4fa7afe5d855860a5d74a7.bam","TCGA-29-1696-01A-01",95,0,NA,NA,0,"TOP",0,NA,"TCGA-29-1696-01A-01-TS1",100,"Cyclophosphamide","Chemotherapy","TCGA-29-1696-D27213",NA,NA,NA,"TCGA-29-1696-F27206_NTE-2",NA,1025,"WITH TUMOR","Dead",1032,"TCGA-29-1696-F27206","TCGA-29-1696",NA,"29","1696","YES","C56.9","8441/3","C56.9",NA,NA,-15818,"FEMALE","WHITE",NA,NA,"No","Dead",1025,1032,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,43,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
249816896,236854745,17448113371,"838BB79C-0B89-4BAC-B1B5-C9524B02EB2E.bw","8ac6ce06-ab50-4ab4-a469-9f8bf01be963","838bb79c-0b89-4bac-b1b5-c9524b02eb2e","2016-09-29T21:02:33.713321-05:00","TCGA-23-1024-01A-02R-1564-13_rnaseq_fastq.tar","f556a0af-d822-412a-8cd3-aef00c3c076d",16401715200,"Illumina HiSeq","ef499f34c997e2c3774ec881017311a9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:11:21.755148-05:00","2016-05-03T11:39:34.528512-05:00","f556a0af-d822-412a-8cd3-aef00c3c076d_analysis.xml","203ec37fddb5cacc703a29e4385c98f8","d37cc6f1-ba12-4ae4-8fd6-e6bdf019a63c",2210,"2016-10-07T16:43:15.684018-05:00","f556a0af-d822-412a-8cd3-aef00c3c076d_experiment.xml","6bbc3028f02f32792511f75152641c14","e75d5513-f478-490d-8666-43fd6975b39b",3916,"2016-09-29T21:28:46.780092-05:00","f556a0af-d822-412a-8cd3-aef00c3c076d_run.xml","6061e175025dddca4f9780e830d3e8f1","9407274f-5e52-4420-a0b9-57894be04172",1990,"2016-09-08T13:06:04.345426-05:00","TCGA-23-1024","2016-09-02T19:05:47.923326-05:00","female","TCGA-23-1024_demographic",1955,"white","83b2a085-d35c-5c1c-a5a5-d0125b3fc24d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1024_diagnosis","not reported",19052,"alive","8441/3",NA,468,"4daaa455-5886-55af-9373-8912838020b3","c56.9",-19052,"TCGA-23-1024_treatment","1ede6ca5-3de4-56d3-913b-e27419c8b222","01",NA,"TCGA-23-1024-01A","0.4","96430cd1-1f32-4d4e-ae16-e39df6405739",FALSE,"1CCE5978-6A4D-427A-9875-47617F6A4258","Primary Tumor","0.2",NA,NA,"0.8",1233705600,"02",85,"TCGA-23-1024-01A-02",80,90,NA,NA,10,5,5,5,"2016-09-08T13:06:04.345426-05:00","2016-09-08T13:06:04.345426-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"abbe97b3-ccf4-417e-b838-715a487e2595","7c5c688d-74e7-470a-95c5-115c73451c0d","TCGA-23-1024-01A-02-BS2","TCGA-23-1024-01A-01-BS1",85,90,"ea0fd884-e677-4f95-b02d-2abda1ba9efb","RNA","TCGA-23-1024-01A-02R","b14b716b-4d12-4490-90a5-c9ad648cfa11",1.8,0.16,"UV Spec","R","22","TCGA-23-1024-01A-02R-1564-13","467ceace-18c4-436b-a8f6-842794c5dfa5",0.16,NA,NA,NA,NA,"bd3701f2-12a5-5597-8403-3a4dbdadcc0b","TCGA-23-1024_exposure","TCGA-23-1024-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-20T04:02:36.000Z","2014-03-20T04:30:01.000Z","F556A0AF-D822-412A-8CD3-AEF00C3C076D","96430CD1-1F32-4D4E-AE16-E39DF6405739","Unaligned reads",16401715200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","467CEACE-18C4-436B-A8F6-842794C5DFA5","Canada's Michael Smith Genome Sciences Centre","564a55f9e4b08c5d869373d5","8AC6CE06-AB50-4AB4-A469-9F8BF01BE963","Ovarian Serous Cystadenocarcinoma","TAR","EA0FD884-E677-4F95-B02D-2ABDA1BA9EFB","2014-03-20T04:30:01.000Z","B14B716B-4D12-4490-90A5-C9AD648CFA11","None","NO",1,0.2,"Primary Tumor","Cedars Sinai",NA,"EA0FD884-E677-4F95-B02D-2ABDA1BA9EFB",0.4,"23","TCGA-23-1024-01A-02W-0484-10_SOLiD_whole_exome_extensions.bam",NA,"TCGA-23-1024-01A",0.8,"AD2CA791-17AD-4489-B546-FFFF653FFF09","TCGA",2007,NA,NA,"TUMOR FREE","96430CD1-1F32-4D4E-AE16-E39DF6405739",52,"nationwidechildrens.org_clinical.TCGA-23-1024.xml","Alive",NA,"TCGA-23-1024","NOT HISPANIC OR LATINO","3E1241B4-C16C-4299-B793-B22309184B85",NA,468,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,85,"ABBE97B3-CCF4-417E-B838-715A487E2595","EDF556DA-479B-4CD3-A12C-86E0D21F7A1E","TCGA-23-1024-01A-02W-0484-10_SOLiD_whole_exome_extensions.bam","TCGA-23-1024-01A-02",80,10,NA,NA,5,"BOTTOM",0,NA,"TCGA-23-1024-01A-02-BS2",85,"Carboplatin","Chemotherapy","TCGA-23-1024-D25608",NA,NA,NA,NA,NA,468,"TUMOR FREE","Alive",NA,"TCGA-23-1024-F25604","TCGA-23-1024",NA,"23","1024","YES","C56.9","8441/3","C56.9",NA,NA,-19052,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",468,NA,NA,NA,"TUMOR FREE","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,52,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
137158808,125939724,9225141378,"E4EADDC1-7E3A-44F5-B1B9-03712D34845E.bw","8cad4217-5699-4735-9be3-fc0015a8d262","e4eaddc1-7e3a-44f5-b1b9-03712d34845e","2016-08-26T21:16:02.919690-05:00","TCGA-13-0911-01A-01R-1564-13_rnaseq_fastq.tar","7afe8a3d-b42a-4c9a-837e-ab0b8711ee44",8975411200,"Illumina HiSeq","acd811f78fad43fa3e42043ad6ae5287","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:04:48.416362-05:00","2016-05-03T11:27:59.332723-05:00","7afe8a3d-b42a-4c9a-837e-ab0b8711ee44_analysis.xml","77e6bb4c7841e66e5a981aa01705a492","150b30ca-0e0c-405d-91b0-91c8462609c1",2210,"2016-08-13T05:46:07.332576-05:00","7afe8a3d-b42a-4c9a-837e-ab0b8711ee44_experiment.xml","6926e857bd2d9c5e74b6662cb1ed0984","45d465a0-c7f7-4d8e-81aa-9101451a105d",3916,"2016-09-29T23:48:56.206985-05:00","7afe8a3d-b42a-4c9a-837e-ab0b8711ee44_run.xml","b6e3d637ff6e61889c79ccb70add62ab","ead046a2-3921-4fb2-ae6b-cf027ea6b259",1990,"2016-09-08T12:18:21.284393-05:00","TCGA-13-0911","2016-09-02T19:06:13.644863-05:00","female","TCGA-13-0911_demographic",1950,"white","d9f04340-86d7-54c3-9770-ba6f4a98c85b","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0911_diagnosis","not reported",20276,"dead","8441/3",1355,843,"37459c7e-8694-5ed7-8555-422cb0f653b7","c56.9",-20276,"TCGA-13-0911_treatment","3842c585-4b74-5358-baef-56414520a21b","01",NA,"TCGA-13-0911-01A","1","b4fb23b6-d4a0-409a-9728-174c871270e3",FALSE,"0DE80BC5-8AA8-423A-B99B-9CD9883F27C2","Primary Tumor","0.8",NA,NA,"1.5",1233705600,"01",129,"TCGA-13-0911-01A-01",85,99,NA,NA,0,0,20,1,"2016-09-08T12:18:21.284393-05:00","2016-09-08T12:18:21.284393-05:00",100,10,NA,NA,"TOP","BOTTOM",5,9,"d038ca6a-0465-4047-a2a9-46ad58627c2e","fbd48661-17fb-44b5-be12-fe788a09667c","TCGA-13-0911-01A-01-TS1","TCGA-13-0911-01A-01-BS1",75,90,"69f5001e-8cca-4ef7-a687-0f806a76decb","RNA","TCGA-13-0911-01A-01R","da0644e1-e1d4-4b4d-920c-d676e9a8d6a0",1.8,0.16,"UV Spec","R","22","TCGA-13-0911-01A-01R-1564-13","d47147ed-fdb1-4921-9db7-1e0aae32aacb",0.16,NA,NA,NA,NA,"5b7f9ccc-2dc7-56c4-9bfb-459510e20e9f","TCGA-13-0911_exposure","TCGA-13-0911-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-21T00:05:26.000Z","2013-12-21T00:22:02.000Z","7AFE8A3D-B42A-4C9A-837E-AB0B8711EE44","B4FB23B6-D4A0-409A-9728-174C871270E3","Unaligned reads",8975411200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D47147ED-FDB1-4921-9DB7-1E0AAE32AACB","Canada's Michael Smith Genome Sciences Centre","564a3e60e4b093830b6a3747","8CAD4217-5699-4735-9BE3-FC0015A8D262","Ovarian Serous Cystadenocarcinoma","TAR","69F5001E-8CCA-4EF7-A687-0F806A76DECB","2013-12-21T00:22:02.000Z","DA0644E1-E1D4-4B4D-920C-D676E9A8D6A0","None","NO",1,0.8,"Primary Tumor","Memorial Sloan Kettering",NA,"69F5001E-8CCA-4EF7-A687-0F806A76DECB",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c2fbc465-c862-412d-8966-d88e0e414316.txt",NA,"TCGA-13-0911-01A",1.5,"E179932C-DB69-4BFD-BB18-71681CF970E4","TCGA",2005,NA,NA,"WITH TUMOR","EAEC0492-0E10-409F-A5BB-18AAC4F72F3E",55,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c2fbc465-c862-412d-8966-d88e0e414316.txt","Alive",NA,"TCGA-13-0911","NOT HISPANIC OR LATINO","18191146-BBB5-4110-AF84-0C6698D2AFC0",NA,843,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,129,"D038CA6A-0465-4047-A2A9-46AD58627C2E","EE266121-6D3C-49D3-A5D2-F96E40839E50","MSK_252152912774_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","TCGA-13-0911-01A-01",99,0,NA,10,1,"BOTTOM",9,NA,"TCGA-13-0911-01A-01-BS1",90,"paclitaxel","Chemotherapy","TCGA-13-0911-D24751",NA,NA,NA,"TCGA-13-0911-F24749_NTE-1",NA,843,"WITH TUMOR","Alive",NA,"TCGA-13-0911-F24749","TCGA-13-0911",NA,"13","0911","YES","C56.9","8441/3","C56.9",NA,NA,-20276,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",843,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,2005,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
140203628,134311809,9909397153,"17FADB7C-F0E7-4197-81DD-6124234F66F6.bw","8e107f4b-1912-4d3e-814a-b863e2d65ed7","17fadb7c-f0e7-4197-81dd-6124234f66f6","2016-08-25T03:39:51.158779-05:00","TCGA-13-1404-01A-01R-1565-13_rnaseq_fastq.tar","f169037d-6283-4ac6-bf17-a05932dfe0b6",8440115200,"Illumina HiSeq","59fb2842466424de2d3535459515d42a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:19:19.752333-05:00","2016-05-03T11:40:21.647690-05:00","f169037d-6283-4ac6-bf17-a05932dfe0b6_analysis.xml","98f73588d543e9fff4355fd8b77017f9","68cbd2ee-769d-44f6-882e-9239a5626352",2208,"2016-10-07T15:42:17.523652-05:00","f169037d-6283-4ac6-bf17-a05932dfe0b6_experiment.xml","aa9eca7daf331a802b9fd1d42be0d13d","8a6abaf5-5d86-43a7-81d1-d626ae1a27d8",3916,"2016-09-29T20:55:58.298819-05:00","f169037d-6283-4ac6-bf17-a05932dfe0b6_run.xml","79a5c6a51516cf39b745dba98af90bf9","7f7a551d-72a5-4941-b5e6-6d86c995ed7d",1988,"2016-09-08T13:16:39.739593-05:00","TCGA-13-1404","2016-09-02T19:12:02.929011-05:00","female","TCGA-13-1404_demographic",1960,"white","edf28ac0-2fef-5d14-9ecd-ff8a593fa717","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1404_diagnosis","not reported",17784,"alive","8441/3",NA,2469,"7b7eb1ba-bb1d-57b4-89e6-1c838f2f540e","c56.9",-17784,"TCGA-13-1404_treatment","4997ac35-df51-529f-91be-802f4bedd7d2","01",NA,"TCGA-13-1404-01A","1","f3cea00c-bc4a-450f-ae7b-cd97ab7369be",FALSE,"39B73962-A374-4521-BFBB-F10D117979F9","Primary Tumor","0.3",NA,NA,"1.5",1230508800,"01",122,"TCGA-13-1404-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T13:16:39.739593-05:00","2016-09-08T13:16:39.739593-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,1,"cecf7044-1d29-4d14-b137-821f8d48881e","04e6176f-aca9-4874-b3d5-baecd5fc11e7","TCGA-13-1404-01A-01-TS1","TCGA-13-1404-01A-01-BS1",75,79,"2d6cb29e-9bd9-434d-8075-806072277d4b","RNA","TCGA-13-1404-01A-01R","3e2d516d-582f-4642-bdb5-25e64723e1a9",1.8,0.17,"UV Spec","R","22","TCGA-13-1404-01A-01R-1565-13","5a24a912-7e38-4d60-a1b9-56023d2a321a",0.17,NA,NA,NA,NA,"d579c7c7-7f54-5792-b79e-94cda4fb5ca0","TCGA-13-1404_exposure","TCGA-13-1404-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T00:47:48.000Z","2014-03-22T01:09:02.000Z","F169037D-6283-4AC6-BF17-A05932DFE0B6","F3CEA00C-BC4A-450F-AE7B-CD97AB7369BE","Unaligned reads",8440115200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5A24A912-7E38-4D60-A1B9-56023D2A321A","Canada's Michael Smith Genome Sciences Centre","564a3adee4b08c5d86915688","8E107F4B-1912-4D3E-814A-B863E2D65ED7","Ovarian Serous Cystadenocarcinoma","TAR","2D6CB29E-9BD9-434D-8075-806072277D4B","2014-03-22T01:09:02.000Z","3E2D516D-582F-4642-BDB5-25E64723E1A9","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"2D6CB29E-9BD9-434D-8075-806072277D4B",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b9dd3b0f-e45a-400a-8078-5d421d257726.txt",NA,"TCGA-13-1404-01A",1.5,"8596919F-9468-4131-9AA4-A6F21E70CEBF","TCGA",2008,NA,NA,"TUMOR FREE","F3CEA00C-BC4A-450F-AE7B-CD97AB7369BE",48,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b9dd3b0f-e45a-400a-8078-5d421d257726.txt","Alive",NA,"TCGA-13-1404","NOT HISPANIC OR LATINO","B605A929-F33E-4BFA-98C1-3BD3D2CE980A",NA,201,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,122,"CECF7044-1D29-4D14-B137-821F8D48881E","7B9E46D0-00CA-42B3-8622-69436B4C7248","TCGA-13-1404-01A-01R-1565-13_GRCh37-lite_rnaseq.bam","TCGA-13-1404-01A-01",80,0,NA,NA,20,"TOP",5,NA,"TCGA-13-1404-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-13-1404-D24800",NA,NA,NA,NA,NA,201,"TUMOR FREE","Alive",NA,"TCGA-13-1404-F24798","TCGA-13-1404",NA,"13","1404","YES","C56.9","8441/3","C56.9",NA,NA,-17784,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",201,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,48,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
174339000,169543477,12551519365,"88578AE6-BEA7-4C8E-B4F1-5AFFC2C860FE.bw","8e1b8811-1eb2-4337-852c-c19eaa0ee418","88578ae6-bea7-4c8e-b4f1-5affc2c860fe","2016-08-25T11:40:57.331636-05:00","TCGA-61-1914-01A-01R-1567-13_rnaseq_fastq.tar","7d4f2b5b-3ec1-4fb2-a9bc-0d660280b35c",10557931520,"Illumina HiSeq","a13f94fb468788bebc40054ab6b4c9ea","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:40:31.555067-05:00","2016-05-03T11:41:05.740436-05:00","7d4f2b5b-3ec1-4fb2-a9bc-0d660280b35c_analysis.xml","09a466882f73789721175e75e879fff8","75d4a7e6-fa50-4ec8-95e9-09b592f7e771",2181,"2016-08-13T06:49:23.093017-05:00","7d4f2b5b-3ec1-4fb2-a9bc-0d660280b35c_experiment.xml","72cf3f456c026b4875f6abf6b621438b","a6186a1f-8978-4141-af2f-d96c9b2565b5",3916,"2016-09-29T22:50:34.767294-05:00","7d4f2b5b-3ec1-4fb2-a9bc-0d660280b35c_run.xml","c7f40bc7fa44f1c2d5318eb30eaed3b0","c68a4c43-7b45-46ea-816b-f0169a6435bd",1988,"2016-09-08T10:39:35.898414-05:00","TCGA-61-1914","2016-09-02T18:47:40.095827-05:00","female","TCGA-61-1914_demographic",1938,"not reported","2133f718-5c09-5c22-a386-00330e432c86","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1914_diagnosis","not reported",23850,"alive","8441/3",NA,1722,"d601544b-eacc-5b79-b206-68fa1be8c0ac","c56.9",-23850,"TCGA-61-1914_treatment","cdfd6ed8-89d3-5764-93ec-e05ccd6b4d7d","01",NA,"TCGA-61-1914-01A","1","98f6fcfd-df24-422f-a14d-144fd1a02849",FALSE,"b634b2cf-9e8d-4dd4-8442-337c22522a43","Primary Tumor","0.4",NA,NA,"1.2",1246233600,"01",119,"TCGA-61-1914-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T10:39:35.898414-05:00","2016-09-08T10:39:35.898414-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,5,"ac6aa78e-762f-4ded-ab0f-7c528cd199e5","740aedb0-ca44-4218-8601-cc068d1cac21","TCGA-61-1914-01A-01-TS1","TCGA-61-1914-01A-01-BS1",89,85,"5d864b1f-cbda-4f7c-aba8-318da921ab54","RNA","TCGA-61-1914-01A-01R","affa6441-08b8-4a3c-af15-b81f6b24af90",1.8,0.14,"UV Spec","R","22","TCGA-61-1914-01A-01R-1567-13","0d75483f-eab3-41c8-b2cc-453af29b6f44",0.14,NA,NA,NA,NA,"5d4f75e6-495a-5b81-8a8a-723a1f7ed1ae","TCGA-61-1914_exposure","TCGA-61-1914-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T01:27:02.000Z","2014-03-27T01:50:01.000Z","7D4F2B5B-3EC1-4FB2-A9BC-0D660280B35C","98F6FCFD-DF24-422F-A14D-144FD1A02849","Unaligned reads",10557931520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0D75483F-EAB3-41C8-B2CC-453AF29B6F44","Canada's Michael Smith Genome Sciences Centre","564a3d5ce4b093830b69e564","8E1B8811-1EB2-4337-852C-C19EAA0EE418","Ovarian Serous Cystadenocarcinoma","TAR","5D864B1F-CBDA-4F7C-ABA8-318DA921AB54","2014-03-27T01:50:01.000Z","AFFA6441-08B8-4A3C-AF15-B81F6B24AF90","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"5D864B1F-CBDA-4F7C-ABA8-318DA921AB54",1,"61","bcgsc.ca.TCGA-61-1914-01A-01R-1567-13.hg19.bcgsc.ca.1.7.0.sv.fa",NA,"TCGA-61-1914-01A",1.2,"B2513645-C71D-4268-BB2E-B6543D55E1B3","TCGA",2003,NA,NA,"WITH TUMOR","98F6FCFD-DF24-422F-A14D-144FD1A02849",65,"TCGA-61-1914-01A-01R-1567-13.hg19.spljxn.quantification.txt","Alive",NA,"TCGA-61-1914",NA,"BF92B598-521F-46B7-A2E9-92A747D5177F",NA,1722,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,NA,NA,1,119,"740AEDB0-CA44-4218-8601-CC068D1CAC21","AC345B60-8644-493F-A69C-206179D0C2C9","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_F06_495158.hg19.seg.txt","TCGA-61-1914-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-61-1914-01A-01-TS1",89,"Carboplatin","Chemotherapy","TCGA-61-1914-D28275",NA,NA,NA,"TCGA-61-1914-F28273_NTE-2",NA,1722,"WITH TUMOR","Alive",NA,"TCGA-61-1914-F28273","TCGA-61-1914",NA,"61","1914","YES","C56.9","8441/3","C56.9",NA,NA,-23850,"FEMALE",NA,NA,NA,"No","Alive",1722,NA,NA,NA,"WITH TUMOR","NO",1,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
272455628,265891063,19659052068,"C2362B18-3B5C-48DD-B9DB-B20861ED73E6.bw","8fac8e40-beac-4059-9d54-7ee530598cfd","c2362b18-3b5c-48dd-b9db-b20861ed73e6","2016-08-26T11:28:42.729661-05:00","TCGA-13-1408-01A-01R-1565-13_rnaseq_fastq.tar","84a1c4b5-c9c4-404d-9ae6-4e228dee84e6",16848353280,"Illumina HiSeq","99fb7f99b45a0203bfef5eff261573e4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:44:24.759731-05:00","2016-05-03T11:40:21.669427-05:00","84a1c4b5-c9c4-404d-9ae6-4e228dee84e6_analysis.xml","1b40948bc100dbd45dec1882461cfbaf","78422713-da09-4389-87bc-d462dfb8c063",2208,"2016-08-28T09:19:10.291140-05:00","84a1c4b5-c9c4-404d-9ae6-4e228dee84e6_experiment.xml","a346dbd6494bd904c535fbe0a473a636","bb216f04-7ad5-4431-8e65-f1e48c71ea72",3916,"2016-09-29T18:28:16.670325-05:00","84a1c4b5-c9c4-404d-9ae6-4e228dee84e6_run.xml","ce21774c7b70dd8cc04eaf119c2046f9","23981749-cf54-430c-aeee-d77d2bc60abc",1989,"2016-09-08T13:21:20.376889-05:00","TCGA-13-1408","2016-09-02T19:11:54.659540-05:00","female","TCGA-13-1408_demographic",1949,"white","45f8a427-8d1d-5aae-b1f3-7f698c460b17","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1408_diagnosis","not reported",21635,"dead","8441/3",1680,180,"8ea974b6-785e-5566-a7c3-61fc6c0fd914","c56.9",-21635,"TCGA-13-1408_treatment","d62233c1-db6f-5c67-8080-81da1707a968","01",NA,"TCGA-13-1408-01A","1.1","1e5e8214-4132-461d-ae3e-bd1f87faa61d",FALSE,"39435FCB-699F-4A2F-9005-E67C9A41C766","Primary Tumor","0.3",NA,NA,"1.8",1230508800,"01",100,"TCGA-13-1408-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T13:21:20.376889-05:00","2016-09-08T13:21:20.376889-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"8ba1c97e-931d-4dab-8ee6-438648815551","daf88d62-ca7c-4479-b027-16e04a5c66e4","TCGA-13-1408-01A-01-TS1","TCGA-13-1408-01A-01-BS1",80,79,"2df889d4-f7e3-4d1e-9250-c4cac83edd18","RNA","TCGA-13-1408-01A-01R","370e6b3f-f96e-4d08-bd34-7ea71459bc3e",1.8,0.16,"UV Spec","R","22","TCGA-13-1408-01A-01R-1565-13","cacecdfe-9e01-409c-b45b-5076281b9da8",0.16,NA,NA,NA,NA,"e7691733-0d2b-5198-9e50-3ba9f1cc8663","TCGA-13-1408_exposure","TCGA-13-1408-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T06:32:05.000Z","2014-03-22T07:04:02.000Z","84A1C4B5-C9C4-404D-9AE6-4E228DEE84E6","1E5E8214-4132-461D-AE3E-BD1F87FAA61D","Unaligned reads",16848353280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CACECDFE-9E01-409C-B45B-5076281B9DA8","Canada's Michael Smith Genome Sciences Centre","564a3c8be4b08c5d8691e0a5","8FAC8E40-BEAC-4059-9D54-7EE530598CFD","Ovarian Serous Cystadenocarcinoma","TAR","2DF889D4-F7E3-4D1E-9250-C4CAC83EDD18","2014-03-22T07:04:02.000Z","370E6B3F-F96E-4D08-BD34-7EA71459BC3E","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"2DF889D4-F7E3-4D1E-9250-C4CAC83EDD18",1.1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c9dc89ec-e887-4acc-90a5-6fd20f4a1483.txt",NA,"TCGA-13-1408-01A",1.8,"E315B96B-2868-4AE0-9096-6C62A57DA9F1","TCGA",2008,NA,NA,"WITH TUMOR","5F8071E1-0332-4609-B7DE-AB29C1F563C4",59,"nationwidechildrens.org_clinical.TCGA-13-1408.xml","Alive",NA,"TCGA-13-1408","NOT HISPANIC OR LATINO","B5EBD8FE-77CE-48FC-B3DE-F0AC628225E4",NA,180,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,100,"DAF88D62-CA7C-4479-B027-16E04A5C66E4","CBEFFDE1-4B2F-48AF-9AA6-772F95BE8EF0","TCGA-13-1408-01A-01W-0490-10_SOLiD_whole_exome_extensions.bam.bai","TCGA-13-1408-01A-01",80,0,NA,NA,20,"BOTTOM",1,NA,"TCGA-13-1408-01A-01-BS1",79,"Paciltaxel","Chemotherapy","TCGA-13-1408-D24813",NA,NA,NA,NA,NA,180,"WITH TUMOR","Alive",NA,"TCGA-13-1408-F24811","TCGA-13-1408",NA,"13","1408","YES","C56.9","8441/3","C56.9",NA,NA,-21635,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",180,NA,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,59,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
99405656,91859046,6755738079,"504270C4-9AD7-47DD-98A3-994713742235.bw","8fe44099-b313-4bfd-a94a-27e72f2a818c","504270c4-9ad7-47dd-98a3-994713742235","2016-08-25T02:25:15.496882-05:00","TCGA-13-0766-01A-02R-1564-13_rnaseq_fastq.tar","d8816024-1816-420c-8936-75e1d8f0dbd2",6266900480,"Illumina HiSeq","75fc7e43992902cec018c93c91717a3e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:11:46.500284-05:00","2016-05-03T11:39:34.528512-05:00","d8816024-1816-420c-8936-75e1d8f0dbd2_analysis.xml","5d2292e38bbe83d776772b6a7cdc0621","3f14135c-47d0-4880-b758-3f85c099e9d4",2267,"2016-08-13T05:27:53.996726-05:00","d8816024-1816-420c-8936-75e1d8f0dbd2_experiment.xml","b0a79c48133423641d852a81773c069e","388bf35c-4602-409a-9728-c0c76a1333c5",3916,"2016-09-29T18:45:35.938683-05:00","d8816024-1816-420c-8936-75e1d8f0dbd2_run.xml","90caa28d60760de4b75cdd15b4b5aa0a","2e92a197-88b4-47fb-aa4c-c19f299b84f0",1990,"2016-09-08T10:38:19.411368-05:00","TCGA-13-0766","2016-09-02T19:09:28.529871-05:00","female","TCGA-13-0766_demographic",1964,"white","e30ceb01-2a0d-5f44-bc94-3364ba25f4fc","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0766_diagnosis","not reported",15571,"dead","8441/3",1725,651,"f8151830-32c5-5123-9995-74276a780df0","c56.9",-15571,"TCGA-13-0766_treatment","a2a52632-1831-541a-9c2c-efc2cc36edfa","01",NA,"TCGA-13-0766-01A","0.9","03e8c3f2-99b6-40da-862a-e8263475c434",FALSE,"7F283E4B-70F9-4834-866C-B91024C74EA3","Primary Tumor","0.3",NA,NA,"1.7",1233705600,"02",180,"TCGA-13-0766-01A-02",80,80,NA,NA,20,20,NA,NA,"2016-09-08T10:38:19.411368-05:00","2016-09-08T10:38:19.411368-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,5,"3710a5cd-90f0-4d8a-9b23-a85b0640f834","50c7234c-9da1-4c26-8ef8-137c0c0c07e8","TCGA-13-0766-01A-02-BS2","TCGA-13-0766-01A-01-BS1",79,75,"4c4dc5a6-0ff3-4007-9328-e6db1995cc16","RNA","TCGA-13-0766-01A-02R","91d2c998-e7df-4e3d-a0b3-6276fac8ebfb",1.8,0.18,"UV Spec","R","22","TCGA-13-0766-01A-02R-1564-13","30be1179-7922-4af7-b234-270fd88a2965",0.18,NA,NA,NA,NA,"826d1560-dc45-59e8-998d-937c05f08c8d","TCGA-13-0766_exposure","TCGA-13-0766-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-20T04:46:20.000Z","2014-03-20T05:00:01.000Z","D8816024-1816-420C-8936-75E1D8F0DBD2","03E8C3F2-99B6-40DA-862A-E8263475C434","Unaligned reads",6266900480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","30BE1179-7922-4AF7-B234-270FD88A2965","Canada's Michael Smith Genome Sciences Centre","564a404ee4b0298dd2c9fb59","8FE44099-B313-4BFD-A94A-27E72F2A818C","Ovarian Serous Cystadenocarcinoma","TAR","4C4DC5A6-0FF3-4007-9328-E6DB1995CC16","2014-03-20T05:00:01.000Z","91D2C998-E7DF-4E3D-A0B3-6276FAC8EBFB","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"4C4DC5A6-0FF3-4007-9328-E6DB1995CC16",0.9,"13","TCGA-13-0766-01A-02R-1564-13_rnaseq_fastq.tar",NA,"TCGA-13-0766-01A",1.7,"E98199F4-62F6-444E-804C-FEA51774AA05","TCGA",2006,NA,NA,"WITH TUMOR","286B46A0-60C8-459C-9220-916D7A01DA20",42,"bcgsc.ca.TCGA-13-0766-01A-02R-1564-13.hg19.bcgsc.ca.1.6.0.indel.vcf","Alive",NA,"TCGA-13-0766","NOT HISPANIC OR LATINO","6F218D11-5224-464E-A2EE-D18E3EAF0DC5",NA,651,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,2,180,"50C7234C-9DA1-4C26-8EF8-137C0C0C07E8","BED689DA-ADFD-4A66-A414-4D619C7C4728","TCGA-13-0766-01A-02R-1564-13_GRCh37-lite_rnaseq.bam.bai","TCGA-13-0766-01A-02",80,20,NA,NA,NA,"BOTTOM",1,NA,"TCGA-13-0766-01A-02-BS2",79,"Carboplatin","Chemotherapy","TCGA-13-0766-D24568",NA,NA,NA,"TCGA-13-0766-F24567_NTE-1",NA,651,"WITH TUMOR","Alive",NA,"TCGA-13-0766-F24567","TCGA-13-0766",NA,"13","0766","YES","C56.9","8441/3","C56.9",NA,NA,-15571,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",651,NA,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,42,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
216288730,203027241,14979812777,"4DC26F02-A83F-4F3A-A5B8-BD798778B022.bw","90f4b65c-cfd4-4066-a5b9-842885c172e2","4dc26f02-a83f-4f3a-a5b8-bd798778b022","2016-08-25T02:04:34.717996-05:00","TCGA-13-0727-01A-01R-1564-13_rnaseq_fastq.tar","6881a384-647d-48c2-9601-472f30314a2f",14447585280,"Illumina HiSeq","c059e554a93d013280fd3a10d445be90","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:44:44.393970-05:00","2016-05-03T11:39:34.522989-05:00","6881a384-647d-48c2-9601-472f30314a2f_analysis.xml","0666196fe4599c044e0b9f652c92fd1d","e83f137c-55e0-4154-867f-6d97c795c629",2210,"2016-10-07T16:58:00.299365-05:00","6881a384-647d-48c2-9601-472f30314a2f_experiment.xml","b86d998b99db92bdb26e60696c3c1caf","283c0a8b-eba1-47f3-9027-0ef4b246172c",3916,"2016-09-29T19:00:16.256848-05:00","6881a384-647d-48c2-9601-472f30314a2f_run.xml","131a6126b6f9d6eea4ccf4830e31b24a","37b8cdb5-9429-4546-9c30-a1882ac023bb",1990,"2016-09-08T13:42:18.188154-05:00","TCGA-13-0727","2016-09-02T19:09:38.457605-05:00","female","TCGA-13-0727_demographic",1932,"white","c607c1f9-1240-5281-9ad1-0481bf7a2684","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0727_diagnosis","not reported",26185,"dead","8441/3",462,462,"b8106532-5977-55ab-8efb-28955ed4a91a","c56.9",-26185,"TCGA-13-0727_treatment","589ab6e4-4f58-560b-9045-b1c606466cfd","01",NA,"TCGA-13-0727-01A","0.9","6fcd7bb8-6cb0-4797-a5b5-d3ec4911a279",FALSE,"EA3709B4-0C79-4CF5-A7D6-DB9F08DD74B5","Primary Tumor","0.3",NA,NA,"1.2",1233705600,"01",155,"TCGA-13-0727-01A-01",95,95,NA,NA,15,10,0,10,"2016-09-08T13:42:18.188154-05:00","2016-09-08T13:42:18.188154-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"aeb63964-0616-4be1-9203-91ea1c0794d4","6d8a1ef4-20dd-4641-9f62-9ee2782e24a5","TCGA-13-0727-01A-01-BS1","TCGA-13-0727-01A-01-TS1",85,80,"06ac143a-983e-4a3a-bae1-e60a3f9a9db4","RNA","TCGA-13-0727-01A-01R","b82028b9-e13e-475c-983c-1ecdba9d790c",1.8,0.16,"UV Spec","R","22","TCGA-13-0727-01A-01R-1564-13","38957b36-539f-42f1-bd83-f8eb348165a4",0.16,NA,NA,NA,NA,"f820881b-3240-54d4-83e2-9fb8a687da8d","TCGA-13-0727_exposure","TCGA-13-0727-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T00:49:42.000Z","2014-03-20T01:21:02.000Z","6881A384-647D-48C2-9601-472F30314A2F","6FCD7BB8-6CB0-4797-A5B5-D3EC4911A279","Unaligned reads",14447585280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","38957B36-539F-42F1-BD83-F8EB348165A4","Canada's Michael Smith Genome Sciences Centre","564a5979e4b09c884b272360","90F4B65C-CFD4-4066-A5B9-842885C172E2","Ovarian Serous Cystadenocarcinoma","TAR","06AC143A-983E-4A3A-BAE1-E60A3F9A9DB4","2014-03-20T01:21:02.000Z","B82028B9-E13E-475C-983C-1ECDBA9D790C","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"06AC143A-983E-4A3A-BAE1-E60A3F9A9DB4",0.9,"13","jhu-usc.edu_OV.HumanMethylation27.1.lvl-2.TCGA-13-0727-01A-01D-0359-05.txt",NA,"TCGA-13-0727-01A",1.2,"C84669F2-EC70-49D1-B206-2DB206E0976A","TCGA",2003,NA,NA,"WITH TUMOR","C34A0507-6FD2-4792-90ED-84DF9C699016",71,"nationwidechildrens.org_clinical.TCGA-13-0727.xml","Dead",462,"TCGA-13-0727","NOT HISPANIC OR LATINO","C54B18DB-AEAB-4253-8E80-49AEAE62F572",NA,462,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,155,"AEB63964-0616-4BE1-9203-91EA1C0794D4","AD73E75C-EE55-4548-9CF8-3F288976CE04","TCGA-13-0727-01A-01R-1564-13.hg19.isoform.quantification.txt","TCGA-13-0727-01A-01",95,15,NA,NA,0,"BOTTOM",0,NA,"TCGA-13-0727-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-13-0727-D24521",NA,NA,NA,"TCGA-13-0727-F24519_NTE-1",NA,462,"WITH TUMOR","Dead",462,"TCGA-13-0727-F24519","TCGA-13-0727",NA,"13","0727","YES","C56.9","8441/3","C56.9",NA,NA,-26185,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",462,462,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
180566564,172710080,12741413147,"057404EA-E563-4BA7-AB70-1791AB89B38F.bw","914d8613-3c25-4a10-be50-28b42f4d3a5d","057404ea-e563-4ba7-ab70-1791ab89b38f","2016-09-29T17:40:23.623442-05:00","TCGA-25-1319-01A-01R-1565-13_rnaseq_fastq.tar","25a57437-f7da-4365-aab7-8e0674edcbe0",11074304000,"Illumina HiSeq","0c1037d27f62fc5c252ff5f76119ef8b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:02:46.337107-05:00","2016-05-03T11:40:21.647690-05:00","25a57437-f7da-4365-aab7-8e0674edcbe0_analysis.xml","58abd94b04cccf3137bd5e0eb5b9103a","396d60b6-5db8-4272-b2a0-e7b58714416b",2181,"2016-09-29T21:43:38.679552-05:00","25a57437-f7da-4365-aab7-8e0674edcbe0_experiment.xml","6f23e19e32ef86773fe197b2ef7bcc76","9d0e4b38-c0f5-4760-94f2-92a3d9fbd3d3",3916,"2016-09-29T18:32:42.955601-05:00","25a57437-f7da-4365-aab7-8e0674edcbe0_run.xml","275feaca6ed21e8ea418980f8d0057f8","26412009-8603-413c-8d8d-3df677f2f682",1988,"2016-09-08T13:21:57.598681-05:00","TCGA-25-1319","2016-09-02T19:12:04.404879-05:00","female","TCGA-25-1319_demographic",1927,"white","87285b0c-753a-5853-a163-2d40aeeb0262","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1319_diagnosis","not reported",26786,"dead","8441/3",1977,1977,"db3baf3d-297f-5c6c-a175-b0c27145f449","c56.9",-26786,"TCGA-25-1319_treatment","92fb3354-b375-5e12-8c52-9863d5367d02","01",NA,"TCGA-25-1319-01A","2.5","c063d066-9073-4f05-8a38-601aa65dc5bf",FALSE,"62BFD64E-1C60-49A8-BAD0-B173DD22C951","Primary Tumor","1",NA,NA,"3",1228435200,"01",162,"TCGA-25-1319-01A-01",95,95,NA,NA,10,0,40,5,"2016-09-08T13:21:57.598681-05:00","2016-09-08T13:21:57.598681-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,5,"ad3a89ef-7efe-4a65-92de-1b4457cf6e84","4d68fbd5-1e16-4050-aeae-c6ca6c0a34f6","TCGA-25-1319-01A-01-BS1","TCGA-25-1319-01A-01-TS1",50,90,"6d5da75a-05f5-44cf-a66f-0b140fce68e3","RNA","TCGA-25-1319-01A-01R","82cd0ab1-2679-4409-826d-bbe43ea6193c",1.8,0.16,"UV Spec","R","22","TCGA-25-1319-01A-01R-1565-13","8f0f34fb-bbef-4a17-8324-4ebda56f9e0e",0.16,NA,NA,NA,NA,"5448ce20-10f2-5436-ac0e-22ab88c5ddb9","TCGA-25-1319_exposure","TCGA-25-1319-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:10:16.000Z","2014-03-22T01:35:02.000Z","25A57437-F7DA-4365-AAB7-8E0674EDCBE0","C063D066-9073-4F05-8A38-601AA65DC5BF","Unaligned reads",11074304000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","8F0F34FB-BBEF-4A17-8324-4EBDA56F9E0E","Canada's Michael Smith Genome Sciences Centre","564a56cfe4b0ef12181cac0a","914D8613-3C25-4A10-BE50-28B42F4D3A5D","Ovarian Serous Cystadenocarcinoma","TAR","6D5DA75A-05F5-44CF-A66F-0B140FCE68E3","2014-03-22T01:35:02.000Z","82CD0AB1-2679-4409-826D-BBE43EA6193C","None","NO",1,1,"Primary Tumor","Mayo Clinic - Rochester",NA,"6D5DA75A-05F5-44CF-A66F-0B140FCE68E3",2.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.09ef1041-497f-409f-9892-b5a1631a647f.txt",NA,"TCGA-25-1319-01A",3,"C61612C2-A456-4253-97B0-A3354DFBD96A","TCGA",2000,NA,NA,NA,"C063D066-9073-4F05-8A38-601AA65DC5BF",73,"nationwidechildrens.org_clinical.TCGA-25-1319.xml","Dead",1977,"TCGA-25-1319","NOT HISPANIC OR LATINO","760F24C1-7601-415F-8C8F-79778D72EEA4",NA,1977,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,162,"AD3A89EF-7EFE-4A65-92DE-1B4457CF6E84","82CD0AB1-2679-4409-826D-BBE43EA6193C","MSK_252152912680_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","TCGA-25-1319-01A-01",95,0,NA,NA,5,"TOP",5,NA,"TCGA-25-1319-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-25-1319-D26662",NA,NA,NA,"TCGA-25-1319-F26660_NTE-1",NA,1977,NA,"Dead",1977,"TCGA-25-1319-F26660","TCGA-25-1319",NA,"25","1319","YES","C56.9","8441/3","C56.9",NA,NA,-26786,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1977,1977,NA,NA,NA,"NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156221384,153545982,11357439796,"2BDB4B13-7B89-454E-B06B-564A8D57CD06.bw","914f84bf-578b-4f4d-93cb-378228ea58f6","2bdb4b13-7b89-454e-b06b-564a8d57cd06","2016-08-25T10:40:45.114456-05:00","TCGA-13-1505-01A-01R-1565-13_rnaseq_fastq.tar","10e9c8f5-1905-41a1-9545-20c04de4638d",9654016000,"Illumina HiSeq","29a00bbde2f530c3f7f7dd9f1de85680","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:04:35.484707-05:00","2016-05-03T11:40:21.648680-05:00","10e9c8f5-1905-41a1-9545-20c04de4638d_analysis.xml","a88d79f0278346896a6334c4ec689473","cf1f5f3d-8d5b-4cdb-9e95-4049e834d855",2181,"2016-09-29T23:48:17.038860-05:00","10e9c8f5-1905-41a1-9545-20c04de4638d_experiment.xml","e1592dcf40f0cdb6dd570754fa551d89","ea656d29-dbaa-4111-a415-d4f339bcc670",3916,"2016-09-29T21:49:29.205707-05:00","10e9c8f5-1905-41a1-9545-20c04de4638d_run.xml","db3406043c90500228af6fc6d8a8ba8e","a0b1595f-fb5c-4c55-a347-944c8d730267",1988,"2016-09-08T13:32:53.515838-05:00","TCGA-13-1505","2016-09-02T19:13:39.135905-05:00","female","TCGA-13-1505_demographic",1945,"white","b7362858-0e48-5035-9da1-763716901ea0","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1505_diagnosis","not reported",23238,"alive","8441/3",NA,1998,"efcf95ec-a94c-5a40-9a69-0f895651d4f8","c56.9",-23238,"TCGA-13-1505_treatment","4bdc11e9-5d64-5fb2-bfc2-28406c6a80de","01",NA,"TCGA-13-1505-01A","1","4fb10554-1573-44d5-99dd-d7abef42e373",FALSE,"ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF","Primary Tumor","0.3",NA,NA,"1.2",1235001600,"01",100,"TCGA-13-1505-01A-01",90,80,NA,NA,0,0,10,20,"2016-09-08T13:32:53.515838-05:00","2016-09-08T13:32:53.515838-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"8eca8e28-c530-40b1-840b-2c50c23758fa","77c5a936-fbd0-44ea-bdca-a1756f1edff1","TCGA-13-1505-01A-01-TS1","TCGA-13-1505-01A-01-BS1",90,80,"2743b09b-d517-4e7e-b0e3-457c8672afb4","RNA","TCGA-13-1505-01A-01R","9a790ed4-64e4-43f4-9eef-d294dd24d612",1.8,0.15,"UV Spec","R","22","TCGA-13-1505-01A-01R-1565-13","7774b7d4-2935-4b9b-bf76-312a625629e1",0.15,NA,NA,NA,NA,"825d2f9f-c2ba-5484-81d9-4bc253050337","TCGA-13-1505_exposure","TCGA-13-1505-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:21:14.000Z","2014-03-21T22:43:02.000Z","10E9C8F5-1905-41A1-9545-20C04DE4638D","4FB10554-1573-44D5-99DD-D7ABEF42E373","Unaligned reads",9654016000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7774B7D4-2935-4B9B-BF76-312A625629E1","Canada's Michael Smith Genome Sciences Centre","564a56abe4b0298dd2ca992a","914F84BF-578B-4F4D-93CB-378228EA58F6","Ovarian Serous Cystadenocarcinoma","TAR","2743B09B-D517-4E7E-B0E3-457C8672AFB4","2014-03-21T22:43:02.000Z","9A790ED4-64E4-43F4-9EEF-D294DD24D612","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"2743B09B-D517-4E7E-B0E3-457C8672AFB4",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d15e55f3-d7f1-4276-9fe1-17cc18dc2515.txt",NA,"TCGA-13-1505-01A",1.2,"CA2B331B-320F-43B9-A347-0998E1B4469F","TCGA",2008,NA,NA,"TUMOR FREE","E892734F-EB53-4DF0-BDB0-F1FFED7839FD",63,"nationwidechildrens.org_clinical.TCGA-13-1505.xml","Alive",NA,"TCGA-13-1505","NOT HISPANIC OR LATINO","E5C8BA1B-3E68-4637-ACF7-695582F4474B",NA,128,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,100,"8ECA8E28-C530-40B1-840B-2C50C23758FA","9CE5BE94-3E20-48B8-A654-D424D6C08780","TCGA-13-1505-01A-01R-1565-13.mirna.quantification.txt","TCGA-13-1505-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-13-1505-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-13-1505-D24940",NA,NA,NA,NA,NA,128,"TUMOR FREE","Alive",NA,"TCGA-13-1505-F24939","TCGA-13-1505",NA,"13","1505","YES","C56.9","8441/3","C56.9",NA,NA,-23238,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",128,NA,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110491670,107517169,7962198063,"0A136122-8233-42FB-89BD-795780B5E94B.bw","91a17d40-c8cb-4cce-b306-966382a8fe4a","0a136122-8233-42fb-89bd-795780b5e94b","2016-09-29T17:47:28.849386-05:00","TCGA-61-2111-01A-01R-1568-13_rnaseq_fastq.tar","4b63ee61-0bb3-4bc8-8456-c7a2ea25f7bc",7211376640,"Illumina HiSeq","618f21368e73209d68ed3ef20da7ef5b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:41:39.981321-05:00","2016-05-03T11:56:42.628342-05:00","4b63ee61-0bb3-4bc8-8456-c7a2ea25f7bc_analysis.xml","aaa27f110cc8cb146d8b092e3ab931d4","2c0fc81f-1df5-4cef-9d80-6518f961e20d",2181,"2016-08-13T03:26:53.022102-05:00","4b63ee61-0bb3-4bc8-8456-c7a2ea25f7bc_experiment.xml","94f80ba49befe7b842593056e41011fd","4c7d14c9-bef3-48b3-bc96-9d9b481c31f1",3916,"2016-09-29T18:54:01.202383-05:00","4b63ee61-0bb3-4bc8-8456-c7a2ea25f7bc_run.xml","c838a19f2ffa1d8aa4c2803770df4057","33e4051c-f27f-4e5c-acc7-dab6ed9f6303",1988,"2016-09-08T11:56:21.149032-05:00","TCGA-61-2111","2016-09-02T18:56:32.144619-05:00","female","TCGA-61-2111_demographic",1937,"white","207b7d58-3bbf-5097-98dd-b566c44fa826","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2111_diagnosis","not reported",22517,"alive","8441/3",NA,3825,"cfac89b4-e306-5fa3-8441-559631390575","c56.9",-22517,"TCGA-61-2111_treatment","dffd8615-b8f5-5ae6-a72a-d6641b0a4c28","01",NA,"TCGA-61-2111-01A","1.4","b469134f-2528-456e-bf69-c5b5a9268145",FALSE,"351930bc-ac4d-468e-9fe2-ba6f16c01444","Primary Tumor","0.3",NA,NA,"1.5",1250467200,"01",129,"TCGA-61-2111-01A-01",75,80,NA,NA,3,0,3,5,"2016-09-08T11:56:21.149032-05:00","2016-09-08T11:56:21.149032-05:00",NA,NA,NA,NA,"TOP","BOTTOM",14,10,"f5cf5d70-ae84-4039-a9b7-bc4af6d21516","1dbf80e0-c681-41e6-a309-a61787c3ffa2","TCGA-61-2111-01A-01-TS1","TCGA-61-2111-01A-01-BS1",80,85,"0a53f31e-370e-4c6c-897b-406a5b7ed3ce","RNA","TCGA-61-2111-01A-01R","62bb5571-e230-42a3-9cf3-c3e0f12f43bd",1.8,0.15,"UV Spec","R","22","TCGA-61-2111-01A-01R-1568-13","25c0888a-25b9-4cc0-a02f-6d363a341e8f",0.15,NA,NA,NA,NA,"8d5e32d6-0f70-51d4-ac5d-cc838904a191","TCGA-61-2111_exposure","TCGA-61-2111-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T23:33:17.000Z","2014-08-27T00:47:15.000Z","4B63EE61-0BB3-4BC8-8456-C7A2EA25F7BC","B469134F-2528-456E-BF69-C5B5A9268145","Unaligned reads",7211376640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","25C0888A-25B9-4CC0-A02F-6D363A341E8F","Canada's Michael Smith Genome Sciences Centre","564a5bafe4b0ef12181e37fd","91A17D40-C8CB-4CCE-B306-966382A8FE4A","Ovarian Serous Cystadenocarcinoma","TAR","0A53F31E-370E-4C6C-897B-406A5B7ED3CE","2014-08-27T00:47:16.000Z","62BB5571-E230-42A3-9CF3-C3E0F12F43BD","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"0A53F31E-370E-4C6C-897B-406A5B7ED3CE",1.4,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.975fb889-32f1-46e2-a558-b32d8a1b353f.txt",NA,"TCGA-61-2111-01A",1.5,"BB037FB1-3DFC-476D-A329-F46E33AFC260","TCGA",1998,NA,NA,"WITH TUMOR","B469134F-2528-456E-BF69-C5B5A9268145",61,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.975fb889-32f1-46e2-a558-b32d8a1b353f.txt","Alive",NA,"TCGA-61-2111","NOT HISPANIC OR LATINO","273E554F-1BB2-4549-A9B8-C642B76E2458",NA,3825,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,129,"F5CF5D70-AE84-4039-A9B7-BC4AF6D21516","E3ED8BFA-0F3D-48CB-90BF-5BC86B7C705D","MSK_252152917429_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","TCGA-61-2111-01A-01",75,3,NA,NA,3,"TOP",14,NA,"TCGA-61-2111-01A-01-TS1",80,"Provera","Hormone Therapy","TCGA-61-2111-D28477",NA,NA,NA,"TCGA-61-2111-F28467_NTE-2",NA,3825,"WITH TUMOR","Alive",NA,"TCGA-61-2111-F28467","TCGA-61-2111",NA,"61","2111","YES","C56.9","8441/3","C56.9",NA,NA,-22517,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",3825,NA,NA,NA,"WITH TUMOR","NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,61,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
276867706,269387436,19933381992,"E87FB9EC-A661-41EA-A6E3-BEB629BB3309.bw","91de8a74-a1e6-46b6-a06e-70aedf2c3eaf","e87fb9ec-a661-41ea-a6e3-beb629bb3309","2016-08-26T23:20:45.285108-05:00","TCGA-13-0886-01A-01R-1569-13_rnaseq_fastq.tar","05f63b58-c91e-47db-9115-0349625f93f9",16992286720,"Illumina HiSeq","998374441216847f457556fe005b098c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:07:22.443549-05:00","2016-05-03T11:41:05.740436-05:00","05f63b58-c91e-47db-9115-0349625f93f9_analysis.xml","dc1b351625b59d209db6c16a37ff0368","f610722d-a634-4b2f-ae5f-0835677a1bd3",2226,"2016-10-07T16:24:22.090066-05:00","05f63b58-c91e-47db-9115-0349625f93f9_experiment.xml","eba5ce22f16a7390e1593d1ced6987d9","86c30afb-729c-4a6e-b1e8-4f690d377392",3916,"2016-09-29T19:39:15.824099-05:00","05f63b58-c91e-47db-9115-0349625f93f9_run.xml","1670baac5dcfb0c98b37a0754bdb1dc2","503f512d-e0a7-468c-a116-12eb352eedcd",1988,"2016-09-08T13:12:21.549558-05:00","TCGA-13-0886","2016-09-02T19:05:42.782586-05:00","female","TCGA-13-0886_demographic",1935,"white","144fbbef-2227-5cdd-8e21-22114001fe47","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0886_diagnosis","not reported",24724,"alive","8441/3",NA,4665,"e3734193-eac9-5df2-9f6d-dfa735dee27b","c56.9",-24724,"TCGA-13-0886_treatment","0692cbb4-fb9a-5464-9bb4-3ca610e4a304","01",NA,"TCGA-13-0886-01A","0.6","91054520-9955-4d9b-bb06-e0bdd253c687",FALSE,"2FB5824C-F30B-4E0B-B787-CBF93A6A48AE","Primary Tumor","0.5",NA,NA,"1",1233705600,"01",70,"TCGA-13-0886-01A-01",70,70,NA,NA,30,30,0,0,"2016-09-08T13:12:21.549558-05:00","2016-09-08T13:12:21.549558-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,5,"d21154a8-2994-4f78-b12c-bd53414d2570","87d770e2-fb08-4fbe-8091-53a12ef5413a","TCGA-13-0886-01A-01-BS1","TCGA-13-0886-01A-01-TS1",68,65,"fd62e4e7-4c9b-485c-8de9-0b2e200471a7","RNA","TCGA-13-0886-01A-01R","782116c6-8d36-4e87-b5b4-dc592e987556",1.8,0.14,"UV Spec","R","22","TCGA-13-0886-01A-01R-1569-13","eac4bb8e-83fe-4fdf-822d-8fb126b1da1e",0.14,NA,NA,NA,NA,"2570eb00-47ec-54a3-8e01-f6cfd9c3a895","TCGA-13-0886_exposure","TCGA-13-0886-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T00:35:32.000Z","2014-03-27T01:11:02.000Z","05F63B58-C91E-47DB-9115-0349625F93F9","91054520-9955-4D9B-BB06-E0BDD253C687","Unaligned reads",16992286720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EAC4BB8E-83FE-4FDF-822D-8FB126B1DA1E","Canada's Michael Smith Genome Sciences Centre","564a3617e4b093830b679194","91DE8A74-A1E6-46B6-A06E-70AEDF2C3EAF","Ovarian Serous Cystadenocarcinoma","TAR","FD62E4E7-4C9B-485C-8DE9-0B2E200471A7","2014-03-27T01:11:02.000Z","782116C6-8D36-4E87-B5B4-DC592E987556","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"FD62E4E7-4C9B-485C-8DE9-0B2E200471A7",0.6,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.97f40569-5280-4c67-831d-dc8fa952e0f8.txt",NA,"TCGA-13-0886-01A",1,"965956E2-03A9-4029-9A70-1BE682B08540","TCGA",2002,NA,NA,"TUMOR FREE","91054520-9955-4D9B-BB06-E0BDD253C687",67,"TCGA-13-0886-10A-01W-0420-08_IlluminaGA-DNASeq_capture.bam","Alive",NA,"TCGA-13-0886","NOT HISPANIC OR LATINO",NA,NA,2259,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,70,"D21154A8-2994-4F78-B12C-BD53414D2570","ABF7C65E-C586-4811-852A-907483ADDC82","TCGA-13-0886-01A-01R-1569-13_mirna.bam.bai","TCGA-13-0886-01A-01",70,30,NA,NA,0,"BOTTOM",2,NA,"TCGA-13-0886-01A-01-BS1",68,"Carboplatin","Chemotherapy","TCGA-13-0886-D24664",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0886",NA,"13","0886","YES","C56.9","8441/3","C56.9",NA,NA,-24724,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2259,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
261415720,241273314,17692716465,"5B41C173-0A28-498B-8245-18C35D31ECCC.bw","92badeb5-a50e-4a62-a67e-6a8a59c948ab","5b41c173-0a28-498b-8245-18c35d31eccc","2016-08-25T07:17:40.866925-05:00","TCGA-04-1341-01A-01R-1564-13_rnaseq_fastq.tar","30be11c5-af4c-4505-b3d8-3d6d20e3ff20",16235182080,"Illumina HiSeq","ee550e788153b0dad9e7872a6696c3ed","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:00:24.898662-05:00","2016-05-03T11:41:05.776497-05:00","30be11c5-af4c-4505-b3d8-3d6d20e3ff20_analysis.xml","7469f4ff084918b35d092e2db9a8b54e","37d3974c-61cb-40dc-9aa0-0fac27e2ffe3",2210,"2016-09-30T00:19:10.655100-05:00","30be11c5-af4c-4505-b3d8-3d6d20e3ff20_experiment.xml","f05b968559a6a7ca554411b61f973c27","fd6d927b-7a9f-412f-83c5-c6eecc1b1351",3916,"2016-09-29T18:17:22.478424-05:00","30be11c5-af4c-4505-b3d8-3d6d20e3ff20_run.xml","4d82d80aab6170354629e0aa863191a4","1ccdefc4-116d-4bb8-8ce2-b77ea4c940df",1991,"2016-09-08T12:45:01.123920-05:00","TCGA-04-1341","2016-09-02T19:06:02.644842-05:00","female","TCGA-04-1341_demographic",1921,"white","a6a82dbe-deda-5ed3-81b8-4300e0617345","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1341_diagnosis","not reported",31215,"alive","8441/3",NA,33,"20316fd4-aca7-57fa-9966-4076874a372f","c56.9",-31215,"TCGA-04-1341_treatment","0d68a73c-3842-5432-bb95-10b03c23f67f","01",NA,"TCGA-04-1341-01A","1","8873baff-198d-4e4c-9d6d-18ee9d164f0d",FALSE,"9DB095E5-19F0-4ECE-9E54-2F030190FDB5","Primary Tumor","0.4",NA,NA,"1.5",1229644800,"01",107,"TCGA-04-1341-01A-01",80,80,NA,NA,NA,NA,28,22,"2016-09-08T12:45:01.123920-05:00","2016-09-08T12:45:01.123920-05:00",NA,NA,NA,NA,"BOTTOM","TOP",17,3,"85fe6a7e-fd57-4f26-a84e-f1688df637b3","c8420eb8-4f42-4b9a-a00e-2e18e43303f8","TCGA-04-1341-01A-01-BS1","TCGA-04-1341-01A-01-TS1",55,75,"582d08e8-91e2-42a0-9254-3f255c8481dd","RNA","TCGA-04-1341-01A-01R","c994cc41-caff-4a87-b7e8-0be34282ba82",1.7,0.17,"UV Spec","R","22","TCGA-04-1341-01A-01R-1564-13","d525e6af-f667-4891-97ee-856e6052982f",0.17,NA,NA,NA,NA,"9f6617ca-3fc8-55bb-85a6-baee8f1cbdfb","TCGA-04-1341_exposure","TCGA-04-1341-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T21:05:34.000Z","2014-04-04T07:09:02.000Z","30BE11C5-AF4C-4505-B3D8-3D6D20E3FF20","8873BAFF-198D-4E4C-9D6D-18EE9D164F0D","Unaligned reads",16235182080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D525E6AF-F667-4891-97EE-856E6052982F","Canada's Michael Smith Genome Sciences Centre","564a5a6be4b09c884b276546","92BADEB5-A50E-4A62-A67E-6A8A59C948AB","Ovarian Serous Cystadenocarcinoma","TAR","582D08E8-91E2-42A0-9254-3F255C8481DD","2014-04-04T07:09:02.000Z","C994CC41-CAFF-4A87-B7E8-0BE34282BA82","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"582D08E8-91E2-42A0-9254-3F255C8481DD",1,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9e5cf025-e667-4a73-94a3-e45255194ec3.txt",NA,"TCGA-04-1341-01A",1.5,NA,"TCGA",2006,NA,NA,NA,"E31641EE-9F88-45B5-8C49-63D73DD4A26E",85,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9e5cf025-e667-4a73-94a3-e45255194ec3.txt","Alive",NA,"TCGA-04-1341","NOT HISPANIC OR LATINO","081A449E-6733-4D5E-9DD0-B22ADD890B42",NA,33,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,NA,NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,107,"C8420EB8-4F42-4B9A-A00E-2E18E43303F8","FA3735E0-5B44-4E4F-AF34-AD7D4F4B14A3","TCGA-04-1341-01A-01R-1564-13_rnaseq_fastq.tar","TCGA-04-1341-01A-01",80,NA,NA,NA,22,"TOP",3,NA,"TCGA-04-1341-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,NA,NA,NA,"WITH TUMOR","Alive",NA,"TCGA-04-1341-F23940","TCGA-04-1341",NA,"04","1341","YES","C56.9","8441/3","C56.9","NO","YES",-31215,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",33,NA,NA,NA,NA,"NO",26,3,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,85,2006,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
67893982,61644140,4509190409,"EE2DCABE-DDD1-4C21-9D42-2E12D2FE16C3.bw","93095c36-2263-438f-a619-a4a4d6ae13c7","ee2dcabe-ddd1-4c21-9d42-2e12d2fe16c3","2016-09-29T23:54:19.780391-05:00","TCGA-61-1911-01A-01R-1567-13_rnaseq_fastq.tar","c8a90505-53d9-4703-8fce-6c5d0c37f0e0",4216514560,"Illumina HiSeq","7a6412618b347dd77c970c527503a9b7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:09:29.045774-05:00","2016-05-03T11:41:05.740436-05:00","c8a90505-53d9-4703-8fce-6c5d0c37f0e0_analysis.xml","38f73f768c9a9e3e1c0474c3b8345b4a","62d80250-7aaf-4ab4-9b60-f95eccaf2f01",2265,"2016-09-29T18:37:10.969273-05:00","c8a90505-53d9-4703-8fce-6c5d0c37f0e0_experiment.xml","7cb74c0f900fc536d2a583f005bd7f9b","2930a7a5-d0b3-4edc-8af4-8ae8d774a814",3916,"2016-09-29T21:25:53.982627-05:00","c8a90505-53d9-4703-8fce-6c5d0c37f0e0_run.xml","3e52aa191c248ef3cab85e56aec308dd","92299b5a-ea43-4449-ae40-8f833c49a911",1988,"2016-09-08T10:25:02.340461-05:00","TCGA-61-1911","2016-09-02T18:48:13.891598-05:00","female","TCGA-61-1911_demographic",1950,"white","da682e41-52c5-5a4f-b12c-62a7252a9929","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1911_diagnosis","not reported",20144,"alive","8441/3",NA,1293,"2fe15ad8-1c35-5513-a742-928b7ffa9166","c56.9",-20144,"TCGA-61-1911_treatment","1bdabded-cf7f-5dda-a880-89807b805126","01",NA,"TCGA-61-1911-01A","0.7","7f7b442a-3985-4f4a-98b1-da82670c957c",FALSE,"ba6325b4-af61-42cc-b84c-aacee9d7ecc8","Primary Tumor","0.4",NA,NA,"2",1246233600,"01",118,"TCGA-61-1911-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T10:25:02.340461-05:00","2016-09-08T10:25:02.340461-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,0,"668ba554-cdf9-422c-8bdb-3faeccefa07c","ea4d8814-16d0-4475-b259-f228f8803b76","TCGA-61-1911-01A-01-BS1","TCGA-61-1911-01A-01-TS1",94,95,"0166ad2a-aece-4167-8a33-6a7e43e8e311","RNA","TCGA-61-1911-01A-01R","365101b3-ec2e-4a41-9948-62824c538ef4",1.8,0.14,"UV Spec","R","22","TCGA-61-1911-01A-01R-1567-13","1ec9cbc3-fd76-4d44-be24-8ff296d3c4c9",0.14,NA,NA,NA,NA,"b81730ab-d11e-5660-bfcf-c57888213686","TCGA-61-1911_exposure","TCGA-61-1911-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T02:19:12.000Z","2014-03-27T02:33:02.000Z","C8A90505-53D9-4703-8FCE-6C5D0C37F0E0","7F7B442A-3985-4F4A-98B1-DA82670C957C","Unaligned reads",4216514560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1EC9CBC3-FD76-4D44-BE24-8FF296D3C4C9","Canada's Michael Smith Genome Sciences Centre","564a414be4b0ef12181c57b9","93095C36-2263-438F-A619-A4A4D6AE13C7","Ovarian Serous Cystadenocarcinoma","TAR","0166AD2A-AECE-4167-8A33-6A7E43E8E311","2014-03-27T02:33:02.000Z","365101B3-EC2E-4A41-9948-62824C538EF4","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"0166AD2A-AECE-4167-8A33-6A7E43E8E311",0.7,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.18959b13-60ff-43b5-8f53-acee023d775a.txt",NA,"TCGA-61-1911-01A",2,"D66C5AA9-31EA-436A-B0F6-83A2A727862C","TCGA",2005,NA,NA,"WITH TUMOR","B4D7333D-07AC-418A-8796-A7C5CAB8C102",55,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.18959b13-60ff-43b5-8f53-acee023d775a.txt","Alive",NA,"TCGA-61-1911","NOT HISPANIC OR LATINO","722712B4-0368-42BD-9D7C-39F03D146E63",NA,1293,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,118,"EA4D8814-16D0-4475-B259-F228F8803B76","A0F1A0A8-3739-41AB-826E-0898CFB3B6BC","4828606002_L_Grn.idat","TCGA-61-1911-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-61-1911-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-61-1911-D28267",NA,NA,NA,"TCGA-61-1911-F28260_NTE-2",NA,1293,"WITH TUMOR","Alive",NA,"TCGA-61-1911-F28260","TCGA-61-1911",NA,"61","1911","YES","C56.9","8441/3","C56.9",NA,NA,-20144,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1293,NA,NA,NA,"WITH TUMOR","NO",1,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,55,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
243524738,236467359,17499174932,"7493CB4A-C641-42A4-9BE9-394F2AE9287D.bw","931738a7-4b5b-46dc-b69f-72600862d8af","7493cb4a-c641-42a4-9be9-394f2ae9287d","2016-08-25T17:36:26.141750-05:00","TCGA-61-1995-01A-01R-1568-13_rnaseq_fastq.tar","1c43cf3a-9793-4c42-be30-5a739a449996",15487569920,"Illumina HiSeq","da922a27ef1079ad76536216c3424d75","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:32:56.862153-05:00","2016-05-03T11:56:42.628809-05:00","1c43cf3a-9793-4c42-be30-5a739a449996_analysis.xml","0147f63c5288ed2bb83ccb62a76f7581","00c810cc-fe0a-4a1f-b0fe-8c3911aee735",2181,"2016-09-29T18:23:18.137116-05:00","1c43cf3a-9793-4c42-be30-5a739a449996_experiment.xml","4a7e048fc78e9ce71493e3e09e61c257","20757285-9ff6-4f38-b43c-d3bda7a2850f",3916,"2016-09-29T17:50:18.441075-05:00","1c43cf3a-9793-4c42-be30-5a739a449996_run.xml","e132e10aeee680dc66c4baee7f69af58","0bdd16a5-d01a-4f04-a7d1-4c218e34475f",1988,"2016-09-08T11:43:08.032392-05:00","TCGA-61-1995","2016-09-02T18:56:14.492255-05:00","female","TCGA-61-1995_demographic",1966,"white","53fc8603-b3cd-55a5-9034-1c63bbb7089d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1995_diagnosis","not reported",16016,"alive","8441/3",NA,61,"5a7c82bd-5460-53e5-8b52-19d8586a011c","c56.9",-16016,"TCGA-61-1995_treatment","44ecbbb3-e9b5-519e-b19b-991a0d510db2","01",NA,"TCGA-61-1995-01A","1.1","2e1fa816-2b90-4c40-8ab5-617d19736cb0",FALSE,"5ea6d43b-376d-43cb-873f-c33ec814a95d","Primary Tumor","0.2",NA,NA,"1.1",1247443200,"01",109,"TCGA-61-1995-01A-01",75,75,NA,NA,8,10,8,10,"2016-09-08T11:43:08.032392-05:00","2016-09-08T11:43:08.032392-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,12,"e7dbda48-4123-45ac-aa6d-22b0d1567285","28ee27c5-9f6c-475f-8943-62896f6d3239","TCGA-61-1995-01A-01-BS1","TCGA-61-1995-01A-01-TS1",74,68,"09b9747e-7699-410f-8f8e-c373975eea0f","RNA","TCGA-61-1995-01A-01R","57e1a300-44f6-468c-b0d2-6adbf4911d98",1.8,0.15,"UV Spec","R","22","TCGA-61-1995-01A-01R-1568-13","13b2c972-c6ef-4d1f-8ada-f831d2606023",0.15,NA,NA,NA,NA,"f3366249-77e0-514f-b7c8-e922997c646f","TCGA-61-1995_exposure","TCGA-61-1995-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T14:20:06.000Z","2014-08-26T16:43:49.000Z","1C43CF3A-9793-4C42-BE30-5A739A449996","2E1FA816-2B90-4C40-8AB5-617D19736CB0","Unaligned reads",15487569920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","13B2C972-C6EF-4D1F-8ADA-F831D2606023","Canada's Michael Smith Genome Sciences Centre","564a3f34e4b0298dd2c99f9c","931738A7-4B5B-46DC-B69F-72600862D8AF","Ovarian Serous Cystadenocarcinoma","TAR","09B9747E-7699-410F-8F8E-C373975EEA0F","2014-08-26T16:43:49.000Z","57E1A300-44F6-468C-B0D2-6ADBF4911D98","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"09B9747E-7699-410F-8F8E-C373975EEA0F",1.1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1bdc5555-06ec-496c-ac44-b8847ca95fb5.txt",NA,"TCGA-61-1995-01A",1.1,"5B457183-3195-43D4-8C3E-F244C641648D","TCGA",2009,NA,NA,"WITH TUMOR","BF7E4FD2-4FB9-4F5C-8A39-3F7622C79C15",43,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1bdc5555-06ec-496c-ac44-b8847ca95fb5.txt","Alive",NA,"TCGA-61-1995","NOT HISPANIC OR LATINO","23CEC1CB-18F5-4261-BB98-4A4260F7306C",NA,61,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,109,"E7DBDA48-4123-45AC-AA6D-22B0D1567285","8937AB57-25C7-45DA-98F6-1FBA2790708A","4814976124_R01C01_Red.idat","TCGA-61-1995-01A-01",75,8,NA,NA,8,"BOTTOM",10,NA,"TCGA-61-1995-01A-01-BS1",74,"Taxol","Chemotherapy","TCGA-61-1995-D28304",NA,NA,NA,NA,NA,61,"WITH TUMOR","Alive",NA,"TCGA-61-1995-F28302","TCGA-61-1995",NA,"61","1995","YES","C56.9","8441/3","C56.9",NA,NA,-16016,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",61,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,43,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
90815966,80406002,5846869504,"7AF6E8FF-2E16-4D5B-A475-8C2492BE0325.bw","933dbfbd-4697-403e-bd73-c17cb300c94b","7af6e8ff-2e16-4d5b-a475-8c2492be0325","2016-08-25T19:37:13.961820-05:00","TCGA-10-0927-01A-02R-1564-13_rnaseq_fastq.tar","10df7ad0-f004-4bc9-ad35-cb280fdd48aa",5476802560,"Illumina HiSeq","f38b8660ddcb2f62c17507070f6d9d55","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:27:31.895311-05:00","2016-05-03T11:39:34.528512-05:00","10df7ad0-f004-4bc9-ad35-cb280fdd48aa_analysis.xml","775015bf052b34dc2bb0031b9b3cd95c","6de75e8f-6864-4cb0-820d-441ea9a45dfe",2208,"2016-09-29T20:45:25.688870-05:00","10df7ad0-f004-4bc9-ad35-cb280fdd48aa_experiment.xml","e32267010cb2a3318c888393e9d5c7df","78ea31b6-8609-4df0-a1b5-2b5b2aa9facb",3916,"2016-09-29T21:45:01.559695-05:00","10df7ad0-f004-4bc9-ad35-cb280fdd48aa_run.xml","784f3555def1a1b40e397c2d1ea98d76","9dec3afd-d8e6-4a03-a800-452746873200",1988,"2016-09-08T13:08:10.565338-05:00","TCGA-10-0927","2016-09-02T19:05:17.090145-05:00","female","TCGA-10-0927_demographic",1935,"not reported","76e6cd60-baff-5f8f-8ad0-ad492278a8ef","hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0927_diagnosis","not reported",23982,"dead","8441/3",2490,2478,"9d23ef93-61ea-5258-8397-89ab16148670","c56.9",-23982,"TCGA-10-0927_treatment","791b367f-dd3b-5eb2-b122-0109685f2baf","01",NA,"TCGA-10-0927-01A","0.7","97efbf70-83ef-49aa-ac3a-f0d0067a2a10",FALSE,"3d93f935-2a93-4987-99c6-0b75e2e59cd3","Primary Tumor","0.6",NA,NA,"1.1",1233705600,"02",95,"TCGA-10-0927-01A-02",95,75,NA,NA,5,10,5,30,"2016-09-08T13:08:10.565338-05:00","2016-09-08T13:08:10.565338-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"9a7313d6-6b16-4e4f-b530-2a37dbc98170","34116420-64e7-415c-bcf4-d6c5c7ba3e7c","TCGA-10-0927-01A-01-BS1","TCGA-10-0927-01A-02-BS2",90,60,"3b87c711-ec50-4d19-8970-242aa215d3a2","RNA","TCGA-10-0927-01A-02R","3b04e4c3-d35f-40e4-bb5f-b854662c1604",1.8,0.15,"UV Spec","R","22","TCGA-10-0927-01A-02R-1564-13","1930e83e-d1aa-459e-9f05-ab347df98dbf",0.15,NA,NA,NA,NA,"c57e9903-b10b-57fc-a92e-bda75f8cbb34","TCGA-10-0927_exposure","TCGA-10-0927-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-20T05:16:29.000Z","2014-03-20T05:30:02.000Z","10DF7AD0-F004-4BC9-AD35-CB280FDD48AA","97EFBF70-83EF-49AA-AC3A-F0D0067A2A10","Unaligned reads",5476802560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1930E83E-D1AA-459E-9F05-AB347DF98DBF","Canada's Michael Smith Genome Sciences Centre","564a32a3e4b08c5d868eb809","933DBFBD-4697-403E-BD73-C17CB300C94B","Ovarian Serous Cystadenocarcinoma","TAR","3B87C711-EC50-4D19-8970-242AA215D3A2","2014-03-20T05:30:02.000Z","3B04E4C3-D35F-40E4-BB5F-B854662C1604","None","NO",1,0.6,"Primary Tumor","MD Anderson Cancer Center",NA,"3B87C711-EC50-4D19-8970-242AA215D3A2",0.7,"10","TCGA-10-0927-01A-02W-0419-10_SOLiD_whole_exome_extensions.bam.bai",NA,"TCGA-10-0927-01A",1.1,"F5B4EECF-392C-4DC2-B6B4-84147F8D78A8","TCGA",2000,NA,NA,"WITH TUMOR","D157747C-FB81-4D7A-9856-A82606F8ACED",65,"RACKS_p_TCGAaffxB10b_11_S_GenomeWideSNP_6_E07_429540.hg18.seg.txt","Dead",2490,"TCGA-10-0927","HISPANIC OR LATINO","086690DA-AA4D-4658-A679-F871FA293B7C",NA,2478,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,NA,NA,2,95,"9A7313D6-6B16-4E4F-B530-2A37DBC98170","AC3564AD-8D11-4C50-ABCE-559E71ED12B3","PSHAW_p_TCGA_Batch11_RNA_HT_HG-U133A_96-HTA_B07_433722.level3.data.txt","TCGA-10-0927-01A-02",75,10,NA,NA,30,"BOTTOM",0,NA,"TCGA-10-0927-01A-02-BS2",60,"Gemcitabine","Chemotherapy","TCGA-10-0927-D24427",NA,NA,NA,"TCGA-10-0927-F24420_NTE-1",NA,2478,"WITH TUMOR","Dead",2490,"TCGA-10-0927-F24420","TCGA-10-0927",NA,"10","0927","YES","C56.9","8441/3","C56.9",NA,NA,-23982,"FEMALE",NA,"HISPANIC OR LATINO",NA,"No","Dead",2478,2490,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2000,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
297309108,279767477,20689589349,"AF9B58D8-D875-412B-99F5-1E7768C18080.bw","94030805-8beb-441a-af73-11a80768edb5","af9b58d8-d875-412b-99f5-1e7768c18080","2016-08-26T04:21:45.401600-05:00","TCGA-20-1684-01A-01R-1566-13_rnaseq_fastq.tar","ddc315ea-c1ec-4b11-b81d-6826eb11ae0a",19803688960,"Illumina HiSeq","ffd078fe15580557418912ef00e3d9ae","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:51:48.405455-05:00","2016-05-03T11:39:34.528512-05:00","ddc315ea-c1ec-4b11-b81d-6826eb11ae0a_analysis.xml","71c574a95bfce134623c7719bb4a88ef","0cd1eb6d-7bb1-47fc-b9bc-20917a305c11",2181,"2016-09-29T18:02:34.763327-05:00","ddc315ea-c1ec-4b11-b81d-6826eb11ae0a_experiment.xml","2b2a6d517d1750749dea962c3cbf4a10","1399c1e7-2522-4f4e-8584-b9a654935cef",3916,"2016-09-29T21:43:34.588707-05:00","ddc315ea-c1ec-4b11-b81d-6826eb11ae0a_run.xml","466f8e597f8ab365c71df1a6ece83321","9d039e45-a634-4d60-be30-5ff08ad70d70",1988,"2016-09-08T13:11:49.074610-05:00","TCGA-20-1684","2016-09-02T19:07:43.487473-05:00","female","TCGA-20-1684_demographic",1956,"white","833acdb5-f0ce-5046-aec5-6eea25c5d804","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-1684_diagnosis","not reported",18755,"alive","8441/3",NA,581,"86651736-aa3a-555d-bf96-24285ca73665","c56.9",-18755,"TCGA-20-1684_treatment","c7c50ae4-9741-5409-a0a1-8dcaade070b8","01",NA,"TCGA-20-1684-01A","0.5","d8ecb5e2-5af0-4a84-8b51-22c395850721",FALSE,"3ce61823-9e89-424f-9ce2-a8987420b2a9","Primary Tumor","0.4",NA,NA,"1",1242604800,"01",120,"TCGA-20-1684-01A-01",95,95,NA,NA,0,0,18,20,"2016-09-08T13:11:49.074610-05:00","2016-09-08T13:11:49.074610-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,3,"468d2ed5-91e2-4a7a-ba3f-9c92ec538e03","13f4bd57-6d3d-4c3f-97ec-7276ddb88f47","TCGA-20-1684-01A-01-BS1","TCGA-20-1684-01A-01-TS1",80,77,"7d1fd887-7872-4315-8782-774bcf3624cf","RNA","TCGA-20-1684-01A-01R","87f4960f-2d6e-42b4-bd90-84708691109e",1.8,0.15,"UV Spec","R","22","TCGA-20-1684-01A-01R-1566-13","91b2872a-73bc-4f52-a8f6-96ce81cbef8a",0.15,NA,NA,NA,NA,"c1c521c6-8be0-5de2-a5d8-8a36d896bc01","TCGA-20-1684_exposure","TCGA-20-1684-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T08:35:05.000Z","2014-03-20T09:09:02.000Z","DDC315EA-C1EC-4B11-B81D-6826EB11AE0A","D8ECB5E2-5AF0-4A84-8B51-22C395850721","Unaligned reads",19803688960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","91B2872A-73BC-4F52-A8F6-96CE81CBEF8A","Canada's Michael Smith Genome Sciences Centre","564a3363e4b0298dd2c5d696","94030805-8BEB-441A-AF73-11A80768EDB5","Ovarian Serous Cystadenocarcinoma","TAR","7D1FD887-7872-4315-8782-774BCF3624CF","2014-03-20T09:09:02.000Z","87F4960F-2D6E-42B4-BD90-84708691109E","None","NO",1,0.4,"Primary Tumor","Fox Chase Cancer Center",NA,"7D1FD887-7872-4315-8782-774BCF3624CF",0.5,"20","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8ba9a6e5-3dc8-4e7b-80ca-17470663b495.txt",NA,"TCGA-20-1684-01A",1,"FD8AC1C7-65CB-4BCA-BFA6-FAB399CF7E57","TCGA",2007,NA,NA,"TUMOR FREE","D8ECB5E2-5AF0-4A84-8B51-22C395850721",51,"4760681047_C_Grn.idat","Alive",NA,"TCGA-20-1684","NOT HISPANIC OR LATINO","C1F2EB5C-51D5-469F-9319-30CFCAEC69E4",NA,581,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,120,"468D2ED5-91E2-4A7A-BA3F-9C92EC538E03","DCCB625E-5296-4F1E-B655-6E5BDDC5CEBC","TCGA-20-1684-01A-01R-1566-13.exon.quantification.txt","TCGA-20-1684-01A-01",95,0,NA,NA,20,"TOP",3,NA,"TCGA-20-1684-01A-01-TS1",77,"Bevacizumab","Chemotherapy","TCGA-20-1684-D25552",NA,NA,NA,NA,NA,581,"TUMOR FREE","Alive",NA,"TCGA-20-1684-F25549","TCGA-20-1684",NA,"20","1684","YES","C56.9","8441/3","C56.9",NA,NA,-18755,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",581,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
214774324,207691307,15238353852,"0EEEDCFE-9FB9-4F12-9ADB-701AF3324B0F.bw","9446e349-71e6-455a-aa8f-53ec96597146","0eeedcfe-9fb9-4f12-9adb-701af3324b0f","2016-08-24T21:32:15.126708-05:00","TCGA-10-0933-01A-01R-1569-13_rnaseq_fastq.tar","b5fa7a50-5211-4226-a827-f16a0d3a95a2",13320867840,"Illumina HiSeq","b9d72d0696e9b7015dacaba8f033a034","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:26:47.477172-05:00","2016-05-03T11:41:05.740436-05:00","b5fa7a50-5211-4226-a827-f16a0d3a95a2_analysis.xml","ff9562c5740eb1b74997fe258a5fa4b7","6d7d10b7-357d-45ea-9d84-9af8e458a224",2235,"2016-08-27T18:06:57.491524-05:00","b5fa7a50-5211-4226-a827-f16a0d3a95a2_experiment.xml","464f3e358798fd1f3b701673bf64b8fc","c0b43d37-0856-43db-b544-114e2aaab95b",3916,"2016-09-29T23:21:40.894967-05:00","b5fa7a50-5211-4226-a827-f16a0d3a95a2_run.xml","8ae29a93db32dc404e7e083ad6a7e181","d9b60f3d-008c-47ec-a9ed-05458f2517a5",1988,"2016-09-08T12:39:44.725924-05:00","TCGA-10-0933","2016-09-02T19:06:18.658477-05:00","female","TCGA-10-0933_demographic",1926,"white","5dcb5210-ad8c-5ee3-806a-4305cfba74e6","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0933_diagnosis","not reported",28433,"dead","8441/3",446,356,"c1a0ef23-5337-5624-91ed-fca9c7b85f47","c56.9",-28433,"TCGA-10-0933_treatment","23a22951-5b42-5c90-ba99-ce22fc046fbc","01",NA,"TCGA-10-0933-01A","0.4","1d568bd2-d658-40fa-a341-daa4d2a5bb22",FALSE,"f973309d-55dd-489b-a7ca-9348666a9129","Primary Tumor","0.4",NA,NA,"1",1233705600,"01",153,"TCGA-10-0933-01A-01",90,90,NA,NA,5,5,5,10,"2016-09-08T12:39:44.725924-05:00","2016-09-08T12:39:44.725924-05:00",0,NA,0,NA,"TOP","BOTTOM",0,0,"4193c207-aac8-400e-be84-1ff6ebccd090","56e3863d-bfc6-4a9c-95e0-e6ee735e134f","TCGA-10-0933-01A-01-TS1","TCGA-10-0933-01A-01-BS1",90,85,"e69a9138-7249-492a-acc4-b61b7c73dbf0","RNA","TCGA-10-0933-01A-01R","d5f967ae-d7f5-4b62-8e28-1e698ebe2f67",1.8,0.15,"UV Spec","R","22","TCGA-10-0933-01A-01R-1569-13","484100a8-fa3b-4d8a-9051-de0ba8035cb4",0.15,NA,NA,NA,NA,"87991217-6530-55c0-9bda-b46d229953e3","TCGA-10-0933_exposure","TCGA-10-0933-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T01:44:09.000Z","2014-03-27T02:13:01.000Z","B5FA7A50-5211-4226-A827-F16A0D3A95A2","1D568BD2-D658-40FA-A341-DAA4D2A5BB22","Unaligned reads",13320867840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","484100A8-FA3B-4D8A-9051-DE0BA8035CB4","Canada's Michael Smith Genome Sciences Centre","564a3a69e4b0ef12181a204c","9446E349-71E6-455A-AA8F-53EC96597146","Ovarian Serous Cystadenocarcinoma","TAR","E69A9138-7249-492A-ACC4-B61B7C73DBF0","2014-03-27T02:13:01.000Z","D5F967AE-D7F5-4B62-8E28-1E698EBE2F67","None","NO",1,0.4,"Primary Tumor","MD Anderson Cancer Center",NA,"E69A9138-7249-492A-ACC4-B61B7C73DBF0",0.4,"10","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7c7459b2-2a24-4866-a4fc-e960ef606d39.txt",NA,"TCGA-10-0933-01A",1,"89E0DD01-E64F-44AB-B287-379AA1C62A89","TCGA",2003,NA,NA,"WITH TUMOR","8FA5DC4B-2285-4124-93B3-3DAA336811F9",77,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7c7459b2-2a24-4866-a4fc-e960ef606d39.txt","Dead",446,"TCGA-10-0933","NOT HISPANIC OR LATINO","4CDDFC2F-91C2-4D1B-959E-A407436F1FAF",NA,356,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,153,"56E3863D-BFC6-4A9C-95E0-E6EE735E134F","FE7C227D-9CE2-4D34-BE19-242D6EB80A22","TCGA-10-0933-01A-01R-1569-13_mirna.bam","TCGA-10-0933-01A-01",90,5,NA,NA,10,"BOTTOM",0,NA,"TCGA-10-0933-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-10-0933-D24455",NA,NA,NA,"TCGA-10-0933-F24454_NTE-1",NA,356,"WITH TUMOR","Dead",446,"TCGA-10-0933-F24454","TCGA-10-0933",NA,"10","0933","YES","C56.9","8441/3","C56.9",NA,NA,-28433,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",356,446,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,77,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
177103988,170964055,12619596286,"F96A4D39-CA48-4D92-94D7-951B746407B5.bw","94769f2c-b6fd-48ec-af34-b41165340b7c","f96a4d39-ca48-4d92-94d7-951b746407b5","2016-09-30T00:12:44.914915-05:00","TCGA-29-1769-01A-01R-1567-13_rnaseq_fastq.tar","5e750b4c-5d47-4f61-8c0e-2a1683f9bb2a",11048867840,"Illumina HiSeq","45cf7dd708d27bdde592708d94dba23f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:52:43.126479-05:00","2016-05-03T11:41:05.740436-05:00","5e750b4c-5d47-4f61-8c0e-2a1683f9bb2a_analysis.xml","dd6a36f67a17a461dc6ee14ba3708fcd","ed29b135-79d5-45b7-8927-b8712830a6d6",2208,"2016-09-29T23:27:29.855352-05:00","5e750b4c-5d47-4f61-8c0e-2a1683f9bb2a_experiment.xml","f0bb655b28a92ef1703fb8df60d50dd3","dd67b015-0d0f-4877-a555-a01a0e3e2cab",3916,"2016-09-29T20:28:07.026626-05:00","5e750b4c-5d47-4f61-8c0e-2a1683f9bb2a_run.xml","c032e8ad4022d966bcdfa11aab2b19dd","6e44d670-2f29-4b6d-b4bc-a178df6fc7eb",1988,"2016-09-08T10:37:49.265963-05:00","TCGA-29-1769","2016-09-02T18:47:43.740640-05:00","female","TCGA-29-1769_demographic",1967,"white","c864bf04-f19e-53ae-98dc-29cf75ba37fe","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1769_diagnosis","not reported",14754,"alive","8441/3",NA,699,"4a6c3210-bd6e-5fed-aa66-cd78f1e21390","c56.9",-14754,"TCGA-29-1769_treatment","11936ff0-0e52-5af1-a590-7c1e25af2352","01",NA,"TCGA-29-1769-01A","0.5","cbfe2502-c3d1-44a5-bd1a-4a775c86d27f",FALSE,"67f144b3-c10b-4f96-a70b-6794d817170f","Primary Tumor","0.4",NA,NA,"1.1",1243296000,"01",113,"TCGA-29-1769-01A-01",80,90,NA,NA,0,10,15,5,"2016-09-08T10:37:49.265963-05:00","2016-09-08T10:37:49.265963-05:00",2,2,NA,NA,"BOTTOM","TOP",0,0,"2138180e-d18f-41c7-b87d-25a179a17229","11d4cb8d-65cc-466b-b776-9488e40cbd13","TCGA-29-1769-01A-01-BS1","TCGA-29-1769-01A-01-TS1",85,85,"96c2d0a0-6bf3-4cf0-a68b-c114d1720a58","RNA","TCGA-29-1769-01A-01R","e5df11e5-e496-4e14-bace-42cbaeacad9b",1.8,0.15,"UV Spec","R","22","TCGA-29-1769-01A-01R-1567-13","f2ac7109-1071-47f7-af2a-2d655c475427",0.15,NA,NA,NA,NA,"10ac90b2-2cf6-58cd-9678-5ceab7af4401","TCGA-29-1769_exposure","TCGA-29-1769-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T03:06:21.000Z","2014-03-27T03:29:02.000Z","5E750B4C-5D47-4F61-8C0E-2A1683F9BB2A","CBFE2502-C3D1-44A5-BD1A-4A775C86D27F","Unaligned reads",11048867840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F2AC7109-1071-47F7-AF2A-2D655C475427","Canada's Michael Smith Genome Sciences Centre","564a5a5ae4b08c5d8694e380","94769F2C-B6FD-48EC-AF34-B41165340B7C","Ovarian Serous Cystadenocarcinoma","TAR","96C2D0A0-6BF3-4CF0-A68B-C114D1720A58","2014-03-27T03:29:02.000Z","E5DF11E5-E496-4E14-BACE-42CBAEACAD9B","None","NO",1,0.4,"Primary Tumor","Duke",NA,"96C2D0A0-6BF3-4CF0-A68B-C114D1720A58",0.5,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.161fd24e-ed8c-41ef-8f00-000b3554d9e8.txt",NA,"TCGA-29-1769-01A",1.1,"F005E844-C120-4A8D-9084-4363E2A321D1","TCGA",2007,NA,NA,"TUMOR FREE","CBFE2502-C3D1-44A5-BD1A-4A775C86D27F",40,"bcgsc.ca.TCGA-29-1769-01A-01R-1567-13.bcgsc.ca.1.4.0.indel.vcf","Alive",NA,"TCGA-29-1769",NA,"B97223F7-BB76-4B6F-A938-A615AA68414A",NA,699,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,113,"11D4CB8D-65CC-466B-B776-9488E40CBD13","E5DF11E5-E496-4E14-BACE-42CBAEACAD9B","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_D03_495034.CEL","TCGA-29-1769-01A-01",90,10,NA,2,5,"TOP",0,NA,"TCGA-29-1769-01A-01-TS1",85,"Paciltaxel","Chemotherapy","TCGA-29-1769-D27369",NA,NA,NA,NA,NA,699,"TUMOR FREE","Alive",NA,"TCGA-29-1769-F27366","TCGA-29-1769",NA,"29","1769","YES","C56.9","8441/3","C56.9",NA,NA,-14754,"FEMALE","WHITE",NA,NA,"No","Alive",699,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,40,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
135369712,125817718,9180733121,"DDB6A47A-3E0A-4738-9D1E-EAB8682485C3.bw","94bd4c68-4bfc-4db3-9365-97c867747133","ddb6a47a-3e0a-4738-9d1e-eab8682485c3","2016-08-26T18:48:05.806409-05:00","TCGA-20-1682-01A-01R-1564-13_rnaseq_fastq.tar","c0ac076f-c5bd-4999-aeb6-52b9a02a31a0",8120596480,"Illumina HiSeq","203c3c28b84ef5c61b116156f8547a29","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:06:58.583879-05:00","2016-05-03T11:41:05.750744-05:00","c0ac076f-c5bd-4999-aeb6-52b9a02a31a0_analysis.xml","e6f9516ea95234c6748e2c39275e1b20","86714ee9-3272-488d-a713-9574dcaa518c",2181,"2016-08-26T09:15:07.044776-05:00","c0ac076f-c5bd-4999-aeb6-52b9a02a31a0_experiment.xml","20fed0e31029368d768e476d5ce656f8","c334d341-d1f4-40d0-898a-9dc7bbca9af6",3916,"2016-09-29T22:55:04.477091-05:00","c0ac076f-c5bd-4999-aeb6-52b9a02a31a0_run.xml","0acb667564ffdc96289ee9f2cf97d728","c9530a77-ebd2-47b2-86ae-4b9f156fd95a",1988,"2016-09-08T12:38:15.106336-05:00","TCGA-20-1682","2016-09-02T19:07:38.945238-05:00","female","TCGA-20-1682_demographic",1951,"white","785a428f-fce0-5477-84d9-dc65a0af2908","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-1682_diagnosis","not reported",20583,"alive","8441/3",NA,837,"72df9e88-9c14-5df0-820e-182c1459f906","c56.9",-20583,"TCGA-20-1682_treatment","fae81cac-35fa-5817-832b-5b69dac21bfc","01",NA,"TCGA-20-1682-01A","0.4","3c3da068-a62f-43c9-91c7-41ead1ca7f75",FALSE,"cf49ea4d-478c-469d-ace2-7ef52b66a332","Primary Tumor","0.3",NA,NA,"1",1242604800,"01",125,"TCGA-20-1682-01A-01",80,80,NA,NA,0,0,38,14,"2016-09-08T12:38:15.106336-05:00","2016-09-08T12:38:15.106336-05:00",5,5,NA,NA,"TOP","BOTTOM",2,1,"8c825440-843e-42d1-bd0e-dd91a64b5d69","c4f1280c-1e62-4d03-9237-35a4ce37f578","TCGA-20-1682-01A-01-TS1","TCGA-20-1682-01A-01-BS1",60,85,"7a3529ad-24c3-4531-a62a-18fdfbe70e99","RNA","TCGA-20-1682-01A-01R","0995338b-45fe-488d-8606-2c2e994a6a21",1.8,0.15,"UV Spec","R","22","TCGA-20-1682-01A-01R-1564-13","f03d023b-cba8-413d-a88d-0378ee7b7748",0.15,NA,NA,NA,NA,"09f30327-5602-5f1f-af5e-023c2324a934","TCGA-20-1682_exposure","TCGA-20-1682-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T17:53:19.000Z","2014-03-28T18:14:02.000Z","C0AC076F-C5BD-4999-AEB6-52B9A02A31A0","3C3DA068-A62F-43C9-91C7-41EAD1CA7F75","Unaligned reads",8120596480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F03D023B-CBA8-413D-A88D-0378EE7B7748","Canada's Michael Smith Genome Sciences Centre","564a5b90e4b09c884b27aee8","94BD4C68-4BFC-4DB3-9365-97C867747133","Ovarian Serous Cystadenocarcinoma","TAR","7A3529AD-24C3-4531-A62A-18FDFBE70E99","2014-03-28T18:14:02.000Z","0995338B-45FE-488D-8606-2C2E994A6A21","None","NO",1,0.3,"Primary Tumor","Fox Chase Cancer Center",NA,"7A3529AD-24C3-4531-A62A-18FDFBE70E99",0.4,"20","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a999220b-fed5-446d-8bba-c4c59428d473.txt",NA,"TCGA-20-1682-01A",1,"F9A9B49A-EEFA-4274-B8B0-542674F06E3E","TCGA",2007,NA,NA,"TUMOR FREE","C87BDD1E-159C-4D83-B66A-D5DC2672C82B",56,"nationwidechildrens.org_clinical.TCGA-20-1682.xml","Alive",NA,"TCGA-20-1682","NOT HISPANIC OR LATINO","C82C3D5F-BDBA-4A46-BFD1-92E930C8674B",NA,837,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,125,"C4F1280C-1E62-4D03-9237-35A4CE37F578","F445DC27-921F-45FE-B560-FD2128EC5C86","TCGA-20-1682-01A-01R-1564-13_GRCh37-lite_mirna.bam","TCGA-20-1682-01A-01",80,0,NA,5,14,"BOTTOM",1,NA,"TCGA-20-1682-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-20-1682-D25541",NA,NA,NA,NA,NA,837,"TUMOR FREE","Alive",NA,"TCGA-20-1682-F25540","TCGA-20-1682",NA,"20","1682","YES","C56.9","8441/3","C56.9",NA,NA,-20583,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",837,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2007,"Tumor resection",NA,NA,NA,"GX",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
278842298,270789052,20048072548,"914276B4-F36B-49F9-8F2A-05296459F3EB.bw","94efd4f9-69b0-4efa-8a0c-61106e898fdd","914276b4-f36b-49f9-8f2a-05296459f3eb","2016-08-21T14:40:02.090758-05:00","TCGA-24-1849-01A-01R-1567-13_rnaseq_fastq.tar","f3ddc816-1db8-4562-afa9-c94e549739b1",17560719360,"Illumina HiSeq","f142cf219897db85b171a8bc8b1ce65e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:51:47.938532-05:00","2016-05-03T11:41:05.740436-05:00","f3ddc816-1db8-4562-afa9-c94e549739b1_analysis.xml","1729fdc94fc6a520a2ce92ea285f1063","a236b7f6-268e-42e5-83ce-0a2abc365bbc",2181,"2016-09-29T17:54:21.534187-05:00","f3ddc816-1db8-4562-afa9-c94e549739b1_experiment.xml","ce937dc5bee062c4a05d361b7992a234","0e594003-4df8-4a21-bd2d-082d2682c690",3916,"2016-09-29T19:50:45.165968-05:00","f3ddc816-1db8-4562-afa9-c94e549739b1_run.xml","1ed93463a56ffabf54a0ff6a34f666ef","577a145e-b934-4fb5-9f20-566a088787fe",1988,"2016-09-08T11:08:45.733208-05:00","TCGA-24-1849","2016-09-02T18:47:45.854123-05:00","female","TCGA-24-1849_demographic",1929,"white","35b4552b-9d9c-59d1-bd1e-e5f0dc255a48","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1849_diagnosis","not reported",29555,"alive","8441/3",NA,176,"70ebbaef-4c30-53d2-8f0e-d3492ba1c271","c56.9",-29555,"TCGA-24-1849_treatment","208bbd86-f85c-5a19-b579-739ad05a310c","01",NA,"TCGA-24-1849-01A","1.4","121db3fb-cc6b-48bb-8bfe-a582075658fe",FALSE,"a2181913-086c-42a2-99fd-057b17025deb","Primary Tumor","0.5",NA,NA,"1.8",1245628800,"01",129,"TCGA-24-1849-01A-01",80,80,NA,NA,0,0,20,15,"2016-09-08T11:08:45.733208-05:00","2016-09-08T11:08:45.733208-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"e8102152-0a58-4ac5-ba56-f53446ca1039","62a67232-6a30-42cd-81c0-f8d714c02a7b","TCGA-24-1849-01A-01-TS1","TCGA-24-1849-01A-01-BS1",80,85,"11abfbf7-1a9a-43ad-8568-a90b948883b0","RNA","TCGA-24-1849-01A-01R","d440cb7f-74e1-41a6-a1b6-5a987e39379b",1.9,0.16,"UV Spec","R","22","TCGA-24-1849-01A-01R-1567-13","58f3764a-4651-4c26-a667-74aef5c5679c",0.16,NA,NA,NA,NA,"0eaeca07-3460-5b05-8396-05f49ed13912","TCGA-24-1849_exposure","TCGA-24-1849-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T01:50:30.000Z","2014-03-27T02:24:01.000Z","F3DDC816-1DB8-4562-AFA9-C94E549739B1","121DB3FB-CC6B-48BB-8BFE-A582075658FE","Unaligned reads",17560719360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","58F3764A-4651-4C26-A667-74AEF5C5679C","Canada's Michael Smith Genome Sciences Centre","564a386ae4b08c5d86909024","94EFD4F9-69B0-4EFA-8A0C-61106E898FDD","Ovarian Serous Cystadenocarcinoma","TAR","11ABFBF7-1A9A-43AD-8568-A90B948883B0","2014-03-27T02:24:01.000Z","D440CB7F-74E1-41A6-A1B6-5A987E39379B","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"11ABFBF7-1A9A-43AD-8568-A90B948883B0",1.4,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.66dc2c60-9fa1-4fb7-8bd4-76da1e11229a.txt",NA,"TCGA-24-1849-01A",1.8,"400D2F6C-3FEA-402D-95B7-44939BD2741C","TCGA",2009,NA,NA,"TUMOR FREE","B539DA11-BA47-4521-817B-5293E38111EC",80,"nationwidechildrens.org_clinical.TCGA-24-1849.xml","Alive",NA,"TCGA-24-1849",NA,"F8E9ABA6-D282-480F-BBEE-D180107708B2",NA,176,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,129,"E8102152-0A58-4AC5-BA56-F53446CA1039","D440CB7F-74E1-41A6-A1B6-5A987E39379B","TCGA-24-1849-01A-01R-1567-13_GRCh37-lite_rnaseq.bam","TCGA-24-1849-01A-01",80,0,NA,NA,15,"BOTTOM",0,NA,"TCGA-24-1849-01A-01-BS1",85,"Carboplatin","Chemotherapy","TCGA-24-1849-D26356",NA,NA,NA,NA,NA,176,"TUMOR FREE","Alive",NA,"TCGA-24-1849-F26355","TCGA-24-1849",NA,"24","1849","YES","C56.9","8441/3","C56.9",NA,NA,-29555,"FEMALE","WHITE",NA,NA,"No","Alive",176,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,80,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
255047564,249420571,18517789069,"94D3B158-1C7B-43A2-AE00-64E115344C52.bw","955c80be-53df-4565-9303-a7abf96a2f81","94d3b158-1c7b-43a2-ae00-64e115344c52","2016-08-21T15:50:54.199586-05:00","TCGA-25-1329-01A-01R-1565-13_rnaseq_fastq.tar","518b6738-5946-4a91-94ae-816135a4c5a8",15349217280,"Illumina HiSeq","1b2fa146464d185197b68afb0095f879","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:45:49.050042-05:00","2016-05-03T11:40:21.647690-05:00","518b6738-5946-4a91-94ae-816135a4c5a8_analysis.xml","c270041b1daed9a13c006c67a8c339eb","0909d97f-3fc4-47ce-9ccc-b34fb56af1c6",2181,"2016-09-29T19:37:52.478049-05:00","518b6738-5946-4a91-94ae-816135a4c5a8_experiment.xml","e1ce0958b2a9278653d07909dbd9368d","4f68e612-efe2-4976-81db-87e38b1e39a6",3916,"2016-09-29T20:45:17.283086-05:00","518b6738-5946-4a91-94ae-816135a4c5a8_run.xml","49545aadb5e0acf6dd40f439f9fc912f","78d526ee-da74-4590-b6fc-4c5cb540e1f5",1989,"2016-09-08T13:41:58.113843-05:00","TCGA-25-1329","2016-09-02T19:12:02.398098-05:00","female","TCGA-25-1329_demographic",1926,"white","3300031e-8802-584a-9af4-d00c691a2330","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1329_diagnosis","not reported",28093,"dead","8441/3",457,90,"728d06d8-6ccd-5a53-90a6-cb4107824d5a","c56.9",-28093,"TCGA-25-1329_treatment","94eb5635-bcdc-5024-98a0-919a48c5108e","01",NA,"TCGA-25-1329-01A","2.6","d7ad6239-b56b-4762-9656-7653f308e01d",FALSE,"857409C6-75EC-4935-85BC-6D5F66AF4DB3","Primary Tumor","0.6",NA,NA,"3",1228435200,"01",157,"TCGA-25-1329-01A-01",95,95,NA,NA,0,0,25,5,"2016-09-08T13:41:58.113843-05:00","2016-09-08T13:41:58.113843-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,10,"53db6a63-1ab7-447b-a356-6af729dad49a","603d7e2c-e298-4d4c-8479-94547312f95a","TCGA-25-1329-01A-01-BS1","TCGA-25-1329-01A-01-TS1",70,75,"a91a4d13-2a51-4378-a5ec-60359d928890","RNA","TCGA-25-1329-01A-01R","2fc5bc02-9b52-4ec3-b03d-bc14f73fb353",1.8,0.15,"UV Spec","R","22","TCGA-25-1329-01A-01R-1565-13","5cf09ce6-44b1-4f0e-89ac-3ea302d684d8",0.15,NA,NA,NA,NA,"110f6b00-6b8a-5ac1-a8e3-9342a137c860","TCGA-25-1329_exposure","TCGA-25-1329-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:58:37.000Z","2014-03-22T03:34:02.000Z","518B6738-5946-4A91-94AE-816135A4C5A8","D7AD6239-B56B-4762-9656-7653F308E01D","Unaligned reads",15349217280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5CF09CE6-44B1-4F0E-89AC-3EA302D684D8","Canada's Michael Smith Genome Sciences Centre","564a3698e4b09c884b22e5d0","955C80BE-53DF-4565-9303-A7ABF96A2F81","Ovarian Serous Cystadenocarcinoma","TAR","A91A4D13-2A51-4378-A5EC-60359D928890","2014-03-22T03:34:02.000Z","2FC5BC02-9B52-4EC3-B03D-BC14F73FB353","None","NO",1,0.6,"Primary Tumor","Mayo Clinic - Rochester",NA,"A91A4D13-2A51-4378-A5EC-60359D928890",2.6,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.299168d0-39ac-4d64-9345-88fe0f6746ee.txt",NA,"TCGA-25-1329-01A",3,NA,"TCGA",2002,NA,NA,NA,"D7AD6239-B56B-4762-9656-7653F308E01D",76,"nationwidechildrens.org_clinical.TCGA-25-1329.xml","Dead",457,"TCGA-25-1329","NOT HISPANIC OR LATINO","F1C2BA9F-692A-4E14-A1FF-B522F182598B",NA,90,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,157,"53DB6A63-1AB7-447B-A356-6AF729DAD49A","EDA6E6EE-B84B-489C-914A-8F519C1576D3","TCGA-25-1329-01A-01R-1565-13_GRCh37-lite_mirna.bam","TCGA-25-1329-01A-01",95,0,NA,NA,25,"BOTTOM",5,NA,"TCGA-25-1329-01A-01-BS1",70,NA,NA,NA,NA,NA,NA,NA,NA,90,NA,"Dead",457,"TCGA-25-1329-F26705","TCGA-25-1329",NA,"25","1329","YES","C56.9","8441/3","C56.9",NA,NA,-28093,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",90,457,NA,NA,NA,"NO",27,3,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,76,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
205916946,198171111,14651799187,"8A125E59-3E7E-4A77-9F5C-94AAD54C95E5.bw","95e58015-a7c0-4bdc-bf64-7617d24d0784","8a125e59-3e7e-4a77-9f5c-94aad54c95e5","2016-08-25T12:23:24.747278-05:00","TCGA-24-0970-01B-01R-1565-13_rnaseq_fastq.tar","0bba3249-a438-4d77-a4cf-555d0e41d5fb",13267394560,"Illumina HiSeq","b34fdc2f3127dc39c932fa5b5a14ca1c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:21:16.261551-05:00","2016-05-03T11:40:21.647690-05:00","0bba3249-a438-4d77-a4cf-555d0e41d5fb_analysis.xml","664407a7aaafadc06d06489fc529efa0","1f15ae9e-ef83-4899-9c95-326737af2823",2210,"2016-09-29T21:37:52.682948-05:00","0bba3249-a438-4d77-a4cf-555d0e41d5fb_experiment.xml","4c37468b039dbf62d677651ecd4eed69","998c6b91-bbc0-465d-bf20-573db5013044",3916,"2016-09-29T20:44:13.956399-05:00","0bba3249-a438-4d77-a4cf-555d0e41d5fb_run.xml","80fc045bc9c3f03e7c342868d372ef8c","782387aa-5ce0-4ae5-a0fb-ddab7ebf71f5",1989,"2016-09-08T13:03:30.529265-05:00","TCGA-24-0970","2016-09-02T19:05:52.921067-05:00","female","TCGA-24-0970_demographic",1942,"white","9338f958-a412-5c8f-8b5e-944eec93124c","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-0970_diagnosis","not reported",23276,"dead","8441/3",354,354,"7d9442c7-a63d-5d58-9578-78601010e061","c56.9",-23276,"TCGA-24-0970_treatment","338e74f4-bc2c-58ab-aad9-ba361960dc59","01",NA,"TCGA-24-0970-01B","0.8","c352a6f8-dee5-473c-a1a4-d85250ac8ddf",FALSE,"50AB91D8-AEC6-46B6-95C1-8F008EE0ED8F","Primary Tumor","0.8",NA,NA,"2",1227657600,"01",115,"TCGA-24-0970-01B-01",95,95,NA,NA,0,0,0,0,"2016-09-08T13:03:30.529265-05:00","2016-09-08T13:03:30.529265-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"97d1c7d0-939c-4b4d-900a-32bde4406a8b","afff57a2-9f27-479f-bf64-47390dc616d9","TCGA-24-0970-01B-01-TS1","TCGA-24-0970-01B-01-BS1",NA,NA,"4a48e55d-fe8f-4222-b5d4-4b39d56f8a64","RNA","TCGA-24-0970-01B-01R","6ec2e7c7-59af-4082-9575-2c1ac9799015",1.8,0.16,"UV Spec","R","22","TCGA-24-0970-01B-01R-1565-13","b8ca62bf-dd6f-4984-b2c5-4d077d46d783",0.16,NA,NA,NA,NA,"291120ac-e797-564e-8f8b-45b60395efbf","TCGA-24-0970_exposure","TCGA-24-0970-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-22T04:05:57.000Z","2014-03-22T04:31:02.000Z","0BBA3249-A438-4D77-A4CF-555D0E41D5FB","C352A6F8-DEE5-473C-A1A4-D85250AC8DDF","Unaligned reads",13267394560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B8CA62BF-DD6F-4984-B2C5-4D077D46D783","Canada's Michael Smith Genome Sciences Centre","564a3fbae4b0ef12181bd362","95E58015-A7C0-4BDC-BF64-7617D24D0784","Ovarian Serous Cystadenocarcinoma","TAR","4A48E55D-FE8F-4222-B5D4-4B39D56F8A64","2014-03-22T04:31:02.000Z","6EC2E7C7-59AF-4082-9575-2C1AC9799015","None","NO",1,0.8,"Primary Tumor","Washington University",NA,"4A48E55D-FE8F-4222-B5D4-4B39D56F8A64",0.8,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.02d6074d-90c9-472f-a355-c799e2c96f4a.txt",NA,"TCGA-24-0970-01B",2,"E1F3DB9F-1BFE-4FCA-8FB6-D17D4AE824FA","TCGA",2005,NA,NA,"WITH TUMOR","C352A6F8-DEE5-473C-A1A4-D85250AC8DDF",63,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.02d6074d-90c9-472f-a355-c799e2c96f4a.txt","Dead",354,"TCGA-24-0970",NA,"CBAAEB30-6A61-4F76-B5FA-B61833E4FDF2",NA,354,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,115,"AFFF57A2-9F27-479F-BF64-47390DC616D9","F44710FA-B795-454E-8D40-C13EC5103554","TCGA-24-0970-01B-01R-1565-13_GRCh37-lite_rnaseq.bam","TCGA-24-0970-01B-01",95,0,NA,NA,0,"TOP",5,NA,"TCGA-24-0970-01B-01-TS1",NA,"Taxol","Chemotherapy","TCGA-24-0970-D25871",NA,NA,NA,"TCGA-24-0970-F25870_NTE-1",NA,354,"WITH TUMOR","Dead",354,"TCGA-24-0970-F25870","TCGA-24-0970",NA,"24","0970","YES","C56.9","8441/3","C56.9",NA,NA,-23276,"FEMALE","WHITE",NA,NA,"No","Dead",354,354,NA,NA,"WITH TUMOR","NO",9,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2005,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
170253364,165952640,12283393079,"F1AD0BF7-6094-4B0D-9FE1-F8439124269A.bw","97ad0360-3be4-401a-a94c-7f2800a1b519","f1ad0bf7-6094-4b0d-9fe1-f8439124269a","2016-08-27T02:33:54.871681-05:00","TCGA-24-2280-01A-01R-1568-13_rnaseq_fastq.tar","f562ba10-ba76-4cbe-ba91-d7460ef3b8f2",10736496640,"Illumina HiSeq","e0faa70f11afc1cc48efcb131bcefaf5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:16:36.854459-05:00","2016-05-03T11:56:42.628342-05:00","f562ba10-ba76-4cbe-ba91-d7460ef3b8f2_analysis.xml","b9e16ebc6aaf03df3b74c3fb0b93d029","8c70672b-a622-4db3-b89e-b8594bde79d9",2208,"2016-09-29T23:16:57.190706-05:00","f562ba10-ba76-4cbe-ba91-d7460ef3b8f2_experiment.xml","da6e7e979ac0ca23caf33816a94c26c8","d6d46828-2445-4739-acff-2e6a8ca3804a",3916,"2016-09-30T00:09:11.203088-05:00","f562ba10-ba76-4cbe-ba91-d7460ef3b8f2_run.xml","0d84a85c23d142117e97cbffa68440eb","f72b1775-09a0-41fd-b326-d05d931cd38c",1988,"2016-09-08T13:37:46.610280-05:00","TCGA-24-2280","2016-09-02T19:11:59.894838-05:00","female","TCGA-24-2280_demographic",1930,"white","20c0c7cf-6af3-503b-bf45-29229f4e17cb","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2280_diagnosis","not reported",27356,"alive","8441/3",NA,2143,"1d5b60d6-7bc9-56ad-8e82-0acd994fd1c7","c56.9",-27356,"TCGA-24-2280_treatment","317d070b-4f4b-58cf-a8e0-83c2f5517b93","01",NA,"TCGA-24-2280-01A","1.3","e24b153c-001b-43a3-b0d4-2b6eec615cfd",FALSE,"deb1a0d1-92a0-4c10-b491-a6a1ca5e3192","Primary Tumor","0.4",NA,NA,"1.5",1251676800,"01",133,"TCGA-24-2280-01A-01",80,75,NA,NA,0,0,10,15,"2016-09-08T13:37:46.610280-05:00","2016-09-08T13:37:46.610280-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,2,"fb1d3270-6539-4e93-b546-a1bcb1d7efe2","2dd90f1f-fe80-438f-bb4e-5d80716e6962","TCGA-24-2280-01A-01-BS1","TCGA-24-2280-01A-01-TS1",88,83,"f85cf897-47a8-4d4f-a43b-7d0fe60b0a53","RNA","TCGA-24-2280-01A-01R","4be130c9-644e-4495-becc-4da775618880",1.8,0.14,"UV Spec","R","22","TCGA-24-2280-01A-01R-1568-13","e39a23c8-1bc3-4bfb-9b1e-3075f98782fa",0.14,NA,NA,NA,NA,"85240d7f-9a44-5e8c-9668-134fbc9cee65","TCGA-24-2280_exposure","TCGA-24-2280-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T20:48:54.000Z","2014-08-27T23:17:05.000Z","F562BA10-BA76-4CBE-BA91-D7460EF3B8F2","E24B153C-001B-43A3-B0D4-2B6EEC615CFD","Unaligned reads",10736496640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E39A23C8-1BC3-4BFB-9B1E-3075F98782FA","Canada's Michael Smith Genome Sciences Centre","564a5806e4b0ef12181d123c","97AD0360-3BE4-401A-A94C-7F2800A1B519","Ovarian Serous Cystadenocarcinoma","TAR","F85CF897-47A8-4D4F-A43B-7D0FE60B0A53","2014-08-27T23:17:05.000Z","4BE130C9-644E-4495-BECC-4DA775618880","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"F85CF897-47A8-4D4F-A43B-7D0FE60B0A53",1.3,"24","4814950013_R01C01_Red.idat",NA,"TCGA-24-2280-01A",1.5,"EA7B837D-BD0D-492E-A86C-465E4BF2BE80","TCGA",2004,NA,NA,"WITH TUMOR","E24B153C-001B-43A3-B0D4-2B6EEC615CFD",74,"nationwidechildrens.org_clinical.TCGA-24-2280.xml","Alive",NA,"TCGA-24-2280",NA,"C813BB0E-AF6A-403D-A7B5-F3561CCC6326",NA,2143,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,133,"FB1D3270-6539-4E93-B546-A1BCB1D7EFE2","CA159374-9401-4959-A401-EB4D3BF3A372","4814950013_R01C01_Red.idat","TCGA-24-2280-01A-01",80,0,NA,NA,10,"BOTTOM",2,NA,"TCGA-24-2280-01A-01-BS1",88,"Avastin","Targeted Molecular therapy","TCGA-24-2280-D26568",NA,NA,NA,"TCGA-24-2280-F26561_NTE-1",NA,2143,"WITH TUMOR","Alive",NA,"TCGA-24-2280-F26561","TCGA-24-2280",NA,"24","2280","YES","C56.9","8441/3","C56.9",NA,NA,-27356,"FEMALE","WHITE",NA,NA,"No","Alive",2143,NA,NA,NA,"WITH TUMOR","NO",5,4,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,74,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
136816018,134594015,9953685007,"3F7EC434-13A6-46C4-8791-C8992192C3D6.bw","99a61986-7b23-46b5-99a4-efba6bad3766","3f7ec434-13a6-46c4-8791-c8992192c3d6","2016-08-25T19:35:10.526310-05:00","TCGA-24-2267-01A-01R-1568-13_rnaseq_fastq.tar","69caa57b-bc55-4a50-bd27-6da34f4aac7e",8236032000,"Illumina HiSeq","fa50cf75aa696c7c60c8672d8e1b298a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:38:01.482323-05:00","2016-05-03T11:56:42.628342-05:00","69caa57b-bc55-4a50-bd27-6da34f4aac7e_analysis.xml","bc57c752dc591faf4039f8bd3ecb3860","03eeec26-0d5f-4ed9-a1b7-edbe0a67cc6d",2181,"2016-08-30T00:54:07.926062-05:00","69caa57b-bc55-4a50-bd27-6da34f4aac7e_experiment.xml","6c0cd8f3dee5ec61668ae16ea6ff021b","ffec7072-2df9-4059-8f98-0e8ab1db5ba4",3916,"2016-09-29T19:01:38.391393-05:00","69caa57b-bc55-4a50-bd27-6da34f4aac7e_run.xml","0505f684b2e64e55c024074008067dda","38a065a9-7159-4f00-8f2e-8b3d8e2ccbbd",1988,"2016-09-08T13:27:15.337805-05:00","TCGA-24-2267","2016-09-02T19:11:49.089528-05:00","female","TCGA-24-2267_demographic",1935,"white","299c04b0-8890-5057-97b4-2e1177e03833","not reported",1996,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2267_diagnosis","not reported",21293,"dead","8441/3",1446,1446,"9e118376-2d24-5552-a922-a86dbf96b389","c56.9",-21293,"TCGA-24-2267_treatment","d930659d-707a-5a63-8b9a-af729088c26b","01",NA,"TCGA-24-2267-01A","1.3","00be5ec1-3b0f-4b5a-b116-4efce25d2cc8",FALSE,"24844312-f32c-4366-945e-96d9a923f82a","Primary Tumor","0.3",NA,NA,"1.5",1251331200,"01",105,"TCGA-24-2267-01A-01",90,95,NA,NA,0,0,14,4,"2016-09-08T13:27:15.337805-05:00","2016-09-08T13:27:15.337805-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"d7bddc1a-9847-4aa6-94eb-c21e45e820c0","1c03b8f4-baa7-4a37-9672-2b91f3ca0f29","TCGA-24-2267-01A-01-BS1","TCGA-24-2267-01A-01-TS1",85,95,"6f23bd0f-e94a-4307-a8ed-1fda008e14cc","RNA","TCGA-24-2267-01A-01R","6d17a41a-de77-457b-89a2-098dd75396ef",1.8,0.15,"UV Spec","R","22","TCGA-24-2267-01A-01R-1568-13","9ebb3535-6536-49fc-a88b-473235972378",0.15,NA,NA,NA,NA,"1c4c8584-8bbc-50ec-aa0f-5e16aaddfc8e","TCGA-24-2267_exposure","TCGA-24-2267-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T17:14:36.000Z","2014-08-28T18:23:25.000Z","69CAA57B-BC55-4A50-BD27-6DA34F4AAC7E","00BE5EC1-3B0F-4B5A-B116-4EFCE25D2CC8","Unaligned reads",8236032000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9EBB3535-6536-49FC-A88B-473235972378","Canada's Michael Smith Genome Sciences Centre","564a5a1ce4b09c884b274f54","99A61986-7B23-46B5-99A4-EFBA6BAD3766","Ovarian Serous Cystadenocarcinoma","TAR","6F23BD0F-E94A-4307-A8ED-1FDA008E14CC","2014-08-28T18:23:25.000Z","6D17A41A-DE77-457B-89A2-098DD75396EF","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"6F23BD0F-E94A-4307-A8ED-1FDA008E14CC",1.3,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.25f1b635-6318-41d5-a0c8-37e8d263dddd.txt",NA,"TCGA-24-2267-01A",1.5,"EE87030E-AB29-41CC-AB1F-578C59409E73","TCGA",1993,NA,NA,"WITH TUMOR","00BE5EC1-3B0F-4B5A-B116-4EFCE25D2CC8",58,"nationwidechildrens.org_clinical.TCGA-24-2267.xml","Dead",1446,"TCGA-24-2267",NA,"A78CF572-E891-4896-A60B-698428CC5672",NA,1446,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,105,"D7BDDC1A-9847-4AA6-94EB-C21E45E820C0","DEB0A58B-2A3C-41D8-B2C4-22C5C9D62E07","TCGA-24-2267-01A-01R-1568-13_rnaseq_fastq.tar","TCGA-24-2267-01A-01",90,0,NA,NA,14,"BOTTOM",1,NA,"TCGA-24-2267-01A-01-BS1",85,"Cisplatin #2-7","Chemotherapy","TCGA-24-2267-D26554",NA,NA,NA,"TCGA-24-2267-F26544_NTE-2",NA,1446,"WITH TUMOR","Dead",1446,"TCGA-24-2267-F26544","TCGA-24-2267",NA,"24","2267","YES","C56.9","8441/3","C56.9",NA,NA,-21293,"FEMALE","WHITE",NA,NA,"No","Dead",1446,1446,NA,NA,"WITH TUMOR","NO",16,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,1993,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
248016270,238186075,17606464204,"65D42DF3-62D8-4B1E-B6EB-A0FEEA01FD70.bw","9a30dee8-962a-49db-a85a-c39515c91b68","65d42df3-62d8-4b1e-b6eb-a0feea01fd70","2016-08-20T17:22:06.123224-05:00","TCGA-24-0979-01A-01R-1565-13_rnaseq_fastq.tar","2ade21d2-108a-46eb-a9a9-f3498ee1778b",16833495040,"Illumina HiSeq","b42bccfa7f93aafbc7a0a8e4f6bc2033","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:27:48.563377-05:00","2016-05-03T11:40:21.648680-05:00","2ade21d2-108a-46eb-a9a9-f3498ee1778b_analysis.xml","2d8d30015740d50a8a1b76a010ed2a7f","6e1416e4-5a98-4e03-a8a5-a46f335639d7",2208,"2016-08-29T08:33:09.053911-05:00","2ade21d2-108a-46eb-a9a9-f3498ee1778b_experiment.xml","77c4c7ee76e23b96cb85817b1b86d1d5","85cd0aca-2b0b-4f72-a625-900ae0ded2b9",3916,"2016-09-30T00:11:57.824913-05:00","2ade21d2-108a-46eb-a9a9-f3498ee1778b_run.xml","10b9e03e1d39e9b30a15a9b4f76cca01","f8eb55ce-8e22-4ea7-9e0e-509d327353cd",1988,"2016-09-08T13:09:22.249465-05:00","TCGA-24-0979","2016-09-02T19:06:00.457421-05:00","female","TCGA-24-0979_demographic",1950,"white","267cae75-6ddd-5309-979e-1fa1196aa5e1","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-0979_diagnosis","not reported",19595,"dead","8441/3",1264,1264,"600bf167-5408-5802-8f4b-f20f53e15337","c56.9",-19595,"TCGA-24-0979_treatment","a25fada3-32e0-5ee1-99b3-944dedf07040","01",NA,"TCGA-24-0979-01A","0.6","9b072344-31cf-471a-af4f-23ae73a98c93",FALSE,"3385E5B4-EBD4-4317-8805-EE6EA47A2E4A","Primary Tumor","0.5",NA,NA,"0.8",1233705600,"01",99,"TCGA-24-0979-01A-01",85,85,NA,NA,0,0,25,25,"2016-09-08T13:09:22.249465-05:00","2016-09-08T13:09:22.249465-05:00",50,NA,NA,NA,"BOTTOM","TOP",5,0,"32ea68ae-904f-4d69-a8ff-5a59e2a65ccd","0dda30a8-16ff-4e27-b1be-bc9327e052c0","TCGA-24-0979-01A-01-BS1","TCGA-24-0979-01A-01-TS1",70,75,"51bea6f7-1023-4a6b-a8f7-96d006b242dc","RNA","TCGA-24-0979-01A-01R","1aaa29cd-d6b5-4fa5-a39f-39c5c45d8ae3",1.8,0.15,"UV Spec","R","22","TCGA-24-0979-01A-01R-1565-13","639429a9-c1d3-410d-828a-c3b44d648609",0.15,NA,NA,NA,NA,"1ef31439-c19a-5113-88c6-6988b3cfbbea","TCGA-24-0979_exposure","TCGA-24-0979-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T21:23:39.000Z","2014-03-21T22:00:02.000Z","2ADE21D2-108A-46EB-A9A9-F3498EE1778B","9B072344-31CF-471A-AF4F-23AE73A98C93","Unaligned reads",16833495040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","639429A9-C1D3-410D-828A-C3B44D648609","Canada's Michael Smith Genome Sciences Centre","564a38e9e4b0ef121819a492","9A30DEE8-962A-49DB-A85A-C39515C91B68","Ovarian Serous Cystadenocarcinoma","TAR","51BEA6F7-1023-4A6B-A8F7-96D006B242DC","2014-03-21T22:00:02.000Z","1AAA29CD-D6B5-4FA5-A39F-39C5C45D8AE3","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"51BEA6F7-1023-4A6B-A8F7-96D006B242DC",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1c5c8013-17c7-4be1-888c-ab0da1e3afdd.txt",NA,"TCGA-24-0979-01A",0.8,"95FA449A-D622-4C36-A4D4-FE256899666F","TCGA",2003,NA,NA,"WITH TUMOR","9B072344-31CF-471A-AF4F-23AE73A98C93",53,"4564639418_R01C01_Grn.idat","Dead",1264,"TCGA-24-0979",NA,"EBE9F336-2883-4474-A721-CB68273F0C20",NA,1264,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,"FAED94C3-B6AF-485D-BE70-907D82F81D1E","WHITE",NA,1,99,"0DDA30A8-16FF-4E27-B1BE-BC9327E052C0","FE335308-BC51-421F-90E9-96806855EEBF","TCGA-24-0979-01A-01R-1565-13_rnaseq.bam","TCGA-24-0979-01A-01",85,0,NA,NA,25,"TOP",0,NA,"TCGA-24-0979-01A-01-TS1",75,"Carboplatin","Chemotherapy","TCGA-24-0979-D25892","TCGA-24-0979-R25894","EXTERNAL BEAM","Distant Recurrence","TCGA-24-0979-F25891_NTE-1",NA,1264,"WITH TUMOR","Dead",1264,"TCGA-24-0979-F25891","TCGA-24-0979",NA,"24","0979","YES","C56.9","8441/3","C56.9",NA,NA,-19595,"FEMALE","WHITE",NA,NA,"No","Dead",1264,1264,NA,NA,"WITH TUMOR","NO",11,5,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2003,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
123896200,120570328,8921224592,"7A42FA71-7FD7-47B6-842B-0BEF0ECD7FB5.bw","9af2248a-d86a-4277-93b4-8eba5a39bd3c","7a42fa71-7fd7-47b6-842b-0bef0ecd7fb5","2016-09-29T20:47:40.841316-05:00","TCGA-24-2254-01A-01R-1568-13_rnaseq_fastq.tar","dd0d8b7b-3f1d-483f-a7c4-b9a78c30ecef",7924469760,"Illumina HiSeq","b2934c57a0d650791638c27ea5098334","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:20:10.038482-05:00","2016-05-03T11:56:42.628809-05:00","dd0d8b7b-3f1d-483f-a7c4-b9a78c30ecef_analysis.xml","223630dc7f378106745b7121059c0faa","b399cede-5086-4778-8f3d-dc65006f003c",2181,"2016-09-29T23:50:00.953143-05:00","dd0d8b7b-3f1d-483f-a7c4-b9a78c30ecef_experiment.xml","efc855ad15864a7cf3a453fc1154a8d5","eb76e1e1-5733-430c-acd0-5392a8a60f7c",3916,"2016-09-29T19:11:55.147368-05:00","dd0d8b7b-3f1d-483f-a7c4-b9a78c30ecef_run.xml","4dd55fe47fd39b482e9f5f08a7027c26","3f2e5594-002b-478b-b26f-0211ffb871f9",1988,"2016-09-08T12:14:23.726557-05:00","TCGA-24-2254","2016-09-02T18:56:14.990422-05:00","female","TCGA-24-2254_demographic",1937,"white","430d063a-f24e-5702-a4b9-2a5bef151ce1","not reported",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2254_diagnosis","not reported",24407,"dead","8441/3",1736,1736,"a00f2045-a1f8-5198-8f98-26c7090ec6c5","c56.9",-24407,"TCGA-24-2254_treatment","4c61d397-260b-583f-bb65-98f9b8feb433","01",NA,"TCGA-24-2254-01A","1","c2699551-32d9-46ad-9c41-04730ef6a8a4",FALSE,"3788629f-17da-4075-af61-cf124bdfb48e","Primary Tumor","0.4",NA,NA,"1",1250812800,"01",150,"TCGA-24-2254-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:14:23.726557-05:00","2016-09-08T12:14:23.726557-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"de52a9bb-d52a-465e-860a-4fdfacb8f9e2","8693850b-af0f-47b9-8113-44ab1cde89cb","TCGA-24-2254-01A-01-TS1","TCGA-24-2254-01A-01-BS1",90,90,"3c0b4ee7-ae8a-4e2c-baf2-9c1142bfcd7e","RNA","TCGA-24-2254-01A-01R","eaf3a99b-20ec-444c-8beb-53408023e340",1.8,0.16,"UV Spec","R","22","TCGA-24-2254-01A-01R-1568-13","e496319b-df71-44a0-bfa6-90f50ae54654",0.16,NA,NA,NA,NA,"cfe838d2-1295-567f-abcb-9a137bf760bc","TCGA-24-2254_exposure","TCGA-24-2254-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T16:28:32.000Z","2014-08-26T17:51:15.000Z","DD0D8B7B-3F1D-483F-A7C4-B9A78C30ECEF","C2699551-32D9-46AD-9C41-04730EF6A8A4","Unaligned reads",7924469760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E496319B-DF71-44A0-BFA6-90F50AE54654","Canada's Michael Smith Genome Sciences Centre","564a3f7ce4b093830b6a930a","9AF2248A-D86A-4277-93B4-8EBA5A39BD3C","Ovarian Serous Cystadenocarcinoma","TAR","3C0B4EE7-AE8A-4E2C-BAF2-9C1142BFCD7E","2014-08-26T17:51:15.000Z","EAF3A99B-20EC-444C-8BEB-53408023E340","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"3C0B4EE7-AE8A-4E2C-BAF2-9C1142BFCD7E",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9525da91-59ae-487e-b9cb-925f263dfcb6.txt",NA,"TCGA-24-2254-01A",1,"F2497656-B837-4017-8AB0-97D93059374A","TCGA",2003,NA,NA,"WITH TUMOR","C2699551-32D9-46AD-9C41-04730EF6A8A4",66,"TCGA-24-2254-01A-01R-1568-13_rnaseq_fastq.tar","Dead",1736,"TCGA-24-2254",NA,"096DA4D1-B2B5-4325-B786-ED88B37BA349",NA,1736,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,150,"DE52A9BB-D52A-465E-860A-4FDFACB8F9E2","EAF3A99B-20EC-444C-8BEB-53408023E340","jhu-usc.edu_OV.HumanMethylation27.11.lvl-3.TCGA-24-2254-01A-01D-0667-05.txt","TCGA-24-2254-01A-01",90,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-24-2254-01A-01-BS1",90,"Taxotere","Chemotherapy","TCGA-24-2254-D26527",NA,NA,NA,"TCGA-24-2254-F26523_NTE-1",NA,1736,"WITH TUMOR","Dead",1736,"TCGA-24-2254-F26523","TCGA-24-2254",NA,"24","2254","YES","C56.9","8441/3","C56.9",NA,NA,-24407,"FEMALE","WHITE",NA,NA,"No","Dead",1736,1736,NA,NA,"WITH TUMOR","NO",19,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
225999984,206649608,15163330592,"57F784E9-1827-476B-9AA6-524E842641EA.bw","9bbc01b4-056c-4ddc-aca4-ff20718646d0","57f784e9-1827-476b-9aa6-524e842641ea","2016-08-20T10:29:29.586863-05:00","TCGA-09-0367-01A-01R-1564-13_rnaseq_fastq.tar","ad7693e5-06cf-4f4a-9959-ff2b6e418de1",14755624960,"Illumina HiSeq","9dab07e681e76f034db9eba3d7c35dca","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:30:12.940659-05:00","2016-05-03T11:27:59.332723-05:00","ad7693e5-06cf-4f4a-9959-ff2b6e418de1_analysis.xml","fb9c175747c9bb5e061d4fa035db94c1","4abe1537-f30b-4129-9ce1-ac6de4b35db9",2183,"2016-09-29T21:56:59.844440-05:00","ad7693e5-06cf-4f4a-9959-ff2b6e418de1_experiment.xml","9e142e702de71a802437889e7617f3ef","a57b297d-b963-437b-a588-c70040ed04bf",3916,"2016-09-29T21:48:53.554568-05:00","ad7693e5-06cf-4f4a-9959-ff2b6e418de1_run.xml","7891f4367adb15b578abaf5fc010d0f7","a059dd6c-4d68-4662-a911-f8f7de6540c7",1990,"2016-09-08T13:41:14.404127-05:00","TCGA-09-0367","2016-09-02T19:09:40.894473-05:00","female","TCGA-09-0367_demographic",1934,"native hawaiian or other pacific islander","51e8191f-bc19-5752-94b7-b3a4ea24578f","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-0367_diagnosis","not reported",24473,"dead","8441/3",547,NA,"3b0fadff-1eaa-5a35-9045-24288b57a3dd","c56.9",-24473,"TCGA-09-0367_treatment","468cac62-c860-5e8f-b4b0-f22c7544080f","01",NA,"TCGA-09-0367-01A",NA,"593a4322-bd6f-49d3-9fc6-0f56a1943664",FALSE,"8a24fe8a-9f7f-4fbf-86c7-704427ccaf89","Primary Tumor",NA,NA,NA,NA,1233705600,"01",NA,"TCGA-09-0367-01A-01",98,95,NA,NA,0,1,5,9,"2016-09-08T13:41:14.404127-05:00","2016-09-08T13:41:14.404127-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"03399067-8b76-4a57-aa39-ba0a642ebe2c","e8d46b30-6655-4c5b-9354-0a193e9467b9","TCGA-09-0367-01A-01-BS1","TCGA-09-0367-01A-01-TS1",95,90,"84fe89e2-4072-495e-b2f7-f57781dc463b","RNA","TCGA-09-0367-01A-01R","8afdc136-3f03-43f4-8ddc-b80c3afa15bc",1.8,0.18,"UV Spec","R","22","TCGA-09-0367-01A-01R-1564-13","047e04aa-6a91-4535-b279-50430098e638",0.18,NA,NA,NA,NA,"09d31723-23ee-572b-8bb5-b687b29c524c","TCGA-09-0367_exposure","TCGA-09-0367-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T21:43:51.000Z","2013-12-20T22:11:01.000Z","AD7693E5-06CF-4F4A-9959-FF2B6E418DE1","593A4322-BD6F-49D3-9FC6-0F56A1943664","Unaligned reads",14755624960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","047E04AA-6A91-4535-B279-50430098E638","Canada's Michael Smith Genome Sciences Centre","564a5b01e4b09c884b278e4c","9BBC01B4-056C-4DDC-ACA4-FF20718646D0","Ovarian Serous Cystadenocarcinoma","TAR","84FE89E2-4072-495E-B2F7-F57781DC463B","2013-12-20T22:11:01.000Z","8AFDC136-3F03-43F4-8DDC-B80C3AFA15BC","None","NO",1,NA,"Primary Tumor","UCSF",NA,"84FE89E2-4072-495E-B2F7-F57781DC463B",NA,"09","C239.TCGA-09-0367-01A-01W.7.bam",NA,"TCGA-09-0367-01A",NA,"C830352B-AC14-400E-A5E8-24D933B324CE","TCGA",2001,NA,NA,"WITH TUMOR","593A4322-BD6F-49D3-9FC6-0F56A1943664",67,"nationwidechildrens.org_clinical.TCGA-09-0367.xml","Dead",547,"TCGA-09-0367","NOT HISPANIC OR LATINO","76060E1E-8FF9-4936-8B9A-5DD98FFB89B3",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,1,NA,"E8D46B30-6655-4C5B-9354-0A193E9467B9","D7EECB91-89B9-4C3F-AA63-1551F22E1619","C239.TCGA-09-0367-01A-01W.7.bam","TCGA-09-0367-01A-01",95,1,NA,NA,9,"TOP",0,NA,"TCGA-09-0367-01A-01-TS1",90,"taxol","Chemotherapy","TCGA-09-0367-D24214",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",547,"TCGA-09-0367-F24212","TCGA-09-0367",NA,"09","0367","YES","C56.9","8441/3","C56.9",NA,NA,-24473,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,547,NA,NA,"WITH TUMOR","NO",4,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
150610688,145317246,10682949087,"5E79792E-CE89-4ECF-BD4E-B12877E63949.bw","9bf16a89-2fc7-4c08-93bc-3105eec5c3cc","5e79792e-ce89-4ecf-bd4e-b12877e63949","2016-08-20T13:14:18.661968-05:00","TCGA-20-1687-01A-01R-1566-13_rnaseq_fastq.tar","99a0bdb2-3dac-4599-a9f7-7861767a3ae4",9175070720,"Illumina HiSeq","b809490d3b5c845c0c39d7e7034da260","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:53:16.525630-05:00","2016-05-03T11:40:21.662944-05:00","99a0bdb2-3dac-4599-a9f7-7861767a3ae4_analysis.xml","6f52d039d5f19485dded1426206d0fb4","ed885d92-b6ee-46af-888a-6a97be50c6b8",2181,"2016-08-28T17:45:10.869166-05:00","99a0bdb2-3dac-4599-a9f7-7861767a3ae4_experiment.xml","5b59e2b7127a3762dee775708f8e71c6","a292d998-a050-40df-a3aa-ab57587065b1",3916,"2016-09-29T20:02:53.471380-05:00","99a0bdb2-3dac-4599-a9f7-7861767a3ae4_run.xml","1d690c0b9e1bfdd7bc351569c912cd14","5ee07e8e-123e-4547-b090-1ccebfb455f1",1988,"2016-09-08T13:25:46.485957-05:00","TCGA-20-1687","2016-09-02T19:07:26.871209-05:00","female","TCGA-20-1687_demographic",1962,"white","c5058873-7e86-55ab-83ec-68f37f816ab9","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-1687_diagnosis","not reported",16961,"alive","8441/3",NA,81,"9729bb87-a1cc-5e8d-9e77-b68ef5b45a33","c56.9",-16961,"TCGA-20-1687_treatment","d9afbb9d-5ca7-5a29-80ac-efbbff19f83b","01",NA,"TCGA-20-1687-01A","0.8","bcd16bf3-0877-4e4b-b70b-7d6a497af7ac",FALSE,"e966d90f-0e5f-42e6-b487-1f10fbef204f","Primary Tumor","0.5",NA,NA,"1.8",1242604800,"01",110,"TCGA-20-1687-01A-01",85,90,NA,NA,0,0,35,15,"2016-09-08T13:25:46.485957-05:00","2016-09-08T13:25:46.485957-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"5f56bb43-6913-4695-a791-568daa718090","1dd87cf9-da7f-4f8c-a47b-ae0a1905c2e1","TCGA-20-1687-01A-01-TS1","TCGA-20-1687-01A-01-BS1",65,85,"45746f80-6ac4-454f-a751-8bda6df6f046","RNA","TCGA-20-1687-01A-01R","d8414027-a74e-4679-91fb-4d713842264c",1.8,0.17,"UV Spec","R","22","TCGA-20-1687-01A-01R-1566-13","ad7529aa-47f7-4207-b0a9-8684ff1e6e80",0.17,NA,NA,NA,NA,"8b6855f9-9319-57fb-9d93-d857d9a94fc1","TCGA-20-1687_exposure","TCGA-20-1687-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T02:23:46.000Z","2014-03-25T02:45:01.000Z","99A0BDB2-3DAC-4599-A9F7-7861767A3AE4","BCD16BF3-0877-4E4B-B70B-7D6A497AF7AC","Unaligned reads",9175070720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AD7529AA-47F7-4207-B0A9-8684FF1E6E80","Canada's Michael Smith Genome Sciences Centre","564a59a1e4b0ef12181d9b20","9BF16A89-2FC7-4C08-93BC-3105EEC5C3CC","Ovarian Serous Cystadenocarcinoma","TAR","45746F80-6AC4-454F-A751-8BDA6DF6F046","2014-03-25T02:45:01.000Z","D8414027-A74E-4679-91FB-4D713842264C","None","NO",1,0.5,"Primary Tumor","Fox Chase Cancer Center",NA,"45746F80-6AC4-454F-A751-8BDA6DF6F046",0.8,"20","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a3332b9e-1a9c-4a7e-81c0-e19de968609b.txt",NA,"TCGA-20-1687-01A",1.8,"C94C5C61-AAA1-4029-BCB9-34B31EBC25D2","TCGA",2008,NA,NA,"TUMOR FREE","D84E02F6-B7F2-4B21-94E0-11C4E2998E32",46,"MSK_252152915135_S01_CGH-v4_10_27Aug08.txt","Alive",NA,"TCGA-20-1687","NOT HISPANIC OR LATINO","F16936BD-4107-4E50-BCD0-DA8F76BA03EB",NA,81,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,110,"5F56BB43-6913-4695-A791-568DAA718090","E9B79724-CA81-4AD9-8335-82DF8E4E3D40","TCGA-20-1687-01A-01R-1566-13_rnaseq.bam","TCGA-20-1687-01A-01",85,0,NA,NA,35,"TOP",0,NA,"TCGA-20-1687-01A-01-TS1",65,"Taxol","Chemotherapy","TCGA-20-1687-D25564",NA,NA,NA,NA,NA,81,"TUMOR FREE","Alive",NA,"TCGA-20-1687-F25563","TCGA-20-1687",NA,"20","1687","YES","C56.9","8441/3","C56.9",NA,NA,-16961,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",81,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,46,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
432954454,413943178,30442956032,"E9DB46D8-5CE4-472C-8F21-9180F2D4C880.bw","9c744ff8-1cde-4176-b6d7-0ab62bf42620","e9db46d8-5ce4-472c-8f21-9180f2d4c880","2016-08-27T00:41:20.785714-05:00","TCGA-24-1428-01A-01R-1564-13_rnaseq_fastq.tar","29a8a6ec-0541-40c8-a6d3-4c8eec54b054",28308183040,"Illumina HiSeq","b691c793698d26071b758f405af9b918","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:17:41.591150-05:00","2016-05-03T11:27:59.332723-05:00","29a8a6ec-0541-40c8-a6d3-4c8eec54b054_analysis.xml","f5b2b42ef12a2da0377d458acdcd1a16","b22fa9ed-2cf3-41d6-9457-e6a8096da133",2183,"2016-09-29T18:12:04.275082-05:00","29a8a6ec-0541-40c8-a6d3-4c8eec54b054_experiment.xml","be68820c07d7d67b70569dc43c1a621b","1989862d-ea7e-40df-bd26-4326386c391a",3916,"2016-09-30T00:10:45.965774-05:00","29a8a6ec-0541-40c8-a6d3-4c8eec54b054_run.xml","4fd649bb6afacf28daa341b47d350d4c","f8296282-7775-4e48-a2c5-c41e6990acaa",1990,"2016-09-08T13:19:21.653536-05:00","TCGA-24-1428","2016-09-02T19:13:42.516031-05:00","female","TCGA-24-1428_demographic",1958,"white","cc02ff8d-6eff-5479-acd0-8b3230bcfafa","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1428_diagnosis","not reported",18306,"alive","8441/3",NA,529,"f6f658e1-75aa-52b0-ae5b-eec6c0b88964","c56.9",-18306,"TCGA-24-1428_treatment","999d1991-c579-5d87-bcc1-95332145d16c","01",NA,"TCGA-24-1428-01A","1.2","b0dfa5b0-79fc-4f28-bca7-d47f54c05775",FALSE,"9fcdd584-25e6-4a5a-ae15-f2956de32822","Primary Tumor","0.5",NA,NA,"1.5",1232409600,"01",103,"TCGA-24-1428-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:19:21.653536-05:00","2016-09-08T13:19:21.653536-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,5,"092eb401-0310-4619-8f06-8fd5b46560bc","cc2baf2f-05d9-4e2a-9dbc-35a2729b00b8","TCGA-24-1428-01A-01-TS1","TCGA-24-1428-01A-01-BS1",89,85,"a7db9467-696c-4516-b788-e243109fdb47","RNA","TCGA-24-1428-01A-01R","34885715-dcac-4ce9-bf28-88177799708b",1.8,0.17,"UV Spec","R","22","TCGA-24-1428-01A-01R-1564-13","30b9b778-1422-4842-ae99-658b8b1d7605",0.17,NA,NA,NA,NA,"0d00342f-c967-5235-af3b-34692e251679","TCGA-24-1428_exposure","TCGA-24-1428-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T22:07:29.000Z","2013-12-20T22:48:01.000Z","29A8A6EC-0541-40C8-A6D3-4C8EEC54B054","B0DFA5B0-79FC-4F28-BCA7-D47F54C05775","Unaligned reads",28308183040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","30B9B778-1422-4842-AE99-658B8B1D7605","Canada's Michael Smith Genome Sciences Centre","564a3f95e4b0ef12181bc849","9C744FF8-1CDE-4176-B6D7-0AB62BF42620","Ovarian Serous Cystadenocarcinoma","TAR","A7DB9467-696C-4516-B788-E243109FDB47","2013-12-20T22:48:01.000Z","34885715-DCAC-4CE9-BF28-88177799708B","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"A7DB9467-696C-4516-B788-E243109FDB47",1.2,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.66bafc53-dafe-493e-8ede-22866b714a76.txt",NA,"TCGA-24-1428-01A",1.5,"D43E79BE-C0CC-4F9B-9631-FBAEBE20DE3A","TCGA",2008,NA,NA,"WITH TUMOR","B0DFA5B0-79FC-4F28-BCA7-D47F54C05775",50,"nationwidechildrens.org_clinical.TCGA-24-1428.xml","Alive",NA,"TCGA-24-1428",NA,"51F0A185-1A9F-486D-AE86-8816F919F682",NA,529,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,103,"CC2BAF2F-05D9-4E2A-9DBC-35A2729B00B8","F18A76EF-9E0B-4FAD-980F-584E726360CE","TCGA-24-1428-01A-01W-0549-09_capture.bam","TCGA-24-1428-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-24-1428-01A-01-TS1",89,"Docetaxel","Chemotherapy","TCGA-24-1428-D25961",NA,NA,NA,"TCGA-24-1428-F25960_NTE-1",NA,529,"WITH TUMOR","Alive",NA,"TCGA-24-1428-F25960","TCGA-24-1428",NA,"24","1428","YES","C56.9","8441/3","C56.9",NA,NA,-18306,"FEMALE","WHITE",NA,NA,"No","Alive",529,NA,NA,NA,"WITH TUMOR","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,50,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
293108416,278217621,20472987316,"7C712EF3-7368-4D97-BB9A-717CF8522C7F.bw","9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d","7c712ef3-7368-4d97-bb9a-717cf8522c7f","2016-08-25T20:50:09.607339-05:00","TCGA-09-1665-01B-01R-1566-13_rnaseq_fastq.tar","5b83fe00-bc97-47e4-b270-af7300b9b159",19194542080,"Illumina HiSeq","8f5ee6fc6c47100e95f7a12add43b672","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:52:51.104048-05:00","2016-05-03T11:41:05.750744-05:00","5b83fe00-bc97-47e4-b270-af7300b9b159_analysis.xml","ab7daa091ef7d154911e0754fe42a342","58c56839-2dfb-4ad8-8596-233ed65095a8",2208,"2016-09-29T23:17:23.754847-05:00","5b83fe00-bc97-47e4-b270-af7300b9b159_experiment.xml","aac412ac9c2f7544c8dba8646da32f12","d7147f5d-f63f-4bad-8809-8c12d004750a",3916,"2016-09-29T20:06:43.859840-05:00","5b83fe00-bc97-47e4-b270-af7300b9b159_run.xml","c1e0b4103f1519d7b43a19df74e2641d","612ea0cb-de41-4200-923c-525e9785cf70",1988,"2016-09-08T10:31:55.486217-05:00","TCGA-09-1665","2016-09-02T18:47:37.440898-05:00","female","TCGA-09-1665_demographic",1929,"white","4b2e1ed3-d88a-581c-a432-bcfc88178a7a","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1665_diagnosis","not reported",27010,"dead","8441/3",1266,NA,"36ea240f-5e4c-59a4-858e-ff2127a15b98","c56.9",-27010,"TCGA-09-1665_treatment","259ed336-fe51-5bcd-8647-917135d01f8f","01",NA,"TCGA-09-1665-01B","0.6","d66fb62f-8483-459c-999e-d5b64b835e11",FALSE,"0e311879-9b25-453d-b41a-7cc3048bb05e","Primary Tumor","0.6",NA,NA,"1.5",1240185600,"01",105,"TCGA-09-1665-01B-01",90,90,NA,NA,25,10,5,0,"2016-09-08T10:31:55.486217-05:00","2016-09-08T10:31:55.486217-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,5,"5a6cb79c-8270-4d29-89f5-ccf0a2192634","34964afd-a82c-411c-9e7e-c3cffa29f204","TCGA-09-1665-01B-01-BS1","TCGA-09-1665-01B-01-TS1",68,85,"713fda59-e947-4dd7-aa2c-71f58b085342","RNA","TCGA-09-1665-01B-01R","c2c10b2c-7ae8-47af-b988-4f8dfb76b6bb",1.8,0.16,"UV Spec","R","22","TCGA-09-1665-01B-01R-1566-13","c06f72e0-e59f-4cbb-8233-1eb6637ea23f",0.16,NA,NA,NA,NA,"0652f2fe-f64a-5f13-9f13-9fb18d5940ac","TCGA-09-1665_exposure","TCGA-09-1665-01B-01R-1566-13_rnaseq_fastq.tar","2014-03-28T15:54:24.000Z","2014-03-28T16:34:02.000Z","5B83FE00-BC97-47E4-B270-AF7300B9B159","D66FB62F-8483-459C-999E-D5B64B835E11","Unaligned reads",19194542080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C06F72E0-E59F-4CBB-8233-1EB6637EA23F","Canada's Michael Smith Genome Sciences Centre","564a3dc3e4b0298dd2c92a34","9D25CD0E-0A3E-4EE0-B1A3-58FFAB348C9D","Ovarian Serous Cystadenocarcinoma","TAR","713FDA59-E947-4DD7-AA2C-71F58B085342","2014-03-28T16:34:02.000Z","C2C10B2C-7AE8-47AF-B988-4F8DFB76B6BB","None","NO",1,0.6,"Primary Tumor","UCSF",NA,"713FDA59-E947-4DD7-AA2C-71F58B085342",0.6,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a565c52a-a226-47db-b68c-d579055e4c06.txt",NA,"TCGA-09-1665-01B",1.5,"B1ED85A0-EAC9-4666-AB39-010C1399D205","TCGA",2002,NA,NA,"WITH TUMOR","F6236A49-C8A5-4E48-8C9B-5A6C2230F208",73,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a565c52a-a226-47db-b68c-d579055e4c06.txt","Dead",1266,"TCGA-09-1665","NOT HISPANIC OR LATINO","85D0D258-5285-40E6-BFD7-45C246449C8E",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,"C227E9CC-5A7D-45A2-A868-101AE1EF3AAB","WHITE",NA,1,105,"5A6CB79C-8270-4D29-89F5-CCF0A2192634","C2C10B2C-7AE8-47AF-B988-4F8DFB76B6BB","TCGA-09-1665-01B-01R-1566-13_mirna.bam","TCGA-09-1665-01B-01",90,25,NA,NA,5,"BOTTOM",2,NA,"TCGA-09-1665-01B-01-BS1",68,"Carboplatin","Chemotherapy","TCGA-09-1665-D24274","TCGA-09-1665-R24277",NA,"Distant Recurrence","TCGA-09-1665-F24272_NTE-1",NA,NA,"WITH TUMOR","Dead",1266,"TCGA-09-1665-F24272","TCGA-09-1665",NA,"09","1665","YES","C56.9","8441/3","C56.9",NA,NA,-27010,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1266,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,73,2002,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
332310492,323455522,23895557441,"30312D82-4966-4EAA-A067-F91852FA8663.bw","9e18238f-ae85-4b75-ae87-d92da9731a40","30312d82-4966-4eaa-a067-f91852fa8663","2016-08-25T12:59:58.914260-05:00","TCGA-23-1023-01R-01R-1564-13_rnaseq_fastq.tar","577dc731-2b0e-498d-91ee-ee27c245c2c2",20999761920,"Illumina HiSeq","939491e0e7f72d9d09da6b6f36e1376d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:52:14.649878-05:00","2016-05-03T11:39:34.522989-05:00","577dc731-2b0e-498d-91ee-ee27c245c2c2_analysis.xml","5d059e5d6bcb8292e4a5476791ffd9e6","c79920d1-d812-44ea-9bda-d3a95be644a8",2183,"2016-08-13T11:27:52.666020-05:00","577dc731-2b0e-498d-91ee-ee27c245c2c2_experiment.xml","45db01e8df31368c31fd78b8ce468409","c4bba1cb-3ed4-445b-bb1f-9aab864dbfa3",3916,"2016-09-29T21:27:36.151728-05:00","577dc731-2b0e-498d-91ee-ee27c245c2c2_run.xml","4dc7043a748de8825f5241044835b499","9348b330-ef4c-44df-ad1d-d7dbbb4f0d90",1990,"2016-09-08T12:56:36.173388-05:00","TCGA-23-1023","2016-09-02T19:05:56.920217-05:00","female","TCGA-23-1023_demographic",1940,"white","5401c2e3-25c5-547a-a9df-fce704e3b3f4","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1023_diagnosis","not reported",23826,"alive","8441/3",NA,1233,"e6fb200e-161a-5533-9fea-45b491af50d2","c56.9",-23826,"TCGA-23-1023_treatment","df39fb19-a55b-5390-b5b6-15c45b5892f4","02",NA,"TCGA-23-1023-01R","0.6","8a53cd24-5041-418b-811b-33b72c165798",FALSE,"98EBC356-C54E-4C1E-9726-BA61397DDA38","Recurrent Tumor","0.3",NA,NA,"1",1244678400,"01",92,"TCGA-23-1023-01R-01",95,95,NA,NA,0,0,5,5,"2016-09-08T12:56:36.173388-05:00","2016-09-08T12:56:36.173388-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"2035b54d-e8ba-4435-92f1-62633ffdf99a","3d1eee4c-c054-420c-bf05-2cf25dc53305","TCGA-23-1023-01R-01-TS1","TCGA-23-1023-01R-01-BS1",94,94,"2e0f394b-40b5-45b4-bf09-1015d514587a","RNA","TCGA-23-1023-01R-01R","581d3d18-aa7e-4d57-984e-808b334d0301",1.8,0.16,"UV Spec","R","22","TCGA-23-1023-01R-01R-1564-13","1c88dde8-4fe6-49e9-8d76-40668ed783ff",0.16,NA,NA,NA,NA,"903c184b-df15-5a62-a9b6-db964a4c935c","TCGA-23-1023_exposure","TCGA-23-1023-01R-01R-1564-13_rnaseq_fastq.tar","2014-03-19T07:10:42.000Z","2014-03-19T07:45:01.000Z","577DC731-2B0E-498D-91EE-EE27C245C2C2","8A53CD24-5041-418B-811B-33B72C165798","Unaligned reads",20999761920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1C88DDE8-4FE6-49E9-8D76-40668ED783FF","Canada's Michael Smith Genome Sciences Centre","564a358ce4b09c884b22931d","9E18238F-AE85-4B75-AE87-D92DA9731A40","Ovarian Serous Cystadenocarcinoma","TAR","2E0F394B-40B5-45B4-BF09-1015D514587A","2014-03-19T07:45:01.000Z","581D3D18-AA7E-4D57-984E-808B334D0301","None","NO",2,0.3,"Recurrent Tumor","Cedars Sinai",NA,"2E0F394B-40B5-45B4-BF09-1015D514587A",0.6,"23","TARRE_p_MultiPlate_TCGA_SS_MA_Ref_HT_HG-U133A_96-HTA_A06_586078.level3.data.txt",NA,"TCGA-23-1023-01R",1,"DE887DE7-B839-47A9-8ED7-E5EDD06ADF99","TCGA",2005,NA,NA,"WITH TUMOR","A6FDFC35-A178-4D5A-8E07-346B55DD936D",65,"4814950029_R01C02_Red.idat","Alive",NA,"TCGA-23-1023","NOT HISPANIC OR LATINO","A457D6C8-D9CB-4D35-8E5C-54D0EF69DE98",NA,1233,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,92,"3D1EEE4C-C054-420C-BF05-2CF25DC53305","C3E57C8C-0B27-4426-92B1-96EE5C0D4329","TARRE_p_MultiPlate_TCGA_SS_MA_Ref_HT_HG-U133A_96-HTA_A06_586078.level3.data.txt","TCGA-23-1023-01R-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-23-1023-01R-01-BS1",94,"Cisplatin","Chemotherapy","TCGA-23-1023-D25594",NA,NA,NA,"TCGA-23-1023-F25587_NTE-2",NA,1233,"WITH TUMOR","Alive",NA,"TCGA-23-1023-F25587","TCGA-23-1023",NA,"23","1023","YES","C56.9","8441/3","C56.9",NA,NA,-23826,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1233,NA,NA,NA,"WITH TUMOR","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,65,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
268915652,251033222,18512157665,"ECC62CBA-16AB-45F0-9C5A-72F302B4A188.bw","9e18238f-ae85-4b75-ae87-d92da9731a40","ecc62cba-16ab-45f0-9c5a-72f302b4a188","2016-08-23T12:49:38.385160-05:00","TCGA-23-1023-01A-02R-1564-13_rnaseq_fastq.tar","e8a88ddf-7d80-45ac-a2a9-96adf919913d",17281259520,"Illumina HiSeq","4f1bed4da2c0d63d517b0a9d8d546ef8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:28:58.048141-05:00","2016-05-03T11:27:59.354684-05:00","e8a88ddf-7d80-45ac-a2a9-96adf919913d_analysis.xml","18263af04fdab21a4df63f76978f8193","9425a7cb-39e8-4196-a633-a886645183f3",2183,"2016-09-29T19:05:15.089978-05:00","e8a88ddf-7d80-45ac-a2a9-96adf919913d_experiment.xml","4c983aebb423de315f26f4b732708d0e","3afe3cf7-2836-48fc-ac8e-6e42d73e99f7",3916,"2016-09-29T23:59:34.382228-05:00","e8a88ddf-7d80-45ac-a2a9-96adf919913d_run.xml","98e7627f95a332acec1d1c0d7c3739d8","f1650a84-f023-488f-b107-4200647cda0e",1990,"2016-09-08T12:56:36.173388-05:00","TCGA-23-1023","2016-09-02T19:05:56.920217-05:00","female","TCGA-23-1023_demographic",1940,"white","5401c2e3-25c5-547a-a9df-fce704e3b3f4","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1023_diagnosis","not reported",23826,"alive","8441/3",NA,1233,"e6fb200e-161a-5533-9fea-45b491af50d2","c56.9",-23826,"TCGA-23-1023_treatment","df39fb19-a55b-5390-b5b6-15c45b5892f4","01",NA,"TCGA-23-1023-01A","0.6","a6fdfc35-a178-4d5a-8e07-346b55dd936d",FALSE,"98EBC356-C54E-4C1E-9726-BA61397DDA38","Primary Tumor","0.4",NA,NA,"0.8",1233705600,"02",127,"TCGA-23-1023-01A-02",70,80,NA,NA,20,5,10,5,"2016-09-08T12:56:36.173388-05:00","2016-09-08T12:56:36.173388-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,20,"1a4fa055-18ac-4c34-aa07-3e6fbba79d49","f2260f08-0126-4fe9-bbb0-09e4fc2fb30e","TCGA-23-1023-01A-02-BS2","TCGA-23-1023-01A-01-BS1",70,70,"98bbc8e1-81f4-4f16-9d23-0257059041d3","RNA","TCGA-23-1023-01A-02R","ada8eaa7-ff36-47e0-8b42-2a6e4edf59f3",1.8,0.16,"UV Spec","R","22","TCGA-23-1023-01A-02R-1564-13","69bec2db-02c3-46ca-b17b-60eae9a1e0bf",0.16,NA,NA,NA,NA,"903c184b-df15-5a62-a9b6-db964a4c935c","TCGA-23-1023_exposure","TCGA-23-1023-01A-02R-1564-13_rnaseq_fastq.tar","2013-12-21T00:56:14.000Z","2013-12-21T01:23:02.000Z","E8A88DDF-7D80-45AC-A2A9-96ADF919913D","A6FDFC35-A178-4D5A-8E07-346B55DD936D","Unaligned reads",17281259520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","69BEC2DB-02C3-46CA-B17B-60EAE9A1E0BF","Canada's Michael Smith Genome Sciences Centre","564a3589e4b09c884b229199","9E18238F-AE85-4B75-AE87-D92DA9731A40","Ovarian Serous Cystadenocarcinoma","TAR","98BBC8E1-81F4-4F16-9D23-0257059041D3","2013-12-21T01:23:02.000Z","ADA8EAA7-FF36-47E0-8B42-2A6E4EDF59F3","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"E9F679AA-4D4B-48BC-9DF0-B7A078652475",0.6,"23","TCGA-23-1023-01A-02R-1564-13_GRCh37-lite_mirna.bam",NA,"TCGA-23-1023-01A",0.8,"DE887DE7-B839-47A9-8ED7-E5EDD06ADF99","TCGA",2005,NA,NA,"WITH TUMOR","A6FDFC35-A178-4D5A-8E07-346B55DD936D",65,"4814950029_R01C02_Red.idat","Alive",NA,"TCGA-23-1023","NOT HISPANIC OR LATINO","A457D6C8-D9CB-4D35-8E5C-54D0EF69DE98",NA,1233,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,127,"F2260F08-0126-4FE9-BBB0-09E4FC2FB30E","B452BB46-3C25-4B1E-9E9A-D6599EBA698D","TCGA-23-1023-01A-02R-1564-13_GRCh37-lite_mirna.bam","TCGA-23-1023-01A-02",70,20,NA,NA,10,"BOTTOM",0,NA,"TCGA-23-1023-01A-02-BS2",70,"Cisplatin","Chemotherapy","TCGA-23-1023-D25594",NA,NA,NA,"TCGA-23-1023-F25587_NTE-2",NA,1233,"WITH TUMOR","Alive",NA,"TCGA-23-1023-F25587","TCGA-23-1023",NA,"23","1023","YES","C56.9","8441/3","C56.9",NA,NA,-23826,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1233,NA,NA,NA,"WITH TUMOR","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,65,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
222895648,216426344,16033495127,"5AF4899F-D8E1-4CB6-B3DC-F0C60C808838.bw","9e48a4b1-6917-4625-9d78-e4832eb816a5","5af4899f-d8e1-4cb6-b3dc-f0c60c808838","2016-08-25T06:59:41.173512-05:00","TCGA-13-0900-01B-01R-1565-13_rnaseq_fastq.tar","77ed4b67-1561-45c7-b7f6-9e8783ce69ee",13786798080,"Illumina HiSeq","13e7b8f54bdb8e65fecc8671b8931762","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:15:55.110582-05:00","2016-05-03T11:40:21.669427-05:00","77ed4b67-1561-45c7-b7f6-9e8783ce69ee_analysis.xml","4ededd500d713ad0d6b6d5eaf77bcd38","b11a3fa7-e119-40bc-968f-aa99524cb2b2",2235,"2016-10-07T16:38:12.745966-05:00","77ed4b67-1561-45c7-b7f6-9e8783ce69ee_experiment.xml","261aca9c267cc9d84d839015b8a53972","36bca8dd-c55c-4555-892d-ecd845b7ad2f",3916,"2016-09-29T19:35:55.214958-05:00","77ed4b67-1561-45c7-b7f6-9e8783ce69ee_run.xml","8e7bb4898c601423842dae35ca24bd12","4e2e03fa-bd48-45fc-8398-2605d34d3211",1989,"2016-09-08T13:26:31.080069-05:00","TCGA-13-0900","2016-09-02T19:12:09.336540-05:00","female","TCGA-13-0900_demographic",1945,"white","5d5bb297-6177-5d8a-8562-cbfa5c0f119a","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0900_diagnosis","not reported",21698,"alive","8441/3",NA,4077,"0637c309-0ed0-5cbf-a47b-4d33baea8096","c56.9",-21698,"TCGA-13-0900_treatment","6fc269ae-92bb-54f9-b556-34237de627ea","01",NA,"TCGA-13-0900-01B","0.6","f9cd355d-0a69-4479-bacd-b281c5056385",FALSE,"27A4B579-9123-431C-95B6-FBC5CB5142C9","Primary Tumor","0.1",NA,NA,"1.5",1230508800,"01",125,"TCGA-13-0900-01B-01",80,85,NA,NA,0,0,20,15,"2016-09-08T13:26:31.080069-05:00","2016-09-08T13:26:31.080069-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,1,"a7ab33bd-827e-4ab7-b7c5-7163a3518e93","bd003171-83a0-4ad5-a012-58abfa9d00de","TCGA-13-0900-01B-01-BS1","TCGA-13-0900-01B-01-TS1",75,84,"85aafcad-c9a1-4fd5-932f-1e326d93b9b2","RNA","TCGA-13-0900-01B-01R","644e9281-6062-48c2-a14c-4dc992e504ad",1.8,0.15,"UV Spec","R","22","TCGA-13-0900-01B-01R-1565-13","48c027ac-0580-43aa-9356-f56b3d897127",0.15,NA,NA,NA,NA,"6fd63f19-3039-587d-88d9-92c485f9f2b5","TCGA-13-0900_exposure","TCGA-13-0900-01B-01R-1565-13_rnaseq_fastq.tar","2014-03-22T06:15:23.000Z","2014-03-22T06:41:02.000Z","77ED4B67-1561-45C7-B7F6-9E8783CE69EE","F9CD355D-0A69-4479-BACD-B281C5056385","Unaligned reads",13786798080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","48C027AC-0580-43AA-9356-F56B3D897127","Canada's Michael Smith Genome Sciences Centre","564a38a1e4b0ef1218198e56","9E48A4B1-6917-4625-9D78-E4832EB816A5","Ovarian Serous Cystadenocarcinoma","TAR","85AAFCAD-C9A1-4FD5-932F-1E326D93B9B2","2014-03-22T06:41:02.000Z","644E9281-6062-48C2-A14C-4DC992E504AD","None","NO",1,0.1,"Primary Tumor","Memorial Sloan Kettering",NA,"85AAFCAD-C9A1-4FD5-932F-1E326D93B9B2",0.6,"13","TCGA-13-0900-01B-01R-1565-13_rnaseq_fastq.tar",NA,"TCGA-13-0900-01B",1.5,"E939513A-A319-4A7F-B724-3D9A24DBB312","TCGA",2004,NA,NA,"TUMOR FREE","F9CD355D-0A69-4479-BACD-B281C5056385",59,"nationwidechildrens.org_clinical.TCGA-13-0900.xml","Alive",NA,"TCGA-13-0900","NOT HISPANIC OR LATINO",NA,NA,1736,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,125,"BD003171-83A0-4AD5-A012-58ABFA9D00DE","E0A6CCEE-0030-4A19-A998-5600D60DB44D","TCGA-13-0900-01B-01R-1565-13_rnaseq_fastq.tar","TCGA-13-0900-01B-01",80,0,NA,NA,20,"BOTTOM",5,NA,"TCGA-13-0900-01B-01-BS1",75,"Carboplatin","Chemotherapy","TCGA-13-0900-D24709",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0900",NA,"13","0900","YES","C56.9","8441/3","C56.9",NA,NA,-21698,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1736,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
220631402,214635903,15879862274,"BBCEA0D1-DE66-4C0C-8D3C-D1398D04B472.bw","9e7d3dea-5d81-4f10-819c-1c2a68ddd150","bbcea0d1-de66-4c0c-8d3c-d1398d04b472","2016-08-31T11:06:33.508697-05:00","TCGA-24-1546-01A-01R-1566-13_rnaseq_fastq.tar","fef9b42d-e986-4508-aa65-d1cff43bddae",14089984000,"Illumina HiSeq","845b3a9b82b840a5382d4041490745fd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:30:05.366428-05:00","2016-05-03T11:39:34.528512-05:00","fef9b42d-e986-4508-aa65-d1cff43bddae_analysis.xml","2df5a4abf814d7e0d6634cd5ace2ac61","4aa44d8f-f089-44ee-b0fb-54a088ac1a2e",2181,"2016-09-29T23:33:30.388898-05:00","fef9b42d-e986-4508-aa65-d1cff43bddae_experiment.xml","1713ea225a2fab551dcacffde697db3a","e1396a16-bc12-43db-82c3-80c19d0bb69f",3916,"2016-09-30T00:21:44.006663-05:00","fef9b42d-e986-4508-aa65-d1cff43bddae_run.xml","8a92a234935e84a52b53ad14ae7c6ed3","ff137e7b-3c0e-4fda-adf9-5d19bdcac77f",1988,"2016-09-08T11:33:04.429508-05:00","TCGA-24-1546","2016-09-02T18:48:59.500276-05:00","female","TCGA-24-1546_demographic",1951,"white","8bff82fb-9ffa-5794-8922-4b2771f31589","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1546_diagnosis","not reported",17130,"dead","8441/3",1955,1955,"4ec47e19-8ac8-5799-995f-ed82d4ebef47","c56.9",-17130,"TCGA-24-1546_treatment","287d5b25-e1ee-5e5b-a4a2-d403b4e54836","01",NA,"TCGA-24-1546-01A","0.4","db9720f0-d7ef-469c-ae11-e8f17488126b",FALSE,"d6eec9a6-7bfd-40e2-891e-0a3cd7759ace","Primary Tumor","0.4",NA,NA,"1.5",1235088000,"01",121,"TCGA-24-1546-01A-01",70,70,NA,NA,0,0,40,40,"2016-09-08T11:33:04.429508-05:00","2016-09-08T11:33:04.429508-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"fce4f2d8-a91c-4dd0-a99a-b75361492286","5c73ae2f-2e1b-4666-a9cb-c02eddcd874d","TCGA-24-1546-01A-01-TS1","TCGA-24-1546-01A-01-BS1",60,60,"f2e4232e-fb30-4e33-8512-d5dc0ba89646","RNA","TCGA-24-1546-01A-01R","0ac93c62-85b5-47b5-b41f-34aa170aa730",1.8,0.15,"UV Spec","R","22","TCGA-24-1546-01A-01R-1566-13","9984be2d-c37f-44cd-9eb8-61b65efcf8cb",0.15,NA,NA,NA,NA,"0f415104-491c-5bda-a5aa-4ded7bdc6cb1","TCGA-24-1546_exposure","TCGA-24-1546-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T07:54:26.000Z","2014-03-20T08:20:02.000Z","FEF9B42D-E986-4508-AA65-D1CFF43BDDAE","DB9720F0-D7EF-469C-AE11-E8F17488126B","Unaligned reads",14089984000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9984BE2D-C37F-44CD-9EB8-61B65EFCF8CB","Canada's Michael Smith Genome Sciences Centre","564a337ce4b0298dd2c5dea2","9E7D3DEA-5D81-4F10-819C-1C2A68DDD150","Ovarian Serous Cystadenocarcinoma","TAR","F2E4232E-FB30-4E33-8512-D5DC0BA89646","2014-03-20T08:20:02.000Z","0AC93C62-85B5-47B5-B41F-34AA170AA730","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"F2E4232E-FB30-4E33-8512-D5DC0BA89646",0.4,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9cdbc7ad-cffd-4f34-b805-47e7c57d9978.txt",NA,"TCGA-24-1546-01A",1.5,"2C1B2AFB-5DBA-4ECC-B390-B8169B0EDFDB","TCGA",1997,NA,NA,NA,"DB9720F0-D7EF-469C-AE11-E8F17488126B",46,"GHYLL_p_TCGABatch17_Mashima45_HT_HG-U133A_96-HTA_D01_472010.level2.data.txt","Dead",1955,"TCGA-24-1546",NA,"0B61178A-F8FB-4A88-8C08-54AE6E0AB3F0",NA,1955,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,121,"FCE4F2D8-A91C-4DD0-A99A-B75361492286","FC56C4AF-2721-4ED1-9584-651D4A3223D5","TCGA-24-1546-01A-01T-0541-07.gene.tcga_level3.data.txt","TCGA-24-1546-01A-01",70,0,NA,NA,40,"TOP",0,NA,"TCGA-24-1546-01A-01-TS1",60,"Taxol","Chemotherapy","TCGA-24-1546-D26099",NA,NA,NA,NA,NA,1955,NA,"Dead",1955,"TCGA-24-1546-F26097","TCGA-24-1546",NA,"24","1546","YES","C56.9","8441/3","C56.9",NA,NA,-17130,"FEMALE","WHITE",NA,NA,"No","Dead",1955,1955,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,46,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
241377350,233419503,17255142365,"154764CD-AC69-4F48-A212-8B27C076C91A.bw","9ec86cbd-8c74-4697-90da-529ab91ab835","154764cd-ac69-4f48-a212-8b27c076c91a","2016-09-29T18:05:10.225668-05:00","TCGA-24-1843-01A-01R-1567-13_rnaseq_fastq.tar","18014824-6083-4e86-b3e1-639f7094916f",15716792320,"Illumina HiSeq","6fdd819a0205476c2b95df5daa7e3a8f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:19:19.382807-05:00","2016-05-03T11:41:05.740763-05:00","18014824-6083-4e86-b3e1-639f7094916f_analysis.xml","109db6d6ceb5b331ff56049a9867a277","d8343d14-e235-4763-8c7d-c014043e0795",2181,"2016-08-26T16:23:07.189857-05:00","18014824-6083-4e86-b3e1-639f7094916f_experiment.xml","b7be3f0d8a796d5645f1f5a8e251fd3c","54d101ee-a752-4585-9791-3cdd0412a76f",3916,"2016-09-29T18:57:23.455331-05:00","18014824-6083-4e86-b3e1-639f7094916f_run.xml","246f85ac6e193a07264ba17dad7f2445","36143b61-9496-4a8d-8e00-05da2010b686",1988,"2016-09-08T11:05:32.144904-05:00","TCGA-24-1843","2016-09-02T18:47:50.516398-05:00","female","TCGA-24-1843_demographic",1943,"white","63120061-1f2d-5054-ae2e-359fc077acae","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1843_diagnosis","not reported",24469,"alive","8441/3",NA,106,"59f8614c-8ad2-570a-9e9e-134adc1741a0","c56.9",-24469,"TCGA-24-1843_treatment","25d0621f-3c4b-56a8-92c5-7b9192816479","01",NA,"TCGA-24-1843-01A","1","737481f9-845a-4c7a-b12f-881d9da3998a",FALSE,"d2625c77-0f03-42ea-b5ea-df45769f0fbb","Primary Tumor","0.4",NA,NA,"1.4",1245628800,"01",100,"TCGA-24-1843-01A-01",80,75,0,0,0,0,20,25,"2016-09-08T11:05:32.144904-05:00","2016-09-08T11:05:32.144904-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"67b22c44-f74a-4da1-b048-b733fa840f44","572a0abb-4f27-4520-982f-ef4fa9183652","TCGA-24-1843-01A-01-BS1","TCGA-24-1843-01A-01-TS1",80,75,"d7087367-20fa-4b50-b1c3-65a703834738","RNA","TCGA-24-1843-01A-01R","a93a8a89-cb0e-4b29-9ee4-263c79bd82bc",1.8,0.14,"UV Spec","R","22","TCGA-24-1843-01A-01R-1567-13","c50cf5af-3375-4748-9894-1f9521f746da",0.14,NA,NA,NA,NA,"bd8ee4e1-b757-521d-a5cb-7e990c0404d1","TCGA-24-1843_exposure","TCGA-24-1843-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T21:58:25.000Z","2014-03-26T22:30:02.000Z","18014824-6083-4E86-B3E1-639F7094916F","737481F9-845A-4C7A-B12F-881D9DA3998A","Unaligned reads",15716792320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C50CF5AF-3375-4748-9894-1F9521F746DA","Canada's Michael Smith Genome Sciences Centre","564a3d12e4b09c884b24df22","9EC86CBD-8C74-4697-90DA-529AB91AB835","Ovarian Serous Cystadenocarcinoma","TAR","D7087367-20FA-4B50-B1C3-65A703834738","2014-03-26T22:30:02.000Z","A93A8A89-CB0E-4B29-9EE4-263C79BD82BC","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"D7087367-20FA-4B50-B1C3-65A703834738",1,"24","TCGA-24-1843-01A-01D-0580-02_S01_CGH_105_Dec08_1_2.txt",NA,"TCGA-24-1843-01A",1.4,"EB2BC7DF-1C3D-4CB5-8759-E3E1F218165B","TCGA",2009,NA,NA,NA,"92F26D59-DE6A-4AA2-A688-C03E2064C210",66,"nationwidechildrens.org_clinical.TCGA-24-1843.xml","Alive",NA,"TCGA-24-1843",NA,"9871548E-8F1F-4D83-87F7-E813B54143BC",NA,106,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,100,"572A0ABB-4F27-4520-982F-EF4FA9183652","CB2B3DE3-C554-4A0F-AB90-778D5A2ACE57","TCGA-24-1843-01A-01R-1567-13.hg19.spljxn.quantification.txt","TCGA-24-1843-01A-01",75,0,0,0,25,"TOP",0,0,"TCGA-24-1843-01A-01-TS1",75,"Taxotere","Chemotherapy","TCGA-24-1843-D26332",NA,NA,NA,NA,NA,106,NA,"Alive",NA,"TCGA-24-1843-F26330","TCGA-24-1843",NA,"24","1843","YES","C56.9","8441/3","C56.9",NA,NA,-24469,"FEMALE","WHITE",NA,NA,"No","Alive",106,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,66,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51958522,49879014,3680365132,"33266777-E07B-49D0-9E24-2EDE2577CF16.bw","9fb1ba57-2007-4477-b000-2d36f163efd2","33266777-e07b-49d0-9e24-2ede2577cf16","2016-08-25T13:53:00.181457-05:00","TCGA-23-1110-01A-01R-1564-13_rnaseq_fastq.tar","1d2a1b37-2404-4ffe-bbb7-55848a2b6710",3286097920,"Illumina HiSeq","e64b05dec23d7513a8b331c4b9db05fc","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:17:30.334111-05:00","2016-05-03T11:39:34.522989-05:00","1d2a1b37-2404-4ffe-bbb7-55848a2b6710_analysis.xml","ead0787b70a56d03711a1d5f39382d6c","d721a816-41a9-4261-b95b-bc2c7bf57e18",2242,"2016-09-29T20:33:28.679870-05:00","1d2a1b37-2404-4ffe-bbb7-55848a2b6710_experiment.xml","808f3e1ef1bf212bd2e1acb461b55808","71715122-93c8-4568-aa33-a7552e5a0b31",3916,"2016-09-29T22:10:36.627538-05:00","1d2a1b37-2404-4ffe-bbb7-55848a2b6710_run.xml","c82f6e30d36abb10735e7264caa281f9","adc8b659-90ee-4c9f-bb51-3c3e192a420d",1990,"2016-09-08T12:52:21.149992-05:00","TCGA-23-1110","2016-09-02T19:05:55.089518-05:00","female","TCGA-23-1110_demographic",1961,"white","bb0f6ffa-ac50-5de2-be4c-54c7494ab86f","hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1110_diagnosis","not reported",15383,"alive","8441/3",NA,1658,"8d884ab0-aab2-532e-8036-a5b79eb4ce6d","c56.9",-15383,"TCGA-23-1110_treatment","e65a832f-f238-5469-b484-f9c0bb0dbe8e","01",NA,"TCGA-23-1110-01A","0.8","5adca90e-f8ae-4a74-9c7f-a2b64fda2b31",FALSE,"07361efd-0b7d-4dcb-afe3-464200f59ac0","Primary Tumor","0.6",NA,NA,"0.8",1227657600,"01",116,"TCGA-23-1110-01A-01",95,95,NA,NA,0,0,NA,NA,"2016-09-08T12:52:21.149992-05:00","2016-09-08T12:52:21.149992-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"04ccc391-1194-4dc4-8692-607901904c83","9586db89-39c2-4109-9575-b2c545d3a490","TCGA-23-1110-01A-01-TS1","TCGA-23-1110-01A-01-BS1",NA,NA,"791b42c2-82db-4e70-bc83-322815d31ac7","RNA","TCGA-23-1110-01A-01R","89633760-be77-432b-b7fd-200e8c070f1b",1.8,0.16,"UV Spec","R","22","TCGA-23-1110-01A-01R-1564-13","d93e1f93-20d0-493f-8b54-939fa4ba64f9",0.16,NA,NA,NA,NA,"a07d5648-22a4-5aea-8c40-de2f83b6ee6e","TCGA-23-1110_exposure","TCGA-23-1110-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-19T07:28:56.000Z","2014-03-19T07:40:02.000Z","1D2A1B37-2404-4FFE-BBB7-55848A2B6710","5ADCA90E-F8AE-4A74-9C7F-A2B64FDA2B31","Unaligned reads",3286097920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D93E1F93-20D0-493F-8B54-939FA4BA64F9","Canada's Michael Smith Genome Sciences Centre","564a36eee4b0ef12181901db","9FB1BA57-2007-4477-B000-2D36F163EFD2","Ovarian Serous Cystadenocarcinoma","TAR","791B42C2-82DB-4E70-BC83-322815D31AC7","2014-03-19T07:40:02.000Z","89633760-BE77-432B-B7FD-200E8C070F1B","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"791B42C2-82DB-4E70-BC83-322815D31AC7",0.8,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e36ba512-a711-4e42-80ce-94edb0be836e.txt",NA,"TCGA-23-1110-01A",0.8,"B9882C4E-8BCD-42A7-BAA4-A91102A3853A","TCGA",2003,NA,NA,"TUMOR FREE","8E9CEC35-D37F-4434-84BD-E682B00BF4C6",42,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e36ba512-a711-4e42-80ce-94edb0be836e.txt","Alive",NA,"TCGA-23-1110","HISPANIC OR LATINO","412125D8-6E4B-4ECE-9596-A1BB77F81E61",NA,1658,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,116,"9586DB89-39C2-4109-9575-B2C545D3A490","89633760-BE77-432B-B7FD-200E8C070F1B","TCGA-23-1110-01A-01R-1564-13_rnaseq.bam.bai","TCGA-23-1110-01A-01",95,0,NA,NA,NA,"BOTTOM",5,NA,"TCGA-23-1110-01A-01-BS1",NA,"Carboplatin","Chemotherapy","TCGA-23-1110-D25668",NA,NA,NA,"TCGA-23-1110-F25666_NTE-1",NA,1658,"TUMOR FREE","Alive",NA,"TCGA-23-1110-F25666","TCGA-23-1110",NA,"23","1110","YES","C56.9","8441/3","C56.9",NA,NA,-15383,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Alive",1658,NA,NA,NA,"TUMOR FREE","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,42,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
112383656,108626279,8057207394,"7DAE9720-3922-4680-9F95-75C029B7FDA9.bw","a09f0626-002a-48fd-8b2d-c66b8285cf23","7dae9720-3922-4680-9f95-75c029b7fda9","2016-08-25T20:40:16.726562-05:00","TCGA-30-1892-01A-01R-1568-13_rnaseq_fastq.tar","9cfa5809-8daf-4d72-bc78-0e0d0925c144",7245352960,"Illumina HiSeq","19919be071b96a759c82ef169e0b6fd3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:44:44.121353-05:00","2016-05-03T11:41:05.755204-05:00","9cfa5809-8daf-4d72-bc78-0e0d0925c144_analysis.xml","10a60165007b421edeb43aafb44b1aa7","787a6c98-d3b8-4831-81f3-e57ae0d08319",2242,"2016-09-29T23:54:07.137589-05:00","9cfa5809-8daf-4d72-bc78-0e0d0925c144_experiment.xml","009f0b486312a630f7f475138546d0e6","ee0a4089-8673-4097-97a2-f5c25cffacce",3916,"2016-09-29T23:34:15.975202-05:00","9cfa5809-8daf-4d72-bc78-0e0d0925c144_run.xml","75a9c812f67a9e08dcb46442b48a8d11","e1a9e0c4-7708-4cb5-bfb3-cd19167f4bb8",1990,"2016-09-08T10:49:04.055437-05:00","TCGA-30-1892","2016-09-02T18:50:17.075015-05:00","female","TCGA-30-1892_demographic",1952,"white","caf0b95d-2121-5698-a1cf-f4408b39c118","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1892_diagnosis","not reported",19256,"dead","8441/3",1484,1484,"2ac4a173-7eee-5fca-8f3f-6ee590714833","c56.9",-19256,"TCGA-30-1892_treatment","53a518b3-e090-5044-9dbf-c2c82ca3ebc3","01",NA,"TCGA-30-1892-01A","0.7","5b68e68c-3cbf-4506-ac94-4b23b3daba70",FALSE,"fb7c966c-9b16-4781-9c01-2db480c88d63","Primary Tumor","0.3",NA,NA,"1.2",1245628800,"01",126,"TCGA-30-1892-01A-01",80,90,NA,NA,0,0,20,10,"2016-09-08T10:49:04.055437-05:00","2016-09-08T10:49:04.055437-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,10,"eea7bc4a-8967-4b50-a476-e5ce862958d9","65549f07-9148-43b5-8c8c-94d17148a918","TCGA-30-1892-01A-01-BS1","TCGA-30-1892-01A-01-TS1",70,80,"92f05631-c736-46b6-a7f3-8a3136a5f869","RNA","TCGA-30-1892-01A-01R","f7c3e41d-d4d7-4e15-a348-d73cf7d8f4d2",1.8,0.15,"UV Spec","R","22","TCGA-30-1892-01A-01R-1568-13","bb8dc795-80ff-4b42-8cf8-9f9716c13967",0.15,NA,NA,NA,NA,"ed8e50d4-facf-51a8-9ddd-9274f55ff2e8","TCGA-30-1892_exposure","TCGA-30-1892-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T05:20:11.000Z","2014-03-27T05:35:01.000Z","9CFA5809-8DAF-4D72-BC78-0E0D0925C144","5B68E68C-3CBF-4506-AC94-4B23B3DABA70","Unaligned reads",7245352960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BB8DC795-80FF-4B42-8CF8-9F9716C13967","Canada's Michael Smith Genome Sciences Centre","564a412be4b0298dd2ca42d1","A09F0626-002A-48FD-8B2D-C66B8285CF23","Ovarian Serous Cystadenocarcinoma","TAR","92F05631-C736-46B6-A7F3-8A3136A5F869","2014-03-27T05:35:01.000Z","F7C3E41D-D4D7-4E15-A348-D73CF7D8F4D2","None","NO",1,0.3,"Primary Tumor","Harvard",NA,"92F05631-C736-46B6-A7F3-8A3136A5F869",0.7,"30","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3c68d944-a329-44c2-8697-2f8c50a8b38c.txt",NA,"TCGA-30-1892-01A",1.2,"EF88B090-EDE2-43BF-B637-D824C853EF5C","TCGA",2004,NA,NA,"WITH TUMOR","5B68E68C-3CBF-4506-AC94-4B23B3DABA70",52,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3c68d944-a329-44c2-8697-2f8c50a8b38c.txt","Dead",1484,"TCGA-30-1892","NOT HISPANIC OR LATINO","0AA2E64A-FE67-47A7-A99B-0BC5D07725B0",NA,1484,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,126,"EEA7BC4A-8967-4B50-A476-E5CE862958D9","F7C3E41D-D4D7-4E15-A348-D73CF7D8F4D2","TCGA-30-1892-01A-01R-1568-13_GRCh37-lite_rnaseq.bam.bai","TCGA-30-1892-01A-01",80,0,NA,NA,20,"BOTTOM",10,NA,"TCGA-30-1892-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-30-1892-D27657",NA,NA,NA,"TCGA-30-1892-F27654_NTE-1",NA,1484,"WITH TUMOR","Dead",1484,"TCGA-30-1892-F27654","TCGA-30-1892",NA,"30","1892","YES","C56.9","8441/3","C56.9",NA,NA,-19256,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1484,1484,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,52,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
160871380,156207398,11562353383,"1BC2ECED-0425-4382-BB94-F57ED2687F18.bw","a2319490-b85d-4219-a1b0-fa1ec432d5c8","1bc2eced-0425-4382-bb94-f57ed2687f18","2016-08-25T04:59:49.527924-05:00","TCGA-29-2414-02A-01R-1569-13_rnaseq_fastq.tar","5180d8e2-06d1-4c7c-9b52-5c7cd72bc315",10222151680,"Illumina HiSeq","67abb70afcc38374e0d647985a777189","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:25:05.225783-05:00","2016-05-03T11:55:09.260045-05:00","5180d8e2-06d1-4c7c-9b52-5c7cd72bc315_analysis.xml","97cef65424b7d47f28acbd3cb3a79be3","21871913-2ce8-430a-81dd-0db1d5f9d748",2181,"2016-09-29T20:13:12.067343-05:00","5180d8e2-06d1-4c7c-9b52-5c7cd72bc315_experiment.xml","ee74f5e642dbf96dd4f5108bb61d7fdb","651a4ddb-487c-4139-8a5c-e80fb6fb3c05",3916,"2016-09-29T23:37:57.360830-05:00","5180d8e2-06d1-4c7c-9b52-5c7cd72bc315_run.xml","6e416ceb1e482adca16f1753baa73525","e3fc4f29-3c43-4614-80e7-d1f3e81b9972",1988,"2016-09-08T10:36:13.963064-05:00","TCGA-29-2414","2016-09-02T19:12:01.667430-05:00","female","TCGA-29-2414_demographic",1923,"white","7b9aeb08-3b4c-5661-bec0-b3b74dc9ec8a","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-2414_diagnosis","not reported",27417,"dead","8441/3",2621,2621,"1911c0e4-d523-5681-9cc6-332707c4c25e","c56.9",-27417,"TCGA-29-2414_treatment","6a5666f9-cc38-5f1c-a8b6-ec1953ac9ff2","02",NA,"TCGA-29-2414-02A","0.7","dffc14ad-f9fc-4d33-b5e2-8c57019816fe",FALSE,"1A4882EA-818E-4A23-8584-2881D0DE8406","Recurrent Tumor","0.3",NA,NA,"1",1259625600,"01",150,"TCGA-29-2414-02A-01",90,90,NA,NA,0,0,20,30,"2016-09-08T10:36:13.963064-05:00","2016-09-08T10:36:13.963064-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,10,"d98dd76c-5162-4b4d-b0fa-0604d8a40117","9e8b6cda-a655-40f9-a448-d45218dc54c8","TCGA-29-2414-02A-01-BS1","TCGA-29-2414-02A-01-TS1",80,60,"fbb635b8-7811-4dab-b8ae-7b88a63f2050","RNA","TCGA-29-2414-02A-01R","4db51ece-d641-4e3d-a214-ec7728b6397d",1.8,0.16,"UV Spec","R","22","TCGA-29-2414-02A-01R-1569-13","1558c0c4-6bd2-482d-9c4e-2430a402dacc",0.16,NA,NA,NA,NA,"9ddfa6c8-882b-5014-b95c-e996183632d0","TCGA-29-2414_exposure","TCGA-29-2414-02A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T11:05:21.000Z","2014-08-08T11:36:26.000Z","5180D8E2-06D1-4C7C-9B52-5C7CD72BC315","DFFC14AD-F9FC-4D33-B5E2-8C57019816FE","Unaligned reads",10222151680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1558C0C4-6BD2-482D-9C4E-2430A402DACC","Canada's Michael Smith Genome Sciences Centre","564a5b30e4b093830b6cee30","A2319490-B85D-4219-A1B0-FA1EC432D5C8","Ovarian Serous Cystadenocarcinoma","TAR","FBB635B8-7811-4DAB-B8AE-7B88A63F2050","2014-08-08T11:36:26.000Z","4DB51ECE-D641-4E3D-A214-EC7728B6397D","None","NO",2,0.3,"Recurrent Tumor","Duke",NA,"FBB635B8-7811-4DAB-B8AE-7B88A63F2050",0.7,"29","TCGA-29-2414-02A-01R-1569-13.exon.quantification.txt",NA,"TCGA-29-2414-02A",1,"F1B37728-C715-49D5-8F09-F3CCD3F67332","TCGA",1998,NA,NA,"WITH TUMOR","DFFC14AD-F9FC-4D33-B5E2-8C57019816FE",75,"PAGED_p_TCGA_182_OvGBM_SNP_N_GenomeWideSNP_6_D08_896202.CEL","Dead",2621,"TCGA-29-2414",NA,"955879E7-53F1-48E3-85C2-47D63A4B8113",NA,2621,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,"4F455D1B-8492-4C47-BC16-01DE2AC1898A","WHITE",NA,1,150,"D98DD76C-5162-4B4D-B0FA-0604D8A40117","A863A633-00E1-4FA9-9B34-51B91CE10C39","TCGA-29-2414-02A-01R-1569-13_mirna.bam","TCGA-29-2414-02A-01",90,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-29-2414-02A-01-BS1",80,"Paclitaxel","Chemotherapy","TCGA-29-2414-D27455","TCGA-29-2414-R27460","EXTERNAL BEAM","Distant Recurrence","TCGA-29-2414-F27451_NTE-2",NA,2621,"WITH TUMOR","Dead",2621,"TCGA-29-2414-F27451","TCGA-29-2414",NA,"29","2414","YES","C56.9","8441/3","C56.9",NA,NA,-27417,"FEMALE","WHITE",NA,NA,"No","Dead",2621,2621,NA,NA,"WITH TUMOR","NO",9,2,2010,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,75,1998,"Tumor resection",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
176257910,172224539,12765569861,"0901D931-77BE-47B0-AE5F-C26C6A144CA0.bw","a2319490-b85d-4219-a1b0-fa1ec432d5c8","0901d931-77be-47b0-ae5f-c26c6a144ca0","2016-08-24T12:06:30.989996-05:00","TCGA-29-2414-01A-02R-1569-13_rnaseq_fastq.tar","a08ad782-bfc2-4f85-b71b-1601c57fe547",10797977600,"Illumina HiSeq","e511b5dae7ea747a3cdcfbc3b1eba516","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:48:44.030440-05:00","2016-05-03T11:41:05.740763-05:00","a08ad782-bfc2-4f85-b71b-1601c57fe547_analysis.xml","e40df137622b534e90f3f27df5155939","0ae13042-7318-4704-9c06-f8b9550a3b0a",2181,"2016-10-07T16:22:43.661559-05:00","a08ad782-bfc2-4f85-b71b-1601c57fe547_experiment.xml","4d130dbd267f09568e73fe42dfbe0025","04a96fba-237d-4d7d-b49a-a78111f08fc1",3916,"2016-09-29T20:13:59.770492-05:00","a08ad782-bfc2-4f85-b71b-1601c57fe547_run.xml","d5074f65f2d78dee3a21a57bb3877ef4","65958ab7-0e60-4a30-b5fa-397cf975e6bc",1988,"2016-09-08T10:36:13.963064-05:00","TCGA-29-2414","2016-09-02T19:12:01.667430-05:00","female","TCGA-29-2414_demographic",1923,"white","7b9aeb08-3b4c-5661-bec0-b3b74dc9ec8a","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-2414_diagnosis","not reported",27417,"dead","8441/3",2621,2621,"1911c0e4-d523-5681-9cc6-332707c4c25e","c56.9",-27417,"TCGA-29-2414_treatment","6a5666f9-cc38-5f1c-a8b6-ec1953ac9ff2","01",NA,"TCGA-29-2414-01A","0.7","c8de9eaf-cda6-4680-a710-93fd9e9a8903",FALSE,"1A4882EA-818E-4A23-8584-2881D0DE8406","Primary Tumor","0.5",NA,NA,"1",1252972800,"02",123,"TCGA-29-2414-01A-02",76,70,NA,NA,35,45,0,0,"2016-09-08T10:36:13.963064-05:00","2016-09-08T10:36:13.963064-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,6,"c86cba2a-8d47-4657-84ad-1a66647440e9","5006bae6-462f-4310-b8ab-8d7d8809cc0f","TCGA-29-2414-01A-01-BS1","TCGA-29-2414-01A-02-BS2",60,49,"0b069ab9-6c2d-48b7-9f49-b9e22019747b","RNA","TCGA-29-2414-01A-02R","9e975fa6-5e54-4b42-89c5-a0324e199fc2",1.8,0.14,"UV Spec","R","22","TCGA-29-2414-01A-02R-1569-13","ecbadb01-01ec-4d9f-877c-75709d6f5914",0.14,NA,NA,NA,NA,"9ddfa6c8-882b-5014-b95c-e996183632d0","TCGA-29-2414_exposure","TCGA-29-2414-01A-02R-1569-13_rnaseq_fastq.tar","2014-03-26T21:20:47.000Z","2014-03-26T21:42:02.000Z","A08AD782-BFC2-4F85-B71B-1601C57FE547","C8DE9EAF-CDA6-4680-A710-93FD9E9A8903","Unaligned reads",10797977600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","ECBADB01-01EC-4D9F-877C-75709D6F5914","Canada's Michael Smith Genome Sciences Centre","564a5b30e4b08c5d869528b5","A2319490-B85D-4219-A1B0-FA1EC432D5C8","Ovarian Serous Cystadenocarcinoma","TAR","0B069AB9-6C2D-48B7-9F49-B9E22019747B","2014-03-26T21:42:02.000Z","9E975FA6-5E54-4B42-89C5-A0324E199FC2","None","NO",1,0.5,"Primary Tumor","Duke",NA,"0B069AB9-6C2D-48B7-9F49-B9E22019747B",0.7,"29","AMISS_p_TCGAb24_SNP_N_GenomeWideSNP_6_D05_542494.ismpolish.data.txt",NA,"TCGA-29-2414-01A",1,"F1B37728-C715-49D5-8F09-F3CCD3F67332","TCGA",1998,NA,NA,"WITH TUMOR","DFFC14AD-F9FC-4D33-B5E2-8C57019816FE",75,"PAGED_p_TCGA_182_OvGBM_SNP_N_GenomeWideSNP_6_D08_896202.CEL","Dead",2621,"TCGA-29-2414",NA,"955879E7-53F1-48E3-85C2-47D63A4B8113",NA,2621,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,"4F455D1B-8492-4C47-BC16-01DE2AC1898A","WHITE",NA,2,123,"C86CBA2A-8D47-4657-84AD-1A66647440E9","F44A65A4-16B4-49FC-A7D0-9E1087881AC5","AMISS_p_TCGAb24_SNP_N_GenomeWideSNP_6_D05_542494.ismpolish.data.txt","TCGA-29-2414-01A-02",70,45,NA,NA,0,"BOTTOM",6,NA,"TCGA-29-2414-01A-02-BS2",49,"Paclitaxel","Chemotherapy","TCGA-29-2414-D27455","TCGA-29-2414-R27460","EXTERNAL BEAM","Distant Recurrence","TCGA-29-2414-F27451_NTE-2",NA,2621,"WITH TUMOR","Dead",2621,"TCGA-29-2414-F27451","TCGA-29-2414",NA,"29","2414","YES","C56.9","8441/3","C56.9",NA,NA,-27417,"FEMALE","WHITE",NA,NA,"No","Dead",2621,2621,NA,NA,"WITH TUMOR","NO",9,2,2010,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,75,1998,"Tumor resection",NA,NA,NA,"G2","R1",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
211982174,203892686,15076973329,"77AFFD5F-F715-4242-95C9-5F36E061B3E2.bw","a36a4440-15ef-4837-904b-380a964d16f1","77affd5f-f715-4242-95c9-5f36e061b3e2","2016-08-21T02:28:54.896970-05:00","TCGA-24-1844-01A-01R-1567-13_rnaseq_fastq.tar","9429c5f6-c280-49a6-835b-417592714ab6",13858365440,"Illumina HiSeq","5ac98cb2382969ae186ee1ef4b5f44fc","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:44:40.594399-05:00","2016-05-03T11:41:05.748550-05:00","9429c5f6-c280-49a6-835b-417592714ab6_analysis.xml","3d8a51a3752678a6ada21cbcd62467cd","2dfc1180-8c8f-4120-b618-6a93f970ddfa",2181,"2016-08-13T04:11:30.030399-05:00","9429c5f6-c280-49a6-835b-417592714ab6_experiment.xml","ff87076f82b4ea113c903150703fdbe5","576940ac-7f65-4d32-89b4-2c332b84ac0b",3916,"2016-09-29T22:51:19.162866-05:00","9429c5f6-c280-49a6-835b-417592714ab6_run.xml","37837dc526e0912d3b84791dcdc2cb4f","c6fbf005-e0d2-4441-bf59-fed65fd50124",1989,"2016-09-08T10:38:37.624289-05:00","TCGA-24-1844","2016-09-02T18:48:16.634526-05:00","female","TCGA-24-1844_demographic",1945,"white","1364e963-dbbb-5881-a86a-ad660efa2898","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1844_diagnosis","not reported",23542,"alive","8441/3",NA,113,"250e6c30-98ff-51b3-bc1f-cb87719b253c","c56.9",-23542,"TCGA-24-1844_treatment","cdc87da0-37fe-53d8-9ce0-60d6f76618d9","01",NA,"TCGA-24-1844-01A","1","8ea52904-f56c-4c1f-b8a4-9906805001ff",FALSE,"5fd30c3c-9734-40dd-b81e-ae3f364c8fa8","Primary Tumor","0.4",NA,NA,"1.1",1245628800,"01",126,"TCGA-24-1844-01A-01",80,90,0,0,0,0,20,10,"2016-09-08T10:38:37.624289-05:00","2016-09-08T10:38:37.624289-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"de22faa4-e6c3-4f51-a17d-d450ee2ee1eb","77eb1696-4cf6-4a2b-a225-52c0ee0f9082","TCGA-24-1844-01A-01-TS1","TCGA-24-1844-01A-01-BS1",80,90,"b64dcd0c-2557-4b91-8d5f-171f02c53c16","RNA","TCGA-24-1844-01A-01R","6da09e60-59a5-448f-9f4c-5fa2cef63eea",1.8,0.16,"UV Spec","R","22","TCGA-24-1844-01A-01R-1567-13","53a60e9f-3541-4fe7-a7ea-87ee888c0446",0.16,NA,NA,NA,NA,"74788be0-74a2-5196-a87b-de9723f364a6","TCGA-24-1844_exposure","TCGA-24-1844-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T21:38:26.000Z","2014-03-28T22:10:01.000Z","9429C5F6-C280-49A6-835B-417592714AB6","8EA52904-F56C-4C1F-B8A4-9906805001FF","Unaligned reads",13858365440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","53A60E9F-3541-4FE7-A7EA-87EE888C0446","Canada's Michael Smith Genome Sciences Centre","564a33e3e4b093830b66de3e","A36A4440-15EF-4837-904B-380A964D16F1","Ovarian Serous Cystadenocarcinoma","TAR","B64DCD0C-2557-4B91-8D5F-171F02C53C16","2014-03-28T22:10:01.000Z","6DA09E60-59A5-448F-9F4C-5FA2CEF63EEA","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"B64DCD0C-2557-4B91-8D5F-171F02C53C16",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d95c8065-b35e-47b0-899a-305b14ed2a56.txt",NA,"TCGA-24-1844-01A",1.1,"A38574DB-890C-452C-ABB7-3C28B26D82AF","TCGA",2009,NA,NA,NA,"C54897B0-DF29-438B-A9D3-E6E7A09E466D",64,"THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_F04_495152.nocnv_hg19.seg.txt","Alive",NA,"TCGA-24-1844",NA,"CDB065D3-625B-4540-9004-D6477DA35365",NA,113,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,126,"DE22FAA4-E6C3-4F51-A17D-D450EE2EE1EB","7A111B11-334C-4EA2-910F-183AEE606F11","TCGA-24-1844-01A-01R-1567-13_rnaseq.bam","TCGA-24-1844-01A-01",90,0,0,0,10,"BOTTOM",0,0,"TCGA-24-1844-01A-01-BS1",90,"Docetaxel","Chemotherapy","TCGA-24-1844-D26336",NA,NA,NA,NA,NA,113,NA,"Alive",NA,"TCGA-24-1844-F26335","TCGA-24-1844",NA,"24","1844","YES","C56.9","8441/3","C56.9",NA,NA,-23542,"FEMALE","WHITE",NA,NA,"No","Alive",113,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,64,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
221442110,213244189,15755141422,"FAB4A6D6-E978-4172-9FE1-79FC50C0F849.bw","a3898640-0d85-441d-a000-b5b8ff857399","fab4a6d6-e978-4172-9fe1-79fc50c0f849","2016-09-30T00:14:45.681386-05:00","TCGA-24-1470-01A-01R-1566-13_rnaseq_fastq.tar","ed59fe28-9256-41c1-9d33-80c3f20c7367",15012024320,"Illumina HiSeq","8543d9393a24e5354dbd06020ca1c456","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:24:08.486645-05:00","2016-05-03T11:39:34.528512-05:00","ed59fe28-9256-41c1-9d33-80c3f20c7367_analysis.xml","aad302ed9772072edf36bbc79fb239a6","20f74a7f-7c60-4a2c-b1cf-df248bf62c05",2208,"2016-10-07T17:53:42.623404-05:00","ed59fe28-9256-41c1-9d33-80c3f20c7367_experiment.xml","68c894c1b52a72dcc74e85eec5ddd224","484976fa-5bb8-4efe-9478-6db1aaea1ddb",3916,"2016-09-29T22:28:53.982402-05:00","ed59fe28-9256-41c1-9d33-80c3f20c7367_run.xml","516ceb18765efab32b27b0e23ea1b1f5","b90c730d-82f7-4ff1-a815-f658e15d1631",1988,"2016-09-08T13:00:33.184818-05:00","TCGA-24-1470","2016-09-02T19:07:08.737587-05:00","female","TCGA-24-1470_demographic",1955,"white","db352bc7-95c7-59df-a9fe-4655e1c409df","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1470_diagnosis","not reported",20007,"alive","8441/3",NA,105,"7baca1af-8043-51b5-ab12-d87b025a8ded","c56.9",-20007,"TCGA-24-1470_treatment","f4a5e8c4-7ce4-5a44-9abd-6942c0721e86","01",NA,"TCGA-24-1470-01A","1","5287e961-91f0-4fb0-a00a-d570377cee62",FALSE,"f47eefcf-f15d-42cb-8bd2-d0c252ecafb3","Primary Tumor","0.5",NA,NA,"1.2",1234310400,"01",131,"TCGA-24-1470-01A-01",70,95,NA,NA,0,0,29,4,"2016-09-08T13:00:33.184818-05:00","2016-09-08T13:00:33.184818-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"b1fce053-0934-489a-b25c-2d05505e4bce","b8c86d30-2ff5-4a29-b5c9-deb324c8427a","TCGA-24-1470-01A-01-BS1","TCGA-24-1470-01A-01-TS1",70,95,"7ec05bd6-a496-440c-b0ec-fc2c468526ab","RNA","TCGA-24-1470-01A-01R","5a7e32dd-3b74-419e-b536-a77367edfe97",1.8,0.16,"UV Spec","R","22","TCGA-24-1470-01A-01R-1566-13","f2066443-2f17-4279-a993-f07961259108",0.16,NA,NA,NA,NA,"d576c7a4-6b92-5735-a833-b247dfb35493","TCGA-24-1470_exposure","TCGA-24-1470-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T05:21:34.000Z","2014-03-20T05:49:03.000Z","ED59FE28-9256-41C1-9D33-80C3F20C7367","5287E961-91F0-4FB0-A00A-D570377CEE62","Unaligned reads",15012024320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F2066443-2F17-4279-A993-F07961259108","Canada's Michael Smith Genome Sciences Centre","564a5b7ae4b093830b6d0204","A3898640-0D85-441D-A000-B5B8FF857399","Ovarian Serous Cystadenocarcinoma","TAR","7EC05BD6-A496-440C-B0EC-FC2C468526AB","2014-03-20T05:49:03.000Z","5A7E32DD-3B74-419E-B536-A77367EDFE97","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"7EC05BD6-A496-440C-B0EC-FC2C468526AB",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c9231718-6532-4ff2-b83f-4050d75b82fe.txt",NA,"TCGA-24-1470-01A",1.2,"C67A8709-2F8F-4D07-B3D0-548234C86B68","TCGA",2009,NA,NA,"TUMOR FREE","5287E961-91F0-4FB0-A00A-D570377CEE62",54,"753e7c8b620c270bc8173c545b141c4e.bam.bai","Alive",NA,"TCGA-24-1470",NA,"64784E56-EEF8-4003-9CC8-7F8BC725B2BD",NA,105,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,131,"B1FCE053-0934-489A-B25C-2D05505E4BCE","D67373DA-4DE9-4D1E-9654-7D9431478CC4","TCGA-24-1470-01A-01R-1566-13_mirna.bam.bai","TCGA-24-1470-01A-01",70,0,NA,NA,29,"BOTTOM",1,NA,"TCGA-24-1470-01A-01-BS1",70,"Docetaxel","Chemotherapy","TCGA-24-1470-D26065",NA,NA,NA,NA,NA,105,"TUMOR FREE","Alive",NA,"TCGA-24-1470-F26064","TCGA-24-1470",NA,"24","1470","YES","C56.9","8441/3","C56.9",NA,NA,-20007,"FEMALE","WHITE",NA,NA,"No","Alive",105,NA,NA,NA,"TUMOR FREE","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,54,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
304844078,296548053,21939810797,"32C4DF54-39DD-4F62-B938-82ED2A0E0FFD.bw","a3e26259-732b-49fb-bc95-2f0ec7a0494e","32c4df54-39dd-4f62-b938-82ed2a0e0ffd","2016-08-25T14:43:24.905037-05:00","TCGA-61-1743-01A-01R-1568-13_rnaseq_fastq.tar","50c8d938-ffd3-4d33-838f-5cdef45bcc1e",19927633920,"Illumina HiSeq","a75e6735f6a9e0f31c1e4929a09db92b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:01:56.328295-05:00","2016-05-03T11:41:05.755204-05:00","50c8d938-ffd3-4d33-838f-5cdef45bcc1e_analysis.xml","63f278791844df389bc6d0c7227ce87f","cd6c4d7d-40d4-421c-90ba-0734dc18f7d3",2183,"2016-09-29T22:28:10.383958-05:00","50c8d938-ffd3-4d33-838f-5cdef45bcc1e_experiment.xml","78dad7b41e9ffd37358cb56ae60294b4","b899a06e-428f-4960-8665-c9afe63fd751",3916,"2016-09-29T18:36:29.478134-05:00","50c8d938-ffd3-4d33-838f-5cdef45bcc1e_run.xml","2d88b93be7860020db6d96a052f2462e","28b5a1d5-3f6c-445f-91b4-926ae0eb5068",1990,"2016-09-08T11:09:49.140189-05:00","TCGA-61-1743","2016-09-02T18:50:42.946527-05:00","female","TCGA-61-1743_demographic",1951,"white","af7506f4-ac24-5171-bb5d-09f46567ea39","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1743_diagnosis","not reported",19365,"dead","8441/3",1329,1329,"93edbb37-2471-5683-98b2-d48d3c5d10c7","c56.9",-19365,"TCGA-61-1743_treatment","cd5d51f4-e605-5068-a5be-428d6c78155b","01",NA,"TCGA-61-1743-01A","1","4090084e-e95a-4112-b87f-bddafc13b333",FALSE,"190b258b-d756-4872-b5f4-53c2d10e86b1","Primary Tumor","0.3",NA,NA,"1.5",1242518400,"01",119,"TCGA-61-1743-01A-01",90,80,NA,NA,0,0,0,0,"2016-09-08T11:09:49.140189-05:00","2016-09-08T11:09:49.140189-05:00",NA,10,NA,NA,"TOP","BOTTOM",5,5,"86fa0bbe-e71b-4451-8b78-a801394d9a85","0361c2a0-1d49-4d4c-923d-1556c6da5b1a","TCGA-61-1743-01A-01-TS1","TCGA-61-1743-01A-01-BS1",95,95,"aebdc4b2-a9d8-40c2-a52a-61a8a6342357","RNA","TCGA-61-1743-01A-01R","a8987ccb-9832-42d8-ad85-85dd899fa6c5",1.8,0.17,"UV Spec","R","22","TCGA-61-1743-01A-01R-1568-13","f3277084-b0a8-43df-946e-dc792bbb8cdb",0.17,NA,NA,NA,NA,"fda313b7-c912-5514-a50f-c6217d4a68cb","TCGA-61-1743_exposure","TCGA-61-1743-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T09:03:24.000Z","2014-03-27T09:38:02.000Z","50C8D938-FFD3-4D33-838F-5CDEF45BCC1E","4090084E-E95A-4112-B87F-BDDAFC13B333","Unaligned reads",19927633920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F3277084-B0A8-43DF-946E-DC792BBB8CDB","Canada's Michael Smith Genome Sciences Centre","564a59e8e4b08c5d8694bd01","A3E26259-732B-49FB-BC95-2F0EC7A0494E","Ovarian Serous Cystadenocarcinoma","TAR","AEBDC4B2-A9D8-40C2-A52A-61A8A6342357","2014-03-27T09:38:02.000Z","A8987CCB-9832-42D8-AD85-85DD899FA6C5","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"AEBDC4B2-A9D8-40C2-A52A-61A8A6342357",1,"61","LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_D06_517978.hg19.seg.txt",NA,"TCGA-61-1743-01A",1.5,"90EA70E1-CEFE-4BEE-B0BB-C04B6269D3A3","TCGA",2004,NA,NA,"WITH TUMOR","42FB2598-AB68-4E94-8EC0-2C26D1444305",53,"jhu-usc.edu_OV.HumanMethylation27.10.lvl-2.TCGA-61-1743-01A-01D-0652-05.txt","Dead",1329,"TCGA-61-1743","NOT HISPANIC OR LATINO","B213F402-12F7-443A-BCE1-F344086505FB",NA,1329,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,119,"86FA0BBE-E71B-4451-8B78-A801394D9A85","A8987CCB-9832-42D8-AD85-85DD899FA6C5","TCGA-61-1743-01A-01R-1568-13_rnaseq.bam","TCGA-61-1743-01A-01",80,0,NA,10,0,"BOTTOM",5,NA,"TCGA-61-1743-01A-01-BS1",95,"Taxol","Chemotherapy","TCGA-61-1743-D28210",NA,NA,NA,"TCGA-61-1743-F28209_NTE-2",NA,1329,"WITH TUMOR","Dead",1329,"TCGA-61-1743-F28209","TCGA-61-1743",NA,"61","1743","YES","C56.9","8441/3","C56.9",NA,NA,-19365,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1329,1329,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,53,2004,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
90120426,78602891,5696707462,"9911D83E-6DDF-4048-9A34-22BFA1D68BBD.bw","a5030259-cf9c-4a58-8710-b9da8ee59320","9911d83e-6ddf-4048-9a34-22bfa1d68bbd","2016-08-25T17:45:29.115374-05:00","TCGA-10-0937-01A-02R-1564-13_rnaseq_fastq.tar","ace0f64f-40d0-4875-b93c-4d6c8bf32872",5401856000,"Illumina HiSeq","9dc12787795038265bb0880e61615b9e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:17:38.515089-05:00","2016-05-03T11:39:34.528512-05:00","ace0f64f-40d0-4875-b93c-4d6c8bf32872_analysis.xml","1249d8182c72dcf54363b6e6d649424e","42c8c04b-c60d-4616-bfe4-6e6b8c9f721a",2265,"2016-09-29T22:04:46.334282-05:00","ace0f64f-40d0-4875-b93c-4d6c8bf32872_experiment.xml","91dd25c9475e5c39a83a74a1a7771338","aa4d4c7a-e7de-4cfb-8036-eeea0920136d",3916,"2016-09-30T00:13:01.901508-05:00","ace0f64f-40d0-4875-b93c-4d6c8bf32872_run.xml","210acb7cbed7a3c01e0a445e236246b2","f996d0f4-557a-4044-9280-1bf57c923504",1988,"2016-09-08T12:19:14.829854-05:00","TCGA-10-0937","2016-09-02T19:06:15.373780-05:00","female","TCGA-10-0937_demographic",1961,"white","ec4793f1-4af3-5052-bc55-d865c8d8a000","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0937_diagnosis","not reported",16222,"dead","8441/3",608,460,"4a6e1e14-2751-5cb3-b3b1-b559944ace34","c56.9",-16222,"TCGA-10-0937_treatment","237d5a37-b0e1-50be-a0bc-5e78e355e012","01",NA,"TCGA-10-0937-01A","0.4","8585d596-4d6b-4f6c-bb46-a2661f9ca05a",FALSE,"2a86dcb5-1af7-447d-b20f-eef4972048a0","Primary Tumor","0.4",NA,NA,"0.6",1233705600,"02",109,"TCGA-10-0937-01A-02",80,85,NA,NA,5,5,20,15,"2016-09-08T12:19:14.829854-05:00","2016-09-08T12:19:14.829854-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"37919e58-3142-472b-8dc2-f55a22a976ce","d5858cfe-47d7-442a-a3a0-fde1e69b919e","TCGA-10-0937-01A-01-BS1","TCGA-10-0937-01A-02-BS2",75,80,"03c4677e-eae6-48b2-8840-9d2ef801a330","RNA","TCGA-10-0937-01A-02R","0c5cdff9-10e5-4d0c-ae72-cebbcd6d47a2",1.8,0.15,"UV Spec","R","22","TCGA-10-0937-01A-02R-1564-13","6392a07a-79e2-4272-abfe-329d1029bb09",0.15,NA,NA,NA,NA,"1389661f-a4b2-5c3b-869d-3a4233d46c07","TCGA-10-0937_exposure","TCGA-10-0937-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-20T03:56:48.000Z","2014-03-20T04:09:02.000Z","ACE0F64F-40D0-4875-B93C-4D6C8BF32872","8585D596-4D6B-4F6C-BB46-A2661F9CA05A","Unaligned reads",5401856000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6392A07A-79E2-4272-ABFE-329D1029BB09","Canada's Michael Smith Genome Sciences Centre","564a3d44e4b0ef12181b0823","A5030259-CF9C-4A58-8710-B9DA8EE59320","Ovarian Serous Cystadenocarcinoma","TAR","03C4677E-EAE6-48B2-8840-9D2EF801A330","2014-03-20T04:09:02.000Z","0C5CDFF9-10E5-4D0C-AE72-CEBBCD6D47A2","None","NO",1,0.4,"Primary Tumor","MD Anderson Cancer Center",NA,"03C4677E-EAE6-48B2-8840-9D2EF801A330",0.4,"10","TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.bam",NA,"TCGA-10-0937-01A",0.6,"F638EA11-A654-4755-AF37-E67DED7C0CA7","TCGA",2005,NA,NA,"WITH TUMOR","8585D596-4D6B-4F6C-BB46-A2661F9CA05A",44,"nationwidechildrens.org_clinical.TCGA-10-0937.xml","Dead",608,"TCGA-10-0937",NA,"33721CD1-5029-49C4-BC36-64EE90E76DF1",NA,460,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,2,109,"D5858CFE-47D7-442A-A3A0-FDE1E69B919E","CCC203E4-CB22-4C22-9BF3-E1CC8378FA6E","TCGA-10-0937-01A-02W-0419-10_SOLiD_whole_exome_extensions.bam.bai","TCGA-10-0937-01A-02",80,5,NA,NA,20,"TOP",0,NA,"TCGA-10-0937-01A-01-BS1",75,"Taxol","Chemotherapy","TCGA-10-0937-D24477",NA,NA,NA,"TCGA-10-0937-F24476_NTE-1",NA,460,"WITH TUMOR","Dead",608,"TCGA-10-0937-F24476","TCGA-10-0937",NA,"10","0937","YES","C56.9","8441/3","C56.9",NA,NA,-16222,"FEMALE","WHITE",NA,NA,"No","Dead",460,608,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
235614184,225064936,16601236718,"4BAC0A03-BB88-4D19-86F9-FF093330C9B3.bw","a6aad7f9-8444-4c2f-8e4b-b19fd453544f","4bac0a03-bb88-4d19-86f9-ff093330c9b3","2016-08-25T01:46:37.847358-05:00","TCGA-04-1361-01A-01R-1565-13_rnaseq_fastq.tar","6d3c5d53-193d-494d-936c-ad9cf6bf96bf",15059568640,"Illumina HiSeq","1545789de24cffc6669ab79373062e29","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:12:54.842818-05:00","2016-05-03T11:40:21.648680-05:00","6d3c5d53-193d-494d-936c-ad9cf6bf96bf_analysis.xml","8a45e0d4c6d049e898728b782b6c6ff7","3fd33591-5c60-4f92-8981-e9ca041599a4",2235,"2016-09-29T21:11:54.246140-05:00","6d3c5d53-193d-494d-936c-ad9cf6bf96bf_experiment.xml","6fb2794d554477e0060a88a0c0164560","897f13ba-8232-410f-a855-f1f027810229",3916,"2016-09-29T22:27:53.316168-05:00","6d3c5d53-193d-494d-936c-ad9cf6bf96bf_run.xml","0fa3dee33861bfb29ae2fc22e3dbb441","b86b2898-f48b-4f6f-9a37-05defc725978",1988,"2016-09-08T13:35:59.167408-05:00","TCGA-04-1361","2016-09-02T19:11:58.104080-05:00","female","TCGA-04-1361_demographic",1948,"white","7640a9d1-04b1-5950-8139-52e731454d82","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1361_diagnosis","not reported",20860,"alive","8441/3",NA,989,"20329fd9-e669-5e99-8572-55ca9d382aec","c56.9",-20860,"TCGA-04-1361_treatment","919c412a-9363-54c4-bacf-d58a709a0a04","01",NA,"TCGA-04-1361-01A","0.4","702cc8d9-38f6-474a-bd7e-e56820c5a5b0",FALSE,"5116FD62-7A2C-425A-A99E-D47C1B456961","Primary Tumor","0.3",NA,NA,"0.8",1229558400,"01",93,"TCGA-04-1361-01A-01",80,80,NA,NA,0,0,30,30,"2016-09-08T13:35:59.167408-05:00","2016-09-08T13:35:59.167408-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"58eecb9c-dfa5-450a-8057-4545340dc5ac","b4e0df05-3e78-4414-9430-b4d97a09befb","TCGA-04-1361-01A-01-TS1","TCGA-04-1361-01A-01-BS1",69,69,"649a4231-7a0f-4457-923c-58b9eedfe777","RNA","TCGA-04-1361-01A-01R","016703b6-0df1-410a-91d9-857da7e01ed2",1.8,0.16,"UV Spec","R","22","TCGA-04-1361-01A-01R-1565-13","746ba0b0-f7a4-4f43-9961-97dccc756e71",0.16,NA,NA,NA,NA,"78e98ab0-3a8d-5688-b36f-e1d9db4e2c02","TCGA-04-1361_exposure","TCGA-04-1361-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T23:09:21.000Z","2014-03-21T23:50:01.000Z","6D3C5D53-193D-494D-936C-AD9CF6BF96BF","702CC8D9-38F6-474A-BD7E-E56820C5A5B0","Unaligned reads",15059568640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","746BA0B0-F7A4-4F43-9961-97DCCC756E71","Canada's Michael Smith Genome Sciences Centre","564a5a61e4b0298dd2cbd36e","A6AAD7F9-8444-4C2F-8E4B-B19FD453544F","Ovarian Serous Cystadenocarcinoma","TAR","649A4231-7A0F-4457-923C-58B9EEDFE777","2014-03-21T23:50:01.000Z","016703B6-0DF1-410A-91D9-857DA7E01ED2","None","NO",1,0.3,"Primary Tumor","Gynecologic Oncology Group",NA,"649A4231-7A0F-4457-923C-58B9EEDFE777",0.4,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.62d06e8a-aed1-4904-8651-c9912e5b1eae.txt",NA,"TCGA-04-1361-01A",0.8,"A5CE32B9-E2C9-4F51-803D-168A80A2A582","TCGA",2005,NA,NA,NA,"702CC8D9-38F6-474A-BD7E-E56820C5A5B0",57,"TCGA-04-1361-01A-01R-1565-13_mirna.bam","Alive",NA,"TCGA-04-1361",NA,"015F5756-302F-4344-B865-61515B2151B8",NA,989,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,93,"B4E0DF05-3E78-4414-9430-B4D97A09BEFB","ABDCF4C1-0D74-4C94-9E45-B4113A4BE93A","bcgsc.ca.TCGA-04-1361-01A-01R-1565-13.bcgsc.ca.1.5.0.snv.vcf","TCGA-04-1361-01A-01",80,0,NA,NA,30,"BOTTOM",1,NA,"TCGA-04-1361-01A-01-BS1",69,"Doxil","Chemotherapy","TCGA-04-1361-D24017",NA,NA,NA,"TCGA-04-1361-F24013_NTE-1",NA,989,NA,"Alive",NA,"TCGA-04-1361-F24013","TCGA-04-1361",NA,"04","1361","YES","C56.9","8441/3","C56.9",NA,NA,-20860,"FEMALE","WHITE",NA,NA,"No","Alive",989,NA,NA,NA,NA,"NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA
121505118,118332491,8729654418,"18F63ADA-1828-43DD-AE1F-F36706C204CD.bw","a6eb0cd0-fe57-41b0-8593-776208684293","18f63ada-1828-43dd-ae1f-f36706c204cd","2016-09-29T18:11:09.640589-05:00","TCGA-61-1725-01A-01R-1567-13_rnaseq_fastq.tar","abd8fb0a-31d6-40de-bd88-9a434fb28d34",7550433280,"Illumina HiSeq","2c21712903e27ad71734f5c3c4b90c03","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:55:31.032650-05:00","2016-05-03T11:41:05.740763-05:00","abd8fb0a-31d6-40de-bd88-9a434fb28d34_analysis.xml","1da1efd24b7739e20826467c3019df12","5a6ad49d-9aca-4c18-9246-9ce3b5a0eadf",2181,"2016-09-29T21:36:39.326424-05:00","abd8fb0a-31d6-40de-bd88-9a434fb28d34_experiment.xml","80af45490d7004342507581c121e0a66","98c8cb1e-cc67-4557-be69-9ce232798d86",3916,"2016-09-29T18:47:15.107576-05:00","abd8fb0a-31d6-40de-bd88-9a434fb28d34_run.xml","2df79a55e6750388ae32474c441a932a","2fa4339e-4489-4f53-8677-c9953e836f37",1988,"2016-09-08T10:38:59.469715-05:00","TCGA-61-1725","2016-09-02T18:47:47.690345-05:00","female","TCGA-61-1725_demographic",1967,"white","1567ed8d-6ce0-5fab-b6a3-901c244c2235","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1725_diagnosis","not reported",14782,"alive","8441/3",NA,956,"9ff03257-e85c-5449-95be-ea2f7d51e27d","c56.9",-14782,"TCGA-61-1725_treatment","d5198be0-1414-55b3-98ae-cbb0ea820f6a","01",NA,"TCGA-61-1725-01A","0.8","6ecade07-4c2f-4587-9c8b-589943f1c9e6",FALSE,"8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04","Primary Tumor","0.4",NA,NA,"1",1242518400,"01",137,"TCGA-61-1725-01A-01",95,90,NA,NA,0,0,0,0,"2016-09-08T10:38:59.469715-05:00","2016-09-08T10:38:59.469715-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,20,"19559478-b60e-4af8-b6f0-a6773f29175a","99fc6def-5952-425f-ac0f-393aac908d99","TCGA-61-1725-01A-01-BS1","TCGA-61-1725-01A-01-TS1",90,80,"6a29c6f2-ee27-475b-b791-8d4c775b47a6","RNA","TCGA-61-1725-01A-01R","e2608fdf-7c1f-4a21-a11a-1d7da53e147b",1.8,0.15,"UV Spec","R","22","TCGA-61-1725-01A-01R-1567-13","748ff969-cb49-4f22-994f-6debe734c38f",0.15,NA,NA,NA,NA,"0afb41eb-ce05-50e8-8958-76ecfbc77d77","TCGA-61-1725_exposure","TCGA-61-1725-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T22:42:10.000Z","2014-03-26T23:10:02.000Z","ABD8FB0A-31D6-40DE-BD88-9A434FB28D34","6ECADE07-4C2F-4587-9C8B-589943F1C9E6","Unaligned reads",7550433280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","748FF969-CB49-4F22-994F-6DEBE734C38F","Canada's Michael Smith Genome Sciences Centre","564a34c4e4b0298dd2c64782","A6EB0CD0-FE57-41B0-8593-776208684293","Ovarian Serous Cystadenocarcinoma","TAR","6A29C6F2-EE27-475B-B791-8D4C775B47A6","2014-03-26T23:10:02.000Z","E2608FDF-7C1F-4A21-A11A-1D7DA53E147B","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"6A29C6F2-EE27-475B-B791-8D4C775B47A6",0.8,"61","TCGA-61-1725-01A-01R-1567-13_rnaseq.bam.bai",NA,"TCGA-61-1725-01A",1,"FF470391-4FB2-4EE9-B99A-DB1CA43E94DF","TCGA",2007,NA,NA,"WITH TUMOR","6ECADE07-4C2F-4587-9C8B-589943F1C9E6",40,"nationwidechildrens.org_clinical.TCGA-61-1725.xml","Alive",NA,"TCGA-61-1725","NOT HISPANIC OR LATINO","4795B469-2EA1-4E65-BB8F-5B401B6632D5",NA,956,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,137,"99FC6DEF-5952-425F-AC0F-393AAC908D99","E2608FDF-7C1F-4A21-A11A-1D7DA53E147B","TCGA-61-1725-01A-01R-1567-13_rnaseq.bam.bai","TCGA-61-1725-01A-01",90,0,NA,NA,0,"TOP",20,NA,"TCGA-61-1725-01A-01-TS1",80,"Gamzar","Chemotherapy","TCGA-61-1725-D28150",NA,NA,NA,"TCGA-61-1725-F28143_NTE-1",NA,956,"WITH TUMOR","Alive",NA,"TCGA-61-1725-F28143","TCGA-61-1725",NA,"61","1725","YES","C56.9","8441/3","C56.9",NA,NA,-14782,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",956,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,40,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
239102064,231236700,17090809139,"66729295-C0AA-42C7-92C9-05194EF02276.bw","a782352e-c4bb-4c3e-ba82-456a47c3689a","66729295-c0aa-42c7-92c9-05194ef02276","2016-08-25T11:47:03.281580-05:00","TCGA-24-1845-01A-01R-1567-13_rnaseq_fastq.tar","f83ed766-8de7-48ee-aa32-91381efcd573",15356835840,"Illumina HiSeq","5c326ffc6c6485436f867d761bd00e0d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:38:59.731423-05:00","2016-05-03T11:41:05.748550-05:00","f83ed766-8de7-48ee-aa32-91381efcd573_analysis.xml","4b6db44fe37a5312e1d36e9a510e5889","048d3235-79bf-49b3-9ea5-289e318c3d28",2210,"2016-09-29T19:14:07.202849-05:00","f83ed766-8de7-48ee-aa32-91381efcd573_experiment.xml","163011df27036c050f8c59a03c573e12","40993756-a3ee-476a-955a-bf3c60b20565",3916,"2016-09-29T22:30:39.116456-05:00","f83ed766-8de7-48ee-aa32-91381efcd573_run.xml","8ea962888f0bfd81d757550894aebbb9","ba2a197b-5842-4439-9cfb-1eff25658fe8",1989,"2016-09-08T10:53:21.775762-05:00","TCGA-24-1845","2016-09-02T18:48:18.694188-05:00","female","TCGA-24-1845_demographic",1967,"white","4992063f-c38e-540f-852c-da0c5b9e027b","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1845_diagnosis","not reported",15599,"alive","8441/3",NA,116,"77f2d86e-3e74-5e0b-a3b4-dc55a7d1702e","c56.9",-15599,"TCGA-24-1845_treatment","7d9db0d7-056f-553a-9d8a-fbfb7f7b2e67","01",NA,"TCGA-24-1845-01A","0.8","c6987abb-e8cb-4701-bee2-416627c1f970",FALSE,"1fda446a-e0d2-422a-a023-57ec5bfae62b","Primary Tumor","0.5",NA,NA,"1.8",1245628800,"01",136,"TCGA-24-1845-01A-01",90,95,0,0,0,0,0,5,"2016-09-08T10:53:21.775762-05:00","2016-09-08T10:53:21.775762-05:00",0,0,10,0,"BOTTOM","TOP",10,0,"fbc4f1c3-ac59-4dab-b77f-61da0511bcad","c7917780-aa0a-4784-8a61-222bb9edf646","TCGA-24-1845-01A-01-BS1","TCGA-24-1845-01A-01-TS1",90,95,"bc78f3b6-2463-4321-a9d0-c69493af2814","RNA","TCGA-24-1845-01A-01R","48420409-efd3-4fec-91c2-8d8bdfa202a3",1.8,0.14,"UV Spec","R","22","TCGA-24-1845-01A-01R-1567-13","78b612c0-5323-46e9-962e-497ad3c877c1",0.14,NA,NA,NA,NA,"c8ff9270-2ab7-5998-8768-70627c680393","TCGA-24-1845_exposure","TCGA-24-1845-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T04:06:12.000Z","2014-03-29T04:33:02.000Z","F83ED766-8DE7-48EE-AA32-91381EFCD573","C6987ABB-E8CB-4701-BEE2-416627C1F970","Unaligned reads",15356835840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","78B612C0-5323-46E9-962E-497AD3C877C1","Canada's Michael Smith Genome Sciences Centre","564a569ee4b0298dd2ca9589","A782352E-C4BB-4C3E-BA82-456A47C3689A","Ovarian Serous Cystadenocarcinoma","TAR","BC78F3B6-2463-4321-A9D0-C69493AF2814","2014-03-29T04:33:02.000Z","48420409-EFD3-4FEC-91C2-8D8BDFA202A3","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"BC78F3B6-2463-4321-A9D0-C69493AF2814",0.8,"24","THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_G04_495032.tangent.copynumber.data.txt",NA,"TCGA-24-1845-01A",1.8,"BD50326E-286B-406C-93DA-AC4A34F33BB0","TCGA",2009,NA,NA,NA,"C6987ABB-E8CB-4701-BEE2-416627C1F970",42,"nationwidechildrens.org_clinical.TCGA-24-1845.xml","Alive",NA,"TCGA-24-1845",NA,"589F82E0-F528-49EC-AB57-8EFFF59E192C",NA,116,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,136,"C7917780-AA0A-4784-8A61-222BB9EDF646","B60223BC-5808-4C28-8502-3757FD6A584E","TCGA-24-1845-01A-01R-1567-13_rnaseq.bam.bai","TCGA-24-1845-01A-01",90,0,0,0,0,"BOTTOM",10,10,"TCGA-24-1845-01A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-24-1845-D26341",NA,NA,NA,NA,NA,116,NA,"Alive",NA,"TCGA-24-1845-F26340","TCGA-24-1845",NA,"24","1845","YES","C56.9","8441/3","C56.9",NA,NA,-15599,"FEMALE","WHITE",NA,NA,"No","Alive",116,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,42,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
145475774,141930637,10513211803,"4CCA3104-B557-403D-AC06-A6D4936DDC04.bw","a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61","4cca3104-b557-403d-ac06-a6d4936ddc04","2016-08-25T01:19:56.510863-05:00","TCGA-13-1488-01A-01R-1565-13_rnaseq_fastq.tar","00fe9b68-df81-4ff2-9fa2-7ca2d4aa737a",8761077760,"Illumina HiSeq","3d2b4641f57b1bf4cc2a04a74a16d638","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:57:10.774513-05:00","2016-05-03T11:40:21.647690-05:00","00fe9b68-df81-4ff2-9fa2-7ca2d4aa737a_analysis.xml","47174da16098bb89371c8067a5f1cbf8","102c04af-bb59-4a6b-b966-a5b8da93f401",2235,"2016-08-13T06:03:14.921022-05:00","00fe9b68-df81-4ff2-9fa2-7ca2d4aa737a_experiment.xml","b4a8a102fd7139b9e50c99b6618715f4","58bf7c34-864d-455e-abdc-02656e2e2084",3916,"2016-09-29T18:23:15.773440-05:00","00fe9b68-df81-4ff2-9fa2-7ca2d4aa737a_run.xml","8e2caf9a367fd0720378a8de6f399b41","206d84fe-cfa1-4f3d-baf0-fa7ec220cf22",1989,"2016-09-08T13:55:57.644653-05:00","TCGA-13-1488","2016-09-02T19:13:58.068523-05:00","female","TCGA-13-1488_demographic",1943,"white","b6bd947a-dae0-5ef3-905e-02630b777a39","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1488_diagnosis","not reported",21726,"dead","8441/3",2154,2154,"04ce8f92-1262-5b87-9371-5b7f0e7d3f5f","c56.9",-21726,"TCGA-13-1488_treatment","1773f89d-ed73-5734-a705-e5272bf0c60c","01",NA,"TCGA-13-1488-01A","1","22461884-5fdb-4188-a469-5dfa55a2823e",FALSE,"79A91E41-0B59-4328-B7BB-2B4EEAD46A89","Primary Tumor","0.4",NA,NA,"2.3",1234396800,"01",134,"TCGA-13-1488-01A-01",85,95,NA,NA,0,0,30,15,"2016-09-08T13:55:57.644653-05:00","2016-09-08T13:55:57.644653-05:00",NA,95,NA,5,"BOTTOM","TOP",0,5,"783d5d20-6ac1-4777-9bf8-dc82d203c7d6","3972462a-d30c-473e-a62b-dae7de1ef2bd","TCGA-13-1488-01A-01-BS1","TCGA-13-1488-01A-01-TS1",70,80,"a215dab2-86d3-4338-89f2-f8540ac64c58","RNA","TCGA-13-1488-01A-01R","e8ef3c13-4826-4c45-b759-cd3ce898b1f2",1.8,0.14,"UV Spec","R","22","TCGA-13-1488-01A-01R-1565-13","fbd513d6-46e8-48f7-9dc3-f7369ad0f3c7",0.14,NA,NA,NA,NA,"b8f30501-ee11-50c5-9c79-09cb051735e2","TCGA-13-1488_exposure","TCGA-13-1488-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T03:20:35.000Z","2014-03-22T03:42:02.000Z","00FE9B68-DF81-4FF2-9FA2-7CA2D4AA737A","22461884-5FDB-4188-A469-5DFA55A2823E","Unaligned reads",8761077760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FBD513D6-46E8-48F7-9DC3-F7369AD0F3C7","Canada's Michael Smith Genome Sciences Centre","564a58efe4b0298dd2cb5993","A85F6F9C-1E1D-44FC-85EB-3B2D96CFBC61","Ovarian Serous Cystadenocarcinoma","TAR","A215DAB2-86D3-4338-89F2-F8540AC64C58","2014-03-22T03:42:02.000Z","E8EF3C13-4826-4C45-B759-CD3CE898B1F2","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"A215DAB2-86D3-4338-89F2-F8540AC64C58",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1ec3bf38-f06e-4789-a298-cde202cf3649.txt",NA,"TCGA-13-1488-01A",2.3,"8B1F61BC-DD0D-42E7-818B-D437B5B7C0A6","TCGA",2002,NA,NA,"WITH TUMOR","D5AE0367-43E7-4D1C-835F-A192D699D49F",59,"TCGA-13-1488-01A-01R-1565-13_mirna.bam","Dead",2154,"TCGA-13-1488","NOT HISPANIC OR LATINO","F8CC6EE8-0004-4C4C-9D2E-38888CD6C5C4",NA,2154,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,134,"783D5D20-6AC1-4777-9BF8-DC82D203C7D6","E8EF3C13-4826-4C45-B759-CD3CE898B1F2","TCGA-13-1488-01A-01R-1565-13_GRCh37-lite_mirna.bam","TCGA-13-1488-01A-01",85,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-13-1488-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-13-1488-D24872",NA,NA,NA,"TCGA-13-1488-F24871_NTE-1",NA,2154,"WITH TUMOR","Dead",2154,"TCGA-13-1488-F24871","TCGA-13-1488",NA,"13","1488","YES","C56.9","8441/3","C56.9",NA,NA,-21726,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",2154,2154,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,59,2002,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
102429422,100927141,7467822310,"77D4165E-7CB1-4D69-AFE5-C8D914531651.bw","a8c4a333-6b67-44c8-9000-516f8ccea788","77d4165e-7cb1-4d69-afe5-c8d914531651","2016-08-21T02:03:46.762201-05:00","TCGA-24-2271-01A-01R-1568-13_rnaseq_fastq.tar","1f0fc50a-3658-4f36-9bbf-a7c01cd7a5d0",5793218560,"Illumina HiSeq","ab09d6015caaab3fa6ecb7850ef0c875","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:37:22.506649-05:00","2016-05-03T11:56:42.628342-05:00","1f0fc50a-3658-4f36-9bbf-a7c01cd7a5d0_analysis.xml","d671e01ec95ed91d4e8158f1227950c0","73d4efab-0f12-493e-8075-2c9e645e384f",2181,"2016-10-07T17:35:29.670699-05:00","1f0fc50a-3658-4f36-9bbf-a7c01cd7a5d0_experiment.xml","27bea62b50a76517ac66319a2935213b","5ca967c8-8dd6-49ac-8ae8-1af9cec41c66",3916,"2016-09-29T22:40:32.959689-05:00","1f0fc50a-3658-4f36-9bbf-a7c01cd7a5d0_run.xml","95d2aeacf80846f0961148b71c59b3e9","c0547865-61d5-46c7-a051-fae95d7e8c27",1988,"2016-09-08T13:48:35.510574-05:00","TCGA-24-2271","2016-09-02T19:11:58.077408-05:00","female","TCGA-24-2271_demographic",1944,"asian","ade57b50-0f6f-525d-b4d9-895575ae7a36","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2271_diagnosis","not reported",20399,"dead","8441/3",962,962,"ae67d486-7f72-5338-90a8-592460e5a8d4","c56.9",-20399,"TCGA-24-2271_treatment","82203de9-9821-59e2-80b1-afd36bf7da68","01",NA,"TCGA-24-2271-01A","0.8","de9d08f5-24f5-4cdc-8f30-d05a2bea5301",FALSE,"87d64a93-9b08-48a5-a26e-1cc4b5ac8bde","Primary Tumor","0.5",NA,NA,"1.6",1251676800,"01",143,"TCGA-24-2271-01A-01",80,80,NA,NA,0,0,15,20,"2016-09-08T13:48:35.510574-05:00","2016-09-08T13:48:35.510574-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"bed2de0b-65ae-49a2-8fc6-a1ad85be2972","b6591fc7-87de-4c84-968f-5a07d4cb9dcc","TCGA-24-2271-01A-01-BS1","TCGA-24-2271-01A-01-TS1",85,80,"83da0e24-3b0e-4cf9-a4ad-34ef419f2316","RNA","TCGA-24-2271-01A-01R","e8406b8d-b1d6-4f96-8a43-8f48c5f1d898",1.8,0.15,"UV Spec","R","22","TCGA-24-2271-01A-01R-1568-13","f3581696-e1db-4d0f-9ce7-5fb0f5c08906",0.15,NA,NA,NA,NA,"4d82013f-496e-5dcb-8d7f-3f151ed1c999","TCGA-24-2271_exposure","TCGA-24-2271-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T02:41:23.000Z","2014-08-28T04:45:35.000Z","1F0FC50A-3658-4F36-9BBF-A7C01CD7A5D0","DE9D08F5-24F5-4CDC-8F30-D05A2BEA5301","Unaligned reads",5793218560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F3581696-E1DB-4D0F-9CE7-5FB0F5C08906","Canada's Michael Smith Genome Sciences Centre","564a5c64e4b0298dd2cc4b91","A8C4A333-6B67-44C8-9000-516F8CCEA788","Ovarian Serous Cystadenocarcinoma","TAR","83DA0E24-3B0E-4CF9-A4AD-34EF419F2316","2014-08-28T04:45:35.000Z","E8406B8D-B1D6-4F96-8A43-8F48C5F1D898","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"83DA0E24-3B0E-4CF9-A4AD-34EF419F2316",0.8,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.9651ae11-92cc-4085-b9f5-b141eff0fb99.txt",NA,"TCGA-24-2271-01A",1.6,"9CC98084-F3E0-467D-AAC7-D99952FA1FC1","TCGA",1999,NA,NA,"WITH TUMOR","E92173A1-8036-40DB-A295-5C15EF18B528",55,"TCGA-24-2271-01A-01D-0707-02_S01_CGH_105_Dec08_1_2.txt","Dead",962,"TCGA-24-2271",NA,"FD661EA5-F3FD-4B72-A100-02BD5CE517DC",NA,962,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"ASIAN",NA,1,143,"BED2DE0B-65AE-49A2-8FC6-A1AD85BE2972","C7D367C8-6E8F-47E5-87CE-858E1E4D5D53","nationwidechildrens.org_biospecimen.TCGA-24-2271.xml","TCGA-24-2271-01A-01",80,0,NA,NA,20,"TOP",0,NA,"TCGA-24-2271-01A-01-TS1",80,NA,"Chemotherapy","TCGA-24-2271-D26558",NA,NA,NA,"TCGA-24-2271-F26557_NTE-2",NA,962,"WITH TUMOR","Dead",962,"TCGA-24-2271-F26557","TCGA-24-2271",NA,"24","2271","YES","C56.9","8441/3","C56.9",NA,NA,-20399,"FEMALE","ASIAN",NA,NA,"No","Dead",962,962,NA,NA,"WITH TUMOR","NO",5,4,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,55,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
136972564,125940745,9269038269,"BA12A05A-622A-424D-8108-3F5916405EB0.bw","a9abe7a7-4126-414b-87d2-a6d25abcf1fa","ba12a05a-622a-424d-8108-3f5916405eb0","2016-08-26T08:07:08.917139-05:00","TCGA-13-0724-01A-01R-1564-13_rnaseq_fastq.tar","13668db0-12e4-406b-ba42-09f1099161dc",8801310720,"Illumina HiSeq","5e78261207d9165f2c4befdcbb8758e3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:20:46.960509-05:00","2016-05-03T11:27:59.332723-05:00","13668db0-12e4-406b-ba42-09f1099161dc_analysis.xml","ef6eb9df1a539006b94beaca3f4ec4cc","8f0f6abe-281f-4bf6-a8a6-2330ac21a918",2210,"2016-09-29T20:49:52.511877-05:00","13668db0-12e4-406b-ba42-09f1099161dc_experiment.xml","1498a1a50a8a88b34fd5a25179e7519c","7ba55cc6-a985-4d89-86ae-4f9ea55afd90",3916,"2016-09-29T23:47:18.949788-05:00","13668db0-12e4-406b-ba42-09f1099161dc_run.xml","82cc6e22d4fd225c9b77c3f53674b6b3","e9dc2855-cf7e-4483-8c61-3c3a9ca330ed",1990,"2016-09-08T10:32:48.380510-05:00","TCGA-13-0724","2016-09-02T19:09:41.981592-05:00","female","TCGA-13-0724_demographic",1930,"white","f7209024-2212-57c6-a911-814f868dded7","hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0724_diagnosis","not reported",26342,"dead","8441/3",83,83,"b91001a3-8a3f-5dfc-8ec8-33576a6f86c7","c56.9",-26342,"TCGA-13-0724_treatment","18f395e7-41cf-5bc5-ae77-985e648fbed5","01",NA,"TCGA-13-0724-01A","0.7","30abe357-43d0-434c-99d1-affe0fd047d8",FALSE,"1EC7581B-E7B6-41B9-B96C-DCAF37912D3F","Primary Tumor","0.4",NA,NA,"1.3",1233705600,"01",84,"TCGA-13-0724-01A-01",95,98,NA,NA,0,0,10,5,"2016-09-08T10:32:48.380510-05:00","2016-09-08T10:32:48.380510-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"d39fed4b-f145-4c60-8fd1-81541b8bbbd1","bb70ca78-9511-406f-b555-917d69bbdddf","TCGA-13-0724-01A-01-BS1","TCGA-13-0724-01A-01-TS1",90,95,"89083700-8720-4128-aae6-c21175e3ddae","RNA","TCGA-13-0724-01A-01R","201b8a36-94fb-4ba8-9bef-47e92bc01a03",1.8,0.19,"UV Spec","R","22","TCGA-13-0724-01A-01R-1564-13","fc6df206-8c77-486c-bc38-06b6cf20139d",0.19,NA,NA,NA,NA,"f28e3a0f-47c2-5c42-8265-33fceb122cf5","TCGA-13-0724_exposure","TCGA-13-0724-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T23:42:51.000Z","2013-12-20T23:57:01.000Z","13668DB0-12E4-406B-BA42-09F1099161DC","30ABE357-43D0-434C-99D1-AFFE0FD047D8","Unaligned reads",8801310720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FC6DF206-8C77-486C-BC38-06B6CF20139D","Canada's Michael Smith Genome Sciences Centre","564a4075e4b08c5d869320d0","A9ABE7A7-4126-414B-87D2-A6D25ABCF1FA","Ovarian Serous Cystadenocarcinoma","TAR","89083700-8720-4128-AAE6-C21175E3DDAE","2013-12-20T23:57:01.000Z","201B8A36-94FB-4BA8-9BEF-47E92BC01A03","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"89083700-8720-4128-AAE6-C21175E3DDAE",0.7,"13","TCGA-13-0724-01A-01R-1564-13_GRCh37-lite_mirna.bam",NA,"TCGA-13-0724-01A",1.3,"821D3091-CD9C-4958-A260-E9EA9CC10B72","TCGA",2002,NA,NA,"WITH TUMOR","F842B0FB-B968-4DB8-A348-73F2D440A739",72,"MSK_252152915096_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Dead",83,"TCGA-13-0724","HISPANIC OR LATINO","F97CC3A0-D1F0-4E85-BCB8-52E1D2D9CD79",NA,83,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Operative","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,84,"D39FED4B-F145-4C60-8FD1-81541B8BBBD1","E9100C37-2D3D-4A76-B04C-926BD1BD28E4","C239.TCGA-13-0724-01A-01W.6.bam","TCGA-13-0724-01A-01",95,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-13-0724-01A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-13-0724-D24508",NA,NA,NA,"TCGA-13-0724-F24507_NTE-1",NA,83,"WITH TUMOR","Dead",83,"TCGA-13-0724-F24507","TCGA-13-0724",NA,"13","0724","YES","C56.9","8441/3","C56.9",NA,NA,-26342,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Dead",83,83,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,72,2002,"Excisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
251741158,239195812,17669253230,"DED4EA4D-9DC2-4419-83EC-2BFE75DC1830.bw","a9d3a7b0-faf8-4e56-8600-d9e6882a4f23","ded4ea4d-9dc2-4419-83ec-2bfe75dc1830","2016-08-23T04:48:37.005882-05:00","TCGA-13-1411-01A-01R-1565-13_rnaseq_fastq.tar","9159aa86-8afe-433d-9e5d-e2d8381fb807",16480286720,"Illumina HiSeq","654fd04cae3c6d58b11e8b1afc065cdd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:55:04.599937-05:00","2016-05-03T11:40:21.669427-05:00","9159aa86-8afe-433d-9e5d-e2d8381fb807_analysis.xml","6b96729bdd5589a9a898f8acfcd63c6e","eeafbbef-808c-4cb3-9620-94e104463100",2181,"2016-09-29T20:25:45.361916-05:00","9159aa86-8afe-433d-9e5d-e2d8381fb807_experiment.xml","a012e07bf43433e91399d6bd7d1d4345","6cd5ed98-ee4f-41fe-85c1-fbc1928688ef",3916,"2016-09-29T21:00:29.733100-05:00","9159aa86-8afe-433d-9e5d-e2d8381fb807_run.xml","11df61bb26368b725a7ca992e1bc0764","824a5cac-34ca-47ba-ad21-f26979fd6f8f",1989,"2016-09-08T13:47:11.103663-05:00","TCGA-13-1411","2016-09-02T19:12:07.594012-05:00","female","TCGA-13-1411_demographic",1927,"white","27139b74-ed7d-5c9a-a505-c3f8562efbce","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1411_diagnosis","not reported",29874,"dead","8441/3",531,128,"33ef06dd-c3cb-5ba0-b224-c83af2b6171b","c56.9",-29874,"TCGA-13-1411_treatment","0023c0f9-b6fb-5ead-b992-e0e4f116abb0","01",NA,"TCGA-13-1411-01A","1.5","157062b7-9451-4a83-9047-294497df3b28",FALSE,"F73F2D6F-3FD9-4457-921A-9EE0E47A6470","Primary Tumor","0.3",NA,NA,"1.7",1230508800,"01",133,"TCGA-13-1411-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:47:11.103663-05:00","2016-09-08T13:47:11.103663-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,0,"8b721a35-974d-4831-90d5-6874833d2a2d","6ad1b17a-2edc-4e90-a769-781e192666b7","TCGA-13-1411-01A-01-TS1","TCGA-13-1411-01A-01-BS1",89,90,"62ac9cfc-84cc-46a7-961c-2b5ffd57dc7a","RNA","TCGA-13-1411-01A-01R","c87b41be-cde2-4237-a1a6-39f8bf4d3187",1.8,0.15,"UV Spec","R","22","TCGA-13-1411-01A-01R-1565-13","0069c63d-f699-41d4-9798-9a109d1c09df",0.15,NA,NA,NA,NA,"f62335ae-6fdd-59de-8cd7-8195679d2578","TCGA-13-1411_exposure","TCGA-13-1411-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:22:48.000Z","2014-03-22T07:55:02.000Z","9159AA86-8AFE-433D-9E5D-E2D8381FB807","157062B7-9451-4A83-9047-294497DF3B28","Unaligned reads",16480286720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0069C63D-F699-41D4-9798-9A109D1C09DF","Canada's Michael Smith Genome Sciences Centre","564a3565e4b0ef12181883b3","A9D3A7B0-FAF8-4E56-8600-D9E6882A4F23","Ovarian Serous Cystadenocarcinoma","TAR","62AC9CFC-84CC-46A7-961C-2B5FFD57DC7A","2014-03-22T07:55:02.000Z","C87B41BE-CDE2-4237-A1A6-39F8BF4D3187","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"62AC9CFC-84CC-46A7-961C-2B5FFD57DC7A",1.5,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.438d9016-0b99-46f7-b8ad-21c125f4bedd.txt",NA,"TCGA-13-1411-01A",1.7,"B3CF475F-FF22-4EFE-A7A9-8909DFF55877","TCGA",2008,NA,NA,"WITH TUMOR","490F7701-C88E-4269-824B-CDEE46ED34EB",81,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.438d9016-0b99-46f7-b8ad-21c125f4bedd.txt","Alive",NA,"TCGA-13-1411","NOT HISPANIC OR LATINO","AEA78EBE-C26B-47E2-A50F-000C9E792FA0",NA,128,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,133,"8B721A35-974D-4831-90D5-6874833D2A2D","006398D0-32DB-4743-AEC8-91B82502C7F9","C239.TCGA-13-1411-01A-01W.2.bam","TCGA-13-1411-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-13-1411-01A-01-TS1",89,"Carboplatin","Chemotherapy","TCGA-13-1411-D24829",NA,NA,NA,NA,NA,128,"WITH TUMOR","Alive",NA,"TCGA-13-1411-F24828","TCGA-13-1411",NA,"13","1411","YES","C56.9","8441/3","C56.9",NA,NA,-29874,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",128,NA,NA,NA,"WITH TUMOR","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,81,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
243014308,237179274,17533000373,"13A35364-57C5-4F5A-B077-3BA2689BFDD3.bw","ac2e88ff-8b1e-4691-9a96-5a581f98d827","13a35364-57c5-4f5a-b077-3ba2689bfdd3","2016-08-25T01:59:54.207900-05:00","TCGA-20-1683-01A-01R-1566-13_rnaseq_fastq.tar","240a6232-97bc-4df2-adcf-799b1d7f25fb",14736404480,"Illumina HiSeq","e545a8ab4ff70f9eb1af6106ac22fedb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:37:53.239540-05:00","2016-05-03T11:39:34.528512-05:00","240a6232-97bc-4df2-adcf-799b1d7f25fb_analysis.xml","6beb9637067a1307490c9c23564f6d02","4f6bb34d-7594-4409-b11a-409ad5dee4ff",2181,"2016-08-29T16:36:06.004980-05:00","240a6232-97bc-4df2-adcf-799b1d7f25fb_experiment.xml","00bbcb48963c2f6b5ce875b25816de0c","ef69555e-1505-411a-a280-ca78abcf62c0",3916,"2016-09-29T19:49:01.380390-05:00","240a6232-97bc-4df2-adcf-799b1d7f25fb_run.xml","d9fc89407f6f7e04a59d1cd31bb5af4d","5656f573-6f3b-4623-9d72-06272905a90d",1988,"2016-09-08T12:46:48.537400-05:00","TCGA-20-1683","2016-09-02T19:07:20.888204-05:00","female","TCGA-20-1683_demographic",1942,"white","7ca939fc-90ab-59cf-bf58-f423d134465e","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-1683_diagnosis","not reported",24006,"alive","8441/3",NA,772,"b3cd76a3-af1c-573b-b5fc-42c3ee779e66","c56.9",-24006,"TCGA-20-1683_treatment","c145f10f-6028-5b8b-9b46-43b0d9d01105","01",NA,"TCGA-20-1683-01A","0.5","a0300830-9dd9-46bc-94c0-23b2e8703e25",FALSE,"5a83e4b3-8be2-4628-bd4b-93d040b43856","Primary Tumor","0.4",NA,NA,"1",1242604800,"01",104,"TCGA-20-1683-01A-01",90,95,NA,NA,0,0,20,30,"2016-09-08T12:46:48.537400-05:00","2016-09-08T12:46:48.537400-05:00",3,2,NA,NA,"TOP","BOTTOM",3,5,"d6e3a27b-344e-4566-ad53-33189f1cbe02","4fa77b3e-e254-44a5-8dbe-ac9089746160","TCGA-20-1683-01A-01-TS1","TCGA-20-1683-01A-01-BS1",72,65,"2f8d71a3-4ea8-4dcb-ae77-76ecd12a0f3d","RNA","TCGA-20-1683-01A-01R","5b59e1f7-acce-434a-8772-b3c96c2f2111",1.8,0.14,"UV Spec","R","22","TCGA-20-1683-01A-01R-1566-13","e78c6cd7-67f2-4ac8-9dd9-c46392459835",0.14,NA,NA,NA,NA,"4af87322-3221-53ff-9ef3-8323165da992","TCGA-20-1683_exposure","TCGA-20-1683-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T06:28:09.000Z","2014-03-20T06:52:01.000Z","240A6232-97BC-4DF2-ADCF-799B1D7F25FB","A0300830-9DD9-46BC-94C0-23B2E8703E25","Unaligned reads",14736404480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E78C6CD7-67F2-4AC8-9DD9-C46392459835","Canada's Michael Smith Genome Sciences Centre","564a3e29e4b093830b6a2590","AC2E88FF-8B1E-4691-9A96-5A581F98D827","Ovarian Serous Cystadenocarcinoma","TAR","2F8D71A3-4EA8-4DCB-AE77-76ECD12A0F3D","2014-03-20T06:52:01.000Z","5B59E1F7-ACCE-434A-8772-B3C96C2F2111","None","NO",1,0.4,"Primary Tumor","Fox Chase Cancer Center",NA,"2F8D71A3-4EA8-4DCB-AE77-76ECD12A0F3D",0.5,"20","4440716606_R01C01_Red.idat",NA,"TCGA-20-1683-01A",1,"7175A7A2-CCB7-4926-88D0-FAC1AF5A4BA7","TCGA",2007,NA,NA,"TUMOR FREE","A0300830-9DD9-46BC-94C0-23B2E8703E25",65,"nationwidechildrens.org_clinical.TCGA-20-1683.xml","Alive",NA,"TCGA-20-1683","NOT HISPANIC OR LATINO","BBB59B9B-39A7-4E23-89CD-1C5B0514362A",NA,772,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,104,"D6E3A27B-344E-4566-AD53-33189F1CBE02","D4341CD1-CDD2-4B3C-A2BD-EB5A0FB86ABD","bcgsc.ca.TCGA-20-1683-01A-01R-1566-13.hg19.bcgsc.ca.1.6.0.indel.vcf","TCGA-20-1683-01A-01",95,0,NA,2,30,"BOTTOM",5,NA,"TCGA-20-1683-01A-01-BS1",65,"Carboplatin","Chemotherapy","TCGA-20-1683-D25545",NA,NA,NA,"TCGA-20-1683-F25544_NTE-1",NA,772,"TUMOR FREE","Alive",NA,"TCGA-20-1683-F25544","TCGA-20-1683",NA,"20","1683","YES","C56.9","8441/3","C56.9",NA,NA,-24006,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",772,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,65,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
82310612,76494720,5594232378,"2641B816-1D21-496E-85AD-1C690C9146A6.bw","acb7ec56-8a47-495f-a11b-2c9fb5d8fe95","2641b816-1d21-496e-85ad-1c690c9146a6","2016-08-25T08:32:01.625282-05:00","TCGA-23-1107-01A-01R-1564-13_rnaseq_fastq.tar","9ca03195-c8b5-4392-9229-0fcd32a2a718",4898856960,"Illumina HiSeq","f79f4ced965337289faa1c80710639d4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:55:42.491302-05:00","2016-05-03T11:27:59.332723-05:00","9ca03195-c8b5-4392-9229-0fcd32a2a718_analysis.xml","5557f58682d8cdce0ebde1bacc1e19d9","5a888bbe-6875-4d40-b9b4-18ccfa598f3a",2267,"2016-09-29T21:36:31.740147-05:00","9ca03195-c8b5-4392-9229-0fcd32a2a718_experiment.xml","e4fd87230127c1de5ffd24bedc22916c","98b7e5df-8a26-484b-90ab-56984480f98b",3916,"2016-09-29T20:22:15.208451-05:00","9ca03195-c8b5-4392-9229-0fcd32a2a718_run.xml","7c57a2e8c0026f53b0dd84af0c26e144","6aa03d42-00ad-40a9-ba4f-8d2999e7f9ff",1990,"2016-09-08T12:23:21.866882-05:00","TCGA-23-1107","2016-09-02T19:05:46.509718-05:00","female","TCGA-23-1107_demographic",1940,"white","a11794df-2f45-5422-bff0-439ff680ce2d","not hispanic or latino",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1107_diagnosis","not reported",21561,"dead","8441/3",9,9,"c5596e3d-d994-5f01-98ef-e04beffcc90b","c56.9",-21561,"TCGA-23-1107_treatment","ff33860a-fae6-5bfe-abe3-29eb0f909303","01",NA,"TCGA-23-1107-01A","0.6","255026d7-92a8-46f3-95ca-d1128e8ec3db",FALSE,"700802e6-8058-4485-8210-3e5b8f10bbf3","Primary Tumor","0.6",NA,NA,"1",1227571200,"01",119,"TCGA-23-1107-01A-01",90,90,NA,NA,0,0,0,0,"2016-09-08T12:23:21.866882-05:00","2016-09-08T12:23:21.866882-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"d6017cb3-c915-4dd1-a1bd-4fe67600ab38","f36ddc6a-25ec-441b-9e70-57810d827977","TCGA-23-1107-01A-01-BS1","TCGA-23-1107-01A-01-TS1",0,0,"996e70d7-cbbd-4772-93da-14664238bc3b","RNA","TCGA-23-1107-01A-01R","d40fca3b-5650-4a88-ad52-a31133848291",1.8,0.15,"UV Spec","R","22","TCGA-23-1107-01A-01R-1564-13","2b25b605-1d45-499e-99ed-ad9b4a7722a5",0.15,NA,NA,NA,NA,"10b608a9-90a8-5f18-ba23-16df62c8b618","TCGA-23-1107_exposure","TCGA-23-1107-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T22:47:24.000Z","2013-12-20T23:01:02.000Z","9CA03195-C8B5-4392-9229-0FCD32A2A718","255026D7-92A8-46F3-95CA-D1128E8EC3DB","Unaligned reads",4898856960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2B25B605-1D45-499E-99ED-AD9B4A7722A5","Canada's Michael Smith Genome Sciences Centre","564a39cbe4b09c884b23df13","ACB7EC56-8A47-495F-A11B-2C9FB5D8FE95","Ovarian Serous Cystadenocarcinoma","TAR","996E70D7-CBBD-4772-93DA-14664238BC3B","2013-12-20T23:01:02.000Z","D40FCA3B-5650-4A88-AD52-A31133848291","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"996E70D7-CBBD-4772-93DA-14664238BC3B",0.6,"23","TCGA-23-1107-01A-01R-0441-02_genes.txt",NA,"TCGA-23-1107-01A",1,NA,"TCGA",1999,NA,NA,"WITH TUMOR","5B009E91-FDDF-4EF1-8522-9DE46EFB091D",59,"TCGA-23-1107-01A-01R-1564-13_mirna.bam","Dead",9,"TCGA-23-1107","NOT HISPANIC OR LATINO","83880442-EE2E-4BA6-A679-94C04B632568",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,119,"F36DDC6A-25EC-441B-9E70-57810D827977","CDBEA1F2-7281-4DE3-A7D6-EF81307A6AF7","TCGA-23-1107-01A-01R-0441-02_genes.txt","TCGA-23-1107-01A-01",90,0,NA,NA,0,"BOTTOM",5,NA,"TCGA-23-1107-01A-01-BS1",0,NA,NA,NA,NA,NA,NA,NA,NA,9,"WITH TUMOR","Dead",9,"TCGA-23-1107-F25661","TCGA-23-1107",NA,"23","1107","YES","C56.9","8441/3","C56.9",NA,NA,-21561,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,9,NA,NA,"WITH TUMOR","NO",19,2,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,59,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
203416500,197242608,14610621733,"96E2AD09-7287-4B91-840E-81444A61D56F.bw","ad2939e6-b8b8-475a-90e2-6a369c3d3167","96e2ad09-7287-4b91-840e-81444a61d56f","2016-10-19T10:16:38.146749-05:00","TCGA-30-1718-01A-01R-1567-13_rnaseq_fastq.tar","bc654d46-9e1a-42ec-ae9a-dd75e7df6492",12727889920,"Illumina HiSeq","c9b818a39ab5901c3ea4b86439c17b04","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:45:21.829958-05:00","2016-05-03T11:41:05.740436-05:00","bc654d46-9e1a-42ec-ae9a-dd75e7df6492_analysis.xml","31d625a57cb2e219bfee25a089dfe0e0","2e7097b3-7fdc-4106-8b66-f66b46a00268",2181,"2016-10-07T17:17:53.591596-05:00","bc654d46-9e1a-42ec-ae9a-dd75e7df6492_experiment.xml","fc3ed0efe4ab879d4529454e94396e68","49842d79-7ebe-4109-91e5-840d51b0d0e5",3916,"2016-09-29T21:50:22.551047-05:00","bc654d46-9e1a-42ec-ae9a-dd75e7df6492_run.xml","9b51dc74ebff672eb80f713d103f506c","a147536c-7f3c-40b9-81a8-ac1fa0400326",1988,"2016-09-08T13:00:56.713311-05:00","TCGA-30-1718","2016-09-02T19:07:33.114778-05:00","female","TCGA-30-1718_demographic",1958,"white","af0f012e-4f9b-5984-9ca8-278a4b50c0ce","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1718_diagnosis","not reported",16400,"dead","8441/3",1579,1579,"a8f15bcc-2d2b-58da-adf9-fe2277971d9e","c56.9",-16400,"TCGA-30-1718_treatment","17cbc288-edde-54bb-a604-7b7421ba7b73","01",NA,"TCGA-30-1718-01A","0.6","9ea630a2-1412-4f40-897a-38a52600a1cb",FALSE,"078da76a-b9f5-40d0-9a57-04c306ade36a","Primary Tumor","0.4",NA,NA,"1.3",1242345600,"01",101,"TCGA-30-1718-01A-01",90,90,NA,NA,0,0,18,40,"2016-09-08T13:00:56.713311-05:00","2016-09-08T13:00:56.713311-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,0,"1442d515-ab98-42d8-ac97-9a823ef7f0f9","882c0856-601e-4428-b950-0d13f28e8da0","TCGA-30-1718-01A-01-BS1","TCGA-30-1718-01A-01-TS1",80,60,"2faa70f5-02fb-418a-8cc3-9f80845adab5","RNA","TCGA-30-1718-01A-01R","2c1a1cdb-4132-4ee9-9824-6136d728cc76",1.8,0.15,"UV Spec","R","22","TCGA-30-1718-01A-01R-1567-13","5abce979-686d-40c4-acd7-ef9cc5acf26f",0.15,NA,NA,NA,NA,"f159c1d9-3b62-5086-9842-8ab1ebb37ef4","TCGA-30-1718_exposure","TCGA-30-1718-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T00:05:50.000Z","2014-03-27T00:31:01.000Z","BC654D46-9E1A-42EC-AE9A-DD75E7DF6492","9EA630A2-1412-4F40-897A-38A52600A1CB","Unaligned reads",12727889920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5ABCE979-686D-40C4-ACD7-EF9CC5ACF26F","Canada's Michael Smith Genome Sciences Centre","564a3484e4b093830b671123","AD2939E6-B8B8-475A-90E2-6A369C3D3167","Ovarian Serous Cystadenocarcinoma","TAR","2FAA70F5-02FB-418A-8CC3-9F80845ADAB5","2014-03-27T00:31:01.000Z","2C1A1CDB-4132-4EE9-9824-6136D728CC76","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"2FAA70F5-02FB-418A-8CC3-9F80845ADAB5",0.6,"30","TCGA-30-1718-01A-01R-1567-13_GRCh37-lite_mirna.bam",NA,"TCGA-30-1718-01A",1.3,"CA71DA11-843D-4468-988F-8A5F48FFBFB5","TCGA",2002,NA,NA,"WITH TUMOR","9EA630A2-1412-4F40-897A-38A52600A1CB",44,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.bd7cf7cb-3d3f-44ff-a0ad-f559a3d26370.txt","Dead",1579,"TCGA-30-1718","NOT HISPANIC OR LATINO","634EFFEE-A1BD-4DD7-A813-4F04F2C4A872",NA,1579,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,101,"882C0856-601E-4428-B950-0D13F28E8DA0","688A3E90-C904-4ECD-87A9-C3D71D62A562","TCGA-30-1718-01A-01R-1567-13_mirna.bam","TCGA-30-1718-01A-01",90,0,NA,NA,40,"TOP",0,NA,"TCGA-30-1718-01A-01-TS1",60,"Taxol","Chemotherapy","TCGA-30-1718-D27537",NA,NA,NA,"TCGA-30-1718-F27534_NTE-1",NA,1579,"WITH TUMOR","Dead",1579,"TCGA-30-1718-F27534","TCGA-30-1718",NA,"30","1718","YES","C56.9","8441/3","C56.9",NA,NA,-16400,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1579,1579,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
198884426,195350908,14454738911,"62F3327F-FB16-4AD0-BCF5-B180F28281A9.bw","ad2b1a0a-153f-483d-b228-5763eba3f6cc","62f3327f-fb16-4ad0-bcf5-b180f28281a9","2016-08-20T15:34:23.939113-05:00","TCGA-25-2399-01A-01R-1569-13_rnaseq_fastq.tar","a198c7f8-c54f-4b97-9cb7-3a1ff4460587",12471654400,"Illumina HiSeq","e327f7cd898f7dbce39b18387754eb64","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:19:14.057435-05:00","2016-05-03T11:55:09.260045-05:00","a198c7f8-c54f-4b97-9cb7-3a1ff4460587_analysis.xml","5c897cab79591e372a7f0934219a2cea","fd767b38-2d4b-4f88-9f80-c59d1f0b205c",2181,"2016-09-29T20:28:09.477989-05:00","a198c7f8-c54f-4b97-9cb7-3a1ff4460587_experiment.xml","7656f40cf49f194bfbfc4e17144b873c","6e4ac463-87c4-4b68-9a29-9f9da13b96fe",3916,"2016-09-29T20:52:57.075617-05:00","a198c7f8-c54f-4b97-9cb7-3a1ff4460587_run.xml","4299cadccfba98fa425f03d4f6aa4df2","7d95d2e1-f868-47f1-aa87-ba13d16ea63e",1988,"2016-09-08T13:45:56.761741-05:00","TCGA-25-2399","2016-09-02T19:11:47.439925-05:00","female","TCGA-25-2399_demographic",1924,"white","bf26361b-e6d4-5693-b15f-d91ed2a71b5f","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2399_diagnosis","not reported",29373,"dead","8441/3",608,608,"e1731d67-eada-531d-baa0-f203daa3117c","c56.9",-29373,"TCGA-25-2399_treatment","b0e7aa92-8bc0-5c75-b202-cda6572df638","01",NA,"TCGA-25-2399-01A","0.8","c9aa6cf0-f536-4640-8290-3e745ae2a36b",FALSE,"38AEA3BF-A853-4719-B308-63884A6F8F13","Primary Tumor","0.4",NA,NA,"1.6",1252022400,"01",104,"TCGA-25-2399-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:45:56.761741-05:00","2016-09-08T13:45:56.761741-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"55932ba7-125d-49c0-bb6d-b1c4b9d2622f","cf0cf6b0-d4ab-45d5-a7f1-16823526f35e","TCGA-25-2399-01A-01-BS1","TCGA-25-2399-01A-01-TS1",90,90,"b474ddc6-6185-4469-b2f1-65584a0a3e5f","RNA","TCGA-25-2399-01A-01R","6b7021e6-8ae5-4446-8455-759e552e6eb8",1.8,0.15,"UV Spec","R","22","TCGA-25-2399-01A-01R-1569-13","28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1",0.15,NA,NA,NA,NA,"38afbc7b-da23-5e37-b5e3-6aefc0737154","TCGA-25-2399_exposure","TCGA-25-2399-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-07T23:53:22.000Z","2014-08-08T01:18:20.000Z","A198C7F8-C54F-4B97-9CB7-3A1FF4460587","C9AA6CF0-F536-4640-8290-3E745AE2A36B","Unaligned reads",12471654400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","28A681DC-3E0F-4A9C-AD0C-F2BB10AAB0E1","Canada's Michael Smith Genome Sciences Centre","564a3f14e4b08c5d8692ae7b","AD2B1A0A-153F-483D-B228-5763EBA3F6CC","Ovarian Serous Cystadenocarcinoma","TAR","B474DDC6-6185-4469-B2F1-65584A0A3E5F","2014-08-08T01:18:20.000Z","6B7021E6-8AE5-4446-8455-759E552E6EB8","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"B474DDC6-6185-4469-B2F1-65584A0A3E5F",0.8,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.27dde0e4-5be8-4045-910b-24c0535a4623.txt",NA,"TCGA-25-2399-01A",1.6,"F67BBE0C-7BE0-4FD0-9911-BDF622D7F6D3","TCGA",2004,NA,NA,"WITH TUMOR","C9AA6CF0-F536-4640-8290-3E745AE2A36B",80,"nationwidechildrens.org_clinical.TCGA-25-2399.xml","Dead",608,"TCGA-25-2399","NOT HISPANIC OR LATINO","F2CA0F5D-438C-46CF-AF2A-976CF4036F11",NA,608,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,104,"CF0CF6B0-D4AB-45D5-A7F1-16823526F35E","DE2CD05C-440D-481E-BCFE-3D2C6278A860","C239.TCGA-25-2399-01A-01W-0799-08.2.bam.bai","TCGA-25-2399-01A-01",95,0,NA,NA,5,"BOTTOM",5,NA,"TCGA-25-2399-01A-01-BS1",90,"Taxol","Chemotherapy","TCGA-25-2399-D26820",NA,NA,NA,"TCGA-25-2399-F26818_NTE-1",NA,608,"WITH TUMOR","Dead",608,"TCGA-25-2399-F26818","TCGA-25-2399",NA,"25","2399","YES","C56.9","8441/3","C56.9",NA,NA,-29373,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",608,608,NA,NA,"WITH TUMOR","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,80,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
170073682,165907929,12294086178,"112F7032-0212-4939-9449-D67E3600CCD5.bw","ae914f23-87b9-4169-a7f7-a3483078c902","112f7032-0212-4939-9449-d67e3600ccd5","2016-08-19T00:05:29.340468-05:00","TCGA-61-2009-01A-01R-1568-13_rnaseq_fastq.tar","933fc32d-0f9a-4c27-8344-ad398548dd49",10854389760,"Illumina HiSeq","332a56b071c44bbd76b81a79783cc618","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:25:13.820859-05:00","2016-05-03T11:41:05.755204-05:00","933fc32d-0f9a-4c27-8344-ad398548dd49_analysis.xml","5702c3b18529a1a43dc3a214e089a0d2","478d919a-48f8-417f-9535-61cb8d73abfc",2183,"2016-10-07T15:51:50.997511-05:00","933fc32d-0f9a-4c27-8344-ad398548dd49_experiment.xml","f6793698c6febb6bb93064c03ac5772e","2a0fe973-c5e7-44b8-9f04-e7aab4d695e2",3916,"2016-09-29T18:26:52.725234-05:00","933fc32d-0f9a-4c27-8344-ad398548dd49_run.xml","ffb6e567cd896e4a3178f45c1bc890b1","22b452ef-e990-4c24-b592-e426ca881e71",1990,"2016-09-08T11:43:15.272086-05:00","TCGA-61-2009","2016-09-02T18:56:16.206438-05:00","female","TCGA-61-2009_demographic",1941,"white","c2e9ac12-63d8-5aff-8006-3a819ceb9302","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2009_diagnosis","not reported",23772,"alive","8441/3",NA,1212,"c813f3eb-5dd8-5697-90d3-e91a0bd284b0","c56.9",-23772,"TCGA-61-2009_treatment","883871c7-ecf6-5669-8b76-a651137bf869","01",NA,"TCGA-61-2009-01A","2","8832fa0d-1bd8-42a9-b002-1a02500d48eb",FALSE,"39de8c59-e593-47d3-932d-575a4537b4dc","Primary Tumor","0.2",NA,NA,"2",1247443200,"01",152,"TCGA-61-2009-01A-01",90,95,NA,NA,0,0,10,5,"2016-09-08T11:43:15.272086-05:00","2016-09-08T11:43:15.272086-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,1,"39107a07-daa5-4194-aedc-269f33d3dd2e","098afc71-5dba-4fcd-8059-9d4d806db2b3","TCGA-61-2009-01A-01-BS1","TCGA-61-2009-01A-01-TS1",85,94,"579bb41a-e5cd-443b-a074-27c61beed930","RNA","TCGA-61-2009-01A-01R","b6362265-9a1d-412b-9768-365ca2adae08",1.8,0.14,"UV Spec","R","22","TCGA-61-2009-01A-01R-1568-13","b6ed2184-0885-49ba-8b00-a3e57e4e5500",0.14,NA,NA,NA,NA,"0e1af3f4-e5a4-5904-812d-8958954af78e","TCGA-61-2009_exposure","TCGA-61-2009-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T04:51:00.000Z","2014-03-27T05:15:01.000Z","933FC32D-0F9A-4C27-8344-AD398548DD49","8832FA0D-1BD8-42A9-B002-1A02500D48EB","Unaligned reads",10854389760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B6ED2184-0885-49BA-8B00-A3E57E4E5500","Canada's Michael Smith Genome Sciences Centre","564a4020e4b09c884b25c5e2","AE914F23-87B9-4169-A7F7-A3483078C902","Ovarian Serous Cystadenocarcinoma","TAR","579BB41A-E5CD-443B-A074-27C61BEED930","2014-03-27T05:15:01.000Z","B6362265-9A1D-412B-9768-365CA2ADAE08","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"579BB41A-E5CD-443B-A074-27C61BEED930",2,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8e12e5af-19de-4c90-a0b6-da67eeb438f4.txt",NA,"TCGA-61-2009-01A",2,"FD4307F9-D370-43DE-9BB1-AA5A096B8295","TCGA",2006,NA,NA,"WITH TUMOR","F8725867-36E0-4355-998C-72E771688BEB",65,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8e12e5af-19de-4c90-a0b6-da67eeb438f4.txt","Alive",NA,"TCGA-61-2009","NOT HISPANIC OR LATINO","FC604495-213E-4FD9-BF0B-968863D4F36D",NA,1212,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,152,"39107A07-DAA5-4194-AEDC-269F33D3DD2E","D2220FBB-89DA-48C6-AA58-0D975EEBF9A6","TCGA-61-2009-01A-01R-1568-13_rnaseq.bam.bai","TCGA-61-2009-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-61-2009-01A-01-BS1",85,"Taxol","Chemotherapy","TCGA-61-2009-D28344",NA,NA,NA,"TCGA-61-2009-F28341_NTE-2",NA,1212,"WITH TUMOR","Alive",NA,"TCGA-61-2009-F28341","TCGA-61-2009",NA,"61","2009","YES","C56.9","8441/3","C56.9",NA,NA,-23772,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1212,NA,NA,NA,"WITH TUMOR","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
205222328,197997864,14611519557,"A3B4DE21-DDF0-4468-A300-7BECBAFD0BCD.bw","afd92922-b8dc-48bd-a9c0-bc8d95855eb7","a3b4de21-ddf0-4468-a300-7becbafd0bcd","2016-08-25T23:59:25.622521-05:00","TCGA-24-1560-01A-01R-1566-13_rnaseq_fastq.tar","46e55638-63d0-41cd-8824-595df1704ee3",13243955200,"Illumina HiSeq","37cd75f7d7fcbd58ece9b7f3d8155688","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:16:46.912096-05:00","2016-05-03T11:40:21.648199-05:00","46e55638-63d0-41cd-8824-595df1704ee3_analysis.xml","421fbf9c058b2e22f23f18591d5da337","1c70a820-c8de-4e67-a960-248c48cc5831",2181,"2016-09-29T19:49:32.074184-05:00","46e55638-63d0-41cd-8824-595df1704ee3_experiment.xml","aa73d026a9cd1217de23045d3a058919","56abf018-2cc2-4578-b7ff-450802276a75",3916,"2016-09-29T18:51:39.970232-05:00","46e55638-63d0-41cd-8824-595df1704ee3_run.xml","dd818b906a00652df232062141224408","326a1687-fbe6-42a7-8e0e-f82e9b0ff35d",1988,"2016-09-08T10:59:48.326156-05:00","TCGA-24-1560","2016-09-02T18:53:43.196703-05:00","female","TCGA-24-1560_demographic",1948,"white","78a963aa-07fe-526a-93c8-3f2bc9d8d317","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1560_diagnosis","not reported",18671,"dead","8441/3",1341,1341,"c81c054c-bd20-5c4f-b3bd-3d67dc613c2b","c56.9",-18671,"TCGA-24-1560_treatment","433292e6-7678-56ee-8919-2c720079f7f2","01",NA,"TCGA-24-1560-01A","1","aeff4cbe-7abb-449a-a6f4-65e030548f4c",FALSE,"464e1a20-b2d1-49c4-8da5-11b8c0f96b4e","Primary Tumor","0.5",NA,NA,"1.1",1235347200,"01",107,"TCGA-24-1560-01A-01",95,95,NA,NA,0,0,2,2,"2016-09-08T10:59:48.326156-05:00","2016-09-08T10:59:48.326156-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"517e0086-04fb-47e2-8809-4b9768c17ba9","f5e67453-b8d9-4f8d-84be-05608fca2722","TCGA-24-1560-01A-01-TS1","TCGA-24-1560-01A-01-BS1",98,98,"340f41e4-6015-4f48-9987-873bbdfadde1","RNA","TCGA-24-1560-01A-01R","eca2adc0-dd4d-4ed6-8aa8-5edb20cc2260",1.8,0.13,"UV Spec","R","22","TCGA-24-1560-01A-01R-1566-13","a7ea40ed-6cfb-42b7-92b7-64d6ba988414",0.13,NA,NA,NA,NA,"5e1bc87b-ca89-5439-8721-a2d853217b3b","TCGA-24-1560_exposure","TCGA-24-1560-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T04:55:38.000Z","2014-03-25T05:19:01.000Z","46E55638-63D0-41CD-8824-595DF1704EE3","AEFF4CBE-7ABB-449A-A6F4-65E030548F4C","Unaligned reads",13243955200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A7EA40ED-6CFB-42B7-92B7-64D6BA988414","Canada's Michael Smith Genome Sciences Centre","564a566ce4b09c884b264b29","AFD92922-B8DC-48BD-A9C0-BC8D95855EB7","Ovarian Serous Cystadenocarcinoma","TAR","340F41E4-6015-4F48-9987-873BBDFADDE1","2014-03-25T05:19:01.000Z","ECA2ADC0-DD4D-4ED6-8AA8-5EDB20CC2260","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"340F41E4-6015-4F48-9987-873BBDFADDE1",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.15295f32-7794-43cb-a943-03a38d4b6016.txt",NA,"TCGA-24-1560-01A",1.1,"F6F38BE5-A3CF-4506-8AFF-4BA14246FDC2","TCGA",1999,NA,NA,"WITH TUMOR","E4588ACE-7E89-4933-BA78-5C04163F315E",51,"nationwidechildrens.org_clinical.TCGA-24-1560.xml","Dead",1341,"TCGA-24-1560",NA,"F5657F7D-8BBE-49B7-875C-32D3C45A6B02",NA,1341,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,107,"F5E67453-B8D9-4F8D-84BE-05608FCA2722","ECA2ADC0-DD4D-4ED6-8AA8-5EDB20CC2260","bcgsc.ca.TCGA-24-1560-01A-01R-1566-13.hg19.bcgsc.ca.1.6.0.indel.vcf","TCGA-24-1560-01A-01",95,0,NA,NA,2,"BOTTOM",0,NA,"TCGA-24-1560-01A-01-BS1",98,"Carboplatin","Chemotherapy","TCGA-24-1560-D26231",NA,NA,NA,"TCGA-24-1560-F26221_NTE-1",NA,1341,"WITH TUMOR","Dead",1341,"TCGA-24-1560-F26221","TCGA-24-1560",NA,"24","1560","YES","C56.9","8441/3","C56.9",NA,NA,-18671,"FEMALE","WHITE",NA,NA,"No","Dead",1341,1341,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,51,1999,"Tumor resection",NA,NA,NA,"G4",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
150819066,147122138,10883069809,"0A03E593-6931-419C-AE47-51D75185C2C0.bw","b0585c7a-7205-4dac-9d54-6da89674accb","0a03e593-6931-419c-ae47-51d75185c2c0","2016-08-25T00:46:14.064351-05:00","TCGA-29-2428-01A-01R-1569-13_rnaseq_fastq.tar","55a1cc4a-7f55-4cc5-9e02-ba8bf98002f3",9393059840,"Illumina HiSeq","5989f38d94c981a8eb5335c31deb9d5f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:39:19.026938-05:00","2016-05-03T11:41:05.740436-05:00","55a1cc4a-7f55-4cc5-9e02-ba8bf98002f3_analysis.xml","5bb550e9558b9164135835ba1319744a","750f93b3-0bc4-4dc6-b8dc-b1d07a078204",2181,"2016-08-13T05:00:30.957007-05:00","55a1cc4a-7f55-4cc5-9e02-ba8bf98002f3_experiment.xml","55b075f4d0a71ae07fed1f769bac5f8f","4b328839-17fb-4d26-bd1a-e6f49a446918",3916,"2016-09-29T22:09:07.211756-05:00","55a1cc4a-7f55-4cc5-9e02-ba8bf98002f3_run.xml","91e8af6bd4825d701fd4592f946e6f18","ace50635-3052-429f-9ef0-00bf5afbb8e3",1988,"2016-09-08T13:50:13.140005-05:00","TCGA-29-2428","2016-09-02T19:11:41.846482-05:00","female","TCGA-29-2428_demographic",1947,"white","f49495f3-6a81-572b-b92a-f1ffdb45a55d","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-2428_diagnosis","not reported",21392,"alive","8441/3",NA,1372,"e20d29d9-559f-572a-8639-75c5d0f20e06","c56.9",-21392,"TCGA-29-2428_treatment","1137f07e-391a-5b5f-a537-bd03d22f3f20","01",NA,"TCGA-29-2428-01A","1.2","15d26f43-0581-4cdd-aa2f-a04ad6901fd8",FALSE,"45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb","Primary Tumor","0.4",NA,NA,"1.7",1252972800,"01",155,"TCGA-29-2428-01A-01",95,90,NA,NA,0,0,5,20,"2016-09-08T13:50:13.140005-05:00","2016-09-08T13:50:13.140005-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,0,"3667d0cf-166c-4f28-85ee-a86aaf1c5667","e5b6420f-0b66-4b78-b396-6bf8a075f55b","TCGA-29-2428-01A-01-TS1","TCGA-29-2428-01A-01-BS1",90,80,"bc5ecdce-6c6d-465c-bbf6-865afc5e7e3c","RNA","TCGA-29-2428-01A-01R","88d4bc02-94ff-4acd-a257-c08f63fccff1",1.8,0.14,"UV Spec","R","22","TCGA-29-2428-01A-01R-1569-13","9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b",0.14,NA,NA,NA,NA,"a27812af-f848-5587-80b1-da526f33abc6","TCGA-29-2428_exposure","TCGA-29-2428-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T02:15:50.000Z","2014-03-27T02:37:01.000Z","55A1CC4A-7F55-4CC5-9E02-BA8BF98002F3","15D26F43-0581-4CDD-AA2F-A04AD6901FD8","Unaligned reads",9393059840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9E4A4BC1-39CF-46DC-B7D3-C7D852CC033B","Canada's Michael Smith Genome Sciences Centre","564a373ae4b093830b67ee99","B0585C7A-7205-4DAC-9D54-6DA89674ACCB","Ovarian Serous Cystadenocarcinoma","TAR","BC5ECDCE-6C6D-465C-BBF6-865AFC5E7E3C","2014-03-27T02:37:01.000Z","88D4BC02-94FF-4ACD-A257-C08F63FCCFF1","None","NO",1,0.4,"Primary Tumor","Duke",NA,"BC5ECDCE-6C6D-465C-BBF6-865AFC5E7E3C",1.2,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.364ced0b-2737-4f70-a7bb-a5a9171e4ef8.txt",NA,"TCGA-29-2428-01A",1.7,"A0DAE621-3815-4B2A-8364-E19198BE75AC","TCGA",2005,NA,NA,"TUMOR FREE","33075F87-D771-465D-8BDC-3FA9CC70ECF6",58,"MSK_252152920201_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Alive",NA,"TCGA-29-2428",NA,"1AAE8AF8-D856-4054-BDCD-5CD78895A694",NA,1372,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,155,"E5B6420F-0B66-4B78-B396-6BF8A075F55B","A4CF6DF9-1327-41AD-8A50-8D524568C3AA","TCGA-29-2428-01A-01R-1569-13_rnaseq.bam","TCGA-29-2428-01A-01",90,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-29-2428-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-29-2428-D27479",NA,NA,NA,NA,NA,1372,"TUMOR FREE","Alive",NA,"TCGA-29-2428-F27478","TCGA-29-2428",NA,"29","2428","YES","C56.9","8441/3","C56.9",NA,NA,-21392,"FEMALE","WHITE",NA,NA,"No","Alive",1372,NA,NA,NA,"TUMOR FREE","NO",8,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,58,2005,"Tumor resection",NA,NA,NA,"G3","R1",NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
192968136,186104664,13791198069,"2416A3DC-A563-4FD1-A139-0E6EF7185211.bw","b0839f46-8c82-4619-be3d-c857a1759463","2416a3dc-a563-4fd1-a139-0e6ef7185211","2016-08-25T07:55:14.173707-05:00","TCGA-31-1951-01A-01R-1568-13_rnaseq_fastq.tar","4f6e6bbc-117f-464a-97f9-418de428a9eb",12878120960,"Illumina HiSeq","d8e43fe7b06e6d9d008c155bba4f2721","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:16:23.438856-05:00","2016-05-03T11:56:42.628809-05:00","4f6e6bbc-117f-464a-97f9-418de428a9eb_analysis.xml","cba3c413d9a6d063892051babf514103","42005272-b95c-4da6-b657-9bd82971c82d",2181,"2016-08-13T04:37:04.462090-05:00","4f6e6bbc-117f-464a-97f9-418de428a9eb_experiment.xml","b4637f45ff9f95fe290e8098dc7023f8","2ae0f4c8-2286-4815-8f6f-117ade58a934",3916,"2016-09-29T21:25:06.541146-05:00","4f6e6bbc-117f-464a-97f9-418de428a9eb_run.xml","d37847458bce702422f007dafe678b27","91b14120-d45c-4e72-bb35-fd1d762c5a79",1988,"2016-09-08T11:06:38.896310-05:00","TCGA-31-1951","2016-09-02T18:50:41.249367-05:00","female","TCGA-31-1951_demographic",1949,"white","1f9b5de4-e9f0-5e4d-8959-ccfe046d49a5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1951_diagnosis","not reported",21352,"alive","8441/3",NA,684,"201d89c4-e6e6-5f26-9ffc-249c94991d25","c56.9",-21352,"TCGA-31-1951_treatment","26eb5580-5888-5b83-8256-0e83babb4ed7","01",NA,"TCGA-31-1951-01A","0.5","cc6a73f6-9dee-4eeb-85c3-c81f02d1adef",FALSE,"b10efe75-1420-47d2-9c5b-202b09099357","Primary Tumor","0.3",NA,NA,"0.7",1246838400,"01",120,"TCGA-31-1951-01A-01",95,90,NA,NA,0,0,19,18,"2016-09-08T11:06:38.896310-05:00","2016-09-08T11:06:38.896310-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,2,"5fe1fa05-31a4-478f-9008-bdb07e1b677f","e4569bfa-757f-4f1e-85a2-8b17bfad7876","TCGA-31-1951-01A-01-TS1","TCGA-31-1951-01A-01-BS1",80,90,"9fe09e22-da6f-44d1-9a4f-4ad31b42d13c","RNA","TCGA-31-1951-01A-01R","14b537f4-0115-4e25-9da5-6bc2f9184ce7",1.8,0.17,"UV Spec","R","22","TCGA-31-1951-01A-01R-1568-13","197ea6b5-5716-4e5c-9c7f-92ed4521682a",0.17,NA,NA,NA,NA,"47185f16-293d-58dc-add1-c4cae3035926","TCGA-31-1951_exposure","TCGA-31-1951-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T09:18:57.000Z","2014-08-26T11:01:11.000Z","4F6E6BBC-117F-464A-97F9-418DE428A9EB","CC6A73F6-9DEE-4EEB-85C3-C81F02D1ADEF","Unaligned reads",12878120960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","197EA6B5-5716-4E5C-9C7F-92ED4521682A","Canada's Michael Smith Genome Sciences Centre","564a32fee4b09c884b21c8b3","B0839F46-8C82-4619-BE3D-C857A1759463","Ovarian Serous Cystadenocarcinoma","TAR","9FE09E22-DA6F-44D1-9A4F-4AD31B42D13C","2014-08-26T11:01:11.000Z","14B537F4-0115-4E25-9DA5-6BC2F9184CE7","None","NO",1,0.3,"Primary Tumor","Imperial College",NA,"9FE09E22-DA6F-44D1-9A4F-4AD31B42D13C",0.5,"31","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a6bb52ad-58cf-4ee0-ae89-9615811f4de6.txt",NA,"TCGA-31-1951-01A",0.7,"C56143B7-C7A5-4BBD-86FC-83FFBD920FC5","TCGA",2007,NA,NA,"WITH TUMOR","CC6A73F6-9DEE-4EEB-85C3-C81F02D1ADEF",58,"nationwidechildrens.org_clinical.TCGA-31-1951.xml","Alive",NA,"TCGA-31-1951","NOT HISPANIC OR LATINO","B880ADD7-CDF8-492C-86F5-A1F8CBCDD513",NA,684,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,120,"E4569BFA-757F-4F1E-85A2-8B17BFAD7876","AAFF1B99-2858-4F7A-97DC-8E74C7F0082A","TCGA-31-1951-01A-01R-1568-13.hg19.spljxn.quantification.txt","TCGA-31-1951-01A-01",95,0,NA,NA,19,"TOP",1,NA,"TCGA-31-1951-01A-01-TS1",80,"Liposomal Doxorubicin","Chemotherapy","TCGA-31-1951-D27694",NA,NA,NA,"TCGA-31-1951-F27692_NTE-1",NA,684,"WITH TUMOR","Alive",NA,"TCGA-31-1951-F27692","TCGA-31-1951",NA,"31","1951","YES","C56.9","8441/3","C56.9",NA,NA,-21352,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",684,NA,NA,NA,"WITH TUMOR","NO",4,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,58,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
230424620,222013784,16439003575,"18B29573-822C-405F-B793-DBC8924866CE.bw","b120b701-c194-43d7-a491-3206fac38ec1","18b29573-822c-405f-b793-dbc8924866ce","2016-08-25T04:06:10.121380-05:00","TCGA-24-1425-01A-02R-1566-13_rnaseq_fastq.tar","b0612fb4-43f6-452e-aece-2a35427f7ae3",14850836480,"Illumina HiSeq","d285e0e5f1b08c1bab9d81c3570ac4bd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:46:35.304890-05:00","2016-05-03T11:40:21.648199-05:00","b0612fb4-43f6-452e-aece-2a35427f7ae3_analysis.xml","a63b94fd41776b4deee39dacb9b7dc2e","2f34cb60-6e31-46f7-ae58-26d7320a22f1",2181,"2016-08-13T03:43:59.335760-05:00","b0612fb4-43f6-452e-aece-2a35427f7ae3_experiment.xml","96ecf672869d09ffa21086dd03a0407f","b30121e1-eeb7-43fb-9294-da0cac9b8e02",3916,"2016-09-29T21:23:12.135615-05:00","b0612fb4-43f6-452e-aece-2a35427f7ae3_run.xml","27cab8b43254116996de3558a2c0b4c3","908c6e02-182b-4da9-a983-a8e3926a4966",1988,"2016-09-08T13:00:11.703427-05:00","TCGA-24-1425","2016-09-02T19:07:15.837231-05:00","female","TCGA-24-1425_demographic",1963,"white","aedc9d93-ac86-5686-a44b-83c6a60b6bcb","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1425_diagnosis","not reported",16764,"alive","8441/3",NA,181,"a4520404-b3dd-59ab-a30e-b3073be4407c","c56.9",-16764,"TCGA-24-1425_treatment","c8533376-0d48-5ff0-a8f4-86f4bd19a3bf","01",NA,"TCGA-24-1425-01A","0.8","7d0d7e28-9530-4d03-9041-aeca61ecf42c",FALSE,"06592570-be8f-49d4-a42f-068ad60efe34","Primary Tumor","0.4",NA,NA,"1.5",1232064000,"02",112,"TCGA-24-1425-01A-02",70,75,NA,NA,0,0,30,25,"2016-09-08T13:00:11.703427-05:00","2016-09-08T13:00:11.703427-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,10,"a6fe1ea1-7b06-4337-8d6e-6a799ef51d5b","a98f855c-c0e6-4815-9a18-395d258e7621","TCGA-24-1425-01A-02-BS2","TCGA-24-1425-01A-01-BS1",69,65,"2698c7f4-148b-4bdb-b704-4eae2b1a15dd","RNA","TCGA-24-1425-01A-02R","17c838ba-fc9c-4c96-ada8-c461a8a4af68",1.8,0.14,"UV Spec","R","22","TCGA-24-1425-01A-02R-1566-13","f580e84b-b405-43dc-9dae-4588cedf435f",0.14,NA,NA,NA,NA,"1f490462-da9b-5cc1-a2ba-b11026e6ff03","TCGA-24-1425_exposure","TCGA-24-1425-01A-02R-1566-13_rnaseq_fastq.tar","2014-03-25T07:25:54.000Z","2014-03-25T07:57:02.000Z","B0612FB4-43F6-452E-AECE-2A35427F7AE3","7D0D7E28-9530-4D03-9041-AECA61ECF42C","Unaligned reads",14850836480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F580E84B-B405-43DC-9DAE-4588CEDF435F","Canada's Michael Smith Genome Sciences Centre","564a5b73e4b08c5d86953bb7","B120B701-C194-43D7-A491-3206FAC38EC1","Ovarian Serous Cystadenocarcinoma","TAR","2698C7F4-148B-4BDB-B704-4EAE2B1A15DD","2014-03-25T07:57:02.000Z","17C838BA-FC9C-4C96-ADA8-C461A8A4AF68","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"2698C7F4-148B-4BDB-B704-4EAE2B1A15DD",0.8,"24","TCGA-24-1425-01A-02R-1566-13_rnaseq.bam.bai",NA,"TCGA-24-1425-01A",1.5,"DEF339B3-1E0A-4329-AAAE-7A397DCD76A1","TCGA",2008,NA,NA,"TUMOR FREE","D17F4E7D-4933-4374-89AC-AB201F86C7DB",45,"APEEK_p_TCGA_GBM16-Ov15_Expr_HT_HG-U133A_96-HTA_A01_464132.level2.data.txt","Alive",NA,"TCGA-24-1425",NA,"4A3AABD7-413A-42FE-A1DD-5AF7E3935EC3",NA,181,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,2,112,"A6FE1EA1-7B06-4337-8D6E-6A799EF51D5B","A95E4291-63BE-405C-96B5-A896E47E154D","TCGA-24-1425-01A-02R-1566-13.hg19.gene.quantification.txt","TCGA-24-1425-01A-02",70,0,NA,NA,30,"BOTTOM",1,NA,"TCGA-24-1425-01A-02-BS2",69,"Taxotere","Chemotherapy","TCGA-24-1425-D25947",NA,NA,NA,NA,NA,181,"TUMOR FREE","Alive",NA,"TCGA-24-1425-F25946","TCGA-24-1425",NA,"24","1425","YES","C56.9","8441/3","C56.9",NA,NA,-16764,"FEMALE","WHITE",NA,NA,"No","Alive",181,NA,NA,NA,"TUMOR FREE","NO",12,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
174736518,165706817,12167508297,"994EC227-B239-4CEE-AC96-EB5CC0AF583E.bw","b1c90c69-6149-4105-8182-ab9212f196be","994ec227-b239-4cee-ac96-eb5cc0af583e","2016-08-25T17:51:36.451086-05:00","TCGA-09-1669-01A-01R-1566-13_rnaseq_fastq.tar","f61e78b9-8581-4927-81aa-c86b438af706",10948423680,"Illumina HiSeq","91f0d0edaa43ec247eec7aec044c1f07","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:51:58.809677-05:00","2016-05-03T11:40:21.648199-05:00","f61e78b9-8581-4927-81aa-c86b438af706_analysis.xml","48be8384a068bdc3430bf55e61a0d5bf","ecb19406-3964-4921-bfea-63af8569a34d",2181,"2016-09-29T22:17:37.256272-05:00","f61e78b9-8581-4927-81aa-c86b438af706_experiment.xml","79ba62285228dccbd4b9f7d2bc973a9f","b223d444-26f1-4d95-9de8-6df1b7296f05",3916,"2016-09-29T21:06:18.267029-05:00","f61e78b9-8581-4927-81aa-c86b438af706_run.xml","a715dd7017222d2efecfb9239f88fb44","8603c2e9-15da-492f-aa74-86a4f9473f2f",1988,"2016-09-08T10:44:02.212637-05:00","TCGA-09-1669","2016-09-02T18:49:50.270433-05:00","female","TCGA-09-1669_demographic",1950,"white","85394400-da7b-574f-8346-6d5fc26b3df5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1669_diagnosis","not reported",20052,"alive","8441/3",NA,928,"a5bcf80f-e5db-5ab5-8c04-57c2093acb89","c56.9",-20052,"TCGA-09-1669_treatment","15a724f5-1a73-51fb-83ad-81dbf48cc564","01",NA,"TCGA-09-1669-01A","0.5","646165d1-4eb0-4dbd-8e05-90cdb30e1d22",FALSE,"7870b5a7-a96c-4e55-b56f-8eca45918251","Primary Tumor","0.3",NA,NA,"0.9",1240185600,"01",86,"TCGA-09-1669-01A-01",70,80,NA,NA,0,0,40,30,"2016-09-08T10:44:02.212637-05:00","2016-09-08T10:44:02.212637-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"f8a5a978-1bfe-40d2-849e-ac225005e7f2","389e7206-51cf-433f-937e-dab344cbc88a","TCGA-09-1669-01A-01-BS1","TCGA-09-1669-01A-01-TS1",55,65,"486497a8-c746-44c7-a85d-3857d5c08b92","RNA","TCGA-09-1669-01A-01R","dc18d6de-70e9-4b40-95a6-a0c288c8a1f2",1.8,0.16,"UV Spec","R","22","TCGA-09-1669-01A-01R-1566-13","a56ccd4c-1959-44a9-968d-57e6c5bc0cf8",0.16,NA,NA,NA,NA,"4905a932-d253-5b54-ae93-d1b3ae64f7d3","TCGA-09-1669_exposure","TCGA-09-1669-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T04:45:17.000Z","2014-03-25T05:08:01.000Z","F61E78B9-8581-4927-81AA-C86B438AF706","646165D1-4EB0-4DBD-8E05-90CDB30E1D22","Unaligned reads",10948423680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A56CCD4C-1959-44A9-968D-57E6C5BC0CF8","Canada's Michael Smith Genome Sciences Centre","564a33d1e4b09c884b220a95","B1C90C69-6149-4105-8182-AB9212F196BE","Ovarian Serous Cystadenocarcinoma","TAR","486497A8-C746-44C7-A85D-3857D5C08B92","2014-03-25T05:08:01.000Z","DC18D6DE-70E9-4B40-95A6-A0C288C8A1F2","None","NO",1,0.3,"Primary Tumor","UCSF",NA,"486497A8-C746-44C7-A85D-3857D5C08B92",0.5,"09","TCGA-09-1669-01A-01R-1566-13_mirna.bam.bai",NA,"TCGA-09-1669-01A",0.9,"50DCC375-FA24-4050-AD1E-92CD42C75E97","TCGA",2004,NA,NA,"WITH TUMOR","A3CC3FA7-F460-4C6E-8CB1-69E6FE9CA244",54,"nationwidechildrens.org_clinical.TCGA-09-1669.xml","Alive",NA,"TCGA-09-1669","NOT HISPANIC OR LATINO","BE4D9604-3E6B-4BF2-BD2A-0BE49751832A",NA,928,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,86,"F8A5A978-1BFE-40D2-849E-AC225005E7F2","54CE7CC9-FBFB-4B1D-9C20-01D6386E8AC9","US82800149_251976010667_S01_GE2-v5_10_Apr08.txt","TCGA-09-1669-01A-01",80,0,NA,NA,30,"TOP",5,NA,"TCGA-09-1669-01A-01-TS1",65,"Carboplatin","Chemotherapy","TCGA-09-1669-D24307",NA,NA,NA,NA,NA,928,"WITH TUMOR","Alive",NA,"TCGA-09-1669-F24305","TCGA-09-1669",NA,"09","1669","YES","C56.9","8441/3","C56.9",NA,NA,-20052,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",928,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,54,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164957900,155391597,11463909167,"950933A3-5757-4914-9DC5-C220C2A455FD.bw","b1e11e94-646b-4c44-9d33-1ca67d8356fb","950933a3-5757-4914-9dc5-c220c2a455fd","2016-09-29T21:30:27.638411-05:00","TCGA-13-0795-01A-01R-1564-13_rnaseq_fastq.tar","9754579d-1c77-4dc6-8fe0-9fca9932cef8",10593884160,"Illumina HiSeq","682bce772c26fc4dcb2e0e7da041ac6e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:04:08.359517-05:00","2016-05-03T11:39:34.522989-05:00","9754579d-1c77-4dc6-8fe0-9fca9932cef8_analysis.xml","26913adb1fcac9c14c006c18003ec92f","848d4b57-6d38-482c-b4c0-a8e2a77c133a",2210,"2016-09-29T19:38:43.073452-05:00","9754579d-1c77-4dc6-8fe0-9fca9932cef8_experiment.xml","01d79f478855b0ed61a5aaad8812d3e2","4fe7085f-2388-4885-a0ab-380b42b9f0d5",3916,"2016-09-29T21:26:11.551595-05:00","9754579d-1c77-4dc6-8fe0-9fca9932cef8_run.xml","deabfca1d2050ea31114306ad8172433","925cb7c8-3703-410c-8d7b-6ef5e2e3b0d3",1990,"2016-09-08T10:27:55.378214-05:00","TCGA-13-0795","2016-09-02T19:09:30.851751-05:00","female","TCGA-13-0795_demographic",1941,"white","765b568d-c940-5239-92dc-26c4c0431db1","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0795_diagnosis","not reported",24403,"dead","8441/3",619,596,"049f6c9e-4b02-5c39-ad7f-5f357c226bc5","c56.9",-24403,"TCGA-13-0795_treatment","61f9e645-1126-57fe-8301-cdfbba84acac","01",NA,"TCGA-13-0795-01A","0.9","61ef4d54-bfa5-4d62-89bc-2717eabc741b",FALSE,"B98206EC-73D1-404F-B497-BAD6C817D9B7","Primary Tumor","0.3",NA,NA,"1.4",1233705600,"01",135,"TCGA-13-0795-01A-01",95,98,NA,NA,0,0,15,5,"2016-09-08T10:27:55.378214-05:00","2016-09-08T10:27:55.378214-05:00",75,NA,NA,NA,"TOP","BOTTOM",0,0,"715a85bd-eb61-468f-8e17-dc8088b4af18","2f633977-70d5-4b3b-878e-64cef7142c05","TCGA-13-0795-01A-01-TS1","TCGA-13-0795-01A-01-BS1",85,95,"81fe814f-4faa-42eb-98f0-f0aac99849bc","RNA","TCGA-13-0795-01A-01R","8db456cc-e692-40fe-9e86-a28751867bdd",1.8,0.19,"UV Spec","R","22","TCGA-13-0795-01A-01R-1564-13","5345eef4-ee81-4128-96fb-85c29750cc96",0.19,NA,NA,NA,NA,"5c96b656-ef31-56c7-afc2-7005e37d12d4","TCGA-13-0795_exposure","TCGA-13-0795-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T01:28:05.000Z","2014-03-20T01:50:02.000Z","9754579D-1C77-4DC6-8FE0-9FCA9932CEF8","61EF4D54-BFA5-4D62-89BC-2717EABC741B","Unaligned reads",10593884160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5345EEF4-EE81-4128-96FB-85C29750CC96","Canada's Michael Smith Genome Sciences Centre","564a35aae4b08c5d868fada9","B1E11E94-646B-4C44-9D33-1CA67D8356FB","Ovarian Serous Cystadenocarcinoma","TAR","81FE814F-4FAA-42EB-98F0-F0AAC99849BC","2014-03-20T01:50:02.000Z","8DB456CC-E692-40FE-9E86-A28751867BDD","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"81FE814F-4FAA-42EB-98F0-F0AAC99849BC",0.9,"13","C239.TCGA-13-0795-01A-01W.3.bam",NA,"TCGA-13-0795-01A",1.4,"A99E93F3-BA26-4014-BBBC-3504115A7F8C","TCGA",2007,NA,NA,"WITH TUMOR","8F17944D-3A5C-43D9-B26B-9F1C7E0F2ED7",66,"nationwidechildrens.org_clinical.TCGA-13-0795.xml","Alive",NA,"TCGA-13-0795","NOT HISPANIC OR LATINO","CA8E4422-C168-479C-A85B-B3B7807D6443",NA,596,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,135,"715A85BD-EB61-468F-8E17-DC8088B4AF18","B5741EBF-32ED-4D2A-B082-4CC4BDA362D3","C239.TCGA-13-0795-01A-01W.3.bam","TCGA-13-0795-01A-01",95,0,NA,75,15,"TOP",0,NA,"TCGA-13-0795-01A-01-TS1",85,"Carboplatin","Chemotherapy","TCGA-13-0795-D24603",NA,NA,NA,"TCGA-13-0795-F24602_NTE-1",NA,596,"WITH TUMOR","Alive",NA,"TCGA-13-0795-F24602","TCGA-13-0795",NA,"13","0795","YES","C56.9","8441/3","C56.9",NA,NA,-24403,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",596,NA,NA,NA,"WITH TUMOR","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,2007,"Fine needle aspiration biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
248108544,239514045,17685189791,"DBDFE95C-F941-407A-BE7D-D43D50143C4D.bw","b25570ed-baca-4e3f-87c6-2ef18119ba49","dbdfe95c-f941-407a-be7d-d43d50143c4d","2016-08-23T03:00:24.159661-05:00","TCGA-13-1499-01A-01R-1565-13_rnaseq_fastq.tar","48025b68-b713-4c4b-a45a-a566e548bc26",14960814080,"Illumina HiSeq","824b6f1b2737760f490e82a816b417cd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:37:06.460252-05:00","2016-05-03T11:40:21.647690-05:00","48025b68-b713-4c4b-a45a-a566e548bc26_analysis.xml","baa14dc564a6080b1ef4fdb403169b1a","73ace3ae-4e6f-4bd2-907b-3f43b21f6f5d",2208,"2016-09-29T23:58:59.108670-05:00","48025b68-b713-4c4b-a45a-a566e548bc26_experiment.xml","26ef9abde1a5820b296e9c09641fd9a2","f107ee06-570a-4e3c-828d-f8e5bd5624d3",3916,"2016-09-29T19:20:59.299077-05:00","48025b68-b713-4c4b-a45a-a566e548bc26_run.xml","a71ccb8ce3e0d3843566d67614f3a65f","44e90e09-e8ed-40f4-8b3c-e3ce99acf53f",1989,"2016-09-08T13:55:46.874228-05:00","TCGA-13-1499","2016-09-02T19:13:54.384202-05:00","female","TCGA-13-1499_demographic",1949,"white","f5853584-62ad-5679-9cb3-8ca4b7d8a998","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1499_diagnosis","not reported",20668,"alive","8441/3",NA,3500,"148128fe-490f-5ecb-9eb0-7bfd1594cfd3","c56.9",-20668,"TCGA-13-1499_treatment","89d4ac03-0516-5efe-87d2-b896c064abf1","01",NA,"TCGA-13-1499-01A","1.1","16220eed-5ba3-4067-9dcf-d7327a44c05d",FALSE,"3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0","Primary Tumor","0.4",NA,NA,"2.1",1234915200,"01",122,"TCGA-13-1499-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T13:55:46.874228-05:00","2016-09-08T13:55:46.874228-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,1,"70245996-46ca-4e68-ab44-0fc043794b88","116d81fb-17b7-46f8-abb6-e1fb37fbbfc9","TCGA-13-1499-01A-01-BS1","TCGA-13-1499-01A-01-TS1",75,79,"e2403b4e-40c4-4cff-973b-b76d4489766b","RNA","TCGA-13-1499-01A-01R","88151a1a-f6cf-4fc3-b17c-661c5cf20938",1.8,0.15,"UV Spec","R","22","TCGA-13-1499-01A-01R-1565-13","1f677d4c-6feb-4a3a-9f12-ba1d43920a80",0.15,NA,NA,NA,NA,"6202f343-9edf-5cbe-85fe-8cc62a838815","TCGA-13-1499_exposure","TCGA-13-1499-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T00:12:38.000Z","2014-03-22T00:45:01.000Z","48025B68-B713-4C4B-A45A-A566E548BC26","16220EED-5BA3-4067-9DCF-D7327A44C05D","Unaligned reads",14960814080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1F677D4C-6FEB-4A3A-9F12-BA1D43920A80","Canada's Michael Smith Genome Sciences Centre","564a56dee4b0298dd2caa976","B25570ED-BACA-4E3F-87C6-2EF18119BA49","Ovarian Serous Cystadenocarcinoma","TAR","E2403B4E-40C4-4CFF-973B-B76D4489766B","2014-03-22T00:45:01.000Z","88151A1A-F6CF-4FC3-B17C-661C5CF20938","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"E2403B4E-40C4-4CFF-973B-B76D4489766B",1.1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.21c833c6-d2bc-4308-a233-894c7a6636f1.txt",NA,"TCGA-13-1499-01A",2.1,"54DEA9E5-ADE7-4B1F-ABFC-F3B1D49DDE54","TCGA",2005,NA,NA,"WITH TUMOR","5F1DF4AC-E4B5-411B-922C-10B64AAAC4C2",56,"nationwidechildrens.org_clinical.TCGA-13-1499.xml","Alive",NA,"TCGA-13-1499","NOT HISPANIC OR LATINO","23F13A5E-8099-432A-A6A2-A3E2D887B8BA",NA,1168,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,122,"70245996-46CA-4E68-AB44-0FC043794B88","FCF35E31-C6F1-4A59-90C9-B969CDA68E1B","ad1e9a14f8c529208b69b064a3965107.bam.bai","TCGA-13-1499-01A-01",80,0,NA,NA,20,"TOP",1,NA,"TCGA-13-1499-01A-01-TS1",79,"Paclitaxel","Chemotherapy","TCGA-13-1499-D24923",NA,NA,NA,"TCGA-13-1499-F24919_NTE-2",NA,1168,"WITH TUMOR","Alive",NA,"TCGA-13-1499-F24919","TCGA-13-1499",NA,"13","1499","YES","C56.9","8441/3","C56.9",NA,NA,-20668,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1168,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,56,2005,"Incisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
311957668,303867289,22466164070,"D024393C-29D0-41C4-AB86-7E94581FDD26.bw","b31d85cc-d2e2-4bd1-9986-d6bbe30e657f","d024393c-29d0-41c4-ab86-7e94581fdd26","2016-08-26T14:27:03.228599-05:00","TCGA-61-2094-01A-01R-1568-13_rnaseq_fastq.tar","38b8d911-8ff9-406e-a850-76d30219ede0",20194979840,"Illumina HiSeq","a3c9ff6241708f9db28e0fc01fe4c887","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:34:58.005224-05:00","2016-05-03T11:41:05.755204-05:00","38b8d911-8ff9-406e-a850-76d30219ede0_analysis.xml","b1e08834af923dc77f82f8a065b59316","e21b0e20-8474-4ce7-9db7-1a9933283ae9",2183,"2016-08-13T09:41:17.756807-05:00","38b8d911-8ff9-406e-a850-76d30219ede0_experiment.xml","257402287ec13d6f627de666cd702d9f","9ebdac4c-d4a3-4c5a-aec9-293626caccb1",3916,"2016-09-29T19:10:05.562031-05:00","38b8d911-8ff9-406e-a850-76d30219ede0_run.xml","c041c697ed45b03a5a32338f2b8b1a04","3e08631d-b02a-421d-a5c1-6c3f31ab5db0",1990,"2016-09-08T12:26:49.045823-05:00","TCGA-61-2094","2016-09-02T18:56:26.016111-05:00","female","TCGA-61-2094_demographic",1940,"white","b5affed5-6e77-5623-b1a4-a0cdcef3b0d9","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2094_diagnosis","not reported",23273,"alive","8441/3",NA,2182,"38e754fd-a254-5193-9f78-49239781ea56","c56.9",-23273,"TCGA-61-2094_treatment","e9c4d759-9318-57e7-ac69-8e7165a8bf5f","01",NA,"TCGA-61-2094-01A","1.1","ae00d18f-7117-4cfb-a306-168f1f5d493a",FALSE,"205b0520-854c-480e-881d-89bc8cbcff75","Primary Tumor","0.3",NA,NA,"2",1250208000,"01",114,"TCGA-61-2094-01A-01",99,99,NA,NA,0,0,18,5,"2016-09-08T12:26:49.045823-05:00","2016-09-08T12:26:49.045823-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,5,"9000f5e5-fec8-4f69-b706-e3a29e96e3e0","411172e6-1e22-4ba7-869b-1af9867c4d4b","TCGA-61-2094-01A-01-BS1","TCGA-61-2094-01A-01-TS1",80,90,"70b3c2ac-41a1-4479-a356-f1f7dbcd7c19","RNA","TCGA-61-2094-01A-01R","02a2bac8-2454-4d1a-b21f-72d4c5c0a843",1.8,0.15,"UV Spec","R","22","TCGA-61-2094-01A-01R-1568-13","c6e1c591-3225-482a-8350-112b664a37e6",0.15,NA,NA,NA,NA,"6c68935c-dd87-5dc1-9def-eec11ac726db","TCGA-61-2094_exposure","TCGA-61-2094-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T05:01:29.000Z","2014-03-27T05:35:01.000Z","38B8D911-8FF9-406E-A850-76D30219EDE0","AE00D18F-7117-4CFB-A306-168F1F5D493A","Unaligned reads",20194979840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C6E1C591-3225-482A-8350-112B664A37E6","Canada's Michael Smith Genome Sciences Centre","564a352ae4b093830b67467d","B31D85CC-D2E2-4BD1-9986-D6BBE30E657F","Ovarian Serous Cystadenocarcinoma","TAR","70B3C2AC-41A1-4479-A356-F1F7DBCD7C19","2014-03-27T05:35:01.000Z","02A2BAC8-2454-4D1A-B21F-72D4C5C0A843","None","NO",1,0.3,"Primary Tumor","University of Pittsburgh",NA,"70B3C2AC-41A1-4479-A356-F1F7DBCD7C19",1.1,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1ac0ed16-0e91-4c45-9b9d-b68ceb9940da.txt",NA,"TCGA-61-2094-01A",2,"384A2E6A-6501-479E-B41C-10713AF19C13","TCGA",2003,NA,NA,"TUMOR FREE","AE00D18F-7117-4CFB-A306-168F1F5D493A",63,"nationwidechildrens.org_clinical.TCGA-61-2094.xml","Alive",NA,"TCGA-61-2094","NOT HISPANIC OR LATINO","D6CA83F9-D13E-48C8-9739-0DDFE7467B49",NA,2182,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,114,"9000F5E5-FEC8-4F69-B706-E3A29E96E3E0","87B9231C-0B68-48DE-BC79-394E649A14D4","SOURS_p_TCGAb22_SNP_N_GenomeWideSNP_6_D05_529968.ismpolish.data.txt","TCGA-61-2094-01A-01",99,0,NA,NA,18,"BOTTOM",2,NA,"TCGA-61-2094-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-61-2094-D28387",NA,NA,NA,NA,NA,2182,"TUMOR FREE","Alive",NA,"TCGA-61-2094-F28385","TCGA-61-2094",NA,"61","2094","YES","C56.9","8441/3","C56.9",NA,NA,-23273,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2182,NA,NA,NA,"TUMOR FREE","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
178137512,173725572,12883474236,"4975AB35-93E5-400D-A429-CEA81BA89FFE.bw","b3511675-fd68-4745-8020-e290ca0fd115","4975ab35-93e5-400d-a429-cea81ba89ffe","2016-08-26T01:21:07.971500-05:00","TCGA-29-1703-01A-01R-1567-13_rnaseq_fastq.tar","ffe29fcb-021f-4383-835a-108cf97dfc14",11454033920,"Illumina HiSeq","b672f33963c178e9f52ff14e72e3d44b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:00:59.568253-05:00","2016-05-03T11:41:05.740436-05:00","ffe29fcb-021f-4383-835a-108cf97dfc14_analysis.xml","061cb1fa9d152e333ff2c9984ad8f58b","a7f06c4f-7d0b-4ab1-92f3-f1ce5b7202e9",2181,"2016-10-07T17:31:55.550593-05:00","ffe29fcb-021f-4383-835a-108cf97dfc14_experiment.xml","7adee033e07531a00b92a5c3b15b10c4","43fde0c2-ec7f-4ded-8cf9-fbd81cb92e48",3916,"2016-09-29T22:27:59.040001-05:00","ffe29fcb-021f-4383-835a-108cf97dfc14_run.xml","8dce1ad8c031c0851c59ce97cbf26911","b87de673-836e-4605-bef3-dba71fb6b302",1988,"2016-09-08T13:12:56.652160-05:00","TCGA-29-1703","2016-09-02T19:07:35.483905-05:00","female","TCGA-29-1703_demographic",1949,"black or african american","d3239bb4-63cb-5ba3-911b-f8ef467f8bb5","not reported",2009,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1703_diagnosis","not reported",20622,"dead","8441/3",1815,1815,"17951518-166e-5b1e-b7a9-d3cda6b3bd1c","c56.9",-20622,"TCGA-29-1703_treatment","2fd1d9cb-646d-5b93-893b-daff67331324","01",NA,"TCGA-29-1703-01A","1","d86b5d2b-9a8e-4bfa-9549-12fd45e8c296",FALSE,"c8397af0-67d2-4e69-993b-7349657e9953","Primary Tumor","0.4",NA,NA,"1.4",1242086400,"01",117,"TCGA-29-1703-01A-01",95,95,NA,NA,0,0,0,0,"2016-09-08T13:12:56.652160-05:00","2016-09-08T13:12:56.652160-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,2,"275260f3-64da-44d8-9488-c53230c4dce2","bac4f162-fe80-42ee-91c2-7a3fa4486957","TCGA-29-1703-01A-01-TS1","TCGA-29-1703-01A-01-BS1",90,98,"38304d01-f347-423f-afe6-060872a71104","RNA","TCGA-29-1703-01A-01R","c99ee4e8-f869-4987-9283-a643412f6ea6",1.8,0.14,"UV Spec","R","22","TCGA-29-1703-01A-01R-1567-13","64e3f978-d213-45e2-bb52-e9b9a2032dc0",0.14,NA,NA,NA,NA,"8331f387-3bbe-5946-a79b-7048b733c756","TCGA-29-1703_exposure","TCGA-29-1703-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T23:32:03.000Z","2014-03-27T00:03:01.000Z","FFE29FCB-021F-4383-835A-108CF97DFC14","D86B5D2B-9A8E-4BFA-9549-12FD45E8C296","Unaligned reads",11454033920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","64E3F978-D213-45E2-BB52-E9B9A2032DC0","Canada's Michael Smith Genome Sciences Centre","564a31b0e4b093830b662af0","B3511675-FD68-4745-8020-E290CA0FD115","Ovarian Serous Cystadenocarcinoma","TAR","38304D01-F347-423F-AFE6-060872A71104","2014-03-27T00:03:01.000Z","C99EE4E8-F869-4987-9283-A643412F6EA6","None","NO",1,0.4,"Primary Tumor","Duke",NA,"38304D01-F347-423F-AFE6-060872A71104",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.13530c03-540d-4e0d-a760-c0f6946f0480.txt",NA,"TCGA-29-1703-01A",1.4,"5A22C5FC-1192-4DB9-86CB-84768E401698","TCGA",2005,NA,NA,"WITH TUMOR","D86B5D2B-9A8E-4BFA-9549-12FD45E8C296",56,"bcgsc.ca.TCGA-29-1703-01A-01R-1567-13.bcgsc.ca.1.5.0.snv.vcf","Dead",1815,"TCGA-29-1703",NA,"AEF081E4-4629-4F49-A25F-0787FE8E2CE5",NA,1815,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,117,"BAC4F162-FE80-42EE-91C2-7A3FA4486957","432B265A-00D6-445D-81F0-214BC6C4DAF7","SAROS_p_TCGA_B18_SNP_N_GenomeWideSNP_6_C04_489684.hg19.seg.txt","TCGA-29-1703-01A-01",95,0,NA,NA,0,"BOTTOM",2,NA,"TCGA-29-1703-01A-01-BS1",98,"Bevacizumab","Targeted Molecular therapy","TCGA-29-1703-D27266",NA,NA,NA,"TCGA-29-1703-F27255_NTE-1",NA,1815,"WITH TUMOR","Dead",1815,"TCGA-29-1703-F27255","TCGA-29-1703",NA,"29","1703","YES","C56.9","8441/3","C56.9",NA,NA,-20622,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",1815,1815,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2005,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
206404546,201810142,14887128597,"666ADCA2-1AE4-4843-B1C8-8EE29C44AE74.bw","b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b","666adca2-1ae4-4843-b1c8-8ee29c44ae74","2016-08-25T11:37:56.516024-05:00","TCGA-29-1691-01A-01R-1566-13_rnaseq_fastq.tar","ca8d18a0-de05-450b-8e57-6d404327cae7",13043353600,"Illumina HiSeq","876531c4afe191afd7a49d2d94257012","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:53:40.358063-05:00","2016-05-03T11:41:05.748550-05:00","ca8d18a0-de05-450b-8e57-6d404327cae7_analysis.xml","1679da7f6e853423decf181106a7ea2e","7e091f7b-61c4-4d13-b756-7024995fc364",2181,"2016-10-07T16:00:40.262176-05:00","ca8d18a0-de05-450b-8e57-6d404327cae7_experiment.xml","9ceb3866d1476a18bd435cab5e9339d0","d31d80c0-6c9d-4eec-97cf-1ba594e4f3f5",3916,"2016-09-29T23:24:20.052449-05:00","ca8d18a0-de05-450b-8e57-6d404327cae7_run.xml","efd3d25d5e7a7724d71555be2ad0a80b","db616735-efba-4c7f-a9b5-d547a0a221e8",1989,"2016-09-08T12:25:21.953115-05:00","TCGA-29-1691","2016-09-02T19:07:30.594495-05:00","female","TCGA-29-1691_demographic",1944,"white","3e0c0748-6430-57d2-81fa-e74f67bba190","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1691_diagnosis","not reported",18664,"dead","8441/3",1470,1435,"462c9b3c-1b04-5e25-bdd0-cb23c26c7256","c56.9",-18664,"TCGA-29-1691_treatment","ab9e8288-c148-5fc9-8502-54b6d560c9a5","01",NA,"TCGA-29-1691-01A","0.4","5dbb6c5e-be66-47ca-9bb4-1845b8004286",FALSE,"74e45220-b3ac-4404-8bb6-811f3d4ba611","Primary Tumor","0.05",NA,NA,"0.5",1241740800,"01",127,"TCGA-29-1691-01A-01",95,90,NA,1,0,0,0,0,"2016-09-08T12:25:21.953115-05:00","2016-09-08T12:25:21.953115-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,2,"eec0bed3-fe05-4128-9bac-92a84c021875","cd851d1b-0bd5-4564-bbe0-4dc4aa293b37","TCGA-29-1691-01A-01-BS1","TCGA-29-1691-01A-01-TS1",98,98,"74a297b6-b3e1-4692-8856-eb9693bd534b","RNA","TCGA-29-1691-01A-01R","64a43887-2a36-4edc-a931-ea5f053be2f0",1.8,0.15,"UV Spec","R","22","TCGA-29-1691-01A-01R-1566-13","f83833b8-8cb2-44d8-8ac7-c4d2d2463053",0.15,NA,NA,NA,NA,"bd75dbc2-7e8d-5ea6-a30d-6313f032e662","TCGA-29-1691_exposure","TCGA-29-1691-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-29T05:11:49.000Z","2014-03-29T05:36:02.000Z","CA8D18A0-DE05-450B-8E57-6D404327CAE7","5DBB6C5E-BE66-47CA-9BB4-1845B8004286","Unaligned reads",13043353600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F83833B8-8CB2-44D8-8AC7-C4D2D2463053","Canada's Michael Smith Genome Sciences Centre","564a4102e4b093830b6b12ba","B4225C44-B9B6-46C5-AABF-7B0D9A9FE20B","Ovarian Serous Cystadenocarcinoma","TAR","74A297B6-B3E1-4692-8856-EB9693BD534B","2014-03-29T05:36:02.000Z","64A43887-2A36-4EDC-A931-EA5F053BE2F0","None","NO",1,0.05,"Primary Tumor","Duke",NA,"74A297B6-B3E1-4692-8856-EB9693BD534B",0.4,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e634e64b-7b5c-4d33-88f9-c5c83442fdc1.txt",NA,"TCGA-29-1691-01A",0.5,"AF8DF55A-1129-4A08-AC99-6B6E6328D6ED","TCGA",1995,NA,NA,"WITH TUMOR","5DBB6C5E-BE66-47CA-9BB4-1845B8004286",51,"nationwidechildrens.org_clinical.TCGA-29-1691.xml","Dead",1470,"TCGA-29-1691",NA,"CD9C0017-F19F-4F93-983C-3B4F58156AED",NA,1435,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,127,"EEC0BED3-FE05-4128-9BAC-92A84C021875","A6EF78B3-A1A4-41F9-8661-EC5201258BED","TCGA-29-1691-01A-01R-1566-13.hg19.isoform.quantification.txt","TCGA-29-1691-01A-01",95,0,NA,NA,0,"BOTTOM",2,NA,"TCGA-29-1691-01A-01-BS1",98,"Cytoxan","Chemotherapy","TCGA-29-1691-D27155",NA,NA,NA,"TCGA-29-1691-F27148_NTE-2",NA,1435,"WITH TUMOR","Dead",1470,"TCGA-29-1691-F27148","TCGA-29-1691",NA,"29","1691","YES","C56.9","8441/3","C56.9",NA,NA,-18664,"FEMALE","WHITE",NA,NA,"No","Dead",1435,1470,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,1995,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
231739074,224838897,16642519692,"A8F79C08-3943-4707-ADCB-890A955B5394.bw","b45c543a-40d9-423a-a7fa-98e4b325b487","a8f79c08-3943-4707-adcb-890a955b5394","2016-08-26T01:48:34.609700-05:00","TCGA-24-1928-01A-01R-1567-13_rnaseq_fastq.tar","96c728bc-0375-47d6-8dc8-8400b0bd16bf",15296399360,"Illumina HiSeq","796dc68a84e740070c5ddbec2c922a07","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:49:42.992846-05:00","2016-05-03T11:41:05.750744-05:00","96c728bc-0375-47d6-8dc8-8400b0bd16bf_analysis.xml","0c5fae5b0457a60da04dcb422d696233","eb48292a-7d1b-4bda-8f48-6b0163cfa501",2181,"2016-10-07T16:46:55.590696-05:00","96c728bc-0375-47d6-8dc8-8400b0bd16bf_experiment.xml","b0a2312e48cd2b19aa7800dd7db7945f","17a56451-4766-45dd-aadc-4901bd3b7896",3916,"2016-09-29T20:51:05.561505-05:00","96c728bc-0375-47d6-8dc8-8400b0bd16bf_run.xml","4e9546bd4892ec77ef3fa9158fceafdd","7c688cb2-18ec-410a-9219-665f5cfe72d9",1989,"2016-09-08T10:39:10.506736-05:00","TCGA-24-1928","2016-09-02T18:50:19.892611-05:00","female","TCGA-24-1928_demographic",1921,"white","e160398a-2b94-5d6a-88dc-1950614fd97d","not reported",1998,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1928_diagnosis","not reported",28126,"dead","8441/3",336,336,"20d832c5-76d1-5895-aa49-3794d469aede","c56.9",-28126,"TCGA-24-1928_treatment","60b47769-537d-536e-bfc4-e058ffe51a16","01",NA,"TCGA-24-1928-01A","0.5","595af317-cf8b-4f25-b005-426b078ffc4a",FALSE,"dc4407fb-d15b-44d5-9c3b-129cca67d8f1","Primary Tumor","0.3",NA,NA,"1.5",1246147200,"01",108,"TCGA-24-1928-01A-01",80,80,0,0,0,0,15,10,"2016-09-08T10:39:10.506736-05:00","2016-09-08T10:39:10.506736-05:00",0,0,5,10,"TOP","BOTTOM",5,10,"590660da-409a-4caf-891f-c804870b37ef","909bd06c-69c4-4de3-a83f-8f84522e9594","TCGA-24-1928-01A-01-TS1","TCGA-24-1928-01A-01-BS1",80,80,"dc0a6dfd-2a03-44d3-b841-d17384be596f","RNA","TCGA-24-1928-01A-01R","78594f1f-b1e6-4768-aaf2-9de8f8646ebd",1.8,0.15,"UV Spec","R","22","TCGA-24-1928-01A-01R-1567-13","433d642a-06fe-454f-a2bf-3e0afb3dd23b",0.15,NA,NA,NA,NA,"0e05d363-f279-572a-9703-bb3a1b08d067","TCGA-24-1928_exposure","TCGA-24-1928-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T20:15:00.000Z","2014-03-28T20:47:01.000Z","96C728BC-0375-47D6-8DC8-8400B0BD16BF","595AF317-CF8B-4F25-B005-426B078FFC4A","Unaligned reads",15296399360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","433D642A-06FE-454F-A2BF-3E0AFB3DD23B","Canada's Michael Smith Genome Sciences Centre","564a5bdde4b09c884b27b93e","B45C543A-40D9-423A-A7FA-98E4B325B487","Ovarian Serous Cystadenocarcinoma","TAR","DC0A6DFD-2A03-44D3-B841-D17384BE596F","2014-03-28T20:47:01.000Z","78594F1F-B1E6-4768-AAF2-9DE8F8646EBD","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"DC0A6DFD-2A03-44D3-B841-D17384BE596F",0.5,"24","TCGA-24-1928-01A-01R-1567-13_rnaseq.bam.bai",NA,"TCGA-24-1928-01A",1.5,"F968A12B-04F3-4647-A29C-B5AF2D7F610A","TCGA",1998,NA,NA,"WITH TUMOR","E3A93C6B-33FD-42FE-9E86-21D34FFECDEA",77,"nationwidechildrens.org_clinical.TCGA-24-1928.xml","Dead",336,"TCGA-24-1928",NA,"144F8C7E-E805-4C4C-92FF-E14D57B79A60",NA,336,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,108,"909BD06C-69C4-4DE3-A83F-8F84522E9594","7C3A3D33-693F-483E-8232-E425A521149C","TCGA-24-1928-01A-01R-1567-13_rnaseq.bam.bai","TCGA-24-1928-01A-01",80,0,0,0,10,"BOTTOM",10,10,"TCGA-24-1928-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-24-1928-D26404",NA,NA,NA,"TCGA-24-1928-F26403_NTE-1",NA,336,"WITH TUMOR","Dead",336,"TCGA-24-1928-F26403","TCGA-24-1928",NA,"24","1928","YES","C56.9","8441/3","C56.9",NA,NA,-28126,"FEMALE","WHITE",NA,NA,"No","Dead",336,336,NA,NA,"WITH TUMOR","NO",15,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,77,1998,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
296808986,289433930,21471778491,"A81614ED-14CB-4EBC-988E-F67FBCBF62D8.bw","b46263ab-c3ca-4fda-a895-74c7e6e6fe22","a81614ed-14cb-4ebc-988e-f67fbcbf62d8","2016-08-26T01:22:16.178586-05:00","TCGA-04-1332-01A-01R-1564-13_rnaseq_fastq.tar","38359804-842a-4dab-bbdb-ce3bfb5463a7",17275217920,"Illumina HiSeq","adb82566b860056b029269ac5be3a5d2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:50:00.699849-05:00","2016-05-03T11:39:34.528512-05:00","38359804-842a-4dab-bbdb-ce3bfb5463a7_analysis.xml","f6e719cb2bf0920a158d186b0ddbf4a0","eb7610d1-20b7-4644-9353-e6f54b83a86b",2203,"2016-09-29T18:34:14.596819-05:00","38359804-842a-4dab-bbdb-ce3bfb5463a7_experiment.xml","58f2f8aa5e8b752ca72a589a66bca997","27301815-1037-482d-bbe7-ed4e21b2ee31",3916,"2016-09-29T18:39:02.730852-05:00","38359804-842a-4dab-bbdb-ce3bfb5463a7_run.xml","4da31784756b18c2ca09f9dc53eaf261","2a5fc073-0957-4ae3-a85b-6411f5eed6ca",1990,"2016-09-08T12:34:54.088346-05:00","TCGA-04-1332","2016-09-02T19:05:44.344532-05:00","female","TCGA-04-1332_demographic",1932,"white","b30355c0-e9f5-5b9d-88e5-05f6e7ec84d8","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1332_diagnosis","not reported",25786,"dead","8441/3",1247,1247,"6686400d-d4de-5369-ae39-7518bd6bfcad","c56.9",-25786,"TCGA-04-1332_treatment","c06afc1b-0d7e-5ba3-a070-aab9e7264afc","01",NA,"TCGA-04-1332-01A","0.6","b8243412-b7b4-4a7b-b823-4b33488ff429",FALSE,"97ED2B5D-4349-40FE-A612-949EBBF108C4","Primary Tumor","0.5",NA,NA,"1",1229558400,"01",100,"TCGA-04-1332-01A-01",89,90,NA,NA,0,0,52,89,"2016-09-08T12:34:54.088346-05:00","2016-09-08T12:34:54.088346-05:00",NA,NA,NA,NA,"BOTTOM","TOP",8,3,"0f52bd8b-65e8-4648-b6b8-05ddc60f143a","7d1ae336-5e74-4d12-9048-04d036f8c676","TCGA-04-1332-01A-01-BS1","TCGA-04-1332-01A-01-TS1",40,8,"2807e17e-0f72-460f-8501-95f029d880a2","RNA","TCGA-04-1332-01A-01R","63a3b660-cc5a-449a-bf08-aee1782fd55a",1.8,0.16,"UV Spec","R","22","TCGA-04-1332-01A-01R-1564-13","08e7c700-7038-40b5-bec0-2dd402e1a225",0.16,NA,NA,NA,NA,"76939224-6fba-5538-8ef6-b261ea4b639e","TCGA-04-1332_exposure","TCGA-04-1332-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T03:32:09.000Z","2014-03-20T04:06:01.000Z","38359804-842A-4DAB-BBDB-CE3BFB5463A7","B8243412-B7B4-4A7B-B823-4B33488FF429","Unaligned reads",17275217920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","08E7C700-7038-40B5-BEC0-2DD402E1A225","Canada's Michael Smith Genome Sciences Centre","564a37b5e4b093830b68161e","B46263AB-C3CA-4FDA-A895-74C7E6E6FE22","Ovarian Serous Cystadenocarcinoma","TAR","2807E17E-0F72-460F-8501-95F029D880A2","2014-03-20T04:06:01.000Z","63A3B660-CC5A-449A-BF08-AEE1782FD55A","None","NO",1,0.5,"Primary Tumor","Gynecologic Oncology Group",NA,"2807E17E-0F72-460F-8501-95F029D880A2",0.6,"04","TCGA-04-1332-01A-01W-0488-09_IlluminaGA-DNASeq_exome.bam.bai",NA,"TCGA-04-1332-01A",1,"EAA50F60-2E69-4F97-B316-7F7B4D6AD0E7","TCGA",2002,NA,NA,"WITH TUMOR","B8243412-B7B4-4A7B-B823-4B33488FF429",70,"bcgsc.ca.TCGA-04-1332-01A-01R-1564-13.hg19.bcgsc.ca.1.6.0.snv.vcf","Dead",1247,"TCGA-04-1332","NOT HISPANIC OR LATINO","10D96C4F-798D-4DB3-95CE-0BA9BEACFC5F",NA,1247,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,100,"7D1AE336-5E74-4D12-9048-04D036F8C676","FDD1FFB1-00B2-472B-862B-4DF0A0A0B171","TCGA-04-1332-01A-01W-0488-09_IlluminaGA-DNASeq_exome.bam.bai","TCGA-04-1332-01A-01",89,0,NA,NA,52,"BOTTOM",8,NA,"TCGA-04-1332-01A-01-BS1",40,"Doxil","Chemotherapy","TCGA-04-1332-D23918",NA,NA,NA,"TCGA-04-1332-F23911_NTE-1",NA,NA,"WITH TUMOR","Dead",1247,"TCGA-04-1332-F23911","TCGA-04-1332",NA,"04","1332","YES","C56.9","8441/3","C56.9",NA,NA,-25786,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1247,1247,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,70,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
194608250,186468145,13835769383,"E27E65C8-5B57-4C91-9D20-C075AEA2F2C5.bw","b4b49027-7815-4813-9769-a3fe3a26a37a","e27e65c8-5b57-4c91-9d20-c075aea2f2c5","2016-08-23T06:37:06.746936-05:00","TCGA-25-2393-01A-01R-1569-13_rnaseq_fastq.tar","2db18f92-2033-4efb-a48a-f37df875a7ab",12227031040,"Illumina HiSeq","80b4f676a41fadd925fbc2c2936e434b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:02:44.556209-05:00","2016-05-03T11:41:05.740436-05:00","2db18f92-2033-4efb-a48a-f37df875a7ab_analysis.xml","a711be8815b8df97e48fb7989ccc76f0","f34eb350-2c81-4dac-8647-20e319adfef6",2181,"2016-09-29T23:20:38.823255-05:00","2db18f92-2033-4efb-a48a-f37df875a7ab_experiment.xml","257ebf9152a89fee0e56aaa4d9f86200","d9110287-9671-4fe2-88b6-138a3abb94c2",3916,"2016-09-29T21:25:54.056543-05:00","2db18f92-2033-4efb-a48a-f37df875a7ab_run.xml","6586275f33dab1bd61cc90b1c28c6e4e","922a2ad9-6856-47b8-9fbc-cea56cb90efd",1988,"2016-09-08T13:41:33.516464-05:00","TCGA-25-2393","2016-09-02T19:12:05.904822-05:00","female","TCGA-25-2393_demographic",1922,"white","d287eb95-3746-5617-b7a4-31ccca93dffb","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2393_diagnosis","not reported",29585,"dead","8441/3",1157,1157,"635b00aa-baef-5228-96e1-96c52b8da8a3","c56.9",-29585,"TCGA-25-2393_treatment","ebf44a84-1696-59f7-9b25-926975930d32","01",NA,"TCGA-25-2393-01A","0.7","e69d97a1-39ab-49a6-9f73-5be13fa49d30",FALSE,"0B780E04-2DE3-4C56-9B93-1919F4BBE5D4","Primary Tumor","0.3",NA,NA,"1.3",1252022400,"01",144,"TCGA-25-2393-01A-01",85,85,NA,NA,1,1,14,14,"2016-09-08T13:41:33.516464-05:00","2016-09-08T13:41:33.516464-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"a20e3f24-82c2-4886-a478-09dc932809fe","57857d1a-37a7-4981-805a-609817bcbe0e","TCGA-25-2393-01A-01-TS1","TCGA-25-2393-01A-01-BS1",80,80,"e56337d7-25e3-48b1-a4fd-5aaaab08f5cf","RNA","TCGA-25-2393-01A-01R","2d7b2444-7987-4522-9c20-92b9f539fe90",1.8,0.14,"UV Spec","R","22","TCGA-25-2393-01A-01R-1569-13","93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e",0.14,NA,NA,NA,NA,"82c906c0-3ffd-5f52-b8c4-bd6e06da34c4","TCGA-25-2393_exposure","TCGA-25-2393-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T02:26:06.000Z","2014-03-27T02:50:02.000Z","2DB18F92-2033-4EFB-A48A-F37DF875A7AB","E69D97A1-39AB-49A6-9F73-5BE13FA49D30","Unaligned reads",12227031040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","93A88EC4-E3ED-4E8D-A83C-3E6C4605E89E","Canada's Michael Smith Genome Sciences Centre","564a563de4b093830b6b4da6","B4B49027-7815-4813-9769-A3FE3A26A37A","Ovarian Serous Cystadenocarcinoma","TAR","E56337D7-25E3-48B1-A4FD-5AAAAB08F5CF","2014-03-27T02:50:02.000Z","2D7B2444-7987-4522-9C20-92B9F539FE90","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"E56337D7-25E3-48B1-A4FD-5AAAAB08F5CF",0.7,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5.txt",NA,"TCGA-25-2393-01A",1.3,"F9F70865-C436-451D-B7CB-66C175893433","TCGA",2003,NA,NA,"WITH TUMOR","E69D97A1-39AB-49A6-9F73-5BE13FA49D30",81,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5.txt","Dead",1157,"TCGA-25-2393","NOT HISPANIC OR LATINO","CA8B79A1-ABA9-4F39-A940-AD6DA40EFD5B",NA,1157,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,144,"A20E3F24-82C2-4886-A478-09DC932809FE","72EA0EBF-6F3A-468C-AA2A-31E4E2F70E6B","DITTY_p_TCGA_B_24_AMplate1_2_HT_HG-U133A_96-HTA_A10_547364.level3.data.txt","TCGA-25-2393-01A-01",85,1,NA,NA,14,"BOTTOM",5,NA,"TCGA-25-2393-01A-01-BS1",80,"Doxil","Chemotherapy","TCGA-25-2393-D26806",NA,NA,NA,"TCGA-25-2393-F26803_NTE-1",NA,1157,"WITH TUMOR","Dead",1157,"TCGA-25-2393-F26803","TCGA-25-2393",NA,"25","2393","YES","C56.9","8441/3","C56.9",NA,NA,-29585,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1157,1157,NA,NA,"WITH TUMOR","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,81,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
262356482,256442578,19022608027,"745F18CA-080D-42FE-BAA6-89AD7E3D3408.bw","b520aae5-65a6-4b27-bc2a-10b02c7b1aeb","745f18ca-080d-42fe-baa6-89ad7e3d3408","2016-09-29T20:38:13.105947-05:00","TCGA-25-1322-01A-01R-1565-13_rnaseq_fastq.tar","b9e9e7d3-4d7a-4823-b234-00fc9cdd5a8a",16682967040,"Illumina HiSeq","f001edca5595c324c7a86332abddd672","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:31:55.463810-05:00","2016-05-03T11:40:21.669427-05:00","b9e9e7d3-4d7a-4823-b234-00fc9cdd5a8a_analysis.xml","fd6b0617b3fa4e8a3c776a3e10460962","e03d9d63-df0c-4d44-9e86-1a25e2891918",2181,"2016-09-29T20:25:07.522324-05:00","b9e9e7d3-4d7a-4823-b234-00fc9cdd5a8a_experiment.xml","44fb43a43ea58d22f647cb4595508374","6c737a01-6cdd-4c55-ba6b-3b2e7c6dfa9c",3916,"2016-09-29T22:15:15.084191-05:00","b9e9e7d3-4d7a-4823-b234-00fc9cdd5a8a_run.xml","deb524557a2893cc21528b24434484d6","b0b3dfc3-719b-43b2-9f01-ac770f766c5c",1989,"2016-09-08T13:54:58.128741-05:00","TCGA-25-1322","2016-09-02T19:12:05.910586-05:00","female","TCGA-25-1322_demographic",1939,"white","895829cd-984f-5029-ac7d-de8de3feb97f","not hispanic or latino",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1322_diagnosis","not reported",22646,"dead","8441/3",91,91,"d7d5faf4-cb8e-5db8-9a9c-7894070b7ead","c56.9",-22646,"TCGA-25-1322_treatment","0552af02-bfa2-562e-a1c2-e127329c9904","01",NA,"TCGA-25-1322-01A","1.8","9bc6ca0e-c74a-49f7-be04-6546e56e8ba2",FALSE,"6EAF4358-51F9-4999-A219-39178418CC9C","Primary Tumor","0.8",NA,NA,"2.6",1228348800,"01",125,"TCGA-25-1322-01A-01",95,95,NA,NA,NA,NA,10,10,"2016-09-08T13:54:58.128741-05:00","2016-09-08T13:54:58.128741-05:00",NA,NA,NA,NA,"TOP","BOTTOM",15,15,"5678ec6d-331d-43fc-9a9a-0ef43c274f73","df752342-0132-40ea-96a4-91c9f7f23eb2","TCGA-25-1322-01A-01-TS1","TCGA-25-1322-01A-01-BS1",75,75,"fb9346c0-edd4-46dd-bbf1-9568a9a6177b","RNA","TCGA-25-1322-01A-01R","4c881e32-be86-4dee-8400-81993776dd24",1.8,0.15,"UV Spec","R","22","TCGA-25-1322-01A-01R-1565-13","bce04e1e-a90c-4e81-bd16-415cccc9d7e2",0.15,NA,NA,NA,NA,"6d9285d5-91ae-537c-827b-2614bdd0139a","TCGA-25-1322_exposure","TCGA-25-1322-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:14:00.000Z","2014-03-22T07:46:02.000Z","B9E9E7D3-4D7A-4823-B234-00FC9CDD5A8A","9BC6CA0E-C74A-49F7-BE04-6546E56E8BA2","Unaligned reads",16682967040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BCE04E1E-A90C-4E81-BD16-415CCCC9D7E2","Canada's Michael Smith Genome Sciences Centre","564a3943e4b09c884b23b5f0","B520AAE5-65A6-4B27-BC2A-10B02C7B1AEB","Ovarian Serous Cystadenocarcinoma","TAR","FB9346C0-EDD4-46DD-BBF1-9568A9A6177B","2014-03-22T07:46:02.000Z","4C881E32-BE86-4DEE-8400-81993776DD24","None","NO",1,0.8,"Primary Tumor","Mayo Clinic - Rochester",NA,"FB9346C0-EDD4-46DD-BBF1-9568A9A6177B",1.8,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.90cba3ae-e75e-4a1e-bc31-293ac260cf96.txt",NA,"TCGA-25-1322-01A",2.6,"739C8FFC-668B-4118-A7A3-5E7BF16EC133","TCGA",2001,NA,NA,"WITH TUMOR","A830320C-B449-4317-B712-85C8FF387F67",62,"nationwidechildrens.org_clinical.TCGA-25-1322.xml","Dead",91,"TCGA-25-1322","NOT HISPANIC OR LATINO","841D1973-7063-4915-BFCC-DE4685A2372D",NA,91,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,125,"DF752342-0132-40EA-96A4-91C9F7F23EB2","F06A35AD-B412-4E8D-BBE0-DC32B168E8A7","TCGA-25-1322-01A-01R-1565-13_rnaseq.bam.bai","TCGA-25-1322-01A-01",95,NA,NA,NA,10,"TOP",15,NA,"TCGA-25-1322-01A-01-TS1",75,"Carbo","Chemotherapy","TCGA-25-1322-D26678",NA,NA,NA,NA,NA,91,"WITH TUMOR","Dead",91,"TCGA-25-1322-F26676","TCGA-25-1322",NA,"25","1322","YES","C56.9","8441/3","C56.9",NA,NA,-22646,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",91,91,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
96660958,95438316,7055004982,"E755A625-799D-4A39-9D56-080228E0B669.bw","b6b607cd-67b8-4c04-a212-a4e8c0743f05","e755a625-799d-4a39-9d56-080228e0b669","2016-08-23T09:02:41.862286-05:00","TCGA-24-1850-01A-01R-1567-13_rnaseq_fastq.tar","246cf927-a407-4c5a-9f60-0822bf34b208",5581066240,"Illumina HiSeq","31bc50baad3252d351df1ec0d808e009","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:39:26.888929-05:00","2016-05-03T11:56:42.628342-05:00","246cf927-a407-4c5a-9f60-0822bf34b208_analysis.xml","f6297a5383a30e3006eeeb1f71f1e6fa","04d34237-8d0b-42f2-a188-3712d3e73529",2181,"2016-08-13T04:20:44.691792-05:00","246cf927-a407-4c5a-9f60-0822bf34b208_experiment.xml","86a52d55dbba1cc09a2cd494bab4f428","665bad36-8e96-4372-b004-3d179fdea3cc",3916,"2016-09-29T18:21:35.703642-05:00","246cf927-a407-4c5a-9f60-0822bf34b208_run.xml","0f2fdeeff99f69d46145a812da87cd17","1f4cee69-c11c-405a-a93d-c6b97afcc6db",1988,"2016-09-08T11:09:07.948841-05:00","TCGA-24-1850","2016-09-02T18:47:50.001900-05:00","female","TCGA-24-1850_demographic",1937,"white","d6afc291-5d82-5eb0-90e0-91d9933e5c0a","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1850_diagnosis","not reported",26369,"alive","8441/3",NA,168,"f34214f1-17e6-51fa-a214-6826ccc10fd8","c56.9",-26369,"TCGA-24-1850_treatment","b0328c0c-f7ff-526e-9535-360ebe7a5d00","01",NA,"TCGA-24-1850-01A","1.5","511be3b8-efdb-4e2e-8115-7b83e16471c1",FALSE,"a8c2f09f-6971-48e1-b890-f1d63611cdbd","Primary Tumor","0.5",NA,NA,"2",1245628800,"01",150,"TCGA-24-1850-01A-01",95,95,NA,NA,0,0,20,10,"2016-09-08T11:09:07.948841-05:00","2016-09-08T11:09:07.948841-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"9fc9bdb4-0398-4cad-8be5-fc656870c9ea","1229a1be-6ac6-49dd-a170-f6a6c4cf796a","TCGA-24-1850-01A-01-TS1","TCGA-24-1850-01A-01-BS1",80,85,"fccb7131-30f9-4d57-b169-566ee6041fdf","RNA","TCGA-24-1850-01A-01R","523d3e82-2929-4434-9fb0-42ee8812935a",1.9,0.15,"UV Spec","R","22","TCGA-24-1850-01A-01R-1567-13","9d88c064-c348-4f3f-a1f1-5884e0b66d9e",0.15,NA,NA,NA,NA,"f6d289a0-18c5-516e-b521-f66848111efe","TCGA-24-1850_exposure","TCGA-24-1850-01A-01R-1567-13_rnaseq_fastq.tar","2014-08-28T18:15:20.000Z","2014-08-28T20:33:23.000Z","246CF927-A407-4C5A-9F60-0822BF34B208","511BE3B8-EFDB-4E2E-8115-7B83E16471C1","Unaligned reads",5581066240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9D88C064-C348-4F3F-A1F1-5884E0B66D9E","Canada's Michael Smith Genome Sciences Centre","564a5abee4b0298dd2cbf1e1","B6B607CD-67B8-4C04-A212-A4E8C0743F05","Ovarian Serous Cystadenocarcinoma","TAR","FCCB7131-30F9-4D57-B169-566EE6041FDF","2014-08-28T20:33:24.000Z","523D3E82-2929-4434-9FB0-42EE8812935A","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"FCCB7131-30F9-4D57-B169-566EE6041FDF",1.5,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eacc0479-97ed-45f6-a4cb-9cca12252bd2.txt",NA,"TCGA-24-1850-01A",2,"F7C53C2B-1B5D-48CE-9A74-26AFFE5D69EE","TCGA",2009,NA,NA,"TUMOR FREE","FF36898C-F752-461E-9FC8-8EF79A58E035",72,"THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_B05_495100.hg19.seg.txt","Alive",NA,"TCGA-24-1850",NA,"1345A9A2-A18F-418A-94BF-EC8AB20404B7",NA,168,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,150,"9FC9BDB4-0398-4CAD-8BE5-FC656870C9EA","724DED08-BE80-4181-96B7-268C000C78A8","TCGA-24-1850-01A-01R-1567-13_GRCh37-lite_rnaseq.bam.bai","TCGA-24-1850-01A-01",95,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-24-1850-01A-01-BS1",85,"Carboplatin","Chemotherapy","TCGA-24-1850-D26360",NA,NA,NA,NA,NA,168,"TUMOR FREE","Alive",NA,"TCGA-24-1850-F26359","TCGA-24-1850",NA,"24","1850","YES","C56.9","8441/3","C56.9",NA,NA,-26369,"FEMALE","WHITE",NA,NA,"No","Alive",168,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,72,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
230484034,223241885,16511988408,"3D94EFB8-94D4-4FDE-97D8-18A159279996.bw","b7715ff6-57a6-4513-9447-aa8bc93f16d4","3d94efb8-94d4-4fde-97d8-18a159279996","2016-08-25T18:49:12.495887-05:00","TCGA-04-1343-01A-01R-1564-13_rnaseq_fastq.tar","b4af1689-0071-4ea0-8a83-dd13dc6d20c7",14223093760,"Illumina HiSeq","1fe0162583d6d518dd91e576427bf5c0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:00:56.923257-05:00","2016-05-03T11:27:59.332723-05:00","b4af1689-0071-4ea0-8a83-dd13dc6d20c7_analysis.xml","290380013f779e65567ce111daaf8983","382a064a-8eb2-4810-bdc5-5c99ff45c18f",2210,"2016-09-29T21:50:32.321565-05:00","b4af1689-0071-4ea0-8a83-dd13dc6d20c7_experiment.xml","abac157fc986eb965661ebc4e8396f5e","a1643b2e-5bdc-42e5-ab7f-22b758f15b3b",3916,"2016-09-29T17:32:36.814738-05:00","b4af1689-0071-4ea0-8a83-dd13dc6d20c7_run.xml","b1fdf37e4c8dd9e13496b137e5c7559b","0094bb26-152a-482f-a581-f7e5e4d931d3",1990,"2016-09-08T12:51:30.437680-05:00","TCGA-04-1343","2016-09-02T19:06:05.387725-05:00","female","TCGA-04-1343_demographic",1930,"white","f71d969e-38e8-523e-8db7-d8b2e3f0ae0c","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1343_diagnosis","not reported",26428,"dead","8441/3",361,NA,"bd744f83-779b-5ca5-af2b-45670de8fcec","c56.9",-26428,"TCGA-04-1343_treatment","3a42b4ee-f935-5ed4-a090-fd63bb17beb5","01",NA,"TCGA-04-1343-01A","0.6","1d8b4c59-7500-4951-80bc-bfd7a035b876",FALSE,"E62828D9-A46C-498F-9976-CC430D16057E","Primary Tumor","0.4",NA,NA,"1",1229644800,"01",108,"TCGA-04-1343-01A-01",88,93,NA,NA,0,0,16,4,"2016-09-08T12:51:30.437680-05:00","2016-09-08T12:51:30.437680-05:00",NA,NA,NA,NA,"BOTTOM","TOP",4,1,"ffc80a0b-db70-456c-8e52-4f59b621a8be","75e55c68-3906-434a-8f27-6e0592e859ba","TCGA-04-1343-01A-01-BS1","TCGA-04-1343-01A-01-TS1",80,95,"833c21be-ce02-4030-8483-0c095df89b4a","RNA","TCGA-04-1343-01A-01R","b014326b-ee98-4e0a-92eb-9d323f79e5c0",1.7,0.15,"UV Spec","R","22","TCGA-04-1343-01A-01R-1564-13","e7aeb2b8-2a2d-4175-94f4-0192bd467fed",0.15,NA,NA,NA,NA,"1e3460de-aa51-5598-9ba7-c25bf5a4b864","TCGA-04-1343_exposure","TCGA-04-1343-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T23:17:58.000Z","2013-12-20T23:44:02.000Z","B4AF1689-0071-4EA0-8A83-DD13DC6D20C7","1D8B4C59-7500-4951-80BC-BFD7A035B876","Unaligned reads",14223093760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E7AEB2B8-2A2D-4175-94F4-0192BD467FED","Canada's Michael Smith Genome Sciences Centre","564a3b3be4b0298dd2c85a65","B7715FF6-57A6-4513-9447-AA8BC93F16D4","Ovarian Serous Cystadenocarcinoma","TAR","833C21BE-CE02-4030-8483-0C095DF89B4A","2013-12-20T23:44:02.000Z","B014326B-EE98-4E0A-92EB-9D323F79E5C0","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"833C21BE-CE02-4030-8483-0C095DF89B4A",0.6,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.58f649ec-b1cd-4775-8c03-4ebdfe0ad072.txt",NA,"TCGA-04-1343-01A",1,"B259FF22-9552-43F2-A065-FAB193830B68","TCGA",2002,NA,NA,"WITH TUMOR","ACE5F52F-CE7A-413C-A833-B9E435A3B54A",72,"TCGA-04-1343-10A-01W-0489-09_IlluminaGA-DNASeq_exome.bam","Dead",361,"TCGA-04-1343","NOT HISPANIC OR LATINO","4E21E399-0648-4940-99E9-5E7EB3BD9C68",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",3,"Pre-Operative","Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,108,"FFC80A0B-DB70-456C-8E52-4F59B621A8BE","B014326B-EE98-4E0A-92EB-9D323F79E5C0","TCGA-04-1343-01A-01R-1564-13_rnaseq.bam.bai","TCGA-04-1343-01A-01",93,0,NA,NA,4,"TOP",1,NA,"TCGA-04-1343-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-04-1343-D23951",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",361,"TCGA-04-1343-F23949","TCGA-04-1343",NA,"04","1343","YES","C56.9","8441/3","C56.9",NA,NA,-26428,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,361,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,72,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,3,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
199667614,178663873,13109073406,"3D305C2E-6C86-4684-AA2A-155291AB4CC3.bw","b8023162-5e82-40e6-ad8c-8acf81821f01","3d305c2e-6c86-4684-aa2a-155291ab4cc3","2016-08-09T14:43:33.437368-05:00","TCGA-WR-A838-01A-12R-A406-31_rnaseq_fastq.tar","5cb6bc65-9cd5-45ac-9078-551bc7408906",12916551680,"Illumina HiSeq","d7e6cbd40ef2f5b6607cb4af982280a9","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T23:23:30.111228-05:00","2016-06-22T11:19:32.361656-05:00","5cb6bc65-9cd5-45ac-9078-551bc7408906_analysis.xml","6624b0085098d06aa974bb6774094e17","dadab2f6-53b3-411a-80aa-18f2a4bb0569",2183,"2016-10-07T15:51:43.761648-05:00","5cb6bc65-9cd5-45ac-9078-551bc7408906_experiment.xml","bb785ad1e71fc0e449b8cf3baecd5119","2213f35b-192c-49c0-ab84-4e183050ba47",3753,"2016-09-29T20:40:27.419977-05:00","5cb6bc65-9cd5-45ac-9078-551bc7408906_run.xml","ed8d1aa8550423ddfbb16dfbfefb4543","75c84e37-51e8-47c4-a441-5108299e4e25",1807,"2016-09-08T11:24:03.620514-05:00","TCGA-WR-A838","2016-09-02T19:00:49.961266-05:00","female","TCGA-WR-A838_demographic",1941,"black or african american","2e3f8de2-09c9-56c0-9615-ff7b01989992","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","NCH","WR","42a549ea-ef41-5923-ae23-e4840b4e8f54","University of Kansas","not reported","c56.9","TCGA-WR-A838_diagnosis","not reported",26418,"dead","8441/3",304,245,"fefb6772-4f28-54b1-8e0d-7b57065372c5","c56.9",-26418,"TCGA-WR-A838_treatment","7cfb0d44-4e59-517a-9019-0834b030ab52","01","false","TCGA-WR-A838-01A",NA,"828b6893-62cd-4248-a31b-7da875d657f1",FALSE,"8F364931-727D-4099-A1D2-E96C61461479","Primary Tumor",NA,110,200,NA,1382659200,"12",30,"TCGA-WR-A838-01A-12",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:24:03.620514-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"e8ca96cd-a253-4090-86ba-60e7192b72fd",NA,"TCGA-WR-A838-01A-01-TS1",NA,85,NA,"fdd4309d-c305-444f-91db-3bed9db0a680","RNA","TCGA-WR-A838-01A-12R","9447f5e7-c0ae-4b58-a1d1-4dacc21f1e03",1.75,0.18,"UV Spec","R","23","TCGA-WR-A838-01A-12R-A406-31","010e9bf0-b7a0-4c68-b028-90299840fbaf",0.18,NA,NA,NA,NA,"ef408a2c-81d9-531c-8e95-cb3b2f0e893d","TCGA-WR-A838_exposure","TCGA-WR-A838-01A-12R-A406-31_rnaseq_fastq.tar","2015-02-07T08:26:51.000Z","2015-02-07T10:01:06.000Z","5CB6BC65-9CD5-45AC-9078-551BC7408906","828B6893-62CD-4248-A31B-7DA875D657F1","Unaligned reads",12916551680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","010E9BF0-B7A0-4C68-B028-90299840FBAF","Canada's Michael Smith Genome Sciences Centre","564a5bcbe4b09c884b27b6ba","B8023162-5E82-40E6-AD8C-8ACF81821F01","Ovarian Serous Cystadenocarcinoma","TAR","FDD4309D-C305-444F-91DB-3BED9DB0A680","2015-02-07T10:01:06.000Z","9447F5E7-C0AE-4B58-A1D1-4DACC21F1E03","United States","NO",1,NA,"Primary Tumor","University of Kansas",110,"FDD4309D-C305-444F-91DB-3BED9DB0A680",NA,"WR","jhu-usc.edu_OV.HumanMethylation450.1.lvl-2.TCGA-WR-A838-01A-12D-A409-05.txt",200,"TCGA-WR-A838-01A",NA,"CCE11CBD-98D9-43FB-99E6-8770D1782337","TCGA",2013,"TCGA-WR-A838_NTE-2","Progressive Disease","WITH TUMOR","828B6893-62CD-4248-A31B-7DA875D657F1",72,"nationwidechildrens.org_clinical.TCGA-WR-A838.xml","Alive",NA,"TCGA-WR-A838","NOT HISPANIC OR LATINO","31A49E6E-CA78-4FD3-AE74-242CC21A8774","YES",245,"No","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,12,30,"E8CA96CD-A253-4090-86BA-60E7192B72FD","9447F5E7-C0AE-4B58-A1D1-4DACC21F1E03","jhu-usc.edu_OV.HumanMethylation450.1.lvl-2.TCGA-WR-A838-01A-12D-A409-05.txt","TCGA-WR-A838-01A-12",90,0,0,0,10,"TOP",5,0,"TCGA-WR-A838-01A-01-TS1",85,"Carboplatin","Chemotherapy","TCGA-WR-A838-D57160",NA,NA,NA,"TCGA-WR-A838-F66184_NTE-1","NO",NA,"WITH TUMOR","Dead",304,"TCGA-WR-A838-F66184","TCGA-WR-A838",NA,"WR","A838","YES","C56.9","8441/3","C56.9","NO","YES",-26418,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",245,NA,"NO","YES","WITH TUMOR","YES",6,3,2014,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,72,2013,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,"Progressive Disease",NA,10,NA,NA,NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
188638364,184059782,13614692303,"E140052A-5434-4C44-9873-0318D1D272CA.bw","b867e933-e3e3-4491-9bb6-b18c48d6f173","e140052a-5434-4c44-9873-0318d1d272ca","2016-09-29T23:33:32.783181-05:00","TCGA-24-2289-01A-01R-1568-13_rnaseq_fastq.tar","f640521c-e9e3-4afa-b58f-8f14d7d48569",11900416000,"Illumina HiSeq","590cff9193836642769b09df594b0a25","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:14:40.893354-05:00","2016-05-03T11:56:42.628342-05:00","f640521c-e9e3-4afa-b58f-8f14d7d48569_analysis.xml","cb03e03d9b2bad5971f927a6b874742b","40ea4f1a-9d1a-4636-9270-e92dc470b0da",2181,"2016-10-07T16:10:52.009439-05:00","f640521c-e9e3-4afa-b58f-8f14d7d48569_experiment.xml","4f1c4e69197496cc87a3211968d44afe","bc3c3864-7ceb-46f5-90d1-d664f6e63d77",3916,"2016-09-30T00:19:18.895230-05:00","f640521c-e9e3-4afa-b58f-8f14d7d48569_run.xml","694e9ded10aede82dfdf7ab2e5207ea5","fd8532b7-acdd-4c00-a25b-1175425c70e0",1988,"2016-09-08T10:35:38.954001-05:00","TCGA-24-2289","2016-09-02T19:11:48.102711-05:00","female","TCGA-24-2289_demographic",1929,"white","c9b134f1-5648-5775-8531-9769fbda3073","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2289_diagnosis","not reported",25191,"dead","8441/3",2049,2049,"566061b0-53fa-5c9b-aba1-fe01ff343b32","c56.9",-25191,"TCGA-24-2289_treatment","13ec1c2a-b48f-5fce-a7c0-e091a367564f","01",NA,"TCGA-24-2289-01A","1","f39ab685-fda1-43e8-aa70-fa3ed1566061",FALSE,"3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d","Primary Tumor","0.4",NA,NA,"1.5",1251676800,"01",139,"TCGA-24-2289-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T10:35:38.954001-05:00","2016-09-08T10:35:38.954001-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"4f5337c4-78ae-449f-8452-71be5ba1dd69","9a729ef3-7079-43be-a05c-14bba09008f5","TCGA-24-2289-01A-01-TS1","TCGA-24-2289-01A-01-BS1",89,89,"e4c845a5-946a-4723-854d-7b6ad1212418","RNA","TCGA-24-2289-01A-01R","0f99983f-913e-44d4-b6db-6962acbf7327",1.8,0.14,"UV Spec","R","22","TCGA-24-2289-01A-01R-1568-13","bdc4400c-c552-450b-a806-2ae10f61cca8",0.14,NA,NA,NA,NA,"94c9a000-21e6-532e-a1f0-0b373eafa3a8","TCGA-24-2289_exposure","TCGA-24-2289-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-27T11:28:20.000Z","2014-08-27T13:17:24.000Z","F640521C-E9E3-4AFA-B58F-8F14D7D48569","F39AB685-FDA1-43E8-AA70-FA3ED1566061","Unaligned reads",11900416000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BDC4400C-C552-450B-A806-2AE10F61CCA8","Canada's Michael Smith Genome Sciences Centre","564a34d6e4b0298dd2c64c7f","B867E933-E3E3-4491-9BB6-B18C48D6F173","Ovarian Serous Cystadenocarcinoma","TAR","E4C845A5-946A-4723-854D-7B6AD1212418","2014-08-27T13:17:24.000Z","0F99983F-913E-44D4-B6DB-6962ACBF7327","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"E4C845A5-946A-4723-854D-7B6AD1212418",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.992227e4-86a6-4703-ac81-cae8ea4a5dac.txt",NA,"TCGA-24-2289-01A",1.5,"E30043AD-C281-46EB-9AA1-A49E87AB0647","TCGA",1997,NA,NA,"WITH TUMOR","F39AB685-FDA1-43E8-AA70-FA3ED1566061",68,"TCGA-24-2289-01A-01W-0799-08_IlluminaGA-DNASeq_capture.bam","Dead",2049,"TCGA-24-2289",NA,"1F1D7A75-371A-409E-ABBA-E228AD2397FC",NA,2049,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,139,"9A729EF3-7079-43BE-A05C-14BBA09008F5","F181910B-702C-4609-8E0A-1C1C9E8B0FC6","5091159045_D_Red.idat","TCGA-24-2289-01A-01",90,0,NA,NA,10,"BOTTOM",1,NA,"TCGA-24-2289-01A-01-BS1",89,"Taxotere","Chemotherapy","TCGA-24-2289-D26581",NA,NA,NA,"TCGA-24-2289-F26578_NTE-1",NA,2049,"WITH TUMOR","Dead",2049,"TCGA-24-2289-F26578","TCGA-24-2289",NA,"24","2289","YES","C56.9","8441/3","C56.9",NA,NA,-25191,"FEMALE","WHITE",NA,NA,"No","Dead",2049,2049,NA,NA,"WITH TUMOR","NO",16,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,1997,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
328813198,314768696,23111040774,"68E56692-D46D-4A27-86CD-717E10AADDDA.bw","b8c3d99c-429b-42a3-b486-6fbcb90cc2e0","68e56692-d46d-4a27-86cd-717e10aaddda","2016-08-25T13:01:13.758749-05:00","TCGA-13-0801-01A-01R-1564-13_rnaseq_fastq.tar","fae491ab-42b1-413e-b0ff-aa881eb3517e",20226887680,"Illumina HiSeq","cbbeeb788e56766c18463c19462d9913","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:23:17.868665-05:00","2016-05-03T11:26:27.043798-05:00","fae491ab-42b1-413e-b0ff-aa881eb3517e_analysis.xml","a54d855f7c56efe3c37f6a7d6337bd2c","dabdd9c8-5049-4146-aea4-2d01f672e966",2183,"2016-09-29T19:04:38.570786-05:00","fae491ab-42b1-413e-b0ff-aa881eb3517e_experiment.xml","0b95cdb604e977c454ab1f883a6f83a4","3a99d9d2-656d-4b8b-9702-41e96a9e46f7",3916,"2016-09-29T20:23:06.749268-05:00","fae491ab-42b1-413e-b0ff-aa881eb3517e_run.xml","cf3adafeb03d2da311296a03dbce5fc7","6b2caea0-aaba-46d0-b8eb-8c75f47cdead",1990,"2016-09-08T14:01:25.298909-05:00","TCGA-13-0801","2016-09-02T19:09:40.425862-05:00","female","TCGA-13-0801_demographic",1962,"black or african american","7bbb9196-227a-56c9-83d2-215537f27f32","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0801_diagnosis","not reported",16812,"dead","8441/3",1399,252,"6d02c417-f8de-5616-9116-d5ca3ede4004","c56.9",-16812,"TCGA-13-0801_treatment","94acb906-c80b-54ca-9199-5e88c45d41d9","01",NA,"TCGA-13-0801-01A","0.6","dfaf19b4-03b4-49d3-b39f-01aaeb897a2a",FALSE,"FA63535E-7499-41E3-AFB1-98EB18DA7371","Primary Tumor","0.3",NA,NA,"1.5",1233705600,"01",108,"TCGA-13-0801-01A-01",98,90,NA,NA,0,0,5,10,"2016-09-08T14:01:25.298909-05:00","2016-09-08T14:01:25.298909-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"069af413-dc3c-4e22-aa53-851bdda172ac","88ab59cb-1d11-4a73-b3d8-5bdea41c8549","TCGA-13-0801-01A-01-TS1","TCGA-13-0801-01A-01-BS1",95,85,"f9858f75-5ce5-45af-999d-0ac00bd37ab6","RNA","TCGA-13-0801-01A-01R","0df12d68-a670-43e9-886f-9324473e73ba",1.8,0.17,"UV Spec","R","22","TCGA-13-0801-01A-01R-1564-13","c51dee3c-5047-4dde-b454-2474de5cf025",0.17,NA,NA,NA,NA,"02ea117b-059b-587d-aaa9-2d7d4da2fcb0","TCGA-13-0801_exposure","TCGA-13-0801-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-13T23:41:49.000Z","2013-12-14T00:27:02.000Z","FAE491AB-42B1-413E-B0FF-AA881EB3517E","DFAF19B4-03B4-49D3-B39F-01AAEB897A2A","Unaligned reads",20226887680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C51DEE3C-5047-4DDE-B454-2474DE5CF025","Canada's Michael Smith Genome Sciences Centre","564a3d97e4b08c5d869234ad","B8C3D99C-429B-42A3-B486-6FBCB90CC2E0","Ovarian Serous Cystadenocarcinoma","TAR","F9858F75-5CE5-45AF-999D-0AC00BD37AB6","2013-12-14T00:27:02.000Z","0DF12D68-A670-43E9-886F-9324473E73BA","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"F9858F75-5CE5-45AF-999D-0AC00BD37AB6",0.6,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.1c4d4161-a528-4601-b512-eb2d5ed8d992.txt",NA,"TCGA-13-0801-01A",1.5,"BB31A332-A1A0-4581-9D52-56985E1E12BC","TCGA",2008,NA,NA,"TUMOR FREE","DFAF19B4-03B4-49D3-B39F-01AAEB897A2A",46,"nationwidechildrens.org_clinical.TCGA-13-0801.xml","Alive",NA,"TCGA-13-0801","NOT HISPANIC OR LATINO",NA,NA,252,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,108,"88AB59CB-1D11-4A73-B3D8-5BDEA41C8549","737F2405-DD01-4610-B654-B495F52B0F68","TCGA-13-0801-01A-01W-0370-10_SOLiD.bam.bai","TCGA-13-0801-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-13-0801-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-13-0801-D24623",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0801",NA,"13","0801","YES","C56.9","8441/3","C56.9",NA,NA,-16812,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Alive",252,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,46,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
111339344,102657504,7576237397,"00A0586E-5F05-47B3-925C-87E811B0893B.bw","b923ac70-70ea-4a82-8466-46350c5803bf","00a0586e-5f05-47b3-925c-87e811b0893b","2016-08-24T12:50:43.205008-05:00","TCGA-23-1021-01B-01R-1564-13_rnaseq_fastq.tar","c91289a6-9e18-4587-84e8-2f4b631a8cce",7465246720,"Illumina HiSeq","b4f8bc09ac5b43242b370ecfa67de9c0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:59:48.171820-05:00","2016-05-03T11:27:59.322672-05:00","c91289a6-9e18-4587-84e8-2f4b631a8cce_analysis.xml","a0118224da3b7666e553d6d18b470af5","81daea25-6ab6-4c31-97a5-649ecdd9f158",2237,"2016-09-30T00:06:21.679859-05:00","c91289a6-9e18-4587-84e8-2f4b631a8cce_experiment.xml","39fb390cbe5118e38cb7c46e6c1001aa","f57338e6-fa72-4b5f-b0b3-4ee668e49ecc",3916,"2016-09-30T00:08:37.351310-05:00","c91289a6-9e18-4587-84e8-2f4b631a8cce_run.xml","483236675daa29f117214516f67bd1cc","f6d99971-b4cf-4ada-af1b-53fb5b0c0a6c",1990,"2016-09-08T12:26:11.018758-05:00","TCGA-23-1021","2016-09-02T19:05:51.153846-05:00","female","TCGA-23-1021_demographic",1959,"white","5bf4dbf9-9ad3-56b4-a16a-b891ca34a898","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1021_diagnosis","not reported",16484,"dead","8441/3",1446,1446,"aa38d2f9-46a7-5bed-ba31-29109424d54a","c56.9",-16484,"TCGA-23-1021_treatment","f3469830-8e5e-50fc-a8df-4e016b741a1e","01",NA,"TCGA-23-1021-01B","0.9","36c901d8-885d-4fc0-8cd2-69229fddc566",FALSE,"4339A934-71A0-4E92-91D6-BEB0207939ED","Primary Tumor","0.5",NA,NA,"1",1227657600,"01",125,"TCGA-23-1021-01B-01",90,80,NA,NA,0,0,NA,0,"2016-09-08T12:26:11.018758-05:00","2016-09-08T12:26:11.018758-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"80c2d0cc-5647-4f11-973d-7ef404254284","43618d42-5e31-4911-b670-ee2d2773bda2","TCGA-23-1021-01B-01-TS1","TCGA-23-1021-01B-01-BS1",NA,NA,"d9acf0b0-d747-41b8-8330-d46b3ffe4eb4","RNA","TCGA-23-1021-01B-01R","cc0e4de8-c805-47fe-b3ae-560b2f9e6a7a",1.8,0.16,"UV Spec","R","22","TCGA-23-1021-01B-01R-1564-13","9819f772-6987-47d5-8ab4-235ac2b993e2",0.16,NA,NA,NA,NA,"700f793b-2cb6-5c75-826c-7c90fa9bcf85","TCGA-23-1021_exposure","TCGA-23-1021-01B-01R-1564-13_rnaseq_fastq.tar","2013-12-20T08:37:21.000Z","2013-12-20T08:52:01.000Z","C91289A6-9E18-4587-84E8-2F4B631A8CCE","36C901D8-885D-4FC0-8CD2-69229FDDC566","Unaligned reads",7465246720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9819F772-6987-47D5-8AB4-235AC2B993E2","Canada's Michael Smith Genome Sciences Centre","564a3c72e4b093830b699a9a","B923AC70-70EA-4A82-8466-46350C5803BF","Ovarian Serous Cystadenocarcinoma","TAR","D9ACF0B0-D747-41B8-8330-D46B3FFE4EB4","2013-12-20T08:52:01.000Z","CC0E4DE8-C805-47FE-B3AE-560B2F9E6A7A","None","NO",1,0.5,"Primary Tumor","Cedars Sinai",NA,"D9ACF0B0-D747-41B8-8330-D46B3FFE4EB4",0.9,"23","bcgsc.ca.TCGA-23-1021-01B-01R-1564-13.hg19.bcgsc.ca.1.7.0.sv.fa",NA,"TCGA-23-1021-01B",1,"F3D78A9B-08EA-4AA8-9CB5-677B67207783","TCGA",2004,NA,NA,"WITH TUMOR","740D3206-6DC8-4AB7-9FAF-E53E21505C55",45,"nationwidechildrens.org_clinical.TCGA-23-1021.xml","Dead",1446,"TCGA-23-1021","NOT HISPANIC OR LATINO","DEFF0C2E-9B3E-4181-97D6-13DDFC9F115A",NA,1446,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,125,"80C2D0CC-5647-4F11-973D-7EF404254284","CC0E4DE8-C805-47FE-B3AE-560B2F9E6A7A","TCGA-23-1021-01B-01R-1564-13_mirna.bam.bai","TCGA-23-1021-01B-01",90,0,NA,NA,NA,"TOP",0,NA,"TCGA-23-1021-01B-01-TS1",NA,"Vinorelbine","Chemotherapy","TCGA-23-1021-D25573",NA,NA,NA,"TCGA-23-1021-F25567_NTE-1",NA,1446,"WITH TUMOR","Dead",1446,"TCGA-23-1021-F25567","TCGA-23-1021",NA,"23","1021","YES","C56.9","8441/3","C56.9",NA,NA,-16484,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1446,1446,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,45,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
330161248,313234847,23140340829,"E2B019A7-7C95-40FE-800C-D30E9730825C.bw","b9418c6d-94f7-4db4-a1e4-f384b09d54cb","e2b019a7-7c95-40fe-800c-d30e9730825c","2016-08-26T21:16:43.766395-05:00","TCGA-13-0799-01A-01R-1564-13_rnaseq_fastq.tar","d0740a42-c0b9-44cc-9239-a109786f5b0c",21740113920,"Illumina HiSeq","bb987ec403478bed4c1943446f2c9cde","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:47:52.227944-05:00","2016-05-03T11:39:34.528512-05:00","d0740a42-c0b9-44cc-9239-a109786f5b0c_analysis.xml","2c06b67f6ef0a312e0994fd5fc231b7a","9fb45778-20b1-463f-b0ad-cd4fb2683e13",2183,"2016-10-07T16:53:02.558121-05:00","d0740a42-c0b9-44cc-9239-a109786f5b0c_experiment.xml","f79a3536b985caaa763ef0c38a5222dc","c09e47d6-e35e-43f0-ae05-3e75c26c0127",3916,"2016-09-29T18:25:34.984243-05:00","d0740a42-c0b9-44cc-9239-a109786f5b0c_run.xml","3a15206b4354d0f4fa56caaf1c120b9d","21d8c4ef-3bae-4719-b389-9b90922e128f",1990,"2016-09-08T13:48:50.026233-05:00","TCGA-13-0799","2016-09-02T19:09:27.211523-05:00","female","TCGA-13-0799_demographic",1964,"asian","7c7c62c8-4ef7-5df4-a00b-512a62df70bf","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0799_diagnosis","not reported",16171,"alive","8441/3",NA,2535,"1216ba5e-1eb5-5540-9476-831e7434c39a","c56.9",-16171,"TCGA-13-0799_treatment","4800630e-79c4-5b3f-a821-3b0ec51f16d5","01",NA,"TCGA-13-0799-01A","1.1","05315ef9-1103-4651-b8e9-a7eb7d71702d",FALSE,"CBB83CF3-9846-409B-858B-C8A7E74CDFF1","Primary Tumor","0.3",NA,NA,"1.6",1233705600,"01",169,"TCGA-13-0799-01A-01",98,98,NA,NA,0,0,10,5,"2016-09-08T13:48:50.026233-05:00","2016-09-08T13:48:50.026233-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"663bb922-1c7a-4eda-a538-20aac42e3e19","7a8d8678-12ef-429b-8286-a6718d779114","TCGA-13-0799-01A-01-BS1","TCGA-13-0799-01A-01-TS1",90,95,"05722a13-0322-4ce9-99c1-a2757d3acf50","RNA","TCGA-13-0799-01A-01R","79040bb5-2a42-4bbd-91fc-747a0c042b64",1.8,0.16,"UV Spec","R","22","TCGA-13-0799-01A-01R-1564-13","a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3",0.16,NA,NA,NA,NA,"94cc63c3-448e-5d97-a29e-ce0ef352ad0c","TCGA-13-0799_exposure","TCGA-13-0799-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-20T04:53:31.000Z","2014-03-20T05:30:02.000Z","D0740A42-C0B9-44CC-9239-A109786F5B0C","05315EF9-1103-4651-B8E9-A7EB7D71702D","Unaligned reads",21740113920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A3FB40BD-3E6A-4A4B-89FB-5A9D5FB67EE3","Canada's Michael Smith Genome Sciences Centre","564a36a4e4b093830b67bee9","B9418C6D-94F7-4DB4-A1E4-F384B09D54CB","Ovarian Serous Cystadenocarcinoma","TAR","05722A13-0322-4CE9-99C1-A2757D3ACF50","2014-03-20T05:30:02.000Z","79040BB5-2A42-4BBD-91FC-747A0C042B64","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"05722A13-0322-4CE9-99C1-A2757D3ACF50",1.1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c91f1247-0579-4c10-8da1-2d62d276e58e.txt",NA,"TCGA-13-0799-01A",1.6,"A3617379-B708-456A-9810-14B2AFA80F6D","TCGA",2008,NA,NA,"TUMOR FREE","974EA7FF-54A6-4B44-9F1B-483E3C010661",44,"nationwidechildrens.org_clinical.TCGA-13-0799.xml","Alive",NA,"TCGA-13-0799","NOT HISPANIC OR LATINO",NA,NA,237,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"ASIAN",NA,1,169,"7A8D8678-12EF-429B-8286-A6718D779114","FEB93BEC-0D8F-4FF0-89A3-07DB8B3348D4","C239.TCGA-13-0799-01A-01W.7.bam","TCGA-13-0799-01A-01",98,0,NA,NA,5,"TOP",0,NA,"TCGA-13-0799-01A-01-TS1",95,"Cisplatin","Chemotherapy","TCGA-13-0799-D24611",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0799",NA,"13","0799","YES","C56.9","8441/3","C56.9",NA,NA,-16171,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",237,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
237496926,215074942,15908580245,"1B9ABB69-5CC6-4B6B-ABBC-71CC3274C7F0.bw","ba68f2cf-9271-41fd-9655-1fac7681f588","1b9abb69-5cc6-4b6b-abbc-71cc3274c7f0","2016-09-29T18:15:31.683858-05:00","TCGA-24-1558-01A-01R-1566-13_rnaseq_fastq.tar","0601984a-7edc-4604-ab3a-7011ffb71035",14824929280,"Illumina HiSeq","9709e28bb1b202dbd758f85cf43fa22d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:56:47.005627-05:00","2016-05-03T11:40:21.662944-05:00","0601984a-7edc-4604-ab3a-7011ffb71035_analysis.xml","b578afe41ffbe16765525a0c89a53f9f","ca613e07-8659-4c7b-9100-ea229ba8e4d0",2181,"2016-09-29T19:48:37.356780-05:00","0601984a-7edc-4604-ab3a-7011ffb71035_experiment.xml","25dc94636c49253d3af81431727eb85e","56107be9-a995-482f-9219-e1ffa61516fa",3916,"2016-09-29T18:16:48.079907-05:00","0601984a-7edc-4604-ab3a-7011ffb71035_run.xml","c7cf2edb734eed2bfe52cc37d9adba4a","1c74300e-d578-42ef-b277-61f4ef9babff",1988,"2016-09-08T10:39:16.895503-05:00","TCGA-24-1558","2016-09-02T18:47:35.329332-05:00","female","TCGA-24-1558_demographic",1927,"white","58103f7a-0d5a-5c6b-b9cb-6214466a0c34","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1558_diagnosis","not reported",27004,"dead","8441/3",594,594,"2c050cd3-82f7-5809-b295-340ecf3cb89c","c56.9",-27004,"TCGA-24-1558_treatment","5e803842-33be-5620-ac0b-2cfd048621d8","01",NA,"TCGA-24-1558-01A","1","3e8bd387-4fda-4623-924e-314267c55eea",FALSE,"62143e5f-4452-47ca-a67c-cd87036424b1","Primary Tumor","0.9",NA,NA,"1.9",1235347200,"01",147,"TCGA-24-1558-01A-01",95,95,NA,NA,0,0,2,2,"2016-09-08T10:39:16.895503-05:00","2016-09-08T10:39:16.895503-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"88c2fa99-388d-4924-93a4-44e541bfc064","64a012b1-90d0-4df7-8b7b-9c3f0ca584b9","TCGA-24-1558-01A-01-TS1","TCGA-24-1558-01A-01-BS1",98,98,"9d933b67-1f83-4a95-aff5-d59ee2ab355a","RNA","TCGA-24-1558-01A-01R","578fab37-8783-4c98-9278-eabc33cec19f",1.8,0.13,"UV Spec","R","22","TCGA-24-1558-01A-01R-1566-13","1b8d5b5e-f671-419a-844a-6640fe5a896d",0.13,NA,NA,NA,NA,"153b7059-443b-5d85-91de-3f494d33bed8","TCGA-24-1558_exposure","TCGA-24-1558-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T03:26:08.000Z","2014-03-25T03:51:02.000Z","0601984A-7EDC-4604-AB3A-7011FFB71035","3E8BD387-4FDA-4623-924E-314267C55EEA","Unaligned reads",14824929280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1B8D5B5E-F671-419A-844A-6640FE5A896D","Canada's Michael Smith Genome Sciences Centre","564a5950e4b09c884b271809","BA68F2CF-9271-41FD-9655-1FAC7681F588","Ovarian Serous Cystadenocarcinoma","TAR","9D933B67-1F83-4A95-AFF5-D59EE2AB355A","2014-03-25T03:51:02.000Z","578FAB37-8783-4C98-9278-EABC33CEC19F","None","NO",1,0.9,"Primary Tumor","Washington University",NA,"9D933B67-1F83-4A95-AFF5-D59EE2AB355A",1,"24","TCGA-24-1558-01A-01W-0615-10_SOLiD.bam",NA,"TCGA-24-1558-01A",1.9,"E59EA4E0-2E2C-4F4A-942B-7EFB1C0870FE","TCGA",2000,NA,NA,"WITH TUMOR","6CF18D9D-2A3B-4F22-89FD-801956564218",73,"nationwidechildrens.org_clinical.TCGA-24-1558.xml","Dead",594,"TCGA-24-1558",NA,"E5C8A6CA-1B37-4965-BF50-3C988437AF33",NA,594,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,147,"88C2FA99-388D-4924-93A4-44E541BFC064","F2F3568B-0A6F-4C29-8F0A-BABB5FC1BF04","TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.bam","TCGA-24-1558-01A-01",95,0,NA,NA,2,"TOP",0,NA,"TCGA-24-1558-01A-01-TS1",98,"Gemcitabine","Chemotherapy","TCGA-24-1558-D26216",NA,NA,NA,"TCGA-24-1558-F26212_NTE-1",NA,594,"WITH TUMOR","Dead",594,"TCGA-24-1558-F26212","TCGA-24-1558",NA,"24","1558","YES","C56.9","8441/3","C56.9",NA,NA,-27004,"FEMALE","WHITE",NA,NA,"No","Dead",594,594,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
326901964,310515659,22969317365,"FAE396AA-3C3C-4AF9-953D-385C41B2DB5B.bw","bbad2efe-e9c7-4f8f-924b-ebbbe4c181d4","fae396aa-3c3c-4af9-953d-385c41b2db5b","2016-08-27T07:07:24.045816-05:00","TCGA-24-2019-01A-02R-1568-13_rnaseq_fastq.tar","e12ccbe4-1757-41cf-86b3-4bc3bfe301a7",22124861440,"Illumina HiSeq","21da727ea1651eb2a610d3d6c645e499","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:22:05.244189-05:00","2016-05-03T11:56:42.631594-05:00","e12ccbe4-1757-41cf-86b3-4bc3bfe301a7_analysis.xml","8d5e7859caec012393f266ca94051f5d","6a88eca3-84eb-4c16-8b6b-7261d49eae40",2181,"2016-10-07T15:52:41.802349-05:00","e12ccbe4-1757-41cf-86b3-4bc3bfe301a7_experiment.xml","01da774715fdbfa434db177e400c62d2","ea4d885b-f6eb-4e48-860c-6f3c739de377",3916,"2016-09-29T23:42:13.887418-05:00","e12ccbe4-1757-41cf-86b3-4bc3bfe301a7_run.xml","147ca36171c1d6cfd61e649948bec0c6","e6a7ff25-a5fd-4990-b601-b0142cbd0abf",1988,"2016-09-08T11:56:00.429224-05:00","TCGA-24-2019","2016-09-02T18:56:07.644130-05:00","female","TCGA-24-2019_demographic",1963,"white","d1eab0fc-7b3b-562a-a9f8-771209dca14f","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2019_diagnosis","not reported",17009,"alive","8441/3",NA,148,"4422c00b-d710-52d1-b3c3-a3b6879dd792","c56.9",-17009,"TCGA-24-2019_treatment","a78e377d-5270-55e9-ba09-406e129ccc09","01",NA,"TCGA-24-2019-01A","1","d2dd3d17-790f-4aa2-945d-db72df6ec8eb",FALSE,"15a77e5d-acfb-4013-81de-ef9d2f6398d1","Primary Tumor","0.3",NA,NA,"1.5",1247529600,"02",141,"TCGA-24-2019-01A-02",85,80,0,0,0,0,18,33,"2016-09-08T11:56:00.429224-05:00","2016-09-08T11:56:00.429224-05:00",0,0,0,0,"BOTTOM","TOP",2,2,"521fa96d-e555-496a-822f-d56f2f48d6bd","21f0edf9-0353-482b-8d1e-2ef74562a535","TCGA-24-2019-01A-02-BS2","TCGA-24-2019-01A-01-BS1",80,65,"2e631947-34be-43c1-8d1b-cf2765f6f019","RNA","TCGA-24-2019-01A-02R","2d19a1ec-5000-4ccf-b0b2-eb994a6afd3f",1.8,0.14,"UV Spec","R","22","TCGA-24-2019-01A-02R-1568-13","52908652-f29a-4517-8ff6-6f4cd31c691b",0.14,NA,NA,NA,NA,"cfaad80a-c8c5-5936-8389-7aed57e04bb9","TCGA-24-2019_exposure","TCGA-24-2019-01A-02R-1568-13_rnaseq_fastq.tar","2014-08-29T16:16:38.000Z","2014-08-29T07:00:02.000Z","E12CCBE4-1757-41CF-86B3-4BC3BFE301A7","D2DD3D17-790F-4AA2-945D-DB72DF6EC8EB","Unaligned reads",22124861440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","52908652-F29A-4517-8FF6-6F4CD31C691B","Canada's Michael Smith Genome Sciences Centre","564a5ab7e4b08c5d869502b9","BBAD2EFE-E9C7-4F8F-924B-EBBBE4C181D4","Ovarian Serous Cystadenocarcinoma","TAR","2E631947-34BE-43C1-8D1B-CF2765F6F019","2014-08-29T07:00:02.000Z","2D19A1EC-5000-4CCF-B0B2-EB994A6AFD3F","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"2E631947-34BE-43C1-8D1B-CF2765F6F019",1,"24","TCGA-24-2019-01A-02R-1568-13_mirna.bam",NA,"TCGA-24-2019-01A",1.5,NA,"TCGA",2009,NA,NA,NA,"D2DD3D17-790F-4AA2-945D-DB72DF6EC8EB",46,"nationwidechildrens.org_clinical.TCGA-24-2019.xml","Alive",NA,"TCGA-24-2019",NA,"478F18EC-C7D2-485E-B83D-1B416C86AC20",NA,148,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Other","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,2,141,"521FA96D-E555-496A-822F-D56F2F48D6BD","E62CB204-9997-41A3-B844-FD1995E505A4","TCGA-24-2019-01A-02R-1568-13_mirna.bam","TCGA-24-2019-01A-02",85,0,0,0,18,"BOTTOM",2,0,"TCGA-24-2019-01A-02-BS2",80,NA,NA,NA,NA,NA,NA,NA,NA,148,NA,"Alive",NA,"TCGA-24-2019-F26429","TCGA-24-2019",NA,"24","2019","YES","C56.9","8441/3","C56.9",NA,NA,-17009,"FEMALE","WHITE",NA,NA,"No","Alive",148,NA,NA,NA,NA,"NO",16,3,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,46,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Other",NA,NA,NA,NA,NA,NA,NA,NA
189851400,183577515,13551955167,"6BE4397D-1E5B-4486-83B4-EE0EC146C805.bw","bc2591b0-65d7-48c3-a5cc-783f67b65869","6be4397d-1e5b-4486-83b4-ee0ec146c805","2016-08-25T13:50:48.265548-05:00","TCGA-25-1635-01A-01R-1566-13_rnaseq_fastq.tar","8733788b-3c2a-4971-8cf7-d333465e36de",12578580480,"Illumina HiSeq","106775d9cff9122e449e13f8b11571a2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:25:30.044402-05:00","2016-05-03T11:39:34.528512-05:00","8733788b-3c2a-4971-8cf7-d333465e36de_analysis.xml","e1032d239c8432eaf3924904d6799746","6caefe81-ecfb-43a5-9f89-8cd811a0b600",2181,"2016-09-29T21:02:42.150096-05:00","8733788b-3c2a-4971-8cf7-d333465e36de_experiment.xml","6a77377db6a053566c73d33b1bbb06ea","839fe3f0-95a0-4b8b-8e21-0b185bd8592c",3916,"2016-09-30T00:18:31.857774-05:00","8733788b-3c2a-4971-8cf7-d333465e36de_run.xml","00942ccd9cefe6312fcda3c37b909fcc","fd02be34-9d4f-4d5c-8f3b-935bf505609b",1988,"2016-09-08T10:38:10.234376-05:00","TCGA-25-1635","2016-09-02T18:48:49.758238-05:00","female","TCGA-25-1635_demographic",1931,"white","79dac28f-6891-5ca1-9a1b-b6b946171961","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1635_diagnosis","not reported",26200,"dead","8441/3",1583,1558,"1b49c382-da56-568d-823a-34afc1fd6a96","c56.9",-26200,"TCGA-25-1635_treatment","73649ab7-ae3a-5923-8c7b-d9afbaf187f4","01",NA,"TCGA-25-1635-01A","1.3","8eab6a91-e73b-4555-9915-8ac4b91d9de3",FALSE,"28168C52-FD75-4B43-918B-C48CC8DA9C66","Primary Tumor","0.3",NA,NA,"1.7",1237420800,"01",128,"TCGA-25-1635-01A-01",85,85,NA,NA,0,0,15,15,"2016-09-08T10:38:10.234376-05:00","2016-09-08T10:38:10.234376-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"bf595f95-9e5f-4b08-8d7e-0b7b08a7c6ee","e3fb13c5-3313-4116-9aff-2dd97b81cace","TCGA-25-1635-01A-01-BS1","TCGA-25-1635-01A-01-TS1",80,80,"4b3bff31-a3a0-49f1-998b-7f40829a3ecd","RNA","TCGA-25-1635-01A-01R","9494afb0-d523-4e93-a25a-89ddf27bdd86",1.8,0.15,"UV Spec","R","22","TCGA-25-1635-01A-01R-1566-13","877d96a2-6e5c-472c-b190-59fcfd1febb4",0.15,NA,NA,NA,NA,"f08969fe-44c3-54e8-9b5d-ce234754e1fd","TCGA-25-1635_exposure","TCGA-25-1635-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T04:44:26.000Z","2014-03-20T05:08:01.000Z","8733788B-3C2A-4971-8CF7-D333465E36DE","8EAB6A91-E73B-4555-9915-8AC4B91D9DE3","Unaligned reads",12578580480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","877D96A2-6E5C-472C-B190-59FCFD1FEBB4","Canada's Michael Smith Genome Sciences Centre","564a3599e4b08c5d868fa7d5","BC2591B0-65D7-48C3-A5CC-783F67B65869","Ovarian Serous Cystadenocarcinoma","TAR","4B3BFF31-A3A0-49F1-998B-7F40829A3ECD","2014-03-20T05:08:01.000Z","9494AFB0-D523-4E93-A25A-89DDF27BDD86","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"4B3BFF31-A3A0-49F1-998B-7F40829A3ECD",1.3,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e22c9a04-50e5-40e2-9df0-66c86b6f3b38.txt",NA,"TCGA-25-1635-01A",1.7,"F2C02ABE-3A05-4BC0-914C-48F367820DFA","TCGA",2002,NA,NA,"WITH TUMOR","8EAB6A91-E73B-4555-9915-8AC4B91D9DE3",71,"nationwidechildrens.org_clinical.TCGA-25-1635.xml","Dead",1583,"TCGA-25-1635","NOT HISPANIC OR LATINO","BA5104EE-89A9-455E-BFF2-E4F3BEC0A20B",NA,1558,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,128,"BF595F95-9E5F-4B08-8D7E-0B7B08A7C6EE","BBD80748-73C9-416B-AED9-77A7B975C075","TCGA-25-1635-01A-01R-1566-13_mirna.bam.bai","TCGA-25-1635-01A-01",85,0,NA,NA,15,"TOP",5,NA,"TCGA-25-1635-01A-01-TS1",80,"Taxol","Chemotherapy","TCGA-25-1635-D26757",NA,NA,NA,"TCGA-25-1635-F26756_NTE-1",NA,1558,"WITH TUMOR","Dead",1583,"TCGA-25-1635-F26756","TCGA-25-1635",NA,"25","1635","YES","C56.9","8441/3","C56.9",NA,NA,-26200,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1558,1583,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
218029398,207914912,15355021734,"EE38BD4E-5A08-4639-912F-04203F53762F.bw","bc3e0b74-ea09-46a5-9f61-16bd15ffd883","ee38bd4e-5a08-4639-912f-04203f53762f","2016-08-27T01:27:08.463858-05:00","TCGA-23-1809-01A-01R-1566-13_rnaseq_fastq.tar","5ce771a2-9aa9-4849-97d9-a3d6fb952c8e",14252267520,"Illumina HiSeq","e5dce239e2ccac18b40d910d36fee93a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:31:21.729369-05:00","2016-05-03T11:40:21.662944-05:00","5ce771a2-9aa9-4849-97d9-a3d6fb952c8e_analysis.xml","a1fe6459714f395903b3cfad035470e1","4b798ea3-50da-4d02-bc3d-a0527565670b",2181,"2016-09-29T19:59:03.162146-05:00","5ce771a2-9aa9-4849-97d9-a3d6fb952c8e_experiment.xml","030c921e9e847ed05843932e2950a7a9","5c8e28a0-690c-49bb-8471-e459e06b93ff",3916,"2016-09-29T17:38:53.904881-05:00","5ce771a2-9aa9-4849-97d9-a3d6fb952c8e_run.xml","4aeac81bc7772f9f4918e3f5f3d38ee7","047bc1e5-1705-435b-972f-0a46481a8b8a",1988,"2016-09-08T12:25:08.215955-05:00","TCGA-23-1809","2016-09-02T19:07:25.777763-05:00","female","TCGA-23-1809_demographic",1946,"white","8cd7c35b-a01a-52cd-b6fe-c23edb79cfc4","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1809_diagnosis","not reported",23111,"alive","8441/3",NA,16,"ba8c7f10-02ed-5863-a63b-881397fd3c13","c56.9",-23111,"TCGA-23-1809_treatment","5825fcbd-3f5b-5845-8028-b80430d579ff","01",NA,"TCGA-23-1809-01A","0.6","ef7f3a0d-b620-4355-8212-4bad381fe29c",FALSE,"f69b3aba-61df-4fd8-94d7-9bb80692464c","Primary Tumor","0.4",NA,NA,"0.9",1244678400,"01",111,"TCGA-23-1809-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T12:25:08.215955-05:00","2016-09-08T12:25:08.215955-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,10,"ee5e78ba-2887-4eab-ad57-edb5efb61942","ae9b5dd9-e156-4990-b851-7a63b4f39e60","TCGA-23-1809-01A-01-TS1","TCGA-23-1809-01A-01-BS1",70,70,"59b97da2-8e0d-4bb3-8508-4d5d0cf0c11e","RNA","TCGA-23-1809-01A-01R","cab2de48-ce3b-4a9b-abf7-95094d6f3cfb",1.8,0.14,"UV Spec","R","22","TCGA-23-1809-01A-01R-1566-13","ac764277-4d48-489a-8625-f27541b11258",0.14,NA,NA,NA,NA,"9ed411a9-4d25-539c-8c7b-3becaa425144","TCGA-23-1809_exposure","TCGA-23-1809-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-24T23:28:22.000Z","2014-03-25T00:02:01.000Z","5CE771A2-9AA9-4849-97D9-A3D6FB952C8E","EF7F3A0D-B620-4355-8212-4BAD381FE29C","Unaligned reads",14252267520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AC764277-4D48-489A-8625-F27541B11258","Canada's Michael Smith Genome Sciences Centre","564a40b8e4b093830b6afa8c","BC3E0B74-EA09-46A5-9F61-16BD15FFD883","Ovarian Serous Cystadenocarcinoma","TAR","59B97DA2-8E0D-4BB3-8508-4D5D0CF0C11E","2014-03-25T00:02:01.000Z","CAB2DE48-CE3B-4A9B-ABF7-95094D6F3CFB","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"59B97DA2-8E0D-4BB3-8508-4D5D0CF0C11E",0.6,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2341af5b-d30e-4ae0-9384-119f66a797ed.txt",NA,"TCGA-23-1809-01A",0.9,"6DAB45BD-9189-4F7A-A844-85635ED7CBF7","TCGA",2009,NA,NA,NA,"EF7F3A0D-B620-4355-8212-4BAD381FE29C",63,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2341af5b-d30e-4ae0-9384-119f66a797ed.txt","Alive",NA,"TCGA-23-1809","NOT HISPANIC OR LATINO","834F38AF-E051-41C8-AAE9-1F2FF067B02E",NA,16,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,111,"EE5E78BA-2887-4EAB-AD57-EDB5EFB61942","BD768EF3-9C53-4C52-AB65-9FD998B3A6F7","ae8ac1bd92e34f28ee24c7c676df4dce.bam.bai","TCGA-23-1809-01A-01",80,0,NA,NA,20,"BOTTOM",10,NA,"TCGA-23-1809-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-23-1809-D25755",NA,NA,NA,NA,NA,16,NA,"Alive",NA,"TCGA-23-1809-F25753","TCGA-23-1809",NA,"23","1809","YES","C56.9","8441/3","C56.9",NA,NA,-23111,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",16,NA,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,63,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
180371276,174454625,12867363586,"4050E7F8-80B6-46F2-8FF0-D4EC313E975B.bw","bc4bc342-20bf-40c3-af26-2c6f942da93d","4050e7f8-80b6-46f2-8ff0-d4ec313e975b","2016-08-25T20:14:07.122092-05:00","TCGA-13-1497-01A-01R-1565-13_rnaseq_fastq.tar","4039d5ca-7ad4-40b7-8898-9435b99d213d",10660096000,"Illumina HiSeq","a723b662e6195f7d0ce322c89cf94b33","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:42:15.789301-05:00","2016-05-03T11:40:21.647690-05:00","4039d5ca-7ad4-40b7-8898-9435b99d213d_analysis.xml","2d36092bb1382898aa1296be923bbbf9","e6ace1fb-cb7f-4b0a-ab15-5fd25368745d",2181,"2016-10-07T16:14:06.666803-05:00","4039d5ca-7ad4-40b7-8898-9435b99d213d_experiment.xml","7566737f11236ab03f4744ee60d9f6d6","b4a7a58a-676d-4ad9-9222-284887b7c981",3916,"2016-09-29T22:47:38.889323-05:00","4039d5ca-7ad4-40b7-8898-9435b99d213d_run.xml","a2937ffd7473f3d0ef1e3b2e66100a1f","c4bc4676-8ab8-4843-a1fa-1df260bfe533",1989,"2016-09-08T13:20:11.069689-05:00","TCGA-13-1497","2016-09-02T19:13:49.063821-05:00","female","TCGA-13-1497_demographic",1957,"white","9c931a7a-6e3c-5a87-a410-c936e9789e42","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1497_diagnosis","not reported",17528,"alive","8441/3",NA,3871,"b1652541-14ef-5640-8541-d042fdc2524a","c56.9",-17528,"TCGA-13-1497_treatment","6399754c-8906-5395-942f-205595f1b6a9","01",NA,"TCGA-13-1497-01A","1.2","87ebfaf3-1ab2-4224-b556-0998a6ac16ff",FALSE,"108519AE-4684-4B6E-8A7D-225BFC5084F3","Primary Tumor","0.3",NA,NA,"1.3",1234483200,"01",124,"TCGA-13-1497-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:20:11.069689-05:00","2016-09-08T13:20:11.069689-05:00",NA,NA,NA,NA,"TOP","BOTTOM",15,10,"df740e3b-2d04-4a35-8927-ed788875d668","4fb415dd-e72d-451a-9064-99c2f28934d5","TCGA-13-1497-01A-01-TS1","TCGA-13-1497-01A-01-BS1",80,85,"060f9936-d9b7-4f3f-8b9a-49b864a12705","RNA","TCGA-13-1497-01A-01R","1a7507bc-9727-461c-8e2a-bd42ad668a87",1.8,0.15,"UV Spec","R","22","TCGA-13-1497-01A-01R-1565-13","eb61bd52-e5fa-4c33-a2e4-1353a42184d9",0.15,NA,NA,NA,NA,"e07e85fd-7754-533b-a3b2-f30bfe6c6685","TCGA-13-1497_exposure","TCGA-13-1497-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T03:30:54.000Z","2014-03-22T03:55:01.000Z","4039D5CA-7AD4-40B7-8898-9435B99D213D","87EBFAF3-1AB2-4224-B556-0998A6AC16FF","Unaligned reads",10660096000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EB61BD52-E5FA-4C33-A2E4-1353A42184D9","Canada's Michael Smith Genome Sciences Centre","564a5ad3e4b09c884b2781fc","BC4BC342-20BF-40C3-AF26-2C6F942DA93D","Ovarian Serous Cystadenocarcinoma","TAR","060F9936-D9B7-4F3F-8B9A-49B864A12705","2014-03-22T03:55:01.000Z","1A7507BC-9727-461C-8E2A-BD42AD668A87","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"060F9936-D9B7-4F3F-8B9A-49B864A12705",1.2,"13","TCGA-13-1497-01A-01R-1565-13_rnaseq.bam",NA,"TCGA-13-1497-01A",1.3,"96FED8B4-C5F5-4CA0-95C4-183C1C2DE11B","TCGA",2004,NA,NA,"WITH TUMOR","FD368B39-24CD-4BFB-B162-A78EBFD5CE96",47,"TCGA-13-1497-01A-01R-1565-13_mirna.bam","Alive",NA,"TCGA-13-1497","NOT HISPANIC OR LATINO","D8A1710D-BBA3-4B22-9C76-124568B7B543",NA,1652,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,124,"DF740E3B-2D04-4A35-8927-ED788875D668","C51D0615-8DDE-45DB-9B74-83E56B6E6DC1","TCGA-13-1497-01A-01R-1565-13_rnaseq.bam","TCGA-13-1497-01A-01",95,0,NA,NA,5,"BOTTOM",10,NA,"TCGA-13-1497-01A-01-BS1",85,"Paciltaxel","Chemotherapy","TCGA-13-1497-D24910",NA,NA,NA,"TCGA-13-1497-F24908_NTE-2",NA,1652,"WITH TUMOR","Alive",NA,"TCGA-13-1497-F24908","TCGA-13-1497",NA,"13","1497","YES","C56.9","8441/3","C56.9",NA,NA,-17528,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1652,NA,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,47,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
259265818,229636376,16753879693,"F3565161-FFBE-4138-9773-558DB386710C.bw","bc84c5c5-1785-4edd-b732-8987f862063e","f3565161-ffbe-4138-9773-558db386710c","2016-08-09T14:43:48.699299-05:00","TCGA-5X-AA5U-01A-11R-A406-31_rnaseq_fastq.tar","5abbe401-9757-484b-9503-ab898d43abaf",15697582080,"Illumina HiSeq","390bdb2af5ab8f9e9037fb78efd6f4ed","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T20:27:51.092711-05:00","2016-06-22T11:19:32.361656-05:00","5abbe401-9757-484b-9503-ab898d43abaf_analysis.xml","558b6eecb7d686f7e9652e2395d8e186","6e1b8dc0-d318-4d20-8b8b-477deb14448e",2183,"2016-10-07T17:30:27.877721-05:00","5abbe401-9757-484b-9503-ab898d43abaf_experiment.xml","a49f02b5b1e18a6d9410803e6ca255de","53a7b530-d207-4943-85cb-b4c07dbe5aac",3753,"2016-09-29T19:07:33.634866-05:00","5abbe401-9757-484b-9503-ab898d43abaf_run.xml","6ddca349f6e32371e8a766b8f17e6f6e","3c71c87f-07bb-4457-b9e5-709ae8f572bb",1808,"2016-09-08T12:15:49.103825-05:00","TCGA-5X-AA5U","2016-09-02T19:00:50.810169-05:00","female","TCGA-5X-AA5U_demographic",1952,"black or african american","168d1029-2d5f-5f1c-8258-18c881e52862","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","NCH","5X","644207ab-0ab6-585c-aeb0-051a7c62fbf9","University of Alabama","not reported","c56.9","TCGA-5X-AA5U_diagnosis","not reported",22438,"alive","8460/3",NA,361,"14b248c8-51a1-5f37-9c1f-5b310254bd02","c56.9",-22438,"TCGA-5X-AA5U_treatment","2fec166a-281f-55ed-97e9-c3513e22fb44","01","true","TCGA-5X-AA5U-01A",NA,"e2d8b59b-b044-4aad-9e1b-f88c3208df3a",FALSE,"28F20F49-20C6-4B93-957D-8DAEF04657AE","Primary Tumor",NA,11,230,NA,1394755200,"11",30,"TCGA-5X-AA5U-01A-11",75,NA,0,NA,5,NA,20,NA,"2016-09-08T12:15:49.103825-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"9d54b87f-491d-4482-a0dd-194417619d7a",NA,"TCGA-5X-AA5U-01A-01-TSA",NA,75,NA,"b85cb060-6a51-443a-9557-24f6c912e428","RNA","TCGA-5X-AA5U-01A-11R","f9f30961-2625-492e-8bae-819431b2209c",1.9,0.16,"UV Spec","R","23","TCGA-5X-AA5U-01A-11R-A406-31","4b0f78ad-6fd4-4aaf-af08-45bb379ba8d9",0.16,NA,NA,NA,NA,"32609c74-35f3-59d0-956f-1f082d609d97","TCGA-5X-AA5U_exposure","TCGA-5X-AA5U-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T01:16:45.000Z","2015-02-07T03:06:18.000Z","5ABBE401-9757-484B-9503-AB898D43ABAF","E2D8B59B-B044-4AAD-9E1B-F88C3208DF3A","Unaligned reads",15697582080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4B0F78AD-6FD4-4AAF-AF08-45BB379BA8D9","Canada's Michael Smith Genome Sciences Centre","564a5856e4b0298dd2cb2591","BC84C5C5-1785-4EDD-B732-8987F862063E","Ovarian Serous Cystadenocarcinoma","TAR","B85CB060-6A51-443A-9557-24F6C912E428","2015-02-07T03:06:18.000Z","F9F30961-2625-492E-8BAE-819431B2209C","United States","NO",1,NA,"Primary Tumor","University of Alabama",11,"B85CB060-6A51-443A-9557-24F6C912E428",NA,"5X","TCGA-5X-AA5U-01A-11R-A406-31_rnaseq.bam",230,"TCGA-5X-AA5U-01A",NA,"BCE4C9F7-2318-4C8B-8545-9F0283051595","TCGA",2013,NA,"Complete Remission/Response","TUMOR FREE","E2D8B59B-B044-4AAD-9E1B-F88C3208DF3A",61,"nationwidechildrens.org_clinical.TCGA-5X-AA5U.xml","Alive",NA,"TCGA-5X-AA5U",NA,"9DD9459C-FB46-4499-8C14-14E222B1DDFD","NO",277,"Yes, History of Synchronous/Bilateral Malignancy","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIC",NA,100,NA,"8460/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"9D54B87F-491D-4482-A0DD-194417619D7A","F9F30961-2625-492E-8BAE-819431B2209C","TCGA-5X-AA5U-01A-11R-A406-31_rnaseq.bam","TCGA-5X-AA5U-01A-11",75,5,0,2,20,"TOP",0,0,"TCGA-5X-AA5U-01A-01-TSA",75,"Carboplatin","Chemotherapy","TCGA-5X-AA5U-D69110",NA,NA,NA,NA,"NO",361,NA,"Alive",NA,"TCGA-5X-AA5U-F69358","TCGA-5X-AA5U",NA,"5X","AA5U","YES","C56.9","8460/3","C56.9","YES","NO",-22438,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"Yes, History of Synchronous/Bilateral Malignancy","No","Alive",277,NA,"NO","YES","TUMOR FREE","YES",1,10,2014,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,61,2013,"Tumor resection",NA,NA,NA,"GX","R0",NA,NA,NA,NA,"Complete Remission/Response",NA,7,NA,NA,NA,100,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
268568878,261703066,19395092385,"BA9ABEB1-D3F0-4F09-A647-25211C47C3D0.bw","bdd792e7-d75f-4aa3-b38e-f0708e112075","ba9abeb1-d3f0-4f09-a647-25211c47c3d0","2016-08-26T08:37:13.256483-05:00","TCGA-24-2293-01A-01R-1568-13_rnaseq_fastq.tar","157f6985-8958-4a7a-8007-85ac40c601d7",17575424000,"Illumina HiSeq","96274f782a6ad5a91c025751b5d6e1a5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:21:24.277782-05:00","2016-05-03T11:41:05.755204-05:00","157f6985-8958-4a7a-8007-85ac40c601d7_analysis.xml","754ffda95d5033cfaaff3684d03a2f39","1f2ad59e-e165-4311-9532-e9cb8d2d6d7d",2183,"2016-09-29T21:37:33.893409-05:00","157f6985-8958-4a7a-8007-85ac40c601d7_experiment.xml","1c22e67638121b5f1c88d42eed174965","995b220b-5a8a-49e0-b42d-7e72fa46d324",3916,"2016-09-29T18:53:34.836836-05:00","157f6985-8958-4a7a-8007-85ac40c601d7_run.xml","c3dbbdc47b1569965a0881b88643ceab","33a0f4ca-22e4-42dd-90d7-afe4720b6e9f",1990,"2016-09-08T13:18:42.172824-05:00","TCGA-24-2293","2016-09-02T19:11:42.984140-05:00","female","TCGA-24-2293_demographic",1948,"white","8d3d202d-b300-5de9-9226-3338350a13e7","not reported",1996,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c48.1","TCGA-24-2293_diagnosis","not reported",17235,"dead","8441/3",506,506,"9b15e2a6-35c6-5b7c-a120-c89694cdd36a","c48.1",-17235,"TCGA-24-2293_treatment","ae907019-965d-5ddf-9959-8803fadc8401","01",NA,"TCGA-24-2293-01A","1.1","542c8797-ff2c-49c6-955b-ef8222194b6d",FALSE,"caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7","Primary Tumor","0.3",NA,NA,"1.3",1251676800,"01",112,"TCGA-24-2293-01A-01",66,74,NA,NA,58,43,0,0,"2016-09-08T13:18:42.172824-05:00","2016-09-08T13:18:42.172824-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,2,"96b19260-6a66-40bb-b472-749fb3caea6e","bbb53d55-4e3b-46a6-aa7a-98b79d7b6591","TCGA-24-2293-01A-01-BS1","TCGA-24-2293-01A-01-TS1",40,55,"8e8db6a9-d98b-4113-a874-c56a61ea67ac","RNA","TCGA-24-2293-01A-01R","2e29f752-96c8-4f49-8366-0711541f2587",1.8,0.14,"UV Spec","R","22","TCGA-24-2293-01A-01R-1568-13","d554a1f1-3e8a-4b8c-a458-36e6550905dd",0.14,NA,NA,NA,NA,"05e9f203-4690-5079-9d1e-81872ce0edb7","TCGA-24-2293_exposure","TCGA-24-2293-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T05:48:46.000Z","2014-03-27T06:22:02.000Z","157F6985-8958-4A7A-8007-85AC40C601D7","542C8797-FF2C-49C6-955B-EF8222194B6D","Unaligned reads",17575424000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D554A1F1-3E8A-4B8C-A458-36E6550905DD","Canada's Michael Smith Genome Sciences Centre","564a3d52e4b08c5d86921f6b","BDD792E7-D75F-4AA3-B38E-F0708E112075","Ovarian Serous Cystadenocarcinoma","TAR","8E8DB6A9-D98B-4113-A874-C56A61EA67AC","2014-03-27T06:22:02.000Z","2E29F752-96C8-4F49-8366-0711541F2587","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"8E8DB6A9-D98B-4113-A874-C56A61EA67AC",1.1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a40fdeac-ebb6-4f9f-9f90-837deef5095e.txt",NA,"TCGA-24-2293-01A",1.3,"C370EF42-66A2-4812-A7B2-C1A6CFDF941D","TCGA",1995,NA,NA,NA,"785628BC-DA57-490D-A3FE-B35F7607800B",47,"TCGA-24-2293-01A-01W-0799-08_IlluminaGA-DNASeq_capture.bam","Dead",506,"TCGA-24-2293",NA,"65EF94B1-F432-43AF-B82B-79EDA4EC62BE",NA,506,NA,"Ovary","C48.1",NA,"Serous Cystadenocarcinoma",NA,NA,NA,NA,NA,NA,"8441/3","FEMALE","C48.1",24,NA,NA,"WHITE",NA,1,112,"BBB53D55-4E3B-46A6-AA7A-98B79D7B6591","E4057796-9B23-4322-8A61-AA52FEFA1704","TCGA-24-2293-01A-01R-1568-13_mirna.bam","TCGA-24-2293-01A-01",66,58,NA,NA,0,"BOTTOM",2,NA,"TCGA-24-2293-01A-01-BS1",40,"Etoposide","Chemotherapy","TCGA-24-2293-D26602",NA,NA,NA,NA,NA,506,NA,"Dead",506,"TCGA-24-2293-F26598","TCGA-24-2293",NA,"24","2293","YES","C48.1","8441/3","C48.1",NA,NA,-17235,"FEMALE","WHITE",NA,NA,"No","Dead",506,506,NA,NA,NA,"NO",26,2,2010,"YES","YES","NO",NA,NA,NA,"Omentum","Serous Cystadenocarcinoma","Right",0,47,1995,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
220152238,212522046,15721419697,"9E41E79A-4028-4F60-8250-411F191B665C.bw","c0c3caab-9277-4a31-a96c-c607e38d5ccc","9e41e79a-4028-4f60-8250-411f191b665c","2016-08-25T20:31:05.703090-05:00","TCGA-23-1114-01B-01R-1566-13_rnaseq_fastq.tar","988ecbd2-252d-4621-8294-3795a33a2e70",14597980160,"Illumina HiSeq","83b0f8add330015e8a714d9990ea0684","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:54:26.225035-05:00","2016-05-03T11:40:21.662944-05:00","988ecbd2-252d-4621-8294-3795a33a2e70_analysis.xml","1b231f348e341244ac56e44a4b8cf013","a3dd9abb-ed9a-49f0-900d-44e98c6378fb",2181,"2016-08-13T04:50:03.613475-05:00","988ecbd2-252d-4621-8294-3795a33a2e70_experiment.xml","4199e798ca9e472f8c25d28385a0a3f1","4778b9b2-90c9-4551-bdf1-5d245ce94e89",3916,"2016-09-29T23:24:31.728578-05:00","988ecbd2-252d-4621-8294-3795a33a2e70_run.xml","59a0c3fb1c0d14dede978cb9f9ee1ce3","db826049-4c8f-460e-a830-9847a13be0b6",1988,"2016-09-08T13:13:21.108219-05:00","TCGA-23-1114","2016-09-02T19:07:40.043287-05:00","female","TCGA-23-1114_demographic",1945,"white","53467ffb-93bb-5572-b01e-19602c063a44","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1114_diagnosis","not reported",20409,"dead","8441/3",2089,2089,"2f26a07c-893d-5252-be5b-5dcb2902113a","c56.9",-20409,"TCGA-23-1114_treatment","4ce7f4c7-428f-5c90-85c3-de43de186e0c","01",NA,"TCGA-23-1114-01B","0.6","424254f5-1bdf-43ed-b867-33a73a3c919f",FALSE,"d5c00586-d7e4-4909-be2b-ffc4f9ef2e82","Primary Tumor","0.4",NA,NA,"1",1244678400,"01",104,"TCGA-23-1114-01B-01",80,80,NA,NA,0,0,20,20,"2016-09-08T13:13:21.108219-05:00","2016-09-08T13:13:21.108219-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"e8ba0c6f-94e8-4ebb-86e4-882753640bbb","453252ed-fb64-497a-ad1e-366b5737eaac","TCGA-23-1114-01B-01-BS1","TCGA-23-1114-01B-01-TS1",80,80,"e51d32a0-c31c-408c-b920-5d93914fafca","RNA","TCGA-23-1114-01B-01R","d96b5c5c-af8f-4015-a50b-4223ce2123c6",1.8,0.17,"UV Spec","R","22","TCGA-23-1114-01B-01R-1566-13","7cfe1419-65be-4860-9f99-75f4a139d9ac",0.17,NA,NA,NA,NA,"f6b9af5a-22bd-5789-9fe6-5091059af95d","TCGA-23-1114_exposure","TCGA-23-1114-01B-01R-1566-13_rnaseq_fastq.tar","2014-03-24T22:33:17.000Z","2014-03-24T23:07:01.000Z","988ECBD2-252D-4621-8294-3795A33A2E70","424254F5-1BDF-43ED-B867-33A73A3C919F","Unaligned reads",14597980160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7CFE1419-65BE-4860-9F99-75F4A139D9AC","Canada's Michael Smith Genome Sciences Centre","564a5bb8e4b08c5d8695461f","C0C3CAAB-9277-4A31-A96C-C607E38D5CCC","Ovarian Serous Cystadenocarcinoma","TAR","E51D32A0-C31C-408C-B920-5D93914FAFCA","2014-03-24T23:07:01.000Z","D96B5C5C-AF8F-4015-A50B-4223CE2123C6","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"E51D32A0-C31C-408C-B920-5D93914FAFCA",0.6,"23","TCGA-23-1114-01B-01R-1566-13.hg19.mirna.quantification.txt",NA,"TCGA-23-1114-01B",1,"E6C36E8F-5244-49FD-B850-7B811204F0E4","TCGA",2000,NA,NA,"WITH TUMOR","424254F5-1BDF-43ED-B867-33A73A3C919F",55,"TCGA-23-1114-10A-01W-0633-09_IlluminaGA-DNASeq_exome_1.bam.bai","Dead",2089,"TCGA-23-1114","NOT HISPANIC OR LATINO","02402E47-4CA1-4879-9D04-12415831D9C0",NA,2089,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,104,"E8BA0C6F-94E8-4EBB-86E4-882753640BBB","D96B5C5C-AF8F-4015-A50B-4223CE2123C6","4760681021_A_Grn.idat","TCGA-23-1114-01B-01",80,0,NA,NA,20,"TOP",0,NA,"TCGA-23-1114-01B-01-TS1",80,"Gemzar","Chemotherapy","TCGA-23-1114-D25692",NA,NA,NA,"TCGA-23-1114-F25685_NTE-2",NA,2089,"WITH TUMOR","Dead",2089,"TCGA-23-1114-F25685","TCGA-23-1114",NA,"23","1114","YES","C56.9","8441/3","C56.9",NA,NA,-20409,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",2089,2089,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,55,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
159049208,157028577,11639030133,"5F1D3EFD-ECDA-4C92-8D81-491484F09C95.bw","c183d3fb-2eee-44f8-890e-b9bf907141e6","5f1d3efd-ecda-4c92-8d81-491484f09c95","2016-08-20T13:36:55.882114-05:00","TCGA-61-2092-01A-01R-1568-13_rnaseq_fastq.tar","4b89ce38-cf96-4a59-857b-54fda16ba7ae",9215989760,"Illumina HiSeq","45f2dd88906e320d7ff1b21b2929a434","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:35:56.557930-05:00","2016-05-03T11:56:42.628342-05:00","4b89ce38-cf96-4a59-857b-54fda16ba7ae_analysis.xml","c4ebe9957b9693d3a89d174bc83c61fd","4e3237d3-45ee-459b-9fe7-52722ace32a6",2181,"2016-09-29T21:26:08.636548-05:00","4b89ce38-cf96-4a59-857b-54fda16ba7ae_experiment.xml","f6fd3a42ac57c9e3a54a3df81a70c48f","925414c9-2b4e-4eb8-a00a-46793e35068b",3916,"2016-09-29T22:27:43.640800-05:00","4b89ce38-cf96-4a59-857b-54fda16ba7ae_run.xml","a6703e2d971a7f2962554a78eef5e0d8","b852025d-822b-4533-9c24-ff20491c2f26",1988,"2016-09-08T11:52:37.988425-05:00","TCGA-61-2092","2016-09-02T18:56:29.592385-05:00","female","TCGA-61-2092_demographic",1947,"white","53de236f-819a-54ee-9111-6556f3647385","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2092_diagnosis","not reported",21072,"alive","8441/3",NA,1573,"8fd8c018-04a7-549f-a3a6-ac8e9b87c065","c56.9",-21072,"TCGA-61-2092_treatment","e69ef619-a6ae-5941-a261-0a6ee83ea47a","01",NA,"TCGA-61-2092-01A","1.2","962bb8fd-018e-49d0-b1df-dc0192e1b2a6",FALSE,"35b4bfa3-e6a5-4b55-a7f1-bc39953422c0","Primary Tumor","0.4",NA,NA,"1.3",1250121600,"01",160,"TCGA-61-2092-01A-01",99,99,NA,NA,0,0,5,10,"2016-09-08T11:52:37.988425-05:00","2016-09-08T11:52:37.988425-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"e19c34fd-bcf6-468f-b1a4-689c912ae78f","060203fd-43c4-4e4c-8b3b-6d537a56e73c","TCGA-61-2092-01A-01-BS1","TCGA-61-2092-01A-01-TS1",95,90,"76aead43-2b3f-459a-98d3-2fc67f762c48","RNA","TCGA-61-2092-01A-01R","49f15675-0238-415a-abe4-cb5c0e6bc87f",1.8,0.15,"UV Spec","R","22","TCGA-61-2092-01A-01R-1568-13","0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a",0.15,NA,NA,NA,NA,"5675456a-dfbb-53ea-93de-8ca30c01cebc","TCGA-61-2092_exposure","TCGA-61-2092-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T21:48:16.000Z","2014-08-28T23:03:19.000Z","4B89CE38-CF96-4A59-857B-54FDA16BA7AE","962BB8FD-018E-49D0-B1DF-DC0192E1B2A6","Unaligned reads",9215989760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0ED6E7A9-CDAA-48DC-962F-219F1EB39C1A","Canada's Michael Smith Genome Sciences Centre","564a3bd3e4b0298dd2c88a95","C183D3FB-2EEE-44F8-890E-B9BF907141E6","Ovarian Serous Cystadenocarcinoma","TAR","76AEAD43-2B3F-459A-98D3-2FC67F762C48","2014-08-28T23:03:19.000Z","49F15675-0238-415A-ABE4-CB5C0E6BC87F","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"76AEAD43-2B3F-459A-98D3-2FC67F762C48",1.2,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.94487130-5cc1-4f68-beab-57c211204449.txt",NA,"TCGA-61-2092-01A",1.3,"310D2D4F-8DAD-40AE-B4E9-74AAD0299EBD","TCGA",2004,NA,NA,"TUMOR FREE","A5436D26-E044-4566-A823-ACF047C464C2",57,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.94487130-5cc1-4f68-beab-57c211204449.txt","Alive",NA,"TCGA-61-2092",NA,NA,NA,1573,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,160,"E19C34FD-BCF6-468F-B1A4-689C912AE78F","B3E9A3AD-DCCA-4624-B515-2FB601BF4245","SOURS_p_TCGAb22_SNP_N_GenomeWideSNP_6_C05_529864.nocnv_hg19.seg.txt","TCGA-61-2092-01A-01",99,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-61-2092-01A-01-BS1",95,"Carboplatin","Chemotherapy","TCGA-61-2092-D28383",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2092",NA,"61","2092","YES","C56.9","8441/3","C56.9",NA,NA,-21072,"FEMALE","WHITE",NA,NA,"No","Alive",1573,NA,NA,NA,"TUMOR FREE","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
240183530,231419123,17130897860,"0DBA04CB-417D-4E2B-BE83-3563F45291C4.bw","c3e443b9-5dc5-4793-91e3-534f21485268","0dba04cb-417d-4e2b-be83-3563f45291c4","2016-08-24T20:14:02.544177-05:00","TCGA-24-1424-01A-01R-1565-13_rnaseq_fastq.tar","39da90c7-9649-40cd-bd1e-f9ae043d0db5",15424972800,"Illumina HiSeq","2e42ac9a1a1bca6c11009a466c46b215","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:34:34.966756-05:00","2016-05-03T11:40:21.647690-05:00","39da90c7-9649-40cd-bd1e-f9ae043d0db5_analysis.xml","431b57e0d37aee12100647b093e5477d","72172095-d03b-4a30-8eeb-6ba0ed2aea08",2181,"2016-09-29T21:04:17.072484-05:00","39da90c7-9649-40cd-bd1e-f9ae043d0db5_experiment.xml","cb62e73126e49a7faca6335bfbc590fc","84a5ae93-8571-45a7-8253-6d887aa2e4df",3916,"2016-09-29T23:18:49.110731-05:00","39da90c7-9649-40cd-bd1e-f9ae043d0db5_run.xml","ff4dc60a0f95bf5442bfeca7f4fc1d32","d7e434a1-04db-4047-8a33-e23182976c96",1989,"2016-09-08T14:04:47.303128-05:00","TCGA-24-1424","2016-09-02T19:13:54.840931-05:00","female","TCGA-24-1424_demographic",1941,"white","63997bed-da2a-57ae-81e4-53468e3d556a","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1424_diagnosis","not reported",24545,"alive","8441/3",NA,183,"51ca0e22-1a4d-5b23-a0bb-f197df114dfe","c56.9",-24545,"TCGA-24-1424_treatment","0abda174-3602-5b21-9c07-80eb17808870","01",NA,"TCGA-24-1424-01A","0.6","9f88d3b0-edc0-4fca-a4a9-4d8aacedf9a7",FALSE,"2b1dfcc6-e4ee-4443-9472-171569244648","Primary Tumor","0.6",NA,NA,"1.2",1231977600,"01",133,"TCGA-24-1424-01A-01",95,95,NA,NA,32,12,0,0,"2016-09-08T14:04:47.303128-05:00","2016-09-08T14:04:47.303128-05:00",NA,NA,NA,NA,"TOP","BOTTOM",3,3,"60fe0b86-27a1-4a3e-ab27-2601008cb58c","c621b053-57a0-46e5-9cb9-b35216aafef9","TCGA-24-1424-01A-01-TS1","TCGA-24-1424-01A-01-BS1",65,85,"55eacb41-678c-42cf-a153-6cfb2f5e84fc","RNA","TCGA-24-1424-01A-01R","812a96f8-bac3-4e38-80ce-e554c399b508",1.8,0.16,"UV Spec","R","22","TCGA-24-1424-01A-01R-1565-13","d3fbcdaa-11af-4233-9700-57c6e1628c4b",0.16,NA,NA,NA,NA,"614c74b3-8847-5705-8125-d9bf87bef7a6","TCGA-24-1424_exposure","TCGA-24-1424-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T03:47:11.000Z","2014-03-22T04:20:01.000Z","39DA90C7-9649-40CD-BD1E-F9AE043D0DB5","9F88D3B0-EDC0-4FCA-A4A9-4D8AACEDF9A7","Unaligned reads",15424972800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D3FBCDAA-11AF-4233-9700-57C6E1628C4B","Canada's Michael Smith Genome Sciences Centre","564a34b8e4b08c5d868f608f","C3E443B9-5DC5-4793-91E3-534F21485268","Ovarian Serous Cystadenocarcinoma","TAR","55EACB41-678C-42CF-A153-6CFB2F5E84FC","2014-03-22T04:20:01.000Z","812A96F8-BAC3-4E38-80CE-E554C399B508","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"55EACB41-678C-42CF-A153-6CFB2F5E84FC",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b64c050d-b09e-4fbb-a906-b5d5e3904149.txt",NA,"TCGA-24-1424-01A",1.2,"763AF0D0-0624-41B1-BD45-20ACE6A3E7C8","TCGA",2008,NA,NA,"TUMOR FREE","B3A84226-479D-425E-8B61-0E3BA8AB8F2A",67,"nationwidechildrens.org_clinical.TCGA-24-1424.xml","Alive",NA,"TCGA-24-1424",NA,"8C85CBC9-0F48-4310-AB56-F53B981E1EE6",NA,183,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,133,"C621B053-57A0-46E5-9CB9-B35216AAFEF9","812A96F8-BAC3-4E38-80CE-E554C399B508","THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_G01_455288.byallele.copynumber.data.txt","TCGA-24-1424-01A-01",95,12,NA,NA,0,"BOTTOM",3,NA,"TCGA-24-1424-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-24-1424-D25943",NA,NA,NA,NA,NA,183,"TUMOR FREE","Alive",NA,"TCGA-24-1424-F25941","TCGA-24-1424",NA,"24","1424","YES","C56.9","8441/3","C56.9",NA,NA,-24545,"FEMALE","WHITE",NA,NA,"No","Alive",183,NA,NA,NA,"TUMOR FREE","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
219670392,209959938,15496910899,"B9B882A5-194B-4F5C-B702-0CF71CA6D9D2.bw","c3f9ee36-d34f-472b-ac7f-801a0d400aa4","b9b882a5-194b-4f5c-b702-0cf71ca6d9d2","2016-08-22T07:42:39.899948-05:00","TCGA-13-1410-01A-01R-1565-13_rnaseq_fastq.tar","39e65b20-2235-4085-a53f-a6b5c697348a",14611548160,"Illumina HiSeq","87d1ca42b0e796374a0522213e6bc121","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:50:31.536712-05:00","2016-05-03T11:40:21.669427-05:00","39e65b20-2235-4085-a53f-a6b5c697348a_analysis.xml","beecdf14b43dedbd4b8654fc35f56d59","0bf626b5-35b9-4d11-9693-49b34e3bcf34",2181,"2016-09-29T19:16:46.979523-05:00","39e65b20-2235-4085-a53f-a6b5c697348a_experiment.xml","29151976040eb53f4a42b1586f5e9cb7","423ec796-09f9-420c-8cf1-a90e3359f4fc",3916,"2016-09-30T00:13:06.979609-05:00","39e65b20-2235-4085-a53f-a6b5c697348a_run.xml","2bf4e625123c52b7635ff5076e498dc4","f9a612c2-2dd2-44f5-b67b-5168992540e1",1989,"2016-09-08T13:43:58.096568-05:00","TCGA-13-1410","2016-09-02T19:12:10.992121-05:00","female","TCGA-13-1410_demographic",1951,"white","dddcc9ce-814f-57e6-88a2-e528d7447fbb","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1410_diagnosis","not reported",20950,"alive","8441/3",NA,2464,"5e13b45b-37a6-5228-8b30-a580f27d1c1a","c56.9",-20950,"TCGA-13-1410_treatment","35b5209f-4450-58fe-87f6-96613c89f7fb","01",NA,"TCGA-13-1410-01A","1.3","62812cb1-e25e-4a3f-9e8e-1993b138e1a6",FALSE,"0F641D88-673B-48C4-97F5-730DA3FD343C","Primary Tumor","0.5",NA,NA,"1.9",1230508800,"01",162,"TCGA-13-1410-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:43:58.096568-05:00","2016-09-08T13:43:58.096568-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"d9211bc5-759c-42ad-acbd-a0dc7798d272","dda5a121-c1dc-4163-a746-af90d53948a8","TCGA-13-1410-01A-01-TS1","TCGA-13-1410-01A-01-BS1",95,94,"741ff0d5-f651-4c21-81e9-9c40c0736fc4","RNA","TCGA-13-1410-01A-01R","d5c0d15c-754f-4d0c-b591-f015734119ac",1.8,0.15,"UV Spec","R","22","TCGA-13-1410-01A-01R-1565-13","fdda1428-ad6b-4337-a959-83bae1f9664b",0.15,NA,NA,NA,NA,"ebeb9e38-32f4-5cac-a4df-fde1ad6d7769","TCGA-13-1410_exposure","TCGA-13-1410-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:01:41.000Z","2014-03-22T05:34:02.000Z","39E65B20-2235-4085-A53F-A6B5C697348A","62812CB1-E25E-4A3F-9E8E-1993B138E1A6","Unaligned reads",14611548160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FDDA1428-AD6B-4337-A959-83BAE1F9664B","Canada's Michael Smith Genome Sciences Centre","564a5c38e4b0298dd2cc4511","C3F9EE36-D34F-472B-AC7F-801A0D400AA4","Ovarian Serous Cystadenocarcinoma","TAR","741FF0D5-F651-4C21-81E9-9C40C0736FC4","2014-03-22T05:34:02.000Z","D5C0D15C-754F-4D0C-B591-F015734119AC","None","NO",1,0.5,"Primary Tumor","Memorial Sloan Kettering",NA,"741FF0D5-F651-4C21-81E9-9C40C0736FC4",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3f2151ce-1e04-4a0e-8ded-e59696b705cb.txt",NA,"TCGA-13-1410-01A",1.9,"D0BA7A4C-CD7A-491E-B632-D4DDEF4A09E8","TCGA",2008,NA,NA,"TUMOR FREE","96D4C70A-94C6-472E-BED9-5A0DE22C4F2D",57,"NEWLY_p_TCGA_Batch13_CN_GenomeWideSNP_6_D05_446170.tangent.copynumber.data.txt","Alive",NA,"TCGA-13-1410","NOT HISPANIC OR LATINO","498F0F25-C651-48D1-A28A-371BA22A446D",NA,143,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,60,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,162,"D9211BC5-759C-42AD-ACBD-A0DC7798D272","FB469527-29D1-403E-BA24-18BECCB6C068","C239.TCGA-13-1410-01A-01W.9.bam.bai","TCGA-13-1410-01A-01",95,0,NA,NA,5,"BOTTOM",1,NA,"TCGA-13-1410-01A-01-BS1",94,"Carboplatin","Chemotherapy","TCGA-13-1410-D24823",NA,NA,NA,NA,NA,143,"TUMOR FREE","Alive",NA,"TCGA-13-1410-F24822","TCGA-13-1410",NA,"13","1410","YES","C56.9","8441/3","C56.9",NA,NA,-20950,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",143,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2008,"Tumor resection",NA,NA,NA,"GX",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
185119668,178480760,13180577542,"67FE7638-B8F5-4631-B178-AC23B0382983.bw","c435627c-159d-4a6d-a819-30abac24bf4d","67fe7638-b8f5-4631-b178-ac23b0382983","2016-08-25T12:15:25.329726-05:00","TCGA-25-1632-01A-01R-1566-13_rnaseq_fastq.tar","eeff99ab-8b22-4e52-a24e-2ead9cc3cab1",11952220160,"Illumina HiSeq","55faf2d01b900e826d9f7e5cb3e749bf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:36:08.016253-05:00","2016-05-03T11:40:21.648199-05:00","eeff99ab-8b22-4e52-a24e-2ead9cc3cab1_analysis.xml","e93743c0a5b40b23128e9b36c684bd6e","4e524a1e-f08e-4162-bdb9-d7e9c733761c",2181,"2016-09-29T21:45:36.805314-05:00","eeff99ab-8b22-4e52-a24e-2ead9cc3cab1_experiment.xml","a426c39515e6fac118f98f0466f2dd64","9e4b7fad-cba6-478e-9234-1036ea7c8bb2",3916,"2016-09-29T23:30:44.736029-05:00","eeff99ab-8b22-4e52-a24e-2ead9cc3cab1_run.xml","6f27e809558e5f84016f60ebf683e14f","df74db6f-f8dd-465d-97ae-9c9ee0a4cd76",1988,"2016-09-08T11:25:04.018872-05:00","TCGA-25-1632","2016-09-02T18:48:47.857087-05:00","female","TCGA-25-1632_demographic",1934,"white","ecf4f54b-a69f-5931-8dc3-82641be4e4f4","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1632_diagnosis","not reported",24993,"dead","8441/3",1799,1732,"c8695a7a-bbd7-5587-abe6-4896e3db73ba","c56.9",-24993,"TCGA-25-1632_treatment","76150ff8-715c-502e-b0a0-483aadf886d4","01",NA,"TCGA-25-1632-01A","0.8","ed9c97d8-4df2-4ed3-b455-4955d72901a8",FALSE,"F083C2B4-20DE-440F-B6A8-2F332346CECA","Primary Tumor","0.3",NA,NA,"1.4",1237420800,"01",128,"TCGA-25-1632-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T11:25:04.018872-05:00","2016-09-08T11:25:04.018872-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"150d6173-6bb4-4d09-9da1-e8898c0e50cc","441ffc0c-d1a4-4154-ac77-a247fdd66727","TCGA-25-1632-01A-01-BS1","TCGA-25-1632-01A-01-TS1",94,94,"a7b83361-c888-4181-95d4-b5b44545e010","RNA","TCGA-25-1632-01A-01R","a46581ab-424d-4286-adc1-b4df1125c6ea",1.8,0.15,"UV Spec","R","22","TCGA-25-1632-01A-01R-1566-13","12c78d62-6045-4f77-bd84-9ab5a38f4635",0.15,NA,NA,NA,NA,"99d4f472-0e0f-5c65-ba70-a3fa8b4fefa5","TCGA-25-1632_exposure","TCGA-25-1632-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T05:08:21.000Z","2014-03-25T05:30:02.000Z","EEFF99AB-8B22-4E52-A24E-2EAD9CC3CAB1","ED9C97D8-4DF2-4ED3-B455-4955D72901A8","Unaligned reads",11952220160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","12C78D62-6045-4F77-BD84-9AB5A38F4635","Canada's Michael Smith Genome Sciences Centre","564a59e0e4b08c5d8694bad8","C435627C-159D-4A6D-A819-30ABAC24BF4D","Ovarian Serous Cystadenocarcinoma","TAR","A7B83361-C888-4181-95D4-B5B44545E010","2014-03-25T05:30:02.000Z","A46581AB-424D-4286-ADC1-B4DF1125C6EA","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"A7B83361-C888-4181-95D4-B5B44545E010",0.8,"25","bcgsc.ca.TCGA-25-1632-01A-01R-1566-13.hg19.bcgsc.ca.1.7.0.sv.fa",NA,"TCGA-25-1632-01A",1.4,"DA7C4E92-7F80-4302-AED3-833DC33E5EE6","TCGA",2002,NA,NA,"WITH TUMOR","ED9C97D8-4DF2-4ED3-B455-4955D72901A8",68,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.105464b7-4efd-4ed6-a906-2dab64b49ad0.txt","Dead",1799,"TCGA-25-1632","NOT HISPANIC OR LATINO","4BA05FE8-8855-4D63-A4A5-E711B36C1AE5",NA,1732,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,128,"441FFC0C-D1A4-4154-AC77-A247FDD66727","F5B1ECFB-326E-4A29-BF49-6215C65749FD","G48125.TCGA-25-1632-01A-01D-A312-08.2.bam.bai","TCGA-25-1632-01A-01",95,0,NA,NA,5,"TOP",1,NA,"TCGA-25-1632-01A-01-TS1",94,"Carboplatin","Chemotherapy","TCGA-25-1632-D26739",NA,NA,NA,"TCGA-25-1632-F26735_NTE-1",NA,1732,"WITH TUMOR","Dead",1799,"TCGA-25-1632-F26735","TCGA-25-1632",NA,"25","1632","YES","C56.9","8441/3","C56.9",NA,NA,-24993,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1732,1799,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,68,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
272793966,264707183,19590209435,"FE03FC2C-9A4E-4F89-8681-E33DFECCC692.bw","c5355491-e1e8-46a4-a05e-bafcaf2e7459","fe03fc2c-9a4e-4f89-8681-e33dfeccc692","2016-08-27T07:57:18.587615-05:00","TCGA-13-1481-01A-01R-1565-13_rnaseq_fastq.tar","eb6b3f6f-51c7-43d2-9fef-0ec086d88af2",16667238400,"Illumina HiSeq","8ead8a230ae7c9a85fd613e4812c5f11","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:28:46.053777-05:00","2016-05-03T11:40:21.669427-05:00","eb6b3f6f-51c7-43d2-9fef-0ec086d88af2_analysis.xml","d5ebaf061c57618098834d1eb830b6c1","49ce7336-dfe2-4e97-aac5-6784e493f182",2181,"2016-09-29T17:43:08.476444-05:00","eb6b3f6f-51c7-43d2-9fef-0ec086d88af2_experiment.xml","c6f0fd2b5a00d977890397a1b8a02cde","073d3593-cdc2-476a-b4ce-e9b49ebf38b7",3916,"2016-09-29T20:38:49.388894-05:00","eb6b3f6f-51c7-43d2-9fef-0ec086d88af2_run.xml","e877b921254cd133d82c71a506644bac","74c1553e-ccb9-48d2-8421-ede5895356ef",1989,"2016-09-08T13:18:17.537284-05:00","TCGA-13-1481","2016-09-02T19:13:46.068928-05:00","female","TCGA-13-1481_demographic",1924,"white","3feefab3-b78e-5f51-a8f7-b0601937c6dc","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1481_diagnosis","not reported",27898,"dead","8441/3",2648,2648,"6876be41-0a9d-5d46-b658-88ac8875f007","c56.9",-27898,"TCGA-13-1481_treatment","59a108b5-57c4-5efc-b34f-97cd49df570c","01",NA,"TCGA-13-1481-01A","1.3","d0021cbe-9f70-47cf-a8ae-f9e07c55f73e",FALSE,"4832CBA4-9482-4A2A-A9E1-4E8489B0F157","Primary Tumor","0.4",NA,NA,"1.4",1234310400,"01",105,"TCGA-13-1481-01A-01",70,90,10,10,0,0,40,17,"2016-09-08T13:18:17.537284-05:00","2016-09-08T13:18:17.537284-05:00",60,60,30,30,"BOTTOM","TOP",0,3,"446cf934-5d0e-463d-8703-cbbf3b8459dc","e7704255-bd11-4c56-b13c-a5b18dc1f315","TCGA-13-1481-01A-01-BS1","TCGA-13-1481-01A-01-TS1",60,80,"87ad06a7-57f5-4482-9ebe-570dae0d8cbc","RNA","TCGA-13-1481-01A-01R","f0c6207f-1155-46cb-ba0a-1b0050d4d2f9",1.8,0.14,"UV Spec","R","22","TCGA-13-1481-01A-01R-1565-13","761f9668-304f-4e22-87cd-2005aa86152c",0.14,NA,NA,NA,NA,"ebdc8ff0-f98a-5b83-bd7e-00e03258ed53","TCGA-13-1481_exposure","TCGA-13-1481-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T07:32:41.000Z","2014-03-22T08:05:02.000Z","EB6B3F6F-51C7-43D2-9FEF-0EC086D88AF2","D0021CBE-9F70-47CF-A8AE-F9E07C55F73E","Unaligned reads",16667238400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","761F9668-304F-4E22-87CD-2005AA86152C","Canada's Michael Smith Genome Sciences Centre","564a3778e4b0ef1218192e93","C5355491-E1E8-46A4-A05E-BAFCAF2E7459","Ovarian Serous Cystadenocarcinoma","TAR","87AD06A7-57F5-4482-9EBE-570DAE0D8CBC","2014-03-22T08:05:02.000Z","F0C6207F-1155-46CB-BA0A-1B0050D4D2F9","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"87AD06A7-57F5-4482-9EBE-570DAE0D8CBC",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8b7b0f6e-4f3b-40f2-8ca0-7de1000f473a.txt",NA,"TCGA-13-1481-01A",1.4,"F88E48AF-F598-4236-BF59-A343851C2D7C","TCGA",2000,NA,NA,"TUMOR FREE","D6CE390E-A2FB-4C17-93A2-37EC91C40956",76,"THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_E09_455254.hg19.seg.txt","Dead",2648,"TCGA-13-1481","NOT HISPANIC OR LATINO","AD6484B6-FB62-4FFE-A5F7-0728B7654D8E",NA,2648,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,105,"E7704255-BD11-4C56-B13C-A5B18DC1F315","53DDFF8C-2BDE-4727-8EA9-AF9706BFD255","TCGA-13-1481-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-13-1481-01A-01",70,0,10,60,40,"BOTTOM",0,30,"TCGA-13-1481-01A-01-BS1",60,"Paciltaxel","Chemotherapy","TCGA-13-1481-D24844",NA,NA,NA,NA,NA,2648,"TUMOR FREE","Dead",2648,"TCGA-13-1481-F24843","TCGA-13-1481",NA,"13","1481","YES","C56.9","8441/3","C56.9",NA,NA,-27898,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",2648,2648,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,76,2000,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
137711558,134732298,9971909619,"2B22B4B7-8A39-435C-BE3B-86FA84C8F941.bw","c6ede8ae-881c-47a0-a0ef-745ed4b7764a","2b22b4b7-8a39-435c-be3b-86fa84c8f941","2016-08-19T14:04:20.119853-05:00","TCGA-23-1026-01B-01R-1569-13_rnaseq_fastq.tar","26398f85-c29e-4a55-9bd7-2f5805df5f1e",8662190080,"Illumina HiSeq","15e3dc2402eb9ddee2309e56087f7bc6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:15:54.518190-05:00","2016-05-03T11:41:05.740436-05:00","26398f85-c29e-4a55-9bd7-2f5805df5f1e_analysis.xml","5ebbe4f10987702845e8067b71f2296b","41adffde-7411-45f0-a66f-27c65bba2f77",2181,"2016-09-29T20:37:02.276508-05:00","26398f85-c29e-4a55-9bd7-2f5805df5f1e_experiment.xml","410eb80e81ae2fe2305acf55cdd9ab2e","73a25702-b346-472e-990b-bd7a6cddd4ac",3916,"2016-09-29T21:34:58.404453-05:00","26398f85-c29e-4a55-9bd7-2f5805df5f1e_run.xml","3cbca025403d1b21584251f94ade7b5b","97b8f169-477b-4f6e-be55-cfebe6b1ddcd",1988,"2016-09-08T12:50:25.466429-05:00","TCGA-23-1026","2016-09-02T19:06:03.802967-05:00","female","TCGA-23-1026_demographic",1959,"white","c1602427-bdf1-51ea-b682-09a7e2a740c1","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1026_diagnosis","not reported",16442,"alive","8441/3",NA,816,"0a5bc544-d5cc-57d6-85e2-fd38deb2fccb","c56.9",-16442,"TCGA-23-1026_treatment","abcd3aa9-29eb-52a2-a30b-9378a2110059","01",NA,"TCGA-23-1026-01B","0.7","30d07f1e-0899-4d8f-9bd9-abe572affc8c",FALSE,"E41E1018-422B-4B4A-8732-C9389847830D","Primary Tumor","0.4",NA,NA,"0.8",1227657600,"01",107,"TCGA-23-1026-01B-01",80,80,NA,NA,0,0,NA,NA,"2016-09-08T12:50:25.466429-05:00","2016-09-08T12:50:25.466429-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"6d8886c6-37c0-4fd8-b847-b5b40d84742f","6f43fabb-d511-4b5f-bd09-37d885a34ddd","TCGA-23-1026-01B-01-TS1","TCGA-23-1026-01B-01-BS1",NA,NA,"093e7505-61c6-4e9a-8477-0502a772efa8","RNA","TCGA-23-1026-01B-01R","99f7299e-9a2f-45c7-8757-819b4142e54f",1.8,0.16,"UV Spec","R","22","TCGA-23-1026-01B-01R-1569-13","973907c7-f259-4d1a-b9df-68db1837af91",0.16,NA,NA,NA,NA,"766ab0bd-a20b-598b-b596-4daa9f5bf337","TCGA-23-1026_exposure","TCGA-23-1026-01B-01R-1569-13_rnaseq_fastq.tar","2014-03-27T02:41:20.000Z","2014-03-27T03:03:01.000Z","26398F85-C29E-4A55-9BD7-2F5805DF5F1E","30D07F1E-0899-4D8F-9BD9-ABE572AFFC8C","Unaligned reads",8662190080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","973907C7-F259-4D1A-B9DF-68DB1837AF91","Canada's Michael Smith Genome Sciences Centre","564a4033e4b0298dd2c9f2ce","C6EDE8AE-881C-47A0-A0EF-745ED4B7764A","Ovarian Serous Cystadenocarcinoma","TAR","093E7505-61C6-4E9A-8477-0502A772EFA8","2014-03-27T03:03:01.000Z","99F7299E-9A2F-45C7-8757-819B4142E54F","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"093E7505-61C6-4E9A-8477-0502A772EFA8",0.7,"23","TCGA-23-1026-01B-01R-1569-13.hg19.mirna.quantification.txt",NA,"TCGA-23-1026-01B",0.8,"98ECA7C8-8F45-43B4-806F-193ABA7901B6","TCGA",2004,NA,NA,"WITH TUMOR","71099CD4-74FF-47F7-9630-399FDED57341",45,"nationwidechildrens.org_clinical.TCGA-23-1026.xml","Alive",NA,"TCGA-23-1026","NOT HISPANIC OR LATINO","ADC0C0F8-0F93-40AF-862A-F2EFC4DD6CF1",NA,816,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,107,"6F43FABB-D511-4B5F-BD09-37D885A34DDD","CD8E6A0C-B0AD-462B-B7B5-55D4B4445565","TCGA-23-1026-01B-01R-1569-13.hg19.isoform.quantification.txt","TCGA-23-1026-01B-01",80,0,NA,NA,NA,"TOP",5,NA,"TCGA-23-1026-01B-01-TS1",NA,"Carboplatin","Chemotherapy","TCGA-23-1026-D25611",NA,NA,NA,"TCGA-23-1026-F25610_NTE-2",NA,816,"WITH TUMOR","Alive",NA,"TCGA-23-1026-F25610","TCGA-23-1026",NA,"23","1026","YES","C56.9","8441/3","C56.9",NA,NA,-16442,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",816,NA,NA,NA,"WITH TUMOR","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,45,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
306736334,291271439,21535843849,"00844B35-C108-4AEC-A687-4A91A2F33E6D.bw","c73244fd-d486-439f-a94f-fb0bd4e9ac8f","00844b35-c108-4aec-a687-4a91a2f33e6d","2016-08-24T13:22:27.300565-05:00","TCGA-25-1324-01A-01R-1565-13_rnaseq_fastq.tar","d01992a5-c9d8-4520-af1c-8a7d39786b8c",20529285120,"Illumina HiSeq","da0d5690000d1e29233463e0e093d1bf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:21:34.098109-05:00","2016-05-03T11:40:21.669427-05:00","d01992a5-c9d8-4520-af1c-8a7d39786b8c_analysis.xml","b5d22a1b327c0a563fb811c1eec1d9a2","d9a132d1-6245-4d79-aabf-7fd09582a714",2181,"2016-08-13T03:36:54.494475-05:00","d01992a5-c9d8-4520-af1c-8a7d39786b8c_experiment.xml","b64e739f77a30d2193d720b0cb61dc42","63a588c0-4e00-4e77-89e1-e3832e3d600e",3916,"2016-09-29T22:37:21.533501-05:00","d01992a5-c9d8-4520-af1c-8a7d39786b8c_run.xml","97b9a685efed0d465b8a51996b16075a","be5081b1-f2b0-4b54-b479-ac16edbade7f",1989,"2016-09-08T13:18:11.548620-05:00","TCGA-25-1324","2016-09-02T19:11:56.356788-05:00","female","TCGA-25-1324_demographic",1927,"white","82f1207d-737a-5fa8-bd7e-a9555193d7ff","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1324_diagnosis","not reported",27090,"dead","8441/3",1035,1035,"bfdec51d-c323-5a52-8541-41131eef2710","c56.9",-27090,"TCGA-25-1324_treatment","a14514cb-922d-5a4e-9c43-0e9387795c08","01",NA,"TCGA-25-1324-01A","1","fedfb74c-a7cd-4900-bdcb-93bdbd095c89",FALSE,"53AE406F-E6E6-4137-A7B3-01DAFAEDE783","Primary Tumor","0.8",NA,NA,"1.5",1228435200,"01",116,"TCGA-25-1324-01A-01",97,95,NA,NA,0,0,10,10,"2016-09-08T13:18:11.548620-05:00","2016-09-08T13:18:11.548620-05:00",NA,20,NA,NA,"TOP","BOTTOM",0,0,"710c2bcd-c909-44b9-bea2-37f173bd3d73","ad12409a-7546-487b-894c-5b779a4be83c","TCGA-25-1324-01A-01-TS1","TCGA-25-1324-01A-01-BS1",90,90,"3f8e3c12-79ed-449f-8b31-81f949d94257","RNA","TCGA-25-1324-01A-01R","50f75747-d720-4991-9f27-edfdda215a37",1.8,0.15,"UV Spec","R","22","TCGA-25-1324-01A-01R-1565-13","790c6d79-9f7d-4e9a-89db-43b26fe16816",0.15,NA,NA,NA,NA,"c80cb9eb-3960-5bdc-9109-fb14e870bd6a","TCGA-25-1324_exposure","TCGA-25-1324-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T05:35:32.000Z","2014-03-22T06:15:01.000Z","D01992A5-C9D8-4520-AF1C-8A7D39786B8C","FEDFB74C-A7CD-4900-BDCB-93BDBD095C89","Unaligned reads",20529285120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","790C6D79-9F7D-4E9A-89DB-43B26FE16816","Canada's Michael Smith Genome Sciences Centre","564a5c33e4b0298dd2cc4447","C73244FD-D486-439F-A94F-FB0BD4E9AC8F","Ovarian Serous Cystadenocarcinoma","TAR","3F8E3C12-79ED-449F-8B31-81F949D94257","2014-03-22T06:15:01.000Z","50F75747-D720-4991-9F27-EDFDDA215A37","None","NO",1,0.8,"Primary Tumor","Mayo Clinic - Rochester",NA,"3F8E3C12-79ED-449F-8B31-81F949D94257",1,"25","US82800149_251911813069_S01_miRNA-v1_10_Apr08_1_3.txt",NA,"TCGA-25-1324-01A",1.5,"DB95BDBB-40B6-444B-B6C7-F8CFD3D260D7","TCGA",2001,NA,NA,NA,"FEDFB74C-A7CD-4900-BDCB-93BDBD095C89",74,"nationwidechildrens.org_clinical.TCGA-25-1324.xml","Dead",1035,"TCGA-25-1324","NOT HISPANIC OR LATINO","275C717D-977D-4A05-A58A-4B111387938A",NA,1035,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,116,"AD12409A-7546-487B-894C-5B779A4BE83C","D73F054C-60AA-4D80-8FFA-450311A542EA","bcgsc.ca.TCGA-25-1324-01A-01R-1565-13.hg19.bcgsc.ca.1.7.0.sv.fa","TCGA-25-1324-01A-01",97,0,NA,NA,10,"TOP",0,NA,"TCGA-25-1324-01A-01-TS1",90,"Carbo","Chemotherapy","TCGA-25-1324-D26687",NA,NA,NA,NA,NA,1035,NA,"Dead",1035,"TCGA-25-1324-F26685","TCGA-25-1324",NA,"25","1324","YES","C56.9","8441/3","C56.9",NA,NA,-27090,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1035,1035,NA,NA,NA,"NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,74,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
226419308,202523835,14848385526,"C221EE7A-6343-4B6D-B322-0A2C0F0B29AF.bw","c7cf6755-8856-435b-a443-174b22a25b07","c221ee7a-6343-4b6d-b322-0a2c0f0b29af","2016-08-09T14:43:05.689994-05:00","TCGA-OY-A56Q-01A-11R-A406-31_rnaseq_fastq.tar","28a4bd90-d313-406b-bdf2-32027b2bb650",14432911360,"Illumina HiSeq","acdb7a1ee59d9e1c7796aff6688ae2ef","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T18:58:38.159097-05:00","2016-06-22T11:19:32.361656-05:00","28a4bd90-d313-406b-bdf2-32027b2bb650_analysis.xml","682bbc9c69bf883d7f0dc104330495b4","36cdb578-ee87-48d8-99cb-89d55943f261",2183,"2016-09-29T22:03:44.672615-05:00","28a4bd90-d313-406b-bdf2-32027b2bb650_experiment.xml","56a9912f5a6feabe7c39c31dd6d338e5","a9a85ac4-03df-4492-84ca-042b84a8a2d3",3753,"2016-09-29T21:15:07.207672-05:00","28a4bd90-d313-406b-bdf2-32027b2bb650_run.xml","ce8c3a4c3ccaf944940ae827cd2e9992","8b84260e-7a23-43b1-a9ed-80681a741917",1807,"2016-09-08T12:03:36.586411-05:00","TCGA-OY-A56Q","2016-09-02T19:00:48.298038-05:00","female","TCGA-OY-A56Q_demographic",1934,"black or african american","d29528b8-bba5-5033-8fed-7dc94e0f4764","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","NCH","OY","722c892a-5131-509d-bfd1-17a1660e9054","University of North Carolina","not reported","c56.9","TCGA-OY-A56Q_diagnosis","not reported",28623,"alive","8441/3",NA,576,"e64f78a3-2512-50f4-8b0c-34493a440422","c56.9",-28623,"TCGA-OY-A56Q_treatment","af64e246-f0f8-51c9-8cc0-473354478c58","01","false","TCGA-OY-A56Q-01A",NA,"d5cad767-265f-480f-a3bf-185bd4a75d5e",FALSE,"3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D","Primary Tumor",NA,120,370,NA,1355184000,"11",30,"TCGA-OY-A56Q-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T12:03:36.586411-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"b98349c7-e9b1-4cab-917b-988a413d8371",NA,"TCGA-OY-A56Q-01A-01-TS1",NA,100,NA,"e98e7efa-66a3-412f-aefc-3a82b024e1c0","RNA","TCGA-OY-A56Q-01A-11R","61db4375-3cda-4a66-869b-74354279dfb3",1.93,0.15,"UV Spec","R","23","TCGA-OY-A56Q-01A-11R-A406-31","3a1867ff-7c1e-47c1-854f-90c0af4b2d03",0.15,NA,NA,NA,NA,"37b06693-d3f5-51d1-90dc-61863e4dcc8d","TCGA-OY-A56Q_exposure","TCGA-OY-A56Q-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T05:14:54.000Z","2015-02-07T06:50:53.000Z","28A4BD90-D313-406B-BDF2-32027B2BB650","D5CAD767-265F-480F-A3BF-185BD4A75D5E","Unaligned reads",14432911360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3A1867FF-7C1E-47C1-854F-90C0AF4B2D03","Canada's Michael Smith Genome Sciences Centre","564a5bdfe4b0ef12181e3f2b","C7CF6755-8856-435B-A443-174B22A25B07","Ovarian Serous Cystadenocarcinoma","TAR","E98E7EFA-66A3-412F-AEFC-3A82B024E1C0","2015-02-07T06:50:53.000Z","61DB4375-3CDA-4A66-869B-74354279DFB3","United States","NO",1,NA,"Primary Tumor","University of North Carolina",120,"E98E7EFA-66A3-412F-AEFC-3A82B024E1C0",NA,"OY","TCGA-OY-A56Q-01A-11R-A406-31_rnaseq_fastq.tar",370,"TCGA-OY-A56Q-01A",NA,"E86F10BA-0449-406C-ABBE-AF17416539F6","TCGA",2012,NA,"Complete Remission/Response","TUMOR FREE","38B25329-0B6E-485B-9063-8A8BAC4A8B62",78,"nationwidechildrens.org_clinical.TCGA-OY-A56Q.xml","Alive",NA,"TCGA-OY-A56Q","NOT HISPANIC OR LATINO","9F8F69EC-4966-4E34-B5EE-5D8956F18154","NO",190,"No","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIA",NA,NA,NA,"8441/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"B98349C7-E9B1-4CAB-917B-988A413D8371","DAD7CF47-3545-476C-B934-DD4C44FF7881","TCGA-OY-A56Q-01A-11R-A406-31_rnaseq_fastq.tar","TCGA-OY-A56Q-01A-11",85,0,0,1,0,"TOP",0,0,"TCGA-OY-A56Q-01A-01-TS1",100,"Taxol","Chemotherapy","TCGA-OY-A56Q-D40756",NA,NA,NA,NA,"NO",576,"TUMOR FREE","Alive",NA,"TCGA-OY-A56Q-F57585","TCGA-OY-A56Q",NA,"OY","A56Q","YES","C56.9","8441/3","C56.9","YES","NO",-28623,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",190,NA,NA,"YES","TUMOR FREE","YES",27,2,2013,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,78,2012,"Tumor resection",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Complete Remission/Response",NA,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
241739030,230644178,17003756458,"B28A6D56-7654-4829-BF1F-657C3C2C10D8.bw","c8acee1b-6854-409b-86ab-bf69dbe22ab6","b28a6d56-7654-4829-bf1f-657c3c2c10d8","2016-09-29T22:18:18.476423-05:00","TCGA-24-1426-01A-01R-1565-13_rnaseq_fastq.tar","f5963478-ea95-466e-9303-b8a4cefb96a0",15975198720,"Illumina HiSeq","1d2eef030b6f6418c279e0d6bbf9e4c1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:33:04.955632-05:00","2016-05-03T11:40:21.662944-05:00","f5963478-ea95-466e-9303-b8a4cefb96a0_analysis.xml","6cd9a3455e850f1f2cf0f15cdb934190","969a081c-c4ed-4d9c-a88a-ade0031b044c",2235,"2016-09-29T20:32:29.020697-05:00","f5963478-ea95-466e-9303-b8a4cefb96a0_experiment.xml","9ffff8b840786c2c1389d48894a32a45","70da25d7-f9f8-41a9-ba96-85956e119472",3916,"2016-09-29T21:39:44.151016-05:00","f5963478-ea95-466e-9303-b8a4cefb96a0_run.xml","f724543664cf3993283ed8941a7132d9","9aa04a96-d7af-4727-820b-b0f4fb279e60",1989,"2016-09-08T13:21:47.475268-05:00","TCGA-24-1426","2016-09-02T19:13:50.166565-05:00","female","TCGA-24-1426_demographic",1965,"white","13753562-152d-554c-9562-f22a3fcf89f7","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1426_diagnosis","not reported",15949,"alive","8441/3",NA,163,"73d04d1d-d04a-5882-9b7c-26f5a22bf03e","c56.9",-15949,"TCGA-24-1426_treatment","4e62a9f2-3ff9-53b6-bc81-449ddbcee8a9","01",NA,"TCGA-24-1426-01A","0.4","4a4ec9eb-d594-449b-adfb-703ac1f25bb5",FALSE,"72914511-b2f7-484f-a7ab-3f4f1868f2cb","Primary Tumor","0.3",NA,NA,"1.2",1232409600,"01",90,"TCGA-24-1426-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:21:47.475268-05:00","2016-09-08T13:21:47.475268-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,0,"365230f5-c1b1-4124-9ba5-1b86ae87e12b","df3cb40f-130c-42db-886a-10e298f9a0ce","TCGA-24-1426-01A-01-TS1","TCGA-24-1426-01A-01-BS1",89,90,"38765edc-6bd6-49fb-b289-79d3cb35c679","RNA","TCGA-24-1426-01A-01R","026fa03c-22ae-4f0a-869a-fa3489c9473a",1.8,0.17,"UV Spec","R","22","TCGA-24-1426-01A-01R-1565-13","8cd9abeb-c09e-4281-a8c8-1b426796d51e",0.17,NA,NA,NA,NA,"2a888d25-0ddb-58b4-8192-cd164c6801a8","TCGA-24-1426_exposure","TCGA-24-1426-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-24T22:10:35.000Z","2014-03-24T22:58:01.000Z","F5963478-EA95-466E-9303-B8A4CEFB96A0","4A4EC9EB-D594-449B-ADFB-703AC1F25BB5","Unaligned reads",15975198720,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","8CD9ABEB-C09E-4281-A8C8-1B426796D51E","Canada's Michael Smith Genome Sciences Centre","564a5be8e4b08c5d86954d1d","C8ACEE1B-6854-409B-86AB-BF69DBE22AB6","Ovarian Serous Cystadenocarcinoma","TAR","38765EDC-6BD6-49FB-B289-79D3CB35C679","2014-03-24T22:58:01.000Z","026FA03C-22AE-4F0A-869A-FA3489C9473A","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"38765EDC-6BD6-49FB-B289-79D3CB35C679",0.4,"24","TCGA-24-1426-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai",NA,"TCGA-24-1426-01A",1.2,"CCAD2740-E09B-4453-8196-CA0BBA953C68","TCGA",2008,NA,NA,"TUMOR FREE","D0C936DC-7E89-47C4-81DF-3FC37C4A268D",43,"nationwidechildrens.org_clinical.TCGA-24-1426.xml","Alive",NA,"TCGA-24-1426",NA,"DCC9DD22-4227-46A6-B054-4B094B5F6718",NA,163,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,90,"DF3CB40F-130C-42DB-886A-10E298F9A0CE","BD22B4AE-BB7E-42FD-B03E-D1FEFBF81BEF","TCGA-24-1426-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai","TCGA-24-1426-01A-01",90,0,NA,NA,10,"TOP",1,NA,"TCGA-24-1426-01A-01-TS1",89,"Cisplatin","Chemotherapy","TCGA-24-1426-D25953",NA,NA,NA,NA,NA,163,"TUMOR FREE","Alive",NA,"TCGA-24-1426-F25951","TCGA-24-1426",NA,"24","1426","YES","C56.9","8441/3","C56.9",NA,NA,-15949,"FEMALE","WHITE",NA,NA,"No","Alive",163,NA,NA,NA,"TUMOR FREE","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,43,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
199122768,194569416,14393641890,"F4C7BCEC-3CD4-4D9A-89EA-0ED58EA0DCFE.bw","c9226204-cb61-40b8-8a94-a7e71c14ea3a","f4c7bcec-3cd4-4d9a-89ea-0ed58ea0dcfe","2016-09-30T00:05:17.133930-05:00","TCGA-24-2036-01A-01R-1568-13_rnaseq_fastq.tar","e9184913-b7bf-43ca-a62c-78215648c021",12201789440,"Illumina HiSeq","808d0edcf3700d301d7fa6c0cc60afbf","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:16:24.779245-05:00","2016-05-03T11:41:05.740436-05:00","e9184913-b7bf-43ca-a62c-78215648c021_analysis.xml","7868cc429b0dbbf45712e069ee0704d9","8c4e550a-ded5-404d-b59e-fe07fc08cdb7",2181,"2016-09-29T19:23:47.028950-05:00","e9184913-b7bf-43ca-a62c-78215648c021_experiment.xml","e7681f173bc80d39039e1b921528b294","46abd3c5-63bc-4a89-8201-dae4d8bcd1d9",3916,"2016-09-29T21:56:39.174195-05:00","e9184913-b7bf-43ca-a62c-78215648c021_run.xml","517870f55067e1058c9977ec84700e5d","a5488b5c-524c-44a8-8efa-f543c5c9b81a",1988,"2016-09-08T12:45:12.076003-05:00","TCGA-24-2036","2016-09-02T18:56:12.757971-05:00","female","TCGA-24-2036_demographic",1946,"white","8d1986bb-40dd-57cb-9ca9-33b4a9651882","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2036_diagnosis","not reported",18582,"dead","8441/3",1947,1947,"74e1f295-8a60-5d66-95ed-2dd395075e1e","c56.9",-18582,"TCGA-24-2036_treatment","1a9d9ad6-eb9a-544e-ae73-fe307f320b65","01",NA,"TCGA-24-2036-01A","0.8","389cd452-fcf0-498b-9e65-7e28dbe8d5a4",FALSE,"3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e","Primary Tumor","0.4",NA,NA,"1.1",1248134400,"01",104,"TCGA-24-2036-01A-01",80,90,0,0,0,0,10,0,"2016-09-08T12:45:12.076003-05:00","2016-09-08T12:45:12.076003-05:00",0,2,0,0,"TOP","BOTTOM",0,0,"a09a994b-2da2-4b47-a479-2ac663d0fa9f","b5e4a123-5f0d-459a-9ab3-7ba94d6f7244","TCGA-24-2036-01A-01-TS1","TCGA-24-2036-01A-01-BS1",90,100,"e818506a-8fd5-4dda-8349-19c409dc7dab","RNA","TCGA-24-2036-01A-01R","eb2d30d2-abe6-4b61-963d-363209c84dbb",1.8,0.13,"UV Spec","R","22","TCGA-24-2036-01A-01R-1568-13","788ade22-382b-49ca-b2b1-447a2072d0ea",0.13,NA,NA,NA,NA,"43a1336a-9ec8-5755-ac33-f3a95cd63615","TCGA-24-2036_exposure","TCGA-24-2036-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-26T23:36:58.000Z","2014-03-27T00:07:01.000Z","E9184913-B7BF-43CA-A62C-78215648C021","389CD452-FCF0-498B-9E65-7E28DBE8D5A4","Unaligned reads",12201789440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","788ADE22-382B-49CA-B2B1-447A2072D0EA","Canada's Michael Smith Genome Sciences Centre","564a5ac2e4b08c5d869505b9","C9226204-CB61-40B8-8A94-A7E71C14EA3A","Ovarian Serous Cystadenocarcinoma","TAR","E818506A-8FD5-4DDA-8349-19C409DC7DAB","2014-03-27T00:07:01.000Z","EB2D30D2-ABE6-4B61-963D-363209C84DBB","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"E818506A-8FD5-4DDA-8349-19C409DC7DAB",0.8,"24","TCGA-24-2036-01A-01R-1568-13_GRCh37-lite_rnaseq.bam",NA,"TCGA-24-2036-01A",1.1,"EE86ED68-4A7A-4351-91FD-30B88A37E9E1","TCGA",1996,NA,NA,"WITH TUMOR","389CD452-FCF0-498B-9E65-7E28DBE8D5A4",50,"nationwidechildrens.org_clinical.TCGA-24-2036.xml","Dead",1947,"TCGA-24-2036",NA,"18DF747D-B014-45A6-A225-5400D8AC2B53",NA,1947,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Other","Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,"0ACDC2D2-F778-4746-98DB-4A2989285077","WHITE",NA,1,104,"A09A994B-2DA2-4B47-A479-2AC663D0FA9F","EFF3FC4A-DA82-423C-BEE9-291BC0B73C9C","TCGA-24-2036-01A-01R-1568-13_mirna.bam.bai","TCGA-24-2036-01A-01",80,0,0,0,10,"TOP",0,0,"TCGA-24-2036-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-24-2036-D26508","TCGA-24-2036-R26516","EXTERNAL BEAM","Local Recurrence","TCGA-24-2036-F26505_NTE-2",NA,1947,"WITH TUMOR","Dead",1947,"TCGA-24-2036-F26505","TCGA-24-2036",NA,"24","2036","YES","C56.9","8441/3","C56.9",NA,NA,-18582,"FEMALE","WHITE",NA,NA,"No","Dead",1947,1947,NA,NA,"WITH TUMOR","NO",19,2,2010,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,50,1996,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
107496522,105298068,7777839448,"F06FBFAB-D143-47AE-BEE7-51B48164764F.bw","c9e28934-8379-4511-817c-d787f2c4ca3a","f06fbfab-d143-47ae-bee7-51b48164764f","2016-08-27T01:48:58.497954-05:00","TCGA-13-1487-01A-01R-1565-13_rnaseq_fastq.tar","579e383e-0cd5-4c87-9b69-5addeb3f5e11",6022860800,"Illumina HiSeq","038e53b7efd7e7a5365893f6964b6baa","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:30:14.358580-05:00","2016-05-03T11:40:21.647690-05:00","579e383e-0cd5-4c87-9b69-5addeb3f5e11_analysis.xml","bddb14129fe8d10d45d70f67572bc424","b9e453cd-fafe-4833-acd4-24b516911c95",2208,"2016-09-29T18:45:23.399581-05:00","579e383e-0cd5-4c87-9b69-5addeb3f5e11_experiment.xml","898572e5595d887118d6c608073f0b21","2e70c888-0974-4546-80fd-c1d4c10959b5",3916,"2016-09-30T00:06:28.283869-05:00","579e383e-0cd5-4c87-9b69-5addeb3f5e11_run.xml","2468e72a3d704f8c8d0b7419639ee3b9","f586f603-4567-4f0a-a5ab-e4f6638939d8",1989,"2016-09-09T16:39:52.119604-05:00","TCGA-13-1487","2016-09-02T19:13:52.506095-05:00","female","TCGA-13-1487_demographic",1928,"white","d660ec1a-93b8-5ce7-9a60-49c9ec945ce8","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1487_diagnosis","not reported",27176,"dead","8441/3",681,681,"f2bef3a1-e2c5-5c6f-8f16-e34d476c1a86","c56.9",-27176,"TCGA-13-1487_treatment","f3bec8f1-1367-5073-a080-dae1f9d758dd","01",NA,"TCGA-13-1487-01A","1","bff12f06-dabc-4424-ac53-65ca01d0a406",FALSE,"30C193A0-7AB5-445D-AD37-3661A89DC06A","Primary Tumor","0.4",NA,NA,"1.4",1234396800,"01",124,"TCGA-13-1487-01A-01",90,80,NA,NA,0,0,15,30,"2016-09-09T16:39:52.119604-05:00","2016-09-09T16:39:52.119604-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,0,"b14479d4-1994-4b5b-9d2e-ef20b92f57a5","a695ac28-7c81-420e-9940-f4cc99483200","TCGA-13-1487-01A-01-TS1","TCGA-13-1487-01A-01-BS1",80,70,"613060cd-276d-46a0-91ad-45588e7b225a","RNA","TCGA-13-1487-01A-01R","8f62af2a-0578-421b-817e-b8c798da6070",1.8,0.14,"UV Spec","R","22","TCGA-13-1487-01A-01R-1565-13","55704c3f-7261-4ab1-bb1e-d8957bfd8952",0.14,NA,NA,NA,NA,"a77fb142-9a0f-5817-aa6d-24f62640e2cf","TCGA-13-1487_exposure","TCGA-13-1487-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:34:29.000Z","2014-03-22T01:49:01.000Z","579E383E-0CD5-4C87-9B69-5ADDEB3F5E11","BFF12F06-DABC-4424-AC53-65CA01D0A406","Unaligned reads",6022860800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","55704C3F-7261-4AB1-BB1E-D8957BFD8952","Canada's Michael Smith Genome Sciences Centre","564a5b65e4b09c884b27a71c","C9E28934-8379-4511-817C-D787F2C4CA3A","Ovarian Serous Cystadenocarcinoma","TAR","613060CD-276D-46A0-91AD-45588E7B225A","2014-03-22T01:49:01.000Z","8F62AF2A-0578-421B-817E-B8C798DA6070","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"613060CD-276D-46A0-91AD-45588E7B225A",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f10389e0-3564-4067-b82a-d0be5d5eec92.txt",NA,"TCGA-13-1487-01A",1.4,"D30E9978-634D-4CB5-8263-C7E78D3A0BB7","TCGA",2002,NA,NA,"WITH TUMOR","D520E8B9-3742-4A18-B11E-36A20FFCCA3C",74,"MSK_252152914289_S01_CGH-v4_10_27Aug08__GCN_V3_A1__CBS_out.txt","Dead",681,"TCGA-13-1487","NOT HISPANIC OR LATINO","07B2D67B-3F42-45DB-8FC3-334FAD4CEAEE",NA,681,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,124,"A695AC28-7C81-420E-9940-F4CC99483200","8F62AF2A-0578-421B-817E-B8C798DA6070","TCGA-13-1487-01A-01R-1565-13_GRCh37-lite_rnaseq.bam","TCGA-13-1487-01A-01",80,0,NA,NA,30,"BOTTOM",0,NA,"TCGA-13-1487-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-13-1487-D24866",NA,NA,NA,"TCGA-13-1487-F24865_NTE-1",NA,681,"WITH TUMOR","Dead",681,"TCGA-13-1487-F24865","TCGA-13-1487",NA,"13","1487","YES","C56.9","8441/3","C56.9",NA,NA,-27176,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",681,681,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,74,2002,"Tumor resection",NA,NA,NA,"GX",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
398940128,372598450,27421987186,"525F522B-E865-4479-AE65-510903ABF46F.bw","c9e58844-9d61-44a2-aee6-1760bc19711b","525f522b-e865-4479-ae65-510903abf46f","2016-08-20T08:02:31.643527-05:00","TCGA-23-1027-01A-02R-1564-13_rnaseq_fastq.tar","3c5cbf1c-4167-4a0f-a48e-57c531ac35d1",26938982400,"Illumina HiSeq","1f49b006e9b52d3c6ae8b6a55e8b1da1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:33:22.329502-05:00","2016-05-03T11:39:34.522989-05:00","3c5cbf1c-4167-4a0f-a48e-57c531ac35d1_analysis.xml","0a4ca38961801e3bd1833c72afcf5076","bbd68552-7969-4984-b88b-72b267728c28",2181,"2016-10-07T15:43:16.653753-05:00","3c5cbf1c-4167-4a0f-a48e-57c531ac35d1_experiment.xml","a932e8d442d2243f032ae7691486eda2","d141452b-a312-4201-9467-bef512bcfb21",3916,"2016-09-29T21:27:05.428103-05:00","3c5cbf1c-4167-4a0f-a48e-57c531ac35d1_run.xml","4d1768e45fb8bcd49d4cbe8a38e162b3","92f7e18b-a99b-42c7-94da-ab805eb74fe7",1988,"2016-09-08T12:37:10.680039-05:00","TCGA-23-1027","2016-09-02T19:05:43.786948-05:00","female","TCGA-23-1027_demographic",1957,"white","de6818be-e2c7-5255-b1fa-d8444f500277","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1027_diagnosis","not reported",17588,"dead","8441/3",976,966,"ed60e55e-cdc8-51e1-9be4-00d4c65cb2ce","c56.9",-17588,"TCGA-23-1027_treatment","9f7b72b5-ce0c-5818-93bd-511e96f93728","01",NA,"TCGA-23-1027-01A","0.8","ddb8c0dd-c3df-4b78-850d-56b0644e12d7",FALSE,"568C3873-A64C-4D46-8001-EF3EC63750ED","Primary Tumor","0.4",NA,NA,"0.8",1233705600,"02",103,"TCGA-23-1027-01A-02",90,95,NA,NA,5,5,10,5,"2016-09-08T12:37:10.680039-05:00","2016-09-08T12:37:10.680039-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"08a84ac3-d0b4-4056-b4df-ef6fa85c9008","ae48dc7c-b645-4baf-8aa9-e4db50ad6c3d","TCGA-23-1027-01A-02-BS2","TCGA-23-1027-01A-01-BS1",85,90,"de198416-4775-4b8e-9d17-039f3e73632c","RNA","TCGA-23-1027-01A-02R","1e52a17b-7e25-45b9-81f4-6a874cb4b8c0",1.8,0.17,"UV Spec","R","22","TCGA-23-1027-01A-02R-1564-13","edbc81a6-2593-45c5-8131-3c4615d1807f",0.17,NA,NA,NA,NA,"e8ff0590-8d15-503c-8910-ee67b28e110a","TCGA-23-1027_exposure","TCGA-23-1027-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-19T23:00:32.000Z","2014-03-19T23:55:01.000Z","3C5CBF1C-4167-4A0F-A48E-57C531AC35D1","DDB8C0DD-C3DF-4B78-850D-56B0644E12D7","Unaligned reads",26938982400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EDBC81A6-2593-45C5-8131-3C4615D1807F","Canada's Michael Smith Genome Sciences Centre","564a395ee4b0ef121819cb4d","C9E58844-9D61-44A2-AEE6-1760BC19711B","Ovarian Serous Cystadenocarcinoma","TAR","DE198416-4775-4B8E-9D17-039F3E73632C","2014-03-19T23:55:01.000Z","1E52A17B-7E25-45B9-81F4-6A874CB4B8C0","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"DE198416-4775-4B8E-9D17-039F3E73632C",0.8,"23","bcgsc.ca.TCGA-23-1027-01A-02R-1564-13.hg19.bcgsc.ca.1.7.0.sv.vcf",NA,"TCGA-23-1027-01A",0.8,"BAE3A196-AD8B-4C6E-BAF3-CC6C49029A2F","TCGA",2005,NA,NA,NA,"DDB8C0DD-C3DF-4B78-850D-56B0644E12D7",48,"TCGA-23-1027-01A-02T-0438-07.probe.tcga_level2.data.txt","Dead",976,"TCGA-23-1027","NOT HISPANIC OR LATINO","517A109A-A6A8-4855-837C-B8D6A48412D3",NA,966,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,103,"AE48DC7C-B645-4BAF-8AA9-E4DB50AD6C3D","DA284C95-6CCF-4348-8672-47D486A87874","bcgsc.ca.TCGA-23-1027-01A-02R-1564-13.hg19.bcgsc.ca.1.7.0.sv.vcf","TCGA-23-1027-01A-02",95,5,NA,NA,5,"TOP",0,NA,"TCGA-23-1027-01A-01-BS1",90,"Docetaxel","Chemotherapy","TCGA-23-1027-D25620",NA,NA,NA,"TCGA-23-1027-F25616_NTE-1",NA,966,NA,"Dead",976,"TCGA-23-1027-F25616","TCGA-23-1027",NA,"23","1027","YES","C56.9","8441/3","C56.9",NA,NA,-17588,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",966,976,NA,NA,NA,"NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,48,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
293875968,284432843,21094726083,"F0CB60E3-C412-46A2-918F-8C5C099AB224.bw","cbc5b936-ead5-4858-ab90-e639402789b0","f0cb60e3-c412-46a2-918f-8c5c099ab224","2016-08-23T15:16:38.820753-05:00","TCGA-20-1685-01A-01R-1566-13_rnaseq_fastq.tar","ce179da1-aa38-4b4a-aa46-2e81a15d6f24",19666227200,"Illumina HiSeq","b49218643d0a232a8e60a7ccbcda8db9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:38:18.016082-05:00","2016-05-03T11:41:05.750744-05:00","ce179da1-aa38-4b4a-aa46-2e81a15d6f24_analysis.xml","f0b10038a664511c386994c0bf61f936","041a74e2-7603-451e-a9ef-dcb3a04813fa",2181,"2016-10-07T16:44:13.840142-05:00","ce179da1-aa38-4b4a-aa46-2e81a15d6f24_experiment.xml","67fe41d202fa630670abc6203e3427c6","cf74d496-2454-4786-87e5-f900687312da",3916,"2016-09-29T20:22:37.218317-05:00","ce179da1-aa38-4b4a-aa46-2e81a15d6f24_run.xml","98399a940f4fb4382ac8e3522e271f55","6addd6ca-f4c7-47f6-81a4-b8640a838a76",1989,"2016-09-08T12:19:29.545978-05:00","TCGA-20-1685","2016-09-02T19:07:44.519548-05:00","female","TCGA-20-1685_demographic",1963,"white","b30231af-aec0-558d-82d5-1c88bcf2176a","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-1685_diagnosis","not reported",16745,"alive","8441/3",NA,508,"bb3ebf3b-4ded-57a8-b64e-eea59df41b37","c56.9",-16745,"TCGA-20-1685_treatment","0e148de3-7555-5e71-a2c8-49923da30177","01",NA,"TCGA-20-1685-01A","0.7","90d6af06-579f-42a2-90f4-bf587e209d70",FALSE,"09b7c163-7ad3-42a2-bc06-32bd55f80327","Primary Tumor","0.3",NA,NA,"0.8",1242604800,"01",110,"TCGA-20-1685-01A-01",95,95,NA,NA,0,0,9,19,"2016-09-08T12:19:29.545978-05:00","2016-09-08T12:19:29.545978-05:00",1,1,NA,NA,"BOTTOM","TOP",1,1,"feed65e0-de49-4233-b948-05c1f13b9375","423bc4cc-37ea-493f-a7cd-67c67eebc4b6","TCGA-20-1685-01A-01-BS1","TCGA-20-1685-01A-01-TS1",90,80,"f0f33e98-9d0f-4f9e-9144-2a7b45861ffd","RNA","TCGA-20-1685-01A-01R","bf9c72b0-d6be-4d7c-97a4-721e6f36a54a",1.8,0.15,"UV Spec","R","22","TCGA-20-1685-01A-01R-1566-13","9f6dd4ad-0130-46fe-9c49-72f378a753fe",0.15,NA,NA,NA,NA,"6c62bc48-1acd-5527-b937-bf0ab48eff4f","TCGA-20-1685_exposure","TCGA-20-1685-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T17:48:58.000Z","2014-03-28T18:30:01.000Z","CE179DA1-AA38-4B4A-AA46-2E81A15D6F24","90D6AF06-579F-42A2-90F4-BF587E209D70","Unaligned reads",19666227200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9F6DD4AD-0130-46FE-9C49-72F378A753FE","Canada's Michael Smith Genome Sciences Centre","564a5a43e4b08c5d8694dba1","CBC5B936-EAD5-4858-AB90-E639402789B0","Ovarian Serous Cystadenocarcinoma","TAR","F0F33E98-9D0F-4F9E-9144-2A7B45861FFD","2014-03-28T18:30:02.000Z","BF9C72B0-D6BE-4D7C-97A4-721E6F36A54A","None","NO",1,0.3,"Primary Tumor","Fox Chase Cancer Center",NA,"F0F33E98-9D0F-4F9E-9144-2A7B45861FFD",0.7,"20","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b1b57151-ff27-4b55-bf89-6e25a61f1060.txt",NA,"TCGA-20-1685-01A",0.8,"61E2A648-EEDE-4DA8-98D8-B59DD2B3D85A","TCGA",2008,NA,NA,"TUMOR FREE","90D6AF06-579F-42A2-90F4-BF587E209D70",45,"TCGA-20-1685-01A-01R-1566-13_rnaseq.bam","Alive",NA,"TCGA-20-1685","NOT HISPANIC OR LATINO","F74F942B-3336-4EAB-B6F5-96EA2715A52E",NA,508,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,110,"FEED65E0-DE49-4233-B948-05C1F13B9375","DACB972B-5CEC-44CB-BC2F-6E14998343C5","TCGA-20-1685-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-20-1685-01A-01",95,0,NA,1,19,"TOP",1,NA,"TCGA-20-1685-01A-01-TS1",80,"Taxol","Chemotherapy","TCGA-20-1685-D25557",NA,NA,NA,NA,NA,508,"TUMOR FREE","Alive",NA,"TCGA-20-1685-F25554","TCGA-20-1685",NA,"20","1685","YES","C56.9","8441/3","C56.9",NA,NA,-16745,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",508,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
114577388,111991819,8277342773,"587F307F-6E1B-487E-8E47-A99AB43DC5B4.bw","cbc7f427-5f7b-4267-ad56-055d8880a4cc","587f307f-6e1b-487e-8e47-a99ab43dc5b4","2016-08-25T05:36:50.567560-05:00","TCGA-30-1866-01A-02R-1568-13_rnaseq_fastq.tar","257a9549-31bf-4c46-9641-744caeb2a70f",7166842880,"Illumina HiSeq","a3a685864eb08e1d2e1b544ee3221b19","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:02:36.221834-05:00","2016-05-03T11:41:05.755204-05:00","257a9549-31bf-4c46-9641-744caeb2a70f_analysis.xml","5cac69cddea8b3dfec6ba29b125957ed","a8f8cdea-6a6f-4e7e-a797-17fcaf9d14b7",2210,"2016-08-27T19:48:35.488208-05:00","257a9549-31bf-4c46-9641-744caeb2a70f_experiment.xml","c9543f02ad8e991f4d4d84017bac1437","0943c07e-2fe4-447b-b339-e3c57ecbc4fb",3916,"2016-09-29T20:27:34.384358-05:00","257a9549-31bf-4c46-9641-744caeb2a70f_run.xml","e02399107d0845e4abb82729e89f199e","6dee7e87-1823-4ebd-b785-2ae534292ded",1990,"2016-09-08T10:39:56.879515-05:00","TCGA-30-1866","2016-09-02T18:49:48.669483-05:00","female","TCGA-30-1866_demographic",1942,"white","279cd324-6a0b-5661-a9fa-20e52a631c31","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","30","304a93b9-960f-5dd3-99c3-7942824b3f0f","Harvard","not reported","c56.9","TCGA-30-1866_diagnosis","not reported",22562,"dead","8441/3",1114,1114,"85df57f5-3d3c-516c-8925-cfddbb62eedd","c56.9",-22562,"TCGA-30-1866_treatment","2e2ad35a-eda0-590a-a6f1-485f44ae5752","01",NA,"TCGA-30-1866-01A","0.8","887e9b15-4a8c-4950-8954-b9f6bff18bb1",FALSE,"bda3960c-1610-4bff-b60e-b9c8f3a4454a","Primary Tumor","0.4",NA,NA,"1.2",1245369600,"02",133,"TCGA-30-1866-01A-02",99,99,NA,NA,0,0,5,5,"2016-09-08T10:39:56.879515-05:00","2016-09-08T10:39:56.879515-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"9116a600-0030-448a-8405-827d06464235","c7539c9f-48aa-4af8-a182-233f4b6d3068","TCGA-30-1866-01A-01-BS1","TCGA-30-1866-01A-02-BS2",95,95,"30685af0-824e-4eea-aaca-c55443589b2f","RNA","TCGA-30-1866-01A-02R","e1fa0c1a-1313-479e-8f28-1a098e58575e",1.8,0.15,"UV Spec","R","22","TCGA-30-1866-01A-02R-1568-13","e2c174f6-eac3-449e-879c-9335ccf4ccd6",0.15,NA,NA,NA,NA,"5962b3b5-e3d6-5d49-bd27-6a1ee2ee63c5","TCGA-30-1866_exposure","TCGA-30-1866-01A-02R-1568-13_rnaseq_fastq.tar","2014-03-27T05:27:08.000Z","2014-03-27T05:42:02.000Z","257A9549-31BF-4C46-9641-744CAEB2A70F","887E9B15-4A8C-4950-8954-B9F6BFF18BB1","Unaligned reads",7166842880,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E2C174F6-EAC3-449E-879C-9335CCF4CCD6","Canada's Michael Smith Genome Sciences Centre","564a385fe4b09c884b236eb4","CBC7F427-5F7B-4267-AD56-055D8880A4CC","Ovarian Serous Cystadenocarcinoma","TAR","30685AF0-824E-4EEA-AACA-C55443589B2F","2014-03-27T05:42:02.000Z","E1FA0C1A-1313-479E-8F28-1A098E58575E","None","NO",1,0.4,"Primary Tumor","Harvard",NA,"30685AF0-824E-4EEA-AACA-C55443589B2F",0.8,"30","LOGIC_p_TCGA_B21_SNP_N_GenomeWideSNP_6_G03_518066.byallele.copynumber.data.txt",NA,"TCGA-30-1866-01A",1.2,"E9F71E7A-9032-4E6D-8906-57B4FA5F37B8","TCGA",2003,NA,NA,"WITH TUMOR","AB94FB79-B1B9-4950-A216-51150E60198D",61,"nationwidechildrens.org_clinical.TCGA-30-1866.xml","Dead",1114,"TCGA-30-1866","NOT HISPANIC OR LATINO","105FDC97-99C0-4FB1-AE9D-4361199BBFC9",NA,1114,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,2,133,"C7539C9F-48AA-4AF8-A182-233F4B6D3068","E1FA0C1A-1313-479E-8F28-1A098E58575E","TCGA-30-1866-01A-02R-1568-13_mirna.bam","TCGA-30-1866-01A-02",99,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-30-1866-01A-02-BS2",95,"Topotecan","Chemotherapy","TCGA-30-1866-D27601",NA,NA,NA,"TCGA-30-1866-F27595_NTE-2",NA,1114,"WITH TUMOR","Dead",1114,"TCGA-30-1866-F27595","TCGA-30-1866",NA,"30","1866","YES","C56.9","8441/3","C56.9",NA,NA,-22562,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1114,1114,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156647372,147800126,10840265023,"883D9145-8414-4571-A3E1-516F03452C46.bw","cbcf6922-a3c0-43a1-826e-642918b0a635","883d9145-8414-4571-a3e1-516f03452c46","2016-08-25T11:38:47.725438-05:00","TCGA-23-1030-01A-02R-1564-13_rnaseq_fastq.tar","2e5da31c-49be-4f87-a0f8-d59f96115e9c",9345740800,"Illumina HiSeq","a161c74edf2b4a14b573e51ba92b1cb8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:32:51.272771-05:00","2016-05-03T11:41:05.750744-05:00","2e5da31c-49be-4f87-a0f8-d59f96115e9c_analysis.xml","c49dbf233c923ef6a8e9c2065a1d1766","2652b936-9e33-40fb-ad30-4e5de3b817e4",2208,"2016-09-29T19:32:53.728972-05:00","2e5da31c-49be-4f87-a0f8-d59f96115e9c_experiment.xml","9eb8c61961fdc14859df84e978230146","4c5dd6d4-2b32-436e-8961-564030fa6d8d",3916,"2016-09-29T22:50:38.380204-05:00","2e5da31c-49be-4f87-a0f8-d59f96115e9c_run.xml","1d3c56181ddcb26fa1189f7d1a84a4cd","c693eaaf-9730-4b5b-a18a-8e8fcf40d550",1988,"2016-09-08T13:15:28.618311-05:00","TCGA-23-1030","2016-09-02T19:06:07.810935-05:00","female","TCGA-23-1030_demographic",1942,"white","e8dc4dd7-3263-5e49-bcf9-65c4e263a04f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1030_diagnosis","not reported",23416,"alive","8441/3",NA,886,"c428661a-76b6-5998-8f9e-3de1a5441bc1","c56.9",-23416,"TCGA-23-1030_treatment","595cde23-d937-59f1-b3f6-4237faf481bc","01",NA,"TCGA-23-1030-01A","0.8","b3716b9c-af9c-41cd-9ceb-f45fcda4a2d5",FALSE,"E44D825F-89EE-4FF7-B6D6-B0B17E305B2C","Primary Tumor","0.5",NA,NA,"1.5",1233705600,"02",52,"TCGA-23-1030-01A-02",95,95,NA,NA,5,5,0,5,"2016-09-08T13:15:28.618311-05:00","2016-09-08T13:15:28.618311-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,5,"d3ebeb41-5e90-4826-bda8-8a48f3669622","b0ce8e47-ce2c-430e-82d7-dbb75c3d373c","TCGA-23-1030-01A-01-BS1","TCGA-23-1030-01A-02-BS2",95,85,"a4b56e1a-ec0f-497e-aaee-d4615bd78f32","RNA","TCGA-23-1030-01A-02R","cbf5bc94-6673-4420-b0bd-ed89eac96e4f",1.8,0.17,"UV Spec","R","22","TCGA-23-1030-01A-02R-1564-13","0cdd0255-c7b2-4cbc-8306-37e74d295324",0.17,NA,NA,NA,NA,"4a09b799-e2b2-5082-b435-b1759a2b2c5e","TCGA-23-1030_exposure","TCGA-23-1030-01A-02R-1564-13_rnaseq_fastq.tar","2014-03-28T18:08:16.000Z","2014-03-28T18:31:02.000Z","2E5DA31C-49BE-4F87-A0F8-D59F96115E9C","B3716B9C-AF9C-41CD-9CEB-F45FCDA4A2D5","Unaligned reads",9345740800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0CDD0255-C7B2-4CBC-8306-37E74D295324","Canada's Michael Smith Genome Sciences Centre","564a565fe4b0ef12181c86fe","CBCF6922-A3C0-43A1-826E-642918B0A635","Ovarian Serous Cystadenocarcinoma","TAR","A4B56E1A-EC0F-497E-AAEE-D4615BD78F32","2014-03-28T18:31:02.000Z","CBF5BC94-6673-4420-B0BD-ED89EAC96E4F","None","NO",1,0.5,"Primary Tumor","Cedars Sinai",NA,"A4B56E1A-EC0F-497E-AAEE-D4615BD78F32",0.8,"23","C239.TCGA-23-1030-01A-02W.5.bam",NA,"TCGA-23-1030-01A",1.5,"D696489A-0CBD-49C2-A070-3D4161BAECC2","TCGA",2006,NA,NA,"TUMOR FREE","B3716B9C-AF9C-41CD-9CEB-F45FCDA4A2D5",64,"TCGA-23-1030-01A-02R-1564-13.hg19.mirna.quantification.txt","Alive",NA,"TCGA-23-1030","NOT HISPANIC OR LATINO","B97FDAD8-B975-4F01-A9AC-CBEDB5E7A9B6",NA,886,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,52,"B0CE8E47-CE2C-430E-82D7-DBB75C3D373C","E588B8B5-F0CE-4B4C-AC04-AB152CB9DAB2","C239.TCGA-23-1030-01A-02W.5.bam","TCGA-23-1030-01A-02",95,5,NA,NA,5,"BOTTOM",5,NA,"TCGA-23-1030-01A-02-BS2",85,"Carboplatin","Chemotherapy","TCGA-23-1030-D25645",NA,NA,NA,"TCGA-23-1030-F25643_NTE-2",NA,886,"TUMOR FREE","Alive",NA,"TCGA-23-1030-F25643","TCGA-23-1030",NA,"23","1030","YES","C56.9","8441/3","C56.9",NA,NA,-23416,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",886,NA,NA,NA,"TUMOR FREE","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,64,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
88853162,87738460,6493579638,"4A917271-7EA0-4F43-B474-7F5EA756EB05.bw","cbd87697-7708-4b69-9e50-9ee474feabe1","4a917271-7ea0-4f43-b474-7f5ea756eb05","2016-08-26T01:49:49.962845-05:00","TCGA-09-2054-01A-01R-1568-13_rnaseq_fastq.tar","bdd42ea4-2d58-4ad2-b2fb-786dd9b6cdc0",5181962240,"Illumina HiSeq","6b8499e8a5518583151418fb8b2c9a7a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:47:09.316856-05:00","2016-05-03T11:56:42.628342-05:00","bdd42ea4-2d58-4ad2-b2fb-786dd9b6cdc0_analysis.xml","a73ae68638cbb96858260ced1013432f","9f436b06-24af-461d-8210-e8ad7c004459",2181,"2016-08-13T06:01:25.458906-05:00","bdd42ea4-2d58-4ad2-b2fb-786dd9b6cdc0_experiment.xml","9e57c6f7082fbebd6ed59fb107477261","ef90a16a-111a-412b-9ba6-a595b028b0ae",3916,"2016-09-30T00:03:05.358670-05:00","bdd42ea4-2d58-4ad2-b2fb-786dd9b6cdc0_run.xml","9274eb636ef1bd930989aa56ce8f063c","f3879949-908c-4251-99ac-3c7ddfae50bd",1988,"2016-09-08T12:27:20.091570-05:00","TCGA-09-2054","2016-09-02T18:56:08.836142-05:00","female","TCGA-09-2054_demographic",1947,"black or african american","8be5e1f5-91eb-53cd-9cfe-8cc67176093b","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2054_diagnosis","not reported",21285,"dead","8441/3",637,637,"90364ee6-2b18-5172-a7f4-b50c4343e0f4","c56.9",-21285,"TCGA-09-2054_treatment","0d318cfb-b4dd-5b02-aac5-d0e3fe6aa09d","01",NA,"TCGA-09-2054-01A","0.8","e2a7621d-3c1d-4b7c-9494-0c02df363ecb",FALSE,"4f0eb2a1-996c-4816-a956-835ce5085438","Primary Tumor","0.4",NA,NA,"2",1248134400,"01",112,"TCGA-09-2054-01A-01",90,90,0,0,0,0,10,10,"2016-09-08T12:27:20.091570-05:00","2016-09-08T12:27:20.091570-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"ca88b75f-1c48-4cce-84e9-97e78412a275","e68f41e6-572a-40f8-9263-cfdd4fe62e8a","TCGA-09-2054-01A-01-TS1","TCGA-09-2054-01A-01-BS1",90,90,"c747b71f-bf22-4c46-810e-6ad17f1d5283","RNA","TCGA-09-2054-01A-01R","c82bb4a9-a0dd-43a8-a9b9-bf8a79795b8f",1.8,0.16,"UV Spec","R","22","TCGA-09-2054-01A-01R-1568-13","5cd7faa0-323a-4ea3-a658-859d0336e0ac",0.16,NA,NA,NA,NA,"652755bf-83bb-5dd2-be52-b44d306a657d","TCGA-09-2054_exposure","TCGA-09-2054-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T21:12:04.000Z","2014-08-28T21:57:23.000Z","BDD42EA4-2D58-4AD2-B2FB-786DD9B6CDC0","E2A7621D-3C1D-4B7C-9494-0C02DF363ECB","Unaligned reads",5181962240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5CD7FAA0-323A-4EA3-A658-859D0336E0AC","Canada's Michael Smith Genome Sciences Centre","564a5c7fe4b0ef12181e5720","CBD87697-7708-4B69-9E50-9EE474FEABE1","Ovarian Serous Cystadenocarcinoma","TAR","C747B71F-BF22-4C46-810E-6AD17F1D5283","2014-08-28T21:57:23.000Z","C82BB4A9-A0DD-43A8-A9B9-BF8A79795B8F","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"C747B71F-BF22-4C46-810E-6AD17F1D5283",0.8,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3b31fec3-6dd6-4ef7-bcb4-8c67007f6937.txt",NA,"TCGA-09-2054-01A",2,"D7D74C67-9D2C-43CE-8CCF-37EBB18B35FC","TCGA",2005,NA,NA,"WITH TUMOR","E2A7621D-3C1D-4B7C-9494-0C02DF363ECB",58,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3b31fec3-6dd6-4ef7-bcb4-8c67007f6937.txt","Dead",637,"TCGA-09-2054","NOT HISPANIC OR LATINO","2616C4A0-CEE6-4A82-941F-C30445131B82",NA,637,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,112,"CA88B75F-1C48-4CCE-84E9-97E78412A275","C82BB4A9-A0DD-43A8-A9B9-BF8A79795B8F","TCGA-09-2054-01A-01R-1568-13_rnaseq.bam.bai","TCGA-09-2054-01A-01",90,0,0,0,10,"TOP",0,0,"TCGA-09-2054-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-09-2054-D24390",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",637,"TCGA-09-2054-F24388","TCGA-09-2054",NA,"09","2054","YES","C56.9","8441/3","C56.9",NA,NA,-21285,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Dead",637,637,NA,NA,"WITH TUMOR","NO",2,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
197367382,192032685,14226176666,"BB33015D-218C-4A1E-8839-95837D6E9B88.bw","cbe3309e-9b7b-4f62-87b5-0f5ed4218ada","bb33015d-218c-4a1e-8839-95837d6e9b88","2016-08-22T08:44:26.087649-05:00","TCGA-25-1627-01A-01R-1566-13_rnaseq_fastq.tar","b75b15af-04b3-4420-a623-87513eb1ccc3",12892508160,"Illumina HiSeq","4b739861cc8e88ca1dd29c0088bda7ab","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:03:20.890155-05:00","2016-05-03T11:41:05.748550-05:00","b75b15af-04b3-4420-a623-87513eb1ccc3_analysis.xml","0bd94244039c57b86d154b0e61a2c069","141982e7-4243-482d-9810-f9ee46c5e662",2181,"2016-09-29T23:41:50.017290-05:00","b75b15af-04b3-4420-a623-87513eb1ccc3_experiment.xml","c2de777f6e20d2b86a2223ec15567281","e66355dc-ab16-4807-b684-345923a10ce0",3916,"2016-09-29T20:46:19.022161-05:00","b75b15af-04b3-4420-a623-87513eb1ccc3_run.xml","7119b08918032b8a07059e871b41c0cb","79728491-0c56-4e40-a16d-a60ab65a5f12",1989,"2016-09-09T16:41:59.743649-05:00","TCGA-25-1627","2016-09-02T18:48:50.882315-05:00","female","TCGA-25-1627_demographic",1930,"white","f17d6310-6505-5f0f-a62b-1a1f807f9e50","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1627_diagnosis","not reported",26784,"dead","8441/3",394,11,"b0bdaa93-0778-58a1-a5ab-dd9f0efa3171","c56.9",-26784,"TCGA-25-1627_treatment","7f8fd9a1-9d68-5d75-850b-b199877c0d1d","01",NA,"TCGA-25-1627-01A","1","c405e873-8ef5-43f6-8065-830fdb99825d",FALSE,"FB36B0F9-6519-4CF5-9A74-F7015FD405FF","Primary Tumor","0.3",NA,NA,"1.5",1237420800,"01",128,"TCGA-25-1627-01A-01",95,95,NA,NA,0,0,10,8,"2016-09-09T16:41:59.743649-05:00","2016-09-09T16:41:59.743649-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,2,"42532801-bad3-4503-8e89-c92084458b14","7d635326-16a2-4ed8-a60f-297b62e42fc0","TCGA-25-1627-01A-01-BS1","TCGA-25-1627-01A-01-TS1",90,90,"183422c9-24c3-46a8-a8d0-d93c86b042b9","RNA","TCGA-25-1627-01A-01R","6f75c8a2-1356-4980-9344-1a6a03f3aacd",1.8,0.15,"UV Spec","R","22","TCGA-25-1627-01A-01R-1566-13","0fc68715-c7fc-4481-a5bf-68a281f5ec64",0.15,NA,NA,NA,NA,"38235f2e-f005-56e8-8583-e22be02a1bf6","TCGA-25-1627_exposure","TCGA-25-1627-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T23:06:50.000Z","2014-03-28T23:45:01.000Z","B75B15AF-04B3-4420-A623-87513EB1CCC3","C405E873-8EF5-43F6-8065-830FDB99825D","Unaligned reads",12892508160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0FC68715-C7FC-4481-A5BF-68A281F5EC64","Canada's Michael Smith Genome Sciences Centre","564a57e9e4b0ef12181d0932","CBE3309E-9B7B-4F62-87B5-0F5ED4218ADA","Ovarian Serous Cystadenocarcinoma","TAR","183422C9-24C3-46A8-A8D0-D93C86B042B9","2014-03-28T23:45:01.000Z","6F75C8A2-1356-4980-9344-1A6A03F3AACD","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"183422C9-24C3-46A8-A8D0-D93C86B042B9",1,"25","TCGA-25-1627-01A-01R-1566-13.hg19.isoform.quantification.txt",NA,"TCGA-25-1627-01A",1.5,NA,"TCGA",2003,NA,NA,NA,"C405E873-8EF5-43F6-8065-830FDB99825D",73,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a2210172-a1e0-4bbf-a38a-363571251f90.txt","Dead",394,"TCGA-25-1627","NOT HISPANIC OR LATINO","20C8251E-9302-47D0-B9FA-9E915447BC3D",NA,11,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,128,"7D635326-16A2-4ED8-A60F-297B62E42FC0","757B27A4-C4C0-4619-82FB-31938CD99E51","TCGA-25-1627-01A-01W-0615-10_SOLiD.bam","TCGA-25-1627-01A-01",95,0,NA,NA,8,"TOP",2,NA,"TCGA-25-1627-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,11,NA,"Dead",394,"TCGA-25-1627-F26722","TCGA-25-1627",NA,"25","1627","YES","C56.9","8441/3","C56.9",NA,NA,-26784,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",11,394,NA,NA,NA,"NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
189592408,184655200,13675040429,"021CC81F-710D-4EEA-B1D8-012A81715ACC.bw","cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56","021cc81f-710d-4eea-b1d8-012a81715acc","2016-09-29T17:35:06.558187-05:00","TCGA-24-1469-01A-01R-1566-13_rnaseq_fastq.tar","887b3ca5-8c51-4487-a99a-6034b937ba99",12191129600,"Illumina HiSeq","23dab2de7ae16b2eaace5b37bc22bca8","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:42:56.981315-05:00","2016-05-03T11:39:34.528512-05:00","887b3ca5-8c51-4487-a99a-6034b937ba99_analysis.xml","c83696d5610506a33629a108ac235184","2ce40960-fed7-4169-a434-394b99f5777f",2181,"2016-09-30T00:05:09.622671-05:00","887b3ca5-8c51-4487-a99a-6034b937ba99_experiment.xml","9d9f8a8fea13b26476902504bdabd832","f4b00072-f1f6-4baa-b4c2-e7e96769d034",3916,"2016-09-29T20:53:53.919647-05:00","887b3ca5-8c51-4487-a99a-6034b937ba99_run.xml","20d8ce3a23048922847631d397d13e02","7e32ba77-370a-4022-8b6b-879871378b50",1988,"2016-09-08T12:11:49.233204-05:00","TCGA-24-1469","2016-09-02T19:07:12.417849-05:00","female","TCGA-24-1469_demographic",1937,"white","a68ea48a-8b0a-554f-a2a7-29d4474fe9e5","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1469_diagnosis","not reported",25937,"alive","8441/3",NA,277,"c35644a3-29fa-58ef-96eb-39833b3fd41f","c56.9",-25937,"TCGA-24-1469_treatment","a3e878cc-484a-5420-bdbf-c28781031d39","01",NA,"TCGA-24-1469-01A","0.7","389c632d-45cf-447e-9069-11b2fcb543f5",FALSE,"8f0b80d0-cf56-477c-898b-bb92934f64d4","Primary Tumor","0.3",NA,NA,"1.5",1234310400,"01",139,"TCGA-24-1469-01A-01",95,95,NA,NA,0,0,4,4,"2016-09-08T12:11:49.233204-05:00","2016-09-08T12:11:49.233204-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"6fc1655c-f6dc-440c-991f-999d34bec42b","9a49f54b-0127-4b14-a85e-269e6d785d26","TCGA-24-1469-01A-01-BS1","TCGA-24-1469-01A-01-TS1",95,95,"7857b385-0c41-4ce1-bcde-ad09dd087823","RNA","TCGA-24-1469-01A-01R","20567842-2a60-4508-843c-7fb1e8fcca43",1.8,0.15,"UV Spec","R","22","TCGA-24-1469-01A-01R-1566-13","7b6fe6e3-145b-46e6-884e-fcec23514674",0.15,NA,NA,NA,NA,"c66710dd-fbf8-502c-89a1-17bd5469fe58","TCGA-24-1469_exposure","TCGA-24-1469-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T07:09:07.000Z","2014-03-20T07:32:02.000Z","887B3CA5-8C51-4487-A99A-6034B937BA99","389C632D-45CF-447E-9069-11B2FCB543F5","Unaligned reads",12191129600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7B6FE6E3-145B-46E6-884E-FCEC23514674","Canada's Michael Smith Genome Sciences Centre","564a5a87e4b093830b6cb857","CD6E5D3D-1C86-40DD-9CB3-B2E2075DEC56","Ovarian Serous Cystadenocarcinoma","TAR","7857B385-0C41-4CE1-BCDE-AD09DD087823","2014-03-20T07:32:02.000Z","20567842-2A60-4508-843C-7FB1E8FCCA43","None","NO",1,0.3,"Primary Tumor","Washington University",NA,"7857B385-0C41-4CE1-BCDE-AD09DD087823",0.7,"24","TCGA-24-1469-01A-01R-1566-13.spljxn.quantification.txt",NA,"TCGA-24-1469-01A",1.5,"8B7E3C93-43CE-4A4C-88E0-EEBFE8E5373A","TCGA",2008,NA,NA,"TUMOR FREE","389C632D-45CF-447E-9069-11B2FCB543F5",71,"nationwidechildrens.org_biospecimen.TCGA-24-1469.xml","Alive",NA,"TCGA-24-1469",NA,"A5D9372B-C1CC-4361-84EE-E8D6DD21DCFB",NA,277,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,139,"9A49F54B-0127-4B14-A85E-269E6D785D26","910DD709-1735-4453-B3E4-0A89D7B398D7","TCGA-24-1469-01A-01R-1566-13_GRCh37-lite_rnaseq.bam.bai","TCGA-24-1469-01A-01",95,0,NA,NA,4,"BOTTOM",1,NA,"TCGA-24-1469-01A-01-BS1",95,"Taxol","Chemotherapy","TCGA-24-1469-D26062",NA,NA,NA,NA,NA,277,"TUMOR FREE","Alive",NA,"TCGA-24-1469-F26060","TCGA-24-1469",NA,"24","1469","YES","C56.9","8441/3","C56.9",NA,NA,-25937,"FEMALE","WHITE",NA,NA,"No","Alive",277,NA,NA,NA,"TUMOR FREE","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,71,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
178719844,169977027,12485889449,"B00C4925-47E3-4442-ABEB-82D714A26587.bw","cddce77f-21e6-4124-9f03-96fb5ca7cefa","b00c4925-47e3-4442-abeb-82d714a26587","2016-08-22T02:28:09.688565-05:00","TCGA-04-1648-01A-01R-1567-13_rnaseq_fastq.tar","d921307c-e69f-4a19-9954-68570098a4a4",10779822080,"Illumina HiSeq","3eb0648dad8cd3f3f3b82e4ef7e19eb7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:56:13.949813-05:00","2016-05-03T11:41:05.740763-05:00","d921307c-e69f-4a19-9954-68570098a4a4_analysis.xml","a9ff617e5958267eab2d0e683f6bf475","35520902-0ae5-4794-a6e4-e25e9c67b79a",2208,"2016-08-27T07:42:50.937121-05:00","d921307c-e69f-4a19-9954-68570098a4a4_experiment.xml","a0053428b864c301273a712e9d62f01c","6e006cdf-a047-4bba-b197-072b2e9d81f3",3916,"2016-09-29T19:07:04.110401-05:00","d921307c-e69f-4a19-9954-68570098a4a4_run.xml","1e3c14da3116468a757a6a16fcad072b","3c2a360f-54be-4ab2-abab-0399a028228c",1988,"2016-09-08T11:11:06.223851-05:00","TCGA-04-1648","2016-09-02T18:48:14.977679-05:00","female","TCGA-04-1648_demographic",1946,"white","bf5dd053-0971-5b16-9bd2-9ee9b821551d","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1648_diagnosis","not reported",21113,"dead","8441/3",871,NA,"258aa1d0-810d-53d9-8274-f290e2d22468","c56.9",-21113,"TCGA-04-1648_treatment","b7ec434e-46b6-5ab5-bc2c-91ed3f4eeb4e","01",NA,"TCGA-04-1648-01A","0.4","bc979254-2b16-43ab-ba8d-7670a3b4ab3a",FALSE,"B35F03FC-84CB-4468-9289-3DB91A6F913E","Primary Tumor","0.4",NA,NA,"1.2",1239235200,"01",118,"TCGA-04-1648-01A-01",80,90,NA,NA,0,0,10,0,"2016-09-08T11:11:06.223851-05:00","2016-09-08T11:11:06.223851-05:00",NA,NA,NA,NA,"BOTTOM","TOP",15,15,"6cecc6c4-6af7-4db1-85c1-e9f88751d7a3","c9581bd1-0449-4188-b93e-911c77a3f3ea","TCGA-04-1648-01A-01-BS1","TCGA-04-1648-01A-01-TS1",75,85,"31ddae1c-4d0f-4d3d-99f6-d78206757f53","RNA","TCGA-04-1648-01A-01R","221e48ca-0fa9-41cd-b68e-68e6da4a8d6a",1.8,0.15,"UV Spec","R","22","TCGA-04-1648-01A-01R-1567-13","9248aa41-9572-4b91-8e00-13aa0e3dce12",0.15,NA,NA,NA,NA,"5ad765c7-6f2e-5200-8f80-f878e3ed9294","TCGA-04-1648_exposure","TCGA-04-1648-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T22:14:56.000Z","2014-03-26T22:44:01.000Z","D921307C-E69F-4A19-9954-68570098A4A4","BC979254-2B16-43AB-BA8D-7670A3B4AB3A","Unaligned reads",10779822080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9248AA41-9572-4B91-8E00-13AA0E3DCE12","Canada's Michael Smith Genome Sciences Centre","564a5c2ce4b08c5d8695578d","CDDCE77F-21E6-4124-9F03-96FB5CA7CEFA","Ovarian Serous Cystadenocarcinoma","TAR","31DDAE1C-4D0F-4D3D-99F6-D78206757F53","2014-03-26T22:44:01.000Z","221E48CA-0FA9-41CD-B68E-68E6DA4A8D6A","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"31DDAE1C-4D0F-4D3D-99F6-D78206757F53",0.4,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f904c338-e425-42f1-a15e-b5eb2dcfe829.txt",NA,"TCGA-04-1648-01A",1.2,"D0BD5F53-352E-4300-B4C2-58609D888103","TCGA",2003,NA,NA,NA,"BC979254-2B16-43AB-BA8D-7670A3B4AB3A",57,"THING_p_TCGA_B19_SNP_N_GenomeWideSNP_6_C01_495184.birdseed.data.txt","Dead",871,"TCGA-04-1648",NA,"00200545-63D3-450E-82A8-E6EDC4048449",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,118,"C9581BD1-0449-4188-B93E-911C77A3F3EA","AD574002-1400-4214-A6F1-F257A9807252","TCGA-04-1648-01A-01R-1567-13_GRCh37-lite_mirna.bam.bai","TCGA-04-1648-01A-01",90,0,NA,NA,0,"TOP",15,NA,"TCGA-04-1648-01A-01-TS1",85,"Topotecan","Chemotherapy","TCGA-04-1648-D24164",NA,NA,NA,"TCGA-04-1648-F24159_NTE-1",NA,NA,NA,"Dead",871,"TCGA-04-1648-F24159","TCGA-04-1648",NA,"04","1648","YES","C56.9","8441/3","C56.9",NA,NA,-21113,"FEMALE","WHITE",NA,NA,"No","Dead",NA,871,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,57,2003,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
139494368,136351787,10086319916,"F79B27D3-0426-47BB-9756-7E0759246E5E.bw","ce871097-a6e9-4139-897e-642ee24ee123","f79b27d3-0426-47bb-9756-7e0759246e5e","2016-08-27T05:02:53.462451-05:00","TCGA-61-1919-01A-01R-1568-13_rnaseq_fastq.tar","596244e7-5be4-4fc1-acc0-29d582775489",8554127360,"Illumina HiSeq","8b427a8e6537055e95beac04f59ce21e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:34:53.287156-05:00","2016-05-03T11:41:05.740436-05:00","596244e7-5be4-4fc1-acc0-29d582775489_analysis.xml","891413cd8ed9afd6d6728636fb65a219","01fb8291-07c1-4e17-b7cc-b4e3657e58b3",2181,"2016-09-29T19:32:26.282277-05:00","596244e7-5be4-4fc1-acc0-29d582775489_experiment.xml","00c509ecad4a5e6baaba75f3b9ef72e8","4c0f59cf-fd85-42ff-94bb-4011a5709375",3916,"2016-09-29T22:23:39.424884-05:00","596244e7-5be4-4fc1-acc0-29d582775489_run.xml","6052d324d2929c045ae5870f56305767","b5bf3631-2a92-4ee3-af37-29c26331b115",1988,"2016-09-08T10:34:52.864188-05:00","TCGA-61-1919","2016-09-02T18:50:19.188246-05:00","female","TCGA-61-1919_demographic",1943,"white","23c0b61b-61e7-5f1e-8ed1-2e01f6ec1a56","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1919_diagnosis","not reported",21199,"dead","8441/3",1161,1161,"41c9c74c-e5f7-5f95-b067-21508c7d5999","c56.9",-21199,"TCGA-61-1919_treatment","03223c84-530f-518f-ad2f-990a1386e1b2","01",NA,"TCGA-61-1919-01A","0.8","207be628-ffc8-4eb6-88b3-1705a3ee2ab5",FALSE,"240a49a3-b611-4949-b3b9-3799d8c0dc46","Primary Tumor","0.4",NA,NA,"1.5",1246233600,"01",104,"TCGA-61-1919-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T10:34:52.864188-05:00","2016-09-08T10:34:52.864188-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,10,"6e069202-dc06-4418-bb6f-6f36113ce7b4","a2bfef73-10d7-4593-9c5b-4b93eddd160b","TCGA-61-1919-01A-01-BS1","TCGA-61-1919-01A-01-TS1",75,70,"2cdd6ba6-9589-485a-9272-bb6c02d16c6a","RNA","TCGA-61-1919-01A-01R","10f39a65-ccb0-419f-8885-15dce96cbc85",1.8,0.14,"UV Spec","R","22","TCGA-61-1919-01A-01R-1568-13","056cca38-92df-42ff-b064-b0c243f8a82f",0.14,NA,NA,NA,NA,"a6ac790d-e915-51c9-a97f-5237815da52b","TCGA-61-1919_exposure","TCGA-61-1919-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-26T23:57:11.000Z","2014-03-27T00:19:01.000Z","596244E7-5BE4-4FC1-ACC0-29D582775489","207BE628-FFC8-4EB6-88B3-1705A3EE2AB5","Unaligned reads",8554127360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","056CCA38-92DF-42FF-B064-B0C243F8A82F","Canada's Michael Smith Genome Sciences Centre","564a590ee4b0298dd2cb6348","CE871097-A6E9-4139-897E-642EE24EE123","Ovarian Serous Cystadenocarcinoma","TAR","2CDD6BA6-9589-485A-9272-BB6C02D16C6A","2014-03-27T00:19:01.000Z","10F39A65-CCB0-419F-8885-15DCE96CBC85","None","NO",1,0.4,"Primary Tumor","University of Pittsburgh",NA,"2CDD6BA6-9589-485A-9272-BB6C02D16C6A",0.8,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.278e1675-c8e6-4578-b83d-4cd82de93d4b.txt",NA,"TCGA-61-1919-01A",1.5,NA,"TCGA",2001,NA,NA,NA,"DEE0D3A7-7744-4174-9F86-2D0340CD7793",58,"nationwidechildrens.org_clinical.TCGA-61-1919.xml","Dead",1161,"TCGA-61-1919","NOT HISPANIC OR LATINO","32F30AA0-9C9E-4A94-8B29-558FB4A1029F",NA,1161,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,104,"A2BFEF73-10D7-4593-9C5B-4B93EDDD160B","D271A30C-41A8-4C65-A19D-B6E54E5A2957","TCGA-61-1919-01A-01W-0699-08_IlluminaGA-DNASeq_capture.bam","TCGA-61-1919-01A-01",80,0,NA,NA,20,"BOTTOM",5,NA,"TCGA-61-1919-01A-01-BS1",75,NA,NA,NA,NA,NA,NA,"TCGA-61-1919-F28300_NTE-2",NA,1161,NA,"Dead",1161,"TCGA-61-1919-F28300","TCGA-61-1919",NA,"61","1919","YES","C56.9","8441/3","C56.9",NA,NA,-21199,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1161,1161,NA,NA,NA,"NO",30,11,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,58,2001,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
284918270,276563683,20518874344,"1F179559-D93E-491C-B499-64F86C31DAE0.bw","ceb19678-b453-4529-b6cb-d02f9cb101b4","1f179559-d93e-491c-b499-64f86c31dae0","2016-08-25T06:16:51.122607-05:00","TCGA-24-1471-01A-01R-1566-13_rnaseq_fastq.tar","7ea2175e-b122-4288-802b-77045b6c755a",18774855680,"Illumina HiSeq","ab630c709953f04104571401e6edf2c6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:22:22.701668-05:00","2016-05-03T11:41:05.748550-05:00","7ea2175e-b122-4288-802b-77045b6c755a_analysis.xml","b1273ceb603a6e73a0053c90e2e598c7","da2a70c4-b787-4aa1-b206-23f4d45323ff",2210,"2016-08-28T22:28:13.184947-05:00","7ea2175e-b122-4288-802b-77045b6c755a_experiment.xml","7fba882892e701c42631459db811a727","16bd9dec-dc76-413b-bac8-4b137c3ce155",3916,"2016-09-29T20:02:41.146174-05:00","7ea2175e-b122-4288-802b-77045b6c755a_run.xml","1d57270206c3f3365117c05d72957aef","5ec292f7-41e0-4520-a400-c34ac39fcde1",1989,"2016-09-08T12:31:23.038666-05:00","TCGA-24-1471","2016-09-02T19:07:16.452737-05:00","female","TCGA-24-1471_demographic",1949,"white","2cc27fab-a108-5748-aefe-0bef861bc009","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1471_diagnosis","not reported",22081,"alive","8441/3",NA,36,"43f6535a-4e53-5545-8cb3-311a4901f939","c56.9",-22081,"TCGA-24-1471_treatment","fc984d64-8a86-5f39-ae93-f96f0a16b7c6","01",NA,"TCGA-24-1471-01A","1","43d7d5cf-e988-4b6b-925e-2b7bbd67e4fc",FALSE,"d20b8ed1-c74e-4ee8-9ae2-5512429810bc","Primary Tumor","0.5",NA,NA,"1.5",1234310400,"01",104,"TCGA-24-1471-01A-01",99,99,NA,NA,0,0,1,1,"2016-09-08T12:31:23.038666-05:00","2016-09-08T12:31:23.038666-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"ff50c1a3-4de7-4dd7-8188-025d1df618d0","5b870680-19ae-42ff-bbf5-2f0d82ca9caa","TCGA-24-1471-01A-01-TS1","TCGA-24-1471-01A-01-BS1",98,98,"7e3f1449-1c50-4790-b16e-e58d86e7e401","RNA","TCGA-24-1471-01A-01R","12c9315b-0088-4ec0-8937-5f0be78d60f8",1.8,0.15,"UV Spec","R","22","TCGA-24-1471-01A-01R-1566-13","a30e415d-8fe3-4d1d-b183-381ab431bb4a",0.15,NA,NA,NA,NA,"954a5ad9-25f5-569f-a86d-2eb2d558be7e","TCGA-24-1471_exposure","TCGA-24-1471-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-29T06:17:33.000Z","2014-03-29T06:52:01.000Z","7EA2175E-B122-4288-802B-77045B6C755A","43D7D5CF-E988-4B6B-925E-2B7BBD67E4FC","Unaligned reads",18774855680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","A30E415D-8FE3-4D1D-B183-381AB431BB4A","Canada's Michael Smith Genome Sciences Centre","564a37c5e4b09c884b233f80","CEB19678-B453-4529-B6CB-D02F9CB101B4","Ovarian Serous Cystadenocarcinoma","TAR","7E3F1449-1C50-4790-B16E-E58D86E7E401","2014-03-29T06:52:01.000Z","12C9315B-0088-4EC0-8937-5F0BE78D60F8","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"7E3F1449-1C50-4790-B16E-E58D86E7E401",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f9ddc125-66a3-4277-ac22-1b3b2acced36.txt",NA,"TCGA-24-1471-01A",1.5,"9214C29B-A67F-4762-9CA0-9297A0BAD8AC","TCGA",2009,NA,NA,NA,"ECCDABA6-8809-438E-9339-A44CD4136831",60,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f9ddc125-66a3-4277-ac22-1b3b2acced36.txt","Alive",NA,"TCGA-24-1471",NA,"4A48CA18-4453-402F-B1B1-F98C79A2793E",NA,36,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,104,"FF50C1A3-4DE7-4DD7-8188-025D1DF618D0","73044576-9D02-4E48-92F9-79E50DE23B12","US82800149_251976010648_S01_GE2-v5_10_Apr08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","TCGA-24-1471-01A-01",99,0,NA,NA,1,"TOP",1,NA,"TCGA-24-1471-01A-01-TS1",98,"GOG 218","Targeted Molecular therapy","TCGA-24-1471-D26071",NA,NA,NA,NA,NA,36,NA,"Alive",NA,"TCGA-24-1471-F26069","TCGA-24-1471",NA,"24","1471","YES","C56.9","8441/3","C56.9",NA,NA,-22081,"FEMALE","WHITE",NA,NA,"No","Alive",36,NA,NA,NA,NA,"NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,60,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
217258820,210240683,15501895171,"6F91B78B-BDEF-4357-B8F5-9478B1A1E1F4.bw","cf1e86ec-4bcb-403c-831b-d67bddef14eb","6f91b78b-bdef-4357-b8f5-9478b1a1e1f4","2016-08-25T15:35:44.813661-05:00","TCGA-24-1565-01A-01R-1566-13_rnaseq_fastq.tar","6636eccc-4af1-4dcd-8c55-1e878c1c4d5f",14098073600,"Illumina HiSeq","62ffeb9520c9b2ef5d52d95aa1dd8beb","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:12:05.512138-05:00","2016-05-03T11:40:21.662944-05:00","6636eccc-4af1-4dcd-8c55-1e878c1c4d5f_analysis.xml","c9d390ffae945c695d7406765f0acb25","3f494abd-82d9-46cf-8b09-d3d2ad8c6401",2235,"2016-09-29T20:19:26.460528-05:00","6636eccc-4af1-4dcd-8c55-1e878c1c4d5f_experiment.xml","8875550f945786532a2b37c806db0800","68dccb67-00b2-4004-9e51-55c224243167",3916,"2016-09-29T20:00:07.189769-05:00","6636eccc-4af1-4dcd-8c55-1e878c1c4d5f_run.xml","681085ce3659074c9a21cd18d2b5d095","5d34c4ad-dac4-4b60-aa2c-203edbed651e",1988,"2016-09-08T13:21:40.095154-05:00","TCGA-24-1565","2016-09-02T19:07:08.156668-05:00","female","TCGA-24-1565_demographic",1923,"white","ff23d451-c438-5f18-9951-f4adc6b0744f","not reported",1997,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1565_diagnosis","not reported",27048,"dead","8441/3",312,312,"e36db772-f900-5281-9362-18c0fa204e9a","c56.9",-27048,"TCGA-24-1565_treatment","461f56c9-ffc0-5212-a78d-f465658fd2ad","01",NA,"TCGA-24-1565-01A","0.7","6feb1257-da6f-4a70-bbd1-f3aa843ef72a",FALSE,"f424905e-3dc2-4e37-b6c4-8a77c7ce817b","Primary Tumor","0.4",NA,NA,"0.8",1235347200,"01",102,"TCGA-24-1565-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:21:40.095154-05:00","2016-09-08T13:21:40.095154-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"1dd6e7fb-cbd7-4da0-923d-d43435834cf0","2f178ae2-c7f7-444e-902a-212be3f0433d","TCGA-24-1565-01A-01-BS1","TCGA-24-1565-01A-01-TS1",95,95,"29e70280-67fb-4c83-a9b1-7a23815da44d","RNA","TCGA-24-1565-01A-01R","41bbfcb1-aa15-4cc5-8d98-be98c87f1ca2",1.8,0.15,"UV Spec","R","22","TCGA-24-1565-01A-01R-1566-13","0d80226b-8c70-44ab-a6d9-f054d89330f3",0.15,NA,NA,NA,NA,"b8936a1d-1971-58c9-842a-0f16463cda74","TCGA-24-1565_exposure","TCGA-24-1565-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-24T23:10:07.000Z","2014-03-24T23:40:02.000Z","6636ECCC-4AF1-4DCD-8C55-1E878C1C4D5F","6FEB1257-DA6F-4A70-BBD1-F3AA843EF72A","Unaligned reads",14098073600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0D80226B-8C70-44AB-A6D9-F054D89330F3","Canada's Michael Smith Genome Sciences Centre","564a3f5ee4b0ef12181bb4db","CF1E86EC-4BCB-403C-831B-D67BDDEF14EB","Ovarian Serous Cystadenocarcinoma","TAR","29E70280-67FB-4C83-A9B1-7A23815DA44D","2014-03-24T23:40:02.000Z","41BBFCB1-AA15-4CC5-8D98-BE98C87F1CA2","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"29E70280-67FB-4C83-A9B1-7A23815DA44D",0.7,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.bd856415-5235-4086-a72f-9d0a65b8867b.txt",NA,"TCGA-24-1565-01A",0.8,"F520E210-C6E9-48C9-BBFF-F257CB97BA74","TCGA",1997,NA,NA,"WITH TUMOR","6FEB1257-DA6F-4A70-BBD1-F3AA843EF72A",74,"US82800149_251911813093_S01_miRNA-v1_10_Apr08_2_2.txt","Dead",312,"TCGA-24-1565",NA,"213A13F2-5A06-4C77-BA1E-0A5FE7281956",NA,312,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,102,"2F178AE2-C7F7-444E-902A-212BE3F0433D","23BE3995-4FA0-48FF-AEF7-7E00DB45D62E","TCGA-24-1565-01A-01W-0551-08_IlluminaGA-DNASeq_capture.bam","TCGA-24-1565-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-24-1565-01A-01-TS1",95,"Cisplatin","Chemotherapy","TCGA-24-1565-D26276",NA,NA,NA,"TCGA-24-1565-F26274_NTE-1",NA,312,"WITH TUMOR","Dead",312,"TCGA-24-1565-F26274","TCGA-24-1565",NA,"24","1565","YES","C56.9","8441/3","C56.9",NA,NA,-27048,"FEMALE","WHITE",NA,NA,"No","Dead",312,312,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,74,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
242837202,235286862,17347932249,"059BA3BD-3DA8-4218-A00F-2C332882BBE9.bw","d0673efd-3315-4dd5-8ab6-912bfa07dceb","059ba3bd-3da8-4218-a00f-2c332882bbe9","2016-09-29T17:40:37.428605-05:00","TCGA-23-1022-01A-01R-1564-13_rnaseq_fastq.tar","2ee608c1-985c-41b1-8fa8-4fa02516aab6",14303877120,"Illumina HiSeq","e08f01fd780c8473f21682032da36d8e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:25:12.417798-05:00","2016-05-03T11:27:59.332723-05:00","2ee608c1-985c-41b1-8fa8-4fa02516aab6_analysis.xml","c53b9097cbd1eb16adf37122f5b6bf7c","478a774d-ee9a-414c-8c2c-0f20fe55cf7e",2210,"2016-10-07T17:38:44.947805-05:00","2ee608c1-985c-41b1-8fa8-4fa02516aab6_experiment.xml","fcd6b95fd438f558df5807fe95304357","6de5194c-b563-4121-bbc3-5e33b476409c",3916,"2016-09-29T20:35:18.783675-05:00","2ee608c1-985c-41b1-8fa8-4fa02516aab6_run.xml","55666b29265065a725bcb983089ee333","728d3a2a-6153-4cf2-b437-cf87995ead59",1990,"2016-09-08T12:20:56.722266-05:00","TCGA-23-1022","2016-09-02T19:05:49.524088-05:00","female","TCGA-23-1022_demographic",1936,"white","c4eab79f-a23b-5be3-abcc-b2e64f7626dc","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1022_diagnosis","not reported",24798,"dead","8441/3",1511,NA,"0cb11846-7903-535a-926e-9347464dcdd3","c56.9",-24798,"TCGA-23-1022_treatment","5eee8d7b-7f8d-591a-8674-7896ce4867ff","01",NA,"TCGA-23-1022-01A","0.7","65e5e0dc-01e3-43b1-80b5-09762432309e",FALSE,"1A674838-E992-4E9B-82AE-FAFA0AD3BF56","Primary Tumor","0.3",NA,NA,"0.7",1233705600,"01",96,"TCGA-23-1022-01A-01",90,90,NA,NA,5,5,5,5,"2016-09-08T12:20:56.722266-05:00","2016-09-08T12:20:56.722266-05:00",NA,NA,NA,NA,"TOP","TOP",0,0,"8e55f9a0-4044-4413-a4f8-e30004575fc3","b230a1dc-5e45-4d8a-9668-91a9e105d1a1","TCGA-23-1022-01A-01-TS1","TCGA-23-1022-01A-01-BS1",90,90,"08b67a5f-a236-467a-8150-6f138ed3d57c","RNA","TCGA-23-1022-01A-01R","11a8ea90-bd92-4f69-9d09-37367c0b95ef",1.8,0.15,"UV Spec","R","22","TCGA-23-1022-01A-01R-1564-13","2eeb258f-bbc2-4412-9673-cc39915da304",0.15,NA,NA,NA,NA,"aef251e9-49c9-5f8d-948b-7aef061f6b39","TCGA-23-1022_exposure","TCGA-23-1022-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T22:28:45.000Z","2013-12-20T22:59:02.000Z","2EE608C1-985C-41B1-8FA8-4FA02516AAB6","65E5E0DC-01E3-43B1-80B5-09762432309E","Unaligned reads",14303877120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2EEB258F-BBC2-4412-9673-CC39915DA304","Canada's Michael Smith Genome Sciences Centre","564a3f36e4b0298dd2c9a0b2","D0673EFD-3315-4DD5-8AB6-912BFA07DCEB","Ovarian Serous Cystadenocarcinoma","TAR","08B67A5F-A236-467A-8150-6F138ED3D57C","2013-12-20T22:59:02.000Z","11A8EA90-BD92-4F69-9D09-37367C0B95EF","None","NO",1,0.3,"Primary Tumor","Cedars Sinai",NA,"C89571E0-ADF6-4A96-A4E2-CDA029710D0A",0.7,"23","TCGA-23-1022-01A-01T-0438-07.gene.tcga_level3.data.txt",NA,"TCGA-23-1022-01A",0.7,"FB478BD8-7B3A-4AC6-8819-9D01950ECFE0","TCGA",2003,NA,NA,"WITH TUMOR","65E5E0DC-01E3-43B1-80B5-09762432309E",67,"nationwidechildrens.org_clinical.TCGA-23-1022.xml","Dead",1511,"TCGA-23-1022","NOT HISPANIC OR LATINO","B55A527B-1275-4988-9DD9-7451A0B6A70C",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,96,"B230A1DC-5E45-4D8A-9668-91A9E105D1A1","11A8EA90-BD92-4F69-9D09-37367C0B95EF","bcgsc.ca.TCGA-23-1022-01A-01R-1564-13.hg19.bcgsc.ca.1.7.0.sv.vcf","TCGA-23-1022-01A-01",90,5,NA,NA,5,"TOP",0,NA,"TCGA-23-1022-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-23-1022-D25580",NA,NA,NA,"TCGA-23-1022-F25576_NTE-1",NA,NA,"WITH TUMOR","Dead",1511,"TCGA-23-1022-F25576","TCGA-23-1022",NA,"23","1022","YES","C56.9","8441/3","C56.9",NA,NA,-24798,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1511,NA,NA,"WITH TUMOR","NO",20,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,67,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
381014232,344028851,25212245921,"09CF2A1C-878F-45BF-A98C-803056C89EAE.bw","d1976840-35f7-4423-8458-12fb32a52b33","09cf2a1c-878f-45bf-a98c-803056c89eae","2016-09-27T17:22:50.083139-05:00","TCGA-23-1032-01A-02R-1564-13_rnaseq_fastq.tar","2f7bbf75-780b-4e4c-8641-c4fa2429f520",25127270400,"Illumina HiSeq","4c067c54b71da3eb2a765c9832047c2e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:35:52.273603-05:00","2016-05-03T11:27:59.332723-05:00","2f7bbf75-780b-4e4c-8641-c4fa2429f520_analysis.xml","5f0b53746e29152214af2991e68a0df9","72e5e88f-57d7-4b1d-b309-3618db5b44c6",2210,"2016-09-29T17:47:22.986905-05:00","2f7bbf75-780b-4e4c-8641-c4fa2429f520_experiment.xml","d9453c78cf48079fc0af9a7ee4413d3e","0a02cd08-ea76-4812-955a-d03c5d598523",3916,"2016-09-29T18:38:08.051966-05:00","2f7bbf75-780b-4e4c-8641-c4fa2429f520_run.xml","3dcacc8c9e2b5d6809c155d8fe20e5a4","29cdf3ee-20b0-4fe6-aff2-889882288701",1990,"2016-09-08T13:13:52.779605-05:00","TCGA-23-1032","2016-09-02T19:05:53.452824-05:00","female","TCGA-23-1032_demographic",1929,"black or african american","11f19a38-9234-583d-bfa1-72d744906534","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1032_diagnosis","not reported",26715,"dead","8441/3",84,68,"ce95a788-c4a1-573a-bf27-259e0b06fc75","c56.9",-26715,"TCGA-23-1032_treatment","ed7d9fbd-a8bd-50cc-acf7-b81fc834bc92","01",NA,"TCGA-23-1032-01A","0.8","a155cdf0-597c-4ddd-a184-10a29ff428e1",FALSE,"6E8A5413-EB7E-49D8-8E11-8CA6A912ED50","Primary Tumor","0.6",NA,NA,"1",1233705600,"02",110,"TCGA-23-1032-01A-02",85,85,NA,NA,10,20,5,5,"2016-09-08T13:13:52.779605-05:00","2016-09-08T13:13:52.779605-05:00",NA,NA,NA,NA,"BOTTOM","TOP",15,0,"36642d6b-d7d7-427e-9663-4a81542c2daa","6511b494-143f-4a03-bb18-3a143e525ee1","TCGA-23-1032-01A-02-BS2","TCGA-23-1032-01A-01-BS1",70,75,"75fd52af-0550-46e1-a461-ba871a6e923d","RNA","TCGA-23-1032-01A-02R","b8b06a5a-57e6-4c2b-9de6-e4d7a34ed0a2",1.8,0.16,"UV Spec","R","22","TCGA-23-1032-01A-02R-1564-13","494182b5-dc71-4f11-add9-c29d2378768d",0.16,NA,NA,NA,NA,"6150dd41-917c-5e70-b9fd-60ff89e0e3e7","TCGA-23-1032_exposure","TCGA-23-1032-01A-02R-1564-13_rnaseq_fastq.tar","2013-12-20T08:43:40.000Z","2013-12-20T21:20:01.000Z","2F7BBF75-780B-4E4C-8641-C4FA2429F520","A155CDF0-597C-4DDD-A184-10A29FF428E1","Unaligned reads",25127270400,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","494182B5-DC71-4F11-ADD9-C29D2378768D","Canada's Michael Smith Genome Sciences Centre","564a5ba3e4b0ef12181e3639","D1976840-35F7-4423-8458-12FB32A52B33","Ovarian Serous Cystadenocarcinoma","TAR","75FD52AF-0550-46E1-A461-BA871A6E923D","2013-12-20T21:20:01.000Z","B8B06A5A-57E6-4C2B-9DE6-E4D7A34ED0A2","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"75FD52AF-0550-46E1-A461-BA871A6E923D",0.8,"23","TCGA-23-1032-01A-02R-1564-13_rnaseq.bam",NA,"TCGA-23-1032-01A",1,NA,"TCGA",2002,NA,NA,"WITH TUMOR","A155CDF0-597C-4DDD-A184-10A29FF428E1",73,"nationwidechildrens.org_clinical.TCGA-23-1032.xml","Dead",84,"TCGA-23-1032","NOT HISPANIC OR LATINO","22B559E9-5E92-444D-93CA-0D357461BD74",NA,68,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,2,110,"6511B494-143F-4A03-BB18-3A143E525EE1","B8B06A5A-57E6-4C2B-9DE6-E4D7A34ED0A2","TCGA-23-1032-01A-02R-1564-13_rnaseq.bam","TCGA-23-1032-01A-02",85,10,NA,NA,5,"BOTTOM",15,NA,"TCGA-23-1032-01A-02-BS2",70,NA,NA,NA,NA,NA,NA,NA,NA,68,"WITH TUMOR","Dead",84,"TCGA-23-1032-F25659","TCGA-23-1032",NA,"23","1032","YES","C56.9","8441/3","C56.9",NA,NA,-26715,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Dead",68,84,NA,NA,"WITH TUMOR","NO",23,2,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,73,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
303737256,291446472,21542040718,"D95632A2-EAC0-4CCE-BA3F-DC2BF563D344.bw","d1e974e7-dd68-40cc-ad06-2b57d964e5a1","d95632a2-eac0-4cce-ba3f-dc2bf563d344","2016-08-26T17:51:26.700396-05:00","TCGA-04-1337-01A-01R-1564-13_rnaseq_fastq.tar","5d9a5a67-3f51-4496-bdff-1f5964163f9e",19906396160,"Illumina HiSeq","5103d5267ae94102f6a11aba8c38dc6f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:34:59.968519-05:00","2016-05-03T11:39:34.522989-05:00","5d9a5a67-3f51-4496-bdff-1f5964163f9e_analysis.xml","84df63564ca4b3ed9adb36f5df7df7bb","bcd858a7-aeb9-410e-ae41-238e23a40d14",2208,"2016-09-29T19:37:41.327327-05:00","5d9a5a67-3f51-4496-bdff-1f5964163f9e_experiment.xml","0411ec99ec8e2fa8556506e3b4bdf97d","4f4a6225-c74f-4554-ab52-9fc650018741",3916,"2016-09-29T23:00:53.899688-05:00","5d9a5a67-3f51-4496-bdff-1f5964163f9e_run.xml","fe11cb931405d19e99f938d00883be43","ccc0d1a2-563a-431f-83c2-3797830b901e",1988,"2016-09-08T12:35:32.497086-05:00","TCGA-04-1337","2016-09-02T19:05:50.113266-05:00","female","TCGA-04-1337_demographic",1927,"white","955e097e-08f9-5ef5-8ca0-932e5d45ac9f","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1337_diagnosis","not reported",28626,"dead","8441/3",61,NA,"34aa5429-9d9e-5eea-bf66-26acfdbb8a96","c56.9",-28626,"TCGA-04-1337_treatment","e50538d0-06ca-523d-b631-9dbc3e96a5f7","01",NA,"TCGA-04-1337-01A","1","d8ab03a2-3dc9-433f-b9f3-644f0fb7313f",FALSE,"BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31","Primary Tumor","0.3",NA,NA,"1.2",1229644800,"01",69,"TCGA-04-1337-01A-01",84,82,NA,NA,0,0,50,21,"2016-09-08T12:35:32.497086-05:00","2016-09-08T12:35:32.497086-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"e91fb11f-2366-47ab-96f3-e92e78c85602","fcf8e211-01f7-4937-b0b1-7a18fd936c09","TCGA-04-1337-01A-01-BS1","TCGA-04-1337-01A-01-TS1",50,79,"69db0717-5c85-471d-ab29-80c1b1414d88","RNA","TCGA-04-1337-01A-01R","65a0436c-21f9-4d2a-aab7-aa00a849dfbd",1.8,0.16,"UV Spec","R","22","TCGA-04-1337-01A-01R-1564-13","42faaf19-95dd-426c-96d5-f3363c2e12ab",0.16,NA,NA,NA,NA,"cad55ea1-2fdd-5762-9aea-61fa28297cb8","TCGA-04-1337_exposure","TCGA-04-1337-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-19T23:48:15.000Z","2014-03-20T00:29:02.000Z","5D9A5A67-3F51-4496-BDFF-1F5964163F9E","D8AB03A2-3DC9-433F-B9F3-644F0FB7313F","Unaligned reads",19906396160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","42FAAF19-95DD-426C-96D5-F3363C2E12AB","Canada's Michael Smith Genome Sciences Centre","564a383ae4b08c5d8690810d","D1E974E7-DD68-40CC-AD06-2B57D964E5A1","Ovarian Serous Cystadenocarcinoma","TAR","69DB0717-5C85-471D-AB29-80C1B1414D88","2014-03-20T00:29:02.000Z","65A0436C-21F9-4D2A-AAB7-AA00A849DFBD","None","NO",1,0.3,"Primary Tumor","Gynecologic Oncology Group",NA,"69DB0717-5C85-471D-AB29-80C1B1414D88",1,"04","TCGA-04-1337-01A-01R-1564-13_GRCh37-lite_rnaseq.bam.bai",NA,"TCGA-04-1337-01A",1.2,NA,"TCGA",2005,NA,NA,"WITH TUMOR","D8AB03A2-3DC9-433F-B9F3-644F0FB7313F",78,"nationwidechildrens.org_clinical.TCGA-04-1337.xml","Dead",61,"TCGA-04-1337","NOT HISPANIC OR LATINO","08769910-7006-46F3-A58F-3C6A4C34BF1F",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,69,"FCF8E211-01F7-4937-B0B1-7A18FD936C09","B407F997-49FC-41A5-8C6A-153A78A061D4","TCGA-04-1337-01A-01R-1564-13_GRCh37-lite_rnaseq.bam.bai","TCGA-04-1337-01A-01",82,0,NA,NA,21,"TOP",0,NA,"TCGA-04-1337-01A-01-TS1",79,NA,NA,NA,NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",61,"TCGA-04-1337-F23931","TCGA-04-1337",NA,"04","1337","YES","C56.9","8441/3","C56.9",NA,NA,-28626,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,61,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,78,2005,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
222304670,213071094,15739783571,"E5783A36-AFAB-4A48-8724-5C7FFB6D8E51.bw","d2c0d320-d1c5-4eed-af4f-15540e60db0b","e5783a36-afab-4a48-8724-5c7ffb6d8e51","2016-09-29T23:40:25.051979-05:00","TCGA-23-1122-01A-01R-1565-13_rnaseq_fastq.tar","5346ebe2-a174-4e32-a041-89b7b99e8a3d",14513991680,"Illumina HiSeq","b3e8b364b7e96d75dcba471703743294","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:50:17.938628-05:00","2016-05-03T11:40:21.648680-05:00","5346ebe2-a174-4e32-a041-89b7b99e8a3d_analysis.xml","a88300c824384237d3198bf995fbf0c9","31853265-d6ce-45b3-a225-e5c6e8622c90",2181,"2016-10-07T17:56:46.378317-05:00","5346ebe2-a174-4e32-a041-89b7b99e8a3d_experiment.xml","ee3416ba7c17b7dd368f87a55ceddef1","50cb302d-d532-4883-b4e9-eb3873291c5a",3916,"2016-09-29T18:44:37.076187-05:00","5346ebe2-a174-4e32-a041-89b7b99e8a3d_run.xml","f3d574b75e973b851ee6e168f126699b","2df25a6f-00cf-4805-9609-5144d3c74677",1988,"2016-09-08T12:59:42.703338-05:00","TCGA-23-1122","2016-09-02T19:06:07.272758-05:00","female","TCGA-23-1122_demographic",1945,"white","35fba336-e795-5600-a892-a3899a3d9fe3","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1122_diagnosis","not reported",19537,"dead","8441/3",1189,NA,"0bf0b7d6-59fd-5d2e-b753-857c4b618889","c56.9",-19537,"TCGA-23-1122_treatment","9d7b0051-95b8-5e5f-850a-505f56d62842","01",NA,"TCGA-23-1122-01A","0.8","ff14c071-ccce-4d44-8d0b-c4cbdfb59c8c",FALSE,"9507d553-b1c7-4b71-90c1-064fd8ef15ba","Primary Tumor","0.5",NA,NA,"1.1",1227657600,"01",132,"TCGA-23-1122-01A-01",80,90,NA,NA,0,0,NA,NA,"2016-09-08T12:59:42.703338-05:00","2016-09-08T12:59:42.703338-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"e47c346e-2941-41b9-910b-713b18c0113d","3856005c-5450-450c-944e-a104156e84ec","TCGA-23-1122-01A-01-BS1","TCGA-23-1122-01A-01-TS1",NA,NA,"f355ea3d-0f49-45bc-b6fe-b1577194ca52","RNA","TCGA-23-1122-01A-01R","f346d7b7-c225-4b49-a7d0-5ebf1d8eb4fe",1.8,0.17,"UV Spec","R","22","TCGA-23-1122-01A-01R-1565-13","54b75801-ad36-49a1-b0c2-edc0053b897e",0.17,NA,NA,NA,NA,"8556d095-09eb-5e30-b9ca-a221adaa26c7","TCGA-23-1122_exposure","TCGA-23-1122-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:38:15.000Z","2014-03-21T23:04:02.000Z","5346EBE2-A174-4E32-A041-89B7B99E8A3D","FF14C071-CCCE-4D44-8D0B-C4CBDFB59C8C","Unaligned reads",14513991680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","54B75801-AD36-49A1-B0C2-EDC0053B897E","Canada's Michael Smith Genome Sciences Centre","564a3e44e4b0ef12181b5aa8","D2C0D320-D1C5-4EED-AF4F-15540E60DB0B","Ovarian Serous Cystadenocarcinoma","TAR","F355EA3D-0F49-45BC-B6FE-B1577194CA52","2014-03-21T23:04:02.000Z","F346D7B7-C225-4B49-A7D0-5EBF1D8EB4FE","None","NO",1,0.5,"Primary Tumor","Cedars Sinai",NA,"F355EA3D-0F49-45BC-B6FE-B1577194CA52",0.8,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2877f544-7459-4a43-9e89-a014008f6a58.txt",NA,"TCGA-23-1122-01A",1.1,"D4BBD55B-FC97-42F6-BB91-518B51AE30D0","TCGA",1998,NA,NA,"WITH TUMOR","FF14C071-CCCE-4D44-8D0B-C4CBDFB59C8C",53,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.2877f544-7459-4a43-9e89-a014008f6a58.txt","Dead",1189,"TCGA-23-1122",NA,"835873B9-9590-4AF3-B5AC-33688F902940",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,"BBCFCD21-0ECD-4B31-AFE0-3287CE3C3B97","WHITE",NA,1,132,"E47C346E-2941-41B9-910B-713B18C0113D","F346D7B7-C225-4B49-A7D0-5EBF1D8EB4FE","TCGA-23-1122-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai","TCGA-23-1122-01A-01",80,0,NA,NA,NA,"BOTTOM",1,NA,"TCGA-23-1122-01A-01-BS1",NA,"Carboplatin","Chemotherapy","TCGA-23-1122-D25725","TCGA-23-1122-R25731","EXTERNAL BEAM","Distant Recurrence","TCGA-23-1122-F25724_NTE-2",NA,NA,"WITH TUMOR","Dead",1189,"TCGA-23-1122-F25724","TCGA-23-1122",NA,"23","1122","YES","C56.9","8441/3","C56.9",NA,NA,-19537,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1189,NA,NA,"WITH TUMOR","NO",19,2,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,53,1998,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
183229270,177419486,13138639304,"ED9794C0-AC60-4B54-8214-D26714871BBF.bw","d3dd5e69-9752-4b50-9b1f-814afbc2c3dd","ed9794c0-ac60-4b54-8214-d26714871bbf","2016-08-27T01:08:18.587269-05:00","TCGA-29-1774-01A-01R-1567-13_rnaseq_fastq.tar","0c4bf26b-5a83-4cf0-904d-ef9a928e6cf8",10835097600,"Illumina HiSeq","2cf265060ed6ed46786b5b6d8532493d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:10:06.344223-05:00","2016-05-03T11:41:05.748550-05:00","0c4bf26b-5a83-4cf0-904d-ef9a928e6cf8_analysis.xml","ebf1f69a28f3d21cc266a7a6744cdb87","8861c784-833e-47fb-9f7c-9cf49134b911",2201,"2016-08-13T07:41:57.363373-05:00","0c4bf26b-5a83-4cf0-904d-ef9a928e6cf8_experiment.xml","f2d59437acfec9e7139736f8838a8489","223b7c94-7ad9-4b18-98a2-6fb004d89928",3916,"2016-09-29T19:56:23.838886-05:00","0c4bf26b-5a83-4cf0-904d-ef9a928e6cf8_run.xml","65f84c0271e5a20c4d95bc18e0c5c564","5af0e2c0-f489-48b6-90d0-20f690ac9990",1989,"2016-09-08T10:30:52.745563-05:00","TCGA-29-1774","2016-09-02T18:48:18.144760-05:00","female","TCGA-29-1774_demographic",1926,"white","1d15823e-4daa-5758-8481-cfa43f826e1e","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1774_diagnosis","not reported",29991,"alive","8441/3",NA,527,"dbf2bcbf-39a4-5c2a-8db3-883fffc89e0e","c56.9",-29991,"TCGA-29-1774_treatment","168ec590-d425-5f64-9493-68e3ea3df84d","01",NA,"TCGA-29-1774-01A","1","145c1cbf-1d36-4439-896b-afabfcc8d864",FALSE,"8d8dd2f0-09d8-42a2-84e0-4209e45e2330","Primary Tumor","1",NA,NA,"1.5",1243296000,"01",131,"TCGA-29-1774-01A-01",90,90,NA,NA,0,0,20,20,"2016-09-08T10:30:52.745563-05:00","2016-09-08T10:30:52.745563-05:00",NA,NA,NA,NA,"BOTTOM","TOP",2,2,"f02c7673-a415-40ac-8e84-3c7ca38b5188","fc56e04c-830f-4e84-ab7f-4a942bcfdfa6","TCGA-29-1774-01A-01-BS1","TCGA-29-1774-01A-01-TS1",78,78,"8e1092a0-c134-4d37-a4a3-bbd5a496f7f1","RNA","TCGA-29-1774-01A-01R","13aaa816-9883-4b1b-9b4d-41c561067491",1.8,0.16,"UV Spec","R","22","TCGA-29-1774-01A-01R-1567-13","bdb953e0-32fc-4f28-b40f-aa870a2bccb6",0.16,NA,NA,NA,NA,"7782c099-47bc-544e-bc6c-34e2fa102ced","TCGA-29-1774_exposure","TCGA-29-1774-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T02:59:20.000Z","2014-03-29T03:23:02.000Z","0C4BF26B-5A83-4CF0-904D-EF9A928E6CF8","145C1CBF-1D36-4439-896B-AFABFCC8D864","Unaligned reads",10835097600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","BDB953E0-32FC-4F28-B40F-AA870A2BCCB6","Canada's Michael Smith Genome Sciences Centre","564a3b59e4b0ef12181a6c45","D3DD5E69-9752-4B50-9B1F-814AFBC2C3DD","Ovarian Serous Cystadenocarcinoma","TAR","8E1092A0-C134-4D37-A4A3-BBD5A496F7F1","2014-03-29T03:23:02.000Z","13AAA816-9883-4B1B-9B4D-41C561067491","None","NO",1,1,"Primary Tumor","Duke",NA,"8E1092A0-C134-4D37-A4A3-BBD5A496F7F1",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.eed4cd8b-16bc-419f-8474-248270a93780.txt",NA,"TCGA-29-1774-01A",1.5,"C9297A2B-C8A3-47DF-A05F-0986A27F2382","TCGA",2008,NA,NA,"WITH TUMOR","145C1CBF-1D36-4439-896B-AFABFCC8D864",82,"nationwidechildrens.org_clinical.TCGA-29-1774.xml","Alive",NA,"TCGA-29-1774","NOT HISPANIC OR LATINO","19FA8C30-7468-4755-A242-B26569E255DA",NA,527,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",2,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"WHITE",NA,1,131,"F02C7673-A415-40AC-8E84-3C7CA38B5188","E6CA7850-71EE-4E85-929D-1E04B2B9F31C","LENOS_p_TCGA_Batch18and19_HT_HG-U133A_96-HTA_G03_491280.CEL","TCGA-29-1774-01A-01",90,0,NA,NA,20,"BOTTOM",2,NA,"TCGA-29-1774-01A-01-BS1",78,"Carboplatin","Chemotherapy","TCGA-29-1774-D27396",NA,NA,NA,"TCGA-29-1774-F27391_NTE-1",NA,527,"WITH TUMOR","Alive",NA,"TCGA-29-1774-F27391","TCGA-29-1774",NA,"29","1774","YES","C56.9","8441/3","C56.9",NA,NA,-29991,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",527,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,82,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA
174850404,169787757,12581296958,"032A168C-58E3-4DB4-9E64-9CA29682CDE4.bw","d73a0a33-e4e8-44bd-9580-2038ab06583a","032a168c-58e3-4db4-9e64-9ca29682cde4","2016-08-24T13:59:58.660550-05:00","TCGA-25-1313-01A-01R-1565-13_rnaseq_fastq.tar","351c95ee-3064-4d2a-9d02-7a6aad811ea5",10680453120,"Illumina HiSeq","b2b8dc68157652b7a7753abce28f9119","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:34:18.947054-05:00","2016-05-03T11:40:21.647690-05:00","351c95ee-3064-4d2a-9d02-7a6aad811ea5_analysis.xml","13e696b1c5433c0bf960f81c08dbf7ff","71eeadca-b404-441e-ae96-f8b1e0d7954b",2181,"2016-09-29T23:08:49.583269-05:00","351c95ee-3064-4d2a-9d02-7a6aad811ea5_experiment.xml","b0570b4f212a7df7b45e9929d5692034","d1dae0ea-98b4-4c14-8401-1cea23a7bd53",3916,"2016-09-29T19:37:05.479422-05:00","351c95ee-3064-4d2a-9d02-7a6aad811ea5_run.xml","a3001f8302b68c2845a0f94e865ebb4e","4eec7179-44fc-46e1-aaf3-b47dc2199575",1989,"2016-09-08T13:20:14.104497-05:00","TCGA-25-1313","2016-09-02T19:12:18.956290-05:00","female","TCGA-25-1313_demographic",1938,"white","eb34da9e-5cca-54f5-8a3b-7a4745c1edb5","not hispanic or latino",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1313_diagnosis","not reported",22982,"dead","8441/3",820,820,"1ad23243-90b7-58dd-a896-f3a3432ad5f2","c56.9",-22982,"TCGA-25-1313_treatment","e9515711-ffd8-53a5-b970-1a4ff3a601d2","01",NA,"TCGA-25-1313-01A","1.5","2e142ad3-0560-4e09-b5ce-ba9df578963d",FALSE,"3F5AAE21-3694-4AC2-8A18-4970090A08F4","Primary Tumor","1.5",NA,NA,"2",1228348800,"01",NA,"TCGA-25-1313-01A-01",90,90,NA,NA,0,0,20,30,"2016-09-08T13:20:14.104497-05:00","2016-09-08T13:20:14.104497-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"737ad7a3-621b-4690-aed5-2c8f6fe5a4e6","b3bd676b-4dfb-4ab3-9f96-5615490ade91","TCGA-25-1313-01A-01-BS1","TCGA-25-1313-01A-01-TS1",80,70,"d2d431ca-0540-4b87-a41d-52df315c3e01","RNA","TCGA-25-1313-01A-01R","0ee2ab6e-46c8-4927-9f8f-95b1a846f79b",1.8,0.16,"UV Spec","R","22","TCGA-25-1313-01A-01R-1565-13","ab99683f-6116-463d-8bf6-5782809d4729",0.16,NA,NA,NA,NA,"adbaa766-3c3d-53d2-ac34-cfd61a418eb8","TCGA-25-1313_exposure","TCGA-25-1313-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T03:56:49.000Z","2014-03-22T04:21:02.000Z","351C95EE-3064-4D2A-9D02-7A6AAD811EA5","2E142AD3-0560-4E09-B5CE-BA9DF578963D","Unaligned reads",10680453120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","AB99683F-6116-463D-8BF6-5782809D4729","Canada's Michael Smith Genome Sciences Centre","564a5a6fe4b0298dd2cbd84f","D73A0A33-E4E8-44BD-9580-2038AB06583A","Ovarian Serous Cystadenocarcinoma","TAR","D2D431CA-0540-4B87-A41D-52DF315C3E01","2014-03-22T04:21:02.000Z","0EE2AB6E-46C8-4927-9F8F-95B1A846F79B","None","NO",1,1.5,"Primary Tumor","Mayo Clinic - Rochester",NA,"D2D431CA-0540-4B87-A41D-52DF315C3E01",1.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.291a8a6a-23e2-42c9-a260-8696b9795cf2.txt",NA,"TCGA-25-1313-01A",2,"9A05FE1C-906F-4D7A-9F6E-1D0FF03B187B","TCGA",2000,NA,NA,"WITH TUMOR","38302E28-E137-4FF0-B441-6457B2E30316",62,"nationwidechildrens.org_clinical.TCGA-25-1313.xml","Dead",820,"TCGA-25-1313","NOT HISPANIC OR LATINO","61ADA3F9-4015-4673-AC92-E08E99FA05B8",NA,820,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,NA,"737AD7A3-621B-4690-AED5-2C8F6FE5A4E6","FA002436-9BA3-4450-BD97-4FA588A7E76B","C239.TCGA-25-1313-01A-01W.9.bam.bai","TCGA-25-1313-01A-01",90,0,NA,NA,30,"TOP",0,NA,"TCGA-25-1313-01A-01-TS1",70,"Topotecan","Chemotherapy","TCGA-25-1313-D26631",NA,NA,NA,"TCGA-25-1313-F26628_NTE-1",NA,820,"WITH TUMOR","Dead",820,"TCGA-25-1313-F26628","TCGA-25-1313",NA,"25","1313","YES","C56.9","8441/3","C56.9",NA,NA,-22982,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",820,820,NA,NA,"WITH TUMOR","NO",27,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
171584498,167599222,12427656369,"254A9134-7D3D-4A21-AADE-C5AC69AA6F9A.bw","d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06","254a9134-7d3d-4a21-aade-c5ac69aa6f9a","2016-08-25T08:13:47.072580-05:00","TCGA-24-1564-01A-01R-1566-13_rnaseq_fastq.tar","373818ab-ec5f-4760-9d5c-cbaa63ab258a",10641387520,"Illumina HiSeq","ca8fb5755b1f6a4cf1b0e77b68438a93","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:33:58.830651-05:00","2016-05-03T11:40:21.662944-05:00","373818ab-ec5f-4760-9d5c-cbaa63ab258a_analysis.xml","8b00250d6d2522522c91f93689f74b49","71b57596-d0ec-4e9f-900e-5ade7ed077cf",2181,"2016-08-26T12:48:30.997434-05:00","373818ab-ec5f-4760-9d5c-cbaa63ab258a_experiment.xml","69d87eb948163f70d4cd26bd551991d7","a8c5a320-e35d-4c1b-82d7-8c1a9e5f99c8",3916,"2016-09-29T20:26:27.812414-05:00","373818ab-ec5f-4760-9d5c-cbaa63ab258a_run.xml","6e524900f6711975958d30a9834c706e","6d4594df-d131-47bb-b688-d20a686ecae9",1988,"2016-09-08T12:16:22.434603-05:00","TCGA-24-1564","2016-09-02T19:07:13.853632-05:00","female","TCGA-24-1564_demographic",1930,"white","3a32c00c-98b2-5f28-ac70-dc47e5e99798","not reported",1999,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1564_diagnosis","not reported",24668,"dead","8441/3",787,787,"049c7bc3-3d4a-5872-8d4a-eaffbf8187f5","c56.9",-24668,"TCGA-24-1564_treatment","223471a9-7d76-54de-b753-01e84ad6be87","01",NA,"TCGA-24-1564-01A","1","e370c642-1d03-4f08-8bd4-1c99dae80679",FALSE,"fa1c8286-2e55-4137-93ae-c19d470ce2e4","Primary Tumor","0.4",NA,NA,"1.4",1235347200,"01",100,"TCGA-24-1564-01A-01",80,90,NA,NA,0,0,20,10,"2016-09-08T12:16:22.434603-05:00","2016-09-08T12:16:22.434603-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"3ba1355e-1542-4882-a805-8d4f1e6549bf","088997e0-aa7c-4e52-8f8c-0e69dba63da3","TCGA-24-1564-01A-01-TS1","TCGA-24-1564-01A-01-BS1",79,89,"5acd0aab-5698-4f4b-a576-0e5278c90ae1","RNA","TCGA-24-1564-01A-01R","bd2c985f-3edf-42fc-a478-0c7b9201e12a",1.8,0.16,"UV Spec","R","22","TCGA-24-1564-01A-01R-1566-13","03b8480f-d19e-43e4-8a09-f9230c525c1e",0.16,NA,NA,NA,NA,"2273a404-93e2-5dd2-8b5d-2202572e2e17","TCGA-24-1564_exposure","TCGA-24-1564-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T03:02:50.000Z","2014-03-25T03:27:02.000Z","373818AB-EC5F-4760-9D5C-CBAA63AB258A","E370C642-1D03-4F08-8BD4-1C99DAE80679","Unaligned reads",10641387520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","03B8480F-D19E-43E4-8A09-F9230C525C1E","Canada's Michael Smith Genome Sciences Centre","564a3e2be4b09c884b2532f2","D77EF9CF-F8E6-4EE9-8D4F-1106885F6B06","Ovarian Serous Cystadenocarcinoma","TAR","5ACD0AAB-5698-4F4B-A576-0E5278C90AE1","2014-03-25T03:27:02.000Z","BD2C985F-3EDF-42FC-A478-0C7B9201E12A","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"5ACD0AAB-5698-4F4B-A576-0E5278C90AE1",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b6e7fde5-418d-4848-a99e-6fc8c943bd7b.txt",NA,"TCGA-24-1564-01A",1.4,"F3A01CF8-D968-4223-82CC-BD63AA6E9E04","TCGA",1997,NA,NA,"WITH TUMOR","E370C642-1D03-4F08-8BD4-1C99DAE80679",67,"nationwidechildrens.org_clinical.TCGA-24-1564.xml","Dead",787,"TCGA-24-1564",NA,"69D2CD4F-E4AC-476B-A837-030181905BB8",NA,787,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,"931C1C42-9FBE-4F2D-91A9-89E79EC27FF5","WHITE",NA,1,100,"3BA1355E-1542-4882-A805-8D4F1E6549BF","3C13041C-EF21-4660-A324-C077917ABFEE","COOKY_p_TCGAb15_ICPp3_061909_GenomeWideSNP_6_A03_465968.CEL","TCGA-24-1564-01A-01",80,0,NA,NA,20,"TOP",1,NA,"TCGA-24-1564-01A-01-TS1",79,"Taxol","Chemotherapy","TCGA-24-1564-D26268","TCGA-24-1564-R26272","EXTERNAL BEAM","Primary Tumor Field","TCGA-24-1564-F26260_NTE-1",NA,787,"WITH TUMOR","Dead",787,"TCGA-24-1564-F26260","TCGA-24-1564",NA,"24","1564","YES","C56.9","8441/3","C56.9",NA,NA,-24668,"FEMALE","WHITE",NA,NA,"No","Dead",787,787,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
278021524,269278223,19926168923,"18D816AF-394A-482F-B22E-896A43B1E481.bw","d7925dfc-18ce-46ab-a47b-9d06eacc96d0","18d816af-394a-482f-b22e-896a43b1e481","2016-09-29T18:10:56.952248-05:00","TCGA-59-2354-01A-01R-1569-13_rnaseq_fastq.tar","64113e3a-184b-451a-a4c0-1910ac3551f6",18281656320,"Illumina HiSeq","1401837d1316c8bd970705ba33ac26af","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:22:47.033775-05:00","2016-05-03T11:56:42.628342-05:00","64113e3a-184b-451a-a4c0-1910ac3551f6_analysis.xml","4f97a1fe0b87b00396c46dc7008c30e6","9045926d-4c05-4ab4-b7f3-09783ad7a13f",2181,"2016-08-29T05:15:07.059446-05:00","64113e3a-184b-451a-a4c0-1910ac3551f6_experiment.xml","634b72b1bbb34b480bb9584109e6d8cb","90ec9c90-7062-403b-9407-7ed7f8f2a9c6",3916,"2016-09-29T21:14:12.786016-05:00","64113e3a-184b-451a-a4c0-1910ac3551f6_run.xml","6cf7dbc431ad9f47a772e10a0cdd53cd","8af4503a-08ed-4e39-9992-e892a865b092",1988,"2016-09-08T13:17:24.432778-05:00","TCGA-59-2354","2016-09-02T19:11:45.933994-05:00","female","TCGA-59-2354_demographic",1942,"white","87faef0a-06fb-53fa-b2e6-7ac6f4cb94c1","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2354_diagnosis","not reported",NA,"dead","8441/3",1046,NA,"d102e815-6af9-5d9f-b5ff-36b7b8730c4b","c56.9",NA,"TCGA-59-2354_treatment","dcbd83c4-6827-5b46-8f65-b68ba8d3b247","01",NA,"TCGA-59-2354-01A","1","7ce668a0-da92-4201-9f07-2c5b02df2c88",FALSE,"cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc","Primary Tumor","0.3",NA,NA,"2.4",1251763200,"01",144,"TCGA-59-2354-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:17:24.432778-05:00","2016-09-08T13:17:24.432778-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"660ad7d8-618f-4b6e-ab96-a070c05adcd9","f9f56cfd-8248-451e-96e1-c803113982fd","TCGA-59-2354-01A-01-BS1","TCGA-59-2354-01A-01-TS1",90,90,"b701256b-4e87-4c3c-bafa-79d4680fe331","RNA","TCGA-59-2354-01A-01R","4f7b1796-92b2-4881-bb35-cdf377f831df",1.8,0.14,"UV Spec","R","22","TCGA-59-2354-01A-01R-1569-13","33367eb6-4ca9-4daf-9e47-30a47a78e144",0.14,NA,NA,NA,NA,"234f9005-f201-5ecf-a5ac-6695a716898d","TCGA-59-2354_exposure","TCGA-59-2354-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-29T00:55:01.000Z","2014-08-29T03:29:23.000Z","64113E3A-184B-451A-A4C0-1910AC3551F6","7CE668A0-DA92-4201-9F07-2C5B02DF2C88","Unaligned reads",18281656320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","33367EB6-4CA9-4DAF-9E47-30A47A78E144","Canada's Michael Smith Genome Sciences Centre","564a5c86e4b093830b6d2a03","D7925DFC-18CE-46AB-A47B-9D06EACC96D0","Ovarian Serous Cystadenocarcinoma","TAR","B701256B-4E87-4C3C-BAFA-79D4680FE331","2014-08-29T03:29:23.000Z","4F7B1796-92B2-4881-BB35-CDF377F831DF","None","NO",1,0.3,"Primary Tumor","Roswell Park",NA,"B701256B-4E87-4C3C-BAFA-79D4680FE331",1,"59","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d80db939-9815-4d8b-8d3d-927a54355003.txt",NA,"TCGA-59-2354-01A",2.4,"EFD422E2-ED42-4926-AC5F-947CB1A6F888","TCGA",2005,NA,NA,"WITH TUMOR","7CE668A0-DA92-4201-9F07-2C5B02DF2C88",63,"TCGA-59-2354-01A-01R-1569-13_GRCh37-lite_mirna.bam.bai","Dead",1046,"TCGA-59-2354","NOT HISPANIC OR LATINO","43712126-05C8-4734-8834-CEEB5A6F0FFE",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,144,"F9F56CFD-8248-451E-96E1-C803113982FD","92527D58-DFA2-4B7B-BA47-4D212CDD24D4","1450.CEL","TCGA-59-2354-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-59-2354-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-59-2354-D28108",NA,NA,NA,"TCGA-59-2354-F28107_NTE-1",NA,NA,"WITH TUMOR","Dead",1046,"TCGA-59-2354-F28107","TCGA-59-2354",NA,"59","2354","YES","C56.9","8441/3","C56.9",NA,NA,NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1046,NA,NA,"WITH TUMOR","NO",29,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,63,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
198204108,193813857,14365014656,"001099D2-E6EA-46E9-AD6F-CD2E800BC6D8.bw","d7b3156d-672a-4a55-868d-9ca6a09fcb0f","001099d2-e6ea-46e9-ad6f-cd2e800bc6d8","2016-09-29T17:31:47.187598-05:00","TCGA-24-1474-01A-01R-1566-13_rnaseq_fastq.tar","43bf72bc-a942-4268-b41c-1481db9863a2",12515860480,"Illumina HiSeq","705c5e9ada14a7557799de8814668e1e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:27:55.305733-05:00","2016-05-03T11:40:21.647690-05:00","43bf72bc-a942-4268-b41c-1481db9863a2_analysis.xml","227f5b24fd84fd4985e4b0d04a5534be","6e288ae1-fc7a-44f9-b900-f7286843f17d",2181,"2016-09-29T21:37:41.971416-05:00","43bf72bc-a942-4268-b41c-1481db9863a2_experiment.xml","6ead9b04e10ed248048e0f6613bc7574","996e8281-5446-4f5e-82b0-bb20e6a2307b",3916,"2016-09-29T23:02:57.478974-05:00","43bf72bc-a942-4268-b41c-1481db9863a2_run.xml","0d96795f7397e9f8e832e56e4c14091e","ce171303-ce13-4511-9f78-534d76d30744",1988,"2016-09-08T12:45:07.204819-05:00","TCGA-24-1474","2016-09-02T19:07:18.526896-05:00","female","TCGA-24-1474_demographic",1943,"black or african american","4812aee4-fa81-5936-a941-fc0d01dba26d","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1474_diagnosis","not reported",20902,"dead","8441/3",676,676,"ed25dede-8f3b-53e0-b342-842614bc07b4","c56.9",-20902,"TCGA-24-1474_treatment","3e543b09-92f6-5b4d-874c-2a0176cd2714","01",NA,"TCGA-24-1474-01A","1","216c9136-673a-4e87-8537-daf1e4fbf394",FALSE,"c4d49a95-0478-4399-a5eb-224ca6d16cd7","Primary Tumor","0.7",NA,NA,"1",1234310400,"01",106,"TCGA-24-1474-01A-01",99,99,NA,NA,0,0,1,1,"2016-09-08T12:45:07.204819-05:00","2016-09-08T12:45:07.204819-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"c53d2d22-c2c3-4620-91f7-42162f8ba3d5","8b1c59c3-2589-42bc-b824-90b082f1e893","TCGA-24-1474-01A-01-BS1","TCGA-24-1474-01A-01-TS1",98,98,"fb049b83-5907-44b5-8182-34d38511a0a9","RNA","TCGA-24-1474-01A-01R","2e1ef287-ce35-4fc7-895c-a50b38928f36",1.8,0.15,"UV Spec","R","22","TCGA-24-1474-01A-01R-1566-13","4da3ccd5-53e1-46f5-874d-e5d131dbfc52",0.15,NA,NA,NA,NA,"3c5f03fe-cd6e-5bb2-b7c8-d4581c1b022c","TCGA-24-1474_exposure","TCGA-24-1474-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-21T23:55:04.000Z","2014-03-22T00:27:01.000Z","43BF72BC-A942-4268-B41C-1481DB9863A2","216C9136-673A-4E87-8537-DAF1E4FBF394","Unaligned reads",12515860480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4DA3CCD5-53E1-46F5-874D-E5D131DBFC52","Canada's Michael Smith Genome Sciences Centre","564a5b5ae4b09c884b27a458","D7B3156D-672A-4A55-868D-9CA6A09FCB0F","Ovarian Serous Cystadenocarcinoma","TAR","FB049B83-5907-44B5-8182-34D38511A0A9","2014-03-22T00:27:01.000Z","2E1EF287-CE35-4FC7-895C-A50B38928F36","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"FB049B83-5907-44B5-8182-34D38511A0A9",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.e5f26e9b-2fc8-4514-a028-cd97c5390b0a.txt",NA,"TCGA-24-1474-01A",1,"EECAC960-1B19-4854-BEB4-AB67384CEE3A","TCGA",2000,NA,NA,"WITH TUMOR","370AFC60-1BCB-495A-BE5D-85FC893DC7E9",57,"COOKY_p_TCGAb15_ICPp3_061909_GenomeWideSNP_6_B04_465836.CEL","Dead",676,"TCGA-24-1474",NA,"76D29B08-30DF-4EFC-8CBA-1BD4D4935300",NA,676,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,106,"C53D2D22-C2C3-4620-91F7-42162F8BA3D5","D2112F1F-25FC-42FD-9A50-690AF1704251","bcgsc.ca.TCGA-24-1474-01A-01R-1566-13.bcgsc.ca.1.4.0.indel.vcf","TCGA-24-1474-01A-01",99,0,NA,NA,1,"TOP",1,NA,"TCGA-24-1474-01A-01-TS1",98,"Topotecan","Chemotherapy","TCGA-24-1474-D26076",NA,NA,NA,"TCGA-24-1474-F26073_NTE-1",NA,676,"WITH TUMOR","Dead",676,"TCGA-24-1474-F26073","TCGA-24-1474",NA,"24","1474","YES","C56.9","8441/3","C56.9",NA,NA,-20902,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",676,676,NA,NA,"WITH TUMOR","NO",13,5,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,57,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
415583602,390100149,28803248281,"FF4E2BA3-AD78-4CEB-9328-C243601E7AB6.bw","d8d13aa4-45d5-4e1a-a6cf-895bdf05e7b2","ff4e2ba3-ad78-4ceb-9328-c243601e7ab6","2016-08-27T08:10:31.539110-05:00","TCGA-13-0760-01A-01R-1564-13_rnaseq_fastq.tar","81f8a6ab-ad47-4379-b7c2-7b58dd32a4dc",27807713280,"Illumina HiSeq","61dab534ba5c1040c1fc1d7a3c305d3c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:38:26.220253-05:00","2016-05-03T11:27:59.332723-05:00","81f8a6ab-ad47-4379-b7c2-7b58dd32a4dc_analysis.xml","70fdd0d47c202d435fbc290cd97f2576","29fded9a-bbad-40ab-b57d-a008818cef09",2237,"2016-08-27T04:13:50.091114-05:00","81f8a6ab-ad47-4379-b7c2-7b58dd32a4dc_experiment.xml","b76342f7abdd224ac06e7d27b80fc74a","b1858e1d-52b9-4c11-bfc3-9acf443cd634",3916,"2016-09-29T17:46:03.961504-05:00","81f8a6ab-ad47-4379-b7c2-7b58dd32a4dc_run.xml","f411c7f63d997201997796c51ec75b4d","09322622-8e57-43bf-8308-af629e238781",1990,"2016-09-08T13:27:18.938618-05:00","TCGA-13-0760","2016-09-02T19:09:38.984684-05:00","female","TCGA-13-0760_demographic",1943,"white","a21a3737-2000-5301-893e-32381b15763d","not hispanic or latino",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0760_diagnosis","not reported",23036,"dead","8441/3",351,351,"d11f1746-a660-5998-8830-1b5d634182a1","c56.9",-23036,"TCGA-13-0760_treatment","16d4d5b9-a87f-5014-9c9d-f47adced18a6","01",NA,"TCGA-13-0760-01A","0.9","f6508c57-7de6-489b-9615-12c56dc8d8af",FALSE,"B0F10C14-A8D9-4885-921C-735B68AF493D","Primary Tumor","0.4",NA,NA,"1.5",1233705600,"01",126,"TCGA-13-0760-01A-01",85,90,NA,NA,0,10,20,NA,"2016-09-08T13:27:18.938618-05:00","2016-09-08T13:27:18.938618-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,1,"197ab768-241c-411d-875f-c84c5c3de1eb","47216554-8878-4390-ab9c-497c94fa9e09","TCGA-13-0760-01A-01-TS1","TCGA-13-0760-01A-01-BS1",80,89,"30a2616f-985d-4498-80cf-d4534ad30007","RNA","TCGA-13-0760-01A-01R","8cc060ab-6420-4d49-863b-f93e46ce59fb",1.8,0.19,"UV Spec","R","22","TCGA-13-0760-01A-01R-1564-13","12f60ee0-fb87-4ac8-9e91-e6d643064c6d",0.19,NA,NA,NA,NA,"aa81201b-6c24-5354-a8ed-b51c7de92832","TCGA-13-0760_exposure","TCGA-13-0760-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T21:21:44.000Z","2013-12-20T22:01:01.000Z","81F8A6AB-AD47-4379-B7C2-7B58DD32A4DC","F6508C57-7DE6-489B-9615-12C56DC8D8AF","Unaligned reads",27807713280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","12F60EE0-FB87-4AC8-9E91-E6D643064C6D","Canada's Michael Smith Genome Sciences Centre","564a3277e4b0ef1218179398","D8D13AA4-45D5-4E1A-A6CF-895BDF05E7B2","Ovarian Serous Cystadenocarcinoma","TAR","30A2616F-985D-4498-80CF-D4534AD30007","2013-12-20T22:01:01.000Z","8CC060AB-6420-4D49-863B-F93E46CE59FB","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"30A2616F-985D-4498-80CF-D4534AD30007",0.9,"13","TCGA-13-0760-01A-01W-0371-08_IlluminaGA-DNASeq_capture.bam",NA,"TCGA-13-0760-01A",1.5,NA,"TCGA",2006,NA,NA,NA,"F6508C57-7DE6-489B-9615-12C56DC8D8AF",63,"nationwidechildrens.org_clinical.TCGA-13-0760.xml","Dead",351,"TCGA-13-0760","NOT HISPANIC OR LATINO","3203AB30-8200-473E-AC09-004D20628514",NA,351,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,126,"47216554-8878-4390-AB9C-497C94FA9E09","D35E8718-3DAB-4C31-9391-33A6AC420EC5","TCGA-13-0760-01A-01W-0371-08_IlluminaGA-DNASeq_capture.bam","TCGA-13-0760-01A-01",90,10,NA,NA,NA,"BOTTOM",1,NA,"TCGA-13-0760-01A-01-BS1",89,NA,NA,NA,NA,NA,NA,NA,NA,351,NA,"Dead",351,"TCGA-13-0760-F24543","TCGA-13-0760",NA,"13","0760","YES","C56.9","8441/3","C56.9",NA,NA,-23036,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",351,351,NA,NA,NA,"NO",24,2,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2006,"Incisional Biopsy",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
173231526,170246505,12609475412,"7A182F36-4FFE-4161-BE92-964B0E99F36A.bw","da274941-3edd-420b-9262-bbd959923c67","7a182f36-4ffe-4161-be92-964b0e99f36a","2016-08-25T19:38:32.131591-05:00","TCGA-31-1946-01A-01R-1568-13_rnaseq_fastq.tar","bc0bd27c-0f8f-4e7d-99c0-914157377f0d",10657955840,"Illumina HiSeq","9df6a511e94daf58937b4fab84cfc2c4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:07:39.183733-05:00","2016-05-03T11:56:42.628342-05:00","bc0bd27c-0f8f-4e7d-99c0-914157377f0d_analysis.xml","ec96ce5ee1f7a6ca618622391bfa00a8","16db903e-7f08-4493-a989-2f42731e5724",2181,"2016-09-29T22:02:42.173980-05:00","bc0bd27c-0f8f-4e7d-99c0-914157377f0d_experiment.xml","e14ce23917ee699ce26caed22a560f67","a90c7fb4-27e8-4ecd-98ad-2605c513a3cb",3916,"2016-09-29T22:32:06.547675-05:00","bc0bd27c-0f8f-4e7d-99c0-914157377f0d_run.xml","0fd402d75eefdc982e947c892e922c6f","bb0b5aea-f5b2-46e9-bb8a-ecb6afd056dc",1988,"2016-09-08T11:55:22.056402-05:00","TCGA-31-1946","2016-09-02T18:50:21.228090-05:00","female","TCGA-31-1946_demographic",1976,"not reported","52037f73-8727-533e-ad4c-c42bb53d20a2","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1946_diagnosis","not reported",11146,"alive","8441/3",NA,918,"c421708e-784f-5520-8391-a1d9ce7ae6ae","c56.9",-11146,"TCGA-31-1946_treatment","d8c671d0-213e-5d91-af1a-cdb539436e7b","01",NA,"TCGA-31-1946-01A","0.9","d445f92f-5b61-4131-b474-f0ce49e52379",FALSE,"5ef31a8f-38e7-486b-8efc-99cd8c1ec06d","Primary Tumor","0.3",NA,NA,"1",1246838400,"01",134,"TCGA-31-1946-01A-01",85,85,NA,NA,0,0,13,40,"2016-09-08T11:55:22.056402-05:00","2016-09-08T11:55:22.056402-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,5,"412289ba-f5a6-43b4-a002-8d95cadc246c","96e4efe5-cf1e-42eb-bb15-b3e7711fe916","TCGA-31-1946-01A-01-TS1","TCGA-31-1946-01A-01-BS1",85,55,"bc3f113f-324e-4fe2-a2e3-7eaf589ad3b9","RNA","TCGA-31-1946-01A-01R","dfa9351a-c515-4797-b960-e4f6672f4ec3",1.8,0.17,"UV Spec","R","22","TCGA-31-1946-01A-01R-1568-13","05abb2f5-07c3-42da-92d9-0b4560fb6f09",0.17,NA,NA,NA,NA,"580351ea-9c84-5556-b522-c23fe0493ac7","TCGA-31-1946_exposure","TCGA-31-1946-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T05:52:04.000Z","2014-08-28T07:59:41.000Z","BC0BD27C-0F8F-4E7D-99C0-914157377F0D","D445F92F-5B61-4131-B474-F0CE49E52379","Unaligned reads",10657955840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","05ABB2F5-07C3-42DA-92D9-0B4560FB6F09","Canada's Michael Smith Genome Sciences Centre","564a3f03e4b093830b6a6b88","DA274941-3EDD-420B-9262-BBD959923C67","Ovarian Serous Cystadenocarcinoma","TAR","BC3F113F-324E-4FE2-A2E3-7EAF589AD3B9","2014-08-28T07:59:41.000Z","DFA9351A-C515-4797-B960-E4F6672F4EC3","None","NO",1,0.3,"Primary Tumor","Imperial College",NA,"BC3F113F-324E-4FE2-A2E3-7EAF589AD3B9",0.9,"31","TCGA-31-1946-01A-01R-1568-13.hg19.isoform.quantification.txt",NA,"TCGA-31-1946-01A",1,"87E7D1D3-165B-4969-BCE1-1A00F13EEC10","TCGA",2006,NA,NA,"WITH TUMOR","D445F92F-5B61-4131-B474-F0CE49E52379",30,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.fb44d557-9e0a-40d5-83c3-3b9431e72d9d.txt","Alive",NA,"TCGA-31-1946",NA,"5A829C07-1749-4281-9D01-CAAB3B1CAF7C",NA,918,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,NA,NA,1,134,"96E4EFE5-CF1E-42EB-BB15-B3E7711FE916","EAEDDD0B-278F-4F1A-8C57-994A848472BF","4841860056_G_Red.idat","TCGA-31-1946-01A-01",85,0,NA,NA,40,"BOTTOM",5,NA,"TCGA-31-1946-01A-01-BS1",55,"Paciltaxel","Chemotherapy","TCGA-31-1946-D27681",NA,NA,NA,"TCGA-31-1946-F27679_NTE-1",NA,918,"WITH TUMOR","Alive",NA,"TCGA-31-1946-F27679","TCGA-31-1946",NA,"31","1946","YES","C56.9","8441/3","C56.9",NA,NA,-11146,"FEMALE",NA,NA,NA,"No","Alive",918,NA,NA,NA,"WITH TUMOR","NO",20,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,30,2006,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
207938008,200502008,14797173778,"23BF8F44-4EFB-491D-AAFF-F27386D0B6BD.bw","dac96910-0cb2-44ea-b108-2d6d51b07112","23bf8f44-4efb-491d-aaff-f27386d0b6bd","2016-08-25T07:49:52.649531-05:00","TCGA-13-1510-01A-02R-1565-13_rnaseq_fastq.tar","96038467-f298-43ca-8abb-a2b6a6e01b4c",12651970560,"Illumina HiSeq","61065eef7de0d9b7638b862c0d497ac0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:02:39.387120-05:00","2016-05-03T11:40:21.647690-05:00","96038467-f298-43ca-8abb-a2b6a6e01b4c_analysis.xml","62d228af20125203cce5aa18b4853fcb","5ebde024-9632-4f25-bbd1-581d5948483d",2208,"2016-09-29T22:34:30.097561-05:00","96038467-f298-43ca-8abb-a2b6a6e01b4c_experiment.xml","d49aa2351edeb040062a98cb6794ef76","bc820beb-a9da-4126-a061-e632d9023a1d",3916,"2016-09-29T22:19:37.816490-05:00","96038467-f298-43ca-8abb-a2b6a6e01b4c_run.xml","1370bf2aea00d1c0d8e1f400d020acca","b349e224-f981-4b14-b46a-7a05150ae0cc",1989,"2016-09-08T13:43:57.018548-05:00","TCGA-13-1510","2016-09-02T19:13:38.105917-05:00","female","TCGA-13-1510_demographic",1946,"white","d5a00182-83dc-5ef7-9d6a-3caf42ebc893","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1510_diagnosis","not reported",22708,"dead","8441/3",1359,78,"f0fc4512-b8f5-52b9-848e-eb15cdedcf49","c56.9",-22708,"TCGA-13-1510_treatment","fe1299cf-07a6-5314-b980-6d27541634b1","01",NA,"TCGA-13-1510-01A","1.1","557f7cab-8204-4295-831e-9a8cacf72231",FALSE,"D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D","Primary Tumor","0.4",NA,NA,"2",1235001600,"02",157,"TCGA-13-1510-01A-02",95,95,NA,NA,0,0,5,5,"2016-09-08T13:43:57.018548-05:00","2016-09-08T13:43:57.018548-05:00",NA,NA,NA,NA,"TOP","BOTTOM",20,20,"a9adcc98-382e-48ca-bd92-c7fdd1007305","870506d6-ca79-4aa2-b3b0-86f7f49f6427","TCGA-13-1510-01A-01-BS1","TCGA-13-1510-01A-02-BS2",75,75,"d1932478-9264-40e4-9107-c8a8f2c7120e","RNA","TCGA-13-1510-01A-02R","bb6c4555-645b-489e-847b-1aea460eb2f8",1.8,0.17,"UV Spec","R","22","TCGA-13-1510-01A-02R-1565-13","b75db551-4254-4736-a089-0a38890e7778",0.17,NA,NA,NA,NA,"f6e9bec3-d9a5-5091-8691-64890e77a539","TCGA-13-1510_exposure","TCGA-13-1510-01A-02R-1565-13_rnaseq_fastq.tar","2014-03-22T00:33:15.000Z","2014-03-22T01:03:02.000Z","96038467-F298-43CA-8ABB-A2B6A6E01B4C","557F7CAB-8204-4295-831E-9A8CACF72231","Unaligned reads",12651970560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B75DB551-4254-4736-A089-0A38890E7778","Canada's Michael Smith Genome Sciences Centre","564a3d6de4b08c5d86922779","DAC96910-0CB2-44EA-B108-2D6D51B07112","Ovarian Serous Cystadenocarcinoma","TAR","D1932478-9264-40E4-9107-C8A8F2C7120E","2014-03-22T01:03:02.000Z","BB6C4555-645B-489E-847B-1AEA460EB2F8","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"D1932478-9264-40E4-9107-C8A8F2C7120E",1.1,"13","TCGA-13-1510-01A-02R-1565-13.spljxn.quantification.txt",NA,"TCGA-13-1510-01A",2,"762831BF-CAFB-4024-AF33-72EFDF3F5222","TCGA",2008,NA,NA,"TUMOR FREE","9A0B1490-0978-4F18-B700-520D44F127F6",62,"nationwidechildrens.org_clinical.TCGA-13-1510.xml","Alive",NA,"TCGA-13-1510","NOT HISPANIC OR LATINO","D8C042C4-CD72-4511-B639-9C2E3D05248C",NA,78,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,2,157,"A9ADCC98-382E-48CA-BD92-C7FDD1007305","BB6C4555-645B-489E-847B-1AEA460EB2F8","TCGA-13-1510-01A-02R-1565-13.spljxn.quantification.txt","TCGA-13-1510-01A-02",95,0,NA,NA,5,"TOP",20,NA,"TCGA-13-1510-01A-01-BS1",75,"Paclitaxel","Chemotherapy","TCGA-13-1510-D24963",NA,NA,NA,NA,NA,78,"TUMOR FREE","Alive",NA,"TCGA-13-1510-F24961","TCGA-13-1510",NA,"13","1510","YES","C56.9","8441/3","C56.9",NA,NA,-22708,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",78,NA,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,62,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156688014,151294647,11189907690,"858BE3D5-C06D-4151-8B99-5EBD0E239464.bw","dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5","858be3d5-c06d-4151-8b99-5ebd0e239464","2016-08-25T23:43:57.154812-05:00","TCGA-61-2109-01A-01R-1568-13_rnaseq_fastq.tar","59452497-9e19-4c2e-a94b-e4ba8de4d39f",10092247040,"Illumina HiSeq","45295d6b8906b22247bbb1c19ad7e343","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:02:29.603290-05:00","2016-05-03T11:41:05.755204-05:00","59452497-9e19-4c2e-a94b-e4ba8de4d39f_analysis.xml","b3dfd4307e392525698b87aa80fd7922","138e0dad-fd5f-4a98-a4d5-ebb70904d45b",2183,"2016-09-29T22:19:07.742093-05:00","59452497-9e19-4c2e-a94b-e4ba8de4d39f_experiment.xml","7306802f8b8195ba04551d0fb2918d61","b306095b-6380-48d2-b266-51673d608f03",3916,"2016-09-29T23:05:02.238001-05:00","59452497-9e19-4c2e-a94b-e4ba8de4d39f_run.xml","deafa0e5e27b7abe99675a5d5e053f95","cf6b6797-b32b-46b7-9fda-d650d2156367",1990,"2016-09-08T11:37:39.251592-05:00","TCGA-61-2109","2016-09-02T18:56:24.918759-05:00","female","TCGA-61-2109_demographic",1959,"white","0fc3268e-adb3-5388-9bfd-2e6056af74e5","not hispanic or latino",2000,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2109_diagnosis","not reported",14900,"dead","8441/3",629,629,"d7e955fc-4cf9-5b0a-8555-41d566bd4e64","c56.9",-14900,"TCGA-61-2109_treatment","f75efd48-3565-5fc6-9030-02c5b62923d7","01",NA,"TCGA-61-2109-01A","0.8","98198891-a060-4107-b56d-61f19ac5fab5",FALSE,"c16bfe93-016f-49d4-8895-05b9055344c9","Primary Tumor","0.2",NA,NA,"1.7",1250467200,"01",136,"TCGA-61-2109-01A-01",97,95,NA,NA,5,13,0,5,"2016-09-08T11:37:39.251592-05:00","2016-09-08T11:37:39.251592-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,7,"3b0f024a-5fd6-430c-8197-649c17917ebf","031075e9-b603-438c-89cb-a22f24f0da61","TCGA-61-2109-01A-01-BS1","TCGA-61-2109-01A-01-TS1",90,75,"96ae7800-836f-4b93-be3d-2e0f57b26b09","RNA","TCGA-61-2109-01A-01R","69525c8d-9d7d-48cd-8957-022691f04ce5",1.8,0.15,"UV Spec","R","22","TCGA-61-2109-01A-01R-1568-13","c87ddfc3-d7a4-4704-b3cc-a19edfb63452",0.15,NA,NA,NA,NA,"2c80b02c-b844-5f8b-a1db-8798ab8ae586","TCGA-61-2109_exposure","TCGA-61-2109-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T06:16:28.000Z","2014-03-27T06:38:02.000Z","59452497-9E19-4C2E-A94B-E4BA8DE4D39F","98198891-A060-4107-B56D-61F19AC5FAB5","Unaligned reads",10092247040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C87DDFC3-D7A4-4704-B3CC-A19EDFB63452","Canada's Michael Smith Genome Sciences Centre","564a3549e4b0ef1218187b54","DC5A6CE7-01E5-408D-812E-E3E0DDC1CDE5","Ovarian Serous Cystadenocarcinoma","TAR","96AE7800-836F-4B93-BE3D-2E0F57B26B09","2014-03-27T06:38:02.000Z","69525C8D-9D7D-48CD-8957-022691F04CE5","None","NO",1,0.2,"Primary Tumor","University of Pittsburgh",NA,"96AE7800-836F-4B93-BE3D-2E0F57B26B09",0.8,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.d3e2505d-0838-4a9c-a626-ad04f9254dd1.txt",NA,"TCGA-61-2109-01A",1.7,"FD722D54-C930-4C8A-B35D-106C76576754","TCGA",1999,NA,NA,"WITH TUMOR","98198891-A060-4107-B56D-61F19AC5FAB5",40,"TCGA-61-2109-01A-01W-0722-08_IlluminaGA-DNASeq_capture.bam","Dead",629,"TCGA-61-2109","NOT HISPANIC OR LATINO","716014BF-2F9F-4DC8-81FE-C2BAA9C4303C",NA,629,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,136,"3B0F024A-5FD6-430C-8197-649C17917EBF","42B6C589-750B-4ECF-8EB2-9ED90926B510","bcgsc.ca.TCGA-61-2109-01A-01R-1568-13.hg19.bcgsc.ca.1.6.0.snv.vcf","TCGA-61-2109-01A-01",97,5,NA,NA,0,"BOTTOM",5,NA,"TCGA-61-2109-01A-01-BS1",90,"Cisplatin","Chemotherapy","TCGA-61-2109-D28454",NA,NA,NA,"TCGA-61-2109-F28450_NTE-1",NA,629,"WITH TUMOR","Dead",629,"TCGA-61-2109-F28450","TCGA-61-2109",NA,"61","2109","YES","C56.9","8441/3","C56.9",NA,NA,-14900,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",629,629,NA,NA,"WITH TUMOR","NO",7,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,40,1999,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
200557712,196069493,14519002275,"0FDD3460-5C5B-4AA2-99DC-3DEED4025172.bw","dce71741-ccbe-40b7-a0b8-2048d07187a4","0fdd3460-5c5b-4aa2-99dc-3deed4025172","2016-08-18T23:15:04.807825-05:00","TCGA-25-2409-01A-01R-1569-13_rnaseq_fastq.tar","50d2959c-734b-40ee-8e2b-261b5338a206",12556226560,"Illumina HiSeq","344565f7be623f3200774e342bbe35d9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:43:04.455840-05:00","2016-05-03T11:55:09.260045-05:00","50d2959c-734b-40ee-8e2b-261b5338a206_analysis.xml","7b33026df73de8a14cf30bb34d1f8fe3","07316f1c-b382-402e-8c0f-a2666fc6e5c4",2181,"2016-09-29T21:21:59.090289-05:00","50d2959c-734b-40ee-8e2b-261b5338a206_experiment.xml","ee913f40fe638237745189da8ae2c018","8fc23226-2942-49e7-ad0a-23751c8c9751",3916,"2016-09-29T18:53:03.955292-05:00","50d2959c-734b-40ee-8e2b-261b5338a206_run.xml","0da87ead6ceda4a553f95831ed34a70c","334ea544-4274-4692-8abf-59077bbb8a16",1988,"2016-09-08T14:04:13.684190-05:00","TCGA-25-2409","2016-09-02T19:11:51.633450-05:00","female","TCGA-25-2409_demographic",1934,"white","5897f462-2f0f-5340-b4d1-bff091eb649b","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2409_diagnosis","not reported",26267,"dead","8441/3",821,821,"c8d48465-069c-5154-9bae-9ce289ab10d4","c56.9",-26267,"TCGA-25-2409_treatment","45822b90-dc03-52ff-8615-95d34501c53e","01",NA,"TCGA-25-2409-01A","1.5","3d0f2483-ae45-4b2f-bba3-76a0eaecff4f",FALSE,"89A631C6-5000-4A96-B752-879EAA7231CB","Primary Tumor","0.4",NA,NA,"1.5",1252368000,"01",159,"TCGA-25-2409-01A-01",95,95,NA,NA,1,1,4,4,"2016-09-08T14:04:13.684190-05:00","2016-09-08T14:04:13.684190-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"91c79a10-fdff-4095-929c-b1b1e1c3b9a0","a28f0475-589d-4831-9186-6b955153f5bb","TCGA-25-2409-01A-01-BS1","TCGA-25-2409-01A-01-TS1",94,94,"d1feca38-9d25-457f-bcdf-497eb7c4b4d5","RNA","TCGA-25-2409-01A-01R","0415d430-4e99-4adf-9ff6-a78068af1cc2",1.8,0.14,"UV Spec","R","22","TCGA-25-2409-01A-01R-1569-13","4e5f3a15-68fd-4be0-b368-e0bd04eaf872",0.14,NA,NA,NA,NA,"c953c546-0d79-5f83-aace-a4e927efe6bf","TCGA-25-2409_exposure","TCGA-25-2409-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T07:08:50.000Z","2014-08-08T08:40:29.000Z","50D2959C-734B-40EE-8E2B-261B5338A206","3D0F2483-AE45-4B2F-BBA3-76A0EAECFF4F","Unaligned reads",12556226560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4E5F3A15-68FD-4BE0-B368-E0BD04EAF872","Canada's Michael Smith Genome Sciences Centre","564a571be4b08c5d8693d100","DCE71741-CCBE-40B7-A0B8-2048D07187A4","Ovarian Serous Cystadenocarcinoma","TAR","D1FECA38-9D25-457F-BCDF-497EB7C4B4D5","2014-08-08T08:40:29.000Z","0415D430-4E99-4ADF-9FF6-A78068AF1CC2","None","NO",1,0.4,"Primary Tumor","Mayo Clinic - Rochester",NA,"D1FECA38-9D25-457F-BCDF-497EB7C4B4D5",1.5,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.bfaa6831-b085-4b98-90a5-fef72266d642.txt",NA,"TCGA-25-2409-01A",1.5,"F9E622C7-2103-4813-979C-461082E72B52","TCGA",2005,NA,NA,"WITH TUMOR","AF849153-DC08-472A-AB16-26C25FE1751F",71,"nationwidechildrens.org_clinical.TCGA-25-2409.xml","Dead",821,"TCGA-25-2409","NOT HISPANIC OR LATINO","C42FE3B3-07FD-4F77-9037-972142140153",NA,821,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,159,"91C79A10-FDFF-4095-929C-B1B1E1C3B9A0","EC96B00C-79AE-4FF4-A6C8-83BD93012EB9","5083933020_I_Grn.idat","TCGA-25-2409-01A-01",95,1,NA,NA,4,"BOTTOM",1,NA,"TCGA-25-2409-01A-01-BS1",94,"Tamoxifen","Hormone Therapy","TCGA-25-2409-D26844",NA,NA,NA,"TCGA-25-2409-F26841_NTE-1",NA,821,"WITH TUMOR","Dead",821,"TCGA-25-2409-F26841","TCGA-25-2409",NA,"25","2409","YES","C56.9","8441/3","C56.9",NA,NA,-26267,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",821,821,NA,NA,"WITH TUMOR","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
192795258,187065699,13803280381,"7E809698-2473-4EFE-B896-1637983EC596.bw","de548bdd-14ca-486b-bd16-a6fbdd5b50d2","7e809698-2473-4efe-b896-1637983ec596","2016-08-25T21:15:55.570525-05:00","TCGA-36-1568-01A-01R-1566-13_rnaseq_fastq.tar","f6cb02a0-fed3-4d49-838a-d68b39cd4383",12230123520,"Illumina HiSeq","10535b6326d77080725ffa440bc203f9","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:09:31.620668-05:00","2016-05-03T11:41:05.750744-05:00","f6cb02a0-fed3-4d49-838a-d68b39cd4383_analysis.xml","7f5b477662b9a72ded780effeb0557fe","f764d99e-7e91-4b68-a1c7-2c99c134a11e",2183,"2016-09-29T23:52:27.217593-05:00","f6cb02a0-fed3-4d49-838a-d68b39cd4383_experiment.xml","75c822b436b5fa976c55eb02d2f89b6f","ecfd78ee-0a9c-4576-9ad1-2494b4b4f445",3916,"2016-09-29T17:47:16.428176-05:00","f6cb02a0-fed3-4d49-838a-d68b39cd4383_run.xml","6318c4f1e47d7ca58586b2ff8a5aa6dd","09f284c5-ebdd-4f80-a84e-7f081464ba0e",1990,"2016-09-08T12:15:35.615297-05:00","TCGA-36-1568","2016-09-02T18:49:49.326318-05:00","female","TCGA-36-1568_demographic",1955,"not reported","357b0c19-bb6c-588d-a652-1d4bf67cc0c4","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1568_diagnosis","not reported",19311,"alive","8441/3",NA,875,"f0ac6623-6d2a-5f87-a515-fe563d907b98","c56.9",-19311,"TCGA-36-1568_treatment","2a0802da-d09e-5156-bca8-f7f3f8d78cb7","01",NA,"TCGA-36-1568-01A","0.5","0c2b931b-813b-450f-a911-d25fd7465e18",FALSE,"dad4bbdc-0156-48c2-a975-27ccfb9152a3","Primary Tumor","0.3",NA,NA,"1.6",1235779200,"01",100,"TCGA-36-1568-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T12:15:35.615297-05:00","2016-09-08T12:15:35.615297-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"1a9c6c51-2b6b-4fa9-ab42-ddf6f921adfb","4356f10e-d4de-400b-8954-eb2e30b693fb","TCGA-36-1568-01A-01-TS1","TCGA-36-1568-01A-01-BS1",95,95,"f32135ee-7587-4664-a4dc-90d905c43873","RNA","TCGA-36-1568-01A-01R","98d419ff-25e6-44b8-86d6-9d699ab48aa3",1.8,0.15,"UV Spec","R","22","TCGA-36-1568-01A-01R-1566-13","4e539c62-454a-4b1c-bde1-6951ee12d109",0.15,NA,NA,NA,NA,"242aeb0c-4420-551d-8c97-e63304088649","TCGA-36-1568_exposure","TCGA-36-1568-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T17:33:32.000Z","2014-03-28T17:58:03.000Z","F6CB02A0-FED3-4D49-838A-D68B39CD4383","0C2B931B-813B-450F-A911-D25FD7465E18","Unaligned reads",12230123520,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","4E539C62-454A-4B1C-BDE1-6951EE12D109","Canada's Michael Smith Genome Sciences Centre","564a5b4fe4b08c5d86953112","DE548BDD-14CA-486B-BD16-A6FBDD5B50D2","Ovarian Serous Cystadenocarcinoma","TAR","F32135EE-7587-4664-A4DC-90D905C43873","2014-03-28T17:58:03.000Z","98D419FF-25E6-44B8-86D6-9D699AB48AA3","None","NO",1,0.3,"Primary Tumor","BC Cancer Agency",NA,"F32135EE-7587-4664-A4DC-90D905C43873",0.5,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b9598717-cdb9-49e1-a8d5-49ec5189cb31.txt",NA,"TCGA-36-1568-01A",1.6,"9D38E2AE-A6BE-479E-9C79-8865A90A7EB5","TCGA",2007,NA,NA,"WITH TUMOR","0C2B931B-813B-450F-A911-D25FD7465E18",52,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b9598717-cdb9-49e1-a8d5-49ec5189cb31.txt","Alive",NA,"TCGA-36-1568",NA,"8050DAA1-0821-4B10-9F7E-13838A72C862",NA,875,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,NA,NA,1,100,"4356F10E-D4DE-400B-8954-EB2E30B693FB","98D419FF-25E6-44B8-86D6-9D699AB48AA3","TCGA-36-1568-01A-01R-1566-13_GRCh37-lite_rnaseq.bam.bai","TCGA-36-1568-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-36-1568-01A-01-TS1",95,"Paclitaxel","Chemotherapy","TCGA-36-1568-D27853",NA,NA,NA,"TCGA-36-1568-F27850_NTE-1",NA,875,"WITH TUMOR","Alive",NA,"TCGA-36-1568-F27850","TCGA-36-1568",NA,"36","1568","YES","C56.9","8441/3","C56.9",NA,NA,-19311,"FEMALE",NA,NA,NA,"No","Alive",875,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,52,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
153807954,136479830,9905715409,"42F39521-E1B9-47BB-B160-DA35133A9C87.bw","df53c3c0-3605-4d2b-bdc7-96d9beab27ea","42f39521-e1b9-47bb-b160-da35133a9c87","2016-08-25T21:26:55.287437-05:00","TCGA-23-1028-01A-01R-1564-13_rnaseq_fastq.tar","987252e3-85d5-4117-a984-a1e31d38e3e5",8648355840,"Illumina HiSeq","1a7ed45193cc2235d6190e21dbd7bf5a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:22:15.488243-05:00","2016-05-03T11:41:05.750744-05:00","987252e3-85d5-4117-a984-a1e31d38e3e5_analysis.xml","1fd285f86b70911182e222417546bc7a","1fbc81e0-32f0-44a4-a37e-ade5b70be78b",2208,"2016-09-29T23:44:38.701438-05:00","987252e3-85d5-4117-a984-a1e31d38e3e5_experiment.xml","5c58edcb652066a115334a6ff8f42ce6","e8314b9c-cb5d-407e-b5b8-37b7fc530d81",3916,"2016-09-29T22:09:50.699265-05:00","987252e3-85d5-4117-a984-a1e31d38e3e5_run.xml","7e5ae70f121a1cae9af28082cde6a007","ad590ba5-9863-4b55-9245-b7a45519aec2",1988,"2016-09-08T12:20:31.174735-05:00","TCGA-23-1028","2016-09-02T19:05:50.709014-05:00","female","TCGA-23-1028_demographic",1961,"white","c98a0351-dc5f-5f3c-984f-638eae453300","hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1028_diagnosis","not reported",16018,"alive","8441/3",NA,1503,"26b720a3-88e1-5202-a2e2-08f958ebe521","c56.9",-16018,"TCGA-23-1028_treatment","a66174fd-178d-511f-9c97-9a42c2cc621e","01",NA,"TCGA-23-1028-01A","0.6","4363b3c8-bfdb-4668-b72a-d15ed0f5bfff",FALSE,"CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2","Primary Tumor","0.4",NA,NA,"0.8",1233705600,"01",97,"TCGA-23-1028-01A-01",80,75,NA,NA,10,15,10,10,"2016-09-08T12:20:31.174735-05:00","2016-09-08T12:20:31.174735-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"56dde40f-224a-49a7-a24c-9fc8b44e0a66","94323365-fde7-4d57-a4c7-0f6ded12fa41","TCGA-23-1028-01A-01-TS1","TCGA-23-1028-01A-01-BS1",75,70,"bbd3516f-ed5e-4d99-8647-0bfad043ffef","RNA","TCGA-23-1028-01A-01R","7ed482a8-aa10-42b3-bd02-57aeaeed76b3",1.8,0.14,"UV Spec","R","22","TCGA-23-1028-01A-01R-1564-13","8f6e45b3-2857-4eb8-a723-5429f7fd8f0c",0.14,NA,NA,NA,NA,"e9edd4f4-fdcd-510f-8e48-b31d11b17e12","TCGA-23-1028_exposure","TCGA-23-1028-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T18:31:47.000Z","2014-03-28T18:54:01.000Z","987252E3-85D5-4117-A984-A1E31D38E3E5","4363B3C8-BFDB-4668-B72A-D15ED0F5BFFF","Unaligned reads",8648355840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","8F6E45B3-2857-4EB8-A723-5429F7FD8F0C","Canada's Michael Smith Genome Sciences Centre","564a5639e4b09c884b263cc1","DF53C3C0-3605-4D2B-BDC7-96D9BEAB27EA","Ovarian Serous Cystadenocarcinoma","TAR","BBD3516F-ED5E-4D99-8647-0BFAD043FFEF","2014-03-28T18:54:01.000Z","7ED482A8-AA10-42B3-BD02-57AEAEED76B3","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"BBD3516F-ED5E-4D99-8647-0BFAD043FFEF",0.6,"23","TCGA-23-1028-01A-01R-1564-13_GRCh37-lite_mirna.bam.bai",NA,"TCGA-23-1028-01A",0.8,"F26754F2-8F61-4593-9928-59D785330F4E","TCGA",2004,NA,NA,"WITH TUMOR","4363B3C8-BFDB-4668-B72A-D15ED0F5BFFF",43,"nationwidechildrens.org_clinical.TCGA-23-1028.xml","Alive",NA,"TCGA-23-1028","HISPANIC OR LATINO","775EA41C-8D7E-4DD1-AF91-41EE25E480D1",NA,1503,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,97,"94323365-FDE7-4D57-A4C7-0F6DED12FA41","E8C7AC3A-5D32-4D43-A5C8-3175ADBFC9DA","QUANT_p_TCGA_Batch12_AFFX_GenomeWideSNP_6_C05_437700.nocnv_hg19.seg.txt","TCGA-23-1028-01A-01",80,10,NA,NA,10,"TOP",5,NA,"TCGA-23-1028-01A-01-TS1",75,"Gemcitabine","Chemotherapy","TCGA-23-1028-D25636",NA,NA,NA,"TCGA-23-1028-F25624_NTE-2",NA,1503,"WITH TUMOR","Alive",NA,"TCGA-23-1028-F25624","TCGA-23-1028",NA,"23","1028","YES","C56.9","8441/3","C56.9",NA,NA,-16018,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Alive",1503,NA,NA,NA,"WITH TUMOR","NO",23,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,43,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
369918074,351641073,25810784447,"1753571F-E6CB-459B-86F0-6304FC8A19AC.bw","e07a61e2-bcd2-4a96-80df-97e04aafbd32","1753571f-e6cb-459b-86f0-6304fc8a19ac","2016-08-19T04:16:28.512601-05:00","TCGA-10-0931-01A-01R-1564-13_rnaseq_fastq.tar","1fd0c6c8-cad5-45e6-ad7b-bfdad7b57faf",23384750080,"Illumina HiSeq","53b4207be46502b90d19df86dff7e23a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:56:35.050988-05:00","2016-05-03T11:27:59.332723-05:00","1fd0c6c8-cad5-45e6-ad7b-bfdad7b57faf_analysis.xml","7db3fd067a1deb88f803e84c5b2f1afd","7fdc756d-2492-4651-aa12-a797c6ac1ec9",2210,"2016-09-29T23:18:41.801024-05:00","1fd0c6c8-cad5-45e6-ad7b-bfdad7b57faf_experiment.xml","48e07caea49ddae53cfa9e3b34ec9a3c","d7d258e9-23c5-40c8-a37e-70d571dae64a",3916,"2016-09-29T17:51:42.294230-05:00","1fd0c6c8-cad5-45e6-ad7b-bfdad7b57faf_run.xml","86db577c77cb81cc027cd954be35cefc","0cc04aae-97b6-46f6-a0f5-c90bcca3d890",1990,"2016-09-08T13:27:26.017598-05:00","TCGA-10-0931","2016-09-02T19:05:20.218188-05:00","female","TCGA-10-0931_demographic",1958,"white","9d30f62d-cadc-5d3f-8505-00561713c897","not reported",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0931_diagnosis","not reported",16262,"dead","8441/3",1000,982,"da8e8e22-7514-538e-8029-9f2dd1dbf55e","c56.9",-16262,"TCGA-10-0931_treatment","9f28ef7c-ec38-53e3-9538-b454efcde173","01",NA,"TCGA-10-0931-01A","0.5","f46d6e67-40ef-4a8c-99fc-700d8e598131",FALSE,"45d8f828-6dfb-4e68-8282-f2ee74671461","Primary Tumor","0.5",NA,NA,"0.5",1233705600,"01",102,"TCGA-10-0931-01A-01",85,98,NA,NA,5,0,10,5,"2016-09-08T13:27:26.017598-05:00","2016-09-08T13:27:26.017598-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"f6dbb223-2348-40fe-8da2-e93c3071d823","0d63b5df-9fa6-4bdf-bd67-69e60e710137","TCGA-10-0931-01A-01-TS1","TCGA-10-0931-01A-01-BS1",85,95,"4326d7e3-06e4-483d-b6b7-f0f8bfa6ec16","RNA","TCGA-10-0931-01A-01R","543f46ee-d47b-481f-b8df-a617bcf2bf85",1.8,0.16,"UV Spec","R","22","TCGA-10-0931-01A-01R-1564-13","3dbc3349-abcf-4e54-879e-1de74ee2b334",0.16,NA,NA,NA,NA,"46c49118-7b30-53bc-b837-3a74c2d4212c","TCGA-10-0931_exposure","TCGA-10-0931-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T21:03:15.000Z","2013-12-20T21:40:02.000Z","1FD0C6C8-CAD5-45E6-AD7B-BFDAD7B57FAF","F46D6E67-40EF-4A8C-99FC-700D8E598131","Unaligned reads",23384750080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3DBC3349-ABCF-4E54-879E-1DE74EE2B334","Canada's Michael Smith Genome Sciences Centre","564a3f8ae4b0298dd2c9bcb4","E07A61E2-BCD2-4A96-80DF-97E04AAFBD32","Ovarian Serous Cystadenocarcinoma","TAR","4326D7E3-06E4-483D-B6B7-F0F8BFA6EC16","2013-12-20T21:40:02.000Z","543F46EE-D47B-481F-B8DF-A617BCF2BF85","None","NO",1,0.5,"Primary Tumor","MD Anderson Cancer Center",NA,"4326D7E3-06E4-483D-B6B7-F0F8BFA6EC16",0.5,"10","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.25a69746-6f70-41eb-9805-6299ea0a4728.txt",NA,"TCGA-10-0931-01A",0.5,"FDAA015F-C778-4F16-8461-FAA4255FC6C0","TCGA",2002,NA,NA,"WITH TUMOR","F46D6E67-40EF-4A8C-99FC-700D8E598131",44,"C239.TCGA-10-0931-01A-01D.2.bam","Dead",1000,"TCGA-10-0931",NA,"C2B9AC2E-F094-4664-81F1-BA7E9A64CA33",NA,982,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,102,"F6DBB223-2348-40FE-8DA2-E93C3071D823","D07536AD-40EF-4A47-B88D-4E92322D7D14","TCGA-10-0931-01A-01R-1564-13_rnaseq.bam.bai","TCGA-10-0931-01A-01",98,0,NA,NA,5,"BOTTOM",0,NA,"TCGA-10-0931-01A-01-BS1",95,"Carboplatin","Chemotherapy","TCGA-10-0931-D24442",NA,NA,NA,"TCGA-10-0931-F24440_NTE-1",NA,982,"WITH TUMOR","Dead",1000,"TCGA-10-0931-F24440","TCGA-10-0931",NA,"10","0931","YES","C56.9","8441/3","C56.9",NA,NA,-16262,"FEMALE","WHITE",NA,NA,"No","Dead",982,1000,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,2002,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
135673578,132632666,9780722052,"B1713B79-888A-4077-A9F3-C47FC754EBD4.bw","e1158102-06f2-47bb-9fe0-49b57f070755","b1713b79-888a-4077-a9f3-c47fc754ebd4","2016-08-22T02:59:16.877711-05:00","TCGA-31-1956-01A-01R-1568-13_rnaseq_fastq.tar","25c3424c-777f-49ea-8044-279f3a422a04",8224512000,"Illumina HiSeq","5a96b99e9098a7cb09cbde131ae55c7b","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:32:26.823128-05:00","2016-05-03T11:58:49.360058-05:00","25c3424c-777f-49ea-8044-279f3a422a04_analysis.xml","04dc680ee1e23fbbf346ac16b074efa0","2612862c-c0e4-4905-9ccc-bf64d829a6bd",2181,"2016-09-29T19:04:39.944756-05:00","25c3424c-777f-49ea-8044-279f3a422a04_experiment.xml","5d7051ac66698e89db28528141d4cdb9","3a9d5e58-1f60-4bf5-bd99-0ae9bb96c638",3916,"2016-09-29T20:07:37.065296-05:00","25c3424c-777f-49ea-8044-279f3a422a04_run.xml","dba268e39d78440f9cffbd68d917f112","61b20934-0a78-409a-9ded-2367e2616999",1988,"2016-09-08T10:46:02.341142-05:00","TCGA-31-1956","2016-09-02T18:49:50.388754-05:00","female","TCGA-31-1956_demographic",1945,"white","567cb496-8b1d-54e3-bfa7-401b51d6b3fd","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","31","551cc026-43d4-5784-b0b5-4eae6ed12c82","Imperial College","not reported","c56.9","TCGA-31-1956_diagnosis","not reported",22100,"alive","8441/3",NA,1342,"cfbadd21-1fd9-5470-bec1-e14b76ad9ae8","c56.9",-22100,"TCGA-31-1956_treatment","01a71b58-c55c-5270-b629-f123096449bb","01",NA,"TCGA-31-1956-01A","0.9","3218e049-6d6a-471c-8453-d8ac52cf9d14",FALSE,"3646c24b-c4b7-400b-bc93-7ef485c6892c","Primary Tumor","0.2",NA,NA,"1.3",1246838400,"01",113,"TCGA-31-1956-01A-01",90,85,NA,3,0,0,18,45,"2016-09-08T10:46:02.341142-05:00","2016-09-08T10:46:02.341142-05:00",NA,5,NA,NA,"BOTTOM","TOP",2,5,"5fafa924-13b2-4b34-9930-1810a3ac5022","e3853ccf-184c-48d1-aeca-6a62e93e3d84","TCGA-31-1956-01A-01-BS1","TCGA-31-1956-01A-01-TS1",80,50,"92ede993-4acc-4e5a-be66-718d422b4839","RNA","TCGA-31-1956-01A-01R","17356abe-8ee8-4e1d-bfec-92bc98d78d73",1.8,0.16,"UV Spec","R","22","TCGA-31-1956-01A-01R-1568-13","24cfcfd9-ce30-4e24-9470-60265efd6721",0.16,NA,NA,NA,NA,"f6ba8f4a-d9ec-574f-ae6d-c0c469e85e13","TCGA-31-1956_exposure","TCGA-31-1956-01A-01R-1568-13_rnaseq_fastq.tar","2014-09-23T02:14:38.000Z","2014-09-23T03:37:23.000Z","25C3424C-777F-49EA-8044-279F3A422A04","3218E049-6D6A-471C-8453-D8AC52CF9D14","Unaligned reads",8224512000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","24CFCFD9-CE30-4E24-9470-60265EFD6721","Canada's Michael Smith Genome Sciences Centre","564a589de4b09c884b26e81f","E1158102-06F2-47BB-9FE0-49B57F070755","Ovarian Serous Cystadenocarcinoma","TAR","92EDE993-4ACC-4E5A-BE66-718D422B4839","2014-09-23T03:37:23.000Z","17356ABE-8EE8-4E1D-BFEC-92BC98D78D73","None","NO",1,0.2,"Primary Tumor","Imperial College",NA,"92EDE993-4ACC-4E5A-BE66-718D422B4839",0.9,"31","TCGA-31-1956-01A-01R-1568-13_rnaseq.bam",NA,"TCGA-31-1956-01A",1.3,"D3E74B41-1369-48F8-A1AD-767692BD830F","TCGA",2005,NA,NA,"WITH TUMOR","4D8936BD-B77C-4E2A-8A9B-551AC7AB8C83",60,"nationwidechildrens.org_clinical.TCGA-31-1956.xml","Alive",NA,"TCGA-31-1956","NOT HISPANIC OR LATINO","97DA6EB3-AE55-4F66-AF96-3A0332182595",NA,1342,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,113,"E3853CCF-184C-48D1-AECA-6A62E93E3D84","EFB9CF23-4788-4F7D-9B36-AA96B644A61F","TCGA-31-1956-01A-01R-1568-13_rnaseq.bam","TCGA-31-1956-01A-01",90,0,NA,NA,18,"BOTTOM",2,NA,"TCGA-31-1956-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-31-1956-D27712",NA,NA,NA,"TCGA-31-1956-F27711_NTE-1",NA,1342,"WITH TUMOR","Alive",NA,"TCGA-31-1956-F27711","TCGA-31-1956",NA,"31","1956","YES","C56.9","8441/3","C56.9",NA,NA,-22100,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1342,NA,NA,NA,"WITH TUMOR","NO",19,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,60,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
236997622,230182162,17050449265,"749025DE-73B0-4880-B777-ECC0BE40E9E1.bw","e20ea417-7296-4da8-9fdb-71cd1f45153a","749025de-73b0-4880-b777-ecc0be40e9e1","2016-08-25T17:28:56.607809-05:00","TCGA-24-2020-01A-01R-1567-13_rnaseq_fastq.tar","dafbc682-c333-4860-9e7a-954ebb207c97",15669698560,"Illumina HiSeq","7cad024efca621d1fb3c70ec01c6df14","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:03:40.637990-05:00","2016-05-03T11:41:05.748550-05:00","dafbc682-c333-4860-9e7a-954ebb207c97_analysis.xml","20bf87be60a11912a6a62b0643c3308a","1452f051-b5b9-4bab-bad0-c45591f26681",2181,"2016-08-28T10:58:48.336952-05:00","dafbc682-c333-4860-9e7a-954ebb207c97_experiment.xml","c4bda9f57fecafe9fae62df259e7fb6b","f17305ab-b66a-45fd-b7b0-8f736e0d9a71",3916,"2016-09-29T23:40:50.022757-05:00","dafbc682-c333-4860-9e7a-954ebb207c97_run.xml","8c614487b83fc5378f8e3957659c73ef","e5be7ec8-08fb-46ea-82d0-3489a79798f6",1989,"2016-09-08T11:32:50.078907-05:00","TCGA-24-2020","2016-09-02T18:50:21.787896-05:00","female","TCGA-24-2020_demographic",1927,"white","bc3036a7-e795-5db4-9293-f25c1dd954ff","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2020_diagnosis","not reported",24682,"dead","8441/3",4624,4624,"2a7a1bf4-1fe5-5d1d-ad8f-a06bdfbe0774","c56.9",-24682,"TCGA-24-2020_treatment","5170fed0-6c99-5fee-a14e-53b3d62e774d","01",NA,"TCGA-24-2020-01A","0.8","871fc478-cf3f-43c2-8aea-0db7c777abe1",FALSE,"4f529d42-acb0-4c02-bd0f-d4a650655df8","Primary Tumor","0.4",NA,NA,"1.1",1247529600,"01",134,"TCGA-24-2020-01A-01",95,95,0,0,0,0,0,5,"2016-09-08T11:32:50.078907-05:00","2016-09-08T11:32:50.078907-05:00",0,0,0,0,"TOP","BOTTOM",0,5,"e210ebcd-ea37-4fe7-9531-1c526757d70a","a863f994-8289-43c8-b1de-2263f5d3bc28","TCGA-24-2020-01A-01-TS1","TCGA-24-2020-01A-01-BS1",100,90,"b90d709a-38ee-4582-bf44-b1d6e42603b6","RNA","TCGA-24-2020-01A-01R","ab297fcf-0cbb-4c04-9986-247ee15f5c38",1.8,0.17,"UV Spec","R","22","TCGA-24-2020-01A-01R-1567-13","19765b4f-458e-4f02-bf96-01498d80ac83",0.17,NA,NA,NA,NA,"18a80ee7-ffab-56c5-8892-0a8b819ac0e0","TCGA-24-2020_exposure","TCGA-24-2020-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T05:44:23.000Z","2014-03-29T06:16:01.000Z","DAFBC682-C333-4860-9E7A-954EBB207C97","871FC478-CF3F-43C2-8AEA-0DB7C777ABE1","Unaligned reads",15669698560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","19765B4F-458E-4F02-BF96-01498D80AC83","Canada's Michael Smith Genome Sciences Centre","564a579ee4b08c5d8693fb7b","E20EA417-7296-4DA8-9FDB-71CD1F45153A","Ovarian Serous Cystadenocarcinoma","TAR","B90D709A-38EE-4582-BF44-B1D6E42603B6","2014-03-29T06:16:02.000Z","AB297FCF-0CBB-4C04-9986-247EE15F5C38","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"B90D709A-38EE-4582-BF44-B1D6E42603B6",0.8,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.809ac07d-5244-462e-a41e-531eeb193296.txt",NA,"TCGA-24-2020-01A",1.1,"DA54104E-EDF3-496D-9BB4-0A3E21627587","TCGA",1994,NA,NA,"WITH TUMOR","871FC478-CF3F-43C2-8AEA-0DB7C777ABE1",67,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.809ac07d-5244-462e-a41e-531eeb193296.txt","Dead",4624,"TCGA-24-2020",NA,"A3ABBFC8-E286-4861-8709-FBE623AD55C4",NA,4624,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,134,"E210EBCD-EA37-4FE7-9531-1C526757D70A","8945289C-59AE-407E-B3C4-AA362222D7C7","4841860026_C_Grn.idat","TCGA-24-2020-01A-01",95,0,0,0,5,"BOTTOM",5,0,"TCGA-24-2020-01A-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-24-2020-D26435",NA,NA,NA,"TCGA-24-2020-F26431_NTE-1",NA,4624,"WITH TUMOR","Dead",4624,"TCGA-24-2020-F26431","TCGA-24-2020",NA,"24","2020","YES","C56.9","8441/3","C56.9",NA,NA,-24682,"FEMALE","WHITE",NA,NA,"No","Dead",4624,4624,NA,NA,"WITH TUMOR","NO",1,3,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,1994,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
227807052,223827375,16581698245,"A59534F6-8637-41FB-A8C2-F8ABAB4E3668.bw","e294b940-2828-499c-be24-47ef6c2e9035","a59534f6-8637-41fb-a8c2-f8abab4e3668","2016-08-26T00:12:11.450266-05:00","TCGA-36-1577-01A-01R-1566-13_rnaseq_fastq.tar","f2e80345-b60e-4284-a377-71d85768a750",13831557120,"Illumina HiSeq","45a4a90417964c004067cba1098b2127","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:34:34.322907-05:00","2016-05-03T11:39:34.528512-05:00","f2e80345-b60e-4284-a377-71d85768a750_analysis.xml","b520a9126a3ad30d46cd5d9374c4b186","e1db9e4b-2d6d-4a4f-8207-0d787d09ca39",2181,"2016-09-29T20:21:58.275175-05:00","f2e80345-b60e-4284-a377-71d85768a750_experiment.xml","0dbae1547b48be6ada10924c455945e1","6a7327f0-2e48-4841-9171-033cd87a7b62",3916,"2016-09-29T23:40:02.811387-05:00","f2e80345-b60e-4284-a377-71d85768a750_run.xml","645c09c21abaa70ab85c56902bf732e4","e54112c1-eceb-47b2-a8ad-9ce7323da763",1988,"2016-09-08T10:45:43.683489-05:00","TCGA-36-1577","2016-09-02T18:48:58.454504-05:00","female","TCGA-36-1577_demographic",1964,"asian","0aeca69b-62e8-51ea-b312-dc3e2ba3237c","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1577_diagnosis","not reported",15804,"alive","8441/3",NA,783,"e3059d66-192a-578d-8167-ccefae83a110","c56.9",-15804,"TCGA-36-1577_treatment","cfd3536f-c38b-5edf-a9c8-7361ace4c9f7","01",NA,"TCGA-36-1577-01A","0.6","73a2a82b-c87c-4c04-8cfe-cc679379b28d",FALSE,"0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc","Primary Tumor","0.6",NA,NA,"1.7",1235952000,"01",104,"TCGA-36-1577-01A-01",70,70,NA,NA,0,0,50,40,"2016-09-08T10:45:43.683489-05:00","2016-09-08T10:45:43.683489-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,10,"ef2d27c9-2651-483e-916d-bd0f0f9b8cc9","68b0e766-085f-40d9-a3ba-2163f81f8af5","TCGA-36-1577-01A-01-TS1","TCGA-36-1577-01A-01-BS1",45,50,"5638e5b1-d2bd-490f-bc95-a61f10c56dd5","RNA","TCGA-36-1577-01A-01R","c4abdc22-3c39-41ae-ac3e-a37132dba82f",1.8,0.14,"UV Spec","R","22","TCGA-36-1577-01A-01R-1566-13","9ec93bbd-5c62-4974-984f-f86301f0d27e",0.14,NA,NA,NA,NA,"8ec631f8-71a6-5955-9e59-8fcb72cf417c","TCGA-36-1577_exposure","TCGA-36-1577-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T08:10:06.000Z","2014-03-20T08:40:01.000Z","F2E80345-B60E-4284-A377-71D85768A750","73A2A82B-C87C-4C04-8CFE-CC679379B28D","Unaligned reads",13831557120,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9EC93BBD-5C62-4974-984F-F86301F0D27E","Canada's Michael Smith Genome Sciences Centre","564a403fe4b093830b6ad345","E294B940-2828-499C-BE24-47EF6C2E9035","Ovarian Serous Cystadenocarcinoma","TAR","5638E5B1-D2BD-490F-BC95-A61F10C56DD5","2014-03-20T08:40:01.000Z","C4ABDC22-3C39-41AE-AC3E-A37132DBA82F","None","NO",1,0.6,"Primary Tumor","BC Cancer Agency",NA,"5638E5B1-D2BD-490F-BC95-A61F10C56DD5",0.6,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ec733c30-ab8b-454e-88f9-8ee34bcf0416.txt",NA,"TCGA-36-1577-01A",1.7,"983593FC-3F1F-42AD-B8AE-4C4868FC29B6","TCGA",2007,NA,NA,"TUMOR FREE","73A2A82B-C87C-4C04-8CFE-CC679379B28D",43,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.ec733c30-ab8b-454e-88f9-8ee34bcf0416.txt","Alive",NA,"TCGA-36-1577",NA,"210FBDA1-7211-4D2B-9EEA-F48F0D3F8567",NA,783,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,"126C8F98-B503-4CFF-AE77-232B4EE73E54","ASIAN",NA,1,104,"EF2D27C9-2651-483E-916D-BD0F0F9B8CC9","C4ABDC22-3C39-41AE-AC3E-A37132DBA82F","TCGA-36-1577-01A-01R-1566-13.hg19.spljxn.quantification.txt","TCGA-36-1577-01A-01",70,0,NA,NA,50,"TOP",5,NA,"TCGA-36-1577-01A-01-TS1",45,"Paclitaxel","Chemotherapy","TCGA-36-1577-D27880","TCGA-36-1577-R27881","EXTERNAL BEAM","Primary Tumor Field",NA,NA,783,"TUMOR FREE","Alive",NA,"TCGA-36-1577-F27878","TCGA-36-1577",NA,"36","1577","YES","C56.9","8441/3","C56.9",NA,NA,-15804,"FEMALE","ASIAN",NA,NA,"No","Alive",783,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,43,2007,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
287409544,267274276,19702911744,"73F28A79-7D35-4FE9-849D-FFE681483928.bw","e35b2813-427e-4e83-95f6-4f0281f42a59","73f28a79-7d35-4fe9-849d-ffe681483928","2016-09-29T20:37:33.516294-05:00","TCGA-3P-A9WA-01A-11R-A406-31_rnaseq_fastq.tar","07b5c2a3-f9cc-4b01-99b8-abaf559dc765",18066739200,"Illumina HiSeq","75a6051ebc1e2429b55906f785ab5a65","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T18:10:57.821672-05:00","2016-06-22T11:19:32.361656-05:00","07b5c2a3-f9cc-4b01-99b8-abaf559dc765_analysis.xml","ae74306eadd635370894c2f788dd2887","18d9c3bb-7433-433c-a9fe-5fb3e6857177",2183,"2016-09-29T17:35:39.477356-05:00","07b5c2a3-f9cc-4b01-99b8-abaf559dc765_experiment.xml","92c1837f83ad5af3d42601fcab2d7bb0","027494c6-c655-4e95-a632-8c9b3d88ba73",3753,"2016-09-29T23:35:17.342641-05:00","07b5c2a3-f9cc-4b01-99b8-abaf559dc765_run.xml","4b7bdbdcc74311bfab9e5acb73fcdd17","e24cb7ff-4045-45e4-9927-e1eb9391c57e",1808,"2016-09-08T12:15:42.384636-05:00","TCGA-3P-A9WA","2016-09-02T19:00:46.121638-05:00","female","TCGA-3P-A9WA_demographic",1958,"black or african american","edad4644-d80b-5b6f-9928-cd2b29f1035b","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","NCH","3P","b298a9df-ecba-591a-985b-655851ac2b46","Greenville Health System","not reported","c56.9","TCGA-3P-A9WA_diagnosis","not reported",20211,"alive","8440/3",NA,420,"a9e4580c-412c-5325-a91d-50fd125a515b","c56.9",-20211,"TCGA-3P-A9WA_treatment","f2773402-3591-5a4f-b4ec-53932172e017","01","false","TCGA-3P-A9WA-01A",NA,"b9e88fa0-fb6d-43c1-b879-bfdc95da9be1",FALSE,"4B2E4D3D-128A-49DD-AE0B-ACFC78615B16","Primary Tumor",NA,126,660,NA,1392595200,"11",30,"TCGA-3P-A9WA-01A-11",80,NA,0,NA,5,NA,15,NA,"2016-09-08T12:15:42.384636-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"ec84245e-56a9-46c1-9496-ccf2587d318e",NA,"TCGA-3P-A9WA-01A-01-TS1",NA,80,NA,"5c04d4a9-0677-4d12-98e8-29b0d4d06d27","RNA","TCGA-3P-A9WA-01A-11R","f0c10dc4-a6d6-4372-a3a5-af61648cd09b",1.89,0.18,"UV Spec","R","23","TCGA-3P-A9WA-01A-11R-A406-31","94e91d8c-244a-48cf-af09-9412659e6759",0.18,NA,NA,NA,NA,"9a1ad833-ca9f-563d-9d7d-2893019e5b3d","TCGA-3P-A9WA_exposure","TCGA-3P-A9WA-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T04:30:54.000Z","2015-02-07T05:04:11.000Z","07B5C2A3-F9CC-4B01-99B8-ABAF559DC765","B9E88FA0-FB6D-43C1-B879-BFDC95DA9BE1","Unaligned reads",18066739200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","94E91D8C-244A-48CF-AF09-9412659E6759","Canada's Michael Smith Genome Sciences Centre","564a5965e4b09c884b271e31","E35B2813-427E-4E83-95F6-4F0281F42A59","Ovarian Serous Cystadenocarcinoma","TAR","5C04D4A9-0677-4D12-98E8-29B0D4D06D27","2015-02-07T05:04:11.000Z","F0C10DC4-A6D6-4372-A3A5-AF61648CD09B","United States","NO",1,NA,"Primary Tumor","Greenville Health System",126,"5C04D4A9-0677-4D12-98E8-29B0D4D06D27",NA,"3P","TCGA-3P-A9WA-01A-11R-A407-13_mirna.bam",660,"TCGA-3P-A9WA-01A",NA,"CBB9DB6A-C8A4-465E-8180-0CE8BB362721","TCGA",2013,NA,"Complete Remission/Response","TUMOR FREE","D4E338E7-C508-41A3-81ED-BFDF7483CC12",55,"nationwidechildrens.org_clinical.TCGA-3P-A9WA.xml","Alive",NA,"TCGA-3P-A9WA","NOT HISPANIC OR LATINO","C711B68A-CDCB-4FDC-A287-F34D57A37C2F",NA,243,"Yes, History of Synchronous/Bilateral Malignancy","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIB",NA,100,NA,"8440/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"EC84245E-56A9-46C1-9496-CCF2587D318E","F0C10DC4-A6D6-4372-A3A5-AF61648CD09B","TCGA-3P-A9WA-01A-11R-A407-13_mirna.bam","TCGA-3P-A9WA-01A-11",80,5,0,5,15,"TOP",0,0,"TCGA-3P-A9WA-01A-01-TS1",80,"Taxol","Chemotherapy","TCGA-3P-A9WA-D60123",NA,NA,NA,NA,"NO",420,"TUMOR FREE","Alive",NA,"TCGA-3P-A9WA-F67273","TCGA-3P-A9WA",NA,"3P","A9WA","YES","C56.9","8440/3","C56.9","YES","NO",-20211,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes, History of Synchronous/Bilateral Malignancy","No","Alive",243,NA,"NO","YES","TUMOR FREE","NO",29,5,2014,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,55,2013,"Other method, specify:",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Complete Remission/Response",NA,6,NA,NA,NA,100,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
128351542,121196967,8903406721,"DBE10F31-6457-4799-A91A-0969ED58A0F4.bw","e43d3769-e25f-4fb7-9080-ea26defaf094","dbe10f31-6457-4799-a91a-0969ed58a0f4","2016-08-26T18:02:39.062780-05:00","TCGA-13-0906-01A-01R-1564-13_rnaseq_fastq.tar","bd206391-fa61-4c88-a0d8-8f7900737601",7671900160,"Illumina HiSeq","6a1691e4bef8c5922832165508893605","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:57:11.085072-05:00","2016-05-03T11:41:05.750744-05:00","bd206391-fa61-4c88-a0d8-8f7900737601_analysis.xml","3d96feb50a65b709d8032858fbc174a7","102cb58f-dc44-4445-8a59-ec21cfa9d486",2208,"2016-10-07T16:49:55.341361-05:00","bd206391-fa61-4c88-a0d8-8f7900737601_experiment.xml","0a97984258eab2a7755de879d8f74db6","a05cd52f-adf0-40a0-841c-48d8730cd358",3916,"2016-09-29T17:53:33.114798-05:00","bd206391-fa61-4c88-a0d8-8f7900737601_run.xml","4bc655cc6311e25e655c01e353ccb5a9","0debb1fc-f5f2-4022-b559-5413027f52bd",1988,"2016-09-08T13:38:24.967862-05:00","TCGA-13-0906","2016-09-02T19:05:32.227557-05:00","female","TCGA-13-0906_demographic",1955,"white","2669e329-d864-59c4-b6a0-2629d82ac5ee","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0906_diagnosis","not reported",18383,"alive","8441/3",NA,3619,"74976cb2-5ac3-5764-a813-40be781e4353","c56.9",-18383,"TCGA-13-0906_treatment","53bebc61-4550-5f45-bb1b-f109e2496117","01",NA,"TCGA-13-0906-01A","1","a0c48680-3caf-49bd-b495-c9fd3a9cbe76",FALSE,"D75790B2-C93F-4723-B691-84EE94656FF1","Primary Tumor","0.4",NA,NA,"1.1",1233705600,"01",150,"TCGA-13-0906-01A-01",80,70,NA,NA,19,30,0,0,"2016-09-08T13:38:24.967862-05:00","2016-09-08T13:38:24.967862-05:00",NA,NA,NA,NA,"BOTTOM","TOP",20,20,"e8aa0544-cc48-4941-9d7f-bbd41aafaa30","7be7e649-9db2-4a60-b120-e912df932701","TCGA-13-0906-01A-01-BS1","TCGA-13-0906-01A-01-TS1",60,50,"908c128c-736e-43ac-b3b9-79b7d6e14632","RNA","TCGA-13-0906-01A-01R","762f9a80-23bd-454b-b066-938480be7a7e",1.8,0.15,"UV Spec","R","22","TCGA-13-0906-01A-01R-1564-13","7fa0eba3-8a33-425d-a7fb-2fa169e5f8e6",0.15,NA,NA,NA,NA,"c134e16e-967a-5b14-8eee-81a0d6f00f99","TCGA-13-0906_exposure","TCGA-13-0906-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T17:25:01.000Z","2014-03-28T17:46:02.000Z","BD206391-FA61-4C88-A0D8-8F7900737601","A0C48680-3CAF-49BD-B495-C9FD3A9CBE76","Unaligned reads",7671900160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7FA0EBA3-8A33-425D-A7FB-2FA169E5F8E6","Canada's Michael Smith Genome Sciences Centre","564a3b71e4b0ef12181a748d","E43D3769-E25F-4FB7-9080-EA26DEFAF094","Ovarian Serous Cystadenocarcinoma","TAR","908C128C-736E-43AC-B3B9-79B7D6E14632","2014-03-28T17:46:02.000Z","762F9A80-23BD-454B-B066-938480BE7A7E","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"908C128C-736E-43AC-B3B9-79B7D6E14632",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.80aaf315-cf54-47e5-b82a-1343e25938ca.txt",NA,"TCGA-13-0906-01A",1.1,"4648BE54-8C2C-4FEF-8FB0-FCB9D8EE65D2","TCGA",2005,NA,NA,"TUMOR FREE","A0C48680-3CAF-49BD-B495-C9FD3A9CBE76",50,"nationwidechildrens.org_biospecimen.TCGA-13-0906.xml","Alive",NA,"TCGA-13-0906","NOT HISPANIC OR LATINO",NA,NA,1367,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,150,"E8AA0544-CC48-4941-9D7F-BBD41AAFAA30","C19D22A1-DB67-4089-B0F4-DE245A4DF3E5","TCGA-13-0906-01A-01R-1564-13_rnaseq_fastq.tar","TCGA-13-0906-01A-01",80,19,NA,NA,0,"BOTTOM",20,NA,"TCGA-13-0906-01A-01-BS1",60,"Paclitaxel","Chemotherapy","TCGA-13-0906-D24737",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0906",NA,"13","0906","YES","C56.9","8441/3","C56.9",NA,NA,-18383,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1367,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
117811840,113939491,8410897144,"40DCBF0D-DA1D-4907-880B-6D12C6C965B0.bw","e5a329ec-e50e-4786-901d-b58474f8ea65","40dcbf0d-da1d-4907-880b-6d12c6c965b0","2016-08-25T20:32:37.184604-05:00","TCGA-13-1496-01A-01R-1565-13_rnaseq_fastq.tar","b1cb7d14-5229-4ac9-8076-febd7c31438c",6618265600,"Illumina HiSeq","d52266758fab436020ea60cdc896e4e2","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:49:16.885797-05:00","2016-05-03T11:40:21.647690-05:00","b1cb7d14-5229-4ac9-8076-febd7c31438c_analysis.xml","b5d95b1976f6c0b0c169d0467c146704","0b34c2c4-051d-4681-81b6-8c04a662c2f7",2208,"2016-08-27T23:11:32.214654-05:00","b1cb7d14-5229-4ac9-8076-febd7c31438c_experiment.xml","77c88e3c785a17a042304110784631cc","2a37d7c9-8714-4f42-af37-0185b52a75b1",3916,"2016-09-29T20:29:44.504262-05:00","b1cb7d14-5229-4ac9-8076-febd7c31438c_run.xml","1ba635172e40211d3d70530a5ad1d272","6f3f7e3c-a5d8-46f4-a0ba-42c75ab22662",1989,"2016-09-08T13:38:26.084369-05:00","TCGA-13-1496","2016-09-02T19:13:51.989298-05:00","female","TCGA-13-1496_demographic",1939,"white","4d5dbb4c-1d7f-5cdf-b9db-1585b9627eb6","not hispanic or latino",2004,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1496_diagnosis","not reported",23993,"dead","8441/3",129,129,"7a1b6225-2e8d-59d5-a142-bc7ed5306fb5","c56.9",-23993,"TCGA-13-1496_treatment","1339ccd3-c639-5b24-b8b2-186a748b9abb","01",NA,"TCGA-13-1496-01A","1","7423b7ef-05e4-4b6c-bad0-bb815d6cfa9a",FALSE,"BCDD1BDE-689B-455D-81A7-C2522417E055","Primary Tumor","0.3",NA,NA,"1.1",1234483200,"01",141,"TCGA-13-1496-01A-01",99,99,NA,NA,0,0,1,1,"2016-09-08T13:38:26.084369-05:00","2016-09-08T13:38:26.084369-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"6e8bc620-4631-48ed-8bf8-866854ef6500","b3b8a7eb-c3a4-406b-8725-ffe82e1427c3","TCGA-13-1496-01A-01-TS1","TCGA-13-1496-01A-01-BS1",94,94,"b9957398-3765-423b-88c5-022c62fb2389","RNA","TCGA-13-1496-01A-01R","2f5e2202-8b25-4e84-a5d2-1783e0b69da0",1.8,0.16,"UV Spec","R","22","TCGA-13-1496-01A-01R-1565-13","cbdfb183-b1af-42ed-a47a-5fee3ac1059e",0.16,NA,NA,NA,NA,"d1424f06-73df-5586-b468-53795552fe56","TCGA-13-1496_exposure","TCGA-13-1496-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:42:37.000Z","2014-03-22T01:58:02.000Z","B1CB7D14-5229-4AC9-8076-FEBD7C31438C","7423B7EF-05E4-4B6C-BAD0-BB815D6CFA9A","Unaligned reads",6618265600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CBDFB183-B1AF-42ED-A47A-5FEE3AC1059E","Canada's Michael Smith Genome Sciences Centre","564a5a74e4b08c5d8694ebac","E5A329EC-E50E-4786-901D-B58474F8EA65","Ovarian Serous Cystadenocarcinoma","TAR","B9957398-3765-423B-88C5-022C62FB2389","2014-03-22T01:58:02.000Z","2F5E2202-8B25-4E84-A5D2-1783E0B69DA0","None","NO",1,0.3,"Primary Tumor","Memorial Sloan Kettering",NA,"B9957398-3765-423B-88C5-022C62FB2389",1,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.35781069-501d-45c3-b3f0-7292b0186211.txt",NA,"TCGA-13-1496-01A",1.1,"B3F86E9E-52C6-40F6-88CF-521BAE342105","TCGA",2004,NA,NA,NA,"7423B7EF-05E4-4B6C-BAD0-BB815D6CFA9A",65,"THETA_p_TCGA_Batch14_SNP_N_GenomeWideSNP_6_B05_455298.raw.copynumber.data.txt","Dead",129,"TCGA-13-1496","NOT HISPANIC OR LATINO","8DF03585-7754-4F4B-A868-BFB88530F053",NA,129,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,141,"B3B8A7EB-C3A4-406B-8725-FFE82E1427C3","6426AD81-7545-4A5D-9241-66A4CB3F7960","TCGA-13-1496-01A-01R-1565-13.gene.quantification.txt","TCGA-13-1496-01A-01",99,0,NA,NA,1,"BOTTOM",5,NA,"TCGA-13-1496-01A-01-BS1",94,"Carboplatin","Chemotherapy","TCGA-13-1496-D24905",NA,NA,NA,NA,NA,129,NA,"Dead",129,"TCGA-13-1496-F24904","TCGA-13-1496",NA,"13","1496","YES","C56.9","8441/3","C56.9",NA,NA,-23993,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",129,129,NA,NA,NA,"NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,65,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
411815388,375578447,27704393360,"3D14F909-A921-43CB-96E8-5F18FC475E49.bw","e641aed9-1dd8-4c30-b231-f12b20a76df0","3d14f909-a921-43cb-96e8-5f18fc475e49","2016-08-19T23:10:03.812958-05:00","TCGA-10-0926-01A-01R-1564-13_rnaseq_fastq.tar","2f9595fd-c47b-495c-bd91-cb04712587cc",27501721600,"Illumina HiSeq","6c5f07c99b4f80b40d6c65b18513c4d6","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:02:06.295591-05:00","2016-05-03T11:39:34.522989-05:00","2f9595fd-c47b-495c-bd91-cb04712587cc_analysis.xml","6f4642f79c44b3d64f7ca1e197188af0","1351f798-15b7-4834-8054-fc89ace04186",2208,"2016-09-29T22:14:54.587373-05:00","2f9595fd-c47b-495c-bd91-cb04712587cc_experiment.xml","52ced099c1a1a01934710f57772f4f89","b078340a-eaf0-43cf-b5c1-2b6165c6a79e",3916,"2016-09-29T21:47:07.408494-05:00","2f9595fd-c47b-495c-bd91-cb04712587cc_run.xml","074659af735bde199acb7c12348f9487","9f3e68c9-b428-4bef-9881-ee15c8671c9a",1988,"2016-09-08T12:58:38.409146-05:00","TCGA-10-0926","2016-09-02T19:06:09.836149-05:00","female","TCGA-10-0926_demographic",1937,"white","4b183665-721a-5e26-a141-269b36017af8","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","10","485f0bc3-42e1-59f9-a4b5-17b11fe02f0c","MD Anderson Cancer Center","not reported","c56.9","TCGA-10-0926_diagnosis","not reported",23307,"dead","8441/3",788,788,"71ac222a-9ac1-59e1-9ee0-70f90b4db4f0","c56.9",-23307,"TCGA-10-0926_treatment","3da69122-0d80-507f-80d5-7c5abfc59d16","01",NA,"TCGA-10-0926-01A","0.8","1c7e0067-e266-4967-9322-5967e112888e",FALSE,"b940b1b3-8278-400e-b43a-e7897e0361b7","Primary Tumor","0.6",NA,NA,"1",1233705600,"01",106,"TCGA-10-0926-01A-01",99,99,NA,NA,5,2,0,0,"2016-09-08T12:58:38.409146-05:00","2016-09-08T12:58:38.409146-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"81702be2-0c3a-4469-9a63-c74a08cc04f5","6cd77de1-2a80-486a-a9dc-aedf82c0921d","TCGA-10-0926-01A-01-TS1","TCGA-10-0926-01A-01-BS1",95,98,"2feeb274-cd14-4e5b-b38b-552be86dcbda","RNA","TCGA-10-0926-01A-01R","b9a23f14-bf2b-486b-955a-e91212ed1bd6",1.7,0.14,"UV Spec","R","22","TCGA-10-0926-01A-01R-1564-13","14bb2756-5d32-4e77-9eec-4e5d44b663b2",0.14,NA,NA,NA,NA,"9afd99cf-bf9a-5986-9af1-80c535175bbd","TCGA-10-0926_exposure","TCGA-10-0926-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-19T21:47:15.000Z","2014-03-19T22:37:01.000Z","2F9595FD-C47B-495C-BD91-CB04712587CC","1C7E0067-E266-4967-9322-5967E112888E","Unaligned reads",27501721600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","14BB2756-5D32-4E77-9EEC-4E5D44B663B2","Canada's Michael Smith Genome Sciences Centre","564a5a2ee4b08c5d8694d4b4","E641AED9-1DD8-4C30-B231-F12B20A76DF0","Ovarian Serous Cystadenocarcinoma","TAR","2FEEB274-CD14-4E5B-B38B-552BE86DCBDA","2014-03-19T22:37:01.000Z","B9A23F14-BF2B-486B-955A-E91212ED1BD6","None","NO",1,0.6,"Primary Tumor","MD Anderson Cancer Center",NA,"2FEEB274-CD14-4E5B-B38B-552BE86DCBDA",0.8,"10","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.fb5e42c3-de28-4dc9-8e33-c56685b72e5e.txt",NA,"TCGA-10-0926-01A",1,"A6419A7D-CF48-41AB-AE3C-4E1E5746E9AD","TCGA",2000,NA,NA,"WITH TUMOR","DEB2588E-18A9-4A43-9394-50623474037C",63,"nationwidechildrens.org_clinical.TCGA-10-0926.xml","Dead",788,"TCGA-10-0926",NA,"7F3CDAF9-ED64-4B9A-8F24-2E9037EB0F86",NA,788,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Operative","Stage IIIC",NA,80,NA,"8441/3","FEMALE","C56.9",11,NA,"7CBE85CE-DC87-48DC-A107-3917C90294B3","WHITE",NA,1,106,"81702BE2-0C3A-4469-9A63-C74A08CC04F5","C082D5FE-F611-41B0-94D2-CA4EF5565237","C239.TCGA-10-0926-01A-01W.8.bam","TCGA-10-0926-01A-01",99,2,NA,NA,0,"BOTTOM",0,NA,"TCGA-10-0926-01A-01-BS1",98,"Doxil","Chemotherapy","TCGA-10-0926-D24416","TCGA-10-0926-R24418",NA,NA,"TCGA-10-0926-F24413_NTE-1",NA,788,"WITH TUMOR","Dead",788,"TCGA-10-0926-F24413","TCGA-10-0926",NA,"10","0926","YES","C56.9","8441/3","C56.9",NA,NA,-23307,"FEMALE","WHITE",NA,NA,"No","Dead",788,788,NA,NA,"WITH TUMOR","NO",6,3,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,63,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,80,NA,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
175072042,171581481,12691161497,"E4E9D828-3904-4014-B1B0-FBF71D4416EB.bw","e732f81c-9b7d-44bd-a905-ff53fbed5009","e4e9d828-3904-4014-b1b0-fbf71d4416eb","2016-09-29T23:39:30.213152-05:00","TCGA-13-0768-01A-01R-1569-13_rnaseq_fastq.tar","97df22b2-724d-4c9a-85f4-81d0321c553a",10795448320,"Illumina HiSeq","510cc77a986c8e59c8223e17316868bd","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:58:42.748232-05:00","2016-05-03T11:56:42.629049-05:00","97df22b2-724d-4c9a-85f4-81d0321c553a_analysis.xml","6b7c02c162f5265746345fed5b09e363","81324dad-e1fa-4f10-b20b-9defb8bec830",2208,"2016-09-29T21:10:09.666626-05:00","97df22b2-724d-4c9a-85f4-81d0321c553a_experiment.xml","dafb9ab746c9fa956892927b2cbe1299","886ad762-021d-448f-bc8b-de9d1b76f414",3916,"2016-09-29T18:30:55.670730-05:00","97df22b2-724d-4c9a-85f4-81d0321c553a_run.xml","6e8d1d45c6859c54610a760445a67395","2534e353-af99-4656-87eb-023c38dcc63a",1988,"2016-09-08T13:45:45.176930-05:00","TCGA-13-0768","2016-09-02T19:09:32.549543-05:00","female","TCGA-13-0768_demographic",1935,"white","966cbbef-f952-52c3-b48d-c694642a69ee","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0768_diagnosis","not reported",26999,"dead","8441/3",1784,257,"d5398208-3c8b-5148-b69e-9f403cbb7786","c56.9",-26999,"TCGA-13-0768_treatment","b31b0776-fe73-5a8b-ae73-4dc7822bd957","01",NA,"TCGA-13-0768-01A","0.7","f2b9f258-092d-4f46-a6c3-f5dc86188746",FALSE,"7D67D0D3-105C-4A00-B104-106BE26FEE2D","Primary Tumor","0.4",NA,NA,"0.8",1233705600,"01",61,"TCGA-13-0768-01A-01",90,94,NA,NA,10,5,NA,1,"2016-09-08T13:45:45.176930-05:00","2016-09-08T13:45:45.176930-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,9,"209a6162-13a3-4fd1-8395-83488491ab9b","a3e6fc49-57bd-4ae6-ab13-bf5e86f13ccf","TCGA-13-0768-01A-01-TS1","TCGA-13-0768-01A-01-BS1",89,85,"5df97230-56c0-4149-8ca2-fee265c3855f","RNA","TCGA-13-0768-01A-01R","0b33334d-b1f5-4369-9195-6ba034c60559",1.8,0.17,"UV Spec","R","22","TCGA-13-0768-01A-01R-1569-13","f6907b8b-95a3-47a8-abe0-239c6ae60482",0.17,NA,NA,NA,NA,"b25fb536-8207-5d75-ae91-e3cbafa93c22","TCGA-13-0768_exposure","TCGA-13-0768-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T01:08:57.000Z","2014-08-20T23:09:37.000Z","97DF22B2-724D-4C9A-85F4-81D0321C553A","F2B9F258-092D-4F46-A6C3-F5DC86188746","Unaligned reads",10795448320,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","F6907B8B-95A3-47A8-ABE0-239C6AE60482","Canada's Michael Smith Genome Sciences Centre","564a3702e4b0ef121819095d","E732F81C-9B7D-44BD-A905-FF53FBED5009","Ovarian Serous Cystadenocarcinoma","TAR","5DF97230-56C0-4149-8CA2-FEE265C3855F","2014-08-08T01:40:37.000Z","0B33334D-B1F5-4369-9195-6BA034C60559","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"5DF97230-56C0-4149-8CA2-FEE265C3855F",0.7,"13","TCGA-13-0768-01A-01R-1569-13_rnaseq.bam.bai",NA,"TCGA-13-0768-01A",0.8,"BC1188FA-1BDD-4A7B-9857-005920B5DDF7","TCGA",2008,NA,NA,"TUMOR FREE","F2B9F258-092D-4F46-A6C3-F5DC86188746",73,"nationwidechildrens.org_clinical.TCGA-13-0768.xml","Alive",NA,"TCGA-13-0768","NOT HISPANIC OR LATINO",NA,NA,257,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,60,NA,"8441/3","FEMALE","C56.9",9,NA,NA,"WHITE",NA,1,61,"A3E6FC49-57BD-4AE6-AB13-BF5E86F13CCF","B6E7BADE-8B4E-483E-9FD7-5147631E18E7","TCGA-13-0768-01A-01R-1569-13_rnaseq.bam.bai","TCGA-13-0768-01A-01",90,10,NA,NA,NA,"TOP",1,NA,"TCGA-13-0768-01A-01-TS1",89,"Paclitaxel","Chemotherapy","TCGA-13-0768-D24574",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0768",NA,"13","0768","YES","C56.9","8441/3","C56.9",NA,NA,-26999,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",257,NA,NA,NA,"TUMOR FREE","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,73,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,60,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
213083752,207688835,15404287730,"7DDC76C2-FE27-4B8C-B750-39F28A057257.bw","e9483296-cb91-497a-b955-39a3c3289dac","7ddc76c2-fe27-4b8c-b750-39f28a057257","2016-08-25T21:00:38.699311-05:00","TCGA-04-1514-01A-01R-1566-13_rnaseq_fastq.tar","693b96fa-603f-4337-af8e-f037f5fab277",13359790080,"Illumina HiSeq","0a1b4c62a688fc15370aae52333cb7c0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:12:40.535270-05:00","2016-05-03T11:40:21.662944-05:00","693b96fa-603f-4337-af8e-f037f5fab277_analysis.xml","ddd927d9a502589e28aea3ffb20b750c","f95dc827-9a0b-40eb-aeeb-99eb0c97ae4e",2181,"2016-10-07T16:37:46.311560-05:00","693b96fa-603f-4337-af8e-f037f5fab277_experiment.xml","e7410fe6e163579a7973cf8c1bd28f6e","36b4bf1f-66c0-42a3-b199-2517401c58dd",3916,"2016-09-29T22:10:35.906815-05:00","693b96fa-603f-4337-af8e-f037f5fab277_run.xml","36dc45a64e625e3bb447130bbce7af86","adc7155e-5efe-4c32-9e52-182c9d5d17bf",1988,"2016-09-08T13:18:43.872488-05:00","TCGA-04-1514","2016-09-02T19:07:10.222166-05:00","female","TCGA-04-1514_demographic",1959,"white","487bc60d-e5db-52e4-88dc-f4f3e93f6695","not hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1514_diagnosis","not reported",16725,"dead","8441/3",1720,NA,"79a5c305-99a7-5b90-b77c-918193fb98fb","c56.9",-16725,"TCGA-04-1514_treatment","f647827c-59b6-586c-b904-2f635ea833ac","01",NA,"TCGA-04-1514-01A","0.5","18e0f4ed-43e2-451f-82bd-102260a30aaa",FALSE,"A0487B93-029F-48EB-AF5C-06A2F5A3FAAA","Primary Tumor","0.5",NA,NA,"1.1",1235260800,"01",103,"TCGA-04-1514-01A-01",95,95,NA,NA,0,0,10,10,"2016-09-08T13:18:43.872488-05:00","2016-09-08T13:18:43.872488-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"e6ce9cf7-7fb0-4dd2-a322-a84becdb2bdc","0a727057-86e2-47b9-be79-eeec6e07542b","TCGA-04-1514-01A-01-BS1","TCGA-04-1514-01A-01-TS1",85,85,"1f648f22-b1db-4e58-9cff-4c620dde71fc","RNA","TCGA-04-1514-01A-01R","eb7409ce-648d-4ac6-b6f1-698e83b7054a",1.8,0.16,"UV Spec","R","22","TCGA-04-1514-01A-01R-1566-13","cc5e2498-a9e6-48be-bbda-9aa101546ca4",0.16,NA,NA,NA,NA,"0b91a603-8787-502e-a2c0-cc765176ea42","TCGA-04-1514_exposure","TCGA-04-1514-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T04:23:20.000Z","2014-03-25T04:47:02.000Z","693B96FA-603F-4337-AF8E-F037F5FAB277","18E0F4ED-43E2-451F-82BD-102260A30AAA","Unaligned reads",13359790080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CC5E2498-A9E6-48BE-BBDA-9AA101546CA4","Canada's Michael Smith Genome Sciences Centre","564a5876e4b0298dd2cb30b0","E9483296-CB91-497A-B955-39A3C3289DAC","Ovarian Serous Cystadenocarcinoma","TAR","1F648F22-B1DB-4E58-9CFF-4C620DDE71FC","2014-03-25T04:47:02.000Z","EB7409CE-648D-4AC6-B6F1-698E83B7054A","None","NO",1,0.5,"Primary Tumor","Gynecologic Oncology Group",NA,"1F648F22-B1DB-4E58-9CFF-4C620DDE71FC",0.5,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8fcd1179-3170-4ca1-b961-dbaa7a391ea4.txt",NA,"TCGA-04-1514-01A",1.1,"FCAB5840-933E-49DF-8FEF-A82D594A24F2","TCGA",2004,NA,NA,"TUMOR FREE","A776A204-BB2F-492F-8934-D91681E28719",45,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.8fcd1179-3170-4ca1-b961-dbaa7a391ea4.txt","Dead",1720,"TCGA-04-1514","NOT HISPANIC OR LATINO","5D6ED657-10C2-447E-BD5E-9A72631507AB",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",15,NA,NA,"WHITE",NA,1,103,"E6CE9CF7-7FB0-4DD2-A322-A84BECDB2BDC","EB7409CE-648D-4AC6-B6F1-698E83B7054A","TCGA-04-1514-01A-01R-1566-13_rnaseq.bam.bai","TCGA-04-1514-01A-01",95,0,NA,NA,10,"TOP",5,NA,"TCGA-04-1514-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-04-1514-D24073",NA,NA,NA,"TCGA-04-1514-F24071_NTE-2",NA,NA,"TUMOR FREE","Dead",1720,"TCGA-04-1514-F24071","TCGA-04-1514",NA,"04","1514","YES","C56.9","8441/3","C56.9",NA,NA,-16725,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1720,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2004,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
169764154,167117855,12376518335,"340E8861-0515-4EC4-B22E-4C9521A16C15.bw","e978a457-92ff-4eab-b759-ec6e74d973e8","340e8861-0515-4ec4-b22e-4c9521a16c15","2016-08-25T14:19:58.379944-05:00","TCGA-59-2350-01A-01R-1569-13_rnaseq_fastq.tar","9a6cfe32-93f2-4e5e-acb9-e56af0fe06e7",10159810560,"Illumina HiSeq","97b86b2a3d32784ab23126f252424ff3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:26:07.817689-05:00","2016-05-03T11:55:09.260045-05:00","9a6cfe32-93f2-4e5e-acb9-e56af0fe06e7_analysis.xml","bf2201bc68eea324057e79d5957f3fb6","2236c652-9a9d-4ac8-b151-fe45b837f2c7",2181,"2016-08-29T19:58:58.243954-05:00","9a6cfe32-93f2-4e5e-acb9-e56af0fe06e7_experiment.xml","cbdaef700e7976336e364108346b5006","cad256c0-ae46-473c-b3f4-ccfa61dfe82c",3916,"2016-09-29T21:06:41.473293-05:00","9a6cfe32-93f2-4e5e-acb9-e56af0fe06e7_run.xml","6dd00cbd1b3016567b433c40bb65529d","8643988f-d86e-468b-aa62-e9fc1d26bba0",1988,"2016-09-08T13:49:32.778472-05:00","TCGA-59-2350","2016-09-02T19:11:57.100357-05:00","female","TCGA-59-2350_demographic",1951,"not reported","acbb0dbd-a668-5906-9c1c-4d880389bda6","not reported",1996,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2350_diagnosis","not reported",NA,"dead","8441/3",679,NA,"ad6e91d2-df71-5fea-b6c5-59d3ea208c19","c56.9",NA,"TCGA-59-2350_treatment","ebdcc39f-1e19-5139-bc18-9fb31e737393","01",NA,"TCGA-59-2350-01A","0.4","d10b7299-8788-4800-b0a4-e836a18d5def",FALSE,"6bd3f7a6-bb9c-42ea-8f20-94db43b51bde","Primary Tumor","0.2",NA,NA,"0.4",1251763200,"01",158,"TCGA-59-2350-01A-01",80,80,NA,NA,1,1,19,19,"2016-09-08T13:49:32.778472-05:00","2016-09-08T13:49:32.778472-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,5,"d023d22a-2e51-4f61-8cd6-b45d4cfdc006","57e502c7-e6b8-4ccc-9ff7-6719c58f48e0","TCGA-59-2350-01A-01-BS1","TCGA-59-2350-01A-01-TS1",79,75,"568ebc92-bbac-4c06-ab2e-55e34b0f1c2f","RNA","TCGA-59-2350-01A-01R","db204de9-4c43-4801-bebe-33eaff5bd7e5",1.8,0.15,"UV Spec","R","22","TCGA-59-2350-01A-01R-1569-13","e05f2e2a-77d2-4f86-8e21-27cdd93b88b0",0.15,NA,NA,NA,NA,"04e692ec-ebec-5678-b3d6-a2dad6d16c07","TCGA-59-2350_exposure","TCGA-59-2350-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-07T23:35:30.000Z","2014-08-08T00:02:20.000Z","9A6CFE32-93F2-4E5E-ACB9-E56AF0FE06E7","D10B7299-8788-4800-B0A4-E836A18D5DEF","Unaligned reads",10159810560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E05F2E2A-77D2-4F86-8E21-27CDD93B88B0","Canada's Michael Smith Genome Sciences Centre","564a58d4e4b0ef12181d562c","E978A457-92FF-4EAB-B759-EC6E74D973E8","Ovarian Serous Cystadenocarcinoma","TAR","568EBC92-BBAC-4C06-AB2E-55E34B0F1C2F","2014-08-08T00:02:20.000Z","DB204DE9-4C43-4801-BEBE-33EAFF5BD7E5","None","NO",1,0.2,"Primary Tumor","Roswell Park",NA,"568EBC92-BBAC-4C06-AB2E-55E34B0F1C2F",0.4,"59","US82800149_251976011206_S01_GE2_105_Dec08.txt_lmean.out.logratio.probe.tcga_level2.data.txt",NA,"TCGA-59-2350-01A",0.4,NA,"TCGA",1995,NA,NA,"WITH TUMOR","D10B7299-8788-4800-B0A4-E836A18D5DEF",44,"nationwidechildrens.org_clinical.TCGA-59-2350.xml","Dead",679,"TCGA-59-2350",NA,"3623594B-C07C-40E0-9EBA-0A95A662D146",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,NA,NA,1,158,"D023D22A-2E51-4F61-8CD6-B45D4CFDC006","FC7CCC84-BC54-42E7-BB52-997D5F07EC8D","US82800149_251976011206_S01_GE2_105_Dec08.txt_lmean.out.logratio.probe.tcga_level2.data.txt","TCGA-59-2350-01A-01",80,1,NA,NA,19,"BOTTOM",1,NA,"TCGA-59-2350-01A-01-BS1",79,NA,NA,NA,NA,NA,NA,"TCGA-59-2350-F28102_NTE-2",NA,NA,"WITH TUMOR","Dead",679,"TCGA-59-2350-F28102","TCGA-59-2350",NA,"59","2350","YES","C56.9","8441/3","C56.9","NO","YES",NA,"FEMALE",NA,NA,NA,"No","Dead",NA,679,NA,NA,"WITH TUMOR","NO",29,1,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,1995,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
163100770,158507143,11703715721,"97FD71A9-2239-4BA0-88DF-0E18774CEE00.bw","e9b5336e-d724-4e7d-8c81-1147abd0a80d","97fd71a9-2239-4ba0-88df-0e18774cee00","2016-08-25T17:49:54.194158-05:00","TCGA-04-1519-01A-01R-1565-13_rnaseq_fastq.tar","09495c68-b745-4353-95ff-fda06095fd89",9612738560,"Illumina HiSeq","7fa8020ad61172a6b80c95a5a4133503","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:48:41.351021-05:00","2016-05-03T11:40:21.647690-05:00","09495c68-b745-4353-95ff-fda06095fd89_analysis.xml","0037aae18fa00535f22c18f48b3c7bec","7ae8410e-3517-4597-9004-6bd33ae31f0b",2181,"2016-09-29T20:10:10.728292-05:00","09495c68-b745-4353-95ff-fda06095fd89_experiment.xml","21910aafeae971d91e2d53cf8fdebd99","63494d98-9fdb-41f5-8d4c-fe4ab0d9f154",3916,"2016-09-30T00:03:43.995795-05:00","09495c68-b745-4353-95ff-fda06095fd89_run.xml","19f1cf935e9c01ca7aa0e5da46929f96","f3ea47ad-c098-4369-a050-4b4327df3304",1989,"2016-09-08T10:48:46.797239-05:00","TCGA-04-1519","2016-09-02T18:47:44.179503-05:00","female","TCGA-04-1519_demographic",1959,"not reported","3f483df1-55d7-5848-ad8c-8ba70f3f0607","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1519_diagnosis","not reported",17671,"alive","8441/3",NA,24,"942ad6a8-7831-5c90-9f54-5783643971c4","c56.9",-17671,"TCGA-04-1519_treatment","cc88078d-f903-5f2e-8c76-a5404d8c8966","01",NA,"TCGA-04-1519-01A","0.4","ef8a2e99-c991-4d51-81ba-34f9a57949b8",FALSE,"53840C6E-E1AA-415E-BB85-8E1B8976F45C","Primary Tumor","0.4",NA,NA,"1.3",1235260800,"01",117,"TCGA-04-1519-01A-01",95,95,NA,NA,0,0,10,10,"2016-09-08T10:48:46.797239-05:00","2016-09-08T10:48:46.797239-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"5b6f7391-88ee-44bc-acf6-076d34d8fa53","46c38c26-c736-4338-8989-5442872dd89b","TCGA-04-1519-01A-01-BS1","TCGA-04-1519-01A-01-TS1",90,90,"1df0a897-76c8-409d-aa28-f0633541dd76","RNA","TCGA-04-1519-01A-01R","4d0203a3-2caf-4664-b90d-068689b3c9cd",1.8,0.16,"UV Spec","R","22","TCGA-04-1519-01A-01R-1565-13","193d3e7f-ec7f-453a-9c2a-77b240c4ba19",0.16,NA,NA,NA,NA,"a3dffe37-015e-5282-8da6-4decaa366aa8","TCGA-04-1519_exposure","TCGA-04-1519-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:13:30.000Z","2014-03-22T02:35:01.000Z","09495C68-B745-4353-95FF-FDA06095FD89","EF8A2E99-C991-4D51-81BA-34F9A57949B8","Unaligned reads",9612738560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","193D3E7F-EC7F-453A-9C2A-77B240C4BA19","Canada's Michael Smith Genome Sciences Centre","564a3e54e4b093830b6a3336","E9B5336E-D724-4E7D-8C81-1147ABD0A80D","Ovarian Serous Cystadenocarcinoma","TAR","1DF0A897-76C8-409D-AA28-F0633541DD76","2014-03-22T02:35:01.000Z","4D0203A3-2CAF-4664-B90D-068689B3C9CD","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"1DF0A897-76C8-409D-AA28-F0633541DD76",0.4,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0ed2d853-f94d-49d0-856b-85d54e4817f5.txt",NA,"TCGA-04-1519-01A",1.3,NA,"TCGA",2007,NA,NA,NA,"EF8A2E99-C991-4D51-81BA-34F9A57949B8",48,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0ed2d853-f94d-49d0-856b-85d54e4817f5.txt",NA,NA,"TCGA-04-1519",NA,"8553B172-7AE7-4A72-8769-5EC3B9F4B20D",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,NA,NA,1,117,"46C38C26-C736-4338-8989-5442872DD89B","F90EF90C-97FA-44B7-A488-D3E8A7CAFC20","TCGA-04-1519-01A-01W-0615-10_SOLiD.bam.bai","TCGA-04-1519-01A-01",95,0,NA,NA,10,"TOP",0,NA,"TCGA-04-1519-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,24,NA,"Alive",NA,"TCGA-04-1519-F58470","TCGA-04-1519",NA,"04","1519","YES","C56.9","8441/3","C56.9",NA,NA,-17671,"FEMALE",NA,NA,NA,"No",NA,NA,NA,NA,NA,NA,"NO",3,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,48,2007,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
173835706,170019089,12574977527,"1BF5E7CD-008A-4CC2-B8A7-7F8E01036D72.bw","ea605be2-6578-4e01-8ec3-bbd84c0b7f1d","1bf5e7cd-008a-4cc2-b8a7-7f8e01036d72","2016-10-13T21:13:58.877146-05:00","TCGA-09-2053-01C-01R-1568-13_rnaseq_fastq.tar","ba463702-e508-4611-bdcf-98a8f28e5a1d",11120496640,"Illumina HiSeq","b5e4eace08ef7a0384d1ac6f70a19a69","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:59:49.313528-05:00","2016-05-03T11:41:05.755204-05:00","ba463702-e508-4611-bdcf-98a8f28e5a1d_analysis.xml","78c35d8ce573e6f7533f567a9e093ad1","f18bea22-4198-456b-b3cc-55a8f7c35c84",2210,"2016-08-13T05:54:35.711231-05:00","ba463702-e508-4611-bdcf-98a8f28e5a1d_experiment.xml","60126cfcbb1a640f953e395f15f852cd","376393fe-2961-4820-9fbb-3f204dadc0c0",3916,"2016-09-29T22:24:38.334322-05:00","ba463702-e508-4611-bdcf-98a8f28e5a1d_run.xml","4d3a7e6705f8f228a277099d2e19e766","b661c0f7-517f-456c-9fff-e0c3a5fe9953",1990,"2016-09-08T12:00:05.689687-05:00","TCGA-09-2053","2016-09-02T18:56:19.747885-05:00","female","TCGA-09-2053_demographic",1933,"white","bb80c4c4-c773-51f5-99e1-61f3b1610405","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2053_diagnosis","not reported",26433,"alive","8441/3",NA,1209,"0517938d-2b87-5aae-a33c-e315635ccbe5","c56.9",-26433,"TCGA-09-2053_treatment","727de4af-4e11-5739-930d-233dbc34ad1f","01",NA,"TCGA-09-2053-01C","0.4","9236e7c0-7b03-4bed-9f19-e3cf805be49b",FALSE,"0d28e549-3ed0-4a22-bac7-9cbe24e44f53","Primary Tumor","0.3",NA,NA,"0.7",1250726400,"01",109,"TCGA-09-2053-01C-01",95,95,NA,NA,0,0,10,10,"2016-09-08T12:00:05.689687-05:00","2016-09-08T12:00:05.689687-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"fd41b083-8281-4f38-8b5a-e9b7ee750d65","195c7a54-114f-4e7c-a4f6-d7283fc4704a","TCGA-09-2053-01C-01-BS1","TCGA-09-2053-01C-01-TS1",90,90,"0e6ff3e8-b75a-4bc3-b69d-7b875bf613a2","RNA","TCGA-09-2053-01C-01R","72df4d8e-1de0-44f2-9718-733423c515f7",1.8,0.14,"UV Spec","R","22","TCGA-09-2053-01C-01R-1568-13","fd1b7b74-067f-4fc9-820a-b80b5954ee10",0.14,NA,NA,NA,NA,"a639c393-e116-5a7e-b95b-9d8b2568f97d","TCGA-09-2053_exposure","TCGA-09-2053-01C-01R-1568-13_rnaseq_fastq.tar","2014-03-27T04:06:47.000Z","2014-03-27T04:29:02.000Z","BA463702-E508-4611-BDCF-98A8F28E5A1D","9236E7C0-7B03-4BED-9F19-E3CF805BE49B","Unaligned reads",11120496640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FD1B7B74-067F-4FC9-820A-B80B5954EE10","Canada's Michael Smith Genome Sciences Centre","564a59eae4b0ef12181db409","EA605BE2-6578-4E01-8EC3-BBD84C0B7F1D","Ovarian Serous Cystadenocarcinoma","TAR","0E6FF3E8-B75A-4BC3-B69D-7B875BF613A2","2014-03-27T04:29:02.000Z","72DF4D8E-1DE0-44F2-9718-733423C515F7","None","NO",1,0.3,"Primary Tumor","UCSF",NA,"0E6FF3E8-B75A-4BC3-B69D-7B875BF613A2",0.4,"09","TCGA-09-2053-01C-01R-1568-13.hg19.gene.quantification.txt",NA,"TCGA-09-2053-01C",0.7,"E2E0C1ED-9AF3-414E-B5E4-B993D4EBF97F","TCGA",2005,NA,NA,"TUMOR FREE","9236E7C0-7B03-4BED-9F19-E3CF805BE49B",72,"nationwidechildrens.org_clinical.TCGA-09-2053.xml","Alive",NA,"TCGA-09-2053","NOT HISPANIC OR LATINO","634220C4-F1BE-44E0-B294-0277C24FF97D",NA,1209,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,109,"FD41B083-8281-4F38-8B5A-E9B7EE750D65","D4E7CFEF-0349-4A05-AD98-1218694E90C2","TCGA-09-2053-01C-01R-1568-13.hg19.gene.quantification.txt","TCGA-09-2053-01C-01",95,0,NA,NA,10,"BOTTOM",0,NA,"TCGA-09-2053-01C-01-BS1",90,"Carboplatin","Chemotherapy","TCGA-09-2053-D24385",NA,NA,NA,NA,NA,1209,"TUMOR FREE","Alive",NA,"TCGA-09-2053-F24384","TCGA-09-2053",NA,"09","2053","YES","C56.9","8441/3","C56.9",NA,NA,-26433,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1209,NA,NA,NA,"TUMOR FREE","NO",2,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,72,2005,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
253111470,247699673,18350527555,"FCC6DE34-0C03-4415-8A7A-3FA5DDBA3105.bw","ea6405c4-0fe4-4f37-bef2-275072f91e39","fcc6de34-0c03-4415-8a7a-3fa5ddba3105","2016-09-30T00:18:10.765448-05:00","TCGA-09-2056-01B-01R-1568-13_rnaseq_fastq.tar","f8a1c7b9-9bf4-430c-afd4-861de4069010",15763343360,"Illumina HiSeq","fdc9dc2c73d96f8b66864a5a59a2a20c","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:55:18.985098-05:00","2016-05-03T11:41:05.755204-05:00","f8a1c7b9-9bf4-430c-afd4-861de4069010_analysis.xml","f68739dd30ba34e616ed557f6ccbcd21","7f1059bb-5c7c-4157-85cf-8934bd3a0df0",2183,"2016-10-07T16:04:20.770113-05:00","f8a1c7b9-9bf4-430c-afd4-861de4069010_experiment.xml","d67349477ba4ac640b85988c416b6c10","13c2ed8c-e8e1-400c-abbe-b7770461df73",3916,"2016-09-29T17:42:49.963689-05:00","f8a1c7b9-9bf4-430c-afd4-861de4069010_run.xml","cf51912742c0653dbc85624f561ec21b","07082194-38d1-415c-b258-b921feed1db6",1990,"2016-09-08T12:19:07.528822-05:00","TCGA-09-2056","2016-09-02T18:56:32.732055-05:00","female","TCGA-09-2056_demographic",1946,"white","639a1216-bb98-5a39-8290-2bc82db55e29","hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-2056_diagnosis","not reported",22864,"alive","8441/3",NA,379,"70e65ccc-6f17-52fe-a1e7-1f828967cdaf","c56.9",-22864,"TCGA-09-2056_treatment","58e398e1-041f-5ea9-b2bc-71395883c72d","01",NA,"TCGA-09-2056-01B","0.7","c6045243-4072-4342-8fb1-f2bbea55fe7b",FALSE,"67bdb457-cfb8-4052-bd33-bff86c736910","Primary Tumor","0.4",NA,NA,"1.6",1248134400,"01",153,"TCGA-09-2056-01B-01",80,80,0,0,0,0,20,20,"2016-09-08T12:19:07.528822-05:00","2016-09-08T12:19:07.528822-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"209a5c45-ac0b-4411-9cb1-7ec50c5f37ff","c06a79f0-b3e3-4099-b892-3ac829ebb42d","TCGA-09-2056-01B-01-BS1","TCGA-09-2056-01B-01-TS1",80,80,"f578774b-fe46-4d47-a3bd-31faadb0b9e6","RNA","TCGA-09-2056-01B-01R","923154b3-a270-44f5-a101-833e19fb1c21",1.8,0.15,"UV Spec","R","22","TCGA-09-2056-01B-01R-1568-13","67670628-ad07-41ef-8977-890080616900",0.15,NA,NA,NA,NA,"9cdf85ae-1322-54f1-8e37-3ddabf716f4d","TCGA-09-2056_exposure","TCGA-09-2056-01B-01R-1568-13_rnaseq_fastq.tar","2014-03-27T05:34:04.000Z","2014-03-27T05:59:02.000Z","F8A1C7B9-9BF4-430C-AFD4-861DE4069010","C6045243-4072-4342-8FB1-F2BBEA55FE7B","Unaligned reads",15763343360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","67670628-AD07-41EF-8977-890080616900","Canada's Michael Smith Genome Sciences Centre","564a5aace4b0298dd2cbec47","EA6405C4-0FE4-4F37-BEF2-275072F91E39","Ovarian Serous Cystadenocarcinoma","TAR","F578774B-FE46-4D47-A3BD-31FAADB0B9E6","2014-03-27T05:59:02.000Z","923154B3-A270-44F5-A101-833E19FB1C21","None","NO",1,0.4,"Primary Tumor","UCSF",NA,"F578774B-FE46-4D47-A3BD-31FAADB0B9E6",0.7,"09","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.568718ea-3d9d-4d09-b155-0b8467a10bbe.txt",NA,"TCGA-09-2056-01B",1.6,"83A5AABD-3F44-4398-9FD1-09FFAC14ACDE","TCGA",2008,NA,NA,"TUMOR FREE","C6045243-4072-4342-8FB1-F2BBEA55FE7B",62,"nationwidechildrens.org_clinical.TCGA-09-2056.xml","Alive",NA,"TCGA-09-2056","HISPANIC OR LATINO","D88C100C-2A42-4EA1-8CF3-60DEF08194E0",NA,379,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,153,"C06A79F0-B3E3-4099-B892-3AC829EBB42D","ABD431A6-9646-4FE5-9328-F84710618496","TCGA-09-2056-01B-01R-1568-13_rnaseq.bam.bai","TCGA-09-2056-01B-01",80,0,0,0,20,"TOP",0,0,"TCGA-09-2056-01B-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-09-2056-D24400",NA,NA,NA,NA,NA,379,"TUMOR FREE","Alive",NA,"TCGA-09-2056-F24399","TCGA-09-2056",NA,"09","2056","YES","C56.9","8441/3","C56.9",NA,NA,-22864,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Alive",379,NA,NA,NA,"TUMOR FREE","NO",2,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
236660356,231812526,17173651209,"F00AFE69-7AA7-49BF-8A46-33CCB5643B1E.bw","eb7c3b35-7a5e-4621-b31f-9775c51f9a23","f00afe69-7aa7-49bf-8a46-33ccb5643b1e","2016-08-23T14:23:58.413257-05:00","TCGA-61-2098-01A-01R-1568-13_rnaseq_fastq.tar","680ed3fa-d07e-4a9f-85e0-fd97f3e8137a",14858321920,"Illumina HiSeq","c99ce86ae635f4e85cdc52b320d1638d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:09:23.180129-05:00","2016-05-03T11:56:42.628342-05:00","680ed3fa-d07e-4a9f-85e0-fd97f3e8137a_analysis.xml","2f33c5afc2f2d4162522f5fe491783b3","ad135c0d-5c90-4f5b-90b4-afe473ce6d8b",2181,"2016-09-29T20:25:05.266368-05:00","680ed3fa-d07e-4a9f-85e0-fd97f3e8137a_experiment.xml","7b354caa5ef6051e04538211b02acf53","6c6b5447-c63b-49bc-b9ac-bdf45c3f1a86",3916,"2016-09-29T18:32:30.304709-05:00","680ed3fa-d07e-4a9f-85e0-fd97f3e8137a_run.xml","3aea4d98430b4202f69d23839ff7c124","261d7d52-b240-49a3-a4f3-a476d3950b6c",1988,"2016-09-08T12:18:43.109190-05:00","TCGA-61-2098","2016-09-02T18:56:26.567359-05:00","female","TCGA-61-2098_demographic",1941,"white","cf4091c2-42a1-5de2-ae37-e74fa4824373","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-2098_diagnosis","not reported",22876,"alive","8441/3",NA,1993,"00f8ee1c-618f-530e-8d64-954aff8478aa","c56.9",-22876,"TCGA-61-2098_treatment","2988bc18-b975-53a3-b1b9-338cb73f5f51","01",NA,"TCGA-61-2098-01A","0.7","60b275ef-91db-4572-a187-74fea2507bb8",FALSE,"d1c8ab49-5ba0-46c3-8205-53b4e39808b3","Primary Tumor","0.5",NA,NA,"2",1250208000,"01",133,"TCGA-61-2098-01A-01",80,70,NA,NA,0,0,20,30,"2016-09-08T12:18:43.109190-05:00","2016-09-08T12:18:43.109190-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"7640aaad-f469-464d-a0cd-efee54d913b9","a353a944-d562-4992-bea2-6c23d01c685a","TCGA-61-2098-01A-01-BS1","TCGA-61-2098-01A-01-TS1",80,70,"2e38f9d2-8051-4cf6-879b-9e5f56bd945c","RNA","TCGA-61-2098-01A-01R","8d77e92b-0e3c-4cce-934e-894e441a8d72",1.8,0.16,"UV Spec","R","22","TCGA-61-2098-01A-01R-1568-13","d855f86a-f302-47fb-aa9f-5977632c695a",0.16,NA,NA,NA,NA,"6375653f-0d84-5775-957c-d9de85ea49c4","TCGA-61-2098_exposure","TCGA-61-2098-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-28T10:58:33.000Z","2014-08-28T12:37:06.000Z","680ED3FA-D07E-4A9F-85E0-FD97F3E8137A","60B275EF-91DB-4572-A187-74FEA2507BB8","Unaligned reads",14858321920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D855F86A-F302-47FB-AA9F-5977632C695A","Canada's Michael Smith Genome Sciences Centre","564a5c0fe4b08c5d86955316","EB7C3B35-7A5E-4621-B31F-9775C51F9A23","Ovarian Serous Cystadenocarcinoma","TAR","2E38F9D2-8051-4CF6-879B-9E5F56BD945C","2014-08-28T12:37:06.000Z","8D77E92B-0E3C-4CCE-934E-894E441A8D72","None","NO",1,0.5,"Primary Tumor","University of Pittsburgh",NA,"2E38F9D2-8051-4CF6-879B-9E5F56BD945C",0.7,"61","TCGA-61-2098-01A-01R-1568-13_rnaseq_fastq.tar",NA,"TCGA-61-2098-01A",2,"E844B70B-EAAE-45A1-98EB-911C6C63E56C","TCGA",2003,NA,NA,"TUMOR FREE","F57D3D51-3754-44B7-88F9-B5B1EAA534C5",62,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f69ce3d8-2a32-4048-a786-50d7e153c051.txt","Alive",NA,"TCGA-61-2098",NA,NA,NA,1993,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,133,"7640AAAD-F469-464D-A0CD-EFEE54D913B9","4E5D81B8-DC06-47EE-839F-72110FC5398C","C239.TCGA-61-2098-01A-01W-0722-08.4.bam","TCGA-61-2098-01A-01",80,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-61-2098-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-61-2098-D28419",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-61-2098",NA,"61","2098","YES","C56.9","8441/3","C56.9",NA,NA,-22876,"FEMALE","WHITE",NA,NA,"No","Alive",1993,NA,NA,NA,"TUMOR FREE","NO",8,12,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,62,2003,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
257128528,247000792,18285773178,"5399B74F-0077-4344-8FEF-5FD21F1FA58F.bw","ebe677e6-94b6-45be-a58d-eaae4cf63d12","5399b74f-0077-4344-8fef-5fd21f1fa58f","2016-08-25T04:07:43.544080-05:00","TCGA-23-2078-01A-01R-1568-13_rnaseq_fastq.tar","b1b9d7e9-996b-4ad1-aac1-1fa659cba1ba",17114787840,"Illumina HiSeq","54b63b28ac888a67bd1176289c99d392","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:39:18.478795-05:00","2016-05-03T11:56:42.628809-05:00","b1b9d7e9-996b-4ad1-aac1-1fa659cba1ba_analysis.xml","d80390dd604f8b58361767d581681bc7","9a5caf86-5fe1-4464-865e-901de3a19ffa",2181,"2016-09-29T21:42:36.782082-05:00","b1b9d7e9-996b-4ad1-aac1-1fa659cba1ba_experiment.xml","1ab841f2150c23eeb522575b9504f4ef","9c6debb6-7db2-4abe-9c87-583a04b77d41",3916,"2016-09-29T21:59:24.253468-05:00","b1b9d7e9-996b-4ad1-aac1-1fa659cba1ba_run.xml","5e4654383280913d7a293f0efce8f9fc","a6fa2fef-8ef2-40e4-a6f1-bc34347d30b0",1988,"2016-09-08T12:58:14.428838-05:00","TCGA-23-2078","2016-09-02T18:56:08.246001-05:00","female","TCGA-23-2078_demographic",1935,"white","ff617d73-37ba-5c86-9928-ca9ee553692f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-2078_diagnosis","not reported",24223,"alive","8441/3",NA,2661,"2d20c4d9-3e33-5e7a-90e1-7a4f1dbae09a","c56.9",-24223,"TCGA-23-2078_treatment","17e4fc0d-a5b6-5818-bdc4-8e2779727abd","01",NA,"TCGA-23-2078-01A","0.6","dc3d8cea-908f-423f-976d-150bb1050063",FALSE,"19ed5fbe-17e1-43f3-bfa0-32f474a00be8","Primary Tumor","0.5",NA,NA,"0.9",1248739200,"01",136,"TCGA-23-2078-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T12:58:14.428838-05:00","2016-09-08T12:58:14.428838-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"c1e1c7cc-0a12-4f15-8b94-57414753099e","7db37047-3ad5-4aff-b568-fc496df7f508","TCGA-23-2078-01A-01-TS1","TCGA-23-2078-01A-01-BS1",89,89,"5d080506-3a0c-493c-8eb3-be36c43e7318","RNA","TCGA-23-2078-01A-01R","9098835a-243b-4757-a39a-edcc5d631fd9",1.8,0.15,"UV Spec","R","22","TCGA-23-2078-01A-01R-1568-13","9f35075d-4d81-44f2-a672-12028d6231be",0.15,NA,NA,NA,NA,"55e16158-ad79-52ac-9253-be2cb97173ff","TCGA-23-2078_exposure","TCGA-23-2078-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T07:37:55.000Z","2014-08-26T09:29:44.000Z","B1B9D7E9-996B-4AD1-AAC1-1FA659CBA1BA","DC3D8CEA-908F-423F-976D-150BB1050063","Unaligned reads",17114787840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9F35075D-4D81-44F2-A672-12028D6231BE","Canada's Michael Smith Genome Sciences Centre","564a571ce4b093830b6b959b","EBE677E6-94B6-45BE-A58D-EAAE4CF63D12","Ovarian Serous Cystadenocarcinoma","TAR","5D080506-3A0C-493C-8EB3-BE36C43E7318","2014-08-26T09:29:45.000Z","9098835A-243B-4757-A39A-EDCC5D631FD9","None","NO",1,0.5,"Primary Tumor","Cedars Sinai",NA,"5D080506-3A0C-493C-8EB3-BE36C43E7318",0.6,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5ea02416-3cd8-443c-8336-4ad367757f38.txt",NA,"TCGA-23-2078-01A",0.9,"E275DC2A-FE10-41D0-9A98-FE92DE858AB9","TCGA",2001,NA,NA,"TUMOR FREE","DC3D8CEA-908F-423F-976D-150BB1050063",66,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5ea02416-3cd8-443c-8336-4ad367757f38.txt","Alive",NA,"TCGA-23-2078","NOT HISPANIC OR LATINO","A7BC8FE5-86CB-4DA0-A383-0BE6D1F16C49",NA,2661,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,136,"C1E1C7CC-0A12-4F15-8B94-57414753099E","C2277CA1-A427-454F-896A-1B29EEF7DCCA","TCGA-23-2078-01A-01R-1568-13.exon.quantification.txt","TCGA-23-2078-01A-01",90,0,NA,NA,10,"BOTTOM",1,NA,"TCGA-23-2078-01A-01-BS1",89,"Taxol","Chemotherapy","TCGA-23-2078-D25773",NA,NA,NA,NA,NA,2661,"TUMOR FREE","Alive",NA,"TCGA-23-2078-F25771","TCGA-23-2078",NA,"23","2078","YES","C56.9","8441/3","C56.9",NA,NA,-24223,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2661,NA,NA,NA,"TUMOR FREE","NO",20,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,66,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
167995098,159497556,11766608021,"76E8D0C1-78E6-469C-878D-BB9D611DB735.bw","ed21615c-0de3-421c-9e8d-8996026c4431","76e8d0c1-78e6-469c-878d-bb9d611db735","2016-08-21T01:42:24.378617-05:00","TCGA-57-1584-01A-01R-1566-13_rnaseq_fastq.tar","55b1ddf7-9faa-4714-a236-ed56fd71a08c",11205232640,"Illumina HiSeq","732ba1d17666753c91be9d5fd84f0c88","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:15:41.426665-05:00","2016-05-03T11:40:21.662944-05:00","55b1ddf7-9faa-4714-a236-ed56fd71a08c_analysis.xml","416f8f232a6fe7661e5d572e4f88545b","d61cdadb-2624-4a1b-90f1-29391269de0a",2181,"2016-10-07T16:46:47.682720-05:00","55b1ddf7-9faa-4714-a236-ed56fd71a08c_experiment.xml","ae19742105aae72f5b7ac08c299fa16c","375cf7a6-891c-440c-9c7b-126048d0fb2e",3916,"2016-09-29T23:02:14.867891-05:00","55b1ddf7-9faa-4714-a236-ed56fd71a08c_run.xml","1e837d37315acafbbc3f32c0c75a56ee","cd9d7179-d1bb-48f5-b4e0-bbb38bb4880f",1988,"2016-09-08T11:16:33.958913-05:00","TCGA-57-1584","2016-09-02T18:47:37.962638-05:00","female","TCGA-57-1584_demographic",1960,"white","7330b127-a51c-583d-a55b-d390f16ea0c2","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","57","0dbb0159-41ed-55fd-a989-c53147a34719","International Genomics Consortium","not reported","c56.9","TCGA-57-1584_diagnosis","not reported",17263,"alive","8441/3",NA,643,"6d0c4029-6165-5461-9759-8581bfb6c538","c56.9",-17263,"TCGA-57-1584_treatment","ff36a589-56d2-535a-9593-1cd26c63b156","01",NA,"TCGA-57-1584-01A","1","99287cbc-e4d4-4d24-b373-7865b7905727",FALSE,"3e4b484e-4727-444f-b2bc-c32d5d1ad815","Primary Tumor","0.8",NA,NA,"2.3",1237161600,"01",147,"TCGA-57-1584-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T11:16:33.958913-05:00","2016-09-08T11:16:33.958913-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"f3dcde68-506f-4250-909b-18833b596180","b57410ca-d6e6-484d-96ad-5ed4d8294995","TCGA-57-1584-01A-01-BS1","TCGA-57-1584-01A-01-TS1",90,90,"3db9d93f-0752-4cc9-b00d-aaba1b4ea3c8","RNA","TCGA-57-1584-01A-01R","4429c3a8-508a-485f-9bd6-8e1d055f0bbf",1.8,0.14,"UV Spec","R","22","TCGA-57-1584-01A-01R-1566-13","e92b95df-bacb-4083-b2de-78e540ec0e68",0.14,NA,NA,NA,NA,"bef717db-3695-50af-8887-85f135932d37","TCGA-57-1584_exposure","TCGA-57-1584-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T00:47:17.000Z","2014-03-25T01:24:01.000Z","55B1DDF7-9FAA-4714-A236-ED56FD71A08C","99287CBC-E4D4-4D24-B373-7865B7905727","Unaligned reads",11205232640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E92B95DF-BACB-4083-B2DE-78E540EC0E68","Canada's Michael Smith Genome Sciences Centre","564a4099e4b0ef12181c1cca","ED21615C-0DE3-421C-9E8D-8996026C4431","Ovarian Serous Cystadenocarcinoma","TAR","3DB9D93F-0752-4CC9-B00D-AABA1B4EA3C8","2014-03-25T01:24:02.000Z","4429C3A8-508A-485F-9BD6-8E1D055F0BBF","None","NO",1,0.8,"Primary Tumor","International Genomics Consortium",NA,"3DB9D93F-0752-4CC9-B00D-AABA1B4EA3C8",1,"57","TCGA-57-1584-01A-01R-1566-13_rnaseq_fastq.tar",NA,"TCGA-57-1584-01A",2.3,"EBF8762C-60C4-480C-B622-F381BD0C690B","TCGA",2007,NA,NA,"WITH TUMOR","F2F1C3DA-CBC7-4B11-888D-ED81B9A685D4",47,"nationwidechildrens.org_clinical.TCGA-57-1584.xml","Alive",NA,"TCGA-57-1584","NOT HISPANIC OR LATINO","ACA7DFDD-2755-43E1-A775-1687DEE80C72",NA,643,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,147,"F3DCDE68-506F-4250-909B-18833B596180","B2E2D77E-34AA-4265-A838-BF7DEDFEDD3D","TCGA-57-1584-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-57-1584-01A-01",90,0,NA,NA,10,"TOP",0,NA,"TCGA-57-1584-01A-01-TS1",90,"Taxol","Chemotherapy","TCGA-57-1584-D28073",NA,NA,NA,"TCGA-57-1584-F28072_NTE-2",NA,643,"WITH TUMOR","Alive",NA,"TCGA-57-1584-F28072","TCGA-57-1584",NA,"57","1584","YES","C56.9","8441/3","C56.9",NA,NA,-17263,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",643,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,47,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
282018388,261690189,19268564314,"C35CBC8E-8243-4AB8-BA23-61DAC181B983.bw","ee0a4a13-613e-4c5d-96c3-8083a013702d","c35cbc8e-8243-4ab8-ba23-61dac181b983","2016-08-22T11:35:08.023789-05:00","TCGA-13-0890-01A-01R-1564-13_rnaseq_fastq.tar","b0f7b8b5-e313-4476-b2f9-44fcaf9c2fb2",18501488640,"Illumina HiSeq","bb31d021d4df8014d8183717623fd79e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:48:28.844417-05:00","2016-05-03T11:27:59.332723-05:00","b0f7b8b5-e313-4476-b2f9-44fcaf9c2fb2_analysis.xml","e18832dbca9d83b9befea89b0500343d","a01558b8-37e5-45c4-af21-0a7ca128f077",2183,"2016-09-29T23:06:24.922142-05:00","b0f7b8b5-e313-4476-b2f9-44fcaf9c2fb2_experiment.xml","c4d1705687081cc624e1a5b38f471dd5","d054c11d-30c7-482a-9d89-36b8737ed2c4",3916,"2016-09-29T19:06:51.030976-05:00","b0f7b8b5-e313-4476-b2f9-44fcaf9c2fb2_run.xml","7c024d5702765936f13314f83844dd1a","3c0bf8d3-ad3f-4050-88a0-a4c76c449b2c",1990,"2016-09-08T13:10:46.907476-05:00","TCGA-13-0890","2016-09-02T19:05:14.425122-05:00","female","TCGA-13-0890_demographic",1947,"white","6960bb68-8fae-5be5-9d7e-982396e47b8d","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0890_diagnosis","not reported",20770,"alive","8441/3",NA,4424,"a88cf420-1c97-5791-903a-e746648a710e","c56.9",-20770,"TCGA-13-0890_treatment","2ca3a348-8e6c-5023-8007-6ba8914c17bc","01",NA,"TCGA-13-0890-01A","1.5","37981859-ba7a-4f93-8fcb-78615e696149",FALSE,"78888517-0ADC-4A78-B7FA-9ACE201795AB","Primary Tumor","0.4",NA,NA,"1.5",1233705600,"01",150,"TCGA-13-0890-01A-01",80,80,NA,NA,20,20,0,0,"2016-09-08T13:10:46.907476-05:00","2016-09-08T13:10:46.907476-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,5,"6433d874-5a87-4965-9072-6cd85d3ab811","90e54a40-8822-418a-873b-a395d8cba02c","TCGA-13-0890-01A-01-BS1","TCGA-13-0890-01A-01-TS1",79,75,"43401017-dce9-4ada-9062-e214bcb4021a","RNA","TCGA-13-0890-01A-01R","5ec75488-7424-4429-8c4d-d66af502da58",1.8,0.16,"UV Spec","R","22","TCGA-13-0890-01A-01R-1564-13","65cc3a15-cfa9-48fb-b9e4-801398b073b8",0.16,NA,NA,NA,NA,"a2a2e2f4-b21b-5b2a-8a0a-1e9ee1f625c5","TCGA-13-0890_exposure","TCGA-13-0890-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T23:50:04.000Z","2013-12-21T00:24:02.000Z","B0F7B8B5-E313-4476-B2F9-44FCAF9C2FB2","37981859-BA7A-4F93-8FCB-78615E696149","Unaligned reads",18501488640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","65CC3A15-CFA9-48FB-B9E4-801398B073B8","Canada's Michael Smith Genome Sciences Centre","564a3673e4b09c884b22da54","EE0A4A13-613E-4C5D-96C3-8083A013702D","Ovarian Serous Cystadenocarcinoma","TAR","43401017-DCE9-4ADA-9062-E214BCB4021A","2013-12-21T00:24:02.000Z","5EC75488-7424-4429-8C4D-D66AF502DA58","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"43401017-DCE9-4ADA-9062-E214BCB4021A",1.5,"13","TCGA-13-0890-01A-01R-1564-13_mirna.bam",NA,"TCGA-13-0890-01A",1.5,"70389C25-6516-4DBE-96A8-657AE7A0C003","TCGA",2003,NA,NA,"TUMOR FREE","37981859-BA7A-4F93-8FCB-78615E696149",56,"nationwidechildrens.org_clinical.TCGA-13-0890.xml","Alive",NA,"TCGA-13-0890","NOT HISPANIC OR LATINO",NA,NA,2068,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,150,"90E54A40-8822-418A-873B-A395D8CBA02C","5EC75488-7424-4429-8C4D-D66AF502DA58","TCGA-13-0890-01A-01R-1564-13_mirna.bam","TCGA-13-0890-01A-01",80,20,NA,NA,0,"BOTTOM",1,NA,"TCGA-13-0890-01A-01-BS1",79,"Paclitaxel","Chemotherapy","TCGA-13-0890-D24684",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-13-0890",NA,"13","0890","YES","C56.9","8441/3","C56.9",NA,NA,-20770,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",2068,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,56,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
189949576,183850382,13606832680,"9ABE2925-DC30-49FC-9A27-1191E2A3388F.bw","eeb9d147-608d-4692-8adf-2f601d23a8ff","9abe2925-dc30-49fc-9a27-1191e2a3388f","2016-08-25T18:27:07.353076-05:00","TCGA-36-1574-01A-01R-1566-13_rnaseq_fastq.tar","9b9e9b38-847d-4fee-9d65-78c3aa0a93d4",12433367040,"Illumina HiSeq","65f147bfa9f662c1048f4afc6113874a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:33:21.170847-05:00","2016-05-03T11:40:21.648199-05:00","9b9e9b38-847d-4fee-9d65-78c3aa0a93d4_analysis.xml","57b73456b79f9241d93f3e8083359e3c","4ca64cc0-797f-4646-a2bd-3c40d737f058",2181,"2016-08-29T02:01:16.699698-05:00","9b9e9b38-847d-4fee-9d65-78c3aa0a93d4_experiment.xml","24beaadc63d54e297ab6912e414c327b","2cb2ddc6-67aa-4256-81c9-505f6e53eb57",3916,"2016-09-29T20:47:32.779428-05:00","9b9e9b38-847d-4fee-9d65-78c3aa0a93d4_run.xml","e2eba0ba818a5b038e5d0b4cf0d05d83","7a2de521-ff69-4923-840a-4129f79cc6d2",1988,"2016-09-08T11:22:12.500267-05:00","TCGA-36-1574","2016-09-02T18:48:46.435180-05:00","female","TCGA-36-1574_demographic",1959,"asian","46847140-fc89-5fa9-934e-d1c3ec70f956","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1574_diagnosis","not reported",17847,"alive","8441/3",NA,686,"c26a3c0e-765f-5b6f-be27-9e886aeaad31","c56.9",-17847,"TCGA-36-1574_treatment","fa6eed8c-3187-56b6-83a7-e6424af3c8ae","01",NA,"TCGA-36-1574-01A","0.5","353b6c00-ebfe-4650-8379-f46c8fe3e9cf",FALSE,"174e0ef6-e8bc-4c43-8253-ee6d3ff9c1ce","Primary Tumor","0.4",NA,NA,"0.7",1235952000,"01",144,"TCGA-36-1574-01A-01",80,80,NA,NA,0,0,20,20,"2016-09-08T11:22:12.500267-05:00","2016-09-08T11:22:12.500267-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"f108ae98-b589-4ddc-91f4-15ab328fc6ba","0ebf58a0-dd01-40b2-9f37-5970f65cf9bb","TCGA-36-1574-01A-01-BS1","TCGA-36-1574-01A-01-TS1",80,80,"e018cce4-4715-4acf-be65-bfac9fcfb6a3","RNA","TCGA-36-1574-01A-01R","9b2353da-8007-4e01-a8ba-9cfed2001a92",1.8,0.15,"UV Spec","R","22","TCGA-36-1574-01A-01R-1566-13","ff781a4f-7281-4195-880f-3df099a401cc",0.15,NA,NA,NA,NA,"685eca3c-d4ab-5d49-85d8-09a25ca59717","TCGA-36-1574_exposure","TCGA-36-1574-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T05:19:43.000Z","2014-03-25T05:45:02.000Z","9B9E9B38-847D-4FEE-9D65-78C3AA0A93D4","353B6C00-EBFE-4650-8379-F46C8FE3E9CF","Unaligned reads",12433367040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","FF781A4F-7281-4195-880F-3DF099A401CC","Canada's Michael Smith Genome Sciences Centre","564a5bf5e4b09c884b27bc6e","EEB9D147-608D-4692-8ADF-2F601D23A8FF","Ovarian Serous Cystadenocarcinoma","TAR","E018CCE4-4715-4ACF-BE65-BFAC9FCFB6A3","2014-03-25T05:45:02.000Z","9B2353DA-8007-4E01-A8BA-9CFED2001A92","None","NO",1,0.4,"Primary Tumor","BC Cancer Agency",NA,"E018CCE4-4715-4ACF-BE65-BFAC9FCFB6A3",0.5,"36","TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.bam.bai",NA,"TCGA-36-1574-01A",0.7,"B60340A0-DAD8-46B3-93D0-E6F6518416C5","TCGA",2007,NA,NA,"WITH TUMOR","BEC8DC7B-A66E-485E-B7E2-0CA00E2FF9AE",48,"nationwidechildrens.org_clinical.TCGA-36-1574.xml","Alive",NA,"TCGA-36-1574",NA,"A362D009-06B1-4EC1-A13B-762036F060A8",NA,686,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"ASIAN",NA,1,144,"F108AE98-B589-4DDC-91F4-15AB328FC6BA","F3D1FE94-6C53-47AE-BA80-720AA9A68232","4760681004_K_Grn.idat","TCGA-36-1574-01A-01",80,0,NA,NA,20,"TOP",0,NA,"TCGA-36-1574-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-36-1574-D27869",NA,NA,NA,"TCGA-36-1574-F27868_NTE-1",NA,686,"WITH TUMOR","Alive",NA,"TCGA-36-1574-F27868","TCGA-36-1574",NA,"36","1574","YES","C56.9","8441/3","C56.9",NA,NA,-17847,"FEMALE","ASIAN",NA,NA,"No","Alive",686,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,48,2007,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
277389376,270409772,20038442273,"C0EC6915-DCA2-48A6-9B6A-171502178AA3.bw","eec69ea9-ceb8-456a-aff4-41fb8a261e36","c0ec6915-dca2-48a6-9b6a-171502178aa3","2016-08-22T10:53:59.280396-05:00","TCGA-24-2261-01A-01R-1568-13_rnaseq_fastq.tar","a6ec5adc-fe60-43d1-a297-6022c42f5c32",17697587200,"Illumina HiSeq","c1856f8947ec61c371b73cd6e51e0c08","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:42:19.016032-05:00","2016-05-03T11:56:42.628809-05:00","a6ec5adc-fe60-43d1-a297-6022c42f5c32_analysis.xml","8e6892104951e72fe7f7b67610e998ab","2c7cbbe8-63a9-45e3-bd15-d903ba29913d",2181,"2016-08-29T16:37:25.527374-05:00","a6ec5adc-fe60-43d1-a297-6022c42f5c32_experiment.xml","301e3b9866ba569fad27bb6f0806a163","07a75884-0d17-412a-8bd0-389bba650cb0",3916,"2016-09-30T00:01:57.498535-05:00","a6ec5adc-fe60-43d1-a297-6022c42f5c32_run.xml","720e0e4f3c37a91cee9cf4578b33d0fa","f2d274ce-22b2-4264-a018-e410b7822702",1988,"2016-09-08T12:50:17.107426-05:00","TCGA-24-2261","2016-09-02T18:56:21.462099-05:00","female","TCGA-24-2261_demographic",1916,"white","ff97c3b6-41e4-5f1e-a06b-1dfb04a62127","not reported",1992,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-2261_diagnosis","not reported",27897,"dead","8441/3",24,24,"98810cc1-7704-5e6c-8b7c-fbd3eaa7803b","c56.9",-27897,"TCGA-24-2261_treatment","be9eddb1-e95e-5731-90c8-be143d3f79d6","01",NA,"TCGA-24-2261-01A","1.4","7bcd356d-7031-44b1-b1d7-8d8f60f0caff",FALSE,"6145afd6-e7d7-47bc-a659-ac84c3434e86","Primary Tumor","0.4",NA,NA,"1.7",1250812800,"01",137,"TCGA-24-2261-01A-01",90,90,NA,NA,1,1,9,9,"2016-09-08T12:50:17.107426-05:00","2016-09-08T12:50:17.107426-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"f82e1a66-2764-4fc1-8a91-3b907c7f54ad","be1df9a9-9cb9-43e5-a447-56368f965041","TCGA-24-2261-01A-01-BS1","TCGA-24-2261-01A-01-TS1",85,85,"82116a0d-70ab-4f58-9172-094937eb01a7","RNA","TCGA-24-2261-01A-01R","eaa2f5c6-40bd-4b73-af56-aaf174197f93",1.8,0.15,"UV Spec","R","22","TCGA-24-2261-01A-01R-1568-13","75e9506a-d007-4fb2-8bdd-7e7780653a63",0.15,NA,NA,NA,NA,"12aeecf9-f969-5c5b-ac8a-6c3b1cbfbcd9","TCGA-24-2261_exposure","TCGA-24-2261-01A-01R-1568-13_rnaseq_fastq.tar","2014-08-26T17:41:19.000Z","2014-08-26T07:47:27.000Z","A6EC5ADC-FE60-43D1-A297-6022C42F5C32","7BCD356D-7031-44B1-B1D7-8D8F60F0CAFF","Unaligned reads",17697587200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","75E9506A-D007-4FB2-8BDD-7E7780653A63","Canada's Michael Smith Genome Sciences Centre","564a3604e4b0ef121818b757","EEC69EA9-CEB8-456A-AFF4-41FB8A261E36","Ovarian Serous Cystadenocarcinoma","TAR","82116A0D-70AB-4F58-9172-094937EB01A7","2014-08-26T07:47:27.000Z","EAA2F5C6-40BD-4B73-AF56-AAF174197F93","None","NO",1,0.4,"Primary Tumor","Washington University",NA,"82116A0D-70AB-4F58-9172-094937EB01A7",1.4,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.cbbb0190-5bfe-4a4f-aabe-63d68021b388.txt",NA,"TCGA-24-2261-01A",1.7,NA,"TCGA",1992,NA,NA,"WITH TUMOR","E7F2D8A0-529C-450B-A11C-D97B563165FB",76,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.cbbb0190-5bfe-4a4f-aabe-63d68021b388.txt","Dead",24,"TCGA-24-2261",NA,"D38E75D8-914A-44FE-8F84-904C95B9A680",NA,24,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,137,"F82E1A66-2764-4FC1-8A91-3B907C7F54AD","B8DE5FBE-81B0-4C28-84E6-FAD2E761184C","TCGA-24-2261-01A-01R-1568-13.gene.quantification.txt","TCGA-24-2261-01A-01",90,1,NA,NA,9,"BOTTOM",5,NA,"TCGA-24-2261-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,NA,NA,24,"WITH TUMOR","Dead",24,"TCGA-24-2261-F26540","TCGA-24-2261",NA,"24","2261","YES","C56.9","8441/3","C56.9",NA,NA,-27897,"FEMALE","WHITE",NA,NA,"No","Dead",24,24,NA,NA,"WITH TUMOR","NO",15,3,2010,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,76,1992,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
176665514,172194028,12741405311,"432CE029-5BE4-48ED-9CED-B8FF2CB4AFEC.bw","ef57bc45-858f-4d4e-8407-b7eadfa43be5","432ce029-5be4-48ed-9ced-b8ff2cb4afec","2016-09-29T19:18:14.243039-05:00","TCGA-23-2077-01A-01R-1568-13_rnaseq_fastq.tar","6a2d4801-fa75-4891-8ca3-01b955fb1a51",11579658240,"Illumina HiSeq","6b1d40fbf5f8c04961918fe5c8627e30","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:36:12.959505-05:00","2016-05-03T11:41:05.755204-05:00","6a2d4801-fa75-4891-8ca3-01b955fb1a51_analysis.xml","8b9da72d845389b189dd4fde5b0067e6","e2e35d39-51d1-48f2-83f0-6588b94d2dc7",2183,"2016-09-29T20:29:13.343247-05:00","6a2d4801-fa75-4891-8ca3-01b955fb1a51_experiment.xml","074a6c9737e25ff399bb7c382a795da5","6ee96a75-b540-4685-9b42-0f7c2f5bb1a6",3916,"2016-09-29T18:33:09.563897-05:00","6a2d4801-fa75-4891-8ca3-01b955fb1a51_run.xml","6badccf2678fa5863c0ba47cd9989dd8","2684fb79-72d2-47a1-bf8d-46e9ef799616",1990,"2016-09-08T12:38:37.798408-05:00","TCGA-23-2077","2016-09-02T18:56:23.976802-05:00","female","TCGA-23-2077_demographic",1954,"white","0710e66b-9d53-5515-b2cb-efd06694efa5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-2077_diagnosis","not reported",16552,"alive","8441/3",NA,3525,"11764381-ed45-5beb-b0c8-dec64df1b651","c56.9",-16552,"TCGA-23-2077_treatment","b3dafbc4-eb4d-5509-9216-2626b9466861","01",NA,"TCGA-23-2077-01A","0.9","70944721-dbf3-4a65-ae98-a008a48ba55e",FALSE,"55589297-f28e-422c-beee-6cb19a2350be","Primary Tumor","0.4",NA,NA,"1.1",1248739200,"01",128,"TCGA-23-2077-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T12:38:37.798408-05:00","2016-09-08T12:38:37.798408-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"fe4d3109-2e84-44ee-8599-04c1931d2012","b658f179-d2f9-4a22-a915-22a36159cf9a","TCGA-23-2077-01A-01-BS1","TCGA-23-2077-01A-01-TS1",95,95,"2625dbfd-43df-41f0-8152-f2a9df1e1648","RNA","TCGA-23-2077-01A-01R","7e750266-09fa-445c-8657-61d609a5e442",1.8,0.16,"UV Spec","R","22","TCGA-23-2077-01A-01R-1568-13","16c61c5a-a9b3-4022-9b79-d593e3519794",0.16,NA,NA,NA,NA,"e5dbbd07-7c1b-5322-a4ad-b10e1188a424","TCGA-23-2077_exposure","TCGA-23-2077-01A-01R-1568-13_rnaseq_fastq.tar","2014-03-27T06:05:43.000Z","2014-03-27T06:28:01.000Z","6A2D4801-FA75-4891-8CA3-01B955FB1A51","70944721-DBF3-4A65-AE98-A008A48BA55E","Unaligned reads",11579658240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","16C61C5A-A9B3-4022-9B79-D593E3519794","Canada's Michael Smith Genome Sciences Centre","564a581ae4b0ef12181d1988","EF57BC45-858F-4D4E-8407-B7EADFA43BE5","Ovarian Serous Cystadenocarcinoma","TAR","2625DBFD-43DF-41F0-8152-F2A9DF1E1648","2014-03-27T06:28:01.000Z","7E750266-09FA-445C-8657-61D609A5E442","None","NO",1,0.4,"Primary Tumor","Cedars Sinai",NA,"2625DBFD-43DF-41F0-8152-F2A9DF1E1648",0.9,"23","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3848ccad-5f29-40f6-8407-05e548a3b8e5.txt",NA,"TCGA-23-2077-01A",1.1,"9C985CB2-5676-4AD4-AE8F-CFD416C28BBB","TCGA",1999,NA,NA,"TUMOR FREE","E1CBEF5C-96C3-4269-B3C7-34D108A4BFC8",45,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.3848ccad-5f29-40f6-8407-05e548a3b8e5.txt","Alive",NA,"TCGA-23-2077","NOT HISPANIC OR LATINO","F560F5C0-882A-44BA-B631-892CCDA55B7E",NA,3525,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",22,NA,NA,"WHITE",NA,1,128,"FE4D3109-2E84-44EE-8599-04C1931D2012","10360B63-438B-4D36-AD18-60EB4F4208D2","C239.TCGA-23-2077-01A-01W-0722-08.2.bam","TCGA-23-2077-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-23-2077-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-23-2077-D25764",NA,NA,NA,"TCGA-23-2077-F25763_NTE-2",NA,3525,"TUMOR FREE","Alive",NA,"TCGA-23-2077-F25763","TCGA-23-2077",NA,"23","2077","YES","C56.9","8441/3","C56.9",NA,NA,-16552,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",3525,NA,NA,NA,"TUMOR FREE","NO",20,11,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,45,1999,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
228045398,221462199,16398501776,"3B9FEA58-E3E7-4F8B-BDD1-4E97AAB310B6.bw","ef5e85cf-2d82-4d52-a02c-fed5c76e4cec","3b9fea58-e3e7-4f8b-bdd1-4e97aab310b6","2016-08-25T17:48:31.368479-05:00","TCGA-36-1581-01A-01R-1566-13_rnaseq_fastq.tar","696eb0d1-c5ea-4fbc-8ad8-69eb7fb6d3ee",14392064000,"Illumina HiSeq","f1c1f149eba1541b5b9f9d5181fef76e","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:49:59.030394-05:00","2016-05-03T11:40:21.662944-05:00","696eb0d1-c5ea-4fbc-8ad8-69eb7fb6d3ee_analysis.xml","1c1373e3f9123ff9b56e6ea82269cc27","0bae0679-37d1-400c-ad26-dadb873691fd",2181,"2016-08-29T18:25:35.444505-05:00","696eb0d1-c5ea-4fbc-8ad8-69eb7fb6d3ee_experiment.xml","e91d83ef7451d6023193a681345297da","063ba10c-9375-4bca-9837-bf213924a602",3916,"2016-09-29T22:56:31.944722-05:00","696eb0d1-c5ea-4fbc-8ad8-69eb7fb6d3ee_run.xml","f8eb6341e5c2f5175a9ce363926fe71d","ca33d0cd-eeab-4b2d-a0d3-a83a7436db96",1988,"2016-09-08T10:28:03.818045-05:00","TCGA-36-1581","2016-09-02T18:50:18.722519-05:00","female","TCGA-36-1581_demographic",1944,"white","45b3ff78-a16c-5228-a88f-e0777a316c9f","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1581_diagnosis","not reported",23272,"alive","8441/3",NA,751,"241ae640-2769-5065-97aa-05298c7b1b9b","c56.9",-23272,"TCGA-36-1581_treatment","0adc4703-4ee1-52fa-b1ca-e461ad689029","01",NA,"TCGA-36-1581-01A","0.6","3d547b69-ceaa-49c1-8ea9-03a32b3fac90",FALSE,"6512ef01-a2fb-4fd8-9e1a-b59855c256de","Primary Tumor","0.6",NA,NA,"1.7",1235952000,"01",120,"TCGA-36-1581-01A-01",95,95,NA,NA,0,0,3,2,"2016-09-08T10:28:03.818045-05:00","2016-09-08T10:28:03.818045-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,5,"eb8eab2e-7062-48bb-bc87-44ca7b8a1cd9","1673dba9-dd32-4927-9f51-3525f0d62786","TCGA-36-1581-01A-01-TS1","TCGA-36-1581-01A-01-BS1",95,93,"6da1522e-8974-4f57-a96d-89609a0acf90","RNA","TCGA-36-1581-01A-01R","defc4c39-849c-471f-a625-5abdc2a83bfe",1.8,0.14,"UV Spec","R","22","TCGA-36-1581-01A-01R-1566-13","d84c76a9-dbee-4720-8639-91382101b27a",0.14,NA,NA,NA,NA,"badd0bdf-bf24-5f9c-b14f-b744c060e468","TCGA-36-1581_exposure","TCGA-36-1581-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-25T02:00:30.000Z","2014-03-25T02:25:02.000Z","696EB0D1-C5EA-4FBC-8AD8-69EB7FB6D3EE","3D547B69-CEAA-49C1-8EA9-03A32B3FAC90","Unaligned reads",14392064000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D84C76A9-DBEE-4720-8639-91382101B27A","Canada's Michael Smith Genome Sciences Centre","564a5ab0e4b08c5d8694ffe9","EF5E85CF-2D82-4D52-A02C-FED5C76E4CEC","Ovarian Serous Cystadenocarcinoma","TAR","6DA1522E-8974-4F57-A96D-89609A0ACF90","2014-03-25T02:25:02.000Z","DEFC4C39-849C-471F-A625-5ABDC2A83BFE","None","NO",1,0.6,"Primary Tumor","BC Cancer Agency",NA,"6DA1522E-8974-4F57-A96D-89609A0ACF90",0.6,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c3ce568b-8558-45db-97b4-23882e482cbf.txt",NA,"TCGA-36-1581-01A",1.7,"EA9B943E-FD52-4668-BFD9-333776986799","TCGA",2007,NA,NA,"WITH TUMOR","3D547B69-CEAA-49C1-8EA9-03A32B3FAC90",63,"bcgsc.ca.TCGA-36-1581-01A-01R-1566-13.hg19.bcgsc.ca.1.6.0.snv.vcf","Alive",NA,"TCGA-36-1581",NA,"434514F8-04E5-4EC5-A694-0216E535FD97",NA,751,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Adjuvant Therapy","Stage IIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,120,"EB8EAB2E-7062-48BB-BC87-44CA7B8A1CD9","DEFC4C39-849C-471F-A625-5ABDC2A83BFE","TCGA-36-1581-01A-01R-1566-13_rnaseq.bam","TCGA-36-1581-01A-01",95,0,NA,NA,3,"TOP",2,NA,"TCGA-36-1581-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-36-1581-D27894",NA,NA,NA,"TCGA-36-1581-F27893_NTE-1",NA,751,"WITH TUMOR","Alive",NA,"TCGA-36-1581-F27893","TCGA-36-1581",NA,"36","1581","YES","C56.9","8441/3","C56.9",NA,NA,-23272,"FEMALE","WHITE",NA,NA,"No","Alive",751,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,63,2007,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,7,NA,NA,NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
225783318,216436103,16001461979,"61AD6A73-A8C1-4C5C-9D6B-45D3831A4F0C.bw","ef653772-e5d2-46ec-8610-f81d75d7353c","61ad6a73-a8c1-4c5c-9d6b-45d3831a4f0c","2016-08-25T09:51:13.989466-05:00","TCGA-61-1900-01A-01R-1567-13_rnaseq_fastq.tar","69221b4b-2afa-4513-81e2-c5f6b56336b8",15040778240,"Illumina HiSeq","258357d1ff8bf8624203150820c8f846","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:47:01.941370-05:00","2016-05-03T11:41:05.748550-05:00","69221b4b-2afa-4513-81e2-c5f6b56336b8_analysis.xml","2770544f9d30dba7466de6f199c8e610","e9b1941b-1b12-4fbe-929b-566761b42efe",2181,"2016-09-29T17:58:51.840541-05:00","69221b4b-2afa-4513-81e2-c5f6b56336b8_experiment.xml","b74e2dd1c857aaf802e08c60611ff1e7","113d08dc-dcee-42d7-a424-cefcb093327c",3916,"2016-09-29T23:48:43.641390-05:00","69221b4b-2afa-4513-81e2-c5f6b56336b8_run.xml","648e7c0284e39a869075a1350e246923","eaaf8931-9155-4037-93dd-e64efe02d9b8",1989,"2016-09-08T10:46:46.077257-05:00","TCGA-61-1900","2016-09-02T18:47:35.325187-05:00","female","TCGA-61-1900_demographic",1957,"black or african american","22cfffda-6e29-57b4-9e79-7c5e73abe719","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","61","dd338563-a74b-5abe-a135-ac0f6ce29e11","University of Pittsburgh","not reported","c56.9","TCGA-61-1900_diagnosis","not reported",18963,"alive","8441/3",NA,176,"c6b4d84c-73bf-54db-b28c-a0e675a19216","c56.9",-18963,"TCGA-61-1900_treatment","50d4f01f-a356-572e-8d49-b21789af5f5b","01",NA,"TCGA-61-1900-01A","0.9","fb634d39-a4fe-493e-a982-2e360e69cbd2",FALSE,"b0dd202d-16dc-42ec-ad83-6f02b37b919f","Primary Tumor","0.6",NA,NA,"1.5",1246233600,"01",101,"TCGA-61-1900-01A-01",95,90,NA,NA,0,0,5,10,"2016-09-08T10:46:46.077257-05:00","2016-09-08T10:46:46.077257-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,10,"cc98d24b-5f6f-4732-ba40-1592f7a5a538","b39e97c1-2493-4131-a66b-67e95511ce4b","TCGA-61-1900-01A-01-TS1","TCGA-61-1900-01A-01-BS1",95,80,"aaaae7e3-9488-4bc3-a96e-481699c214fc","RNA","TCGA-61-1900-01A-01R","fababb90-b818-4b8d-a624-ed22523314ea",1.8,0.15,"UV Spec","R","22","TCGA-61-1900-01A-01R-1567-13","92adf6a1-4880-4ee4-8ebe-09a943dbfe04",0.15,NA,NA,NA,NA,"b5800fb4-f058-51e9-a055-270c7393eba9","TCGA-61-1900_exposure","TCGA-61-1900-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-29T02:06:32.000Z","2014-03-29T02:38:02.000Z","69221B4B-2AFA-4513-81E2-C5F6B56336B8","FB634D39-A4FE-493E-A982-2E360E69CBD2","Unaligned reads",15040778240,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","92ADF6A1-4880-4EE4-8EBE-09A943DBFE04","Canada's Michael Smith Genome Sciences Centre","564a5c6ce4b08c5d8695618f","EF653772-E5D2-46EC-8610-F81D75D7353C","Ovarian Serous Cystadenocarcinoma","TAR","AAAAE7E3-9488-4BC3-A96E-481699C214FC","2014-03-29T02:38:02.000Z","FABABB90-B818-4B8D-A624-ED22523314EA","None","NO",1,0.6,"Primary Tumor","University of Pittsburgh",NA,"AAAAE7E3-9488-4BC3-A96E-481699C214FC",0.9,"61","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.c3a92cba-410a-4853-8bae-4bec74b693d7.txt",NA,"TCGA-61-1900-01A",1.5,"EE2B9E79-59A9-465A-BEF5-7C013A3693C7","TCGA",2008,NA,NA,"TUMOR FREE","FB634D39-A4FE-493E-A982-2E360E69CBD2",51,"nationwidechildrens.org_clinical.TCGA-61-1900.xml","Alive",NA,"TCGA-61-1900","NOT HISPANIC OR LATINO","8B7BEBBA-673B-4D44-B33D-6A5D7409982F",NA,176,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",19,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,101,"CC98D24B-5F6F-4732-BA40-1592F7A5A538","FABABB90-B818-4B8D-A624-ED22523314EA","TCGA-61-1900-01A-01R-1567-13_mirna.bam.bai","TCGA-61-1900-01A-01",90,0,NA,NA,10,"BOTTOM",10,NA,"TCGA-61-1900-01A-01-BS1",80,"Taxol","Chemotherapy","TCGA-61-1900-D28222",NA,NA,NA,NA,NA,176,"TUMOR FREE","Alive",NA,"TCGA-61-1900-F28221","TCGA-61-1900",NA,"61","1900","YES","C56.9","8441/3","C56.9",NA,NA,-18963,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Alive",176,NA,NA,NA,"TUMOR FREE","NO",1,10,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
150826036,143167473,10497816533,"5549E32A-A485-4FFA-8363-9700AA8C92B7.bw","f007fa7a-7da9-4cb0-8aea-623af1a122c5","5549e32a-a485-4ffa-8363-9700aa8c92b7","2016-08-20T08:48:31.596316-05:00","TCGA-20-1686-01A-01R-1566-13_rnaseq_fastq.tar","0abf815b-4e52-4942-8c36-6ca87d5e7003",9137264640,"Illumina HiSeq","4593d2bb41a6e28c1763e91aecf22a30","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:51:34.266608-05:00","2016-05-03T11:41:05.755204-05:00","0abf815b-4e52-4942-8c36-6ca87d5e7003_analysis.xml","a9a6ccabfa644893d290848783360cee","ec6fdf74-4b9c-40ae-9b99-426e9bcc4c8c",2210,"2016-10-07T17:25:03.998266-05:00","0abf815b-4e52-4942-8c36-6ca87d5e7003_experiment.xml","c245e31a75561e87ef1cb2f10e642b9c","528961ab-b35f-4bec-8763-26403f8d49c6",3916,"2016-09-29T20:17:13.445356-05:00","0abf815b-4e52-4942-8c36-6ca87d5e7003_run.xml","3858dd756bded5c991c51ceac9e32057","67813289-4cbf-4433-b4ab-55241696c51a",1990,"2016-09-08T12:51:54.085166-05:00","TCGA-20-1686","2016-09-02T19:07:29.504431-05:00","female","TCGA-20-1686_demographic",1933,"white","197ab3f9-6726-5731-bfc7-6b08ced01e17","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","20","ad8af71e-5dd4-5925-a473-91acd372bed5","Fox Chase Cancer Center","not reported","c56.9","TCGA-20-1686_diagnosis","not reported",27588,"alive","8441/3",NA,89,"1ed1ad50-2936-5821-988a-f9c6e3f2728f","c56.9",-27588,"TCGA-20-1686_treatment","216371a2-e571-542c-bb72-ee0f63f7346e","01",NA,"TCGA-20-1686-01A","0.4","13f9890c-e405-4625-888e-496eee30dfb4",FALSE,"c87ff195-1793-455a-bb19-e495a915befe","Primary Tumor","0.4",NA,NA,"0.8",1242604800,"01",115,"TCGA-20-1686-01A-01",80,80,NA,NA,0,0,35,30,"2016-09-08T12:51:54.085166-05:00","2016-09-08T12:51:54.085166-05:00",NA,1,NA,NA,"TOP","BOTTOM",0,0,"228c3630-c8f7-40cc-8cb9-30fd3859f7d1","f7d1707d-5007-4774-8ca7-49c62b6dfc22","TCGA-20-1686-01A-01-TS1","TCGA-20-1686-01A-01-BS1",65,70,"776492c5-ff6f-4ae8-bcb6-9ed639992f96","RNA","TCGA-20-1686-01A-01R","baf3c6b0-8c73-43b3-8e94-dac06e10aa26",1.8,0.17,"UV Spec","R","22","TCGA-20-1686-01A-01R-1566-13","efabaf9d-2e46-4d4e-9b1b-763ec4d8d537",0.17,NA,NA,NA,NA,"fd716e57-c73a-585b-a0f9-e4d4fd5f5b14","TCGA-20-1686_exposure","TCGA-20-1686-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-27T08:27:08.000Z","2014-03-27T08:43:01.000Z","0ABF815B-4E52-4942-8C36-6CA87D5E7003","13F9890C-E405-4625-888E-496EEE30DFB4","Unaligned reads",9137264640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EFABAF9D-2E46-4D4E-9B1B-763EC4D8D537","Canada's Michael Smith Genome Sciences Centre","564a5a24e4b093830b6c9768","F007FA7A-7DA9-4CB0-8AEA-623AF1A122C5","Ovarian Serous Cystadenocarcinoma","TAR","776492C5-FF6F-4AE8-BCB6-9ED639992F96","2014-03-27T08:43:02.000Z","BAF3C6B0-8C73-43B3-8E94-DAC06E10AA26","None","NO",1,0.4,"Primary Tumor","Fox Chase Cancer Center",NA,"776492C5-FF6F-4AE8-BCB6-9ED639992F96",0.4,"20","4440716366_R01C01_Grn.idat",NA,"TCGA-20-1686-01A",0.8,"D4A19506-867A-4FF5-914F-9656355A77DC","TCGA",2008,NA,NA,"TUMOR FREE","982FF31C-F8AE-45CC-9369-885AB731394A",75,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.92c3ac1c-3e84-4448-8587-8c95329d0549.txt","Alive",NA,"TCGA-20-1686","NOT HISPANIC OR LATINO","E8BFA672-1402-4260-A0E1-041491DB061C",NA,89,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,115,"F7D1707D-5007-4774-8CA7-49C62B6DFC22","D9D748C5-78D7-4F30-BC55-3EF53B122CCE","TCGA-20-1686-01A-01R-1566-13_rnaseq_fastq.tar","TCGA-20-1686-01A-01",80,0,NA,1,30,"BOTTOM",0,NA,"TCGA-20-1686-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-20-1686-D25561",NA,NA,NA,NA,NA,89,"TUMOR FREE","Alive",NA,"TCGA-20-1686-F25559","TCGA-20-1686",NA,"20","1686","YES","C56.9","8441/3","C56.9",NA,NA,-27588,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",89,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,75,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
146136678,136963665,10023375963,"42255FA4-6E66-461B-B6EF-C7CB27C4370F.bw","f0c353fd-947c-41e2-b643-3ecc0d69796c","42255fa4-6e66-461b-b6ef-c7cb27c4370f","2016-08-25T21:09:34.997261-05:00","TCGA-04-1347-01A-01R-1564-13_rnaseq_fastq.tar","8a5dbaa5-8673-4693-be54-e98930355e54",8949288960,"Illumina HiSeq","e39b02cd44040400c07e9d6d85b95b34","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:27:21.281007-05:00","2016-05-03T11:41:05.776497-05:00","8a5dbaa5-8673-4693-be54-e98930355e54_analysis.xml","d5dd96a043cbd4749d3af0c89592ed10","2303e9ee-eab3-4689-82f0-ee92a9f75090",2208,"2016-10-07T15:43:48.639771-05:00","8a5dbaa5-8673-4693-be54-e98930355e54_experiment.xml","9b3b7bdfd1d76f3d639ecdbffdca33df","f8c0a0eb-2675-4dc9-bbf6-aa63b714ae87",3916,"2016-09-29T19:22:54.017970-05:00","8a5dbaa5-8673-4693-be54-e98930355e54_run.xml","d432e8ca85c703bad85afecafa7b1033","46212b08-1347-4d43-9fd7-87058d2f47c6",1988,"2016-09-08T13:10:34.482789-05:00","TCGA-04-1347","2016-09-02T19:06:04.876806-05:00","female","TCGA-04-1347_demographic",1923,"white","cef50119-cfb0-5a18-84b4-6b9a87c26e3f","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1347_diagnosis","not reported",29695,"alive","8441/3",NA,1919,"603b066e-4598-53b0-8ea1-c4772b8e2165","c56.9",-29695,"TCGA-04-1347_treatment","767a0eff-c49f-561c-9def-532f6d7b1aeb","01",NA,"TCGA-04-1347-01A","1","4c4747d9-c0bc-486e-b88c-5c1b8214d4de",FALSE,"18BFB10C-5EDC-4253-A2A8-93533CB4B471","Primary Tumor","0.1",NA,NA,"1.1",1229644800,"01",159,"TCGA-04-1347-01A-01",99,70,NA,NA,0,0,5,40,"2016-09-08T13:10:34.482789-05:00","2016-09-08T13:10:34.482789-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,5,"c1c1b478-dc0f-4680-955b-2a40aeece34f","f281f888-c433-4fa6-8957-3ace3e9e4f6c","TCGA-04-1347-01A-01-TS1","TCGA-04-1347-01A-01-BS1",93,55,"980ab54a-cf04-4c49-abef-6d21c0b658d3","RNA","TCGA-04-1347-01A-01R","eb47d4b9-237c-4137-8789-329f2b7f50f3",1.8,0.16,"UV Spec","R","22","TCGA-04-1347-01A-01R-1564-13","1a59f822-d8fc-4c7a-ad7b-b1b84078e09d",0.16,NA,NA,NA,NA,"d688124e-21ab-52e8-a4e1-e30fa4eda648","TCGA-04-1347_exposure","TCGA-04-1347-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T21:05:24.000Z","2014-04-04T07:06:02.000Z","8A5DBAA5-8673-4693-BE54-E98930355E54","4C4747D9-C0BC-486E-B88C-5C1B8214D4DE","Unaligned reads",8949288960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1A59F822-D8FC-4C7A-AD7B-B1B84078E09D","Canada's Michael Smith Genome Sciences Centre","564a5970e4b0298dd2cb83f6","F0C353FD-947C-41E2-B643-3ECC0D69796C","Ovarian Serous Cystadenocarcinoma","TAR","980AB54A-CF04-4C49-ABEF-6D21C0B658D3","2014-04-04T07:06:02.000Z","EB47D4B9-237C-4137-8789-329F2B7F50F3","None","NO",1,0.1,"Primary Tumor","Gynecologic Oncology Group",NA,"980AB54A-CF04-4C49-ABEF-6D21C0B658D3",1,"04","TCGA-04-1347-01A-01R-0441-02_frequency.txt",NA,"TCGA-04-1347-01A",1.1,"A176CAD9-0E04-4138-802E-18D4935F981F","TCGA",2004,NA,NA,"TUMOR FREE","54A8FDB2-D9D9-4A89-987A-DA9BED69D145",81,"TCGA-04-1347-01A-01R-1564-13_GRCh37-lite_mirna.bam.bai","Alive",NA,"TCGA-04-1347","NOT HISPANIC OR LATINO","930A5B42-2E0E-4912-901D-B712DE302D38",NA,1919,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IV",NA,100,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,1,159,"F281F888-C433-4FA6-8957-3ACE3E9E4F6C","6EC685C7-8985-49C7-BA51-2F2B017C7F96","TCGA-04-1347-01A-01R-0441-02_frequency.txt","TCGA-04-1347-01A-01",99,0,NA,NA,5,"TOP",2,NA,"TCGA-04-1347-01A-01-TS1",93,"Carboplatin","Chemotherapy","TCGA-04-1347-D23963",NA,NA,NA,NA,NA,1919,"TUMOR FREE","Alive",NA,"TCGA-04-1347-F23961","TCGA-04-1347",NA,"04","1347","YES","C56.9","8441/3","C56.9",NA,NA,-29695,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",1919,NA,NA,NA,"TUMOR FREE","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,81,2004,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,100,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
252296602,230494832,16952988454,"B7719660-1262-4E18-B6D3-FBAD6137DB22.bw","f1cb3d48-1415-408d-89d1-dfdcc5924963","b7719660-1262-4e18-b6d3-fbad6137db22","2016-08-05T01:49:23.648376-05:00","TCGA-29-A5NZ-01A-11R-A406-31_rnaseq_fastq.tar","b06c98f1-39de-4fdc-8f6a-7242317de9bb",15699476480,"Illumina HiSeq","aae03ca208bec068d0262273c40a884d","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T21:12:38.152184-05:00","2016-06-22T11:19:32.361656-05:00","b06c98f1-39de-4fdc-8f6a-7242317de9bb_analysis.xml","870d349b257260b92815cb2d72fb41be","89f70461-ff2c-49ca-a9a6-922ab54c305b",2183,"2016-08-13T07:11:29.290926-05:00","b06c98f1-39de-4fdc-8f6a-7242317de9bb_experiment.xml","6e24791f55095493d53dd6703aa77267","7dc4651a-988a-45ee-beae-3a09cd7fc11c",3753,"2016-09-29T22:45:00.555749-05:00","b06c98f1-39de-4fdc-8f6a-7242317de9bb_run.xml","af61998f89bce0a1b927492196ae1197","c314c0ad-45c8-46e7-87ae-e3b5ab4308a2",1808,"2016-09-08T12:13:10.248556-05:00","TCGA-29-A5NZ","2016-09-02T19:00:51.950036-05:00","female","TCGA-29-A5NZ_demographic",1945,"black or african american","5fcf9981-1d44-5962-8284-883451d2d003","not reported",2013,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c48.1","TCGA-29-A5NZ_diagnosis","not reported",24161,"dead","8460/3",1088,984,"ac1e9d43-af66-5f28-8eff-48495da484b3","c48.1",-24161,"TCGA-29-A5NZ_treatment","275f3df6-15f6-50ba-ac5d-5173abae5a42","01","true","TCGA-29-A5NZ-01A",NA,"cfa92815-5221-46e2-b7a2-958c556bb390",FALSE,"B7F69EE0-E844-434B-A76B-390590C85864","Primary Tumor",NA,515,1040,NA,1360800000,"11",30,"TCGA-29-A5NZ-01A-11",80,NA,0,NA,0,NA,10,NA,"2016-09-08T12:13:10.248556-05:00",NA,0,NA,5,NA,"TOP",NA,10,NA,"f88dabee-0b8b-4c80-990f-36467458ea03",NA,"TCGA-29-A5NZ-01A-01-TSA",NA,80,NA,"b0e103fb-82fc-44dd-9a45-35d8b4020b3c","RNA","TCGA-29-A5NZ-01A-11R","e8767908-d2ad-4e8d-a452-59bed409ab0c",1.91,0.18,"UV Spec","R","23","TCGA-29-A5NZ-01A-11R-A406-31","ea715147-2b94-4bed-9531-ba91c13630fe",0.18,NA,NA,NA,NA,"77648193-9746-56d4-b1d0-4e1f399cf3c3","TCGA-29-A5NZ_exposure","TCGA-29-A5NZ-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T02:54:21.000Z","2015-02-07T04:38:33.000Z","B06C98F1-39DE-4FDC-8F6A-7242317DE9BB","CFA92815-5221-46E2-B7A2-958C556BB390","Unaligned reads",15699476480,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EA715147-2B94-4BED-9531-BA91C13630FE","Canada's Michael Smith Genome Sciences Centre","564a5909e4b09c884b27041e","F1CB3D48-1415-408D-89D1-DFDCC5924963","Ovarian Serous Cystadenocarcinoma","TAR","B0E103FB-82FC-44DD-9A45-35D8B4020B3C","2015-02-07T04:38:33.000Z","E8767908-D2AD-4E8D-A452-59BED409AB0C","United States","NO",1,NA,"Primary Tumor","Duke",515,"B0E103FB-82FC-44DD-9A45-35D8B4020B3C",NA,"29","aae5e180041e88696d8d634d3786ec08.bam",1040,"TCGA-29-A5NZ-01A",NA,"2ABD0BB8-6960-48F8-B08D-28AB17CF9FE6","TCGA",2011,"TCGA-29-A5NZ_NTE-2","Complete Remission/Response","WITH TUMOR","D97AEE28-9CE1-4D92-84CD-EE09810EA6C8",66,"nationwidechildrens.org_clinical.TCGA-29-A5NZ.xml","Dead",1088,"TCGA-29-A5NZ",NA,"B059FE0D-3A99-4FB1-AFEB-7E44CA131810",NA,NA,"No","Ovary","C48.1",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8460/3","FEMALE","C48.1",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"F88DABEE-0B8B-4C80-990F-36467458EA03","E8767908-D2AD-4E8D-A452-59BED409AB0C","aae5e180041e88696d8d634d3786ec08.bam","TCGA-29-A5NZ-01A-11",80,0,0,0,10,"TOP",10,5,"TCGA-29-A5NZ-01A-01-TSA",80,"Doxil",NA,"TCGA-29-A5NZ-D59535",NA,NA,NA,"TCGA-29-A5NZ-F59529_NTE-2","YES",NA,"WITH TUMOR","Dead",1088,"TCGA-29-A5NZ-F59529","TCGA-29-A5NZ",NA,"29","A5NZ","YES","C48.1","8460/3","C48.1",NA,NA,-24161,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,1088,"NO","YES","WITH TUMOR","YES",20,8,2013,"YES","YES","NO",NA,NA,NA,"Omentum","Serous Cystadenocarcinoma",NA,0,66,2011,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,"Complete Remission/Response",NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
238900648,220607789,16227030066,"83E80F88-7F57-4BFE-B528-49C96BB8B970.bw","f2dcf4cc-609d-4532-a90d-6ae2bbb53365","83e80f88-7f57-4bfe-b528-49c96bb8b970","2016-09-29T21:03:08.505349-05:00","TCGA-13-1407-01A-01R-1565-13_rnaseq_fastq.tar","585f2760-d836-4ed1-a1df-04833b80cc1f",14967459840,"Illumina HiSeq","e339ab4a1836329e158b2fc9e8b0ab60","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:22:57.008842-05:00","2016-05-03T11:40:21.648680-05:00","585f2760-d836-4ed1-a1df-04833b80cc1f_analysis.xml","11664db273ddd7bce481194f9cd988d5","2037c987-b728-4663-9a8a-a296589b6ea4",2235,"2016-09-29T19:12:01.964651-05:00","585f2760-d836-4ed1-a1df-04833b80cc1f_experiment.xml","6e0ae46d8e2d3e823a93b90704642f56","3f3ea119-b675-444a-9c28-997de5c56925",3916,"2016-09-29T19:13:15.825725-05:00","585f2760-d836-4ed1-a1df-04833b80cc1f_run.xml","2f7c563d2f0e5f10dae56fa5bfac75a7","4011d47d-0b1a-48da-95d1-4f9ff959a2c4",1988,"2016-09-08T13:43:10.134045-05:00","TCGA-13-1407","2016-09-02T19:12:14.499331-05:00","female","TCGA-13-1407_demographic",1957,"white","ce1b2666-1364-5381-ae68-062a3cc7e5d5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1407_diagnosis","not reported",18896,"alive","8441/3",NA,2534,"3b851cf3-1472-5cb5-8f7a-4543fadcd62d","c56.9",-18896,"TCGA-13-1407_treatment","c01352be-2ef4-5b20-9594-a127ad0d4767","01",NA,"TCGA-13-1407-01A","0.7","f7011673-3a61-4450-b6b9-043ef33ac682",FALSE,"CCAF94A8-AA26-46FE-B3D3-22C9B750344A","Primary Tumor","0.4",NA,NA,"1.5",1230508800,"01",135,"TCGA-13-1407-01A-01",95,95,NA,NA,0,0,5,5,"2016-09-08T13:43:10.134045-05:00","2016-09-08T13:43:10.134045-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"05372268-5e6e-416e-a3e3-1047cee97d57","a6dbdc72-d387-4fc3-a469-57ea6084908b","TCGA-13-1407-01A-01-BS1","TCGA-13-1407-01A-01-TS1",95,95,"fb8f5368-01f6-4097-ae16-5a75e4330371","RNA","TCGA-13-1407-01A-01R","cd2f3447-2c4a-41ee-ada1-de3f528fc9a4",1.8,0.17,"UV Spec","R","22","TCGA-13-1407-01A-01R-1565-13","2afc4437-8c6b-4f79-804c-b37ed04c4c77",0.17,NA,NA,NA,NA,"5bb83df8-a4fc-533e-b75d-f49e7671759a","TCGA-13-1407_exposure","TCGA-13-1407-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T23:36:00.000Z","2014-03-22T00:08:02.000Z","585F2760-D836-4ED1-A1DF-04833B80CC1F","F7011673-3A61-4450-B6B9-043EF33AC682","Unaligned reads",14967459840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","2AFC4437-8C6B-4F79-804C-B37ED04C4C77","Canada's Michael Smith Genome Sciences Centre","564a3a48e4b0298dd2c80c83","F2DCF4CC-609D-4532-A90D-6AE2BBB53365","Ovarian Serous Cystadenocarcinoma","TAR","FB8F5368-01F6-4097-AE16-5A75E4330371","2014-03-22T00:08:02.000Z","CD2F3447-2C4A-41EE-ADA1-DE3F528FC9A4","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"FB8F5368-01F6-4097-AE16-5A75E4330371",0.7,"13","TCGA-13-1407-01A-01R-1565-13.isoform.quantification.txt",NA,"TCGA-13-1407-01A",1.5,"8ADA4CC3-F455-4065-9DEF-1341957F353D","TCGA",2008,NA,NA,"TUMOR FREE","F7011673-3A61-4450-B6B9-043EF33AC682",51,"nationwidechildrens.org_clinical.TCGA-13-1407.xml","Alive",NA,"TCGA-13-1407","NOT HISPANIC OR LATINO","019F9660-F6A5-40C5-A156-998044AF77A1",NA,184,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,135,"A6DBDC72-D387-4FC3-A469-57EA6084908B","9B332D34-C8DA-4716-9D30-6B52D2F7E996","TCGA-13-1407-01A-01W-0490-10_SOLiD.bam","TCGA-13-1407-01A-01",95,0,NA,NA,5,"TOP",0,NA,"TCGA-13-1407-01A-01-TS1",95,"Carboplatin","Chemotherapy","TCGA-13-1407-D24808",NA,NA,NA,NA,NA,184,"TUMOR FREE","Alive",NA,"TCGA-13-1407-F24807","TCGA-13-1407",NA,"13","1407","YES","C56.9","8441/3","C56.9",NA,NA,-18896,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",184,NA,NA,NA,"TUMOR FREE","NO",20,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,51,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
286912876,270295423,19863061575,"2CAC1B67-18C9-459B-8398-2CCA0E2C44AC.bw","f2ec64f5-a414-4c34-99c7-d59bc4e831e0","2cac1b67-18c9-459b-8398-2cca0e2c44ac","2016-08-25T11:26:24.613233-05:00","TCGA-24-1545-01A-01R-1566-13_rnaseq_fastq.tar","b7c14327-6451-4803-95a9-c6dae1a218e6",18094069760,"Illumina HiSeq","7b603233fd85a14b8f4c71df903978de","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:01:04.306418-05:00","2016-05-03T11:39:34.528512-05:00","b7c14327-6451-4803-95a9-c6dae1a218e6_analysis.xml","406ef493feeb1e5fd7c1b4b46f5a47d1","12a4a12a-98d0-48a2-bc47-462e807f7802",2181,"2016-09-29T21:55:44.367483-05:00","b7c14327-6451-4803-95a9-c6dae1a218e6_experiment.xml","05fb2108b5cc072148320a647858177a","a4b957f2-c80a-4214-a17a-5d74392c8e02",3916,"2016-09-29T22:40:15.340446-05:00","b7c14327-6451-4803-95a9-c6dae1a218e6_run.xml","9acb6e1c817022d0b8f22112108ad21d","c0258518-f708-42e5-9308-63af5762dd05",1988,"2016-09-08T10:46:30.137716-05:00","TCGA-24-1545","2016-09-02T18:47:39.341417-05:00","female","TCGA-24-1545_demographic",1928,"white","1d9ea521-4431-55d4-8082-d86421ddebe7","not reported",2001,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1545_diagnosis","not reported",25460,"dead","8441/3",1746,1746,"f4ff0564-e1c9-5baa-805d-e0331fd5245c","c56.9",-25460,"TCGA-24-1545_treatment","92fe51b2-9040-5c9a-af61-f7f023ffef76","01",NA,"TCGA-24-1545-01A","1","ed59c414-e594-44c8-b920-159336d45b4f",FALSE,"0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975","Primary Tumor","0.5",NA,NA,"1.8",1235088000,"01",114,"TCGA-24-1545-01A-01",90,80,NA,NA,0,0,20,30,"2016-09-08T10:46:30.137716-05:00","2016-09-08T10:46:30.137716-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"15782ecc-b634-4add-918a-e78c62c77bd0","bb95934d-79b6-4172-8dd1-a849daf1c4c3","TCGA-24-1545-01A-01-BS1","TCGA-24-1545-01A-01-TS1",80,70,"aca55ead-eba3-433f-af60-85fbde6ae6ee","RNA","TCGA-24-1545-01A-01R","d22f3b4d-a30f-4b72-9c8a-9dbe27ed48ad",1.8,0.14,"UV Spec","R","22","TCGA-24-1545-01A-01R-1566-13","e2fcba09-755d-425d-ab4d-cede8ef86e48",0.14,NA,NA,NA,NA,"c922fb4f-016c-5732-a9ce-16e73763bc8e","TCGA-24-1545_exposure","TCGA-24-1545-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T05:38:35.000Z","2014-03-20T06:12:02.000Z","B7C14327-6451-4803-95A9-C6DAE1A218E6","ED59C414-E594-44C8-B920-159336D45B4F","Unaligned reads",18094069760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","E2FCBA09-755D-425D-AB4D-CEDE8EF86E48","Canada's Michael Smith Genome Sciences Centre","564a5903e4b08c5d86947125","F2EC64F5-A414-4C34-99C7-D59BC4E831E0","Ovarian Serous Cystadenocarcinoma","TAR","ACA55EAD-EBA3-433F-AF60-85FBDE6AE6EE","2014-03-20T06:12:02.000Z","D22F3B4D-A30F-4B72-9C8A-9DBE27ED48AD","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"ACA55EAD-EBA3-433F-AF60-85FBDE6AE6EE",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f3a3c3dc-4069-4c53-9017-c6dc610240e4.txt",NA,"TCGA-24-1545-01A",1.8,"F2C12AE2-10B5-4066-B8C4-2538743A8FFF","TCGA",1997,NA,NA,"WITH TUMOR","ED59C414-E594-44C8-B920-159336D45B4F",69,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.f3a3c3dc-4069-4c53-9017-c6dc610240e4.txt","Dead",1746,"TCGA-24-1545",NA,"84F70A51-070E-4649-8A9E-DF72B6B5E095",NA,1746,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,114,"BB95934D-79B6-4172-8DD1-A849DAF1C4C3","E7A20973-6515-45DE-9647-96E736B6BBCB","TCGA-24-1545-01A-01R-1566-13_mirna.bam","TCGA-24-1545-01A-01",90,0,NA,NA,20,"BOTTOM",0,NA,"TCGA-24-1545-01A-01-BS1",80,"Carboplatin","Chemotherapy","TCGA-24-1545-D26090",NA,NA,NA,"TCGA-24-1545-F26088_NTE-1",NA,1746,"WITH TUMOR","Dead",1746,"TCGA-24-1545-F26088","TCGA-24-1545",NA,"24","1545","YES","C56.9","8441/3","C56.9",NA,NA,-25460,"FEMALE","WHITE",NA,NA,"No","Dead",1746,1746,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,69,1997,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
163344564,159059500,11743627327,"B3D17D9D-B753-40E0-A289-72F94F478C4C.bw","f34aa3b6-e966-49c6-bc55-130545772c53","b3d17d9d-b753-40e0-a289-72f94f478c4c","2016-09-29T22:20:35.491750-05:00","TCGA-24-1103-01A-01R-1565-13_rnaseq_fastq.tar","877d516e-b9ee-4056-8e7b-feafaca0341d",9573580800,"Illumina HiSeq","a3328caeda843c8ea7ce0a8a9e197668","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:12:11.065041-05:00","2016-05-03T11:40:21.647690-05:00","877d516e-b9ee-4056-8e7b-feafaca0341d_analysis.xml","6aad98c336d8ae43a0463039931bed62","aeba670a-dba9-49fe-b876-e5a68ad2649a",2181,"2016-08-13T05:58:25.425203-05:00","877d516e-b9ee-4056-8e7b-feafaca0341d_experiment.xml","13396836502280193c291d4b52321f2f","178db847-b311-4189-a90a-1db7c4899bc4",3916,"2016-09-29T18:36:57.188549-05:00","877d516e-b9ee-4056-8e7b-feafaca0341d_run.xml","76b72b0adcf42770be0da0813113c12c","290305f3-1faf-4ae7-9f25-34282d3cb95e",1989,"2016-09-08T12:46:44.072023-05:00","TCGA-24-1103","2016-09-02T19:05:56.425949-05:00","female","TCGA-24-1103_demographic",1951,"black or african american","70b9fc46-3ebc-5ab0-adbb-162e6a4ea01c","not reported",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1103_diagnosis","not reported",18583,"dead","8441/3",1646,1646,"d8c22b70-6252-5c9a-ad92-ede1bb3d8804","c56.9",-18583,"TCGA-24-1103_treatment","bb613be8-961d-5e06-a8fd-8cf0bbb11dac","01",NA,"TCGA-24-1103-01A","1","6f9a6f73-285d-4a9c-80eb-5f2ebc1787a4",FALSE,"B9628222-5530-4A82-9F13-2773173A0C95","Primary Tumor","0.6",NA,NA,"1.5",1227657600,"01",140,"TCGA-24-1103-01A-01",90,90,NA,NA,0,0,0,0,"2016-09-08T12:46:44.072023-05:00","2016-09-08T12:46:44.072023-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,5,"7318516f-445c-4455-bef7-4229045e6edd","626b516a-0522-4cf6-ac17-458fb9b39297","TCGA-24-1103-01A-01-BS1","TCGA-24-1103-01A-01-TS1",0,0,"80b520fe-b033-48a3-b0c3-dba65b795c07","RNA","TCGA-24-1103-01A-01R","5b1a8147-dc5a-40ff-8071-30d495de5dcb",1.8,0.15,"UV Spec","R","22","TCGA-24-1103-01A-01R-1565-13","202abe19-20e0-4ea9-8653-bf5145da351c",0.15,NA,NA,NA,NA,"7c264428-6916-56e2-bc0e-b468daeeee19","TCGA-24-1103_exposure","TCGA-24-1103-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:00:08.000Z","2014-03-22T02:23:01.000Z","877D516E-B9EE-4056-8E7B-FEAFACA0341D","6F9A6F73-285D-4A9C-80EB-5F2EBC1787A4","Unaligned reads",9573580800,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","202ABE19-20E0-4EA9-8653-BF5145DA351C","Canada's Michael Smith Genome Sciences Centre","564a334ce4b0ef121817d88e","F34AA3B6-E966-49C6-BC55-130545772C53","Ovarian Serous Cystadenocarcinoma","TAR","80B520FE-B033-48A3-B0C3-DBA65B795C07","2014-03-22T02:23:01.000Z","5B1A8147-DC5A-40FF-8071-30D495DE5DCB","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"80B520FE-B033-48A3-B0C3-DBA65B795C07",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.6f0a19c3-b3d6-44da-8962-79cd723f0fab.txt",NA,"TCGA-24-1103-01A",1.5,"F44476CF-CC04-42D3-BB41-71B9B94DD313","TCGA",2001,NA,NA,"WITH TUMOR","A6AE520E-D19F-4848-9149-ABB90ED1C9A6",50,"nationwidechildrens.org_clinical.TCGA-24-1103.xml","Dead",1646,"TCGA-24-1103",NA,"37EAC75A-A99B-46EA-AB5F-172EA3B9CBB4",NA,1646,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,140,"7318516F-445C-4455-BEF7-4229045E6EDD","6AD7150C-F012-4593-A8CD-2F44519E92EB","TCGA-24-1103-01A-01W-0488-09_capture.bam.bai","TCGA-24-1103-01A-01",90,0,NA,NA,0,"BOTTOM",5,NA,"TCGA-24-1103-01A-01-BS1",0,"Topotecan","Chemotherapy","TCGA-24-1103-D25826",NA,NA,NA,"TCGA-24-1103-F25824_NTE-1",NA,1646,"WITH TUMOR","Dead",1646,"TCGA-24-1103-F25824","TCGA-24-1103",NA,"24","1103","YES","C56.9","8441/3","C56.9",NA,NA,-18583,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Dead",1646,1646,NA,NA,"WITH TUMOR","NO",9,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,50,2001,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
225990584,198489369,14512991808,"3786C1AD-F06B-4A0D-B633-B86D2082AFEF.bw","f3618472-32dc-4c90-a407-90050f68be85","3786c1ad-f06b-4a0d-b633-b86d2082afef","2016-08-05T04:00:53.163142-05:00","TCGA-13-A5FT-01A-11R-A406-31_rnaseq_fastq.tar","95896b1e-63e2-49d2-a526-95493556fe65",14480783360,"Illumina HiSeq","88a1fe6b2733423427c5457c35e9581c","TAR","31","Canada's Michael Smith Genome Sciences Centre","BCGSC","0c99fc04-ab33-5be0-9054-def804b6f365","bcgsc.ca","2016-09-29T19:51:22.414747-05:00","2016-06-22T11:19:32.361656-05:00","95896b1e-63e2-49d2-a526-95493556fe65_analysis.xml","864cf5552c70cdfdb1e8f72c7ac9d403","57d641d0-4973-44b2-a4bf-df7491786d92",2183,"2016-10-07T16:47:13.846832-05:00","95896b1e-63e2-49d2-a526-95493556fe65_experiment.xml","235d32c8e3e55bc1ec3ef3d3afd330b5","17bccc52-a067-4146-a883-9f63af3c5058",3753,"2016-09-29T19:02:36.762763-05:00","95896b1e-63e2-49d2-a526-95493556fe65_run.xml","da4ea30d31cdd5f5c5b739154c30ed7d","3954523f-6cf5-4837-ba0a-700e8afc202f",1807,"2016-09-08T12:08:17.428697-05:00","TCGA-13-A5FT","2016-09-02T19:00:46.782868-05:00","female","TCGA-13-A5FT_demographic",1942,"black or african american","496656d8-5645-5852-b629-f8e4c3b9647e","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-A5FT_diagnosis","not reported",24743,"alive","8441/3",NA,2143,"46512cdd-749b-5942-92b7-1bce1b8021a2","c56.9",-24743,"TCGA-13-A5FT_treatment","762c2a4d-d8c9-5cca-bb9a-17112fcc9206","01","true","TCGA-13-A5FT-01A",NA,"64bb8411-d52d-4ec9-b6a7-f0c25d8a050a",FALSE,"B67517DE-A483-4563-8698-51CB95DC5CF1","Primary Tumor",NA,1211,230,NA,1358726400,"11",30,"TCGA-13-A5FT-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:08:17.428697-05:00",NA,1,NA,0,NA,"TOP",NA,8,NA,"85eaefa5-9f54-4a1a-b907-393ca55b627d",NA,"TCGA-13-A5FT-01A-01-TSA",NA,92,NA,"322c2111-1d14-4123-be9b-8be1407f3b22","RNA","TCGA-13-A5FT-01A-11R","2b08989a-3379-4f13-bd0e-e22865f1edc0",1.83,0.18,"UV Spec","R","23","TCGA-13-A5FT-01A-11R-A406-31","819ce36b-9256-4ea0-947f-694029850c9d",0.18,NA,NA,NA,NA,"9a181513-cf32-5546-9457-a33f41b7df69","TCGA-13-A5FT_exposure","TCGA-13-A5FT-01A-11R-A406-31_rnaseq_fastq.tar","2015-02-07T04:54:58.000Z","2015-02-07T05:27:07.000Z","95896B1E-63E2-49D2-A526-95493556FE65","64BB8411-D52D-4EC9-B6A7-F0C25D8A050A","Unaligned reads",14480783360,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","819CE36B-9256-4EA0-947F-694029850C9D","Canada's Michael Smith Genome Sciences Centre","564a5c51e4b0298dd2cc48c8","F3618472-32DC-4C90-A407-90050F68BE85","Ovarian Serous Cystadenocarcinoma","TAR","322C2111-1D14-4123-BE9B-8BE1407F3B22","2015-02-07T05:27:07.000Z","2B08989A-3379-4F13-BD0E-E22865F1EDC0","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",1211,"322C2111-1D14-4123-BE9B-8BE1407F3B22",NA,"13","TCGA-13-A5FT-01A-11R-A407-13_mirna.bam.bai",230,"TCGA-13-A5FT-01A",NA,"F6311109-F942-40EE-BBC7-BC3334388892","TCGA",2009,NA,"Complete Remission/Response","TUMOR FREE","784E2D20-21E1-4C2C-AF73-C1D47B9FD234",67,"nationwidechildrens.org_clinical.TCGA-13-A5FT.xml","Alive",NA,"TCGA-13-A5FT",NA,"47557746-8652-4B47-8CA5-06831E01FA32","NO",1296,"No","Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IIIC",NA,70,NA,"8441/3","FEMALE","C56.9",409,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"85EAEFA5-9F54-4A1A-B907-393CA55B627D","5D49CFBB-47C6-4DEF-822F-DD6E2CA2B8DC","TCGA-13-A5FT-01A-11R-A407-13_mirna.bam.bai","TCGA-13-A5FT-01A-11",80,0,0,1,0,"TOP",8,0,"TCGA-13-A5FT-01A-01-TSA",92,"Cisplatin","Chemotherapy","TCGA-13-A5FT-D43570",NA,NA,NA,NA,"NO",1666,"TUMOR FREE","Alive",NA,"TCGA-13-A5FT-F58072","TCGA-13-A5FT",NA,"13","A5FT","YES","C56.9","8441/3","C56.9","NO","YES",-24743,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1296,NA,"NO","YES","TUMOR FREE","YES",26,5,2013,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,67,2009,"Tumor resection",NA,NA,NA,"G3","RX",NA,NA,NA,NA,"Complete Remission/Response",NA,10,NA,NA,NA,70,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
385374826,368582912,27217496224,"1839B1D7-F5D9-4D6D-8AB4-64656DFA38F5.bw","f3af727e-b592-4828-94f5-22008666cf8c","1839b1d7-f5d9-4d6d-8ab4-64656dfa38f5","2016-09-29T18:09:56.379664-05:00","TCGA-13-1482-01A-01R-1565-13_rnaseq_fastq.tar","1120a487-3a2e-4cda-bda4-a477b7d74c53",24218009600,"Illumina HiSeq","27f270aac6b3a0fbce4d4176953d8a3d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:12:57.416831-05:00","2016-05-03T11:40:21.647690-05:00","1120a487-3a2e-4cda-bda4-a477b7d74c53_analysis.xml","a511c8de0d08cfd450953b80ba43355d","af3d1c93-73b9-455f-bd49-6ffb664069bb",2235,"2016-09-29T22:38:54.096589-05:00","1120a487-3a2e-4cda-bda4-a477b7d74c53_experiment.xml","b836541e3e9131b15974b5ea19eec4fd","bf482d31-6db0-444e-a7d9-9264cbbdb7af",3916,"2016-09-29T21:23:41.366887-05:00","1120a487-3a2e-4cda-bda4-a477b7d74c53_run.xml","738721e325925fe66a5d8c4fcdd2ac10","90d5bfac-57dc-492a-8cec-9401e7da79e6",1989,"2016-09-08T10:32:13.136970-05:00","TCGA-13-1482","2016-09-02T19:13:47.067665-05:00","female","TCGA-13-1482_demographic",1948,"white","5bce3e7c-4446-514f-bcfe-66719143e11c","not hispanic or latino",2005,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1482_diagnosis","not reported",19178,"dead","8441/3",1877,1877,"ca932ee8-4c96-5161-b508-2be33bc85b22","c56.9",-19178,"TCGA-13-1482_treatment","b123e1bb-4d75-5f6b-b843-485cae1de357","01",NA,"TCGA-13-1482-01A","1.3","2067e680-a491-40d4-ba54-2fb7f46698e4",FALSE,"58881EFF-AD88-4A0D-BC66-31E2B04D4B8C","Primary Tumor","0.4",NA,NA,"1.3",1234396800,"01",100,"TCGA-13-1482-01A-01",90,85,5,5,0,0,15,20,"2016-09-08T10:32:13.136970-05:00","2016-09-08T10:32:13.136970-05:00",65,65,30,30,"TOP","BOTTOM",0,0,"37b613d9-d73a-4160-992e-35d2aa54520b","721cf135-b705-4810-b65e-9e37ab895a34","TCGA-13-1482-01A-01-TS1","TCGA-13-1482-01A-01-BS1",85,80,"0b0e19ae-ad05-469b-8e32-c316ef4366ea","RNA","TCGA-13-1482-01A-01R","6e6b6e29-9bcb-4a13-8a30-62e7fd051db2",1.8,0.15,"UV Spec","R","22","TCGA-13-1482-01A-01R-1565-13","197bc1c2-fb72-422a-b6b0-d07cf5b737ef",0.15,NA,NA,NA,NA,"89f45b2d-f906-5f08-9d5d-d5a1a5f4fa67","TCGA-13-1482_exposure","TCGA-13-1482-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T02:56:37.000Z","2014-03-22T03:45:01.000Z","1120A487-3A2E-4CDA-BDA4-A477B7D74C53","2067E680-A491-40D4-BA54-2FB7F46698E4","Unaligned reads",24218009600,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","197BC1C2-FB72-422A-B6B0-D07CF5B737EF","Canada's Michael Smith Genome Sciences Centre","564a36dee4b0ef121818fe12","F3AF727E-B592-4828-94F5-22008666CF8C","Ovarian Serous Cystadenocarcinoma","TAR","0B0E19AE-AD05-469B-8E32-C316EF4366EA","2014-03-22T03:45:01.000Z","6E6B6E29-9BCB-4A13-8A30-62E7FD051DB2","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"0B0E19AE-AD05-469B-8E32-C316EF4366EA",1.3,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.db641a43-1973-4213-a4ed-42fa9ff8e8ec.txt",NA,"TCGA-13-1482-01A",1.3,"15515EA8-488A-4962-8719-11B9D4BDA728","TCGA",2000,NA,NA,"WITH TUMOR","6DB71E84-2799-4F12-9D40-D3E50F3336B7",52,"TCGA-13-1482-01A-01R-1565-13.hg19.exon.quantification.txt","Dead",1877,"TCGA-13-1482","NOT HISPANIC OR LATINO","6827F11A-2B5C-4F30-9223-474C514708E6",NA,1877,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Operative","Stage IV",NA,80,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,100,"721CF135-B705-4810-B65E-9E37AB895A34","DB72B46C-187A-4340-869B-F6A313033EF6","67c4dae44efb6f957423847db7f0eb51.bam.bai","TCGA-13-1482-01A-01",90,0,5,65,15,"TOP",0,30,"TCGA-13-1482-01A-01-TS1",85,"Carboplatin","Chemotherapy","TCGA-13-1482-D24849",NA,NA,NA,"TCGA-13-1482-F24848_NTE-1",NA,1877,"WITH TUMOR","Dead",1877,"TCGA-13-1482-F24848","TCGA-13-1482",NA,"13","1482","YES","C56.9","8441/3","C56.9",NA,NA,-19178,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1877,1877,NA,NA,"WITH TUMOR","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,52,2000,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,80,NA,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
159295526,155944511,11529131717,"C6DD8040-FBB2-4A98-AC2B-36DE345532EB.bw","f4d95c8e-fb84-46ca-acc0-827015cc9d0a","c6dd8040-fbb2-4a98-ac2b-36de345532eb","2016-08-22T13:02:10.223199-05:00","TCGA-59-2363-01A-01R-1569-13_rnaseq_fastq.tar","7e359fdf-3d92-409d-ba3f-168166df282c",9913927680,"Illumina HiSeq","8ad172369fcaba577b15ded133751500","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:38:11.229440-05:00","2016-05-03T11:41:05.740436-05:00","7e359fdf-3d92-409d-ba3f-168166df282c_analysis.xml","63e948b1c3f934f5598a2f12b2f0b6ee","29d7a2be-d1b2-42f2-9348-98e91b52f781",2181,"2016-08-26T02:15:51.840043-05:00","7e359fdf-3d92-409d-ba3f-168166df282c_experiment.xml","174c887b442ea4a94ac6ad3b6e6fa9cd","df104f02-6911-4220-88b5-dc4b08056b09",3916,"2016-09-29T20:23:02.467424-05:00","7e359fdf-3d92-409d-ba3f-168166df282c_run.xml","bfea820a13b36dea26f82460f3a1b4b6","6b209a35-3f86-4ab2-b1ee-5f521319d261",1988,"2016-09-08T13:33:05.290265-05:00","TCGA-59-2363","2016-09-02T19:11:40.305911-05:00","female","TCGA-59-2363_demographic",1967,"asian","70e5088b-a97a-527d-8705-0671fabd9fdb","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","59","2782a374-0344-524e-b32b-38c2f9596173","Roswell Park","not reported","c56.9","TCGA-59-2363_diagnosis","not reported",NA,"alive","8441/3",NA,165,"219b42b0-2897-5644-adb6-0bd82706bdac","c56.9",NA,"TCGA-59-2363_treatment","15958777-9f8e-50af-995d-a42f6d60595c","01",NA,"TCGA-59-2363-01A","1","faf406a4-d3d4-4ff5-8a3b-86ecbc6802ab",FALSE,"9b047485-eb2b-4fc1-a22a-d96046b63bf2","Primary Tumor","0.4",NA,NA,"1.5",1251676800,"01",108,"TCGA-59-2363-01A-01",90,90,NA,NA,1,0,10,10,"2016-09-08T13:33:05.290265-05:00","2016-09-08T13:33:05.290265-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,0,"ea7d9017-b715-46a3-aa0a-dca2748be4d4","40e807a6-44b6-41a0-ae0e-0d202fd9cc1d","TCGA-59-2363-01A-01-BS1","TCGA-59-2363-01A-01-TS1",84,90,"f09435db-d83c-4af6-b126-6cbcd305cd6b","RNA","TCGA-59-2363-01A-01R","a444db59-d50b-4337-a5e6-92d5256bd67f",1.8,0.15,"UV Spec","R","22","TCGA-59-2363-01A-01R-1569-13","1d3f29ac-5f19-452d-99b6-72c0abf1ce32",0.15,NA,NA,NA,NA,"9cf1a7f2-3a7a-5b24-aec4-f4a2fa870e59","TCGA-59-2363_exposure","TCGA-59-2363-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T01:19:06.000Z","2014-03-27T01:41:02.000Z","7E359FDF-3D92-409D-BA3F-168166DF282C","FAF406A4-D3D4-4FF5-8A3B-86ECBC6802AB","Unaligned reads",9913927680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1D3F29AC-5F19-452D-99B6-72C0ABF1CE32","Canada's Michael Smith Genome Sciences Centre","564a5b69e4b0ef12181e2c15","F4D95C8E-FB84-46CA-ACC0-827015CC9D0A","Ovarian Serous Cystadenocarcinoma","TAR","F09435DB-D83C-4AF6-B126-6CBCD305CD6B","2014-03-27T01:41:02.000Z","A444DB59-D50B-4337-A5E6-92D5256BD67F","None","NO",1,0.4,"Primary Tumor","Roswell Park",NA,"F09435DB-D83C-4AF6-B126-6CBCD305CD6B",1,"59","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.abdc5a45-9e20-4c0e-b854-9a2ec535245a.txt",NA,"TCGA-59-2363-01A",1.5,"3947E570-C2AF-4B0D-8D63-FB7EB1A976CA","TCGA",2007,NA,NA,"TUMOR FREE","FAF406A4-D3D4-4FF5-8A3B-86ECBC6802AB",40,"nationwidechildrens.org_clinical.TCGA-59-2363.xml","Alive",NA,"TCGA-59-2363","NOT HISPANIC OR LATINO","B9FA6C71-A686-47CC-8B85-BA5CCA27A399",NA,165,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIA",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"ASIAN",NA,1,108,"EA7D9017-B715-46A3-AA0A-DCA2748BE4D4","A0600BE7-E0A9-4028-A33D-49909D961C15","TCGA-59-2363-01A-01T-0712-07.probe.tcga_level2.data.txt","TCGA-59-2363-01A-01",90,1,NA,NA,10,"BOTTOM",5,NA,"TCGA-59-2363-01A-01-BS1",84,"Taxol","Chemotherapy","TCGA-59-2363-D28117",NA,NA,NA,NA,NA,165,"TUMOR FREE","Alive",NA,"TCGA-59-2363-F28115","TCGA-59-2363",NA,"59","2363","YES","C56.9","8441/3","C56.9",NA,NA,NA,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",165,NA,NA,NA,"TUMOR FREE","NO",12,2,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,40,2007,"Tumor resection",NA,NA,NA,"G3","R0",NA,NA,NA,NA,NA,NA,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
229174892,223504373,16556606009,"1CBF5BEA-00B4-4F17-A6EC-4F3354CC15EB.bw","f5033d52-ec36-4e67-88d8-b6d898b81b2f","1cbf5bea-00b4-4f17-a6ec-4f3354cc15eb","2016-08-25T05:27:04.304519-05:00","TCGA-25-2391-01A-01R-1569-13_rnaseq_fastq.tar","73a6e816-39ea-4425-a07d-e4cd531ee254",14365521920,"Illumina HiSeq","dcc95f35aba309ac360ad96af5cdb61a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:20:28.565918-05:00","2016-05-03T11:41:05.740436-05:00","73a6e816-39ea-4425-a07d-e4cd531ee254_analysis.xml","530944689261990f798f9650ddd989b8","1e9dec68-9676-4af1-af45-349e8e14fd77",2181,"2016-10-07T15:37:25.401349-05:00","73a6e816-39ea-4425-a07d-e4cd531ee254_experiment.xml","990dc4939b4bae157ab2a64c8e761d51","30b949d9-2899-45ae-8e71-a0dd3a41ff00",3916,"2016-09-29T18:20:07.980006-05:00","73a6e816-39ea-4425-a07d-e4cd531ee254_run.xml","994841b44a4f87460224c24f64754eac","1e637def-3b16-4970-a92a-b01e58ac0eef",1988,"2016-09-08T13:24:42.084796-05:00","TCGA-25-2391","2016-09-02T19:11:49.569243-05:00","female","TCGA-25-2391_demographic",1946,"white","8b704245-4ea7-56dc-bc6e-04c1ea8b05a8","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2391_diagnosis","not reported",20939,"dead","8441/3",1492,1492,"33b6e169-a746-5ca1-ab5c-eeaa38b79c2b","c56.9",-20939,"TCGA-25-2391_treatment","42ae62e3-b52d-5a77-b8f1-a4b696c24efa","01",NA,"TCGA-25-2391-01A","1","2179798c-4fd4-4434-b1d5-1453f6054fa2",FALSE,"32AC761D-67A0-46C5-AB01-AE9BBE7307CA","Primary Tumor","0.3",NA,NA,"1.5",1252022400,"01",161,"TCGA-25-2391-01A-01",90,90,NA,NA,1,0,9,10,"2016-09-08T13:24:42.084796-05:00","2016-09-08T13:24:42.084796-05:00",NA,NA,NA,NA,"BOTTOM","TOP",1,1,"36d1284c-605f-4346-b6c6-048f71df6393","8356e1f7-f054-4869-9793-39e86a37225a","TCGA-25-2391-01A-01-BS1","TCGA-25-2391-01A-01-TS1",89,89,"9b808684-4e13-4564-92e1-4a4d48bbcc17","RNA","TCGA-25-2391-01A-01R","7e919246-646e-478b-b6c9-f5e65ad5f948",1.7,0.15,"UV Spec","R","22","TCGA-25-2391-01A-01R-1569-13","0ee0c708-77c4-4ac3-be13-0d08e6444003",0.15,NA,NA,NA,NA,"80794472-40a2-5f55-b17b-c2f0c5011ea5","TCGA-25-2391_exposure","TCGA-25-2391-01A-01R-1569-13_rnaseq_fastq.tar","2014-03-27T01:59:21.000Z","2014-03-27T02:30:01.000Z","73A6E816-39EA-4425-A07D-E4CD531EE254","2179798C-4FD4-4434-B1D5-1453F6054FA2","Unaligned reads",14365521920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","0EE0C708-77C4-4AC3-BE13-0D08E6444003","Canada's Michael Smith Genome Sciences Centre","564a5832e4b09c884b26cb0f","F5033D52-EC36-4E67-88D8-B6D898B81B2F","Ovarian Serous Cystadenocarcinoma","TAR","9B808684-4E13-4564-92E1-4A4D48BBCC17","2014-03-27T02:30:01.000Z","7E919246-646E-478B-B6C9-F5E65AD5F948","None","NO",1,0.3,"Primary Tumor","Mayo Clinic - Rochester",NA,"9B808684-4E13-4564-92E1-4A4D48BBCC17",1,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.53220d7f-967c-4101-82ce-24495a3e2b9a.txt",NA,"TCGA-25-2391-01A",1.5,"C57FB4B0-6CDC-4067-95A8-0F82C14E07AC","TCGA",2003,NA,NA,"TUMOR FREE","59001597-3894-47FB-B926-B6AC5DA947D6",57,"bcgsc.ca.TCGA-25-2391-01A-01R-1569-13.hg19.bcgsc.ca.1.6.0.indel.vcf","Dead",1492,"TCGA-25-2391","NOT HISPANIC OR LATINO","6EC2F13A-7241-400E-BA92-E194AF3034C7",NA,1492,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,161,"8356E1F7-F054-4869-9793-39E86A37225A","AB03602F-AA37-4D68-AB3E-1FCD6323C996","TCGA-25-2391-01A-01W-0799-08_IlluminaGA-DNASeq_capture.bam.bai","TCGA-25-2391-01A-01",90,1,NA,NA,9,"BOTTOM",1,NA,"TCGA-25-2391-01A-01-BS1",89,"Taxotere","Chemotherapy","TCGA-25-2391-D26799",NA,NA,NA,NA,NA,1492,"TUMOR FREE","Dead",1492,"TCGA-25-2391-F26796","TCGA-25-2391",NA,"25","2391","YES","C56.9","8441/3","C56.9",NA,NA,-20939,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1492,1492,NA,NA,"TUMOR FREE","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2003,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
124562600,121372730,8985008591,"258EB185-DECE-41B5-8EE3-C3883D7285F8.bw","f58e49fc-9641-4b46-be4c-766445ec70a3","258eb185-dece-41b5-8ee3-c3883d7285f8","2016-08-25T08:21:41.745429-05:00","TCGA-29-1711-01A-01R-1567-13_rnaseq_fastq.tar","cafa7fc7-82e8-42be-91d7-75b28a1d08c1",8146544640,"Illumina HiSeq","5766ae079d43e04cc94d31e5ec29a9c7","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:53:52.991540-05:00","2016-05-03T11:41:05.740763-05:00","cafa7fc7-82e8-42be-91d7-75b28a1d08c1_analysis.xml","a4e2ee47be9be4e18f49dd6fdabaacc0","a3880484-37f6-492b-84bd-82c6fcd62d62",2181,"2016-09-29T19:39:58.115572-05:00","cafa7fc7-82e8-42be-91d7-75b28a1d08c1_experiment.xml","6fafcff12c691326c01852071f8c4dee","50af6869-6bf9-411e-a30b-300c5a06d5f4",3916,"2016-09-29T20:21:02.651121-05:00","cafa7fc7-82e8-42be-91d7-75b28a1d08c1_run.xml","6e4ed04d82bb6ae932296cc751a0af48","69dba877-d9a7-4c27-9367-243a750fda33",1988,"2016-09-08T13:52:22.359803-05:00","TCGA-29-1711","2016-09-02T19:07:24.243662-05:00","female","TCGA-29-1711_demographic",1961,"black or african american","8281281b-4e5e-598a-b5f4-68ff6e315138","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1711_diagnosis","not reported",16485,"alive","8441/3",NA,1053,"eda2964c-ca2e-5949-a47e-bde81da98557","c56.9",-16485,"TCGA-29-1711_treatment","440d246c-0fd0-58e7-be8a-18e0015a9589","01",NA,"TCGA-29-1711-01A","1.1","f0f721b2-edab-49c9-b271-2204878c2ae5",FALSE,"e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d","Primary Tumor","0.4",NA,NA,"1.2",1242345600,"01",126,"TCGA-29-1711-01A-01",90,90,3,NA,0,0,0,0,"2016-09-08T13:52:22.359803-05:00","2016-09-08T13:52:22.359803-05:00",2,NA,NA,NA,"BOTTOM","TOP",2,2,"cee261be-39be-457f-8b61-31eca4d7e795","abf41830-7901-443a-a734-4696c4bc7893","TCGA-29-1711-01A-01-BS1","TCGA-29-1711-01A-01-TS1",98,98,"5543b859-960d-4c3d-9079-f0b66ce73d8d","RNA","TCGA-29-1711-01A-01R","fa811206-1b28-4221-bc5c-4bf30564acf1",1.8,0.16,"UV Spec","R","22","TCGA-29-1711-01A-01R-1567-13","c512a6e3-8bc8-4188-b264-89b2fe02baa8",0.16,NA,NA,NA,NA,"0dac7ec5-37a3-57e2-bb74-ff0193549a2a","TCGA-29-1711_exposure","TCGA-29-1711-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-26T21:49:58.000Z","2014-03-26T22:10:01.000Z","CAFA7FC7-82E8-42BE-91D7-75B28A1D08C1","F0F721B2-EDAB-49C9-B271-2204878C2AE5","Unaligned reads",8146544640,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","C512A6E3-8BC8-4188-B264-89B2FE02BAA8","Canada's Michael Smith Genome Sciences Centre","564a3aa2e4b0298dd2c8298f","F58E49FC-9641-4B46-BE4C-766445EC70A3","Ovarian Serous Cystadenocarcinoma","TAR","5543B859-960D-4C3D-9079-F0B66CE73D8D","2014-03-26T22:10:01.000Z","FA811206-1B28-4221-BC5C-4BF30564ACF1","None","NO",1,0.4,"Primary Tumor","Duke",NA,"5543B859-960D-4C3D-9079-F0B66CE73D8D",1.1,"29","jhu-usc.edu_OV.HumanMethylation27.8.lvl-3.TCGA-29-1711-01A-01D-0563-05.txt",NA,"TCGA-29-1711-01A",1.2,"C10283D7-F31A-4930-B91D-E81E88307348","TCGA",2006,NA,NA,"TUMOR FREE","F0F721B2-EDAB-49C9-B271-2204878C2AE5",45,"nationwidechildrens.org_clinical.TCGA-29-1711.xml","Alive",NA,"TCGA-29-1711",NA,"764F8125-40F5-4183-8365-5D97C30CBDF0",NA,1053,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,126,"ABF41830-7901-443A-A734-4696C4BC7893","A22313AF-848F-48F5-A6E9-1718D2612377","3cf3819aa7c6eb554e8e0ec71ecb98b4.bam","TCGA-29-1711-01A-01",90,0,NA,NA,0,"TOP",2,NA,"TCGA-29-1711-01A-01-TS1",98,"Oxaliplatin","Chemotherapy","TCGA-29-1711-D27309",NA,NA,NA,NA,NA,1053,"TUMOR FREE","Alive",NA,"TCGA-29-1711-F27307","TCGA-29-1711",NA,"29","1711","YES","C56.9","8441/3","C56.9",NA,NA,-16485,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,NA,"No","Alive",1053,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2006,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
252536716,245945482,18184674560,"9C9BB49E-493B-4DBB-9FC8-F304B1D742F4.bw","f64ebc7f-0e5a-42b4-af57-6cdb90d24f90","9c9bb49e-493b-4dbb-9fc8-f304b1d742f4","2016-08-25T19:18:09.478809-05:00","TCGA-24-1423-01A-01R-1565-13_rnaseq_fastq.tar","05e20596-a5f3-46ac-a748-d88d08db98ec",15581911040,"Illumina HiSeq","7c47e2954442d94632bc7521db4092b4","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:15:44.267292-05:00","2016-05-03T11:40:21.647690-05:00","05e20596-a5f3-46ac-a748-d88d08db98ec_analysis.xml","9dca93ed9e3bf66762c25f6158e2a0a6","1bc1131c-7bca-4de0-b351-65c2c9263821",2181,"2016-09-29T19:24:16.630200-05:00","05e20596-a5f3-46ac-a748-d88d08db98ec_experiment.xml","a94c34463361d12d56ad3c06a288b0d4","46fa53f0-f866-4b24-ab47-2d404a694847",3916,"2016-09-30T00:10:53.605352-05:00","05e20596-a5f3-46ac-a748-d88d08db98ec_run.xml","786d44efdd4f18b3c6a73ed0373a321c","f83e6ee8-1b13-4556-9273-94c50d226e20",1989,"2016-09-08T13:51:35.579206-05:00","TCGA-24-1423","2016-09-02T19:13:42.012155-05:00","female","TCGA-24-1423_demographic",1947,"white","a4ae248f-d90b-5ced-a3c7-bf5619b4bffd","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1423_diagnosis","not reported",22281,"alive","8441/3",NA,190,"4b898782-211b-5014-b4fc-29731d9e4489","c56.9",-22281,"TCGA-24-1423_treatment","daf9c3a2-fdd8-55fa-aeed-0b37b8fd4d57","01",NA,"TCGA-24-1423-01A","1","eaf742ea-5bdc-4f44-a390-77cba766d260",FALSE,"47331163-68e9-44fd-8b80-b9f70058957f","Primary Tumor","0.6",NA,NA,"1.8",1231977600,"01",182,"TCGA-24-1423-01A-01",90,95,NA,NA,5,30,0,0,"2016-09-08T13:51:35.579206-05:00","2016-09-08T13:51:35.579206-05:00",NA,NA,NA,NA,"TOP","BOTTOM",10,10,"43615c8b-4834-48bd-b92f-251ceb7073fe","8e1e9415-8cf4-41b5-a038-1e6f03193d0f","TCGA-24-1423-01A-01-TS1","TCGA-24-1423-01A-01-BS1",85,60,"0556782f-6b2c-4867-9bbd-624d1c312738","RNA","TCGA-24-1423-01A-01R","6312898c-065a-4b4c-8706-69374b2d6f5b",1.8,0.17,"UV Spec","R","22","TCGA-24-1423-01A-01R-1565-13","b493df11-1929-4e35-ac44-49057cdbd86b",0.17,NA,NA,NA,NA,"2471cd1a-245f-5e4f-ae19-d6830608c4af","TCGA-24-1423_exposure","TCGA-24-1423-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T00:50:04.000Z","2014-03-22T01:23:02.000Z","05E20596-A5F3-46AC-A748-D88D08DB98EC","EAF742EA-5BDC-4F44-A390-77CBA766D260","Unaligned reads",15581911040,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","B493DF11-1929-4E35-AC44-49057CDBD86B","Canada's Michael Smith Genome Sciences Centre","564a5b5ae4b0298dd2cc210a","F64EBC7F-0E5A-42B4-AF57-6CDB90D24F90","Ovarian Serous Cystadenocarcinoma","TAR","0556782F-6B2C-4867-9BBD-624D1C312738","2014-03-22T01:23:02.000Z","6312898C-065A-4B4C-8706-69374B2D6F5B","None","NO",1,0.6,"Primary Tumor","Washington University",NA,"0556782F-6B2C-4867-9BBD-624D1C312738",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5a0afbd0-e504-46d6-b268-2b04d7f8be98.txt",NA,"TCGA-24-1423-01A",1.8,"DFA0C377-EF42-4909-977C-58D6C1D64FE9","TCGA",2008,NA,NA,"TUMOR FREE","EAF742EA-5BDC-4F44-A390-77CBA766D260",61,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.5a0afbd0-e504-46d6-b268-2b04d7f8be98.txt","Alive",NA,"TCGA-24-1423",NA,"2C5EDEAA-427C-44B6-893C-797F75CDD9A8",NA,190,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,182,"8E1E9415-8CF4-41B5-A038-1E6F03193D0F","CD8A617C-C714-4C5F-9531-38BC358CBAC6","TCGA-24-1423-01A-01R-1565-13_rnaseq.bam","TCGA-24-1423-01A-01",95,30,NA,NA,0,"BOTTOM",10,NA,"TCGA-24-1423-01A-01-BS1",60,"Cisplatin","Chemotherapy","TCGA-24-1423-D25938",NA,NA,NA,NA,NA,190,"TUMOR FREE","Alive",NA,"TCGA-24-1423-F25936","TCGA-24-1423",NA,"24","1423","YES","C56.9","8441/3","C56.9",NA,NA,-22281,"FEMALE","WHITE",NA,NA,"No","Alive",190,NA,NA,NA,"TUMOR FREE","NO",16,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,61,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
281830920,267581306,19785941707,"051FBD9E-564F-4E17-851A-CF3980457DF9.bw","f65f2e78-c001-4ef3-ae88-3e4f83c7aceb","051fbd9e-564f-4e17-851a-cf3980457df9","2016-08-24T07:47:37.719884-05:00","TCGA-36-1578-01A-01R-1566-13_rnaseq_fastq.tar","5a06ace3-a979-475c-a402-ba0393b2f7ce",19116257280,"Illumina HiSeq","da2fc917a14d1c5b79b0f7c77ca9d356","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:09:46.674256-05:00","2016-05-03T11:41:05.750744-05:00","5a06ace3-a979-475c-a402-ba0393b2f7ce_analysis.xml","6408129be4cd5a7169488ee7eab988c3","f78c0cef-cccb-413a-98a4-b1f440ff5f09",2181,"2016-09-29T23:22:05.630237-05:00","5a06ace3-a979-475c-a402-ba0393b2f7ce_experiment.xml","1b6607ca3f25d4c5711ecb50ec968663","d9fb134f-7146-43de-b2be-6f6a074dba9a",3916,"2016-09-29T21:44:59.161227-05:00","5a06ace3-a979-475c-a402-ba0393b2f7ce_run.xml","334d151fad262df066df9d911f7c256f","9de623e9-679d-474c-b5e1-85cc02704304",1988,"2016-09-08T10:47:23.523191-05:00","TCGA-36-1578","2016-09-02T18:54:35.678004-05:00","female","TCGA-36-1578_demographic",1944,"asian","753ed5fb-e73a-5641-941d-45f244e4c82e","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","36","aeb45a0d-9f6b-5350-88a5-704885d09ec0","BC Cancer Agency","not reported","c56.9","TCGA-36-1578_diagnosis","not reported",23329,"alive","8441/3",NA,847,"d74b9bf5-e84c-53ac-84a4-1a646a896e4f","c56.9",-23329,"TCGA-36-1578_treatment","3b2f7435-8ce2-5f3a-aad9-c4fb3a9696e4","01",NA,"TCGA-36-1578-01A","0.6","25d8f564-9ba7-4336-9b92-038fc26dcbd1",FALSE,"6BD44F43-7D75-4DF3-891D-7E08291F020C","Primary Tumor","0.5",NA,NA,"0.6",1235952000,"01",108,"TCGA-36-1578-01A-01",95,95,NA,NA,0,0,8,8,"2016-09-08T10:47:23.523191-05:00","2016-09-08T10:47:23.523191-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,2,"3dcbd7a4-25bc-4cf5-a4eb-8b22076299b9","2481bf3c-f696-4858-b10e-71bee3337268","TCGA-36-1578-01A-01-TS1","TCGA-36-1578-01A-01-BS1",90,90,"00a1f413-f858-43d5-ba71-ca3a48ce59ee","RNA","TCGA-36-1578-01A-01R","15763240-f6f8-46e3-b6d4-74cbd0535082",1.8,0.14,"UV Spec","R","22","TCGA-36-1578-01A-01R-1566-13","7ecb58fe-e2fe-4dc8-996b-2b959da43566",0.14,NA,NA,NA,NA,"91624496-57e1-5041-a332-c0116529ac0b","TCGA-36-1578_exposure","TCGA-36-1578-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-28T16:52:42.000Z","2014-03-28T17:34:01.000Z","5A06ACE3-A979-475C-A402-BA0393B2F7CE","25D8F564-9BA7-4336-9B92-038FC26DCBD1","Unaligned reads",19116257280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","7ECB58FE-E2FE-4DC8-996B-2B959DA43566","Canada's Michael Smith Genome Sciences Centre","564a56bce4b0298dd2ca9f4c","F65F2E78-C001-4EF3-AE88-3E4F83C7ACEB","Ovarian Serous Cystadenocarcinoma","TAR","00A1F413-F858-43D5-BA71-CA3A48CE59EE","2014-03-28T17:34:01.000Z","15763240-F6F8-46E3-B6D4-74CBD0535082","None","NO",1,0.5,"Primary Tumor","BC Cancer Agency",NA,"00A1F413-F858-43D5-BA71-CA3A48CE59EE",0.6,"36","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.cb41005f-cf76-417e-9ce8-8b5d3047609c.txt",NA,"TCGA-36-1578-01A",0.6,"F8BB0861-FE1F-4810-B9CA-BBFB06383418","TCGA",2007,NA,NA,"WITH TUMOR","25D8F564-9BA7-4336-9B92-038FC26DCBD1",63,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.cb41005f-cf76-417e-9ce8-8b5d3047609c.txt","Alive",NA,"TCGA-36-1578","NOT HISPANIC OR LATINO","35CAAAE5-E969-4B89-BBA6-DFC7859AE181",NA,847,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Operative","Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"ASIAN",NA,1,108,"3DCBD7A4-25BC-4CF5-A4EB-8B22076299B9","7CA35ED3-8878-47C7-9D1C-8651D94E285F","TCGA-36-1578-01A-01R-1566-13_mirna.bam","TCGA-36-1578-01A-01",95,0,NA,NA,8,"TOP",2,NA,"TCGA-36-1578-01A-01-TS1",90,"Liposomal Doxorubicin","Chemotherapy","TCGA-36-1578-D27887",NA,NA,NA,"TCGA-36-1578-F27884_NTE-1",NA,847,"WITH TUMOR","Alive",NA,"TCGA-36-1578-F27884","TCGA-36-1578",NA,"36","1578","YES","C56.9","8441/3","C56.9",NA,NA,-23329,"FEMALE","ASIAN","NOT HISPANIC OR LATINO",NA,"No","Alive",847,NA,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,63,2007,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
195360252,190343005,14011908893,"44EB6D2D-6A11-4235-BEE2-19744C26C104.bw","f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6","44eb6d2d-6a11-4235-bee2-19744c26c104","2016-08-25T23:24:42.096027-05:00","TCGA-29-1781-01A-01R-1567-13_rnaseq_fastq.tar","0089b8f7-d34d-49d6-b06d-7bccfa44cbb3",12165283840,"Illumina HiSeq","26363c326ff8449dedcf1d70f62879b0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T21:44:48.564335-05:00","2016-05-03T11:41:05.740436-05:00","0089b8f7-d34d-49d6-b06d-7bccfa44cbb3_analysis.xml","85d3b9691228f7b4a0588a58904754fc","9dcacf08-6e95-4f2f-8f21-de07978acb52",2181,"2016-10-07T17:22:34.921191-05:00","0089b8f7-d34d-49d6-b06d-7bccfa44cbb3_experiment.xml","5542d907deeef35288d5e117d0b154c0","72e1d359-22bf-4bd7-8e36-ed771be596fd",3916,"2016-09-29T23:30:38.770897-05:00","0089b8f7-d34d-49d6-b06d-7bccfa44cbb3_run.xml","06c4dfda4196aec2e0a2f2afb2e13f67","df67b048-db8f-4e1d-a6c6-92444b655d3a",1988,"2016-09-08T13:24:48.196913-05:00","TCGA-29-1781","2016-09-02T19:07:33.780353-05:00","female","TCGA-29-1781_demographic",1940,"white","34cdc2c3-656e-598f-98cd-ba99fa210ff2","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1781_diagnosis","not reported",25404,"alive","8441/3",NA,255,"d76e4af6-34c3-5b30-9645-83c9a06479ea","c56.9",-25404,"TCGA-29-1781_treatment","32792d93-6714-57b9-a3dc-5bc59a18a6f1","01",NA,"TCGA-29-1781-01A","1","b9a63363-bd0c-496f-a375-fce0d0a370d8",FALSE,"959c11fe-f170-49bc-a1fe-73b799741b93","Primary Tumor","0.4",NA,NA,"1.2",1243296000,"01",114,"TCGA-29-1781-01A-01",90,85,NA,NA,0,0,0,5,"2016-09-08T13:24:48.196913-05:00","2016-09-08T13:24:48.196913-05:00",5,10,NA,NA,"TOP","BOTTOM",20,10,"9de32ae8-99c2-4de0-8dfe-0a7431145cce","cfa47f58-9a94-4faf-ad7e-2e5901d649f9","TCGA-29-1781-01A-01-TS1","TCGA-29-1781-01A-01-BS1",80,85,"7d7e116a-24fe-4756-a4c9-b42ecd647af5","RNA","TCGA-29-1781-01A-01R","cb76e438-6be3-4609-bdd6-50cc3436dccb",1.9,0.15,"UV Spec","R","22","TCGA-29-1781-01A-01R-1567-13","5fd66773-ed5a-438c-a7c1-d029f05798e5",0.15,NA,NA,NA,NA,"8d8b688c-0544-586b-b61b-0e85b2c0c789","TCGA-29-1781_exposure","TCGA-29-1781-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T00:20:50.000Z","2014-03-27T00:45:02.000Z","0089B8F7-D34D-49D6-B06D-7BCCFA44CBB3","B9A63363-BD0C-496F-A375-FCE0D0A370D8","Unaligned reads",12165283840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","5FD66773-ED5A-438C-A7C1-D029F05798E5","Canada's Michael Smith Genome Sciences Centre","564a5c24e4b0ef12181e4950","F6EBF3A7-31C6-4F4C-9A0B-74CF35BFEDF6","Ovarian Serous Cystadenocarcinoma","TAR","7D7E116A-24FE-4756-A4C9-B42ECD647AF5","2014-03-27T00:45:02.000Z","CB76E438-6BE3-4609-BDD6-50CC3436DCCB","None","NO",1,0.4,"Primary Tumor","Duke",NA,"7D7E116A-24FE-4756-A4C9-B42ECD647AF5",1,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7b26743c-756e-45d0-8eaa-cffb1c11fef1.txt",NA,"TCGA-29-1781-01A",1.2,"CF2A312B-1BEA-47BB-8927-FEC695033234","TCGA",2009,NA,NA,"TUMOR FREE","B9A63363-BD0C-496F-A375-FCE0D0A370D8",69,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.7b26743c-756e-45d0-8eaa-cffb1c11fef1.txt","Alive",NA,"TCGA-29-1781",NA,"1B223132-EE30-413C-B80B-15986F45F9A3",NA,255,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,114,"9DE32AE8-99C2-4DE0-8DFE-0A7431145CCE","945D48AF-CFC2-4560-9BF1-B6B37E7C67A1","TCGA-29-1781-01A-01R-1567-13_rnaseq_fastq.tar","TCGA-29-1781-01A-01",90,0,NA,5,0,"TOP",20,NA,"TCGA-29-1781-01A-01-TS1",80,"Paclitaxel","Chemotherapy","TCGA-29-1781-D27429",NA,NA,NA,NA,NA,255,"TUMOR FREE","Alive",NA,"TCGA-29-1781-F27427","TCGA-29-1781",NA,"29","1781","YES","C56.9","8441/3","C56.9",NA,NA,-25404,"FEMALE","WHITE",NA,NA,"No","Alive",255,NA,NA,NA,"TUMOR FREE","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,69,2009,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
291631516,280932468,20792867042,"F177F929-546B-4A0F-A7F9-32477B32C1DA.bw","f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4","f177f929-546b-4a0f-a7f9-32477b32c1da","2016-09-29T23:59:40.629713-05:00","TCGA-04-1348-01A-01R-1565-13_rnaseq_fastq.tar","a236c04f-0d40-48fe-b94e-bd0007bb0b91",19032156160,"Illumina HiSeq","c13b792f2f1c63a6356a0eac70cb6935","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:45:26.378265-05:00","2016-05-03T11:40:21.647690-05:00","a236c04f-0d40-48fe-b94e-bd0007bb0b91_analysis.xml","1aa3506a506a4c360b8defc16ffa017e","2e77a794-0de3-4eba-9475-01e678dc6dda",2181,"2016-08-13T06:50:31.959722-05:00","a236c04f-0d40-48fe-b94e-bd0007bb0b91_experiment.xml","2403926604dbc5f412027cb5b74d8da1","68b2659f-61b5-4f04-84a2-bcc518c2b488",3916,"2016-09-29T18:10:47.863223-05:00","a236c04f-0d40-48fe-b94e-bd0007bb0b91_run.xml","6b8c92bd02601a5d3597462029224b71","18bd969a-c45c-4590-a946-3b17a77f05ff",1989,"2016-09-08T13:38:32.734408-05:00","TCGA-04-1348","2016-09-02T19:12:10.005935-05:00","female","TCGA-04-1348_demographic",1960,"white","6c0da9cf-4281-50f8-8be6-cdae39813f3b","hispanic or latino",2008,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1348_diagnosis","not reported",16236,"dead","8441/3",1483,NA,"97f080aa-d9d0-5451-b6d1-71fab2c5a759","c56.9",-16236,"TCGA-04-1348_treatment","723636c3-1416-5ecd-adf8-fe85c73c12f6","01",NA,"TCGA-04-1348-01A","1","cdaa3a57-c3e7-4858-a048-8f75b882dde7",FALSE,"51B558EF-C11B-41A7-A7BF-15D201506006","Primary Tumor","0.4",NA,NA,"1.5",1229644800,"01",105,"TCGA-04-1348-01A-01",99,99,NA,NA,0,0,2,1,"2016-09-08T13:38:32.734408-05:00","2016-09-08T13:38:32.734408-05:00",NA,NA,NA,NA,"BOTTOM","TOP",8,4,"06d57b7b-b6c9-49ae-86a9-9a28de14443d","ffb07f65-72b7-494c-abf8-c94d8007321b","TCGA-04-1348-01A-01-BS1","TCGA-04-1348-01A-01-TS1",90,95,"4ed2c866-a732-4821-93ec-a2a89f458420","RNA","TCGA-04-1348-01A-01R","3bd7e2f2-2350-44bf-bdd5-71d20902bf10",1.8,0.15,"UV Spec","R","22","TCGA-04-1348-01A-01R-1565-13","1465139e-d1b2-4026-a532-08513fe0ad4d",0.15,NA,NA,NA,NA,"196740e5-5bbc-5dc2-886f-2a31188ab465","TCGA-04-1348_exposure","TCGA-04-1348-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T01:11:44.000Z","2014-03-22T01:53:01.000Z","A236C04F-0D40-48FE-B94E-BD0007BB0B91","CDAA3A57-C3E7-4858-A048-8F75B882DDE7","Unaligned reads",19032156160,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","1465139E-D1B2-4026-A532-08513FE0AD4D","Canada's Michael Smith Genome Sciences Centre","564a5b80e4b09c884b27ac86","F7752D6E-F9CD-4DC9-AB01-3AB87ACB21E4","Ovarian Serous Cystadenocarcinoma","TAR","4ED2C866-A732-4821-93EC-A2A89F458420","2014-03-22T01:53:01.000Z","3BD7E2F2-2350-44BF-BDD5-71D20902BF10","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"4ED2C866-A732-4821-93EC-A2A89F458420",1,"04","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.21a891e7-6da2-4d9e-a1e3-e760605d9dee.txt",NA,"TCGA-04-1348-01A",1.5,"D3ABAE36-F4B5-4D43-B4F8-AF47F4AD136E","TCGA",2004,NA,NA,"WITH TUMOR","CDAA3A57-C3E7-4858-A048-8F75B882DDE7",44,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.21a891e7-6da2-4d9e-a1e3-e760605d9dee.txt","Dead",1483,"TCGA-04-1348","HISPANIC OR LATINO","4BD91396-4007-4FF3-9673-58E37B089FE6",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,"WHITE",NA,1,105,"FFB07F65-72B7-494C-ABF8-C94D8007321B","B5ACB875-51C0-4A16-B334-C223C3F36780","4520661220_R01C01_Red.idat","TCGA-04-1348-01A-01",99,0,NA,NA,1,"TOP",4,NA,"TCGA-04-1348-01A-01-TS1",95,"Cisplatin/Gemzar","Chemotherapy","TCGA-04-1348-D23972",NA,NA,NA,"TCGA-04-1348-F23967_NTE-2",NA,NA,"WITH TUMOR","Dead",1483,"TCGA-04-1348-F23967","TCGA-04-1348",NA,"04","1348","YES","C56.9","8441/3","C56.9",NA,NA,-16236,"FEMALE","WHITE","HISPANIC OR LATINO",NA,"No","Dead",NA,1483,NA,NA,"WITH TUMOR","NO",26,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,44,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
156236144,152618957,11221620837,"9C01F1DD-7AFD-43D6-A824-29A61A07F103.bw","f8a5547f-f1bc-4c01-8b68-25b5ee0caeab","9c01f1dd-7afd-43d6-a824-29a61a07f103","2016-08-25T19:08:00.411626-05:00","TCGA-04-1655-01A-01R-1566-13_rnaseq_fastq.tar","46454ddf-5be1-479f-bee7-d639380a5a63",9467330560,"Illumina HiSeq","2dd10b9200c147329bfdabc4f426bf28","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:52:53.372966-05:00","2016-05-03T11:39:34.528512-05:00","46454ddf-5be1-479f-bee7-d639380a5a63_analysis.xml","7508b5b192bc4484bba95f2c79308127","c8048b8d-d63d-438a-a768-fc258b88f17e",2235,"2016-09-29T22:04:25.075790-05:00","46454ddf-5be1-479f-bee7-d639380a5a63_experiment.xml","9057a8279252b0e7faa3d36d65553619","aa114e14-afa8-4bee-bd4f-061e1fac48e3",3916,"2016-09-29T23:45:32.890583-05:00","46454ddf-5be1-479f-bee7-d639380a5a63_run.xml","8a4d4913dda089962f2bc79ab4ee427a","e8c36951-4c13-4729-b060-3898fbb3d49d",1988,"2016-09-08T12:23:51.835027-05:00","TCGA-04-1655","2016-09-02T19:07:32.626746-05:00","female","TCGA-04-1655_demographic",1950,"white","f5f5b470-d479-571a-9747-9f299b78084b","not reported",2002,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1655_diagnosis","not reported",17988,"dead","8441/3",1380,NA,"776c7f23-897d-51d4-8cf1-95e17ae2cf79","c56.9",-17988,"TCGA-04-1655_treatment","ea73130c-0d24-5dbd-bb73-eb3208584a6f","01",NA,"TCGA-04-1655-01A","0.6","43d20453-c167-4893-819d-754785da9a71",FALSE,"D808763E-D67C-460C-B5D6-85CC5C1C05BC","Primary Tumor","0.4",NA,NA,"1.1",1244160000,"01",158,"TCGA-04-1655-01A-01",99,95,NA,NA,0,0,2,10,"2016-09-08T12:23:51.835027-05:00","2016-09-08T12:23:51.835027-05:00",NA,NA,NA,NA,"TOP","BOTTOM",3,0,"41e4592c-b94d-4f45-bd36-911bf75248bc","55f36120-46fb-4c88-b137-81798b011a9f","TCGA-04-1655-01A-01-TS1","TCGA-04-1655-01A-01-BS1",95,90,"bbed134d-6132-47cf-ac23-e565d05c1958","RNA","TCGA-04-1655-01A-01R","0fc23fa3-5152-407e-b0be-e8d5ecd576bd",1.8,0.16,"UV Spec","R","22","TCGA-04-1655-01A-01R-1566-13","520e1d91-a556-4443-8c08-feec29c0c4fe",0.16,NA,NA,NA,NA,"84e4d127-17cd-5be7-9c8c-d847d1829cf2","TCGA-04-1655_exposure","TCGA-04-1655-01A-01R-1566-13_rnaseq_fastq.tar","2014-03-20T08:25:50.000Z","2014-03-20T08:47:02.000Z","46454DDF-5BE1-479F-BEE7-D639380A5A63","43D20453-C167-4893-819D-754785DA9A71","Unaligned reads",9467330560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","520E1D91-A556-4443-8C08-FEEC29C0C4FE","Canada's Michael Smith Genome Sciences Centre","564a34ede4b0298dd2c653e7","F8A5547F-F1BC-4C01-8B68-25B5EE0CAEAB","Ovarian Serous Cystadenocarcinoma","TAR","BBED134D-6132-47CF-AC23-E565D05C1958","2014-03-20T08:47:02.000Z","0FC23FA3-5152-407E-B0BE-E8D5ECD576BD","None","NO",1,0.4,"Primary Tumor","Gynecologic Oncology Group",NA,"BBED134D-6132-47CF-AC23-E565D05C1958",0.6,"04","TCGA-04-1655-01A-01R-1566-13_mirna.bam.bai",NA,"TCGA-04-1655-01A",1.1,"D6EE6177-9651-4002-8886-321A006DDB09","TCGA",1999,NA,NA,NA,"7C0D31DD-F5F3-4C2A-811B-6CAF7E06DA06",49,"bcgsc.ca.TCGA-04-1655-01A-01R-1566-13.hg19.bcgsc.ca.1.6.0.indel.vcf","Dead",1380,"TCGA-04-1655",NA,"6FDC0964-BA27-42BC-BB14-FF4240C2B90E",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,158,"55F36120-46FB-4C88-B137-81798B011A9F","ED05868D-C522-402B-88AA-A01073285297","TCGA-04-1655-01A-01R-1566-13_mirna.bam.bai","TCGA-04-1655-01A-01",99,0,NA,NA,2,"TOP",3,NA,"TCGA-04-1655-01A-01-TS1",95,"Taxol","Chemotherapy","TCGA-04-1655-D24194",NA,NA,NA,"TCGA-04-1655-F24191_NTE-1",NA,NA,NA,"Dead",1380,"TCGA-04-1655-F24191","TCGA-04-1655",NA,"04","1655","YES","C56.9","8441/3","C56.9",NA,NA,-17988,"FEMALE","WHITE",NA,NA,"No","Dead",NA,1380,NA,NA,NA,"NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,49,1999,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
131264474,127250146,9372678142,"EF2446B3-18FA-4CDF-A39B-ED70FF952B4B.bw","f8e9d538-7291-4fe7-b3f2-d01676a027f9","ef2446b3-18fa-4cdf-a39b-ed70ff952b4b","2016-09-29T23:55:53.061315-05:00","TCGA-09-1661-01B-01R-1566-13_rnaseq_fastq.tar","b391b364-bed1-419e-9abe-40104a413532",7728435200,"Illumina HiSeq","f5e22fd0cc7c34717aaf2ba4325c6ce3","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:36:59.074266-05:00","2016-05-03T11:40:21.648199-05:00","b391b364-bed1-419e-9abe-40104a413532_analysis.xml","c52984fa48717fb4bfc1186767a5bb12","7397da0c-4b1f-4e64-b07b-a381e77cc352",2235,"2016-09-29T20:59:59.230862-05:00","b391b364-bed1-419e-9abe-40104a413532_experiment.xml","58d5f1a0cf0efef396a5cf6ec4bfae64","81f644c4-e29e-4cd9-8d99-00799218ffd1",3916,"2016-09-29T18:14:37.359848-05:00","b391b364-bed1-419e-9abe-40104a413532_run.xml","7006c87fb4538db307c73b087301fefd","1b1008b1-86a4-439e-9a02-6063f81f979f",1988,"2016-09-08T10:40:41.361196-05:00","TCGA-09-1661","2016-09-02T18:48:53.268576-05:00","female","TCGA-09-1661_demographic",1925,"white","7d5dcebc-ff09-52ee-aedc-34d4ec8683e2","not hispanic or latino",2003,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","09","ae7d82a9-9661-589b-95cd-d4ad283fd3ca","UCSF","not reported","c56.9","TCGA-09-1661_diagnosis","not reported",27486,"dead","8441/3",1169,NA,"28f74326-0db8-5d53-bab2-b64acfa0aa64","c56.9",-27486,"TCGA-09-1661_treatment","3b4c753c-2b7c-5f2d-8b7d-751e0bc8d35e","01",NA,"TCGA-09-1661-01B","0.4","a7e17e91-e9d2-4118-8215-86546f8e2feb",FALSE,"1910251f-8c5c-4067-91dc-87bfdaf77283","Primary Tumor","0.1",NA,NA,"0.6",1240185600,"01",50,"TCGA-09-1661-01B-01",80,80,NA,NA,20,28,0,0,"2016-09-08T10:40:41.361196-05:00","2016-09-08T10:40:41.361196-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,2,"54e51666-b7bb-4bc7-b043-1ce3f71a0d85","0f6d83b1-1a23-4b61-b9c7-6b73071f3d24","TCGA-09-1661-01B-01-TS1","TCGA-09-1661-01B-01-BS1",75,70,"980c9e88-6f3d-4fb1-b609-70303f84bac8","RNA","TCGA-09-1661-01B-01R","1561f73e-d3f2-4866-a590-4a3d2bbfaa95",1.8,0.17,"UV Spec","R","22","TCGA-09-1661-01B-01R-1566-13","582e6ac5-273a-423d-9169-6393e1b79393",0.17,NA,NA,NA,NA,"964cb08a-da14-56b3-bcb2-45fae5472e90","TCGA-09-1661_exposure","TCGA-09-1661-01B-01R-1566-13_rnaseq_fastq.tar","2014-03-25T08:08:07.000Z","2014-03-25T08:23:02.000Z","B391B364-BED1-419E-9ABE-40104A413532","A7E17E91-E9D2-4118-8215-86546F8E2FEB","Unaligned reads",7728435200,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","582E6AC5-273A-423D-9169-6393E1B79393","Canada's Michael Smith Genome Sciences Centre","564a5bb5e4b09c884b27b3f4","F8E9D538-7291-4FE7-B3F2-D01676A027F9","Ovarian Serous Cystadenocarcinoma","TAR","980C9E88-6F3D-4FB1-B609-70303F84BAC8","2014-03-25T08:23:02.000Z","1561F73E-D3F2-4866-A590-4A3D2BBFAA95","None","NO",1,0.1,"Primary Tumor","UCSF",NA,"980C9E88-6F3D-4FB1-B609-70303F84BAC8",0.4,"09","TCGA-09-1661-01B-01W-0615-10_SOLiD.bam.bai",NA,"TCGA-09-1661-01B",0.6,"E2248B7D-7614-4BCD-9650-8067047DC92B","TCGA",2000,NA,NA,"WITH TUMOR","A7E17E91-E9D2-4118-8215-86546F8E2FEB",75,"nationwidechildrens.org_clinical.TCGA-09-1661.xml","Dead",1169,"TCGA-09-1661","NOT HISPANIC OR LATINO","9763F5EE-7F9A-4E7B-8FD1-98CE241E0D5F",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",17,NA,NA,"WHITE",NA,1,50,"54E51666-B7BB-4BC7-B043-1CE3F71A0D85","FABA3C74-C275-44E0-A6CB-FED0BC61B6BD","TCGA-09-1661-01B-01W-0615-10_SOLiD.bam.bai","TCGA-09-1661-01B-01",80,28,NA,NA,0,"BOTTOM",2,NA,"TCGA-09-1661-01B-01-BS1",70,"Doxil","Chemotherapy","TCGA-09-1661-D24234",NA,NA,NA,NA,NA,NA,"WITH TUMOR","Dead",1169,"TCGA-09-1661-F24233","TCGA-09-1661",NA,"09","1661","YES","C56.9","8441/3","C56.9",NA,NA,-27486,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",NA,1169,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,75,2000,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
120561046,114786875,8440291745,"79EF6FB4-0968-4A2E-8CE8-9A67FBD5F408.bw","f9793a4b-c0e7-4475-bf80-69543b7ee2f6","79ef6fb4-0968-4a2e-8ce8-9a67fbd5f408","2016-08-25T19:22:56.144616-05:00","TCGA-24-1416-01A-01R-1565-13_rnaseq_fastq.tar","c2403243-0049-47ac-8296-6e24fbbde066",7527598080,"Illumina HiSeq","d70d54b2b3f3e219ee4cf3d111abebf0","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T18:51:14.261604-05:00","2016-05-03T11:40:21.648680-05:00","c2403243-0049-47ac-8296-6e24fbbde066_analysis.xml","3e9e01a2a7c5902b0e2e73fb1c13c2a9","322695fb-3a55-4805-a17f-ed32e53a52c5",2181,"2016-08-27T12:52:10.794383-05:00","c2403243-0049-47ac-8296-6e24fbbde066_experiment.xml","7a2b03a9b34286308bebc8879a50303b","40cd2ef0-70ed-491b-993b-9d9e7d0e01c6",3916,"2016-09-29T20:26:44.836205-05:00","c2403243-0049-47ac-8296-6e24fbbde066_run.xml","fba07e8dcd5f633c2e5ee72068468d7d","6d74fa1c-78df-4e4b-8729-4c36ddbcb379",1988,"2016-09-08T13:26:20.347079-05:00","TCGA-24-1416","2016-09-02T19:13:59.075679-05:00","female","TCGA-24-1416_demographic",1974,"white","37d34efc-4522-5f67-89af-6ad888895583","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1416_diagnosis","not reported",12772,"alive","8441/3",NA,194,"3bef7a6b-f7be-543c-a896-f3126e11480c","c56.9",-12772,"TCGA-24-1416_treatment","b6c3d59a-b00d-5004-b272-f08a9ae2aee4","01",NA,"TCGA-24-1416-01A","0.6","7404e874-190e-4353-8755-1d9be35eedb7",FALSE,"c5a7b8b5-65b5-47d0-84dc-882024042a6f","Primary Tumor","0.5",NA,NA,"1.5",1231977600,"01",141,"TCGA-24-1416-01A-01",80,80,NA,NA,40,25,0,0,"2016-09-08T13:26:20.347079-05:00","2016-09-08T13:26:20.347079-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"dbe2dee5-0c05-46cd-baec-7293be19fd17","9af08ca1-7925-4689-9ade-e5a848e9ca19","TCGA-24-1416-01A-01-TS1","TCGA-24-1416-01A-01-BS1",55,70,"44fdf578-b65c-4d5d-a1aa-d76f5d5871f6","RNA","TCGA-24-1416-01A-01R","43545411-bd66-4d8f-836d-194c3d5011a8",1.8,0.16,"UV Spec","R","22","TCGA-24-1416-01A-01R-1565-13","67fcea16-d5bc-4edd-b66d-bfc5d56d976d",0.16,NA,NA,NA,NA,"4516ea3f-c4a3-5fe7-bbb3-dfa97950ab75","TCGA-24-1416_exposure","TCGA-24-1416-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:32:27.000Z","2014-03-21T22:47:01.000Z","C2403243-0049-47AC-8296-6E24FBBDE066","7404E874-190E-4353-8755-1D9BE35EEDB7","Unaligned reads",7527598080,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","67FCEA16-D5BC-4EDD-B66D-BFC5D56D976D","Canada's Michael Smith Genome Sciences Centre","564a343ae4b0ef1218182508","F9793A4B-C0E7-4475-BF80-69543B7EE2F6","Ovarian Serous Cystadenocarcinoma","TAR","44FDF578-B65C-4D5D-A1AA-D76F5D5871F6","2014-03-21T22:47:01.000Z","43545411-BD66-4D8F-836D-194C3D5011A8","None","NO",1,0.5,"Primary Tumor","Washington University",NA,"44FDF578-B65C-4D5D-A1AA-D76F5D5871F6",0.6,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0eda7c90-97fe-4184-b8ad-73e7820c3b7e.txt",NA,"TCGA-24-1416-01A",1.5,"D5C511D8-151F-4705-9BC4-F38116984562","TCGA",2008,NA,NA,"TUMOR FREE","7404E874-190E-4353-8755-1D9BE35EEDB7",34,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.0eda7c90-97fe-4184-b8ad-73e7820c3b7e.txt","Alive",NA,"TCGA-24-1416",NA,"CF7AD1D4-C805-41B7-8C74-2E09210BFD7E",NA,194,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,141,"DBE2DEE5-0C05-46CD-BAEC-7293BE19FD17","B8C6D276-56AB-4548-AB43-C08BA8775363","TCGA-24-1416-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-24-1416-01A-01",80,40,NA,NA,0,"TOP",5,NA,"TCGA-24-1416-01A-01-TS1",55,"Taxol","Chemotherapy","TCGA-24-1416-D25917",NA,NA,NA,NA,NA,194,"TUMOR FREE","Alive",NA,"TCGA-24-1416-F25914","TCGA-24-1416",NA,"24","1416","YES","C56.9","8441/3","C56.9",NA,NA,-12772,"FEMALE","WHITE",NA,NA,"No","Alive",194,NA,NA,NA,"TUMOR FREE","NO",1,4,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,34,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
357993788,338212826,25010842080,"5FCAF646-B82E-4CF5-9FEF-339105444B45.bw","f9c835db-2ab6-4bf5-826f-48723493c0ec","5fcaf646-b82e-4cf5-9fef-339105444b45","2016-08-25T09:27:23.804485-05:00","TCGA-29-1705-02A-01R-1567-13_rnaseq_fastq.tar","7d5181be-3ef8-4566-ab4b-f1256f65a843",21153105920,"Illumina HiSeq","94b6cf984080b5ae0801df677199c527","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:21:34.899040-05:00","2016-05-03T11:41:05.740436-05:00","7d5181be-3ef8-4566-ab4b-f1256f65a843_analysis.xml","3dfcec321a279b5fb6ece9605b3b417f","454c251c-d3e5-4c40-a986-cd9b3db15d5a",2201,"2016-10-07T16:47:40.361034-05:00","7d5181be-3ef8-4566-ab4b-f1256f65a843_experiment.xml","962620c11d776e96abf9d80455a967d8","3fadb067-d109-41b8-9eea-0a7121d4bb67",3916,"2016-09-29T18:58:32.806724-05:00","7d5181be-3ef8-4566-ab4b-f1256f65a843_run.xml","51566540ddd41714ad96fbdc1509413e","36c0aca8-1898-402c-a7d1-b5780a7b9245",1988,"2016-09-08T12:17:11.996600-05:00","TCGA-29-1705","2016-09-02T19:07:19.648463-05:00","female","TCGA-29-1705_demographic",1958,"white","3d81138a-577c-5983-a1ce-b5d08a9a5faa","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1705_diagnosis","not reported",17530,"dead","8441/3",555,555,"cdcf923e-15c6-5ee7-9cac-bda5bcaad9b7","c56.9",-17530,"TCGA-29-1705_treatment","41aa04ab-c1bc-57e4-99c3-5de2f16cf42a","02",NA,"TCGA-29-1705-02A","0.5","b5163587-a94d-4674-9f11-76a5adc9151d",FALSE,"EADA1E69-0CAB-4521-ABE4-035F73ABB54A","Recurrent Tumor","0.4",NA,NA,"1.3",1259712000,"01",104,"TCGA-29-1705-02A-01",90,80,NA,NA,0,0,15,40,"2016-09-08T12:17:11.996600-05:00","2016-09-08T12:17:11.996600-05:00",NA,NA,NA,NA,"BOTTOM","TOP",5,10,"86d821d7-64f1-4d24-9708-7877b856b1a2","4d5e4d51-e4ba-4d62-925e-3a3c302c9195","TCGA-29-1705-02A-01-BS1","TCGA-29-1705-02A-01-TS1",80,50,"53e71226-1677-424c-8ede-0115ab106f29","RNA","TCGA-29-1705-02A-01R","656f95dd-960a-46c9-88d9-060adfc1de0b",1.8,0.16,"UV Spec","R","22","TCGA-29-1705-02A-01R-1567-13","cc3afd8c-3639-437f-a22b-aadc9f6c5aaa",0.16,NA,NA,NA,NA,"3e9341aa-6e61-513d-9856-9cb2257de028","TCGA-29-1705_exposure","TCGA-29-1705-02A-01R-1567-13_rnaseq_fastq.tar","2014-03-27T02:24:19.000Z","2014-03-27T03:07:01.000Z","7D5181BE-3EF8-4566-AB4B-F1256F65A843","B5163587-A94D-4674-9F11-76A5ADC9151D","Unaligned reads",21153105920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","CC3AFD8C-3639-437F-A22B-AADC9F6C5AAA","Canada's Michael Smith Genome Sciences Centre","564a331be4b093830b669d26","F9C835DB-2AB6-4BF5-826F-48723493C0EC","Ovarian Serous Cystadenocarcinoma","TAR","53E71226-1677-424C-8EDE-0115AB106F29","2014-03-27T03:07:01.000Z","656F95DD-960A-46C9-88D9-060ADFC1DE0B","None","NO",2,0.4,"Recurrent Tumor","Duke",NA,"53E71226-1677-424C-8EDE-0115AB106F29",0.5,"29","TCGA-29-1705-02A-01R-1567-13_mirna.bam.bai",NA,"TCGA-29-1705-02A",1.3,"12ACE512-A8B1-4ED4-816F-77013D68EF1F","TCGA",2005,NA,NA,"WITH TUMOR","FD3E7BA8-21A5-438B-82EE-482ED6905310",47,"bcgsc.ca.TCGA-29-1705-01A-01R-1567-13.bcgsc.ca.1.4.0.indel.vcf","Dead",555,"TCGA-29-1705",NA,"1FE3BCD4-E15D-4D28-A88D-81CE50F34996",NA,555,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,104,"86D821D7-64F1-4D24-9708-7877B856B1A2","CDB8CE0D-24AA-46E9-B235-21553198B7BF","bcgsc.ca.TCGA-29-1705-02A-01R-1567-13.hg19.bcgsc.ca.1.7.0.sv.vcf","TCGA-29-1705-02A-01",80,0,NA,NA,40,"TOP",10,NA,"TCGA-29-1705-02A-01-TS1",50,"Carboplatin","Chemotherapy","TCGA-29-1705-D27285",NA,NA,NA,"TCGA-29-1705-F27279_NTE-2",NA,555,"WITH TUMOR","Dead",555,"TCGA-29-1705-F27279","TCGA-29-1705",NA,"29","1705","YES","C56.9","8441/3","C56.9",NA,NA,-17530,"FEMALE","WHITE",NA,NA,"No","Dead",555,555,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,47,2005,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
203253166,196698302,14553647295,"AC629EEC-9C39-4445-9A30-EC2EF52DB41F.bw","f9c835db-2ab6-4bf5-826f-48723493c0ec","ac629eec-9c39-4445-9a30-ec2ef52db41f","2016-08-26T03:01:52.303634-05:00","TCGA-29-1705-01A-01R-1567-13_rnaseq_fastq.tar","f589ffa1-3158-4613-969f-61b04e48e3f0",13513123840,"Illumina HiSeq","148a1081ff82ab39d503872f47d3c8e5","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:47:45.852238-05:00","2016-05-03T11:41:05.750744-05:00","f589ffa1-3158-4613-969f-61b04e48e3f0_analysis.xml","cee4edc6af841cfb6ddac5bfa4563c41","7a4d59b6-e1ca-42e5-9bf4-5c2688d34aa3",2181,"2016-09-29T22:16:37.042835-05:00","f589ffa1-3158-4613-969f-61b04e48e3f0_experiment.xml","7faf3ee650eb9418dd73001bb7d625f9","b18c0bd3-00e5-4d05-974c-5b9fc5dbfda1",3916,"2016-09-29T23:47:14.972001-05:00","f589ffa1-3158-4613-969f-61b04e48e3f0_run.xml","43ebd5d1693af2665a6a34904856c23c","e9d31d28-481f-48f6-b881-2048fe8fefe1",1989,"2016-09-08T12:17:11.996600-05:00","TCGA-29-1705","2016-09-02T19:07:19.648463-05:00","female","TCGA-29-1705_demographic",1958,"white","3d81138a-577c-5983-a1ce-b5d08a9a5faa","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1705_diagnosis","not reported",17530,"dead","8441/3",555,555,"cdcf923e-15c6-5ee7-9cac-bda5bcaad9b7","c56.9",-17530,"TCGA-29-1705_treatment","41aa04ab-c1bc-57e4-99c3-5de2f16cf42a","01",NA,"TCGA-29-1705-01A","1.1","fd3e7ba8-21a5-438b-82ee-482ed6905310",FALSE,"e7a899e9-2c61-4bda-874c-0f1b456e5dfc","Primary Tumor","0.7",NA,NA,"1.8",1242086400,"01",97,"TCGA-29-1705-01A-01",85,80,NA,NA,0,0,0,0,"2016-09-08T12:17:11.996600-05:00","2016-09-08T12:17:11.996600-05:00",NA,NA,NA,NA,"TOP","BOTTOM",2,15,"b4cec7c6-267d-4b63-bb60-1e9b618ea03e","febc5de5-d46e-4d34-a597-501782af363a","TCGA-29-1705-01A-01-TS1","TCGA-29-1705-01A-01-BS1",98,85,"29080803-f621-4ddd-98e3-539042ec7b1c","RNA","TCGA-29-1705-01A-01R","6f80f52b-cd1b-4998-8872-8231f968813f",1.8,0.15,"UV Spec","R","22","TCGA-29-1705-01A-01R-1567-13","d1603029-2b45-4c5c-b313-8846d0ebdbdb",0.15,NA,NA,NA,NA,"3e9341aa-6e61-513d-9856-9cb2257de028","TCGA-29-1705_exposure","TCGA-29-1705-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T07:08:04.000Z","2014-03-28T07:33:01.000Z","F589FFA1-3158-4613-969F-61B04E48E3F0","FD3E7BA8-21A5-438B-82EE-482ED6905310","Unaligned reads",13513123840,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","D1603029-2B45-4C5C-B313-8846D0EBDBDB","Canada's Michael Smith Genome Sciences Centre","564a3318e4b09c884b21d1bb","F9C835DB-2AB6-4BF5-826F-48723493C0EC","Ovarian Serous Cystadenocarcinoma","TAR","29080803-F621-4DDD-98E3-539042EC7B1C","2014-03-28T07:33:01.000Z","6F80F52B-CD1B-4998-8872-8231F968813F","None","NO",1,0.7,"Primary Tumor","Duke",NA,"29080803-F621-4DDD-98E3-539042EC7B1C",1.1,"29","TCGA-29-1705-01A-01R-1567-13_mirna.bam.bai",NA,"TCGA-29-1705-01A",1.8,"12ACE512-A8B1-4ED4-816F-77013D68EF1F","TCGA",2005,NA,NA,"WITH TUMOR","FD3E7BA8-21A5-438B-82EE-482ED6905310",47,"bcgsc.ca.TCGA-29-1705-01A-01R-1567-13.bcgsc.ca.1.4.0.indel.vcf","Dead",555,"TCGA-29-1705",NA,"1FE3BCD4-E15D-4D28-A88D-81CE50F34996",NA,555,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",0,"Post-Adjuvant Therapy","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,97,"FEBC5DE5-D46E-4D34-A597-501782AF363A","DA88963F-AB9D-45B6-A320-0218141B526D","TCGA-29-1705-01A-01R-1567-13_mirna.bam","TCGA-29-1705-01A-01",80,0,NA,NA,0,"BOTTOM",15,NA,"TCGA-29-1705-01A-01-BS1",85,"Carboplatin","Chemotherapy","TCGA-29-1705-D27285",NA,NA,NA,"TCGA-29-1705-F27279_NTE-2",NA,555,"WITH TUMOR","Dead",555,"TCGA-29-1705-F27279","TCGA-29-1705",NA,"29","1705","YES","C56.9","8441/3","C56.9",NA,NA,-17530,"FEMALE","WHITE",NA,NA,"No","Dead",555,555,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,47,2005,"Tumor resection",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
195593094,186142785,13751852755,"A7C07081-F6D3-47F0-96DA-D5C6FCE58040.bw","f9f44f86-10c7-4473-b156-5afbfa9a2ad0","a7c07081-f6d3-47f0-96da-d5c6fce58040","2016-08-26T01:08:36.205812-05:00","TCGA-24-1104-01A-01R-1565-13_rnaseq_fastq.tar","1f71f5fc-e3e4-459d-9c5d-0ae61a4a874f",12500961280,"Illumina HiSeq","bff1a95b3f834f299b82a548e9d7e5da","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T20:39:27.153032-05:00","2016-05-03T11:40:21.648680-05:00","1f71f5fc-e3e4-459d-9c5d-0ae61a4a874f_analysis.xml","42c8f5c120b7a00777bfd80d54e03387","7522f440-eb0a-4e4e-96a2-46091dd75ce7",2210,"2016-09-29T19:01:30.506474-05:00","1f71f5fc-e3e4-459d-9c5d-0ae61a4a874f_experiment.xml","1d914530834f9dd188ad0d016d3d2c9a","388d522b-9eb3-4d0c-88e4-bbf8067e4e5b",3916,"2016-09-29T20:12:16.927336-05:00","1f71f5fc-e3e4-459d-9c5d-0ae61a4a874f_run.xml","87565954a662c5b5f71750d7435bf75e","64909a38-a792-48fe-a2b9-a4dd62f3aa20",1988,"2016-09-08T12:24:54.492580-05:00","TCGA-24-1104","2016-09-02T19:05:54.039530-05:00","female","TCGA-24-1104_demographic",1945,"white","2ab1be5c-ffea-5f82-b277-6ac057112641","not reported",2006,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-1104_diagnosis","not reported",20527,"dead","8441/3",1933,1933,"ac7b7a1d-8dbb-502b-bd62-6f2ca7f711c4","c56.9",-20527,"TCGA-24-1104_treatment","4b77d291-8bc5-5c6b-8245-beef617493f5","01",NA,"TCGA-24-1104-01A","1","fce206e4-6f50-466b-800c-7e295ea56124",FALSE,"4991D5F7-0259-430F-AFF7-1307DF563E41","Primary Tumor","0.7",NA,NA,"1.5",1227657600,"01",157,"TCGA-24-1104-01A-01",80,90,NA,NA,NA,NA,NA,NA,"2016-09-08T12:24:54.492580-05:00","2016-09-08T12:24:54.492580-05:00",NA,NA,NA,NA,"TOP","BOTTOM",1,1,"5f113d14-b733-4f7d-ad0d-3d2a0771bb8b","c0b24512-3855-4e5f-9214-1823828394ef","TCGA-24-1104-01A-01-TS1","TCGA-24-1104-01A-01-BS1",NA,NA,"ee53731b-c0da-4c04-a86d-6f2844668fcc","RNA","TCGA-24-1104-01A-01R","42b4c310-e383-4920-9d76-b9aee23f4255",1.8,0.14,"UV Spec","R","22","TCGA-24-1104-01A-01R-1565-13","3947333f-7cc5-4044-bc18-01a8f4426017",0.14,NA,NA,NA,NA,"e7a49ffe-8c98-53e2-a0a1-db7c8904fcad","TCGA-24-1104_exposure","TCGA-24-1104-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-21T22:54:43.000Z","2014-03-21T23:19:02.000Z","1F71F5FC-E3E4-459D-9C5D-0AE61A4A874F","FCE206E4-6F50-466B-800C-7E295EA56124","Unaligned reads",12500961280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3947333F-7CC5-4044-BC18-01A8F4426017","Canada's Michael Smith Genome Sciences Centre","564a3ef9e4b08c5d8692a550","F9F44F86-10C7-4473-B156-5AFBFA9A2AD0","Ovarian Serous Cystadenocarcinoma","TAR","EE53731B-C0DA-4C04-A86D-6F2844668FCC","2014-03-21T23:19:02.000Z","42B4C310-E383-4920-9D76-B9AEE23F4255","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"EE53731B-C0DA-4C04-A86D-6F2844668FCC",1,"24","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.14177a50-0360-47ce-b24b-3468b4a2b75f.txt",NA,"TCGA-24-1104-01A",1.5,"E9DE231F-AB26-4ED6-AF61-FA3E6E1173F7","TCGA",2001,NA,NA,"WITH TUMOR","5C7D24BA-CA79-4A60-A747-58D64D3C4D88",56,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.14177a50-0360-47ce-b24b-3468b4a2b75f.txt","Dead",1933,"TCGA-24-1104",NA,"E919193F-C3A5-4DC0-B6CE-3C6D7F1A727E",NA,1933,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,"BDF8FDE3-3D66-4C7F-B088-22BDDEC5AAD5","WHITE",NA,1,157,"C0B24512-3855-4E5F-9214-1823828394EF","B7FEC334-D085-4BF6-847B-231CED8C5BBD","TCGA-24-1104-01A-01R-1565-13_rnaseq_fastq.tar","TCGA-24-1104-01A-01",90,NA,NA,NA,NA,"BOTTOM",1,NA,"TCGA-24-1104-01A-01-BS1",NA,"Cisplatin","Chemotherapy","TCGA-24-1104-D25837","TCGA-24-1104-R25842",NA,"Distant Recurrence","TCGA-24-1104-F25834_NTE-1",NA,1933,"WITH TUMOR","Dead",1933,"TCGA-24-1104-F25834","TCGA-24-1104",NA,"24","1104","YES","C56.9","8441/3","C56.9",NA,NA,-20527,"FEMALE","WHITE",NA,NA,"No","Dead",1933,1933,NA,NA,"WITH TUMOR","NO",9,3,2009,"YES","YES","YES",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Left",0,56,2001,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114794766,107159078,7881952822,"10EA52A2-FD54-4C34-965A-9CC66C161CF1.bw","fbb45305-de8d-4baf-8bd0-047b29c2e9d9","10ea52a2-fd54-4c34-965a-9cc66c161cf1","2016-08-24T23:38:48.359753-05:00","TCGA-13-0924-01A-01R-1564-13_rnaseq_fastq.tar","c736476f-9e1c-42dc-9be1-923d5d9f210e",7013089280,"Illumina HiSeq","4b7da43d27e0397250117255f9c3eb6a","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:43:41.456373-05:00","2016-05-03T11:27:59.332723-05:00","c736476f-9e1c-42dc-9be1-923d5d9f210e_analysis.xml","cd1650605667f0b9eb8f4116135feb11","e792cb50-3b7f-47c3-81e4-b4e43b540c1c",2183,"2016-09-29T18:12:42.045434-05:00","c736476f-9e1c-42dc-9be1-923d5d9f210e_experiment.xml","7c4702f524e9d2d1eedf66774c407c24","19eb9801-8610-4efe-88b2-4ed92213020b",3916,"2016-09-30T00:18:36.980054-05:00","c736476f-9e1c-42dc-9be1-923d5d9f210e_run.xml","ca56fb3259627c066b5345c5e05ac8e7","fd10e32b-637a-45de-b47c-6ddc47877b5d",1990,"2016-09-08T13:04:34.429447-05:00","TCGA-13-0924","2016-09-02T19:05:19.296691-05:00","female","TCGA-13-0924_demographic",1963,"white","2bf5429c-69b5-528e-ba15-0b4626f97010","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-0924_diagnosis","not reported",16670,"alive","8441/3",NA,2614,"5fece8ec-73b8-509c-8a0c-0f513822d210","c56.9",-16670,"TCGA-13-0924_treatment","2faff6a9-9bea-53eb-9127-0273d6838332","01",NA,"TCGA-13-0924-01A",NA,"5be2767c-8f8e-4b30-a3fa-bfbcce461c5c",FALSE,"2EA17F21-1594-430A-97E3-29C5F49CB3BC","Primary Tumor",NA,NA,NA,NA,1233705600,"01",NA,"TCGA-13-0924-01A-01",80,70,NA,NA,0,0,25,35,"2016-09-08T13:04:34.429447-05:00","2016-09-08T13:04:34.429447-05:00",NA,NA,NA,NA,"TOP","BOTTOM",0,0,"c61ffb1a-c4d3-463d-93ec-1ea5bb9ace24","24f68578-f603-437a-894e-a74abecbb93c","TCGA-13-0924-01A-01-TS1","TCGA-13-0924-01A-01-BS1",75,65,"2b7faaee-8756-4558-b9ab-56c937f30f0f","RNA","TCGA-13-0924-01A-01R","38682764-e412-4260-b8d6-74cd8b038351",1.7,0.14,"UV Spec","R","22","TCGA-13-0924-01A-01R-1564-13","85a4c41b-9829-48f8-9c7a-a9de870332b6",0.14,NA,NA,NA,NA,"b1891f21-0d2e-574c-a78d-4b3642c43de0","TCGA-13-0924_exposure","TCGA-13-0924-01A-01R-1564-13_rnaseq_fastq.tar","2013-12-20T23:12:07.000Z","2013-12-20T23:26:02.000Z","C736476F-9E1C-42DC-9BE1-923D5D9F210E","5BE2767C-8F8E-4B30-A3FA-BFBCCE461C5C","Unaligned reads",7013089280,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","85A4C41B-9829-48F8-9C7A-A9DE870332B6","Canada's Michael Smith Genome Sciences Centre","564a3c2ae4b08c5d8691c0d1","FBB45305-DE8D-4BAF-8BD0-047B29C2E9D9","Ovarian Serous Cystadenocarcinoma","TAR","2B7FAAEE-8756-4558-B9AB-56C937F30F0F","2013-12-20T23:26:02.000Z","38682764-E412-4260-B8D6-74CD8B038351","None","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",NA,"2B7FAAEE-8756-4558-B9AB-56C937F30F0F",NA,"13","0769.CEL",NA,"TCGA-13-0924-01A",NA,"1D2653D7-CAD8-4CBA-805F-3B87337A64ED","TCGA",2008,NA,NA,"TUMOR FREE","954D6169-838B-4EEA-B8F2-36FF8D91CD06",45,"nationwidechildrens.org_clinical.TCGA-13-0924.xml","Alive",NA,"TCGA-13-0924","NOT HISPANIC OR LATINO","FAE23792-AEDA-4037-82CF-B8D048036938",NA,185,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IV",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"WHITE",NA,1,NA,"C61FFB1A-C4D3-463D-93EC-1EA5BB9ACE24","E7D26941-95B6-48B1-AA02-ED9186DD92BA","C239.TCGA-13-0924-01A-01W.5.bam.bai","TCGA-13-0924-01A-01",70,0,NA,NA,35,"BOTTOM",0,NA,"TCGA-13-0924-01A-01-BS1",65,"Carboplatin","Chemotherapy","TCGA-13-0924-D24788",NA,NA,NA,NA,NA,185,"TUMOR FREE","Alive",NA,"TCGA-13-0924-F24787","TCGA-13-0924",NA,"13","0924","YES","C56.9","8441/3","C56.9",NA,NA,-16670,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",185,NA,NA,NA,"TUMOR FREE","NO",25,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,45,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
138241772,136561714,10101285888,"0C887B65-DB94-446E-B9BA-646CECA2154C.bw","fd4740db-76a8-4362-be71-7b609479bb67","0c887b65-db94-446e-b9ba-646ceca2154c","2016-08-24T17:48:25.326033-05:00","TCGA-25-2398-01A-01R-1569-13_rnaseq_fastq.tar","7d4c44c4-9684-4126-a790-04672585ca01",7938498560,"Illumina HiSeq","7b722351b44cbd3751ed538a811ff8df","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:46:48.841439-05:00","2016-05-03T11:55:09.260045-05:00","7d4c44c4-9684-4126-a790-04672585ca01_analysis.xml","947bca001b75bc6af8f4dd83aa692a62","e993f64c-133d-46d7-ac08-9df8efcbb660",2181,"2016-08-28T00:50:07.870479-05:00","7d4c44c4-9684-4126-a790-04672585ca01_experiment.xml","ac7cb48244b1cb0b0568a706130fc8e3","49948a79-70f3-492e-ba33-e16b9e881abd",3916,"2016-09-29T19:55:36.522787-05:00","7d4c44c4-9684-4126-a790-04672585ca01_run.xml","fb0363914b9f8b0b3eff40472e3381f4","5a77e986-294e-49ad-b1fd-04f76c1f5931",1989,"2016-09-08T13:20:31.557381-05:00","TCGA-25-2398","2016-09-02T19:11:46.469490-05:00","female","TCGA-25-2398_demographic",1933,"white","f3608d2c-1467-5436-8977-622ae51edd70","not hispanic or latino",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-2398_diagnosis","not reported",26267,"dead","8441/3",1369,1369,"b83acbb5-bdc4-5596-ae26-e11bf4b79790","c56.9",-26267,"TCGA-25-2398_treatment","d4a15da1-ef9a-5d35-804f-0da34e4d7b6b","01",NA,"TCGA-25-2398-01A","1.3","a5ad2377-7f60-4c8a-8343-4589b01dc4c5",FALSE,"CFF4E9E3-AC10-4A50-BE90-5A12822FEF42","Primary Tumor","0.5",NA,NA,"1.5",1252022400,"01",151,"TCGA-25-2398-01A-01",65,75,NA,NA,0,0,35,25,"2016-09-08T13:20:31.557381-05:00","2016-09-08T13:20:31.557381-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"db9bffbb-cffb-48c6-9494-10677a3fc7aa","6cd65019-046f-4701-ba45-95c5a357e0f4","TCGA-25-2398-01A-01-TS1","TCGA-25-2398-01A-01-BS1",60,70,"eddbd412-f149-4d71-aaf5-f4ef85e5f49f","RNA","TCGA-25-2398-01A-01R","f86a52d7-cebb-4eaf-b477-26618a2a5d80",1.8,0.14,"UV Spec","R","22","TCGA-25-2398-01A-01R-1569-13","3a080008-8266-4e2d-a143-adac14991b22",0.14,NA,NA,NA,NA,"624971e8-e23c-56b8-b576-de89105d1d4e","TCGA-25-2398_exposure","TCGA-25-2398-01A-01R-1569-13_rnaseq_fastq.tar","2014-08-08T06:36:21.000Z","2014-08-08T07:00:18.000Z","7D4C44C4-9684-4126-A790-04672585CA01","A5AD2377-7F60-4C8A-8343-4589B01DC4C5","Unaligned reads",7938498560,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","3A080008-8266-4E2D-A143-ADAC14991B22","Canada's Michael Smith Genome Sciences Centre","564a3285e4b08c5d868eae6d","FD4740DB-76A8-4362-BE71-7B609479BB67","Ovarian Serous Cystadenocarcinoma","TAR","EDDBD412-F149-4D71-AAF5-F4EF85E5F49F","2014-08-08T07:00:18.000Z","F86A52D7-CEBB-4EAF-B477-26618A2A5D80","None","NO",1,0.5,"Primary Tumor","Mayo Clinic - Rochester",NA,"EDDBD412-F149-4D71-AAF5-F4EF85E5F49F",1.3,"25","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b081cedd-6727-478d-9ebf-22ad78c34b27.txt",NA,"TCGA-25-2398-01A",1.5,"F6A05E71-BCAD-4194-9D40-47255DD4CB92","TCGA",2004,NA,NA,"WITH TUMOR","EEBB311F-5C20-46C3-9382-B6A2696EEB12",71,"mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.b081cedd-6727-478d-9ebf-22ad78c34b27.txt","Dead",1369,"TCGA-25-2398","NOT HISPANIC OR LATINO","0FA5671B-B95A-432F-A2EF-0BAED081C586",NA,1369,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",24,NA,NA,"WHITE",NA,1,151,"DB9BFFBB-CFFB-48C6-9494-10677A3FC7AA","F6BDA7C0-1AAF-4B0C-81ED-03382B3DC837","TCGA-25-2398-01A-01R-1569-13_GRCh37-lite_mirna.bam","TCGA-25-2398-01A-01",75,0,NA,NA,25,"BOTTOM",5,NA,"TCGA-25-2398-01A-01-BS1",70,"Carboplatin","Chemotherapy","TCGA-25-2398-D26816",NA,NA,NA,"TCGA-25-2398-F26812_NTE-1",NA,1369,"WITH TUMOR","Dead",1369,"TCGA-25-2398-F26812","TCGA-25-2398",NA,"25","2398","YES","C56.9","8441/3","C56.9",NA,NA,-26267,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",1369,1369,NA,NA,"WITH TUMOR","NO",5,1,2010,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,71,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
227727982,218723247,16170884168,"2F71AA2B-4CE9-47D8-AA65-02090A0939CD.bw","fdf83fdf-dfbb-4306-9a1b-b4487d18b402","2f71aa2b-4ce9-47d8-aa65-02090a0939cd","2016-08-25T12:36:09.004745-05:00","TCGA-23-1120-01A-02R-1565-13_rnaseq_fastq.tar","bfc8b83c-89d6-4df7-8b84-a58064b4add7",14453063680,"Illumina HiSeq","359187d7457b25605e806ff3dc4f396d","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-30T00:09:05.928198-05:00","2016-05-03T11:40:21.648680-05:00","bfc8b83c-89d6-4df7-8b84-a58064b4add7_analysis.xml","3d968cbdd15f9926689c79200333d059","f71f5d83-1e8d-4519-820e-e558c98a2089",2181,"2016-09-29T18:36:46.045987-05:00","bfc8b83c-89d6-4df7-8b84-a58064b4add7_experiment.xml","9a6e3b64a18ac364dd44a4091e154364","28e5885f-fe06-44a6-ac7c-12fb117d7153",3916,"2016-09-29T19:21:53.197812-05:00","bfc8b83c-89d6-4df7-8b84-a58064b4add7_run.xml","6ecef3cd0b66e4beb7515c867d2bcc96","457b7ba2-fdc4-4afd-9716-5f35205ba423",1988,"2016-09-08T12:18:39.849632-05:00","TCGA-23-1120","2016-09-02T19:06:00.928619-05:00","female","TCGA-23-1120_demographic",1948,"white","46d2a0a9-20fb-5a03-b80b-113e9217d392","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","23","40a976f8-8df6-576b-bef5-a50b24f3a9a2","Cedars Sinai","not reported","c56.9","TCGA-23-1120_diagnosis","not reported",22148,"alive","8441/3",NA,130,"efacf32e-acbf-5aa1-bc08-b71cd624aea2","c56.9",-22148,"TCGA-23-1120_treatment","b15fe942-b529-546b-a2da-c3bc718654e9","01",NA,"TCGA-23-1120-01A","0.8","6fc497cb-41c0-487c-b527-b33a9af83ef2",FALSE,"e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37","Primary Tumor","0.6",NA,NA,"1.8",1227657600,"02",105,"TCGA-23-1120-01A-02",95,95,NA,NA,0,0,0,0,"2016-09-08T12:18:39.849632-05:00","2016-09-08T12:18:39.849632-05:00",NA,NA,NA,NA,"BOTTOM","TOP",10,10,"4cbf84a4-9b8f-4448-a066-3978b5fca0aa","7a9f0eb0-59d5-46ee-ae3e-4c9c21218ded","TCGA-23-1120-01A-02-BS2","TCGA-23-1120-01A-01-BS1",0,0,"af06629a-5506-4bac-9698-421c3bb1af58","RNA","TCGA-23-1120-01A-02R","50c2ca86-3411-4ba0-b4e0-5a80b227f072",1.8,0.16,"UV Spec","R","22","TCGA-23-1120-01A-02R-1565-13","9b64998e-eed9-428b-97ac-4de398caaf81",0.16,NA,NA,NA,NA,"96b82cca-c110-5109-9608-7aeb2bbd8ffd","TCGA-23-1120_exposure","TCGA-23-1120-01A-02R-1565-13_rnaseq_fastq.tar","2014-03-21T21:34:26.000Z","2014-03-21T22:00:02.000Z","BFC8B83C-89D6-4DF7-8B84-A58064B4ADD7","6FC497CB-41C0-487C-B527-B33A9AF83EF2","Unaligned reads",14453063680,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","9B64998E-EED9-428B-97AC-4DE398CAAF81","Canada's Michael Smith Genome Sciences Centre","564a32f3e4b08c5d868ed258","FDF83FDF-DFBB-4306-9A1B-B4487D18B402","Ovarian Serous Cystadenocarcinoma","TAR","AF06629A-5506-4BAC-9698-421C3BB1AF58","2014-03-21T22:00:02.000Z","50C2CA86-3411-4BA0-B4E0-5A80B227F072","None","NO",1,0.6,"Primary Tumor","Cedars Sinai",NA,"AF06629A-5506-4BAC-9698-421C3BB1AF58",0.8,"23","TCGA-23-1120-01A-02W-0484-10_SOLiD_whole_exome_extensions.bam.bai",NA,"TCGA-23-1120-01A",1.8,"14E5FA9C-6598-4755-8DCF-A2AD8F0253C2","TCGA",2008,NA,NA,NA,"9BF4536B-4A4D-4097-ACFD-2543A4840210",60,"QUANT_p_TCGA_Batch12_AFFX_GenomeWideSNP_6_C10_437710.hg18.seg.txt","Alive",NA,"TCGA-23-1120","NOT HISPANIC OR LATINO","1F657A1B-69CB-4138-929B-AECB50C96B69",NA,130,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",12,NA,NA,"WHITE",NA,2,105,"7A9F0EB0-59D5-46EE-AE3E-4C9C21218DED","EB15396C-D261-42E5-8F47-D057A1E6CE76","TCGA-23-1120-01A-02T-0438-07.gene.tcga_level3.data.txt","TCGA-23-1120-01A-02",95,0,NA,NA,0,"BOTTOM",10,NA,"TCGA-23-1120-01A-02-BS2",0,"Paclitaxel","Chemotherapy","TCGA-23-1120-D25717",NA,NA,NA,NA,NA,130,NA,"Alive",NA,"TCGA-23-1120-F25715","TCGA-23-1120",NA,"23","1120","YES","C56.9","8441/3","C56.9",NA,NA,-22148,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",130,NA,NA,NA,NA,"NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Right",0,60,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
452162088,438252864,32474130550,"C75FE73A-7F99-41C8-9B0F-0CB839ADEA39.bw","fe0e3851-d8cb-4533-9536-b4826cd25f87","c75fe73a-7f99-41c8-9b0f-0cb839adea39","2016-08-31T12:51:42.885901-05:00","TCGA-29-1699-01A-01R-1567-13_rnaseq_fastq.tar","a4e0037c-8afa-4d50-947f-a7354ddd34fc",29729341440,"Illumina HiSeq","c8b495fe318571d6c746a134c0cbba07","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T17:41:24.525164-05:00","2016-05-03T11:41:05.750744-05:00","a4e0037c-8afa-4d50-947f-a7354ddd34fc_analysis.xml","ec5f2852ec7ae1f577d3f379dd35e942","0618b572-03d7-4284-b4b4-dfab22ec5ea9",2181,"2016-09-29T21:21:02.117541-05:00","a4e0037c-8afa-4d50-947f-a7354ddd34fc_experiment.xml","4436f7e152f0335b6a457afb4b77258e","8f32368c-686e-411e-9390-8a00b5795af0",3916,"2016-09-29T22:55:39.277990-05:00","a4e0037c-8afa-4d50-947f-a7354ddd34fc_run.xml","09480af2cd2c0300d75412cce73f8375","c9a35bf1-7547-48f3-bc10-3505861bc00a",1989,"2016-09-08T13:13:16.080498-05:00","TCGA-29-1699","2016-09-02T19:07:37.252838-05:00","female","TCGA-29-1699_demographic",1947,"white","5ee5fdf5-f33a-5bd5-81e5-568f5772b628","not reported",2007,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","29","437033a7-2ce9-5a51-bf56-320376923526","Duke","not reported","c56.9","TCGA-29-1699_diagnosis","not reported",21130,"dead","8441/3",1106,16,"1bd094f3-6920-5234-b706-e5a90b2cdf6c","c56.9",-21130,"TCGA-29-1699_treatment","5b601ac5-c8b3-5cdd-988e-48b7c7fb7061","01",NA,"TCGA-29-1699-01A","0.8","a0a9b124-82fa-4eff-a5df-38932e8ce44a",FALSE,"9e2cf2f9-c45c-4702-8b6f-565c59730036","Primary Tumor","0.6",NA,NA,"1.5",1242086400,"01",102,"TCGA-29-1699-01A-01",90,90,NA,NA,0,0,0,0,"2016-09-08T13:13:16.080498-05:00","2016-09-08T13:13:16.080498-05:00",NA,5,NA,NA,"TOP","BOTTOM",2,2,"afdc3c80-fb8c-473f-9195-c680a82bfc74","60235f11-bfac-4f22-b602-c4c5b0cb0f54","TCGA-29-1699-01A-01-TS1","TCGA-29-1699-01A-01-BS1",98,98,"6bab65c5-bd72-48cf-b9a7-c51658077ada","RNA","TCGA-29-1699-01A-01R","57f6a919-5f02-42ed-a152-7e0cd733619d",1.8,0.15,"UV Spec","R","22","TCGA-29-1699-01A-01R-1567-13","6d1d8c8a-fea0-4a47-bd2a-124270561406",0.15,NA,NA,NA,NA,"80d616ea-f963-594e-8cc0-65d3359ccd82","TCGA-29-1699_exposure","TCGA-29-1699-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T18:33:00.000Z","2014-03-28T07:28:01.000Z","A4E0037C-8AFA-4D50-947F-A7354DDD34FC","A0A9B124-82FA-4EFF-A5DF-38932E8CE44A","Unaligned reads",29729341440,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6D1D8C8A-FEA0-4A47-BD2A-124270561406","Canada's Michael Smith Genome Sciences Centre","564a3750e4b093830b67f643","FE0E3851-D8CB-4533-9536-B4826CD25F87","Ovarian Serous Cystadenocarcinoma","TAR","6BAB65C5-BD72-48CF-B9A7-C51658077ADA","2014-03-28T07:28:02.000Z","57F6A919-5F02-42ED-A152-7E0CD733619D","None","NO",1,0.6,"Primary Tumor","Duke",NA,"6BAB65C5-BD72-48CF-B9A7-C51658077ADA",0.8,"29","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.21c96f53-087e-42c2-86ce-ea45cf876627.txt",NA,"TCGA-29-1699-01A",1.5,NA,"TCGA",2004,NA,NA,NA,"A0A9B124-82FA-4EFF-A5DF-38932E8CE44A",57,"nationwidechildrens.org_clinical.TCGA-29-1699.xml","Dead",1106,"TCGA-29-1699",NA,"E35B9DF2-19B1-4DDB-BFE2-9C7D7E028D9E",NA,16,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",1,"Pre-Operative","Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",18,NA,NA,"WHITE",NA,1,102,"AFDC3C80-FB8C-473F-9195-C680A82BFC74","E4CFBDEB-52E2-4B80-A345-14D50F565E8A","TCGA-29-1699-01A-01R-1567-13_GRCh37-lite_rnaseq.bam","TCGA-29-1699-01A-01",90,0,NA,NA,0,"TOP",2,NA,"TCGA-29-1699-01A-01-TS1",98,NA,NA,NA,NA,NA,NA,NA,"NO",NA,NA,"Dead",1106,"TCGA-29-1699-F41729","TCGA-29-1699",NA,"29","1699","YES","C56.9","8441/3","C56.9",NA,NA,-21130,"FEMALE","WHITE",NA,NA,"No","Dead",16,1106,NA,NA,NA,"NO",2,6,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,57,2004,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
248250752,229613986,16924790951,"07F29A3E-F230-4AB3-A474-E841533D1FDE.bw","fe402983-70da-44db-b7b1-c32702ddde26","07f29a3e-f230-4ab3-a474-e841533d1fde","2016-09-29T17:44:10.417024-05:00","TCGA-13-1509-01A-01R-1565-13_rnaseq_fastq.tar","615bdb1a-4e66-4bf7-a251-118322ee3d35",16228341760,"Illumina HiSeq","17ceab1ac0bcec3dfc318db3064043df","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T22:13:05.955502-05:00","2016-05-03T11:40:21.647690-05:00","615bdb1a-4e66-4bf7-a251-118322ee3d35_analysis.xml","6e9e04e69d51d36859062a93f8ebcaaa","af54be07-37a6-4cab-a4a7-ce852e9f110e",2235,"2016-09-29T23:12:41.131376-05:00","615bdb1a-4e66-4bf7-a251-118322ee3d35_experiment.xml","12295dcc8bec98124819f9b7828a639c","d44e7e21-2296-4185-b5d7-21dfdf592382",3916,"2016-09-29T23:17:18.307784-05:00","615bdb1a-4e66-4bf7-a251-118322ee3d35_run.xml","10eaed59605fd38bdf8b461adb370c4b","d7093aa6-ef61-4b2f-acd5-c596a6e23263",1988,"2016-09-08T13:56:01.595439-05:00","TCGA-13-1509","2016-09-02T19:13:55.899875-05:00","female","TCGA-13-1509_demographic",1944,"white","1c90a4f4-86be-5c63-81d0-0a48ef654c51","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","13","eb592928-d4e7-5283-bca1-06fe5ed399e8","Memorial Sloan Kettering","not reported","c56.9","TCGA-13-1509_diagnosis","not reported",23481,"alive","8441/3",NA,2438,"67fe78ea-3168-5753-80bf-85495328d780","c56.9",-23481,"TCGA-13-1509_treatment","87c1a7a8-25cc-545d-977d-350a3fdf0993","01",NA,"TCGA-13-1509-01A","1.5","832fbf68-76dc-47f7-b0ac-257d77d69bdf",FALSE,"5FB47FA9-299B-4466-A324-20D44C788F8B","Primary Tumor","0.4",NA,NA,"1.7",1235001600,"01",153,"TCGA-13-1509-01A-01",90,90,NA,NA,0,0,10,10,"2016-09-08T13:56:01.595439-05:00","2016-09-08T13:56:01.595439-05:00",NA,NA,NA,NA,"TOP","BOTTOM",5,5,"c55b2176-151c-4d47-a9ce-e219fcf78418","031e3f43-6049-4cef-9b2b-b856aa268557","TCGA-13-1509-01A-01-TS1","TCGA-13-1509-01A-01-BS1",85,85,"635eb50e-6d68-4f01-aca7-57cc01c4ac11","RNA","TCGA-13-1509-01A-01R","75941df7-c517-4f24-84dd-5f55e919e2a4",1.8,0.16,"UV Spec","R","22","TCGA-13-1509-01A-01R-1565-13","6e57a2e1-2894-421d-bdeb-7e532a78bdeb",0.16,NA,NA,NA,NA,"1442997e-cc50-595a-a61f-f319d4580fca","TCGA-13-1509_exposure","TCGA-13-1509-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-22T00:16:19.000Z","2014-03-22T00:50:02.000Z","615BDB1A-4E66-4BF7-A251-118322EE3D35","832FBF68-76DC-47F7-B0AC-257D77D69BDF","Unaligned reads",16228341760,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","6E57A2E1-2894-421D-BDEB-7E532A78BDEB","Canada's Michael Smith Genome Sciences Centre","564a4076e4b09c884b25e016","FE402983-70DA-44DB-B7B1-C32702DDDE26","Ovarian Serous Cystadenocarcinoma","TAR","635EB50E-6D68-4F01-ACA7-57CC01C4AC11","2014-03-22T00:50:02.000Z","75941DF7-C517-4F24-84DD-5F55E919E2A4","None","NO",1,0.4,"Primary Tumor","Memorial Sloan Kettering",NA,"635EB50E-6D68-4F01-ACA7-57CC01C4AC11",1.5,"13","mdanderson.org_OV.MDA_RPPA_Core.SuperCurve.Level_2.a35cc137-a072-4287-8248-dbc4df213144.txt",NA,"TCGA-13-1509-01A",1.7,"F341BFEE-7F12-4172-BE59-3F8386E19360","TCGA",2008,NA,NA,"TUMOR FREE","9A8FC989-B34E-4DF3-8D76-4FE8CADB5A92",64,"TCGA-13-1509-01A-01W-0549-09_capture.bam","Alive",NA,"TCGA-13-1509","NOT HISPANIC OR LATINO","770C3446-50ED-4950-B822-5710CFEA1B64",NA,127,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,"Pre-Adjuvant Therapy","Stage IV",NA,40,NA,"8441/3","FEMALE","C56.9",14,NA,NA,"WHITE",NA,1,153,"C55B2176-151C-4D47-A9CE-E219FCF78418","72027A08-8BDF-4F8D-8A87-00D48B26F9BB","MSK_252152914179_S01_CGH-v4_10_27Aug08.txt","TCGA-13-1509-01A-01",90,0,NA,NA,10,"BOTTOM",5,NA,"TCGA-13-1509-01A-01-BS1",85,"Paclitaxel","Chemotherapy","TCGA-13-1509-D24959",NA,NA,NA,NA,NA,127,"TUMOR FREE","Alive",NA,"TCGA-13-1509-F24957","TCGA-13-1509",NA,"13","1509","YES","C56.9","8441/3","C56.9",NA,NA,-23481,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Alive",127,NA,NA,NA,"TUMOR FREE","NO",31,3,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,64,2008,"Cytology (e.g. Peritoneal or pleural fluid)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,11,NA,NA,NA,40,NA,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
156161118,151878575,11214798995,"CA356591-D24F-41A8-8C9A-1178C7781510.bw","feda41d8-ca56-425d-b149-4d5485328107","ca356591-d24f-41a8-8c9a-1178c7781510","2016-09-29T22:56:32.735441-05:00","TCGA-04-1357-01A-01R-1565-13_rnaseq_fastq.tar","cdbd6519-047b-4a9e-9a61-0be2af33d80a",9240064000,"Illumina HiSeq","c8f0a442cd2d7ee0ba61333ba264499f","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T23:02:53.564319-05:00","2016-05-03T11:41:05.750744-05:00","cdbd6519-047b-4a9e-9a61-0be2af33d80a_analysis.xml","f41299fe5b105bdffd91cbd54698c3c4","ce0f23b1-fe97-4d61-b6b7-530072b3dbf9",2181,"2016-10-07T16:32:28.820681-05:00","cdbd6519-047b-4a9e-9a61-0be2af33d80a_experiment.xml","12458b1522ae17ed7d69aa00e27626b0","de349716-05e9-4c3a-b8d0-6546e4f8b2f8",3916,"2016-09-29T19:28:19.537485-05:00","cdbd6519-047b-4a9e-9a61-0be2af33d80a_run.xml","988210c48efdb69c7e6e5fc5e5ac5641","49876c98-5b77-48e4-b023-b6d3da4eba6b",1988,"2016-09-08T13:17:05.751076-05:00","TCGA-04-1357","2016-09-02T19:11:55.877133-05:00","female","TCGA-04-1357_demographic",1953,"not reported","d7683fcc-e135-5577-a315-c40ebae61ab8","not reported",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","04","fd0360d6-adbd-5043-a5b5-fbf5691d4098","Gynecologic Oncology Group","not reported","c56.9","TCGA-04-1357_diagnosis","not reported",18999,"alive","8441/3",NA,NA,"8c7d9620-74be-55aa-a89c-500df4e535a1","c56.9",-18999,"TCGA-04-1357_treatment","ad9e2c2c-271c-5716-a98c-7fd282c7ccfd","01",NA,"TCGA-04-1357-01A","0.6","45893b0e-301f-474a-b390-936d7d74f57e",FALSE,"D1D902A3-DF76-4623-B2E7-88FFA9E1542F","Primary Tumor","0.6",NA,NA,"1.5",1229558400,"01",100,"TCGA-04-1357-01A-01",70,90,NA,NA,0,0,50,20,"2016-09-08T13:17:05.751076-05:00","2016-09-08T13:17:05.751076-05:00",NA,50,NA,NA,"TOP","BOTTOM",0,1,"82ac1e1c-e4a7-4ff9-ab5b-bbf3cbe9ba1f","96386ac1-65c6-413e-8c0e-f3ede77e195d","TCGA-04-1357-01A-01-TS1","TCGA-04-1357-01A-01-BS1",50,79,"9365488b-2e3a-4433-86a4-ec98d186abe3","RNA","TCGA-04-1357-01A-01R","fd2b5f5e-838f-4781-aecd-76d9deef488c",1.8,0.15,"UV Spec","R","22","TCGA-04-1357-01A-01R-1565-13","ec1fc406-d1c4-4eba-ab6b-6cfb460f0862",0.15,NA,NA,NA,NA,"75777ee1-f4b0-533b-8393-cc50ca0bb327","TCGA-04-1357_exposure","TCGA-04-1357-01A-01R-1565-13_rnaseq_fastq.tar","2014-03-28T16:27:58.000Z","2014-03-28T16:57:02.000Z","CDBD6519-047B-4A9E-9A61-0BE2AF33D80A","45893B0E-301F-474A-B390-936D7D74F57E","Unaligned reads",9240064000,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EC1FC406-D1C4-4EBA-AB6B-6CFB460F0862","Canada's Michael Smith Genome Sciences Centre","564a3fcde4b0ef12181bda6b","FEDA41D8-CA56-425D-B149-4D5485328107","Ovarian Serous Cystadenocarcinoma","TAR","9365488B-2E3A-4433-86A4-EC98D186ABE3","2014-03-28T16:57:02.000Z","FD2B5F5E-838F-4781-AECD-76D9DEEF488C","None","NO",1,0.6,"Primary Tumor","Gynecologic Oncology Group",NA,"9365488B-2E3A-4433-86A4-EC98D186ABE3",0.6,"04","CELLS_p_TCGA_B13__RNA_HT_HG-U133A_96-HTA_C03_452002.level3.data.txt",NA,"TCGA-04-1357-01A",1.5,NA,"TCGA",2005,NA,NA,NA,"45893B0E-301F-474A-B390-936D7D74F57E",52,"US82800149_251976010532_S01_GE2-v5_10_Apr08.txt","Alive",NA,"TCGA-04-1357",NA,"111F374E-4892-4400-8DD3-60C2E3D4F213",NA,NA,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8441/3","FEMALE","C56.9",13,NA,NA,NA,NA,1,100,"96386AC1-65C6-413E-8C0E-F3EDE77E195D","FD2B5F5E-838F-4781-AECD-76D9DEEF488C","TCGA-04-1357-01A-01R-1565-13_GRCh37-lite_mirna.bam.bai","TCGA-04-1357-01A-01",70,0,NA,NA,50,"TOP",0,NA,"TCGA-04-1357-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Alive",NA,"TCGA-04-1357-F24009","TCGA-04-1357",NA,"04","1357","YES","C56.9","8441/3","C56.9",NA,NA,-18999,"FEMALE",NA,NA,NA,"No","Alive",NA,NA,NA,NA,NA,"NO",26,3,2009,"YES","NO","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma",NA,0,52,2005,NA,NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
182064414,168948596,12320650739,"F1A533BE-D13F-4DFF-B160-9C472EFFFEB4.bw","fef1696c-a8f4-4db6-8615-e486522baaaa","f1a533be-d13f-4dff-b160-9c472efffeb4","2016-08-23T14:49:57.622423-05:00","TCGA-24-0966-01A-01R-1564-13_rnaseq_fastq.tar","95536732-dacd-4a7d-b3c6-b255bad86614",11073832960,"Illumina HiSeq","dc92f3bee4a9b59017aea8556eafae27","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:27:48.977829-05:00","2016-05-03T11:41:05.776497-05:00","95536732-dacd-4a7d-b3c6-b255bad86614_analysis.xml","5235b728eb209b9169b7b3c50ceca246","493641ad-bbd1-47df-bd05-4040fd937d27",2208,"2016-08-28T12:37:40.083870-05:00","95536732-dacd-4a7d-b3c6-b255bad86614_experiment.xml","d68a3e36b1434d22b1c65f7502849e40","abfee9fe-edfc-41ce-b54f-261a6ae45345",3916,"2016-09-29T19:04:55.435906-05:00","95536732-dacd-4a7d-b3c6-b255bad86614_run.xml","dc79e2232ceae6fa24c65ec4394f5e8b","3ac9f357-9252-4c2a-8b76-4ab184db2710",1988,"2016-09-08T13:13:49.506919-05:00","TCGA-24-0966","2016-09-02T19:05:29.896376-05:00","female","TCGA-24-0966_demographic",1930,"black or african american","385531c7-4f02-5ce6-97f6-56ec690678d5","not hispanic or latino",NA,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","24","20a4db51-754b-5cab-81cf-9a336da9a422","Washington University","not reported","c56.9","TCGA-24-0966_diagnosis","not reported",28529,"alive","8441/3",NA,232,"6068ff26-e91d-597d-ae69-4436a0c104bb","c56.9",-28529,"TCGA-24-0966_treatment","ce67b43c-ed64-51ef-999f-c4ee5733ecb5","01",NA,"TCGA-24-0966-01A","0.7","67c7b4cb-5fe3-49cf-9aa3-df23717553bb",FALSE,"99D5CA9E-3E3F-4037-96B9-9D4A34C614B3","Primary Tumor","0.7",NA,NA,"1.3",1233705600,"01",132,"TCGA-24-0966-01A-01",95,98,NA,NA,0,0,10,5,"2016-09-08T13:13:49.506919-05:00","2016-09-08T13:13:49.506919-05:00",NA,NA,NA,NA,"BOTTOM","TOP",0,0,"a6800fb7-6124-452d-84d7-29222262792c","c31b0a81-6484-4f31-a765-008b25eb5f1e","TCGA-24-0966-01A-01-BS1","TCGA-24-0966-01A-01-TS1",90,95,"e293c072-11cc-448d-bde3-01b629ef3fc0","RNA","TCGA-24-0966-01A-01R","4c16f7f3-2328-4bf9-bc25-1cb1bb2033af",1.8,0.13,"UV Spec","R","22","TCGA-24-0966-01A-01R-1564-13","63a8de0c-927c-4faf-a596-841871ceb8f9",0.13,NA,NA,NA,NA,"6890ce1e-8c0c-5ea2-9384-45fcaa82cb1e","TCGA-24-0966_exposure","TCGA-24-0966-01A-01R-1564-13_rnaseq_fastq.tar","2014-03-28T21:05:19.000Z","2014-04-04T07:07:02.000Z","95536732-DACD-4A7D-B3C6-B255BAD86614","67C7B4CB-5FE3-49CF-9AA3-DF23717553BB","Unaligned reads",11073832960,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","63A8DE0C-927C-4FAF-A596-841871CEB8F9","Canada's Michael Smith Genome Sciences Centre","564a3399e4b0ef121817f0fa","FEF1696C-A8F4-4DB6-8615-E486522BAAAA","Ovarian Serous Cystadenocarcinoma","TAR","E293C072-11CC-448D-BDE3-01B629EF3FC0","2014-04-04T07:07:02.000Z","4C16F7F3-2328-4BF9-BC25-1CB1BB2033AF","None","NO",1,0.7,"Primary Tumor","Washington University",NA,"E293C072-11CC-448D-BDE3-01B629EF3FC0",0.7,"24","TCGA-24-0966-01A-01R-1564-13.hg19.isoform.quantification.txt",NA,"TCGA-24-0966-01A",1.3,"D59AE257-AAED-4B32-B2EE-4819C0C1F330","TCGA",2008,NA,NA,"WITH TUMOR","B8C42084-62D7-48FB-879D-A38ACC532F6F",78,"nationwidechildrens.org_biospecimen.TCGA-24-0966.xml","Alive",NA,"TCGA-24-0966","NOT HISPANIC OR LATINO","23C1520B-680F-4177-AB0B-E2188BBE2E81",NA,232,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",11,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,1,132,"C31B0A81-6484-4F31-A765-008B25EB5F1E","F927923D-2249-432B-A590-1A65F06B7CE4","C239.TCGA-24-0966-01A-01W.4.bam","TCGA-24-0966-01A-01",98,0,NA,NA,5,"TOP",0,NA,"TCGA-24-0966-01A-01-TS1",95,"paclitaxel","Chemotherapy","TCGA-24-0966-D25876",NA,NA,NA,NA,NA,232,"WITH TUMOR","Alive",NA,"TCGA-24-0966-F25875","TCGA-24-0966",NA,"24","0966","YES","C56.9","8441/3","C56.9",NA,NA,-28529,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO",NA,"No","Alive",232,NA,NA,NA,"WITH TUMOR","NO",24,2,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,78,2008,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
297400678,284913293,21077514537,"825309CC-4841-4475-BF77-8250C5EEADD8.bw","ff844242-7559-4b07-b09e-69ea40e5ac6b","825309cc-4841-4475-bf77-8250c5eeadd8","2016-09-29T21:00:33.489808-05:00","TCGA-25-1871-01A-01R-1567-13_rnaseq_fastq.tar","cb974819-1542-4ad8-aa85-b64e863e6f45",19587409920,"Illumina HiSeq","649a24625e77a6321c33d10d64b00ef1","TAR","13","Canada's Michael Smith Genome Sciences Centre","BCGSC","6eba705a-0f00-5aa2-b1d0-04dbf62100cc","bcgsc.ca","2016-09-29T19:29:43.568617-05:00","2016-05-03T11:41:05.750744-05:00","cb974819-1542-4ad8-aa85-b64e863e6f45_analysis.xml","64581a541fb6f6a111e5dd245d748422","4a6a7a84-ab59-499e-8a76-9e123f327751",2181,"2016-08-26T00:24:43.485518-05:00","cb974819-1542-4ad8-aa85-b64e863e6f45_experiment.xml","3eba4bb6d54568431b01c55d47fee33e","eb11fb55-b050-44b6-8db0-be1781c9b76f",3916,"2016-09-29T23:44:12.032469-05:00","cb974819-1542-4ad8-aa85-b64e863e6f45_run.xml","ffb602a2e92290f95d5b58ab9d6da9f9","e7e8d03b-d090-466f-a2fb-4f8d54f52daa",1989,"2016-09-08T10:38:44.270015-05:00","TCGA-25-1871","2016-09-02T18:49:49.895911-05:00","female","TCGA-25-1871_demographic",1923,"white","11b4e5ef-b402-56df-93fc-234b9948ff8a","not hispanic or latino",1995,"Ovarian Serous Cystadenocarcinoma","Ovary","TCGA-OV","Ovarian serous cystadenocarcinoma","IGC","25","009c081a-4497-58e6-b73b-0644d461bcf2","Mayo Clinic - Rochester","not reported","c56.9","TCGA-25-1871_diagnosis","not reported",25627,"dead","8441/3",760,760,"3ad77def-4237-50a7-8713-aced286f9033","c56.9",-25627,"TCGA-25-1871_treatment","cc5e28af-74cd-5bc1-90fe-341af0a76949","01",NA,"TCGA-25-1871-01A","0.5","19e1d694-4cae-4fd9-92fb-4d8395c8d75a",FALSE,"737827A6-C99E-49BE-90AD-004FE8DF11F1","Primary Tumor","0.1",NA,NA,"0.7",1247529600,"01",102,"TCGA-25-1871-01A-01",70,80,0,0,0,0,30,20,"2016-09-08T10:38:44.270015-05:00","2016-09-08T10:38:44.270015-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"5584c8b9-b703-4a7e-b2dd-c8a30454f99c","089d9b28-9918-4329-b34f-b6115a2952c4","TCGA-25-1871-01A-01-TS1","TCGA-25-1871-01A-01-BS1",70,80,"3f64feb8-5ec9-40b9-a65b-47b222af16d4","RNA","TCGA-25-1871-01A-01R","5cfe943b-bbca-440b-9855-c36bc2b01498",1.8,0.15,"UV Spec","R","22","TCGA-25-1871-01A-01R-1567-13","efcc36b2-e351-4875-b743-df58480bc9fb",0.15,NA,NA,NA,NA,"041bc297-3d03-554e-99fb-c999d7e36732","TCGA-25-1871_exposure","TCGA-25-1871-01A-01R-1567-13_rnaseq_fastq.tar","2014-03-28T07:22:15.000Z","2014-03-28T07:59:02.000Z","CB974819-1542-4AD8-AA85-B64E863E6F45","19E1D694-4CAE-4FD9-92FB-4D8395C8D75A","Unaligned reads",19587409920,"Controlled","Illumina HiSeq","TCGA-OV","RNA-Seq","Raw sequencing data","EFCC36B2-E351-4875-B743-DF58480BC9FB","Canada's Michael Smith Genome Sciences Centre","564a3a3be4b0ef12181a1179","FF844242-7559-4B07-B09E-69EA40E5AC6B","Ovarian Serous Cystadenocarcinoma","TAR","3F64FEB8-5EC9-40B9-A65B-47B222AF16D4","2014-03-28T07:59:02.000Z","5CFE943B-BBCA-440B-9855-C36BC2B01498","None","NO",1,0.1,"Primary Tumor","Mayo Clinic - Rochester",NA,"3F64FEB8-5EC9-40B9-A65B-47B222AF16D4",0.5,"25","TCGA-25-1871-01A-01R-1567-13_rnaseq_fastq.tar",NA,"TCGA-25-1871-01A",0.7,"D92A92DD-9124-458E-BC3C-4809BA6811C5","TCGA",1993,NA,NA,"WITH TUMOR","F772636B-4C9E-4518-AAF6-E00303AEEDCF",70,"nationwidechildrens.org_clinical.TCGA-25-1871.xml","Dead",760,"TCGA-25-1871","NOT HISPANIC OR LATINO","797EAE07-F777-48E4-A573-C5CBAD320184",NA,760,NA,"Ovary","C56.9",NA,"Serous Cystadenocarcinoma",NA,NA,"Stage IIIC",NA,NA,NA,"8441/3","FEMALE","C56.9",21,NA,NA,"WHITE",NA,1,102,"5584C8B9-B703-4A7E-B2DD-C8A30454F99C","6C0A8675-0EF5-4D5B-B329-478456E01ED0","TCGA-25-1871-01A-01R-1567-13_rnaseq_fastq.tar","TCGA-25-1871-01A-01",70,0,0,0,30,"TOP",0,0,"TCGA-25-1871-01A-01-TS1",70,"Carboplatin","Chemotherapy","TCGA-25-1871-D26772",NA,NA,NA,"TCGA-25-1871-F26769_NTE-2",NA,760,"WITH TUMOR","Dead",760,"TCGA-25-1871-F26769","TCGA-25-1871",NA,"25","1871","YES","C56.9","8441/3","C56.9",NA,NA,-25627,"FEMALE","WHITE","NOT HISPANIC OR LATINO",NA,"No","Dead",760,760,NA,NA,"WITH TUMOR","NO",2,6,2009,"YES","YES","NO",NA,NA,NA,"Ovary","Serous Cystadenocarcinoma","Bilateral",0,70,1993,"Tumor resection",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
